Citrus Sinensis ID: 005045
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.940 | 0.667 | 0.365 | 1e-124 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.873 | 0.610 | 0.383 | 1e-114 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.857 | 0.596 | 0.344 | 1e-105 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.899 | 0.658 | 0.326 | 3e-82 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.912 | 0.557 | 0.291 | 6e-79 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.889 | 0.535 | 0.319 | 3e-77 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.927 | 0.669 | 0.294 | 2e-73 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.860 | 0.609 | 0.313 | 4e-69 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.843 | 0.603 | 0.292 | 6e-69 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.863 | 0.495 | 0.305 | 7e-69 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 288/788 (36%), Positives = 421/788 (53%), Gaps = 114/788 (14%)
Query: 4 IMIPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPN----------- 52
I++P L N+ NY +G IPT LS+ + L + N+ G IP
Sbjct: 256 ILLPNLL---SFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLF 312
Query: 53 ------------------QLSSLTKLEIIGLGGSNLTGNVPAWIGNFSS-LKALSLAWNN 93
L++ T+LE +G+G + L G++P I N S+ L L L
Sbjct: 313 LHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTL 372
Query: 94 LRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLT 153
+ GSIP ++G L L L N +SG +P+S+ + ++ Y S+ N+L G +P +G
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIG-N 431
Query: 154 LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQN 213
+ L+ + N F G +P SL N S+L L +N L GTIP ++ L+RL+ N
Sbjct: 432 MTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGN 491
Query: 214 ELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGN 273
L D+ L+ +L L L N G++P ++ N T + L + NL +G+
Sbjct: 492 SLIGSLPQDIGALQ------NLGTLSLGDNKLSGKLPQTLGNCLT-MESLFLEGNLFYGD 544
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS--LGNLTI 331
IP + LV + + L N+LSGS+PE +KLE L L+ N G +P N T
Sbjct: 545 IP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATT 603
Query: 332 LTRLWMEENRLEGSI-----PPSLGNCQK----------------------LLVLNLSS- 363
++ + N L G I P L LL+L ++S
Sbjct: 604 VS--IVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASV 661
Query: 364 -----------NDLNGTIPK--EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL 410
+ N P EV +SY D+ +T+ FS N++G+GSFG+VYK L
Sbjct: 662 TLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALL 721
Query: 411 -GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469
+ +VA+KVL +Q++GA+KSF+ EC +LK RHRN+++++TACSS+D +GN+F+AL++
Sbjct: 722 LTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIY 781
Query: 470 EFMSNGNLDQWLHPSPAE--HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLK 527
EFM NG+LD WLHP E H + L++++RLNIAIDVAS LDYLH HC PIAHCDLK
Sbjct: 782 EFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLK 841
Query: 528 PSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSIL 586
PSNVLLD D+TAHV DFGLA+ L + + NQ S G++G+IGY PE+ + GQ SI
Sbjct: 842 PSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSIN 901
Query: 587 GDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQ 646
GD+YS+GILLLEMFTGKRPT ++F +F+++ + ALP+ ++DI+D
Sbjct: 902 GDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVD------------- 948
Query: 647 IEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706
E ++HI L V + EC V +GL C SP R+A ++VV L +IR
Sbjct: 949 --------ESILHIGLRVGF--PVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
Query: 707 NCFLEFKK 714
F + +
Sbjct: 999 ERFFKASR 1006
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 280/730 (38%), Positives = 383/730 (52%), Gaps = 104/730 (14%)
Query: 30 LSHCTELRSFEASVNDFVGQIPNQLSSL-TKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
L++C++L+ N GQ+P +++L T+L + LGG+ ++G++P IGN SL+ L
Sbjct: 348 LTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLD 407
Query: 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT 148
L N L G +P LG+LS L LY N +SG IPSS+ NIS + Y + N G +P+
Sbjct: 408 LGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPS 467
Query: 149 DVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRL 208
+G L + G N GSIP L +L VL+ + N L G + + G LK L+ L
Sbjct: 468 SLGSCSYLLDLNLGT-NKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLAL 526
Query: 209 NFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN 268
+ N+L + + LANC SLE L L NSF G +P
Sbjct: 527 DVSYNKLSGQ------IPQTLANCLSLEFLLLQGNSFVGPIP------------------ 562
Query: 269 LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP----- 323
I L L L L NNLSG++PE + +KL+ L L++N F G +P
Sbjct: 563 --------DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVF 614
Query: 324 ------SSLGNLTI--------LTRLWMEENRLEGSIPPSLGNC---------------- 353
S GN+ + L +E R S+ + C
Sbjct: 615 RNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVV 674
Query: 354 ----QKLLVLNLSSND---LNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVY 406
KL V ++ +N+ P + +SY ++ K+T FS NLIG+G+FG+V+
Sbjct: 675 YLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVF 734
Query: 407 KGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465
KG LG VAIKVL L ++GA KSFI EC AL RHRN+++++T CSS D EGNDF+
Sbjct: 735 KGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFR 794
Query: 466 ALVFEFMSNGNLDQWLHPSPAEHY--QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523
ALV+EFM NGNLD WLHP E + L + RLNIAIDVASAL YLH +C PIAH
Sbjct: 795 ALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAH 854
Query: 524 CDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQ 582
CD+KPSN+LLDKD+TAHV DFGLA+ L + + Q S G++G+IGY PE+ M G
Sbjct: 855 CDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGH 914
Query: 583 VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD-HVMDILDPSMPLDEE 641
SI+GD+YS+GI+LLE+FTGKRPT +F D ++H F AL +DI D
Sbjct: 915 PSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITD-------- 966
Query: 642 NDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701
E I H ++ EC V R+G+ CS SP RI+M ++
Sbjct: 967 -------ETILRGAYAQHFNMV--------ECLTLVFRVGVSCSEESPVNRISMAEAISK 1011
Query: 702 LKTIRNCFLE 711
L +IR F
Sbjct: 1012 LVSIRESFFR 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-105, Method: Compositional matrix adjust.
Identities = 253/734 (34%), Positives = 369/734 (50%), Gaps = 119/734 (16%)
Query: 30 LSHCTELRSFEASVNDFVGQIPNQLSSL-TKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
+++CT+L + N G++P +++L T L + LG + ++G +P IGN SL+ LS
Sbjct: 340 VANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELS 399
Query: 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT 148
L N L G +P G+L L LY N ISG IPS N++ + + N HG++P
Sbjct: 400 LETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQ 459
Query: 149 DVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRL 208
+G L ++ N G+IP + +L +D + N LTG P G L+ LV L
Sbjct: 460 SLGRCRYLLDLWMD-TNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGL 518
Query: 209 NFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN 268
N+L + + + C S+E L + NSF G +P
Sbjct: 519 GASYNKLSGK------MPQAIGGCLSMEFLFMQGNSFDGAIP------------------ 554
Query: 269 LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS--- 325
I LV+L + NNLSG +P + L L L L++NKF G +P++
Sbjct: 555 --------DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVF 606
Query: 326 --------LGNLTILTRLWMEENRLEGSIPPS-------------------LGNCQKLLV 358
GN I + E +L+ I + +G LL+
Sbjct: 607 RNATAVSVFGNTNICG--GVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLI 664
Query: 359 LNLSS----------NDLNGTIPKEVRQSGM-----SYSDISKSTDNFSKENLIGTGSFG 403
+ ++S N+ + P + GM SY ++ +T FS NLIG+G+FG
Sbjct: 665 IIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFG 724
Query: 404 SVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462
+V+KG LG + +VA+KVL L + GA KSF+ EC K RHRN++++IT CSS+D EGN
Sbjct: 725 NVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGN 784
Query: 463 DFKALVFEFMSNGNLDQWLHPSPAEHY--QFKKLSVIQRLNIAIDVASALDYLHHHCDTP 520
DF+ALV+EFM G+LD WL E + L+ ++LNIAIDVASAL+YLH HC P
Sbjct: 785 DFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDP 844
Query: 521 IAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-M 579
+AHCD+KPSN+LLD D+TAHV DFGLA+ L++ NQ S G++G+IGY PE+ M
Sbjct: 845 VAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGM 904
Query: 580 NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLD 639
GQ SI GD+YS+GILLLEMF+GK+PT + F D+++H + L
Sbjct: 905 GGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCT----------- 953
Query: 640 EENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699
N ++E VL++G+ CS PR+R+ + V
Sbjct: 954 -----------------------SSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAV 990
Query: 700 NNLKTIRNCFLEFK 713
L +IR+ F K
Sbjct: 991 RELISIRSKFFSSK 1004
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 230/705 (32%), Positives = 356/705 (50%), Gaps = 60/705 (8%)
Query: 14 DLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN 73
++L N + G IP +S+ L S N G IP +L L+KLE + L ++LTG
Sbjct: 301 QIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGE 360
Query: 74 VPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133
+P +G+ L L ++ NNL GSIP+ G LS L LYGN +SG +P S+ ++
Sbjct: 361 IPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLE 420
Query: 134 YFSVTQNQLHGQLPTDVGLTLPNLKIFAG-AVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
++ N L G +P +V L NLK++ + N+ +G IP+ LS + +D + N L+
Sbjct: 421 ILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELS 480
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
G IP GS L LN +N S L L +L L ++ N G +P S
Sbjct: 481 GKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKE------LDVSFNRLTGAIPPS 534
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL-SGSVPEVIGRLNKLEGL 311
ST L+ L NL+ GN+ G+ L + G++L GS+ + K +
Sbjct: 535 FQQSST-LKHLNFSFNLLSGNVS-DKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYP 592
Query: 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371
+ + LI + + L + ++ +R + L K V + + N P
Sbjct: 593 SVLLPVLLSLIATPV--LCVFGYPLVQRSRFGKN----LTVYAKEEVEDEEKQNQND--P 644
Query: 372 KEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALK- 430
K R +SY + +T F+ +LIG+G FG VYKG L + T VA+KVL + AL+
Sbjct: 645 KYPR---ISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL--DPKTALEF 699
Query: 431 --SFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH 488
SF EC LK TRHRN++R+IT CS F ALV M NG+L++ L+P
Sbjct: 700 SGSFKRECQILKRTRHRNLIRIITTCSKPG-----FNALVLPLMPNGSLERHLYPG---E 751
Query: 489 YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
Y K L +IQ +NI DVA + YLHH+ + HCDLKPSN+LLD +MTA V DFG+++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 549 FLFEISDNPSKNQTVSIG-----LKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTG 602
+ + + S + +VS G L GS+GYI PE+ M + S GD+YS+G+LLLE+ +G
Sbjct: 812 LVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMP-LDEENDEEQIEEVIEEKEMMIHID 661
+RPT + + S+H F+ PD + I++ ++ + E+ E++
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKL----------- 920
Query: 662 LEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706
E + ++ +GL+C+ +P R M V + + ++
Sbjct: 921 --------WREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 227/778 (29%), Positives = 372/778 (47%), Gaps = 124/778 (15%)
Query: 15 LNLTY-----NYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN 69
+NLT+ N+ +G+IP ++ +C+ L + + N+ G + + L KL I+ + ++
Sbjct: 431 MNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNS 490
Query: 70 LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
LTG +P IGN L L L N G IP E+ L+ L +Y N + G IP ++++
Sbjct: 491 LTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDM 550
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+ ++ N+ GQ+P L +L + N F GSIP SL + S L D ++N
Sbjct: 551 KLLSVLDLSNNKFSGQIPALFS-KLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDN 609
Query: 190 GLTGTIPGNF-GSLKDL-VRLNFDQNELGS---REIGDLNFL---------------KFL 229
LTGTIPG SLK++ + LNF N L +E+G L + + L
Sbjct: 610 LLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSL 669
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
C ++ L ++N+ G +P + + L + N G IP GN+ +L L L
Sbjct: 670 QACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDL 729
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS 349
NNL+G +PE + L+ L+ L L N G +P S I M L GS P
Sbjct: 730 SSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKP- 788
Query: 350 LGNCQ------------KLLVLNLSS-------------------------NDLNGTIP- 371
L C +++++ L S N ++P
Sbjct: 789 LKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPD 848
Query: 372 --KEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL 429
++ ++ ++TD+F+ N+IG+ S +VYKG L DGT++A+KVL L++ A
Sbjct: 849 LDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAE 908
Query: 430 --KSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE 487
K F E L +HRN+++++ E KALV FM NGNL+ +H S A
Sbjct: 909 SDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAP 964
Query: 488 HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
S+++++++ + +AS +DYLH PI HCDLKP+N+LLD D AHV DFG A
Sbjct: 965 IG-----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTA 1019
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ L D + T + +G+IGY+ PE +M +V+ D++S+GI+++E+ T +RP
Sbjct: 1020 RILGFREDGSTTASTSA--FEGTIGYLAPEFAYMR-KVTTKADVFSFGIIMMELMTKQRP 1076
Query: 606 TGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEE------KEMMIH 659
T S++ DE++ + + +++E+ K M+
Sbjct: 1077 T--------SLN---------------------DEDSQDMTLRQLVEKSIGNGRKGMVRV 1107
Query: 660 IDLEVN---TKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR---NCFLE 711
+D+E+ K EE L++ L C+++ P +R MN ++ +L +R N F E
Sbjct: 1108 LDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGKANSFRE 1165
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 247/773 (31%), Positives = 366/773 (47%), Gaps = 135/773 (17%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ L L+ N L+G+IP + T L + N F G+IP +L T L + LG +NL G
Sbjct: 475 KRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQG 534
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPN---------ELGQLSGL---GFFTLYGNFISG 120
+P I + L+ L L++NNL GSIP+ E+ LS L G F L N +SG
Sbjct: 535 QIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSG 594
Query: 121 IIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASN 180
IP + + S++ N L G++P + L NL I + N TGSIP + N+
Sbjct: 595 PIPEELGECLVLVEISLSNNHLSGEIPASLS-RLTNLTILDLSGNALTGSIPKEMGNSLK 653
Query: 181 LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN--------- 231
LQ L+ A N L G IP +FG L LV+LN +N+L L LK L +
Sbjct: 654 LQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLS 713
Query: 232 -------CTSLEVLGL--ARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV 282
T +++GL +N F GE+P + NL T L L + ENL+ G IP I L
Sbjct: 714 GELSSELSTMEKLVGLYIEQNKFTGEIPSELGNL-TQLEYLDVSENLLSGEIPTKICGLP 772
Query: 283 NLNLLGLEGNNLSGSVP---------------------EVIGRLNKLEGLGL-NVNKFSG 320
NL L L NNL G VP V+G K+EG L + +G
Sbjct: 773 NLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAG 832
Query: 321 LIPSSLGNLTIL------TRLW--------------MEENRLEGSIPPSLGNCQKLLVLN 360
L+ LG I+ R W MEE+RL+G + Q L L+
Sbjct: 833 LM---LGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVD------QNLYFLS 883
Query: 361 LSSNDLNGTIPKEVRQSGM---SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVA 417
S + +I + + + DI ++TD+FSK+N+IG G FG+VYK L VA
Sbjct: 884 GSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVA 943
Query: 418 IKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL 477
+K L + + F+ E L +H N++ ++ CS ++ K LV+E+M NG+L
Sbjct: 944 VKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSF-----SEEKLLVYEYMVNGSL 998
Query: 478 DQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537
D WL + + L +RL IA+ A L +LHH I H D+K SN+LLD D
Sbjct: 999 DHWLR---NQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDF 1055
Query: 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILL 596
V DFGLA+ + + VS + G+ GYIPPE+ + + + GD+YS+G++L
Sbjct: 1056 EPKVADFGLARLISACESH------VSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVIL 1109
Query: 597 LEMFTGKRPTGDMFKDDFSIHMFVSMALPD----HVMDILDPSMPLDEENDEEQIEEVIE 652
LE+ TGK PTG FK+ ++ V A+ +D++DP
Sbjct: 1110 LELVTGKEPTGPDFKESEGGNL-VGWAIQKINQGKAVDVIDP------------------ 1150
Query: 653 EKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
+++ + L+ N++ +L L+I ++C +P +R M V+ LK I
Sbjct: 1151 ---LLVSVALK-NSQLRL-------LQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 232/789 (29%), Positives = 356/789 (45%), Gaps = 124/789 (15%)
Query: 14 DLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN 73
DL LT++ L G+IP ++ + L + + ++N G+IP + L + I L + L+G
Sbjct: 224 DLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGK 283
Query: 74 VPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF----------------------- 110
+P IGN + L+ ++ NNL G +P ++ L + F
Sbjct: 284 LPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDVVALNPNLVE 343
Query: 111 FTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
F ++ N +G +P ++ S I F V+ N+ G+LP + KI + N +G
Sbjct: 344 FKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFS-NQLSGE 402
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQN---------------EL 215
IP S + +L + A+N L+G +P F L L RL N L
Sbjct: 403 IPESYGDCHSLNYIRMADNKLSGEVPARFWELP-LTRLELANNNQLQGSIPPSISKARHL 461
Query: 216 GSREIGDLNFLKF----LANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
EI NF L + L V+ L+RNSF G +P I L +L R+ M EN++
Sbjct: 462 SQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLK-NLERVEMQENMLD 520
Query: 272 GNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI 331
G IP + + L L L N L G +P +G L L L L+ N+ +G IP+ L L
Sbjct: 521 GEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLK- 579
Query: 332 LTRLWMEENRLEGSIP---------PS-LGN-------------CQK------------- 355
L + + +N+L G IP PS LGN C+
Sbjct: 580 LNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILPISIL 639
Query: 356 --------LLVLNLSSNDLNGTIPKEV------RQSGMSYSDISKSTDNFSKENLIGTGS 401
L+ L + + L PK ++ G + DI +++N+IG+G
Sbjct: 640 CIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEEDIYPQ---LTEDNIIGSGG 696
Query: 402 FGSVYKGTLGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458
G VY+ L G +A+K L Q+ + F E L RH NI++++ C+
Sbjct: 697 SGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCN--- 753
Query: 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518
G +F+ LV+EFM NG+L LH S EH L R +IA+ A L YLHH
Sbjct: 754 --GEEFRFLVYEFMENGSLGDVLH-SEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSV 810
Query: 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH 578
PI H D+K +N+LLD +M V DFGLAK L + DN + + GS GYI PE+
Sbjct: 811 PPIVHRDVKSNNILLDHEMKPRVADFGLAKPL-KREDNDGVSDVSMSCVAGSYGYIAPEY 869
Query: 579 -MNGQVSILGDIYSYGILLLEMFTGKRPTGDMF---KDDFSIHMFVSMALPDHVMDILDP 634
+V+ D+YS+G++LLE+ TGKRP F KD M ++ P + D
Sbjct: 870 GYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAE--DG 927
Query: 635 SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694
+M D + + ++++ K + L ++E+ VL + L+C+++ P R
Sbjct: 928 AMNQDSLGNYRDLSKLVDPK-----MKLSTREYEEIEK----VLDVALLCTSSFPINRPT 978
Query: 695 MNVVVNNLK 703
M VV LK
Sbjct: 979 MRKVVELLK 987
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 224/715 (31%), Positives = 339/715 (47%), Gaps = 98/715 (13%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q L L N LSG++P++L + L+ + S N F G+IP+ L + L + L + TG
Sbjct: 335 QVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTG 394
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+PA + SL + + N L GSIP G+L L L GN +SG IP I + S+
Sbjct: 395 QIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSL 454
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+ ++NQ+ LP+ + L++ NL+ F A N+ +G +P + +L LD + N LT
Sbjct: 455 SFIDFSRNQIRSSLPSTI-LSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLT 513
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
GTIP + S + LV LN N L + EI + + ++L VL L+ NS G +P S
Sbjct: 514 GTIPSSIASCEKLVSLNLRNNNL-TGEIP-----RQITTMSALAVLDLSNNSLTGVLPES 567
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN-LSGSVPEVIGRLNK---- 307
I S L L + N + G +P+ G L +N L GN+ L G V + +
Sbjct: 568 IGT-SPALELLNVSYNKLTGPVPIN-GFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSS 625
Query: 308 ---LEGLGLNVNKFSGLIPS-SLGNLTILTRL----WM------EENRLEGSIPPSLGNC 353
L G + G+ +LG LTI+TR W +E +G P L
Sbjct: 626 HSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAF 685
Query: 354 QKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-D 412
+L G + SDI + N+IG G+ G VYK +
Sbjct: 686 HRL---------------------GFTASDILAC---IKESNMIGMGATGIVYKAEMSRS 721
Query: 413 GTIVAIKVLKLQ----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468
T++A+K L + G F+ E N L RHRNI+R++ L + +V
Sbjct: 722 STVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGF-----LYNDKNMMIV 776
Query: 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528
+EFM NGNL +H A + + R NIA+ VA L YLHH C P+ H D+K
Sbjct: 777 YEFMLNGNLGDAIHGKNAAGRLL--VDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKS 834
Query: 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILG 587
+N+LLD ++ A + DFGLA+ + K +TVS+ + GS GYI PE+ +V
Sbjct: 835 NNILLDANLDARIADFGLARMMAR------KKETVSM-VAGSYGYIAPEYGYTLKVDEKI 887
Query: 588 DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQI 647
DIYSYG++LLE+ TG+RP F + I +V + D++ +
Sbjct: 888 DIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNI-----------------SL 930
Query: 648 EEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702
EE +D V ++E + VL+I L+C+T P++R +M V++ L
Sbjct: 931 EEA---------LDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 230/787 (29%), Positives = 334/787 (42%), Gaps = 182/787 (23%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN--- 69
+ L+L NY SGKIP L S N+ G+IP ++ +LT L + +G N
Sbjct: 169 RHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFE 228
Query: 70 ----------------------LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSG 107
LTG +P IG L L L N G+I ELG +S
Sbjct: 229 NGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISS 288
Query: 108 LGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYF 167
L L N +G IP+S + ++ ++ +N+L+G +P +G +P L++ N F
Sbjct: 289 LKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIG-EMPELEVLQLWENNF 347
Query: 168 TGSIPVSLSNASNLQVLDFAENGLTGTIPGN-----------------FGSLKD------ 204
TGSIP L L +LD + N LTGT+P N FGS+ D
Sbjct: 348 TGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCE 407
Query: 205 -LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRL 263
L R+ +N L + K L L + L N GE+PIS +S L ++
Sbjct: 408 SLTRIRMGENFLNG------SIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQI 461
Query: 264 TMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL------------------ 305
++ N + G++P IGNL + L L+GN SGS+P IGRL
Sbjct: 462 SLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIA 521
Query: 306 ----------------NKLEG--------------LGLNVNKFSGLIPSSLGNLTILTRL 335
N+L G L L+ N G IP ++ ++ LT +
Sbjct: 522 PEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSV 581
Query: 336 WMEENRLEGSIP---------------------PSLGNCQK------------------- 355
N L G +P P LG C K
Sbjct: 582 DFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLV 641
Query: 356 ----------LLVLNLSSNDL-NGTIPKEVRQSGMSYSDIS--KSTDNFSKENLIGTGSF 402
+V + + L N + K R + D + D+ ++N+IG G
Sbjct: 642 LGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGA 701
Query: 403 GSVYKGTLGDGTIVAIKVLKLQQQGALKS--FIDECNALKSTRHRNILRVITACSSVDLE 460
G VYKGT+ G +VA+K L G+ F E L RHR+I+R++ CS+
Sbjct: 702 GIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN---- 757
Query: 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP 520
++ LV+E+M NG+L + LH H + R IA++ A L YLHH C
Sbjct: 758 -HETNLLVYEYMPNGSLGEVLHGKKGGHLHWNT-----RYKIALEAAKGLCYLHHDCSPL 811
Query: 521 IAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN 580
I H D+K +N+LLD + AHV DFGLAKFL + S + GS GYI PE+
Sbjct: 812 IVHRDVKSNNILLDSNFEAHVADFGLAKFLQD-----SGTSECMSAIAGSYGYIAPEYAY 866
Query: 581 G-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL---PDHVMDILD--- 633
+V D+YS+G++LLE+ TGK+P G+ F D I +V D V+ ++D
Sbjct: 867 TLKVDEKSDVYSFGVVLLELITGKKPVGE-FGDGVDIVQWVRSMTDSNKDCVLKVIDLRL 925
Query: 634 PSMPLDE 640
S+P+ E
Sbjct: 926 SSVPVHE 932
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 217/711 (30%), Positives = 326/711 (45%), Gaps = 92/711 (12%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L L N L+GKIP L EL + S N G IP QL KL I L + L+G +
Sbjct: 604 LRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPI 663
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134
P W+G S L L L+ N S+P EL + L +L GN ++G IP I N+ ++
Sbjct: 664 PPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV 723
Query: 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQ-VLDFAENGLTG 193
++ +NQ G LP +G L L + N TG IPV + +LQ LD + N TG
Sbjct: 724 LNLDKNQFSGSLPQAMG-KLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTG 782
Query: 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253
IP G+L + LE L L+ N GE+P S+
Sbjct: 783 DIPSTIGTL------------------------------SKLETLDLSHNQLTGEVPGSV 812
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL---NKLEG 310
++ + L L + N + G + + LG G L GS R+ NK +G
Sbjct: 813 GDMKS-LGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG--LCGSPLSRCNRVRSNNKQQG 869
Query: 311 LGLN----VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
L ++ S L +++G + ++ L+ ++ R + G+ + S
Sbjct: 870 LSARSVVIISAISAL--TAIGLMILVIALFFKQ-RHDFFKKVGHGSTAYTSSSSSSQATH 926
Query: 367 NGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIK-VLKLQQ 425
+S + + DI ++T N S+E +IG+G G VYK L +G VA+K +L
Sbjct: 927 KPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDD 986
Query: 426 QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHP-S 484
+ KSF E L RHR++++++ CSS + L++E+M NG++ WLH
Sbjct: 987 LMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDK 1043
Query: 485 PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544
P + K L RL IA+ +A ++YLHH C PI H D+K SNVLLD +M AH+GDF
Sbjct: 1044 PVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDF 1103
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGK 603
GLAK L E D + + T S GYI PE+ + + D+YS GI+L+E+ TGK
Sbjct: 1104 GLAKVLTENCDTNTDSNT---WFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGK 1160
Query: 604 RPTGDMFKDDFSI------HMFVSMALPDHVMD-ILDPSMPLDEENDEEQIEEVIEEKEM 656
PT +F + + H+ V+ + D ++D L P +P +
Sbjct: 1161 MPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE----------------- 1203
Query: 657 MIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707
E+ VL I L C+ TSP+ER + ++L + N
Sbjct: 1204 --------------EDAACQVLEIALQCTKTSPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| 255576770 | 851 | serine-threonine protein kinase, plant-t | 0.956 | 0.806 | 0.441 | 1e-165 | |
| 224139072 | 970 | predicted protein [Populus trichocarpa] | 0.979 | 0.723 | 0.416 | 1e-160 | |
| 449483694 | 1005 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.688 | 0.390 | 1e-145 | |
| 218185336 | 828 | hypothetical protein OsI_35297 [Oryza sa | 0.945 | 0.818 | 0.394 | 1e-143 | |
| 449440269 | 1041 | PREDICTED: probable LRR receptor-like se | 0.962 | 0.662 | 0.407 | 1e-142 | |
| 296088096 | 715 | unnamed protein product [Vitis vinifera] | 0.854 | 0.857 | 0.425 | 1e-142 | |
| 357505893 | 1003 | Receptor kinase-like protein [Medicago t | 0.942 | 0.673 | 0.414 | 1e-141 | |
| 297819322 | 919 | hypothetical protein ARALYDRAFT_347815 [ | 0.942 | 0.735 | 0.378 | 1e-140 | |
| 449483698 | 1099 | PREDICTED: probable LRR receptor-like se | 0.962 | 0.627 | 0.403 | 1e-140 | |
| 302142240 | 869 | unnamed protein product [Vitis vinifera] | 0.931 | 0.768 | 0.396 | 1e-138 |
| >gi|255576770|ref|XP_002529272.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223531261|gb|EEF33104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 324/734 (44%), Positives = 469/734 (63%), Gaps = 48/734 (6%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q L L N G+IP+NLSHC+ L N VG+IP +LS+L+ L + + G+ +G
Sbjct: 132 QVLRLENNSFEGEIPSNLSHCSNLFFLRLGYNKLVGKIPVELSTLSNLIRLSIIGNYFSG 191
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+P +GN SSL+ + N L G+IP G+L L + L+GN +SG P+SIYN+SSI
Sbjct: 192 GIPPSLGNLSSLEVFAADGNLLDGTIPESFGKLKYLAYIGLHGNKLSGTFPASIYNLSSI 251
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+ V+ N LHG +P+++GL LP+L+ N+F+GSIPVSLSNAS L +D N T
Sbjct: 252 IFLLVSDNLLHGSIPSNIGLQLPHLQELEMWGNHFSGSIPVSLSNASELVYVDLGTNNFT 311
Query: 193 GTI-PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251
G + +FG L+ L L QN LGS + DL+F+ L N TS L L+ N G P
Sbjct: 312 GKVLSAHFGGLRHLSHLALYQNSLGSNKDDDLDFITSLLNSTSFVFLDLSTNQLEGAFPN 371
Query: 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGL 311
S+ANLS+ L+ L++G+N +HG +P + LV+L+ L ++ N ++GS+P +G+L L +
Sbjct: 372 SVANLSSPLQWLSLGQNRIHGRLPSWLSGLVSLSRLSIQFNQITGSIPSDMGKLQNLYSM 431
Query: 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTI- 370
+ N+ +G+IPSS+GNL+ L L + +N L G+IP SLGNC +L+ ++LS N+LNG+I
Sbjct: 432 FFDHNRLTGIIPSSIGNLSFLNLLHLNDNNLHGTIPSSLGNCHELVFIDLSQNNLNGSIS 491
Query: 371 ----------------PK-EVRQSGM--------SYSDISKSTDNFSKENLIGTGSFGSV 405
PK EV + SY I K+T+ FS E+LIG GSFGSV
Sbjct: 492 DQLFALPTFFYCWFQHPKTEVVSDTLVLKSLEEVSYKSILKATNGFSAESLIGAGSFGSV 551
Query: 406 YKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464
YK L DG +AIKVL LQ +GA KSF+ EC ALKS RHRN++++IT+C+S+D +GNDF
Sbjct: 552 YKVILDEDGPALAIKVLNLQHRGASKSFMAECEALKSIRHRNLVKIITSCTSIDFQGNDF 611
Query: 465 KALVFEFMSNGNLDQWLHPSPA---EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521
KALV+E+M NGNL+ WLH ++ LS++QR++IAID+ +ALDYLHH C+ PI
Sbjct: 612 KALVYEYMPNGNLENWLHLGSGIGVAPFETNSLSLLQRIDIAIDIGNALDYLHHQCERPI 671
Query: 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MN 580
HCDLKPSNVLLD DM AH+GDFGLAKFL +++ NP+ Q+ S+G++G+IGY PPE+ +
Sbjct: 672 IHCDLKPSNVLLDIDMVAHIGDFGLAKFLPQLA-NPA--QSSSMGVRGTIGYAPPEYGLG 728
Query: 581 GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDE 640
+VS GD+YSYGILLLEM TGK+PT D F + ++H MALPD V +I+DP + +
Sbjct: 729 SEVSTSGDVYSYGILLLEMMTGKKPTDDNFTGNHNLHSICRMALPDEVSEIVDPILLQGD 788
Query: 641 ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700
E + Q +E + +C +S++++G+ CS SP++R+ ++ +
Sbjct: 789 ETNNNQGS-------------MEPKAADSKVKCLISMIKVGIACSMESPQDRMDISNALT 835
Query: 701 NLKTIRNCFLEFKK 714
NL I++ ++ ++
Sbjct: 836 NLHYIKSNYIRTRE 849
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139072|ref|XP_002322973.1| predicted protein [Populus trichocarpa] gi|222867603|gb|EEF04734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1471), Expect = e-160, Method: Compositional matrix adjust.
Identities = 365/876 (41%), Positives = 480/876 (54%), Gaps = 174/876 (19%)
Query: 6 IPEHL----MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLE 61
+PE L Q +N+T+N GKIP NL++CTEL F +VN F G+IP+QLSSLTKL
Sbjct: 93 LPEELGRLSRLQHINVTFNSFGGKIPANLTYCTELTVFSVAVNKFTGEIPHQLSSLTKLV 152
Query: 62 IIGLGGSNLTGN------------------------------------------------ 73
+ GG+N TG+
Sbjct: 153 FLHFGGNNFTGSIPSWIGNFSSLSSLSLPLNNLRGSIPNELGQLTGLGYFQVYGIYLSGP 212
Query: 74 VPAWIGNFSSLKALSLAWNNLRGSIPNELGQLS------------------GLGFFTLYG 115
+P + N S L+ L + N L G+IP LG L GL F +
Sbjct: 213 IPVSLSNASRLQILDFSINGLTGTIPKNLGSLKSLVRLNFDLNNLGNGEVDGLNFLSSLA 272
Query: 116 NFIS------------GIIPSSIYNISS-IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG 162
N S G + +SI N+S+ + ++ QN +HG +P ++ + +
Sbjct: 273 NCTSLEVLGLSENNFGGELHNSIGNLSTQLKILTLGQNLIHGNIPAEIENLVNLNLLGLE 332
Query: 163 AVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGD 222
NY TGS+P + L+ L N +G+IP G+L L RL ++N +
Sbjct: 333 G-NYLTGSVPDLIGKQKKLEGLHLHVNRFSGSIPSALGNLTRLTRLFLEENRF------E 385
Query: 223 LNFLKFLANCTSL----------------EVLG---------LARNSFGGEMPISIANLS 257
N L NC SL EVLG ++ NS G + + + NL
Sbjct: 386 GNIPSSLGNCKSLQNLNLSSNNLNGTIPEEVLGLSSLSISLVMSNNSLTGSLSLKVGNLH 445
Query: 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNK 317
+L L + N + G IP +G+ ++L L LEGN G +PE + L LE L L+ N
Sbjct: 446 -NLVELDISGNKLSGTIPSTLGSCISLERLHLEGNKFEGPIPESLETLRGLEELDLSENN 504
Query: 318 FSGLIPSSLGNLTILTRLWMEENRLEGSI------------------------------P 347
+G +P LG ++L L + N LEG + P
Sbjct: 505 LTGRVPEFLGGFSVLRHLNLSHNNLEGEVSRDGILANASAFSVVGNDKLCGGIPELHLPP 564
Query: 348 PSLGNCQK------------------LLVLNLSSNDLNGTIPK-------EVRQSGMSYS 382
S N ++ +L+ +LS + +P+ E +Q G+SYS
Sbjct: 565 CSRKNPREPLSFKVVIPATIAAVFISVLLCSLSIFCIRRKLPRNSNTPTPEEQQVGISYS 624
Query: 383 DISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKS 441
++ KST+ F+ ENLIG+GSFGSVYKG L G+GTIVAIK++ L Q+GA KSFIDECNAL+S
Sbjct: 625 ELIKSTNGFAAENLIGSGSFGSVYKGILSGEGTIVAIKIMNLLQKGASKSFIDECNALRS 684
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
RHRN+L++ITACS+VD +GNDFK LVFEFMSNGNLDQWLHP+ + Y+ KKLS QRLN
Sbjct: 685 IRHRNLLKIITACSTVDHQGNDFKGLVFEFMSNGNLDQWLHPTTEQQYRTKKLSFTQRLN 744
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
IAIDVASALDYLHH C T I HCDLKPSNVLLD DMTAHVGDF LAKFL E S NPS NQ
Sbjct: 745 IAIDVASALDYLHHQCKTTIVHCDLKPSNVLLDDDMTAHVGDFELAKFLSEASKNPSINQ 804
Query: 562 TVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
++S+ LKGSIGYIPPE+ M +VS+LGDIYSYGILLLEMFTGKRPT DMF+ D +IH F
Sbjct: 805 SISVALKGSIGYIPPEYGMRSEVSVLGDIYSYGILLLEMFTGKRPTDDMFEGDLNIHKFA 864
Query: 621 SMALPDHVMDILDPSM-PLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679
MA P +VM I+DPSM +E N+ E E IEE+ ++ + D +VN + +EEC VS++
Sbjct: 865 DMAFPGNVMAIIDPSMLAEEEINENEVNEHGIEERAIIHNNDFQVNRTSNIEECLVSLME 924
Query: 680 IGLMCSTTSPRERIAMNVVVNNLKTIRNCFLEFKKR 715
IGL CS SP +R+AMN+VVN L+ IR+ F R
Sbjct: 925 IGLSCSNKSPGKRMAMNIVVNKLQVIRDSFFRSINR 960
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483694|ref|XP_004156662.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 352/902 (39%), Positives = 464/902 (51%), Gaps = 210/902 (23%)
Query: 18 TYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN-------- 69
++N G+I +N+SHCTEL E S N+FVGQIP+Q +L+KLE IG GG+N
Sbjct: 106 SFNNFDGEIASNISHCTELLVLELSRNEFVGQIPHQFFTLSKLERIGFGGNNLVGTIPPW 165
Query: 70 ----------------------------------------LTGNVPAWIGNFSSLKALSL 89
LTG VP I N +SL SL
Sbjct: 166 IGNFSSLFSLSFALNSFQGSIPSELGRLSRLKLFSVYGNYLTGTVPPSIYNITSLTYFSL 225
Query: 90 AWNNLRGSIPNELG-QLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT 148
N LRG++P ++G L L F N G IP+S+ NIS + +N L G LP
Sbjct: 226 TQNRLRGTLPPDVGFTLPNLQVFAGGVNNFGGPIPTSLANISGLQVLDFAENSLIGTLPH 285
Query: 149 DVG----------------------------------------------LTLP------- 155
D+G TLP
Sbjct: 286 DLGNLKELVRFNFDDNRLGSGKVDDLNVIRSLTNCTSLSVLGLSGNRFGGTLPLSISNLS 345
Query: 156 -NLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNE 214
L I N +G IPV + N NLQ+L N L G++P N G L L + N+
Sbjct: 346 NQLTILTLGRNLLSGGIPVGIDNLINLQLLGVEGNNLNGSVPSNIGKFHKLAALYVNNNK 405
Query: 215 LGS---REIGDLNFLK---------------FLANCTSLEVLGLARNSFGGEMPISIANL 256
L IG+L+ L L C L+VL L+ N+ G +P + +L
Sbjct: 406 LSGTIPSSIGNLSLLTKLFMEDNRLEGSIPPSLGQCKRLQVLDLSGNNLSGTIPKEVLSL 465
Query: 257 STHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR------------ 304
S+ L + N + G +P +G+LV+L LL + N LSG +P +G+
Sbjct: 466 SSLSIYLALNHNALTGPLPREVGDLVSLTLLDVSQNKLSGGIPSNLGKCISMVHLYLGGN 525
Query: 305 ------------LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS--- 349
L LE L L+ N G IP LGNL L L + N +G +
Sbjct: 526 QFEGTIPESLKALKGLEELNLSSNNLFGPIPQFLGNLFSLKFLDLSYNNFKGKVAKEGIF 585
Query: 350 --------LGN---CQKLLVLNLSSNDLNGT------------IP--------------- 371
LGN C L L+L S N T IP
Sbjct: 586 SNSTMFSILGNNNLCDGLEELHLPSCTSNRTRLSNKLLTPKVLIPVVSTLTFLVISLSIL 645
Query: 372 ------KEVRQ------------SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GD 412
K+ R+ S +SY ++++ST+ FS ENLIG+GSFGSVYKG L +
Sbjct: 646 SVFFMMKKSRKNVLTSAGSLDLLSQISYLELNRSTNGFSVENLIGSGSFGSVYKGILLNN 705
Query: 413 GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472
+VA+KV+ LQQ GA KSF+DEC+ L + RHRN+L++IT+CSS D EGN+FKA+VF+FM
Sbjct: 706 KPVVAVKVINLQQHGASKSFVDECSTLTNIRHRNLLKIITSCSSTDEEGNEFKAIVFDFM 765
Query: 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532
SNGNLD WLHP+ E+ + +KLS IQRL+IAIDVA+ALDYLH+HC+TPI HCDLKPSNVL
Sbjct: 766 SNGNLDSWLHPTHVENNK-RKLSFIQRLDIAIDVANALDYLHNHCETPIVHCDLKPSNVL 824
Query: 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYS 591
LD DM AHVGDFGLA+F+ E S++ QT+SI LKGSIGYIPPE+ G +SI GDI+S
Sbjct: 825 LDDDMVAHVGDFGLARFILEGSNHSVSRQTMSIALKGSIGYIPPEYGTGGNISIEGDIFS 884
Query: 592 YGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEE--NDEEQIEE 649
YGILLLEMFTGKRPT +F D IH+F +M LP V+DI+D S+ L EE E + E+
Sbjct: 885 YGILLLEMFTGKRPTDSLFSDGVDIHLFTAMTLPHGVLDIVDHSL-LSEETCQQEAENEK 943
Query: 650 VIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCF 709
I+ +M D + ++EE VS++RIGL CS+T+PRER+ MN+VV L+TI+ +
Sbjct: 944 KIQTIAIMSEEDQSGVGQRRMEEYLVSIMRIGLSCSSTTPRERMPMNIVVKKLQTIKCSY 1003
Query: 710 LE 711
E
Sbjct: 1004 HE 1005
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218185336|gb|EEC67763.1| hypothetical protein OsI_35297 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 300/761 (39%), Positives = 437/761 (57%), Gaps = 83/761 (10%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q L L+YN L G+IP +L++C+ LRS N+ VG+IPN L +L L +NL+G
Sbjct: 89 QTLVLSYNKLQGRIP-DLANCSNLRSLWLDRNNLVGKIPNLPPRLQELM---LHVNNLSG 144
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+P +GN ++L A+NN+ G+IP E +L GL + ++ N ++G +I NIS++
Sbjct: 145 TIPPSLGNITTLTKFGCAFNNIEGNIPTEFERLPGLQYLSVNTNKLAGWFQLAILNISTL 204
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+ N L G++P+++G +LPNL+ + N+F G P SL N+S L ++D AEN T
Sbjct: 205 VTLDLGANNLRGEVPSNLGNSLPNLQYLILSDNFFHGHFPSSLINSSKLNLIDMAENNFT 264
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
G IP + G L L L+ N+ + + F+ LANCT LEV +ARN G++P S
Sbjct: 265 GVIPSSIGKLAKLNVLSLQLNQFQAGTKKEWEFMDSLANCTELEVFSVARNHLQGQVPSS 324
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
++N+S+ L+ L +G+N + G P GI NL +LGL+ N +G VPE +G L L+ L
Sbjct: 325 LSNISSQLQYLYLGKNQLSGGFPSGIAKFHNLIILGLDHNQFTGVVPEWLGTLQALQKLS 384
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN----- 367
L N F G +P+SL NL+ L+ L++ N+ +G+IP LG+ Q L VL++S+N++
Sbjct: 385 LLDNNFIGFLPTSLSNLSQLSELFLGSNKFDGNIPLGLGDLQMLQVLSISNNNIQGRVPK 444
Query: 368 -------------------GTIPKEV--------------------RQSGMS-------- 380
G +P E+ + G S
Sbjct: 445 EIFNLPTITEIDLSFNKLFGQLPTEIGNAKQLASLELSSNKLFWRRKHEGNSTSLPSFGR 504
Query: 381 ------YSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGT-IVAIKVLKLQQQGALKSFI 433
Y++++++T+ FS+ NLIG G +G VY+G L GT +VAIKV L+ GA KSFI
Sbjct: 505 KFPKVPYNELAEATEGFSESNLIGKGRYGYVYRGNLFQGTNVVAIKVFNLETMGAQKSFI 564
Query: 434 DECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK 493
ECNAL++ RHRN++ ++TACSS+D GNDFKALV+EFM G+L L+ +P +
Sbjct: 565 AECNALRNVRHRNLVPILTACSSIDPNGNDFKALVYEFMPMGDLYNLLY-APQCDSNLRH 623
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF-- 551
+++ QR+ I DVA A+DYLHH+ I HCDLKPS +LLD +MTAHVGDFGLA+F F
Sbjct: 624 ITLAQRIGIVADVADAMDYLHHNNQGTIVHCDLKPSKILLDDNMTAHVGDFGLARFNFGS 683
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMF 610
+ N T S +KG+IGYI PE GQVS D+YS+G++LLE+F +RPT DMF
Sbjct: 684 TTASLGDTNSTSSAAIKGTIGYIAPECAGGGQVSTAADVYSFGVVLLEIFIRRRPTDDMF 743
Query: 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKL 670
KD +I F + +PD + DI+DP + Q + EE M D E +
Sbjct: 744 KDGLTIAKFTEINIPDKMQDIVDPQL--------AQELGLCEEAPMA---DEESGAR--- 789
Query: 671 EECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFLE 711
C +SVL IGL C+ +P ERI+M V + + IR +L
Sbjct: 790 --CLLSVLNIGLCCTRLAPNERISMKEVASKMHGIRGAYLR 828
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440269|ref|XP_004137907.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1317), Expect = e-142, Method: Compositional matrix adjust.
Identities = 327/802 (40%), Positives = 449/802 (55%), Gaps = 112/802 (13%)
Query: 15 LNLTYNYLSGKIPTNLSHC-TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN 73
L+L N L G +P N+ L++ VN+F G IP L++++ L+I+ + L G
Sbjct: 247 LSLADNQLQGTLPPNIGFTLPNLQALGGGVNNFHGPIPKSLANISGLQILDFPQNKLVGM 306
Query: 74 VPAWIGNFSSLKALSLAWNNL-RGSIPN-----ELGQLSGLGFFTLYGNFISGIIPSSIY 127
+P +G L+ L+ A N L RG + + L + L +L N G++PSSI
Sbjct: 307 LPDDMGRLKYLEHLNFASNRLGRGKVGDLNFISYLANCTSLRILSLSSNHFGGVLPSSIG 366
Query: 128 NISS-IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDF 186
N+S+ + + QN L G +PT +G L NL+ A VN+ GSIP ++ NL+VL
Sbjct: 367 NLSTQMRSLVLGQNMLSGSIPTGIG-NLINLQRLAMEVNFLNGSIPPNIGKLKNLEVLYL 425
Query: 187 AENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246
N L+G +P + +L L +L N+L + L C SL L L+ N+
Sbjct: 426 NYNELSGPVPSSIANLSSLTKLYMSHNKLKE------SIPAGLGQCESLLTLELSSNNLS 479
Query: 247 GEMPISI----------------------------------------------ANLSTHL 260
G +P I NL +
Sbjct: 480 GTIPKEILYLSSLSMSLALDHNSFTGPLPHEVGLLVRLSKLDVSENQLSGDIPTNLENCI 539
Query: 261 R--RLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKF 318
R RL +G N G IP +G L + L L NNLSG +P+ +G+L L+ L L+ N F
Sbjct: 540 RMERLNLGGNQFEGTIPESLGALKGIEELNLSSNNLSGKIPQFLGKLGSLKYLNLSYNNF 599
Query: 319 SGLIPSS--LGNLTILTRLWMEENRLEGSIPP-SLGNCQK-------------------- 355
G +P N T+++ + N L G +P L C+
Sbjct: 600 EGQVPKEGVFSNSTMISVIG--NNNLCGGLPELHLPPCKYDRTYSRKKFMAPRVLIPIAS 657
Query: 356 --------------LLVLNLSSNDL--NGTIPKEVRQSGMSYSDISKSTDNFSKENLIGT 399
VL S D N + KE +SY ++SKST+ FSKEN IG+
Sbjct: 658 TVTFLVILVSIIFVCFVLRKSKKDASTNSSSTKEFLPQ-ISYLELSKSTNGFSKENFIGS 716
Query: 400 GSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458
GSFGSVYKG L DG+IVAIKVL LQ QGA KSF+DECNAL + RHRN+L++IT+CSS+D
Sbjct: 717 GSFGSVYKGILSSDGSIVAIKVLNLQHQGASKSFVDECNALSNIRHRNLLKIITSCSSID 776
Query: 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518
++GN+FKAL+F FMSNGNLD LHP+ ++ Q ++LS+IQRLNIAID+A LDYLH+HC+
Sbjct: 777 VQGNEFKALIFNFMSNGNLDCLLHPTNKQNNQ-RRLSLIQRLNIAIDIAYGLDYLHNHCE 835
Query: 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS-DNPSKNQTVSIGLKGSIGYIPPE 577
PIAHCDLKPSN+LLD DM AHVGDFGLA+F+ E S D S +QT+S+ LKGSIGYIPPE
Sbjct: 836 PPIAHCDLKPSNILLDDDMVAHVGDFGLARFMLEGSNDQTSLSQTMSLALKGSIGYIPPE 895
Query: 578 H-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSM 636
+ G++S GD++SYGILLLEM GKRPT + F D IH+F MAL V++I+DPS+
Sbjct: 896 YGTGGRISTEGDVFSYGILLLEMIIGKRPTDEKFGDSVDIHLFTEMALSQGVINIVDPSL 955
Query: 637 PLD---EENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693
+ E N E + E+ +E +M D + + +EEC +S+LRIGL CS PRER
Sbjct: 956 LYEETGETNQEGKSEDKTQEIAVMSEEDHKGFVLSWMEECIISILRIGLSCSLRMPRERK 1015
Query: 694 AMNVVVNNLKTIRNCFLEFKKR 715
+NVV+N L+TI++ +L+FKKR
Sbjct: 1016 PINVVINELQTIKSSYLKFKKR 1037
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088096|emb|CBI35485.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1315), Expect = e-142, Method: Compositional matrix adjust.
Identities = 299/703 (42%), Positives = 400/703 (56%), Gaps = 90/703 (12%)
Query: 18 TYNYLSGKIPTNL-SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPA 76
T L IP++ SHC LR + N VG +P+QL L++L+ + + +NL+G +P
Sbjct: 94 TSTPLQPHIPSSFRSHCYNLREINLTRNQLVGSLPSQLGHLSRLKFMDVYANNLSGAIPP 153
Query: 77 WIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136
GN +SL L+L NN RG IP ELG L L L N SG IP+S+YNISS+ + S
Sbjct: 154 TFGNLTSLTHLNLGRNNFRGEIPKELGNLHNLVSLRLSENQFSGQIPNSLYNISSLSFLS 213
Query: 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP 196
+TQN L G+LPTD+GL LPNL+ A N F G IP SL+NAS +QVLD N G+IP
Sbjct: 214 LTQNHLVGKLPTDMGLALPNLRQLLLAENSFEGLIPNSLNNASQIQVLDLTSNLFQGSIP 273
Query: 197 GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANL 256
G++ L+ LN N L S +L L NCT LE
Sbjct: 274 F-LGNMNKLIMLNLGTNYLSSTTELNLQVFNSLTNCTLLE-------------------- 312
Query: 257 STHLRRLTMGENLMHGNIPVGIGNLV-NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNV 315
LT+ N + G++P + NL+ L+LL + N LSG++PE IG L+ L +
Sbjct: 313 -----SLTLDSNKLAGDLPSSVANLLKQLSLLDVSDNQLSGNIPETIGACLSLQTLSMAR 367
Query: 316 NKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVR 375
N+ G IP +G L L + + N L G IP LG+ + L LNLS NDL G
Sbjct: 368 NEIMGSIPDKVGKLVALESMDLSSNNLSGPIPEDLGSLKVLQSLNLSFNDLEG------- 420
Query: 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALK 430
++TD F+ ENLIG G FGSVYKG G G+ +AIKVL LQQ A +
Sbjct: 421 ---------QQATDRFAAENLIGKGGFGSVYKGAFRTGEDGVGSTLAIKVLDLQQSKASE 471
Query: 431 SFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
SF EC AL++ RHRN+++V+T+CSS+D G +FKALV EFMSNG+L WL+P ++
Sbjct: 472 SFYAECEALRNIRHRNLVKVVTSCSSIDHSGGEFKALVMEFMSNGSLHNWLYPEDSQSR- 530
Query: 491 FKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
LS+IQRLNIAID+ASA+DYLHH CD P+ HCDLKP NVLLD DM AHVGDFGLA+FL
Sbjct: 531 -SSLSLIQRLNIAIDIASAMDYLHHDCDPPVVHCDLKPGNVLLDDDMAAHVGDFGLARFL 589
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
S NPS++++ +IGLKGSIGYI PE+ + G+ S GD+YSYGILLLE+FT ++PT ++
Sbjct: 590 ---SQNPSQSESSTIGLKGSIGYIAPEYGLGGKASTNGDVYSYGILLLEIFTARKPTDEV 646
Query: 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNK 669
F+ + + + V I+DP + H
Sbjct: 647 FQQGLNQKKYALAVEANQVSGIVDP--------------------RLFSH---------- 676
Query: 670 LEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFLEF 712
+++R+GL C+ SP ER+ M + L+ I+ LE
Sbjct: 677 -----TAIIRVGLFCADHSPNERLTMRETLTKLQEIKKFLLEL 714
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 327/789 (41%), Positives = 442/789 (56%), Gaps = 113/789 (14%)
Query: 15 LNLTYNYLSGKIPTNLSHC-TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN 73
L + N L G +P ++ L +F VNDF G IP LS+ ++LEI+ +NL G
Sbjct: 233 LTFSQNNLHGNLPYDVGFTLPNLETFAGGVNDFTGTIPESLSNASRLEILDFAENNLIGT 292
Query: 74 VPAWIG------------------------------NFSSLKALSLAWNNLRGSIPNELG 103
+P IG N ++L+ L LA N G +P+ +G
Sbjct: 293 LPKNIGRLTLLKRLNFDTNRLGNGEDGELNFLTSLINCTALEVLGLAENQFGGKLPSSIG 352
Query: 104 QLS-GLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGL--TLPNLKIF 160
LS L L N I G IP I N+ ++ + +N L G +P +G+ L +L+++
Sbjct: 353 NLSINLNALDLGENAIYGSIPIGISNLVNLTSLGMEKNNLSGFVPDTIGMLQKLVDLELY 412
Query: 161 AGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNEL-GS-- 217
+ N F+G IP S+ N + L L A+N G+IP + + + L+ LN N L GS
Sbjct: 413 S---NKFSGVIPSSIGNLTRLTKLLIADNNFEGSIPTSLENCQRLLMLNLSHNMLNGSIP 469
Query: 218 REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVG 277
R++ L+ L L L+ NS G +P I L +L L + +N + G IP
Sbjct: 470 RQVFALSSLSI--------YLDLSHNSLTGSLPFEIGKL-VNLANLDLSKNKLSGMIPSS 520
Query: 278 IGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWM 337
IG+ V+L L ++GN G++P I L ++ + L+ N SG IP LG + L L +
Sbjct: 521 IGSCVSLEWLHMQGNFFEGNIPSTIQNLRGIQHIDLSCNNLSGKIPEFLGEIKGLMHLNL 580
Query: 338 EENRLEG--------------SIPPSLGNCQKLLVLNLSS--------NDLNGTIP---- 371
N L+G SI ++ C + LNL + + L IP
Sbjct: 581 SYNNLDGELPMNGIFKNATSFSINGNIKLCGGVPELNLPACTIKKEKFHSLKVIIPIASA 640
Query: 372 ---------------------KEVRQS--------GMSYSDISKSTDNFSKENLIGTGSF 402
K R++ +SYS+I K T FS +NLIG+GSF
Sbjct: 641 LIFLLFLSGFLIIIVIKRSRKKTSRETTTIEDLELNISYSEIVKCTGGFSNDNLIGSGSF 700
Query: 403 GSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461
GSVYKGTL DGT +AIKVL L+Q+GA KSFIDECNALK RHRN+L++ITA SS+D +G
Sbjct: 701 GSVYKGTLSSDGTTIAIKVLNLEQRGASKSFIDECNALKVIRHRNLLKIITAISSIDHQG 760
Query: 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521
DFKALV+EFMSNG+L+ WLHP Q K L+ +QRLNIAIDVA AL+YLHH C+TPI
Sbjct: 761 KDFKALVYEFMSNGSLEDWLHPIN----QKKTLTFVQRLNIAIDVACALEYLHHFCETPI 816
Query: 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MN 580
HCD+KPSNVLLD DM A VGDFGLA FLFE S + K+ T+S LKGS+GYIPPE+ M
Sbjct: 817 VHCDIKPSNVLLDNDMVARVGDFGLATFLFEESCDSPKHSTMSASLKGSVGYIPPEYGMG 876
Query: 581 GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDE 640
G S LGD+YSYGILLLE+FTGKRPT +MF+ I F ++ALP+H +DI+DPS+ D+
Sbjct: 877 GHPSALGDVYSYGILLLEIFTGKRPTNEMFEGGMGIQQFTALALPNHAIDIIDPSLLYDQ 936
Query: 641 ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700
E D + + EEK + + E + +E C +SVL+IG+ CS+TSP ERI M +VVN
Sbjct: 937 EFDGKD-HDYSEEKAL--RREKEPGDFSTMENCLISVLQIGVSCSSTSPNERIPMTLVVN 993
Query: 701 NLKTIRNCF 709
L I N F
Sbjct: 994 KLHAINNSF 1002
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297819322|ref|XP_002877544.1| hypothetical protein ARALYDRAFT_347815 [Arabidopsis lyrata subsp. lyrata] gi|297323382|gb|EFH53803.1| hypothetical protein ARALYDRAFT_347815 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-140, Method: Compositional matrix adjust.
Identities = 310/818 (37%), Positives = 432/818 (52%), Gaps = 142/818 (17%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L + NYL G IPT LS+C+ L + N +P++L SL L + +NL G +
Sbjct: 122 LYMGINYLGGGIPTTLSNCSRLLDLDLFSNPLGRGVPSELGSLANLVSLNFRENNLQGKL 181
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134
PA +GN +SL S NN+ G IP+++ +LS + L N SG+ P +IYN+SS+
Sbjct: 182 PASLGNLTSLIRASFGGNNMEGEIPDDVARLSQMMILELSFNQFSGVFPPAIYNMSSLEN 241
Query: 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194
+ N G+L G+ LPNL+ N+FTGSIP +LSN S LQ + +N LTG+
Sbjct: 242 LYMAFNHFSGRLRPGFGILLPNLQELNMGGNFFTGSIPTTLSNISTLQKVGLNDNNLTGS 301
Query: 195 IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA 254
IP F + +L L +N LGS GDL+F+ L NCT LE LGL N GG+ PISI
Sbjct: 302 IP-TFEKVPNLQWLLLRRNSLGSYSFGDLDFISSLTNCTQLEKLGLGGNRLGGDFPISIT 360
Query: 255 NLSTHLRRL----------------------TMG--ENLMHGNIPVGIGNLVNLNLLGLE 290
NLS L L T+G EN++ G +P +GNL L +L L
Sbjct: 361 NLSAELTDLLLEYNHISGRIPQDIGNLLGLQTLGLRENMLSGPLPTSLGNLFGLGVLDLS 420
Query: 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSL------------------------ 326
N LSG +P IG L +L+ L L+ N F G IP SL
Sbjct: 421 SNKLSGVIPSTIGNLTRLQKLRLSNNIFEGTIPPSLSNCSELLHLEIGYNKLNGTIPKEI 480
Query: 327 ------------------------GNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLS 362
G L L L + +N+L G + +LGNC + + L
Sbjct: 481 MQLSHLLTLSMPSNSISGTLPNDVGRLQNLVLLSVSDNKLSGELSQTLGNCLSMEEIYLQ 540
Query: 363 SNDLNGTIPK------------------------------------------EVRQSGMS 380
N +G IP E+ +S
Sbjct: 541 GNSFDGIIPNIKGLVGVKRDDMSNNNLSGISLRWLRKRKKNQKTNNSAASTLEIFHEKIS 600
Query: 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNAL 439
Y D+ +TD FS N++G+GSFG+V+K L + IVA+KVL ++++GA+KSF+ EC +L
Sbjct: 601 YGDLRNATDGFSASNMVGSGSFGTVFKALLPEENKIVAVKVLNMERRGAMKSFMAECESL 660
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSVI 497
K RHRN+++++TAC+S+D +GN+F+AL++EFM NG+LD WLHP E + + L++
Sbjct: 661 KDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDMWLHPEEIEEIRRPSRTLTLR 720
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+RLNIA+DVAS LDYLH HC PIAHCDLKPSNVLLD D+TAHV DFGLA+ L +
Sbjct: 721 ERLNIAVDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDQES 780
Query: 558 SKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
NQ S G++G+IGY PE+ M GQ SI GD+YS+G+L+LEMFTGKRPT ++F+ F++
Sbjct: 781 FFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFEGSFTL 840
Query: 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676
H + ALP+ V+DI D S ++H L V + EC
Sbjct: 841 HSYTRSALPERVLDIADKS---------------------ILHSGLRVGF--PVVECLKV 877
Query: 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFLEFKK 714
+L +GL C SP R+A + L +IR F + ++
Sbjct: 878 ILDVGLRCCEESPMNRLATSEAAKELISIRERFFKTRR 915
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483698|ref|XP_004156663.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1302), Expect = e-140, Method: Compositional matrix adjust.
Identities = 322/799 (40%), Positives = 439/799 (54%), Gaps = 109/799 (13%)
Query: 15 LNLTYNYLSGKIPTNLS-HCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN 73
L+L YN G +P ++ L+ F S N+F G IPN L+++ L+II +NL G
Sbjct: 294 LSLGYNQFKGTLPPDIGLSLPNLQVFGCSGNNFHGPIPNSLANIVSLQIIDFFDNNLVGT 353
Query: 74 VPAWIGNF------------------------------SSLKALSLAWNNLRGSIPNELG 103
+P +GN + L+AL L N+ G +P+ +
Sbjct: 354 LPDDMGNLRNLERLNLGENSLGSGEAGDLNFINSLVNCTRLRALGLDTNHFGGVLPSSIA 413
Query: 104 QLSG-LGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG 162
LS L +L N +SG IPS N+ ++ F V N ++G +P ++G L NL +
Sbjct: 414 NLSNQLTALSLGYNMLSGSIPSGTTNLINLQGFGVEGNIMNGSIPPNIG-NLKNLVLLYL 472
Query: 163 AVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS---RE 219
N FTG IP S+ N S+L L + N L G+IP + G K L L N L +E
Sbjct: 473 YENEFTGPIPYSIGNLSSLTKLHMSHNQLDGSIPTSLGQCKSLTSLKLSSNNLNGTIPKE 532
Query: 220 IGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA-----------------------NL 256
I L L L L NSF G +P + +
Sbjct: 533 IFALPSLSI--------TLALDHNSFTGSLPNEVDGLLGLLELDVSENKLFGDIPNNLDK 584
Query: 257 STHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVN 316
T++ RL +G N G IP + L +L L L NNLSG +P+ + +L L + L+ N
Sbjct: 585 CTNMERLYLGGNKFGGTIPQSLEALKSLKKLNLSSNNLSGPIPQFLSKLLFLVSVDLSYN 644
Query: 317 KFSGLIP-----------SSLGNLTILTRLWMEENRLEGSIPPSLGNCQKL--------- 356
F G +P S +GN + L L S L N Q L
Sbjct: 645 NFEGKVPIEGVFSNSTMFSIIGNNNLCGGLHELHLPLCTSNQTRLSNKQFLKSRVLIPMA 704
Query: 357 ----------------LVLNLSSNDLNGTIPKEVRQ--SGMSYSDISKSTDNFSKENLIG 398
VL S D + T ++ +SY ++SKST FS ENLIG
Sbjct: 705 IVITFVGILVVFILVCFVLRKSRKDASTTNSLSAKEFIPQISYLELSKSTSGFSTENLIG 764
Query: 399 TGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSV 457
+GSFGSVYKG L DG++VA+KVL LQQQGA KSF+DECNAL + RHRN+L++IT+CSS+
Sbjct: 765 SGSFGSVYKGVLSNDGSVVAVKVLNLQQQGASKSFVDECNALSNIRHRNLLKIITSCSSI 824
Query: 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC 517
D +GN+FKALVF FMSNGNLD WLHP + ++LS+IQRLNIAID+A LDYLH HC
Sbjct: 825 DGQGNEFKALVFNFMSNGNLDCWLHPK-NQGTNLRRLSLIQRLNIAIDIACGLDYLHTHC 883
Query: 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS-DNPSKNQTVSIGLKGSIGYIPP 576
+TPI HCD+KPSN+LLD DM AHVGDFGLA+F+ E S D S +QT+S+ LKGSIGYIPP
Sbjct: 884 ETPIIHCDIKPSNILLDDDMVAHVGDFGLARFMLEESNDQISFSQTMSLALKGSIGYIPP 943
Query: 577 EHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPS 635
E+ +G ++S GD++SYGILLLEM GKRP D F + IH+F + LP + I+DPS
Sbjct: 944 EYGSGSRISTEGDVFSYGILLLEMIIGKRPIDDTFDNGVDIHLFTATMLPHEALGIIDPS 1003
Query: 636 MPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695
+ +E + EE+ + +++ ++ D + +EEC VS++RIGL CS PRER+AM
Sbjct: 1004 IVFEETHQEEETNDEMQKIAIVSEQDCKEIVPRWMEECLVSIMRIGLSCSLREPRERMAM 1063
Query: 696 NVVVNNLKTIRNCFLEFKK 714
+VVVN L+ I++ +L+FKK
Sbjct: 1064 DVVVNELQAIKSSYLKFKK 1082
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142240|emb|CBI19443.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1287), Expect = e-138, Method: Compositional matrix adjust.
Identities = 298/751 (39%), Positives = 427/751 (56%), Gaps = 83/751 (11%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
LN++ N++ G IP N++ C EL + N+ G IP +L L LEI+ LG + L G++
Sbjct: 130 LNMSSNHIRGAIPLNITMCLELEILDLKENEISGTIPAELGRLRNLEILKLGSNQLVGDI 189
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134
P I N SSL LSL NNL G IP++LG+L L L N + G +PSSIYNI+S+
Sbjct: 190 PPSISNLSSLDTLSLGTNNLGGRIPDDLGRLQNLKELDLTINQLEGTVPSSIYNITSLVN 249
Query: 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194
+V N L G++P+DVG LPNL IF +N FTG IP SL N +N+ V+ A N L G+
Sbjct: 250 LAVASNNLWGEIPSDVGDRLPNLLIFNFCINKFTGGIPGSLHNLTNINVIRMAHNLLEGS 309
Query: 195 IPGNFGSLKDLVRLNFDQNEL-GS--------------------------REIGDLNFLK 227
+P G+L L L+ QN++ GS EIG+L
Sbjct: 310 VPSGLGNLPQLRILHMGQNKIYGSIPPSISHLSSLALLNLSHNLISGEIPPEIGELG--- 366
Query: 228 FLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLL 287
++ L LA N+ G +P S+ NL L +L + N + G IP N L +
Sbjct: 367 ------EMQELYLASNNISGRIPSSLGNLR-QLSQLDLSSNRLVGGIPTNFSNFQRLLSM 419
Query: 288 GLEGNNLSGSVP-EVIGRLNKLEGLGLNVNKFSGLIPSSLGNL-TILTRLWMEENRLEGS 345
L N L+ S+P E++G L L+ N +G +P + L + L L+M N+ GS
Sbjct: 420 DLSNNRLNESIPKEILGLPGLSTLLNLSKNSLTGPLPQEVEALESSLEELFMANNKFSGS 479
Query: 346 IPPSLGNCQKLLVLNLSSNDLNGTIPK----------------------EVRQSGMSYSD 383
IP +LG + L +L+LS+N L G+IP +V +SY D
Sbjct: 480 IPDTLGEVRGLEILDLSTNQLTGSIPSIGVLAYLKKSKAKKLPITSDSFKVLHQVVSYDD 539
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR 443
+ +T NF+++NLIG GSFGSVYKG L +GT VAIKVL +Q+ G+ KSF EC AL++ R
Sbjct: 540 LRMATGNFNQQNLIGKGSFGSVYKGYLTEGTAVAIKVLDIQRNGSWKSFFAECEALRTVR 599
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
HRN++++IT+CSS+D + +F AL+++FM NG+L+ W+ + H L++++RL IA
Sbjct: 600 HRNLVKLITSCSSLDFKNVEFLALIYDFMHNGSLEDWIKGT-RRHASGCALNLVERLKIA 658
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
IDVA A+DYLHH +TPIAHCDLKPSNVLLDKDMTA VGDFGLA+ L D + Q++
Sbjct: 659 IDVACAMDYLHHDSETPIAHCDLKPSNVLLDKDMTAKVGDFGLARLLM---DRAADQQSI 715
Query: 564 SI--GLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
+ GL+GSIGYIPPE+ + G+ + GD+YSYG++LLEMFTGK PT + F ++ +V
Sbjct: 716 ASTHGLRGSIGYIPPEYGLGGKPTTSGDVYSYGVMLLEMFTGKSPTHESFLGGLTLAQWV 775
Query: 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680
A P +V ++DP + L + + + EE + EC ++V+ +
Sbjct: 776 QSAFPTNVRQVVDPELLLPTGALQHEGHPISEEVQ---------------HECLIAVIGV 820
Query: 681 GLMCSTTSPRERIAMNVVVNNLKTIRNCFLE 711
L C+ S RI+ ++ LKT L+
Sbjct: 821 ALSCTVDSSDRRISSRDALSQLKTAAKALLK 851
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.359 | 0.251 | 0.551 | 7.1e-143 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.343 | 0.238 | 0.532 | 5.5e-141 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.368 | 0.261 | 0.544 | 1.7e-121 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.368 | 0.261 | 0.537 | 5.7e-113 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.368 | 0.261 | 0.514 | 2.4e-110 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.912 | 0.638 | 0.346 | 3.5e-98 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.345 | 0.253 | 0.430 | 1.3e-88 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.359 | 0.206 | 0.383 | 1.4e-78 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.343 | 0.490 | 0.516 | 1.7e-78 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.320 | 0.196 | 0.370 | 1.5e-76 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 738 (264.8 bits), Expect = 7.1e-143, Sum P(3) = 7.1e-143
Identities = 145/263 (55%), Positives = 186/263 (70%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECN 437
+SY ++ K+T FS NLIG+G+FG+V+KG LG VAIKVL L ++GA KSFI EC
Sbjct: 707 ISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECE 766
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY--QFKKLS 495
AL RHRN+++++T CSS D EGNDF+ALV+EFM NGNLD WLHP E + L
Sbjct: 767 ALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLG 826
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+ RLNIAIDVASAL YLH +C PIAHCD+KPSN+LLDKD+TAHV DFGLA+ L +
Sbjct: 827 LFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR 886
Query: 556 NPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614
+ Q S G++G+IGY PE+ M G SI+GD+YS+GI+LLE+FTGKRPT +F D
Sbjct: 887 DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGL 946
Query: 615 SIHMFVSMALPDH-VMDILDPSM 636
++H F AL +DI D ++
Sbjct: 947 TLHSFTKSALQKRQALDITDETI 969
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-141, Sum P(3) = 5.5e-141
Identities = 133/250 (53%), Positives = 179/250 (71%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECN 437
+SY ++ +T FS NLIG+G+FG+V+KG LG + +VA+KVL L + GA KSF+ EC
Sbjct: 700 VSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECE 759
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ--FKKLS 495
K RHRN++++IT CSS+D EGNDF+ALV+EFM G+LD WL E + L+
Sbjct: 760 TFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLT 819
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
++LNIAIDVASAL+YLH HC P+AHCD+KPSN+LLD D+TAHV DFGLA+ L++
Sbjct: 820 PAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDR 879
Query: 556 NPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614
NQ S G++G+IGY PE+ M GQ SI GD+YS+GILLLEMF+GK+PT + F D+
Sbjct: 880 ESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDY 939
Query: 615 SIHMFVSMAL 624
++H + L
Sbjct: 940 NLHSYTKSIL 949
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 1.7e-121, Sum P(3) = 1.7e-121
Identities = 146/268 (54%), Positives = 203/268 (75%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKS 431
EV +SY D+ +T+ FS N++G+GSFG+VYK L + +VA+KVL +Q++GA+KS
Sbjct: 684 EVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKS 743
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE--HY 489
F+ EC +LK RHRN+++++TACSS+D +GN+F+AL++EFM NG+LD WLHP E H
Sbjct: 744 FMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHR 803
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ L++++RLNIAIDVAS LDYLH HC PIAHCDLKPSNVLLD D+TAHV DFGLA+
Sbjct: 804 PSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARL 863
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGD 608
L + + NQ S G++G+IGY PE+ + GQ SI GD+YS+GILLLEMFTGKRPT +
Sbjct: 864 LLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNE 923
Query: 609 MFKDDFSIHMFVSMALPDHVMDILDPSM 636
+F +F+++ + ALP+ ++DI+D S+
Sbjct: 924 LFGGNFTLNSYTKSALPERILDIVDESI 951
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 5.7e-113, Sum P(3) = 5.7e-113
Identities = 144/268 (53%), Positives = 202/268 (75%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKS 431
E+ +SY D+ +TD FS N++G+GSFG+V+K L + IVA+KVL +Q++GA+KS
Sbjct: 683 EIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKS 742
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE--HY 489
F+ EC +LK RHRN+++++TAC+S+D +GN+F+AL++EFM NG+LD+WLHP E H
Sbjct: 743 FMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHR 802
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ L++++RLNIAIDVAS LDYLH HC PIAHCDLKPSN+LLD D+TAHV DFGLA+
Sbjct: 803 PSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARL 862
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGD 608
L + NQ S G++G+IGY PE+ M GQ SI GD+YS+G+L+LEMFTGKRPT +
Sbjct: 863 LLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNE 922
Query: 609 MFKDDFSIHMFVSMALPDHVMDILDPSM 636
+F +F+++ + ALP+ V+DI D S+
Sbjct: 923 LFGGNFTLNSYTKAALPERVLDIADKSI 950
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 2.4e-110, Sum P(3) = 2.4e-110
Identities = 138/268 (51%), Positives = 199/268 (74%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKS 431
E+ +SY D+ +T+ FS N++G+GSFG+V+K L + IVA+KVL +Q++GA+KS
Sbjct: 685 EIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKS 744
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF 491
F+ EC +LK TRHRN+++++TAC+S D +GN+F+AL++E++ NG++D WLHP E +
Sbjct: 745 FMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRR 804
Query: 492 --KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ L++++RLNI IDVAS LDYLH HC PIAHCDLKPSNVLL+ D+TAHV DFGLA+
Sbjct: 805 PPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARL 864
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGD 608
L + NQ S G++G+IGY PE+ M GQ SI GD+YS+G+LLLEMFTGKRPT +
Sbjct: 865 LLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDE 924
Query: 609 MFKDDFSIHMFVSMALPDHVMDILDPSM 636
+F + ++H + +ALP+ V +I D ++
Sbjct: 925 LFGGNLTLHSYTKLALPEKVFEIADKAI 952
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 3.5e-98, P = 3.5e-98
Identities = 239/689 (34%), Positives = 344/689 (49%)
Query: 28 TNLSHCTELRSFEASVNDFVGQIPNQLSSL-TKLEIIGLGGSNLTGNVPAWIGNFSSLKA 86
++L++C++L++ N+ G +PN S+L T L + L + +TG++P IGN L+
Sbjct: 345 SDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQH 404
Query: 87 LSLAWNNLRGSIPNELGQLSGLGFFTLYGNFXXXXXXXXXXXXXXXXXXXVTQNQLHGQL 146
L L NN RGS+P+ LG+L LG Y N + N+ G +
Sbjct: 405 LYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWI 464
Query: 147 PTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL-DFAENGLTGTIPGNFGSLKDL 205
P + L NL + N +G IP L N L ++ + ++N L G+IP G LK+L
Sbjct: 465 PYTLS-NLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNL 523
Query: 206 VRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTM 265
V + + N L S +I + L +C L L L N G +P ++ L L L +
Sbjct: 524 VEFHAESNRL-SGKIPNT-----LGDCQLLRYLYLQNNLLSGSIPSALGQLKG-LETLDL 576
Query: 266 GENLMHGNIPVXXXXXXXXXXXXXXXXXXXXSVPEVIGRLNKLEGLGLNVN-KFSGLIPS 324
N + G IP VP IG G+ + N K G IP
Sbjct: 577 SSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVP-TIGAFAAASGISIQGNAKLCGGIPD 635
Query: 325 -SLGNLTIL--TRLWMEENRLEGSIPPSLGNCQKXXXXXXXXXXXXGTIPKEVRQSG--- 378
L L R + S+ +L P G
Sbjct: 636 LHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPL 695
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNA 438
+SYS + K+TD F+ NL+G+GSFGSVYKG L VA+KVLKL+ ALKSF EC A
Sbjct: 696 VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEA 755
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
L++ RHRN+++++T CSS+D GNDFKA+V++FM NG+L+ W+HP + + L++ +
Sbjct: 756 LRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHR 815
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
R+ I +DVA ALDYLH H P+ HCD+K SNVLLD DM AHVGDFGLA+ L + +
Sbjct: 816 RVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVD-GTSLI 874
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
+ T S+G G+IGY PE+ G + S GDIYSYGIL+LE+ TGKRPT F+ D +
Sbjct: 875 QQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLR 934
Query: 618 MFVSMALPDHVMDILDPSMPLDXXXXXXXXXXXXXXXXXXXXXDLEVNTKNKLEECFVSV 677
+V + L V D++D + LD + ++ EC V +
Sbjct: 935 QYVELGLHGRVTDVVDTKLILDSENWLNSTNN---------------SPCRRITECIVWL 979
Query: 678 LRIGLMCSTTSPRERIAMNVVVNNLKTIR 706
LR+GL CS P R +++ L I+
Sbjct: 980 LRLGLSCSQELPSSRTPTGDIIDELNAIK 1008
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 1.3e-88, Sum P(3) = 1.3e-88
Identities = 115/267 (43%), Positives = 165/267 (61%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALK---SFIDE 435
+SY + +T F+ +LIG+G FG VYKG L + T VA+KVL + AL+ SF E
Sbjct: 649 ISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL--DPKTALEFSGSFKRE 706
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLS 495
C LK TRHRN++R+IT CS G F ALV M NG+L++ L+P Y K L
Sbjct: 707 CQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPG---EYSSKNLD 758
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+IQ +NI DVA + YLHH+ + HCDLKPSN+LLD +MTA V DFG+++ + + +
Sbjct: 759 LIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEE 818
Query: 556 NPSKNQTVSIG-----LKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
S + +VS G L GS+GYI PE+ M + S GD+YS+G+LLLE+ +G+RPT +
Sbjct: 819 TVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVL 878
Query: 610 FKDDFSIHMFVSMALPDHVMDILDPSM 636
+ S+H F+ PD + I++ ++
Sbjct: 879 VNEGSSLHEFMKSHYPDSLEGIIEQAL 905
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.4e-78, Sum P(3) = 1.4e-78
Identities = 105/274 (38%), Positives = 155/274 (56%)
Query: 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIK-VLKLQQQGALKSFID 434
+S + + DI ++T N S+E +IG+G G VYK L +G VA+K +L + KSF
Sbjct: 936 KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSR 995
Query: 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS-PAEHYQFKK 493
E L RHR++++++ CSS EG L++E+M NG++ WLH P + K
Sbjct: 996 EVKTLGRIRHRHLVKLMGYCSSKS-EG--LNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL 1052
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
L RL IA+ +A ++YLHH C PI H D+K SNVLLD +M AH+GDFGLAK L E
Sbjct: 1053 LDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTEN 1112
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKD 612
D + + T S GYI PE+ + + D+YS GI+L+E+ TGK PT +F
Sbjct: 1113 CDTNTDSNT---WFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGA 1169
Query: 613 DFSI------HMFVSMALPDHVMDI-LDPSMPLD 639
+ + H+ V+ + D ++D L P +P +
Sbjct: 1170 EMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE 1203
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 1.7e-78, Sum P(3) = 1.7e-78
Identities = 129/250 (51%), Positives = 177/250 (70%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECN 437
+SY ++ +T FS NLIG+G+F V+KG LG + +VA+KVL L + GA KSFI EC
Sbjct: 197 ISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECE 256
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE--HYQFKKLS 495
+ K RHRN+ ++IT CSS+D +GNDF+ALV+EFM G+LD WL P E + + L+
Sbjct: 257 SFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLT 316
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+++NIAIDVASAL+YLH +C P+AHCD+KPSNVLLD D+TAHV DFGLA+ L+ +
Sbjct: 317 FAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDE 376
Query: 556 NPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614
NQ S G++G+IGY PE+ M + SI GD+YS+G+LLLEMFTGK+PT + F +
Sbjct: 377 KTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGY 436
Query: 615 SIHMFVSMAL 624
++H + L
Sbjct: 437 NLHGYTKSVL 446
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 1.5e-76, Sum P(3) = 1.5e-76
Identities = 92/248 (37%), Positives = 147/248 (59%)
Query: 383 DISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALK 440
++ ++TD+F+ N+IG+ S +VYKG L DGT++A+KVL L++ A K F E L
Sbjct: 862 ELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLS 921
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
+HRN+++++ E KALV FM NGNL+ +H S A S+++++
Sbjct: 922 QLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG-----SLLEKI 972
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
++ + +AS +DYLH PI HCDLKP+N+LLD D AHV DFG A+ L D +
Sbjct: 973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032
Query: 561 QTVSIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRPTG--DMFKDDFSI 616
T + +G+IGY+ PE +M +V+ D++S+GI+++E+ T +RPT D D ++
Sbjct: 1033 STSAF--EGTIGYLAPEFAYMR-KVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTL 1089
Query: 617 HMFVSMAL 624
V ++
Sbjct: 1090 RQLVEKSI 1097
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 717 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-61 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-53 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-51 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-51 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 4e-61
Identities = 141/375 (37%), Positives = 199/375 (53%), Gaps = 21/375 (5%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L+L N L GKIP +L++ T L + N VGQIP +L + L+ I LG +NL+G +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134
P IG +SL L L +NNL G IP+ LG L L + LY N +SG IP SI+++ +
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194
++ N L G++P V + L NL+I N FTG IPV+L++ LQVL N +G
Sbjct: 289 LDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347
Query: 195 IPGNFGSLKDLVRLNFDQNELGSR------EIGDLNFL------------KFLANCTSLE 236
IP N G +L L+ N L G+L L K L C SL
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407
Query: 237 VLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
+ L NSF GE+P L + L + N + G I ++ +L +L L N G
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPL-VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466
Query: 297 SVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKL 356
+P+ G +LE L L+ N+FSG +P LG+L+ L +L + EN+L G IP L +C+KL
Sbjct: 467 GLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL 525
Query: 357 LVLNLSSNDLNGTIP 371
+ L+LS N L+G IP
Sbjct: 526 VSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 9e-53
Identities = 130/362 (35%), Positives = 182/362 (50%), Gaps = 35/362 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSH-CTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
Q +NL+ N LSG IP ++ + LR S N+F G IP S+ LE + L + L+
Sbjct: 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLS 153
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
G +P IG+FSSLK L L N L G IPN L L+ L F TL N + G IP + + S
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213
Query: 132 IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191
+ + + N L G++P ++G L +L N TG IP SL N NLQ L +N L
Sbjct: 214 LKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 192 TGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251
+G IP + SL+ L+ L+ N L S EI +L + +LE+L L N+F G+
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSL-SGEIPEL-----VIQLQNLEILHLFSNNFTGK--- 323
Query: 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGL 311
IPV + +L L +L L N SG +P+ +G+ N L L
Sbjct: 324 ----------------------IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371
L+ N +G IP L + L +L + N LEG IP SLG C+ L + L N +G +P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 372 KE 373
E
Sbjct: 422 SE 423
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 4e-51
Identities = 129/384 (33%), Positives = 194/384 (50%), Gaps = 33/384 (8%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L+L+ N LSG+IP ++ + L+ + N VG+IPN L++LT LE + L + L G +
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134
P +G SLK + L +NNL G IP E+G L+ L L N ++G IPSS+ N+ ++ Y
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194
+ QN+L G +P + +L L + N +G IP + NL++L N TG
Sbjct: 265 LFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323
Query: 195 IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA 254
IP SL L L N+ S EI K L +L VL L+ N+ GE+P +
Sbjct: 324 IPVALTSLPRLQVLQLWSNKF-SGEIP-----KNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 255 NLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL--------- 305
+ S +L +L + N + G IP +G +L + L+ N+ SG +P +L
Sbjct: 378 S-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 306 -NKLEG--------------LGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSL 350
N L+G L L NKF G +P S G+ L L + N+ G++P L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 351 GNCQKLLVLNLSSNDLNGTIPKEV 374
G+ +L+ L LS N L+G IP E+
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 5e-51
Identities = 121/373 (32%), Positives = 186/373 (49%), Gaps = 21/373 (5%)
Query: 17 LTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPA 76
L YN LSG+IP + T L + N+ G IP+ L +L L+ + L + L+G +P
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 77 WIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136
I + L +L L+ N+L G IP + QL L L+ N +G IP ++ ++ +
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338
Query: 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP 196
+ N+ G++P ++G NL + + N TG IP L ++ NL L N L G IP
Sbjct: 339 LWSNKFSGEIPKNLG-KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
Query: 197 GNFGSLKDLVRLNFDQNELG---SREIGDL---NFLKFLAN------------CTSLEVL 238
+ G+ + L R+ N E L FL N SL++L
Sbjct: 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298
LARN F G +P S S L L + N G +P +G+L L L L N LSG +
Sbjct: 458 SLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLV 358
P+ + KL L L+ N+ SG IP+S + +L++L + +N+L G IP +LGN + L+
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575
Query: 359 LNLSSNDLNGTIP 371
+N+S N L+G++P
Sbjct: 576 VNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-43
Identities = 194/754 (25%), Positives = 314/754 (41%), Gaps = 134/754 (17%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L+L+ N LSG+IP + L N+F G+IP L+SL +L+++ L + +G +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNEL---GQLSGLGFFT------------------- 112
P +G ++L L L+ NNL G IP L G L L F+
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408
Query: 113 --LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
L N SG +PS + +Y+ ++ N L G++ + +P+L++ + A N F G
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR-KWDMPSLQMLSLARNKFFGG 467
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
+P S + L+ LD + N +G +P GSL +L++L +N+L S EI D L+
Sbjct: 468 LPDS-FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL-SGEIPDE-----LS 520
Query: 231 NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290
+C L L L+ N G++P S + + L +L + +N + G IP +GN+ +L + +
Sbjct: 521 SCKKLVSLDLSHNQLSGQIPASFSEMPV-LSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 291 GNNLSGSVPEVIGRL--NKLEGLGLNV----NKFSGLIPSSLGNLTILTRLWMEENRLEG 344
N+L GS+P L N G + SGL P T W
Sbjct: 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC---KRVRKTPSWWF------ 630
Query: 345 SIPPSLGNCQKLLVLNLSSNDL------NGTIPKEVRQSGMSY------SDISKST---- 388
I +LG LVL L + N K V ++ S +SKS
Sbjct: 631 YITCTLG---AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND 687
Query: 389 --DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL-KSFIDECNALKSTRHR 445
+ +EN+I G G+ YKG + + V ++ ++ S I + L +H
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFV-VKEINDVNSIPSSEIADMGKL---QHP 743
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+++I C S L+ E++ NL + L + LS +R IAI
Sbjct: 744 NIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIG 788
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+A AL +LH C + +L P +++D H+ L L
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL-----------CTDT 836
Query: 566 GLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624
S Y+ PE ++ DIY +G++L+E+ TGK P F SI +
Sbjct: 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896
Query: 625 PDHVMDI-LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683
D +D+ +DPS+ D ++ +I V V+ + L
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEI---------------------------VEVMNLALH 929
Query: 684 CSTTSPRERIAMNVVVNNL----KTIRNCFLEFK 713
C+ T P R N V+ L ++ +C K
Sbjct: 930 CTATDPTARPCANDVLKTLESASRSSSSCVTGLK 963
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 71/218 (32%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNIL 448
+ +G GSFG VY G +VAIKV+K ++ + + E LK +H NI+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
R+ E D LV E+ G+L L + +LS + + S
Sbjct: 61 RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLK-------KRGRLSEDEARFYLRQILS 108
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
AL+YLH I H DLKP N+LLD+D + DFGLA+ L D K T
Sbjct: 109 ALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFV---- 157
Query: 569 GSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + DI+S G++L E+ TGK P
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITAC 454
+G G FG+VY G VAIK++K + L+ + E LK H NI+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
+ LV E+ G+L L KLS + L I + + L+YLH
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKDLLK------ENEGKLSEDEILRILLQILEGLEYLH 109
Query: 515 HHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGY 573
+ I H DLKP N+LLD D + DFGL+K L + G+ Y
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-------IVGTPAY 159
Query: 574 IPPEHMNGQVSI--LGDIYSYGILLLEM 599
+ PE + G+ DI+S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 80/261 (30%), Positives = 119/261 (45%), Gaps = 37/261 (14%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNILRVITA 453
+G+GSFG+VYK G G IVA+K+LK + + ++ E L+ H NI+R+I A
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
E D LV E+ G+L +L LS + IA+ + L+YL
Sbjct: 67 F-----EDKDHLYLVMEYCEGGDLFDYLSRG-------GPLSEDEAKKIALQILRGLEYL 114
Query: 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGY 573
H + I H DLKP N+LLD++ + DFGLAK L K+ + G+ Y
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL-------LKSSSSLTTFVGTPWY 164
Query: 574 IPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631
+ PE + G D++S G++L E+ TGK P F + + + I
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRR------I 214
Query: 632 LDPSMPLDEENDEEQIEEVIE 652
L P + DE EE +
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKD 235
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-37
Identities = 101/264 (38%), Positives = 140/264 (53%), Gaps = 33/264 (12%)
Query: 113 LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172
L G ISG I S+I+ + I +++ NQL G +P D+ T +L+ + N FTGSIP
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 173 VSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANC 232
+ NL+ LD + N L+G IP + GS
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSF------------------------------ 163
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGN 292
+SL+VL L N G++P S+ NL T L LT+ N + G IP +G + +L + L N
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNL-TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222
Query: 293 NLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGN 352
NLSG +P IG L L L L N +G IPSSLGNL L L++ +N+L G IPPS+ +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 353 CQKLLVLNLSSNDLNGTIPKEVRQ 376
QKL+ L+LS N L+G IP+ V Q
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQ 306
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 2e-37
Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 27/221 (12%)
Query: 397 IGTGSFGSVYKGTL-----GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRV 450
+G G+FG VYKGTL G T VA+K LK + + F++E + +K H NI+R+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ C+ +G +V E+M G+L +L +KL++ L +A+ +A +
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMALQIAKGM 115
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
+YL H DL N L+ +++ + DFGL++ ++E G K
Sbjct: 116 EYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLP 167
Query: 571 IGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
I ++ PE +G+ + D++S+G+LL E+FT G++P M
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 392 SKENLIGTGSFGSVYKGTL----GDGTI-VAIKVLKL-QQQGALKSFIDECNALKSTRHR 445
+ +G G+FG VYKG L G + VA+K LK + ++ F+ E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
N+++++ C+ + +V E+M G+L +L + KLS+ L+ A+
Sbjct: 62 NVVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNR------PKLSLSDLLSFALQ 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+A ++YL H DL N L+ +++ + DFGL++ L +
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL------YDDDYYRKR 161
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K I ++ PE + G+ + D++S+G+LL E+FT G++P M
Sbjct: 162 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 395 NLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILR 449
+G G+FG VYKG L G T VA+K LK + K F+ E +K H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIAIDVA 507
++ C+ E + LV E+M G+L +L + LS+ L+ AI +A
Sbjct: 61 LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
++YL H DL N L+ +D+ + DFGL++ +++ K
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP-- 170
Query: 568 KGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRPTGDM 609
I ++ PE + + + D++S+G+LL E+FT G P +
Sbjct: 171 ---IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 27/226 (11%)
Query: 392 SKENLIGTGSFGSVYKGTL----GDGTI-VAIKVLKL-QQQGALKSFIDECNALKSTRHR 445
+ +G G+FG VYKGTL + VA+K LK + ++ F+ E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI++++ C+ + +V E+M G+L +L + K+LS+ L+ A+
Sbjct: 62 NIVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRP-----KELSLSDLLSFALQ 111
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+A ++YL H DL N L+ +++ + DFGL++ L++ K
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK------ 162
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K I ++ PE + G+ + D++S+G+LL E+FT G+ P M
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 32/250 (12%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRN 446
+++ L+G GSFGSVY D G ++A+K ++L L++ E L S +H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL--SVIQRLNIAI 504
I+R S D E N + E++S G+L L +F KL VI++
Sbjct: 61 IVRYYG--SERDEEKNTLN-IFLEYVSGGSLSSLLK-------KFGKLPEPVIRKY--TR 108
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L YLH + I H D+K +N+L+D D + DFG AK + D + T S
Sbjct: 109 QILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAK---RLGDIETGEGTGS 162
Query: 565 IGLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
+ +G+ ++ PE + G+ DI+S G ++EM TGK P + + + + +
Sbjct: 163 V--RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE-LGNPMAALYKIGSS 219
Query: 624 -----LPDHV 628
+P+H+
Sbjct: 220 GEPPEIPEHL 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F IG G FG VYK G VAIKV+KL+ + + I+E LK +H NI++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN------IA 503
+ D +V EF S G+L L + Q L +
Sbjct: 62 YYGSYLK-----KDELWIVMEFCSGGSLKDLLKSTN------------QTLTESQIAYVC 104
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
++ L+YLH + I H D+K +N+LL D + DFGL+ ++SD ++N V
Sbjct: 105 KELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMV 158
Query: 564 SIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE +NG+ DI+S GI +E+ GK P ++
Sbjct: 159 -----GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 39/255 (15%)
Query: 396 LIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
IG G FG V G G VA+K LK A ++F+ E + + + RH N+++++
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLL---- 66
Query: 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH 515
V L+GN +V E+M+ G+L +L Q+L A+DV ++YL
Sbjct: 67 GVVLQGNPL-YIVTEYMAKGSLVDYLRSRGRAVITLA-----QQLGFALDVCEGMEYLE- 119
Query: 516 HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP 575
+ H DL NVL+ +D+ A V DFGLAK +Q G K + +
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSG-KLPVKWTA 167
Query: 576 PEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIH------MFVSMALPDH 627
PE + + S D++S+GILL E+++ G+ P + D H M P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227
Query: 628 VMDI------LDPSM 636
V + LDP+
Sbjct: 228 VYKVMKDCWELDPAK 242
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRH-R 445
++ +G GSFG VY D +VA+KVL + + ++ F+ E L S H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+++ + LV E++ G+L+ L + + LS + L I
Sbjct: 59 NIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQ 109
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ SAL+YLH I H D+KP N+LLD+D + DFGLAK L + + S +
Sbjct: 110 ILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD-PGSTSSIPALP 165
Query: 565 IGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
G+ GY+ PE + G S DI+S GI L E+ TG P K+ + +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG-EKNSSATSQTL 224
Query: 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIE 652
+ L + P P + E + ++++
Sbjct: 225 KIILELPTPSLASPLSPSNPELISKAASDLLK 256
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 391 FSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450
F+ E +G+G FG V++G + VAIK+LK + F E ALK RH++++ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
CS + ++ E M G+L +L SP + L V +++A VA +
Sbjct: 68 FAVCS-----VGEPVYIITELMEKGSLLAFLR-SPEG----QVLPVASLIDMACQVAEGM 117
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
YL + H DL N+L+ +D+ V DFGLA+ + E S + I K
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK---IPYK-- 169
Query: 571 IGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
+ PE + G S D++S+GILL EMFT G+ P
Sbjct: 170 --WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 67/236 (28%), Positives = 101/236 (42%), Gaps = 34/236 (14%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVL---KLQQQGALKSFIDECNAL-KSTR 443
D+F +IG GSF +V AIK+L +L ++ +K E L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H I+++ E N + V E+ NG L Q++ ++ L A
Sbjct: 61 HPGIIKLYYTFQD---EENLY--FVLEYAPNGELLQYIR-------KYGSLDEKCTRFYA 108
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL----FEISDNPSK 559
++ AL+YLH I H DLKP N+LLDKDM + DFG AK L S+
Sbjct: 109 AEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 560 NQTVSIGLK---------GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
S K G+ Y+ PE +N + D+++ G ++ +M TGK P
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 22/220 (10%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRN 446
+ IG GSFG VY DG + +K + L + ++E LK H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I++ E +V E+ G+L Q + E K Q L+ + +
Sbjct: 61 IIKYYE-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEG---KPFPEEQILDWFVQL 112
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
AL YLH I H D+KP N+ L + +GDFG++K L S +TV
Sbjct: 113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVV-- 164
Query: 567 LKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + + DI+S G +L E+ T K P
Sbjct: 165 --GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALK--SFIDECNALKSTRHRNILRVITAC 454
+G G FG V+ GT T VA+K LK G + +F+ E +K RH ++++ C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
S E +V E+MS G+L +L KKL + Q +++A +A + YL
Sbjct: 71 S----EEEPI-YIVTEYMSKGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLE 120
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI 574
H DL N+L+ +++ + DFGLA+ I D+ T G K I +
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARL---IEDD---EYTAREGAKFPIKWT 171
Query: 575 PPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
PE N G+ +I D++S+GILL E+ T G+ P M
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 32/226 (14%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRN 446
N+ +LIG G+FG VYKG L G VAIK + L+ ++ ALKS + E + LK+ +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I++ I + +E +D ++ E+ NG+L Q + F + L +A+ V
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKK-------FGPFP--ESL-VAVYV 105
Query: 507 A---SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
L YLH + + H D+K +N+L KD + DFG+A +++D + +V
Sbjct: 106 YQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVAT---KLNDVSKDDASV 159
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGD 608
G+ ++ PE + S DI+S G ++E+ TG P D
Sbjct: 160 V----GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/246 (30%), Positives = 117/246 (47%), Gaps = 34/246 (13%)
Query: 395 NLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVI 451
N IG G+FG VY L G ++A+K +++Q +K DE L+ +H N+++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 452 TACSSVDLEGNDFKALVF-EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
V++ K +F E+ S G L++ L EH + VI+ + + L
Sbjct: 64 --YYGVEVHRE--KVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVY--TLQLLEGL 112
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
YLH H I H D+KP+N+ LD + +GDFG A ++ +N + L G+
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAV---KLKNNTTTMGEEVQSLAGT 166
Query: 571 IGYIPPEHMNGQVSI--LG--DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF-VSM--- 622
Y+ PE + G DI+S G ++LEM TGKRP + ++F I MF V
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE-LDNEFQI-MFHVGAGHK 224
Query: 623 -ALPDH 627
+PD
Sbjct: 225 PPIPDS 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 32/226 (14%)
Query: 394 ENLIGTGSFGSVYKGTL---GDGTI-VAIKVLKLQQQGALKS-FIDECNALKSTRHRNIL 448
E +IG G FG V +G L G I VAIK LK + F+ E + + H NI+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 449 R---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
R V+T V ++ E+M NG+LD++L E+ K +V Q + +
Sbjct: 69 RLEGVVTKSRPV--------MIITEYMENGSLDKFLR----ENDG--KFTVGQLVGMLRG 114
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+AS + YL H DL N+L++ ++ V DFGL++ L ++ T
Sbjct: 115 IASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL----EDSEATYTTKG 167
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K I + PE + + + D++S+GI++ E+ + G+RP DM
Sbjct: 168 G-KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 73/233 (31%), Positives = 115/233 (49%), Gaps = 35/233 (15%)
Query: 394 ENLIGTGSFGSVYKGTLG----DGTIVAIKVLKL----QQQGALKSFIDECNALKSTRHR 445
E +IG G FG V +G L VAIK LK +Q+ + F+ E + + H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHP 65
Query: 446 NILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
NI+ V+T V ++ EFM NG LD +L + QF +VIQ + +
Sbjct: 66 NIIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQNDG---QF---TVIQLVGM 111
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+A+ + YL + H DL N+L++ ++ V DFGL++FL + + +P+ T
Sbjct: 112 LRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YT 166
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLE-MFTGKRPTGDMFKDD 613
S+G K I + PE + + + D++SYGI++ E M G+RP DM D
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 70/257 (27%), Positives = 106/257 (41%), Gaps = 43/257 (16%)
Query: 397 IGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFID-ECNALKSTRHRNILRVITAC 454
+G GS G VYK G I A+K + + + + E L+S +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV------- 61
Query: 455 SSVDLEGNDFK----ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
V G +K ++V E+M G+L L + K+ IA + L
Sbjct: 62 --VKCYGAFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGL 112
Query: 511 DYLH--HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
DYLH H I H D+KPSN+L++ + DFG++K L D +
Sbjct: 113 DYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------- 161
Query: 569 GSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
G++ Y+ PE + G+ S DI+S G+ LLE GK P + F L
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-------FELMQA 214
Query: 628 VMDILDPSMPLDEENDE 644
+ D PS+P +E + E
Sbjct: 215 ICDGPPPSLPAEEFSPE 231
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 47/234 (20%)
Query: 397 IGTGSFGSVYKGTL------GDGTIVAIKVLK-LQQQGALKSFIDECNALKSTRHRNILR 449
+G G+FG V+ G D +VA+K LK A K F E L + +H NI++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLH----------PSPAEHYQFKKLSVIQR 499
C EG D +VFE+M +G+L+++L + + L++ Q
Sbjct: 73 FYGVC----TEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE---LTLSQL 124
Query: 500 LNIAIDVASALDYL--HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
L IA+ +AS + YL H H DL N L+ D+ +GDFG+++ ++
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVY------ 173
Query: 558 SKNQTVSIGLKGS----IGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
T + G I ++PPE M + + D++S+G++L E+FT GK+P
Sbjct: 174 ---TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 7e-22
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNI 447
+ K +G G++G VYK G IVA+K ++L + G + + E + LK +H NI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 448 LR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
++ VI + LVFE+ +L ++L P LS +I
Sbjct: 61 VKLLDVIHTERKL--------YLVFEYCDM-DLKKYLDKRP------GPLSPNLIKSIMY 105
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L Y H H I H DLKP N+L+++D + DFGLA+ F I P + T
Sbjct: 106 QLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA-FGI---PLRTYTHE 158
Query: 565 IGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
+ ++ Y PE + G ++ DI+S G + EM TGK
Sbjct: 159 V---VTLWYRAPEILLGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 391 FSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNI 447
+ K IG G++G VYK G +VA+K ++++ +G + I E L+ RH NI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 448 LRVITACSSVDLEGNDFKALVFEFMS---NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
+R+ +S +G+ + +VFE+M G LD P K + Q
Sbjct: 61 VRLKEIVTS-KGKGSIY--MVFEYMDHDLTGLLD---SPE-------VKFTESQIKCYMK 107
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L YLH + I H D+K SN+L++ D + DFGLA+ + + N+ +
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 565 IGLKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
++ Y PPE +V D++S G +L E+F GK
Sbjct: 164 -----TLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 396 LIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALK-SFIDECNALKSTRHRNILRVITAC 454
IG G+FG VYKG L T VA+K + LK F+ E LK H NI+++I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
V + +V E + G+L +L L+V + L +++D A+ ++YL
Sbjct: 62 --VQKQP---IYIVMELVPGGSLLTFLRKKKNR------LTVKKLLQMSLDAAAGMEYLE 110
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG-SIGY 573
H DL N L+ ++ + DFG+++ + TVS GLK I +
Sbjct: 111 SKN---CIHRDLAARNCLVGENNVLKISDFGMSR------EEEGGIYTVSDGLKQIPIKW 161
Query: 574 IPPEHMN-GQVSILGDIYSYGILLLEMFTG 602
PE +N G+ + D++SYGILL E F+
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 72/225 (32%), Positives = 95/225 (42%), Gaps = 49/225 (21%)
Query: 397 IGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILR-- 449
+G GSFG V K T G + A+KVLK K I + ++ T RNIL
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRI 50
Query: 450 -----VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS---PAEHYQFKKLSVIQRLN 501
V + E + LV E+ G L L E +F
Sbjct: 51 NHPFIVKLHYAFQT-EEKLY--LVLEYAPGGELFSHLSKEGRFSEERARF---------- 97
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
A ++ AL+YLH I + DLKP N+LLD D + DFGLAK E+S S+
Sbjct: 98 YAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTN 151
Query: 562 TVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
T G+ Y+ PE + D +S G+LL EM TGK P
Sbjct: 152 TFC----GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 391 FSKENL-----IGTGSFGSVYKGT---LGDGT--IVAIKVLKLQQQGALKS-FIDECNAL 439
F K +L +G G FG V LGD T VA+K L + +S F E L
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
++ H NI++ C G L+ E++ +G+L +L ++++ +
Sbjct: 61 RTLDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQ------RHRDQINLKRL 111
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
L + + +DYL H DL N+L++ + + DFGLAK L E D
Sbjct: 112 LLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168
Query: 560 NQTVSIGLKGSIG---YIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPT 606
+ G Y P + S D++S+G+ L E+FT P+
Sbjct: 169 KE------PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 76/250 (30%), Positives = 112/250 (44%), Gaps = 36/250 (14%)
Query: 393 KENLIGTGSFGSVYKG-TLGDGTIVAIKVLKL-----QQQGALKSFIDECNALKSTRHRN 446
K L+G+GSFGSVY+G L DG A+K + L Q A+K E L +H N
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 447 ILRVI-TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I++ + T +L + E + G+L + L + Y VI+
Sbjct: 64 IVQYLGTEREEDNL------YIFLELVPGGSLAKLL-----KKYGSFPEPVIR--LYTRQ 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L+YLH D H D+K +N+L+D + + DFG+AK + E S S
Sbjct: 111 ILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS------- 160
Query: 566 GLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
KGS ++ PE + G + DI+S G +LEM TGK P + + S
Sbjct: 161 -FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 624 L---PDHVMD 630
L PDH+ D
Sbjct: 220 LPPIPDHLSD 229
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKS 441
I S F KE +G+G FG V+ G VAIK+++ +GA+ FI+E +
Sbjct: 1 IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMK 55
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
H N++++ C+ +V E+M+NG L +L KL L+
Sbjct: 56 LSHPNLVQLYGVCTK-----QRPIFIVTEYMANGCLLNYLRERK------GKLGTEWLLD 104
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ DV A++YL + H DL N L+ +D V DFGLA+++ +
Sbjct: 105 MCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD------DQY 155
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
T S G K + + PPE + + S D++S+G+L+ E+F+ GK P
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 392 SKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKL-QQQGALKSFIDECNALKSTRHRN 446
+K+ +IG G FG V++G L VAIK LK + + F+ E + + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 447 ILRVITACSSVDLEG--NDFK--ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
I+R LEG FK ++ E+M NG LD++L E S Q + +
Sbjct: 68 IIR---------LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE------FSSYQLVGM 112
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+A+ + YL D H DL N+L++ ++ V DFGL++ L D+P T
Sbjct: 113 LRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYT 166
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
S G K I + PE + + + D++S+GI++ E+ + G+RP DM
Sbjct: 167 TS-GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456
+G G FG V+ GT T VAIK LK ++F+ E +K RH ++++ S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516
+ +V E+MS G+L +L K L + Q +++A +AS + Y+
Sbjct: 73 EPI------YIVTEYMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVER- 120
Query: 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576
H DL+ +N+L+ +++ V DFGLA+ I DN T G K I + P
Sbjct: 121 --MNYVHRDLRAANILVGENLVCKVADFGLARL---IEDN---EYTARQGAKFPIKWTAP 172
Query: 577 E-HMNGQVSILGDIYSYGILLLEMFTGKR 604
E + G+ +I D++S+GILL E+ T R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 34/229 (14%)
Query: 395 NLIGTGSFGSVYKGT----LGDGT---IVAIKVLKLQQQGAL----KSFIDECNALKSTR 443
N +G+G+FG VY+GT LG G+ VA+K L+ +GA K F+ E + + +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H NI++++ C N+ + ++ E M G+L +L + E + L++ + L+I
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLL-----DKDMTAHVGDFGLAKFLFEISDNPS 558
+DVA YL H DL N L+ D D +GDFGLA+ +++ SD
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYR 168
Query: 559 KNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
K + ++ ++ PE ++G+ + D++S+G+L+ E+ T G++P
Sbjct: 169 KEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456
+G G FG V++G + T VA+K LK K F+ E +K RH ++++ C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516
+ +V E M G+L ++L + L + Q +++A VAS + YL
Sbjct: 73 -----EEPIYIVTELMKYGSLLEYLQ-----GGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576
H DL NVL+ ++ V DFGLA+ + E + G K I + P
Sbjct: 123 ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE------GAKFPIKWTAP 173
Query: 577 E--HMNGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
E N + SI D++S+GILL E+ T G+ P M
Sbjct: 174 EAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456
IG G FG+V +G G VA+K +K ++F++E + H+N++R++
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516
L +V E MS GNL +L +SVIQ L ++DVA ++YL
Sbjct: 71 NGLY------IVMELMSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576
+ H DL N+L+ +D A V DFGLA+ + +K + P
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARV------GSMGVDNSKLPVK----WTAP 166
Query: 577 EHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
E + + + S D++SYG+LL E+F+ G+ P M
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 37/242 (15%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKG---TLGDG---TIVAIKVLKLQQQGALKS-FIDEC 436
I S F +E +G G+FG VYKG + T VAIK LK + ++ F E
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-HPSPAEHYQF---- 491
+ +H NI+ ++ C+ ++FE++++G+L ++L SP
Sbjct: 60 ELMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 492 ----KKLSVIQRLNIAIDVASALDYL--HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545
L L+IAI +A+ ++YL HH H DL N L+ + +T + DFG
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFG 169
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GK 603
L++ ++ S + + Q+ S+ + ++PPE + G+ + DI+S+G++L E+F+ G
Sbjct: 170 LSRDIY--SADYYRVQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 604 RP 605
+P
Sbjct: 225 QP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 74/230 (32%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 394 ENLIGTGSFGSVYKGTL---GDGTI-VAIKVLKL-QQQGALKSFIDECNALKSTRHRNIL 448
E +IG G FG V G L G I VAIK LK + + F+ E + + H NI+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 449 R---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
V+T V +V E+M NG+LD +L QF +VIQ + +
Sbjct: 69 HLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDG---QF---TVIQLVGMLRG 114
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+AS + YL D H DL N+L++ ++ V DFGL++ L D+P T
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTR- 167
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLE-MFTGKRPTGDMFKDD 613
G K I + PE + + + D++SYGI++ E M G+RP +M D
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 31/220 (14%)
Query: 396 LIGTGSFGSVYKGT----LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILR- 449
+G GSFG V +G G VA+K LK + + F+ E + S H N++R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 450 --VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
V+ + +V E G+L L H+ L + A+ +A
Sbjct: 62 YGVVLTHPLM---------MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIA 107
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ + YL H DL N+LL D +GDFGL + L + D + + L
Sbjct: 108 NGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----HYVMEEHL 160
Query: 568 KGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
K + PE + S D++ +G+ L EMFT G+ P
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 75/244 (30%), Positives = 104/244 (42%), Gaps = 62/244 (25%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKS---FIDECNALKS 441
D+F +GTGSFG V +KG+ G A+K+L + LK ++E L+S
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 442 TRHRNILRVITACSSVDLEGNDFKAL--VFEFMSNGNLDQWLHPS---PAEHYQFKKLSV 496
RH ++ + + D L V E++ G L L S P +F
Sbjct: 58 IRHPFLVNLYGSFQ-------DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF----- 105
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
A V AL+YLH D I + DLKP N+LLD D + DFG AK +
Sbjct: 106 -----YAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV------ 151
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRPTGDM 609
K +T + L G+ Y+ PE IL D ++ GIL+ EM G P
Sbjct: 152 --KGRTYT--LCGTPEYLAPE------IILSKGYGKAVDWWALGILIYEMLAGYPP---- 197
Query: 610 FKDD 613
F DD
Sbjct: 198 FFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITA 453
E +G G FG V+ T T VA+K +K ++++F+ E N +K+ +H ++++
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
+ + ++ EFM+ G+L +L KL ++ + +A + ++
Sbjct: 70 VTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFI 118
Query: 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGY 573
H DL+ +N+L+ + + DFGLA+ I DN T G K I +
Sbjct: 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARV---IEDN---EYTAREGAKFPIKW 169
Query: 574 IPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
PE +N G +I D++S+GILL+E+ T G+ P M
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 395 NLIGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGALKSFIDECNALK---STRHRNIL 448
IG G++G+VYK L G VA+K ++ L ++G S + E LK S H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIAIDV 506
R++ C + LVFE + +L +L P P L ++ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-------LPPETIKDLMRQL 116
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+D+LH H I H DLKP N+L+ D + DFGLA+ I +V +
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEMALTSVVVT 169
Query: 567 LKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMF 600
L Y PE +L D++S G + E+F
Sbjct: 170 L----WYRAPE------VLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456
+G G FG V+ G + T VA+K LK ++++F++E N +K+ +H ++R+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516
+ ++ E+M+ G+L +L KL ++ + +A + Y+
Sbjct: 73 -----EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER- 121
Query: 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576
H DL+ +NVL+ + + + DFGLA+ I DN T G K I + P
Sbjct: 122 --KNYIHRDLRAANVLVSESLMCKIADFGLARV---IEDN---EYTAREGAKFPIKWTAP 173
Query: 577 EHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613
E +N G +I D++S+GILL E+ T GK P M D
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 397 IGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450
+G G+FG V+ D +VA+K LK + A + F E L +H++I+R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPA------EHYQFKKLSVIQRLNI 502
C+ EG +VFE+M +G+L+++L H A E +L++ Q L I
Sbjct: 73 YGVCT----EG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
A +AS + YL H DL N L+ + + +GDFG+++ ++ +T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 563 VSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
+ I ++PPE + + + DI+S+G++L E+FT GK+P
Sbjct: 185 ML-----PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGT---LGDGTI--VAIKVLKLQQ-QGALKSFIDECN 437
I K T+ K ++G+G+FG+VYKG G+ VAIKVL+ + A K +DE
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ S H +++R++ C S + L+ + M G L ++ H +
Sbjct: 62 VMASVDHPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVR----NHKD--NIGSQ 109
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
LN + +A + YL + H DL NVL+ + DFGLAK L +
Sbjct: 110 YLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----DV 161
Query: 558 SKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRP 605
+ + + G K I ++ E + + + D++SYG+ + E+ T G +P
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRNILRVITAC 454
+G G FG V+ G T VAIK LK QG++ ++F+ E N +K +H ++R+
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
+ + ++ E+M NG+L +L KL++ + +++A +A + ++
Sbjct: 71 TQEPI------YIITEYMENGSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIE 119
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI 574
H DL+ +N+L+ + + + DFGLA+ I DN T G K I +
Sbjct: 120 RK---NYIHRDLRAANILVSETLCCKIADFGLARL---IEDN---EYTAREGAKFPIKWT 170
Query: 575 PPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
PE +N G +I D++S+GILL E+ T G+ P M
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVL-------KLQQQGALKSFIDECNALKSTRHRNIL 448
IG GSFG+V K DG I+ K + K +QQ + E N L+ +H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-----LVSEVNILRELKHPNIV 62
Query: 449 RVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
R D + +V E+ G+L Q + E ++ + + I
Sbjct: 63 RYY------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR---ILTQ 113
Query: 506 VASALDYLHH--HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ AL H+ + H DLKP+N+ LD + +GDFGLAK + + S +T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---ILGHDSSFAKTY 170
Query: 564 SIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE +N DI+S G L+ E+ P
Sbjct: 171 V----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456
+G G FG V+ GT T VA+K LK +SF++E +K RH ++++ S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516
+ +V E+MS G+L +L + L + +++A VA+ + Y+
Sbjct: 73 EPI------YIVTEYMSKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIER- 120
Query: 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576
H DL+ +N+L+ + + DFGLA+ I DN T G K I + P
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARL---IEDN---EYTARQGAKFPIKWTAP 172
Query: 577 E-HMNGQVSILGDIYSYGILLLEMFTGKR 604
E + G+ +I D++S+GILL E+ T R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRNILRVITAC 454
+G G FG V+ GT T VAIK LK G + ++F+ E +K RH ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
S + +V EFM G+L +L ++ L + Q +++A +A + Y+
Sbjct: 71 SEEPI------YIVTEFMGKGSLLDFLKEGDGKY-----LKLPQLVDMAAQIADGMAYIE 119
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI 574
H DL+ +N+L+ ++ + DFGLA+ I DN T G K I +
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARL---IEDN---EYTARQGAKFPIKWT 170
Query: 575 PPE-HMNGQVSILGDIYSYGILLLEMFTGKR 604
PE + G+ +I D++S+GILL E+ T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKL----------QQQGALKSFIDECNA 438
+ K LIG G++G VY + G ++A+K ++L +Q+ +K+ E
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH-PSPAEHYQFKKLSVI 497
LK H NI++ + ++ ++ E++ G++ L E + +
Sbjct: 62 LKDLDHLNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE- 115
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
V L YLH I H DLK N+L+D D + DFG++K +I DN
Sbjct: 116 -------QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND 165
Query: 558 SKNQTVSIGLKGSIGYIPPE--HMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609
++GS+ ++ PE H Q S DI+S G ++LEMF G+RP D
Sbjct: 166 QNMS-----MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 391 FSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKS--FIDECNALKSTRHRNIL 448
F KE +GTG FG V G VAIK++K +G++ FI+E + H ++
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ C+ + + +V E+MSNG L +L EH K+ Q L + DV
Sbjct: 63 QLYGVCTK---QRPIY--IVTEYMSNGCLLNYLR----EH--GKRFQPSQLLEMCKDVCE 111
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ YL H DL N L+D V DFGL++++ + T S+G K
Sbjct: 112 GMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD------DEYTSSVGSK 162
Query: 569 GSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFT-GKRP 605
+ + PPE + + S D++++G+L+ E+++ GK P
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 396 LIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALK-SFIDECNALKSTRHRNILRVITAC 454
L+G G+FG V+KGTL D T VA+K K LK F+ E LK H NI+++I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
+ +V E + G+ +L E L Q + A+D A+ + YL
Sbjct: 62 TQ-----RQPIYIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAYLE 110
Query: 515 -HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG-SIG 572
+C H DL N L+ ++ + DFG+++ S GLK I
Sbjct: 111 SKNC----IHRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIK 159
Query: 573 YIPPEHMN-GQVSILGDIYSYGILLLEMFT 601
+ PE +N G+ S D++SYGILL E F+
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKS 441
I S +E IG+G FG V+ G + VAIK ++ +GA+ + FI+E +
Sbjct: 1 IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMK 55
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
H ++++ C+ LVFEFM +G L +L Q K S L
Sbjct: 56 LSHPKLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYLRA------QRGKFSQETLLG 104
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ +DV + YL + H DL N L+ ++ V DFG+ +F+ +
Sbjct: 105 MCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD------DQY 155
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
T S G K + + PE + + S D++S+G+L+ E+F+ GK P
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTR 443
NF E IG G F VYK L DG +VA+K ++ + A + + E + LK
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL--N 501
H N+++ + + +E N+ +V E G+L + + +H++ +K + +R
Sbjct: 61 HPNVIKYLASF----IENNELN-IVLELADAGDLSRMI-----KHFKKQKRLIPERTIWK 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ + SAL+++H I H D+KP+NV + +GD GL +F S
Sbjct: 111 YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT 160
Query: 562 TVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
T + L G+ Y+ PE ++ + DI+S G LL EM + P F D
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD------- 209
Query: 621 SMALPDHVMDILDPSM-PLDEENDEEQIEEVIEEKEMMIHID 661
M L I PL ++ E++ +++ I+ D
Sbjct: 210 KMNLYSLCKKIEKCDYPPLPADHYSEELRDLV---SRCINPD 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 27/237 (11%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGAL 429
K + +S D + N K IG G+ G VYK T G VAIK ++L++Q
Sbjct: 4 LKAALKDIVSEGDPRELYKNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NK 59
Query: 430 KSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY 489
+ I+E +K +H NI+ S + + +V E+M G+L +
Sbjct: 60 ELIINEILIMKDCKHPNIVDYY---DSYLVGDELW--VVMEYMDGGSLTDII-----TQN 109
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
F +++ Q + +V L+YLH + H D+K N+LL KD + + DFG A
Sbjct: 110 -FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
L K++ S+ G+ ++ PE + + DI+S GI+ +EM G+ P
Sbjct: 166 L-----TKEKSKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIK---VLKLQQQGALKSFIDECNALKSTRHR 445
NF E IG G F VY+ T L DG VA+K + L A I E + LK H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL--NIA 503
N+++ + +E N+ +V E G+L + + +H++ +K + ++
Sbjct: 63 NVIKYYASF----IEDNELN-IVLELADAGDLSRMI-----KHFKKQKRLIPEKTVWKYF 112
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ + SAL+++H + H D+KP+NV + +GD GL +F S T
Sbjct: 113 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTA 162
Query: 564 SIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ L G+ Y+ PE H NG + DI+S G LL EM + P
Sbjct: 163 AHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVL---KLQQQGALKSFIDECNALKSTRHR 445
+F +IG G+FG V D + A+K + K ++G++++ ++E L+ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
++ + S E N + LV + + G+L H S F + V + I +
Sbjct: 61 FLVNL---WYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVK--FSEEQV--KFWIC-E 108
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ AL+YLH I H D+KP N+LLD+ H+ DF +A + T++
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--------TPDTLTT 157
Query: 566 GLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G+ GY+ PE + Q S+ D +S G+ E GKRP
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 394 ENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVIT 452
++ +G G +G VY+G VA+K LK + ++ F+ E +K +H N+++++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
C+ E + ++ EFM+ GNL +L + +++ + L +A ++SA++Y
Sbjct: 70 VCT---REPPFY--IITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEY 119
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
L H DL N L+ ++ V DFGL++ + T G K I
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGAKFPIK 170
Query: 573 YIPPEHMN-GQVSILGDIYSYGILLLEMFT 601
+ PE + + SI D++++G+LL E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 397 IGTGSFGSVYKGTLGD------GTIVAIKVLKLQQQGALK---SFIDECNALKSTRHRNI 447
+G GSFG VY+G T VAIK + + +++ F++E + +K ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVMKEFNCHHV 71
Query: 448 LRVITACSSVDLEGNDFKALV-FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR---LNIA 503
+R++ S+ LV E M+ G+L +L E L + +A
Sbjct: 72 VRLLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
++A + YL H DL N ++ +D+T +GDFG+ + ++E +D K
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-TDYYRK---- 177
Query: 564 SIGLKG--SIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT 601
G KG + ++ PE +G + D++S+G++L EM T
Sbjct: 178 --GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 397 IGTGSFGSVYKGTL----GDGTIVAIKVLKLQQQGALKS-FIDECNALKSTRHRNILRVI 451
+G G+FGSV KG G VA+K LK + A K F+ E + + H I+R+I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
C +G LV E G L ++L ++ V +A VA +
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYLKKRR-------EIPVSDLKELAHQVAMGMA 109
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YL H DL NVLL A + DFG+++ L + + T + +
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATT---AGRWPL 162
Query: 572 GYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ PE +N G+ S D++SYG+ L E F+ G +P G+M
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 18/219 (8%)
Query: 396 LIGTGSFGSVYKGTLG--DGTI--VAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILR 449
++G G FGSV +G L DG+ VA+K +KL ++ F+ E +K H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 450 VITAC-SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+I C + L+ ++ FM +G+L +L S +KL + L +D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG-LPEKLPLQTLLKFMVDIAL 124
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
++YL + H DL N +L +DMT V DFGL+K ++ S + + ++ K
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQGRIA---K 176
Query: 569 GSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRP 605
+ +I E + +V + D++++G+ + E+ T G+ P
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 65/244 (26%), Positives = 115/244 (47%), Gaps = 43/244 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LG-----DGTIVAIKVLK----LQQQGALKSFIDECNA 438
+N IG G+FG V++ G T+VA+K+LK Q F E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAAL 61
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-HPSPAEHYQFKK---- 493
+ H NI++++ C+ G L+FE+M+ G+L+++L H SP
Sbjct: 62 MAEFDHPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 494 ----------LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543
LS ++L IA VA+ + YL + H DL N L+ ++M + D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT- 601
FGL++ ++ +D ++ +I I ++PPE + + + D+++YG++L E+F+
Sbjct: 174 FGLSRNIYS-ADYYKASENDAI----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228
Query: 602 GKRP 605
G +P
Sbjct: 229 GMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 56/169 (33%), Positives = 77/169 (45%), Gaps = 30/169 (17%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNAL---KSTR----HRNIL 448
+G G+FGSVY G +VAIK +K S+ +EC L KS R H NI+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ V E ND VFE+M GNL Q + + + K S +I +
Sbjct: 62 KLK----EVFRE-NDELYFVFEYM-EGNLYQLM-----KDRKGKPFSESVIRSIIYQILQ 110
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
L ++H H H DLKP N+L+ + DFGLA+ EI P
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRP 153
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 27/223 (12%)
Query: 397 IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450
+G G+FG V+ D +VA+K LK A K F E L + +H +I++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---PSP---AEHYQFKKLSVIQRLNIAI 504
C +EG+ +VFE+M +G+L+++L P AE + +L+ Q L+IA
Sbjct: 73 YGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+A+ + YL H DL N L+ +++ +GDFG+++ ++ T+
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 565 IGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
I ++PPE M + + D++S G++L E+FT GK+P
Sbjct: 185 -----PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 390 NFSKENLIGTGSFGSVYK-GTLGDGTIVAIKVLKL--QQQGALKSFIDECNALKSTRHRN 446
+F +G GS+GSVYK L D A+K + L Q + ++E L S H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+ A L+GN +V E+ G+L + + + + + I I +
Sbjct: 61 IISYKEAF----LDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQL 112
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
L LH + I H DLK +N+LL + +GD G++K L N +K Q
Sbjct: 113 LRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI---- 162
Query: 567 LKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE G+ S DI+S G LL EM T P
Sbjct: 163 --GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 30/226 (13%)
Query: 397 IGTGSFGSVYKGT------LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450
+G G+FG V+ D +VA+K LK A K F E L + +H +I++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPA------EHYQFK-KLSVIQRLN 501
C D +VFE+M +G+L+++L H A + Q K +L + Q L+
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
IA +AS + YL H DL N L+ ++ +GDFG+++ ++
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 562 TVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
T+ I ++PPE M + + D++S+G++L E+FT GK+P
Sbjct: 185 TML-----PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID---ECNALKSTRHRN 446
F+ IG GSFG VYK +VAIKV+ L++ A D E L R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPY 60
Query: 447 ILRVITACSSVDLEGNDFK-ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I + S + K ++ E+ G+ L P + ++ I R +
Sbjct: 61 ITKYYG--SFLK----GSKLWIIMEYCGGGSCLDLLKPGKLDE---TYIAFILR-----E 106
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
V L+YLH + I H D+K +N+LL ++ + DFG++ +++ SK T
Sbjct: 107 VLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNT--- 157
Query: 566 GLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE DI+S GI +E+ G+ P D+
Sbjct: 158 -FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIK---VLKLQQQGALKSFIDECNALKSTRHR 445
NF E IG G F VY+ T L D VA+K + ++ A + + E + LK H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL--NIA 503
N+++ + + +E N+ +V E G+L Q + ++++ +K + +R
Sbjct: 63 NVIKYLDSF----IEDNELN-IVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYF 112
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ + SA++++H + H D+KP+NV + +GD GL +F S T
Sbjct: 113 VQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTA 162
Query: 564 SIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ L G+ Y+ PE H NG + DI+S G LL EM + P
Sbjct: 163 AHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 43/221 (19%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGAL-KSFIDECNALKSTRHRNILRVITAC 454
+G G+ G V K G I+A+K ++L+ A+ K + E + L I+ A
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN------IAIDVAS 508
+ G+ + E+M G+LD+ K V R+ IA+ V
Sbjct: 69 YN---NGDIS--ICMEYMDGGSLDK-----------ILK-EVQGRIPERILGKIAVAVLK 111
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
L YLH I H D+KPSN+L++ + DFG+ S S+ K
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV-----------SGQLVNSLA-K 157
Query: 569 GSIG---YIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
+G Y+ PE + G S+ DI+S G+ L+E+ TG+ P
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 37/216 (17%)
Query: 397 IGTGSFGSVYKGTLGD--GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITAC 454
IG G FG V LGD G VA+K +K ++F+ E + + RH N+++++
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL--- 65
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI---QRLNIAIDVASALD 511
V +E +V E+M+ G+L +L + SV+ L ++DV A++
Sbjct: 66 -GVIVEEKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAME 116
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YL + H DL NVL+ +D A V DFGL K E S S T + +K
Sbjct: 117 YLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS---STQDTGKLPVK--- 164
Query: 572 GYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRP 605
+ PE + + S D++S+GILL E+++ G+ P
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 31/171 (18%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-----ECNALKSTR 443
+ K +G G++ VYK G IVAIK +KL ++ K I+ E L+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHP-----SPAEHYQFKKLSVIQ 498
H NI+ ++ LVFEFM +L++ + +PA+ K ++
Sbjct: 61 HPNIIGLLDVFGH-----KSNINLVFEFME-TDLEKVIKDKSIVLTPAD----IKSYMLM 110
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
L L+YLH + I H DLKP+N+L+ D + DFGLA+
Sbjct: 111 TLR-------GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 52/232 (22%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNI 447
NF + +G G++ +VYKG G IVA+K + L ++G + I E + +K +H NI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 448 LR---VITACSSVDLEGNDFKALVFEFMSNGNLDQW---------LHPSPAEHYQFKKLS 495
+R VI + + LVFE+M +L ++ L P+ + + ++ L
Sbjct: 61 VRLHDVIHTENKL--------MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+ + H + + H DLKP N+L++K + DFGLA+ F I
Sbjct: 112 -------------GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPV 154
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
N N+ V ++ Y P+ + G SI DI+S G ++ EM TG+
Sbjct: 155 NTFSNEVV------TLWYRAPDVLLGSRTYSTSI--DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 397 IGTGSFGSVY---KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRV 450
I G++G V+ K + GD I AIKV+K + ++ + + E + L + V
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY---V 55
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ S + N + LV E++ G+L L L ++ AL
Sbjct: 56 VKLYYSFQGKKNLY--LVMEYLPGGDLASLLE-------NVGSLDEDVARIYIAEIVLAL 106
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF-LFEISDNPSKNQTVSIGLKG 569
+YLH + I H DLKP N+L+D + + DFGL+K L N + ++ + G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 570 SIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ YI PE + GQ S D +S G +L E G P
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 34/79 (43%), Positives = 53/79 (67%)
Query: 48 GQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSG 107
G IPN +S L L+ I L G+++ GN+P +G+ +SL+ L L++N+ GSIP LGQL+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 108 LGFFTLYGNFISGIIPSSI 126
L L GN +SG +P+++
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKL--QQQGALKSFIDECNALKSTRHRNI---LRV 450
IG G++G VYK G IVAIK +KL + +G K+ + E LK H NI L V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ LVFEFM +L + + + Q + L + + L
Sbjct: 67 FRHKGDL--------YLVFEFMDT-DLYKLI-----KDRQ-RGLPESLIKSYLYQLLQGL 111
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
+ H H I H DLKP N+L++ + + DFGLA+ F P + V +
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVV------T 161
Query: 571 IGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGK 603
Y PE + G S DI+S G + E+ + +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 77/250 (30%), Positives = 120/250 (48%), Gaps = 31/250 (12%)
Query: 393 KENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGA-----LKSFID----ECNALKST 442
K LIG+GSFGSVY G G ++A+K ++L A +S +D E LK
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
+H NI++ + SS+D D + E++ G++ L+ A + V Q L
Sbjct: 64 QHENIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-- 116
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
L+YLH+ I H D+K +N+L+D + DFG++K L E + +K
Sbjct: 117 -----KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNG 167
Query: 563 VSIGLKGSIGYIPPEHMNGQVSIL--GDIYSYGILLLEMFTGKRPTGDM--FKDDFSIHM 618
L+GS+ ++ PE + Q S DI+S G L++EM TGK P D + F I
Sbjct: 168 ARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 619 FVSMALPDHV 628
S +P ++
Sbjct: 227 NASPEIPSNI 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 6e-15
Identities = 59/235 (25%), Positives = 89/235 (37%), Gaps = 62/235 (26%)
Query: 395 NLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALKSTRHRNI 447
IG+G++G V G VAIK K+ ID E L+ RH NI
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISN--VFDDLIDAKRILREIKLLRHLRHENI 61
Query: 448 LRVITACSSVDLEGNDFKAL--VFEFMSNGNLDQWLH-PSP--AEHYQFKKLSVIQRLNI 502
+ ++ E DF + V E M +L + + P P +H Q+
Sbjct: 62 IGLLDILRPPSPE--DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY----------F 108
Query: 503 AIDVASALDYLH--HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ L YLH + + H DLKPSN+L++ + + DFGLA+ + D
Sbjct: 109 LYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG-F 162
Query: 561 QTVSIGLKGSIGYI------PPEHM------NGQVSILGDIYSYGILLLEMFTGK 603
T Y+ PE + + DI+S G + E+ T K
Sbjct: 163 LT---------EYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 395 NLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFI-DECNALKSTRHRNILRVIT 452
N IG+G+ G+VYK G + A+KV+ + ++ I E L+ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
C + + + L+ EFM G+L+ E + L+ ++A + S + Y
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQF----LA-----DVARQILSGIAY 183
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
LH I H D+KPSN+L++ + DFG+++ L + D P N +V G+I
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC-NSSV-----GTIA 233
Query: 573 YIPPEHMNGQVS------ILGDIYSYGILLLEMFTGKRPTG 607
Y+ PE +N ++ GDI+S G+ +LE + G+ P G
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 31/235 (13%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTL---GDGTIVAIKVLKLQQQGALKSF---IDECN 437
I K T+ K L+G+G FG+V+KG GD + + + +Q + ++F D
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
A+ S H I+R++ C L+ LV + G+L + Q +
Sbjct: 62 AMGSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVR-------QHRDSLDP 108
Query: 498 QRL-NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
QRL N + +A + YL H + H +L N+LL D + DFG+A L+
Sbjct: 109 QRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY----- 160
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
P + K I ++ E + G+ + D++SYG+ + EM + G P M
Sbjct: 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 68/235 (28%), Positives = 105/235 (44%), Gaps = 44/235 (18%)
Query: 389 DNFSKENLIGTGSFGSVY--KGTLGDGTIVAIKVLKLQQQGALKS---FIDECNALKSTR 443
D+ + +GTG+FG V+ + + A+KV+ + + LK +E LK
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H I+R+ + D F ++ E++ G L +L S + S L A
Sbjct: 60 HPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYA 107
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
++ AL+YLH I + DLKP N+LLDK+ + DFG AK ++ D + T
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRD---RTWT- 157
Query: 564 SIGLKGSIGYIPPEHM-----NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
L G+ Y+ PE + N V D ++ GIL+ EM G P F DD
Sbjct: 158 ---LCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP----FFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 394 ENLIGTGSFGSVYKGTL---GDGTIVAIKVLK-LQQQGALKSFIDECNAL-KSTRHRNIL 448
E++IG G+FG V + + G AIK+LK + + F E L K H NI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS------PA---EHYQFKKLSVIQR 499
++ AC E + + E+ GNL +L S PA EH L+ Q
Sbjct: 67 NLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
L A DVA+ + YL + H DL NVL+ +++ + + DFGL S+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL-----------SR 167
Query: 560 NQTVSIGLKGSIGYIPP-----EHMNGQV-SILGDIYSYGILLLEMFT 601
+ V + K ++G +P E +N V + D++S+G+LL E+ +
Sbjct: 168 GEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/229 (26%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 391 FSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL------KSFIDECNALKSTRH 444
++K ++G G++G+VY G G ++A+K ++L L + +E + LKS +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI++ + C L+ N ++ EF+ G++ L+ +F L
Sbjct: 62 VNIVQYLGTC----LDDNTI-SIFMEFVPGGSISSILN-------RFGPLPEPVFCKYTK 109
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ + YLH++C + H D+K +NV+L + + DFG A+ L + + + + +
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 565 IGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+ G+ ++ PE +N G+ S DI+S G + EM TGK P M
Sbjct: 167 -SMHGTPYWMAPEVINESGYGRKS---DIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 39/237 (16%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKL--QQQGALKSFIDECNALKS 441
+ D F IG G++G VYK D G +VA+K ++L +++G + I E L+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 442 TRHRNILRVITACSSVDLEGNDFKA------LVFEFMSN---GNLDQWLHPSPAEHYQFK 492
HRNI+ + + + DFK LVFE+M + G L+ L +H +
Sbjct: 63 LNHRNIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-- 119
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
S +++L L+Y H H D+K SN+LL+ + DFGLA+
Sbjct: 120 --SFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRP 605
P N+ + ++ Y PPE + G+ +I D++S G +L E+FT K+P
Sbjct: 169 EESRPYTNKVI------TLWYRPPELLLGEERYGPAI--DVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 21/231 (9%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTI-----VAIKVLKLQ-QQGALKSFIDECN 437
I+ S D + +L+ G+FG ++ G L D V +K +K + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH-PSPAEHYQFKKLSV 496
L H+NIL ++ C E + +++ +M+ GNL +L E + LS
Sbjct: 61 LLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
Q +++AI +A + YLH + H D+ N ++D+++ + D L++ LF
Sbjct: 117 QQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLF----- 168
Query: 557 PSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRP 605
P + + ++ E + N + S D++S+G+LL E+ T G+ P
Sbjct: 169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITAC 454
IG G+ VY L + VAIK + L++ Q ++ E A+ H N+ V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV--VKYYT 66
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI---DVASALD 511
S V G++ LV ++S G+L + + + + IA +V L+
Sbjct: 67 SFV--VGDEL-WLVMPYLSGGSLLDIMK------SSYPR-GGLDEAIIATVLKEVLKGLE 116
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YLH + H D+K N+LL +D + + DFG++ L + D K + + G+
Sbjct: 117 YLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV---GTP 170
Query: 572 GYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRP 605
++ PE M QV DI+S+GI +E+ TG P
Sbjct: 171 CWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 397 IGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKS-FIDECNALKSTRHRNILRVITAC 454
IG G+FG V+ G L D T VA+K + LK+ F+ E LK H NI+R+I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514
+ +V E + G+ +L + + K+L + + + A+ ++YL
Sbjct: 63 TQ-----KQPIYIVMELVQGGDFLTFLR-TEGPRLKVKEL-----IQMVENAAAGMEYLE 111
Query: 515 -HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG-SIG 572
HC H DL N L+ + + DFG+++ E D + G+K +
Sbjct: 112 SKHC----IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV---YASTGGMKQIPVK 161
Query: 573 YIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ PE +N G+ S D++S+GILL E F+ G P ++
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-ECNALKSTRHRNIL 448
+ + LIG G++G+VY+G + G +VA+K++ L S I E L R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP-AEHYQFKKLSVIQRLNIAIDVA 507
+ S L+G ++ E+ G++ + P AE Y +SVI R +V
Sbjct: 63 NITKYYGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKY----ISVIIR-----EVL 111
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
AL Y+H + H D+K +N+L+ + DFG+A ++ N SK T
Sbjct: 112 VALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAA---LLNQNSSKRST----F 161
Query: 568 KGSIGYIPPEHMNGQVS--ILGDIYSYGILLLEMFTGKRPTGD 608
G+ ++ PE + DI+S GI + EM TG P D
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 53/235 (22%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F +G GS+GSVYK G +VAIKV+ ++ L+ I E + LK I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYI-- 60
Query: 450 VITACSSVDLEGNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN---- 501
V G+ FK +V E+ G++ +++ N
Sbjct: 61 -------VKYYGSYFKNTDLWIVMEYCGAGSV----------------SDIMKITNKTLT 97
Query: 502 ---IAI---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
IA L+YLH + H D+K N+LL+++ A + DFG++ +++D
Sbjct: 98 EEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS---GQLTD 151
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609
+K TV G+ ++ PE + + DI+S GI +EM GK P D+
Sbjct: 152 TMAKRNTVI----GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 36/249 (14%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKL--QQQGALKSFIDECNALKSTRHRN 446
NF K IG G++G VYK G +VA+K ++L + +G + I E + LK H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 447 ILRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I++++ D+ + K LVFEF+ + +L +++ SP L +I+ +
Sbjct: 61 IVKLL------DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGI---PLPLIK--SYLFQ 108
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L + H H + H DLKP N+L++ + + DFGLA+ F + ++ V
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-- 162
Query: 566 GLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI----HMF 619
++ Y PE + G S DI+S G + EM T + +F D I +F
Sbjct: 163 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIF 214
Query: 620 VSMALPDHV 628
++ PD V
Sbjct: 215 RTLGTPDEV 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 395 NLIGTGSFGSVYKGTL----GDGTIVAIKVL-KLQQQGALKSFIDECNALKSTRHRNILR 449
+IG G FG VY GTL G A+K L ++ ++ F+ E +K H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
++ C + EG+ +V +M +G+L ++ S + K L + + VA
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIR-SETHNPTVKDL-----IGFGLQVAKG 110
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
++YL H DL N +LD+ T V DFGLA+ +++ N T G K
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT---GAKL 164
Query: 570 SIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620
+ ++ E + Q + D++S+G+LL E+ T G P D+ D F I +++
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYL 215
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 390 NFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRN 446
+F N IG GSFG V+K D + A+K + L + + IDE L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+R + L+ +V E+ NG+L + L + + L Q I +
Sbjct: 61 IIRYYESF----LDKGKLN-IVMEYAENGDLHKLLK-----MQRGRPLPEDQVWRFFIQI 110
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
L +LH I H D+K N+ LD +GD G+AK L SDN + T+
Sbjct: 111 LLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIV-- 162
Query: 567 LKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + + D+++ G++L E TGK P
Sbjct: 163 --GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 31/224 (13%)
Query: 396 LIGTGSFGSVYKGTLGD------GTIVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNI 447
+G G+FG V K + VA+K+LK + L + E +K +H+NI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQF-------KKLSVIQ 498
+ ++ C+ EG + +V E+ ++GNL +L P E+ + L+
Sbjct: 79 INLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
++ A VA +++L H DL NVL+ +D + DFGLA+ + I D
Sbjct: 134 LVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI-DYYR 189
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
K + +K ++ PE + +V + D++S+G+LL E+FT
Sbjct: 190 KTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 33/228 (14%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKS 441
I+ S F KE +G+G FG V+ G VAIK + +GA+ + FI+E +
Sbjct: 1 INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMK 55
Query: 442 TRHRNILRVITACSSVDLEGNDFKAL--VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
H ++++ C+ K L V EFM NG L +L + KLS
Sbjct: 56 LSHPKLVQLYGVCTQQ-------KPLYIVTEFMENGCLLNYLRQ------RQGKLSKDML 102
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
L++ DV ++YL H DL N L+ V DFG+ +++ +
Sbjct: 103 LSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD------D 153
Query: 560 NQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
T S G K + + PPE N + S D++S+G+L+ E+FT GK P
Sbjct: 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 396 LIGTGSFGSVYK---GTLGDGT--IVAIKVLKLQQQGA--LKSFIDECNALKSTRHRNIL 448
+G G+FGSV L D T +VA+K KLQ A L+ F E LKS +H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+ C S G LV E++ G+L +L E +KL L A +
Sbjct: 69 KYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKL-----LLYASQICK 119
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
++YL H DL N+L++ + +GDFGL K L P + +
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL------PQDKEYYKVREP 170
Query: 569 GS--IGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
G I + PE + S+ D++S+G++L E+FT
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 393 KENLIGTGSFGSV----YKGTL-GDGTIVAIKVLKLQQQGALKS-FIDECNALKSTRHRN 446
K ++G G FG V Y G G +VA+K LK + S + E N LK+ H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I++ CS +G L+ E++ G+L +L +H KL++ Q L A +
Sbjct: 68 IVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL----PKH----KLNLAQLLLFAQQI 116
Query: 507 ASALDYLH--HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ YLH H+ H DL NVLLD D +GDFGLAK + P ++
Sbjct: 117 CEGMAYLHSQHYI-----HRDLAARNVLLDNDRLVKIGDFGLAKAV------PEGHEYYR 165
Query: 565 IGLKGS--IGYIPPEHMN-GQVSILGDIYSYGILLLEMFT 601
+ G + + E + + S D++S+G+ L E+ T
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 58/260 (22%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
IG+G++G VYK + G +VAIKV+KL+ + E + LK RH NI+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 456 SVDLEGNDFKALVFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
D +V E+ G+L P Q ++ + R + L YL
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---IAYVCR-----ETLKGLAYL 117
Query: 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG- 572
H T H D+K +N+LL +D + DFG++ +++ +K ++ IG
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRKSF-------IGT 164
Query: 573 --YIPPE----HMNGQVSILGDIYSYGILLLEMFTGKRPTGD---------MFKDDF--- 614
++ PE G DI++ GI +E+ + P D + K +F
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP 224
Query: 615 ----------SIHMFVSMAL 624
H F+ L
Sbjct: 225 KLKDKEKWSPVFHDFIKKCL 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 29/232 (12%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRN 446
+++K IG G++G VYKG G IVA+K ++L+ ++G + I E + LK +H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+ + V ++ + L+FEF+S +L ++L P Y +L V L +
Sbjct: 61 IVCLQ----DVLMQESRL-YLIFEFLSM-DLKKYLDSLPKGQYMDAEL-VKSYL---YQI 110
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+ + H + H DLKP N+L+D + DFGLA+ F I ++ V
Sbjct: 111 LQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV--- 163
Query: 567 LKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
++ Y PE + G S DI+S G + EM T K+P +F D I
Sbjct: 164 ---TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 33/186 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIK-VLKLQQQGALK-SFIDECNALKSTRHR 445
+ K IG G+FG V+K IVA+K VL ++ + + E L+ +H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 446 NILRVITACSSVDLEGNDFKA---LVFEF--------MSNGNLDQWLHPSPAEHYQFKKL 494
N++ +I C + N +K LVFEF +SN N+ +F L
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV------------KFT-L 118
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
S I++ + + + L Y+H + I H D+K +N+L+ KD + DFGLA+ F +S
Sbjct: 119 SEIKK--VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR-AFSLS 172
Query: 555 DNPSKN 560
N N
Sbjct: 173 KNSKPN 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQ--GALKSFIDECNALKST 442
+S F K N IG G++G VY+ G IVA+K +++ + G S + E L +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRL 500
RH NI+ + L+ + F LV E+ +L L P+P Q K
Sbjct: 64 RHPNIVELKEVVVGKHLD-SIF--LVMEYCEQ-DLASLLDNMPTPFSESQVK-------- 111
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ + + L YLH + I H DLK SN+LL + DFGLA+ + + P
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTP 167
Query: 561 QTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGK 603
+ V ++ Y PE + G +I D+++ G +L E+ K
Sbjct: 168 KVV------TLWYRAPELLLGCTTYTTAI--DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 37/221 (16%)
Query: 396 LIGTGSFGSVY---KGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVI 451
++G GSFG V+ K T D G + A+KVLK K+ + + +++ R+IL +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEV 55
Query: 452 TACSSVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
V L EG + L+ +F+ G+L L ++ F + V + +A +
Sbjct: 56 NHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRL----SKEVMFTEEDV--KFYLA-E 106
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+A ALD+LH I + DLKP N+LLD++ + DFGL+K E D+ K +
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFC- 159
Query: 566 GLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G++ Y+ PE +N + + D +S+G+L+ EM TG P
Sbjct: 160 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 1/136 (0%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q L+L N G +P + L + + S N F G +P +L SL++L + L + L+G
Sbjct: 455 QMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+P + + L +L L+ N L G IP ++ L L N +SG IP ++ N+ S+
Sbjct: 514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573
Query: 133 YYFSVTQNQLHGQLPT 148
+++ N LHG LP+
Sbjct: 574 VQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 238 LGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS 297
LGL G +P I+ L HL+ + + N + GNIP +G++ +L +L L N+ +GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI 331
+PE +G+L L L LN N SG +P++LG +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 36/88 (40%), Positives = 50/88 (56%)
Query: 287 LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSI 346
LGL+ L G +P I +L L+ + L+ N G IP SLG++T L L + N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 347 PPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
P SLG L +LNL+ N L+G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 30/240 (12%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVL-KLQQQGALKSFIDECNA 438
F + NL +G G FG V+ G T+V +K L K + + F E +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSV 496
+ H+N++R++ C + ++ E+ G+L Q+L S E + LS
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
Q++ + +A +D+L + H DL N L+ V L+K ++
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 557 PSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDF 614
+N + + ++ PE + S D++S+G+L+ E+FT G+ P + ++
Sbjct: 174 KLRNALIPLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 43/230 (18%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHR 445
+ + ++G G++G V K G IVAIK K + K+ + E L+ RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE-HYQFKKLSVIQRLNIAI 504
NI+ + A +G + LVFE++ L + L SP + + Q L
Sbjct: 61 NIVNLKEAFRR---KGRLY--LVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQ--- 111
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
A+ Y H H I H D+KP N+L+ + + DFG A+ L P+ T
Sbjct: 112 ----AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL---RARPASPLTDY 161
Query: 565 IG---------LKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ L G Y P D+++ G ++ E+ G P
Sbjct: 162 VATRWYRAPELLVGDTNYGKPV----------DVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 28/219 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRN 446
D++ K +G GS+ +VYKG + +G +VA+KV++LQ++ G + I E + LK +H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE-HYQFKKLSVIQRLNIAID 505
I+ + + + LVFE++ +L Q++ P H + KL + Q L
Sbjct: 65 IVLLHDI-----IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR---- 114
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
L Y+H I H DLKP N+L+ + DFGLA+ + + N+ V
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-- 165
Query: 566 GLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTG 602
++ Y PP+ + G + S D++ G + +EM G
Sbjct: 166 ----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 394 ENLIGTGSFGSVYKGTL-GDGTIV--AIKVLK-LQQQGALKSFIDECNAL-KSTRHRNIL 448
+++IG G+FG V K + DG + AIK +K + + F E L K H NI+
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS------PA---EHYQFKKLSVIQR 499
++ AC E + L E+ +GNL +L S PA + LS Q
Sbjct: 72 NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
L+ A DVA +DYL H DL N+L+ ++ A + DFGL S+
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL-----------SR 172
Query: 560 NQTVSIGLKGSIGYIPP-----EHMNGQV-SILGDIYSYGILLLEMFT 601
Q V + K ++G +P E +N V + D++SYG+LL E+ +
Sbjct: 173 GQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTR---HRNILRV 450
IG G++G+VYK G VA+K +++Q + G S + E LK H NI+R+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ C++ + LVFE + +L +L P + + + R L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMR-----QFLRGL 121
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK-FLFEISDNPSKNQTVSIGLKG 569
D+LH +C I H DLKP N+L+ + DFGLA+ + +++ P V + L
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP-----VVVTL-- 171
Query: 570 SIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGK 603
Y PE + + D++S G + EMF K
Sbjct: 172 --WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 397 IGTGSFGSV----YKGTLGD--GTIVAIKVLKLQQQGA-LKSFIDECNALKSTRHRNILR 449
+G G FG V Y GD G VA+K LK + G + E L++ H NI++
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
C+ + GN K L+ EF+ +G+L ++L P K Q+L A+ +
Sbjct: 71 YKGICT--EDGGNGIK-LIMEFLPSGSLKEYL-PRNKNKINLK-----QQLKYAVQICKG 121
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
+DYL H DL NVL++ + +GDFGL K I + + TV L
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK---AIETD-KEYYTVKDDLDS 174
Query: 570 SIGYIPPE-HMNGQVSILGDIYSYGILLLEMFT 601
+ + PE + + I D++S+G+ L E+ T
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 41/227 (18%)
Query: 391 FSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNI 447
+ K IG G++G VYK G IVA+K ++L+ +G + I E + LK H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 448 LRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWL------HPSPAEHYQFKKLSVIQRL 500
+R++ D+ ++ K LVFEF LD L P K + Q L
Sbjct: 61 VRLL------DVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ Y H H + H DLKP N+L+D++ + DFGLA+ F + P +
Sbjct: 110 -------QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-AFGV---PVRT 155
Query: 561 QTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRP 605
T + ++ Y PE + G Q S DI+S G + EM +RP
Sbjct: 156 YTHEV---VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 19/218 (8%)
Query: 397 IGTGSFGSVYKGTLG-DGTI--VAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVI 451
+G G FGSV +G L D +I VA+K +K+ + ++ F+ E +K H N++R+I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 452 TAC-SSVDLEGNDFKALVFEFMSNGNLDQWL-HPSPAEHYQFKKLSVIQRLNIAIDVASA 509
C +V+ EG ++ FM +G+L +L + + Q+ L + D+AS
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY--LPTQMLVKFMTDIASG 124
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
++YL H DL N +L+++M V DFGL+K ++ D + + + +K
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN-GDYYRQGRIAKMPVK- 179
Query: 570 SIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRP 605
+I E + +V + D++S+G+ + E+ T G+ P
Sbjct: 180 ---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTL----GDGT--IVAIKVLKLQQQGALKS-FIDECNAL 439
D+ + +G G+FG VY+G GD VA+K L +S F+ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
H+NI+R+I V E + ++ E M+ G+L +L + + L++
Sbjct: 64 SKFNHQNIVRLI----GVSFERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTAHVGDFGLAKFLFEISDN 556
L A DVA YL + H D+ N LL A + DFG+A+ ++ +
Sbjct: 119 LFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR-ASY 174
Query: 557 PSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFT 601
K + +K ++PPE ++G + D++S+G+LL E+F+
Sbjct: 175 YRKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 72/256 (28%), Positives = 117/256 (45%), Gaps = 45/256 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHR 445
D + K IG G++G VYK +A+K ++L+Q+ G + I E + LK +H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 446 NILRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLH----PSPAEHYQFKKLSVIQRL 500
NI+R+ D+ ++ + LVFE++ +LD H P A++ + K + Q L
Sbjct: 62 NIVRL------QDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA-HVGDFGLAKFLFEISDNPSK 559
+ Y H H + H DLKP N+L+D+ A + DFGLA+ F I
Sbjct: 113 -------RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFT 161
Query: 560 NQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI- 616
++ V ++ Y PE + G S DI+S G + EM ++P +F D I
Sbjct: 162 HEVV------TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP---LFPGDSEID 211
Query: 617 ---HMFVSMALPDHVM 629
+F + P+
Sbjct: 212 ELFKIFRILGTPNEET 227
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLK-LQQQGALK---SFIDECNALKSTRHRNILRVIT 452
IG G FG V G G A V+K L+ F+ E + H N+L+ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
C +E + LV EF G+L +L + Q + V+QR+ A +VAS L +
Sbjct: 63 QC----IESIPY-LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLW 115
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
LH H DL N L D++ +GD+GLA + +K+ +
Sbjct: 116 LHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-----PLR 167
Query: 573 YIPPEHMNGQVSIL--------GDIYSYGILLLEMFT-GKRPTGDM 609
++ PE + + L +I+S G+ + E+FT +P D+
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 34/82 (41%), Positives = 48/82 (58%)
Query: 270 MHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNL 329
+ G IP I L +L + L GN++ G++P +G + LE L L+ N F+G IP SLG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 330 TILTRLWMEENRLEGSIPPSLG 351
T L L + N L G +P +LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 397 IGTGSFGSVY--------KGTLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKST-RHRN 446
+G G FG V K T VA+K+LK + L I E +K +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS--PAEHYQF-------KKLSVI 497
I+ ++ AC+ +G + ++ E+ S GNL ++L P Y + ++LS
Sbjct: 86 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
++ A VA ++YL H DL NVL+ +D + DFGLA+ + I D
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYY 196
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
K + +K ++ PE + ++ + D++S+G+LL E+FT
Sbjct: 197 KKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA------LKSFIDECNALKST 442
+ K +GTG+F S Y+ + GT++A+K + + + +++ E +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H +I+R E + F V E+M+ G++ L A FK+ +I
Sbjct: 61 NHPHIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGA----FKEAVIINYTE- 110
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH---VGDFGLAKFLFEISDNPSK 559
+ L YLH + I H D+K +N+L+D T + DFG A L +
Sbjct: 111 --QLLRGLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGE 163
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
Q L G+I ++ PE + G+ D++S G +++EM T K P
Sbjct: 164 FQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 397 IGTGSFGSVYKGTLGDG---TIVAIKVLK----LQQQGALKSFIDECNALKSTRHRNILR 449
IG G FG V G + G V +K L+ +Q+Q F++E +S +H N+L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ---MKFLEEAQPYRSLQHSNLLQ 59
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ C+ V LV EF G+L +L + +QR+ A ++A
Sbjct: 60 CLGQCTEVTP-----YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALG 112
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
L +LH + H DL N LL D+T +GD+GL+ ++ + +Q L
Sbjct: 113 LLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ-----LWV 164
Query: 570 SIGYIPPE-----HMNGQV---SILGDIYSYGILLLEMFT-GKRP 605
+ +I PE H N V + +++S G+ + E+F G +P
Sbjct: 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 69/241 (28%), Positives = 112/241 (46%), Gaps = 59/241 (24%)
Query: 397 IGTGSFGSVYKGTL-----GDGTIVAIKVLK----LQQQGALKSFIDECNALKSTRHRNI 447
+G +FG +YKG L +VAIK LK QQ G F E + + H NI
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69
Query: 448 ---LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-----HP-------------SPA 486
L V+T V ++FE+++ G+L ++L H S
Sbjct: 70 VCLLGVVTQEQPV--------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
+H F L+IAI +A+ ++YL H H DL N+L+ + + + D GL
Sbjct: 122 DHGDF--------LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGL 170
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKR 604
++ ++ S + + Q S+ I ++PPE M G+ S DI+S+G++L E+F+ G +
Sbjct: 171 SREIY--SADYYRVQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225
Query: 605 P 605
P
Sbjct: 226 P 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 391 FSKENLIGTGSFGSVYKGTLGDGT-IVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F+K IG GSFG VYKG +VAIK++ L++ DE ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE------DEIEDIQQE-----IT 54
Query: 450 VITACSSVDLE---GNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
V++ C S + G+ K ++ E++ G+ L P P E ++ I R
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE---TYIATILR--- 108
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
++ LDYLH H D+K +NVLL + + DFG+A +++D K T
Sbjct: 109 --EILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNT 160
Query: 563 VSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE + DI+S GI +E+ G+ P D+
Sbjct: 161 ----FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 51/233 (21%)
Query: 390 NFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRN 446
+ K IG G++G+V+K IVA+K ++L +G S + E LK +H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMS----------NGNLDQWLHPSPAEHYQFKKLSV 496
I+R+ L + LVFE+ NG++D P + + F+ L
Sbjct: 61 IVRLYDV-----LHSDKKLTLVFEYCDQDLKKYFDSCNGDID----PEIVKSFMFQLLK- 110
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
L + H H + H DLKP N+L++K+ + DFGLA+ F I
Sbjct: 111 ------------GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVR 154
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRP 605
+ V ++ Y PP+ + G SI D++S G + E+ RP
Sbjct: 155 CYSAEVV------TLWYRPPDVLFGAKLYSTSI--DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGAL-KSFIDECNALKSTRHRN 446
+ + + +G G+ GSV K L G I A+K + L K + E KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLS------VIQRL 500
I++ A E + + E+ G+LD + + + KK V+ +
Sbjct: 61 IVKYYGAFLD---ESSSSIGIAMEYCEGGSLD-------SIYKKVKKRGGRIGEKVLGK- 109
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
IA V L YLH I H D+KPSN+LL + + DFG++ L
Sbjct: 110 -IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------- 157
Query: 561 QTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+++ G+ Y+ PE + G+ SI D++S G+ LLE+ + P
Sbjct: 158 -SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 397 IGTGSFGSVY--------KGTLGDGTIVAIKVLKLQQQGA-LKSFIDECNALKST-RHRN 446
+G G FG V K VA+K+LK L + E +K +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS--PAEHYQF-------KKLSVI 497
I+ ++ AC+ + LV E+ S GNL ++L P Y F ++L+
Sbjct: 80 IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
++ A VA ++YL H DL NVL+ +D + DFGLA+ + I D
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI-DYY 190
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
K + +K ++ PE + +V + D++S+G+LL E+FT
Sbjct: 191 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 28/172 (16%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL--QQQGALKSFIDECNALKST 442
+S D + K N I G++G VY+ G IVA+K LK+ +++G + + E N L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL 61
Query: 443 RHRNILRV--ITACSSVDLEGNDFKALVFEFMSN---GNLDQWLHP-SPAEHYQFKKLSV 496
+H NI+ V + S++D + +V E++ + ++ P +E K +
Sbjct: 62 QHPNIVTVKEVVVGSNLD---KIY--MVMEYVEHDLKSLMETMKQPFLQSE----VKCLM 112
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
+Q L S + +LH + I H DLK SN+LL+ + DFGLA+
Sbjct: 113 LQLL-------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 42/258 (16%)
Query: 391 FSKENL-----IGTGSFGSVYKGT---LG--DGTI-VAIKVLK----LQQQGALKSFIDE 435
F + NL +G G+FG V + T L D + VA+K+LK ++ AL S +
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLS 495
+ L + H NI+ ++ AC+ + G ++ E+ G+L +L + L
Sbjct: 92 MSHLGN--HENIVNLLGACT---IGGPIL--VITEYCCYGDLLNFLRRKRESFLTLEDL- 143
Query: 496 VIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
L+ + VA + +L +C H DL NVLL + DFGLA+ + S
Sbjct: 144 ----LSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612
+ K + + ++ PE + N + D++SYGILL E+F+ G P M D
Sbjct: 196 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250
Query: 613 DFSIHMFVS---MALPDH 627
+ MA P+H
Sbjct: 251 SKFYKLIKEGYRMAQPEH 268
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 41/227 (18%)
Query: 395 NLIGTGSFGSVYKGTLG-DGTIV--AIKVLK-LQQQGALKSFIDECNAL-KSTRHRNILR 449
++IG G+FG V K + DG + AIK +K + + F E L K H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS------PA---EHYQFKKLSVIQRL 500
++ AC E + L E+ +GNL +L S PA + LS Q L
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ A DVA +DYL H DL N+L+ ++ A + DFGL S+
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL-----------SRG 161
Query: 561 QTVSIGLKGSIGYIPP-----EHMNGQV-SILGDIYSYGILLLEMFT 601
Q V + K ++G +P E +N V + D++SYG+LL E+ +
Sbjct: 162 QEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 390 NFSKENLIGTGSFGSVY--KGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHR 445
+ K ++G G+FG V+ + D +V IK + ++Q + + +EC LK H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+ LE +V E+ G L +++ +R N +D
Sbjct: 60 NIIEYYENF----LEDKAL-MIVMEYAPGGTLAEYIQ---------------KRCNSLLD 99
Query: 506 VASALDY-------LHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFGLAKFLFEISDNP 557
+ L + LHH I H DLK N+LLDK M +GDFG++K L +
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSK 155
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKR 604
SK TV G+ YI PE G+ + DI++ G +L E+ + KR
Sbjct: 156 SKAYTVV----GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKS 431
E +S +S D K F K IG G+ G+VY + G VAIK + LQQQ +
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL 62
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF 491
I+E ++ ++ NI+ + + L G++ +V E+++ G+L + + + Q
Sbjct: 63 IINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551
+ + ALD+LH + H D+K N+LL D + + DFG F
Sbjct: 118 AA--------VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCA 163
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
+I+ SK T + G+ ++ PE + + DI+S GI+ +EM G+ P
Sbjct: 164 QITPEQSKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKL----QQQGALKSFIDECNALKSTRHRNILRVI 451
+G G++G V K + GTI+A+K ++ Q+Q L +D +R +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS-----------MRSV 57
Query: 452 TACSSVDLEGNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+V G F+ + E M +LD+ + + ++ + IA+ +
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVMDT-SLDK-FYKKVYDKGLTIPEDILGK--IAVSIV 113
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
AL+YLH + H D+KPSNVL++++ + DFG++ +L + S +T+ G
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-----SVAKTIDAGC 166
Query: 568 KGSIGYIPPEHMNGQVSILG-----DIYSYGILLLEMFTGKRP 605
K Y+ PE +N +++ G D++S GI ++E+ TG+ P
Sbjct: 167 K---PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 391 FSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRH 444
F+ ++G G FGSV + L G VA+K+LK + ++ F+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 445 RNILRVITACSSVDLEGN-DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
N++++I +G ++ FM +G+L +L S F L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFM 119
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
ID+AS ++YL H DL N +L+++MT V DFGL+K ++ S + +
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGCA 174
Query: 564 SIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRP 605
S K + ++ E + V + D++++G+ + E+ T G+ P
Sbjct: 175 S---KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 41/236 (17%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTL---GDGT--IVAIKVLK-LQQQGALKSFIDECN 437
I K T+ F K ++G+G+FG+VYKG G+ VAIK L+ A K +DE
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ S + ++ R++ C + ++ L+ + M G L ++ EH +
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR----EHKD--NIGSQ 109
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
LN + +A ++YL + + H DL NVL+ + DFGLAK L
Sbjct: 110 YLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GA 161
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQVSIL-------GDIYSYGILLLEMFT-GKRP 605
+ + + G K I ++ E SIL D++SYG+ + E+ T G +P
Sbjct: 162 DEKEYHAEGGKVPIKWMALE------SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 394 ENLIGTGSFGSVYKGTLG----DGTIVAIKVLKL----QQQGALKSFIDECNALKSTRHR 445
E ++GTG FG + +G L VAI L+ +Q+ + F+ E L H
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHS 66
Query: 446 NILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
NI+R VIT +++ +V E+MSNG LD +L + L Q + +
Sbjct: 67 NIVRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ------LVAGQLMGM 112
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+AS + YL + H L VL++ D+ + F + ++ S+
Sbjct: 113 LPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIY 163
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLE-MFTGKRPTGDMFKDD 613
++ K + + PE + S D++S+GI++ E M G+RP DM D
Sbjct: 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 397 IGTGSFGSVYKG---TLGDGTIVAIKVLKLQQQG-ALK-SFIDECNALKSTRHRNILRVI 451
+G+G+FG+V KG VA+K+LK ALK + E N ++ + I+R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
C + LV E G L+++L + K ++ + V+ +
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFLQ-------KNKHVTEKNITELVHQVSMGMK 109
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YL H DL NVLL A + DFGL+K L +N K +T K +
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHG---KWPV 162
Query: 572 GYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ PE MN + S D++S+G+L+ E F+ G++P M
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 30/213 (14%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITA 453
IG G+ G V+K G VA+K + L+ + G + E AL++ +H +++++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRLNIAIDVASALD 511
V G+ F LV E+M + L + L P Q K L +
Sbjct: 66 --DVFPHGSGF-VLVMEYMPSD-LSEVLRDEERPLPEAQVKSYM-RMLLK-------GVA 113
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
Y+H I H DLKP+N+L+ D + DFGLA+ E +Q +
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------ATR 164
Query: 572 GYIPPEHMNGQ--VSILGDIYSYGILLLEMFTG 602
Y PE + G D+++ G + E+ G
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRN 446
+ + K + +G GS+ +VYKG + G +VA+K ++L+ +GA + I E + LK +H N
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 447 ILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLN 501
I+ +I ++ LVFE++ +L Q++ + + L + Q L
Sbjct: 65 IVTLHDIIHTKKTL--------TLVFEYLDT-DLKQYMDDCGGGLSMHNVR-LFLFQLLR 114
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK-- 559
L Y H + H DLKP N+L+ + + DFGLA+ PSK
Sbjct: 115 -------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSKTY 160
Query: 560 -NQTVSIGLKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGKRPT 606
N+ V ++ Y PP+ + G S D++ G + EM TG RP
Sbjct: 161 SNEVV------TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 28/225 (12%)
Query: 397 IGTGSFGSVYKGTL-GDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRVIT 452
+G G FG V + A+K +K + + G + E L+ H I+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
+ D + ++ E+ G L L + F + R IA V A +Y
Sbjct: 60 -RTFKD---KKYIYMLMEYCLGGELWTILR----DRGLFDEY--TARFYIAC-VVLAFEY 108
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
LH+ I + DLKP N+LLD + + DFG AK L S +T + G+
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK------SGQKTWTF--CGTPE 157
Query: 573 YIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
Y+ PE + + D +S GILL E+ TG+ P G+ +D I
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI 202
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F+K IG GSFG V+KG +VAIK++ L++ DE ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE------DEIEDIQQE-----IT 54
Query: 450 VITACSS---VDLEGNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
V++ C S G+ K ++ E++ G+ L P + +Q +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-------- 106
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
++ LDYLH H D+K +NVLL + + DFG+A +++D K T
Sbjct: 107 LKEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNT 160
Query: 563 VSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE + DI+S GI +E+ G+ P DM
Sbjct: 161 ----FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITAC 454
+G GS+ +VYKG + +G +VA+KV+ ++ ++G + I E + LK +H NI+ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI- 71
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
+ + VFE+M +L Q++ HP Y + L + Q L L Y
Sbjct: 72 ----IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVR-LFMFQLLR-------GLAY 118
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
+H I H DLKP N+L+ + DFGLA+ PS+ + + ++
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEV---VTLW 168
Query: 573 YIPPEHMNGQV--SILGDIYSYGILLLEMFTGK 603
Y PP+ + G S DI+ G + +EM G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 48/272 (17%)
Query: 396 LIGTGSFGSVYK--GTLGDGTIVAIKVL----------KLQQQGALKSFIDECNALKST- 442
+G+G+FG VYK ++A+K + K ++ ++ + E +K
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL-N 501
RH NI+R LE ND +V + + L + + + +F + +R+ N
Sbjct: 67 RHPNIVRYYKTF----LE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE----ERIWN 117
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
I + + AL YLH + I H DL P+N++L +D + DFGLAK P
Sbjct: 118 IFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKL 170
Query: 562 TVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
T + G+I Y PE + + D++++G +L +M T + P +S +M +
Sbjct: 171 TSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-------YSTNM-L 219
Query: 621 SMALPDHVMDILDPSM-PLDEENDEEQIEEVI 651
S+A I++ PL E E + +VI
Sbjct: 220 SLA-----TKIVEAVYEPLPEGMYSEDVTDVI 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 391 FSKENLI-----GTGSFGSVYKGTL--------GDGTIVAIKVLKLQQQGA-LKSFIDEC 436
F ++ L+ G G FG V + VA+K+LK L I E
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 437 NALKST-RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH----PSPAEHYQF 491
+K +H+NI+ ++ C+ EG + ++ E+ + GNL ++L P P +
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 492 KK-----LSVIQRLNIAIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545
K LS ++ A VA ++YL C H DL NVL+ +D + DFG
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFG 179
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
LA+ + +I D K + +K ++ PE + +V + D++S+GIL+ E+FT
Sbjct: 180 LARGVHDI-DYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
+++ IG G+ G+VY + G VAIK + LQQQ + I+E ++ +H NI+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ + L G++ +V E+++ G+L + + + Q ++ + R + A
Sbjct: 81 YLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCR-----ECLQA 127
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
L++LH + + H D+K N+LL D + + DFG F +I+ SK T + G
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRST----MVG 177
Query: 570 SIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRP 605
+ ++ PE + DI+S GI+ +EM G+ P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIK--VLKLQQQGALKSFIDECNALKSTRHR 445
D + K IG G++G VYK G +VA+K L++ ++G + + E + L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 446 N-ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--------HPSPAEHYQFKKLSV 496
I+R++ + G LVFE++ + +L +++ P PA
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPA--------KT 111
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISD 555
I+ + A + H H + H DLKP N+L+DK + D GL + F I
Sbjct: 112 IKSFMYQLLKGVA--HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSI-- 163
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTG 602
P K+ T I ++ Y PE + G S DI+S G + EM
Sbjct: 164 -PVKSYTHEI---VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 390 NFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK----LQQQGALKSFIDECNALKS 441
NF ++GTG++G V+ G G + A+KVLK +Q+ + E L++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
R L + D + + L+ ++++ G L + H EH F + V R+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLH----LILDYVNGGEL--FTHLYQREH--FTESEV--RVY 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
IA ++ ALD+LH I + D+K N+LLD + + DFGL+K + +
Sbjct: 111 IA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA----EEEER 162
Query: 562 TVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRP 605
S G+I Y+ PE + G D +S G+L E+ TG P
Sbjct: 163 AYSFC--GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 397 IGTGSFGSVYKGT--LGDGTI-VAIKVLKLQQQGALK-SFIDECNALKSTRHRNILRVIT 452
+G+G+FG V KG + I VAIKVLK + + +++ + E + + I+R+I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
C + L LV E S G L+++L E ++V + + V+ + Y
Sbjct: 63 VCEAEAL------MLVMEMASGGPLNKFLSGKKDE------ITVSNVVELMHQVSMGMKY 110
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
L H DL NVLL A + DFGL+K L D+ K ++ K +
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARS---AGKWPLK 163
Query: 573 YIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ PE +N + S D++SYGI + E F+ G++P M
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 416 VAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472
VAIK+L+ +++ F E H NI+ ++ + + VFE++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFAVFEYV 61
Query: 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532
L + L A L + + + V LD L + I H DLKP N++
Sbjct: 62 PGRTLREVLAADGA-------LPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIM 111
Query: 533 LD-KDMTAH--VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGD 588
+ + H V DFG+ L + D T + + G+ Y PE + G+ V+ D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 589 IYSYGILLLEMFTGKR 604
+Y++G++ LE TG+R
Sbjct: 172 LYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/241 (27%), Positives = 113/241 (46%), Gaps = 33/241 (13%)
Query: 383 DISKSTDNFSKENLIGTGSFGSVYKGTL-----GDGT-IVAIKVLKLQQQGALKS-FIDE 435
+I+ ST F +E +G FG VYKG L G+ T VAIK LK + +G L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-----HP---SPAE 487
+H NI+ ++ + +++F + S+ +L ++L H S +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 488 HYQFKK-LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
K L ++I +A+ +++L H + H DL NVL+ + + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKR 604
+ ++ ++ I ++ PE M G+ SI DI+SYG++L E+F+ G +
Sbjct: 171 FREVYAADYYKLMGNSLL-----PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225
Query: 605 P 605
P
Sbjct: 226 P 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 46/222 (20%)
Query: 397 IGTGSFGSVY---KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRV-- 450
I G+FGSVY K + GD AIKVLK KS + N + + + R I+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGD--YFAIKVLK-------KSDMIAKNQVTNVKAERAIMMIQG 54
Query: 451 ---ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR---LNIAI 504
A + D+ LV E+++ G+ + K L +
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI----------KTLGGLPEDWAKQYIA 104
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+V ++ LH I H D+KP N+L+D+ + DFGL S+N +
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL-----------SRNGLEN 150
Query: 565 IGLKGSIGYIPPEHMNGQVSI-LGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + G + D +S G ++ E G P
Sbjct: 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLK-LQQQGALK---SFIDECNALKSTRHRNILRVIT 452
IG G FG V + T VA V+K L+ + K F+ + + + +H NIL+ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
C +E + LVFE+ G+L +L H + +L ++QR+ A ++A+ + +
Sbjct: 63 QC----VEAIPY-LLVFEYCELGDLKSYLS-QEQWHRRNSQLLLLQRM--ACEIAAGVTH 114
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
+H H H DL N L D+T VGD+G+ ++ D + L+
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAP 170
Query: 573 YIPPEHMNGQVSI----LGDIYSYGILLLEMF 600
+ E G ++ ++++ G+ L E+F
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIV----AIKVL-KLQQQGALKSFIDECN 437
I K T+ + ++G+G+FG+VYKG + +G V AIK+L + A F+DE
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ S H +++R++ C S ++ LV + M +G L ++H EH ++
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVH----EHKDNIGSQLL 111
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
LN + +A + YL + + H DL NVL+ + DFGLA+ L
Sbjct: 112 --LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EG 161
Query: 558 SKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
+ + + G K I ++ E ++ + + D++SYG+ + E+ T G +P
Sbjct: 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 38/230 (16%)
Query: 397 IGTGSFGSVYKGT------LGDGTIVAIKVLKL-QQQGALKSFIDECNALKSTRHRNILR 449
+G G FG V K T T VA+K+LK L+ + E N LK H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS----PA-------------EHYQFK 492
+ ACS + L+ E+ G+L +L S P+ ++ +
Sbjct: 68 LYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
L++ ++ A ++ + YL + + H DL NVL+ + + DFGL++ ++E
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
D+ K I +K ++ E + + + D++S+G+LL E+ T
Sbjct: 180 -EDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 70/236 (29%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 390 NFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKS---FIDECNALKST 442
+F +GTGSFG V +KGT G AIK LK ++ +K E + L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS---PAEHYQFKKLSVIQR 499
H I+ ++ CS D + + EF+ G L L + P + +F ++
Sbjct: 76 SHPFIVNMM--CSFQD---ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL- 129
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
A +YLH D I + DLKP N+LLD V DFG AK + P +
Sbjct: 130 ---------AFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDR 171
Query: 560 NQTVSIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
T L G+ Y+ PE G + D ++ G+LL E G P F DD
Sbjct: 172 TFT----LCGTPEYLAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPP----FFDD 218
|
Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 396 LIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQQGALKS-FIDECNALKSTRHRNILRV 450
IG G FG VY+G + VA+K K +++ F+ E ++ H +I+++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
I + + +V E G L +L Y S+I + +++AL
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYLQ---VNKYSLDLASLIL---YSYQLSTAL 120
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
YL H D+ NVL+ +GDFGL+++L + S G K
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKASKG-KLP 171
Query: 571 IGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
I ++ PE +N + + D++ +G+ + E+ G +P
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 48/254 (18%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGAL-KSFIDECNALKSTRHRNILRVITAC 454
+G G+ G+VYK L I+A+KV+ L L K + E L ++ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56
Query: 455 SS---VDLEGNDFK----ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
S + G F ++ EFM G+LD ++ EH V+ R IA+ V
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPEH-------VLGR--IAVAVV 105
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
L YL I H D+KPSN+L++ + DFG++ L +++
Sbjct: 106 KGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---------NSIAKTY 153
Query: 568 KGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626
G+ Y+ PE ++G Q I D++S GI +E+ G+ P + K+ S+ + + L
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---MPLQLLQ 210
Query: 627 HVMDILDPSMPLDE 640
++D P +P+ +
Sbjct: 211 CIVDEDPPVLPVGQ 224
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 48/237 (20%)
Query: 393 KENLIGTGSFGSVY-------KGTLGDGT--------IVAIKVLKLQ-QQGALKSFIDEC 436
KE L G G FG V+ LG+G +VA+K+L+ + A F+ E
Sbjct: 10 KEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK--- 493
+ ++ NI+R++ C S +D ++ E+M NG+L+Q+L E F
Sbjct: 69 KIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIES-TFTHANN 122
Query: 494 ---LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
+S+ L +A+ +AS + YL H DL N L+ T + DFG+++ L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEMFT 601
+ S + + Q ++ +P M + +LG D++++G+ L EMFT
Sbjct: 180 Y--SGDYYRIQGRAV--------LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 47/252 (18%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGAL----KSFIDECNALKSTR 443
+ IG+G++G V G VAIK K+ + K + E L+ +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 444 HRNILRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLH---PSPAEHYQFKKLSVIQ 498
H NI+ + G DFK +V + M + +L +H P EH ++ L +
Sbjct: 63 HDNIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF-LYQLL 117
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
R L Y+H + H DLKPSN+L+++D +GDFG+A+ +S +P+
Sbjct: 118 R---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSPT 162
Query: 559 KNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEM------FTGKRPTGDMF 610
+++ + Y PE + + + D++S G + EM F GK
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--- 219
Query: 611 KDDFSIHMFVSM 622
+ + +S+
Sbjct: 220 ----QLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 397 IGTGSFGSVYKGT--LGDGTIVAIKVLKLQ--QQGALKSFIDECNALK---STRHRNILR 449
IG G++G V+K G VA+K +++Q ++G S I E L+ + H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRLNIAIDVA 507
+ C+ + LVFE + +L +L P P + K + Q L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR------ 121
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
LD+LH H + H DLKP N+L+ + DFGLA+ Q +
Sbjct: 122 -GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMALTSV 169
Query: 568 KGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
++ Y PE + + D++S G + EMF ++P
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 396 LIGTGSFGSV----YKGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNIL 448
++G GSFG V KGT + A+KVLK + Q ++ + E L L
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLD---QWLHPSPAEHYQFKKLSVIQRLNIAID 505
+ +C + D V E+++ G+L Q +F A +
Sbjct: 59 TQLHSC----FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF----------YAAE 104
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L +LH I + DLK NVLLD + + DFG+ K + T S
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK------EGILGGVTTST 155
Query: 566 GLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ YI PE ++ Q D ++ G+LL EM G+ P
Sbjct: 156 -FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 29/230 (12%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL--QQQGALKSFIDECNALKS-TRHRN 446
F L+G G++G VYKG + G + AIKV+ + ++ +K E N LK + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64
Query: 447 ILRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I A + G D + LV EF G++ + + + + ++ I R +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----E 119
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L +LH H + H D+K NVLL ++ + DFG++ L D + I
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFI 172
Query: 566 GLKGSIGYIPP------EHMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ P E+ + D++S GI +EM G P DM
Sbjct: 173 ---GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 396 LIGTGSFGSVYKGTLGD-GTIVAIKV-LKLQQQGALKSF-IDECNALKSTRHRNILRVIT 452
L+G GS+G V K + G IVAIK L+ + +K + E LK RH N++ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 453 ACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
K LVFEF+ + LD + + Q L
Sbjct: 68 VFRR--------KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR-------G 112
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
+++ H H I H D+KP N+L+ + + DFG A+ L P + T + +
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYTDYVATR- 164
Query: 570 SIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTG 602
Y PE + G G DI++ G L+ EM TG
Sbjct: 165 --WYRAPELLVGDTK-YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGA-----LKSFIDECNALKSTR 443
N+ + L+G G+FG VY D G +A+K + + + E LK+ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H I++ L ++ ++ E+M G++ L + Y +V ++
Sbjct: 63 HERIVQYYGC-----LRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQ 112
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
I ++YLH + I H D+K +N+L D +GDFG +K L I + + ++V
Sbjct: 113 I--LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGD 608
+ G+ ++ PE ++G+ D++S G ++EM T K P +
Sbjct: 168 T----GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 397 IGTGSFGSVYKGTLGD------GTIVAIKVLKLQQQGALKS---FIDECNALKSTRHRNI 447
+G GSFG VY+G D T VA+K + + +L+ F++E + +K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 71
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHP--SPAEHYQFKKLSVIQRL-NIAI 504
+R++ S +V E M++G+L +L AE+ + +Q + +A
Sbjct: 72 VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
++A + YL+ H DL N ++ D T +GDFG+ + ++E +D K
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRK----- 177
Query: 565 IGLKG--SIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT 601
G KG + ++ PE + +G + D++S+G++L E+ +
Sbjct: 178 -GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 63/235 (26%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKS 431
E +S +S D K F K IG G+ G+VY + G VAI+ + LQQQ +
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF 491
I+E ++ ++ NI+ + + L G++ +V E+++ G+L + + + Q
Sbjct: 64 IINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551
+ + AL++LH + + H D+K N+LL D + + DFG F
Sbjct: 119 AA--------VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCA 164
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
+I+ SK T + G+ ++ PE + + DI+S GI+ +EM G+ P
Sbjct: 165 QITPEQSKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 65/252 (25%), Positives = 99/252 (39%), Gaps = 58/252 (23%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
D+F +IG G+FG V+ K T G + A+KVL+ + ++ + E + L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---HPSPAEHYQFKKLSVIQ 498
I+++ S D + LV E+M G+L L P E +F I
Sbjct: 58 ADSPWIVKLY--YSFQD---EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF----YIA 108
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAK-------- 548
L +A+D L ++H D+KP N+L+D D H+ DFGL K
Sbjct: 109 ELVLALDSVHKLGFIHR---------DIKPDNILIDAD--GHIKLADFGLCKKMNKAKDR 157
Query: 549 ---FLFEISDNPSKNQTVSIGLK-----------GSIGYIPPEHMNGQ-VSILGDIYSYG 593
+ N V G+ YI PE + G + D +S G
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG 217
Query: 594 ILLLEMFTGKRP 605
++L EM G P
Sbjct: 218 VILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 30/240 (12%)
Query: 379 MSYSDISK-STDNFSKEN--LIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA---LKSF 432
+DI +D+ K LI S+YKG + V I+ K +G +
Sbjct: 7 SYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDIT 65
Query: 433 IDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK 492
+E L+ NIL++ + ++ +L+ E+ + G L + L + K
Sbjct: 66 ENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILEYCTRGYLREVL-------DKEK 117
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
LS +L++AID L L+ + + P + L + L+ ++ + GL K L
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKIL-- 173
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVS---ILGDIYSYGILLLEMFTGKRPTGDM 609
S P KN + Y + +N S I DIYS G++L E+FTGK P ++
Sbjct: 174 -SSPPFKNVNFMV-------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 38/236 (16%)
Query: 391 FSKENL-----IGTGSFGSVY--------KGTLGDGTIVAIKVLKLQ-QQGALKSFIDEC 436
FS++ L +G G FG V K + VA+K+LK + L + E
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71
Query: 437 NALKST-RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS--PAEHYQF-- 491
+K +H+NI+ ++ AC+ + +V E+ S GNL ++L P Y +
Sbjct: 72 EMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDI 126
Query: 492 -----KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
++++ ++ VA ++YL H DL NVL+ ++ + DFGL
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 183
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT 601
A+ + I D K + +K ++ PE + +V + D++S+G+L+ E+FT
Sbjct: 184 ARDVNNI-DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRVIT 452
+G G +G V+ D G IVA+K +K L + ++ + E + L +T+ +++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 453 A---CSSVDLE-----GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
A + L G DF+ L ++N + L A Y + + A+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTL----LNNLGV---LSEDHARFY-------MAEMFEAV 114
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
D L Y+H DLKP N L+D + DFGL+K + + N V
Sbjct: 115 DALHELGYIHR---------DLKPENFLIDASGHIKLTDFGLSKGIVTYA-----NSVV- 159
Query: 565 IGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
GS Y+ PE + G+ D +S G +L E G P
Sbjct: 160 ----GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 25/236 (10%)
Query: 372 KEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALK 430
+E+ + + I +++ IG G+ G+V+ + G VAIK + LQ+Q +
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE 61
Query: 431 SFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
I+E +K ++ NI+ + + L G++ +V E+++ G+L + + + Q
Sbjct: 62 LIINEILVMKELKNPNIVNFLDSF----LVGDEL-FVVMEYLAGGSLTDVVTETCMDEAQ 116
Query: 491 FKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
+ + AL++LH + + H D+K NVLL D + + DFG F
Sbjct: 117 IAA--------VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG---FC 162
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
+I+ SK T + G+ ++ PE + + DI+S GI+ +EM G+ P
Sbjct: 163 AQITPEQSKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 25/228 (10%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKS-TRHRNIL 448
F ++G G++G VYKG + G + AIKV+ + + + E N LK + HRNI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 449 RVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
A G+D + LV EF G++ + + + ++ I R ++
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EIL 131
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
L +LH H + H D+K NVLL ++ + DFG++ L D + IG
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIG- 183
Query: 568 KGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+ ++ PE + + DI+S GI +EM G P DM
Sbjct: 184 --TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 74/281 (26%)
Query: 392 SKENLIGTGSFGSVY------------KGTLGDG-----TIVAIKVLKL-QQQGALKSFI 433
E L G G FG V+ K + +VA+KVL+ A + F+
Sbjct: 9 FVEKL-GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 434 DECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH----PSPAEHY 489
E L NI R++ C+ + ++ E+M NG+L+Q+L +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
K LS L +A +AS + YL H DL N L+ K+ T + DFG+++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 550 LFEISDNPSKNQTVSIGLKGS----IGYIPPEHMNGQVSILG-------DIYSYGILLLE 598
L+ S + + ++G I ++ E S+L D++++G+ L E
Sbjct: 180 LY--SSDYYR-------VQGRAPLPIRWMAWE------SVLLGKFTTKSDVWAFGVTLWE 224
Query: 599 MFT-GKRP-------------TGDMFKDDFSIHMFVSMALP 625
+ T + G F+DD + + P
Sbjct: 225 ILTLCREQPYEHLTDQQVIENAGHFFRDD---GRQIYLPRP 262
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 64/226 (28%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRN 446
+ + K + +G G++ +V+KG + +VA+K ++L+ ++GA + I E + LK+ +H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 447 ILRVITACSSVDLEGNDFK-ALVFEFMSNGNLDQWL-HPSPAEHYQFKKLSVIQRLNIAI 504
I+ + D+ + LVFE++ + +L Q+L + K+ + Q L
Sbjct: 65 IVTL------HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR--- 114
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK---NQ 561
L Y H I H DLKP N+L+++ + DFGLA+ P+K N+
Sbjct: 115 ----GLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNE 163
Query: 562 TVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRP 605
V ++ Y PP+ + G + S D++ G +L EM TG RP
Sbjct: 164 VV------TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 502 IAIDVASALDYL--HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
+ + + AL YL H + H D+KPSN+LLD + DFG++ L + SK
Sbjct: 119 MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-----SK 169
Query: 560 NQTVSIGLKGSIGYIPPEHM-----NGQVSILGDIYSYGILLLEMFTGKRP 605
+T S G Y+ PE + N + I D++S GI L+E+ TG+ P
Sbjct: 170 AKTRS---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIK--VLKLQQQGALKSFIDECNALKSTRHRNILRVI-T 452
+G G+FG VYK + G +VA+K ++ ++ G + + E LK +H N++ +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 453 ACSSVDLEGNDFKA--LVFEFMSNGNLDQWLH-PSPAEHYQFKKLSVIQRLNIAIDVASA 509
A D + +V +M + +L L PS KL+ Q + +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-------VKLTESQIKCYMLQLLEG 127
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
++YLH + I H D+K +N+L+D + DFGLA+ P + G
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR---PYDGPPPNPKGGGGGGTR 181
Query: 570 SIG-------YIPPEHMNG--QVSILGDIYSYGILLLEMFTGK 603
Y PPE + G + + DI+ G + EMFT +
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 52/218 (23%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 397 IGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKS---FIDECNALKSTRHRNILR 449
+G GSFG VY KG + D + + + + +++ F++E + +K +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---PSPAEHYQFKKLSVIQRLNIAIDV 506
++ S +G ++ E M+ G+L +L P + S+ + + +A ++
Sbjct: 74 LLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
A + YL+ + H DL N ++ +D T +GDFG+ + ++E +D K G
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRK------G 178
Query: 567 LKG--SIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT 601
KG + ++ PE + +G + D++S+G++L E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKG--TLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHR 445
+ + K + +G G++ +VYKG L D +VA+K ++L+ ++GA + I E + LK +H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHP-SPAEHYQFKKLSVIQRLNIAI 504
NI +T + E + LVFE++ + +L Q+L + + KL + Q L
Sbjct: 65 NI---VTLHDIIHTEKS--LTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR--- 115
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
L+Y H + H DLKP N+L+++ + DFGLA+ I N+ V
Sbjct: 116 ----GLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV- 166
Query: 565 IGLKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGK 603
++ Y PP+ + G S D++ G + EM TG+
Sbjct: 167 -----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 65/235 (27%), Positives = 93/235 (39%), Gaps = 56/235 (23%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHR 445
D + + +G+G++G V G VAIK L Q A+ K E LK H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 446 NI---LRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
N+ L V T SS+ DF+ LV M L+ + Q+L
Sbjct: 75 NVIGLLDVFTPASSL----EDFQDVYLVTHLM-----GADLN----------NIVKCQKL 115
Query: 501 N------IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
+ + + L Y+H I H DLKPSN+ +++D + DFGLA+
Sbjct: 116 SDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---- 168
Query: 555 DNPSKNQTVSIGLKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
T G + Y PE H N V DI+S G ++ E+ TGK
Sbjct: 169 ---DDEMT---GYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
DNF K IG GS G V T G VA+K + L++Q + +E ++ +H NI
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
+ + S L G++ +V EF+ G L D H E Q + + V
Sbjct: 79 VEMY----SSYLVGDEL-WVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLAV 124
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
AL +LH + H D+K ++LL D + DFG F ++S + ++
Sbjct: 125 LKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKS---- 174
Query: 567 LKGSIGYIPPEHMNGQVSIL-----GDIYSYGILLLEMFTGKRP 605
L G+ ++ PE +S L DI+S GI+++EM G+ P
Sbjct: 175 LVGTPYWMAPE----VISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
+G G+FG VYK G A K+++++ + L+ F+ E + L +H NI+ + A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 456 SVDLEGNDFKA-LVFEFMSNGNLDQWL----HPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ K ++ EF G LD + ++ + + AL
Sbjct: 73 ------YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY----------VCRQMLEAL 116
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL-AKFLFEISDNPSKNQTVSIGLKG 569
++LH H + H DLK N+LL D + DFG+ AK + K T G
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----QKRDT----FIG 165
Query: 570 SIGYIPPEHMNGQVS------ILGDIYSYGILLLEMFTGKRPTGDM 609
+ ++ PE + + DI+S GI L+E+ + P ++
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 391 FSKENLIGTGSFGSVYKGTLGDGT--IVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
F+K IG GSFG V+KG + + T +VAIK++ L++ DE ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAE------DEIEDIQQE-----I 53
Query: 449 RVITACSS---VDLEGNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
V++ C S G+ K ++ E++ G+ L P P + Q ++ I R
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IATILR-- 108
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
++ LDYLH H D+K +NVLL + + DFG+A +++D K
Sbjct: 109 ---EILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRN 159
Query: 562 TVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE + DI+S GI +E+ G+ P ++
Sbjct: 160 ----TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 54/214 (25%), Positives = 84/214 (39%), Gaps = 26/214 (12%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILRVIT 452
+G G FG V + G + A K L +L+++ + ++E L+ R I+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
+ E D LV M+ G+L ++ + + + A + L++
Sbjct: 57 -SLAYAFETKDDLCLVMTLMNGGDLKYHIY-----NVGEPGFPEARAIFYAAQIICGLEH 110
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
LH I + DLKP NVLLD + D GLA L K G G+ G
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL--------KGGKKIKGRAGTPG 159
Query: 573 YIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
Y+ PE D ++ G L EM G+ P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 67/232 (28%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
IG G+FG VY+ D I A+KVL + K + + + RNIL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 456 SVDLEGNDFK-------ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI-DVA 507
S + G F LV ++MS G L W H Q + R I ++
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FW-------HLQKEGRFSEDRAKFYIAELV 106
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
AL++LH + I + DLKP N+LLD + DFGL+K N + N+T +
Sbjct: 107 LALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK------ANLTDNKTTNT-F 156
Query: 568 KGSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGKRP-----TGDMFKD 612
G+ Y+ PE + + D +S G+L+ EM G P T M+++
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 28/69 (40%), Positives = 42/69 (60%)
Query: 308 LEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
++GLGL+ G IP+ + L L + + N + G+IPPSLG+ L VL+LS N N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 368 GTIPKEVRQ 376
G+IP+ + Q
Sbjct: 480 GSIPESLGQ 488
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 396 LIGTGSFGSVYKGTLGDGT-IVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITA 453
++G GSFG V L AIK LK K + E + ++ T R +L +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-------KDVVLEDDDVECTMVERRVLALAWE 54
Query: 454 CSSV-----DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI-AIDVA 507
+ + + V E+++ G+L H Q R A ++
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDL--------MFHIQSSGRFDEARARFYAAEII 106
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
L +LH I + DLK NVLLDKD + DFG+ K +N + S
Sbjct: 107 CGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKAST-F 156
Query: 568 KGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
G+ YI PE + GQ D +S+G+LL EM G+ P
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 415 IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMS 473
+VA+K+L+ + A F+ E + + NI+R++ C + +D ++ E+M
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYME 102
Query: 474 NGNLDQWLH----PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPS 529
NG+L+Q+L AE +S + +A +AS + YL H DL
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159
Query: 530 NVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-- 587
N L+ K+ T + DFG+++ L+ S + + Q ++ +P M+ + +LG
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLY--SGDYYRIQGRAV--------LPIRWMSWESILLGKF 209
Query: 588 ----DIYSYGILLLEMFT 601
D++++G+ L E+ T
Sbjct: 210 TTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 388 TDNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
D + ++G G++G VY L +AIK + + ++ +E +HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS--P-AEHYQFKKLSVIQRLNIA 503
I++ + + S E FK + E + G+L L P ++ Q Q L
Sbjct: 67 IVQYLGSDS----ENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFGLAKFLFEISDNPSKNQT 562
L YLH D I H D+K NVL++ + DFG +K L I NP
Sbjct: 119 ----EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NP----- 164
Query: 563 VSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRP 605
+ G++ Y+ PE ++ G DI+S G ++EM TGK P
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 391 FSKENLIGTGSFGSVYKGTL-GDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRN 446
F + ++G G FG V + G + A K L +++++ ++E L+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
++ + A E D LV M+ G+L ++ H + + A ++
Sbjct: 62 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY-----HMGEAGFEEGRAVFYAAEI 111
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
L+ LH I + DLKP N+LLD + D GLA + E QT+ G
Sbjct: 112 CCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-------GQTIK-G 160
Query: 567 LKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRP 605
G++GY+ PE + N + + D ++ G LL EM G+ P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 32/227 (14%)
Query: 390 NFSKENLIGTGSFGSVY---KGTLGD-GTIVAIKVLK----LQQQGALKSFIDECNALKS 441
NF ++GTG++G V+ K T D G + A+KVL+ +Q+ ++ E N L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
R L + + + + L+ +++S G + L+ + F + V R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLH----LILDYVSGGEMFTHLY----QRDNFSEDEV--RFY 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK-FLFEISDNPSKN 560
++ AL++LH I + D+K N+LLD + + DFGL+K FL E K
Sbjct: 111 SG-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-----EKE 161
Query: 561 QTVSIGLKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGKRP 605
+T S G+I Y+ PE + G+ D +S GIL+ E+ TG P
Sbjct: 162 RTYS--FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 33/89 (37%), Positives = 49/89 (55%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L L L G IP ++S L+S S N G IP L S+T LE++ L ++ G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 75 PAWIGNFSSLKALSLAWNNLRGSIPNELG 103
P +G +SL+ L+L N+L G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGT-LGDG----TIVAIKVLKLQQQ-GALKSFIDECN 437
I K T+ K ++G+G+FG+VYKG + DG VAIKVL+ A K +DE
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ + R++ C + ++ LV + M G L ++ E+ ++
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVR----ENKD--RIGSQ 109
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
LN + +A + YL + + H DL NVL+ + DFGLA+ L +
Sbjct: 110 DLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DI 161
Query: 558 SKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRP 605
+ + + G K I ++ E ++ + + D++SYG+ + E+ T G +P
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 38/226 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
D+F K + +G G+ G V+K + G I+A K++ L+ + A+++ I R
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--------IRE--- 53
Query: 448 LRVITACSS---VDLEGNDFK----ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
L+V+ C+S V G + ++ E M G+LDQ L + Q ++ ++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ-----ILGKV 108
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+IA V L YL I H D+KPSN+L++ + DFG++ L + N
Sbjct: 109 SIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---- 160
Query: 561 QTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + G S+ DI+S G+ L+EM G+ P
Sbjct: 161 -----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 31/72 (43%), Positives = 41/72 (56%), Gaps = 2/72 (2%)
Query: 8 EHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGG 67
HL Q +NL+ N + G IP +L T L + S N F G IP L LT L I+ L G
Sbjct: 442 RHL--QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 68 SNLTGNVPAWIG 79
++L+G VPA +G
Sbjct: 500 NSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 8e-09
Identities = 59/183 (32%), Positives = 82/183 (44%), Gaps = 53/183 (28%)
Query: 397 IGTGSFGSVYKGTLGD---GTIVAIKVLKL-----QQQGALKSFIDECNALKSTR-HRNI 447
+G G++G V+K D +VA+K K+ A ++F E L+ H NI
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALK--KIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 448 ---LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
L VI A + D+ LVFE+M + LH +VI R NI
Sbjct: 70 VKLLNVIKAENDKDI------YLVFEYM-----ETDLH------------AVI-RANILE 105
Query: 505 DV---------ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
DV AL Y+H + H DLKPSN+LL+ D + DFGLA+ L E+ +
Sbjct: 106 DVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 556 NPS 558
NP
Sbjct: 163 NPE 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 28/89 (31%), Positives = 50/89 (56%)
Query: 63 IGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII 122
+GL L G +P I L++++L+ N++RG+IP LG ++ L L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVG 151
P S+ ++S+ ++ N L G++P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 86 ALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQ 145
L L LRG IPN++ +L L L GN I G IP S+ +I+S+ ++ N +G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 146 LPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS-NLQVLDFAEN-GLTGTIPG 197
+P +G L +L+I N +G +P +L + +F +N GL G IPG
Sbjct: 482 IPESLGQ-LTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPG 533
|
Length = 623 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 61/243 (25%), Positives = 101/243 (41%), Gaps = 56/243 (23%)
Query: 393 KENLIGTGSFGSVYKG--TLGDGTIVAIKVLKLQQ----QGALKSFIDEC---------- 436
K +G G++G V K TL G IVAIK +K+ + + + C
Sbjct: 13 KGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK--- 493
+ +H NI+ ++ V +EG DF LV + M KK
Sbjct: 72 KIMNEIKHENIMGLV----DVYVEG-DFINLVMDIM---------------ASDLKKVVD 111
Query: 494 ----LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA-K 548
L+ Q I + + + L+ LH H DL P+N+ ++ + DFGLA +
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168
Query: 549 FLFE-ISDNPSKNQTVSIGLKG-----SIGYIPPEHMNG--QVSILGDIYSYGILLLEMF 600
+ + SD SK++T+ + ++ Y PE + G + D++S G + E+
Sbjct: 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 601 TGK 603
TGK
Sbjct: 229 TGK 231
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
D+F K +G G+ G V K G I+A K++ L+ + A+++ I R
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI--------IRE--- 49
Query: 448 LRVITACSSVDLEG-------NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
L+V+ C+S + G + ++ E M G+LDQ L KK I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEN 99
Query: 501 ---NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
I+I V L YL I H D+KPSN+L++ + DFG++ L +
Sbjct: 100 ILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DS 153
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
N V G+ Y+ PE + G ++ DI+S G+ L+EM G+ P
Sbjct: 154 MANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ S L++LH I + DLKP NVLLD D + D GLA E+ D SK +
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQSKTK---- 155
Query: 566 GLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRP 605
G G+ G++ PE + G+ S+ D ++ G+ L EM + P
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 396 LIGTGSFGSVYKGTL-GDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRVI 451
++G GSFG V L G + A+KVLK + Q ++ + E L R+ L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
C + D V EF++ G+L H + + + A ++ SAL
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY-----AAEITSALM 110
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
+LH D I + DLK NVLLD + + DFG+ K N + G+
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTP 160
Query: 572 GYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
YI PE + D ++ G+LL EM G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 37/232 (15%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQG-ALKSFIDECNALKSTRH 444
+ ++ IG G+FG+V K GTI+A+K ++ K + + + + +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 445 -RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN-- 501
I++ A EG+ + + E M +LD++ Y++ + +
Sbjct: 62 CPYIVKFYGALFR---EGDCW--ICMELMDI-SLDKF--------YKYVYEVLKSVIPEE 107
Query: 502 ----IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
IA+ AL+YL + I H D+KPSN+LLD++ + DFG++ L +
Sbjct: 108 ILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----- 160
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQVS----ILGDIYSYGILLLEMFTGKRP 605
S +T G + Y+ PE ++ + D++S GI L E+ TGK P
Sbjct: 161 SIAKTRDAGCR---PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 396 LIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITAC 454
++G GSFG V L G G A+K LK + L EC ++ RV+
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVVLIDDDVECTMVEK-------RVLALA 52
Query: 455 SS--------VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK-KLSVIQRLNIAID 505
+ + V EF++ G+L H Q K + + + A +
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--------MFHIQDKGRFDLYRATFYAAE 104
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L +LH I + DLK NV+LD+D + DFG+ K E ++ T
Sbjct: 105 IVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFC- 157
Query: 566 GLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
G+ YI PE + G + + D +S+G+LL EM G+ P
Sbjct: 158 ---GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
+G G+FG VYK + G + A KV+ + + L+ ++ E + L S H NI++++ A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK-LSVIQRLNIAIDVASALDYLH 514
E N + ++ EF + G +D A + ++ L+ Q + AL+YLH
Sbjct: 71 -FYYENNLW--ILIEFCAGGAVD-------AVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS-IG- 572
+ I H DLK N+L D + DFG+ S T +I + S IG
Sbjct: 121 ---ENKIIHRDLKAGNILFTLDGDIKLADFGV-----------SAKNTRTIQRRDSFIGT 166
Query: 573 --YIPPEHMNGQVS------ILGDIYSYGILLLEM 599
++ PE + + S D++S GI L+EM
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 37/238 (15%)
Query: 388 TDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKL--QQQGALKSFIDECNALKS-TR 443
T F +IG G++G VYK G +VAIK++ + ++ +K E N L+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSN 61
Query: 444 HRNILRVITACSSVDLEGNDFKA-LVFEFMSNG---NLDQWLHPSPAEHYQFKKLSVIQR 499
H NI A + GND + LV E G +L + L K+L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWI 115
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG--DFGLAKFLFEISDNP 557
I + L YLH + + H D+K N+LL K+ A V DFG++ L D+
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSAQL----DST 166
Query: 558 SKNQTVSIGLKGSIGYIPPE----HMNGQVSI--LGDIYSYGILLLEMFTGKRPTGDM 609
+ I G+ ++ PE S D++S GI +E+ GK P DM
Sbjct: 167 LGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 67/220 (30%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNILR--- 449
+G+G++GSV G VAIK L Q + K E LK +H N++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
V T+ S D E DF LV +M HP + Q+ V Q L
Sbjct: 82 VFTSAVSGD-EFQDF-YLVMPYMQTDLQKIMGHPLSEDKVQYL---VYQML-------CG 129
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
L Y+H I H DLKP N+ +++D + DFGLA+ +D V
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTGYVV------ 176
Query: 570 SIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
+ Y PE H N V DI+S G ++ EM TGK
Sbjct: 177 TRWYRAPEVILNWMHYNQTV----DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 390 NFSKENLIGTGSFGS--VYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHR 445
++ ++G G+FG +Y+ T D ++V K + L + + + ++E L +H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI I + + + E+ + G L + + ++ + L
Sbjct: 60 NI---IAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEE-----MVLWYLFQ 109
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ SA+ Y+H I H D+K N+ L K +GDFG++K L S +TV
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVV- 162
Query: 566 GLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKR 604
G+ Y+ PE G + + DI++ G +L E+ T KR
Sbjct: 163 ---GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 391 FSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F ++G G FG V + G + A K KL+++ +K E AL + IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKK-RIKKRKGEAMALNEKQ---ILE 55
Query: 450 VITACSSVDL----EGNDFKALVFEFMSNGNLDQWLH----PS-PAEHYQFKKLSVIQRL 500
+ + V L E D LV M+ G+L ++ P E F
Sbjct: 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF--------- 106
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
A ++ L+ LH I + DLKP N+LLD + D GLA EI +
Sbjct: 107 -YAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA---VEIPE----G 155
Query: 561 QTVSIGLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
+T+ G G++GY+ PE + + D + G L+ EM GK P
Sbjct: 156 ETIR-GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 29/176 (16%)
Query: 397 IGTGSFGSVYKG---TLGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRV 450
IG G++G VYK DG AIK K Q G +S E L+ +H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 451 ITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL--NIAIDVA 507
+ LE D L+F++ + +L Q + H Q K++S+ + ++ +
Sbjct: 68 VEVF----LEHADKSVYLLFDY-AEHDLWQIIK----FHRQAKRVSIPPSMVKSLLWQIL 118
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLL--DKDMTAHV--GDFGLAKFLFEISDNPSK 559
+ + YLH + H DLKP+N+L+ + V GD GLA+ + P K
Sbjct: 119 NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF----NAPLK 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 391 FSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F + ++G G FG V + G + A K L+ ++ +K E AL + IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR---IKKRKGESMALN---EKQILE 55
Query: 450 VITACSSVDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
+ + V+L E D LV M+ G+L ++ ++ ++ L A +
Sbjct: 56 KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAE 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L+ LH + DLKP N+LLD + D GLA +I + S
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIR----- 159
Query: 566 GLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
G G++GY+ PE +N Q L D + G L+ EM G+ P
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKS 441
D + D+F K IG GS G V T G VA+K + L++Q + +E ++
Sbjct: 19 DPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD 75
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRL 500
H N++ + + L G++ +V EF+ G L D H E Q
Sbjct: 76 YHHENVVDMYNSY----LVGDEL-WVVMEFLEGGALTDIVTHTRMNEE---------QIA 121
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ + V AL YLH+ + H D+K ++LL D + DFG F ++S K
Sbjct: 122 TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKR 175
Query: 561 QTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
++ L G+ ++ PE ++ DI+S GI+++EM G+ P
Sbjct: 176 KS----LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 51/271 (18%)
Query: 383 DISKST--DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNAL 439
D+S+ ++F IG+G++G VYK + G + AIKV+KL+ E +
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
K +H NI+ + D + EF G+L H + LS Q
Sbjct: 61 KDCKHSNIVAYFGSYLR-----RDKLWICMEFCGGGSLQDIYHVT-------GPLSESQI 108
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
++ + L YLH H D+K +N+LL + + DFG++ +I+ +K
Sbjct: 109 AYVSRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSA---QITATIAK 162
Query: 560 NQTVSIGLKGSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFTGKRPTGD------- 608
++ G+ ++ PE G + L DI++ GI +E+ + P D
Sbjct: 163 RKS----FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 609 --MFKDDF-------------SIHMFVSMAL 624
M K +F S H FV MAL
Sbjct: 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 67/221 (30%), Positives = 95/221 (42%), Gaps = 44/221 (19%)
Query: 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRNI---LRV 450
+G+G++G+V G VAIK L Q L K E LK +H N+ L V
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
T S+D +DF LV FM +L + + + +KLS + + + L
Sbjct: 83 FTPDLSLD-RFHDF-YLVMPFMGT-DLGKLM--------KHEKLSEDRIQFLVYQMLKGL 131
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS--IGLK 568
Y+H I H DLKP N+ +++D + DFGLA+ QT S G
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------QTDSEMTGYV 176
Query: 569 GSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
+ Y PE H V DI+S G ++ EM TGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTV----DIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 59/252 (23%)
Query: 397 IGTGSFGSVYK-GTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR------ 449
+G G+ GSV K + GT++A KV+ I KS+ + ILR
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV----------HIGA----KSSVRKQILRELQIMH 58
Query: 450 -----VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
I + L N+ + EFM G+LD+ + + V IA+
Sbjct: 59 ECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYK-------KGGPIPVEILGKIAV 110
Query: 505 DVASALDYLH--HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
V L YL+ H I H D+KPSN+L++ + DFG++ L +
Sbjct: 111 AVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI---------NS 157
Query: 563 VSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621
++ G+ Y+ PE + G + ++ D++S GI ++E+ GK P DD
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------ 211
Query: 622 MALPDHVMDILD 633
D M ILD
Sbjct: 212 ---QDDPMGILD 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 49/271 (18%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV--ITA 453
+G GS G V+ D VA+K + L ++K + E ++ H NI++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 454 CSSVDLEGN-----DFKAL--VFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRLNIAI 504
S DL + + ++ V E+M +L L P EH +L + Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEH---ARLFMYQLLR--- 125
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFL---FEISDNPSKN 560
L Y+H + H DLKP+NV ++ +D+ +GDFGLA+ + + S+
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 561 QTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
V+ + + P + + D+++ G + EM TGK +F H
Sbjct: 179 -LVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKP----LFAGA---HELE 226
Query: 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVI 651
M L IL+ S+P+ E D ++ VI
Sbjct: 227 QMQL------ILE-SVPVVREEDRNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
DNF K IG GS G V T+ G +VA+K + L++Q + +E ++ +H N+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
+ + + L G++ +V EF+ G L D H E Q + + V
Sbjct: 80 VEMYNSY----LVGDEL-WVVMEFLEGGALTDIVTHTRMNEE---------QIAAVCLAV 125
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
AL LH + H D+K ++LL D + DFG F ++S + ++
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKS---- 175
Query: 567 LKGSIGYIPPEHMNGQVSILG-----DIYSYGILLLEMFTGKRP 605
L G+ ++ PE +S L DI+S GI+++EM G+ P
Sbjct: 176 LVGTPYWMAPE----LISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 396 LIGTGSFGSVYKGTL-GDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNILRVI 451
++G GSFG V L G + AIKVLK + Q + + E L L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
C + D V E+++ G+L + S +K + A +V AL
Sbjct: 62 HCC----FQTKDRLFFVMEYVNGGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALM 110
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
+LH H + + DLK N+LLD + + DFG+ K + T + G+
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK------EGILNGVTTTT-FCGTP 160
Query: 572 GYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628
YI PE + S+ D ++ G+L+ EM G+ P F+ D +F S+ L D V
Sbjct: 161 DYIAPEILQELEYGPSV--DWWALGVLMYEMMAGQPP----FEADNEDDLFESI-LHDDV 213
Query: 629 M 629
+
Sbjct: 214 L 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 396 LIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITA- 453
+IG G FG VY D G + A+K L ++ +K E AL R +L +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 454 ------CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
C + D + + M+ G+L HY + V +
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDL----------HYHLSQHGVFSEKEMRFYAT 104
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ L H + + + DLKP+N+LLD+ + D GLA D K S+
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHASV-- 156
Query: 568 KGSIGYIPPEHMNGQVSI--LGDIYSYGILLLEMFTGKRP-----TGDMFKDDFSIHMFV 620
G+ GY+ PE + + D +S G +L ++ G P T D + D + + V
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTV 214
Query: 621 SMALPD 626
++ LPD
Sbjct: 215 NVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 389 DNFSKENLIGTGSFGSVYKG--TLGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHR 445
+ + K +G G++ +V+KG L + +VA+K ++L+ ++GA + I E + LK +H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 446 NILRVITACSSVDLEGNDFK-ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI+ + D+ D LVFE++ + +L Q++ +++ N+ I
Sbjct: 65 NIVTL------HDIVHTDKSLTLVFEYL-DKDLKQYMDDCG---------NIMSMHNVKI 108
Query: 505 ---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK-- 559
+ L Y H + H DLKP N+L+++ + DFGLA+ P+K
Sbjct: 109 FLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTY 161
Query: 560 -NQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGK 603
N+ V ++ Y PP+ + G + S D++ G + EM +G+
Sbjct: 162 SNEVV------TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 396 LIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTRHRNIL 448
L+G G+FG V K T G A+K+LK + + + + E L++TRH +
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+ + +D V E+ + G L + H S + + R A ++ S
Sbjct: 59 AL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDR----ARFYGA-EIVS 106
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
AL YLH CD + + DLK N++LDKD + DFGL K ISD + +T
Sbjct: 107 ALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFC---- 156
Query: 569 GSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + G+ D + G+++ EM G+ P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 39/245 (15%)
Query: 396 LIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITA- 453
+IG G FG VY D G + A+K L ++ +K E AL R +L +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 454 ------CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
C S D + + + M+ G+L HY + V + A
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDL----------HYHLSQHGVFSEAEMRFYAA 104
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ L H + + + DLKP+N+LLD+ + D GLA D K S+
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHASV-- 156
Query: 568 KGSIGYIPPEHMNGQVSI--LGDIYSYGILLLEMFTGKRPT-GDMFKDDFSIH---MFVS 621
G+ GY+ PE + V+ D +S G +L ++ G P KD I + ++
Sbjct: 157 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 622 MALPD 626
+ LPD
Sbjct: 216 VELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 140 NQ-LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGN 198
NQ L G +P D+ L +L+ + N G+IP SL + ++L+VLD + N G+IP +
Sbjct: 427 NQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 199 FGSLKDLVRLNFDQNELGSR 218
G L L LN + N L R
Sbjct: 486 LGQLTSLRILNLNGNSLSGR 505
|
Length = 623 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 440 KSTRHRNILRVITACSSV-------DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK 492
++ R+ L + AC D + +D L+ E+ S G+L++ + EH F+
Sbjct: 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
+ V + + ALD +H + H DLK +N+ L +GDFG +K +
Sbjct: 168 EYEVGL---LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---Q 218
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRP 605
SD+ S + V+ G+ Y+ PE + S D++S G++L E+ T RP
Sbjct: 219 YSDSVSLD--VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 36/174 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHR 445
+ + K + IG GS+G V+K + G IVAIK + + K + E LK +H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 446 NILRVITACSSVDLEGNDFKA-----LVFEFMSN---GNLDQWLHPSPAEHYQFKKLSVI 497
N++ +I F+ LVFE+ + L++ +P + KK
Sbjct: 61 NLVNLIEV----------FRRKRKLHLVFEYCDHTVLNELEK--NPRGVPEHLIKK---- 104
Query: 498 QRLNIAIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
I A+++ H H+C H D+KP N+L+ K + DFG A+ L
Sbjct: 105 ----IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 396 LIGTGSFGSV-YKGTLGDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVI 451
L+G G+FG V G A+K+LK + + + + E LK+TRH + +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
+ D V E+++ G L + H S + + ++ SALD
Sbjct: 61 ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFY-----GAEIVSALD 109
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YLH I + DLK N++LDKD + DFGL K E + + +T G+
Sbjct: 110 YLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFC----GTP 159
Query: 572 GYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRP 605
Y+ PE + + D + G+++ EM G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
+G+G++G VYK L G + A+K++KL+ E +K +H NI+ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH 515
S + + E+ G+L H + LS +Q + + L YLH
Sbjct: 77 S-----REKLWICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHS 124
Query: 516 HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP 575
H D+K +N+LL + + DFG+A +I+ +K ++ G+ ++
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKS----FIGTPYWMA 174
Query: 576 PE----HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
PE NG + L DI++ GI +E+ + P D+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 61/238 (25%), Positives = 91/238 (38%), Gaps = 68/238 (28%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKL---QQQGALKSFIDECNALKSTRHRNILRVIT 452
IG GSFG+VY + +VAIK + Q + I E L+ RH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI---- 78
Query: 453 ACSSVDLEGNDFKA---------LVFEFMSNGNLDQW-LHPSPAEHYQFKKLSVIQRLNI 502
++K LV E+ D +H P +Q + I
Sbjct: 79 ----------EYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-----------LQEVEI 117
Query: 503 AI---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
A L YLH H H D+K N+LL + T + DFG A + +P+
Sbjct: 118 AAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLV-----SPA- 168
Query: 560 NQTVSIGLKGSIGYIPPE--------HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
N V G+ ++ PE +G+V D++S GI +E+ K P +M
Sbjct: 169 NSFV-----GTPYWMAPEVILAMDEGQYDGKV----DVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 21/154 (13%)
Query: 411 GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469
G +VA+K+L+ + A F+ E L + NI+R++ C D ++
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMIT 98
Query: 470 EFMSNGNLDQWL------------HPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC 517
E+M NG+L+Q+L + + + +S L++A+ +AS + YL
Sbjct: 99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155
Query: 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551
H DL N L+ +++T + DFG+++ L+
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 64/240 (26%), Positives = 95/240 (39%), Gaps = 44/240 (18%)
Query: 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFID 434
R++ M Y D NF + +GTGSFG V T + + + + ++ +K
Sbjct: 23 RKNKMKYEDF-----NFIRT--LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ--- 72
Query: 435 ECNALKSTRH----RNILRVITACSSVDLEGN----DFKALVFEFMSNGNLDQWLHPSPA 486
K H R IL I V+L G+ + LV EF+ G +L +
Sbjct: 73 -----KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-- 125
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
K+ A + +YL I + DLKP N+LLDKD + DFG
Sbjct: 126 -----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
AK + T + L G+ YI PE +N D ++ GI + E+ G P
Sbjct: 178 AKVV----------DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 389 DNFSKENLIGTGSFGSV-YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
+N+ K IG GS G V G VA+K++ L++Q + +E ++ +H+N+
Sbjct: 24 ENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ + + L G + L+ EF+ G L + + +L+ Q + V
Sbjct: 81 VEMYKSY----LVGEELWVLM-EFLQGGALTDIVSQT--------RLNEEQIATVCESVL 127
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
AL YLH + H D+K ++LL D + DFG F +IS + K ++ L
Sbjct: 128 QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKS----L 177
Query: 568 KGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G+ ++ PE ++ DI+S GI+++EM G+ P
Sbjct: 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 50/209 (23%)
Query: 467 LVFEFMSNGNLD---QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523
LV E+++ G+L Q P EH +F A ++ AL++LH + I +
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARF----------YAAEICIALNFLH---ERGIIY 119
Query: 524 CDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ- 582
DLK NVLLD D + D+G+ K D S G+ YI PE + G+
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-------FCGTPNYIAPEILRGEE 172
Query: 583 VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEEN 642
D ++ G+L+ EM G+ P D+ D +P M N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF-DIITD--------------------NPDM-----N 206
Query: 643 DEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
E+ + +VI EK + I L V + L+
Sbjct: 207 TEDYLFQVILEKPIRIPRFLSVKASHVLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 40/236 (16%)
Query: 396 LIGTGSFGSVYKGTLGD---GTIVAIKVLK--LQQQGALKS-FIDECNALKSTRHRNILR 449
LIG G G VY D VA+K ++ L + LK F+ E H I+
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 450 VITACSSVD--------LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
V + CS D +EG K+L+ +L + L +K SV L+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---------EKTSVGAFLS 117
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL----------- 550
I + + ++Y+H + H DLKP N+LL + D+G A F
Sbjct: 118 IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
+ + + T+ + G+ Y+ PE + G S DIY+ G++L +M T P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 60/227 (26%), Positives = 86/227 (37%), Gaps = 51/227 (22%)
Query: 397 IGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFI---DECNALKSTRHRNILR 449
+G G FG V YK T G + AIK LK K I DE +L + R
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALK-------KGDIIARDEVESLMCEK-----R 51
Query: 450 VITACSS------VDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
+ +S V+L D V E+ + G+L H S +
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--------MMHIHTDVFSEPRA 103
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
+ A V L YLH + I + DLK N+LLD + + DFGL K +
Sbjct: 104 VFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK------EGMGF 154
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
S G+ ++ PE + D + G+L+ EM G+ P
Sbjct: 155 GDRTST-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIK-VLKLQQQGAL-KSFIDECNALKSTRH 444
T+ + +G G+FG V G VAIK ++K L K E LK RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI+ + S + + + V E + +L + L P E QF + + Q L
Sbjct: 69 ENIISL----SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEK-QFIQYFLYQILR--- 119
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
L Y+H + H DLKPSN+L++++ + DFGLA+ I D P VS
Sbjct: 120 ----GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR----IQD-PQMTGYVS 167
Query: 565 IGLKGSIGYIPPEHM------NGQVSILGDIYSYGILLLEMFTGK 603
Y PE M + +V DI+S G + EM GK
Sbjct: 168 TRY-----YRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 396 LIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITAC 454
++G GSFG V+ L G AIK LK + L EC ++ RV++
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVECTMVEK-------RVLSLA 52
Query: 455 ----------SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
+ + N F V E+++ G+L H + + + A
Sbjct: 53 WEHPFLTHLYCTFQTKENLF--FVMEYLNGGDL--MFHIQSCHKFDLPRATFY-----AA 103
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
++ L +LH I + DLK N+LLD D + DFG+ K E +K T
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC 157
Query: 565 IGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRP 605
G+ YI PE + GQ S+ D +S+G+LL EM G+ P
Sbjct: 158 ----GTPDYIAPEILLGQKYNTSV--DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 467 LVFEFMSNGNLD---QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523
V EF+S G+L Q P EH +F + +++ AL++LH + I +
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARF----------YSAEISLALNFLH---ERGIIY 119
Query: 524 CDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ- 582
DLK NVLLD + + D+G+ K + T S G+ YI PE + G+
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCK------EGIRPGDTTST-FCGTPNYIAPEILRGED 172
Query: 583 --VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDE 640
S+ D ++ G+L+ EM G+ P F I V M+ +
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGRSP--------FDI---VGMS-------------DNPD 206
Query: 641 ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
+N E+ + +VI EK++ I L V + L+
Sbjct: 207 QNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 44/229 (19%)
Query: 389 DNFSKENLIGTGSFGSVYK-GTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
D+F + + +G G+ G V K G I+A K++ L+ + A+++ I R
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--------IRE--- 53
Query: 448 LRVITACSS---VDLEGNDFK----ALVFEFMSNGNLDQWLHPS---PAEHYQFKKLSVI 497
L+V+ C+S V G + ++ E M G+LDQ L + P E ++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE--------IL 105
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+++IA V L YL I H D+KPSN+L++ + DFG++ L + N
Sbjct: 106 GKVSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN- 160
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + G S+ DI+S G+ L+E+ G+ P
Sbjct: 161 --------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 491 FKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ L+ + L+ VA +++L +C H DL NVLL + + DFGLA+
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARD 286
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTG 607
+ S+ SK T + ++ PE + + + L D++SYGILL E+F+ G P
Sbjct: 287 IMHDSNYVSKGSTFL-----PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341
Query: 608 DMFKDDFSIHMFVS---MALPDH 627
M D + S MA PDH
Sbjct: 342 GMIVDSTFYNKIKSGYRMAKPDH 364
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 396 LIGTGSFGSVYKGTLG-DGTIVAIKVLK---LQQQGALKSFIDECNAL-KSTRHRNILRV 450
+IG GSFG V DG A+KVL+ + + K + E N L K+ +H ++ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLH-------PSPAEHYQFKKLSVIQRLNIA 503
+ + V +F++ G L + H P P + A
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF------------YA 102
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
++ASAL YLH I + DLKP N+LLD + DFGL K SD +
Sbjct: 103 AEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT---- 155
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + Q D + G +L EM G P
Sbjct: 156 ---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 45/255 (17%)
Query: 391 FSKENLIGTGSFGS---VYKGTLGDGTIVA-IKVLKLQQQGALKSFIDECNALKSTRHRN 446
+ K IG GSFG V G ++ I + K+ + +S E L + +H N
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR-KEVAVLSNMKHPN 60
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I + S + GN + +V ++ G+L + ++ + Q L+ + +
Sbjct: 61 I---VQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVLFPED-----QILDWFVQI 110
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
AL ++H D I H D+K N+ L KD T +GDFG+A+ L N TV +
Sbjct: 111 CLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---------NSTVELA 158
Query: 567 LKGSIG---YIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622
+ IG Y+ PE N + DI++ G +L EM T K H F +
Sbjct: 159 -RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK-------------HAFEAG 204
Query: 623 ALPDHVMDILDPSMP 637
+ + V+ I+ S P
Sbjct: 205 NMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 28/223 (12%)
Query: 388 TDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLK---LQQQGALKSFIDECNALKSTR 443
NF ++G GSFG V G + AIK+LK + Q ++ + E L
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
L + +C + D V E+++ G+L + Q K Q + A
Sbjct: 59 KPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPQAVFYA 107
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+++ L +LH I + DLK NV+LD + + DFG+ K ++ T
Sbjct: 108 AEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTT 158
Query: 564 SIGLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
G+ YI PE + Q D ++YG+LL EM G+ P
Sbjct: 159 RT-FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKL-----QQQGALKSFIDECNALKSTR 443
N+ + L+G G+FG VY D G +A K ++ + + + E LK+ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H R++ + + E+M G++ L + Y SV ++
Sbjct: 63 HE---RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQ 114
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
I + YLH + I H D+K +N+L D +GDFG +K L I + + ++V
Sbjct: 115 I--LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ G+ ++ PE ++G+ D++S G ++EM T K P
Sbjct: 170 T----GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 70/236 (29%), Positives = 100/236 (42%), Gaps = 65/236 (27%)
Query: 396 LIGTGSFGSVYKGTLGDGT----IVAIKVLKLQQQGALKSFIDECNALKSTRH----RNI 447
++G G +G V++ G I A+KVLK K+ I K T H RNI
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATI--VRNQKDTAHTKAERNI 53
Query: 448 LRVITACSSVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
L + VDL G + L+ E++S G L ++H ++R
Sbjct: 54 LEAVKHPFIVDLIYAFQTGGKLY--LILEYLSGGEL--FMH--------------LEREG 95
Query: 502 IAI-DVAS--------ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
I + D A AL++LH I + DLKP N+LLD + DFGL K
Sbjct: 96 IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ES 150
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRP 605
I + TV+ G+I Y+ PE + S G D +S G L+ +M TG P
Sbjct: 151 IHEG-----TVTHTFCGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH---RNILRVI 451
+IG GSFG V + A+KVL Q++ LK E + S R+ +N+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVL--QKKAILKK--KEEKHIMSERNVLLKNVKHPF 57
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI-AIDVASAL 510
+ D V ++++ G L H Q ++ + R A ++ASAL
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGEL--------FYHLQRERCFLEPRARFYAAEIASAL 109
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
YLH I + DLKP N+LLD + DFGL K +N N T S G+
Sbjct: 110 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTST-FCGT 159
Query: 571 IGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTG-----KRPTGDMFKD 612
Y+ PE ++ Q D + G +L EM G R T +M+ +
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455
+G G+FG VYK + G + A KV++ + + L+ ++ E L + H I++++ A
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK-LSVIQRLNIAIDVASALDYLH 514
+G + ++ EF G +D A + + L+ Q I + AL YLH
Sbjct: 78 -FYWDGKLW--IMIEFCPGGAVD-------AIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 515 HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI 574
I H DLK NVLL D + DFG +S K G+ ++
Sbjct: 128 ---SMKIIHRDLKAGNVLLTLDGDIKLADFG-------VSAKNVKTLQRRDSFIGTPYWM 177
Query: 575 PPEHM------NGQVSILGDIYSYGILLLEM 599
PE + + DI+S GI L+EM
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 69/267 (25%), Positives = 97/267 (36%), Gaps = 86/267 (32%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR- 443
+F K L+G G G V+ KGT G + A+KVL K + + N +K
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVL-------DKKEMIKRNKVKRVLT 50
Query: 444 HRNILR------VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA-----EHYQFK 492
+ IL + T +S E + LV ++ G L + L P E +F
Sbjct: 51 EQEILATLDHPFLPTLYASFQTE--TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF- 107
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFL 550
A +V AL+YLH I + DLKP N+LL + H+ DF L+K
Sbjct: 108 ---------YAAEVLLALEYLHL---LGIVYRDLKPENILLHES--GHIMLSDFDLSK-- 151
Query: 551 FEISDNPSKNQTVSIGLKGSIG---------------------------YIPPEHMNGQV 583
+ KGS YI PE ++G
Sbjct: 152 ---QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD- 207
Query: 584 SILG-----DIYSYGILLLEMFTGKRP 605
G D ++ GILL EM G P
Sbjct: 208 ---GHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
S + F I G+FG VY G + + A+KV+K + + + E +AL +
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP--AEHYQFKKLSVIQRL 500
+ I+ + + L+ + LV E++ G++ LH E K +S
Sbjct: 62 KSPFIVHLYYS-----LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----- 111
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
+VA ALDYLH H I H DLKP N+L+ + + DFGL+K
Sbjct: 112 ----EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 48/209 (22%)
Query: 467 LVFEFMSNGNLD---QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523
V E+++ G+L Q P EH +F + +++ AL+YLH + I +
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARF----------YSAEISLALNYLH---ERGIIY 119
Query: 524 CDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ- 582
DLK NVLLD + + D+G+ K D S G+ YI PE + G+
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFCGTPNYIAPEILRGED 172
Query: 583 VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEEN 642
D ++ G+L+ EM G+ P DI+ S D +N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP-----------------------FDIVGSSDNPD-QN 208
Query: 643 DEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
E+ + +VI EK++ I L V + L+
Sbjct: 209 TEDYLFQVILEKQIRIPRSLSVKAASVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 34/96 (35%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 184 LDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN 243
L GL G IP + L+ L +N N + N L + TSLEVL L+ N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG------NIPPSLGSITSLEVLDLSYN 476
Query: 244 SFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIG 279
SF G +P S+ L T LR L + N + G +P +G
Sbjct: 477 SFNGSIPESLGQL-TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 396 LIGTGSFGSVY----KGTLGDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNIL 448
L+G G+FG V K T G A+K+LK + + + + E L+++RH
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 55
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+TA + +D V E+ + G L + H S + + ++ S
Sbjct: 56 -FLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY-----GAEIVS 106
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
ALDYLH + + + DLK N++LDKD + DFGL K K+
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFC 157
Query: 569 GSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + + D + G+++ EM G+ P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 390 NFSKENLIGTGSFGSVY--KGTLGDGTIVAIKVLKL-----QQQGALKSFIDECNALKST 442
+ IG GSFG +Y K D IK + L +++ A K E L
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKM 56
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
+H NI +T +S G F +V E+ G+L + ++ + S Q L+
Sbjct: 57 KHPNI---VTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLF-----SEDQILSW 106
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQ 561
+ ++ L ++H D I H D+K N+ L K+ M A +GDFG+A+ L +D+
Sbjct: 107 FVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAY 160
Query: 562 TVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
T G+ Y+ PE N + DI+S G +L E+ T K P
Sbjct: 161 TCV----GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 394 ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVIT 452
+ +IG GS+G V G VAIK K+ F +A + R +LR++
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIK--KIND-----VFEHVSDATRILREIKLLRLLR 57
Query: 453 ACSSVDLEG-------NDFKAL--VFEFMSNGNLDQWLHPS---PAEHYQFKKLSVIQRL 500
V+++ +FK + VFE M + +L Q + + EH+QF + Q L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQF---FLYQLL 113
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
AL Y+H + H DLKP N+L + D + DFGLA+ F +D P+
Sbjct: 114 R-------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF--NDTPT-- 159
Query: 561 QTVSIGLKGSIGYIPPE---HMNGQVSILGDIYSYGILLLEMFTGK 603
+ Y PE + + DI+S G + E+ TGK
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 63/228 (27%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 391 FSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
F ++G G FG V + G + A K KL+++ +K E AL R IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKK-RIKKRKGEAMALNEKR---ILE 55
Query: 450 VITACSSVDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
+ + V L E D LV M+ G+L K + N D
Sbjct: 56 KVNSRFVVSLAYAYETKDALCLVLTIMNGGDL---------------KFHIYNMGNPGFD 100
Query: 506 VASALDYLHHHC-------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
A+ Y C I + DLKP N+LLD + D GLA + E
Sbjct: 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQVSILG-DIYSYGILLLEMFTGKRP 605
+TV G G++GY+ PE +N + D + G L+ EM G+ P
Sbjct: 155 -GETVR-GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNAL-KSTRHRNILRVI 451
IG GSFG V DG A+KVL+ + ++ K + E N L K+ +H ++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
+ D V ++++ G L + H + R A ++ASAL
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSF----PEPRARF-YAAEIASALG 110
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YLH I + DLKP N+LLD + DFGL K E S S G+
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-------FCGTP 160
Query: 572 GYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRP 605
Y+ PE + Q ++ D + G +L EM G P
Sbjct: 161 EYLAPEVLRKQPYDRTV--DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVL---KLQQQGALKSFIDECNALKS 441
D+F +IG G+FG V K T G + A+K+L ++ ++ F +E + L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNT---GQVYAMKILNKWEMLKRAETACFREERDVLVN 57
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS----PAEHYQFKKLSVI 497
R I + A + + LV ++ G+L L P + +F +
Sbjct: 58 GDRRWITNLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF----YL 108
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+ +AID L Y+H D+KP NVLLDK+ + DFG + +
Sbjct: 109 AEMVLAIDSVHQLGYVHR---------DIKPDNVLLDKNGHIRLADFGSC---LRLLADG 156
Query: 558 SKNQTVSIGLKGSIGYIPPE---HMNGQVSILG---DIYSYGILLLEMFTGKRP 605
+ V++ G+ YI PE M G D +S G+ + EM G+ P
Sbjct: 157 TVQSNVAV---GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 390 NFSKENLIGTGSFGSVY---KGTLGD-GTIVAIKVLK----LQQQGALKSFIDECNALKS 441
NF ++GTG++G V+ K + D G + A+KVLK +Q+ + E L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
R L + D + + L+ ++++ G L + H S E ++ +++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLH----LILDYINGGEL--FTHLSQRERFKEQEVQIY---- 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ ++ AL++LH I + D+K N+LLD + + DFGL+K E + +
Sbjct: 111 -SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS- 165
Query: 562 TVSIGLKGSIGYIPPEHMNGQVS---ILGDIYSYGILLLEMFTGKRP 605
G+I Y+ P+ + G D +S G+L+ E+ TG P
Sbjct: 166 -----FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 396 LIGTGSFGSVY----KGTLGDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNIL 448
L+G G+FG V K T G A+K+L+ + + + + E L++TRH +
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+ A + +D V E+ + G L + H S + ++ ++ S
Sbjct: 59 ALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY-----GAEIVS 106
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
AL+YLH + + D+K N++LDKD + DFGL K ISD +
Sbjct: 107 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-----FC 156
Query: 569 GSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + + D + G+++ EM G+ P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 79/268 (29%), Positives = 118/268 (44%), Gaps = 48/268 (17%)
Query: 352 NCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTD-NFSKENLIGTGSFGSVYKGTL 410
N +KL S N+ G E + M +DI++S + ++ N+IG GSFG VY+
Sbjct: 31 NDKKLDEEERSHNNNAGEDEDEEK---MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 411 GDGT-IVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV----ITACSSVDLEGNDFK 465
D + VAIK K+ Q K+ E +K+ H NI+ + T C + E N F
Sbjct: 88 IDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKN-EKNIFL 142
Query: 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN--IAIDVASALDYLHHHCDTPIAH 523
+V EF+ Q +H +HY ++ L + + AL Y+H I H
Sbjct: 143 NVVMEFIP-----QTVHKY-MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICH 193
Query: 524 CDLKPSNVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI------PP 576
DLKP N+L+D T + DFG AK L + + S+ YI P
Sbjct: 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNL--------------LAGQRSVSYICSRFYRAP 239
Query: 577 EHMNGQVSILG--DIYSYGILLLEMFTG 602
E M G + D++S G ++ EM G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 390 NFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
+F+ ++G GSFG V KGT + AIK+LK + Q ++ + E L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
L + +C + D V E+++ G+L + Q K +
Sbjct: 58 GKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPHAVFY 106
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
A ++A L +LH I + DLK NV+LD + + DFG+ K E +T
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 563 VSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRP 605
G+ YI PE + Q S+ D +++G+LL EM G+ P
Sbjct: 161 FC----GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 12/111 (10%)
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
L Y+H + H DLKP N+L++ D + DFGLA+ S+NP +N
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFMTEYV 170
Query: 569 GSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
+ Y PE M + D++S G +L E G++P +FK +
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 71/254 (27%), Positives = 101/254 (39%), Gaps = 47/254 (18%)
Query: 397 IGTGSFGSVYKGTL----GDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRNILRV 450
+G GS+G V +L DG IK L L+ K+ E L +H NI+
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 451 ITACSSVDLEGND-FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ EG D +V F G+L L + + K L Q + + +A A
Sbjct: 65 RES-----WEGEDGLLYIVMGFCEGGDLYHKL-----KEQKGKLLPENQVVEWFVQIAMA 114
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
L YLH + I H DLK NV L + VGD G+A+ L D S L G
Sbjct: 115 LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-------LIG 164
Query: 570 SIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628
+ Y+ PE N + D+++ G + EM T K H F + + V
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK-------------HAFNAKDMNSLV 211
Query: 629 MDILD---PSMPLD 639
I++ P MP D
Sbjct: 212 YRIIEGKLPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 42/127 (33%), Positives = 58/127 (45%), Gaps = 24/127 (18%)
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT-AHVGDFGLAKFL 550
KLS + I + AL+ LH H I H D+K NVL D+ ++ D+GL K
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-- 158
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTG 607
I PS G++ Y PE + G VS D ++ G+L E+ TGK P
Sbjct: 159 --IIGTPSC-------YDGTLDYFSPEKIKGHNYDVSF--DWWAVGVLTYELLTGKHP-- 205
Query: 608 DMFKDDF 614
FK+D
Sbjct: 206 --FKEDE 210
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 66/244 (27%), Positives = 100/244 (40%), Gaps = 63/244 (25%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALK--SFIDECNALKST 442
+F ++L+G G FG V K T G I A+KV+K A + SF +E
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEE------- 50
Query: 443 RHRNILRVITACSSVDL----EGNDFKALVFEFMSNGNL-------DQWLHPSPAEHYQF 491
R+IL + + L + D LV E+ G+L + A+ Y
Sbjct: 51 -ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-- 107
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKF 549
+ L +AI + Y+H D+KP NVL+D+ T H+ DFG A
Sbjct: 108 -----LAELVLAIHSVHQMGYVHR---------DIKPENVLIDR--TGHIKLADFGSAAR 151
Query: 550 LFEISDNPSKNQTVSIGLK-GSIGYIPPEHM-------NGQVSILGDIYSYGILLLEMFT 601
L + N+ V+ L G+ YI PE + G + D +S G++ EM
Sbjct: 152 L-------TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
Query: 602 GKRP 605
G+ P
Sbjct: 205 GRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 396 LIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKS-----FIDECNAL-KSTRHRNIL 448
+IG GSFG V DG+ A+KVL Q++ LK + E N L K+ +H ++
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVL--QKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI-AIDVA 507
+ + + V ++++ G L H Q ++ + R A +VA
Sbjct: 60 GL-----HYSFQTAEKLYFVLDYVNGGEL--------FFHLQRERCFLEPRARFYAAEVA 106
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
SA+ YLH I + DLKP N+LLD + DFGL K E + S
Sbjct: 107 SAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-------F 156
Query: 568 KGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE + + D + G +L EM G P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQ---QQGALKSFIDEC--NALKSTR 443
N+ L+G G+FG VY D G +A+K + Q+ + + EC LK+ R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H I++ C D E V E+M G++ L + Y +V +R
Sbjct: 63 HDRIVQYY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQL-----KAYGALTENVTRRYTRQ 114
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
I + YLH + I H D+K +N+L D +GDFG +K + I + + ++V
Sbjct: 115 I--LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ G+ ++ PE ++G+ D++S ++EM T K P
Sbjct: 170 T----GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 15/143 (10%)
Query: 494 LSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
LS + + + VA+ +++L +C H DL NVL+ + + DFGLA+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDM- 609
S+ SK T + LK ++ PE + N + L D++S+GILL E+FT G P ++
Sbjct: 292 DSNYISKGSTF-LPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 610 FKDDF--SIHMFVSMALPDHVMD 630
+ F +I MA P H D
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASD 369
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLK-----LQQQGALKSFIDECNALKS-TRHRNILR 449
IG G+F V K + G AIK +K L+Q L+ E AL+ + H NILR
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR----EIQALRRLSPHPNILR 62
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+I D + ALVFE M + NL + + + V + + +
Sbjct: 63 LIEVL--FDRKTGRL-ALVFELM-DMNLYELIK---GRKRPLPEKRV---KSYMYQLLKS 112
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
LD++H + I H D+KP N+L+ D + DFG +
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 76/310 (24%), Positives = 121/310 (39%), Gaps = 62/310 (20%)
Query: 391 FSKENLIGTGSFGSVY-KGTLGDGTIVAIKVLKL---QQQGALKSFIDECNALKSTRHRN 446
F+ IG GSFG+VY + +VAIK + Q + I E L+ +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 447 ILRVITACSSVDLEGNDFKA----LVFEFMSNGNLDQW-LHPSPAEHYQFKKLSVIQRLN 501
S++ +G + LV E+ D +H P +Q +
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVE 126
Query: 502 IAIDVASALD---YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
IA AL YLH H + H D+K N+LL + + DFG A +P+
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPA 178
Query: 559 KNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614
+ G+ ++ PE + GQ D++S GI +E+ K P +M
Sbjct: 179 NS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232
Query: 615 SIHM-------FVSMALPDHVMDILDPSM---PLDEENDEEQIEE--VIEEKEMMIHIDL 662
H+ S D+ + +D + P D EE ++ V+ E+ + IDL
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDL 292
Query: 663 EVNTKNKLEE 672
TK+ + E
Sbjct: 293 IQRTKDAVRE 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 397 IGTGSFGSVYKGTLGDGTIVA---IKVLKLQQQGALK-----SFIDECNALKSTRHRNIL 448
+G GSFG+VY + D VA +KVLK G L E L H I+
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+ + LE + F ++ E+ +LD L + V + I +
Sbjct: 66 KFHASF----LERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF---IQLLL 117
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ Y+H I H DLK N+ L ++ +GDFG+++ L D ++
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD-------LATTFT 166
Query: 569 GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEM 599
G+ Y+ PE + Q DI+S G +L EM
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 22/163 (13%)
Query: 446 NILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
+ILR I S + L+G N F L+ + D + + + + +++ L
Sbjct: 135 HILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-----RNIAICDILA 186
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
I V A+ YLH + I H D+K N+ ++ +GDFG A F +I N
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI------NA 237
Query: 562 TVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGK 603
G G+I PE + DI+S GI+L EM T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 79/320 (24%), Positives = 118/320 (36%), Gaps = 100/320 (31%)
Query: 391 FSKENL-----IGTGSFGSVYKGT---LG--DGTI-VAIKVLKLQQQGALKSFIDECNAL 439
F ++NL +G G+FG V + T LG D + VA+K+LK DE AL
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT------DEREAL 88
Query: 440 KST--------RHRNILR------------VITA-CSSVDL------------------- 459
S +H+NI+ VIT C DL
Sbjct: 89 MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP 148
Query: 460 ----EGNDFKALVFE---------FMSNGNLDQWLHPSPAEHYQFKKLSVIQR------- 499
+D+K + E F S G D ++ P +
Sbjct: 149 EISETSSDYKNITLEKKYIRSDSGFSSQG-SDTYVEMRPVSSSSSQSSDSKDEEDTEDSW 207
Query: 500 -------LNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551
L + VA +D+L +C H D+ NVLL A + DFGLA+ +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRPTGDM 609
S N V + + ++ PE + V ++ D++SYGILL E+F+ GK P +
Sbjct: 264 NDS-----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
Query: 610 FKDDFSIHMFVS---MALPD 626
+ M M+ PD
Sbjct: 319 LVNSKFYKMVKRGYQMSRPD 338
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRNI---LRV 450
+G+G++GSV G VA+K L Q + K E LK +H N+ L V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
T S++ E ND + ++ N +H QF + + L
Sbjct: 85 FTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRGL 133
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
Y+H I H DLKPSN+ +++D + DFGLA+ + T G +
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMT---GYVAT 180
Query: 571 IGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
Y PE H N V DI+S G ++ E+ TG+
Sbjct: 181 RWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 67/257 (26%), Positives = 102/257 (39%), Gaps = 62/257 (24%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRN 446
D+F +IG G+FG V D G I A+K+L+ K+ + E + R R+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 447 ILR------VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA---EHYQFKKLSVI 497
IL V+ S + N + L+ EF+ G++ L E QF I
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQF----YI 107
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL---------AK 548
+AID L ++H D+KP N+LLD + DFGL +
Sbjct: 108 AETVLAIDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158
Query: 549 FLFEISDNP------------------SKN-QTVSIGLKGSIGYIPPE-HMNGQVSILGD 588
F ++ NP KN + ++ G+ YI PE M + L D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 589 IYSYGILLLEMFTGKRP 605
+S G+++ EM G P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITAC 454
+G G++GSVYK G +A+K ++L+ + I E + L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 455 SSVDLEGNDF-KALVF---EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
VD G F + V+ E+M G+LD+ A + V++R I V L
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVAT--EGIPEDVLRR--ITYAVVKGL 115
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS 570
+L + I H D+KP+NVL++ + + DFG+ S N S+ K +
Sbjct: 116 KFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----------SGNLVASLA-KTN 161
Query: 571 IG---YIPPEHM-------NGQVSILGDIYSYGILLLEMFTGKRP 605
IG Y+ PE + N ++ D++S G+ +LEM G+ P
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 43/253 (16%)
Query: 381 YSDISKSTDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDEC 436
Y D + + IG G FG V+ K T AI L+++ + I E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EV 63
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
N ++ +H+NI+R I + + N ++ EF G+L + + + F K+
Sbjct: 64 NVMRELKHKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKC---YKMFGKIEE 117
Query: 497 IQRLNIAIDVASALDYLHHHCDTP----IAHCDLKPSNVLLDKDM--------------- 537
++I + AL Y H+ D P + H DLKP N+ L +
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 538 --TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPE---HMNGQVSILGDIYSY 592
A +GDFGL+K + ++++ G+ Y PE H D+++
Sbjct: 178 RPIAKIGDFGLSKNI--------GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 593 GILLLEMFTGKRP 605
G ++ E+ +GK P
Sbjct: 230 GCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 397 IGTGSFG---SVYKGTLGDGTIVAIKVL--KLQQQGALKSFIDECNALKSTRHRNILRVI 451
IG+G+ G + + LG VA+K L Q Q K E LK H+NI+ ++
Sbjct: 29 IGSGAQGIVCAAFDTVLG--INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 452 TACS-SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ LE LV E M + NL Q +H +H + L + +
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME-LDHERMSYL--------LYQMLCGI 136
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
+LH I H DLKPSN+++ D T + DFGLA+
Sbjct: 137 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRH--RN 446
N+ L+G G+FG VY D G +A+K ++ + S E NAL+ +N
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS--KEVNALECEIQLLKN 60
Query: 447 IL--RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
+L R++ + ++ E M G++ L + Y +V ++ I
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQI 115
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ YLH + I H D+K +N+L D +GDFG +K L I + + ++V+
Sbjct: 116 --LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 565 IGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM- 622
G+ ++ PE ++G+ DI+S G ++EM T K P + F+ +I +
Sbjct: 171 ----GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQP 225
Query: 623 ---ALPDHVMD 630
LP HV D
Sbjct: 226 TNPVLPPHVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 54/169 (31%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 394 ENL--IGTGSFGSV---YKGTLGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRN 446
+NL IG+G+ G V Y G VAIK L Q K E +K H+N
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 447 I---LRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSPAEHYQFKKLS--VIQR 499
I L V T S++ +F+ LV E M + NL Q + +H +++S + Q
Sbjct: 77 IIGLLNVFTPQKSLE----EFQDVYLVMELM-DANLCQVIQMD-LDH---ERMSYLLYQM 127
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
L + +LH I H DLKPSN+++ D T + DFGLA+
Sbjct: 128 L-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 37/224 (16%)
Query: 400 GSFGSVYKGTLGDGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRNILRVITACSSV 457
+ K T+VA+K + L LK E + +H NIL +T+
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF--- 68
Query: 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ--FKKLSVIQRLNIAIDVASALDYLHH 515
+ ++ +V M+ G+ + L H+ +L I I DV +ALDY+H
Sbjct: 69 -IVDSEL-YVVSPLMAYGSCEDLL----KTHFPEGLPEL-AIA--FILKDVLNALDYIHS 119
Query: 516 -HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL-KGSIGY 573
H +K S++LL D + + + + K Q V K S+
Sbjct: 120 KGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIK----HGKRQRVVHDFPKSSVKN 171
Query: 574 IP---PEHMNGQVSILG-----DIYSYGILLLEMFTGKRPTGDM 609
+P PE + Q ++ G DIYS GI E+ G P DM
Sbjct: 172 LPWLSPEVL--QQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 48/177 (27%), Positives = 70/177 (39%), Gaps = 32/177 (18%)
Query: 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
E + LK+ HR I+ +I A +K+ V M D + + + ++
Sbjct: 136 EIDILKTISHRAIINLIHAYR--------WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
IQR + AL YLH I H D+K N+ LD+ A +GDFG A L
Sbjct: 188 ITIQR-----RLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEMFTGKRP 605
D P G G++ PE + L DI+S G++L EM
Sbjct: 240 DTPQ-----CYGWSGTLETNSPE-----LLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKL---QQQGALKSFIDECNALKSTRHRNILRVIT 452
IG GSFG+VY T +VA+K + Q + I E L+ +H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82
Query: 453 ACSSVDLEGNDFKA----LVFEFMSNGNLDQW-LHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+++ +G K LV E+ D +H P +Q + IA
Sbjct: 83 ---TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVEIAAITH 128
Query: 508 SALD---YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
AL YLH H + H D+K N+LL + + DFG A S + N V
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFV- 178
Query: 565 IGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE + GQ D++S GI +E+ K P +M
Sbjct: 179 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 48/233 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ----QQGALKSFIDECNALKSTR 443
+ + IG G++G V T G VAIK K+ Q ++ + E L+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRT-LREIKILRRFK 61
Query: 444 HRNILRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLH------PSPAEHYQFKKLS 495
H NI+ ++ E F +V E M L+ +H Q+
Sbjct: 62 HENIIGILDIIRPPSFE--SFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQY---F 111
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+ Q L L Y+H + H DLKPSN+LL+ + + DFGLA+ I+D
Sbjct: 112 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IAD 157
Query: 556 NPSKNQTVSIGLKGSIG---YIPPEHM--NGQVSILGDIYSYGILLLEMFTGK 603
+ + L + Y PE M + + DI+S G +L EM + +
Sbjct: 158 PEHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 28/246 (11%)
Query: 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFI 433
S + + TD + IG G++G VYK T DG++ A+K+L +
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIE 66
Query: 434 DECNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK 492
E N L+S H N+++ D LV E + G++ + +
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK---------G 117
Query: 493 KLSVIQRLN---IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
L QRL+ I+ + AL L H + I H D+K +N+LL + + DFG++
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
L S +N +V G+ ++ PE + D++S GI +E+ G
Sbjct: 178 L--TSTRLRRNTSV-----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 604 RPTGDM 609
P DM
Sbjct: 231 PPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253
N +L L L+ + N L + + L T+L L L N+ ++P I
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRL-------RSNISELLELTNLTSLDLDNNNIT-DIPPLI 135
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL 313
L ++L+ L + +N + ++P + NL NL L L N+LS +P+++ L+ L L L
Sbjct: 136 GLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193
Query: 314 NVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTI 370
+ NK S +P + L+ L L + N + + SL N + L L LS+N L
Sbjct: 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 62/235 (26%), Positives = 92/235 (39%), Gaps = 50/235 (21%)
Query: 391 FSKENLIGTGSFGSVYKG-TLGDGTIVAIKVLKL---QQQGALKSFIDECNALKSTRHRN 446
FS IG GSFG+VY + + +VAIK + Q + I E L+ RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 447 ILRVITACSSVDLEGNDFKA----LVFEFMSNGNLDQW-LHPSPAEHYQFKKLSVIQRLN 501
++ G + LV E+ D +H P +Q +
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVE 116
Query: 502 IAIDVASALD---YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
IA AL YLH H + H D+K N+LL + +GDFG A + P+
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APA 168
Query: 559 KNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE + GQ D++S GI +E+ K P +M
Sbjct: 169 NX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 20/113 (17%)
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551
+ L + Q L I + L YLH I H D+K N+ ++ +GD G A+F
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHM-----NGQVSILGDIYSYGILLLEM 599
+GL G++ PE + N + DI+S GI+L EM
Sbjct: 207 ------PVVAPAFLGLAGTVETNAPEVLARDKYNSKA----DIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 63/232 (27%), Positives = 94/232 (40%), Gaps = 66/232 (28%)
Query: 397 IGTGSFGSV---YKGTLGDGTIVAIKVLKLQQQGALKS--FIDECNALKSTRHRNI---L 448
+G+G++GSV Y L VA+K L Q + + E LK +H N+ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 449 RVITACSSVD----------LEGNDFKALV-FEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
V T +S++ L G D +V + +S+ EH QF
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD------------EHVQF------ 122
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+ + L Y+H I H DLKPSNV +++D + DFGLA+ + D
Sbjct: 123 ----LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM 172
Query: 558 SKNQTVSIGLKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
+ G + Y PE H N V DI+S G ++ E+ GK
Sbjct: 173 T-------GYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGT-IVAIKVL---KLQQQGALKSFIDECNALKSTRH 444
D+F +IG G+FG V + I A+K+L ++ ++ F +E N L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS----PAEHYQFKKLSVIQRL 500
+ I + A + ++ LV ++ G+L L P + +F I +
Sbjct: 61 QWITTLHYA-----FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF----YIAEM 111
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+AI L Y+H D+KP NVLLD + + DFG +++ + +
Sbjct: 112 VLAIHSIHQLHYVHR---------DIKPDNVLLDMNGHIRLADFGSC---LKMNQDGTVQ 159
Query: 561 QTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEMFTGKRP 605
+V++ G+ YI PE + +G D +S G+ + EM G+ P
Sbjct: 160 SSVAV---GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 397 IGTGSFGSV----YKGTLGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILR 449
+G G FG V K T G + A K L +L+++ K + E L+ I+
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ A E LV M+ G+L ++ + + L + + ++ + +
Sbjct: 58 LAYA-----FESKTHLCLVMSLMNGGDLKYHIY-----NVGERGLEMERVIHYSAQITCG 107
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
+ +LH I + D+KP NVLLD + D GLA E+ D + Q G
Sbjct: 108 ILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRA-----G 156
Query: 570 SIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628
+ GY+ PE + + S D ++ G + EM G+ P D K+ + L D V
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK-FLFEISDNPSKNQTVSIGLKGSI 571
+HH + H D+K +N+LL + +GDFG +K + +SD+ + G+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209
Query: 572 GYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
Y+ PE + S D++S G+LL E+ T KRP
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNILRVITA 453
IG G+FG V+ T DG VA+K + Q + K E L +H N+L +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLH-----PSP--AEHYQFKKLSVIQRLNIAIDV 506
++ + +V E M + LH P P ++H K+ + Q L
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHV---KVFLYQILR----- 114
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
L YLH I H D+KP N+L++ + + DFGLA+ E D SK+ T +
Sbjct: 115 --GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPD-ESKHMTQEVV 166
Query: 567 LKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGK 603
+ Y PE H V DI+S G + E+ +
Sbjct: 167 TQ---YYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
AL+ LH + + DLKP N+LLD + DFGL K + D K T
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFC---- 154
Query: 569 GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGD 608
G+ Y+ PE + G + D ++ G+LL EM TG P D
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 60/256 (23%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKL------QQQGALKSFIDECNALKS 441
++F +IG G+FG V D G + A+K+L+ +Q G +++ D S
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA---EHYQFKKLSVIQ 498
L V+ S + N + L+ EF+ G++ L E QF I
Sbjct: 61 ------LWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQF----YIA 108
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL------------ 546
+AID L ++H D+KP N+LLD + DFGL
Sbjct: 109 ETVLAIDSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159
Query: 547 ---------AKFLFEISDNPSKNQT-------VSIGLKGSIGYIPPE-HMNGQVSILGDI 589
+ F F+ ++ K +T ++ G+ YI PE M + L D
Sbjct: 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW 219
Query: 590 YSYGILLLEMFTGKRP 605
+S G+++ EM G P
Sbjct: 220 WSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 397 IGTGSFGSVYKGTL---GDGTI--------VAIKVLKLQQQGALKSFIDECNALKSTRHR 445
+G G+F ++YKG L D I V +KVL + +L +F + + + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
+++++ C D +V E++ G LD +LH KL V ++L
Sbjct: 62 HLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL----- 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN--PSKNQTV 563
ASAL YL D + H ++ N+L+ + G ++SD P +
Sbjct: 111 -ASALHYLE---DKKLVHGNVCGKNILVARY-----GLNEGYVPFIKLSDPGIPITVLSR 161
Query: 564 SIGLKGSIGYIPPEHM-NGQVS--ILGDIYSYGILLLEMFT-GKRP 605
++ I +I PE + NGQ S I D +S+G LLE+ + G+ P
Sbjct: 162 EERVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDG-TIVAIKVL---KLQQQGALKSFIDECNALKSTRH 444
++F +IG G+FG V L + + A+K+L ++ ++ F +E + L + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS----PAEHYQFKKLSVIQRL 500
+ I + A + + LV ++ G+L L P + +F + +
Sbjct: 61 QWITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF----YLAEM 111
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
IAID L Y+H D+KP N+L+D + + DFG L E + +
Sbjct: 112 VIAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLME---DGTVQ 159
Query: 561 QTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRP 605
+V++ G+ YI PE + G+ D +S G+ + EM G+ P
Sbjct: 160 SSVAV---GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 48/232 (20%)
Query: 390 NFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
+F+ ++G GSFG V KGT + AIK+LK + Q ++ + E L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR--- 499
L + +C + D V E+++ G+L YQ +++ +
Sbjct: 58 GKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDL----------MYQIQQVGRFKEPHA 103
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
+ A ++A L +LH I + DLK NV+LD + + DFG+ K +
Sbjct: 104 VFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------E 150
Query: 560 NQTVSIGLK---GSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRP 605
N + K G+ YI PE + Q S+ D +++G+LL EM G+ P
Sbjct: 151 NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
NI D+ + L+Y+H H I+H D+KP N+++D + ++ D+G+A F I +
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASH-FIIHGKHIEY 185
Query: 561 QTVSIGL-KGSIGYIPPEHMNG-QVSILGDIYSYGILLLE 598
L +G++ Y + NG V+ GD+ S G +L+
Sbjct: 186 SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 396 LIGTGSFGS--VYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITA 453
++G GSFG + + D ++ + A++ E L +H NI +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI---VAF 63
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
S + +G+ + +V E+ G+L Q + + + + L + + + ++
Sbjct: 64 KESFEADGHLY--IVMEYCDGGDLMQKIKLQRGKLFPEDTI-----LQWFVQMCLGVQHI 116
Query: 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGY 573
H + + H D+K N+ L ++ +GDFG A+ L +P + G+ Y
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYV---GTPYY 166
Query: 574 IPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP 605
+PPE N + DI+S G +L E+ T K P
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 24/172 (13%)
Query: 434 DECNALKSTRHRNILRVITACSSVD---LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
+E AL H NIL++ S + + ++ FM + D W P
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W-KDRPL---- 265
Query: 491 FKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
+ Q I + A++Y+H D + H D+K N+ L+ D +GDFG A
Sbjct: 266 -----LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MP 316
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSI-LGDIYSYGILLLEMFT 601
FE + G G++ PE + G + DI+S G++LL+M +
Sbjct: 317 FE---KE--REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 74/294 (25%), Positives = 115/294 (39%), Gaps = 42/294 (14%)
Query: 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139
SL LS + + N L L L L N + I S + ++++ +
Sbjct: 68 RLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDN 125
Query: 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNF 199
N + +P +GL NLK + N S+P L N NL+ LD + N L+ +P
Sbjct: 126 NNI-TDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182
Query: 200 GSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTH 259
+L +L L+ N++ + L L +
Sbjct: 183 SNLSNLNNLDLSGNKI-----------------SDLPPE---------------IELLSA 210
Query: 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS 319
L L + N + + + NL NL+ L L NN +PE IG L+ LE L L+ N+ S
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS 268
Query: 320 GLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKE 373
SSLG+LT L L + N L + P + LL L L+ + +
Sbjct: 269 --SISSLGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLKALELK 319
|
Length = 394 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 9/106 (8%)
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
L + Q +A + SA+DY+H I H D+K NVL++ +GDFG A F
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA--- 310
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLE 598
S + G+ G++ PE + G + DI+S G+++ E
Sbjct: 311 --RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 89/298 (29%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGALKSFIDECNAL 439
F ++ L +G G+FG V + + VA+K+LK +GA S E AL
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK---EGATAS---EHKAL 57
Query: 440 KST--------RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHP-------- 483
S H N++ ++ AC+ + N ++ EF GNL +L
Sbjct: 58 MSELKILIHIGNHLNVVNLLGACT----KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPY 113
Query: 484 ---SPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC-----------------DTPIA- 522
SP + +F+ + R++ I+ A +P+
Sbjct: 114 REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTM 173
Query: 523 -----------------------HCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
H DL N+LL ++ + DFGLA+ +++ D K
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFT-GKRP-TGDMFKDDF 614
+ + LK ++ PE + +V + D++S+G+LL E+F+ G P G ++F
Sbjct: 234 G-SARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 45/239 (18%)
Query: 383 DISKSTDNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNA 438
D+ +++ +IG G+FG V +K T + A+K+L + I ++
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFE------MIKRSDS 87
Query: 439 LKSTRHRNILRVITACSSVDL----EGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFK 492
R+I+ + V L + + + +V E+M G+L + + P + +F
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 147
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
V+ +A+D ++ ++H D+KP N+LLDK + DFG +
Sbjct: 148 TAEVV----LALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTCMKM-- 192
Query: 553 ISDNPSKNQTVSIGLK-GSIGYIPPEHM-----NGQVSILGDIYSYGILLLEMFTGKRP 605
+K V G+ YI PE + +G D +S G+ L EM G P
Sbjct: 193 -----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 397 IGTGSFGSVYKGTLGDGT-------------IVAIKVLKLQQQGALKSFIDECNALKSTR 443
+G G+ +Y G L V +KVL + +F + + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H++I+ + C D+E +V EF+ G LD ++H + L+ + +A
Sbjct: 63 HKHIVLLYGVCVR-DVE----NIMVEEFVEFGPLDLFMH------RKSDVLTTPWKFKVA 111
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNP----- 557
+ASAL YL D + H ++ N+LL ++ + G F ++SD P
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF------IKLSD-PGIPIT 161
Query: 558 --SKNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEM-FTGKRPTGD 608
S+ + V I +I PE + + +SI D +S+G L E+ + G+ P D
Sbjct: 162 VLSRQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 60/186 (32%), Positives = 82/186 (44%), Gaps = 29/186 (15%)
Query: 375 RQSGMSYSDISKSTDNFSK--ENL--IGTGSFGSV---YKGTLGDGTIVAIKVLK--LQQ 425
R + +I ST K +NL IG+G+ G V Y L VAIK L Q
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQN 63
Query: 426 QGALKSFIDECNALKSTRHRNI---LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH 482
Q K E +K H+NI L V T S++ E D +V E M + NL Q +
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE-EFQDV-YIVMELM-DANLCQVIQ 120
Query: 483 PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542
+H + L + Q L + +LH I H DLKPSN+++ D T +
Sbjct: 121 -MELDHERMSYL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 543 DFGLAK 548
DFGLA+
Sbjct: 169 DFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 12/113 (10%)
Query: 500 LNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
L+ + VA + +L +C H DL N+LL + DFGLA+ +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI-----RND 267
Query: 559 KNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
N V + + ++ PE + N + D++SYGILL E+F+ G P M
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 388 TDNFSKENLIGTGSFGSVYK-GTLGDGTIVAIKVLKLQQQGALKSFIDE-----CNALKS 441
+D + IG G++G V+K +G+ A+K+L IDE N LK+
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKA 70
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
+ H N+++ D++ D LV E + G++ + K+ ++
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG------FLKRGERMEEP 124
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
IA + AL L H H D+K +N+LL + + DFG++ L S +N
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRN 182
Query: 561 QTVSIGLKGSIGYIPPE------HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+V G+ ++ PE ++ D++S GI +E+ G P D+
Sbjct: 183 TSV-----GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 25/82 (30%), Positives = 45/82 (54%), Gaps = 10/82 (12%)
Query: 523 HCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS--KNQTVSIGLKGSIGYIPPEHMN 580
H DL N+LL ++ + DFGLA+ +I +P + + LK ++ PE +
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDARLPLK----WMAPESIF 248
Query: 581 GQV-SILGDIYSYGILLLEMFT 601
+V + D++S+G+LL E+F+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 397 IGTGSFGSV---YKGTLGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNILRVI 451
IG+G+ G V Y L VAIK L Q Q K E +K H+NI+ ++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 452 TACS-SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ LE LV E M + NL Q + +H + L + Q L +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYL-LYQML-------CGI 132
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
+LH I H DLKPSN+++ D T + DFGLA+
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 523 HCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ 582
H DL N+LL ++ + DFGLA+ +++ D K + LK ++ PE + +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLPLK----WMAPETIFDR 256
Query: 583 V-SILGDIYSYGILLLEMFT-GKRP 605
V +I D++S+G+LL E+F+ G P
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 44/182 (24%), Positives = 66/182 (36%), Gaps = 60/182 (32%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
D+F +G G+FG VYK +L +G V + K + GA++ +++E
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV---LKKATEYGAVEIWMNE------- 181
Query: 443 RHRNILRVITACS------------SVDLEGNDFKALV---------FEFMSNGNLDQWL 481
RV AC V + D LV + M +
Sbjct: 182 ------RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEF---- 231
Query: 482 HPSPAEHYQFKKLSV----IQRLNIAI-----DVASALDYLHHHCDTPIAHCDLKPSNVL 532
P E Y K+ ++R N I + ALD LH T I H D+KP N++
Sbjct: 232 -PYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII 287
Query: 533 LD 534
Sbjct: 288 FS 289
|
Length = 566 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 64/268 (23%), Positives = 97/268 (36%), Gaps = 81/268 (30%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR- 443
D+F +IG G+FG V K T G I A+K L+ KS + E + R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT---GHIYAMKKLR-------KSEMLEKEQVAHVRA 50
Query: 444 HRNILR-------VITACSSVDLEGNDFKALVFEFMSNGNL-------DQWLHPSPAEHY 489
R+IL V S D ++ L+ E++ G++ D + E
Sbjct: 51 ERDILAEADNPWVVKLYYSFQD---ENYLYLIMEYLPGGDMMTLLMKKDTFTE----EET 103
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+F I +AID L Y+H D+KP N+LLD + DFGL
Sbjct: 104 RF----YIAETILAIDSIHKLGYIHR---------DIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 550 L--------FEISDNPSKNQTVSIGLK-----------------------GSIGYIPPE- 577
L + I + + + K G+ YI PE
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 578 HMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ + D +S G+++ EM G P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQG-ALKSFIDECNALKS-- 441
++F LI G++G+VY K T A+K K+ +Q L++ I + +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMK--KINKQNLILRNQIQQVFVERDIL 55
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---PSPAEHYQFKKLSVIQ 498
T N V CS E +V E++ G+ L P + +
Sbjct: 56 TFAENPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKNIGALPVD---------MA 103
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF--------L 550
R+ A V AL+YLH++ I H DLKP N+L+ + DFGL+K L
Sbjct: 104 RMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-----DIYSYGILLLEMFTGKRP 605
+E + + + G+ YI PE + Q G D ++ GI+L E G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ----GYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 397 IGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFID------ECNALKSTRHRNILR 449
IG G++G V + VAIK + A + ID E L+ H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA---EHYQFKKLSVIQRLNIAIDV 506
+ E + +V+E M +L Q + S +H Q+ + Q L
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY---FLYQLLR----- 119
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
L Y+H + H DLKPSN+LL+ + + DFGLA+
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 35/250 (14%)
Query: 397 IGTGSFGSVYKGTLGDGTIVAIKVLK-LQQQGALKSFIDECNALKSTRHRNILRVITACS 455
+G G++G VYK DG LK ++ G S E L+ +H N++ A
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----ALQ 64
Query: 456 SVDLEGNDFKA-LVFEFMSNGNLDQW----LHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
V L +D K L+F++ + D W H + + + +L ++ + +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 511 DYLHHHCDTPIAHCDLKPSNVLL----DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
YLH + + H DLKP+N+L+ + + D G A+ ++P K
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDP 174
Query: 567 LKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKR---------PTGDMFKDDFS 615
+ + Y PE + G + DI++ G + E+ T + T + F D
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234
Query: 616 IHMFVSMALP 625
+F M P
Sbjct: 235 DRIFSVMGFP 244
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 17/65 (26%), Positives = 32/65 (49%), Gaps = 3/65 (4%)
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF--- 549
++S ++ +IA +A L LH + H DL P N+L+D + D+ A +
Sbjct: 82 EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
Query: 550 LFEIS 554
F+++
Sbjct: 142 AFDLA 146
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 32/149 (21%)
Query: 467 LVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524
+V E+M G+L + + P + +F V+ ALD +H + H
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL----------ALDAIH---SMGLIHR 166
Query: 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG---YIPPEHM-- 579
D+KP N+LLDK + DFG + ++T + ++G YI PE +
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKM---------DETGMVRCDTAVGTPDYISPEVLKS 217
Query: 580 ---NGQVSILGDIYSYGILLLEMFTGKRP 605
+G D +S G+ L EM G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.54 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.35 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.34 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.32 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.29 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.2 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.2 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.05 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.01 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.71 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.65 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-80 Score=736.43 Aligned_cols=632 Identities=30% Similarity=0.497 Sum_probs=470.3
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
++++|+|++|++.+.+|..|+.+++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..+.++++|++|+|+
T Consensus 213 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 292 (968)
T PLN00113 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292 (968)
T ss_pred CccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECc
Confidence 67777777777777777777777777777777777777777777777777777777777776777777777777777777
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.+++.+|..+.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++.+|..+. .+++|+.|++++|.+.+.
T Consensus 293 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~~~~L~~L~Ls~n~l~~~ 371 (968)
T PLN00113 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG-KHNNLTVLDLSTNNLTGE 371 (968)
T ss_pred CCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHh-CCCCCcEEECCCCeeEee
Confidence 7777767777777777777777777777766777777777777777777777655555443 556666666666666555
Q ss_pred CCccCCCC------------------------CCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhh
Q 005045 171 IPVSLSNA------------------------SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL 226 (717)
Q Consensus 171 ~~~~~~~l------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 226 (717)
.|..+..+ ++|+.|++++|++++..|..|..+++|+.|++++|.++... +
T Consensus 372 ~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~------~ 445 (968)
T PLN00113 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI------N 445 (968)
T ss_pred CChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc------C
Confidence 55555444 45555555555555445555555555555555555555433 3
Q ss_pred hhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCC
Q 005045 227 KFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLN 306 (717)
Q Consensus 227 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 306 (717)
..+..+++|+.|+|++|.+.+.+|..+.. ++|+.|++++|++.+..|..|.++++|+.|+|++|++.+.+|..+..++
T Consensus 446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~--~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 523 (968)
T PLN00113 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523 (968)
T ss_pred hhhccCCCCcEEECcCceeeeecCccccc--ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence 44556667777777777776666655432 4789999999999989999999999999999999999999999999999
Q ss_pred CCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCcccccC---------
Q 005045 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQS--------- 377 (717)
Q Consensus 307 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--------- 377 (717)
+|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|..-...
T Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 603 (968)
T PLN00113 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603 (968)
T ss_pred CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC
Confidence 99999999999999999999999999999999999999999999999999999999999998888531100
Q ss_pred -----------CCC-c-----------------------------------------ccc--------------------
Q 005045 378 -----------GMS-Y-----------------------------------------SDI-------------------- 384 (717)
Q Consensus 378 -----------~~s-~-----------------------------------------~~~-------------------- 384 (717)
..+ . ..+
T Consensus 604 n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (968)
T PLN00113 604 NIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683 (968)
T ss_pred CccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhh
Confidence 000 0 000
Q ss_pred --cccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 385 --SKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 385 --~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
......|...+.||+|+||.||+|+. .+++.||+|.+..... ....|++.+++++||||+++++++..
T Consensus 684 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~----- 754 (968)
T PLN00113 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS----- 754 (968)
T ss_pred hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-----
Confidence 00012345567899999999999996 4889999998864322 12346889999999999999999643
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++|+|.++++ .+++..+.+++.||++|++|||..+.++|+||||||+||+++.++.+++
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 347899999999999999984 3688899999999999999999665569999999999999999888887
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
. ||.+.... ......++..|+|||++.+ .++.++|||||||++|||+||+.||+...........|.
T Consensus 825 ~-~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 892 (968)
T PLN00113 825 R-LSLPGLLC-----------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892 (968)
T ss_pred E-eccccccc-----------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence 5 65543320 0112357889999999655 589999999999999999999999965544444444554
Q ss_pred HhcCCh-hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 621 SMALPD-HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 621 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...... ....++|+.+.... ....++..++.+++.+||+.+|++||||+||+
T Consensus 893 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 893 RYCYSDCHLDMWIDPSIRGDV---------------------------SVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHhcCccchhheeCccccCCC---------------------------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 433322 23344444442211 01223355678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 700 NNLKTIRNCF 709 (717)
Q Consensus 700 ~~l~~i~~~~ 709 (717)
+.|+++.+..
T Consensus 946 ~~L~~~~~~~ 955 (968)
T PLN00113 946 KTLESASRSS 955 (968)
T ss_pred HHHHHhhccc
Confidence 9999987644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=356.33 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=209.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
....+.+.+..||+|..|+||+++++ +++.+|+|++... ++..++++.+|+++++++.||+||++|+.++... .
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----E 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----c
Confidence 44557778899999999999999976 8999999999644 4556788999999999999999999999964322 2
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+|+||||++|+|++++... +++++....+++.+|++||.|||.. .+|+||||||+||+|+..|+|||+|
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence 699999999999999999855 6799999999999999999999974 3999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+..+.. .....+.||..|||||-++|. |+.++||||||++++|+.+|+.||....+......
T Consensus 223 FGVS~~lvn---------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~----- 288 (364)
T KOG0581|consen 223 FGVSGILVN---------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF----- 288 (364)
T ss_pred ccccHHhhh---------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-----
Confidence 999998721 244568899999999998885 99999999999999999999999976411111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+.+..+++..-+.-+ ...|+.++..|+..||+.||.+|||++|+++.
T Consensus 289 ---~Ll~~Iv~~ppP~lP-----------------------------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 289 ---ELLCAIVDEPPPRLP-----------------------------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---HHHHHHhcCCCCCCC-----------------------------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222221111110 11357889999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=375.77 Aligned_cols=290 Identities=36% Similarity=0.639 Sum_probs=237.4
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
...|++.++..++++|...+.||+|+||.||+|...+|+.||||.+........+.|.+|+.++.+++|||+++++++|.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34599999999999999999999999999999999888999999777554320355999999999999999999999985
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
+.. ++.++|+||++.|+|.+++..... ..++|..+++||.++|+||+|||..+.+.|+||||||+|||+|+
T Consensus 142 e~~----~~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 142 EGG----EHRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred cCC----ceEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 432 268999999999999999987642 17899999999999999999999988778999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCC-CCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMF-KDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~-~~~ 613 (717)
++++||+|||+|+..... ........ .||.+|+|||+. .|..+.++|||||||++.|++||+.|.+... ...
T Consensus 213 ~~~aKlsDFGLa~~~~~~-----~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEG-----DTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred CCCEEccCccCcccCCcc-----ccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 999999999999654110 11111111 799999999996 5789999999999999999999999887654 334
Q ss_pred hhhhHHHHhcCCh-hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 614 FSIHMFVSMALPD-HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 614 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
..+..|+...+.+ .+.+++|+.+...... ..++..++..++.+|++.+|.+|
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~---------------------------~~~~~~~~~~~a~~C~~~~~~~R 339 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYP---------------------------DEKEVKKLAELALRCLRPDPKER 339 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCC---------------------------hHHHHHHHHHHHHHHcCcCCCcC
Confidence 4467776665555 5888999988632100 01345668999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIRN 707 (717)
Q Consensus 693 ps~~eil~~l~~i~~ 707 (717)
|+|.||+++|+.+..
T Consensus 340 P~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 340 PTMSQVVKELEGILS 354 (361)
T ss_pred cCHHHHHHHHHhhcc
Confidence 999999999966653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.50 Aligned_cols=265 Identities=31% Similarity=0.499 Sum_probs=212.4
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.......+.+.+|+|+||.||+|.+.....||+|.+...+. ...+.|.+|+.++.+++||||++++++|... ..
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~ 113 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PG 113 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CC
Confidence 33445566677999999999999986444499999986532 2267999999999999999999999997543 22
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCEEeCCCC-ceEE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP-IAHCDLKPSNVLLDKDM-TAHV 541 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl 541 (717)
..++||||+++|+|.+++.... ...+++..+..+|.|||+||.|||++ + ||||||||+||+++.++ ++||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEE
Confidence 6899999999999999998631 16899999999999999999999998 7 99999999999999998 9999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
+|||+++...... ...+...||+.|||||++.+. ++.|+||||||+++|||+||+.||...... .....
T Consensus 186 ~DFGlsr~~~~~~-------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~ 257 (362)
T KOG0192|consen 186 ADFGLSREKVISK-------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASA 257 (362)
T ss_pred CCCccceeecccc-------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 9999998652110 222336799999999998853 999999999999999999999999876441 11111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+....+ +. .+.+|+..+..++.+||..+|+.||++.||
T Consensus 258 v~~~~~R--------p~---------------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 258 VVVGGLR--------PP---------------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred HHhcCCC--------CC---------------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 1111110 00 122357889999999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 005045 699 VNNLKTIRNCFLE 711 (717)
Q Consensus 699 l~~l~~i~~~~~~ 711 (717)
+..|+.+......
T Consensus 297 ~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 297 VSRLESIMSHISS 309 (362)
T ss_pred HHHHHHHHHhhcc
Confidence 9999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.43 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=207.1
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+|...+.||+|||+.||.+++ .+|+.||+|++... ....++...+|+++.++++|||||+++.+ +++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 6899999999999999999997 79999999999754 45567889999999999999999999999 677779
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+|.|+|+.++|..+++++ +.+++.+++.++.||+.|+.|||+. +|+|||||-.|+|++++.+|||+||
T Consensus 93 VYivLELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred eEEEEEecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence 99999999999999999865 7899999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|..+ ..+.....+.+||+.|.|||++.+ .++..+||||+|||+|-|+.|++||....-
T Consensus 163 GLAt~l-------e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------------ 223 (592)
T KOG0575|consen 163 GLATQL-------EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------------ 223 (592)
T ss_pred ceeeee-------cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------------
Confidence 999987 223344567889999999999765 489999999999999999999999965311
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+.........+..+. .-+.+..+||.++|+.+|.+|||+.+|+..
T Consensus 224 ------------------------kety~~Ik~~~Y~~P~--------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 224 ------------------------KETYNKIKLNEYSMPS--------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------------------------HHHHHHHHhcCccccc--------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111111111111111 113445789999999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.14 Aligned_cols=204 Identities=33% Similarity=0.553 Sum_probs=181.4
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
....++|...+.||+|+|+.||+|+++ ++..||||.+... ..+.++.+..|+++++.++|||||.++++ ...
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~-----~~~ 80 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC-----IED 80 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE-----Eec
Confidence 345679999999999999999999965 7899999999866 45667888999999999999999999999 455
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-----
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD----- 536 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----- 536 (717)
++.+|+|||||.||+|.+|+++. +.+++..++.++.|||.|+++||++ +||||||||+||+++..
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCC
Confidence 66999999999999999999976 6799999999999999999999998 99999999999999865
Q ss_pred -CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 537 -MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 537 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
-.+||+|||.|+.+. ........+|++.|||||++ .++|+.|+|+||+|+++|+|++|..||+....
T Consensus 151 ~~~LKIADFGfAR~L~--------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQ--------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CceEEecccchhhhCC--------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 468999999999873 23344567899999999996 67899999999999999999999999986543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=349.42 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=201.6
Q ss_pred ccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhh-------HHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQG-------ALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
.+.|.+.+.+|+|+||.|-+|. .++|+.||||+++..... .....++|+++|++++||+||++.++ +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence 5578899999999999999999 458999999999754211 12345799999999999999999999 5
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD--- 536 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--- 536 (717)
+.++..|+||||++||.|.+.+-.+ +.+.+...+.++.|++.|+.|||++ ||+||||||+||+++.+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 6667889999999999999998766 5688888899999999999999998 99999999999999865
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~ 612 (717)
..+||+|||+|+.. .......+.+||+.|.|||++.++ ++.++|+||+||++|-+++|.+||.+...+
T Consensus 316 ~llKItDFGlAK~~--------g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 316 CLLKITDFGLAKVS--------GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred eEEEecccchhhcc--------ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 78999999999975 122334568899999999997654 345889999999999999999999875433
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
.-.. .++..-+.+..+ ..-.+..++..++|.+||..||+.|
T Consensus 388 ~sl~------------eQI~~G~y~f~p---------------------------~~w~~Iseea~dlI~~mL~VdP~~R 428 (475)
T KOG0615|consen 388 PSLK------------EQILKGRYAFGP---------------------------LQWDRISEEALDLINWMLVVDPENR 428 (475)
T ss_pred ccHH------------HHHhcCcccccC---------------------------hhhhhhhHHHHHHHHHhhEeCcccC
Confidence 2111 112222222111 0112235667899999999999999
Q ss_pred CCHHHHHHH
Q 005045 693 IAMNVVVNN 701 (717)
Q Consensus 693 ps~~eil~~ 701 (717)
||+.|+++.
T Consensus 429 ~s~~eaL~h 437 (475)
T KOG0615|consen 429 PSADEALNH 437 (475)
T ss_pred cCHHHHhcC
Confidence 999999853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=418.38 Aligned_cols=358 Identities=34% Similarity=0.510 Sum_probs=306.2
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
.++++|+|++|.+.+.+|..|+++++|+.|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..|+++++|++|+|
T Consensus 188 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 267 (968)
T PLN00113 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267 (968)
T ss_pred cCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEEC
Confidence 38899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
++|++++.+|..+.++++|++|+|++|.+.+..|..+.++++|+.|++++|.+++.+|..+. .+++|+.|++++|.+.+
T Consensus 268 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~-~l~~L~~L~L~~n~l~~ 346 (968)
T PLN00113 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT-SLPRLQVLQLWSNKFSG 346 (968)
T ss_pred cCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHh-cCCCCCEEECcCCCCcC
Confidence 99999999999999999999999999999999999999999999999999999977776554 89999999999999999
Q ss_pred cCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcC
Q 005045 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 249 (717)
.+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+.... +..+..+++|+.|++++|.+++.+
T Consensus 347 ~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~------p~~~~~~~~L~~L~L~~n~l~~~~ 420 (968)
T PLN00113 347 EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI------PKSLGACRSLRRVRLQDNSFSGEL 420 (968)
T ss_pred cCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccC------CHHHhCCCCCCEEECcCCEeeeEC
Confidence 99999999999999999999999888888888778888888877776544 445555556666666666555555
Q ss_pred chhhhhccccccEEecCCCccCCCCCccccC-----------------------CCCCCEEEccCCcCccccchhhhcCC
Q 005045 250 PISIANLSTHLRRLTMGENLMHGNIPVGIGN-----------------------LVNLNLLGLEGNNLSGSVPEVIGRLN 306 (717)
Q Consensus 250 p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-----------------------l~~L~~L~L~~N~l~~~~~~~~~~l~ 306 (717)
|..+..+ +.|+.|++++|.+.+.++..+.. .++|+.|++++|++++..|..+..++
T Consensus 421 p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~ 499 (968)
T PLN00113 421 PSEFTKL-PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499 (968)
T ss_pred ChhHhcC-CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence 5555444 24555555555444444333322 35677777777788778888888899
Q ss_pred CCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCcccc
Q 005045 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVR 375 (717)
Q Consensus 307 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 375 (717)
+|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|+.+.
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 568 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence 999999999999988999999999999999999999999999999999999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=334.15 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=209.0
Q ss_pred cccccccccccccCcccccceEEEE-eCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.....+|+++++||+|.||+||+++ ..+|..+|.|.++-. +..+++.+..|+.+|++++||||+++++..+ .++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~ 91 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IED 91 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hcc
Confidence 4556789999999999999999999 559999999999843 4566788999999999999999999998532 233
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCEEeCCCCceE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDT-PIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~k 540 (717)
...++||||+|.+|+|.++++..+. +.+.+++..+++++.|++.||..+|...++ -|.||||||.|||++.+|.||
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 4458999999999999999976533 347899999999999999999999994422 399999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+++.+. ..........|||.||+||.+.+ +|+.+|||||+||++|||+.-++||.+. .+..
T Consensus 169 LGDfGL~r~l~-------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~- 235 (375)
T KOG0591|consen 169 LGDFGLGRFLS-------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLS- 235 (375)
T ss_pred eccchhHhHhc-------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHH-
Confidence 99999999872 22233445789999999999655 6999999999999999999999999764 1100
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+ ..++-.-..+.. ..+-++..+.++|..|+..||+.||+...++
T Consensus 236 ----L---~~KI~qgd~~~~-----------------------------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 236 ----L---CKKIEQGDYPPL-----------------------------PDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred ----H---HHHHHcCCCCCC-----------------------------cHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 0 001111111111 1234577889999999999999999865555
Q ss_pred HHHH
Q 005045 700 NNLK 703 (717)
Q Consensus 700 ~~l~ 703 (717)
+.+.
T Consensus 280 ~di~ 283 (375)
T KOG0591|consen 280 QDIQ 283 (375)
T ss_pred HHHH
Confidence 5443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=363.10 Aligned_cols=352 Identities=21% Similarity=0.224 Sum_probs=316.4
Q ss_pred CCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCC
Q 005045 7 PEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSL 84 (717)
Q Consensus 7 p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 84 (717)
+..+ .+++|+|++|+|..+.+..|.++++|+++++.+|.++ .+|.......+|+.|+|.+|.|+.+-.+.++.++.|
T Consensus 73 ~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~al 151 (873)
T KOG4194|consen 73 KGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPAL 151 (873)
T ss_pred CCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhh
Confidence 4444 7888999999999999999999999999999999999 899865666679999999999998888899999999
Q ss_pred CEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccc
Q 005045 85 KALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAV 164 (717)
Q Consensus 85 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~ 164 (717)
++||||.|.|+.+.-.+|..-.++++|+|++|.|+.+..+.|.++.+|..|.|+.|+|+ .+|...|..+++|+.|+|..
T Consensus 152 rslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnr 230 (873)
T KOG4194|consen 152 RSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNR 230 (873)
T ss_pred hhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccc
Confidence 99999999999777778998899999999999999999999999999999999999998 99999998899999999999
Q ss_pred ccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCc
Q 005045 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244 (717)
Q Consensus 165 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 244 (717)
|+|.....-.|.++++|+.|.|..|.|+....+.|..+.++++|+|+.|+++.+. ..++.+++.|+.|+||+|.
T Consensus 231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn------~g~lfgLt~L~~L~lS~Na 304 (873)
T KOG4194|consen 231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN------EGWLFGLTSLEQLDLSYNA 304 (873)
T ss_pred cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh------cccccccchhhhhccchhh
Confidence 9999655677999999999999999999888889999999999999999999987 5688999999999999999
Q ss_pred ccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCC--
Q 005045 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI-- 322 (717)
Q Consensus 245 l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-- 322 (717)
|....++++... ++|++|+|++|+|+...+..|..+..|++|+|++|+|+..-..+|.++.+|++|||++|.|+..+
T Consensus 305 I~rih~d~Wsft-qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 305 IQRIHIDSWSFT-QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred hheeecchhhhc-ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 996667776665 58999999999999888888999999999999999999777778999999999999999987554
Q ss_pred -CcccccccccceeecccccccccCCcCccCcCCCceEEeecccCC
Q 005045 323 -PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 323 -~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 367 (717)
...|.+|++|+.|+|.||+|..+.-.+|.++++|+.|||.+|.|.
T Consensus 384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence 356788999999999999998555578999999999999999885
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=328.00 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=208.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+.|+.+.++|+|+||.||+|+++ +|+.||||.+... ++...+-..+|++++++++|+|+|.++++ +......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 46899999999999999999976 8999999999744 34556778999999999999999999999 4556699
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++|||||+. ++.+-+.+.+ ..++...+.+++.|++.|+.|+|++ +++||||||+||+|+.+|.+||||||
T Consensus 77 hLVFE~~dh-TvL~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYP------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred EEEeeecch-HHHHHHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence 999999964 6666666554 5689999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh--hhHHHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS--IHMFVS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~ 621 (717)
.|+.+..+ ....+-+..|..|+|||.+-| +|+..+||||+||++.||++|.+.|.+.++-+.. +....+
T Consensus 147 FAR~L~~p-------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 147 FARTLSAP-------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred hhHhhcCC-------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 99988432 223344678999999999766 5999999999999999999999999876544332 222223
Q ss_pred hcCChhhhhhcCCC-------CCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 622 MALPDHVMDILDPS-------MPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 622 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
..+|.. .+++... ++... ..+. -+.+.+.....+.+++..|++.||++|++
T Consensus 220 ~L~prh-q~iF~~N~~F~Gv~lP~~~--~~ep-------------------Le~k~p~~s~~~ld~~k~cL~~dP~~R~s 277 (396)
T KOG0593|consen 220 NLIPRH-QSIFSSNPFFHGVRLPEPE--HPEP-------------------LERKYPKISNVLLDLLKKCLKMDPDDRLS 277 (396)
T ss_pred ccCHHH-HHHhccCCceeeeecCCCC--Cccc-------------------hhhhcccchHHHHHHHHHHhcCCcccccc
Confidence 333333 2222221 11110 0011 11122333556899999999999999999
Q ss_pred HHHHHH
Q 005045 695 MNVVVN 700 (717)
Q Consensus 695 ~~eil~ 700 (717)
.+|++.
T Consensus 278 c~qll~ 283 (396)
T KOG0593|consen 278 CEQLLH 283 (396)
T ss_pred HHHHhc
Confidence 999983
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.43 Aligned_cols=265 Identities=26% Similarity=0.474 Sum_probs=218.3
Q ss_pred cccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.+.+......++.++.||+|-||.||.|.+.....||+|.++..... ...|.+|+++|++++|++||+++++|..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~---- 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTK---- 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEec----
Confidence 55556667778899999999999999999987779999999865322 3678899999999999999999999743
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
++.++|||||++.|+|.+|++.... ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+|
T Consensus 273 -~~piyIVtE~m~~GsLl~yLr~~~~-----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vK 343 (468)
T KOG0197|consen 273 -QEPIYIVTEYMPKGSLLDYLRTREG-----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVK 343 (468)
T ss_pred -CCceEEEEEecccCcHHHHhhhcCC-----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEE
Confidence 3379999999999999999997322 6789999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+|+... .+.+....+..-+..|.|||.+ .++++.|||||||||+||||+| |+.||.++...+.
T Consensus 344 IsDFGLAr~~~------d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---- 413 (468)
T KOG0197|consen 344 ISDFGLARLIG------DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---- 413 (468)
T ss_pred EcccccccccC------CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----
Confidence 99999999542 1222233344567789999995 5679999999999999999999 9999977633221
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
-+.+++... .+.++.||..+.+++..||..+|++|||++.+
T Consensus 414 ----------~~~le~GyR-----------------------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 414 ----------LELLERGYR-----------------------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred ----------HHHHhccCc-----------------------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 111222211 23667889999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
...++.+...
T Consensus 455 ~~~l~~~~~~ 464 (468)
T KOG0197|consen 455 REVLEDFFTS 464 (468)
T ss_pred HHHHHHhhhc
Confidence 9999888654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.17 Aligned_cols=278 Identities=21% Similarity=0.274 Sum_probs=209.7
Q ss_pred ccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhH-HHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGA-LKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
-++|.+++++|.|.||.||+|+. .+|..||||.++..-... ...-.+|++.++++. ||||+++.+++.+ ....
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCce
Confidence 46899999999999999999994 489999999998653322 233458999999998 9999999999633 3348
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
+|+||||| ..+|++.++.+. +.+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+||
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 99999999 589999999774 7899999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCcc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|+|+.+ ......+.+..|..|+|||++ .+-|+.+.||||+|||++|+.+-++.|.+..+-+..+.
T Consensus 155 GLARev--------~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K----- 221 (538)
T KOG0661|consen 155 GLAREV--------RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK----- 221 (538)
T ss_pred cccccc--------ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH-----
Confidence 999976 233445567899999999994 34589999999999999999999999988755433221
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+.+++..-..... .....+.......-+.-...........++.+..+++.+|++|||++||||+|.+++
T Consensus 222 -----Ic~VLGtP~~~~~----~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 222 -----ICEVLGTPDKDSW----PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred -----HHHHhCCCccccc----hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1121111111100 000111111111001111111122333467788999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.98 Aligned_cols=202 Identities=32% Similarity=0.464 Sum_probs=179.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++++.||+|+||.||.++.+ +++.+|+|+++... ....+...+|..++.+++||.|+++... +++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----ccc
Confidence 44678999999999999999999955 79999999998653 3456788999999999999999999988 777
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+.+|+|+||+.||.|.-.+++. +.+++..++.++..|+.||.|||+. |||||||||+|||++..|+++|
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~L 166 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKL 166 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEE
Confidence 88999999999999999999865 6799999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|||+++... .......+++||+.|||||++.+ .++.++|+||+|+++|||++|.+||...
T Consensus 167 tDFgL~k~~~-------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 167 TDFGLCKEDL-------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred eccccchhcc-------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 9999998642 22223345789999999999554 6999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.34 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=209.5
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVDL 459 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 459 (717)
.....+|...+.||.|+|++|++|+.+ +++.||||++... .....+....|-.+|.++ .||.|++++.. +
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 566779999999999999999999954 8999999999754 334457778899999999 99999999998 6
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
.+...+|+|+||+++|.|.++|++. +.+++.-++.++.+|+.|++|||++ |||||||||+|||++.+|++
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHI 213 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcE
Confidence 6777999999999999999999865 7899999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCC------CCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDN------PSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~ 612 (717)
+|+|||.|..+...... ..........+.||..|.+||++... .++.+|+||||||+|+|+.|.+||.+..+
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne- 292 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE- 292 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-
Confidence 99999999988543322 11111223568999999999997665 79999999999999999999999976421
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
+.. +.++++-..... +..++...+|+.+.|..||.+|
T Consensus 293 -yli-----------FqkI~~l~y~fp-------------------------------~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 293 -YLI-----------FQKIQALDYEFP-------------------------------EGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred -HHH-----------HHHHHHhcccCC-------------------------------CCCCHHHHHHHHHHHccCcccc
Confidence 111 111222111111 1224566789999999999999
Q ss_pred CCHHHHHH
Q 005045 693 IAMNVVVN 700 (717)
Q Consensus 693 ps~~eil~ 700 (717)
+|++||-+
T Consensus 330 lt~~qIk~ 337 (604)
T KOG0592|consen 330 LTSQQIKA 337 (604)
T ss_pred ccHHHHhh
Confidence 99988765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=330.22 Aligned_cols=268 Identities=23% Similarity=0.359 Sum_probs=213.0
Q ss_pred cccccccccccccccCcccccceEEEE-eCCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
......+.|+..+.||.|..+.||+|+ .+.++.||||++.... ....+.+++|+..++.++||||++++..+ .
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----v 94 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----V 94 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----E
Confidence 344567799999999999999999999 5588999999998764 33468899999999999999999999884 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.+..+|+||.||.+|++.++++..-. ..+.+..+..|.+++++||.|||.+ |++|||||+.||+|+.+|.||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEE
Confidence 45699999999999999999986532 4589999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
|+|||.+..+...+ .........+.|+++|||||++ +. .|+.|+||||||++..||.+|+.||....+-.. +.
T Consensus 167 LadFgvsa~l~~~G---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll 242 (516)
T KOG0582|consen 167 LADFGVSASLFDSG---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LL 242 (516)
T ss_pred EcCceeeeeecccC---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HH
Confidence 99999987775533 2222222677899999999994 33 489999999999999999999999987644322 22
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
.......|......++. +....+...+.+++..|++.||.+||||.+
T Consensus 243 ~tLqn~pp~~~t~~~~~---------------------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 243 LTLQNDPPTLLTSGLDK---------------------------------DEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred HHhcCCCCCcccccCCh---------------------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 22222222111111111 112223557889999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
++.
T Consensus 290 Llk 292 (516)
T KOG0582|consen 290 LLK 292 (516)
T ss_pred Hhc
Confidence 984
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=307.93 Aligned_cols=281 Identities=20% Similarity=0.273 Sum_probs=219.8
Q ss_pred cccccccccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
-..+..-.++|++.+.+|.|||+.||+++ ..+++.+|+|.+.....+..+..++|++..++++|||++++++++....-
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 45567788999999999999999999999 56899999999987776778899999999999999999999998766555
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+.....|++++|+..|+|.+.++.... +...+++.+++.|+.+|++||.+||+.. .+|.||||||.||++++++.+
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCce
Confidence 556679999999999999999876532 2246899999999999999999999972 249999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCc--ceeecccccccccCCCccCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQ--TVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
++.|||.++...-......+.. ........|..|+|||.+.-+ .+.++|||||||++|.|+.|..||.......
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 9999999986522111111110 111123478899999997543 6899999999999999999999997654332
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
.++...+ .-.++.-|. ...++..+.+++.+|++.||.+||
T Consensus 249 gSlaLAv------~n~q~s~P~----------------------------------~~~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 249 GSLALAV------QNAQISIPN----------------------------------SSRYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred CeEEEee------eccccccCC----------------------------------CCCccHHHHHHHHHHhcCCcccCC
Confidence 2221110 001111111 111367789999999999999999
Q ss_pred CHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTI 705 (717)
Q Consensus 694 s~~eil~~l~~i 705 (717)
++.|++..+..+
T Consensus 289 ~i~~ll~~~d~L 300 (302)
T KOG2345|consen 289 TIPELLSKLDDL 300 (302)
T ss_pred CHHHHHHHHHhh
Confidence 999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.94 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=202.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..+|...+.||+|.||.||++... +|+.+|||..........+.+.+|+.+|++++|||||++++...... . ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 457889999999999999999965 59999999988664333677899999999999999999999743221 1 3689
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 545 (717)
+.|||+++|+|.+++.+.. ..+++..++.+++||++||+|||++ |||||||||+||+++. ++.+||+|||
T Consensus 93 i~mEy~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred eeeeccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence 9999999999999998763 2699999999999999999999997 9999999999999999 7999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC-CCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+..... ............||+.|||||++. |.. .+++||||+||++.||+||..||.............
T Consensus 164 ~a~~~~~----~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i---- 235 (313)
T KOG0198|consen 164 LAKKLES----KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI---- 235 (313)
T ss_pred ccccccc----ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH----
Confidence 9987632 011122233567999999999977 433 459999999999999999999997641110000000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
......+. .+...+....+|+.+|++.+|++||||+|+++.-.
T Consensus 236 -------g~~~~~P~------------------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 236 -------GREDSLPE------------------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -------hccCCCCC------------------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00000110 11112556788999999999999999999997654
Q ss_pred HH
Q 005045 704 TI 705 (717)
Q Consensus 704 ~i 705 (717)
-.
T Consensus 279 ~~ 280 (313)
T KOG0198|consen 279 LK 280 (313)
T ss_pred hh
Confidence 43
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=346.25 Aligned_cols=353 Identities=22% Similarity=0.215 Sum_probs=319.1
Q ss_pred eecEEEcCCCcCcCCCCcCCcCC--CCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEe
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHC--TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 88 (717)
....|+.++++|..+.-..+..+ +.-+.|++++|.+..+-+..|.++++|++++|..|.++ .+|.......+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 67889999999985433222222 34567999999999888888999999999999999999 8998777777899999
Q ss_pred ccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccc
Q 005045 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT 168 (717)
Q Consensus 89 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~ 168 (717)
|.+|.|+++-.+.+..++.|++||||.|.|+.+.-.+|..-.++++|+|++|.|+ .+..+.|..+.+|..|.|+.|+++
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrit 210 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRIT 210 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCccc
Confidence 9999999888899999999999999999999888889999899999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCc
Q 005045 169 GSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248 (717)
Q Consensus 169 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 248 (717)
.+.+..|.++++|+.|+|..|+|.-+.--.|.++++|+.|.|..|.|..+.. ..|..+.++++|+|+.|++...
T Consensus 211 tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D------G~Fy~l~kme~l~L~~N~l~~v 284 (873)
T KOG4194|consen 211 TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD------GAFYGLEKMEHLNLETNRLQAV 284 (873)
T ss_pred ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC------cceeeecccceeecccchhhhh
Confidence 9888999999999999999999995556789999999999999999999884 4688999999999999999955
Q ss_pred CchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccc
Q 005045 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGN 328 (717)
Q Consensus 249 ~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 328 (717)
-..+++++ +.|+.|++|+|.|..+.+++++..+.|++|+|++|+|+...+++|..|..|++|+|++|.++.+....|.+
T Consensus 285 n~g~lfgL-t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 285 NEGWLFGL-TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred hccccccc-chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 56677777 69999999999999999999999999999999999999888999999999999999999999999999999
Q ss_pred ccccceeecccccccccCCc---CccCcCCCceEEeecccCCCCCCcc
Q 005045 329 LTILTRLWMEENRLEGSIPP---SLGNCQKLLVLNLSSNDLNGTIPKE 373 (717)
Q Consensus 329 l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~ 373 (717)
+++|+.|||++|.|+..+.+ .|..|++|+.|++.||+|. .||..
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~kr 410 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKR 410 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchh
Confidence 99999999999999876654 5788999999999999997 55543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.28 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=208.5
Q ss_pred cccccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
......|....+||+|+.|.||.|. ..+++.||+|.+........+-+.+|+.+|+..+|+|||.+++.+. ..+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~d 343 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGD 343 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccc
Confidence 3456689999999999999999999 4578899999998877777788899999999999999999999853 336
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
.+|+||||++||+|.|.+... .+++.++..|++++++||+|||.+ ||+|||||.+||+++.+|.+||+|
T Consensus 344 eLWVVMEym~ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEee
Confidence 899999999999999999754 589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+..+.+. ...+....||+.|||||+... .|++++||||||++++||+-|++||-.. ......+.
T Consensus 413 FGFcaqi~~~-------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~PlrAlyL--- 480 (550)
T KOG0578|consen 413 FGFCAQISEE-------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYL--- 480 (550)
T ss_pred eeeeeccccc-------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC--ChHHHHHH---
Confidence 9999887322 224556789999999999765 5999999999999999999999999642 11111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+..-..+.+ ..++..+..|.+|+.+||+.||++||||+|+|+
T Consensus 481 -----Ia~ng~P~l-------------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 481 -----IATNGTPKL-------------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----HhhcCCCCc-------------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111111111 122334777899999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.64 Aligned_cols=265 Identities=27% Similarity=0.495 Sum_probs=216.9
Q ss_pred cccccccccccCcccccceEEEEe------CCCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
...+-+..+.+|+|+||+||+|+. +....||||.++..... +++.|++|++.+..++|||||++++.|..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--- 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE--- 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc---
Confidence 344556778999999999999983 24557999999876554 78999999999999999999999999754
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcc-------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHY-------QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
++..|+|||||..|+|.+++..+.+... ....++..+.+.||.|||.||.||-++ .+|||||.++|.+
T Consensus 561 --~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 561 --GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred --CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 4589999999999999999875432211 124488999999999999999999998 8999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCc-cCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-GKRPTGDMF 610 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~ 610 (717)
|.++..|||+|||+++.....+++ .......-+..|||||. +.|+++.+|||||||||+||+++ |..||.+..
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYY-----k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYY-----KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred eccceEEEecccccchhhhhhhhh-----cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 999999999999999987443332 22233446788999999 67889999999999999999999 999998764
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.++.. +.++ .....+.+++||.++.+|+..||+..|.
T Consensus 711 n~EVI---------------------------------e~i~----------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 711 NQEVI---------------------------------ECIR----------AGQLLSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred hHHHH---------------------------------HHHH----------cCCcccCCCCCCHHHHHHHHHHhhcCcc
Confidence 43211 1110 1111347789999999999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~ 707 (717)
+||+++||...|+..-+
T Consensus 748 ~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 748 RRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred cCCCHHHHHHHHHHHHh
Confidence 99999999999988754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=330.62 Aligned_cols=278 Identities=25% Similarity=0.379 Sum_probs=207.4
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...+.|+.+++||+|.||.||+|++ .+|+.||+|.+..+. .+......+||.||++++||||+++.+..++. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~ 190 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS 190 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence 4577899999999999999999994 589999999998664 55667788999999999999999999987543 24
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
..+|+|||||+. +|.-++.... -.+++.++..+|+|++.||+|||++ ||+|||||.+||||+.+|.+||+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEec
Confidence 689999999964 7887776543 5799999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||+|+++.... ....+...-|..|+|||++.|. |+.++|+||.|||+.||++|++.|.+..+-++ +...+
T Consensus 261 DFGLAr~y~~~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIf 333 (560)
T KOG0600|consen 261 DFGLARFYTPSG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIF 333 (560)
T ss_pred cccceeeccCCC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHH
Confidence 999999773221 2224556689999999998774 99999999999999999999999976533221 11111
Q ss_pred Hh-cCC-hhhhhhcCCCCCCCC-CCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 621 SM-ALP-DHVMDILDPSMPLDE-ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 621 ~~-~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
.. .-| +..... ..++... ......+...+.+. ....+....+|+..+|..||++|.||.+
T Consensus 334 klcGSP~e~~W~~--~kLP~~~~~kp~~~y~r~l~E~---------------~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 334 KLCGSPTEDYWPV--SKLPHATIFKPQQPYKRRLRET---------------FKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred HHhCCCChhcccc--ccCCcccccCCCCcccchHHHH---------------hccCCHHHHHHHHHHhccCccccccHHH
Confidence 11 111 111110 0111000 00001111111111 1122445678999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 397 aL~ 399 (560)
T KOG0600|consen 397 ALQ 399 (560)
T ss_pred Hhc
Confidence 875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.14 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=210.4
Q ss_pred cccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.|..++.....++-+|.|+.|.||+|+.. ++.||||.++... ..+|+-|++++||||+.+.++|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP---- 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP---- 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc----
Confidence 34455666777888999999999999985 6789999987433 34788999999999999999976544
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
.+|||||||+.|-|+..++.+ ..++......|..+||.||.|||.+ +|+|||||.-||+|+.+..|||+
T Consensus 186 -cyCIiMEfCa~GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 186 -CYCIIMEFCAQGQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred -eeEEeeeccccccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEec
Confidence 889999999999999999977 6788999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||-+....+ ......++||..|||||+++.+ .+.|+||||||||||||+||..||.+.+...+
T Consensus 255 DFGTS~e~~~--------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------- 319 (904)
T KOG4721|consen 255 DFGTSKELSD--------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------- 319 (904)
T ss_pred cccchHhhhh--------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------
Confidence 9998876521 1223457899999999998876 69999999999999999999999987643321
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+..+-...+. ...+.+|+.-|.-|+++||+-.|..|||+++|+..
T Consensus 320 ------IwGVGsNsL~-----------------------------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 320 ------IWGVGSNSLH-----------------------------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ------EEeccCCccc-----------------------------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1112222221 22456789999999999999999999999999998
Q ss_pred HHHHHHHH
Q 005045 702 LKTIRNCF 709 (717)
Q Consensus 702 l~~i~~~~ 709 (717)
++-...++
T Consensus 365 ldIa~pel 372 (904)
T KOG4721|consen 365 LDIASPEL 372 (904)
T ss_pred HhhcCHHH
Confidence 87655443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.14 Aligned_cols=271 Identities=29% Similarity=0.480 Sum_probs=217.2
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
..+..++.+..+...+...||+|.||+||+|+|- -.||||+++... ++..+.|++|+.++++-+|.||+-++++|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 4556778888999999999999999999999973 349999998664 456789999999999999999999999964
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.. .. .||+.||+|-+|+.+++... .++.+...++||+||++|+.|||.. +|+|||||..|||+.+
T Consensus 459 ~p-----~~-AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 459 NP-----PL-AIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHE 523 (678)
T ss_pred CC-----ce-eeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEcc
Confidence 43 34 99999999999999998654 6789999999999999999999996 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
++.|||+|||++..-..+. ........-|...|||||+++. .+++.+||||||+|+|||++|..||.....
T Consensus 524 ~~kVkIgDFGLatvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred CCcEEEecccceeeeeeec-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 9999999999997653331 1111222347789999999654 389999999999999999999999983322
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
+.+ + ..++.. ++.+.+ .....+|++++.+|+..||..++++
T Consensus 599 dqI-i-fmVGrG-------~l~pd~------------------------------s~~~s~~pk~mk~Ll~~C~~~~~~e 639 (678)
T KOG0193|consen 599 DQI-I-FMVGRG-------YLMPDL------------------------------SKIRSNCPKAMKRLLSDCWKFDREE 639 (678)
T ss_pred hhe-E-EEeccc-------ccCccc------------------------------hhhhccCHHHHHHHHHHHHhcCccc
Confidence 211 1 111111 001111 0123467889999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHH
Q 005045 692 RIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 692 Rps~~eil~~l~~i~~~~ 709 (717)
||.+.+|+..|+.+....
T Consensus 640 RP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 640 RPLFPQLLSKLEELLPSL 657 (678)
T ss_pred CccHHHHHHHHHHhhhcc
Confidence 999999999999888754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=302.40 Aligned_cols=273 Identities=25% Similarity=0.343 Sum_probs=207.0
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.+|..++++|+|.||.||+|++ ++|+.||+|.++... .+......+|++.|+.++|+||+.++++ +...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 5799999999999999999994 599999999998653 3345677899999999999999999999 6667799
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
.+|+||++ .+|...++... -.++...+..++.++++|++|||++ .|+||||||.|++++.+|.+||+|||
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred EEEEEecc-ccHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence 99999996 68999998664 5788999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH--HH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF--VS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~--~~ 621 (717)
+|+.+..+ .....+..-|..|+|||.+-| .|+..+||||.||++.||+.|.+-|.+..+-++...-+ .+
T Consensus 147 LAr~f~~p-------~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 147 LARFFGSP-------NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred chhccCCC-------CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 99987322 222333467889999999655 49999999999999999999988887654332211111 11
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..-++.+.++..- .++..+. +..... .......+.....+++.+|+.++|-+|+|++|++++
T Consensus 220 TP~~~~WP~~~~l-------pdY~~~~----------~~P~~~-~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 220 TPTPDQWPEMTSL-------PDYVKIQ----------QFPKPP-LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCcccCcccccc-------ccHHHHh----------cCCCCc-cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1112222221110 0010000 000000 011334446667999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.58 Aligned_cols=211 Identities=23% Similarity=0.362 Sum_probs=179.4
Q ss_pred cccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
....++|..+..||+|+||.||+|+- .+|..+|+|+++... ....+....|.++|...++|.||+++.. ++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ec
Confidence 34688999999999999999999994 489999999998653 4567888999999999999999999999 67
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+.+|+||||+|||++..++.+. +.+++..++.++.+++-|++.+|+. ||+||||||+|++||..|++|
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEe
Confidence 778999999999999999999865 6799999999999999999999998 999999999999999999999
Q ss_pred Eeeeccchhccccc------------------CCCCCCc---ce-------------------eecccccccccCCCccC
Q 005045 541 VGDFGLAKFLFEIS------------------DNPSKNQ---TV-------------------SIGLKGSIGYIPPEHMN 580 (717)
Q Consensus 541 l~Dfg~~~~~~~~~------------------~~~~~~~---~~-------------------~~~~~~~~~y~aPE~~~ 580 (717)
|+|||++.-..... ....... .. .....|||.|+|||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 99999995432100 0000000 00 01246999999999976
Q ss_pred CC-CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 581 GQ-VSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 581 ~~-~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|+ |+..+|+||||||+|||+.|.+||....
T Consensus 362 ~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 362 GKGYGKECDWWSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred cCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 65 8999999999999999999999997653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.69 Aligned_cols=270 Identities=23% Similarity=0.378 Sum_probs=203.9
Q ss_pred cccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
..+.++|++.++||+|+||.||+|.+ .+++.||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~- 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT- 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec-
Confidence 45678999999999999999999973 245789999987432 23456788999999999 8999999999863
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCc------------------------------------------------
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH------------------------------------------------ 488 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------------------------------------------ 488 (717)
......++||||+++|+|.+++.......
T Consensus 82 ---~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 82 ---KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ---CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 23456899999999999999886432100
Q ss_pred -------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCc
Q 005045 489 -------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561 (717)
Q Consensus 489 -------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 561 (717)
.....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-----~~ 230 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DY 230 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc-----ch
Confidence 0013478889999999999999999997 99999999999999999999999999997642111 11
Q ss_pred ceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCC
Q 005045 562 TVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLD 639 (717)
Q Consensus 562 ~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (717)
.......++..|+|||++.+ .++.++|||||||++|||++ |..||........ ..... .+.....
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~-----------~~~~~~~- 297 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRL-----------KDGTRMR- 297 (338)
T ss_pred hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHH-----------hcCCCCC-
Confidence 11122345678999999654 58999999999999999997 9999976432211 11000 0000000
Q ss_pred CCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 640 EENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
.+..++..+.+++.+||+.+|++|||+.||++.|+.+..+
T Consensus 298 -----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 298 -----------------------------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0112245678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=302.23 Aligned_cols=201 Identities=30% Similarity=0.424 Sum_probs=179.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
-..++|+..+.+|.|+||+|.+++.+ +|..+|+|++.... ....+...+|..+++.+.||.++++++.+ .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 34568999999999999999999966 79999999997653 45567788999999999999999999984 45
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+.+++||||++||-+..++++. +++++..++.+|.+|+.|++|||+. +|++||+||+|||+|++|.+||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEE
Confidence 56999999999999999999866 6899999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+|||.|+.. .....+.+||+.|+|||++..+ ++.++|+|||||++|||+.|..||....+
T Consensus 186 tDFGFAK~v----------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 186 TDFGFAKRV----------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EeccceEEe----------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 999999976 2335668899999999997665 89999999999999999999999976533
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=322.17 Aligned_cols=270 Identities=25% Similarity=0.317 Sum_probs=207.7
Q ss_pred CCCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--------------hHHHHHHHHHHHHhc
Q 005045 377 SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--------------GALKSFIDECNALKS 441 (717)
Q Consensus 377 ~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~ 441 (717)
..+.-.+-.+..++|++.+.||+|.||.|-+|... +++.||+|++..... ...+...+|+.++++
T Consensus 85 ~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 85 VRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred eeecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 34445555677899999999999999999999965 899999999864321 113578999999999
Q ss_pred CCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005045 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521 (717)
Q Consensus 442 l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 521 (717)
++|||||+++++..+. ..+.+|+|+|||..|.+...-... ..+++.++++++++++.||+|||.+ ||
T Consensus 165 l~H~nVV~LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~-------~els~~~Ar~ylrDvv~GLEYLH~Q---gi 231 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDK-------PELSEQQARKYLRDVVLGLEYLHYQ---GI 231 (576)
T ss_pred cCCcCeeEEEEeecCc---ccCceEEEEEeccCCccccCCCCc-------ccccHHHHHHHHHHHHHHHHHHHhc---Ce
Confidence 9999999999996554 356899999999988775433221 3389999999999999999999999 99
Q ss_pred eecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---C--CCcccchhhHHHHH
Q 005045 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---Q--VSILGDIYSYGILL 596 (717)
Q Consensus 522 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~sDvwslG~vl 596 (717)
+||||||+|++++.+|+|||+|||.+......... ..........||+.|+|||...+ . .+.+.||||+||+|
T Consensus 232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~--~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDE--GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred eccccchhheEEcCCCcEEeeccceeeecccCCcc--ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 99999999999999999999999999865332111 12222233789999999999544 2 37888999999999
Q ss_pred HHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 597 LEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 597 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
|+|+.|+.||.+...- +...+++...+.... .++....
T Consensus 310 YCllfG~~PF~~~~~~-------------~l~~KIvn~pL~fP~-----------------------------~pe~~e~ 347 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFEL-------------ELFDKIVNDPLEFPE-----------------------------NPEINED 347 (576)
T ss_pred HHhhhccCCcccchHH-------------HHHHHHhcCcccCCC-----------------------------cccccHH
Confidence 9999999999653111 112233333332211 1123556
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
+.++|.++|++||+.|.+..+|.....
T Consensus 348 ~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 348 LKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHHhhcChhheeehhhheecce
Confidence 789999999999999999999875543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=334.09 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=203.9
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh----hh-hHHHHHHHHHHHHhcCC-CCceeEEEEeeccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ----QQ-GALKSFIDECNALKSTR-HRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~ 457 (717)
....++|.+.+.||+|+||.|+.|++. +++.||+|++... .. ...+.+.+|+.+++.++ ||||++++++.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~--- 89 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF--- 89 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE---
Confidence 456789999999999999999999854 7899999976653 12 23456778999999998 99999999994
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD- 536 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~- 536 (717)
......++||||+.||.|.+++... +++.+.+++++++|++.|++|||+. ||+||||||+||+++.+
T Consensus 90 --~t~~~~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 90 --ATPTKIYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNE 157 (370)
T ss_pred --ecCCeEEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCC
Confidence 4555799999999999999999874 6789999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--C-CcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--V-SILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~-~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
+++||+|||++.... ..........|++.|+|||++.++ | +.++||||+||++|-|++|..||++....
T Consensus 158 ~~~Kl~DFG~s~~~~-------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~- 229 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISP-------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP- 229 (370)
T ss_pred CCEEEeccccccccC-------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-
Confidence 999999999998752 223344567899999999998875 3 68999999999999999999999872111
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHH-HHHHHHHhhccCCCCcCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC-FVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~R 692 (717)
.... .+....... +.-. +..+..++.+|+..+|.+|
T Consensus 230 -~l~~-----------ki~~~~~~~-------------------------------p~~~~S~~~~~Li~~mL~~~P~~R 266 (370)
T KOG0583|consen 230 -NLYR-----------KIRKGEFKI-------------------------------PSYLLSPEARSLIEKMLVPDPSTR 266 (370)
T ss_pred -HHHH-----------HHhcCCccC-------------------------------CCCcCCHHHHHHHHHHcCCCcccC
Confidence 1111 111111110 0111 3346789999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIR 706 (717)
Q Consensus 693 ps~~eil~~l~~i~ 706 (717)
+|+.||+ .-.-++
T Consensus 267 ~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 267 ITLLEIL-EHPWFQ 279 (370)
T ss_pred CCHHHHh-hChhhc
Confidence 9999998 433333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=305.14 Aligned_cols=280 Identities=23% Similarity=0.254 Sum_probs=210.5
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
-+.+.++|++++.|++|.||.||+|+++ +++.||+|.++... .+..-...+|+.++.+++|||||.+-.+.+..
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~--- 147 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS--- 147 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---
Confidence 3467789999999999999999999976 89999999998653 33445567899999999999999998886543
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+-+..|+|||||+ -+|...+...+ +.+...+++.++.|+++|++|||.+ .|+||||||+|++++..|.+|
T Consensus 148 ~~d~iy~VMe~~E-hDLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 148 NMDKIYIVMEYVE-HDLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred ccceeeeeHHHHH-hhHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEE
Confidence 3456999999996 48888887654 6799999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|+|||+|+.+..+ ....+...-|..|+|||++-|. |+.+.|+||+|||+.||+++++.|.+..+-++...-
T Consensus 218 iaDFGLAR~ygsp-------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I 290 (419)
T KOG0663|consen 218 IADFGLAREYGSP-------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI 290 (419)
T ss_pred ecccchhhhhcCC-------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence 9999999987322 2233456789999999997663 899999999999999999999999876554443332
Q ss_pred HHHhcCChh--hhhhcCCCCC---CCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 619 FVSMALPDH--VMDILDPSMP---LDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 619 ~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
+.....|.. +..+-..... ..+...+...+... ..+ . -.+.=++|+...+.+||.+|.
T Consensus 291 f~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF----~~~------------~-lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 291 FKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKF----GAL------------S-LSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred HHHhCCCccccCCCccccchhhccccCCCCchhhhhhc----ccc------------c-cchhHHHHHHHHhccCccccc
Confidence 322222221 2221111100 00111111111100 000 0 124457899999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
||.|.++
T Consensus 354 tA~~~L~ 360 (419)
T KOG0663|consen 354 TAEDGLK 360 (419)
T ss_pred cHHHhhc
Confidence 9999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=311.77 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=205.2
Q ss_pred cccccccccccCcccccceEEEE-eCCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..-+|++.+.+|+|.||.|-+|. ++.|+.||||.+.... .+..-.+++|++||..++||||+.++.+ +++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCC
Confidence 34589999999999999999999 5799999999998653 4456678999999999999999999999 7788
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+...|||||..+|.|+||+.+. +.+++.+++.+++||++|+.|+|++ ++||||||.+||++|+++++||+
T Consensus 126 dKIvivMEYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeee
Confidence 8999999999999999999876 7899999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCCC--CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||++..+ .....-..++|.+-|.+||++.|.+ ++.+|-|||||++|.|+.|..||++.+-.
T Consensus 196 DFGLSNly--------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------- 259 (668)
T KOG0611|consen 196 DFGLSNLY--------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------- 259 (668)
T ss_pred ccchhhhh--------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--------
Confidence 99999876 1223345688999999999999873 79999999999999999999999875211
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.++-.-+....+ . +....-+|++|+..+|++|.|+.+|..
T Consensus 260 -----~lvrQIs~GaYrEP~-----------------------~---------PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 260 -----RLVRQISRGAYREPE-----------------------T---------PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----HHHHHhhcccccCCC-----------------------C---------CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 111121111111100 0 222345889999999999999999875
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 303 H 303 (668)
T KOG0611|consen 303 H 303 (668)
T ss_pred h
Confidence 4
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=323.89 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=206.7
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.....|+..+.||+|.||.||+|.+ .+++.||+|++.... ......++.|+.++.+++++||.++|+.+ -.+.
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~ 84 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGT 84 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecc
Confidence 3455788899999999999999995 489999999998764 33467889999999999999999999984 3455
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
.++++|||+.||++.+.++.. ..+.+..+.-++++++.|+.|+|.. +.+|||||+.||++..+|.||++|
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred cHHHHHHHhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEe
Confidence 899999999999999999865 3447778888999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+..+. ........+.||+.|||||++.+ .|+.++||||||++.+||.+|.+|+.+..+.... .
T Consensus 155 fgVa~ql~-------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------f 221 (467)
T KOG0201|consen 155 FGVAGQLT-------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------F 221 (467)
T ss_pred cceeeeee-------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------E
Confidence 99998762 22333367889999999999876 5999999999999999999999999876552211 1
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+| +.-+.. ....+...+.+|+..|++.+|+.||||.++++
T Consensus 222 lIp--------k~~PP~-----------------------------L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 222 LIP--------KSAPPR-----------------------------LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ecc--------CCCCCc-----------------------------cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111 111111 11134667899999999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.27 Aligned_cols=287 Identities=22% Similarity=0.276 Sum_probs=210.8
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhH--hhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.......|..++.||+|++|.|+.|.++ +|+.||+|.+. .......++..+|+++++.++|+||+.+.+.......+
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3345567777899999999999999965 89999999997 34455678899999999999999999999987664445
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.-...|+|+|+| +.+|...++.+ +.++...+..++.||++|+.|+|+. +|+|||+||+|++++.++.+|
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEE
Confidence 556799999999 67899999865 5589999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc-C-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-hhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-N-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF-SIH 617 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~~ 617 (717)
|+|||+|+..... .....-+.+..|..|+|||++ . .+|+.+.||||+||++.||++|+..|.+.+.-+. ..-
T Consensus 166 I~DFGLAR~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 166 ICDFGLARYLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred eccccceeecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 9999999987332 122233557789999999994 3 3699999999999999999999999976532211 111
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
.......++.....+. .+.+...++ ..+..+...-....+.......+++.+||..||.+|+|++|
T Consensus 241 ~~~lGtP~~e~l~~i~----------s~~ar~yi~----slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIR----------SEKARPYIK----SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred HHhcCCCCHHHHHHhc----------cHHHHHHHH----hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 1111111111100000 000000000 00011111111222334556789999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
.++
T Consensus 307 AL~ 309 (359)
T KOG0660|consen 307 ALA 309 (359)
T ss_pred Hhc
Confidence 986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.42 Aligned_cols=245 Identities=32% Similarity=0.458 Sum_probs=203.5
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|-+.+.||+|.||.||+|+.+ +.+.||+|.+.+.. .+..+.+.+|++++++++||||+.+++. ++...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 57899999999999999999966 89999999997654 3456789999999999999999999999 6777899
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+|+||+.| +|..++... +.++++.++.++.+++.||.|||++ +|.|||+||+||+++..|.+|++|||
T Consensus 77 ~vVte~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred EEEehhhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence 999999965 999999855 7899999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+|+-+ ......-..+.||+-|||||+..++ |+..+|+||+||++||+++|++||... ++.
T Consensus 146 ~Ar~m-------~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~------- 206 (808)
T KOG0597|consen 146 LARAM-------STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SIT------- 206 (808)
T ss_pred hhhhc-------ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHH-------
Confidence 99976 2233344567899999999997765 899999999999999999999999542 111
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+..+......+. .+....+..|+...++.||..|.|..+++.
T Consensus 207 -~Lv~~I~~d~v~~p-------------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 207 -QLVKSILKDPVKPP-------------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -HHHHHHhcCCCCCc-------------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11112221111111 122556788999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=350.39 Aligned_cols=270 Identities=27% Similarity=0.464 Sum_probs=219.4
Q ss_pred ccccccccccCcccccceEEEEeC--CCc----hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG--DGT----IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..+-+..+.||+|+||.||.|... .|. .||+|.+... +.+....|.+|..+|+.++||||+++++.|.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 456677899999999999999944 343 3888888754 45667899999999999999999999999854
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
....+|++|||.||+|..++++.+....+...++..+...++.|||+|+.||+++ ++|||||.++|+|++....||
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 4478999999999999999998766655667899999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+|+.+...+. +.......-+..|||||.+ .+.++.|+|||||||++||++| |..||......+.....
T Consensus 843 IaDFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred EcccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence 999999995522221 1111122345789999995 5789999999999999999999 99999775433221111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... -.+.+..|+..+.+++.+||+.+|++||++..|
T Consensus 918 ~~gg-------------------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i 954 (1025)
T KOG1095|consen 918 LEGG-------------------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTI 954 (1025)
T ss_pred HhCC-------------------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHH
Confidence 1111 122566789999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhh
Q 005045 699 VNNLKTIRNCFLEFK 713 (717)
Q Consensus 699 l~~l~~i~~~~~~~~ 713 (717)
++.+..+.+......
T Consensus 955 ~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 955 VEQDPAISNAALGTI 969 (1025)
T ss_pred HhhhhhhhhhhccCc
Confidence 999999987765443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.83 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=197.8
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhhh---hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEec
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ---GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
..+++|+++.||+|.+ +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+. .+.....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEEe
Confidence 5689999999999998 688999999875432 2257788999999999999999999987542 1234578999999
Q ss_pred CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcc
Q 005045 472 MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551 (717)
Q Consensus 472 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 551 (717)
+++|+|.+++... +.+++..+..++.+++.|++|||+.. +++||||||+||+++.++.+||+|||.+....
T Consensus 104 ~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 104 CTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 9999999999754 46888999999999999999999842 78899999999999999999999999987652
Q ss_pred cccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.. .....++..|+|||++.+ .++.++|||||||++|||++|..||......+ .....
T Consensus 175 ~~----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i-------- 234 (283)
T PHA02988 175 SP----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLI-------- 234 (283)
T ss_pred cc----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHH--------
Confidence 11 112357889999999754 58999999999999999999999997542211 10000
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
....... ..+..++..+.+++.+||+.+|++|||++|+++.|++++.
T Consensus 235 ---~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 ---INKNNSL-----------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HhcCCCC-----------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0000000 0111346678999999999999999999999999998864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.83 Aligned_cols=281 Identities=22% Similarity=0.262 Sum_probs=219.1
Q ss_pred CCcccccccccccccccccCcccccceEEEEeCCC-chhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEe-ec
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDG-TIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITA-CS 455 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~-~~ 455 (717)
+...-+..-.-+++|.+.|.+|||+.||+|++..+ ..||+|++-..+..+.+.+.+|+++|+.|. |+|||.+++. ..
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 33444455566889999999999999999996644 999999998888888999999999999995 9999999993 33
Q ss_pred cccCCC-CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 456 SVDLEG-NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 456 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
...... .-.+.|.||||+||.|-|++..+.. ..+++.++++|+.++++|+++||.. ..+++|||||-+||||+
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLS 180 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEc
Confidence 222222 2468899999999999999985532 4599999999999999999999996 45699999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCC--cceeecccccccccCCCcc---CC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKN--QTVSIGLKGSIGYIPPEHM---NG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~---~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.+|+.||||||.+............. .........|+.|+|||++ .| .+++|+|||||||+||.|+....||.+
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 99999999999997653222110000 0011123479999999994 34 379999999999999999999999976
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
...-. +++-.... +..+.++..+.+||..||+.+
T Consensus 261 sg~la-----------------Ilng~Y~~-----------------------------P~~p~ys~~l~~LI~~mL~~n 294 (738)
T KOG1989|consen 261 SGKLA-----------------ILNGNYSF-----------------------------PPFPNYSDRLKDLIRTMLQPN 294 (738)
T ss_pred Cccee-----------------EEeccccC-----------------------------CCCccHHHHHHHHHHHHhccC
Confidence 42221 12212111 122445888999999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHh
Q 005045 689 PRERIAMNVVVNNLKTIRNCFLE 711 (717)
Q Consensus 689 p~~Rps~~eil~~l~~i~~~~~~ 711 (717)
|++||++-+|+..+.+++..-+.
T Consensus 295 P~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 295 PDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred cccCCCHHHHHHHHHHHhcCCCC
Confidence 99999999999999999865443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.90 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=204.9
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..+-|...+.+|.|+.|.|-+|++ .+|+.+|||++.... ......+.+|+-+|+-+.|||++.+|++ .++.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccC
Confidence 456789999999999999999995 499999999998652 2335678899999999999999999999 5566
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
.++|+|.||++||-|.+++-+. +.+++.++.++++||+.|+.|||.. +|+|||+||+|++++..+++||+
T Consensus 85 ~~lylvlEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeee
Confidence 6999999999999999998765 6799999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||+|..- .....-.+.+|.+.|.|||++.|+ | +.++||||+|||+|.|+||+.||++. .-..+...+
T Consensus 155 DFGMAsLe--------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV 224 (786)
T KOG0588|consen 155 DFGMASLE--------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKV 224 (786)
T ss_pred ccceeecc--------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHH
Confidence 99999752 233344567899999999998886 4 89999999999999999999999742 111111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ... -+.+.+.+..+|+.+|+..||++|.|++||++
T Consensus 225 ~~G-----------~f~-------------------------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 225 QRG-----------VFE-------------------------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HcC-----------ccc-------------------------------CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 111 000 11112455678999999999999999999987
Q ss_pred HH
Q 005045 701 NL 702 (717)
Q Consensus 701 ~l 702 (717)
.-
T Consensus 263 HP 264 (786)
T KOG0588|consen 263 HP 264 (786)
T ss_pred Cc
Confidence 54
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.25 Aligned_cols=283 Identities=24% Similarity=0.297 Sum_probs=202.4
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..-.|+..+.+|+|+||.||.|.. .+++.||||..-.+.+ .-.+|+++|+.++||||+++..++....-.+.-..
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 445788899999999999999994 4789999998875543 22369999999999999999988766542223356
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-CceEEeee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDF 544 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Df 544 (717)
.+||||+| .+|.++++.... ....++...++-++.||.+||+|||+. +|+||||||+|+++|.+ |.+||+||
T Consensus 98 nlVleymP-~tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 79999997 599998874211 115688889999999999999999997 99999999999999955 99999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH-
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS- 621 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~- 621 (717)
|.|+.+.. ......+..+..|+|||.+-| +|+.+.||||.|||+.||+-|++-|.+.+..++ +.+.+.
T Consensus 171 GSAK~L~~--------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eIik~ 241 (364)
T KOG0658|consen 171 GSAKVLVK--------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEIIKV 241 (364)
T ss_pred Ccceeecc--------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHHHHH
Confidence 99998721 122244678899999999766 499999999999999999999999987543332 222221
Q ss_pred hcCCh--hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 622 MALPD--HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 622 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...|. .+..+--...... +..+.... ... -.....+.+..+|+.++++++|.+|.++.|++
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~----~p~ik~~~---------~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFK----FPQIKAHP---------WHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred hCCCCHHHHhhcCccccccc----Cccccccc---------cee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 12221 1222111111000 00000000 000 01112255678999999999999999999998
Q ss_pred H--HHHHHH
Q 005045 700 N--NLKTIR 706 (717)
Q Consensus 700 ~--~l~~i~ 706 (717)
+ ...+++
T Consensus 305 ~h~fFdelr 313 (364)
T KOG0658|consen 305 AHPFFDELR 313 (364)
T ss_pred cchhhHHhh
Confidence 4 344444
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.86 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=170.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.+.||+|++|.||+++++ ++..+|+|.+... .......+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 578999999999999999999965 7888999988754 2344577899999999999999999999853 34589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... ..+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred EEEeecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence 9999999999999999754 45889999999999999999999852 69999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.+...... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 150 VSGQLIDS---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cccccccc---------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98754211 1123458999999999765 4899999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.51 Aligned_cols=244 Identities=27% Similarity=0.354 Sum_probs=195.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++. +.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 47999999999999999999965 78999999986432 2345678899999999999999999887 445568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +++||||||+||+++.+|.+||+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEec
Confidence 99999999999999998754 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+..... ......|++.|+|||++.+. ++.++|||||||++|+|++|..||....... ....
T Consensus 146 g~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~---- 209 (291)
T cd05612 146 GFAKKLRD----------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEK---- 209 (291)
T ss_pred CcchhccC----------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----
Confidence 99876511 11224589999999997654 7899999999999999999999996542211 1000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----HHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----MNVV 698 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~ei 698 (717)
+....... +...+..+.+++.+||+.||.+||+ +.|+
T Consensus 210 -------i~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 251 (291)
T cd05612 210 -------ILAGKLEF-------------------------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV 251 (291)
T ss_pred -------HHhCCcCC-------------------------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH
Confidence 00000000 0111445788999999999999995 8888
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 252 l~h 254 (291)
T cd05612 252 KNH 254 (291)
T ss_pred hcC
Confidence 754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.97 Aligned_cols=268 Identities=22% Similarity=0.402 Sum_probs=197.4
Q ss_pred cccccccccccCcccccceEEEEeCC-----------------CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCcee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD-----------------GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNIL 448 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~ 448 (717)
..++|++.++||+|+||.||+|.+.+ +..||+|.+.... ......+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 35789999999999999999997532 3358999887542 33456788999999999999999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCc------------ccccccCHHHHHHHHHHHHHHHHHHHhc
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH------------YQFKKLSVIQRLNIAIDVASALDYLHHH 516 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 516 (717)
++++++. +.+..++||||+++++|.+++....... .....+++..+.+++.||+.||+|||+.
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999864 3457899999999999999886432100 1113578889999999999999999998
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHH
Q 005045 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGIL 595 (717)
Q Consensus 517 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~v 595 (717)
+|+||||||+||+++.++.+||+|||.+....... .........++..|+|||++ .+.++.++|||||||+
T Consensus 158 ---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 158 ---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD-----YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred ---CccccCcchhheEEcCCccEEECCCccceecccCc-----eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 99999999999999999999999999987542111 11112223457789999995 4568999999999999
Q ss_pred HHHHHh--CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHH
Q 005045 596 LLEMFT--GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC 673 (717)
Q Consensus 596 l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (717)
+|+|++ +..||....... ........+........ ...+..+
T Consensus 230 l~el~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~ 273 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQ--VIENAGEFFRDQGRQVY----------------------------------LFRPPPC 273 (304)
T ss_pred HHHHHHccCCCCCCcCCHHH--HHHHHHHHhhhcccccc----------------------------------ccCCCCC
Confidence 999987 566776542211 11111100000000000 0011234
Q ss_pred HHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 674 FVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 674 ~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
+..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 274 ~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 274 PQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 667899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.20 Aligned_cols=280 Identities=21% Similarity=0.277 Sum_probs=198.7
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.++||+|+||.||.|+++ +++.||+|.+... .......+.+|+++++.++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999965 7899999988643 223345688999999999999999999887544333334689
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999994 6899888754 4689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
+........ .........|+..|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+...
T Consensus 150 ~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~ 223 (338)
T cd07859 150 ARVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDL 223 (338)
T ss_pred ccccccccC----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHH
Confidence 875421111 1111233568999999999653 57899999999999999999999996542211 11111000
Q ss_pred C---C-hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 624 L---P-DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 624 ~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
. + .....+.. ....+.......... .........++..+.+++.+||+.+|++|||++|++
T Consensus 224 ~~~~~~~~~~~i~~-----------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 224 LGTPSPETISRVRN-----------EKARRYLSSMRKKQP----VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred hCCCCHHHHHHhhh-----------hhHHHHHHhhcccCC----CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 0 0 00000000 000011110000000 000001112345678999999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 289 ~h 290 (338)
T cd07859 289 AD 290 (338)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=301.67 Aligned_cols=281 Identities=24% Similarity=0.347 Sum_probs=207.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCCCCc-eeEEEEeecccc-CCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRN-ILRVITACSSVD-LEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~-~~~~ 462 (717)
...|..++++|+|+||.||+|+.+ +|+.||+|.+..... +......+|+.++++++|+| |+.+++++.... ....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456889999999999999999955 899999999986643 45677789999999999999 999999964322 1223
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+ .-+|..++....... ..++...++.++.||+.|++|||++ +|+||||||+||+|+..|.+||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence 4789999999 469999998664211 3567789999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||+|+....+ .....+..+|..|+|||++-|. |+...||||+||+++||++++..|.+..+.+....-+-
T Consensus 163 DFGlAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 163 DFGLARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred ccchHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 99999965211 2224456689999999997654 88999999999999999999999988765433322222
Q ss_pred HhcCCh--hhhhhc---CCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 621 SMALPD--HVMDIL---DPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 621 ~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
....|. .+.... +-........+........ ........+++.+|++++|..|.||
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~-------------------~~~~~~~~dll~~~L~y~p~~R~Sa 296 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL-------------------PKLDPDGIELLSKLLQYDPAKRISA 296 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhc-------------------cccCccHHHHHHHHhccCcccCcCH
Confidence 222221 121111 1111110000011111000 0001356789999999999999999
Q ss_pred HHHHHH
Q 005045 696 NVVVNN 701 (717)
Q Consensus 696 ~eil~~ 701 (717)
+.++++
T Consensus 297 ~~al~h 302 (323)
T KOG0594|consen 297 KGALTH 302 (323)
T ss_pred HHHhcC
Confidence 999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=320.18 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=207.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
-++|..++.+|+|+||.++.++++ +++.+++|.+.... ...++....|+.+++++.||||+.+.+.+ ..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCc
Confidence 468999999999999999999976 78889999987553 33456788999999999999999999995 33445
Q ss_pred -EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 465 -KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 465 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
.+|||+|++||++.+.+.+... .-+++..+.+++.|++.|+.|||++ .|+|||||+.|||++.++.|||+|
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecc
Confidence 9999999999999999986532 5689999999999999999999987 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||+|+.+... ........||+.|+.||++.+. |+.|+|||||||++|||++-+++|...+-...
T Consensus 150 fGlaK~l~~~-------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------- 214 (426)
T KOG0589|consen 150 FGLAKILNPE-------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------- 214 (426)
T ss_pred hhhhhhcCCc-------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------
Confidence 9999987221 2234557899999999998774 89999999999999999999999976532211
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+.++..... .+.+..+..++..++..|++.+|+.||++.+++.+
T Consensus 215 -----i~ki~~~~~------------------------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 -----ILKINRGLY------------------------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----HHHHhhccC------------------------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111111111 11334447788999999999999999999999976
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.61 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=167.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.++||.|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++ ...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 357999999999999999999965 78899999886442 22345677899999999999999999984 345589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence 99999996 58998886442 4578899999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+...... ........+++.|+|||++.+ .++.++||||+||++|+|++|+.||....
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 149 LARAKSVP-------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred ceeeccCC-------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98754111 111123457889999999654 47899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.84 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=200.2
Q ss_pred cccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
....++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+++++.+ +|+||+++++.+.
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~- 112 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT- 112 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-
Confidence 345668999999999999999998842 34579999987542 33456788999999999 8999999999853
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCC-------------------------------------------------
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAE------------------------------------------------- 487 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------- 487 (717)
..+..++||||+++|+|.+++......
T Consensus 113 ----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 113 ----HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred ----CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 445899999999999999987532110
Q ss_pred --------------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccc
Q 005045 488 --------------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553 (717)
Q Consensus 488 --------------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 553 (717)
......+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 00113478889999999999999999997 9999999999999999999999999998764211
Q ss_pred cCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 554 SDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
. .........++..|+|||++. +.++.++|||||||++|+|++ |..||........ ........
T Consensus 266 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~-------- 331 (374)
T cd05106 266 S-----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRG-------- 331 (374)
T ss_pred c-----ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcc--------
Confidence 1 111112233566799999954 468999999999999999997 9999976432211 11111000
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
..... +...+..+.+++.+||+.+|++|||+.||++.|+++.
T Consensus 332 ~~~~~---------------------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSR---------------------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccC---------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000 0011456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.08 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=170.3
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++.+.||+|+||.||+|+++ +++.||+|++.... ......+.+|++++++++||||+++++.+ .+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 468999999999999999999965 78899999886432 23456788999999999999999999984 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEee
Confidence 899999999999999998754 5688999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||.+..... ......|++.|+|||++.+. ++.++|||||||++|+|++|..||...
T Consensus 162 fg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 162 FGFAKKVPD----------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ccCceEcCC----------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 999876411 11234689999999997654 789999999999999999999999653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.76 Aligned_cols=277 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|... ...+.+|++++++++||||+++++++ ......
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCee
Confidence 4568999999999999999999964 78999999754 24567899999999999999999985 345588
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++|||++. ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 159 ~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred EEEEecCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCC
Confidence 99999994 7888887644 4588999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch------hhhH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF------SIHM 618 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~------~~~~ 618 (717)
.+...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||......+. .+..
T Consensus 228 ~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 228 AACFPVDI------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred cccccccc------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 98753211 1112234569999999999755 589999999999999999999988754321110 1110
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhh-hhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHID-LEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
.... .. ......+. .......+............ ..........+.+..+.+++.+||++||++||||+|
T Consensus 302 i~~~-~g-----~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 302 IIRR-SG-----THPNEFPI---DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred HHHH-hc-----CChhhcCc---chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 0000 00 00000000 00111111110100000000 000111122234667889999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 373 lL~ 375 (391)
T PHA03212 373 LLD 375 (391)
T ss_pred Hhc
Confidence 985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=299.83 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=210.9
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
.+..--.+.|+.++.+|+|.-|+||++..+ ++..+|+|++.... .....+.+.|.+||+.++||.++++|+.
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~---- 145 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS---- 145 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe----
Confidence 344445678999999999999999999965 66899999997553 4456788899999999999999999999
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
++.++..|+|||||+||+|....++... +.+++..++.++..|+-||+|||-. |||+|||||+||||.++|
T Consensus 146 -fet~~~~cl~meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredG 216 (459)
T KOG0610|consen 146 -FETDKYSCLVMEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDG 216 (459)
T ss_pred -eeccceeEEEEecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCC
Confidence 6777899999999999999999887754 7899999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhccc------c--------------------------c-CC----------------CCCCcceeeccc
Q 005045 538 TAHVGDFGLAKFLFE------I--------------------------S-DN----------------PSKNQTVSIGLK 568 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~------~--------------------------~-~~----------------~~~~~~~~~~~~ 568 (717)
++-|+||.++..... . . .. ..........+.
T Consensus 217 HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFV 296 (459)
T KOG0610|consen 217 HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFV 296 (459)
T ss_pred cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccc
Confidence 999999988755411 0 0 00 001112334577
Q ss_pred ccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHH
Q 005045 569 GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQI 647 (717)
Q Consensus 569 ~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (717)
||..|.|||++.|. .+.++|+|+||+++|||+.|.-||.+...+.. +..++.+.+....
T Consensus 297 GThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv~~~l~Fp~------- 356 (459)
T KOG0610|consen 297 GTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIVGQPLKFPE------- 356 (459)
T ss_pred cccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHhcCCCcCCC-------
Confidence 99999999999886 89999999999999999999999988644321 2222332222211
Q ss_pred HHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC----HHHHHH
Q 005045 648 EEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA----MNVVVN 700 (717)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~eil~ 700 (717)
.++.+....+||++.|.+||.+|-. |+||-+
T Consensus 357 ----------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 357 ----------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ----------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1123566789999999999999987 777643
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.56 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=205.3
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.+..+|++.++||.|++|.||.|..+.++.+++|.+..........+..|+++++.++|+||+++++.+. ..+..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 5667899999999999999999998889999999988766555677889999999999999999999853 44578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..++.++.||+.|++|||+. +++||||+|+||+++.++.+||+|||
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence 999999999999999976422 4679999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+...... ........++..|+|||...+ .++.++|||||||++|+|++ |..||......+ .......
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~- 219 (261)
T cd05148 150 LARLIKED-------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITA- 219 (261)
T ss_pred chhhcCCc-------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHh-
Confidence 98765211 111112335678999999654 58899999999999999998 899996542111 1000000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.... +.+..++..+.+++.+||+.+|++|||++|+++.|+
T Consensus 220 -----------~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 220 -----------GYRM-----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred -----------CCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000 011223566889999999999999999999999998
Q ss_pred HH
Q 005045 704 TI 705 (717)
Q Consensus 704 ~i 705 (717)
.+
T Consensus 260 ~~ 261 (261)
T cd05148 260 NI 261 (261)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=313.24 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=194.1
Q ss_pred ccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.|+..+.||+|+||.||+|.+ .+|+.||+|.+.... ......+.+|+++++++.|++|+++++.+ .+.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 378889999999999999996 489999999876432 22345678899999999999999999884 445589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999888754321 4588999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+..... ........|+..|+|||++.+ .++.++|||||||++|+|++|+.||......... ......+
T Consensus 148 ~~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~~ 217 (285)
T cd05631 148 LAVQIPE--------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRV 217 (285)
T ss_pred CcEEcCC--------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHHh
Confidence 9875411 111123468999999999755 5899999999999999999999999754321110 0000000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----HHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----MNVVV 699 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~eil 699 (717)
. .... ..+.+.+..+.+++.+||+.+|++||+ ++|++
T Consensus 218 ~-------~~~~-------------------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~ 259 (285)
T cd05631 218 K-------EDQE-------------------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK 259 (285)
T ss_pred h-------cccc-------------------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh
Confidence 0 0000 011122556788999999999999997 88888
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 260 ~h 261 (285)
T cd05631 260 QH 261 (285)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.10 Aligned_cols=202 Identities=29% Similarity=0.462 Sum_probs=167.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.++||+|+||.||.|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++ .....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~ 77 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCe
Confidence 3578999999999999999999965 788999999875432 2234677899999999999999999984 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++ +++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df 147 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF 147 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence 999999995 68887776432 4578899999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|.+...... ........+++.|+|||++.+ .++.++||||+||++|+|++|..||.+..
T Consensus 148 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 148 GLARAKSVP-------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CcceeccCC-------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 998643111 111123457899999999654 47889999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=320.24 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=189.5
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|++++++++||||+++++.+ ...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46899999999999964 78999999886542 23446678899999999999999999884 44568999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 76 YANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred CCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999999998754 5689999999999999999999998 9999999999999999999999999998753
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhh
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVM 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 629 (717)
.. .........|++.|+|||++.+ .++.++||||+||++|||++|..||...... .....
T Consensus 146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~---------- 206 (323)
T cd05571 146 IS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL---------- 206 (323)
T ss_pred cc-------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHH----------
Confidence 11 1111233568999999999765 4899999999999999999999999653211 00000
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHH
Q 005045 630 DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVN 700 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~ 700 (717)
+...... .+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 207 -~~~~~~~-------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 207 -ILMEEIR-------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -HHcCCCC-------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0000000 0011245678899999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.29 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=198.4
Q ss_pred ccccccccccCcccccceEEEEeC----CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+.++++++||||+++++.+. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 467999999999999999999753 46689999887542 334567889999999999999999999853 45
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++.... ..+++..++.++.||+.|++|||+. +++||||||+||+++.++.++++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~ 149 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS 149 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEEC
Confidence 58999999999999999987542 4689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+..... ..........++..|+|||.+. +.++.++|||||||++||+++ |..||......+ .....
T Consensus 150 dfg~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~ 221 (266)
T cd05064 150 GFRRLQEDKS------EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV 221 (266)
T ss_pred CCcccccccc------cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH
Confidence 9997764311 0011111223467899999964 458999999999999999876 999996542211 10000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. + ... .+.+..++..+.+++.+||+.+|++|||++||++
T Consensus 222 ~-----------~-~~~-----------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 222 E-----------D-GFR-----------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred H-----------C-CCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0 0 000 0012334667889999999999999999999999
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.|.++
T Consensus 261 ~l~~~ 265 (266)
T cd05064 261 ILSKM 265 (266)
T ss_pred HHHhh
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=313.54 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=212.1
Q ss_pred ccccccccCcccccceEEEEeC---CCc--hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG---DGT--IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..+..++||.|-||.||.|... .|+ .||||.++.+ .....+.|..|+-+++.++||||+++++.|.+.
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------ 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------
Confidence 3455788999999999999843 344 4889999874 345578899999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|||||.++.|-|..|++.+. ..++......++.||+.||+|||+. .+|||||..+||+|....-|||+|
T Consensus 464 P~WivmEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 5899999999999999998775 5788889999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||+++.+.... +.......-+.-|||||.+. ++++.+||||.|||++||+++ |..||.+....+.-.....+
T Consensus 535 FGLSR~~ed~~------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG 608 (974)
T KOG4257|consen 535 FGLSRYLEDDA------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG 608 (974)
T ss_pred cchhhhccccc------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC
Confidence 99999873221 22222344577899999975 469999999999999999998 99999876554432222222
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.++ +.++.||..+..++.+||.++|.+||.+.||...
T Consensus 609 eRl-------------------------------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 609 ERL-------------------------------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred CCC-------------------------------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 221 2567899999999999999999999999999999
Q ss_pred HHHHHHHH
Q 005045 702 LKTIRNCF 709 (717)
Q Consensus 702 l~~i~~~~ 709 (717)
|+.+.++.
T Consensus 646 lsdv~qee 653 (974)
T KOG4257|consen 646 LSDVLQEE 653 (974)
T ss_pred HHHHHHHh
Confidence 99999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=319.52 Aligned_cols=205 Identities=26% Similarity=0.395 Sum_probs=178.2
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 458 (717)
.....++|+.++.+|+|.||+|++|..+ +++.+|||++++.. ....+..+.|.+|+... +||.++.++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~----- 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC----- 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----
Confidence 3455779999999999999999999976 78899999998653 45567788888888877 69999999998
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
++..+++|+||||+.||++..+.+. +.+++..++.+|..|+.||.|||++ ||++||||-+||++|.+|.
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 7778899999999999996555543 5799999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+||+|||+++.. ........++.||+.|+|||++.+ .|+.++|+|||||+||||+.|+.||.+.++
T Consensus 507 ~kiADFGlcKe~-------m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 507 VKIADFGLCKEG-------MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred EEeccccccccc-------CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999854 222234567899999999999766 599999999999999999999999987543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.83 Aligned_cols=287 Identities=26% Similarity=0.312 Sum_probs=207.4
Q ss_pred ccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-C-----CceeEEEEeeccccCCCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-H-----RNILRVITACSSVDLEGN 462 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~~~~~~ 462 (717)
+|.+.+.||+|.||.|-+|.+ ++++.||||+++.... ...+...|+.+|..++ | -|+|+++++ +...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 999999999999999999995 5899999999986643 3466678999999996 3 379999999 5556
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--CceE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD--MTAH 540 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~k 540 (717)
++.|||+|.+ +.+|+++++.+ .+..++...++.++.||+.||..||+. +|||+||||+|||+-.. ..+|
T Consensus 261 ~HlciVfELL-~~NLYellK~n-----~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNN-----KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence 6999999999 67999999977 347799999999999999999999998 99999999999999743 3899
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh-H
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH-M 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~-~ 618 (717)
|+|||.|++.. ... ..++.+..|+|||++-| +|+.+.||||||||++||++|.+.|.+..+-+.-.. .
T Consensus 332 VIDFGSSc~~~---------q~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 332 VIDFGSSCFES---------QRV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred EEecccccccC---------Ccc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 99999999751 112 25778889999999655 799999999999999999999988877654333111 1
Q ss_pred HHHhcCChhhhhhcCCCCCCCCC------------Cc----HHHHHHHHHHHHHH-hhh-hhhhcchhhhHHHHHHHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEE------------ND----EEQIEEVIEEKEMM-IHI-DLEVNTKNKLEECFVSVLRI 680 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~------------~~----~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~l~~l 680 (717)
.+....|.++.+...+.-..... .. ...+.......... ..+ +...............+.++
T Consensus 402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df 481 (586)
T KOG0667|consen 402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF 481 (586)
T ss_pred HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence 11122333333333222111110 00 00011111111111 011 11111111222446678999
Q ss_pred hhccCCCCcCCCCCHHHHHHH
Q 005045 681 GLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 681 i~~cl~~~p~~Rps~~eil~~ 701 (717)
+++|+.|||.+|+|..|+++.
T Consensus 482 lk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 482 LKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHhccCchhcCCHHHHhcC
Confidence 999999999999999998853
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.06 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||+|.+. +++.||+|++.... ......+..|+++++.++||||+++++.+ ...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 47999999999999999999965 68899999987542 23456788899999999999999999884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999754 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+..... ......|++.|+|||++.+ .++.++|||||||++|||++|..||......+. ......
T Consensus 146 g~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~- 212 (333)
T cd05600 146 GLSKGIVT----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKY- 212 (333)
T ss_pred cCCccccc----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHh-
Confidence 99876421 2233568999999999765 589999999999999999999999975432211 000000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....+....... .....+..+.+++.+|++.+|++|||++|+++.
T Consensus 213 ----~~~~~~~~~~~~-----------------------------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 ----WKETLQRPVYDD-----------------------------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccccCCCCCc-----------------------------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000000 001124567889999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.16 Aligned_cols=270 Identities=21% Similarity=0.358 Sum_probs=202.9
Q ss_pred ccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
|..+.++|++.+.||+|+||.||.|... +++.||+|++.... ....+.+..|+.+++++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3456779999999999999999999632 35789999886432 23345677899999999 8999999999873
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------------------------------------------
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH----------------------------------------------- 488 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------------------------------------------- 488 (717)
..+...+++|||+++++|.+++.......
T Consensus 82 ----~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 82 ----KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred ----cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 34457899999999999999885421100
Q ss_pred -------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCc
Q 005045 489 -------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561 (717)
Q Consensus 489 -------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 561 (717)
.....+++..+.+++.||+.|++|||+. +|+||||||+||+++.++.++|+|||++..+.... ..
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-----~~ 229 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DY 229 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc-----ch
Confidence 0013678999999999999999999997 99999999999999999999999999998652111 11
Q ss_pred ceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCC
Q 005045 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLD 639 (717)
Q Consensus 562 ~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (717)
.......++..|+|||++. +.++.++|||||||++|+|++ |..||......+. ...... ......
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~------------~~~~~~ 296 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLK------------EGTRMR 296 (337)
T ss_pred hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHh------------ccCCCC
Confidence 1112234567899999854 458999999999999999998 9999965422211 110000 000000
Q ss_pred CCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 640 EENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.+..++..+.+++.+||+.+|++||++.||++.|+++.+
T Consensus 297 -----------------------------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 -----------------------------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011124567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=282.27 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=196.5
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
-.+.|++-+.||+|+|+.|+++.. .+|+.+|+|++... .....+.+.+|++|.+.++||||+++.+. +....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence 356899999999999999999985 48999999999754 23345788899999999999999999988 55666
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 540 (717)
..|+|||++.|+.|-.=+-.+ ..+++..+...++||++|++|+|.+ +|||||+||+|+++.. ..-+|
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred eeEEEEecccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCcee
Confidence 899999999999886433322 4578899999999999999999998 9999999999999963 34799
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+|..+. ......+..||+.|+|||++.. +|+..+||||.||++|-|+.|..||.+..... +.+.
T Consensus 154 L~~FGvAi~l~--------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~ 223 (355)
T KOG0033|consen 154 LADFGLAIEVN--------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQ 223 (355)
T ss_pred ecccceEEEeC--------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHH
Confidence 99999998762 2334567889999999999765 58999999999999999999999996532221 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+.......++ +++. ...+...+++.+|+..||.+|.|+.|.+
T Consensus 224 -----------I~~g~yd~~~---------------------~~w~------~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 224 -----------IKAGAYDYPS---------------------PEWD------TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -----------HhccccCCCC---------------------cccC------cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1111111110 0000 1133456899999999999999999987
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
.
T Consensus 266 ~ 266 (355)
T KOG0033|consen 266 K 266 (355)
T ss_pred C
Confidence 4
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.94 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=199.1
Q ss_pred cccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
....++|++.++||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+++++.+ +||||+++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-- 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-- 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee--
Confidence 34466899999999999999999963 246679999986432 33456788999999999 899999999985
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCc------------------------------------------------
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH------------------------------------------------ 488 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------------------------------------------ 488 (717)
...+..++||||+++|+|.+++.......
T Consensus 109 ---~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 109 ---TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred ---ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 34457899999999999999886432100
Q ss_pred --------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 489 --------------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 489 --------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
.....+++..+.+++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccce
Confidence 0012478889999999999999999997 99999999999999999999999999987
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...... .........++..|+|||++.+ .++.++|||||||++|+|++ |..||........ .....
T Consensus 263 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~------ 330 (375)
T cd05104 263 DIRNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMI------ 330 (375)
T ss_pred eccCcc-----cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHH------
Confidence 652111 1111122335667999999654 58999999999999999998 8889865432211 11111
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
....... .+...+.++.+++.+||+.+|++|||++||++.|++.
T Consensus 331 ------~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 ------KEGYRML-----------------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------HhCccCC-----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1000000 0011145678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.11 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=197.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.+.||+|++|.||+|+++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47999999999999999999975 78889999886432 23356778899999999999999999884 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++++.+..+.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence 9999999887766554322 4688999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh-HHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH-MFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~-~~~~~~ 623 (717)
.+....... ........|+..|+|||++.+ .++.++|||||||++|+|++|+.||......+.... ......
T Consensus 146 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07848 146 FARNLSEGS------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219 (287)
T ss_pred Ccccccccc------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence 987652111 111223458899999999654 589999999999999999999999976432211110 011111
Q ss_pred CChhhhhhc--CCCCC---CCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 624 LPDHVMDIL--DPSMP---LDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 624 ~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
++....... ++... .......... ........+..+.+++.+||+.+|++|||++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSL------------------ERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccH------------------HHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 111111100 00000 0000000000 000112235678999999999999999999998
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 282 l~ 283 (287)
T cd07848 282 LN 283 (287)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.44 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=201.1
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
....++|++.++||+|++|.||+|...+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+ ...+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEP 75 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCC
Confidence 345678999999999999999999987788899998764432 346788999999999999999999884 34557
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCC
Confidence 8999999999999999865421 5678889999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... ........++..|+|||.+.+ .++.++|||||||++|+|++ |..||....... .......
T Consensus 148 g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~ 219 (261)
T cd05072 148 GLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQR 219 (261)
T ss_pred ccceecCCCc------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHc
Confidence 9997652111 011122335678999999654 57899999999999999998 999986532211 1111100
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
. ... + ....++..+.+++.+|+..+|++|||++++.+.|
T Consensus 220 ~--------~~~--~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 220 G--------YRM--P-------------------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred C--------CCC--C-------------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 0 000 0 0111245678899999999999999999999999
Q ss_pred HH
Q 005045 703 KT 704 (717)
Q Consensus 703 ~~ 704 (717)
++
T Consensus 259 ~~ 260 (261)
T cd05072 259 DD 260 (261)
T ss_pred hc
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.71 Aligned_cols=275 Identities=24% Similarity=0.367 Sum_probs=194.6
Q ss_pred cccccccccCcccccceEEEEeC--CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccccCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG--DGTIVAIKVLKLQQ--QGALKSFIDECNALKST---RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~ 461 (717)
++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46889999876432 22234455677766655 7999999999875443445
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 151 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEE
Confidence 567899999996 689998865421 4589999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... .......|+..|+|||++. +.++.++|||||||++|||++|..||......+. .....
T Consensus 152 ~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~ 222 (290)
T cd07862 152 ADFGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKIL 222 (290)
T ss_pred ccccceEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHH
Confidence 999998754111 1223355899999999964 4589999999999999999999999976533221 11111
Q ss_pred H-hcCC--hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 621 S-MALP--DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 621 ~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
. ...+ ..+..... +... . .............++.+..+.+++.+|++.+|++|||+.|
T Consensus 223 ~~~~~~~~~~~~~~~~--~~~~----------~-------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 223 DVIGLPGEEDWPRDVA--LPRQ----------A-------FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred HHhCCCChhhchhhhc--ccch----------h-------ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 0 0011 00100000 0000 0 0000000000011223556789999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 284 ~l~ 286 (290)
T cd07862 284 ALS 286 (290)
T ss_pred Hhc
Confidence 985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.46 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=170.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.++||+|+||.||+|.++ +++.+|+|.+... .......+.+|++++++++|+||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 578999999999999999999966 7888999987654 2334567889999999999999999999954 34589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... ..+++..+..++.|++.|++|||+. .+++||||||+||+++.++.+||+|||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred EEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999999999754 4578899999999999999999974 279999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
++...... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 150 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 150 VSGQLIDS---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cchhhhhh---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 98754211 1123458899999999765 4789999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.77 Aligned_cols=268 Identities=25% Similarity=0.423 Sum_probs=208.5
Q ss_pred CcccccccccccccccccCcccccceEEEEeC--CC---chhhhHHhHh---hhhhHHHHHHHHHHHHhcCCCCceeEEE
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG--DG---TIVAIKVLKL---QQQGALKSFIDECNALKSTRHRNILRVI 451 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~--~~---~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~ 451 (717)
.-+.|.-...+-...+++|+|+||.||.|..+ ++ ..||+|.... ........+.+|++++++++||||+++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 33444455555666699999999999999954 22 2289999885 2356788999999999999999999999
Q ss_pred EeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
|++...+ .+++|||+|+||+|.+++++.. ..++..+...++.+.|.||+|||+. +++||||.++|+
T Consensus 228 GVa~~~~-----Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNc 293 (474)
T KOG0194|consen 228 GVAVLEE-----PLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNC 293 (474)
T ss_pred EEEcCCC-----ccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHh
Confidence 9965543 8999999999999999999764 3699999999999999999999997 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 609 (717)
+++.++.+||+|||+++...... .......-+..|+|||.+. +.+++++|||||||++||+++ |..||.+.
T Consensus 294 L~~~~~~vKISDFGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred eecCCCeEEeCccccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 99999999999999988642110 0000113567899999965 458999999999999999999 89999775
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
... .....+ ........ .+...+..+..++.+||..+|
T Consensus 367 ~~~--~v~~kI-----------~~~~~r~~-----------------------------~~~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 367 KNY--EVKAKI-----------VKNGYRMP-----------------------------IPSKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred CHH--HHHHHH-----------HhcCccCC-----------------------------CCCCCHHHHHHHHHHhccCCh
Confidence 322 111111 00000000 111226778889999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 690 ~~Rps~~eil~~l~~i~~~~~ 710 (717)
++||||.++.+.++.+.....
T Consensus 405 ~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 405 EDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred hhccCHHHHHHHHHHHHhccc
Confidence 999999999999999886543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.71 Aligned_cols=276 Identities=24% Similarity=0.382 Sum_probs=201.8
Q ss_pred ccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..+|++.+.||+|+||.||.|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence 35789999999999999999973 2678899999876655556788999999999999999999987643 234
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~ 150 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIG 150 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEEC
Confidence 56899999999999999986542 4589999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+....... ..........++..|+|||...+ .++.++|||||||++|||++|..|+...... ....
T Consensus 151 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~-- 221 (284)
T cd05081 151 DFGLTKVLPQDK----EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRM-- 221 (284)
T ss_pred CCcccccccCCC----cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhh--
Confidence 999998652111 10111111224456999999654 5889999999999999999988776432110 0000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........ .......+.+... ........++..+.+++.+||+.+|++||||+||++.
T Consensus 222 ----------~~~~~~~~--~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 222 ----------MGNDKQGQ--MIVYHLIELLKNN----------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred ----------cccccccc--cchHHHHHHHhcC----------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000000 0000000011000 0001123346678999999999999999999999999
Q ss_pred HHHHH
Q 005045 702 LKTIR 706 (717)
Q Consensus 702 l~~i~ 706 (717)
|+.++
T Consensus 280 l~~~~ 284 (284)
T cd05081 280 VEAIR 284 (284)
T ss_pred HHhcC
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.05 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=188.9
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|+++++.++||||+++++.+ ...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46899999999999964 78999999986542 23446677899999999999999999884 44568999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 76 YANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred CCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99999999888654 4689999999999999999999997 9999999999999999999999999988743
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhh
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVM 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 629 (717)
.. .........|++.|+|||++.+ .++.++|||||||++|+|++|..||........ . .
T Consensus 146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~------------~ 205 (323)
T cd05595 146 IS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-F------------E 205 (323)
T ss_pred cC-------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-H------------H
Confidence 11 1111223568999999999754 589999999999999999999999965422110 0 0
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHH
Q 005045 630 DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVN 700 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~ 700 (717)
.+...... .+..++..+.+++.+||+.+|++|| ++.++++
T Consensus 206 ~~~~~~~~-------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 206 LILMEEIR-------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHhcCCCC-------------------------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00000000 0111245678899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.49 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=201.5
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||.|+.+ +++.||+|.+... .......+.+|+++++.++||||+++++.+. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 58999999999999999999965 7899999976532 2344567889999999999999999999853 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++..... ....+++..+..++.|++.|++|||++ +++|+||+|+||+++.++.++|+||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence 8999999999999988853211 114578999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+...... ........++..|+|||.+.+ .++.++|+||+|+++|+|++|..||................
T Consensus 151 g~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~- 222 (267)
T cd08228 151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ- 222 (267)
T ss_pred ccceeccch-------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-
Confidence 988765211 111122457888999999654 57899999999999999999999986532221111111100
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
...+.. ....++..+.+++.+||+.+|++|||+.||++.++
T Consensus 223 -------~~~~~~--------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 223 -------CDYPPL--------------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred -------CCCCCC--------------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 000000 01223566889999999999999999999999999
Q ss_pred HHH
Q 005045 704 TIR 706 (717)
Q Consensus 704 ~i~ 706 (717)
+++
T Consensus 264 ~~~ 266 (267)
T cd08228 264 QMH 266 (267)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.14 Aligned_cols=191 Identities=27% Similarity=0.397 Sum_probs=162.3
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||+|+||.||+|.+. +++.||+|++... .......+..|+.++++++||||+++++.+ ...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999965 6888999988643 233456778899999999999999998884 4456899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 76 ~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 76 NGGELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 999999998754 5689999999999999999999997 999999999999999999999999999875311
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.........|++.|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 146 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 146 -------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred -------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 1112233568999999999765 4899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.75 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=194.9
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++. ..+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 57889999999999999999988778899998764332 2356788999999999999999999853 44578999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+.
T Consensus 78 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEcCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 99999999999987542 3578999999999999999999997 99999999999999999999999999887
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...... ........++..|+|||.+.+ .++.++|||||||++|+|++ |+.||...... .........
T Consensus 149 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~--- 217 (256)
T cd05114 149 YVLDDE------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRG--- 217 (256)
T ss_pred ccCCCc------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCC---
Confidence 542111 111112235567999999765 58899999999999999999 89998653211 111111000
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
.... .+...+..+.+++.+||+.+|++|||++|+++.|
T Consensus 218 --------~~~~------------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 --------FRLY------------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCCC------------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0000 0011144678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.05 Aligned_cols=261 Identities=26% Similarity=0.480 Sum_probs=200.8
Q ss_pred ccccccccccCcccccceEEEEeC-C-----CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-D-----GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++|++.+.||+|++|.||.|... . .+.|++|.+.... ......+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~----- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT----- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----
Confidence 458999999999999999999853 2 2568999886442 334567889999999999999999999853
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
.....+++|||+++++|.+++....... .....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni 155 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC 155 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence 3457899999999999999986542110 0114578899999999999999999998 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 609 (717)
+++.++.++|+|||.+....... .........++..|+|||.+ .+.++.++|||||||++|||++ |..||.+.
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSAD-----YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred EEcCCCcEEECCCcceeeccccc-----cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999987542111 11112233467889999985 4568999999999999999998 99998764
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
...+ ....+. ..... ..+..++.++.+++.+||+.+|
T Consensus 231 ~~~~--~~~~i~-----------~~~~~------------------------------~~~~~~~~~~~~l~~~c~~~~p 267 (283)
T cd05048 231 SNQE--VIEMIR-----------SRQLL------------------------------PCPEDCPARVYALMIECWNEIP 267 (283)
T ss_pred CHHH--HHHHHH-----------cCCcC------------------------------CCcccCCHHHHHHHHHHccCCh
Confidence 3221 110000 00000 0123457789999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKT 704 (717)
Q Consensus 690 ~~Rps~~eil~~l~~ 704 (717)
++||+++||++.|++
T Consensus 268 ~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 268 ARRPRFKDIHTRLRS 282 (283)
T ss_pred hhCcCHHHHHHHHhc
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.07 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=199.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...+|++.++||+|++|.||+|.++ .++.||+|.+.... .....+.+|++++++++|+||+++++.+. ..+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence 3567899999999999999999965 68889999887443 23467889999999999999999999853 34578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+++|||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCc
Confidence 999999999999999865421 4688999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+....... ........++..|+|||.+.+ .++.++|||||||++|+|++ |..||.....++ ......
T Consensus 150 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~-- 219 (263)
T cd05052 150 LSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE-- 219 (263)
T ss_pred cccccccce------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--
Confidence 987652211 011111234567999999655 57899999999999999998 999986532111 100000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
...... .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 220 ------~~~~~~---------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 220 ------KGYRME---------------------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred ------CCCCCC---------------------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 000000 11223567889999999999999999999999998
Q ss_pred HH
Q 005045 704 TI 705 (717)
Q Consensus 704 ~i 705 (717)
.+
T Consensus 261 ~~ 262 (263)
T cd05052 261 TM 262 (263)
T ss_pred hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.56 Aligned_cols=199 Identities=28% Similarity=0.380 Sum_probs=169.8
Q ss_pred ccccccccccccCcccccceEEEEeC-C-CchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-D-GTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...++|++.+.||+|+||.||+|.++ . ++.||+|.+.... ......+.+|+++++.++||||+++++++ .
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence 35668999999999999999999854 3 3679999875432 33456788999999999999999999985 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence 456899999999999999999755 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|+|||.+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 172 L~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 172 MTDFGFAKVVDT----------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred EecCCCCeecCC----------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999999875411 1123568999999999755 4799999999999999999999999754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.47 Aligned_cols=266 Identities=25% Similarity=0.443 Sum_probs=203.8
Q ss_pred ccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..+|.+.+.+|+|+||.||.+... ++..+|+|.+..........+.+|+++++++.||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 457999999999999999999842 34568889887655555678899999999999999999999854 3
Q ss_pred CceEEEEEecCCCCChhhhccCCCCC------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAE------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.+..++||||+++++|.+++...... ......+++..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 45889999999999999998643211 01123589999999999999999999997 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 613 (717)
++.++|+|||.+....... .........++..|+|||.+.+ .++.++|||||||++|+|++ |..||.......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~ 230 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230 (288)
T ss_pred CCcEEeccCCccccccCCc-----eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999987542111 1111122335678999999765 47999999999999999998 999986543211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
....... ..... .+..++..+.+++.+||+.+|.+||
T Consensus 231 --~~~~i~~-----------~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 267 (288)
T cd05093 231 --VIECITQ-----------GRVLQ------------------------------RPRTCPKEVYDLMLGCWQREPHMRL 267 (288)
T ss_pred --HHHHHHc-----------CCcCC------------------------------CCCCCCHHHHHHHHHHccCChhhCC
Confidence 0000000 00000 0011245688999999999999999
Q ss_pred CHHHHHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTIRNCF 709 (717)
Q Consensus 694 s~~eil~~l~~i~~~~ 709 (717)
|+.|+++.|+.+....
T Consensus 268 t~~~v~~~l~~~~~~~ 283 (288)
T cd05093 268 NIKEIHSLLQNLAKAS 283 (288)
T ss_pred CHHHHHHHHHHHHHhc
Confidence 9999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.65 Aligned_cols=271 Identities=27% Similarity=0.373 Sum_probs=200.0
Q ss_pred ccc-ccccccCcccccceEEEEe-----CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 389 DNF-SKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 389 ~~y-~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
++| ++.+.||+|+||.||.+.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 355 8999999999999988652 367789999987543 2345678899999999999999999998643 22
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEE
Confidence 4468999999999999999864 3489999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+....... ..........++..|+|||.+. +.++.++|||||||++|+|++|..||......-.......
T Consensus 149 ~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 224 (283)
T cd05080 149 GDFGLAKAVPEGH----EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK 224 (283)
T ss_pred eecccccccCCcc----hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc
Confidence 9999987652111 1011111223566799999965 4589999999999999999999999865422110000000
Q ss_pred Hhc-CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 621 SMA-LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 621 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
... ....+.+..+.... ...+..++..+.+++.+||+.+|++|||+++|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~ 275 (283)
T cd05080 225 QGQMTVVRLIELLERGMR-----------------------------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275 (283)
T ss_pred ccccchhhhhhhhhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHH
Confidence 000 00001111111100 011233467889999999999999999999999
Q ss_pred HHHHHHH
Q 005045 700 NNLKTIR 706 (717)
Q Consensus 700 ~~l~~i~ 706 (717)
+.|+.+.
T Consensus 276 ~~l~~~~ 282 (283)
T cd05080 276 PILKEMH 282 (283)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.88 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=189.8
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||++..+ +++.||+|++.... ......+.+|+++++.++||||+++.+.+ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36899999999999965 78999999986442 33456778899999999999999998884 45568999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 76 y~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 76 YVNGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99999999888654 5689999999999999999999997 9999999999999999999999999998753
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhh
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVM 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 629 (717)
.. .........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... .. .
T Consensus 146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~-----------~ 205 (328)
T cd05593 146 IT-------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF-----------E 205 (328)
T ss_pred CC-------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HH-----------H
Confidence 11 1111233568999999999755 58999999999999999999999996532111 00 0
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHHH
Q 005045 630 DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVNN 701 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~~ 701 (717)
.+...... .+...+..+.+++.+||+.+|++|| ++.|+++.
T Consensus 206 ~~~~~~~~-------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 206 LILMEDIK-------------------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HhccCCcc-------------------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00000000 0011245578899999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.40 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=214.8
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+.+...+.++||+|-||.|.++....+..||+|.++... ...+..|.+|+++|.+++||||+.++++|.. ++.+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePi 610 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPL 610 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCch
Confidence 455678899999999999999998778999999998664 4456899999999999999999999999754 3489
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++|+||++.|+|.+++.++.. +.+.......|+.||+.||+||.+. .+||||+.++|++++.++++||+|||
T Consensus 611 cmI~EYmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence 999999999999999987743 2344455667999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCc-cCCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCchhhhHHHHh
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT--GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~sDvwslG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~ 622 (717)
+++-+. ....+...+...-+..|||||. +.|+++.+||||+||+++||+++ .+.||....++ ...+....
T Consensus 683 msR~ly-----sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~ 755 (807)
T KOG1094|consen 683 MSRNLY-----SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGE 755 (807)
T ss_pred cccccc-----cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhh
Confidence 999652 2233444455667789999999 78999999999999999999887 88999776443 22223222
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
.++..-.+ .-...+.-|+..+.+++.+||..+.++|||++++...|
T Consensus 756 ~~~~~~~~----------------------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 756 FFRDQGRQ----------------------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred hcCCCCcc----------------------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 22221111 11124567899999999999999999999999999887
Q ss_pred HHH
Q 005045 703 KTI 705 (717)
Q Consensus 703 ~~i 705 (717)
...
T Consensus 802 q~~ 804 (807)
T KOG1094|consen 802 QED 804 (807)
T ss_pred HHh
Confidence 653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.80 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=200.5
Q ss_pred ccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+++++.+.|+||+++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 567999999999999999999853 3477999998754333 4578899999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCC-------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAE-------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 533 (717)
.....++||||+++++|.+++...... ......+++..+..++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 345899999999999999998754321 11225688999999999999999999997 99999999999999
Q ss_pred CCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 005045 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFK 611 (717)
Q Consensus 534 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 611 (717)
+.++.++|+|||.+....... .........++..|+|||++.+ .++.++|||||||++|+|++ |..||.....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred cCCCeEEECCcccceecccCc-----ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999987542111 1111223345678999999654 58999999999999999998 9999865432
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
+. ...... ...... .+..++..+.+++.+||+.+|++
T Consensus 231 ~~--~~~~~~-----------~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~ 267 (280)
T cd05049 231 EE--VIECIT-----------QGRLLQ------------------------------RPRTCPSEVYDIMLGCWKRDPQQ 267 (280)
T ss_pred HH--HHHHHH-----------cCCcCC------------------------------CCCCCCHHHHHHHHHHcCCCccc
Confidence 21 111110 000000 01122566889999999999999
Q ss_pred CCCHHHHHHHHH
Q 005045 692 RIAMNVVVNNLK 703 (717)
Q Consensus 692 Rps~~eil~~l~ 703 (717)
|||+.||++.|+
T Consensus 268 Rp~~~eil~~l~ 279 (280)
T cd05049 268 RINIKDIHERLQ 279 (280)
T ss_pred CCCHHHHHHHhh
Confidence 999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.97 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=199.8
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...++|++.+.||+|++|.||+|.+.+++.||+|.+..... ..+.+.+|++++++++||||+++++.+ ...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCe
Confidence 34578999999999999999999987778899999875432 246688899999999999999999985 344578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAG-----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred eeeeecccCCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence 999999999999999875421 4689999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+....... .....+...+..|+|||.+.+ .++.++||||||+++|+|++ |+.||...... .......
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~-- 218 (261)
T cd05068 149 LARVIKEDI------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVD-- 218 (261)
T ss_pred eEEEccCCc------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH--
Confidence 988652110 111111223457999999655 57999999999999999999 99998653211 0100000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
...... .+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus 219 ----------~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 219 ----------QGYRMP-----------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred ----------cCCCCC-----------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 000000 01122556889999999999999999999999997
Q ss_pred H
Q 005045 704 T 704 (717)
Q Consensus 704 ~ 704 (717)
.
T Consensus 260 ~ 260 (261)
T cd05068 260 D 260 (261)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.03 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=201.4
Q ss_pred ccccccCcccccceEEEEeC-CCchhhhHHhHhh----hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 392 SKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+...+||+|+|-+||+|.+. +|-.||--.++.. .++..++|..|+.+|+.|+||||+++|..+++.. .+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 44578999999999999975 7888887666543 3455689999999999999999999999987654 36688
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg 545 (717)
+|+|.+..|+|+.|.++. ++++...++.|++||++||.|||++ ..+|+|||||-+||||+ ..|.|||+|+|
T Consensus 120 ~iTEL~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred eeeecccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence 999999999999999876 6789999999999999999999997 46899999999999998 46899999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+|... ........+|||.|||||+....|...+||||||+++.||.|+..||..-.....-+....+..-|
T Consensus 192 LAtl~---------r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 192 LATLL---------RKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred HHHHh---------hccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 99876 122334478999999999999999999999999999999999999997643332222222222223
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+..+-| .++.+||.+|+.. .++|||+.|+++
T Consensus 263 ~sl~kV~d-----------------------------------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 AALSKVKD-----------------------------------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhhccCC-----------------------------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 33333332 2357899999998 899999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.30 Aligned_cols=339 Identities=25% Similarity=0.393 Sum_probs=178.4
Q ss_pred cEEEcCCCcCc-CCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 13 QDLNLTYNYLS-GKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 13 ~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
+-.|+++|.++ +..|.....++++++|.|...++. .+|..++.+.+|+.|.+++|++. .+-..++.|+.|+.+++.+
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 44566666665 445666666666666666666665 56666666666666666666665 4555556666666666666
Q ss_pred CcCcc-cCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 92 NNLRG-SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 92 n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
|+++. -+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|. .+|..+|..+..|-.|+||+|++. .
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~ 164 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-M 164 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-h
Confidence 66542 24555555666666666666665 45555555566666666666665 666666666666666666666665 3
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+|.....+..|++|+|++|.+...--..+..+++|..|.+++.+-+-..+ |..+..+.+|..+|||.|.+. .+|
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~-----Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI-----PTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC-----CCchhhhhhhhhccccccCCC-cch
Confidence 45555556666666666665543222333344444444444433322211 333444445555555555555 455
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC-CCCcccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG-LIPSSLGNL 329 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l 329 (717)
+.+..+ ++|+.|+||+|+|+ .+........+|+.|+||+|+++ .+|++++++++|+.|.+.+|+++- -+|..++.+
T Consensus 239 ecly~l-~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 239 ECLYKL-RNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred HHHhhh-hhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 555544 24555555555544 23333334444555555555554 445555555555555555554431 124444444
Q ss_pred cccceeecccccccccCCcCccCcCCCceEEeecccC
Q 005045 330 TILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 330 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
.+|+.+..++|++. .+|++++.|..|+.|.|++|.+
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence 44444444444444 4444444444444444444444
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=303.52 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=199.4
Q ss_pred ccccccccccCcccccceEEEEeC----CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|.++ +...||+|.+.... ......+.+|+.++++++||||+++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 467999999999999999999964 24578999876442 33456788999999999999999999984 345
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +|+||||+|+||+++.++.++|+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~ 148 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS 148 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEEC
Confidence 57899999999999999987543 4689999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+....... .........++..|+|||.+.+ .++.++||||||+++|+|++ |..||....... .....
T Consensus 149 dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~ 221 (266)
T cd05033 149 DFGLSRRLEDSE-----ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV 221 (266)
T ss_pred ccchhhcccccc-----cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH
Confidence 999998763111 1111112334678999999764 58999999999999999998 999986532111 10000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. + .... +.+..++..+.+++.+|++.+|++||+++||++
T Consensus 222 ~--------~----~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 222 E--------D----GYRL-----------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred H--------c----CCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 0 0000 001123566889999999999999999999999
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.|+++
T Consensus 261 ~l~~~ 265 (266)
T cd05033 261 TLDKM 265 (266)
T ss_pred HHHhh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=307.10 Aligned_cols=267 Identities=25% Similarity=0.444 Sum_probs=204.8
Q ss_pred cccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|.+.+.||+|++|.||.|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++ .
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 77 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----G 77 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----c
Confidence 3567899999999999999999742 3456888888765555557788999999999999999999985 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
..+..++||||+++++|.+++....... .....+++..+++++.||+.|++|||++ +++||||||+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 154 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNC 154 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence 4557899999999999999986542110 0114589999999999999999999997 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~ 609 (717)
+++.++.++|+|||.+....... .........++..|+|||.+.+ .++.++|||||||++|+|++ |..||...
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEccCCcEEECCCCcccccCCCc-----eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999987542111 1111223446788999999654 57899999999999999999 99998654
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
.... ..... ....... ....++..+.+++.+||+.+|
T Consensus 230 ~~~~--~~~~~-----------~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~P 266 (291)
T cd05094 230 SNTE--VIECI-----------TQGRVLE------------------------------RPRVCPKEVYDIMLGCWQREP 266 (291)
T ss_pred CHHH--HHHHH-----------hCCCCCC------------------------------CCccCCHHHHHHHHHHcccCh
Confidence 3221 10000 0000000 011125568899999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 690 ~~Rps~~eil~~l~~i~~~~ 709 (717)
++|||+++|++.|+++....
T Consensus 267 ~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 267 QQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred hhCcCHHHHHHHHHHHHhhc
Confidence 99999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.41 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=192.1
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.....+|+..++||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++|+||+++++++ ...
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHN 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccC
Confidence 334568899999999999999999965 78999999986432 33456788999999999999999999984 455
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~ 210 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA 210 (353)
T ss_pred CeEEEEEecCCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence 6899999999999886532 345677889999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-----C-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----Q-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
|||.+....... .......|+..|+|||++.. . .+.++|||||||++|||++|+.||......+.
T Consensus 211 DfG~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-- 281 (353)
T PLN00034 211 DFGVSRILAQTM-------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-- 281 (353)
T ss_pred ccccceeccccc-------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--
Confidence 999987652111 11123468999999998642 2 35789999999999999999999973321111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
..... ...... . ......++..+.+++.+||+.+|++|||+.
T Consensus 282 ~~~~~--------~~~~~~-~-----------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 323 (353)
T PLN00034 282 ASLMC--------AICMSQ-P-----------------------------PEAPATASREFRHFISCCLQREPAKRWSAM 323 (353)
T ss_pred HHHHH--------HHhccC-C-----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 00000 000000 0 001122356788999999999999999999
Q ss_pred HHHHH
Q 005045 697 VVVNN 701 (717)
Q Consensus 697 eil~~ 701 (717)
|+++.
T Consensus 324 ell~h 328 (353)
T PLN00034 324 QLLQH 328 (353)
T ss_pred HHhcC
Confidence 99874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=312.57 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=199.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCc----hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..+|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence 457999999999999999999854 344 38999886442 3445778899999999999999999998743
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl 150 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKI 150 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEE
Confidence 24679999999999999987543 4578899999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.++...... .........++..|+|||.+.+ .++.++|||||||++|||++ |..||.+..... ....
T Consensus 151 ~DfG~a~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~ 223 (316)
T cd05108 151 TDFGLAKLLGADE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI 223 (316)
T ss_pred ccccccccccCCC-----cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 9999998652111 1111122234668999999654 58999999999999999998 999986542211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
. ...... ..+..++..+.+++.+||+.+|++|||+.+++
T Consensus 224 ~------------~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 224 L------------EKGERL-----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262 (316)
T ss_pred H------------hCCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1 000000 00112245678899999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 700 NNLKTIRNC 708 (717)
Q Consensus 700 ~~l~~i~~~ 708 (717)
+.+..+...
T Consensus 263 ~~l~~~~~~ 271 (316)
T cd05108 263 IEFSKMARD 271 (316)
T ss_pred HHHHHHHcC
Confidence 999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.06 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=197.2
Q ss_pred ccccccccccCcccccceEEEEeC-C-CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-D-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...|.+.+.+|+|++|.||.|... + ++.||+|.+..........+..|+.+++.++||||+++++.+. ..+..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEE
Confidence 445999999999999999999854 4 6778888776555555567888999999999999999999953 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence 999999999999988753211 114588999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
++....... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .
T Consensus 215 la~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~-------- 279 (478)
T PTZ00267 215 FSKQYSDSV-----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--I-------- 279 (478)
T ss_pred CceecCCcc-----ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--H--------
Confidence 998652111 1112234568999999999755 48999999999999999999999996532110 0
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+..+....... .+..++..+.+++.+||+.+|++|||+.++++
T Consensus 280 ---~~~~~~~~~~~------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 280 ---MQQVLYGKYDP------------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---HHHHHhCCCCC------------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00111100000 00112456788999999999999999999975
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.40 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=198.5
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..++|++.++||+|++|.||.|.+.++..||+|.+..... ....+.+|+++++.++|+||+++++.+. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 4578999999999999999999977666799999875332 2357889999999999999999988742 23579
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ..+++..+..++.|++.||+|+|+. +++||||+|+||+++.++.++|+|||.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCc
Confidence 99999999999999975421 4578999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+....... ........++..|+|||... +.++.++|||||||++|+|++ |..||........ . ..
T Consensus 149 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~-~~----- 215 (262)
T cd05071 149 ARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-L-DQ----- 215 (262)
T ss_pred eeeccccc------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-H-HH-----
Confidence 87652111 11112234567899999964 468999999999999999999 8888865422110 0 00
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
+...... ....+++..+.+++.+|++.+|++|||++++++.|+.
T Consensus 216 -------~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 216 -------VERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -------HhcCCCC-----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0000000 0112235678899999999999999999999999886
Q ss_pred H
Q 005045 705 I 705 (717)
Q Consensus 705 i 705 (717)
.
T Consensus 260 ~ 260 (262)
T cd05071 260 Y 260 (262)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=278.83 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=205.1
Q ss_pred cccccccccccCcccccceEEEE-eCCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+.++|.+.+.+|+|.||.||.|+ .+++-.||+|++.... ......+.+|++|-..++||||+++|++ +-+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 45689999999999999999999 4588889999987553 3345778899999999999999999999 5566
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+++||.++|.++..+..+. ..++++.....++.|+|.|+.|+|.. .|+||||||+|++++..|..||+
T Consensus 95 ~riyLilEya~~gel~k~L~~~~-----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGR-----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcc-----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence 79999999999999999888543 26788999999999999999999996 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+... +.......+||..|.|||..++. ++..+|+|++|+..||++.|.+||.... .+..+.+...
T Consensus 167 dfGwsV~~---------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 167 DFGWSVHA---------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred CCCceeec---------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 99998753 35566778899999999998876 7999999999999999999999997653 1111111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. ++..| ...+....++|++|+..+|.+|.+..|+++.
T Consensus 237 ~-------~~~~p------------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 V-------DLKFP------------------------------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred c-------cccCC------------------------------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0 00111 1114456789999999999999999999864
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=305.68 Aligned_cols=263 Identities=22% Similarity=0.414 Sum_probs=197.5
Q ss_pred cccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
....++|++.+.||+|++|.||.|.++ .++.||+|.+.... ......+.+|+.+++.++||||+++++.+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--- 78 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--- 78 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE---
Confidence 346789999999999999999998743 35679999876432 23345688999999999999999999985
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
......++||||+++++|.+++....... ......++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 79 --~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~ 153 (277)
T cd05062 79 --SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 153 (277)
T ss_pred --cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEc
Confidence 34558899999999999999986532110 0113467888999999999999999997 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.++.++|+|||.+........ ........++..|+|||.+.+ .++.++|||||||++|+|++ |..||......
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~ 228 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228 (277)
T ss_pred CCCCEEECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999875421111 111112235678999999654 58999999999999999999 78888654221
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
. .... ........ .+..++..+.+++.+|++.+|++|
T Consensus 229 ~--~~~~-----------~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05062 229 Q--VLRF-----------VMEGGLLD------------------------------KPDNCPDMLFELMRMCWQYNPKMR 265 (277)
T ss_pred H--HHHH-----------HHcCCcCC------------------------------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 1 1000 00000000 011225568899999999999999
Q ss_pred CCHHHHHHHHH
Q 005045 693 IAMNVVVNNLK 703 (717)
Q Consensus 693 ps~~eil~~l~ 703 (717)
||+.|+++.++
T Consensus 266 ps~~e~l~~l~ 276 (277)
T cd05062 266 PSFLEIISSIK 276 (277)
T ss_pred cCHHHHHHHhh
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.49 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=199.8
Q ss_pred ccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCC
Q 005045 396 LIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSN 474 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~ 474 (717)
++|+|.||+||.|++. +...+|||.+...+.+..+-+.+|+...++++|.|||++++. +.++++.-|.||.+||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs-----~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGS-----VSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhc-----cCCCCeEEEEeecCCC
Confidence 5899999999999966 667799999988777777888999999999999999999999 5566799999999999
Q ss_pred CChhhhccCCCCCccccccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCceEEeeeccchhcc
Q 005045 475 GNLDQWLHPSPAEHYQFKKL--SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLF 551 (717)
Q Consensus 475 ~~L~~~l~~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 551 (717)
|+|.+.++.. ++.+ .+..+-.+.+||++||.|||++ .|||||||-+||+|+ ..|.+||+|||-++++
T Consensus 657 GSLSsLLrsk------WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL- 726 (1226)
T KOG4279|consen 657 GSLSSLLRSK------WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL- 726 (1226)
T ss_pred CcHHHHHHhc------cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh-
Confidence 9999999743 2455 7888889999999999999998 999999999999996 6899999999999887
Q ss_pred cccCCCCCCcceeecccccccccCCCccC-C--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMN-G--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
..-......+.||..|||||++. | .|+.++|||||||++.||-||++||............ ++.
T Consensus 727 ------AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGm------ 793 (1226)
T KOG4279|consen 727 ------AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGM------ 793 (1226)
T ss_pred ------ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcc------
Confidence 34455666788999999999974 3 3899999999999999999999999876433221110 000
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
-+ ..|. .+++-+.+...||.+|+.++|.+||+|+++++
T Consensus 794 yK-vHP~---------------------------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YK-VHPP---------------------------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ee-cCCC---------------------------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 0111 22334556688999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=311.48 Aligned_cols=241 Identities=27% Similarity=0.331 Sum_probs=187.9
Q ss_pred ccccCcccccceEEEEe----CCCchhhhHHhHhhh----hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 394 ENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ----QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++.||+|+||.||+++. .+++.||+|++.... ......+..|+++++.++||||+++++.+ ..++..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 36799999999999984 267889999886432 22345678899999999999999999884 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 145 (323)
T cd05584 76 YLILEYLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG 145 (323)
T ss_pred EEEEeCCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999998754 5578889999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
++...... ........|++.|+|||++.+ .++.++|||||||++|||++|..||.......
T Consensus 146 ~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------- 207 (323)
T cd05584 146 LCKESIHE-------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------- 207 (323)
T ss_pred CCeecccC-------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----------
Confidence 98643111 111223468999999999765 47899999999999999999999996532110
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVV 699 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil 699 (717)
.+..+....... +...+..+.+++.+|++.+|++|| ++.+++
T Consensus 208 --~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 208 --TIDKILKGKLNL-------------------------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred --HHHHHHcCCCCC-------------------------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 011111111110 111245678899999999999999 788877
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 255 ~ 255 (323)
T cd05584 255 S 255 (323)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.00 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=197.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|++|.||+|... +++.||+|++..........+.+|+.++++++||||+++++.+. ..+..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEE
Confidence 3458999999999999999999964 78899999987554444567888999999999999999999853 34588
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 82 ~iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence 9999999999999988644 4578999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
.+...... ........++..|+|||.+. +.++.++||||+||++|+|++|..||....+.....
T Consensus 152 ~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----- 219 (267)
T cd06646 152 VAAKITAT-------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----- 219 (267)
T ss_pred cceeeccc-------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----
Confidence 98765211 11112345788999999863 236789999999999999999999986542211100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+......... .......+..+.+++.+||+.+|++|||+++|++.
T Consensus 220 --------~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 220 --------LMSKSNFQPPK--------------------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --------eeecCCCCCCC--------------------------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000000000 00001124567899999999999999999999875
Q ss_pred H
Q 005045 702 L 702 (717)
Q Consensus 702 l 702 (717)
+
T Consensus 266 l 266 (267)
T cd06646 266 L 266 (267)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.21 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=198.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|+++++.++|+||+++++. +.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence 47999999999999999999965 79999999987542 2345678899999999999999999988 445668
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecC
Confidence 99999999999999998754 4689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCC----------------------CCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh
Q 005045 545 GLAKFLFEISDN----------------------PSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 545 g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt 601 (717)
|.+......... ............|++.|+|||++.+ .++.++|||||||++|+|++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 998765322100 0000112234568999999999765 48999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHhcCChhhhhhcC--CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILD--PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
|..||........ . ..+.. ....... ...++..+.+
T Consensus 226 g~~Pf~~~~~~~~-~------------~~i~~~~~~~~~p~-----------------------------~~~~~~~~~~ 263 (350)
T cd05573 226 GFPPFYSDTLQET-Y------------NKIINWKESLRFPP-----------------------------DPPVSPEAID 263 (350)
T ss_pred CCCCCCCCCHHHH-H------------HHHhccCCcccCCC-----------------------------CCCCCHHHHH
Confidence 9999976431110 0 00000 0000000 0012556788
Q ss_pred HhhccCCCCcCCCCC-HHHHHHH
Q 005045 680 IGLMCSTTSPRERIA-MNVVVNN 701 (717)
Q Consensus 680 li~~cl~~~p~~Rps-~~eil~~ 701 (717)
++.+|++ +|++||+ ++|+++.
T Consensus 264 li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 264 LICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=301.02 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=195.3
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
..+|++.+.||+|++|.||+|.+++++.+|+|++..... ....+.+|+++++.++||||+++++.+ ...+..++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI 76 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence 457899999999999999999987777899998764322 234677899999999999999999985 34457899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||+++++|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 77 VTEYMANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred EEecCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccc
Confidence 999999999999987542 4689999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........++..|+|||.+. +.++.++|||||||++|+|++ |..||......+ ........
T Consensus 148 ~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~-- 217 (256)
T cd05059 148 RYVLDDQ------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAG-- 217 (256)
T ss_pred eeccccc------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcC--
Confidence 7542110 01111122345799999965 458999999999999999999 899986542211 11111000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
.... .+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus 218 ------~~~~---------------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 ------YRLY---------------------------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------CcCC---------------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0000 0112366789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.42 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=166.6
Q ss_pred ccccccccCcccccceEEEEe----CCCchhhhHHhHhhh----hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ----QGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+++++.+ .|++|+++++. +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 588999999999999999884 267889999886432 23346678899999999 59999999888 44
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~k 145 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVV 145 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEE
Confidence 556899999999999999998754 5689999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|+|||++....... ........|+..|+|||++.+. ++.++|||||||++|+|++|..||...
T Consensus 146 l~DfG~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 146 LTDFGLSKEFLSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred EeeCcCCccccccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 99999987542111 1112235689999999997653 688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.96 Aligned_cols=274 Identities=24% Similarity=0.325 Sum_probs=193.8
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKST---RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|++.+.||+|++|.||+|.++ +++.||+|.+.... ......+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999965 78899999886432 12223455677766655 799999999987654444456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||++ +++.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 7899999996 588888865421 4589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH-
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS- 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~- 621 (717)
||.+...... .......++..|+|||++. +.++.++||||+||++|+|++|..||......+. ......
T Consensus 152 fg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~ 222 (288)
T cd07863 152 FGLARIYSCQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDL 222 (288)
T ss_pred cCccccccCc--------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHH
Confidence 9998765211 1112345788999999964 4589999999999999999999999965432211 111110
Q ss_pred hcCCh--hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 622 MALPD--HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 622 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...+. .+.............. .........++++..+.+++.+|++.||++|||+.|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPR-------------------GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCCCChhhCcccccccccccCCC-------------------CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 00100 0000000000000000 00000011123456678999999999999999999997
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
.
T Consensus 284 ~ 284 (288)
T cd07863 284 Q 284 (288)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.76 Aligned_cols=198 Identities=26% Similarity=0.361 Sum_probs=164.8
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCC-ceeEEEEeeccccCCCCce
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHR-NILRVITACSSVDLEGNDF 464 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~~~~ 464 (717)
+|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+..|+++++.+.|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 5889999999999999999965 67889999886542 33456778899999999765 577777773 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeec
Confidence 99999999999999988754 4688999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|++..... .........|++.|+|||++.+. ++.++||||+||++|+|++|+.||...
T Consensus 146 g~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 146 GMCKENIF-------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CcceecCC-------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 98864310 11122345689999999997654 789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.52 Aligned_cols=269 Identities=25% Similarity=0.376 Sum_probs=202.3
Q ss_pred cccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCC-CCceeEEEEee
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTR-HRNILRVITAC 454 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~ 454 (717)
.+....++|++.++||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34455779999999999999999999842 23469999886432 334567899999999995 99999999996
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc----------------------------------------------
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------------------------------------------- 488 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------------- 488 (717)
. +....++||||+++|+|.+++.......
T Consensus 111 ~-----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 111 T-----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 3 4458999999999999998875421100
Q ss_pred -------------------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 489 -------------------------------------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 489 -------------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
.....+++..+..++.||+.|++|||+. +++|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~d 262 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRD 262 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 0013478888999999999999999997 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CC
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GK 603 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~ 603 (717)
|||+||+++.++.+||+|||++....... .........++..|+|||.+.+ .++.++|||||||++|+|++ |.
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDS-----NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccc-----cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999987642111 1111122346678999999654 58999999999999999997 99
Q ss_pred CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhc
Q 005045 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683 (717)
Q Consensus 604 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.||.......... .... ... .. ..+..++..+.+++.+
T Consensus 338 ~P~~~~~~~~~~~-~~~~--------~~~--~~-------------------------------~~~~~~~~~l~~li~~ 375 (400)
T cd05105 338 TPYPGMIVDSTFY-NKIK--------SGY--RM-------------------------------AKPDHATQEVYDIMVK 375 (400)
T ss_pred CCCcccchhHHHH-HHHh--------cCC--CC-------------------------------CCCccCCHHHHHHHHH
Confidence 9986542221110 0000 000 00 0112235678899999
Q ss_pred cCCCCcCCCCCHHHHHHHHHHHH
Q 005045 684 CSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 684 cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
||+.+|++|||+.+|.++|+++.
T Consensus 376 cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 376 CWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HCccCHhHCcCHHHHHHHHHHHc
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.44 Aligned_cols=283 Identities=23% Similarity=0.297 Sum_probs=201.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.++||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++||||+++++.+. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 47999999999999999999965 7888999987654 2334567889999999999999999999853 456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ +++||||+|+||+++.++.+||+|||.
T Consensus 76 lv~ey~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEeeccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCC
Confidence 999999999999999754 56889999999999999999999732 899999999999999999999999998
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||....... ........ .
T Consensus 147 ~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~-~ 214 (308)
T cd06615 147 SGQLIDS---------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRP-V 214 (308)
T ss_pred ccccccc---------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCc-c
Confidence 8654111 1123467889999999765 47899999999999999999999996543211 11111110 0
Q ss_pred hhhhhh---cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 626 DHVMDI---LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 626 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
...... .................+......... .+.. ....++..+.+++.+|++.+|++|||++||++.-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP--PPKL----PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCC--CccC----cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000 000000000011111111111111000 0000 1112456689999999999999999999999764
Q ss_pred H
Q 005045 703 K 703 (717)
Q Consensus 703 ~ 703 (717)
.
T Consensus 289 ~ 289 (308)
T cd06615 289 F 289 (308)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.40 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=189.9
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
+.||+|++|.||+|.++ +++.+|+|.+... .......+.+|+++++.++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 46899999999999965 7889999987543 2344577889999999999999999999854 345789999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 76 ~~~~L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 76 QGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred cCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence 9999999986432 4578999999999999999999997 999999999999999999999999999875421
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhh
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMD 630 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (717)
.. ..........+..|+|||.+.+ .++.++|||||||++|+|++ |..||....... ....
T Consensus 147 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~----------- 208 (252)
T cd05084 147 GV-----YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREA----------- 208 (252)
T ss_pred cc-----ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHH-----------
Confidence 10 0000111123457999999654 58999999999999999998 888886432211 1000
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 631 ILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
+....... .+..++..+.+++.+|++.+|++|||+.|++++|.
T Consensus 209 -~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 -IEQGVRLP-----------------------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -HHcCCCCC-----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00000000 11123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.87 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=195.4
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
++|++.+.||+|++|.||.|.++.+..+|+|.+..... ....+.+|+.++++++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence 57899999999999999999987667799998764332 2366889999999999999999999864 34478999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++++|.+++.... ..+++..++.++.||+.|++|||+. +++|+||+|+||+++.++.+||+|||.+.
T Consensus 78 ~e~~~~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 78 TEYMSNGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEcCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 99999999999987542 3589999999999999999999997 99999999999999999999999999987
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... .........++..|+|||.+.+ .++.++|||||||++|+|++ |..||....... .....
T Consensus 149 ~~~~~------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~------ 214 (256)
T cd05113 149 YVLDD------EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV------ 214 (256)
T ss_pred ecCCC------ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH------
Confidence 54211 1111122345678999999754 58899999999999999999 999986543211 11110
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
........ +...+..+.+++.+||+.+|++|||+.+|++.++
T Consensus 215 -----~~~~~~~~------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 -----SQGLRLYR------------------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----hcCCCCCC------------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00000000 0011456789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.84 Aligned_cols=196 Identities=27% Similarity=0.415 Sum_probs=162.8
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHH---hcCCCCceeEEEEeeccccCCCCc
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNAL---KSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
|++.+.||+|++|.||+|.+. +++.||+|++.... ....+.+..|++++ +.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 778999999999999999965 78999999986442 22345566666654 567899999999984 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||+++++|..++.. ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCc
Confidence 89999999999999888753 3589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||.+..... .........|++.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 145 fg~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 145 FGLCKEGMG-------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred ccCCccCCC-------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 998864311 1111234568999999999765 4789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=293.99 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=210.5
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+..-|.++.++|+|.||.||+|.++ +|+.+|+|.+.... ..+.+..|+.++++++.|++|++|+.++- ...+
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDL 103 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDL 103 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCce
Confidence 4456889999999999999999966 89999999987653 45778899999999999999999999643 3479
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|||||||..|++.|.++.+. +.+++.++..+.+..++||.|||.. .-+|||||+.||+++.+|.+||+|||
T Consensus 104 WIVMEYCGAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG 174 (502)
T ss_pred EeehhhcCCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence 99999999999999998664 7899999999999999999999998 78999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.|-.+ .+........+||+.|||||++.. .|..++||||||++..||..|++||.+..+-... ..+
T Consensus 175 VAGQL-------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMI 241 (502)
T KOG0574|consen 175 VAGQL-------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMI 241 (502)
T ss_pred ccchh-------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------Eec
Confidence 99876 223334445789999999999765 5899999999999999999999999886442110 011
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
| ..+...+.++++-+..+.+|+++|+-..|++|.||.++++.
T Consensus 242 P-----------------------------------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 242 P-----------------------------------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred c-----------------------------------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 11122344667778899999999999999999999998864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.52 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=202.0
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|++++++++.+. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 68999999999999999999976 8999999987632 2334577889999999999999999999853 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++..... ....+++..+..++.+++.|++|||+. |++||||+|+||+++.++.++|+||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence 8999999999999998864321 114578999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+...... ........++..|+|||.+.+ .++.++|||||||++|+|++|..||...............
T Consensus 151 ~~~~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 221 (267)
T cd08224 151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-- 221 (267)
T ss_pred ceeeeccCC-------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh--
Confidence 998754211 111122457888999999655 4889999999999999999999998643211111100000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
....... ....++..+.+++.+||+.+|++|||+.+|++++.
T Consensus 222 ---------~~~~~~~-----------------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 222 ---------KCDYPPL-----------------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred ---------cCCCCCC-----------------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 0000000 01123556789999999999999999999999998
Q ss_pred HHH
Q 005045 704 TIR 706 (717)
Q Consensus 704 ~i~ 706 (717)
.++
T Consensus 264 ~~~ 266 (267)
T cd08224 264 EMH 266 (267)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.82 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=211.5
Q ss_pred ccccccccCcccccceEEEEeC-C---CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-D---GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...+.++||.|.||.|+.|+.+ . ...||||.++... .+++..|..|+.||-+++||||+++.++ ....+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCce
Confidence 4478899999999999999965 3 4469999998663 4567889999999999999999999999 556678
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+||+|||++|+|+.+++.+. +.+++.+...+.++||.||.||-+. +||||||.++||+|+.+-.+|++||
T Consensus 705 vMIiTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccc
Confidence 999999999999999999875 5688888999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|+++.+.+.. .......+..-+..|-|||.+. ++++.+|||||||+||||.++ |..||=++...+
T Consensus 776 GLSRvledd~----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------- 842 (996)
T KOG0196|consen 776 GLSRVLEDDP----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------- 842 (996)
T ss_pred cceeecccCC----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------
Confidence 9999662211 1111222233457899999964 579999999999999999998 999986553322
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
+++..+..+. .+.+.+||..|.+|+..|||+|-.+||.+.+|+..|
T Consensus 843 ---------------------------VIkaIe~gyR-------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 843 ---------------------------VIKAIEQGYR-------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred ---------------------------HHHHHHhccC-------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 1111111111 125678999999999999999999999999999999
Q ss_pred HHHHHH
Q 005045 703 KTIRNC 708 (717)
Q Consensus 703 ~~i~~~ 708 (717)
.++-..
T Consensus 889 DklIrn 894 (996)
T KOG0196|consen 889 DKLIRN 894 (996)
T ss_pred HHHhcC
Confidence 987644
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.43 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=202.2
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+......++|++.+.||+|+||.||.|... +|+.||+|++... .......+.+|+..+..++|+||+++...+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344556789999999999999999999954 7999999998654 2344567889999999999999999877643221
Q ss_pred C---CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 459 L---EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 459 ~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
. ......++||||+++|+|.+++..... ....+++..+..++.|++.||+|+|+. +|+||||||+||+++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 1 111246899999999999999864321 114689999999999999999999997 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
++.+||+|||+++...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||......
T Consensus 179 ~~~vkL~DFGls~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-- 251 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATV-----SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-- 251 (496)
T ss_pred CCCEEEEecccCeeccccc-----cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--
Confidence 9999999999987652211 1112234568999999999765 4899999999999999999999999653211
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
..+. ......... .+..++..+.+++.+||+.+|++|||
T Consensus 252 ---~~~~--------~~~~~~~~~------------------------------~~~~~~~~l~~li~~~L~~dP~~RPs 290 (496)
T PTZ00283 252 ---EVMH--------KTLAGRYDP------------------------------LPPSISPEMQEIVTALLSSDPKRRPS 290 (496)
T ss_pred ---HHHH--------HHhcCCCCC------------------------------CCCCCCHHHHHHHHHHcccChhhCcC
Confidence 1110 111100000 11123556889999999999999999
Q ss_pred HHHHHHH
Q 005045 695 MNVVVNN 701 (717)
Q Consensus 695 ~~eil~~ 701 (717)
+.|+++.
T Consensus 291 ~~ell~~ 297 (496)
T PTZ00283 291 SSKLLNM 297 (496)
T ss_pred HHHHHhC
Confidence 9999864
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.36 Aligned_cols=270 Identities=20% Similarity=0.268 Sum_probs=206.0
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
.+.++.+....++|++.+.||+|++|.||+|..+ +++.+|+|++.... .....+.+|+.+++.+ +||||+++++.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3567788889999999999999999999999965 78899999876432 2235677899999999 7999999999876
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
......++..++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 5444556789999999999999998753211 114678899999999999999999997 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
++.++|+|||.+...... ........|+..|+|||++. ..++.++||||+||++|+|++|+.||...
T Consensus 160 ~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 160 EGGVKLVDFGVSAQLTST-------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CCCEEEccCCceeecccC-------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999998765211 11122345889999999864 23788999999999999999999998654
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
..... . .. . .....+... .+..++..+.+++.+||+.+|
T Consensus 233 ~~~~~-~---~~--~----~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p 271 (286)
T cd06638 233 HPMRA-L---FK--I----PRNPPPTLH-------------------------------QPELWSNEFNDFIRKCLTKDY 271 (286)
T ss_pred chhHH-H---hh--c----cccCCCccc-------------------------------CCCCcCHHHHHHHHHHccCCc
Confidence 22110 0 00 0 000000000 001124457889999999999
Q ss_pred CCCCCHHHHHHHH
Q 005045 690 RERIAMNVVVNNL 702 (717)
Q Consensus 690 ~~Rps~~eil~~l 702 (717)
++|||+.||++..
T Consensus 272 ~~Rps~~ell~~~ 284 (286)
T cd06638 272 EKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCHHHHhhcc
Confidence 9999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.55 Aligned_cols=282 Identities=18% Similarity=0.223 Sum_probs=193.0
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC------CceeEEEEee
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRH------RNILRVITAC 454 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~ 454 (717)
.++....++|++.++||+|+||.||+|.+. .++.||||++.... ........|+++++.+.| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999965 68889999986432 122345567777766644 4588887775
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
. ....+.|+|||++ +++|.+++... ..+++..+..++.||+.||+|||+. .+|+||||||+||+++
T Consensus 201 ~----~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 201 Q----NETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILME 266 (467)
T ss_pred E----cCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEe
Confidence 3 2345789999998 78899888654 5689999999999999999999973 2899999999999998
Q ss_pred CCC----------------ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHH
Q 005045 535 KDM----------------TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLL 597 (717)
Q Consensus 535 ~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ 597 (717)
.++ .+||+|||.+... ........||..|+|||++.+ .++.++|||||||++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~----------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDE----------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccC----------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 665 4999999987542 111234568999999999765 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCch-hhhHHHHhcCChhhhhh---------cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcch
Q 005045 598 EMFTGKRPTGDMFKDDF-SIHMFVSMALPDHVMDI---------LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTK 667 (717)
Q Consensus 598 elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (717)
||++|+.||......+. .........+|..+... ++......+.........+.... ..
T Consensus 337 elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~------- 405 (467)
T PTZ00284 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR----PV------- 405 (467)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhccc----ch-------
Confidence 99999999976432211 11111111223222111 11000000000111111110000 00
Q ss_pred hhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 668 NKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 668 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...-....+.+|+.+||++||++||||+|+++
T Consensus 406 -~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 406 -REVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred -hhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00011346789999999999999999999986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.50 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=201.6
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||+|.. .+++.+++|.+... .......+.+|+++++.+.|+||+++++.+. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 5799999999999999999995 48899999977542 2334567889999999999999999999853 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++..... ....+++..++.++.||+.|++|||+. +++|+||+|+||+++.++.++|+||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence 8999999999999998864211 114689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+...... ........++..|+|||...+ .++.++||||||+++|+|++|..||.....+......
T Consensus 151 g~~~~~~~~-------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----- 218 (267)
T cd08229 151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----- 218 (267)
T ss_pred hhhhccccC-------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-----
Confidence 988754211 111123457889999999755 4789999999999999999999998653222111100
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.+.....+.. ....++..+.+++.+||+.+|++||||.+|++.++
T Consensus 219 ---~~~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 219 ---KIEQCDYPPL--------------------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred ---hhhcCCCCCC--------------------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 0000000100 01123567889999999999999999999999998
Q ss_pred HHH
Q 005045 704 TIR 706 (717)
Q Consensus 704 ~i~ 706 (717)
++.
T Consensus 264 ~~~ 266 (267)
T cd08229 264 RMH 266 (267)
T ss_pred hhc
Confidence 763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=279.51 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=196.8
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--------hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--------QQGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
.+.|.-.+.+|.|..+.|-++.++ +|+.+|+|++... ..+..+.-..|+.|++++ .||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 456788899999999999999865 8888999988532 123355667899999998 89999999999
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
++.+.+.++|+|.|+.|-|.|++... -.+++.+.++||+|+..|+.|||.. .|||||+||+||+++++.
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNM 160 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecccc
Confidence 55566999999999999999999865 6789999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-------CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-------QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
++||+|||.++.+. ....-...+||++|.|||.+.. .|+..+|+||+||++|.|+.|.+||---
T Consensus 161 ~i~isDFGFa~~l~--------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR- 231 (411)
T KOG0599|consen 161 NIKISDFGFACQLE--------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR- 231 (411)
T ss_pred ceEEeccceeeccC--------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-
Confidence 99999999999872 1122345779999999999642 3788899999999999999999998310
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
...... +-+..-... .+ .+.=++.+....++|.+|++.||.
T Consensus 232 -kQmlML-----------R~ImeGkyq----F~-----------------------speWadis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 232 -KQMLML-----------RMIMEGKYQ----FR-----------------------SPEWADISATVKDLISRLLQVDPT 272 (411)
T ss_pred -HHHHHH-----------HHHHhcccc----cC-----------------------CcchhhccccHHHHHHHHHeeCch
Confidence 000000 000000000 00 001123355578999999999999
Q ss_pred CCCCHHHHHHH
Q 005045 691 ERIAMNVVVNN 701 (717)
Q Consensus 691 ~Rps~~eil~~ 701 (717)
.|.|++|+++.
T Consensus 273 ~Ritake~LaH 283 (411)
T KOG0599|consen 273 KRITAKEALAH 283 (411)
T ss_pred hcccHHHHhcC
Confidence 99999999964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=310.52 Aligned_cols=273 Identities=21% Similarity=0.306 Sum_probs=195.8
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.++||+|+||.||+|.++ +++.||+|.+.... ......+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 57999999999999999999965 78889999886443 223356778999999999999999999853 455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||++ +++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred EEEeCCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccc
Confidence 9999996 58888876442 4578899999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH---
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS--- 621 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--- 621 (717)
+...... ........++..|+|||++.+ .++.++|||||||++|+|++|+.||......+. ......
T Consensus 151 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~ 222 (309)
T cd07872 151 ARAKSVP-------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLG 222 (309)
T ss_pred ceecCCC-------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Confidence 8753111 111123457889999999644 478999999999999999999999976533221 111110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...+..+..+..... +.. ..................+..+.+++.+|++.+|++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~-------------~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 223 TPTEETWPGISSNDE-------------FKN---YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCHHHHhhhcchhh-------------hhh---hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 001111111110000 000 000000000000111223556789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.58 Aligned_cols=206 Identities=23% Similarity=0.361 Sum_probs=170.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999965 78999999987542 33456788999999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+|.++|+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeec
Confidence 99999999999999998754 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCC-------------------------------cceeecccccccccCCCccCC-CCCcccchhhH
Q 005045 545 GLAKFLFEISDNPSKN-------------------------------QTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSY 592 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwsl 592 (717)
|++..+.......... ........||+.|+|||++.+ .++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987542211000000 000112458999999999654 58999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 005045 593 GILLLEMFTGKRPTGDM 609 (717)
Q Consensus 593 G~vl~elltg~~p~~~~ 609 (717)
||++|+|++|..||...
T Consensus 226 G~il~el~~G~~Pf~~~ 242 (364)
T cd05599 226 GVIMYEMLVGYPPFCSD 242 (364)
T ss_pred hhHHHHhhcCCCCCCCC
Confidence 99999999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=323.18 Aligned_cols=276 Identities=23% Similarity=0.292 Sum_probs=192.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC---CCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL---EGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~ 462 (717)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+|+.+++.++||||+++++++....+ ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999964 78899999875332 233469999999999999999887543221 223
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHV 541 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl 541 (717)
...++||||++ +++.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 35789999996 577776643211 115689999999999999999999997 999999999999999665 7999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|||+++..... .......|++.|+|||++.+ .++.++|||||||++|||++|.+||.+....+. +...
T Consensus 213 ~DFGla~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i 283 (440)
T PTZ00036 213 CDFGSAKNLLAG--------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRI 283 (440)
T ss_pred eccccchhccCC--------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 999999865211 11223567899999999654 489999999999999999999999976432211 1111
Q ss_pred HHh-cCC--hhhhhhcCCCCCC--CCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 620 VSM-ALP--DHVMDILDPSMPL--DEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 620 ~~~-~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
... .-+ +.+.. ..+.... .+......... ..+...+.++.+|+.+||+++|.+|||
T Consensus 284 ~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~l~~------------------~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 284 IQVLGTPTEDQLKE-MNPNYADIKFPDVKPKDLKK------------------VFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred HHHhCCCCHHHHHH-hchhhhcccCCccCchhHHH------------------HhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 110 000 00100 0000000 00000000000 001122456889999999999999999
Q ss_pred HHHHHHH
Q 005045 695 MNVVVNN 701 (717)
Q Consensus 695 ~~eil~~ 701 (717)
+.|+++.
T Consensus 345 a~e~l~h 351 (440)
T PTZ00036 345 PIEALAD 351 (440)
T ss_pred HHHHhCC
Confidence 9999843
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.22 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+.....+|++.+.+|+|++|.||+|... +++.|++|.+..........+.+|+.+++.+.|+||+++++.+. ..
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~ 89 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eC
Confidence 4455679999999999999999999954 78899999887655445577889999999999999999999854 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~ 158 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEC
Confidence 589999999999999999863 3468889999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... ........+++.|+|||.+.+ .++.++|||||||++|+|++|..||........ ......
T Consensus 159 dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~ 230 (296)
T cd06654 159 DFGFCAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT 230 (296)
T ss_pred ccccchhcccc-------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc
Confidence 99988754211 111122457889999999655 478999999999999999999999965432111 000000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.. .+... .+.+.+..+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~---------~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 NG---------TPELQ-------------------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC---------CCCCC-------------------------------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 00000 011224567889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=313.19 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=188.4
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||+|... +|+.||+|++.... ......+..|+++++.++||||+++.+.+ ...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46899999999999964 78999999986542 23346677899999999999999998884 44568999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++... ..+++..+..++.||+.||+|||+. ++|+||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99999999888654 5689999999999999999999973 29999999999999999999999999998643
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhh
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVM 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 629 (717)
.. .........|++.|+|||++.+ .++.++|||||||++|+|++|..||.....+. ...
T Consensus 147 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~----------- 206 (325)
T cd05594 147 IK-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----------- 206 (325)
T ss_pred CC-------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHH-----------
Confidence 11 1111223568999999999755 58999999999999999999999996532211 000
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHHH
Q 005045 630 DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVNN 701 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~~ 701 (717)
.+...... .+...+..+.+++.+||+.+|++|+ +++|+++.
T Consensus 207 ~i~~~~~~-------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 207 LILMEEIR-------------------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhcCCCC-------------------------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00000000 0011245578899999999999996 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.11 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=198.2
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...++|++.++||+|++|.||.|..+.+..+|+|.+..... ....+.+|+.++++++|++++++++.+. ....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCc
Confidence 34568999999999999999999988788899998875433 2356889999999999999999998742 2357
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+++|||+++++|.+++..... ..+++..++.++.+++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCce
Confidence 899999999999999875421 4589999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+....... ........++..|+|||... +.++.++||||||+++|+|++ |..||......+ ......
T Consensus 148 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~-- 217 (260)
T cd05070 148 LARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVE-- 217 (260)
T ss_pred eeeeccCcc------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH--
Confidence 987642111 11111223556799999964 458999999999999999999 889986532111 111110
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
...... .+..++..+.+++.+|++.+|++|||++++.+.|+
T Consensus 218 ----------~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 218 ----------RGYRMP-----------------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred ----------cCCCCC-----------------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 000000 01122556889999999999999999999999887
Q ss_pred H
Q 005045 704 T 704 (717)
Q Consensus 704 ~ 704 (717)
.
T Consensus 259 ~ 259 (260)
T cd05070 259 D 259 (260)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.45 Aligned_cols=268 Identities=24% Similarity=0.425 Sum_probs=202.4
Q ss_pred cccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEee
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITAC 454 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~ 454 (717)
++....++|++.+.||+|++|.||++... ....+|+|.+.... .+....+.+|+++++++ +|+||+++++.+
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556778999999999999999999853 23578999887432 23446688999999999 899999999985
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
. ..+..+++|||+++++|.+++....... .....+++..+++++.|++.|++|||+. +++|||
T Consensus 86 ~-----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~d 157 (293)
T cd05053 86 T-----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRD 157 (293)
T ss_pred c-----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence 3 3457899999999999999986432100 1225689999999999999999999997 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CC
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GK 603 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~ 603 (717)
|||+||+++.++.+||+|||.+..+..... ........++..|+|||...+ .++.++|||||||++|++++ |.
T Consensus 158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 158 LAARNVLVTEDHVMKIADFGLARDIHHIDY-----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred cceeeEEEcCCCeEEeCccccccccccccc-----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence 999999999999999999999986522111 111112234567999999654 58999999999999999998 99
Q ss_pred CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhc
Q 005045 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683 (717)
Q Consensus 604 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.||....... .... +...... ..+..++..+.+++.+
T Consensus 233 ~p~~~~~~~~--~~~~------------~~~~~~~-----------------------------~~~~~~~~~~~~li~~ 269 (293)
T cd05053 233 SPYPGIPVEE--LFKL------------LKEGYRM-----------------------------EKPQNCTQELYHLMRD 269 (293)
T ss_pred CCCCCCCHHH--HHHH------------HHcCCcC-----------------------------CCCCCCCHHHHHHHHH
Confidence 9986532111 0000 0000000 0111235568899999
Q ss_pred cCCCCcCCCCCHHHHHHHHHHHH
Q 005045 684 CSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 684 cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
|++.+|++||||+|+++.|+.+.
T Consensus 270 ~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 270 CWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HcccCcccCcCHHHHHHHHHHhh
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.37 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=199.3
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
+.+.....++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-- 112 (370)
T cd05596 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-- 112 (370)
T ss_pred hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--
Confidence 4455566789999999999999999999965 78899999886432 23345678899999999999999999884
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.++...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~ 178 (370)
T cd05596 113 ---QDDKYLYMVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 178 (370)
T ss_pred ---ecCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCC
Confidence 455689999999999999998864 3478888999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+.+||+|||.+...... .........|++.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus 179 ~~~kL~DfG~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 179 GHLKLADFGTCMKMDAN------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CCEEEEeccceeeccCC------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 99999999998764211 1111223568999999999643 378999999999999999999999975422
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
.. . ...+.+....... +.....+..+.+++.+|++.+|.+
T Consensus 253 ~~--~-----------~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~~p~r 292 (370)
T cd05596 253 VG--T-----------YSKIMDHKNSLTF---------------------------PDDIEISKQAKDLICAFLTDREVR 292 (370)
T ss_pred HH--H-----------HHHHHcCCCcCCC---------------------------CCcCCCCHHHHHHHHHHccChhhc
Confidence 10 0 0111110000000 000112456788999999999987
Q ss_pred --CCCHHHHHHH
Q 005045 692 --RIAMNVVVNN 701 (717)
Q Consensus 692 --Rps~~eil~~ 701 (717)
|||+.|+++.
T Consensus 293 ~~R~s~~ell~h 304 (370)
T cd05596 293 LGRNGVDEIKSH 304 (370)
T ss_pred cCCCCHHHHhcC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.66 Aligned_cols=202 Identities=28% Similarity=0.310 Sum_probs=166.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4679999999999999999999965 7899999998643 2334567789999999999999999999864322 1223
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||++ +++.+.+. ..++...+..++.||+.||+|||+. +|+||||||+||+++.+|.+||+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 45799999996 46766654 3478888999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+..... ........++..|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 166 Dfg~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 166 DFGLARTACT--------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cCCCcccccc--------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999875411 111223468899999999765 5899999999999999999999999765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.44 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=197.6
Q ss_pred ccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|.+.+.||+|++|.||.|.+. .+..|++|...... ......+..|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-- 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--
Confidence 35678999999999999999999964 35678899876443 3334668889999999999999999998543
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM- 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~- 537 (717)
....++||||+++++|.+++............+++..++.++.||+.|++|||+. +++||||+|+||+++.++
T Consensus 81 ---~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 81 ---RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred ---CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCC
Confidence 3467999999999999999875532222224689999999999999999999997 999999999999998655
Q ss_pred --ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 005045 538 --TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613 (717)
Q Consensus 538 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 613 (717)
.+||+|||.+....... ..........+..|+|||++. +.++.++|||||||++|+|++ |..||.......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~ 229 (277)
T cd05036 155 GRVAKIADFGMARDIYRAS-----YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229 (277)
T ss_pred CcceEeccCccccccCCcc-----ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 69999999988652111 011111222356799999964 568999999999999999997 999987542211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
.... +....... .+..++..+.+++.+|++.+|++||
T Consensus 230 --~~~~------------~~~~~~~~-----------------------------~~~~~~~~~~~~i~~cl~~~p~~Rp 266 (277)
T cd05036 230 --VMEF------------VTGGGRLD-----------------------------PPKGCPGPVYRIMTDCWQHTPEDRP 266 (277)
T ss_pred --HHHH------------HHcCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCc
Confidence 1111 10000000 0112255688999999999999999
Q ss_pred CHHHHHHHHH
Q 005045 694 AMNVVVNNLK 703 (717)
Q Consensus 694 s~~eil~~l~ 703 (717)
|+.||++.|.
T Consensus 267 s~~~vl~~l~ 276 (277)
T cd05036 267 NFATILERIQ 276 (277)
T ss_pred CHHHHHHHhh
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.06 Aligned_cols=193 Identities=28% Similarity=0.409 Sum_probs=162.0
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
++||+|+||.||+|+.+ +++.||+|++.... ......+..|.++++.+ +||+|+++++++ ...+..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46899999999999965 68899999987542 23445677888888866 899999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 E~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 76 EYVNGGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 999999999988754 5688999999999999999999998 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 146 GIL-------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ccc-------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 311 1111233568999999999765 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.84 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=197.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCc---hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT---IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|+..+.||+|++|.||+|..+ +++ .+++|.+... .....+.+..|++++++++|+|++++.+.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 568899999999999999999965 333 6888888644 233456788999999999999999999985 344
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 149 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVS 149 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEEC
Confidence 57899999999999999986532 4688999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+........ ..........+..|+|||++.+ .++.++|||||||++|+|++ |..||......+ .....
T Consensus 150 dfg~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i 223 (268)
T cd05063 150 DFGLSRVLEDDPE----GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAI 223 (268)
T ss_pred CCccceecccccc----cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHH
Confidence 9999876522111 0111111223457999999654 58899999999999999998 999986432211 11110
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..... +...+++..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~------------~~~~~-----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 224 N------------DGFRL-----------------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred h------------cCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 00000 011123566789999999999999999999999
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.|+++
T Consensus 263 ~l~~~ 267 (268)
T cd05063 263 LLDKL 267 (268)
T ss_pred HHHhh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.50 Aligned_cols=205 Identities=22% Similarity=0.358 Sum_probs=169.2
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.|++++.||+|+||.||+|+.. +++.||+|++.... ......+..|++++++++|+||+++++.+ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 6889999999999999999954 78899999986532 33456788999999999999999999995 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence 9999999999999998754 5688999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCC----------------------------------------CCCcceeecccccccccCCCccCC-CCC
Q 005045 546 LAKFLFEISDNP----------------------------------------SKNQTVSIGLKGSIGYIPPEHMNG-QVS 584 (717)
Q Consensus 546 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 584 (717)
++.......... ...........||..|+|||++.+ .++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 875431100000 000001123569999999999655 489
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCC
Q 005045 585 ILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 585 ~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.++|||||||++|||++|..||...
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCC
Confidence 9999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.63 Aligned_cols=193 Identities=29% Similarity=0.420 Sum_probs=161.7
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+.+ +++.||+|++.... ......+..|..+++.. .||||+++++++ ...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46899999999999965 78899999886432 23456677888888876 799999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 76 Ey~~~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 76 EFVNGGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred cCCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 999999999988754 5689999999999999999999997 999999999999999999999999999864
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 146 GIF-------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cCc-------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 311 1111223568999999999765 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.32 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=196.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+.||+|++|.||.|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+ ...+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence 458999999999999999999954 7889999998765444456678899999999999999999985 3445899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++... +.+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.
T Consensus 83 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EEEeccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccee
Confidence 999999999999998654 5689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
+..... .........|+..|+|||++. +.++.++|||||||++|+|++|..||....+..... .....
T Consensus 153 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~ 224 (267)
T cd06645 153 SAQITA-------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKS 224 (267)
T ss_pred eeEccC-------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhcc
Confidence 875421 111122346889999999862 347899999999999999999999986543211100 00000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ..+... ....++..+.+++.+|++.+|++|||++||++
T Consensus 225 ~~-------~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 NF-------QPPKLK-------------------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CC-------CCCccc-------------------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 000000 00012345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.66 Aligned_cols=256 Identities=25% Similarity=0.458 Sum_probs=200.0
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
....++|++.++||+|++|.||+|..++++.||+|.+...... ...+.+|+.++++++|+||+++++.+. .+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT------QEP 74 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc------cCC
Confidence 3456789999999999999999999888899999988754332 367889999999999999999988742 246
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccC
Confidence 8999999999999999865421 4688999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+...... .........++..|+|||++.+ .++.++|||||||++|++++ |..||....... .......
T Consensus 147 g~~~~~~~~------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~ 218 (260)
T cd05067 147 GLARLIEDN------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLER 218 (260)
T ss_pred cceeecCCC------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHc
Confidence 998765211 1111122345678999999654 57899999999999999999 999997542211 1111100
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
.. ... .+..++.++.+++.+|++.+|++|||++++++.|
T Consensus 219 ~~--------~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 219 GY--------RMP---------------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred CC--------CCC---------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 00 000 0111245688999999999999999999999998
Q ss_pred HH
Q 005045 703 KT 704 (717)
Q Consensus 703 ~~ 704 (717)
+.
T Consensus 258 ~~ 259 (260)
T cd05067 258 ED 259 (260)
T ss_pred hc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.51 Aligned_cols=193 Identities=26% Similarity=0.402 Sum_probs=162.9
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|.++ +++.||+|+++... ......+..|..+++.+ +||||+++++++ ......|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46899999999999965 78899999987542 23456678899999988 799999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 e~~~~g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 76 EFVSGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999999999888654 5689999999999999999999997 999999999999999999999999999864
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|+..|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 146 GIR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred ccc-------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 211 1112223568999999999765 4789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.15 Aligned_cols=206 Identities=23% Similarity=0.342 Sum_probs=169.3
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++|+||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 47999999999999999999965 78999999886432 23356688999999999999999999884 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999754 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCC------------------------------------CCCCcceeecccccccccCCCccCC-CCCccc
Q 005045 545 GLAKFLFEISDN------------------------------------PSKNQTVSIGLKGSIGYIPPEHMNG-QVSILG 587 (717)
Q Consensus 545 g~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~s 587 (717)
|++..+...... ............||+.|+|||++.+ .++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 997532100000 0000001123569999999999765 489999
Q ss_pred chhhHHHHHHHHHhCCCCCCCC
Q 005045 588 DIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 588 DvwslG~vl~elltg~~p~~~~ 609 (717)
|||||||++|+|++|+.||...
T Consensus 226 DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.98 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=200.7
Q ss_pred cccccccccccCcccccceEEEEeCC----CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD----GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...+|++.+.||+|++|.||.|.+.+ ...|++|...... ....+.+.+|+.+++++.||||+++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 45678999999999999999998542 2468888887554 4456788999999999999999999998632
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
...++||||+++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEE
Confidence 35689999999999999997542 4589999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+....... ........++..|+|||.+.+ .++.++|||||||++|++++ |..||......+.. ..
T Consensus 149 ~d~g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~ 220 (270)
T cd05056 149 GDFGLSRYLEDES------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GR 220 (270)
T ss_pred ccCceeeeccccc------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH
Confidence 9999987652211 011112234567999999654 47899999999999999996 99999655322111 11
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... . .. ..+..++..+.+++.+|+.++|++|||+.|++
T Consensus 221 ~~~~--------~--~~-------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~ 259 (270)
T cd05056 221 IENG--------E--RL-------------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259 (270)
T ss_pred HHcC--------C--cC-------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 0000 0 00 01122356788999999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 700 NNLKTIRNC 708 (717)
Q Consensus 700 ~~l~~i~~~ 708 (717)
+.|++++.+
T Consensus 260 ~~l~~~~~~ 268 (270)
T cd05056 260 AQLSDILQE 268 (270)
T ss_pred HHHHHHHhc
Confidence 999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.90 Aligned_cols=269 Identities=22% Similarity=0.398 Sum_probs=205.8
Q ss_pred cccccccccccccCcccccceEEEEeCC-----CchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGD-----GTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
....++|++.+.||+|+||.||.|.+.. +..|++|.+... .......+.+|+.+++.+.|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--- 78 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI--- 78 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---
Confidence 3456789999999999999999999654 678999987643 2344577889999999999999999999874
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCC-cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAE-HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
..+...++++||+++++|.+++...... ......+++..+..++.|++.|++|||+. +++||||+|+||+++.++
T Consensus 79 -~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 79 -EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154 (280)
T ss_pred -cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCC
Confidence 3345789999999999999998653211 00114589999999999999999999997 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 615 (717)
.+||+|||+++.+..... ........++..|+|||++.+ .++.++|||||||++|++++ |+.||...... .
T Consensus 155 ~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~ 227 (280)
T cd05043 155 QVKITDNALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--E 227 (280)
T ss_pred cEEECCCCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--H
Confidence 999999999976522111 111112335678999999654 47999999999999999999 99999654221 1
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
...+..... ... ....++..+.+++.+||+.+|++|||+
T Consensus 228 ~~~~~~~~~--------~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 228 MAAYLKDGY--------RLA---------------------------------QPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred HHHHHHcCC--------CCC---------------------------------CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 111111000 000 011235567899999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 005045 696 NVVVNNLKTIRNC 708 (717)
Q Consensus 696 ~eil~~l~~i~~~ 708 (717)
.|+++.|+.+.++
T Consensus 267 ~~~~~~l~~~~~~ 279 (280)
T cd05043 267 SQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHHHHHHHhc
Confidence 9999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.49 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=187.1
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||+|+||.||+++.+ +|+.||+|.+.... ......+..|++++++++||||+++.+.+ ..+.+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999965 78999999886432 12234556799999999999999998884 4456899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++..... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 76 ~g~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 76 NGGDLKYHIYNVGE-----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred CCCCHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 99999988764421 4578899999999999999999997 999999999999999999999999999876521
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
........|+..|+|||++.+ .++.++||||+||++|+|++|..||....... ...... ...
T Consensus 148 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~--------~~~ 210 (277)
T cd05607 148 --------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELK--------RRT 210 (277)
T ss_pred --------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHH--------HHh
Confidence 111223458899999999654 48999999999999999999999996542211 000000 001
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
+...... ....++.++.+++.+||+.+|++||+++|+++.+.
T Consensus 211 ~~~~~~~------------------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 211 LEDEVKF------------------------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred hcccccc------------------------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1101000 00112456789999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.38 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=193.8
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4889999999999999999964 78999999886432 22335577899999999999999999884 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999988764321 4589999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+..... ........|+..|+|||++.+ .++.++||||+||++|+|++|..||........ . ....
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~-~~~~--- 214 (285)
T cd05605 148 LAVEIPE--------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-R-EEVE--- 214 (285)
T ss_pred CceecCC--------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-H-HHHH---
Confidence 9875411 011123458899999999654 588999999999999999999999975322110 0 0000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVV 699 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil 699 (717)
..+..... ..+...+..+.+++.+||+.+|++|| ++++++
T Consensus 215 -----~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 215 -----RRVKEDQE------------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred -----HHhhhccc------------------------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 00000000 01122355678999999999999999 888887
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 260 ~~ 261 (285)
T cd05605 260 AH 261 (285)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.43 Aligned_cols=206 Identities=23% Similarity=0.370 Sum_probs=170.9
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|+.++.+++|++|+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47999999999999999999965 78999999986432 33456788899999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeec
Confidence 99999999999999998754 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCC----------------------------CCcceeecccccccccCCCccCC-CCCcccchhhHHHH
Q 005045 545 GLAKFLFEISDNPS----------------------------KNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGIL 595 (717)
Q Consensus 545 g~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~v 595 (717)
|++........... ..........||+.|+|||++.+ .++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 99875422110000 00000123569999999999655 58999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 005045 596 LLEMFTGKRPTGDM 609 (717)
Q Consensus 596 l~elltg~~p~~~~ 609 (717)
+|||++|..||...
T Consensus 226 l~ell~G~~Pf~~~ 239 (363)
T cd05628 226 MYEMLIGYPPFCSE 239 (363)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=299.04 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=196.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCc----hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......+..|+..++++.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------ 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------ 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------
Confidence 357899999999999999999964 454 47777775332 233466778888999999999999999853
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++++||+++++|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl 150 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQI 150 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEE
Confidence 235689999999999999997542 4689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.++...... .........++..|+|||.+. +.++.++|||||||++||+++ |..||.+..... ..
T Consensus 151 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~-- 221 (279)
T cd05111 151 ADFGVADLLYPDD-----KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VP-- 221 (279)
T ss_pred cCCccceeccCCC-----cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH--
Confidence 9999997652111 111122344677899999964 568999999999999999998 999986542211 11
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+.+....... .+..|+..+.+++.+||+.+|++|||+.|++
T Consensus 222 ----------~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~ 262 (279)
T cd05111 222 ----------DLLEKGERLA-----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELA 262 (279)
T ss_pred ----------HHHHCCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 1111000000 0011234567899999999999999999999
Q ss_pred HHHHHHHH
Q 005045 700 NNLKTIRN 707 (717)
Q Consensus 700 ~~l~~i~~ 707 (717)
+.+..+.+
T Consensus 263 ~~l~~~~~ 270 (279)
T cd05111 263 NEFTRMAR 270 (279)
T ss_pred HHHHHHHh
Confidence 99988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=298.64 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=187.8
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||+|+||.||.+.++ +++.||+|.+.... ......+..|+++++.++|++|+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999965 78899999986442 22335677899999999999999998884 4456899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.+.....
T Consensus 76 ~~g~L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 76 NGGDLRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 99999887743211 114689999999999999999999997 999999999999999999999999999875421
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
. ........|++.|+|||++.+ .++.++|||||||++|+|++|+.||........ ..... ...
T Consensus 150 ~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~--------~~~ 213 (280)
T cd05608 150 G-------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK--------QRI 213 (280)
T ss_pred C-------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHH--------Hhh
Confidence 1 111223568899999999655 588999999999999999999999975422110 00000 000
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVNN 701 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~~ 701 (717)
...... .+..++..+.+++.+||+.+|++|| +++|+++.
T Consensus 214 ~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 LNDSVT-------------------------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCC-------------------------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 000000 1112356678999999999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.60 Aligned_cols=207 Identities=23% Similarity=0.348 Sum_probs=173.0
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
+..+....++|++.+.||+|+||.||+|.++ +++.||+|++... .......+.+|+.+++.++||||+++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-- 112 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 3445566789999999999999999999965 6888999987542 222345678899999999999999999984
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.++...|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~ 178 (370)
T cd05621 113 ---QDDKYLYMVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKH 178 (370)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC
Confidence 455689999999999999999864 3478889999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+.+||+|||.+...... .........||+.|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 179 ~~~kL~DFG~a~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 179 GHLKLADFGTCMKMDET------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred CCEEEEecccceecccC------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 99999999998765211 1111234569999999999653 2688999999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.39 Aligned_cols=249 Identities=31% Similarity=0.524 Sum_probs=187.5
Q ss_pred cccccCcccccceEEEEeC-----CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 393 KENLIGTGSFGSVYKGTLG-----DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||+++++++. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 5678999999999999965 36679999996542 334788999999999999999999999975 334689
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++|+|.+++..... ..+++..+..|+.||+.||+|||+. +++||+|+++||+++.++.+||+|||.
T Consensus 78 lv~e~~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 99999999999999986511 5689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+...... ..............|+|||.+.+ .++.++||||||+++||+++ |..||....... ........
T Consensus 150 ~~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~~~- 221 (259)
T PF07714_consen 150 SRPISEK-----SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLKQG- 221 (259)
T ss_dssp GEETTTS-----SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHHTT-
T ss_pred ccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc-
Confidence 8765111 11122223346778999999754 48999999999999999999 788986542211 11111000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
. ..+.+..++..+.+++.+||..+|++|||++||++.|
T Consensus 222 ----------~------------------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 ----------Q------------------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----------E------------------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----------c------------------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 0011223466788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.18 Aligned_cols=192 Identities=26% Similarity=0.401 Sum_probs=161.6
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+.+ +++.||+|++... .......+..|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46899999999999965 7889999998754 233456677888888877 899999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 E~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 76 EYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 999999999888654 5689999999999999999999997 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 146 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 146 GLRP-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCC-------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 3111 111223568999999999765 478999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.34 Aligned_cols=263 Identities=24% Similarity=0.426 Sum_probs=198.0
Q ss_pred cccccccCcccccceEEEEeC----CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCCc
Q 005045 391 FSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGND 463 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~~ 463 (717)
|.+.+.+|+|+||.||.|... .+..||+|.++... ......+..|++.++.++||||+++++.+..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 578899999999999999854 24679999887542 2345678899999999999999999998654331 2334
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+++|||+++++|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 579999999999999888543211 1124689999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||.++........ .......++..|+|||.+.+ .++.++|||||||++|||++ |..||....... ......
T Consensus 157 fg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~ 229 (273)
T cd05035 157 FGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLR 229 (273)
T ss_pred ccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence 9998865222111 11111234668999999755 48999999999999999999 888986542211 111110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+..... .+..++..+.+++.+||+.+|.+|||+.|+++.
T Consensus 230 -----------~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 230 -----------HGNRLK------------------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------cCCCCC------------------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000 112235678899999999999999999999999
Q ss_pred HHHH
Q 005045 702 LKTI 705 (717)
Q Consensus 702 l~~i 705 (717)
|+++
T Consensus 269 l~~~ 272 (273)
T cd05035 269 LENI 272 (273)
T ss_pred HHhh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.38 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=200.6
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
+......|++++.||+||.+.||++...+.+.+|+|.+... +......|.+|+..|.++ .|.+|++++++- -
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v 430 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----V 430 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----c
Confidence 34457789999999999999999999877788888877643 566678899999999999 689999999994 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.++.+|+||||= ..+|..+++... ..++...++.+-.||+.|+.++|.+ ||||.||||.|+++ -.|.+|
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~------~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LK 499 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKK------SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLK 499 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEE
Confidence 356999999974 579999998653 3344347889999999999999998 99999999999998 468999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------------CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------------QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
|+|||.|..+. ...........+||+.||+||.+.. +++.++|||||||+||+|+.|+.||..
T Consensus 500 LIDFGIA~aI~-----~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 500 LIDFGIANAIQ-----PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred eeeechhcccC-----ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 99999998762 2233445566789999999998521 258899999999999999999999965
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
... .-..+..+.++.....+.. ... ..++.++++.||++|
T Consensus 575 ~~n------------~~aKl~aI~~P~~~Iefp~---------------------~~~-------~~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 575 IIN------------QIAKLHAITDPNHEIEFPD---------------------IPE-------NDELIDVMKCCLARD 614 (677)
T ss_pred HHH------------HHHHHHhhcCCCccccccC---------------------CCC-------chHHHHHHHHHHhcC
Confidence 311 1122444455533221100 000 223889999999999
Q ss_pred cCCCCCHHHHHH
Q 005045 689 PRERIAMNVVVN 700 (717)
Q Consensus 689 p~~Rps~~eil~ 700 (717)
|.+|||+.|+++
T Consensus 615 PkkR~si~eLLq 626 (677)
T KOG0596|consen 615 PKKRWSIPELLQ 626 (677)
T ss_pred cccCCCcHHHhc
Confidence 999999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=321.17 Aligned_cols=345 Identities=25% Similarity=0.366 Sum_probs=306.2
Q ss_pred eeCCcc----eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccc-cCCcccc
Q 005045 5 MIPEHL----MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG-NVPAWIG 79 (717)
Q Consensus 5 ~~p~~~----~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~ 79 (717)
.+|... +++-|.|...++. .+|..++.|.+|+.|.+++|++. .+-+.++.|+.|+.+++.+|++.. -+|..+.
T Consensus 23 ~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF 100 (1255)
T KOG0444|consen 23 RFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF 100 (1255)
T ss_pred cCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhc
Confidence 455555 6788999999998 79999999999999999999998 677789999999999999999852 4666788
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcce
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKI 159 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~ 159 (717)
.+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..++...|.+|+.|-.||||+|++. .+|+.+. .+..|++
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R-RL~~Lqt 177 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR-RLSMLQT 177 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHH-HHhhhhh
Confidence 8999999999999999 88999999999999999999999887788899999999999999997 8888876 8899999
Q ss_pred eecccccccccCCccCCCCCCCCEEeccCcccc-ccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEE
Q 005045 160 FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT-GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238 (717)
Q Consensus 160 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L 238 (717)
|.|++|.+....-..+..+++|+.|.+++.+=+ ..+|..+..+.+|..+++|.|.+..+ |+.+.++++|+.|
T Consensus 178 L~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~v-------Pecly~l~~LrrL 250 (1255)
T KOG0444|consen 178 LKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIV-------PECLYKLRNLRRL 250 (1255)
T ss_pred hhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcc-------hHHHhhhhhhhee
Confidence 999999988776677778889999999986533 25788899999999999999999877 6888999999999
Q ss_pred EeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcc-ccchhhhcCCCCCeEEcccCc
Q 005045 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG-SVPEVIGRLNKLEGLGLNVNK 317 (717)
Q Consensus 239 ~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~ 317 (717)
+||+|+|+ .+......+ .+|+.|++|.|+++ .+|.+++.++.|+.|.+.+|+++. -+|+.++++.+|+.+.+++|.
T Consensus 251 NLS~N~it-eL~~~~~~W-~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 251 NLSGNKIT-ELNMTEGEW-ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred ccCcCcee-eeeccHHHH-hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence 99999999 777777776 58999999999998 799999999999999999999873 378889999999999999999
Q ss_pred CCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccC
Q 005045 318 FSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 318 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
+. ..|+.++.+.+|+.|.|+.|++. ++|+++.-++.|+.||++.|+=
T Consensus 328 LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 328 LE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred cc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 97 78999999999999999999998 8999999999999999999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.16 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=196.5
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|.+.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|++++++++||||+++++.+ ...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 5788899999999999999965 7889999987643 234457788999999999999999999985 3446899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccccc
Confidence 99999999999999875421 5688999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........++..|+|||+..+ .++.++|+|||||++|+|++|+.||...... ....
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~------- 211 (256)
T cd08529 148 AKLLSDN-------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALIL------- 211 (256)
T ss_pred ceeccCc-------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH-------
Confidence 8765211 111123457889999999654 5789999999999999999999999654311 1100
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+.....+. ....++..+.+++.+||+.+|++||++.|+++.
T Consensus 212 ----~~~~~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 ----KIIRGVFPP------------------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----HHHcCCCCC------------------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000000000 011235668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.36 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=164.6
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
+|++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..++..+ .|++|+++.+++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 5889999999999999999965 67889999886542 22345566788888777 578888888884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccC
Confidence 99999999999999988654 4688999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+..... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 G~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 146 GMCKENMW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCceecCC-------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 99874311 1112234568999999999765 4899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.83 Aligned_cols=270 Identities=25% Similarity=0.402 Sum_probs=203.0
Q ss_pred ccccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+....++|.+.+.||+|+||.||.|++. .+..+|+|.+.... ......+..|+++++.+ +||||+++++.
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3445689999999999999999999742 23468999887542 33456788899999999 89999999998
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+. ..+..++||||+++++|.+++....... .....+++..+++++.|++.|++|||+. +++||
T Consensus 93 ~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~ 164 (307)
T cd05098 93 CT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHR 164 (307)
T ss_pred Ee-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 53 3457899999999999999997543211 1123588999999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.+........ ........++..|+|||.+.+ .++.++|||||||++|+|++ |
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccch-----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999875421110 011111224467999999654 48999999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||.....+ ....... ..... +.+..++..+.+++.
T Consensus 240 ~~p~~~~~~~--~~~~~~~------------~~~~~-----------------------------~~~~~~~~~~~~li~ 276 (307)
T cd05098 240 GSPYPGVPVE--ELFKLLK------------EGHRM-----------------------------DKPSNCTNELYMMMR 276 (307)
T ss_pred CCCCCcCCHH--HHHHHHH------------cCCCC-----------------------------CCCCcCCHHHHHHHH
Confidence 8888543211 1111000 00000 011223567888999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+|++.+|++|||+.||++.|+++....
T Consensus 277 ~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 277 DCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=301.92 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=197.8
Q ss_pred cccccccccCcccccceEEEEeC-CCc--hhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGT--IVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 68999999999999999999865 343 3677777632 233456788999999999 7999999999853 345
Q ss_pred eEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
..++||||+++++|.+++....... .....+++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 7899999999999999986532100 0113588999999999999999999997 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.++.+||+|||++..... .........+..|+|||.+.+ .++.++|||||||++|||++ |..||......
T Consensus 154 ~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEV--------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred CCCeEEECCcCCCccccc--------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999864210 001111123457999999655 47999999999999999998 99999654221
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
+ .... +....... .+..++..+.+++.+|++.+|.+|
T Consensus 226 ~--~~~~------------~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~R 262 (297)
T cd05089 226 E--LYEK------------LPQGYRME-----------------------------KPRNCDDEVYELMRQCWRDRPYER 262 (297)
T ss_pred H--HHHH------------HhcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 1 0000 00000000 111235567899999999999999
Q ss_pred CCHHHHHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 693 ps~~eil~~l~~i~~~~~ 710 (717)
||+.++++.|+.+.++..
T Consensus 263 p~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 263 PPFAQISVQLSRMLEARK 280 (297)
T ss_pred cCHHHHHHHHHHHHHhhc
Confidence 999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.54 Aligned_cols=193 Identities=28% Similarity=0.436 Sum_probs=159.6
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++... .||||+++++.+ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46899999999999965 68889999886542 22334555677776654 899999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 e~~~gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 76 EYLNGGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 999999999988754 5689999999999999999999997 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 146 NMNG-------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCCC-------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 3111 112234568999999999765 4799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.59 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=190.6
Q ss_pred ccCcccccceEEEEeC---CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEec
Q 005045 396 LIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
.||+|+||.||.|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++.+. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999753 45568999887543 334567889999999999999999999852 2367999999
Q ss_pred CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcc
Q 005045 472 MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLF 551 (717)
Q Consensus 472 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 551 (717)
+++++|.+++.... ..+++..+++++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 76 ASGGPLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred CCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 99999999986432 4689999999999999999999997 99999999999999999999999999987542
Q ss_pred cccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhh
Q 005045 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVM 629 (717)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 629 (717)
.... .........++..|+|||.+.+ .++.++|||||||++|++++ |..||......+ ........
T Consensus 147 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~------ 214 (257)
T cd05115 147 ADDS----YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQG------ 214 (257)
T ss_pred CCcc----ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCC------
Confidence 1110 0111112233568999999654 57899999999999999996 999997653221 11111100
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 630 DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
... +.+..++.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 215 ------~~~-----------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 ------KRL-----------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ------CCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 000 01122366788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=302.40 Aligned_cols=268 Identities=22% Similarity=0.377 Sum_probs=197.6
Q ss_pred cccccccccccCcccccceEEEEeC-----------------CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCcee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-----------------DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNIL 448 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~ 448 (717)
+.++|++.++||+|+||.||.+.+. ++..+|+|.+... .......+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3568999999999999999998532 2345888888754 234457888999999999999999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCC----cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE----HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
++++++. ..+..++||||+++++|.+++...... ......+++..+..++.|++.|++|||+. +++||
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~ 154 (296)
T cd05095 83 RLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHR 154 (296)
T ss_pred eEEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence 9999853 345789999999999999998754321 11224578889999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCc-cCCCCCcccchhhHHHHHHHHHh--
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFT-- 601 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~sDvwslG~vl~ellt-- 601 (717)
||||+||+++.++.++|+|||.+..+.... .........++..|+|||. ..+.++.++|||||||++|||++
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGD-----YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCc-----ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 999999999999999999999987652111 1111122334678999998 45668999999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHh
Q 005045 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 681 (717)
|..||........ ..... ......... ...+.+..++..+.+++
T Consensus 230 ~~~p~~~~~~~~~--~~~~~--------~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li 273 (296)
T cd05095 230 KEQPYSQLSDEQV--IENTG--------EFFRDQGRQ--------------------------VYLPKPALCPDSLYKLM 273 (296)
T ss_pred CCCCccccChHHH--HHHHH--------HHHhhcccc--------------------------ccCCCCCCCCHHHHHHH
Confidence 7788865322111 00000 000000000 00011223456788999
Q ss_pred hccCCCCcCCCCCHHHHHHHHH
Q 005045 682 LMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 682 ~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.+||+.+|++|||+.||++.|+
T Consensus 274 ~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 274 LSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHcCCCcccCCCHHHHHHHHh
Confidence 9999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.36 Aligned_cols=206 Identities=23% Similarity=0.351 Sum_probs=169.3
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.++||+|+||.||+|..+ +++.||+|++... .......+.+|++++++++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47999999999999999999954 8899999987543 233456788999999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeec
Confidence 99999999999999998754 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCC------CC-Cc---------------------------------ceeecccccccccCCCccCC-CC
Q 005045 545 GLAKFLFEISDNP------SK-NQ---------------------------------TVSIGLKGSIGYIPPEHMNG-QV 583 (717)
Q Consensus 545 g~~~~~~~~~~~~------~~-~~---------------------------------~~~~~~~~~~~y~aPE~~~~-~~ 583 (717)
|++.......... .. .. .......||+.|+|||++.+ .+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 9986431110000 00 00 00012468999999999755 48
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 584 SILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 584 ~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+.++|||||||++|||++|..||...
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCC
Confidence 99999999999999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=301.20 Aligned_cols=273 Identities=24% Similarity=0.407 Sum_probs=199.6
Q ss_pred cccccccccCcccccceEEEEe-----CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.-|++.+.||+|+||.||.|.. .+++.||+|.+.... ......+.+|+++++.+.|||++++.+++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3578999999999999999973 257889999986442 33456789999999999999999999986432 23
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|+|+. |++||||||+||+++.++.++|+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~ 151 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 151 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEEC
Confidence 56899999999999999986542 3579999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+....... ..........++..|+|||++.+ .++.++|||||||++|+|+++..|+.......
T Consensus 152 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-------- 219 (284)
T cd05079 152 DFGLTKAIETDK----EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-------- 219 (284)
T ss_pred CCccccccccCc----cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh--------
Confidence 999987652111 11111223456778999999554 58899999999999999999877653321100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+...+.- .+.......+.+.. .. ..+....++..+.+++.+|++.+|++|||++|+++.
T Consensus 220 -------~~~~~~~~---~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 220 -------LKMIGPTH---GQMTVTRLVRVLEE---GK-------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -------hhhccccc---ccccHHHHHHHHHc---Cc-------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 00000000000000 00 001122346788999999999999999999999999
Q ss_pred HHHH
Q 005045 702 LKTI 705 (717)
Q Consensus 702 l~~i 705 (717)
++++
T Consensus 280 l~~~ 283 (284)
T cd05079 280 FEAI 283 (284)
T ss_pred HHhh
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.62 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=200.1
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...++|++.+.||+|++|.||.|..++++.+|+|.+..... ....+.+|+.++++++|+||+++++.+ ......
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence 45678999999999999999999987778899998875432 246788999999999999999999984 344578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence 999999999999999976421 4689999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+...... ..........+..|+|||.+.+ .++.++||||+||++|++++ |+.||...... .........
T Consensus 149 ~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~ 220 (261)
T cd05034 149 LARLIEDD------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERG 220 (261)
T ss_pred cceeccch------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence 98765211 0111112224567999999655 57899999999999999999 99998653211 111111000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
. . .. .+.+++..+.+++.+|++.+|++||+++|+.+.|+
T Consensus 221 ~--------~--~~-------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 221 Y--------R--MP-------------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred C--------C--CC-------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 0 0 00 01122556789999999999999999999999887
Q ss_pred H
Q 005045 704 T 704 (717)
Q Consensus 704 ~ 704 (717)
.
T Consensus 260 ~ 260 (261)
T cd05034 260 D 260 (261)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.29 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=194.7
Q ss_pred cccccccCcccccceEEEEeCC-Cc--hhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCCce
Q 005045 391 FSKENLIGTGSFGSVYKGTLGD-GT--IVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGNDF 464 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~~~ 464 (717)
|.+.+.||+|+||.||+|++.. ++ .+|+|.++.. .....+.+..|+++++.++|+||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999653 33 5888887643 23445778899999999999999999998754321 12235
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++...... .....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 78999999999999887432110 0124589999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+........ ........+++.|+|||...+ .++.++|||||||++|+|++ |..||...... ........
T Consensus 157 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~ 229 (272)
T cd05075 157 GLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ 229 (272)
T ss_pred CcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 99886522110 011122335678999999655 48999999999999999999 88898653221 11111000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
..... ....++..+.+++.+||+.+|++|||+.||++.|
T Consensus 230 -----------~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 230 -----------GNRLK------------------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred -----------CCCCC------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000 0112255678999999999999999999999999
Q ss_pred HHH
Q 005045 703 KTI 705 (717)
Q Consensus 703 ~~i 705 (717)
+.+
T Consensus 269 ~~~ 271 (272)
T cd05075 269 EKA 271 (272)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=300.46 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=197.8
Q ss_pred ccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+|++.+.||+|+||.||+|... ..+.+++|.+.... ......+.+|+.+++.+.||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 4788999999999999999843 23468888776442 233567889999999999999999999853 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCc-----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEH-----------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
+..+++|||+++++|.+++....... .....+++..+..++.|++.|+.|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 57899999999999999876432110 0123578999999999999999999997 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CC
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GK 603 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~ 603 (717)
|||+||+++.++.+||+|||.+........ ........++..|+|||...+ .++.++|||||||++|+|++ |.
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence 999999999999999999999876422111 111112335678999998544 48999999999999999998 99
Q ss_pred CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhc
Q 005045 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683 (717)
Q Consensus 604 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.||....++. +.+.+....... .+..++..+.+++.+
T Consensus 228 ~p~~~~~~~~--------------~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~ 264 (290)
T cd05045 228 NPYPGIAPER--------------LFNLLKTGYRME-----------------------------RPENCSEEMYNLMLT 264 (290)
T ss_pred CCCCCCCHHH--------------HHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHH
Confidence 9986542211 111111111100 112235568899999
Q ss_pred cCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 684 CSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 684 cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
|++.+|++||+++|+++.|+++..
T Consensus 265 cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 265 CWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HccCCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.72 Aligned_cols=269 Identities=26% Similarity=0.383 Sum_probs=201.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCch--hhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTI--VAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|.++ ++.. +++|.+... .......+.+|++++.++ +|+||+++++.+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 3568999999999999999999964 4543 566665532 233456788899999999 899999999985 34
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
.+..++||||+++++|.+++....... .....+++..++.++.||+.|++|||+. +++||||||+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEE
Confidence 558999999999999999986442110 0113588999999999999999999997 9999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFT-GKRPTGDMF 610 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~ellt-g~~p~~~~~ 610 (717)
++.++.+||+|||.+..... .........+..|+|||.+.+. ++.++|||||||++|+|+| |..||....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred ecCCCcEEeCccccCcccch--------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999999998863210 0011112245679999996554 7899999999999999998 999986432
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
..+ ..... + ....... +..++..+.+++.+||+.+|+
T Consensus 229 ~~~--~~~~~----~----~~~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~ 265 (303)
T cd05088 229 CAE--LYEKL----P----QGYRLEK---------------------------------PLNCDDEVYDLMRQCWREKPY 265 (303)
T ss_pred hHH--HHHHH----h----cCCcCCC---------------------------------CCCCCHHHHHHHHHHcCCChh
Confidence 211 11000 0 0000000 011244578899999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHHhhhh
Q 005045 691 ERIAMNVVVNNLKTIRNCFLEFKK 714 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~~~~~~~ 714 (717)
+||++.++++.++.+.++-.++.+
T Consensus 266 ~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 266 ERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred hCcCHHHHHHHHHHHHHhhhhhhh
Confidence 999999999999998877665544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.52 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=195.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++|++|+++++.+ .+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 47999999999999999999965 78999999987542 23456788999999999999999999884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccC
Confidence 999999999999999997542 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
|.+...... .........|++.|+|||++. +.++.++|||||||++|+|++|..||....... ..
T Consensus 147 g~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~- 218 (330)
T cd05601 147 GSAARLTAN------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TY- 218 (330)
T ss_pred CCCeECCCC------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HH-
Confidence 998765211 111223346899999999964 247899999999999999999999996542211 00
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+........ .+.....+..+.+++.+|++ +|++|||+.+
T Consensus 219 -----------~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 219 -----------NNIMNFQRFLK---------------------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred -----------HHHHcCCCccC---------------------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 00100000000 00001124557889999998 9999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 260 l~~ 262 (330)
T cd05601 260 LCC 262 (330)
T ss_pred HhC
Confidence 985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.80 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=187.4
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|.++ +++.||+|++.... ......+..|.++++.+ +||||+++++++ ...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46899999999999965 68889999887542 23345677888888887 799999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 76 EYVNGGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 999999999988754 4689999999999999999999997 999999999999999999999999998864
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... ...
T Consensus 146 ~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~---------- 206 (318)
T cd05570 146 GIL-------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQ---------- 206 (318)
T ss_pred cCc-------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHH----------
Confidence 311 1111223458999999999765 58999999999999999999999996542111 100
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH-----HHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM-----NVVVN 700 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~eil~ 700 (717)
.+...... .+...+..+.+++.+||+.+|++|||+ .++++
T Consensus 207 -~i~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 207 -SILEDEVR-------------------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -HHHcCCCC-------------------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00000000 001124567899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.89 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=195.7
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
..+|++.+.+|+|++|.||++..+ |+.+++|...... ..+.+.+|+.++++++|++++++++++. ......++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 458999999999999999999864 7788999876432 3467889999999999999999998753 34457899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
+|||+++++|.+++..... ..+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred EEECCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence 9999999999999875421 4578999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
...... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||...... .........
T Consensus 150 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~-- 215 (256)
T cd05082 150 KEASST----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG-- 215 (256)
T ss_pred eecccc----------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcC--
Confidence 754111 111234567999999655 48899999999999999998 99998643111 111110000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
..+. ....++..+.+++.+|++.+|++|||++++++.|+++
T Consensus 216 ------~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 ------YKMD---------------------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCC---------------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0000 1112356788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=303.45 Aligned_cols=269 Identities=23% Similarity=0.403 Sum_probs=203.4
Q ss_pred ccccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+....++|.+.+.||+|+||.||.|+.. .+..||+|...... ......+.+|+.+++.+ +||||+++++.
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3456789999999999999999999731 34568999886432 33456788999999999 89999999998
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+. .....++||||+++++|.+++....... .....+++..+..++.||+.|+.|||++ |++||
T Consensus 90 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~ 161 (304)
T cd05101 90 CT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHR 161 (304)
T ss_pred Ee-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeec
Confidence 53 3458899999999999999987542111 0124578899999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.+........ ........++..|+|||++.+ .++.++|||||||++|+|++ |
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999886522111 111122335678999999654 58999999999999999998 7
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||......+ ...... ..... ..+..++..+.+++.
T Consensus 237 ~~p~~~~~~~~--~~~~~~------------~~~~~-----------------------------~~~~~~~~~~~~li~ 273 (304)
T cd05101 237 GSPYPGIPVEE--LFKLLK------------EGHRM-----------------------------DKPANCTNELYMMMR 273 (304)
T ss_pred CCCcccCCHHH--HHHHHH------------cCCcC-----------------------------CCCCCCCHHHHHHHH
Confidence 88885432111 100000 00000 011233567889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+||+.+|++|||+.|+++.|.++..-
T Consensus 274 ~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 274 DCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHcccChhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.91 Aligned_cols=205 Identities=23% Similarity=0.359 Sum_probs=168.9
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+|+++++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++.+ .+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 6899999999999999999965 78899999986542 33456788999999999999999999995 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||+|||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence 9999999999999998754 4578999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCC----------------------------------------CCCcceeecccccccccCCCccCC-CCC
Q 005045 546 LAKFLFEISDNP----------------------------------------SKNQTVSIGLKGSIGYIPPEHMNG-QVS 584 (717)
Q Consensus 546 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 584 (717)
++.......... ...........||+.|+|||++.+ .++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 975321000000 000001123468999999999655 589
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCC
Q 005045 585 ILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 585 ~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.++||||+||++|||++|..||...
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.47 Aligned_cols=193 Identities=26% Similarity=0.438 Sum_probs=160.6
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+++ +|+.||+|++.... .........|..++... +||+|+++++.+ ...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46899999999999965 78899999987542 22345566777777754 899999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||.+..
T Consensus 76 E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 76 EFLNGGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 999999999988754 4688999999999999999999998 999999999999999999999999998864
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|+..|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 146 NVF-------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred ccc-------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 211 1112234568999999999765 5899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=301.11 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=198.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...+.|++.++||+|++|.||+|++. +++.+++|.+..........+..|+++++.++|+||+++++.+. .+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 83 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGK 83 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCe
Confidence 34578999999999999999999965 68899999988666666778889999999999999999999853 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++++++..++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 999999999999988875432 4589999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|.+..... .........++..|+|||.+.+ .++.++|||||||++|+|++|..||........ ...
T Consensus 155 g~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~ 226 (292)
T cd06644 155 GVSAKNVK-------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLK 226 (292)
T ss_pred ccceeccc-------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHH
Confidence 98765311 1111223457889999999642 367899999999999999999999865422110 000
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.. ....+... .+..++..+.+++.+||+.+|++||++.|+
T Consensus 227 ~~---------~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 227 IA---------KSEPPTLS-------------------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred Hh---------cCCCccCC-------------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00 00000000 111224567889999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 267 l~ 268 (292)
T cd06644 267 LE 268 (292)
T ss_pred hc
Confidence 76
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=328.32 Aligned_cols=271 Identities=24% Similarity=0.305 Sum_probs=202.5
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.++||+|+||.||+|.+. +|+.||+|++... .....+++.+|++++++++||||+++++.+. +++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 68999999999999999999965 7899999998643 2334577899999999999999999999853 4558
Q ss_pred EEEEEecCCCCChhhhccCCCCC----cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAE----HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.++||||++|++|.+++...... .......++..++.++.||+.||+|||+. +|+||||||+||+++.++.++
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 99999999999999988642110 00113467788899999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCC-----------CCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPS-----------KNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
|+|||.+........... ..........||+.|+|||.+.+ .++.++|||||||++|||++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999976521110000 00111223569999999999765 479999999999999999999999965
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
......... .. ..++.. . ....+.+..+.+++.+|++.+
T Consensus 234 ~~~~ki~~~----~~-------i~~P~~-~-----------------------------~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 234 KKGRKISYR----DV-------ILSPIE-V-----------------------------APYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred cchhhhhhh----hh-------ccChhh-c-----------------------------cccccCCHHHHHHHHHHccCC
Confidence 322111000 00 000000 0 001123556788999999999
Q ss_pred cCCCC-CHHHHHHHHHHHHHH
Q 005045 689 PRERI-AMNVVVNNLKTIRNC 708 (717)
Q Consensus 689 p~~Rp-s~~eil~~l~~i~~~ 708 (717)
|++|| +++++.+.|+...+.
T Consensus 273 P~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 273 PAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhCcCHHHHHHHHHHHHHhc
Confidence 99996 778888888887653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.50 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=196.7
Q ss_pred ccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..+|++.+.||+|+||.||+|.. ..++.|++|.+.... ......+.+|++++++++||||+++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence 35788999999999999999983 256789999886432 33346788999999999999999999985 34
Q ss_pred CceEEEEEecCCCCChhhhccCCCCC----------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAE----------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
....|+||||+++++|.+++...... ......+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ni 155 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNI 155 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceE
Confidence 45789999999999999998532110 00113578899999999999999999998 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 609 (717)
+++.++.+||+|||.+....... .........++..|+|||.+. +.++.++|||||||++|||++ |..||...
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSAD-----YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred EEcCCCcEEeccccccccccCCc-----ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999987652111 111112233567799999965 458999999999999999999 99998654
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
... .......... ... .+..++..+.+++.+|++.+|
T Consensus 231 ~~~--~~~~~~~~~~----------~~~-------------------------------~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05090 231 SNQ--EVIEMVRKRQ----------LLP-------------------------------CSEDCPPRMYSLMTECWQEGP 267 (283)
T ss_pred CHH--HHHHHHHcCC----------cCC-------------------------------CCCCCCHHHHHHHHHHcccCc
Confidence 221 1111111000 000 111235567889999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKT 704 (717)
Q Consensus 690 ~~Rps~~eil~~l~~ 704 (717)
++||++.+|.+.+..
T Consensus 268 ~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 268 SRRPRFKDIHTRLRS 282 (283)
T ss_pred ccCcCHHHHHHHhhc
Confidence 999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.33 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+.++|++.+.||.|++|.||.|.+. +++.+|+|.+........+.+..|++++++++||||+++++.+. .+...
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeE
Confidence 4678999999999999999999964 78899999987665556678889999999999999999999853 45589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g 148 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCc
Confidence 99999999999999987542 4689999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
.+..... .........++..|+|||.+. ..++.++|||||||++|+|++|..||........ .. .
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~-~ 219 (280)
T cd06611 149 VSAKNKS-------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LL-K 219 (280)
T ss_pred cchhhcc-------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HH-H
Confidence 8765411 111223355888999999953 2367899999999999999999999975422110 00 0
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+.....+.+ ..+..++..+.+++.+||+.+|++|||+.+++
T Consensus 220 --------~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 220 --------ILKSEPPTL-------------------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred --------HhcCCCCCc-------------------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 000000000 01112245678899999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 261 ~~ 262 (280)
T cd06611 261 KH 262 (280)
T ss_pred cC
Confidence 75
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=311.62 Aligned_cols=194 Identities=29% Similarity=0.412 Sum_probs=163.1
Q ss_pred ccccCcccccceEEEEe----CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 394 ENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
++.||+|+||.||.++. .+|+.||+|++.... ......+..|++++++++||||+++++.+ ...+..|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence 36799999999999874 367889999887543 22345677899999999999999999984 44568999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 145 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 145 (318)
T ss_pred EEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCC
Confidence 99999999999998654 4689999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
..... .........|++.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 146 ~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 146 KESID-------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred cccCC-------CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 75411 1112233568999999999765 4789999999999999999999999653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.51 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=197.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCc----hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.++|++.++||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.+.|+||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 468899999999999999999853 454 47889886432 3345678899999999999999999998642
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
...+++|||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL 150 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKI 150 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEE
Confidence 24679999999999999987542 4689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.++...... .........++..|+|||... +.++.++|||||||++|||++ |..||....... ....
T Consensus 151 ~dfG~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~ 223 (279)
T cd05109 151 TDFGLARLLDIDE-----TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDL 223 (279)
T ss_pred CCCCceeeccccc-----ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 9999987652111 011111223467899999964 458999999999999999998 999986532211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.. ..... ..+..++..+.+++.+||+.+|+.||++.|++
T Consensus 224 ~~------------~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~ 262 (279)
T cd05109 224 LE------------KGERL-----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262 (279)
T ss_pred HH------------CCCcC-----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 11 00000 00112355678899999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 700 NNLKTIRNC 708 (717)
Q Consensus 700 ~~l~~i~~~ 708 (717)
+.++++...
T Consensus 263 ~~l~~~~~~ 271 (279)
T cd05109 263 DEFSRMARD 271 (279)
T ss_pred HHHHHhhcC
Confidence 998887644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.98 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=197.6
Q ss_pred ccccccccccCcccccceEEEEeC-C---CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-D---GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+..|+.++++++||||+++++++ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 468999999999999999999853 2 3368888876432 33456788999999999999999999985 345
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~ 148 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVS 148 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeC
Confidence 58899999999999999987542 4578999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+....... ..........++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+ .....
T Consensus 149 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~ 222 (267)
T cd05066 149 DFGLSRVLEDDP----EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI 222 (267)
T ss_pred CCCccccccccc----ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH
Confidence 999988652211 00111111223567999999764 58999999999999999887 999986542211 11111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. +... .+ .+..++..+.+++.+|++.+|++|||+.++++
T Consensus 223 ~--------~~~~--~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 223 E--------EGYR--LP-------------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred h--------CCCc--CC-------------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0 0000 00 01122556789999999999999999999999
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.|.++
T Consensus 262 ~l~~~ 266 (267)
T cd05066 262 ILDKL 266 (267)
T ss_pred HHHhh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.57 Aligned_cols=205 Identities=21% Similarity=0.254 Sum_probs=163.8
Q ss_pred cccccCcc--cccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 393 KENLIGTG--SFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 393 ~~~~ig~g--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
++++||+| +++.||++..+ +|+.||+|.+.... ......+.+|+++++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 56789999 67899999864 89999999987542 334567888999999999999999999854 3458999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++++++.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++||+.+
T Consensus 77 v~e~~~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEeccCCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence 9999999999999865421 4588999999999999999999997 9999999999999999999999999876
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.....................++..|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 5432111111000111122346778999999754 37899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.46 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=198.3
Q ss_pred ccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..+|+..+++|+|+||.||.|... ++..+++|.+..........+.+|+++++.++|+||+++++.+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----E 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----c
Confidence 467889999999999999999631 45678888887655556678999999999999999999999853 3
Q ss_pred CceEEEEEecCCCCChhhhccCCCCC--------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAE--------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 533 (717)
....+++|||+++++|.+++...... ......+++..++.++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence 45789999999999999998754311 01113578999999999999999999997 99999999999999
Q ss_pred CCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 005045 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFK 611 (717)
Q Consensus 534 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 611 (717)
+.++.+||+|||.+...... ..........+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.....
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYST-----DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred cCCCCEEECCCCceeEcCCC-----ceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 99999999999998754211 11111122335678999999654 58999999999999999998 9999865322
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
.+. .... ...... ..+..++..+.+++.+||+.+|++
T Consensus 231 ~~~--~~~~-----------~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~P~~ 267 (280)
T cd05092 231 TEA--IECI-----------TQGREL------------------------------ERPRTCPPEVYAIMQGCWQREPQQ 267 (280)
T ss_pred HHH--HHHH-----------HcCccC------------------------------CCCCCCCHHHHHHHHHHccCChhh
Confidence 110 0000 000000 011123556789999999999999
Q ss_pred CCCHHHHHHHHH
Q 005045 692 RIAMNVVVNNLK 703 (717)
Q Consensus 692 Rps~~eil~~l~ 703 (717)
||+++||++.|+
T Consensus 268 Rp~~~~l~~~l~ 279 (280)
T cd05092 268 RMVIKDIHSRLQ 279 (280)
T ss_pred CCCHHHHHHHHh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=295.01 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=195.4
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-----hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-----QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
++|.+.+.||+|++|.||.|... +++.||+|.+.... ......+.+|++++++++||||+++++++ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 57999999999999999999954 78999999875331 22346788999999999999999999995 344
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 5899999999999999998754 4578899999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+......... ........++..|+|||...+. ++.++||||+||++|+|++|+.||........ ...
T Consensus 147 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~--- 218 (263)
T cd06625 147 DFGASKRLQTICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFK--- 218 (263)
T ss_pred ecccceeccccccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHH---
Confidence 99998754221110 0101224477889999997654 78999999999999999999999865321110 000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........ ..+..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 219 ---------~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 ---------IATQPTNP-----------------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---------HhccCCCC-----------------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00000000 0111235567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.29 Aligned_cols=263 Identities=25% Similarity=0.433 Sum_probs=214.0
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
+.|..-..+...-+++|-|-||.||.|.|+ -.-.||||.++.+.. ....|..|+.+|+.++|||+|+++++|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E--- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence 444444556677889999999999999987 456799999986654 368899999999999999999999997543
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
...|||+|||..|+|.||+++... ..++....+.+|.||+.||.||... .++||||.++|.+|.++..||
T Consensus 336 --pPFYIiTEfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 336 --PPFYIITEFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred --CCeEEEEecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEE
Confidence 378999999999999999987643 5677778889999999999999996 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
++|||+++.+.... +....+..-+.-|-|||-+.- .++-|+|||+|||++||+-| |-.||.+.+-
T Consensus 406 vADFGLsRlMtgDT------YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------- 472 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------- 472 (1157)
T ss_pred eeccchhhhhcCCc------eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------
Confidence 99999999883321 222223345678999999654 58999999999999999999 9999977522
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+++++++.... ++.++-|+..+++|++.||+|+|.+||+++||
T Consensus 473 --------------------------SqVY~LLEkgyR----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 473 --------------------------SQVYGLLEKGYR----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --------------------------HHHHHHHhcccc----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 122222222111 23667899999999999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 699 VNNLKTIRN 707 (717)
Q Consensus 699 l~~l~~i~~ 707 (717)
.+.+|++-.
T Consensus 517 HqafEtmf~ 525 (1157)
T KOG4278|consen 517 HQAFETMFS 525 (1157)
T ss_pred HHHHHHHhc
Confidence 999998763
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.62 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=184.5
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhc-CCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKS-TRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|.++ +++.||+|++.... ......+..|..+++. ++||||+++++.+ .+.+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46899999999999965 68889999886542 2234556677777776 4999999999985 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 ey~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 76 EYLNGGDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999999999998754 4688999999999999999999998 999999999999999999999999999864
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .........|++.|+|||++.+ .++.++||||+||++|+|++|..||...... ........
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~------ 210 (316)
T cd05619 146 NML-------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRM------ 210 (316)
T ss_pred CCC-------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------
Confidence 311 1112234568999999999765 4899999999999999999999999754211 11111000
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH-HHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN-VVVN 700 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-eil~ 700 (717)
..+..+ ...+..+.+++.+||+.+|++||++. ++.+
T Consensus 211 ---~~~~~~---------------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 ---DNPCYP---------------------------------RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCCCC---------------------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000000 01134567899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=295.46 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=190.2
Q ss_pred ccCcccccceEEEEe---CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 396 LIGTGSFGSVYKGTL---GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+||+|+||.||+|.+ ++++.+|+|++.... ....+.+..|+.+++.+.||||+++++.+. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999974 367889999886442 334577889999999999999999998852 235789999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 76 LAELGPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 99999999998654 4688999999999999999999997 9999999999999999999999999998765
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
..... .........++..|+|||.+.+ .++.++|||||||++|||++ |..||...... ......
T Consensus 146 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i-------- 211 (257)
T cd05116 146 GADEN----YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI-------- 211 (257)
T ss_pred CCCCC----eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--------
Confidence 21111 0111122234578999999654 57889999999999999998 99999754221 111111
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
....... .+..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 212 ----~~~~~~~-----------------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 212 ----ESGERME-----------------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----HCCCCCC-----------------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1100000 111235668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.89 Aligned_cols=193 Identities=30% Similarity=0.422 Sum_probs=158.9
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHH-HHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECN-ALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+++ +|+.||+|++.... ......+..|.. +++.++||||+++++.+ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46899999999999965 78999999986432 222344445544 56789999999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 76 DYVNGGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred cCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 999999999988754 5688999999999999999999997 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 146 GIE-------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccc-------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 311 1112233568999999999765 4889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.28 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=198.4
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC-C
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLE-G 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~-~ 461 (717)
..+.+.|++.+.||+|++|.||.|..+ +++.||+|.+..... ....+..|+.+++++ +|+||+++++.+...... .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467889999999999999999999965 788899998865432 235677899999998 799999999987543221 1
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence 3468999999999999999875321 4688999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+|||.+...... ........|+..|+|||++. ..++.++||||+||++|+|++|..||.........
T Consensus 153 ~Dfg~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 153 VDFGVSAQLDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred ccCCCceecccc-------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 999998754211 11223356888999999964 23788999999999999999999999654221110
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
. .. .....+.. ....++..+.+++.+||+.+|.+|||+
T Consensus 226 ~---~~-------~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 226 F---LI-------PRNPAPRL--------------------------------KSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred H---HH-------hcCCCCCC--------------------------------CCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 0 00 00000000 011224567899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
.|+++
T Consensus 264 ~~il~ 268 (272)
T cd06637 264 EQLMK 268 (272)
T ss_pred HHHhh
Confidence 99975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.98 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=195.3
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
+|++.++||.|++|.||.++++ +++.+|+|.+... .....+.+..|+.+++.++|+||+++.+.+ ...+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 5889999999999999999965 7889999987543 233457788899999999999999999984 44568999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
+|||++++++.+++..... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+
T Consensus 76 v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEeeCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcc
Confidence 9999999999998864321 4578999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...... ........++..|+|||+..+ .++.++|+||||+++|+|++|..||........ ...
T Consensus 148 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~------- 211 (255)
T cd08219 148 RLLTSP-------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILK------- 211 (255)
T ss_pred eeeccc-------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHH-------
Confidence 755211 111223558889999999765 488999999999999999999999965321110 000
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........ .+..++..+.+++.+||+.+|++|||+.||+..
T Consensus 212 ----~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 ----VCQGSYKP------------------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----HhcCCCCC------------------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00000000 011124457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.45 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred ccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..+|++.++||+|+||.||+|... .++.||+|++..... .....+..|+.+++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~----- 78 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT----- 78 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 356889999999999999999853 356799999875432 33567889999999999999999999853
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
.....++++||+++++|.+++...... ......+++..+..++.|++.|++|+|+. +++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni 155 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV 155 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence 445789999999999999987532110 01124578889999999999999999997 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 609 (717)
+++.++.+||+|||.++...... .........+++.|+|||.+ .+.++.++|||||||++|||++ |..||...
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAAD-----YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred EecCCCceEecccccccccccch-----heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999987642111 11111223456789999995 4568999999999999999998 88888654
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
...+ .... +.+.... ..+.+++..+.+++.+||+.+|
T Consensus 231 ~~~~--~~~~-----------i~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05091 231 SNQD--VIEM-----------IRNRQVL------------------------------PCPDDCPAWVYTLMLECWNEFP 267 (283)
T ss_pred CHHH--HHHH-----------HHcCCcC------------------------------CCCCCCCHHHHHHHHHHhCCCc
Confidence 2211 1111 0111000 0122346678899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKT 704 (717)
Q Consensus 690 ~~Rps~~eil~~l~~ 704 (717)
++||+++||++.|++
T Consensus 268 ~~RP~~~~i~~~l~~ 282 (283)
T cd05091 268 SRRPRFKDIHSRLRT 282 (283)
T ss_pred ccCCCHHHHHHHhhC
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=295.37 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=196.8
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..++|++.++||+|++|.||+|.++.+..+|+|.+.... ...+.+.+|+++++.++|+|++++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcE
Confidence 456799999999999999999998766679999876433 23466888999999999999999988742 23578
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~ 148 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGL 148 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCcc
Confidence 99999999999999975421 4578999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+....... ........++..|+|||... +.++.++|||||||++|+|++ |..||....... .........
T Consensus 149 ~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~ 220 (260)
T cd05069 149 ARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGY 220 (260)
T ss_pred ceEccCCc------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC
Confidence 87642111 11111233567899999965 458999999999999999999 899987542211 111111000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
... .+.+.+..+.+++.+||..+|++||++++|++.|++
T Consensus 221 --------~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 --------RMP---------------------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --------CCC---------------------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 011225568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.93 Aligned_cols=240 Identities=25% Similarity=0.312 Sum_probs=182.2
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHH-HHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDEC-NALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+++ +++.||+|++.... ......+..|. .+++.++||||+++++.+ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46899999999999965 67889999886432 12223334444 456788999999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 76 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 76 DYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999999998754 4578889999999999999999998 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... ..
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~----------- 205 (325)
T cd05602 146 NIE-------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MY----------- 205 (325)
T ss_pred ccc-------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HH-----------
Confidence 311 1112234568999999999765 48899999999999999999999996532111 00
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+....... ..+.+..+.+++.+|++.+|.+||++.+.+.
T Consensus 206 ~~i~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 206 DNILNKPLQL-------------------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHhCCcCC-------------------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0011111100 0112456788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.01 Aligned_cols=269 Identities=22% Similarity=0.366 Sum_probs=200.3
Q ss_pred ccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
-+.++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-- 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-- 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee--
Confidence 4567999999999999999999973 257889999987532 23346788999999999 7899999998863
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCc-------------------------------------------------
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEH------------------------------------------------- 488 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------------------------------------------- 488 (717)
..+...++||||+++|+|.+++.......
T Consensus 82 --~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 82 --KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred --cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 33456899999999999999886421100
Q ss_pred -----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCC
Q 005045 489 -----------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557 (717)
Q Consensus 489 -----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 557 (717)
.....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 233 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--- 233 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc---
Confidence 0012468888999999999999999997 99999999999999999999999999987642111
Q ss_pred CCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCC
Q 005045 558 SKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPS 635 (717)
Q Consensus 558 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (717)
.........++..|+|||.+.+ .++.++|||||||++|+|++ |..||........ ........ ....
T Consensus 234 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~--------~~~~ 302 (343)
T cd05103 234 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEG--------TRMR 302 (343)
T ss_pred --chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhcc--------CCCC
Confidence 1111122335677999999644 58999999999999999997 9999865422111 10000000 0000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 636 MPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
. +...+..+.+++.+||+.+|++|||+.||++.|+.+.++
T Consensus 303 ~---------------------------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 A---------------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred C---------------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 001134578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.23 Aligned_cols=204 Identities=24% Similarity=0.296 Sum_probs=166.8
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.++||+|+||.||+|.++ +++.||+|.+... .....+++.+|+++++.++|+||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 7899999988643 223456788999999999999999999986543222223789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999995 6888877644 5689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+...... .........++..|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 150 a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 150 ARVEEPD------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred eeecccC------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 8754211 1111123457889999999765 37899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.69 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=200.2
Q ss_pred ccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.+......+|++.+.+|.|++|.||.|.+ .+++.|++|.+..........+.+|+.+++.++||||+++++.+ .
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~ 86 (296)
T cd06655 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----L 86 (296)
T ss_pred HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----e
Confidence 34445567899999999999999999995 47899999988765544567788999999999999999999985 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~k 155 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVK 155 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45689999999999999998863 3478999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||........ ....
T Consensus 156 l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~ 227 (296)
T cd06655 156 LTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI 227 (296)
T ss_pred EccCccchhccccc-------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999887642111 11122457889999999655 488999999999999999999999965432111 0000
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... .+.. ..+.+++..+.+++.+||+.+|++|||+.+|+
T Consensus 228 ~~~~---------~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 228 ATNG---------TPEL-------------------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred HhcC---------Cccc-------------------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 0000 0000 01122355678899999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
.
T Consensus 268 ~ 268 (296)
T cd06655 268 Q 268 (296)
T ss_pred h
Confidence 5
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=294.34 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=192.2
Q ss_pred cccCcccccceEEEEeC-C---CchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-D---GTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
++||+|++|.||+|.+. . +..+|+|.+..... ...+.+.+|+++++.+.|+||+++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999843 2 36799998875432 34567889999999999999999998753 23579999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.|++.|++|||.. +++||||||+||+++.++.+||+|||.+..
T Consensus 75 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 75 ELAPLGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred EeCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence 999999999999755 4689999999999999999999997 999999999999999999999999999886
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... ........++..|+|||.+.+ .++.++|||||||++|+|++ |..||...... ..........+
T Consensus 145 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-- 216 (257)
T cd05060 145 LGAGSDY----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGER-- 216 (257)
T ss_pred eecCCcc----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCc--
Confidence 5321111 111111223567999999654 58999999999999999998 99999654221 11111111000
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
. +.+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 217 --------~-------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 --------L-------------------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --------C-------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 011223567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.70 Aligned_cols=259 Identities=28% Similarity=0.487 Sum_probs=197.4
Q ss_pred ccccccccccCcccccceEEEEeC-CCc---hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT---IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|..+ +++ .||+|.+... .......+..|+.+++++.||||+++.+.+ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCC
Confidence 356889999999999999999965 333 5999988754 344567899999999999999999999984 445
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+++++|.+++.... ..+++..++.++.|++.|++|||+. |++||||+|+||+++.++.+||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEEC
Confidence 57899999999999999987542 4578999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+........... .........+..|+|||.+.+ .++.++|||||||++||+++ |..||...... ......
T Consensus 149 dfg~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 149 DFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred CCccccccccCccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 9999876522111100 000011112457999999654 58999999999999999987 99998654221 111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ... +.+.+++..+.+++.+||+.+|++||++++|++
T Consensus 225 ~~~----------~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 225 EQD----------YRL-------------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HcC----------CcC-------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 000 011234566789999999999999999999999
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.|+++
T Consensus 264 ~l~~~ 268 (269)
T cd05065 264 TLDKM 268 (269)
T ss_pred HHHhh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.02 Aligned_cols=268 Identities=22% Similarity=0.397 Sum_probs=195.4
Q ss_pred cccccccccccCcccccceEEEEeCC---------------CchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD---------------GTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
..++|++.+.||+|+||.||+|.... ...||+|.+... .......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 35689999999999999999987532 224889988654 23445678899999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCC-----cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE-----HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
++++. .....++||||+++++|.+++...... ......+++..++.++.|++.|++|||+. +++|||
T Consensus 83 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~d 154 (295)
T cd05097 83 LGVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRD 154 (295)
T ss_pred EEEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence 99963 345789999999999999988643210 00113468899999999999999999998 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh--C
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT--G 602 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt--g 602 (717)
|||+||+++.++.+||+|||.+...... ..........++..|+|||.. .+.++.++|||||||++|+|++ |
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSG-----DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccC-----cceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 9999999999999999999998754211 111111223356789999995 4568999999999999999998 6
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||.....+.. ..... +.........+ ...+..++..+.+++.
T Consensus 230 ~~p~~~~~~~~~--~~~~~--------~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~ 273 (295)
T cd05097 230 EQPYSLLSDEQV--IENTG--------EFFRNQGRQIY--------------------------LSQTPLCPSPVFKLMM 273 (295)
T ss_pred CCCCcccChHHH--HHHHH--------Hhhhhcccccc--------------------------CCCCCCCCHHHHHHHH
Confidence 677765322110 00000 00000000000 0001112567899999
Q ss_pred ccCCCCcCCCCCHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~ 703 (717)
+|++.+|++|||+.+|++.|.
T Consensus 274 ~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 274 RCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHcCCCchhCcCHHHHHHHHh
Confidence 999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=329.51 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=198.7
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
+.+.....++|++.++||+|+||.||+|.+. +++.||+|++... .......+..|+.+++++.||||+++++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d- 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN- 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe-
Confidence 4455566789999999999999999999965 6788999987643 23345678899999999999999999998643
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCEEe
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC----DTPIAHCDLKPSNVLL 533 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlkp~NIll 533 (717)
.....+|+||||+++++|.+++..... ....+++..++.|+.||+.||+|||+.. .++||||||||+|||+
T Consensus 84 --e~~~~lyIVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 84 --KANQKLYILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred --cCCCEEEEEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 234578999999999999999864311 1146899999999999999999999852 1359999999999999
Q ss_pred CCC-----------------CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHH
Q 005045 534 DKD-----------------MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYG 593 (717)
Q Consensus 534 ~~~-----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG 593 (717)
+.+ +.+||+|||++..... ........||+.|+|||++.+ .++.++||||||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~--------~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG 230 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI--------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccc--------cccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence 642 3589999999875411 111223468999999999643 378999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHH
Q 005045 594 ILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC 673 (717)
Q Consensus 594 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (717)
|++|+|++|..||........ +..... . .+.++ ...+
T Consensus 231 ~ILYELLTGk~PF~~~~~~~q-li~~lk--------~--~p~lp--------------------------------i~~~ 267 (1021)
T PTZ00266 231 CIIYELCSGKTPFHKANNFSQ-LISELK--------R--GPDLP--------------------------------IKGK 267 (1021)
T ss_pred HHHHHHHHCCCCCCcCCcHHH-HHHHHh--------c--CCCCC--------------------------------cCCC
Confidence 999999999999965321110 000000 0 00000 0111
Q ss_pred HHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 674 FVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 674 ~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+..+.+||.+||+.+|++|||+.|+++
T Consensus 268 S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 268 SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 456788999999999999999999984
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=301.23 Aligned_cols=262 Identities=25% Similarity=0.451 Sum_probs=198.1
Q ss_pred cccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
..++|++.+.||+|+||.||.|..+ +++.+|+|.+.... ......+.+|+.+++++.||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~---- 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA---- 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc----
Confidence 4578999999999999999999853 46789999886542 334567889999999999999999999853
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCc---------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEH---------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
.++..++||||+++++|.+++....... .....+++..++.++.|++.||+|||+. +++||
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~ 154 (288)
T cd05050 79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154 (288)
T ss_pred -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence 4457899999999999999986432100 0113578889999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g 602 (717)
||+|+||+++.++.++|+|||.+....... ..........+..|+|||.+. +.++.++|||||||++|+|++ |
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCc-----cccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999987542111 011111223456799999965 458999999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||......+ ... .+.+..... .+..++..+.+++.
T Consensus 230 ~~p~~~~~~~~--~~~-----------~~~~~~~~~------------------------------~~~~~~~~l~~li~ 266 (288)
T cd05050 230 MQPYYGMAHEE--VIY-----------YVRDGNVLS------------------------------CPDNCPLELYNLMR 266 (288)
T ss_pred CCCCCCCCHHH--HHH-----------HHhcCCCCC------------------------------CCCCCCHHHHHHHH
Confidence 88886442211 100 000000000 01123567889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~ 704 (717)
+|++.+|++|||+.|+++.|++
T Consensus 267 ~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 267 LCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHcccCcccCCCHHHHHHHhhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.27 Aligned_cols=251 Identities=28% Similarity=0.456 Sum_probs=199.7
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..++|++.+.+|+|++|.||.|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++.+. .....+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 4668999999999999999999875 78899999876544 4578889999999999999999999953 345789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccc
Confidence 99999999999999875421 3689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+....... .....+..|+|||.+. +.++.++||||||+++|++++ |..||....... ........
T Consensus 149 ~~~~~~~~----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~- 215 (256)
T cd05039 149 AKEASQGQ----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKG- 215 (256)
T ss_pred cccccccc----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcC-
Confidence 87651110 0122456799999964 568899999999999999997 999986542111 11111000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
.... .+..++..+.+++.+||+.+|++|||+.|++++|+.
T Consensus 216 -------~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -------YRME---------------------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -------CCCC---------------------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0000 011225678899999999999999999999999875
Q ss_pred H
Q 005045 705 I 705 (717)
Q Consensus 705 i 705 (717)
+
T Consensus 256 ~ 256 (256)
T cd05039 256 I 256 (256)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.76 Aligned_cols=203 Identities=27% Similarity=0.275 Sum_probs=167.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~ 461 (717)
...++|++.+.||+|+||.||.|.+. .++.||+|.+... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999965 7889999988643 2334567788999999999999999999864322 223
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||++ +++.+.+. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence 346899999996 56777664 3478888999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|||.++.... ........++..|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 161 ~Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 161 LDFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred eeCcccccCCC--------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999975411 111233568999999999765 4899999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.62 Aligned_cols=262 Identities=24% Similarity=0.430 Sum_probs=199.7
Q ss_pred ccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|++|.||.|.++ .++.||+|.+.... ......+.+|+.+++.++|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--- 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc---
Confidence 34578999999999999999999854 24679999986442 234567889999999999999999999853
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEH---YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.....++||||+++++|.+++....... .....+++..+..++.||+.|++|||+. +++||||+|+||+++.
T Consensus 80 --~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~ 154 (277)
T cd05032 80 --TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAE 154 (277)
T ss_pred --CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcC
Confidence 4468999999999999999986532211 1124578899999999999999999997 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 613 (717)
++.+||+|||.++....... ........++..|+|||.+. +.++.++|||||||++|++++ |..||.......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred CCCEEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 99999999999876522111 11112234577899999964 568999999999999999998 999986532211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
...... +.... ..+..++..+.+++.+||+.+|++||
T Consensus 230 --~~~~~~-----------~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 230 --VLKFVI-----------DGGHL------------------------------DLPENCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred --HHHHHh-----------cCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 111000 00000 01112256788999999999999999
Q ss_pred CHHHHHHHHH
Q 005045 694 AMNVVVNNLK 703 (717)
Q Consensus 694 s~~eil~~l~ 703 (717)
|+.|+++.|+
T Consensus 267 t~~~l~~~l~ 276 (277)
T cd05032 267 TFLEIVSSLK 276 (277)
T ss_pred CHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.88 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=204.0
Q ss_pred CCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
+++.++..+.++|.+.+.+|+|++|.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++.+..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 567888889999999999999999999999964 78899999886432 2235667899999998 89999999998765
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
......+..++||||+++++|.++++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 433334578999999999999998763211 114688999999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+.+||+|||.+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||....
T Consensus 165 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred CCEEEeecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999987652111 11123457888999999643 25789999999999999999999997542
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.... ...... ..+ +... .+++....+.+++.+||+.+|+
T Consensus 238 ~~~~-~~~~~~-~~~--------~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~ 276 (291)
T cd06639 238 PVKT-LFKIPR-NPP--------PTLL-------------------------------HPEKWCRSFNHFISQCLIKDFE 276 (291)
T ss_pred HHHH-HHHHhc-CCC--------CCCC-------------------------------cccccCHHHHHHHHHHhhcChh
Confidence 2111 000000 000 0000 0112245688999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+||++.|+++
T Consensus 277 ~Rps~~~il~ 286 (291)
T cd06639 277 ARPSVTHLLE 286 (291)
T ss_pred hCcCHHHHhc
Confidence 9999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.06 Aligned_cols=193 Identities=26% Similarity=0.400 Sum_probs=162.8
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++.++ +||+|+++++++ ...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46899999999999965 78889999987542 33456788899999888 699999999984 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 76 EYVNGGDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 999999999888654 5689999999999999999999997 999999999999999999999999999874
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 146 GLG-------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ccC-------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 311 1111234568999999999655 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=297.54 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=191.3
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.++||+|++|.||+|.+ .+++.||+|.+... .......+.+|++++++++||||+++++.+.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 3688999999999999999995 47889999988644 23345678899999999999999999999543 45789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||++++++..+ ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 76 ICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred EEEecCCCCChHHh-----------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99999999988654 2367888899999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+..... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||.............
T Consensus 142 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~------ 206 (279)
T cd06619 142 STQLVN---------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL------ 206 (279)
T ss_pred ceeccc---------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH------
Confidence 875411 11223468889999999655 48999999999999999999999997543221110000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.......+...... .....+.++.+++.+|++.+|++||+++|+++.
T Consensus 207 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 207 QLLQCIVDEDPPVL-----------------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHhccCCCCC-----------------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000000000 001124457899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.04 Aligned_cols=270 Identities=23% Similarity=0.407 Sum_probs=202.6
Q ss_pred ccccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+....++|.+.++||+|++|.||+|+.. ....+|+|.+.... ......+..|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3456689999999999999999999742 24568888876432 33456788899999999 69999999998
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+. ..+..+++|||+++++|.+++...... ......+++..+..++.||+.|++|||+. |++||
T Consensus 87 ~~-----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~ 158 (314)
T cd05099 87 CT-----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHR 158 (314)
T ss_pred Ec-----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeec
Confidence 53 345789999999999999998653210 01124588999999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.++....... ........++..|+|||.+.+ .++.++|||||||++|+|++ |
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDY-----YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred cccceeEEEcCCCcEEEcccccccccccccc-----ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence 9999999999999999999999976522111 011111223467999999654 58899999999999999999 8
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||......+ ...... ..... +.+..++.++.+++.
T Consensus 234 ~~p~~~~~~~~--~~~~~~------------~~~~~-----------------------------~~~~~~~~~l~~li~ 270 (314)
T cd05099 234 GSPYPGIPVEE--LFKLLR------------EGHRM-----------------------------DKPSNCTHELYMLMR 270 (314)
T ss_pred CCCCCCCCHHH--HHHHHH------------cCCCC-----------------------------CCCCCCCHHHHHHHH
Confidence 89986542211 110000 00000 011223556789999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+|++.+|++|||+.|+++.|.++....
T Consensus 271 ~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 271 ECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=303.65 Aligned_cols=203 Identities=21% Similarity=0.272 Sum_probs=159.0
Q ss_pred ccccCcccccceEEEEeC---CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 394 ENLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
.++||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++.+.. ......+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999854 56789999876432 22456789999999999999999988643 23457899999
Q ss_pred cCCCCChhhhccCCCCCc--ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----CCCCceEEeee
Q 005045 471 FMSNGNLDQWLHPSPAEH--YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTAHVGDF 544 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Df 544 (717)
|+. +++.+++....... .....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 985 68888775322111 1123589999999999999999999998 99999999999999 45679999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+....... ..........+|+.|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 157 G~a~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCC----ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9997652111 11112234568999999999755 3789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.22 Aligned_cols=197 Identities=26% Similarity=0.301 Sum_probs=164.3
Q ss_pred ccccccccccCcccccceEEEEeC---CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..+|.+.+.||+|++|.||.|... .++.|++|.+... ....+|++++++++||||+++++.+ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 458999999999999999999743 4677899987633 2345799999999999999999884 34558
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+|||++. +++.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccC
Confidence 999999995 6888888533 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|++....... .........||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 230 G~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 230 GAACKLDAHP-----DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccCccc-----ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9987652211 1112234568999999999765 48999999999999999999999997653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.07 Aligned_cols=196 Identities=24% Similarity=0.326 Sum_probs=162.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...+|.+.+.||+|+||.||+|.+. .++.||+|... ...+.+|++++++++|+||+++++++. ..+..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 3558999999999999999999965 68889999633 234568999999999999999999854 34588
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++|||++ .++|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 236 ~lv~e~~-~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 236 CLVLPKY-RSDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred EEEEEcc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccC
Confidence 9999999 478888876432 4689999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
+++...... .........||..|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus 306 la~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 306 AACFARGSW-----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred Cceeccccc-----ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 987652111 1111223568999999999755 489999999999999999998876543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.91 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=199.5
Q ss_pred cccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
.-..++|.+.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +|+||+++++.+.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 109 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT- 109 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-
Confidence 345578999999999999999999731 34578999876442 34456788999999999 7999999999853
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
..+..++||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.+
T Consensus 110 ----~~~~~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 110 ----IGGPILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG 177 (302)
T ss_pred ----cCCceEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC
Confidence 34578999999999999999875321 3379999999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCch
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDF 614 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 614 (717)
+.++++|||.+....... .........++..|+|||.+.+ .++.++||||+||++|+|++ |..||......+.
T Consensus 178 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~ 252 (302)
T cd05055 178 KIVKICDFGLARDIMNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252 (302)
T ss_pred CeEEECCCcccccccCCC-----ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH
Confidence 999999999987652111 0111122345678999998654 58999999999999999998 9999875432211
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
.... ++...... .+...+..+.+++.+|++.+|++|||
T Consensus 253 -~~~~------------~~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt 290 (302)
T cd05055 253 -FYKL------------IKEGYRMA-----------------------------QPEHAPAEIYDIMKTCWDADPLKRPT 290 (302)
T ss_pred -HHHH------------HHcCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 1000 00000000 00011456789999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 695 MNVVVNNLKTI 705 (717)
Q Consensus 695 ~~eil~~l~~i 705 (717)
+.|+++.|+++
T Consensus 291 ~~ell~~l~~~ 301 (302)
T cd05055 291 FKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHHhh
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.24 Aligned_cols=241 Identities=26% Similarity=0.328 Sum_probs=183.5
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHH-HHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECN-ALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||.|+.+ +|+.||+|++.... ......+..|.. +++.++||||+++++.+ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46899999999999965 78999999886432 223344555554 56778999999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 76 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 76 DFVNGGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 999999999888754 5689999999999999999999997 999999999999999999999999999874
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... . .
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~-----------~ 205 (325)
T cd05604 146 GIA-------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--M-----------Y 205 (325)
T ss_pred CCC-------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--H-----------H
Confidence 311 1111233568999999999765 48899999999999999999999996532111 0 0
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..+........ +..+..+.+++.+|++.+|.+||++++.++.
T Consensus 206 ~~~~~~~~~~~-------------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 206 DNILHKPLVLR-------------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHHHcCCccCC-------------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 11111111100 0114456789999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.65 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=195.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
+-|++.++||+|++|.||+|... ++..+++|.+..........+.+|+++++.++|||++++++.+. .....++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEE
Confidence 34789999999999999999965 67888999887655555677889999999999999999999854 3458899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++++++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 80 v~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred EEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccc
Confidence 999999999998876432 4689999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
...... ........++..|+|||++. ..++.++|||||||++|+|++|..||.......... ...
T Consensus 151 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~ 221 (282)
T cd06643 151 AKNTRT-------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL--KIA 221 (282)
T ss_pred cccccc-------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH--HHh
Confidence 754211 11122345888999999863 236789999999999999999999986543211100 000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
... .+... .+..++..+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~--------~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 222 KSE--------PPTLA-------------------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred hcC--------CCCCC-------------------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 011224567899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.34 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=184.3
Q ss_pred cccCcccccceEEEEeC-C-------CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 395 NLIGTGSFGSVYKGTLG-D-------GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+.||+|+||.||+|..+ . ...+++|.+........+.+.+|+.+++.+.||||+++++.+.. +...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 46899999999999853 2 33588999876655556788899999999999999999998643 34789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc--------
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT-------- 538 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------- 538 (717)
+||||+++++|.+++.... ..+++..++.++.||+.|++|||+. +++||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred EEEecCCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCce
Confidence 9999999999999997653 3578999999999999999999997 9999999999999987764
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCC-CCCCCCCCCchh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGK-RPTGDMFKDDFS 615 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~ 615 (717)
++++|||.+..... .....++..|+|||++.+ .++.++|||||||++|+|++|. .||........
T Consensus 147 ~~l~d~g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~- 214 (258)
T cd05078 147 IKLSDPGISITVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK- 214 (258)
T ss_pred EEecccccccccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-
Confidence 69999998865411 112447788999999765 3789999999999999999985 55543211110
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
...... ...++ .....++.+++.+||+.+|++|||+
T Consensus 215 -~~~~~~----------~~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rps~ 250 (258)
T cd05078 215 -LQFYED----------RHQLP---------------------------------APKWTELANLINQCMDYEPDFRPSF 250 (258)
T ss_pred -HHHHHc----------cccCC---------------------------------CCCcHHHHHHHHHHhccChhhCCCH
Confidence 000000 00000 0113457899999999999999999
Q ss_pred HHHHHHHH
Q 005045 696 NVVVNNLK 703 (717)
Q Consensus 696 ~eil~~l~ 703 (717)
+||++.|+
T Consensus 251 ~~il~~l~ 258 (258)
T cd05078 251 RAIIRDLN 258 (258)
T ss_pred HHHHHhcC
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.83 Aligned_cols=208 Identities=23% Similarity=0.337 Sum_probs=174.2
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
.+.++....++|++.+.||+|+||.||+|+++ +++.||+|++... .......+.+|+.+++.++||||+++++.+
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~- 112 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF- 112 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 35566777899999999999999999999966 7888999987542 223345678899999999999999999884
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.++...++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 113 ----~~~~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~ 177 (371)
T cd05622 113 ----QDDRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK 177 (371)
T ss_pred ----EcCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECC
Confidence 445689999999999999999864 3478888999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
++.+||+|||.+...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 178 ~~~ikL~DfG~a~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 178 SGHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCCEEEEeCCceeEcCcC------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999999999998765211 1111234568999999999653 2688999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.50 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=198.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+++|+|++|.||.|... +++.+++|.+..... ...+.+|++++++++|+||+++++.+. .....|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 578999999999999999999976 588999999875543 578899999999999999999999853 446899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+++||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 75 l~~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred EEEecCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccccc
Confidence 9999999999999986432 5689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||.......... .
T Consensus 146 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~------ 210 (256)
T cd06612 146 SGQLTDTM-------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--M------ 210 (256)
T ss_pred chhcccCc-------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--h------
Confidence 88652211 11222447889999999755 47899999999999999999999997542221100 0
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+.....+. ...+..++..+.+++.+||+.+|++|||+.||++
T Consensus 211 --~~~~~~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 --IPNKPPPT-------------------------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --hccCCCCC-------------------------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000000 0011223556889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.62 Aligned_cols=256 Identities=24% Similarity=0.459 Sum_probs=199.0
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
....++|++.++||+|++|.||+|....+..+++|.+.... .....+.+|+++++.++|+||+++.+.+. . ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CC
Confidence 34567899999999999999999997777889999876433 23467888999999999999999988853 2 46
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++..... ...++..++.++.|++.|+.|||+. +++||||+|+||+++.++.+||+||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCC
Confidence 8999999999999999975421 4578889999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... ........++..|+|||++.+ .++.++|+|||||++|++++ |..||....... .......
T Consensus 147 ~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~ 218 (260)
T cd05073 147 GLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALER 218 (260)
T ss_pred cceeeccCCC------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhC
Confidence 9987542111 111122335677999999654 47889999999999999999 999986532211 1111100
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
. .... .....+..+.+++.+|++.+|++||++.++.+.|
T Consensus 219 ~------------~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 219 G------------YRMP-----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred C------------CCCC-----------------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 0 0000 0112255688999999999999999999999998
Q ss_pred HH
Q 005045 703 KT 704 (717)
Q Consensus 703 ~~ 704 (717)
+.
T Consensus 258 ~~ 259 (260)
T cd05073 258 DD 259 (260)
T ss_pred hc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=293.73 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=196.0
Q ss_pred ccccccccCcccccceEEEEeCCCchhhhHHhHhhh------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ------QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++.+. +.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence 588999999999999999998788999999876331 233466889999999999999999999953 446
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 899999999999999999754 4578899999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+........... .........++..|+|||.+.+ .++.++|||||||++|+|++|..||.......... ....
T Consensus 146 fg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~ 222 (265)
T cd06631 146 FGCARRLAWVGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGA 222 (265)
T ss_pred chhhHhhhhcccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhhh
Confidence 999876522111111 1111223458889999999765 47899999999999999999999996532111100 0000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.....+.. +..++..+.+++.+||+.+|++||++.|+++
T Consensus 223 ------~~~~~~~~---------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 ------HRGLMPRL---------------------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------ccCCCCCC---------------------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001 1112556789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.88 Aligned_cols=266 Identities=23% Similarity=0.389 Sum_probs=198.1
Q ss_pred cccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
....++|++.++||+|++|.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-- 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-- 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--
Confidence 445789999999999999999998743 24578999876432 233456788999999999999999999853
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.....++||||+++++|.+++....... ......++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~ 153 (288)
T cd05061 80 ---KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA 153 (288)
T ss_pred ---CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEc
Confidence 3457899999999999999996532111 0123457788899999999999999997 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.++.++|+|||.++....... ........++..|+|||.+. +.++.++|||||||++|||++ |..||.....+
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred CCCcEEECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999875421111 11111123466799999965 458999999999999999999 78888653221
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
+ ... .+.+..... .+..++..+.+++.+|++.+|++|
T Consensus 229 ~--~~~-----------~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 229 Q--VLK-----------FVMDGGYLD------------------------------QPDNCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred H--HHH-----------HHHcCCCCC------------------------------CCCCCCHHHHHHHHHHcCCChhHC
Confidence 1 000 001110000 011225578899999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIR 706 (717)
Q Consensus 693 ps~~eil~~l~~i~ 706 (717)
||+.|+++.+....
T Consensus 266 ps~~~ll~~l~~~~ 279 (288)
T cd05061 266 PTFLEIVNLLKDDL 279 (288)
T ss_pred cCHHHHHHHHHhhc
Confidence 99999998887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=302.67 Aligned_cols=273 Identities=22% Similarity=0.315 Sum_probs=196.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.++||.|++|.||+|.++ +++.||+|.+.... ......+.+|+.+++.++||||+++++++ ...+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 468999999999999999999965 78889999886442 23345677899999999999999999995 345689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 149 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG 149 (301)
T ss_pred EEEEeccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence 99999996 68988886542 4578999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+...... ........+++.|+|||++.+ .++.++|||||||++|+|++|..||......+ ........
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~ 220 (301)
T cd07873 150 LARAKSIP-------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRI 220 (301)
T ss_pred chhccCCC-------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence 98754211 111122346889999999654 37889999999999999999999997653221 11111111
Q ss_pred CC----hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 624 LP----DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 624 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+. ..+..+.+......... .....+.. ....+..+..+.+++.+|++.+|.+|||++|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 221 LGTPTEETWPGILSNEEFKSYNY-PKYRADCL---------------HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred cCCCChhhchhhhcccccccccc-CccccccH---------------HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 11 11111111100000000 00000000 001122355678999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 285 ~ 285 (301)
T cd07873 285 K 285 (301)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.07 Aligned_cols=202 Identities=27% Similarity=0.282 Sum_probs=167.0
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|+||.||.|.+. .++.||+|++... .......+.+|+.+++.++||||+++++.+.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4679999999999999999999965 7888999988643 2334567788999999999999999998754322 2333
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||++ +++.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence 46899999996 57777764 3478888999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+..... ........++..|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 169 DfG~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 169 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred eCCCccccCC--------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999975411 111233568999999999765 4899999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.44 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=198.6
Q ss_pred ccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
......+|++.+.||+|++|.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++.+. .+
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~ 88 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG 88 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence 345568999999999999999999995 479999999987655445577889999999999999999999853 45
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~ 157 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEC
Confidence 589999999999999999864 3478889999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... ........+++.|+|||...+ .++.++|||||||++|++++|..||....+...... ..
T Consensus 158 Dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~- 228 (297)
T cd06656 158 DFGFCAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA- 228 (297)
T ss_pred cCccceEccCC-------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ec-
Confidence 99988754111 111123457889999999655 478999999999999999999999965422111000 00
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+.. ..+...+..+.+++.+||+.+|++||+++||++
T Consensus 229 --------~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 --------TNGTPEL-------------------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --------cCCCCCC-------------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 001122455778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=299.53 Aligned_cols=273 Identities=22% Similarity=0.361 Sum_probs=203.1
Q ss_pred cccccccccCcccccceEEEEeC-----CCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-----DGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..|++.+.||+|+||.||.|++. +++.+|+|++...... ....+.+|+++++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 56888999999999999999843 4778999998755443 46789999999999999999999988643 224
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 151 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKIS 151 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence 57899999999999999997543 3589999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+....... ..........++..|+|||... ..++.++|||||||++|+|++|..|+......... ...
T Consensus 152 dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~ 224 (284)
T cd05038 152 DFGLAKVLPEDK----DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG 224 (284)
T ss_pred ccccccccccCC----cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence 999998762111 1111111233556799999954 45899999999999999999999998653221100 000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
... .........+.+. ... ....+..++.++.+++.+||+.+|++||||.||+++
T Consensus 225 ~~~---------------~~~~~~~~~~~~~---~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 225 IAQ---------------GQMIVTRLLELLK---EGE-------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred ccc---------------ccccHHHHHHHHH---cCC-------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 000 0000111111110 000 011223456778999999999999999999999999
Q ss_pred HHHH
Q 005045 702 LKTI 705 (717)
Q Consensus 702 l~~i 705 (717)
|+++
T Consensus 280 l~~i 283 (284)
T cd05038 280 VDRL 283 (284)
T ss_pred Hhhc
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.88 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=199.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+.+|.|++|.||.|... +++.+++|++........+.+.+|++++++++||||+++++.+ ......+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence 468999999999999999999965 6788999998866555667889999999999999999999985 3455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 77 l~~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcccc
Confidence 9999999999999887542 4588999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||....+..... .....
T Consensus 148 ~~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~ 219 (262)
T cd06613 148 SAQLTATI-------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKS 219 (262)
T ss_pred chhhhhhh-------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc
Confidence 87652211 11223457888999999643 47889999999999999999999997543221110 00000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..+.. .......+..+.+++.+||+.+|++|||+.+|+.
T Consensus 220 ~--------~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 220 N--------FPPPK------------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--------CCCcc------------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000 0011223566889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.90 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=195.1
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
|+....+.......||+|+||.||+|.+. +++.|++|.+........+.+.+|+.+++.++|+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 76 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----E 76 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----c
Confidence 34455666666678999999999999954 67889999887655555678899999999999999999999853 3
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCccccccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCc
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL--SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMT 538 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~ 538 (717)
++..++||||+++++|.+++.... ..+ ++..+..++.||+.|++|||+. +++||||||+||+++. ++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCe
Confidence 458999999999999999987532 223 7888899999999999999997 9999999999999986 679
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
++|+|||.+....... .......++..|+|||.+.+ .++.++||||||+++|+|++|..||.........
T Consensus 148 ~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~ 220 (268)
T cd06624 148 VKISDFGTSKRLAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220 (268)
T ss_pred EEEecchhheecccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh
Confidence 9999999987542111 11122357889999999643 2688999999999999999999998654221111
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
........ ..+. .+..++..+.+++.+||+.+|++|||+
T Consensus 221 ~~~~~~~~--------~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 259 (268)
T cd06624 221 MFKVGMFK--------IHPE---------------------------------IPESLSAEAKNFILRCFEPDPDKRASA 259 (268)
T ss_pred Hhhhhhhc--------cCCC---------------------------------CCcccCHHHHHHHHHHcCCCchhCCCH
Confidence 10000000 0000 111235567889999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
.|+++
T Consensus 260 ~~ll~ 264 (268)
T cd06624 260 HDLLQ 264 (268)
T ss_pred HHHHh
Confidence 99986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.28 Aligned_cols=276 Identities=24% Similarity=0.306 Sum_probs=194.8
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||+|++|.||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++.+. .++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 5889999999999999999965 78899999886442 223466788999999999999999999953 456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||++ +++.+++..... ...+++..+..++.||+.||+|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 9999996 688888764321 14689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||......+.... .... .
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~-~ 218 (285)
T cd07861 148 ARAFGIP-------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRI-L 218 (285)
T ss_pred eeecCCC-------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHH-h
Confidence 8754111 111122346788999999654 368899999999999999999999975432211111 0000 0
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.......+. . .....+.... ...............++.++.+++.+||+.+|++|||++||+.
T Consensus 219 ~~~~~~~~~-~--------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 219 GTPTEDVWP-G--------VTSLPDYKNT----FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCChhhhh-c--------chhhHHHHhh----ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0 0000000000 0000000000011223567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=292.40 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=185.2
Q ss_pred cccCcccccceEEEEeC---CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++.+. +....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 36899999999999854 34568888876443 233457888999999999999999999854 3457899999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred CCCCCcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999998643211 113456778889999999999999997 9999999999999999999999999998643
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC--------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--------QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
... ..........++..|+|||++.+ .++.++|||||||++|||++ |..||......+. ......
T Consensus 151 ~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~ 224 (269)
T cd05087 151 YKE-----DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVR 224 (269)
T ss_pred cCc-----ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhh
Confidence 111 01111122446788999999653 24789999999999999996 9999975433221 110000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.......++.... .++..+.+++.+|+ .+|++|||++||++.
T Consensus 225 ----~~~~~~~~~~~~~---------------------------------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 225 ----EQQLKLPKPRLKL---------------------------------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred ----cccCCCCCCccCC---------------------------------CCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 0000111111110 11345677899998 589999999999988
Q ss_pred HH
Q 005045 702 LK 703 (717)
Q Consensus 702 l~ 703 (717)
|+
T Consensus 267 l~ 268 (269)
T cd05087 267 LS 268 (269)
T ss_pred hc
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=308.47 Aligned_cols=201 Identities=26% Similarity=0.336 Sum_probs=166.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.... ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578999999999999999999954 78889999886432 223456778999999999999999998754321 1223
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...+++++++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 4579999988 7899888753 3589999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+..... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 161 Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 161 DFGLARQADD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred CCccceecCC----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999876411 1123468899999999755 4789999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.85 Aligned_cols=190 Identities=24% Similarity=0.377 Sum_probs=158.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..+|++.+.||+|+||.||+|... +++.||+|+... .....|+.++++++|+||+++++.+. .....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCeeE
Confidence 457999999999999999999965 677899997432 22346899999999999999999854 345889
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|||++. +++.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 134 lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EEEEccC-CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 9999995 68888876432 5689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
+.... .........||..|+|||++.+ .++.++|||||||++|||+++..|+
T Consensus 204 a~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPV--------VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccc--------cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 87431 1111234568999999999655 5899999999999999999965554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=303.82 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=164.2
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
+|+..+.||+|+||.||+|..+ +|+.||+|++.... ....+.+..|..+++.+. |++|+++.+++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 4778899999999999999965 78999999886442 233466778888988885 56677777773 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecc
Confidence 99999999999999998754 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+..... .........|++.|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 146 g~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 146 GMCKEHMV-------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred ccccccCC-------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 99875311 1111223458999999999765 4799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.54 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=194.6
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.+|.|++|.||.+..+ +++.||+|.+.... ....+.+..|++++++++|+|++++.+.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5899999999999999999965 67889999886432 334567889999999999999999988742 2344689
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||+++++|.+++..... ..+++.++..++.+++.|++++|+. +++||||+|+||+++.++.++|+|||.
T Consensus 77 lv~e~~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred EEecccCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence 99999999999999875321 4589999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........+++.|+|||+..+ .++.++||||+||++|+|++|+.||........ ......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~---- 216 (257)
T cd08223 149 ARVLENQ-------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIE---- 216 (257)
T ss_pred eEEeccc-------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHh----
Confidence 8765211 111223457889999999654 478999999999999999999999864321110 000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...+. .+...+..+.+++.+|++.+|++|||+.|+++.
T Consensus 217 --------~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 --------GKLPP------------------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --------cCCCC------------------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 011224567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.75 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=202.1
Q ss_pred ccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCC-CCceeEEEEeec
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTR-HRNILRVITACS 455 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~ 455 (717)
+....++|.+.++||+|+||.||+|.+. .++.||+|++.... ....+.+..|++++.++. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 5566778999999999999999999853 34679999997542 233457889999999997 999999999864
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------------------------------------------
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH----------------------------------------------- 488 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------------------------------------------- 488 (717)
. .+..++||||+++|+|.++++......
T Consensus 112 ~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 112 K-----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred c-----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 3 457899999999999999986532100
Q ss_pred --------------------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 489 --------------------------------------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 489 --------------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
.....+++..+.+++.||+.|++|||+. +++||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence 0113467888999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.+........ ........++..|+|||.+.+ .++.++|||||||++|||++ |
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999875421111 011122346788999999654 57899999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||......+. ..... ....... .+..++..+.+++.
T Consensus 339 ~~P~~~~~~~~~-~~~~~------------~~~~~~~-----------------------------~p~~~~~~l~~li~ 376 (401)
T cd05107 339 GTPYPELPMNEQ-FYNAI------------KRGYRMA-----------------------------KPAHASDEIYEIMQ 376 (401)
T ss_pred CCCCCCCCchHH-HHHHH------------HcCCCCC-----------------------------CCCCCCHHHHHHHH
Confidence 999865422211 10000 0000000 01122556889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
+||..+|++||+++||++.|+.+.
T Consensus 377 ~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 377 KCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCChhHCcCHHHHHHHHHHHh
Confidence 999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=302.74 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=200.2
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh---hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ---GALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++...|..++.||.|+||.||-|++. +.+.||||.+..... +.-..+..|++.+++++|||++.+-+||-
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL----- 96 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL----- 96 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----
Confidence 345668899999999999999999954 889999999975432 22366789999999999999999998853
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.....|+|||||- |+-.|++.-.. +.+.+.++..|..+.+.||+|||+. +.+|||||+.||++++.|.||
T Consensus 97 re~TaWLVMEYCl-GSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 97 REHTAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred ccchHHHHHHHHh-ccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeee
Confidence 3347899999994 68888876554 6788999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
|+|||.|..+. ....++|||.|||||++ .|+|+-++||||||++-.||--.++|+..+..-. .
T Consensus 167 LaDFGSAsi~~-----------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--A 233 (948)
T KOG0577|consen 167 LADFGSASIMA-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A 233 (948)
T ss_pred eccccchhhcC-----------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--H
Confidence 99999998762 12247799999999994 5789999999999999999999999976552211 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.+++..+ -.|.+. ..+-+..|..|+..|++.-|.+|||..
T Consensus 234 LYHIAQN--------esPtLq--------------------------------s~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 234 LYHIAQN--------ESPTLQ--------------------------------SNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred HHHHHhc--------CCCCCC--------------------------------CchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 1111111 111111 122366788999999999999999999
Q ss_pred HHHHH
Q 005045 697 VVVNN 701 (717)
Q Consensus 697 eil~~ 701 (717)
+++..
T Consensus 274 ~ll~H 278 (948)
T KOG0577|consen 274 ELLKH 278 (948)
T ss_pred HHhhc
Confidence 98753
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.18 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=203.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+.+-|.|+..+|.|+||.||+|+.+ ++-..|.|++.....+....+.-|++||..++||+|+++++.|+. .+.+
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----enkL 104 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----ENKL 104 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCce
Confidence 4567899999999999999999976 445567788887777788999999999999999999999998543 3489
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
||+.|||+||-++.++-... ..+++.++.-++.|++.||.|||++ .|+|||||+.||+++.+|.++|+|||
T Consensus 105 wiliEFC~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EEEEeecCCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence 99999999999998876543 6789999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
.+... .........++||+.|||||+.. ..|++++||||||+++.||..+.+|.....+-...+ .
T Consensus 176 VSAKn-------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll--K 246 (1187)
T KOG0579|consen 176 VSAKN-------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--K 246 (1187)
T ss_pred ccccc-------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH--H
Confidence 98754 22334456789999999999952 248999999999999999999999987653321100 0
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+ ..--.|.+. .++ .-...|.+|+.+||..+|+.||++.+++
T Consensus 247 i--------aKSePPTLl--------------------------qPS-----~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 247 I--------AKSEPPTLL--------------------------QPS-----HWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred H--------hhcCCCccc--------------------------Ccc-----hhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 0 000011111 111 1266788999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 288 ~ 288 (1187)
T KOG0579|consen 288 K 288 (1187)
T ss_pred h
Confidence 5
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.61 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=182.0
Q ss_pred ccCcccccceEEEEeC-------------------------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEE
Q 005045 396 LIGTGSFGSVYKGTLG-------------------------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
+||+|+||.||+|... ....|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998732 113478888876555555678889999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 530 (717)
++++.. ....++||||+++++|.+++.... ..+++..+..++.||++||+|||+. +++||||||+|
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~N 147 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKN 147 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCccc
Confidence 999643 447899999999999999986532 5688999999999999999999997 99999999999
Q ss_pred EEeCCCC-------ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHH-
Q 005045 531 VLLDKDM-------TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMF- 600 (717)
Q Consensus 531 Ill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~ell- 600 (717)
|+++..+ .+|++|||.+..... .....++..|+|||.+.+ .++.++|||||||++||++
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~-----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALS-----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEEeccCcccCccceeeecCCcccccccc-----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9997644 489999998764311 011246778999998754 4789999999999999995
Q ss_pred hCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHH
Q 005045 601 TGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680 (717)
Q Consensus 601 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 680 (717)
+|..||........ .... ....... +.....+.++
T Consensus 217 ~g~~p~~~~~~~~~--~~~~------------~~~~~~~-------------------------------~~~~~~~~~l 251 (274)
T cd05076 217 DGEVPLKERTPSEK--ERFY------------EKKHRLP-------------------------------EPSCKELATL 251 (274)
T ss_pred CCCCCccccChHHH--HHHH------------HhccCCC-------------------------------CCCChHHHHH
Confidence 69999865432211 0000 0000000 0012357889
Q ss_pred hhccCCCCcCCCCCHHHHHHHHH
Q 005045 681 GLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 681 i~~cl~~~p~~Rps~~eil~~l~ 703 (717)
+.+||+.+|++|||+++|++.|+
T Consensus 252 i~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 252 ISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHcccChhhCcCHHHHHHhhC
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=296.18 Aligned_cols=268 Identities=23% Similarity=0.370 Sum_probs=197.7
Q ss_pred cccccccccccCcccccceEEEEeCC-----------------CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCcee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD-----------------GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNIL 448 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~ 448 (717)
..++|++.+.||+|+||.||.|.... +..||+|.+.... ....+.+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34689999999999999999988542 2347888876542 34467788999999999999999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCc----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH----YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
++++++. .+...+++||++++++|.+++....... .....+++..++.++.|++.||+|||+. +++||
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~ 154 (296)
T cd05051 83 RLLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHR 154 (296)
T ss_pred EEEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 9999853 3458899999999999999987542100 0113689999999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh--
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-- 601 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-- 601 (717)
||||+||+++.++.++|+|||.+....... .........++..|+|||.+.+ .++.++|||||||++|||++
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSD-----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred ccchhceeecCCCceEEccccceeecccCc-----ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 999999999999999999999987542111 1111223446778999999654 68999999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHh
Q 005045 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 681 (717)
|..||....... ............ +.... ...+..++.++.+++
T Consensus 230 ~~~p~~~~~~~~--~~~~~~~~~~~~-----~~~~~-----------------------------~~~~~~~~~~l~~li 273 (296)
T cd05051 230 REQPYEHLTDQQ--VIENAGHFFRDD-----GRQIY-----------------------------LPRPPNCPKDIYELM 273 (296)
T ss_pred CCCCCCCcChHH--HHHHHHhccccc-----ccccc-----------------------------CCCccCCCHHHHHHH
Confidence 677775432111 111110000000 00000 001112356789999
Q ss_pred hccCCCCcCCCCCHHHHHHHHH
Q 005045 682 LMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 682 ~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.+|++.+|++|||+.||++.|+
T Consensus 274 ~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 274 LECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhccChhcCCCHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.11 Aligned_cols=193 Identities=29% Similarity=0.401 Sum_probs=158.2
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHH-HHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECN-ALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|++. +++.||+|++.... ......+..|.. +++.++||||+++++.+ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 46899999999999965 78899999886432 223344555544 67889999999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+|.+||+|||++..
T Consensus 76 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 76 DYVNGGELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999999888644 5688899999999999999999997 999999999999999999999999999874
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 146 GVE-------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CCC-------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 311 1112233568999999999765 4889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.40 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=191.2
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCC
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMS 473 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 473 (717)
++||+|++|.||.|.+..++.|++|.+..... .....+..|+++++++.|+||+++++.+. .....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCC
Confidence 47899999999999976699999998875433 24567889999999999999999999853 4458899999999
Q ss_pred CCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccc
Q 005045 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553 (717)
Q Consensus 474 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 553 (717)
+++|.+++.... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 76 GGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 999999986532 4578899999999999999999998 9999999999999999999999999998754211
Q ss_pred cCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 554 SDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
. ..........+..|+|||.+. +.++.++|||||||++|+|++ |..||....... .....
T Consensus 147 ~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~----------- 208 (251)
T cd05041 147 I-----YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERI----------- 208 (251)
T ss_pred c-----ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHH-----------
Confidence 0 001111122356799999965 458999999999999999999 888886543211 11000
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
....... .+..++..+.+++.+|++.+|++|||+.|+++.|.
T Consensus 209 -~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 -ESGYRMP-----------------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -hcCCCCC-----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0000000 01122556889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=289.95 Aligned_cols=246 Identities=29% Similarity=0.438 Sum_probs=190.1
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCC
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMS 473 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 473 (717)
+.||+|++|.||+|...+++.+|+|.+.... ......+.+|+++++.++||||+++++.+. ..+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence 3689999999999998788899999876442 233456889999999999999999999864 3447899999999
Q ss_pred CCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccc
Q 005045 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553 (717)
Q Consensus 474 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 553 (717)
+++|.+++.... ..+++..+..++.|++.|+.|+|+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 76 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 76 GGDFLSFLRKKK------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 999999986542 4578999999999999999999997 9999999999999999999999999998754111
Q ss_pred cCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 554 SDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
. ........++..|+|||++. +.++.++|||||||++|++++ |..||....... ........
T Consensus 147 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~-------- 210 (250)
T cd05085 147 I------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKG-------- 210 (250)
T ss_pred c------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcC--------
Confidence 1 11111123456799999965 458999999999999999998 999996542211 10000000
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.... .+..++..+.+++.+|++.+|++|||+.|+++.|.
T Consensus 211 ~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 YRMS---------------------------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCC---------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0000 01112567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.24 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=194.3
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhH--HHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.++||+|++|.||+++.+ +++.||+|++....... ......|+.++++++||||+++++.+.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 788999999999999999966 67789999998664332 2234569999999999999999999543 568899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
|||++++++|.+++... ..+++..+..++.||+.||++||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 v~~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEETTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccc-------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999988999999732 5689999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
... ...........++..|+|||+.. ..++.++||||+|+++|+|++|..||...... ........
T Consensus 146 ~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~--- 213 (260)
T PF00069_consen 146 VKL-------SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEK--- 213 (260)
T ss_dssp EES-------TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHH---
T ss_pred ccc-------cccccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhh---
Confidence 753 11222334456888999999976 45899999999999999999999999754100 00000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
........ ... ........+.+++.+||+.+|++|||+.|+++
T Consensus 214 ---------------------------~~~~~~~~--~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 214 ---------------------------ILKRPLPS--SSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---------------------------HHHTHHHH--HTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---------------------------cccccccc--ccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 000 00011367899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.67 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=201.3
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccC-CC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDL-EG 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~-~~ 461 (717)
..+.++|++.+.+|+|++|.||.|..+ +++.+++|++..... ....+.+|+.+++++ .|+||+++++.+..... ..
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457799999999999999999999975 678899998875543 346788999999999 79999999999765432 34
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 5678999999999999998864321 115689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+|||.+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||........
T Consensus 155 ~d~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 226 (275)
T cd06608 155 VDFGVSAQLDST-------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA- 226 (275)
T ss_pred CCCccceecccc-------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-
Confidence 999998754211 111223458889999998642 367899999999999999999999964322110
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
.. ++...... ....+.+++..+.+++.+||..+|++|||+
T Consensus 227 ~~------------~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~ 266 (275)
T cd06608 227 LF------------KIPRNPPP----------------------------TLKSPENWSKKFNDFISECLIKNYEQRPFM 266 (275)
T ss_pred HH------------HhhccCCC----------------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence 00 00000000 000112235678899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
.|+++
T Consensus 267 ~~ll~ 271 (275)
T cd06608 267 EELLE 271 (275)
T ss_pred HHHhc
Confidence 99986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.32 Aligned_cols=201 Identities=27% Similarity=0.377 Sum_probs=168.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||.++.+ +++.||+|++... .....+.+.+|+.+++.++|++|+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 47999999999999999999965 7899999998643 233456688999999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999986532 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+....... ........|++.|+|||++. +.++.++||||+||++|+|++|..||...
T Consensus 147 g~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 147 GSCLRLLADG------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CceeecCCCC------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 9987542111 11112245899999999965 24688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.08 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=202.3
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
++.+...+.+.|++.+.+|.|+||.||+|.+. +++.+|+|+...... ....+..|+.+++++ +|+||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 56666678899999999999999999999964 788999998765432 335678899999998 799999999987543
Q ss_pred cC-CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 458 DL-EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 458 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.. ......+++|||+++++|.+++..... ..+++..+..++.||+.|++|||+. +++||||+|+||+++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 21 235678999999999999999875421 4578888999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+.++|+|||.+...... ........++..|+|||.+. ..++.++|||||||++|+|++|..||....
T Consensus 158 ~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 158 AEVKLVDFGVSAQLDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred CCEEEeeCcchhhhhcc-------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 99999999998754211 11122345888999999864 247889999999999999999999996542
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
+..... . ......+.. ....++..+.+++.+||+.+|.
T Consensus 231 ~~~~~~--~--------~~~~~~~~~--------------------------------~~~~~~~~~~~li~~cl~~~p~ 268 (282)
T cd06636 231 PMRALF--L--------IPRNPPPKL--------------------------------KSKKWSKKFIDFIEGCLVKNYL 268 (282)
T ss_pred HHhhhh--h--------HhhCCCCCC--------------------------------cccccCHHHHHHHHHHhCCChh
Confidence 211000 0 000000000 1112356789999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||+.||++
T Consensus 269 ~Rp~~~ell~ 278 (282)
T cd06636 269 SRPSTEQLLK 278 (282)
T ss_pred hCcCHHHHhc
Confidence 9999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.06 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=192.6
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.|++.+.||+|+||.||.|.+. +++.||+|.+.... ......+..|+.++++++|++|+.+++.+ ...+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 3778899999999999999965 78999999876432 22335567899999999999999999884 345589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999998854321 4589999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+...... .......|+..|+|||++.+ .++.++||||+||++|+|++|..||........ .. ..
T Consensus 148 ~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~-~~---- 213 (285)
T cd05630 148 LAVHVPEG--------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-RE-EV---- 213 (285)
T ss_pred ceeecCCC--------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HH-HH----
Confidence 98654111 11123468999999999654 589999999999999999999999975322110 00 00
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----HHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----MNVVV 699 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~eil 699 (717)
....+ .... ..+..++..+.+++.+||+.+|++||| ++|++
T Consensus 214 ----~~~~~-------------------~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 214 ----ERLVK-------------------EVQE-----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred ----Hhhhh-------------------hhhh-----------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH
Confidence 00000 0000 001122455788999999999999999 88998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 260 ~h 261 (285)
T cd05630 260 EH 261 (285)
T ss_pred cC
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.91 Aligned_cols=342 Identities=28% Similarity=0.444 Sum_probs=246.6
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+..|+.++|.++ .+|+.++.+-.|..|+..+|+++ ..|+.+..+.+|..|++.+|+++. .|...-+++.|++||..
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccc
Confidence 4455555555555 45555555555666666666655 555556666666666666666663 33333336667777777
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|-++ .+|..++.+.+|..|+|.+|+|. ..| .|.+++.|++|++..|.|. .+|......+++|.+|||.+|++. .
T Consensus 192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 192 SNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred hhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-c
Confidence 77776 77777888888888888888888 455 7888888888888888887 888888888999999999999998 6
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCccc-----Cchhhhhhh----------------
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREI-----GDLNFLKFL---------------- 229 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~~~~~---------------- 229 (717)
.|+.++-+.+|++||+|+|.|+ ..|..++++ .|+.|.+.+|.++.+.- |.-...+.+
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~ 344 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT 344 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence 7888888999999999999999 677788888 88888888888764321 000000000
Q ss_pred -------------------------------------c---cCCCCCEEEeecCcccCcCch------------------
Q 005045 230 -------------------------------------A---NCTSLEVLGLARNSFGGEMPI------------------ 251 (717)
Q Consensus 230 -------------------------------------~---~l~~L~~L~L~~N~l~~~~p~------------------ 251 (717)
. .-.-....+++.|++. ++|.
T Consensus 345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 345 ETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred cccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 0 0011445555555554 4444
Q ss_pred ------hhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcc
Q 005045 252 ------SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS 325 (717)
Q Consensus 252 ------~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 325 (717)
.+..+ ++|..|+|++|.+. .+|..+..+..|+.|+++.|++. ..|.++..+..|+.+-.++|++..+.+..
T Consensus 424 isfv~~~l~~l-~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 424 ISFVPLELSQL-QKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred cccchHHHHhh-hcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence 34444 46777777777776 56777777777777777777777 67777777777777777778888777778
Q ss_pred cccccccceeecccccccccCCcCccCcCCCceEEeecccCC
Q 005045 326 LGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 367 (717)
+.+|.+|.+|||.+|.+. .+|..+++|++|++|++.||||.
T Consensus 501 l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 999999999999999999 99999999999999999999997
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.52 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=194.4
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---------QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
+|.+...||+|++|.||.|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 5788899999999999999964 68889999775321 123467889999999999999999999853
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
..+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGI 145 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCE
Confidence 445889999999999999999754 4578899999999999999999997 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
+|+|||.+........... .........++..|+|||.+.+ .++.++||||+||++|+|++|..||....... ...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~- 222 (267)
T cd06628 146 KISDFGISKKLEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIF- 222 (267)
T ss_pred EecccCCCcccccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHH-
Confidence 9999999886632111100 1111123457889999999655 57889999999999999999999997532111 000
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+.....+.. +...+..+.+++.+||+.+|.+||++.||
T Consensus 223 --------~~~~~~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (267)
T cd06628 223 --------KIGENASPEI---------------------------------PSNISSEAIDFLEKTFEIDHNKRPTAAEL 261 (267)
T ss_pred --------HHhccCCCcC---------------------------------CcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence 0000001111 11225567889999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 262 l~ 263 (267)
T cd06628 262 LK 263 (267)
T ss_pred hh
Confidence 86
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=290.23 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=193.4
Q ss_pred cccCcccccceEEEEeC--CCc--hhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG--DGT--IVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|++|.||+|.+. .++ .||+|.+..... ...+.+..|++++++++||||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 46899999999999864 233 589999876654 566789999999999999999999998532 5789999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+..
T Consensus 75 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred EecCCCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence 99999999999876421 3579999999999999999999997 999999999999999999999999999987
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
...... .........++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+ ........
T Consensus 147 ~~~~~~----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~---- 216 (257)
T cd05040 147 LPQNED----HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE---- 216 (257)
T ss_pred cccccc----ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc----
Confidence 632111 1111123446788999999765 58999999999999999999 999986542211 11110000
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.... ..+..++..+.+++.+|++.+|++|||++|+++.|.
T Consensus 217 -----~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 -----GERL-------------------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCcC-------------------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000 011123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=291.52 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=188.9
Q ss_pred cccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.+++.++||||+++++.+. ..++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 46899999999999843 3456899987533 3344577889999999999999999999763 2345678999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 77 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 77 PYMKHGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred ecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccc
Confidence 9999999999987542 3457778899999999999999997 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCchhhhHHHHhcCChh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTG-KRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... .........++..|+|||.+. +.++.++|||||||++|||++| ..||..... .......
T Consensus 148 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~------- 215 (262)
T cd05058 148 IYDKEYY---SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL------- 215 (262)
T ss_pred ccCCcce---eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH-------
Confidence 4211100 001111234567899999964 4588999999999999999995 555643211 1111110
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
....... .+..++..+.+++.+||+.+|++||++.||++.++++..
T Consensus 216 ----~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 216 ----LQGRRLL------------------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----hcCCCCC------------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0000000 011124568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.57 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=170.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||.|..+ +++.||+|++.... ......+..|+.++.+++|++|+++++.+ .+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47899999999999999999965 78999999886432 33456788899999999999999999884 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.+|.++|+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeec
Confidence 99999999999999998754 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCC----------------------------CCcceeecccccccccCCCccCC-CCCcccchhhHHHH
Q 005045 545 GLAKFLFEISDNPS----------------------------KNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGIL 595 (717)
Q Consensus 545 g~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~v 595 (717)
|++........... ..........||+.|+|||++.+ .++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 99875421110000 00001123468999999999655 48999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 005045 596 LLEMFTGKRPTGDM 609 (717)
Q Consensus 596 l~elltg~~p~~~~ 609 (717)
+|||++|..||...
T Consensus 226 lyel~tG~~Pf~~~ 239 (360)
T cd05627 226 MYEMLIGYPPFCSE 239 (360)
T ss_pred eeecccCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.68 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=194.4
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
..+|++.+.||+|++|.||+|.+.+++.+|+|.+..... ....+.+|+++++++.||+++++++.+. .....++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence 357899999999999999999987788899998764322 2356888999999999999999999853 4457899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||+++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 77 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EEEcCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence 999999999999987542 4578899999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
...... .........++..|+|||.+. +.++.++|||||||++|+|++ |..||...... .......
T Consensus 148 ~~~~~~------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~---- 215 (256)
T cd05112 148 RFVLDD------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETIN---- 215 (256)
T ss_pred eecccC------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHh----
Confidence 754211 111112233567899999965 458899999999999999998 99998653211 1111100
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
....... +...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 216 ----~~~~~~~---------------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 ----AGFRLYK---------------------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCCCCC---------------------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0000000 001145688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.34 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=203.5
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhh---HHHHHHHHHHHHhcCC-CCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG---ALKSFIDECNALKSTR-HRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 460 (717)
.....|++.+.+|+|.||.||.++.+ +|+.+|+|.+...... ....+.+|+++|+++. ||||+.+++. ++
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FE 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EE
Confidence 34568999999999999999999976 6999999999866432 3468899999999997 9999999999 45
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC----
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD---- 536 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---- 536 (717)
.....++|||++.||.|.+.+... .+++..+..++.||+.|++|||+. ||+|||+||+|+++...
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCC
Confidence 556999999999999999998743 289999999999999999999998 99999999999999633
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+.+|++|||++.... . .......+||+.|+|||++. ..++..+||||+||++|.|++|..||.........
T Consensus 176 ~~ik~~DFGla~~~~-------~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~ 247 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIK-------P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF 247 (382)
T ss_pred CcEEEeeCCCceEcc-------C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence 579999999999762 1 33456688999999999987 57999999999999999999999999765332211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
. ......+ .....+ -+..+....+++.+|+..||..|+|+
T Consensus 248 ~-~i~~~~~----------~f~~~~-----------------------------w~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 248 L-AILRGDF----------DFTSEP-----------------------------WDDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred H-HHHcCCC----------CCCCCC-----------------------------ccccCHHHHHHHHHhcccCcccCCCH
Confidence 1 0000000 111111 11224556889999999999999999
Q ss_pred HHHHHH
Q 005045 696 NVVVNN 701 (717)
Q Consensus 696 ~eil~~ 701 (717)
+++++.
T Consensus 288 ~~~L~H 293 (382)
T KOG0032|consen 288 AQALQH 293 (382)
T ss_pred HHHhcC
Confidence 999984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.30 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=200.5
Q ss_pred cccccccccccCcccccceEEEEeC-CCc----hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|++.+.||+|+||.||+|.++ +|+ .+|+|...... ......+.+|+.+++++.||||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 3468999999999999999999854 343 47888776543 3345678899999999999999999998743
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
...++||||+++++|.+++.... ..+++..+..++.||+.|++|||+. +++||||+|+||+++.++.+|
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEE
Confidence 47899999999999999987543 4589999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.++....... ........++..|+|||.+. +.++.++|+|||||++||+++ |..||.....++ ...
T Consensus 150 L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~ 222 (279)
T cd05057 150 ITDFGLAKLLDVDEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPD 222 (279)
T ss_pred ECCCcccccccCccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH
Confidence 999999986521111 11111222456799999964 458999999999999999998 999997642211 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... .... ..+..++..+.+++.+||..+|++|||+.++
T Consensus 223 ~~~~------------~~~~-----------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 223 LLEK------------GERL-----------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred HHhC------------CCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1110 0000 0111124567889999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
++.++++.+.
T Consensus 262 ~~~l~~~~~~ 271 (279)
T cd05057 262 INEFSKMARD 271 (279)
T ss_pred HHHHHHHHhC
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.30 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=202.0
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++-|...+.||+|.|..|-+|++- +|++||||++.... .-....+..|++.|+-+.|||||++|++ ++...
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 4567999999999999999999954 89999999997653 3345678899999999999999999999 66677
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe-CCCCceEEe
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHVG 542 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~ 542 (717)
.+|+|+|.=++|+|+|||.++. ..+.+..+.++++||+.|+.|+|+. .+|||||||+||.+ ..-|-|||+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEee
Confidence 9999999999999999998775 5689999999999999999999998 89999999999766 577899999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+..+. +...-...+|...|.|||++.|. | .+++|||||||++|.|+.|+.||....+.+. +
T Consensus 162 DFGFSNkf~--------PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-L---- 228 (864)
T KOG4717|consen 162 DFGFSNKFQ--------PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-L---- 228 (864)
T ss_pred eccccccCC--------CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-h----
Confidence 999987652 22233456799999999997664 5 5889999999999999999999988754421 1
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.-+.|=.. . .+...+.+..++|.+|+..||.+|.|.+||+.
T Consensus 229 --------TmImDCKY--------------------------t-----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 --------TMIMDCKY--------------------------T-----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --------hhhhcccc--------------------------c-----CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 01111111 0 11122555678999999999999999999874
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=289.36 Aligned_cols=238 Identities=22% Similarity=0.382 Sum_probs=182.3
Q ss_pred cccCcccccceEEEEeCC-------------CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 395 NLIGTGSFGSVYKGTLGD-------------GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
+.||+|++|.||.|.... ...|++|++..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 468999999999998431 22488888776655556678899999999999999999998643
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc---
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT--- 538 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--- 538 (717)
....++||||+++++|..++.... ..+++..+..++.||++|++|||+. +++||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCC
Confidence 346799999999999998876432 4589999999999999999999997 9999999999999986654
Q ss_pred ----eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHH-hCCCCCCCCCC
Q 005045 539 ----AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMF-TGKRPTGDMFK 611 (717)
Q Consensus 539 ----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~ell-tg~~p~~~~~~ 611 (717)
++++|||.+.... ......++..|+|||.+. +.++.++|||||||++|+|+ +|..||.....
T Consensus 147 ~~~~~~l~d~g~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 147 CGPFIKLSDPGIPITVL-----------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCceeEeCCCCCCcccc-----------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 8999999886541 111234678899999964 34889999999999999998 58888764321
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
.+. ... ........ ......+.+++.+||+.+|++
T Consensus 216 ~~~--~~~------------~~~~~~~~-------------------------------~~~~~~~~~li~~cl~~dp~~ 250 (262)
T cd05077 216 AEK--ERF------------YEGQCMLV-------------------------------TPSCKELADLMTHCMNYDPNQ 250 (262)
T ss_pred hHH--HHH------------HhcCccCC-------------------------------CCChHHHHHHHHHHcCCChhh
Confidence 110 000 00000000 001345788999999999999
Q ss_pred CCCHHHHHHHH
Q 005045 692 RIAMNVVVNNL 702 (717)
Q Consensus 692 Rps~~eil~~l 702 (717)
||+++||++.|
T Consensus 251 Rp~~~~il~~~ 261 (262)
T cd05077 251 RPFFRAIMRDI 261 (262)
T ss_pred CcCHHHHHHhc
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.71 Aligned_cols=271 Identities=24% Similarity=0.406 Sum_probs=202.3
Q ss_pred cccccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEE
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVIT 452 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~ 452 (717)
++.....+|++.+.||+|+||.||.|.+. .+..||+|.+.... ....+.+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34445568999999999999999999742 12358899876432 33457788999999999 8999999999
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 523 (717)
.+. ..+..+++|||+++++|.+++....... .....+++..+..++.|++.|++|||++ +++|
T Consensus 86 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH 157 (334)
T cd05100 86 ACT-----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIH 157 (334)
T ss_pred EEc-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 853 3457899999999999999987532110 1124588899999999999999999997 9999
Q ss_pred cCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-
Q 005045 524 CDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT- 601 (717)
Q Consensus 524 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt- 601 (717)
|||||+||+++.++.+||+|||.++....... ........++..|+|||++.+ .++.++|||||||++|+|++
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999876521110 111111224567999999654 58899999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHh
Q 005045 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 681 (717)
|..||.....++ ...... ..... +.+..++..+.+++
T Consensus 233 g~~p~~~~~~~~--~~~~~~------------~~~~~-----------------------------~~~~~~~~~l~~li 269 (334)
T cd05100 233 GGSPYPGIPVEE--LFKLLK------------EGHRM-----------------------------DKPANCTHELYMIM 269 (334)
T ss_pred CCCCCCCCCHHH--HHHHHH------------cCCCC-----------------------------CCCCCCCHHHHHHH
Confidence 888886542111 100000 00000 01112355688999
Q ss_pred hccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 682 LMCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 682 ~~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
.+||+.+|++|||+.|+++.|+++....
T Consensus 270 ~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 270 RECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 9999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.00 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=200.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+. .....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence 468999999999999999999965 68889999876442 344678899999999999999999999953 34689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... +.+++..+..++.+++.|+.|||+. .+++||||+|+||+++.++.++|+|||
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred EEEEecCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCC
Confidence 9999999999999998754 4689999999999999999999974 289999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
++...... ......++..|+|||++ .+.++.++|||||||++|++++|..||.......... .....+
T Consensus 150 l~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--~~~~~~ 218 (284)
T cd06620 150 VSGELINS---------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--DDPMGI 218 (284)
T ss_pred cccchhhh---------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--hhhhHH
Confidence 87654111 11234588899999995 4568899999999999999999999997653321100 000000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
...+..++....+. ....+++..+.+++.+|++.+|++|||+.|+++...-
T Consensus 219 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 219 LDLLQQIVQEPPPR-----------------------------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHHHHHhhccCCC-----------------------------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00011111000000 0011245678899999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=288.81 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=196.7
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|+..+.||.|++|.||.++.. +++.+++|.+... .......+.+|++++++++|+||+++++++. +.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5899999999999999999954 7888999987643 2344567889999999999999999999953 456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred EEEEecCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcc
Confidence 99999999999999875421 4689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+....... .......+++.|+|||...+ .++.++|||||||++|+|++|..||........
T Consensus 148 ~~~~~~~~-------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----------- 209 (256)
T cd08221 148 SKILGSEY-------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL----------- 209 (256)
T ss_pred eEEccccc-------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----------
Confidence 87652111 11223458899999999755 478999999999999999999999865321110
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...+....... ....++..+.+++.+||+.+|++|||++|+++.
T Consensus 210 --~~~~~~~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 --VVKIVQGNYTP------------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --HHHHHcCCCCC------------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00111000000 001225567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=288.93 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=195.1
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.+|+|++|.+|.+... +|+.||+|.+.... ......+.+|++++++++||||+++++.+ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5899999999999999999954 78899999876432 33456788999999999999999999984 4556899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred EEEecCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999999999998865321 3578899999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........++..|+|||+..+ .++.++|+|||||++|+|++|..||......+ .
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~--------- 209 (256)
T cd08218 148 ARVLNST-------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--L--------- 209 (256)
T ss_pred eeecCcc-------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--H---------
Confidence 8754211 111122347888999999654 47899999999999999999999986431110 0
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...+....... .+.+++..+.+++.+||+.+|++||++.||++.
T Consensus 210 --~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 210 --VLKIIRGSYPP------------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHHHhcCCCCC------------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111000 111225568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=289.53 Aligned_cols=253 Identities=27% Similarity=0.482 Sum_probs=190.4
Q ss_pred cccCcccccceEEEEeCC-------CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 395 NLIGTGSFGSVYKGTLGD-------GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+.||+|++|.||.|+.++ ++.+++|.+.... ......+.+|+++++.++||||+++++++. ..+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 368999999999998542 2579999886442 234567889999999999999999999853 345789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-----ceEE
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-----TAHV 541 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl 541 (717)
+||||+++++|.+++............+++..++.++.|++.|++|||+. +++|+||+|+||+++.++ .+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 99999999999999875322111224578899999999999999999997 999999999999999877 8999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+........ ........++..|+|||.+. +.++.++|||||||++|+|++ |..||...... .....
T Consensus 153 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~ 225 (269)
T cd05044 153 GDFGLARDIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH 225 (269)
T ss_pred CCcccccccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH
Confidence 99999876522111 11112234567899999964 568999999999999999998 99998643211 11100
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
. ...... ..+..++..+.+++.+||+.+|++||++++|+
T Consensus 226 ~------------~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 226 V------------TAGGRL-----------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred H------------hcCCcc-----------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 0 000000 01122356788999999999999999999999
Q ss_pred HHHH
Q 005045 700 NNLK 703 (717)
Q Consensus 700 ~~l~ 703 (717)
+.|+
T Consensus 265 ~~l~ 268 (269)
T cd05044 265 EILQ 268 (269)
T ss_pred HHHh
Confidence 9885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=292.22 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=166.0
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.|+..+.||+|+||.||.|.+. +++.+|+|.+.... ......+.+|+++++.++|++|+.+.+.+ ..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 3778899999999999999964 78999999886432 22335577899999999999999998884 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg 147 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred EEEEEeccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence 999999999999988864321 4689999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.+..... ........|+..|+|||++.+ .++.++|+|||||++|+|++|..||...
T Consensus 148 ~~~~~~~--------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 148 LAVKIPE--------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred cceecCC--------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 8865411 011123468999999999654 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.70 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||+|++|.||+|.++ +|+.||+|.+.... ......+.+|++++++++||||+++++. +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 5889999999999999999965 78999999886432 2233567789999999999999999988 44556899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|+||++ +++.+++.... ..+++..++.++.||++||+|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred EEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccch
Confidence 9999996 58888776432 4589999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc-
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA- 623 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~- 623 (717)
+...... ........++..|+|||.+.+. ++.++|||||||++|+|++|..|+.................
T Consensus 146 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 146 ARAFGIP-------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred hhccCCC-------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 8754211 1111234567899999996553 68999999999999999999998644322211111111100
Q ss_pred CCh-h-h---hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 624 LPD-H-V---MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 624 ~~~-~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+. . + .+..+....... .....-....+..+..+.+++.+||+.+|++|||++|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPMY--------------------PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred CCChHHhHHhhhcccccccCCC--------------------CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 000 0 0 000000000000 00000001112335677899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 279 l~ 280 (284)
T cd07839 279 LQ 280 (284)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.81 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=195.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...|++.+.||+|++|.||.|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+ ......
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKL 77 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCce
Confidence 346888999999999999999864 68889999876432 34456789999999999999999999984 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||
T Consensus 78 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEEEEccCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence 999999999999998853 3478899999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+...... ........++..|+|||.+.+ .++.++|||||||++|+|++|..||....+.... ..
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~----- 212 (277)
T cd06642 147 VAGQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FL----- 212 (277)
T ss_pred ccccccCc-------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hh-----
Confidence 98765211 111122457888999999765 4789999999999999999999998654222110 00
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+.....+. ....++..+.+++.+|++.+|++|||+.|+++.
T Consensus 213 ---~~~~~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 ---IPKNSPPT---------------------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---hhcCCCCC---------------------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00000000 011235567899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=288.20 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=168.0
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.+|++.+.+|+|++|.||+|... +++.|++|.+... ..+....+.+|+.++++++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 47899999999999999999964 6889999987533 12345678899999999999999999987542 124
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 5789999999999999998754 4578899999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+......... ........++..|+|||.+.+ .++.++||||+||++|+|++|+.||...
T Consensus 149 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 149 DFGASKRLQTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cCCCcccccccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 99998765221111 111122457889999999765 4789999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.67 Aligned_cols=271 Identities=24% Similarity=0.321 Sum_probs=197.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.+.+|+|++|.||+|+++ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+ ..+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 47999999999999999999976 68999999876432 22345678999999999999999999985 345589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++++++..+.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||
T Consensus 76 ~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred EEEEeccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence 9999999988888776543 4589999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH-HHh
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF-VSM 622 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~-~~~ 622 (717)
.+........ ......++..|+|||.+.+ .++.++|||||||++|+|++|..||.+....+...... ...
T Consensus 146 ~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 146 FARILTGPGD-------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred cceecCCCcc-------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9886522110 1123457788999999654 47899999999999999999999997654322111100 000
Q ss_pred cCChhhhhhcCCCC-----CCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 623 ALPDHVMDILDPSM-----PLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 623 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..........+... ............ ...+..+..+.+++.+||+.+|++|||+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLE-------------------SKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHH-------------------HHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 11111111111100 000000000000 011122566889999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
++.
T Consensus 280 il~ 282 (286)
T cd07847 280 LLE 282 (286)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=288.87 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=183.0
Q ss_pred cccCcccccceEEEEeC---CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++|+||+++++.+. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 36899999999999743 34467888765332 333467788999999999999999999853 4457899999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++...... .....++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred eCCCCcHHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence 99999999998754321 113356788899999999999999998 9999999999999999999999999998653
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC--------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--------QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
.... .........++..|+|||+... .++.++|||||||++|||++ |..||....+.+ .......
T Consensus 151 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~ 224 (269)
T cd05042 151 YPED-----YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR 224 (269)
T ss_pred ccch-----heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh
Confidence 1110 0111122345677999998532 36789999999999999999 788886542211 1111100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.. .....++.. ...++..+.+++..|+ .+|++|||++||++.
T Consensus 225 ~~----~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 225 EQ----DIKLPKPQL---------------------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cc----CccCCCCcc---------------------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 00 000001111 1122555677888888 599999999999998
Q ss_pred HH
Q 005045 702 LK 703 (717)
Q Consensus 702 l~ 703 (717)
+.
T Consensus 267 l~ 268 (269)
T cd05042 267 LT 268 (269)
T ss_pred hc
Confidence 73
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.92 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
...|+..++||.|++|.||.|.++ +++.||+|.+.... ......+.+|+++++++.|+||+++++.+. ++...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKL 77 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEE
Confidence 357889999999999999999965 68899999886443 344578889999999999999999999954 44589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++.. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||
T Consensus 78 ~lv~e~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg 146 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEEEecCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence 999999999999999864 3478888999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+...... ........++..|+|||++.+ .++.++|+|||||++|+|++|..||....+.... .
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~------ 211 (277)
T cd06640 147 VAGQLTDT-------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--F------ 211 (277)
T ss_pred cceeccCC-------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--h------
Confidence 98765211 111123457888999999655 4789999999999999999999998654321110 0
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........ .....++..+.+++.+||+.+|++||++.|+++.
T Consensus 212 ------~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 ------LIPKNNPP-----------------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------hhhcCCCC-----------------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000000 0122346678899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=290.62 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=188.8
Q ss_pred cccCcccccceEEEEeC-CCc--hhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGT--IVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|++|.||+|..+ +++ .+++|.+... .....+.+.+|+++++++ +||||+++++.+. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 36899999999999965 444 4677877643 233456788999999999 8999999999854 345789999
Q ss_pred ecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 470 EFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
||+++++|.+++....... .....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 9999999999986532100 1123578999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||++..... .........+..|+|||++.+ .++.++|||||||++|+|++ |..||......+ ...
T Consensus 153 l~dfgl~~~~~~--------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~ 222 (270)
T cd05047 153 IADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE 222 (270)
T ss_pred ECCCCCccccch--------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHH
Confidence 999998753210 001111223567999999654 47899999999999999997 999996532111 100
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.. ....... .+..++..+.+++.+|++.+|.+|||+.|+
T Consensus 223 ~~------------~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 223 KL------------PQGYRLE-----------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred HH------------hCCCCCC-----------------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 00 0000000 011124567899999999999999999999
Q ss_pred HHHHHHHH
Q 005045 699 VNNLKTIR 706 (717)
Q Consensus 699 l~~l~~i~ 706 (717)
++.|.++.
T Consensus 262 l~~l~~~~ 269 (270)
T cd05047 262 LVSLNRML 269 (270)
T ss_pred HHHHHHhh
Confidence 99998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.94 Aligned_cols=202 Identities=21% Similarity=0.276 Sum_probs=158.2
Q ss_pred cccCcccccceEEEEeC---CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEec
Q 005045 395 NLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
.+||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. ......++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 57999999999999954 45789999876432 22457789999999999999999998643 234578999999
Q ss_pred CCCCChhhhccCCCCC--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----CCCCceEEeeec
Q 005045 472 MSNGNLDQWLHPSPAE--HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTAHVGDFG 545 (717)
Q Consensus 472 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg 545 (717)
++ +++.+++...... ......+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 85 5887776532111 11124588999999999999999999997 99999999999999 466799999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.++....... .........++..|+|||++.+ .++.++|||||||++|||+||..||...
T Consensus 158 ~a~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9986522111 1112233568899999999754 3789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.80 Aligned_cols=253 Identities=29% Similarity=0.501 Sum_probs=196.4
Q ss_pred cccCcccccceEEEEeC-C---CchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-D---GTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.||+|+||.||.|... . +..|++|.+...... ..+.+.+|++.++.++|+|++++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 46899999999999965 3 788999998765433 3678889999999999999999999854 356899999
Q ss_pred ecCCCCChhhhccCCCCCc--ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 470 EFMSNGNLDQWLHPSPAEH--YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||+++++|.+++....... .....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999987642100 0015689999999999999999999997 9999999999999999999999999999
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
........ ........++..|+|||.+.+ .++.++||||+||++|+|++ |..||...... ......
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~----- 220 (262)
T cd00192 153 RDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYL----- 220 (262)
T ss_pred cccccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-----
Confidence 87632211 112233457889999999654 58999999999999999999 69998765211 111110
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.+.... ..+..++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 221 ------~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 ------RKGYRL------------------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------HcCCCC------------------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000000 012223567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=292.41 Aligned_cols=270 Identities=20% Similarity=0.274 Sum_probs=197.5
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||.|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++.+ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 5889999999999999999965 78999999987543 33456788999999999999999999985 3456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 76 ~v~e~~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred EEeccc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 999999 999999986542 4689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+........ .......++..|+|||.+.+ .++.++||||+||++|+|++|..||....+. .... .....+
T Consensus 146 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~-~~~~~~ 217 (286)
T cd07832 146 ARLFSEEEP------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLA-IVFRTL 217 (286)
T ss_pred cccccCCCC------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHH-HHHHHc
Confidence 876522110 11223458889999999644 3689999999999999999998877543221 1111 111111
Q ss_pred C----hhhhhhcC---CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 625 P----DHVMDILD---PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 625 ~----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
. ..+..+.+ .............. ....++.+..+.+++.+|++.+|++|||+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 218 GTPNEETWPGLTSLPDYNKITFPESKPIPL-------------------EEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred CCCChHHHhhccCcchhhcccCCCCCcchH-------------------HHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 0 00110000 00000000000000 0011223567899999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
+++.
T Consensus 279 ~l~h 282 (286)
T cd07832 279 ALRH 282 (286)
T ss_pred HhhC
Confidence 9863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.75 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=167.9
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.++||+|+||.||.++.+ +++.+|+|++... .......+..|+.++..++|++|+++++.+ .+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999965 6788999988542 223345678899999999999999999884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++|+|.+++.... ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999997532 4688999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+...... .........||+.|+|||++. +.++.++|||||||++|||++|+.||...
T Consensus 147 G~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 147 GSCLKLMED------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred chheecccC------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 998654211 111122346899999999964 34789999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.56 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=181.6
Q ss_pred cccCcccccceEEEEeCCCc---hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 395 NLIGTGSFGSVYKGTLGDGT---IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
++||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 36899999999999854333 34455544332 334578899999999999999999999854 3457899999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+++++|.+++..... .....+...+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 76 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~ 149 (268)
T cd05086 76 YCELGDLKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149 (268)
T ss_pred cCCCCcHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence 9999999999875421 113467778889999999999999997 9999999999999999999999999987642
Q ss_pred ccccCCCCCCcceeecccccccccCCCccCC--------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--------QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
... ..........++..|+|||++.+ .++.++|||||||++|||++ |..||......+ .....
T Consensus 150 ~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~-- 221 (268)
T cd05086 150 YKE-----DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHV-- 221 (268)
T ss_pred Ccc-----hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH--
Confidence 110 00111123457888999999632 24788999999999999997 566875432211 11111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+........++.+... ....+.+++..|| .+|++|||++||++.
T Consensus 222 --~~~~~~~~~~~~~~~~---------------------------------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 222 --IKDQQVKLFKPQLELP---------------------------------YSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred --HhhcccccCCCccCCC---------------------------------CcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 1111111122222111 1445677888999 579999999999987
Q ss_pred HH
Q 005045 702 LK 703 (717)
Q Consensus 702 l~ 703 (717)
|.
T Consensus 266 l~ 267 (268)
T cd05086 266 LT 267 (268)
T ss_pred hc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=290.23 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=195.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.+.+|.|++|.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+||+++++.+. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 47999999999999999999965 78899999987543 334567889999999999999999999853 346899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|+||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 76 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred EEEEeeCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence 999999999999998742 578999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||....... ......
T Consensus 145 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~---- 211 (274)
T cd06609 145 SGQLTSTM-------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIP---- 211 (274)
T ss_pred ceeecccc-------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhh----
Confidence 87762211 11223457888999999654 58999999999999999999999996542111 000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+.... ..++..+.+++.+||..+|++|||++++++
T Consensus 212 ----~~~~~~~~~--------------------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 212 ----KNNPPSLEG--------------------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----hcCCCCCcc--------------------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 000011000 002456788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=291.17 Aligned_cols=260 Identities=21% Similarity=0.399 Sum_probs=197.7
Q ss_pred ccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..+|++.+.+|+|+||.||.|+.+ ..+.|++|.+...... ....+.+|++++++++|+||+++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 78 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR----- 78 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----
Confidence 368999999999999999999854 3456888888654433 4678899999999999999999999853
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCc--ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEH--YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
+....++||||+++++|.+++....... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 3457899999999999999987543110 0112589999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
++++|||.+...... .........++..|+|||.+. +.++.++|||||||++|+|++ |..||....... .
T Consensus 156 ~~l~~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~ 227 (275)
T cd05046 156 VKVSLLSLSKDVYNS------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--V 227 (275)
T ss_pred EEEcccccccccCcc------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--H
Confidence 999999988654211 111122234567799999965 457899999999999999999 888986543221 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
..... ....... ....++..+.+++.+||+.+|++|||+.
T Consensus 228 ~~~~~-----------~~~~~~~-----------------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 267 (275)
T cd05046 228 LNRLQ-----------AGKLELP-----------------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFS 267 (275)
T ss_pred HHHHH-----------cCCcCCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 11000 0000000 0112356788999999999999999999
Q ss_pred HHHHHHH
Q 005045 697 VVVNNLK 703 (717)
Q Consensus 697 eil~~l~ 703 (717)
|+++.|.
T Consensus 268 ~~l~~l~ 274 (275)
T cd05046 268 ELVSALG 274 (275)
T ss_pred HHHHHhc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.65 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=197.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCc----hhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.++|+..+.||+|++|.||+|.+. +|+ .+|+|.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 567889999999999999999854 454 46888776443 2334568899999999999999999998642
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
...++++||+++|++.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL 150 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKI 150 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEE
Confidence 23579999999999999987542 4578999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+........ ........++..|+|||.+.+ .++.++|||||||++|||++ |..||....... ....
T Consensus 151 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~ 223 (303)
T cd05110 151 TDFGLARLLEGDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDL 223 (303)
T ss_pred ccccccccccCccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence 99999986521111 111112335678999999654 57999999999999999998 999986542111 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... ...+ .+..++..+.+++.+||..+|++||+++|++
T Consensus 224 ~~~~----------~~~~-------------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~ 262 (303)
T cd05110 224 LEKG----------ERLP-------------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELA 262 (303)
T ss_pred HHCC----------CCCC-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 1100 0000 0011244578899999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 700 NNLKTIRNC 708 (717)
Q Consensus 700 ~~l~~i~~~ 708 (717)
+.+.++...
T Consensus 263 ~~l~~~~~~ 271 (303)
T cd05110 263 AEFSRMARD 271 (303)
T ss_pred HHHHHHHhc
Confidence 999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.57 Aligned_cols=275 Identities=23% Similarity=0.318 Sum_probs=196.9
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.+.||+|++|.||.|.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 47999999999999999999975 68899999886432 22356678899999999999999999884 456689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++++++.++.... ..+++..++.++.||+.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred EEEEecCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence 9999999998888876543 4589999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH--HH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF--VS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~--~~ 621 (717)
.+....... .......++..|+|||++.+ .++.++|||||||++|+|++|..||......+ ..... ..
T Consensus 146 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~ 217 (286)
T cd07846 146 FARTLAAPG-------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCL 217 (286)
T ss_pred eeeeccCCc-------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHh
Confidence 987652111 11123457889999999654 36889999999999999999999986432211 00000 00
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+........+....... .. ..............+..+..+.+++.+||+.+|++||+++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-------------~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAG-------------MR-LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhc-------------cc-cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 1111111111110000000 00 00000000000112234667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.05 Aligned_cols=282 Identities=22% Similarity=0.259 Sum_probs=200.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+++|++.++||+|++|.||.|.+. +|+.||+|++... .......+.+|+.++++++|+||+++++.+..........
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999954 7899999988643 2334566788999999999999999998876554555567
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++|+||++ +++.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~df 150 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDF 150 (336)
T ss_pred EEEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcc
Confidence 899999995 588777753 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+........ .........++..|+|||.+.+ .++.++||||+||++|+|++|+.||....... ....+..
T Consensus 151 g~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~ 224 (336)
T cd07849 151 GLARIADPEHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILG 224 (336)
T ss_pred cceeecccccc----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 99876422111 1111223467889999998543 47899999999999999999999996532111 0000100
Q ss_pred cC----ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 623 AL----PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 623 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+ ++.+..+.+... .+.. ...............+..+..+.+++.+||+.+|++|||+.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~-----------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 225 VLGTPSQEDLNCIISLRA-----------RNYI----KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred HcCCCCHHHHHHhhchhh-----------hhHH----hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 011111111000 0000 0000000000000112235668899999999999999999999
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 290 l~h 292 (336)
T cd07849 290 LAH 292 (336)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=298.89 Aligned_cols=201 Identities=25% Similarity=0.345 Sum_probs=168.8
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+++.+ +++.||+|++... .......+.+|..++..+.|++|+++++++ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999965 7888999988643 223345678899999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEec
Confidence 999999999999999997532 4688999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+...... .........|++.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 147 G~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 147 GSCLKMNQD------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cceeeccCC------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 998754211 1111223458999999999653 4788999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.80 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=195.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.+.||+|++|.||+|.++ +++.||+|.+... .......+.+|++++++++|+||+++++.+ ...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 47899999999999999999965 8899999987643 233456788999999999999999999984 3456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. .+++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred EEEeecCCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 9999999999999887532 114689999999999999999999974 2899999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCCC-------CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-------VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+..... .......++..|+|||.+.+. ++.++|||||||++|+|++|..||........ ..
T Consensus 150 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~- 217 (286)
T cd06622 150 SGNLVA---------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FA- 217 (286)
T ss_pred cccccC---------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HH-
Confidence 875411 111234577889999996432 47899999999999999999999965321110 00
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.+..+.+..... .+.+++..+.+++.+||+.+|++||+++|++
T Consensus 218 -------~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 218 -------QLSAIVDGDPPT------------------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred -------HHHHHhhcCCCC------------------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 011111100000 1122356678899999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 261 ~~ 262 (286)
T cd06622 261 EH 262 (286)
T ss_pred cC
Confidence 74
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.83 Aligned_cols=259 Identities=21% Similarity=0.276 Sum_probs=194.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.+|+|++|.||++..+ +++.|++|.+.... ......+.+|+++++.++||||+++++.+ ..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 47899999999999999999965 68889999876543 23456788999999999999999999884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++|++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence 99999999999999999754 4589999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCC--------CCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 545 GLAKFLFEISDNP--------SKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 545 g~~~~~~~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
|.+.......... ...........++..|+|||.+. +.++.++|+|||||++|+|++|..||.+.....
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-- 223 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-- 223 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9886421100000 00001111245788899999964 458999999999999999999999996432111
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
.... .......... ....++..+.+++.+||+.+|++||++
T Consensus 224 ~~~~-----------~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~ 264 (305)
T cd05609 224 LFGQ-----------VISDDIEWPE----------------------------GDEALPADAQDLISRLLRQNPLERLGT 264 (305)
T ss_pred HHHH-----------HHhcccCCCC----------------------------ccccCCHHHHHHHHHHhccChhhccCc
Confidence 0000 0000000000 001225567899999999999999996
Q ss_pred HHHHHHHH
Q 005045 696 NVVVNNLK 703 (717)
Q Consensus 696 ~eil~~l~ 703 (717)
.++.+.++
T Consensus 265 ~~~~~ll~ 272 (305)
T cd05609 265 GGAFEVKQ 272 (305)
T ss_pred cCHHHHHh
Confidence 55555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.87 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=167.4
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.+|++.+.||+|++|.||.|..+ +++.||+|.+... .......+.+|++++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 47899999999999999999965 6889999987532 123356788999999999999999999985321 23
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEEC
Confidence 4688999999999999998754 4578888999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+......... ........++..|+|||.+.+ .++.++|||||||++|+|++|+.||...
T Consensus 149 Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 149 DFGASKRLQTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cCcccccccccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 99998765221111 111122447889999999654 4789999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=287.64 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=193.5
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..++|++.+.+|+|++|.||.+.. +++.||+|.+.... ....+.+|+.+++.++|||++++++.+.. +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~ 74 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLY 74 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcE
Confidence 346799999999999999999875 67889999886432 23578899999999999999999988532 2369
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EEEECCCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcc
Confidence 99999999999999875421 4578999999999999999999997 999999999999999999999999998
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+...... ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||....... .....
T Consensus 147 ~~~~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~---- 210 (254)
T cd05083 147 ARVGSMG----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECV---- 210 (254)
T ss_pred ceecccc----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH----
Confidence 8753110 01122456799999965 458899999999999999998 999986542211 11110
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
....... ....++..+.+++.+||+.+|++||+++++++.+++
T Consensus 211 --------~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 --------EKGYRME-----------------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------hCCCCCC-----------------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0000000 011235667899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.40 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=197.4
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|+..+.||.|++|.||+|.++ +++.+++|.+.... ......+.+|+++++++.||||+++++.+. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 47889999999999999999965 78899999886542 344567889999999999999999998853 346899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+++||+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++||||+|+||+++.++.++|+|||
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g 146 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFG 146 (265)
T ss_pred EEEEecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999987542 468889999999999999999999 7 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+....... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||..............
T Consensus 147 ~~~~~~~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---- 213 (265)
T cd06605 147 VSGQLVNSL---------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL---- 213 (265)
T ss_pred cchhhHHHH---------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH----
Confidence 987652111 111457888999999655 488999999999999999999999976532111111111
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........+..+ ...++..+.+++.+||..+|++|||+.|++..
T Consensus 214 ----~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 214 ----QYIVNEPPPRLP-----------------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----HHHhcCCCCCCC-----------------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111000000 01135668899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.64 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=174.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..-+.|+.-+++|+||||.||.++.+ +|+.+|.|.+.... ........+|.+++++++.+.||.+..+ ++.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feT 256 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FET 256 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecC
Confidence 34557788899999999999999944 89999999987553 3334667889999999999999998777 667
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+.+|+|+..|.||+|.-.+..... +.+++..++.+|.+|+-||.+||.. .||.||+||+||++|+.|+++|
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 7799999999999999988876543 6799999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|+|+|+.+.+ .....+..||.+|||||++.+ .|+...|+||+||++|||+.|+.||...
T Consensus 329 SDLGLAvei~~--------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 329 SDLGLAVEIPE--------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred eccceEEecCC--------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 99999997621 112233479999999999654 5999999999999999999999999653
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.13 Aligned_cols=191 Identities=29% Similarity=0.376 Sum_probs=156.9
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccccCCCCceEEEEE
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST---RHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
||+|+||.||+|+++ +++.||+|++.... .........|..++... .||+|+++++.+ ......|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 699999999999965 78999999886432 22234455666776665 699999999884 4456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 76 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 76 DYMSGGELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred cCCCCChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 999999999988754 5689999999999999999999998 999999999999999999999999999875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
... .........|+..|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 146 NLT-------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CCC-------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 311 1111223568999999999754 3789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.98 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=196.4
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.+|.|++|.||+|.+. +++.||+|.+... .....+.+..|+++++.++|+||+++++.+.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 5889999999999999999954 7888999988643 23345678899999999999999999987532 2345789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH-----HHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
++|||+++++|.+++..... ....+++..++.++.||+.|++||| +. +++||||+|+||+++.++.+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEehhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEE
Confidence 99999999999999864321 1256899999999999999999999 65 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... ........++..|+|||.+.+ .++.++|+||||+++|+|++|..||..... .......
T Consensus 152 ~d~g~~~~~~~~-------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~ 222 (265)
T cd08217 152 GDFGLAKILGHD-------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKI 222 (265)
T ss_pred ecccccccccCC-------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHH
Confidence 999998865211 111223458889999999654 478999999999999999999999975431 1111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ..... .+...+..+.+++.+|++.+|++|||++||++
T Consensus 223 ~~-----------~~~~~------------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 223 KE-----------GKFRR------------------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hc-----------CCCCC------------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00000 11123567889999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 262 ~ 262 (265)
T cd08217 262 L 262 (265)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.98 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=195.9
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|+..+.||.|++|.||.|..+ +++.+|+|.+.... ......+.+|++++++++||||+++++++.. ...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 47889999999999999999965 78899999887543 2345678899999999999999999988643 2345789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ....++...+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 78 lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~ 151 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV 151 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccc
Confidence 99999999999988653211 114578899999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||................
T Consensus 152 ~~~~~~~---------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 219 (287)
T cd06621 152 SGELVNS---------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--- 219 (287)
T ss_pred ccccccc---------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH---
Confidence 8754211 1112446788999999654 58999999999999999999999997653211110000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+...-.+.+.... ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 --~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 220 --IVNMPNPELKDEP---------------------------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --HhcCCchhhccCC---------------------------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000000000 000112456789999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.40 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=203.4
Q ss_pred cccccccccccCcccccceEEEE-eCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..-+|+...+||.|.||.||.|. ..+|+..|+|.+...+ ....+...+|..++..++|||+|++|++-. +.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----HRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----HRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----cHH
Confidence 34578889999999999999999 4589999999998654 334566789999999999999999999843 445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+|.||||.+|+|.+.+..+ ...++....-+..|++.|++|||++ |||||||||.||+++.+|.+|++|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence 789999999999999999866 4567777778899999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
||.|..+.... ....+.-....||+.|||||++.|- ..-++||||+|||+.||.||+.||...+.+- .+.++
T Consensus 1378 FGsa~ki~~~~---~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~ 1453 (1509)
T KOG4645|consen 1378 FGSAVKIKNNA---QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYH 1453 (1509)
T ss_pred ccceeEecCch---hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhH
Confidence 99999874432 1222333467899999999998662 5789999999999999999999998764442 33333
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+.....+++. +..+.+=.+|+.+|++.||..|.++.|++
T Consensus 1454 V~~gh~Pq~P-----------------------------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1454 VAAGHKPQIP-----------------------------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred HhccCCCCCc-----------------------------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 3332211111 11133446799999999999999998877
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 1493 e~ 1494 (1509)
T KOG4645|consen 1493 EH 1494 (1509)
T ss_pred Hh
Confidence 53
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=286.83 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=193.6
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|+..+.||+|++|.||.|... +++.+|+|.+... .......+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5899999999999999999964 7888999988643 233457788999999999999999999884 4456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-CceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg 545 (717)
+||||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.+ +.+||+|||
T Consensus 76 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence 99999999999999975421 4579999999999999999999998 99999999999999855 468999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+...... .......++..|+|||.+.+. ++.++||||||+++|+|++|..||....... .....
T Consensus 148 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~---- 213 (256)
T cd08220 148 ISKILSSK--------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKI---- 213 (256)
T ss_pred CceecCCC--------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHH----
Confidence 98765211 111234578899999997654 7899999999999999999999986542211 10000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...... +.+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 214 -------~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 214 -------MSGTFA------------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -------HhcCCC------------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 001122556789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.88 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=165.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.+.||+|++|.||+|..+ +++.||+|.+.... ......+.+|++++++++|+||+++++++ ...+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 468999999999999999999965 78899999986442 22234567899999999999999999984 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++.+||+|||
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred EEEEecCC-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence 99999997 58999886542 4578999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+...... ........++..|+|||++.+ .++.++||||+||++|+|++|..||....
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 149 LARAKSVP-------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccCCC-------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 98753111 011112235788999999654 37889999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=286.44 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=192.9
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh----------hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ----------QGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+|.+.+.||.|++|.||.|... +++.+|+|.+.... ....+.+..|+.+++.++|||++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 5888999999999999999854 78899999875321 112356788999999999999999999853
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.|+.|||+. +++||||+|+||+++.++.
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGI 146 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCe
Confidence 445889999999999999998754 4688899999999999999999997 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
++++|||.+....... .........++..|+|||...+ .++.++|+||||+++|++++|..||....... .
T Consensus 147 ~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~ 220 (272)
T cd06629 147 CKISDFGISKKSDDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-A 220 (272)
T ss_pred EEEeeccccccccccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-H
Confidence 9999999987542110 1111223457889999999654 26899999999999999999999985432111 0
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
........ ....+... ...+++..+.+++.+||+.+|++|||+
T Consensus 221 ~~~~~~~~----~~~~~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~ 263 (272)
T cd06629 221 MFKLGNKR----SAPPIPPD---------------------------------VSMNLSPVALDFLNACFTINPDNRPTA 263 (272)
T ss_pred HHHhhccc----cCCcCCcc---------------------------------ccccCCHHHHHHHHHHhcCChhhCCCH
Confidence 00000000 00000000 001225678889999999999999999
Q ss_pred HHHHHH
Q 005045 696 NVVVNN 701 (717)
Q Consensus 696 ~eil~~ 701 (717)
+||++.
T Consensus 264 ~~il~~ 269 (272)
T cd06629 264 RELLQH 269 (272)
T ss_pred HHHhhC
Confidence 999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.27 Aligned_cols=237 Identities=24% Similarity=0.445 Sum_probs=183.8
Q ss_pred cccCcccccceEEEEeCC-C----------chhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 395 NLIGTGSFGSVYKGTLGD-G----------TIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+.||+|+||.||+|.++. + ..+++|.+...... ...+.+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 468999999999999753 3 24777876654433 5788899999999999999999998643 3
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC------
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM------ 537 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~------ 537 (717)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~ 144 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYV 144 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCc
Confidence 5699999999999999987652 3688999999999999999999997 999999999999999887
Q ss_pred -ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 538 -TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 538 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.+||+|||.+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||......
T Consensus 145 ~~~kl~Dfg~a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 145 PFIKLSDPGIPITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred eeEEeCCCCccccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 799999999886421 112346678999999755 47899999999999999999 57777654321
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
.. ..... .....+... ...+.+++.+||+.+|++|
T Consensus 214 ~~--~~~~~----------~~~~~~~~~---------------------------------~~~~~~li~~~l~~~p~~R 248 (259)
T cd05037 214 EK--ERFYQ----------DQHRLPMPD---------------------------------CAELANLINQCWTYDPTKR 248 (259)
T ss_pred hH--HHHHh----------cCCCCCCCC---------------------------------chHHHHHHHHHhccChhhC
Confidence 11 00000 000000000 1457889999999999999
Q ss_pred CCHHHHHHHHH
Q 005045 693 IAMNVVVNNLK 703 (717)
Q Consensus 693 ps~~eil~~l~ 703 (717)
||+.||++.|+
T Consensus 249 pt~~~il~~l~ 259 (259)
T cd05037 249 PSFRAILRDLN 259 (259)
T ss_pred CCHHHHHHhcC
Confidence 99999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.36 Aligned_cols=257 Identities=27% Similarity=0.358 Sum_probs=196.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||.|... +++.||+|.+.... ....+.+..|+++++.++|+||+++++.+ ...+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 47899999999999999999965 68999999887543 22456788999999999999999999884 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeec
Confidence 9999999999999999875421 5689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCC----------------------CcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh
Q 005045 545 GLAKFLFEISDNPSK----------------------NQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 545 g~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt 601 (717)
|.+............ .........|+..|+|||+..+ .++.++|||||||++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754221110000 0001113457889999999655 47899999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHh
Q 005045 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 681 (717)
|..||........ +..+.+....... ....+..+.+++
T Consensus 228 g~~pf~~~~~~~~-------------~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li 265 (316)
T cd05574 228 GTTPFKGSNRDET-------------FSNILKKEVTFPG-----------------------------SPPVSSSARDLI 265 (316)
T ss_pred CCCCCCCCchHHH-------------HHHHhcCCccCCC-----------------------------ccccCHHHHHHH
Confidence 9999975432210 1111111111000 001256788999
Q ss_pred hccCCCCcCCCCC----HHHHHH
Q 005045 682 LMCSTTSPRERIA----MNVVVN 700 (717)
Q Consensus 682 ~~cl~~~p~~Rps----~~eil~ 700 (717)
.+|++.+|++||| ++|+++
T Consensus 266 ~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 266 RKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHccCCHhHCCCchhhHHHHHc
Confidence 9999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.54 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=207.8
Q ss_pred ccccccccccCcccccceEEEEeC--CCc--hhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG--DGT--IVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.+.....++||+|.||.||+|.|+ +|+ .||||.+...... ....|.+|+.+|.+++|+|++++|+...+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------
Confidence 445567789999999999999975 455 4899999866543 67899999999999999999999999632
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
....+|||.++.|+|.+.+++.. ...+.....-.++.|||.||.||.+. ++||||+.++|+++...-.|||+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~-----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK-----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc-----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence 35789999999999999998732 26788888999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||+.+.+....+ .+.......-...|||||.++ ++++.++|||+|||+|||||| |+.||.+....
T Consensus 255 DFGLmRaLg~ned----~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------- 322 (1039)
T KOG0199|consen 255 DFGLMRALGENED----MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------- 322 (1039)
T ss_pred cccceeccCCCCc----ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------
Confidence 9999998743322 233334455677899999975 569999999999999999999 99999764221
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+.+.+|.... .+++..|++.+++++.+||..+|++|||+..|.+
T Consensus 323 ------qIL~~iD~~er-----------------------------LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 323 ------QILKNIDAGER-----------------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ------HHHHhcccccc-----------------------------CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 12233332211 1256788999999999999999999999999986
Q ss_pred HHHHH
Q 005045 701 NLKTI 705 (717)
Q Consensus 701 ~l~~i 705 (717)
.+-..
T Consensus 368 ~~~l~ 372 (1039)
T KOG0199|consen 368 DLVLA 372 (1039)
T ss_pred hHHHH
Confidence 55443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.49 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=165.5
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++++|++.+.||+|++|.||.|... +++.||+|.+.... ......+.+|+++++.++|+||+++.+++ ...+.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 5678999999999999999999854 78899999986543 22334667899999999999999999985 34568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++ +++.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence 999999995 67777765432 4567888999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|.+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||....
T Consensus 148 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 148 GLARAKSIPS-------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccccccCCCC-------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 9987542111 11122346888999999754 47889999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.08 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=155.1
Q ss_pred cccccccccccCcccccceEEEEeC--CCchhhhH--------------HhHh---hhhhHHHHHHHHHHHHhcCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG--DGTIVAIK--------------VLKL---QQQGALKSFIDECNALKSTRHRNI 447 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK--------------~~~~---~~~~~~~~~~~e~~~l~~l~h~ni 447 (717)
..++|+++++||+|+||.||+|..+ .+..++.| .+.. ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998743 22222222 1111 112334668899999999999999
Q ss_pred eEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005045 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLK 527 (717)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 527 (717)
+++++++. ..+..|+|++++ ++++.+++...... .........++.++.||+.||+|||+. +|+|||||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK 294 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK 294 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999953 445789999998 46777776543211 012344667889999999999999997 99999999
Q ss_pred CCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCC-C
Q 005045 528 PSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKR-P 605 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~-p 605 (717)
|+||+++.++.+||+|||++..+... .........|+..|+|||++.+ .++.++|||||||++|||++|.. |
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKE------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCcc------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999765211 1111223568999999999765 48999999999999999999875 4
Q ss_pred CCC
Q 005045 606 TGD 608 (717)
Q Consensus 606 ~~~ 608 (717)
+..
T Consensus 369 ~~~ 371 (501)
T PHA03210 369 IGD 371 (501)
T ss_pred ccC
Confidence 443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.93 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=199.4
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.+.||+|++|.||+|..+ +++.|++|.+..... .....+.+|++.+++++|+|++++++.+. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 47889999999999999999966 699999998876543 44578899999999999999999999953 446899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+||||+++++|.+++... ..+++..+..++.|++.|++|+|+ . +++||||+|+||+++.++.++|+|||
T Consensus 76 lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred EEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence 999999999999999754 568999999999999999999999 8 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+....... .......++..|+|||.+.+ .++.++|+||||+++|+|++|..||........ ..
T Consensus 146 ~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~------ 210 (264)
T cd06623 146 ISKVLENTL-------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--FE------ 210 (264)
T ss_pred cceecccCC-------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH--HH------
Confidence 987652211 11123457889999999655 478999999999999999999999976532110 00
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHH-HHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEE-CFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....+....... .+.. ++..+.+++.+|+..+|++|||+.|+++.
T Consensus 211 --~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 --LMQAICDGPPPS------------------------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --HHHHHhcCCCCC------------------------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111111100 0011 35678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.25 Aligned_cols=199 Identities=29% Similarity=0.457 Sum_probs=164.9
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||.|++|.||+|+.+ +++.||+|.+.... ......+.+|++++++++||||+++++++ .+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 5889999999999999999965 78899999886442 22345788999999999999999999984 4556899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||++ +++.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999995 689888865421 5689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+...... ........++..|+|||.+.+ . ++.++|||||||++|+|+||..||...
T Consensus 147 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 147 ARAFGVP-------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred hhhcccC-------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 8754211 111122346788999998654 3 588999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.88 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=198.2
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.....++|.+.+.+|+|++|.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++.+. ..
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~ 88 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VG 88 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eC
Confidence 3445689999999999999999999854 67889999987555445577889999999999999999998853 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++|+||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~ 157 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEc
Confidence 5889999999999999998642 468889999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... ........+++.|+|||.+. +.++.++|||||||++|++++|..||..........
T Consensus 158 dfg~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----- 225 (293)
T cd06647 158 DFGFCAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----- 225 (293)
T ss_pred cCcceeccccc-------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----
Confidence 99988654211 11112345788899999964 457899999999999999999999996542211100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.......+. .......+..+.+++.+||+.+|++||++.|++..
T Consensus 226 --------~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 --------LIATNGTPE----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------ehhcCCCCC----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00111124567889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.77 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=195.3
Q ss_pred ccccccccCcccccceEEEEe-CCCchhhhHHhHhhh------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ------QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+|+..+.||+|++|.||.|.. .+++.||+|++.... ....+.+..|++++++++|+||+++++.+ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 588899999999999999995 478999999886432 22457789999999999999999999994 455
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHV 541 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl 541 (717)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEE
Confidence 6899999999999999998754 4678999999999999999999997 999999999999998776 6999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+.......... ........++..|+|||.+.+ .++.++||||+||++|+|++|..||.......... .
T Consensus 146 ~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~- 219 (268)
T cd06630 146 ADFGAAARLAAKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA--L- 219 (268)
T ss_pred cccccccccccccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH--H-
Confidence 9999987763221111 111223457889999999654 47899999999999999999999986432111100 0
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+........ ..+.+...+..+.+++.+|++.+|++|||+.|+++
T Consensus 220 -------~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 -------IFKIASATT-----------------------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------HHHHhccCC-----------------------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000000 00011233567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.12 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=194.3
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-----hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-----QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|+..+.||+|++|.||.|..+ +++.|++|.+.... .+..+.+.+|+++++.++|+||+++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 5888899999999999999966 78999999876432 23456788999999999999999999985 3445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+++|||+++++|.+++... ..+++..+..++.||+.|++|||+. +++|+||+|+||+++.++.+||+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999999754 4578999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||.+....... ......++..|+|||.+.. . ++.++|+|||||++|+|++|..||........ .....
T Consensus 146 ~~~~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~ 215 (258)
T cd06632 146 FGMAKQVVEFS--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG 215 (258)
T ss_pred Cccceeccccc--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH
Confidence 99987652111 1223457888999999644 3 78999999999999999999999976431110 00000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ....+. .++.++..+.+++.+||+.+|++||++.|+++
T Consensus 216 ~----------~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 R----------SKELPP------------------------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred h----------cccCCC------------------------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 000000 01122456788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=293.07 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=194.3
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.+.|.....||+|++|.||.+... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+ ...+..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEE
Confidence 445666788999999999999964 7889999988655555567788999999999999999999884 3456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++.. ..+++..+..++.||+.|++|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 96 lv~e~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 96 VVMEFLEGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred EEEeCCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 99999999999998853 3478899999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........++..|+|||...+ .++.++|||||||++|||++|..||....... .....
T Consensus 165 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~----- 230 (292)
T cd06658 165 CAQVSKE-------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRI----- 230 (292)
T ss_pred hhhcccc-------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-----
Confidence 8754211 111123457889999999655 57899999999999999999999986532111 00000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.....+.... ....+..+.+++.+|+..+|++|||++|+++.
T Consensus 231 ---~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 ---RDNLPPRVKD-------------------------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---HhcCCCcccc-------------------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111111100 01124457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.19 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=194.9
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-----hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-----GALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|++.+.||+|++|.||+|.+. +++.||+|.+..... .....+..|++++++++|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 5888999999999999999965 789999999875432 23456778999999999999999999853 356
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+ +++|.+++.... ..+++..+..++.||++||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcc
Confidence 899999999 899999997542 3689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||.+....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||....+.+. . ....
T Consensus 146 fg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~-~~~~ 216 (298)
T cd07841 146 FGLARSFGSPN-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-L-GKIF 216 (298)
T ss_pred ceeeeeccCCC-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-H-HHHH
Confidence 99987652211 11122346778999999643 478999999999999999999777765332111 1 1111
Q ss_pred hcCC----hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 622 MALP----DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 622 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+. ............... .... ...........+..+.+++.+||+++|++|||++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 217 EALGTPTEENWPGVTSLPDYVEF----------------KPFP--PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred HHcCCCchhhhhhcccccccccc----------------cccC--CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 1000 000000000000000 0000 00000011223567889999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
+++.
T Consensus 279 ~l~~ 282 (298)
T cd07841 279 ALEH 282 (298)
T ss_pred HhhC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=292.99 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=194.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
....|....+||+|+||.||.|... +++.||+|.+........+.+.+|+.+++.++|||++++++.+ ..++..
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~ 93 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEEL 93 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeE
Confidence 3445666778999999999999965 7889999998654444456788999999999999999999984 345689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 94 ~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg 162 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG 162 (297)
T ss_pred EEEEecCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence 999999999999987753 3578999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||....... .........
T Consensus 163 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~ 233 (297)
T cd06659 163 FCAQISKD-------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSP 233 (297)
T ss_pred hHhhcccc-------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhccC
Confidence 88654111 111123458889999999654 58999999999999999999999996432211 111110000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+ .... .....+..+.+++.+|++.+|++||++.|+++.
T Consensus 234 ~--------~~~~-------------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 P--------PKLK-------------------------------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred C--------CCcc-------------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000 001114457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.44 Aligned_cols=202 Identities=28% Similarity=0.353 Sum_probs=167.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|++.+.||+|++|.||+|.++ +++.+++|.++... ......+.+|+.++++++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 458999999999999999999976 68889999887443 22234567899999999999999999986432 2368
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++ ++|.+++.... ..+++..++.++.||+.||+|||+. +++||||+|+||+++.++.++|+||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred EEEEehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeec
Confidence 999999996 59998886542 3589999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+....... .......++..|+|||.+.+. ++.++|+||+||++|+|++|..||...
T Consensus 151 g~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 151 GLAREYGSPL-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CceeeccCCc-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9988652211 111224467889999997543 589999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=312.23 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=191.4
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC-
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG- 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~- 461 (717)
..+..+|+.++.+|+||||.||+++.+ +|+.||||++... .......+.+|+..+++++|||||+++..+.+.....
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 457889999999999999999999987 9999999999855 3344567889999999999999999985443321000
Q ss_pred --------------------------------------------------------------------------------
Q 005045 462 -------------------------------------------------------------------------------- 461 (717)
Q Consensus 462 -------------------------------------------------------------------------------- 461 (717)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHH
Q 005045 462 ---------------------------------NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508 (717)
Q Consensus 462 ---------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~ 508 (717)
.-.+||=||||+..++++++.++.- .-....+++++++|+.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~------~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF------NSQRDEAWRLFREILE 708 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc------chhhHHHHHHHHHHHH
Confidence 0125677788877666666665421 1146788999999999
Q ss_pred HHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc-----------ccCCCCCCcceeecccccccccCCC
Q 005045 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE-----------ISDNPSKNQTVSIGLKGSIGYIPPE 577 (717)
Q Consensus 509 ~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~y~aPE 577 (717)
|++|+|++ |+|||||||.|||+++++.|||+|||+|..... .........+..+..+||.-|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999998 999999999999999999999999999988320 1112222233556788999999999
Q ss_pred ccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHH
Q 005045 578 HMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEE 653 (717)
Q Consensus 578 ~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (717)
++.+ +|+.|+|+||||+|++||+ .||....+.-..+...-...+|.. .++.++..
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~----------------- 844 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-ADFFDPEH----------------- 844 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-cccccccc-----------------
Confidence 9654 4899999999999999999 456443111000000000011111 11122111
Q ss_pred HHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 654 KEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..=..+|.++++.||++||||.|++.
T Consensus 845 ---------------------~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 845 ---------------------PEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---------------------hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 12256899999999999999999985
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=288.31 Aligned_cols=268 Identities=19% Similarity=0.253 Sum_probs=185.5
Q ss_pred cccccccccccCcccccceEEEEeCC----CchhhhHHhHhhhhhH-----------HHHHHHHHHHHhcCCCCceeEEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD----GTIVAIKVLKLQQQGA-----------LKSFIDECNALKSTRHRNILRVI 451 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni~~~~ 451 (717)
..++|.+.+.||+|+||.||+|.+.+ +..+|+|+........ ......+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 35789999999999999999999653 4456666543221110 11223344556677999999999
Q ss_pred EeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
+++.... ......+++++++ ..++.+.+... ...++..+..++.|++.|++|||+. +|+||||||+||
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Ni 157 (294)
T PHA02882 90 GCGSFKR-CRMYYRFILLEKL-VENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENI 157 (294)
T ss_pred EeeeEec-CCceEEEEEEehh-ccCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 8754321 1122457888887 35676666533 3357788899999999999999997 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+++.++.++|+|||+|+....................||+.|+|||+..+ .++.++|||||||++|||++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999998663221111111112223468999999999765 48999999999999999999999997653
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
....... .... +.+..+..... ....++..+.+++..|++.+|+
T Consensus 238 ~~~~~~~-~~~~---~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~ 281 (294)
T PHA02882 238 HNGNLIH-AAKC---DFIKRLHEGKI--------------------------------KIKNANKFIYDFIECVTKLSYE 281 (294)
T ss_pred cchHHHH-HhHH---HHHHHhhhhhh--------------------------------ccCCCCHHHHHHHHHHHhCCCC
Confidence 2221110 0000 00000000000 1123366789999999999999
Q ss_pred CCCCHHHHHHHH
Q 005045 691 ERIAMNVVVNNL 702 (717)
Q Consensus 691 ~Rps~~eil~~l 702 (717)
+||++.++++.+
T Consensus 282 ~rp~~~~l~~~~ 293 (294)
T PHA02882 282 EKPDYDALIKIF 293 (294)
T ss_pred CCCCHHHHHHhh
Confidence 999999999876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.20 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=198.5
Q ss_pred cccccccc-cccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKE-NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~-~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.+++|++. ++||-|-.|.|-.+..+ +++++|+|++.-. ...++|++..-.. .|||||.+++++.-. +...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 35567664 57899999999999966 8999999998622 4456788876665 799999999987554 56667
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 540 (717)
.+.+|||.++||.|...++.+.. ..+++.++..|++||..|++|||+. .|.||||||+|++.+. +..+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 78899999999999999987643 6799999999999999999999998 9999999999999974 45899
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.|+... ....-....-|+.|+|||++.. +|+...|+||+||++|-|+.|.+||.......
T Consensus 205 LtDfGFAK~t~--------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------ 270 (400)
T KOG0604|consen 205 LTDFGFAKETQ--------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ 270 (400)
T ss_pred ecccccccccC--------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------
Confidence 99999998642 2333445678999999999765 58999999999999999999999997654321
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
++..+..-+....-.. ++++ =.+.++...++|+.+|+.+|.+|.|+.|+.
T Consensus 271 ----ispgMk~rI~~gqy~F--------------------P~pE------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 271 ----ISPGMKRRIRTGQYEF--------------------PEPE------WSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred ----CChhHHhHhhccCccC--------------------CChh------HhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 1111111111111000 1111 123466678899999999999999999987
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
.
T Consensus 321 ~ 321 (400)
T KOG0604|consen 321 D 321 (400)
T ss_pred c
Confidence 4
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=300.24 Aligned_cols=202 Identities=27% Similarity=0.286 Sum_probs=166.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|++|.||.|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 7899999988642 2333456778999999999999999998864322 2233
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||++ +++.+++.. .++...+..++.|++.||+|||+. |++||||||+||+++.++.+||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 46899999995 588887752 378889999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+...... .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...
T Consensus 161 Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 161 DFGLARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cCccceeCCCC--------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999765211 11223457889999999655 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.56 Aligned_cols=204 Identities=24% Similarity=0.338 Sum_probs=161.1
Q ss_pred ccccCcc--cccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 394 ENLIGTG--SFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 394 ~~~ig~g--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
...||.| ++|.||.|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..++..++|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEE
Confidence 3466776 88999999965 89999999987532 33457888999999999999999999995 345588999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||++++++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.
T Consensus 78 ~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 78 SPFMAYGSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred EecccCCCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 999999999999875421 4588999999999999999999997 99999999999999999999999998654
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCCC---CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
....................++..|+|||++.+. ++.++|||||||++|+|++|..||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 4321111110001111112356679999997553 6899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=267.69 Aligned_cols=208 Identities=24% Similarity=0.321 Sum_probs=172.3
Q ss_pred ccccccccccCcccccceEEEEeC---C--CchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG---D--GTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...|+.+.+||+|.+|.||+|..+ + .+.+|+|.++... .+.-...-+|+..++.++|||++.+..++ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf----l~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF----LS 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH----hc
Confidence 347999999999999999999632 2 3479999998652 22335567899999999999999998886 44
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC----
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD---- 536 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---- 536 (717)
.+...++++||.+ -+|+++++-++.... +.++...++.|+.||+.|+.|||++ =|.||||||.||||..+
T Consensus 99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~--~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 99 HDKKVWLLFDYAE-HDLWHIIKFHRASKA--KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred cCceEEEEehhhh-hhHHHHHHHhccchh--ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence 4778999999996 589999876654333 5789999999999999999999998 89999999999999877
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.|||+|+|+++.+..+-.... ......-|..|+|||.+-| .||.+.||||.||++.||+|-++.|.+.
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~----s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLA----SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred CeeEeecccHHHHhhccccccc----cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 8999999999999854443332 2334567899999999765 4899999999999999999999988764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=285.61 Aligned_cols=263 Identities=23% Similarity=0.422 Sum_probs=194.1
Q ss_pred cccccccCcccccceEEEEeC----CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC-CCc
Q 005045 391 FSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE-GND 463 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-~~~ 463 (717)
|.+.+.||+|++|.||+|.++ +++.||+|++... .....+.+.+|++++++++||||+++++.+...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999843 4688999988643 233456788999999999999999999986543211 112
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++++||++++++.+++....... ....+++..+.+++.||+.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 3578999999999988864321100 113578899999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||.++...... .........++..|++||...+ .++.++|||||||++|+|++ |..||......+ ......
T Consensus 157 fg~~~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 229 (273)
T cd05074 157 FGLSKKIYSGD-----YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLI 229 (273)
T ss_pred ccccccccCCc-----ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHH
Confidence 99988652111 0111112234567999999654 47889999999999999999 888886542211 110000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. . .... .+..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 230 ~--------~--~~~~-------------------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 230 K--------G--NRLK-------------------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred c--------C--CcCC-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 0000 001125578899999999999999999999999
Q ss_pred HHHH
Q 005045 702 LKTI 705 (717)
Q Consensus 702 l~~i 705 (717)
|+++
T Consensus 269 l~~~ 272 (273)
T cd05074 269 LELI 272 (273)
T ss_pred HHhh
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=283.64 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=199.0
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.+.+|.|++|.||.|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+. .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47999999999999999999954 78889999886432 235577899999999999999999998853 455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|||++++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.
T Consensus 76 iv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 99999999999999875321 14588999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+..+....... ........++..|+|||.+.. .++.++|+|||||++|+|++|+.||........ .......
T Consensus 149 ~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~-- 222 (267)
T cd06610 149 SASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN-- 222 (267)
T ss_pred HHHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC--
Confidence 88763322111 011223457889999999644 478999999999999999999999975432211 1110000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+...... ....++..+.+++.+|++.+|++|||++|+++
T Consensus 223 -------~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 -------DPPSLETGA----------------------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -------CCCCcCCcc----------------------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 01233566789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.39 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.....+.|++.+.+|+|++|.||.|.++ +++.|++|++..... ....+.+|++.++.++|+|++++++.+.. .
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 87 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----G 87 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----C
Confidence 3467888999999999999999999976 788899999876544 45678899999999999999999998543 4
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++|+||+++++|.+++.... ..+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEEC
Confidence 58999999999999999998652 3689999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... ........++..|+|||.+.+ .++.++|||||||++|+|++|..||....... ......
T Consensus 159 d~~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~- 229 (286)
T cd06614 159 DFGFAAQLTKE-------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLIT- 229 (286)
T ss_pred ccchhhhhccc-------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-
Confidence 99988754211 111123347788999999655 47899999999999999999999986532211 010000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...... ......++..+.+++.+|++.+|.+|||+.+|++.
T Consensus 230 -----------~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 230 -----------TKGIPP----------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----------hcCCCC----------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000000 00112235678899999999999999999999864
Q ss_pred H
Q 005045 702 L 702 (717)
Q Consensus 702 l 702 (717)
-
T Consensus 271 ~ 271 (286)
T cd06614 271 P 271 (286)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.92 Aligned_cols=196 Identities=31% Similarity=0.419 Sum_probs=169.0
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||.+.+. +++.||+|++.... ......+.+|+++++++.||||+++++.+ ..+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47999999999999999999965 78999999886432 23456788999999999999999999985 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999998755 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...
T Consensus 146 g~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 146 GFAKRVKGR----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCccccCCC----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 998765211 123457889999999654 4789999999999999999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=281.87 Aligned_cols=250 Identities=28% Similarity=0.537 Sum_probs=193.4
Q ss_pred cccccccCcccccceEEEEeC-C----CchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-D----GTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
+++.+.+|.|+||.||.|.+. . +..||+|.+...... ..+.+..|++.++.++|+||+++++.+. ..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 457789999999999999965 3 378999998755432 5678899999999999999999999853 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||+++++|.+++..... ..+++..+..++.|++.|+++||+. +++||||+|+||+++.++.++|+||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df 147 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF 147 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence 9999999999999999875421 2289999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+......... ......+++.|+|||.+. +.++.++||||+||++|+|++ |..||...... ........
T Consensus 148 g~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~ 219 (258)
T smart00219 148 GLSRDLYDDDYY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKK 219 (258)
T ss_pred CCceeccccccc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc
Confidence 998765322111 111223678899999964 458999999999999999998 78888652111 11111100
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
..... .+..++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 220 -----------~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 -----------GYRLP------------------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----------CCCCC------------------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00000 0111356788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=309.84 Aligned_cols=207 Identities=26% Similarity=0.372 Sum_probs=181.9
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
+.++.-..++|.+++.||+|+||.|..++.+ +++.||+|+++... ......|..|.++|..-+.+=|+.+...
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 4556667889999999999999999999965 89999999998753 3445778999999998888888887666
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
+++..++|+||||++||+|-..+.+. ..+++..++.++..|+-||+.+|+. |||||||||+||++|..
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~ 211 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKS 211 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEeccc
Confidence 78888999999999999999999865 5799999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
|++||+|||.+..+. .+.........|||.|.+||++. |.|+..+|+||+||++|||+.|.-||..
T Consensus 212 GHikLADFGsClkm~------~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMD------ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CcEeeccchhHHhcC------CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999999999998872 23344556678999999999952 4589999999999999999999999964
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.73 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=195.2
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+|++.+.||.|++|.||.|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++. +.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 5889999999999999999975 78999999887542 2446788999999999999999999888 4456689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... ..+++..+..++.|+++|++|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence 9999999999999998754 4688999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+....... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||....... .....
T Consensus 146 ~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~---- 211 (258)
T cd05578 146 IATKVTPDT--------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIR---- 211 (258)
T ss_pred cccccCCCc--------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHH----
Confidence 987652111 1223457888999999655 47999999999999999999999997653321 00000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH--HHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM--NVVV 699 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~eil 699 (717)
......... .++..+..+.+++.+||+.+|.+||++ +|++
T Consensus 212 -----~~~~~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 -----AKQETADVL------------------------------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----HHhcccccc------------------------------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 000000000 111225677899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=287.50 Aligned_cols=278 Identities=22% Similarity=0.285 Sum_probs=197.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.++||+|++|.||+|.++ +++.|++|.+.... ......+.+|+++++++.|+||+++++.+. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 47999999999999999999965 68899999987542 334578899999999999999999999853 35589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||++++.+..+.... ..+++..+..++.||+.|++|||+. +++||||+|+||+++.++.+||+|||
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence 9999999876666655433 4589999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH-HHHh
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM-FVSM 622 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~~~ 622 (717)
.+........ .......++..|+|||++.+ .++.++||||||+++|+|++|..||......+..... ....
T Consensus 146 ~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 219 (288)
T cd07833 146 FARALRARPA------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219 (288)
T ss_pred cccccCCCcc------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9886522211 11223457888999999644 4689999999999999999999999754322111100 0011
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.++..........-.... ... .+. .+........+..++.++.+++.+||+.+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~-~~~---~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 220 PLPPSHQELFSSNPRFAG-VAF---PEP---------SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCHHHhhhcccCccccc-ccc---CCC---------CCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 111111111110000000 000 000 00000000011223677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=282.89 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=196.5
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|.+.+.||+|++|.||.|... +++.|++|.+..... ...+.+..|+++++.++|+||+++++.+ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 5889999999999999999954 788999999875543 3567889999999999999999999984 3456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|+||+++++|.+++... ..+++..+..++.++++|++|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred EEEecCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence 999999999999999754 4578899999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
+............ ......++..|+|||.+.+. ++.++||||||+++|++++|..||....... ........
T Consensus 146 ~~~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 221 (264)
T cd06626 146 AVKLKNNTTTMGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA 221 (264)
T ss_pred ccccCCCCCcccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc
Confidence 8875322111110 01224578899999996543 6899999999999999999999996542211 11111000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..+.++ ....++..+.+++.+||+.+|++|||+.|++.
T Consensus 222 ~--------~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 G--------HKPPIP-------------------------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C--------CCCCCC-------------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000110 01112455778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.68 Aligned_cols=204 Identities=30% Similarity=0.430 Sum_probs=179.9
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
+-....+.|.++..||+|.|+.|.+|.+. ++..||+|.+.... ....+.+.+|+++++.+.||||++++.+ .
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~ 124 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----I 124 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----e
Confidence 44566789999999999999999999955 89999999998653 3344568899999999999999999999 5
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+....+|+||||+.+|.+.+|+.+. +++.+..+..++.|+++|++|||+. .|||||||++||+++.+.++
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 5566899999999999999999877 5677799999999999999999997 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||+|||.+.++. .......+.|++.|.|||++.|. .++++|+||+|+++|-|+.|..||++.
T Consensus 195 kIaDfgfS~~~~--------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 195 KIADFGFSTFFD--------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred eeeccccceeec--------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 999999998872 22333457899999999998885 589999999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=284.97 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=192.9
Q ss_pred ccccccccCcccccceEEEEe-CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCC---CCceeEEEEeeccccCCCCce
Q 005045 390 NFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTR---HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.|++.+.+|+|++|.||+|.+ .+++.||+|.+... .......+.+|+++++++. |||++++++.+. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 588899999999999999996 47899999988654 2334567888999999986 999999999853 4458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccC
Confidence 8999999999999998854 3578999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... .......|+..|+|||.+.+ . ++.++|||||||++|+|++|..||........ ..
T Consensus 146 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~- 212 (277)
T cd06917 146 GVAALLNQNS-------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MM- 212 (277)
T ss_pred CceeecCCCc-------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hh-
Confidence 9987652211 11223458889999999654 3 68899999999999999999999965422110 00
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. ......+.+.. ...+..+.+++.+||+.+|++||++.|++..
T Consensus 213 ~----~~~~~~~~~~~--------------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 L----IPKSKPPRLED--------------------------------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c----cccCCCCCCCc--------------------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 00000000100 0124567889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=288.29 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=192.6
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
....+|++.+.+|+|++|.||.|... +++.||+|.+.... ....+.+.+|+++++.++||||+++.+++..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----- 86 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----- 86 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----
Confidence 44567999999999999999999965 78899999875332 2334678899999999999999999999643
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||++ +++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEE
Confidence 457899999996 57777765332 4589999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
+|||.+..... .....++..|+|||++. +.++.++||||||+++|+|++|..||........ .
T Consensus 157 ~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~ 223 (307)
T cd06607 157 ADFGSASLVSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L 223 (307)
T ss_pred eecCcceecCC-----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--H
Confidence 99998865411 11235778899999863 3478999999999999999999999865321110 0
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
....... .+.. ....++..+.+++.+||+.+|++||++.+
T Consensus 224 ~~~~~~~--------~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 224 YHIAQND--------SPTL--------------------------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred HHHhcCC--------CCCC--------------------------------CchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0000000 0000 01123567889999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
|+..
T Consensus 264 il~~ 267 (307)
T cd06607 264 LLKH 267 (307)
T ss_pred HhcC
Confidence 9874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=282.72 Aligned_cols=279 Identities=26% Similarity=0.359 Sum_probs=208.4
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC--CCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST--RHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
....+..+.+|+|.||.||+|+.. ++.||||++... ..+.+.+|.+|.+.. .|+||+++++.-.... .....+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccce
Confidence 446677889999999999999974 589999999854 456788888887764 8999999998854332 224578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCEEeCCCCce
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC------DTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlkp~NIll~~~~~~ 539 (717)
++|++|.+.|+|.+|++.+ .++|....+++..+++||+|||+.. .++|+|||||++||+|..++++
T Consensus 284 wLVt~fh~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred eEEeeeccCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 9999999999999999864 5899999999999999999999765 3479999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCC-------cccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVS-------ILGDIYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~sDvwslG~vl~elltg~~p~~~~~~~ 612 (717)
.|+|||+|.++. .........+..||..|||||++.|... .+.||||+|.|+|||++.-.-+......
T Consensus 356 cIaDFGLAl~~~-----p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 356 CIADFGLALRLE-----PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred EeeccceeEEec-----CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 999999999874 2233334445789999999999988643 3479999999999999854433222222
Q ss_pred chhhhHHHHhcCCh---hhhhhc-CCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 613 DFSIHMFVSMALPD---HVMDIL-DPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 613 ~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
++...........+ .++..+ .++. ++..++.+.-......+.+.+..||+.|
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~------------------------RP~~p~~W~~h~~~~~l~et~EeCWDhD 486 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQ------------------------RPKIPDAWRKHAGMAVLCETIEECWDHD 486 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhcc------------------------CCCChhhhhcCccHHHHHHHHHHHcCCc
Confidence 22222221111111 122211 1111 1222233333345778899999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHH
Q 005045 689 PRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 689 p~~Rps~~eil~~l~~i~~~ 708 (717)
|+-|-||.-+.+++.++..-
T Consensus 487 aeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 487 AEARLTAGCVEERMAELMML 506 (534)
T ss_pred hhhhhhhHHHHHHHHHHhcc
Confidence 99999999999999887643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=286.10 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=187.7
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHH-HhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNA-LKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.+.||+|+||.||+|+++ +|+.||+|.+.... ......+..|+.+ ++..+||||+++++.+. .++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 47999999999999999999965 79999999886542 1222344455554 66679999999999864 34578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+++|||++ ++|.+++..... ....+++..+..++.||+.|++|||+++ +++||||||+||+++.++.+||+|||
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999996 688877754211 1146899999999999999999999852 89999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
.+...... .......++..|+|||.+.+ .++.++|+|||||++|+|++|+.||..........
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---- 217 (283)
T cd06617 150 ISGYLVDS--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---- 217 (283)
T ss_pred cccccccc--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----
Confidence 98765211 11122457888999998654 35789999999999999999999986432111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
........... ....++..+.+++.+||+.+|++|||+.++++
T Consensus 218 --------~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 --------KQVVEEPSPQL-----------------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------HHHHhcCCCCC-----------------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01110000000 00123566889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.16 Aligned_cols=209 Identities=23% Similarity=0.323 Sum_probs=166.9
Q ss_pred ccccccccCcccccceEEEEeC---CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|++.++||+|++|.||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++.+... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 5889999999999999999964 47899999988632 33346677899999999999999999996432 236
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC----CCce
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK----DMTA 539 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~----~~~~ 539 (717)
..++||||++ +++.+++...... ....+++..+..++.||+.|++|||+. +++||||||+||+++. ++.+
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 8999999996 5777766433211 113689999999999999999999997 9999999999999999 8999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
||+|||.+......... ........++..|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 152 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 152 KIGDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred EECCCccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99999998865222111 112223457888999998654 378999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=265.68 Aligned_cols=206 Identities=28% Similarity=0.405 Sum_probs=174.2
Q ss_pred ccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEEEec
Q 005045 394 ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
.+.+|+|+++.|-.++ .++|..+|||++.......+.+..+|++++.++ .|+||+.++++ +++++..|+|||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence 4679999999999998 679999999999988767788999999999999 79999999999 7778899999999
Q ss_pred CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---ceEEeeeccch
Q 005045 472 MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM---TAHVGDFGLAK 548 (717)
Q Consensus 472 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~~~ 548 (717)
+.||+|...|+.+ .-+++.++..+.++|+.||++||.. ||.|||+||+||+..... -|||+||.++.
T Consensus 158 m~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred ccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccc
Confidence 9999999999865 6799999999999999999999996 999999999999997544 58999998876
Q ss_pred hcccccCCCCCCcceeecccccccccCCCcc---CCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHM---NGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
-+....+-.......-....|+..|||||+. .++ |+.+.|.||||||+|-|++|.+||.+..+++.
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 5432222112222233456789999999983 343 78999999999999999999999988765543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=281.97 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=192.7
Q ss_pred ccccccccCcccccceEEEEeC--CCchhhhHHhHhh----------hhhHHHHHHHHHHHHhc-CCCCceeEEEEeecc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG--DGTIVAIKVLKLQ----------QQGALKSFIDECNALKS-TRHRNILRVITACSS 456 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~ 456 (717)
+|++.+.||+|++|.||.|.++ .++.+|+|.+... .......+..|+.++.+ ++||||+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 4889999999999999999965 4778999987532 22234556778888765 7999999999985
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
..++..+++|||+++++|.+++..... ....+++..++.++.|++.|+.|||+. ++++||||+|+||+++.+
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGED 150 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCC
Confidence 345689999999999999988753211 114689999999999999999999963 289999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+.++|+|||.+....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 151 ~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-- 220 (269)
T cd08528 151 DKVTITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-- 220 (269)
T ss_pred CcEEEecccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--
Confidence 999999999987642111 2233457889999999654 48899999999999999999999986431110
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
... .+.+...... ....++..+.+++.+||+.+|++||++
T Consensus 221 ~~~-----------~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~ 260 (269)
T cd08528 221 LAT-----------KIVEAVYEPL-----------------------------PEGMYSEDVTDVITSCLTPDAEARPDI 260 (269)
T ss_pred HHH-----------HHhhccCCcC-----------------------------CcccCCHHHHHHHHHHCCCCCccCCCH
Confidence 000 0000000000 001124567899999999999999999
Q ss_pred HHHHHHHH
Q 005045 696 NVVVNNLK 703 (717)
Q Consensus 696 ~eil~~l~ 703 (717)
.|+.++++
T Consensus 261 ~e~~~~~~ 268 (269)
T cd08528 261 IQVSAMIS 268 (269)
T ss_pred HHHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.13 Aligned_cols=285 Identities=19% Similarity=0.225 Sum_probs=201.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|.+.+.||+|++|.||.|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3568999999999999999999954 7899999987643 222345677899999999999999999876544333334
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~D 151 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICD 151 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 6899999995 7899888754 5689999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH-
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV- 620 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~- 620 (717)
||.+....... .......++..|+|||.+. +.++.++|||||||++|+|++|..||....... ......
T Consensus 152 fg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 223 (337)
T cd07858 152 FGLARTTSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITE 223 (337)
T ss_pred CccccccCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHH
Confidence 99987652111 1112345788999999854 358899999999999999999999996542111 000000
Q ss_pred -HhcCC-hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 621 -SMALP-DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 621 -~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
....+ +.+..+.+. ...+..+.. ....+. ......++++..+.+++.+||+.+|++|||++|+
T Consensus 224 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 224 LLGSPSEEDLGFIRNE-----------KARRYIRSL--PYTPRQ--SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred HhCCCChHHhhhcCch-----------hhhHHHHhc--Cccccc--CHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 00000 001000000 000000000 000000 0001123456778999999999999999999999
Q ss_pred HHH--HHHH
Q 005045 699 VNN--LKTI 705 (717)
Q Consensus 699 l~~--l~~i 705 (717)
++. +..+
T Consensus 289 l~h~~~~~~ 297 (337)
T cd07858 289 LAHPYLASL 297 (337)
T ss_pred HcCcchhhh
Confidence 976 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.51 Aligned_cols=283 Identities=20% Similarity=0.272 Sum_probs=200.6
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|++.+.||+|++|.||.|..+ +|+.||+|++.... ......+.+|+.++++++||||+++.+.+.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 478999999999999999999965 79999999887532 234567778999999999999999988754332 34457
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~df 151 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDF 151 (334)
T ss_pred EEEEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccc
Confidence 899999995 6899988754 4589999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH--
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV-- 620 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~-- 620 (717)
|.+......... .........++..|+|||.+.+ .++.++|||||||++|+|++|..||........ .....
T Consensus 152 g~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~ 227 (334)
T cd07855 152 GMARGLSSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSV 227 (334)
T ss_pred ccceeecccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHH
Confidence 998765221111 1111223468889999999644 478999999999999999999999965432211 11000
Q ss_pred HhcCChhh-hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 621 SMALPDHV-MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 621 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
....+..+ ....+. .+.+.... ........-....++.+..+.+++.+||+.+|++|||++|++
T Consensus 228 ~g~~~~~~~~~~~~~-----------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 228 LGSPSEEVLNRIGSD-----------RVRKYIQN----LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hCCChhHhhhhhchh-----------hHHHHHhh----cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00111111 000000 00000000 000000000011123367789999999999999999999988
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 293 ~~ 294 (334)
T cd07855 293 QH 294 (334)
T ss_pred hC
Confidence 74
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.80 Aligned_cols=204 Identities=29% Similarity=0.382 Sum_probs=166.5
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...++|++.+.||+|++|.||+|.++ +|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence 35678999999999999999999965 78999999886442 22234566899999999999999999986432 23
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+. ++|.+++.... ..+++..+..++.||+.|++|||+. +++||||+|+||+++.++.+||+
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 46899999995 58888876532 4689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+....... .......++..|+|||.+.+ .++.++||||+||++|+|++|..||...
T Consensus 151 dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 151 DFGLARTYGLPA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred ccceeeecCCcc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999988652111 11122335778999999754 3789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=282.86 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=194.0
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+-|++.+.||.|+||.||+|... +++.||+|...... ......+.+|++++++++||||+++++.+. .+...+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence 45788999999999999999854 78899999876432 334567889999999999999999999853 455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 79 lv~e~~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~ 147 (277)
T cd06641 79 IIMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 147 (277)
T ss_pred EEEEeCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccc
Confidence 99999999999999864 3478999999999999999999997 999999999999999999999999998
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ........++..|+|||.+.+ .++.++|+|||||++|+|++|..||....... ......
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~---- 214 (277)
T cd06641 148 AGQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP---- 214 (277)
T ss_pred ceecccc-------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh----
Confidence 8654211 111122457888999999654 57889999999999999999999986532211 000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....+. ....++..+.+++.+|++.+|++||+++++++.
T Consensus 215 ----~~~~~~---------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 215 ----KNNPPT---------------------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----cCCCCC---------------------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 011225567889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.44 Aligned_cols=284 Identities=19% Similarity=0.200 Sum_probs=190.2
Q ss_pred cccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 393 KENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.+.+|.| +.||.++.. +++.||+|++... .......+..|+++++.++|+||+++++++ ...+..+++|
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVS 78 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEE
Confidence 34444444 445555533 7899999998754 344567899999999999999999999984 3455889999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||++++++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 79 e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 79 PLMAYGSCEDLLKTHFP-----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred eccCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcccee
Confidence 99999999999875421 4578899999999999999999998 999999999999999999999999998876
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...................++..|+|||++.+ .++.++|||||||++|+|++|..||........ ..+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 229 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPC 229 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCcc
Confidence 53322211111222233457788999999754 378899999999999999999999976532211 11111111111
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+....-+............... .. ................+.+++.+||+++|++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEH----PN-----NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccCchhhhcCCcCcccccccc----cc-----hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 11000000000000000000000 00 00000001122235568899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=285.07 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=193.1
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
+|...++||+|++|.||.+..+ +++.+++|.+........+.+.+|+.+++.+.||||+++++.+. ..+..+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 5666789999999999999954 78889999886554444567889999999999999999999853 45588999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
+||+++++|.+++.. ..+++..+..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+.
T Consensus 95 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 95 MEFLEGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EeccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccch
Confidence 999999999999864 3478899999999999999999998 99999999999999999999999999876
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.... .........|+..|+|||...+ .++.++|||||||++|+|++|..||...... .......
T Consensus 164 ~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~------ 228 (285)
T cd06648 164 QVSK-------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIR------ 228 (285)
T ss_pred hhcc-------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHH------
Confidence 5411 1111223457889999999655 4789999999999999999999998643211 0000000
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+... ....++..+.+++.+||+.+|++|||+.|+++
T Consensus 229 --~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 229 --DNLPPKLK-------------------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --hcCCCCCc-------------------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00000000 01112456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=289.95 Aligned_cols=287 Identities=23% Similarity=0.293 Sum_probs=205.3
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~~~ 465 (717)
..|..-+.+|+||||.||++++ ++|+.||||.+.... ...+++..+|++++++++|+|||+.++.-.... ..-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3566778899999999999995 499999999998643 344677889999999999999999988743322 1124467
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCC--ceEE
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD--KDM--TAHV 541 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl 541 (717)
.+|||||+||+|+..+++... ...+++.+.+.+..+++.||.|||++ |||||||||.||++- .+| .-||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN----~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPEN----AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred eEEEeecCCCcHHHHhcCccc----ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEee
Confidence 899999999999999986542 26799999999999999999999998 999999999999994 334 5799
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC--chhhh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKD--DFSIH 617 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~--~~~~~ 617 (717)
+|||.|+.. .+........||..|.+||+.. +.++..+|.|||||++||+.||..||-..... .....
T Consensus 166 tDfG~Arel--------~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 166 TDFGAAREL--------DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM 237 (732)
T ss_pred ecccccccC--------CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence 999999976 2223556688999999999976 56899999999999999999999999655333 22233
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC--CH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI--AM 695 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp--s~ 695 (717)
+.....-|..+.-...+.......+.+ .+..+.. ...--...+...+..++.++|++|. ..
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~--------------~lP~p~~---Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~ 300 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSS--------------TLPQPNH---LSRGLATRLTKWLASMLEWNPRKRGHEGF 300 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeec--------------cCCCccc---ccHHHHhhhhHHHHHHHhhhHHHhCCCCc
Confidence 333333333333333322221110000 0000000 1111133445566667777888888 77
Q ss_pred HHHHHHHHHHHH
Q 005045 696 NVVVNNLKTIRN 707 (717)
Q Consensus 696 ~eil~~l~~i~~ 707 (717)
.+....+..|..
T Consensus 301 ~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 301 DRFFAEVDDILN 312 (732)
T ss_pred chHHHHHHHHHh
Confidence 777766666653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.20 Aligned_cols=283 Identities=19% Similarity=0.276 Sum_probs=202.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC--CCc----eeEEEEeeccccC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR--HRN----ILRVITACSSVDL 459 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~n----i~~~~~~~~~~~~ 459 (717)
..++|.+...+|+|.||.|-.+.+. .+..||+|+++... ..++...-|+++++++. -|+ ++.+.++ +
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----F 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----F 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----h
Confidence 4889999999999999999999954 68899999998654 23456677999999983 222 4555555 5
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC----
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---- 535 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---- 535 (717)
+..++.|||+|.+ |.+++|++..+. +..++...++.++.|+++++++||+. +++|.||||+||++..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 6678999999998 779999998763 37799999999999999999999998 9999999999999942
Q ss_pred ----------------CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHH
Q 005045 536 ----------------DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLE 598 (717)
Q Consensus 536 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~e 598 (717)
+..++++|||.|.+-.+ .......|..|+|||++.| .|++.+||||+||||+|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc----------CcceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 23689999999986411 1234678999999999766 79999999999999999
Q ss_pred HHhCCCCCCCCCC-CchhhhHHHHhcCChhhhh-h-----cCC-CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhh
Q 005045 599 MFTGKRPTGDMFK-DDFSIHMFVSMALPDHVMD-I-----LDP-SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKL 670 (717)
Q Consensus 599 lltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~-~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
++||...|..... +...+.+.+...+|..+.. . ... ++.++............ +.--+++..+. ..
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~---~~ckpl~~~~~---~~ 375 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVF---EPCKPLKKYML---QD 375 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhh---cCCccHHHHhc---cC
Confidence 9999999987652 2222333333344443211 1 111 11111111000001111 11111111111 22
Q ss_pred HHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 671 EECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.....+|++|+++||..||.+|+|++|++.
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 233567999999999999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.99 Aligned_cols=271 Identities=22% Similarity=0.313 Sum_probs=195.4
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
+|++.++||.|++|.||+|+.+ +|+.||+|.+.... ......+.+|++++++++|+||+++++.+. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 5899999999999999999975 78999999887543 223466778999999999999999999954 3457899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++ +++.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred EEecCC-ccHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 999997 488888764421 14589999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh---
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM--- 622 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--- 622 (717)
....... .......++..|+|||.+.+ .++.++|||||||++|+|++|..||......+. .......
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~ 219 (284)
T cd07836 148 RAFGIPV-------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGT 219 (284)
T ss_pred hhhcCCc-------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCC
Confidence 7542110 11112346788999999654 368899999999999999999999976533211 1111110
Q ss_pred cCChhhhhhcCCC-CCCCC-CCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPS-MPLDE-ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.....+..+.+.. ..... ....... ....+.++..+.+++.+|++.+|++||+++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDL-------------------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHH-------------------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001111111000 00000 0000000 0111233667889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.83 Aligned_cols=270 Identities=22% Similarity=0.246 Sum_probs=191.2
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.+++|+|++|.||+|... +++.||+|.+.... ........+|+.+++++. |+|++++++.+.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 678899999999999999955 78899999887542 222234457888888884 99999999986432 2257899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++ +++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+
T Consensus 78 v~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 78 VFELMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred EEecCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccc
Confidence 999996 58888776432 4689999999999999999999997 9999999999999999 99999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCcc-C-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh---
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-N-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM--- 622 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--- 622 (717)
...... .......++..|+|||.+ . +.++.++||||+||++|+|++|..||......+ .......
T Consensus 147 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~ 216 (282)
T cd07831 147 RGIYSK--------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG 216 (282)
T ss_pred cccccC--------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence 765211 111223478899999974 3 346899999999999999999999997643221 1111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..++.+................. ............+..+.+++.+||+.+|++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSK----------------KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHHHhhcccccccccCccc----------------ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11111111111111000000000 000000112234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.96 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=193.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.+|++.+.||+|++|.||.|.++ +++.||+|.+... .......+.+|++++++++|+||+++++.+... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47999999999999999999965 7899999986432 233456888999999999999999999986432 23
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence 5688999999999999998754 4578889999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+........ .........++..|+|||.+.+ .++.++|+|||||++|+|++|..||....... .......
T Consensus 149 dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 223 (264)
T cd06653 149 DFGASKRIQTICM----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIAT 223 (264)
T ss_pred ccccccccccccc----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHc
Confidence 9999886521110 0111123458889999999765 47899999999999999999999996531111 0000000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+.+ +......+.+++.+|++ +|..|||+.+++.
T Consensus 224 --------~~~~~~~---------------------------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 --------QPTKPML---------------------------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------CCCCCCC---------------------------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0000111 11225567899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.13 Aligned_cols=241 Identities=21% Similarity=0.288 Sum_probs=180.9
Q ss_pred ccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHH---HHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 396 LIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECN---ALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
.||+|+||.||++... +++.+|+|.+.... ......+.+|.. ++....||+|+.+++.+ ...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 4899999999999965 78899999875432 111223334443 33345799999998884 344588999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 76 ~e~~~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 76 LDLMNGGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999999999988754 5689999999999999999999997 99999999999999999999999999986
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccC-C-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-G-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... ......|+..|+|||... + .++.++||||+||++|+|++|..||................
T Consensus 146 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---- 212 (279)
T cd05633 146 DFSKK---------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---- 212 (279)
T ss_pred ecccc---------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----
Confidence 54111 112245889999999964 3 37899999999999999999999997543322111000000
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVNN 701 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~~ 701 (717)
..... .++.++..+.+++.+|++.+|++|| |++|+++.
T Consensus 213 ----~~~~~---------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 ----TVNVE---------------------------------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cCCcC---------------------------------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00000 1122356778999999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=285.58 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=189.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|...+.||+|++|.||++.+. +++.||+|.+.... ......+.+|+.++.++. |+||+++++.+. .++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 46778899999999999999965 78999999887542 234567889999999995 999999999853 34578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
+++|||++ +++.++...... .....+++..+..++.+++.|++|||+. .+++||||||+||+++.++.++|+|||
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecc
Confidence 99999985 566554321000 0115689999999999999999999974 289999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
++....... ......++..|+|||.+.+ .++.++||||+||++|+|++|..||..... ......
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~ 221 (288)
T cd06616 154 ISGQLVDSI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLT 221 (288)
T ss_pred hhHHhccCC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHh
Confidence 987652111 1122347888999999654 378999999999999999999999965421 100000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..... ..+.+... ...+++..+.+++.+||+.+|++|||++||++.
T Consensus 222 ~~~~~-----~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 QVVKG-----DPPILSNS-----------------------------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hhcCC-----CCCcCCCc-----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00011000 012235678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.17 Aligned_cols=208 Identities=25% Similarity=0.348 Sum_probs=165.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|++|.||+|.+. +++.||+|...... ......+.+|+.+++.+. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999965 78999999876542 223456788999999994 699999998865443222334
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~D 543 (717)
.++||||+++ ++.+++...... ....+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.+||+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 8999999975 888887643211 114579999999999999999999997 9999999999999998 88999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||.+...... ........+++.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 155 fg~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 155 LGLGRAFSIP-------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cccceecCCC-------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9998754211 111122346788999998644 3689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.61 Aligned_cols=276 Identities=22% Similarity=0.273 Sum_probs=192.3
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.+.||+|++|.||+|.++ +++.||+|.+.... ......+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 57999999999999999999965 78899999886542 233466788999999999999999999953 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCceEEeee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDF 544 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Df 544 (717)
++||||++ +++.+++..... ..+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccc
Confidence 99999995 588887754321 3467888899999999999999997 9999999999999985 557999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+...... ........++..|+|||.+.+ .++.++||||+||++|+|++|..||......+. ..... .
T Consensus 148 g~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~-~ 218 (294)
T PLN00009 148 GLARAFGIP-------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIF-R 218 (294)
T ss_pred ccccccCCC-------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-H
Confidence 998754111 111122346789999998654 368999999999999999999999975432211 11100 0
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.........+..... ..+.. ...............+..+.++.+++.+|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 219 ILGTPNEETWPGVTS---------LPDYK----SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HhCCCChhhcccccc---------chhhh----hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000000 00000 000000000000011223556789999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=290.67 Aligned_cols=283 Identities=22% Similarity=0.319 Sum_probs=197.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|++|.||+|.+. +++.+|+|.+... .......+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 4578999999999999999999965 6888999987532 223345677899999999 99999999998632 234
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +++||||+|+||+++.++.+||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 46899999996 5898888642 467888899999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+.......... .........++..|+|||.+.+ .++.++|||||||++|+|++|+.||........ .....
T Consensus 150 d~g~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~ 226 (337)
T cd07852 150 DFGLARSLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII 226 (337)
T ss_pred eccchhccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 999998653221110 0112233568889999998643 478999999999999999999999965433211 11100
Q ss_pred Hh--cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 621 SM--ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 621 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.. ..+......+.. ....++.. ...-...........+++..+.+++.+||+.+|++|||+.++
T Consensus 227 ~~~~~~~~~~~~~~~~----------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 227 EVIGPPSAEDIESIKS----------PFAATMLD----SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred HHhCCCCHHHHHHHHh----------hhHHHhhh----hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 00 000000000000 00000000 000000000011112246778999999999999999999999
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 293 l~~ 295 (337)
T cd07852 293 LEH 295 (337)
T ss_pred hhC
Confidence 975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.12 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=198.7
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||+|++|.||.|... +++.|++|++.... ....+.+.+|++++++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4788899999999999999966 78999999987554 245678899999999999999999999864321 26889
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+++||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 78 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred EEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999998754 4689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+......... .......++..|+|||...+. .+.++||||||+++|+|++|..||....... ...
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-------- 213 (260)
T cd06606 148 AKRLGDIETG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AAL-------- 213 (260)
T ss_pred EEeccccccc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHH--------
Confidence 8866222110 112234578899999997654 8999999999999999999999997654111 000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.......... +.+...+..+.+++.+|++.+|++||++.|+++
T Consensus 214 ---~~~~~~~~~~-----------------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 214 ---YKIGSSGEPP-----------------------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---HhccccCCCc-----------------------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000000000 011222567889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=280.01 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=192.7
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.+|+|++|.||+|..+ +|..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 5889999999999999999965 68889999986542 22346778999999999999999999884 4456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg 545 (717)
+|+||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .+||+|||
T Consensus 76 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred EEEecCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence 99999999999999875421 3578999999999999999999997 999999999999999876 56999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+....... .......|++.|+|||... +.++.++|+|||||++|+|++|..||....... ...
T Consensus 148 ~~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~--- 212 (257)
T cd08225 148 IARQLNDSM-------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVL--- 212 (257)
T ss_pred cchhccCCc-------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHH---
Confidence 887652111 1112245788999999965 458899999999999999999999986432111 110
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.......... .+..+..+.+++.+|++.+|++|||++|+++
T Consensus 213 -----~~~~~~~~~~------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 -----KICQGYFAPI------------------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -----HHhcccCCCC------------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111110000 0112446788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=287.69 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=168.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC---
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDL--- 459 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--- 459 (717)
...++|++.++||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999965 78999999876432 2223456689999999999999999998754331
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
......++||||+. +++.+++.... ..+++.+++.++.||+.|++|||++ +++|+||+|+||+++.++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 12346799999995 58888776432 3689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||+|||.+.......... ........++..|+|||.+.+. ++.++||||||+++|+|++|..||...
T Consensus 159 kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 159 KLADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred EECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999998653221111 1112234578889999986553 688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=283.83 Aligned_cols=198 Identities=30% Similarity=0.453 Sum_probs=164.1
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.++||.|++|.||+|.++ +|+.||+|++.... ......+.+|++++++++|||++++++.+. +.+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999965 79999999886543 223456788999999999999999999853 4468999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
+|||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 76 v~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred EEeccC-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 999995 689998875421 3689999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 147 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 147 RAFGVP-------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccCCC-------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 754211 111122345788999998654 3688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=275.49 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=197.0
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
+|++.+.||+|++|.||.+..+ +++.+++|.+..........+.+|+++++++.|++++++++.+. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4888999999999999999975 78899999987665455678899999999999999999999853 34588999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
+||+++++|.+++.... ..+++..+..++.|++.|+++||.. +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EecCCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 99999999999987542 4689999999999999999999997 99999999999999999999999999987
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.......... ....
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~----- 211 (253)
T cd05122 147 QLSDTKA--------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIAT----- 211 (253)
T ss_pred ccccccc--------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHh-----
Confidence 6521110 223457889999999654 47899999999999999999999986542111100 0000
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..-+... ....++..+.+++.+|++.+|++|||+.|+++
T Consensus 212 ---~~~~~~~-------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 212 ---NGPPGLR-------------------------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---cCCCCcC-------------------------------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 00112456889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=292.99 Aligned_cols=206 Identities=24% Similarity=0.330 Sum_probs=165.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc--------
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD-------- 458 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-------- 458 (717)
.++|++.+.||.|++|.||+|..+ +++.||+|.+........+.+.+|+++++.++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 579999999999999999999964 78899999887665555677889999999999999999987754322
Q ss_pred -CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CC
Q 005045 459 -LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KD 536 (717)
Q Consensus 459 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~ 536 (717)
+.+....++||||++ ++|.+++.. ..+++..++.++.||+.|++|||+. +++||||||+||+++ .+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 112246899999996 588888753 3578999999999999999999997 999999999999997 45
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+.++++|||.+......... ........++..|+|||.+.+ .++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ceEEECCcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 68899999998765221111 111122346888999998533 4788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=264.09 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=174.6
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
-++|..++.+|+|.||.|.+++-+ +|+.+|+|+++... ......-..|-++++..+||.+..+-.. ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 457888999999999999999955 89999999998653 3445667789999999999998776655 66778
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
.+|+||||..||.|.-.+.+. ..+++..++.+...|+.||.|||++ +||.||+|.+|.|+|.+|++||+|
T Consensus 242 rlCFVMeyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred eEEEEEEEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence 999999999999998888765 6799999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||+++.- .........++||+.|.|||++... |+.++|+|++|||+|||+.|+.||..-
T Consensus 312 FGLCKE~-------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 312 FGLCKEE-------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cccchhc-------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 9999743 2333345678899999999998765 999999999999999999999999754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.76 Aligned_cols=361 Identities=24% Similarity=0.389 Sum_probs=233.4
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.++.|+.++|+++ .+|.+++.+.+|+.|++++|.+. .+|+.++.+..|..|+..+|+++ ..|..+..+.+|..|++.
T Consensus 92 ~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~ 168 (565)
T KOG0472|consen 92 ALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLE 168 (565)
T ss_pred HHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhcc
Confidence 4455555555555 55555555555666666666555 45555555556666666666665 555555566666666666
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|+++...|+.+ +++.|++||..+|-++ .+|+.++++.+|..|+|..|+|. .+| -|.+++.|+.|+++.|.|...
T Consensus 169 ~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~l 243 (565)
T KOG0472|consen 169 GNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIEML 243 (565)
T ss_pred ccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHHhh
Confidence 666663333333 3666777777777666 56666777777777777777776 666 344677777777777777744
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC---
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG--- 247 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~--- 247 (717)
..+...++++|..|||.+|+++ ..|+.++-+.+|.+||+|+|.|++++ ..++++ .|+.|-+.+|.+..
T Consensus 244 pae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp-------~sLgnl-hL~~L~leGNPlrTiRr 314 (565)
T KOG0472|consen 244 PAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLP-------YSLGNL-HLKFLALEGNPLRTIRR 314 (565)
T ss_pred HHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCC-------cccccc-eeeehhhcCCchHHHHH
Confidence 3344558888888888888888 78888888888888888888888875 446666 66666666665520
Q ss_pred -------------------------------------------------------------cCchhhhhccc--cccEEe
Q 005045 248 -------------------------------------------------------------EMPISIANLST--HLRRLT 264 (717)
Q Consensus 248 -------------------------------------------------------------~~p~~~~~~~~--~L~~L~ 264 (717)
.+|...+...+ -.+..+
T Consensus 315 ~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~Vn 394 (565)
T KOG0472|consen 315 EIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVN 394 (565)
T ss_pred HHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEe
Confidence 33333333211 155566
Q ss_pred cCCCccCC-----------------------CCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCC
Q 005045 265 MGENLMHG-----------------------NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321 (717)
Q Consensus 265 l~~N~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 321 (717)
++.|++.. .+|..++.+++|..|+|++|-+. .+|..++.+..|+.|++|+|++. .
T Consensus 395 fskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~ 472 (565)
T KOG0472|consen 395 FSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-M 472 (565)
T ss_pred cccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-c
Confidence 66666641 34444555667777777777776 56666777777777777777766 4
Q ss_pred CCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCcccccCCCCcccccccccccc
Q 005045 322 IPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFS 392 (717)
Q Consensus 322 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~s~~~~~~~~~~y~ 392 (717)
.|..+..+..|+.+-.++|++....|+++.++.+|..|||.+|++. .+|+.++.. .++..+.-..+.|+
T Consensus 473 lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnm-tnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 473 LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNM-TNLRHLELDGNPFR 541 (565)
T ss_pred chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccc-cceeEEEecCCccC
Confidence 4665555556666666667777555666899999999999999998 888887542 23333333344443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=283.57 Aligned_cols=274 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.+.||+|++|.||+|..+ +++.+++|.+..... .....+..|++++++++|++|+++++.+ ..++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 678899999999999999965 788999998865432 3456788899999999999999999984 34468999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++ +++.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 v~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 76 VFEFMD-TDLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred EEeccC-CCHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 999996 48888876532 4689999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
....... .......++..|+|||.+.+ .++.++|+||+||++|+|++|+.||......+. .......+.
T Consensus 146 ~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~ 216 (283)
T cd05118 146 RSFGSPV-------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLG 216 (283)
T ss_pred EecCCCc-------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcC
Confidence 7652211 11122457788999999654 478999999999999999999999966432211 111111110
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
......+... .+..........-..........++++.++.+++.+||+.+|.+||++.|++.
T Consensus 217 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 217 TPDPEVWPKF------------TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCchHhcccc------------hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000 00000000000000000111123445778999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.38 Aligned_cols=201 Identities=30% Similarity=0.444 Sum_probs=166.2
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.+.+|+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|+|++++++.+... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999965 68899999998653 33456788899999999999999999986432 1368999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++ +++.+++.... ..+++..++.++.||+.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 78 v~e~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred Eecccc-ccHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccce
Confidence 999996 58888876542 4689999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
........ .......++..|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 148 ~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 148 RPYTKRNS------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred eeccCCCc------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 86532211 11122346778999998654 47899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=278.65 Aligned_cols=192 Identities=28% Similarity=0.409 Sum_probs=160.3
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||+|+||.||.|... +|+.||+|.+.... ......+..|++++++++||||+++++.+ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999854 78899999886432 22345667899999999999999999884 4456899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~~~L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 76 NGGDLKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred CCCcHHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 99999999875421 3689999999999999999999997 999999999999999999999999999876521
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
........++..|+|||.+.+ .++.++||||+||++|+|++|+.||...
T Consensus 148 --------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 148 --------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred --------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 111123457788999999654 4789999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.45 Aligned_cols=282 Identities=23% Similarity=0.307 Sum_probs=196.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc----
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVD---- 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 458 (717)
...++|++.+.+|+|++|.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68899999986442 223356778999999999999999998864422
Q ss_pred -CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 459 -LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 459 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
..+....++||||+++ ++.+.+.... ..+++..+..++.||+.||+|||+. +++||||+|+||+++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 1223478999999975 7777665432 4689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||.+........ .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||....... .
T Consensus 154 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~ 226 (302)
T cd07864 154 QIKLADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-Q 226 (302)
T ss_pred cEEeCcccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-H
Confidence 999999999876522111 11112335778999998654 36899999999999999999999997532211 1
Q ss_pred hhHHH---HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 616 IHMFV---SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 616 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
..... ....+.....+............. ... . .........+..+.+++.+||+.+|++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-------------~--~~~~~~~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKK-QYR-------------R--RLREEFSFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred HHHHHHHhCCCChhhccccccccccccccccc-ccc-------------c--chhhhcCCCCHHHHHHHHHHccCChhhC
Confidence 11111 111111111111100000000000 000 0 0000111225678999999999999999
Q ss_pred CCHHHHHH
Q 005045 693 IAMNVVVN 700 (717)
Q Consensus 693 ps~~eil~ 700 (717)
||+.++++
T Consensus 291 p~~~~il~ 298 (302)
T cd07864 291 CTAEEALN 298 (302)
T ss_pred CCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=277.65 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=181.2
Q ss_pred ccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHH---HHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 396 LIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDE---CNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
.||+|++|.||.|... +++.||+|.+.... ......+..| .+.++...||+|+++.+.+ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4799999999999964 78899999876432 1111223333 3345556899999998884 445689999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||++|++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 ~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 76 LDLMNGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 9999999999988644 5689999999999999999999997 99999999999999999999999999987
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... ......|+..|+|||.+.+ .++.++||||+||++|+|++|..||................
T Consensus 146 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---- 212 (278)
T cd05606 146 DFSKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---- 212 (278)
T ss_pred ccCcc---------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh----
Confidence 54111 1122458899999999753 47899999999999999999999997642221111000000
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNVVVNN 701 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~eil~~ 701 (717)
.....+ +..++..+.+++.+|++.+|++|| ++.|+++.
T Consensus 213 ----~~~~~~---------------------------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 ----TMAVEL---------------------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----ccCCCC---------------------------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000111 111255678999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=278.14 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=187.4
Q ss_pred ccccccccccccccccc--CcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 381 YSDISKSTDNFSKENLI--GTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~i--g~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
+++.....++|.+.+.+ |.|+||.||.+..+ +++.+|+|.+........ |+.....+ +||||+++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe-
Confidence 33444456688888887 99999999999954 788899998764422211 22222222 7999999999854
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
..+..++||||+++++|.+++... ..+++..+..++.||++|++|||+. +++||||+|+||+++.+
T Consensus 80 ----~~~~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 80 ----TLKGHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred ----cCCeeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 345899999999999999999754 4689999999999999999999998 99999999999999998
Q ss_pred C-ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 537 M-TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 537 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
+ .++|+|||.+.... ......++..|+|||++.+ .++.++||||+||++|+|++|..||.....+..
T Consensus 146 ~~~~~l~dfg~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 146 KDRIYLCDYGLCKIIG-----------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CCeEEEecCccceecC-----------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 8 99999999887541 1112357889999999755 578999999999999999999999975433322
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
....+... ...... .....+..+.+++.+||+.+|.+||+
T Consensus 215 ~~~~~~~~---------~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~ 254 (267)
T PHA03390 215 DLESLLKR---------QQKKLP-------------------------------FIKNVSKNANDFVQSMLKYNINYRLT 254 (267)
T ss_pred hHHHHHHh---------hcccCC-------------------------------cccccCHHHHHHHHHHhccChhhCCc
Confidence 11111100 000000 11123567889999999999999996
Q ss_pred -HHHHHH
Q 005045 695 -MNVVVN 700 (717)
Q Consensus 695 -~~eil~ 700 (717)
++|+++
T Consensus 255 ~~~~~l~ 261 (267)
T PHA03390 255 NYNEIIK 261 (267)
T ss_pred hHHHHhc
Confidence 688874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=280.61 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=191.5
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
.|....+||+|++|.||.+..+ +++.||+|.+..........+.+|+.+++.++|+|++++++.+ ...+..++|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEE
Confidence 3444578999999999999864 7899999987654444567788999999999999999999985 345689999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+.
T Consensus 96 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 96 MEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred EecCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccce
Confidence 999999999998753 3478899999999999999999998 99999999999999999999999999876
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.... .........++..|+|||...+ .++.++|+||+||++|+|++|..||...... ..........+
T Consensus 165 ~~~~-------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~-- 233 (292)
T cd06657 165 QVSK-------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP-- 233 (292)
T ss_pred eccc-------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCC--
Confidence 5411 1111123457889999999654 5789999999999999999999998643111 11111111111
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+... .....+..+.+++.+||+.+|.+||++.|+++
T Consensus 234 ------~~~~-------------------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 234 ------PKLK-------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ------cccC-------------------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0000 00112445778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=277.38 Aligned_cols=248 Identities=26% Similarity=0.323 Sum_probs=195.1
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+++|+|++|.||.+..+ +++.+++|.+.... ......+.+|+++++.++|+||+++.+.+ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 5889999999999999999855 78889999886532 23456778899999999999999998884 3446899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred EEehhcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccc
Confidence 99999999999999865321 124678999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... ......++..|+|||...+ .++.++|+||+|+++|+|++|..||....... ......
T Consensus 150 ~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~---- 214 (256)
T cd08530 150 SKVLKKN---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKVQ---- 214 (256)
T ss_pred hhhhccC---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh----
Confidence 8765221 1122447889999999655 47889999999999999999999996542211 111100
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+. .+..++..+.+++.+|++.+|++|||+.|+++
T Consensus 215 -------~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 215 -------RGKYPP------------------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------cCCCCC------------------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 11123566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=289.57 Aligned_cols=289 Identities=20% Similarity=0.228 Sum_probs=203.6
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||.|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++|+||+++.+++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999965 68999999887543 34457788999999999999999999986543322334789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||++ ++|.+++... ..+++..++.++.||+.||+|||+. |++||||||+||+++.++.++|+|||.
T Consensus 81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 9999996 5898888754 4689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+......... ........++..|+|||.+.+ .++.++|+||+||++|+|++|..||......+. . .......
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~-~~i~~~~ 223 (330)
T cd07834 150 ARGVDPDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-L-NLIVEVL 223 (330)
T ss_pred eEeecccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHhc
Confidence 9875322110 011223457888999999654 478999999999999999999999976543211 1 1111101
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH--H
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN--L 702 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~--l 702 (717)
.....+.+.. .....+.+........ ....-....++.+..+.+++.+||+++|++|||+.++++. +
T Consensus 224 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 224 GTPSEEDLKF-------ITSEKARNYLKSLPKK----PKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred CCCChhHhhh-------ccccchhhHHhhcccC----CcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 0000000000 0000011111100000 0000000112236678999999999999999999999974 5
Q ss_pred HHHH
Q 005045 703 KTIR 706 (717)
Q Consensus 703 ~~i~ 706 (717)
+.++
T Consensus 293 ~~~~ 296 (330)
T cd07834 293 AQLH 296 (330)
T ss_pred Hhhc
Confidence 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=273.92 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=195.3
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|++.+.||+|++|.||.|... +++.|++|.+..... .....+.+|++++++++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 5889999999999999999865 688899999876543 45578899999999999999999999853 345899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||+++++|.+++... ..+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred EEEecCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccc
Confidence 999999999999998754 5689999999999999999999997 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+........ ......++..|+|||...+ .++.++||||+|+++|+|++|..||....... ......
T Consensus 146 ~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~~~---- 212 (254)
T cd06627 146 ATKLNDVSK-------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRIV---- 212 (254)
T ss_pred ceecCCCcc-------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHh----
Confidence 986622111 1223457889999999654 37899999999999999999999986542111 000000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...... .+...+..+.+++.+||+.+|++|||+.|++.
T Consensus 213 -------~~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 213 -------QDDHPP------------------------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -------ccCCCC------------------------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000000 01112456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=274.98 Aligned_cols=241 Identities=25% Similarity=0.339 Sum_probs=188.6
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||.|++|.||.|... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+ .++...+++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 689999999999965 68899999886432 23457789999999999999999999984 4456899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++.+. ..+++..+..++.||+.|++|+|+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 76 LGGELWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred CCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999999999754 4588999999999999999999997 999999999999999999999999999886522
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
.. ......++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.....+..... ..+
T Consensus 146 ~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------~~~ 206 (262)
T cd05572 146 GQ--------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-----------NDI 206 (262)
T ss_pred cc--------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-----------HHH
Confidence 11 1122457888999999654 588999999999999999999999976532111111 111
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----HHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----MNVVVN 700 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~eil~ 700 (717)
.+...... .+...+..+.+++.+||+.+|++||+ ++|+++
T Consensus 207 ~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGNGKLE-----------------------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccCCCCC-----------------------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 10000000 01112456789999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=277.49 Aligned_cols=275 Identities=24% Similarity=0.338 Sum_probs=192.2
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccccCCCCce
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKST---RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
|++.+.||+|++|.||+|+++ +++.||+|.+.... ......+.+|+.+++++ .|+|++++++.+..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 58999999987432 22234556677776655 6999999999976554333345
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|||++ +++.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 899999996 589888865421 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh-
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM- 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~- 622 (717)
|.+...... .......++..|+|||++.+ .++.++|||||||++|+|++|..||......+ ........
T Consensus 152 g~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~ 222 (287)
T cd07838 152 GLARIYSFE--------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVI 222 (287)
T ss_pred CcceeccCC--------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHc
Confidence 998765211 11112346788999999654 57899999999999999999999987543221 11111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.................. .....-.....+.+..+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPS-----------------YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhccc-----------------ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000000000000 0000000111233567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=281.02 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=190.8
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..|...+.+|+|+||.||+|++. +++.+|+|.+... .......+..|++++++++|||++++++++. .+..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCe
Confidence 45889999999999999999954 7889999987633 2233467888999999999999999999854 3457
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++ +++.+.+.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+||
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~df 169 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF 169 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecC
Confidence 899999996 57777765432 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|.+..... .....++..|+|||.+. +.++.++|||||||++|+|++|..||........ .....
T Consensus 170 g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~ 237 (317)
T cd06635 170 GSASIASP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA 237 (317)
T ss_pred CCccccCC-----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHH
Confidence 98764311 11235788899999952 3578999999999999999999999865321110 00000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....... ....++..+.+++.+|++.+|.+||++.||++
T Consensus 238 ------------~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 238 ------------QNESPTL-----------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred ------------hccCCCC-----------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 0000000 01123556789999999999999999999998
Q ss_pred HH
Q 005045 701 NL 702 (717)
Q Consensus 701 ~l 702 (717)
..
T Consensus 277 ~~ 278 (317)
T cd06635 277 HM 278 (317)
T ss_pred Ch
Confidence 54
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=273.47 Aligned_cols=217 Identities=29% Similarity=0.450 Sum_probs=182.9
Q ss_pred cccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh-------hhHHHHHHHHHHHHhcCCCCceeEEEE
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-------QGALKSFIDECNALKSTRHRNILRVIT 452 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~ 452 (717)
+.|-.-..++|-.++.+|+|||+.||+|.+ ...+.||+|+..... ....+...+|.+|.+.++||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 455666788999999999999999999994 478889999876431 123466778999999999999999999
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
++. -+.+..|-|+|||+|-+|+-|++.+ +.+++.+++.|+-||+.||.||.+. ..+|+|-||||.||+
T Consensus 535 yfs----lDtdsFCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 535 YFS----LDTDSFCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNIL 602 (775)
T ss_pred eee----eccccceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEE
Confidence 963 3456789999999999999999866 6799999999999999999999985 468999999999999
Q ss_pred eC---CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CC----CCCcccchhhHHHHHHHHHhCCC
Q 005045 533 LD---KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NG----QVSILGDIYSYGILLLEMFTGKR 604 (717)
Q Consensus 533 l~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~----~~~~~sDvwslG~vl~elltg~~ 604 (717)
+. ..|.+||+|||++.++....+............+||..|.+||.+ -| +++.++||||+||++|.++.|+.
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 95 457999999999999966555545555556678899999999994 44 36899999999999999999999
Q ss_pred CCCCC
Q 005045 605 PTGDM 609 (717)
Q Consensus 605 p~~~~ 609 (717)
||...
T Consensus 683 PFGhn 687 (775)
T KOG1151|consen 683 PFGHN 687 (775)
T ss_pred CCCCc
Confidence 99654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=284.68 Aligned_cols=213 Identities=26% Similarity=0.375 Sum_probs=167.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC---CC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDL---EG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~ 461 (717)
.++|++.++||.|++|.||+|.++ +++.+|+|.+.... ......+.+|++++++++||||+++++.+..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 679999999999999999999965 78899999875432 1223456789999999999999999887543321 23
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+. +++.+.+.... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 346899999985 56777665432 4689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCC----CcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSK----NQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+|||.+............ .........++..|+|||.+.+ .++.++|||||||++|+|++|..||....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999765322111110 1111123456788999998644 37899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=272.97 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=197.1
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+|.+.+.||.|++|.||.+.+. +++.|++|.+.... ......+.+|+++++.++|+|++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 5889999999999999999965 78899999987553 245677889999999999999999999853 346899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+|+||+++++|.+++..... ....+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccc
Confidence 99999999999999875421 115689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
+....... .......+++.|+|||...+ .++.++|+||+|+++|+|++|..||....... ...
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~------- 213 (258)
T cd08215 150 SKVLSSTV-------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL------- 213 (258)
T ss_pred eeecccCc-------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH-------
Confidence 87652111 12233457889999999654 47899999999999999999999986542111 000
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
......... .+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 214 ----~~~~~~~~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 214 ----KILKGQYPP------------------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----HHhcCCCCC------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001100000 00122556788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=281.31 Aligned_cols=278 Identities=23% Similarity=0.264 Sum_probs=197.1
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
++...+++|++.+.||.|++|.||+|..+ +++.||+|.+... .....+.+..|++++++++||||+++.+++.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 79 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI---- 79 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----
Confidence 44567889999999999999999999955 8899999987532 2223466778999999999999999999863
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
......+++|||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDL 147 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCE
Confidence 2345789999998 5789888763 3468888899999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-hh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF-SI 616 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~ 616 (717)
+|+|||.+..... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||........ ..
T Consensus 148 ~l~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~ 217 (328)
T cd07856 148 KICDFGLARIQDP----------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217 (328)
T ss_pred EeCccccccccCC----------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999875311 1112346788999998654 478999999999999999999999965432110 00
Q ss_pred hHHHHhcCChhh-hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 617 HMFVSMALPDHV-MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 617 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
........++.+ ....+... .++...... ............++..+.+++.+|++.+|++|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 282 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENT-----------LRFVQSLPK----REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA 282 (328)
T ss_pred HHHHhCCCCHHHHHhccchhh-----------HHHHhhccc----cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 000001111111 11110000 000000000 00000000111235678899999999999999999
Q ss_pred HHHHHH
Q 005045 696 NVVVNN 701 (717)
Q Consensus 696 ~eil~~ 701 (717)
.|++..
T Consensus 283 ~ell~~ 288 (328)
T cd07856 283 AEALAH 288 (328)
T ss_pred HHHhcC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=257.00 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=192.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++...+..+|.|.-|.||+++.+ +|...|||.+.... .+..+++...++++... ++|.||+.++++. .+..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~d 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTD 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCch
Confidence 345667888999999999999965 78999999997553 45567888888876655 5999999999953 3446
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++.||.|. ..+...+++-. +.+++..+-++...+++||.||.+.| +|+|||+||+||++|+.|++|++||
T Consensus 166 V~IcMelMs-~C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 166 VFICMELMS-TCAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHHHHH-HHHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence 789999983 34444444322 56899999999999999999999986 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|.+-++.+.. .....+|.+.|||||-+.- +|+-++||||||++++||.||+.||.....+-..+....
T Consensus 237 GIsGrlvdSk--------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl 308 (391)
T KOG0983|consen 237 GISGRLVDSK--------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL 308 (391)
T ss_pred cccceeeccc--------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence 9998873222 2233568899999999643 488999999999999999999999987533322221111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..| |.++. ...++..+.+|+..||+.|+.+||...++++
T Consensus 309 n-~eP--------P~L~~-------------------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 309 N-EEP--------PLLPG-------------------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred h-cCC--------CCCCc-------------------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 111 11111 0113667889999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 349 h 349 (391)
T KOG0983|consen 349 H 349 (391)
T ss_pred C
Confidence 3
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=268.42 Aligned_cols=273 Identities=25% Similarity=0.387 Sum_probs=206.3
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC--CCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST--RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+++.+..+.||+|.||.||+|.|. |+.||||++...++ +...+|.+|.+.. +|+||+.+++.-.-. -..-.+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 3567788999999999999999995 89999999986543 4566788888774 999999999873221 123347
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCEEeCCCCce
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC-----DTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+|+|++|.+.|+|+||+.+. .++...+++++..+|.||++||..+ ...|.|||||+.||+|..+|.+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~--------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN--------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred EEEeeecccCCcHHHHHhhc--------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 89999999999999999764 5899999999999999999999654 3469999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCC-------CcccchhhHHHHHHHHHh----C------
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-------SILGDIYSYGILLLEMFT----G------ 602 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~sDvwslG~vl~ellt----g------ 602 (717)
.|+|+|+|.......+.. ....-...||..|||||++.... ...+||||||.|+||+.- |
T Consensus 356 ~IADLGLAv~h~~~t~~i---di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTI---DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EEeeceeeEEecccCCcc---cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999998763322111 11223467999999999976532 356899999999999874 2
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
+.||.+.-+.+.++.+.-.. +....+.. .....+...++...+.++++
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkV--------VCv~~~RP------------------------~ipnrW~s~~~l~~m~klMk 480 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKV--------VCVQKLRP------------------------NIPNRWKSDPALRVMAKLMK 480 (513)
T ss_pred cCCcccCCCCCCCHHHHhcc--------eeecccCC------------------------CCCcccccCHHHHHHHHHHH
Confidence 35777765555444322111 11111111 11222344556778899999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.||..+|+-|-||=-|-..+.++.+
T Consensus 481 eCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 481 ECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhhcCCchhhhHHHHHHHHHHHHhc
Confidence 9999999999999888888887775
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=277.82 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=197.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCc
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGND 463 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 463 (717)
++|.+.+.||+|++|.||.|... +++.||+|++... .......+.+|+++++++. |+||+++++. +..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 47999999999999999999965 7999999988653 2233467888999999998 9999999888 44556
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++|||++++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecC
Confidence 899999999999999999754 4689999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCC-------------CCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPS-------------KNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||.+........... ..........++..|+|||... +.++.++||||||+++|++++|..||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999886633221100 0012223455788999999954 45789999999999999999999999754
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
... ... ..+...... .+...+..+.+++.+||+.+|
T Consensus 226 ~~~-~~~------------~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 226 NEY-LTF------------QKILKLEYS-------------------------------FPPNFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred cHH-HHH------------HHHHhcCCC-------------------------------CCCccCHHHHHHHHHHhcCCH
Confidence 311 000 000000000 111124567899999999999
Q ss_pred CCCCCH----HHHHH
Q 005045 690 RERIAM----NVVVN 700 (717)
Q Consensus 690 ~~Rps~----~eil~ 700 (717)
++|||+ +|+++
T Consensus 262 ~~R~~~~~~~~~ll~ 276 (280)
T cd05581 262 QDRLGVNEGYDELKA 276 (280)
T ss_pred hhCCCcccCHHHHhc
Confidence 999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=286.27 Aligned_cols=282 Identities=21% Similarity=0.261 Sum_probs=196.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~ 463 (717)
.++|.+.+.||+|++|.||.|.+. +|+.||+|.+... .......+.+|+++++.++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999965 7899999987643 2223456788999999999999999999865432 12224
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++|+||+. .++.++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred eEEEEecccc-cCHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 5799999985 47766653 3578899999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||.+..... ......++..|+|||.+.+ .++.++|||||||++|||++|+.||....... .......
T Consensus 161 fg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~ 229 (342)
T cd07879 161 FGLARHADA----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 229 (342)
T ss_pred CCCCcCCCC----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999875311 1123456788999999654 47899999999999999999999997532111 1111100
Q ss_pred --hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 622 --MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 622 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...+..+.+.+..... ...... ..... ........+..+..+.+++.+||+.+|++||+++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAA----------KSYIKS---LPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred hcCCCCHHHHHHhcccch----------HHHHhh---cCCcc-cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000111111110000 000000 00000 0000000112345678999999999999999999999
Q ss_pred HH--HHHHHH
Q 005045 700 NN--LKTIRN 707 (717)
Q Consensus 700 ~~--l~~i~~ 707 (717)
+. ++..+.
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 54 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=280.73 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=191.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
....|...+.+|+|++|.||+|+.+ +++.+++|.+... .......+.+|+++++.++|+|++++.+++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----C
Confidence 4567999999999999999999965 6788999987532 22334567889999999999999999998543 4
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+. +++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEEC
Confidence 58899999996 68877765332 4578999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|||.+..... .....++..|+|||.+. +.++.++|||||||++|+|++|..||.......... .
T Consensus 158 dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~ 225 (308)
T cd06634 158 DFGSASIMAP-----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-H 225 (308)
T ss_pred CcccceeecC-----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-H
Confidence 9998875411 11234778899999953 357889999999999999999999986532111100 0
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
...... +.. ....++..+.+++.+||+.+|++||++.++
T Consensus 226 ~~~~~~---------~~~--------------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 264 (308)
T cd06634 226 IAQNES---------PAL--------------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (308)
T ss_pred HhhcCC---------CCc--------------------------------CcccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence 000000 000 011235567899999999999999999999
Q ss_pred HHHHH
Q 005045 699 VNNLK 703 (717)
Q Consensus 699 l~~l~ 703 (717)
++.-.
T Consensus 265 l~~~~ 269 (308)
T cd06634 265 LKHRF 269 (308)
T ss_pred hhCcc
Confidence 86543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.55 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=181.3
Q ss_pred cccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHH-HhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNA-LKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+.+|+|++|.||+|... +++.||+|.+.... ......+..|..+ .....|+|++++++.+ ...+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 56899999999999964 78899999886432 1222334445444 4455899999999985 3456899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+..
T Consensus 77 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 77 EYLNGGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred eccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 999999999998754 4588999999999999999999997 999999999999999999999999998875
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHV 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .....++..|+|||.+.+. ++.++||||||+++|+|++|..||....... .......
T Consensus 147 ~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------- 207 (260)
T cd05611 147 GLE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILS------- 207 (260)
T ss_pred ccc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh-------
Confidence 311 1224578889999997654 6899999999999999999999996532211 0000000
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 629 MDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...... ......++..+.+++.+||+.+|++|||+.++.+.
T Consensus 208 -----~~~~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 208 -----RRINWP---------------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred -----cccCCC---------------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 000000 00111235678899999999999999987655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=288.19 Aligned_cols=280 Identities=22% Similarity=0.282 Sum_probs=197.3
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL- 459 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~- 459 (717)
.....++|++.+.||+|++|.||.|... +++.||+|++... .......+.+|+.+++++.|+|++++.+.+.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3445779999999999999999999965 6889999987643 22334567789999999999999998876533221
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
......++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||+++.++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence 2223589999998 6799998864 3589999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
+|+|||.+...... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||....... ...
T Consensus 158 kL~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~ 226 (343)
T cd07851 158 KILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLK 226 (343)
T ss_pred EEcccccccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHH
Confidence 99999998765211 123457888999999644 47899999999999999999999997542211 111
Q ss_pred HHHHh--cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 618 MFVSM--ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 618 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
..... ..++.+.. ... ......+..... ......-.......+.++.+++.+|++.+|++|||+
T Consensus 227 ~i~~~~~~~~~~~~~----~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~ 292 (343)
T cd07851 227 RIMNLVGTPDEELLQ----KIS------SESARNYIQSLP----QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA 292 (343)
T ss_pred HHHHhcCCCCHHHHh----hcc------chhHHHHHHhcc----ccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH
Confidence 11000 01111100 000 000011110000 000000000111225678999999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
.||++
T Consensus 293 ~ell~ 297 (343)
T cd07851 293 AEALA 297 (343)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=277.03 Aligned_cols=197 Identities=28% Similarity=0.369 Sum_probs=162.3
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-GALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.+.||+|++|.||.|... +++.|++|.+..... .......+|+..++++. |+|++++++.+. .++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 678899999999999999965 688899998765422 12234457899999998 999999999853 4568999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||+ ++++.+++..... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 v~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred EEecC-CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccc
Confidence 99999 7899988875421 4689999999999999999999997 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
...... .......++..|+|||++.+ .++.++|+||||+++|+|++|..||...
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 147 REIRSR--------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred eeccCC--------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 755211 11122457888999998643 4789999999999999999999999665
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=283.28 Aligned_cols=205 Identities=23% Similarity=0.284 Sum_probs=164.7
Q ss_pred ccccccccCcccccceEEEEeC-C--CchhhhHHhHhh--hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-D--GTIVAIKVLKLQ--QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|++.+.||+|+||.||.+... . ++.||+|.+... .....+.+.+|+++++++ .||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 5888999999999999999965 4 778999987643 222346678899999999 599999999875432 12334
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+++++++. ++|.+++... ..+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCc
Confidence 6789999985 6899888654 5689999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||.+......... .........|+..|+|||.+.+ .++.++||||+||++|+|++|..||...
T Consensus 149 fg~a~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 149 FGLARGFSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred CCCceeccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 9999765322111 1111223468899999998644 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=275.96 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=192.1
Q ss_pred ccccccccCcccccceEEEEeC----CCchhhhHHhHhhh----hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQ----QGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
+|++.+.||+|++|.||.++.. +++.||+|.+.... ......+.+|+++++++ +||+|+++.+. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4888999999999999998842 56789999876332 23346788999999999 69999999887 44
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.++..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~ 145 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVV 145 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence 556899999999999999998654 4578899999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
|+|||.+....... ........++..|+|||...+. .+.++||||||+++|+|++|..||....... ...
T Consensus 146 l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~ 218 (288)
T cd05583 146 LTDFGLSKEFLAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQS 218 (288)
T ss_pred EEECcccccccccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHH
Confidence 99999987642211 1111234578899999996543 6889999999999999999999986422111 000
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
.... .+..... ..+..++..+.+++.+||+.+|++|||+++
T Consensus 219 ~~~~--------~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 219 EISR--------RILKSKP-------------------------------PFPKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred HHHH--------HHHccCC-------------------------------CCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 0000 0000000 011112456788999999999999999887
Q ss_pred HHHHHHH
Q 005045 698 VVNNLKT 704 (717)
Q Consensus 698 il~~l~~ 704 (717)
+.+.++-
T Consensus 260 ~~~~l~~ 266 (288)
T cd05583 260 ADEIKNH 266 (288)
T ss_pred HHHHhcC
Confidence 7665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.41 Aligned_cols=278 Identities=20% Similarity=0.289 Sum_probs=193.6
Q ss_pred ccccccc-ccccCcccccceEEEEeC-CCchhhhHHhHhhhhhH--------------HHHHHHHHHHHhcCCCCceeEE
Q 005045 387 STDNFSK-ENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGA--------------LKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 387 ~~~~y~~-~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
..++|.. .+.||+|++|.||+|.++ +++.||+|.+....... ...+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3567765 577999999999999965 78999999886432111 1246789999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 530 (717)
++.+ ...+..++||||++ +++.+++... ..+++..+..++.|++.|++|||+. +++||||+|+|
T Consensus 86 ~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~n 149 (335)
T PTZ00024 86 VDVY-----VEGDFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPAN 149 (335)
T ss_pred eEEE-----ecCCcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHH
Confidence 9985 34558999999996 6899988654 4689999999999999999999997 99999999999
Q ss_pred EEeCCCCceEEeeeccchhcccccCCCC-------CCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHh
Q 005045 531 VLLDKDMTAHVGDFGLAKFLFEISDNPS-------KNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 531 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~ellt 601 (717)
|+++.++.++|+|||.+........... ..........++..|+|||.+.+ .++.++|||||||++|+|++
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 150 IFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred eEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999876531110000 00111122346788999999755 36899999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHh---cCChhhhhhcCCCCCCCC-CCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHH
Q 005045 602 GKRPTGDMFKDDFSIHMFVSM---ALPDHVMDILDPSMPLDE-ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSV 677 (717)
Q Consensus 602 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (717)
|..||....+.+. ....... .....+.+..+-...... ........ .....++..+
T Consensus 230 g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 289 (335)
T PTZ00024 230 GKPLFPGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-------------------TIFPNASDDA 289 (335)
T ss_pred CCCCCCCCCHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-------------------HhCcCCChHH
Confidence 9999976533211 1111100 000001100000000000 00000000 0111235567
Q ss_pred HHHhhccCCCCcCCCCCHHHHHH
Q 005045 678 LRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 678 ~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+++.+|++.+|++|||+.|++.
T Consensus 290 ~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 290 IDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHcCCCchhccCHHHHhc
Confidence 89999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=277.19 Aligned_cols=244 Identities=25% Similarity=0.318 Sum_probs=188.0
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.|...+++|+|++|.||.|+.. +++.|++|.+.... ......+.+|+++++.++|||++++++++. +....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 4777788999999999999964 78899999886432 233456788999999999999999999954 34588
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+. +++.+++.... ..+++..+..++.||+.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence 99999995 57777775432 4588999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
.+.... ......++..|+|||.+. +.++.++|||||||++|+|++|..||........ .....
T Consensus 167 ~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~~~ 233 (313)
T cd06633 167 SASKSS-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA 233 (313)
T ss_pred CCcccC-----------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH
Confidence 876421 111245788899999963 3478899999999999999999999865422111 10000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.. ..+.. .....+..+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~-----------~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 QN-----------DSPTL-----------------------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hc-----------CCCCC-----------------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 001124457889999999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=274.74 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=188.3
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhhh---hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ---GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
+|.|++|.||.|.+. +|+.+++|.+..... .....+.+|++++++++||||+++++.+ ......|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999976 699999998865432 4567788999999999999999998874 4556899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++.+. ..+++..+..++.||+.||+|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 76 PGGDLASLLENV-------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 999999998754 4689999999999999999999998 999999999999999999999999999876421
Q ss_pred ccCCC-CCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhh
Q 005045 553 ISDNP-SKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMD 630 (717)
Q Consensus 553 ~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (717)
..... ...........++..|+|||...+ ..+.++||||||+++|++++|..||........ .. .
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~-----------~ 212 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQ-----------N 212 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH-----------H
Confidence 11000 000112233457788999999544 478999999999999999999999965432110 00 0
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 631 ILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
......... .....+..+.+++.+|++.+|++|||++++.+.+
T Consensus 213 ~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 213 ILNGKIEWP-----------------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HhcCCcCCC-----------------------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000000000 0000155678999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=277.76 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=190.2
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
....++|++.+.+|+|++|.||+|.+. +++.||+|.+.... ......+..|+.++.+. .|+||+++++.+. .
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~ 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----T 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----c
Confidence 345678999999999999999999976 58999999986432 22345566677766666 5999999999853 3
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....+++|||++ +++.++..... ..+++..+..++.||+.|++|||+. .+++||||+|+||+++.++.+||
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence 458999999984 57777665422 4688999999999999999999973 28999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
+|||.+....... ......++..|+|||.+.+. ++.++||||||+++|+|++|..||.....+....
T Consensus 157 ~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 228 (296)
T cd06618 157 CDFGISGRLVDSK--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228 (296)
T ss_pred CccccchhccCCC--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence 9999987652111 11123467889999997543 6889999999999999999999996432211111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
. ..........+ ....++.++.+++.+||+.+|++||++.
T Consensus 229 ~------------~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 268 (296)
T cd06618 229 T------------KILQEEPPSLP----------------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYR 268 (296)
T ss_pred H------------HHhcCCCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 1 11111100000 0011255688999999999999999999
Q ss_pred HHHHHH
Q 005045 697 VVVNNL 702 (717)
Q Consensus 697 eil~~l 702 (717)
++++.-
T Consensus 269 ~il~~~ 274 (296)
T cd06618 269 ELLQHP 274 (296)
T ss_pred HHhcCh
Confidence 998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=273.59 Aligned_cols=198 Identities=25% Similarity=0.380 Sum_probs=164.4
Q ss_pred ccccccccCcccccceEEEEe----CCCchhhhHHhHhhh----hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 390 NFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ----QGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
+|++.+.||.|++|.||.|.. .+|+.||+|++.... ....+.+.+|+++++++ +|++|+++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 488999999999999999985 368889999886432 22346778899999999 699999998884 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.+...++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k 145 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 145 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEE
Confidence 456889999999999999998754 4578899999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
|+|||.+....... ........++..|+|||...+ .++.++||||||+++|+|++|..||..
T Consensus 146 l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 146 LTDFGLSKEFHEDE------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred EeeCccceeccccc------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 99999987542111 111123457889999999653 367899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=252.04 Aligned_cols=212 Identities=25% Similarity=0.389 Sum_probs=174.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC--
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE-- 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-- 460 (717)
+..+.|....+||+|.||.||+|+.+ +|++||+|+.-.. ..+......+|++++..++|+|++.+++.|......
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34568999999999999999999954 7889999887653 334456677899999999999999999988665422
Q ss_pred -CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 461 -GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 461 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+....|+||.+|+ -+|.-.+.... .+++..++.+++.+++.||.|+|.+ .|+|||+||.|++|+.+|.+
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence 2335899999996 47887776543 6789999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
||+|||+++.+.-..+. .....++..-|..|++||.+-| +++++.|||+-||++.||.||++-+.+..
T Consensus 164 klADFGlar~fs~~~n~---~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNV---VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred Eeeccccccceeccccc---CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 99999999766332221 1222455667999999999765 49999999999999999999999887653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=284.20 Aligned_cols=285 Identities=21% Similarity=0.275 Sum_probs=199.8
Q ss_pred CcccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
...++....++|++.+.||+|++|.||.|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3445566778999999999999999999985 47899999988643 22234667889999999999999999987643
Q ss_pred cc-CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 457 VD-LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 457 ~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.. .......+++++++ +++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 22 12234578899887 7899888753 3478999999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
++.+||+|||.+..... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||.......
T Consensus 156 ~~~~kl~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 156 DCELKILDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred CCCEEEecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999875411 1123457888999999654 47889999999999999999999996532211
Q ss_pred hhhhHHHHh--cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 614 FSIHMFVSM--ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 614 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
........ ..+..+...+... ............. ...-.+.....+..+.+++.+|++.+|.+
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 226 -QLKLILRLVGTPGAELLKKISSE----------SARNYIQSLTQMP----KMNFANVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred -HHHHHHHHhCCCCHHHHhhcccH----------hHHHHHHHhcccC----CcchhhhcCCCCHHHHHHHHHHcCCChhh
Confidence 11111110 0111111101000 0001110000000 00000000112456789999999999999
Q ss_pred CCCHHHHHHH
Q 005045 692 RIAMNVVVNN 701 (717)
Q Consensus 692 Rps~~eil~~ 701 (717)
|||+.|+++.
T Consensus 291 R~t~~e~l~h 300 (345)
T cd07877 291 RITAAQALAH 300 (345)
T ss_pred cCCHHHHhcC
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.06 Aligned_cols=279 Identities=22% Similarity=0.254 Sum_probs=196.6
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~ 460 (717)
....++|++.+.||+|++|.||.|... +++.||+|.+... .......+.+|++++++++||||+++++++.... ..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999954 7899999987532 2233456789999999999999999999864322 11
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.....++||||+ +++|.+++.. ..+++..++.++.||+.|++|||+. +++||||+|+||+++.++.++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 123568999998 7799888753 3578999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|+|||.+..... ......++..|+|||.+.+ .++.++|+||+||++|++++|..||........ ...
T Consensus 159 l~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~ 227 (343)
T cd07880 159 ILDFGLARQTDS----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LME 227 (343)
T ss_pred Eeeccccccccc----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 999999875411 1123456888999999654 478999999999999999999999975432111 111
Q ss_pred HHHh--cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 619 FVSM--ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 619 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.... ..+..+...+.... .......... .... .-....+.++..+.+++.+|++.+|++|||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSED----------AKNYVKKLPR---FRKK-DFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred HHHhcCCCCHHHHHhhcchh----------HHHHHHhccc---cCcc-hHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 1110 01111111111000 0000000000 0000 00001123355688999999999999999999
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
++++
T Consensus 294 ~~l~ 297 (343)
T cd07880 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=258.86 Aligned_cols=291 Identities=21% Similarity=0.325 Sum_probs=230.9
Q ss_pred ecccCCCCCCcccccCCCCcccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHH
Q 005045 362 SSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFID 434 (717)
Q Consensus 362 ~~N~l~~~~p~~~~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ 434 (717)
++|.+-..-|+++ .-...++.....+++....+.+|.||.||.|.|. +.+.|.+|.++... .-....+..
T Consensus 260 ~~ns~~~~~p~e~---~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~ 336 (563)
T KOG1024|consen 260 SPNSEYEHEPEEF---NRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQ 336 (563)
T ss_pred CCCccccCChHHH---hhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHH
Confidence 6666665555555 2346677777788999999999999999999653 35568889887543 335677888
Q ss_pred HHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCC-CCcccccccCHHHHHHHHHHHHHHHHHH
Q 005045 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP-AEHYQFKKLSVIQRLNIAIDVASALDYL 513 (717)
Q Consensus 435 e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~L 513 (717)
|.-.+....|||+..+.+.+ .++.+..++++.+...|+|+.++.-.+ ......+.++..+...++.|++.|++||
T Consensus 337 es~lly~~sH~nll~V~~V~----ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 337 ESMLLYGASHPNLLSVLGVS----IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred HHHHHhcCcCCCccceeEEE----eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999998 456678899999999999999987221 1111236678888999999999999999
Q ss_pred HhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhH
Q 005045 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSY 592 (717)
Q Consensus 514 H~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwsl 592 (717)
|++ ++||.||.++|..|++.-+|||+|=.+++.+++.+.+.-.+... .+..||+||.+.. .++.++|||||
T Consensus 413 h~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEn-----RPvkWMslEal~n~~yssasDvWsf 484 (563)
T KOG1024|consen 413 HNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNEN-----RPVKWMSLEALQNSHYSSASDVWSF 484 (563)
T ss_pred Hhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCC-----CcccccCHHHHhhhhhcchhhhHHH
Confidence 998 99999999999999999999999999999987777665554433 5678999999655 59999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhH
Q 005045 593 GILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671 (717)
Q Consensus 593 G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (717)
||++|||+| |+.||.+.++.+..- ++... .. ..++-
T Consensus 485 GVllWELmtlg~~PyaeIDPfEm~~--------------ylkdG-------------------yR----------laQP~ 521 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFEMEH--------------YLKDG-------------------YR----------LAQPF 521 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHHHHH--------------HHhcc-------------------ce----------ecCCC
Confidence 999999999 999998775443211 11111 00 01456
Q ss_pred HHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 672 ECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 672 ~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
+||.+++.++.-||...|++||++++++.-|.+...+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 789999999999999999999999999999988776553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=289.61 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=204.9
Q ss_pred ccccccccCcccccceEEEEe-CCCc----hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTL-GDGT----IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..+..++||+|+||+||+|.+ +.|+ +||+|++... ..+.-..+.+|+-+|.+++|||+++++++|-..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 345578899999999999984 4455 4777777644 344567889999999999999999999997432
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
...||++|+|+|+|.||++.++ ..+.....+.|..|||+||.|||.+ .+|||||.++||+|..-..+||.|
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitd 841 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITD 841 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEe
Confidence 3789999999999999998765 6788899999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||+++...... .........-.+.|+|=|.+. +.++.++|||||||++||++| |..|+++...+++
T Consensus 842 fgla~ll~~d~-----~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------- 909 (1177)
T KOG1025|consen 842 FGLAKLLAPDE-----KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------- 909 (1177)
T ss_pred cchhhccCccc-----ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------
Confidence 99998763221 112222334566788888854 569999999999999999999 9999988754432
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+.+..... ...++-|...++.++.+||..|++.||+++++.+.
T Consensus 910 -------~dlle~geR-----------------------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 910 -------PDLLEKGER-----------------------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred -------hHHHhcccc-----------------------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 222221111 12556778889999999999999999999999999
Q ss_pred HHHHHHH
Q 005045 702 LKTIRNC 708 (717)
Q Consensus 702 l~~i~~~ 708 (717)
+.+....
T Consensus 954 fs~~ard 960 (1177)
T KOG1025|consen 954 FSRMARD 960 (1177)
T ss_pred HHHHhcC
Confidence 8877643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=284.46 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=218.9
Q ss_pred CCCcccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
...++.....++.|++++.||.|.+|.||+++. ++++.+|+|+....... ....+.|.++++.. .|||++.+++++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 455677788899999999999999999999994 48999999998766433 36677889999887 8999999999988
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
...-..++.+|+|||||.|||..|+++.... .++.|..+..|++.++.|+.+||.+ .++|||||-.||+++.
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG-----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTE 158 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcc-----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEec
Confidence 7777788899999999999999999986642 7899999999999999999999998 8999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|.||++|||.+..+ ..........+||+.|||||++.. -|+..+|+||||++.-||--|.+|+.++
T Consensus 159 e~~VKLvDFGvSaQl-------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQL-------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred cCcEEEeeeeeeeee-------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 999999999999876 334455567889999999999643 2678899999999999999999999876
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
.+--. ...+|.. +.. ....+..-.++|.+||..|+..|-
T Consensus 232 HPmra------LF~IpRN---------PPP--------------------------kLkrp~kWs~~FndFIs~cL~Kd~ 270 (953)
T KOG0587|consen 232 HPMRA------LFLIPRN---------PPP--------------------------KLKRPKKWSKKFNDFISTCLVKDY 270 (953)
T ss_pred chhhh------hccCCCC---------CCc--------------------------cccchhhHHHHHHHHHHHHHhhcc
Confidence 44311 1111111 100 011223337788999999999999
Q ss_pred CCCCCHHHHHH
Q 005045 690 RERIAMNVVVN 700 (717)
Q Consensus 690 ~~Rps~~eil~ 700 (717)
+.||++.++++
T Consensus 271 e~RP~~~~ll~ 281 (953)
T KOG0587|consen 271 EQRPSTEELLK 281 (953)
T ss_pred ccCcchhhhcc
Confidence 99999999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=233.22 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=172.3
Q ss_pred cccccccccCcccccceEEEE-eCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.+|...++||+|.+|+||+|+ +.+++.||+|.+..++ .+......+|+-+++.++|.||+++++. ...++..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCcee
Confidence 367888999999999999999 4589999999988653 4456778899999999999999999998 5566789
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
.+|+||| ..+|..|..... +.++.+.++.++.|+++|+.++|++ .+.|||+||+|.+|+.+|++|++|||
T Consensus 77 tlvfe~c-dqdlkkyfdsln------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfg 146 (292)
T KOG0662|consen 77 TLVFEFC-DQDLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFG 146 (292)
T ss_pred EEeHHHh-hHHHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccc
Confidence 9999999 468888876543 6789999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHh-CCCCCCCCCCCch
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFT-GKRPTGDMFKDDF 614 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 614 (717)
+++-+ ..+........-|..|++|.++-|. |+...|+||-||++.|+-. |.+.|.+.+.++.
T Consensus 147 laraf-------gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 147 LARAF-------GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred hhhhc-------CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 99865 2223333445578899999996653 7899999999999999998 7777777655444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=278.10 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=188.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+..|.....+|.|+|+.|-.+... +++.+++|++.... ....+|+.++... .||||+++.+. +.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCce
Confidence 3678999999999999999999854 88999999987552 2334577666665 89999999999 566779
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe-CCCCceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~D 543 (717)
.|+|||.+.|+-+.+.+... +... ..+..|+++|+.|+.|||++ |+||||+||+||++ +..|+++|+|
T Consensus 391 ~~~v~e~l~g~ell~ri~~~-------~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSK-------PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred eeeeehhccccHHHHHHHhc-------chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEE
Confidence 99999999998877776543 2233 77889999999999999997 99999999999999 5899999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.++..... ..+.+-|..|+|||+... .+++++||||||+++|+|++|..||.....+ ..+...+
T Consensus 460 FG~a~~~~~~----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i-- 526 (612)
T KOG0603|consen 460 FGFWSELERS----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRI-- 526 (612)
T ss_pred echhhhCchh----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhh--
Confidence 9999865111 234456889999999665 5999999999999999999999999876444 1111100
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.. .+..+....+|+.+||+.+|.+||+|.|+..
T Consensus 527 ---------~~~~~---------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 ---------QMPKF---------------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---------cCCcc---------------------------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 00000 0222566789999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=300.33 Aligned_cols=146 Identities=30% Similarity=0.474 Sum_probs=129.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++.++||+|+||.||+|.+. +++.||+|++.... ......+..|+.+++.++|+||+++++.+ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 468999999999999999999965 78999999986432 33456788999999999999999999884 3445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||+++++|.+++... ..+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~D 147 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTD 147 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEe
Confidence 899999999999999998754 4578899999999999999999997 999999999999999999999999
Q ss_pred eccch
Q 005045 544 FGLAK 548 (717)
Q Consensus 544 fg~~~ 548 (717)
||+++
T Consensus 148 FGls~ 152 (669)
T cd05610 148 FGLSK 152 (669)
T ss_pred CCCCc
Confidence 99886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=272.35 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=193.9
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
|++.+.||+|++|.||.|+.. +++.||+|.+.... ......+..|+.++++++|+|++++++.+ ...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 677889999999999999965 69999999987653 33346778899999999999999999985 34468999
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++ ++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 76 v~e~~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred EecCcC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcc
Confidence 999996 69999997542 3689999999999999999999998 9999999999999999999999999998
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH---Hh
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV---SM 622 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---~~ 622 (717)
....... .......++..|+|||.+.+ .++.++|||||||++||+++|..||......+. ..... ..
T Consensus 146 ~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~ 217 (282)
T cd07829 146 RAFGIPL-------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGT 217 (282)
T ss_pred cccCCCc-------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCC
Confidence 7652111 01122345678999999643 578999999999999999999999966432111 10000 00
Q ss_pred cCChhhhhhcC-----CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 623 ALPDHVMDILD-----PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 623 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+..+..+.+ ...+..... . . ....+..+..+.+++.+||+.+|++||++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~---~-------------~------~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPK---D-------------L------EKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CcHHHHHhhcccccccccccccCcc---c-------------h------HHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 00111111111 000000000 0 0 0011122557899999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
++.
T Consensus 276 ~l~ 278 (282)
T cd07829 276 ALK 278 (282)
T ss_pred Hhh
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=269.04 Aligned_cols=249 Identities=23% Similarity=0.270 Sum_probs=185.4
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|.+.++||+|++|.||++.+. .+..+++|+++.. .......+..|+.+++.++||||+++++.+ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 5889999999999999999864 3444555554421 122234566789999999999999999884 3445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++|+||+|+||+++. +.++|+|
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecc
Confidence 78999999999999988864211 115689999999999999999999997 9999999999999975 5799999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+....... .......++..|+|||...+ .++.++|+||||+++|+|++|..||...... ....
T Consensus 149 ~g~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~- 215 (260)
T cd08222 149 FGVSRLLMGSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVL- 215 (260)
T ss_pred cCceeecCCCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHH-
Confidence 99987652211 11223457888999999654 4788999999999999999999998542110 0000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.......+. .+..++..+.+++.+|++.+|++||++.|+++
T Consensus 216 -------~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 216 -------RIVEGPTPS------------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -------HHHcCCCCC------------------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 000000000 11223567788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=263.61 Aligned_cols=155 Identities=28% Similarity=0.430 Sum_probs=127.1
Q ss_pred CCcccccCCCCccccccc--ccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC---
Q 005045 370 IPKEVRQSGMSYSDISKS--TDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR--- 443 (717)
Q Consensus 370 ~p~~~~~~~~s~~~~~~~--~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--- 443 (717)
-|+..++.+|-.-.+-.. .++|.+.+++|.|-|++||+|.+ +..+.||+|+.+... ...+....||++|++++
T Consensus 57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcC
Confidence 344555665554444443 36999999999999999999995 478899999987553 23467788999999982
Q ss_pred --C---CceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 444 --H---RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 444 --h---~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
| ..||++++.+... ...+.++|+|+|++ |.+|..+|... .++.++...+++|++||+.||+|||..|
T Consensus 136 p~~~~~~~VV~LlD~Fkhs-GpNG~HVCMVfEvL-GdnLLklI~~s-----~YrGlpl~~VK~I~~qvL~GLdYLH~ec- 207 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHS-GPNGQHVCMVFEVL-GDNLLKLIKYS-----NYRGLPLSCVKEICRQVLTGLDYLHREC- 207 (590)
T ss_pred CCCCCCceeeeeeccceec-CCCCcEEEEEehhh-hhHHHHHHHHh-----CCCCCcHHHHHHHHHHHHHHHHHHHHhc-
Confidence 2 3599999997766 47788999999999 88999998865 3478999999999999999999999997
Q ss_pred CCeeecCCCCCCEEeC
Q 005045 519 TPIAHCDLKPSNVLLD 534 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~ 534 (717)
||+|.||||+||++.
T Consensus 208 -gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 208 -GIIHTDLKPENVLLC 222 (590)
T ss_pred -CccccCCCcceeeee
Confidence 999999999999993
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=242.26 Aligned_cols=278 Identities=22% Similarity=0.315 Sum_probs=198.8
Q ss_pred cccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+++|+|.++.||.|. ..+.+++++|++++.. .+.+.+|+++++.+. ||||+++++...++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence 56799999999999999999999 5578899999998654 356778999999995 999999999976543 556
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-CceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D 543 (717)
..+||||+.+.++.... +.++...++..+.++++||+|||+. ||.|||+||.|+||+.. -.++|+|
T Consensus 110 paLiFE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred chhHhhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeee
Confidence 78999999887777655 5677888999999999999999998 99999999999999965 4899999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
+|+|.++. +...... ...+..|.-||.+-. .++++-|+|||||++..|+..+.||....+....+...+.
T Consensus 177 WGLAEFYH-----p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 177 WGLAEFYH-----PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred cchHhhcC-----CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 99999872 2222222 235567889999543 4899999999999999999999998665444444443333
Q ss_pred hcCChhhhhhcCC-CCCCCCCCcHHHH--HHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 622 MALPDHVMDILDP-SMPLDEENDEEQI--EEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 622 ~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
..--+.+...+.+ .+..++. +..+ ....+.....++.+..... ..+..+++.+.+.+|-.+|+||+|.
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~--~~~i~~~~~rk~w~~Fi~~~n~hl~-------~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQ--FEDILGRHSRKPWSRFINSENQHLV-------SPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HhChHHHHHHHHHHccCCChh--HhhHhhccccccHHHhCCccccccC-------ChHHHHHHHHHHhhccccccchHHH
Confidence 2222222222111 1111110 0000 0000111111122211111 3456789999999999999999998
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
.+
T Consensus 320 m~ 321 (338)
T KOG0668|consen 320 MA 321 (338)
T ss_pred hc
Confidence 74
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=263.87 Aligned_cols=235 Identities=30% Similarity=0.363 Sum_probs=185.2
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
||.|++|.||.+... +++.+++|.+.... ......+..|++++++++|+||+++++. ++.+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 689999999999965 68899999876442 2245678899999999999999999988 44566899999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccc
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 552 (717)
++++|.+++... ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 76 PGGELFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999999999754 4589999999999999999999997 999999999999999999999999999876521
Q ss_pred ccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
.. .......++..|+|||...+ .++.++|+||||+++|++++|..||...... .. ...+
T Consensus 146 ~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~-----------~~~~ 205 (250)
T cd05123 146 EG-------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EI-----------YEKI 205 (250)
T ss_pred CC-------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HH-----------HHHH
Confidence 11 11233457889999999655 4788999999999999999999999654221 00 0011
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
...... .+...+..+.+++.+||..+|++|||+++
T Consensus 206 ~~~~~~-------------------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 206 LKDPLR-------------------------------FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred hcCCCC-------------------------------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111111 11111556788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=267.12 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=176.1
Q ss_pred ccccccccccccCcccccceEEEEeCC-CchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
....+..++..+|.||||.|-+++.++ ...+|+|+++.. +....+....|..+|.+++.|.|+++|.. +.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hcc
Confidence 345677888999999999999999653 345999999754 34556788899999999999999999998 566
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|++||-|-||.++..++.+ +.++...++.++..+++|++|||+. +||.|||||+|.+++.+|-+||
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEE
Confidence 77999999999999999999866 6789999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCc-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.|||.|+.+. .....-+++||+.|.|||+ +....+.++|.||||+++|||++|.+||.+.+
T Consensus 562 VDFGFAKki~--------~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 562 VDFGFAKKIG--------SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred eehhhHHHhc--------cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999872 2223345889999999999 55668999999999999999999999998753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=257.85 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=191.4
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhc-CCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKS-TRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.+.+.+..||.|+||+|++-.++ +|+..|||.+.... ....+++..|.+...+ -+.|+||++|+.++. .+..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdc 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDC 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCce
Confidence 34456778999999999998865 89999999997654 3556788888886554 489999999999643 3478
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+.||.| ..+++-+.+.-- ..+...+++.-.-+|....+.||+||-... .|+|||+||+||+++..|.+||+|||
T Consensus 139 WiCMELM-d~SlDklYk~vy--~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVY--SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHH--HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 9999999 467765432110 002257899888899999999999999874 89999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC--C-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--G-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
.+-.+.+ ....+.-+|..+|||||-+. + .|+-+|||||||+++||+-||..||..+..--..+...+..
T Consensus 214 IcGqLv~--------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 214 ICGQLVD--------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred chHhHHH--------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 9987622 22223346888999999964 3 38999999999999999999999998764311111111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..|. +..+. ..-++...+.+++--|+..|-.+||...++..
T Consensus 286 dpp~---------l~~~~----------------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPI---------LLFDK----------------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCe---------ecCcc----------------------------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1110 10000 11223567889999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=289.74 Aligned_cols=268 Identities=26% Similarity=0.426 Sum_probs=206.9
Q ss_pred ccccccccccccccCcccccceEEEEeC----C----CchhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG----D----GTIVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+.....+..+.+.+|+|+||.||+|... . ...||||..+.. .....+.+..|+++++.+ .|+||+.++++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555567779999999999999832 1 446899998744 235678899999999999 69999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCC-CCcccc--------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP-AEHYQF--------KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
|.. .+..++|+||+..|+|.++++..+ ...... ..++..+...++.|||.|++||++. ++|||
T Consensus 371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHR 442 (609)
T KOG0200|consen 371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHR 442 (609)
T ss_pred ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccch
Confidence 754 558999999999999999998765 111111 2389999999999999999999997 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeeccc--ccccccCCCccCC-CCCcccchhhHHHHHHHHHh
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK--GSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt 601 (717)
|+.++||++..+..+||+|||+|+.... ........-. -+..|||||.+.. .++.+|||||||+++||++|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~------~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYN------KDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCC------CCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 9999999999999999999999986421 1111112122 2445999999766 58999999999999999999
Q ss_pred -CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHH
Q 005045 602 -GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680 (717)
Q Consensus 602 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 680 (717)
|..||.+...... +.++... . .-.+.+..|..++.++
T Consensus 517 LG~~PYp~~~~~~~-l~~~l~~------------G-----------------------------~r~~~P~~c~~eiY~i 554 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEE-LLEFLKE------------G-----------------------------NRMEQPEHCSDEIYDL 554 (609)
T ss_pred CCCCCCCCCCcHHH-HHHHHhc------------C-----------------------------CCCCCCCCCCHHHHHH
Confidence 9999976421111 1111111 1 1122556678889999
Q ss_pred hhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 681 GLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 681 i~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
++.||+.+|++||++.|+.+.++....
T Consensus 555 M~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 555 MKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999999999999999999999999643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=258.77 Aligned_cols=179 Identities=21% Similarity=0.173 Sum_probs=147.6
Q ss_pred ccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChh
Q 005045 400 GSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLD 478 (717)
Q Consensus 400 g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 478 (717)
|.+|.||+++++ +++.||+|.+.... .+..|...+....||||+++++.+ ...+..++||||+++++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 889999999965 78999999987543 223445555566799999999984 4456899999999999999
Q ss_pred hhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCC
Q 005045 479 QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558 (717)
Q Consensus 479 ~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 558 (717)
+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 74 SHISKF-------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred HHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 998654 4589999999999999999999997 9999999999999999999999999987654111
Q ss_pred CCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 559 KNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 559 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.....++..|+|||...+ .++.++||||+||++|+|++|..|+..
T Consensus 139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 112335677999999754 478999999999999999999988743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=232.08 Aligned_cols=219 Identities=23% Similarity=0.321 Sum_probs=173.5
Q ss_pred cccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
.+.....++....+..||+|++|.|-..++ .+|+..|+|.+...- .+..++..+|+++..+. .+|.++.+|+..+
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-- 115 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-- 115 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--
Confidence 334566777888889999999999988885 489999999987552 34567788889887766 8999999999853
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
+....||.||.|+ .+++-+.+.--. +...+++.-.-+||..|++||.|||+. -.++|||+||+||+++.+|
T Consensus 116 ---regdvwIcME~M~-tSldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 116 ---REGDVWICMELMD-TSLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDG 186 (282)
T ss_pred ---ccccEEEeHHHhh-hhHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCC
Confidence 3447899999994 677655432100 116799999999999999999999998 4899999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~~ 612 (717)
+||+||||.+-.+... ...+...|...|+|||.+.. .|+.+|||||||+++.||-+++.||+.+...
T Consensus 187 qVKiCDFGIsG~L~dS--------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDS--------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred cEEEcccccceeehhh--------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 9999999999876221 11122458889999999754 3788999999999999999999999887555
Q ss_pred chhhhH
Q 005045 613 DFSIHM 618 (717)
Q Consensus 613 ~~~~~~ 618 (717)
-..+.+
T Consensus 259 F~qLkq 264 (282)
T KOG0984|consen 259 FQQLKQ 264 (282)
T ss_pred HHHHHH
Confidence 444433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=265.09 Aligned_cols=194 Identities=26% Similarity=0.456 Sum_probs=164.3
Q ss_pred ccccCcccccceEEEEe-CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 394 ENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
.+.+|+|-||+||.|++ ++|+.||||++.+.+ ......+++|+.|++++.||.||.+..- ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 47899999999999995 599999999997542 2334778899999999999999998877 566779999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---CceEEeeeccc
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD---MTAHVGDFGLA 547 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~ 547 (717)
.+. |+..+++-... .+++++.....+..||+.||+|||.. +|||+||||+||++... -++||+|||.|
T Consensus 644 Kl~-GDMLEMILSsE-----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 644 KLH-GDMLEMILSSE-----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred hhc-chHHHHHHHhh-----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence 995 56666655442 27899999999999999999999997 99999999999999743 38999999999
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+++. .........||+.|.|||+++.+ |...-|+||.||++|--++|..||.+.
T Consensus 715 RiIg--------EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 715 RIIG--------EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred eecc--------hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 9872 23334567899999999997665 788889999999999999999999754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=251.76 Aligned_cols=205 Identities=25% Similarity=0.351 Sum_probs=169.1
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDL 459 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 459 (717)
.....+|..+..+|+|+||.|.+|..+ +.+.+|||+++.+. ....+--+.|-++|+-- +.|.++.+..+ +
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----F 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----F 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----h
Confidence 445668999999999999999999965 78889999998652 22334455677777766 45566665555 5
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+.-+.+|+||||+.||+|--.++ +.+++-+..+..+|..||-||-+||+. ||+.||||.+|||++.+|++
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQ-------Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHH-------HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCce
Confidence 56679999999999999987776 336788888999999999999999997 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
||+|||++..- .........+.||+.|+|||++.. .|+.++|+||+||++|||+.|++||++.++
T Consensus 490 Ki~DFGmcKEn-------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 490 KIADFGMCKEN-------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred Eeeeccccccc-------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998742 233344567899999999999655 589999999999999999999999987543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=256.92 Aligned_cols=209 Identities=23% Similarity=0.384 Sum_probs=172.0
Q ss_pred cccccccccCcccccceEEEE-eCCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.-|..++.||-|+||.|.+++ ..+...+|+|.+...+ .........|.+||..-+.+=||++|.. +.+++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 346789999999999999998 4467789999987653 3445677889999999999999999988 677889
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
+|+||+|++||++-.++.+. +.+.+..++.++..+.-|+++.|+. |++||||||+||+||.+|++||+||
T Consensus 704 LYFVMdYIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence 99999999999998887644 6799999999999999999999998 9999999999999999999999999
Q ss_pred ccchhc--------ccccCCCCCCcc---------------------------eeecccccccccCCCcc-CCCCCcccc
Q 005045 545 GLAKFL--------FEISDNPSKNQT---------------------------VSIGLKGSIGYIPPEHM-NGQVSILGD 588 (717)
Q Consensus 545 g~~~~~--------~~~~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~-~~~~~~~sD 588 (717)
|++.-+ ...+++.-.+.. ......||+.|+|||++ ...++..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 998532 111111111000 00124699999999996 456999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 589 IYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 589 vwslG~vl~elltg~~p~~~~~~~ 612 (717)
+||.|||||||+.|++||....+.
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCC
Confidence 999999999999999999775443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=271.51 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=183.6
Q ss_pred cccccccCccccc-ceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCceEEEE
Q 005045 391 FSKENLIGTGSFG-SVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 391 y~~~~~ig~g~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
|.-.+.+|.|..| .||+|.. .||.||||.+-.. ....+.+|++.++.- .||||+++++. -.+..+.||+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence 3345667888886 6899998 4889999998754 345667899999988 79999999988 4455699999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---C--CceEEee
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---D--MTAHVGD 543 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~D 543 (717)
.|.| ..+|.|++..... +.........+.+..|+++|+++||+. +||||||||+||+|+. + ..++|+|
T Consensus 582 lELC-~~sL~dlie~~~~---d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGL---DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred ehHh-hhhHHHHHhcccc---chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 9999 5899999986411 111111145677899999999999997 9999999999999975 3 4899999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||+++.+. ..........+..||.+|+|||++.. .-+.++||||+|||+|+.++ |.+||.+....+..+.
T Consensus 655 fglsKkl~----~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---- 726 (903)
T KOG1027|consen 655 FGLSKKLA----GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---- 726 (903)
T ss_pred cccccccC----CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh----
Confidence 99999872 22333344566789999999999765 46779999999999999999 5999976532211110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... ..-.....++| ...+||.+|+.++|..||+|.+|+
T Consensus 727 -----------~~~~--------------------------~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 727 -----------TGNY--------------------------TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----------cCcc--------------------------ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0000 00001112222 567899999999999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=281.13 Aligned_cols=208 Identities=21% Similarity=0.219 Sum_probs=139.7
Q ss_pred cccccccccccCcccccceEEEEeC-C----CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecc-ccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-D----GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS-VDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~ 460 (717)
..++|++.++||+|+||.||+|.+. + ++.||+|.+...... +....+ .++...+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 5 788999986532211 111111 1111122222222111110 0013
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCc-------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEH-------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLK 527 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 527 (717)
.....++||||+++++|.+++....... ..........+..++.||+.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 4567899999999999999886432100 0001122345678999999999999997 99999999
Q ss_pred CCCEEeCC-CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----------------------CC
Q 005045 528 PSNVLLDK-DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----------------------QV 583 (717)
Q Consensus 528 p~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------------------~~ 583 (717)
|+|||++. ++.+||+|||++..+... .........+++.|+|||.+.. .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999985 589999999999754211 1112234568899999996321 13
Q ss_pred CcccchhhHHHHHHHHHhCCCCCC
Q 005045 584 SILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 584 ~~~sDvwslG~vl~elltg~~p~~ 607 (717)
+.++|||||||++|||+++..|++
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCc
Confidence 346699999999999999776643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=236.24 Aligned_cols=204 Identities=24% Similarity=0.376 Sum_probs=176.5
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 458 (717)
..-..++|..++.||+|++++|-.++++ +.+.+|+|+++.. +.+.....+.|-.+..+- +||.++.+..+
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc----- 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC----- 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----
Confidence 3445778999999999999999999954 8899999999864 345567788888888876 79999998877
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
++....+++|.||++||+|--.+++. .+++++.++.+...|.-||.|||+. ||+.||+|.+|++++.+|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCc
Confidence 56667899999999999998777655 6799999999999999999999997 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|++|+|+++.-. .+......+.||+.|.|||+++|. |+..+|+|++||+++||+.|+.||+-.
T Consensus 390 ikltdygmcke~l-------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 390 IKLTDYGMCKEGL-------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eeecccchhhcCC-------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999997542 222234568899999999999886 999999999999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=246.49 Aligned_cols=237 Identities=29% Similarity=0.384 Sum_probs=185.4
Q ss_pred cccceEEEEeC-CCchhhhHHhHhhhhhH-HHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChh
Q 005045 401 SFGSVYKGTLG-DGTIVAIKVLKLQQQGA-LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLD 478 (717)
Q Consensus 401 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 478 (717)
++|.||.|... +++.+++|++....... .+.+.+|++.+++++|++++++++.+.. ....+++||++++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 57899999976 68999999987654433 6889999999999999999999998543 35889999999988999
Q ss_pred hhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCC
Q 005045 479 QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558 (717)
Q Consensus 479 ~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 558 (717)
+++... ..+++..+..++.+++.++++||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---- 141 (244)
T smart00220 76 DLLKKR-------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---- 141 (244)
T ss_pred HHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc----
Confidence 998754 2378899999999999999999998 99999999999999999999999999988752211
Q ss_pred CCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCC
Q 005045 559 KNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMP 637 (717)
Q Consensus 559 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (717)
......++..|+|||... +.++.++||||||+++|++++|..||........ ...... .....
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~-----------~~~~~ 205 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIG-----------KPKPP 205 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHh-----------ccCCC
Confidence 223345788899999965 4578899999999999999999999865311111 110100 00000
Q ss_pred CCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 638 LDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ....++..+.+++.+|+..+|++||++.++++
T Consensus 206 ~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 FPP----------------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred Ccc----------------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000 00003567889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=253.02 Aligned_cols=198 Identities=23% Similarity=0.359 Sum_probs=170.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh--------hHHHHHHHHHHHHhcCC---CCceeEEEEee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ--------GALKSFIDECNALKSTR---HRNILRVITAC 454 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~ni~~~~~~~ 454 (717)
...+|+.++++|.|+||.|++|.++ +...|++|.+.+.+. ...-..-.|++||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf- 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF- 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence 4567999999999999999999977 566788898875431 11122456999999996 9999999999
Q ss_pred ccccCCCCceEEEEEecC-CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 005045 455 SSVDLEGNDFKALVFEFM-SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 533 (717)
+++++.+|++||.- +|.+|.+++... +.+++.++..|++||+.|+++||++ ||||||||-+|+.+
T Consensus 638 ----FEddd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv 703 (772)
T KOG1152|consen 638 ----FEDDDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV 703 (772)
T ss_pred ----eecCCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence 77888999999984 456889999866 6799999999999999999999998 99999999999999
Q ss_pred CCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 534 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
+.+|-+||+|||.+... ..+....+.||..|.|||++.|. .+..-|||++|+++|.++....||..
T Consensus 704 d~~g~~klidfgsaa~~---------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYT---------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ecCCeEEEeeccchhhh---------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999998865 34455668899999999999886 37888999999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-31 Score=280.71 Aligned_cols=344 Identities=26% Similarity=0.373 Sum_probs=204.1
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
+.++.|+|++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.+|.+. ..|..+..+.+|+.||+
T Consensus 45 v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 45 VKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 36888999999887 78888888899999999999888 78888888889999999888888 88888888899999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCC-------------------CCCCCCCccccCCCCccEEEcccCcccccCCcc-
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGN-------------------FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTD- 149 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N-------------------~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~- 149 (717)
|+|++. .+|..+..++.+..+..++| .+.+.++..+..++. .|+|++|.+. .+...
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dls~ 197 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDLSN 197 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhhhh
Confidence 998887 56655555544444444444 333333333333333 3555555553 11110
Q ss_pred ----------------cccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeecccc
Q 005045 150 ----------------VGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQN 213 (717)
Q Consensus 150 ----------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 213 (717)
+-...++|+.|+.++|.++...+.. .-.+|+++++++|+++ .+|++++.+.+|+.+...+|
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHN 274 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccch
Confidence 0012233444444444444221111 1135555666666655 34455555566666655555
Q ss_pred ccCCcccCch----------------hhhhhhccCCCCCEEEeecCcccCcCchhhhhcc--------------------
Q 005045 214 ELGSREIGDL----------------NFLKFLANCTSLEVLGLARNSFGGEMPISIANLS-------------------- 257 (717)
Q Consensus 214 ~l~~~~~~~~----------------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~-------------------- 257 (717)
++..++.... ..+....+++.|++|+|..|+|. .+|+.+....
T Consensus 275 ~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~ 353 (1081)
T KOG0618|consen 275 RLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSY 353 (1081)
T ss_pred hHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccc
Confidence 5544332111 01233445677778888888777 6665443221
Q ss_pred -----ccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccccc
Q 005045 258 -----THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTIL 332 (717)
Q Consensus 258 -----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 332 (717)
..|+.|++.+|.++......+.+..+|+.|+|++|+|.......+.+|+.|+.|+||+|+++ .+|..+..++.|
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L 432 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL 432 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence 23455566666666555555666666666666666666333334556666666666666666 334555555555
Q ss_pred ceeecccccccccCCcCccCcCCCceEEeecccCC
Q 005045 333 TRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 333 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 367 (717)
++|...+|++. ..| .+..++.|+.+|++.|+|+
T Consensus 433 ~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 433 HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred HHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 55555555555 444 5555555555555555554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=260.51 Aligned_cols=215 Identities=23% Similarity=0.278 Sum_probs=152.5
Q ss_pred cccccccccccccCcccccceEEEEe-----------------CCCchhhhHHhHhhhhhHHHH--------------HH
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTL-----------------GDGTIVAIKVLKLQQQGALKS--------------FI 433 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~ 433 (717)
....++|++.++||+|+||.||+|.. ..++.||||.+........+. ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34577999999999999999999863 245679999886443222222 33
Q ss_pred HHHHHHhcCCCCce-----eEEEEeecccc---CCCCceEEEEEecCCCCChhhhccCCCCC-----------------c
Q 005045 434 DECNALKSTRHRNI-----LRVITACSSVD---LEGNDFKALVFEFMSNGNLDQWLHPSPAE-----------------H 488 (717)
Q Consensus 434 ~e~~~l~~l~h~ni-----~~~~~~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~ 488 (717)
.|+..+.+++|.++ +++++++.... ....+..++||||+++++|.++++..... .
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666777766554 55555543321 11234689999999999999988643110 0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeeccc
Q 005045 489 YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568 (717)
Q Consensus 489 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 568 (717)
......++..++.++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||++...... .........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------~~~~~~~g~ 371 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------INFNPLYGM 371 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC------CccCccccC
Confidence 0113456788999999999999999997 9999999999999999999999999998754211 011111123
Q ss_pred ccccccCCCccCCC---------------------C--CcccchhhHHHHHHHHHhCCC-CCCC
Q 005045 569 GSIGYIPPEHMNGQ---------------------V--SILGDIYSYGILLLEMFTGKR-PTGD 608 (717)
Q Consensus 569 ~~~~y~aPE~~~~~---------------------~--~~~sDvwslG~vl~elltg~~-p~~~ 608 (717)
+++.|+|||.+... + ..+.||||+||++|+|++|.. ||..
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 47899999985321 1 134699999999999999875 6643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-30 Score=252.74 Aligned_cols=350 Identities=23% Similarity=0.260 Sum_probs=253.3
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccC-ccccccCCccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGG-SNLTGNVPAWI 78 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~ 78 (717)
.|+.||..+ .++.++|..|+|+.+.|.+|+.+++|+.||||+|.|+.+-|++|.++.+|..|.+.+ |+|+....+.|
T Consensus 57 GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F 136 (498)
T KOG4237|consen 57 GLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF 136 (498)
T ss_pred CcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence 578999999 899999999999999999999999999999999999999999999999999887777 99997777789
Q ss_pred cCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccc---------------
Q 005045 79 GNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLH--------------- 143 (717)
Q Consensus 79 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--------------- 143 (717)
.+|.+|+.|.+.-|++.-+..++|..+++|..|.|.+|.+..+.-.+|..+..++.+++..|.+.
T Consensus 137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~ 216 (498)
T KOG4237|consen 137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN 216 (498)
T ss_pred hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence 99999999999999999888999999999999999999999666669999999999999988721
Q ss_pred --------------------ccCCcccccCCCCccee--ecc-cccccccCC-ccCCCCCCCCEEeccCccccccCCCCc
Q 005045 144 --------------------GQLPTDVGLTLPNLKIF--AGA-VNYFTGSIP-VSLSNASNLQVLDFAENGLTGTIPGNF 199 (717)
Q Consensus 144 --------------------~~l~~~~~~~l~~L~~L--~l~-~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~ 199 (717)
+.++..-|. -.++.+ .++ .+......| ..|..+++|+.|+|++|+|+.+.+.+|
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~--c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDARKFL--CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchhhhh--hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 001111110 001111 111 111112222 336677777777777777777777777
Q ss_pred cCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCC-----C
Q 005045 200 GSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGN-----I 274 (717)
Q Consensus 200 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~-----~ 274 (717)
.+...+++|.|..|+|..+. ...|.++..|+.|+|.+|+|+...|..|..+ ..|.+|.+-.|.+.-. .
T Consensus 295 e~~a~l~eL~L~~N~l~~v~------~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~-~~l~~l~l~~Np~~CnC~l~wl 367 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVS------SGMFQGLSGLKTLSLYDNQITTVAPGAFQTL-FSLSTLNLLSNPFNCNCRLAWL 367 (498)
T ss_pred cchhhhhhhhcCcchHHHHH------HHhhhccccceeeeecCCeeEEEeccccccc-ceeeeeehccCcccCccchHHH
Confidence 77777777777777777665 5567777777777777777776666666555 3677777766654310 0
Q ss_pred Ccc-----------ccCCCCCCEEEccCCcCccc---cch------------------hhhcC-------------CCCC
Q 005045 275 PVG-----------IGNLVNLNLLGLEGNNLSGS---VPE------------------VIGRL-------------NKLE 309 (717)
Q Consensus 275 ~~~-----------~~~l~~L~~L~L~~N~l~~~---~~~------------------~~~~l-------------~~L~ 309 (717)
.+| -.....++.+.++.+.+... .|+ .+..+ ..-.
T Consensus 368 ~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~d~t 447 (498)
T KOG4237|consen 368 GEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPVDVT 447 (498)
T ss_pred HHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCchhH
Confidence 111 11122455555555543211 111 01111 1245
Q ss_pred eEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecc
Q 005045 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364 (717)
Q Consensus 310 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 364 (717)
+|++.+|.++.+ |.. .+..| .+|+++|+++...-..|.++.+|.+|-|+.|
T Consensus 448 elyl~gn~~~~v-p~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 448 ELYLDGNAITSV-PDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HHhcccchhccc-CHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 689999999955 554 66778 8999999998666678999999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=235.30 Aligned_cols=206 Identities=24% Similarity=0.311 Sum_probs=164.8
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.+.+--+.||.|+||.||.+.++ +|+.||+|.+... .-...+++.+|++++..++|.|++..++...-...+.=...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34556789999999999999965 8999999998643 23346788899999999999999988876433222222246
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+++|.+ ..+|..++-.. +.++.+.++-+..||++||.|||+. +|.||||||.|.+++.+..+||+|||
T Consensus 133 YV~TELm-QSDLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHHHHH-HhhhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 8888988 45777776543 5688888899999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+++.- ..+....-+...-|..|+|||++.| +|+.+.||||.||++.|++..+..|....+
T Consensus 202 LARve------e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 202 LARTW------DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred ccccc------chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 99853 1122222334457889999999766 489999999999999999999888866533
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-30 Score=275.13 Aligned_cols=342 Identities=26% Similarity=0.340 Sum_probs=231.0
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+|++|+++.|-|. ..|.+.+++.+|++|.|.+|.+. ..|..+..+.+|+.|+++.|.+. .+|..+..++.+++++.+
T Consensus 69 ~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s 145 (1081)
T KOG0618|consen 69 HLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAAS 145 (1081)
T ss_pred HHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhh
Confidence 5677777777776 56667777777777777777766 67777777777777777777766 555544444444444433
Q ss_pred CC-------------------cCcccCChhhhccCCCCeEeccCCCCCCCCCcc--------------------------
Q 005045 91 WN-------------------NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSS-------------------------- 125 (717)
Q Consensus 91 ~n-------------------~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-------------------------- 125 (717)
+| .+.+.++..+..+++ .|+|++|.+....-..
T Consensus 146 ~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~ 223 (1081)
T KOG0618|consen 146 NNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTA 223 (1081)
T ss_pred cchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchhe
Confidence 33 222222222222222 3444444443110000
Q ss_pred -------------ccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccc
Q 005045 126 -------------IYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 126 -------------~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
-.--.+|+++++++|+++ .+| ++...+++|+.++...|.+. .+|..+...++|+.|++..|.++
T Consensus 224 L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~ 300 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE 300 (1081)
T ss_pred eeeccCcceeeccccccccceeeecchhhhh-cch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh
Confidence 011124555566666665 555 33335666666666666663 45555555566666666666666
Q ss_pred ccCCCCccCCCCCCeeeccccccCCcccCchhhhhh----h---------------ccCCCCCEEEeecCcccCcCchhh
Q 005045 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKF----L---------------ANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 193 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~----~---------------~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
.+|.....++.|++|+|..|+|...+..-+..+.. + ..++.|+.|.+.+|.+++..-..+
T Consensus 301 -yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l 379 (1081)
T KOG0618|consen 301 -YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVL 379 (1081)
T ss_pred -hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhh
Confidence 56666777888999999999888876422211111 0 134568899999999998776677
Q ss_pred hhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccc
Q 005045 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333 (717)
Q Consensus 254 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 333 (717)
.+. ++|+.|+|++|++.......+.++..|++|+||||+++ .+|..+..++.|++|...+|++. ..| .+..++.|+
T Consensus 380 ~~~-~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 380 VNF-KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred ccc-cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 776 59999999999999655566999999999999999999 78999999999999999999998 556 789999999
Q ss_pred eeeccccccccc-CCcCccCcCCCceEEeecccC
Q 005045 334 RLWMEENRLEGS-IPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 334 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l 366 (717)
.+|++.|+|+.. +|.... .++|++||++||..
T Consensus 456 ~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred EEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 999999999854 333333 38999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=230.99 Aligned_cols=199 Identities=28% Similarity=0.301 Sum_probs=163.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~ 463 (717)
..+|.-+..+|.|+. .|..|.+. .+++||+|..... .....++..+|...+..+.|+||++.+.++.-.. .+.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 458888899999998 77777765 7899999988643 2334578889999999999999999999864322 11122
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+|||++ ..++.+.+. -.++-..+.++..|++.|+.|+|+. ||+||||||+||++..++.+||.|
T Consensus 95 e~y~v~e~m-~~nl~~vi~---------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL---------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH---------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 479999999 579988876 2356678899999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
||+|+.- .....-+.+..+..|+|||++-| .+.+.+||||+||++.||++|...|.+
T Consensus 162 fg~ar~e--------~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 162 FGLARTE--------DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred chhhccc--------CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 9999863 22234456778999999999544 588999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-28 Score=246.86 Aligned_cols=302 Identities=20% Similarity=0.216 Sum_probs=210.5
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC------CCcee
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR------HRNIL 448 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~ 448 (717)
.++|.+.-....-++|.+....|+|-||.|..|.+. .|..||||++...... .+.-..|+++|+++. .-+.+
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 456666666667889999999999999999999965 6889999999755322 244567999999984 23567
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 528 (717)
+++.. |....++|+|||.+ ..+|.++++..+.. -.+....+..++.|+.-||..|-.. ||+|.||||
T Consensus 498 rl~r~-----F~hknHLClVFE~L-slNLRevLKKyG~n----vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKP 564 (752)
T KOG0670|consen 498 RLFRH-----FKHKNHLCLVFEPL-SLNLREVLKKYGRN----VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKP 564 (752)
T ss_pred HHHHH-----hhhcceeEEEehhh-hchHHHHHHHhCcc----cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCc
Confidence 76666 55667999999998 58999999876432 4477888999999999999999997 999999999
Q ss_pred CCEEeCCC-CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCC
Q 005045 529 SNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 529 ~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~ 606 (717)
+||+|++. ..+||||||.|....+ ...+++.-+..|.|||++-|. |++..|+||+||+||||.||+..|
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~e---------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASE---------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cceEeccCcceeeeccCcccccccc---------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 99999865 4799999999987622 122345566789999998774 899999999999999999999999
Q ss_pred CCCCCCch-hhhHHHHhcCChh-------hhhhcCCCCCCCCCCcHHH--------HHHHHHHHHHHhhhhhhhcchhhh
Q 005045 607 GDMFKDDF-SIHMFVSMALPDH-------VMDILDPSMPLDEENDEEQ--------IEEVIEEKEMMIHIDLEVNTKNKL 670 (717)
Q Consensus 607 ~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
.+...... .+...+...+|.. ..+-+|..+...+..-... +.-+.........+...++..+..
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 87543322 1222222334433 1222333222111100000 000000000011111111122233
Q ss_pred HHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 671 EECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....++|.+|+.+|+..||++|.|..+.++
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 444678899999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=237.54 Aligned_cols=296 Identities=21% Similarity=0.269 Sum_probs=209.3
Q ss_pred ccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 458 (717)
+....+.|.++++||.|.|++||++.+. .++.||+|.+.... ...+..+|++.+..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence 4455678999999999999999999843 57789999887554 236788999999999 68899999988
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCC
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDM 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~ 537 (717)
+...++.++|+||++.....++.. .++...++.+++.+..||+++|++ |||||||||+|++.+ ..+
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccC
Confidence 667789999999999999998874 467888999999999999999998 999999999999998 567
Q ss_pred ceEEeeeccchhccccc------C----CCC---------------------------CCcceeecccccccccCCCccC
Q 005045 538 TAHVGDFGLAKFLFEIS------D----NPS---------------------------KNQTVSIGLKGSIGYIPPEHMN 580 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~------~----~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~ 580 (717)
.-.|+|||+|....... . +.. ......-..+||++|+|||++.
T Consensus 171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~ 250 (418)
T KOG1167|consen 171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF 250 (418)
T ss_pred CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence 88999999998321111 0 000 0001112356999999999965
Q ss_pred CC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhh---hcCCCCCCCCCCcHHHHHHHHHHHH
Q 005045 581 GQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMD---ILDPSMPLDEENDEEQIEEVIEEKE 655 (717)
Q Consensus 581 ~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
+. -+.++||||.||++..++++..||.....+-..+.+.+..--+..+.+ ..+..+-... .....+.+.....+
T Consensus 251 k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k-sn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 251 RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK-SNIPTIPELRVNFE 329 (418)
T ss_pred hccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc-ccccccHHHHhchh
Confidence 53 588999999999999999999999887666655555554433333222 1121001110 11111122111111
Q ss_pred HH-----hhhhhh-hcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 656 MM-----IHIDLE-VNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 656 ~~-----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ...+.. ....+..+-.+..+.+++.+|+..+|.+|.||+|.+.
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11 011111 1111222333447899999999999999999999884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=250.33 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=204.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+.++|..+..+|.|.+|.||+|+++ +++..|+|+++........-.+.|+-+++.++||||+.+++.+ -..+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcC
Confidence 45779999999999999999999966 8999999999977655667778899999999999999999984 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+.||||.||+|.+..+.. ..+++.++..+.+..++|++|||+. |-+|||||-.||+++..|.+|++||
T Consensus 87 lwicMEycgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDf 156 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADF 156 (829)
T ss_pred cEEEEEecCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeeccc
Confidence 99999999999999988755 6789999999999999999999998 8899999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCcc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|.+..+ ...-..+..++||+.|||||+. .|.|...+||||+|++.-|+---+.|..+..+-...+....
T Consensus 157 gvsaqi-------tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk 229 (829)
T KOG0576|consen 157 GVSAQI-------TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK 229 (829)
T ss_pred Cchhhh-------hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc
Confidence 998766 3344556678999999999993 45689999999999999999887777544322211111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+. .++--..+. ..-...|-+|++.|+..+|.+|||+..+++
T Consensus 230 S~---------~qpp~lkDk------------------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 SG---------FQPPTLKDK------------------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC---------CCCCcccCC------------------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 111111110 111456788999999999999999998775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=219.94 Aligned_cols=211 Identities=22% Similarity=0.317 Sum_probs=170.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...+.|.+.+.+|+|-||.+-++.++ +.+.+++|.++.... ..+.|.+|...--.+ .|.||+..|+.. ++..+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d 95 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSD 95 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHH----hhcCc
Confidence 35778999999999999999999966 788899998875533 357788888765556 689999998886 55567
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-C-CCceEE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-K-DMTAHV 541 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~-~~~~kl 541 (717)
.+++++||+|.|+|..-+... .+.+....+++.|+++|+.|+|+. .+||||||.+||+|- . ..++|+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~--------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA--------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred eEEEeeccCccchhhhhcCcc--------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEe
Confidence 899999999999999888653 478888999999999999999997 999999999999994 3 348999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCcc----CCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----NGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+|||.++...- .......+-.|.+||+. .++ ..+.+|+|.||+++|.++||..||......+..
T Consensus 165 cDFG~t~k~g~----------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~ 234 (378)
T KOG1345|consen 165 CDFGLTRKVGT----------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP 234 (378)
T ss_pred eecccccccCc----------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch
Confidence 99999886411 11122345679999983 233 578999999999999999999999987777776
Q ss_pred hhHHHHh
Q 005045 616 IHMFVSM 622 (717)
Q Consensus 616 ~~~~~~~ 622 (717)
+.+|...
T Consensus 235 Y~~~~~w 241 (378)
T KOG1345|consen 235 YWEWEQW 241 (378)
T ss_pred HHHHHHH
Confidence 6666543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=239.29 Aligned_cols=304 Identities=20% Similarity=0.195 Sum_probs=175.9
Q ss_pred EEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc-Cc
Q 005045 63 IGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ-NQ 141 (717)
Q Consensus 63 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~ 141 (717)
.+.++-.++ .+|..+. ..-..++|..|+|+.+.+.+|..+++|+.||||+|+|+.+.|++|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344444444 3443333 2334444444444444444444444444444444444444444444444444433333 44
Q ss_pred ccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC-ccc
Q 005045 142 LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS-REI 220 (717)
Q Consensus 142 l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~ 220 (717)
|+ .+|.+.|.++..|+.|.+.-|++.....+.|..+++|..|.+-+|.+..+--..|..+..++.+.+..|.+.. -..
T Consensus 128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 44 4444444444444444444444444444444444444444444444442222244444444444444443110 000
Q ss_pred -----CchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCC-ccccCCCCCCEEEccCCcC
Q 005045 221 -----GDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIP-VGIGNLVNLNLLGLEGNNL 294 (717)
Q Consensus 221 -----~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l 294 (717)
-....+..++.........+.++++...-+..+......+..=-.+.+...++.| ..|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 0000122344444455555555555533333333322222222223333333444 4589999999999999999
Q ss_pred ccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCC
Q 005045 295 SGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTI 370 (717)
Q Consensus 295 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 370 (717)
+.+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.||+...+
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 9999999999999999999999999888889999999999999999999999999999999999999999997654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=264.41 Aligned_cols=338 Identities=20% Similarity=0.217 Sum_probs=251.8
Q ss_pred ceecEEEcCCCc------CcCCCCcCCcCCC-CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCC
Q 005045 10 LMTQDLNLTYNY------LSGKIPTNLSHCT-ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFS 82 (717)
Q Consensus 10 ~~~~~L~L~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 82 (717)
.+++.|.+.++. +...+|..|..++ +|+.|++.++.++ .+|..| ...+|+.|+|++|++. .++..+..++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~ 634 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLT 634 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCC
Confidence 366777775543 3334677777765 4888888888887 777766 4688889999998888 6777788888
Q ss_pred CCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeec
Q 005045 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG 162 (717)
Q Consensus 83 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l 162 (717)
+|+.|+|++|.....+|+ +..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|... .+++|+.|++
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~L 711 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNL 711 (1153)
T ss_pred CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeC
Confidence 899999988764436664 7788889999998887666788888888999999998865434777765 6888899999
Q ss_pred ccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhh-hhhhccCCCCCEEEee
Q 005045 163 AVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNF-LKFLANCTSLEVLGLA 241 (717)
Q Consensus 163 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~~~l~~L~~L~L~ 241 (717)
++|......|.. ..+|++|++++|.++ .+|..+ .+++|+.|.+.++....+....... +..+...++|+.|+|+
T Consensus 712 sgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls 786 (1153)
T PLN03210 712 SGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLS 786 (1153)
T ss_pred CCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCC
Confidence 888655555543 357888899998887 566554 5778888888764332211000000 1123345789999999
Q ss_pred cCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCC
Q 005045 242 RNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321 (717)
Q Consensus 242 ~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 321 (717)
+|...+.+|..+..+ ++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++ .
T Consensus 787 ~n~~l~~lP~si~~L-~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~ 860 (1153)
T PLN03210 787 DIPSLVELPSSIQNL-HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-E 860 (1153)
T ss_pred CCCCccccChhhhCC-CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-c
Confidence 998777889988887 589999999876444667665 6889999999998655456543 367899999999998 4
Q ss_pred CCcccccccccceeeccccc-ccccCCcCccCcCCCceEEeeccc
Q 005045 322 IPSSLGNLTILTRLWMEENR-LEGSIPPSLGNCQKLLVLNLSSND 365 (717)
Q Consensus 322 ~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~N~ 365 (717)
+|..+..+++|++|+|++|+ +. .+|..+..+++|+.+++++|.
T Consensus 861 iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 861 VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 57888999999999999854 55 688888889999999998885
|
syringae 6; Provisional |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=219.87 Aligned_cols=209 Identities=31% Similarity=0.505 Sum_probs=175.7
Q ss_pred cCcccccceEEEEeC-CCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCC
Q 005045 397 IGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSN 474 (717)
Q Consensus 397 ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~ 474 (717)
||+|++|.||++... +++.+++|++...... ....+.+|++.++.+.|++++++++.+. .....+++||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 689999999999965 5899999998865432 3577899999999999999999999954 33588999999998
Q ss_pred CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCceEEeeeccchhcccc
Q 005045 475 GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFGLAKFLFEI 553 (717)
Q Consensus 475 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 553 (717)
++|.+++.... ..++...+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+......
T Consensus 76 ~~l~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 76 GSLKDLLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 99999987542 3578999999999999999999998 9999999999999998 899999999998765211
Q ss_pred cCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhh
Q 005045 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDI 631 (717)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (717)
.. ......+...|++||...+ .++.++|+|++|+++|++
T Consensus 147 ~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 147 KS-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred cc-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 10 1222447788999999655 678999999999999999
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 632 LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 125678999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=249.66 Aligned_cols=264 Identities=25% Similarity=0.331 Sum_probs=170.9
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+-..|+|++|.++ .+|..+. .+|+.|++++|+|+ .+|. ..++|++|+|++|+|+.+ |.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 3456666666666 5555554 35666666666666 3443 235666666666666633 322 3456666777
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|.++ .+|. ...+|+.|++++|.++. +|. .+++|+.|+|++|++++ +|.. ..+|+.|++++|.|+.+
T Consensus 271 ~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 271 SNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSL 337 (788)
T ss_pred CCchh-hhhh----chhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccccCccccc
Confidence 77665 5553 22456666777776663 333 23567777777777773 4432 23566777777777765
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 298 (717)
+. -..+|+.|+|++|+|+ .+|.. +.+|+.|++++|.|.. +|.. ..+|+.|+|++|+|+ .+
T Consensus 338 P~----------lp~~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~L 397 (788)
T PRK15387 338 PT----------LPSGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SL 397 (788)
T ss_pred cc----------cccccceEecCCCccC-CCCCC----Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CC
Confidence 41 1146778888888887 55542 2467778888888773 4543 246788888888887 45
Q ss_pred chhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCccc
Q 005045 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 299 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
|.. .++|+.|++++|+++++ |..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 398 P~l---~s~L~~LdLS~N~LssI-P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 398 PVL---PSELKELMVSGNRLTSL-PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCc---ccCCCEEEccCCcCCCC-Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 543 35688888888888754 4332 46778888888887 778888888888888888888887777654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=247.82 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=145.7
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
...|+|++|+|+ .+|+.+. ++|+.|++++|+++ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 356788888887 5676665 47888888888887 5664 2467888888888887 55543 35677888888
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|.|+ .+|..+ ++|+.|+|++|+++. +|. .+++|+.|+|++|+++ .+|. ..++|+.|++++|.++. +
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~-~Lp~----lp~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLA-SLPA----LPSELCKLWAYNNQLTS-L 337 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccc-cCCC----CcccccccccccCcccc-c
Confidence 8877 444432 457777788887774 343 2356777778777776 5554 12356666666666663 3
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCch
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 251 (717)
|.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+.++ . ...+|+.|+|++|.|+ .+|.
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~LP-------~---l~~~L~~LdLs~N~Lt-~LP~ 399 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSLP-------A---LPSGLKELIVSGNRLT-SLPV 399 (788)
T ss_pred ccc---ccccceEecCCCccC-CCCCC---CcccceehhhccccccCc-------c---cccccceEEecCCccc-CCCC
Confidence 321 135666666666666 34432 234555566666655443 1 1134555555555555 3332
Q ss_pred hhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCC
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 321 (717)
. +++|+.|++++|.+++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++.
T Consensus 400 l----~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 400 L----PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred c----ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 1 1244444444444442 2321 123444444444444 3444444444444444444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=215.48 Aligned_cols=198 Identities=32% Similarity=0.507 Sum_probs=166.2
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhhhh-HHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
|.+.+.||.|++|.||++... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++.+. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 567889999999999999966 5889999999865444 5678899999999999999999999853 34578999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
+|++++++|.+++.... ..+++..+..++.+++.++.++|+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred EeccCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 99999999999987542 1178899999999999999999998 99999999999999999999999999988
Q ss_pred hcccccCCCCCCcceeecccccccccCCCcc-CC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
...... ........++..|++||.. .+ .++.++||||||+++|+|++|+.||+.
T Consensus 147 ~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDL------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcc------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 652211 0012234577889999996 33 367899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-24 Score=254.48 Aligned_cols=326 Identities=18% Similarity=0.204 Sum_probs=261.1
Q ss_pred CCCcCCcCCCCCCEEECCCCc------ccccCCcCCCCCC-CCCEEEccCccccccCCccccCCCCCCEEeccCCcCccc
Q 005045 25 KIPTNLSHCTELRSFEASVND------FVGQIPNQLSSLT-KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGS 97 (717)
Q Consensus 25 ~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 97 (717)
..+.+|.++.+|+.|.+.++. +...+|..|..++ +|+.|.+.++.++ .+|..| ...+|+.|+|++|+|. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 456679999999999997653 3345777787764 6999999999998 788877 5789999999999998 7
Q ss_pred CChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCC
Q 005045 98 IPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSN 177 (717)
Q Consensus 98 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 177 (717)
++..+..+++|+.|+|++|.....+| .++.+++|+.|+|++|.....+|..+. .+++|+.|++++|..-..+|..+ +
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~-~L~~L~~L~L~~c~~L~~Lp~~i-~ 702 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQ-YLNKLEDLDMSRCENLEILPTGI-N 702 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhh-ccCCCCEEeCCCCCCcCccCCcC-C
Confidence 78889999999999999886544566 488999999999999876558887764 89999999999976555677665 7
Q ss_pred CCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC------cCch
Q 005045 178 ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG------EMPI 251 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~------~~p~ 251 (717)
+++|+.|++++|......|.. .++|+.|++++|.+..++ ..+ .+++|+.|++.++.... .++.
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP-------~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~ 771 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFP-------SNL-RLENLDELILCEMKSEKLWERVQPLTP 771 (1153)
T ss_pred CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccc-------ccc-cccccccccccccchhhccccccccch
Confidence 899999999999765566643 468999999999998765 222 57888888888744320 1122
Q ss_pred hhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccc
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI 331 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 331 (717)
.....+++|+.|++++|.....+|..++++++|+.|+|++|...+.+|..+ .+++|+.|+|++|......|.. ..+
T Consensus 772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 223334689999999998777899999999999999999986544777765 7999999999998755555543 368
Q ss_pred cceeecccccccccCCcCccCcCCCceEEeecc-cCCCCCCcc
Q 005045 332 LTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN-DLNGTIPKE 373 (717)
Q Consensus 332 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~ 373 (717)
|+.|+|++|.++ .+|..+..+++|+.|++++| .+. .+|..
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~ 888 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLN 888 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcc
Confidence 999999999998 78999999999999999994 555 45554
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=200.87 Aligned_cols=169 Identities=21% Similarity=0.247 Sum_probs=123.7
Q ss_pred CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhccccc
Q 005045 475 GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554 (717)
Q Consensus 475 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 554 (717)
|+|.+++.... ..+++..++.++.||+.||+|||+. + ||+||+++.++.+|+ ||.+......
T Consensus 1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~- 62 (176)
T smart00750 1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE- 62 (176)
T ss_pred CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-
Confidence 68888887542 4689999999999999999999997 5 999999999999999 9998765210
Q ss_pred CCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcC
Q 005045 555 DNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILD 633 (717)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (717)
...|++.|+|||++.+ .++.++|||||||++|||++|..||................. .
T Consensus 63 -----------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---------~ 122 (176)
T smart00750 63 -----------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM---------P 122 (176)
T ss_pred -----------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh---------c
Confidence 1247899999999755 589999999999999999999999865422111111111000 0
Q ss_pred CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHH--HHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 634 PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECF--VSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+...... ....... ..+.+++.+||+.+|++|||+.|+++.+..+..+
T Consensus 123 ~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 123 ADDPRDR---------------------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cCCcccc---------------------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0000000 0011112 2588999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=247.92 Aligned_cols=153 Identities=16% Similarity=0.236 Sum_probs=105.9
Q ss_pred CceeEEEEeecccc--CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005045 445 RNILRVITACSSVD--LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIA 522 (717)
Q Consensus 445 ~ni~~~~~~~~~~~--~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 522 (717)
.||..+++.+.... ..+.+..+.+||++ +++|.+++.... ..+++.+++.++.||++||+|||++ ||+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 35555555432111 12234577889987 679999997432 5689999999999999999999997 999
Q ss_pred ecCCCCCCEEeCCCCceEE-------------------eeeccchhcccccCC----C-----CCCcceeeccccccccc
Q 005045 523 HCDLKPSNVLLDKDMTAHV-------------------GDFGLAKFLFEISDN----P-----SKNQTVSIGLKGSIGYI 574 (717)
Q Consensus 523 H~dlkp~NIll~~~~~~kl-------------------~Dfg~~~~~~~~~~~----~-----~~~~~~~~~~~~~~~y~ 574 (717)
||||||+|||++..|.+|+ +|||.++........ . ...........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999976555554 455544322100000 0 00000011235788899
Q ss_pred CCCccCC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 575 PPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 575 aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
|||++.+ .++.++|||||||++|||++|..|+.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 9999654 58999999999999999999888764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=233.90 Aligned_cols=278 Identities=23% Similarity=0.426 Sum_probs=147.2
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+.+.|+|++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3456677777666 4555443 45667777777666 4554443 36666777766666 4555443 356666666
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|+++ .+|..+. .+|+.|+|++|+|+. +|..+. ++|+.|+|++|+++ .+|..++ ++|+.|++++|.+..
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA- 318 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-
Confidence 66666 4554443 356666666666663 444333 35666666666665 4544322 245555555555542
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+|..+. ++|++|++++|.++ .+|..+. ++|+.|++++|+|+ .+|
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--------------------------------~sL~~L~Ls~N~L~-~LP 362 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALT-SLPASLP--------------------------------PELQVLDVSKNQIT-VLP 362 (754)
T ss_pred CCcccc--ccceeccccCCccc-cCChhhc--------------------------------CcccEEECCCCCCC-cCC
Confidence 222221 34444555555444 2333221 35555555555555 444
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchh----hhcCCCCCeEEcccCcCCCCCCccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV----IGRLNKLEGLGLNVNKFSGLIPSSL 326 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~~~~~ 326 (717)
..+. ++|+.|++++|.++ .+|..+. ..|+.|++++|+|+ .+|.. +..++.+..|+|.+|+++.
T Consensus 363 ~~lp---~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------ 429 (754)
T PRK15370 363 ETLP---PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------ 429 (754)
T ss_pred hhhc---CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------
Confidence 4332 35666666666665 2343332 24666666666666 34433 3345677778888887762
Q ss_pred ccccccceeecccccccc-cCCcCccCcCCCce
Q 005045 327 GNLTILTRLWMEENRLEG-SIPPSLGNCQKLLV 358 (717)
Q Consensus 327 ~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 358 (717)
..+.+|+.| ++.+.+.| .++.....+.+++.
T Consensus 430 ~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~ 461 (754)
T PRK15370 430 RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRV 461 (754)
T ss_pred HHHHHHHHh-hhcccccCCcccccccccccccc
Confidence 344445555 34444432 22333333444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=196.76 Aligned_cols=248 Identities=22% Similarity=0.372 Sum_probs=189.5
Q ss_pred ccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
......++.....|..|+|+++ |..++.|++...+ ...-+.|..|.-.++.+.||||..+++.|.+. ..+.+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~ 264 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVI 264 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceE
Confidence 4456778999999999999996 5556778887654 23346789999999999999999999997554 48899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCee-ecCCCCCCEEeCCCCceEEe--ee
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIA-HCDLKPSNVLLDKDMTAHVG--DF 544 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~dlkp~NIll~~~~~~kl~--Df 544 (717)
+..|+|.|+|+..++.... -.++..++.+++.+|++|++|||+.. +++ .-.+++.+++||++.+++|+ |-
T Consensus 265 isq~mp~gslynvlhe~t~-----vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeeeccchHHHHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccc
Confidence 9999999999999987642 55778889999999999999999974 444 44589999999999888874 32
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCCC----CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV----SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
..+ ....+..-.+.|++||.++.++ -.++|+|||++++||+-|...||.+..+-+....-.
T Consensus 338 kfs--------------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia- 402 (448)
T KOG0195|consen 338 KFS--------------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA- 402 (448)
T ss_pred eee--------------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-
Confidence 222 1223344577899999987653 467899999999999999999999876544322110
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...+ ...+ ++-.+..+..++.-|+..||.+||.+..|+-
T Consensus 403 legl--------rv~i---------------------------------ppgis~hm~klm~icmnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 403 LEGL--------RVHI---------------------------------PPGISRHMNKLMNICMNEDPGKRPKFDMIVP 441 (448)
T ss_pred hccc--------cccC---------------------------------CCCccHHHHHHHHHHhcCCCCcCCCcceehh
Confidence 0011 1111 1112556778999999999999999999999
Q ss_pred HHHHHH
Q 005045 701 NLKTIR 706 (717)
Q Consensus 701 ~l~~i~ 706 (717)
+||+++
T Consensus 442 ilekm~ 447 (448)
T KOG0195|consen 442 ILEKMI 447 (448)
T ss_pred hHHHhc
Confidence 999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=233.34 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=190.3
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+.+.|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+++. +|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECc
Confidence 4567777777777 5665554 46777777777777 4554443 467777777777773 444443 367777777
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|++. .+|..++ ++|+.|++++|.++. +|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.++.+
T Consensus 250 ~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 250 INRIT-ELPERLP---SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred CCccC-cCChhHh---CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccC
Confidence 77776 6776553 467777888777773 555553 57899999999888 4555443 4788999999999876
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 298 (717)
+. .+ .++|+.|++++|.++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|+|+ .+
T Consensus 320 P~-------~l--~~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 320 PE-------TL--PPGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL 382 (754)
T ss_pred Cc-------cc--cccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence 51 11 268999999999999 6787654 58999999999998 4666553 68999999999999 56
Q ss_pred chhhhcCCCCCeEEcccCcCCCCCCccc----ccccccceeecccccccccCCcCccCcCCCceEEeecccCCCC
Q 005045 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSL----GNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369 (717)
Q Consensus 299 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 369 (717)
|..+.. .|+.|++++|+++++ |..+ ..++.+..|+|.+|+++. ..+++|+.+ ++.+.+.|+
T Consensus 383 P~~l~~--sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 383 PENLPA--ALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGP 447 (754)
T ss_pred CHhHHH--HHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCC
Confidence 766653 699999999999954 5544 345889999999999972 344555555 455666554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=208.92 Aligned_cols=178 Identities=22% Similarity=0.191 Sum_probs=134.3
Q ss_pred CCcccccccccccccccccCcccccceEEEEeC--CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEE
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG--DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVI 451 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~ 451 (717)
.+.+......++|++.+.||+|+||.||+|.++ +++.+|+|+.... .......+.+|+++++++.|+|++..+
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 445566677889999999999999999999864 5777899876422 223456789999999999999998543
Q ss_pred EeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCC
Q 005045 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDL-KPSN 530 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~N 530 (717)
..+ +..|+||||++|++|... ... . ...++.++++||+|||+. ||+|||| ||+|
T Consensus 88 ~~~--------~~~~LVmE~~~G~~L~~~-~~~-------~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~N 142 (365)
T PRK09188 88 LAT--------GKDGLVRGWTEGVPLHLA-RPH-------G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQN 142 (365)
T ss_pred EEc--------CCcEEEEEccCCCCHHHh-Ccc-------c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcce
Confidence 321 246999999999999632 111 1 146788999999999998 9999999 9999
Q ss_pred EEeCCCCceEEeeeccchhcccccCCCCC-CcceeecccccccccCCCccCC
Q 005045 531 VLLDKDMTAHVGDFGLAKFLFEISDNPSK-NQTVSIGLKGSIGYIPPEHMNG 581 (717)
Q Consensus 531 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~ 581 (717)
|+++.++.+||+|||+|+.+......... ......+..+++.|+|||.+..
T Consensus 143 ILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999999999999876332211110 0111245678889999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.79 Aligned_cols=208 Identities=24% Similarity=0.311 Sum_probs=163.9
Q ss_pred ccccccccCcccccceEEEEeCCC--chhhhHHhHhhhhhHHHHHHHHHHHHhcCC----CCceeEEEEeeccccCCCCc
Q 005045 390 NFSKENLIGTGSFGSVYKGTLGDG--TIVAIKVLKLQQQGALKSFIDECNALKSTR----HRNILRVITACSSVDLEGND 463 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~ni~~~~~~~~~~~~~~~~ 463 (717)
+|.+.++||+|+||.||.|..... +.+|+|............+..|+.++..+. .+++..+++.+. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 899999999999999999996543 478888876543332236777888888886 368888888852 3556
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-----Cc
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-----MT 538 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-----~~ 538 (717)
..++||+.+ |.+|.++...... +.++..++..++.|++.+|.++|+. |++||||||.|+++... ..
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~-----~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPP-----GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCC-----CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence 889999988 8999998865532 6799999999999999999999997 99999999999999865 36
Q ss_pred eEEeeeccchhcccccCCCC--CCcce-eecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 539 AHVGDFGLAKFLFEISDNPS--KNQTV-SIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~--~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+.+.|||+++...-...... ..... .....||..|+++.+..+ +.+.+.|+||++.++.+++.|..||....
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 99999999993321111111 11111 234669999999999665 58999999999999999999999996543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=180.71 Aligned_cols=208 Identities=23% Similarity=0.335 Sum_probs=170.3
Q ss_pred cccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC-CceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~~ 464 (717)
..+.|.++++||+|+||.+|.|. ..+|+.||+|+-...... ..+..|.++...+++ ..|+.+..+ ..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 46789999999999999999999 569999999987654332 456678888888854 566666666 445568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl 541 (717)
-.+||+.. |.+|.+.+.-.. ..++..+++-+|.|++.-++|+|.. +++||||||+|++..- ...+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEE
Confidence 89999998 899999886443 6799999999999999999999997 9999999999999963 347999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+|||+|+.+........-+........||..|.+-...-| +-+.+.|+=|+|.++-++--|..||.+.-.
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9999999886655555555666677889999988777554 357889999999999999999999988643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-23 Score=223.06 Aligned_cols=274 Identities=22% Similarity=0.263 Sum_probs=199.4
Q ss_pred cccCCCCCCcccccCCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhH----HHHHHHHHHH
Q 005045 363 SNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA----LKSFIDECNA 438 (717)
Q Consensus 363 ~N~l~~~~p~~~~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~ 438 (717)
||.+++ |..+.....-++++.. +|.-.+-+|++.|=+|.+|++..|. |+||++...++.. ..+...|++
T Consensus 2 Gnqls~--~sQi~~~e~yfsd~~~---e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik- 74 (1431)
T KOG1240|consen 2 GNQLSL--PSQISPVEVYFSDLSV---ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK- 74 (1431)
T ss_pred Cccccc--ccccchHHHHhhcCcc---ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-
Confidence 566765 4444433344445443 6777889999999999999998888 8889987654321 222233444
Q ss_pred HhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 439 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
....++||.+.+... ....+..|+|-+|+. -+|+|.+..+ +-+...+.+-||.|++.|+..+|..
T Consensus 75 ~~l~~~pn~lPfqk~-----~~t~kAAylvRqyvk-hnLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~-- 139 (1431)
T KOG1240|consen 75 FALMKAPNCLPFQKV-----LVTDKAAYLVRQYVK-HNLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKL-- 139 (1431)
T ss_pred HHhhcCCcccchHHH-----HHhhHHHHHHHHHHh-hhhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHc--
Confidence 555699999987666 455567889999984 6999999866 5688889999999999999999998
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------------CCCcc
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------------QVSIL 586 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~ 586 (717)
||+|||||.+||||+....+.|+||..-+...-+.+++.+......+-..-.+|.|||-+-. ..+++
T Consensus 140 -gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~pa 218 (1431)
T KOG1240|consen 140 -GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPA 218 (1431)
T ss_pred -CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChh
Confidence 99999999999999999999999998877766666666666555666666779999997421 14688
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH-hcCChh-hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhh
Q 005045 587 GDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS-MALPDH-VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663 (717)
Q Consensus 587 sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (717)
.||||+|||++|+++ |++||.-. ..+.+..+ ...++. +.++-|
T Consensus 219 MDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ied------------------------------ 264 (1431)
T KOG1240|consen 219 MDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDPEQLLEKIED------------------------------ 264 (1431)
T ss_pred hhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCHHHHHHhCcC------------------------------
Confidence 899999999999999 78888531 00000000 000111 111111
Q ss_pred hcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 664 VNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 664 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
..+..++..|++.||+.|-||.+.++.-..
T Consensus 265 -----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 265 -----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 135678999999999999999999987443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=213.70 Aligned_cols=256 Identities=23% Similarity=0.260 Sum_probs=180.6
Q ss_pred ccccccCcccccceEEEEeC-CCchhhhHHhH----hh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 392 SKENLIGTGSFGSVYKGTLG-DGTIVAIKVLK----LQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~----~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...+.+|.|++|.|+.+... ..+.++.|.+. .. .......+..|+.+-..+.|+|++..+....+. ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence 34567899999988877733 44445555443 11 111223366777788889999998777664332 23
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
..-+||||++ +|...+... ..+...++-.+++|++.|++|+|+. |+.|||+|++|++++.+|.+||+||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df 464 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF 464 (601)
T ss_pred chhhhhcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence 3334999998 999988754 4688889999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....-.. ........+..|..+|+|||++.+. | ....||||.|+++..|.+|+.||.....++..+.....
T Consensus 465 g~~~vf~~~~---e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~- 540 (601)
T KOG0590|consen 465 GAASVFRYPW---EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY- 540 (601)
T ss_pred CcceeeccCc---chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-
Confidence 9987552111 1112344567899999999997664 5 56679999999999999999999877555443200000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..+ .... ..+ . .....-+.+-..++.+|++++|.+|.|+++|++.
T Consensus 541 --~~~------~~~~----~~~---~-------------------~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 --SDQ------RNIF----EGP---N-------------------RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --ccc------cccc----cCh---H-------------------HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000 0000 000 0 0112225556779999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=176.53 Aligned_cols=211 Identities=22% Similarity=0.320 Sum_probs=177.9
Q ss_pred cccccccccccccccCcccccceEEEE-eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
.+....-.|++.++||+|.||.++.|+ .-+++.||||.-.... ....+..|.+..+.+ ..+.|..+|.+ .+
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----Gq 94 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQ 94 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----cc
Confidence 445566789999999999999999999 4589999999865433 235677888888888 67899999888 55
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM--- 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--- 537 (717)
++.+-.+|+|.+ |.+|.|.+.-.. .+++..++..+|.|++.-++|+|+. ..|.|||||+|++|...+
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~ 164 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKD 164 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCC
Confidence 667888999998 889998876543 6799999999999999999999997 899999999999997544
Q ss_pred --ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 538 --TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 538 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+.++|||+|+.+..+...-.-++...+...||..||+-....| +-+.+.|+=|+|=|+.+.+-|..||.+.-
T Consensus 165 ~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 165 ANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 68999999999987766666666666677889999999888444 57889999999999999999999998763
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-22 Score=205.76 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=121.7
Q ss_pred EEEcCCCcCc-CCCCcCCcCCCCCCEEECCCCcccc----cCCcCCCCCCCCCEEEccCccccc------cCCccccCCC
Q 005045 14 DLNLTYNYLS-GKIPTNLSHCTELRSFEASVNDFVG----QIPNQLSSLTKLEIIGLGGSNLTG------NVPAWIGNFS 82 (717)
Q Consensus 14 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~ 82 (717)
.|+|.++.++ ...+..|..+.+|++|++++|.++. .++..+...++|+.|+++++.+.. .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3556666665 2334445555566666666666532 233344555556666666655541 1223344455
Q ss_pred CCCEEeccCCcCcccCChhhhccCC---CCeEeccCCCCCC----CCCccccCC-CCccEEEcccCcccccCCcccccCC
Q 005045 83 SLKALSLAWNNLRGSIPNELGQLSG---LGFFTLYGNFISG----IIPSSIYNI-SSIYYFSVTQNQLHGQLPTDVGLTL 154 (717)
Q Consensus 83 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~i~~----~~~~~~~~l-~~L~~L~L~~N~l~~~l~~~~~~~l 154 (717)
+|+.|+|++|.+.+..+..|..+.+ |+.|++++|.++. .+...+..+ ++|+.|+|++|.+++....
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------ 155 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE------ 155 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH------
Confidence 5555555555554434444444333 5555555555441 111223333 4444444444444311100
Q ss_pred CCcceeecccccccccCCccCCCCCCCCEEeccCcccccc----CCCCccCCCCCCeeeccccccCCcccCchhhhhhhc
Q 005045 155 PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230 (717)
Q Consensus 155 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 230 (717)
.++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.++...... +...+.
T Consensus 156 ---------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--l~~~~~ 218 (319)
T cd00116 156 ---------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA--LAETLA 218 (319)
T ss_pred ---------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH--HHHHhc
Confidence 1222344555666666666666531 2223344456666666666665433221 133455
Q ss_pred cCCCCCEEEeecCcccCcCchhhhhcc----ccccEEecCCCccCC----CCCccccCCCCCCEEEccCCcCc
Q 005045 231 NCTSLEVLGLARNSFGGEMPISIANLS----THLRRLTMGENLMHG----NIPVGIGNLVNLNLLGLEGNNLS 295 (717)
Q Consensus 231 ~l~~L~~L~L~~N~l~~~~p~~~~~~~----~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 295 (717)
.+++|+.|++++|.+++.....+.... +.|++|++++|.++. .+...+..+++|++|++++|.++
T Consensus 219 ~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred ccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 566666667766666643333332221 244555555554431 11122333344555555555444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=180.71 Aligned_cols=174 Identities=14% Similarity=0.133 Sum_probs=132.4
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhh---hHHHH------HHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ---GALKS------FIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
..++|++.+.+|.|+||.||++.. +++.+|+|++..... ....+ +++|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367999999999999999999766 577899999975432 22223 68999999999999999988875432
Q ss_pred cC---CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 458 DL---EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 458 ~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.. ......++||||++|.+|.++.. ++. ....+++.++..+|.. |++|||++|+||+++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 21 12346899999999999988732 222 2466999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCC-c-cCCCCCcccchhhHHHHHHHHH
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPE-H-MNGQVSILGDIYSYGILLLEMF 600 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~-~~~~~~~~sDvwslG~vl~ell 600 (717)
.+| ++++|||......+ . .|-+ + +...++.++|+||||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e-------~-------------~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQ-------R-------------KAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccc-------h-------------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence 988 99999998764310 0 0011 2 3444668999999999887554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-21 Score=203.17 Aligned_cols=108 Identities=20% Similarity=0.263 Sum_probs=62.1
Q ss_pred cccEEecCCCccCCC----CCccccCCCCCCEEEccCCcCccccchhhhc-----CCCCCeEEcccCcCCCC----CCcc
Q 005045 259 HLRRLTMGENLMHGN----IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR-----LNKLEGLGLNVNKFSGL----IPSS 325 (717)
Q Consensus 259 ~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~ 325 (717)
+|+.|++++|.+.+. +...+..+++|++|++++|++++.....+.. .+.|+.|++++|.++.. ....
T Consensus 194 ~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~ 273 (319)
T cd00116 194 NLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEV 273 (319)
T ss_pred CCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHH
Confidence 455555555544322 2223455667777777777776433333322 36777777777777622 1233
Q ss_pred cccccccceeeccccccccc----CCcCccCc-CCCceEEeecccC
Q 005045 326 LGNLTILTRLWMEENRLEGS----IPPSLGNC-QKLLVLNLSSNDL 366 (717)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l 366 (717)
+..+++|+++++++|.++.. +...+... +.|++|++.+|+|
T Consensus 274 ~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 274 LAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 44456777777777777743 33444444 5777777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-19 Score=185.06 Aligned_cols=205 Identities=34% Similarity=0.505 Sum_probs=164.8
Q ss_pred cccccccCcccccceEEEEeCCCchhhhHHhHhhhhh---HHHHHHHHHHHHhcCCCC-ceeEEEEeeccccCCCCceEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQG---ALKSFIDECNALKSTRHR-NILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~~~~~~ 466 (717)
|.+.+.+|.|+|+.||.+.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+ ......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEEE
Confidence 778899999999999999976 66788887654322 467889999999999988 799999985 3334589
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg 545 (717)
++++++.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 999999999999777654210 2688999999999999999999998 899999999999999988 79999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+............. .......|+..|+|||...+ ......|+||+|++++++++|..||....
T Consensus 148 ~~~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 148 LAKLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cceecCCCCcccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 987542211111000 12355679999999999765 57889999999999999999999976543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-21 Score=170.04 Aligned_cols=164 Identities=23% Similarity=0.465 Sum_probs=84.3
Q ss_pred cCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCe
Q 005045 31 SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110 (717)
Q Consensus 31 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 110 (717)
..+++++.|.||+|+++ .+|..+..+.+|++|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 33444445555555554 34444455555555555555554 44444555555555555555554 44445555555555
Q ss_pred EeccCCCCC-CCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCc
Q 005045 111 FTLYGNFIS-GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189 (717)
Q Consensus 111 L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 189 (717)
|||++|++. ..+|+.|..++.|+-|+|++|.+. -+|.++. .+.+|++|.+.+|.+- .+|..++.++.|++|.+.+|
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 555554443 234444555555555555555554 4444444 4455555555555444 35666666666777777777
Q ss_pred cccccCCCCccC
Q 005045 190 GLTGTIPGNFGS 201 (717)
Q Consensus 190 ~l~~~~~~~~~~ 201 (717)
+++ ++|..+++
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 776 55544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=172.67 Aligned_cols=139 Identities=22% Similarity=0.176 Sum_probs=106.3
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhH--------------------------HHHHHHHHHHHhcCCCCce
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA--------------------------LKSFIDECNALKSTRHRNI 447 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 447 (717)
...||+|++|.||.|..++|+.||+|++....... ......|+++++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998789999999986442110 1223459999999977765
Q ss_pred eEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCC
Q 005045 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDL 526 (717)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl 526 (717)
....... . ...++||||++|+++....... ..++...+..++.|++.+|+++ |+. ||+||||
T Consensus 82 ~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 82 PCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCcEEE----e---cCCEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 3322211 0 1238999999887665443222 4578899999999999999999 676 9999999
Q ss_pred CCCCEEeCCCCceEEeeeccchhc
Q 005045 527 KPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 527 kp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
||+||+++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 578999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-21 Score=169.31 Aligned_cols=160 Identities=24% Similarity=0.409 Sum_probs=124.2
Q ss_pred CCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCcc
Q 005045 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133 (717)
Q Consensus 54 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 133 (717)
+.++.+++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|.++..+++|+.|+++-|++. +.|..|+.++-|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 455667777888888888 66666778888888888888887 77777888888888888888877 7788888888888
Q ss_pred EEEcccCcccc-cCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccc
Q 005045 134 YFSVTQNQLHG-QLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQ 212 (717)
Q Consensus 134 ~L~L~~N~l~~-~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 212 (717)
.|||++|++.. .+|..+| .+..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|..++.++.|++|.+.+
T Consensus 106 vldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 88888888764 4565555 7777888888888887 67777888888888888888777 6777788888888888888
Q ss_pred cccCCcc
Q 005045 213 NELGSRE 219 (717)
Q Consensus 213 N~l~~~~ 219 (717)
|+++.++
T Consensus 183 nrl~vlp 189 (264)
T KOG0617|consen 183 NRLTVLP 189 (264)
T ss_pred ceeeecC
Confidence 8887765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=165.33 Aligned_cols=190 Identities=16% Similarity=0.064 Sum_probs=136.5
Q ss_pred ccccccCcccccceEEEEeCCCchhhhHHhHhhhh----hHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEE
Q 005045 392 SKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ----GALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.+...+++|+||+||.+.. .+++++.+.+..... .+...+.+|+++++++. |+++++++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 3567899999999998776 577777666654322 12346889999999995 57888888751 468
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEeCCCCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDL-KPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg 545 (717)
++|||+.|.+|.+.... ....++.|++.++.++|++ ||+|||| ||+||+++.+|.++|+|||
T Consensus 75 lvmeyI~G~~L~~~~~~--------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEeeecCccHHhhhhh--------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 99999999888654321 1135788999999999998 9999999 7999999999999999999
Q ss_pred cchhcccccCC----CCCC--cceeecccccccccCCCc--cCCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 005045 546 LAKFLFEISDN----PSKN--QTVSIGLKGSIGYIPPEH--MNGQV-SILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 546 ~~~~~~~~~~~----~~~~--~~~~~~~~~~~~y~aPE~--~~~~~-~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.+........- ...+ .....-...++.|++|+. +.... -.+.++++.|+.+|.++|+..|+-.
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 99854211100 0000 000011224666777765 22233 3678999999999999999998644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=170.36 Aligned_cols=205 Identities=22% Similarity=0.242 Sum_probs=141.1
Q ss_pred CCCceeEEEEeeccc----------------------cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHH
Q 005045 443 RHRNILRVITACSSV----------------------DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500 (717)
Q Consensus 443 ~h~ni~~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 500 (717)
+||||+++..++.+. ...++..+|+||.-++ .+|.+|+-.+ ..+.....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--------~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--------HRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--------CCchHHHH
Confidence 599999998765332 1344667899999985 6999998643 34666778
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCC--ceEEeeeccchhcccccCCCCCCcceeecccccccccCC
Q 005045 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD--KDM--TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPP 576 (717)
Q Consensus 501 ~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 576 (717)
-+..|+++|+.|||++ ||.|||+|++||++. +++ .+.|+|||++--....+-... .........|...-|||
T Consensus 345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp-y~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP-YESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc-cccccccCCCcceecch
Confidence 8899999999999998 999999999999995 333 688999998754322110000 01111223477788999
Q ss_pred CccCCC-------CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHH
Q 005045 577 EHMNGQ-------VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEE 649 (717)
Q Consensus 577 E~~~~~-------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (717)
|+.... ...++|.|+.|.+.||++....||..-.+--.+...+ -...++.
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y------------qe~qLPa----------- 477 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY------------QESQLPA----------- 477 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh------------hhhhCCC-----------
Confidence 996532 2468999999999999999999997632211111100 0000110
Q ss_pred HHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 650 VIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
.++.|+..+.+++...++.+|.+|+|..=....+
T Consensus 478 -------------------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 478 -------------------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -------------------CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 2234566778899999999999999876554443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-19 Score=196.77 Aligned_cols=203 Identities=22% Similarity=0.254 Sum_probs=154.6
Q ss_pred CcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC---CCceeEEEEeecc
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR---HRNILRVITACSS 456 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~ 456 (717)
...+.......|.|.+.+|+|+||.||+|...+|+.||+|+=+.... -.|.--.+++.+++ -+-|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a--- 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSA--- 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHH---
Confidence 34455566788999999999999999999977799999998764421 11111122333333 1122222222
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK- 535 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~- 535 (717)
+...+..++|+||.+.|||.+++... +.+++..++.++.|+++.++.||.. +||||||||+|+|+..
T Consensus 763 --~~~~~~S~lv~ey~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 763 --HVFQNASVLVSEYSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRRE 830 (974)
T ss_pred --HccCCcceeeeeccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecc
Confidence 22334568999999999999999844 7799999999999999999999998 9999999999999953
Q ss_pred ------CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCC
Q 005045 536 ------DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605 (717)
Q Consensus 536 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p 605 (717)
...++|+|||.+..+... .+........+|-.+-.+|+..|+ |++.+|.|+++.++|-|+.|+.-
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lf-----p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLF-----PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cCCCCcccceEEEecccceeeeEc-----CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 337999999999776221 122344566788889999998876 89999999999999999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=165.84 Aligned_cols=140 Identities=21% Similarity=0.190 Sum_probs=108.7
Q ss_pred cccccCcccccceEEEEeCCCchhhhHHhHhhhhh--------------------------HHHHHHHHHHHHhcCCCCc
Q 005045 393 KENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQG--------------------------ALKSFIDECNALKSTRHRN 446 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n 446 (717)
+...||+|++|.||+|...+|+.||+|++...... ....+..|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999778999999998754210 0223467899999998888
Q ss_pred eeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecC
Q 005045 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCD 525 (717)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~d 525 (717)
+........ . ..++||||++|+++....... ..++...+..++.|++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~----~---~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILL----K---KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEe----c---CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 743333211 1 248999999887554332211 346788899999999999999999 7 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhc
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|||+||+++ ++.++|+|||++...
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceec
Confidence 999999998 899999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-19 Score=172.80 Aligned_cols=209 Identities=22% Similarity=0.314 Sum_probs=130.8
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCC----------CceeEE
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRH----------RNILRV 450 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~ni~~~ 450 (717)
......+...+.||.|+++.||.+.+. +++.+|+|++.... ....+.+.+|.-....+.+ -.++..
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 344556777889999999999999976 79999999886432 2234555555544444322 122222
Q ss_pred EEeecccc-------CCCCc-----eEEEEEecCCCCChhhhccC---CCCCcccccccCHHHHHHHHHHHHHHHHHHHh
Q 005045 451 ITACSSVD-------LEGND-----FKALVFEFMSNGNLDQWLHP---SPAEHYQFKKLSVIQRLNIAIDVASALDYLHH 515 (717)
Q Consensus 451 ~~~~~~~~-------~~~~~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~ 515 (717)
++...... ..+.. ..+++|+-+ .++|.+++.. ... .........+..+..|+++.+++||+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---THSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---TSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---ccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22221110 00011 236788877 5688777542 110 01234455567777999999999999
Q ss_pred cCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---------CCCcc
Q 005045 516 HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---------QVSIL 586 (717)
Q Consensus 516 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~ 586 (717)
. |+||+||+|+|++++++|.+.|+||+....... .... ...+..|.+||.... .++.+
T Consensus 164 ~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---------~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~ 230 (288)
T PF14531_consen 164 Y---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---------RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFA 230 (288)
T ss_dssp T---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE---------EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred c---ceEecccceeeEEEcCCCCEEEcChHHHeecCc---------eeec-cCCCcccCChhhhhhhcccCcccceeeec
Confidence 8 999999999999999999999999988775411 1111 334577999998421 26889
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCC
Q 005045 587 GDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 587 sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.|.|++|+++|.|.+|..||+...
T Consensus 231 ~DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 231 TDAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHHHHHHHHHHHSS-STCCCG
T ss_pred cCHHHHHHHHHHHHHccCCCCCCC
Confidence 999999999999999999998653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.3e-19 Score=183.40 Aligned_cols=185 Identities=28% Similarity=0.351 Sum_probs=153.5
Q ss_pred cCcccccceEEEE----eCCCchhhhHHhHhhhh--hHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEEEEE
Q 005045 397 IGTGSFGSVYKGT----LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 397 ig~g~~g~v~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
+|+|.+|.|+++. ...|+-+|+|+...... +.+.....|..++..++ ||.++++... ++.+...++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHhh
Confidence 6899999999876 23678899998875421 11225567888888886 9999998877 55667899999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
++..||.+...+... ..+++.........++-|++++|+. +++|||+|++||+++.+|++++.|||.++.
T Consensus 77 d~~rgg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhcccchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 999998887777654 5678888888889999999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.... ...+||..|||||++. ....++|+||||++++||+||..||..
T Consensus 147 ~v~~-----------~~~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKE-----------KIACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhh-----------hhcccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 6211 1116899999999988 567899999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-18 Score=176.17 Aligned_cols=218 Identities=24% Similarity=0.322 Sum_probs=159.9
Q ss_pred HhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 439 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
|+++.|.|+.++++.+... ...++|.+||..|+|.|.+.... ..+++.-...++++|+.||+|+|...
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~s~- 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHNSP- 68 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhcCc-
Confidence 3578999999999997543 58899999999999999998643 56888889999999999999999972
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--------CCcccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--------VSILGDIY 590 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~sDvw 590 (717)
..+|+.++++|.+++....+|++|||+...... ..............-|.|||.+++. .+.++|||
T Consensus 69 -i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~-----~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiY 142 (484)
T KOG1023|consen 69 -IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEE-----TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIY 142 (484)
T ss_pred -ceeeeeeccccceeeeeEEEEechhhhcccccc-----cccccccchhHHHHhccCHHHhcccccccccccccccCCee
Confidence 339999999999999999999999999877532 1111111222355678999997653 46789999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhh
Q 005045 591 SYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKL 670 (717)
Q Consensus 591 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (717)
|||++++|+++.+.||+........ .+.+.. +.+...+.. .+... ..
T Consensus 143 s~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~-----~~~~~~~~~------------------------rP~i~---~~ 189 (484)
T KOG1023|consen 143 SFGIIMYEILFRSGPFDLRNLVEDP-DEIILR-----VKKGGSNPF------------------------RPSIE---LL 189 (484)
T ss_pred hHHHHHHHHHhccCccccccccCCh-HHHHHH-----HHhcCCCCc------------------------Ccchh---hh
Confidence 9999999999999999875332221 111110 111000000 00000 11
Q ss_pred HHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 671 EECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 671 ~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.+.+..+..++.+||..+|++||+++.|-..++.+..
T Consensus 190 ~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 190 NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 1335578899999999999999999999998887765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=153.21 Aligned_cols=139 Identities=19% Similarity=0.258 Sum_probs=104.6
Q ss_pred cccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-----CCCceeEEEEeeccccCCCCce
Q 005045 391 FSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-----RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
+.-.+.||+|+++.||. ++ ++.. +||+.........+.+.+|+++++++ .||||+++++++.... ..+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence 34467899999999995 44 4444 68887765444557789999999999 5799999999864421 1123
Q ss_pred -EEEEEec--CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCEEeCC----C
Q 005045 465 -KALVFEF--MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL-DYLHHHCDTPIAHCDLKPSNVLLDK----D 536 (717)
Q Consensus 465 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~NIll~~----~ 536 (717)
..+|+|| +++++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+||+++. +
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCC
Confidence 4488999 5579999999643 24444 35678888777 999998 9999999999999974 3
Q ss_pred CceEEeeeccc
Q 005045 537 MTAHVGDFGLA 547 (717)
Q Consensus 537 ~~~kl~Dfg~~ 547 (717)
+.++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 38999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.2e-17 Score=157.91 Aligned_cols=144 Identities=19% Similarity=0.136 Sum_probs=112.3
Q ss_pred cccccccccccCcccccceEEEE--eCCCchhhhHHhHhhhh------------------------hHHHHHHHHHHHHh
Q 005045 387 STDNFSKENLIGTGSFGSVYKGT--LGDGTIVAIKVLKLQQQ------------------------GALKSFIDECNALK 440 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~ 440 (717)
...-|.+.+.||+|++|.||.|. ..+|+.||+|++..... .....+..|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34468899999999999999998 45899999998864321 01234678999999
Q ss_pred cCCC--CceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 441 STRH--RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 441 ~l~h--~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
++.+ ..++++++. ...++||||++|.++..+.... .......+..++.||+.++.+||+.
T Consensus 106 ~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~-- 167 (237)
T smart00090 106 RLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLYKE-- 167 (237)
T ss_pred HHHhcCCCCCeeeEe---------cCceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHHhc--
Confidence 9965 334444443 1248999999988887655322 2345566789999999999999998
Q ss_pred CC-eeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 519 TP-IAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 519 ~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
+ ++||||||+||+++ ++.++|+|||.+...
T Consensus 168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 8 99999999999999 889999999988754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.3e-17 Score=167.37 Aligned_cols=128 Identities=27% Similarity=0.466 Sum_probs=105.9
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...||.|++|...+|.+|+.+.+. ...-++.....++.|++.|++| . +.+|+|+||.||+...+.++||.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~----~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT----GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc----ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhh
Confidence 358899999999999999975542 2556888899999999999999 3 89999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~ellt 601 (717)
|||+........ .............||..||+||.+.|+ |+.++||||||++++|++.
T Consensus 399 DFgl~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhheeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999987653222 111122333456799999999999875 9999999999999999996
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=174.99 Aligned_cols=176 Identities=28% Similarity=0.362 Sum_probs=124.7
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.-.....+|..++.|..|++|.||.++++ +.+++|+|+ +.+.. +++ ||..+.+.
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilR-----nilt~a~n-------- 131 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILR-----NILTFAGN-------- 131 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhh-----ccccccCC--------
Confidence 44556789999999999999999999977 678898843 32110 111 23333222
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.++| |+-...++.- +.++.. ++.+++|+|+- ||||||+||+|.+|+.-|++|+
T Consensus 132 ---pfvv------gDc~tllk~~-------g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKl 184 (1205)
T KOG0606|consen 132 ---PFVV------GDCATLLKNI-------GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKL 184 (1205)
T ss_pred ---ccee------chhhhhcccC-------CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccc
Confidence 2233 3333333322 233332 37899999997 9999999999999999999999
Q ss_pred eeeccchhcccccCC--------CCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDN--------PSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+|||+++........ ........+...||+.|.|||++ ...|+..+|+|++|+++||.+.|.+||.+..
T Consensus 185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 999998765321111 11112333456799999999995 5569999999999999999999999997653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-15 Score=146.90 Aligned_cols=136 Identities=24% Similarity=0.196 Sum_probs=107.0
Q ss_pred ccccccccCcccccceEEEEeCCCchhhhHHhHhhhh----------------------hHHHHHHHHHHHHhcCCCCc-
Q 005045 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ----------------------GALKSFIDECNALKSTRHRN- 446 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~n- 446 (717)
-|.+.+.||+|++|.||.|..++|+.||+|++..... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4888999999999999999988899999997543210 11224677888999887774
Q ss_pred -eeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 447 -ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 447 -i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
++..++. ...++||||++|+++.+.... .....++.+++.++.++|+. +++|||
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 4444332 245899999999988765421 23457889999999999997 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhc
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+|+||+++.++.++|+|||.+...
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=148.35 Aligned_cols=134 Identities=22% Similarity=0.311 Sum_probs=107.4
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+.||+|++|.||.|.+ .|..+++|+..... .....++.+|++++..+.|+++.....++. .....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCCE
Confidence 5789999999999987 67788888754321 112356788999999998888765544432 223578
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++|||++|++|.+++... .. .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.
T Consensus 76 lv~e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 999999999999988633 11 7789999999999999998 999999999999999 78999999998
Q ss_pred chh
Q 005045 547 AKF 549 (717)
Q Consensus 547 ~~~ 549 (717)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 763
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-16 Score=162.52 Aligned_cols=180 Identities=26% Similarity=0.426 Sum_probs=145.1
Q ss_pred CCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhcc
Q 005045 178 ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 257 (717)
+.--...||+.|++. .+|..++.+-.|..+.|..|.+..++ ..+.++..|..|+|+.|++. .+|..++.+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip-------~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l- 143 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIP-------EAICNLEALTFLDLSSNQLS-HLPDGLCDL- 143 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecc-------hhhhhhhHHHHhhhccchhh-cCChhhhcC-
Confidence 344455677777777 77777777777777788888777763 56777788888888888888 888888887
Q ss_pred ccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeec
Q 005045 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWM 337 (717)
Q Consensus 258 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 337 (717)
-|+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|.+... |+.++.| .|..||+
T Consensus 144 -pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l-p~El~~L-pLi~lDf 218 (722)
T KOG0532|consen 144 -PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL-PEELCSL-PLIRLDF 218 (722)
T ss_pred -cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC-CHHHhCC-ceeeeec
Confidence 4888888888887 67888888888999999999988 7888889999999999999998854 6667765 4888999
Q ss_pred ccccccccCCcCccCcCCCceEEeecccCCCCCCccc
Q 005045 338 EENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 338 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
+.|+++ .+|..|.+|+.|++|-|.+|||+ +.|+.+
T Consensus 219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred ccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 999998 89999999999999999999998 556654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.2e-15 Score=141.65 Aligned_cols=130 Identities=23% Similarity=0.327 Sum_probs=101.0
Q ss_pred ccCcccccceEEEEeCCCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 396 LIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 396 ~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
.||+|++|.||+|.+ .|+.+++|...... .....++.+|++++..+.|+++......+. .....++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCEE
Confidence 479999999999985 57788998854321 112466788999999998776433332221 1235689
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
||||++|++|.+++.... . .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+
T Consensus 75 v~e~~~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEECCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 999999999998875321 1 7899999999999997 999999999999999 889999999987
Q ss_pred hh
Q 005045 548 KF 549 (717)
Q Consensus 548 ~~ 549 (717)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.7e-16 Score=160.46 Aligned_cols=213 Identities=29% Similarity=0.434 Sum_probs=168.3
Q ss_pred EEEccCccccccCCccc--cCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 62 IIGLGGSNLTGNVPAWI--GNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 62 ~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
.|.|++-++. ..|..- ..+.--...||+.|+.. .+|..++.+..|+.|.|++|.|. .+|..++++..|++|||+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 4566666666 344321 34555678899999998 88988999999999999999998 7888999999999999999
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcc
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSRE 219 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 219 (717)
|+++ .+|..++ .+ -|+.|-+++|+++ .+|..++.++.|..|+.+.|.+..+
T Consensus 131 NqlS-~lp~~lC-------------------------~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~sl- 181 (722)
T KOG0532|consen 131 NQLS-HLPDGLC-------------------------DL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSL- 181 (722)
T ss_pred chhh-cCChhhh-------------------------cC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhc-
Confidence 9998 6666554 22 2777888888888 6777777778888888888888776
Q ss_pred cCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccc
Q 005045 220 IGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299 (717)
Q Consensus 220 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 299 (717)
+..+.++.+|+.|.+..|++. .+|..+..+ .|..||+|.|++. .+|..|.+|..|++|-|.+|.++ ..|
T Consensus 182 ------psql~~l~slr~l~vrRn~l~-~lp~El~~L--pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPP 250 (722)
T KOG0532|consen 182 ------PSQLGYLTSLRDLNVRRNHLE-DLPEELCSL--PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPP 250 (722)
T ss_pred ------hHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC--ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CCh
Confidence 456788888888888888888 888888876 6999999999998 78999999999999999999998 777
Q ss_pred hhhhcCCC---CCeEEcccCc
Q 005045 300 EVIGRLNK---LEGLGLNVNK 317 (717)
Q Consensus 300 ~~~~~l~~---L~~L~Ls~N~ 317 (717)
..++-.-+ -++|+..-++
T Consensus 251 AqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 251 AQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HHHHhccceeeeeeecchhcc
Confidence 76664333 3566666664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-14 Score=160.79 Aligned_cols=140 Identities=22% Similarity=0.283 Sum_probs=108.5
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHh--------hhhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKL--------QQQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
......|...+.||+|+||.||+|.+... .+++|+... .......++.+|+++++.++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445567789999999999999986533 333332211 111234678899999999999998876655432
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
....++||||++|++|.+++. ....++.+++.++.+||+. +++||||||+||++ .+
T Consensus 408 -----~~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~ 463 (535)
T PRK09605 408 -----PEEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RD 463 (535)
T ss_pred -----CCCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-EC
Confidence 235689999999999988774 2467899999999999998 99999999999999 67
Q ss_pred CceEEeeeccchh
Q 005045 537 MTAHVGDFGLAKF 549 (717)
Q Consensus 537 ~~~kl~Dfg~~~~ 549 (717)
+.++|+|||.++.
T Consensus 464 ~~~~liDFGla~~ 476 (535)
T PRK09605 464 DRLYLIDFGLGKY 476 (535)
T ss_pred CcEEEEeCccccc
Confidence 8999999999874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-14 Score=153.43 Aligned_cols=200 Identities=29% Similarity=0.448 Sum_probs=135.0
Q ss_pred EEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCC-CCCEEeccCCcCcccCChhhhccCCCCeEeccCC
Q 005045 38 SFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFS-SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN 116 (717)
Q Consensus 38 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 116 (717)
.++++.|.+. .....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5677777664 23333555677777778777777 5666566664 7778888888777 55566777777888888888
Q ss_pred CCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCC
Q 005045 117 FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP 196 (717)
Q Consensus 117 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 196 (717)
++. ..|...+.++.|+.|++++|+++ .+|.... .+..|+.|.+++|.+. ..+..+..+.++..|.+.+|++. ..+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 777 45555557777777788888777 6666541 3445777777777433 35556777777777777777776 445
Q ss_pred CCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhh
Q 005045 197 GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 197 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
..+..+++++.|++++|.++.++ . +..+.+|+.|++++|.+....|...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~------~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSIS------S--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceeccccccccccc------c--ccccCccCEEeccCccccccchhhh
Confidence 66667777777777777777764 2 6666777777777777774444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-14 Score=154.19 Aligned_cols=193 Identities=34% Similarity=0.473 Sum_probs=93.4
Q ss_pred EEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCC-CccEEEcccCcccccCCcccccCCCCcceeeccc
Q 005045 86 ALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNIS-SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAV 164 (717)
Q Consensus 86 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~ 164 (717)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+. .+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~-~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR-NLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhh-ccccccccccCC
Confidence 5667777664 33444555566777777777777 4444455553 6777777777776 4442222 344444444444
Q ss_pred ccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCc
Q 005045 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244 (717)
Q Consensus 165 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 244 (717)
|++. .+|.....++.|+.|++++|+++ .+|........|++|.+++|.+... +..+.++.++..|.+.+|+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~-------~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL-------LSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceec-------chhhhhcccccccccCCce
Confidence 4444 22222224455555555555555 4444333334455555555532221 2234444444444455554
Q ss_pred ccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCc
Q 005045 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS 295 (717)
Q Consensus 245 l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 295 (717)
+. .++..+..+ .+++.|++++|.++.... +..+.+|+.|++++|.+.
T Consensus 244 ~~-~~~~~~~~l-~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 244 LE-DLPESIGNL-SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred ee-eccchhccc-cccceecccccccccccc--ccccCccCEEeccCcccc
Confidence 44 223333333 234444444444442221 444444444444444444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-15 Score=166.52 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=186.0
Q ss_pred cccccccccccCcccccceEEEEeC--CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG--DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTR-HRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 461 (717)
+...|.+.+.+|+|+++.|-.+... ....+|+|.+.... .....+...|..+-+.+. |+|++.+++. ..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~ 92 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSS 92 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCC
Confidence 5678899999999999998887743 33445556555432 223445556777777776 9999999998 455
Q ss_pred CceEEEEEecCCCCChhhhc-cCCCCCcccccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCEEeCCCC-c
Q 005045 462 NDFKALVFEFMSNGNLDQWL-HPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDM-T 538 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~-~ 538 (717)
....++++++..|+++.+.+ .... ...+...+...+.|+..++.|+| .. +++|+||||+|.+++..+ .
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~ 163 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSA 163 (601)
T ss_pred CcccccccCcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCc
Confidence 56899999999999998887 4321 24566677889999999999999 65 999999999999999999 9
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccc-cccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKG-SIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+++|||.|..+... ...........| ++.|+|||...++ ..+..|+||.|+++.-+++|..|+.........
T Consensus 164 l~~~df~~At~~~~~----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~ 239 (601)
T KOG0590|consen 164 LKIADFGLATAYRNK----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR 239 (601)
T ss_pred ccCCCchhhcccccc----CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence 999999999876321 122223334556 9999999997663 578999999999999999999999877655543
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
...|...... ........ -......++.+++..+|+.|.+.
T Consensus 240 ~~~~~~~~~~--~~~~~~~~-------------------------------------~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 240 YSSWKSNKGR--FTQLPWNS-------------------------------------ISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred ceeecccccc--cccCcccc-------------------------------------CChhhhhcccccccCCchhcccc
Confidence 3333322100 00000000 02234567888888899999988
Q ss_pred HHHH
Q 005045 696 NVVV 699 (717)
Q Consensus 696 ~eil 699 (717)
+++-
T Consensus 281 ~~~~ 284 (601)
T KOG0590|consen 281 EELK 284 (601)
T ss_pred cccc
Confidence 7764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-14 Score=137.44 Aligned_cols=135 Identities=24% Similarity=0.266 Sum_probs=97.1
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhh--HHH----------------------HHHHHHHHHhcCCCCc--e
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQG--ALK----------------------SFIDECNALKSTRHRN--I 447 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~----------------------~~~~e~~~l~~l~h~n--i 447 (717)
.+.||+|++|.||.|...+++.||+|++...... ... ....|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999987643211 001 1135666666654332 4
Q ss_pred eEEEEeeccccCCCCceEEEEEecCCCCChhhh-ccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecC
Q 005045 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQW-LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCD 525 (717)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~d 525 (717)
.+.++. ...++||||++++++... +... ... ..+..++.+++.++.++|. . +++|||
T Consensus 82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CceEec---------CCCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 444433 135899999998554321 1111 001 5678899999999999999 6 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhc
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|||+||+++ ++.++++|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-13 Score=125.26 Aligned_cols=135 Identities=22% Similarity=0.269 Sum_probs=109.1
Q ss_pred cccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC--CceeEEEEeeccccCCCCceEEEEEe
Q 005045 393 KENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH--RNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
+.+.+++|.++.||.+.... +.+++|....... ...+..|+.+++.+.+ ..+++++... ...+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEE
Confidence 45789999999999999754 6788998765432 4578889999999966 5888887773 33457899999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
|++++.+..+ +......++.+++++++++|....++++|||++|+||+++..+.++++|||.+..
T Consensus 74 ~~~g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9987766433 3455677899999999999996444799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.3e-13 Score=134.19 Aligned_cols=138 Identities=17% Similarity=0.159 Sum_probs=100.9
Q ss_pred cccC-cccccceEEEEeCCCchhhhHHhHh----------h---hhhHHHHHHHHHHHHhcCCCCce--eEEEEeecccc
Q 005045 395 NLIG-TGSFGSVYKGTLGDGTIVAIKVLKL----------Q---QQGALKSFIDECNALKSTRHRNI--LRVITACSSVD 458 (717)
Q Consensus 395 ~~ig-~g~~g~v~~~~~~~~~~vavK~~~~----------~---~~~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~~ 458 (717)
..+| .||.|+||.+... ++.+++|.+.. . ......++.+|++++.++.|++| +..++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 8889999998874 55667665531 1 11234678899999999988775 55665532211
Q ss_pred CCCCceEEEEEecCCC-CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 459 LEGNDFKALVFEFMSN-GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
......++|||+++| .+|.+++... .++.. .+.+|+.++++||+. ||+||||||.||+++.++
T Consensus 116 -~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 116 -GLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred -CcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 111234699999997 6898887542 23433 367899999999998 999999999999999989
Q ss_pred ceEEeeeccchh
Q 005045 538 TAHVGDFGLAKF 549 (717)
Q Consensus 538 ~~kl~Dfg~~~~ 549 (717)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998775
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.5e-12 Score=136.35 Aligned_cols=167 Identities=22% Similarity=0.250 Sum_probs=121.1
Q ss_pred CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccc
Q 005045 412 DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF 491 (717)
Q Consensus 412 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 491 (717)
++.+|.|..++....+......+.++.++.++||+|+++++. .+..+..|+|+|-+ ..|..++..
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV--~Pl~~~lk~-------- 100 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERV--RPLETVLKE-------- 100 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeecc--ccHHHHHHH--------
Confidence 555555555544333334556677888999999999999998 55666999999998 478777753
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccc
Q 005045 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571 (717)
Q Consensus 492 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (717)
.+...+...+.||+.||.+||..+ +++|++|+.+.|+|+..|+.||++|..+........ ......--.
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~ 169 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIE 169 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhh
Confidence 335566778899999999999763 999999999999999999999999998875421110 111122333
Q ss_pred cccCCCccCCCCCcccchhhHHHHHHHHHhCCCC
Q 005045 572 GYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605 (717)
Q Consensus 572 ~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p 605 (717)
.|..|+.+... +-..|.|.|||++||++.|..+
T Consensus 170 s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 170 SFDDPEEIDPS-EWSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred cccChhhcCcc-ccchhhhhHHHHHHHHhCcccC
Confidence 45666654221 1346999999999999999433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-13 Score=131.38 Aligned_cols=133 Identities=29% Similarity=0.349 Sum_probs=113.9
Q ss_pred ccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCC
Q 005045 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE 309 (717)
Q Consensus 230 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 309 (717)
..+..|++||||+|.|+ .+.++..-. +.++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+.++-.++-+.+
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~-Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLA-PKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhc-cceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 34578999999999999 888887776 5999999999999843 34899999999999999999 6777888899999
Q ss_pred eEEcccCcCCCCCCcccccccccceeeccccccccc-CCcCccCcCCCceEEeecccCCCC
Q 005045 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGS-IPPSLGNCQKLLVLNLSSNDLNGT 369 (717)
Q Consensus 310 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ 369 (717)
+|.|++|.+... ..++.+-+|..||+++|+|... -...++++|-|..+.|.+||+.+.
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999999999755 4577888999999999999732 235789999999999999999853
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-13 Score=137.44 Aligned_cols=214 Identities=23% Similarity=0.230 Sum_probs=131.5
Q ss_pred CCCCCCCEEEccCccccccCC--ccccCCCCCCEEeccCCcCcccCC--hhhhccCCCCeEeccCCCCCCCCCc-cccCC
Q 005045 55 SSLTKLEIIGLGGSNLTGNVP--AWIGNFSSLKALSLAWNNLRGSIP--NELGQLSGLGFFTLYGNFISGIIPS-SIYNI 129 (717)
Q Consensus 55 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l 129 (717)
+++.+|+...|.++.+. ..+ .....+++++.||||+|-+..-.+ .....|++|+.|+|+.|++...... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 56777888888888777 444 356778888888888887763322 2345688888888888887622222 22356
Q ss_pred CCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCC--CCccCCCCCCe
Q 005045 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP--GNFGSLKDLVR 207 (717)
Q Consensus 130 ~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~ 207 (717)
++|+.|.|+.|.++-.--..+....|+|+.|+|+.|...........-+..|++|||++|++- ..+ ...+.++.|..
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 678888888888862222233346778888888887544344445556677888888887776 333 34566777777
Q ss_pred eeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCC-CCccccCCCCCCE
Q 005045 208 LNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGN-IPVGIGNLVNLNL 286 (717)
Q Consensus 208 L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~ 286 (717)
|+++.+.+.++...+.....-...+++ |++|+++.|+|... ....+..+++|+.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~k-------------------------L~~L~i~~N~I~~w~sl~~l~~l~nlk~ 330 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPK-------------------------LEYLNISENNIRDWRSLNHLRTLENLKH 330 (505)
T ss_pred hhccccCcchhcCCCccchhhhccccc-------------------------ceeeecccCccccccccchhhccchhhh
Confidence 777777777655322111111233444 44555555544311 1122344567777
Q ss_pred EEccCCcCc
Q 005045 287 LGLEGNNLS 295 (717)
Q Consensus 287 L~L~~N~l~ 295 (717)
|.+..|.+.
T Consensus 331 l~~~~n~ln 339 (505)
T KOG3207|consen 331 LRITLNYLN 339 (505)
T ss_pred hhccccccc
Confidence 777777776
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.9e-13 Score=126.91 Aligned_cols=161 Identities=23% Similarity=0.328 Sum_probs=120.0
Q ss_pred HHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 005045 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC 517 (717)
Q Consensus 438 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 517 (717)
.+-++.|.|++++..++.+...++.....++.||+..|++.+++++... ....+....-.+|+.||+.||.|||+ |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~---~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK---NQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH---hhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 3445679999999999888877777788999999999999999986532 22567777888999999999999999 5
Q ss_pred CCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCc-cCCCCCcccchhhHHHHH
Q 005045 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILL 596 (717)
Q Consensus 518 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~sDvwslG~vl 596 (717)
...++|+++.-+.|++..+|-+|++--.-.... .. ...... .......+.++|.+||. -..+.+.++|||+||+..
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-~s-~~~~~~-~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PS-VNSTRE-AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccc-hh-hhhhhH-hhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 678999999999999999998887532111110 00 000000 01112236788999998 444678899999999999
Q ss_pred HHHHhCCCC
Q 005045 597 LEMFTGKRP 605 (717)
Q Consensus 597 ~elltg~~p 605 (717)
.+|-.|..-
T Consensus 273 lemailEiq 281 (458)
T KOG1266|consen 273 LEMAILEIQ 281 (458)
T ss_pred HHHHHheec
Confidence 999887754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=120.67 Aligned_cols=120 Identities=26% Similarity=0.361 Sum_probs=38.3
Q ss_pred cCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCC-CCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCc
Q 005045 17 LTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLS-SLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLR 95 (717)
Q Consensus 17 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 95 (717)
|..+.|. ..+. +.+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..+++|++|+|++|+|+
T Consensus 4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-cccc-cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 3444454 3333 455567888888888888 443 354 5778888888888888 444 4777888888888888888
Q ss_pred ccCChhh-hccCCCCeEeccCCCCCCCC-CccccCCCCccEEEcccCccc
Q 005045 96 GSIPNEL-GQLSGLGFFTLYGNFISGII-PSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 96 ~~~~~~~-~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~ 143 (717)
.+.+.+ ..+++|+.|+|++|+|.... -..+..+++|+.|+|.+|.++
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 444444 46788888888888887432 245667788888888888876
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-13 Score=146.96 Aligned_cols=247 Identities=29% Similarity=0.382 Sum_probs=136.3
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcce
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKI 159 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~ 159 (717)
.+..++.+++..|.|. .+-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|.|+ .+.
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~-~i~------------ 134 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKIT-KLE------------ 134 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccc-ccc------------
Confidence 3445555556666655 2333355555666666666666522 222555555666666666655 222
Q ss_pred eecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhh-hhhccCCCCCEE
Q 005045 160 FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL-KFLANCTSLEVL 238 (717)
Q Consensus 160 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~~~~l~~L~~L 238 (717)
.+..++.|+.|++++|.|+ .+. .+..++.|+.+++++|++..+. . . ...+.+++.+
T Consensus 135 --------------~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie------~~~-~~~~~~l~~l 191 (414)
T KOG0531|consen 135 --------------GLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIE------NDE-LSELISLEEL 191 (414)
T ss_pred --------------chhhccchhhheeccCcch-hcc-CCccchhhhcccCCcchhhhhh------hhh-hhhccchHHH
Confidence 1233333555555555554 222 2333555555555555555443 1 1 2445555666
Q ss_pred EeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCC--CCCEEEccCCcCccccchhhhcCCCCCeEEcccC
Q 005045 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV--NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVN 316 (717)
Q Consensus 239 ~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 316 (717)
++++|.+........ . ..+..+++..|.++...+ +..+. .|+.+++++|++. ..+..+..+.++..|++++|
T Consensus 192 ~l~~n~i~~i~~~~~--~-~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n 265 (414)
T KOG0531|consen 192 DLGGNSIREIEGLDL--L-KKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSN 265 (414)
T ss_pred hccCCchhcccchHH--H-HHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhc
Confidence 666666552211111 1 234444666666653222 22222 3788888888887 44456777888888888888
Q ss_pred cCCCCCCcccccccccceeeccccccccc---CCcC-ccCcCCCceEEeecccCCCCCCc
Q 005045 317 KFSGLIPSSLGNLTILTRLWMEENRLEGS---IPPS-LGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 317 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
++... ..+...+.+..+.+..|.+... .... ....+.+..+.+.+|++....+.
T Consensus 266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 266 RISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred ccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 88755 3355667788888888887621 2222 45677888888888888754443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.2e-14 Score=137.09 Aligned_cols=177 Identities=22% Similarity=0.281 Sum_probs=94.5
Q ss_pred hccCCCCeEeccCCCCCCCCCcc----ccCCCCccEEEcccCcccccCCcc-cccCCCCcceeecccccccccCCccCCC
Q 005045 103 GQLSGLGFFTLYGNFISGIIPSS----IYNISSIYYFSVTQNQLHGQLPTD-VGLTLPNLKIFAGAVNYFTGSIPVSLSN 177 (717)
Q Consensus 103 ~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~L~~N~l~~~l~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 177 (717)
.+.++|++||||+|.+.-..+.. +..+++|++|.|.+|.+. ..... +. ..|..|. .| ...+.
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~---~al~~l~--~~-------kk~~~ 155 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG---RALFELA--VN-------KKAAS 155 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH---HHHHHHH--HH-------hccCC
Confidence 34456666666666665332222 345667777777777765 22111 11 1111111 11 12334
Q ss_pred CCCCCEEeccCccccccC----CCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhh
Q 005045 178 ASNLQVLDFAENGLTGTI----PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
-+.|+.+...+|++.... ...|...+.|+.+.++.|.|..-++. .....|..++.|+.|||..|-++......+
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~--al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVT--ALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhH--HHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 467888888888776322 23456667788888888877765542 224567778888888888888874433332
Q ss_pred ----hhccccccEEecCCCccCCCCCcccc-----CCCCCCEEEccCCcCc
Q 005045 254 ----ANLSTHLRRLTMGENLMHGNIPVGIG-----NLVNLNLLGLEGNNLS 295 (717)
Q Consensus 254 ----~~~~~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~ 295 (717)
..+ ++|+.|++++|.+......+|. ..++|+.|.|.+|.|+
T Consensus 234 akaL~s~-~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 234 AKALSSW-PHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHHhccc-chheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 223 2455555555555433222221 2345555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.7e-13 Score=125.80 Aligned_cols=127 Identities=24% Similarity=0.306 Sum_probs=74.4
Q ss_pred CCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCC
Q 005045 204 DLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVN 283 (717)
Q Consensus 204 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~ 283 (717)
.|++++||+|.|+.++ ....-.|+++.|++|+|.|+ .+.. +..+ .+|+.||||+|.++ ....+-..+-|
T Consensus 285 ~LtelDLS~N~I~~iD-------ESvKL~Pkir~L~lS~N~i~-~v~n-La~L-~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 285 ELTELDLSGNLITQID-------ESVKLAPKLRRLILSQNRIR-TVQN-LAEL-PQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred hhhhccccccchhhhh-------hhhhhccceeEEecccccee-eehh-hhhc-ccceEeecccchhH-hhhhhHhhhcC
Confidence 4444455555444443 23334455555555555554 2221 3333 25555566655555 23334445666
Q ss_pred CCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCC-Ccccccccccceeeccccccc
Q 005045 284 LNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI-PSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 284 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 343 (717)
.+.|.|++|.|. .+ +.+.++-+|..||+++|+|.... -..++++|-|+.|.|.+|.+.
T Consensus 354 IKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 354 IKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred EeeeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 777777777776 22 23566667777888888776542 246788888888888888887
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.4e-13 Score=146.29 Aligned_cols=249 Identities=25% Similarity=0.292 Sum_probs=163.8
Q ss_pred CCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccE
Q 005045 55 SSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 55 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 134 (717)
..+..++.+++..|.|. .+-..+..+.+|+.|++.+|+|+ .+...+..+++|++|+|++|.|+.+ ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 45677778888888888 44455778888999999999998 4444478888999999999999854 34666777888
Q ss_pred EEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCC-CCccCCCCCCeeecccc
Q 005045 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP-GNFGSLKDLVRLNFDQN 213 (717)
Q Consensus 135 L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N 213 (717)
|++++|.|+ .+.. +..++.|+.+++++|.++...+ . ...+.+++.+++.+|
T Consensus 145 L~l~~N~i~-~~~~--------------------------~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n 196 (414)
T KOG0531|consen 145 LNLSGNLIS-DISG--------------------------LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGN 196 (414)
T ss_pred heeccCcch-hccC--------------------------CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCC
Confidence 888888887 3332 2234555555556655553322 1 355566666666666
Q ss_pred ccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCc
Q 005045 214 ELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293 (717)
Q Consensus 214 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 293 (717)
.+..+. .+..+..+..+++..|.++..-+...... ..|+.+++++|.+. ..+..+..+.++..|++.+|+
T Consensus 197 ~i~~i~--------~~~~~~~l~~~~l~~n~i~~~~~l~~~~~-~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~ 266 (414)
T KOG0531|consen 197 SIREIE--------GLDLLKKLVLLSLLDNKISKLEGLNELVM-LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNR 266 (414)
T ss_pred chhccc--------chHHHHHHHHhhcccccceeccCcccchh-HHHHHHhcccCccc-cccccccccccccccchhhcc
Confidence 665543 23334444555667777662222111111 03778888888877 333667778888999999998
Q ss_pred CccccchhhhcCCCCCeEEcccCcCCCC---CCcc-cccccccceeecccccccccCC
Q 005045 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGL---IPSS-LGNLTILTRLWMEENRLEGSIP 347 (717)
Q Consensus 294 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~L~~N~l~~~~p 347 (717)
+.... .+.....+..+.++.|++... .... ....+.++.+.+.+|.+....+
T Consensus 267 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 267 ISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 87322 255667777788888887632 1221 4566888899999998875444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=135.56 Aligned_cols=141 Identities=23% Similarity=0.253 Sum_probs=98.7
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhH----------------------------------H------HHHH
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA----------------------------------L------KSFI 433 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~----------------------------------~------~~~~ 433 (717)
.+.+|.|+.|.||+|+.++|+.||||+..+.-.+. . -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999874321000 0 1244
Q ss_pred HHHHHHhcC----CCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHH-
Q 005045 434 DECNALKST----RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS- 508 (717)
Q Consensus 434 ~e~~~l~~l----~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~- 508 (717)
.|++.+.++ .|.+-+.+...+.+ ..+..++||||++|+++.++..... ... ...+++.+++.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~------~~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDE------AGL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHh------cCC---CHHHHHHHHHHH
Confidence 566655555 23333444444322 1234689999999999988764221 111 23456666666
Q ss_pred HHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 509 ~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
.+..+|.. |++|+|++|.||+++.+|.++++|||++..+
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 46788887 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.6e-12 Score=114.70 Aligned_cols=127 Identities=26% Similarity=0.356 Sum_probs=44.8
Q ss_pred CCCCCCCCEEeccCccccccCCCCcc-CCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhh
Q 005045 175 LSNASNLQVLDFAENGLTGTIPGNFG-SLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 175 ~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
+.+..++++|+|++|.|+ .+. .++ .+.+|+.|++++|.|+.++ .+..+++|++|++++|+|+ .++..+
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--------~l~~L~~L~~L~L~~N~I~-~i~~~l 83 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLE--------GLPGLPRLKTLDLSNNRIS-SISEGL 83 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--------T----TT--EEE--SS----S-CHHH
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcccc--------CccChhhhhhcccCCCCCC-ccccch
Confidence 444556777888888777 343 344 5677778888888777754 4666788888888888888 555444
Q ss_pred hhccccccEEecCCCccCCCC-CccccCCCCCCEEEccCCcCccccch----hhhcCCCCCeEEc
Q 005045 254 ANLSTHLRRLTMGENLMHGNI-PVGIGNLVNLNLLGLEGNNLSGSVPE----VIGRLNKLEGLGL 313 (717)
Q Consensus 254 ~~~~~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L 313 (717)
....++|++|++++|+|.... -..+..+++|+.|+|.+|+++.. +. .+..+|+|+.||-
T Consensus 84 ~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 84 DKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp HHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred HHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 432247888888888876432 24566778888888888888732 32 3556777777764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-12 Score=133.47 Aligned_cols=203 Identities=28% Similarity=0.319 Sum_probs=155.8
Q ss_pred ccccccccccCc--ccccceEEEEe--C-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccC
Q 005045 388 TDNFSKENLIGT--GSFGSVYKGTL--G-DGTIVAIKVLKLQQ--QGALKSFIDECNALKST-RHRNILRVITACSSVDL 459 (717)
Q Consensus 388 ~~~y~~~~~ig~--g~~g~v~~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 459 (717)
...+.+...+|. |.+|.+|.+.. . ++..+|+|.-+... +....+-.+|+...+.+ .|++.++.... .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~ 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----W 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----c
Confidence 345667788899 99999999885 3 78889988844332 22334445677777777 68999886666 5
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS----ALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
++.+..++-+|.+ +.++.++..... ..++....+....+... |+.++|.. .++|-|++|.||+...
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTS 257 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccc
Confidence 6677899999998 578888876543 34677777778888888 99999998 9999999999999999
Q ss_pred C-CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 536 D-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 536 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
+ ...+++|||....+....-. ..........+..-|++||..++-++.++|+||+|.++.+..+|..+..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~--~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFS--SVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ccceeecCCcceeEEccCCccc--cceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence 9 89999999998776322211 1122223346788899999999999999999999999999999887753
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.1e-13 Score=130.93 Aligned_cols=109 Identities=17% Similarity=0.224 Sum_probs=77.2
Q ss_pred cccEEecCCCccCCC----CCccccCCCCCCEEEccCCcCccc----cchhhhcCCCCCeEEcccCcCCCCCCcccc---
Q 005045 259 HLRRLTMGENLMHGN----IPVGIGNLVNLNLLGLEGNNLSGS----VPEVIGRLNKLEGLGLNVNKFSGLIPSSLG--- 327 (717)
Q Consensus 259 ~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--- 327 (717)
.|+.+.++.|.|... ....|..+++|+.|||..|-++.. +...++.|+.|+.|++++|.+......+|.
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 455555555544321 234577788888888888887642 344667788899999999988876555543
Q ss_pred --cccccceeeccccccccc----CCcCccCcCCCceEEeecccCC
Q 005045 328 --NLTILTRLWMEENRLEGS----IPPSLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 328 --~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 367 (717)
..++|+.|.|.+|.++.. +...+...+.|..|+|++|.+.
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 357899999999998732 3334556889999999999994
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-12 Score=130.47 Aligned_cols=208 Identities=21% Similarity=0.238 Sum_probs=114.8
Q ss_pred cCCCCccEEEcccCcccccCCc-ccccCCCCcceeecccccccccCC--ccCCCCCCCCEEeccCccccccCCCCc-cCC
Q 005045 127 YNISSIYYFSVTQNQLHGQLPT-DVGLTLPNLKIFAGAVNYFTGSIP--VSLSNASNLQVLDFAENGLTGTIPGNF-GSL 202 (717)
Q Consensus 127 ~~l~~L~~L~L~~N~l~~~l~~-~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l 202 (717)
.++.+|+.+.|.+..+. ..+. .....+++++.|+|+.|-+....+ .-...+++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35667777778777775 3332 333456666666666666653322 223456666666666666652222111 134
Q ss_pred CCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCC
Q 005045 203 KDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV 282 (717)
Q Consensus 203 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~ 282 (717)
+.|+.|.|+.|.++..++ ...+..+| +|+.|+|..|....+......-+.
T Consensus 197 ~~lK~L~l~~CGls~k~V-----~~~~~~fP-------------------------sl~~L~L~~N~~~~~~~~~~~i~~ 246 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDV-----QWILLTFP-------------------------SLEVLYLEANEIILIKATSTKILQ 246 (505)
T ss_pred hhhheEEeccCCCCHHHH-----HHHHHhCC-------------------------cHHHhhhhcccccceecchhhhhh
Confidence 445555555555543221 12233344 444455544432212222333445
Q ss_pred CCCEEEccCCcCccccc--hhhhcCCCCCeEEcccCcCCCCCCccc------ccccccceeecccccccccCC--cCccC
Q 005045 283 NLNLLGLEGNNLSGSVP--EVIGRLNKLEGLGLNVNKFSGLIPSSL------GNLTILTRLWMEENRLEGSIP--PSLGN 352 (717)
Q Consensus 283 ~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~~~~p--~~~~~ 352 (717)
.|+.|||++|++. ..+ ...+.++.|+.|+++.|.+.++.-... ..+++|++|+++.|++. ..+ ..+..
T Consensus 247 ~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~ 324 (505)
T KOG3207|consen 247 TLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRT 324 (505)
T ss_pred HHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhc
Confidence 5666666666665 233 235566677777777777665432222 34578888888888886 222 34566
Q ss_pred cCCCceEEeecccCC
Q 005045 353 CQKLLVLNLSSNDLN 367 (717)
Q Consensus 353 l~~L~~L~l~~N~l~ 367 (717)
+++|+.|.+..|+|+
T Consensus 325 l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 325 LENLKHLRITLNYLN 339 (505)
T ss_pred cchhhhhhccccccc
Confidence 778888888888886
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.3e-10 Score=111.53 Aligned_cols=275 Identities=14% Similarity=0.123 Sum_probs=165.5
Q ss_pred cccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEe-eccc-cCCCCceEEEEE
Q 005045 393 KENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITA-CSSV-DLEGNDFKALVF 469 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~-~~~~-~~~~~~~~~lv~ 469 (717)
..+.+|+|+.+.+|-.- .-+..+.|++........... +..|... .||-+..-+.+ .... .-.......++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999988643 122245577765543332222 2222333 55543331111 0000 012233477899
Q ss_pred ecCCCC-ChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 470 EFMSNG-NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 470 e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
+.+++. .+.++..... .........|.-.+..++.++.+.+.||.. |++-||++++|+||++++.|.|.|-..-.
T Consensus 90 P~v~g~~pI~~~y~p~t-RRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPAT-RRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchh-hcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 988765 3333333211 111235678999999999999999999998 99999999999999999999998854322
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccC-C-----CCCcccchhhHHHHHHHHHhC-CCCCCCCCC---Cchhhh-
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-G-----QVSILGDIYSYGILLLEMFTG-KRPTGDMFK---DDFSIH- 617 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-----~~~~~sDvwslG~vl~elltg-~~p~~~~~~---~~~~~~- 617 (717)
.. ..........|...|.+||.-+ + .-+...|.|.||+++++++.| .+||.+... ......
T Consensus 166 i~--------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 IN--------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ec--------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 21 1122233466889999999844 2 247889999999999999995 999988632 111111
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC--cCCCCCH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS--PRERIAM 695 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~--p~~Rps~ 695 (717)
......+...-.. .+.+...+ ..+...--+..+.-++.+|+... +.-|||+
T Consensus 238 ~Ia~g~f~ya~~~--~~g~~p~P-------------------------~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 238 DIAHGRFAYASDQ--RRGLKPPP-------------------------RSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred hhhcceeeechhc--cCCCCCCC-------------------------CCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 1222222111000 00000000 00011112444566777887753 4579999
Q ss_pred HHHHHHHHHHHHHHHh
Q 005045 696 NVVVNNLKTIRNCFLE 711 (717)
Q Consensus 696 ~eil~~l~~i~~~~~~ 711 (717)
+.++..|..+++++.+
T Consensus 291 ~aW~aAl~al~~~L~~ 306 (637)
T COG4248 291 KAWVAALDALRQQLKK 306 (637)
T ss_pred HHHHHHHHHHHHhhhh
Confidence 9999999999988765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-11 Score=140.97 Aligned_cols=134 Identities=21% Similarity=0.320 Sum_probs=92.9
Q ss_pred eeCCcc---eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCc--ccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 5 MIPEHL---MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVND--FVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 5 ~~p~~~---~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.+|+.. ..+...+-+|.+. .++.+.. ++.|++|-+..|. +.....+.|..++.|++|||++|.=.+.+|..++
T Consensus 515 ~~~~~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~ 592 (889)
T KOG4658|consen 515 EIPQVKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG 592 (889)
T ss_pred ccccccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence 345444 4477777777776 4444433 3468787777775 4433334467788888888887764447888888
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCc
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 141 (717)
+|-+|++|+|++..|+ .+|..+.+|+.|.+||+..+.-....|.....|++|++|.+-.-.
T Consensus 593 ~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 593 ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 8888888888888887 777788888888888888777655556667777888887776544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.9e-11 Score=134.98 Aligned_cols=112 Identities=35% Similarity=0.566 Sum_probs=91.1
Q ss_pred ccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccc
Q 005045 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE 339 (717)
Q Consensus 260 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 339 (717)
+..|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67788888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccccCCcCccCc-CCCceEEeecccCCCCCC
Q 005045 340 NRLEGSIPPSLGNC-QKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 340 N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p 371 (717)
|++++.+|..+..+ .++..+++.+|+..+.+|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 88888888877653 466778888887654444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.1e-11 Score=134.03 Aligned_cols=109 Identities=34% Similarity=0.572 Sum_probs=97.2
Q ss_pred CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEecc
Q 005045 35 ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 114 (717)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999998999889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccCC-CCccEEEcccCccc
Q 005045 115 GNFISGIIPSSIYNI-SSIYYFSVTQNQLH 143 (717)
Q Consensus 115 ~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~ 143 (717)
+|++++.+|..+..+ .++..+++++|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999888764 46778899998765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-10 Score=108.30 Aligned_cols=136 Identities=24% Similarity=0.192 Sum_probs=96.8
Q ss_pred ccccCcccccceEEEEeCC-------CchhhhHHhHhh-------------h---------hhHH----HHHHHHHHHHh
Q 005045 394 ENLIGTGSFGSVYKGTLGD-------GTIVAIKVLKLQ-------------Q---------QGAL----KSFIDECNALK 440 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~-------~~~vavK~~~~~-------------~---------~~~~----~~~~~e~~~l~ 440 (717)
...||.|--+.||.|...+ +..+|+|++... + .... ...++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568899999999998542 478899987421 0 0111 23348999999
Q ss_pred cCC--CCceeEEEEeeccccCCCCceEEEEEecCCCCChhh-hccCCCCCcccccccCHHHHHHHHHHHHHHHHHH-Hhc
Q 005045 441 STR--HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQ-WLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHH 516 (717)
Q Consensus 441 ~l~--h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~ 516 (717)
++. .-++++.++. ...++||||+.+..+.. .++. ..++......++.+++.++..+ |+.
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 983 4566666654 14589999996543321 1211 1234456677889999999999 776
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 517 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
|+||||+++.||++. ++.+.|+|||.+...
T Consensus 145 ---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 ---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ---CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999996 578999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.3e-11 Score=105.11 Aligned_cols=141 Identities=25% Similarity=0.291 Sum_probs=100.9
Q ss_pred cccccCcccccceEEEEeCCCchhhhHHhHhh--------hhhHHHHHHHHHHHHhcCCCCce--eEEEEeeccccCCCC
Q 005045 393 KENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--------QQGALKSFIDECNALKSTRHRNI--LRVITACSSVDLEGN 462 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~~~~~~ 462 (717)
....+-+|+-+.|+.+.+ .|+.++||.-... ..-..++...|++.+.++.--.| ++++.+ +.
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D~ 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------DT 82 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------ec
Confidence 577889999999999988 4777777754322 12235777889999998843332 222222 22
Q ss_pred ceEEEEEecCCC-CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---c
Q 005045 463 DFKALVFEFMSN-GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM---T 538 (717)
Q Consensus 463 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~ 538 (717)
..-+|+|||++| .++.+++..... ..........++++|-+.+.-||.+ +|+||||.++||++..++ .
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence 345799999976 378888765432 1222223367899999999999998 999999999999998666 4
Q ss_pred eEEeeeccchh
Q 005045 539 AHVGDFGLAKF 549 (717)
Q Consensus 539 ~kl~Dfg~~~~ 549 (717)
+.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 58999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.9e-11 Score=128.19 Aligned_cols=147 Identities=20% Similarity=0.192 Sum_probs=96.5
Q ss_pred ccccccccccccCcccccceEEEEeCC-CchhhhHHhHhhhh----------------------------------hHHH
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQ----------------------------------GALK 430 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~-~~~vavK~~~~~~~----------------------------------~~~~ 430 (717)
.....|.. +.+|+|+.|.||.|+.++ |+.||||+..+.-. +..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 33556776 789999999999999876 99999998853210 0011
Q ss_pred ------HHHHHHHHHhcC----CCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhc--cCCCCCcccccccCHHH
Q 005045 431 ------SFIDECNALKST----RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQ 498 (717)
Q Consensus 431 ------~~~~e~~~l~~l----~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~ 498 (717)
.+.+|+..+.++ .+...+.+...+.+ -....++||||++|+.+.++- .... .....+....
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~la~~~ 268 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAG---TDMKLLAERG 268 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcC---CCHHHHHHHH
Confidence 134455555444 24444444444322 124568999999999998742 2111 0112333334
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC----ceEEeeeccchhc
Q 005045 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM----TAHVGDFGLAKFL 550 (717)
Q Consensus 499 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~~~~~ 550 (717)
+..++.|+. .. |++|+|+||.||+++.+| +++++|||++..+
T Consensus 269 v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 269 VEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 444444443 34 999999999999999888 9999999998766
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-10 Score=108.10 Aligned_cols=131 Identities=20% Similarity=0.171 Sum_probs=93.9
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCce-eEEEEeeccccCCCCceEEEEEecC
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI-LRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
++.++.|..+.||.+... ++.+++|+...... ....+..|+++++.+.+.++ ++++... . ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEEEec
Confidence 467889999999999875 77799998764432 12345778888888855443 3444432 1 1347999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC--DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
+|.++.+.- .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~~---------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTED---------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCcccccc---------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 998775430 011245788999999999972 11259999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.6e-10 Score=100.62 Aligned_cols=129 Identities=24% Similarity=0.293 Sum_probs=95.6
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCC--CCceeEEEEeeccccCCCCce
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTR--HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..+++|+-+.+|.+.+. |..+++|.-.+.. .-...+..+|++++.++. .-+.+.++++ +.+.
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPDN 73 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCC
Confidence 35789999999998763 4446666543221 112466778999998874 3444455554 2335
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
..|+|||++|..|.+++... ...++..+-.-+.-||.+ ||+|||+.++||+++.++ +.++||
T Consensus 74 ~~I~me~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 67999999999999888643 245677888888999998 999999999999997654 999999
Q ss_pred ccchh
Q 005045 545 GLAKF 549 (717)
Q Consensus 545 g~~~~ 549 (717)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99874
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=133.65 Aligned_cols=183 Identities=21% Similarity=0.282 Sum_probs=131.0
Q ss_pred CcceecEEEcCCCc--CcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCC
Q 005045 8 EHLMTQDLNLTYNY--LSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLK 85 (717)
Q Consensus 8 ~~~~~~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 85 (717)
....+++|-+.+|. +....++.|..++.|+.|||++|.--+.+|..+++|-+|++|+|++..|+ .+|..+++|..|.
T Consensus 543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 33378999999997 66455556888999999999998777799999999999999999999999 8999999999999
Q ss_pred EEeccCCcCcccCChhhhccCCCCeEeccCCCC--CCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcc----e
Q 005045 86 ALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFI--SGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLK----I 159 (717)
Q Consensus 86 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i--~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~----~ 159 (717)
+|++.++.-...+|..+..+.+|++|.|..-.. ....-..+.+|.+|+.|........ +-... ..+..|. .
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~--~~e~l-~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVL--LLEDL-LGMTRLRSLLQS 698 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhH--hHhhh-hhhHHHHHHhHh
Confidence 999999987667788888899999999976542 2233334455555555555333220 00111 1333333 2
Q ss_pred eecccccccccCCccCCCCCCCCEEeccCccccccC
Q 005045 160 FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTI 195 (717)
Q Consensus 160 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 195 (717)
+.+.++... ..+..+..+.+|+.|.+.++.+....
T Consensus 699 l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~ 733 (889)
T KOG4658|consen 699 LSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIV 733 (889)
T ss_pred hhhcccccc-eeecccccccCcceEEEEcCCCchhh
Confidence 332232222 34556777888888888888776433
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.2e-10 Score=86.64 Aligned_cols=60 Identities=27% Similarity=0.482 Sum_probs=32.6
Q ss_pred CCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcc
Q 005045 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQL 142 (717)
Q Consensus 83 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 142 (717)
+|++|+|++|+|+.+.++.|.++++|++|++++|.++.+.+++|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555555555555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.5e-10 Score=84.86 Aligned_cols=60 Identities=30% Similarity=0.460 Sum_probs=34.5
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCC
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFI 118 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 118 (717)
+|++|++++|+|+...+..|.++++|++|++++|+|+...+++|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455556666655544445555556666666666666555555566666666666665553
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.1e-10 Score=122.64 Aligned_cols=212 Identities=25% Similarity=0.314 Sum_probs=145.9
Q ss_pred ccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
...+.+.+.+.+.+.+|.++.++.+.- .+|...+.|+..... ....+....+-.++....+|.+++.... +
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~ 873 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----F 873 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----C
Confidence 445677888888999999999998873 356555666654332 1112222233333333455666554443 3
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
......+++++|+.++++...++... ..+..-++.....+..+.++||.. .+.|+|++|.++++..+|..
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCc
Confidence 34457899999999999988887653 234444455666788999999996 68999999999999999999
Q ss_pred EEeeeccchhcccc------------------------cCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHH
Q 005045 540 HVGDFGLAKFLFEI------------------------SDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGI 594 (717)
Q Consensus 540 kl~Dfg~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~ 594 (717)
+++|||........ .....+.........+|+.|.+||...| ..+..+|+|+.|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 99999733221100 0000111122334569999999999554 5899999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 005045 595 LLLEMFTGKRPTGDMF 610 (717)
Q Consensus 595 vl~elltg~~p~~~~~ 610 (717)
++++.++|..||....
T Consensus 1024 ~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAET 1039 (1205)
T ss_pred hhhhhhcCCCCCCCcc
Confidence 9999999999997653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.6e-09 Score=101.32 Aligned_cols=138 Identities=22% Similarity=0.153 Sum_probs=101.7
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhh----------------------hhHHHHHHHHHHHHhcCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ----------------------QGALKSFIDECNALKSTRHR 445 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~ 445 (717)
..=+.+..+||.|--|.||.|..++|.++|+|...... .-.+...++|.++|+++...
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 33456778999999999999999999999999753210 11245578899999999544
Q ss_pred --ceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005045 446 --NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523 (717)
Q Consensus 446 --ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 523 (717)
.+++.++. +..++|||+++|..|...-- .......++..|+.-+..+-.. ||||
T Consensus 170 G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~------------~~en~~~il~~il~~~~~~~~~---GiVH 225 (304)
T COG0478 170 GVKVPKPIAW---------NRHAVVMEYIEGVELYRLRL------------DVENPDEILDKILEEVRKAYRR---GIVH 225 (304)
T ss_pred CCCCCCcccc---------ccceeeeehcccceeecccC------------cccCHHHHHHHHHHHHHHHHHc---Cccc
Confidence 67776665 35689999998866654321 2233444555666666555555 9999
Q ss_pred cCCCCCCEEeCCCCceEEeeeccchh
Q 005045 524 CDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 524 ~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++-||+++++|.+.++||--+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999976553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-09 Score=115.16 Aligned_cols=202 Identities=24% Similarity=0.216 Sum_probs=147.1
Q ss_pred CCccc-ccccccccccccccCcccccceEEEEe--CCCchhhhHHhHhhhhh--HHHHHHHHHHHHhcC-CCCceeEEEE
Q 005045 379 MSYSD-ISKSTDNFSKENLIGTGSFGSVYKGTL--GDGTIVAIKVLKLQQQG--ALKSFIDECNALKST-RHRNILRVIT 452 (717)
Q Consensus 379 ~s~~~-~~~~~~~y~~~~~ig~g~~g~v~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~ 452 (717)
+.-.+ -.+...+|..+..||.+.++.|+.+.. .++..+++|.....-.. ....-..|+.+...+ .|.++++.+.
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 55555 667788999999999999999998873 36778888887644322 222234555555555 5778887666
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
.+. .....|+=-|||++++........ ..+.+...+.+..|++.++.++|+. .++|+|++|+||+
T Consensus 334 ~W~-----~~r~~~ip~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~ 398 (524)
T KOG0601|consen 334 SWS-----QLRQGYIPLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNIL 398 (524)
T ss_pred Ccc-----ccccccCchhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhccccccch---hhhccccccccee
Confidence 643 334667999999988877655211 5677888899999999999999997 9999999999999
Q ss_pred eCCC-CceEEeeeccchhcccccCCCCCCcceeeccccccccc-CCCccCC--CCCcccchhhHHHHHHHHHhCCCC
Q 005045 533 LDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI-PPEHMNG--QVSILGDIYSYGILLLEMFTGKRP 605 (717)
Q Consensus 533 l~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~-aPE~~~~--~~~~~sDvwslG~vl~elltg~~p 605 (717)
+..+ +..+++|||.+..+.. ..+...+.-.++ .+|++.. .+..++|++|||..+.+..+|.+.
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~----------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAF----------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred eccchhhhhccccccccccce----------ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 9876 7889999998864311 111122333444 2555433 367899999999999999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.1e-09 Score=102.00 Aligned_cols=145 Identities=21% Similarity=0.210 Sum_probs=106.3
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCC--CceeEEEEeeccccCCCCceEEEEEec
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRH--RNILRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
+.++.|..+.+|++...+|+.+++|....... .....+..|+++++.+.+ ..+++++....... ..+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 56899999999999876678899998764432 134567889999999865 34566666643211 11356899999
Q ss_pred CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005045 472 MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC---------------------------------- 517 (717)
Q Consensus 472 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 517 (717)
++|.++.+.+.. ..++......++.+++++++.||+..
T Consensus 82 i~G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 82 VDGRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred eCCEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 999888775531 23566667778888888888888421
Q ss_pred -------------------CCCeeecCCCCCCEEeCC--CCceEEeeeccchh
Q 005045 518 -------------------DTPIAHCDLKPSNVLLDK--DMTAHVGDFGLAKF 549 (717)
Q Consensus 518 -------------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~~~~ 549 (717)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.5e-09 Score=98.50 Aligned_cols=124 Identities=23% Similarity=0.226 Sum_probs=79.4
Q ss_pred eEEEEeCCCchhhhHHhHhh--------------------------hhhHHHHHHHHHHHHhcCCCC--ceeEEEEeecc
Q 005045 405 VYKGTLGDGTIVAIKVLKLQ--------------------------QQGALKSFIDECNALKSTRHR--NILRVITACSS 456 (717)
Q Consensus 405 v~~~~~~~~~~vavK~~~~~--------------------------~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~ 456 (717)
||.|...+|..+|+|+.... ......+..+|++.|.++... ++++.+++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 67777666777777765321 011245678899999999654 567776652
Q ss_pred ccCCCCceEEEEEecCC--CCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCEEe
Q 005045 457 VDLEGNDFKALVFEFMS--NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY-LHHHCDTPIAHCDLKPSNVLL 533 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlkp~NIll 533 (717)
..++||||++ |..+..+... .++......++.+++..+.. +|+. |++|||+++.||++
T Consensus 80 -------~~~ivME~I~~~G~~~~~l~~~---------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv 140 (188)
T PF01163_consen 80 -------RNVIVMEYIGEDGVPLPRLKDV---------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILV 140 (188)
T ss_dssp -------TTEEEEE--EETTEEGGCHHHC---------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEE
T ss_pred -------CCEEEEEecCCCccchhhHHhc---------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEe
Confidence 3379999997 5555443321 11133456678888886666 4676 99999999999999
Q ss_pred CCCCceEEeeeccchhc
Q 005045 534 DKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 534 ~~~~~~kl~Dfg~~~~~ 550 (717)
+++ .+.++|||.+...
T Consensus 141 ~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp ETT-CEEE--GTTEEET
T ss_pred ecc-eEEEEecCcceec
Confidence 877 9999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.2e-11 Score=126.92 Aligned_cols=127 Identities=27% Similarity=0.253 Sum_probs=87.1
Q ss_pred CCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccch-hhhcCCCCCeE
Q 005045 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGRLNKLEGL 311 (717)
Q Consensus 233 ~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L 311 (717)
..|.+.+.+.|.+. .+..++.-+ +.|+.|+|++|+++.. +.+..++.|++|||++|.+. .+|. ...++. |..|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll-~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L 237 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLL-PALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL 237 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHH-HHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heee
Confidence 35677777777777 666666655 4777788888877633 26777778888888888877 4553 223333 7778
Q ss_pred EcccCcCCCCCCcccccccccceeecccccccccCC-cCccCcCCCceEEeecccCC
Q 005045 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP-PSLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 312 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 367 (717)
.+++|.++.. ..+.+|++|+.||+++|-|.+.-- ..++.|..|+.|+|.|||+.
T Consensus 238 ~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 238 NLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8888877754 456777888888888887775433 23456677788888888875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-08 Score=97.73 Aligned_cols=110 Identities=15% Similarity=0.092 Sum_probs=78.8
Q ss_pred HHHHHHHHHhcCCCC--ceeEEEEeeccccCCCCceEEEEEecCCCC-ChhhhccCCCCCcccccccCHHHHHHHHHHHH
Q 005045 431 SFIDECNALKSTRHR--NILRVITACSSVDLEGNDFKALVFEFMSNG-NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507 (717)
Q Consensus 431 ~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~ 507 (717)
.+.+|+..+..+... ..+..++++...........++|||++++. +|.+++..... ...+......++.+++
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la 148 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVA 148 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHH
Confidence 467888888777322 233334443221111123578999999875 79888753211 3345667789999999
Q ss_pred HHHHHHHhcCCCCeeecCCCCCCEEeCC-------CCceEEeeeccch
Q 005045 508 SALDYLHHHCDTPIAHCDLKPSNVLLDK-------DMTAHVGDFGLAK 548 (717)
Q Consensus 508 ~~l~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~kl~Dfg~~~ 548 (717)
..++-||.. |++|||++++||+++. ++.+.++||+.+.
T Consensus 149 ~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 149 TMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999999998 9999999999999975 4689999999775
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-09 Score=92.78 Aligned_cols=138 Identities=22% Similarity=0.280 Sum_probs=85.3
Q ss_pred CCCEEEeecCcccCcCchhhhhcc--ccccEEecCCCccCCCCCcccc-CCCCCCEEEccCCcCccccchhhhcCCCCCe
Q 005045 234 SLEVLGLARNSFGGEMPISIANLS--THLRRLTMGENLMHGNIPVGIG-NLVNLNLLGLEGNNLSGSVPEVIGRLNKLEG 310 (717)
Q Consensus 234 ~L~~L~L~~N~l~~~~p~~~~~~~--~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 310 (717)
.+..++|+++.+- .+++....+. ..|+..+|++|.+.. +|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3445555555554 4444444332 234555666666653 333333 3456777777777777 56777777788888
Q ss_pred EEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCccccc
Q 005045 311 LGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQ 376 (717)
Q Consensus 311 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 376 (717)
|++++|++. ..|..+..+.+|-.|+..+|.+. .+|-.+-.-...-..++.+++|.+..|...+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa 168 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA 168 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence 888888777 55666777777888887777776 55544332233334456788888877766543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-09 Score=91.59 Aligned_cols=142 Identities=20% Similarity=0.197 Sum_probs=105.4
Q ss_pred CCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCC
Q 005045 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNL 284 (717)
Q Consensus 205 L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L 284 (717)
+..++|+++.+..+.. .+..+.....|+..+|++|.+. .+|..|...++.++.|++++|.|. .+|..+..++.|
T Consensus 29 ~h~ldLssc~lm~i~d----avy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aL 102 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIAD----AVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPAL 102 (177)
T ss_pred hhhcccccchhhHHHH----HHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHh
Confidence 4455666665554321 1445666777888899999998 888888777668899999999998 677779999999
Q ss_pred CEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcC
Q 005045 285 NLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQ 354 (717)
Q Consensus 285 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 354 (717)
+.|+++.|.+. ..|..+..|.+|..|+..+|.+..+.-+ +-.-...-..++.++.+.+.-+..+..+.
T Consensus 103 r~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 103 RSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred hhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccccCcccccccC
Confidence 99999999999 7888888899999999999998855444 33334444556677778766665554443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-09 Score=102.46 Aligned_cols=85 Identities=24% Similarity=0.249 Sum_probs=44.3
Q ss_pred CCCEEEccCccccccCCc-cc-cCCCCCCEEeccCCcCcc--cCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccE
Q 005045 59 KLEIIGLGGSNLTGNVPA-WI-GNFSSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~-~~-~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 134 (717)
-++.|.+.++.|...-.. .| ...+.++.|||.+|.|+. .+-..+.+++.|++|+|+.|++...+-..-..+.+|+.
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 444556666655421111 12 234556777777777762 22233456667777777777766222111134456666
Q ss_pred EEcccCccc
Q 005045 135 FSVTQNQLH 143 (717)
Q Consensus 135 L~L~~N~l~ 143 (717)
|-|.+..+.
T Consensus 126 lVLNgT~L~ 134 (418)
T KOG2982|consen 126 LVLNGTGLS 134 (418)
T ss_pred EEEcCCCCC
Confidence 666665553
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.5e-10 Score=119.30 Aligned_cols=198 Identities=24% Similarity=0.194 Sum_probs=111.1
Q ss_pred CCCCCEEEccCccccccC-CccccCCCCCCEEeccCCcCcccCChhhhccC-CCCeEeccCCCCCCCCCcc-------cc
Q 005045 57 LTKLEIIGLGGSNLTGNV-PAWIGNFSSLKALSLAWNNLRGSIPNELGQLS-GLGFFTLYGNFISGIIPSS-------IY 127 (717)
Q Consensus 57 l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~-------~~ 127 (717)
+++++.|.+-.-.=.+.. |-.+..+.+|++|.|.++.|.. -..+..+. .|++|- .+|.+. .+... |+
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~-Al~~v~ascggd~~ 158 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLD-ALRHVFASCGGDIS 158 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHH-HHHHHHHHhccccc
Confidence 344455554443332222 4556667778888888887763 12222222 344442 223222 01111 11
Q ss_pred C---CCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCC
Q 005045 128 N---ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKD 204 (717)
Q Consensus 128 ~---l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 204 (717)
+ ...|...+.++|.+. .+...+- -++.|+.|+|++|+++.. +.+..+++|++|||++|.++ .+|..=..-.+
T Consensus 159 ns~~Wn~L~~a~fsyN~L~-~mD~SLq-ll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~ 233 (1096)
T KOG1859|consen 159 NSPVWNKLATASFSYNRLV-LMDESLQ-LLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK 233 (1096)
T ss_pred cchhhhhHhhhhcchhhHH-hHHHHHH-HHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh
Confidence 1 125666777777775 4444432 567777777777777733 36777778888888888877 44442222233
Q ss_pred CCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccC
Q 005045 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 205 L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~ 271 (717)
|..|.+++|.++.+ ..+.++.+|+-||+++|-|.+.-.-.+......|+.|+|.+|.+-
T Consensus 234 L~~L~lrnN~l~tL--------~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 234 LQLLNLRNNALTTL--------RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred heeeeecccHHHhh--------hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77777777777763 356777777777777777764222222222236777777777664
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.2e-09 Score=101.56 Aligned_cols=109 Identities=20% Similarity=0.230 Sum_probs=76.4
Q ss_pred CCCEEECCCCcccccCC-cCC-CCCCCCCEEEccCccccc--cCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCe
Q 005045 35 ELRSFEASVNDFVGQIP-NQL-SSLTKLEIIGLGGSNLTG--NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p-~~~-~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 110 (717)
.+..|-+.++.|-.+-. ..| ...+.++.|||.+|.|++ .+-..+.+++.|++|+|+.|.+...+-..-..+.+|++
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 44456666666542111 112 446789999999999983 22334578999999999999998443322257789999
Q ss_pred EeccCCCCCC-CCCccccCCCCccEEEcccCccc
Q 005045 111 FTLYGNFISG-IIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 111 L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
|-|.+..+.- ..-..+..++.++.|++|.|.+.
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r 159 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR 159 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence 9999998873 23345678889999999999664
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4e-09 Score=99.59 Aligned_cols=87 Identities=22% Similarity=0.168 Sum_probs=46.1
Q ss_pred CCCCCEEEccCCcCccc----cchhhhcCCCCCeEEcccCcCCCCCCcccc------cccccceeecccccccccCCcC-
Q 005045 281 LVNLNLLGLEGNNLSGS----VPEVIGRLNKLEGLGLNVNKFSGLIPSSLG------NLTILTRLWMEENRLEGSIPPS- 349 (717)
Q Consensus 281 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------~l~~L~~L~L~~N~l~~~~p~~- 349 (717)
+.+|+.|||..|-++-. +..+++.++.|+.|.+.+|-++.....++- ..++|..|-+.+|...+.+-..
T Consensus 213 ~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~ 292 (388)
T COG5238 213 SHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDI 292 (388)
T ss_pred hCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeee
Confidence 34555555555554421 223444555666666666666544332221 1356666666666654332221
Q ss_pred ----c--cCcCCCceEEeecccCC
Q 005045 350 ----L--GNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 350 ----~--~~l~~L~~L~l~~N~l~ 367 (717)
+ .+++-|..|.+.||.|.
T Consensus 293 ~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 293 SLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred chhhhhhcccHHHHHHHHccCcch
Confidence 1 34667777777888776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.6e-08 Score=108.33 Aligned_cols=101 Identities=18% Similarity=0.437 Sum_probs=75.4
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCC--cceeecccccccccCCCccCC
Q 005045 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN--QTVSIGLKGSIGYIPPEHMNG 581 (717)
Q Consensus 504 ~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~ 581 (717)
.+++.|+.|+|.. .++||++|.|++|.++..|.+||+.|+.+....+....+... .....-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999987 699999999999999999999999999887654322211111 111112235568999999766
Q ss_pred C-CCcccchhhHHHHHHHHHhCCCCC
Q 005045 582 Q-VSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 582 ~-~~~~sDvwslG~vl~elltg~~p~ 606 (717)
. .+.++|+||+||.+|.+..|..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcch
Confidence 4 689999999999999999655543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.4e-07 Score=85.61 Aligned_cols=142 Identities=15% Similarity=0.163 Sum_probs=91.5
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHH---------HHHHHHHHhcC---CCCceeEEEEee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKS---------FIDECNALKST---RHRNILRVITAC 454 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l---~h~ni~~~~~~~ 454 (717)
..++|.+.+.+.......|.+... +|+.+++|..........+. ..+.+....++ .-...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888887777777766665 56778888876543222122 12233333333 333333333333
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.-..+.-....+++|||++|..+.+... +++ .++..++.++.-+|+. |++|||.+|.|++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 3222333445679999999988866532 222 2556788889999998 999999999999998
Q ss_pred CCCceEEeeeccch
Q 005045 535 KDMTAHVGDFGLAK 548 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~ 548 (717)
.+ .++++||+..+
T Consensus 170 ~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NN-GIRIIDTQGKR 182 (229)
T ss_pred CC-cEEEEECcccc
Confidence 55 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 717 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-24 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-24 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 5e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 5e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 1e-94
Identities = 114/365 (31%), Positives = 179/365 (49%), Gaps = 14/365 (3%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ L+++ N S IP L C+ L+ + S N G +S+ T+L+++ + + G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIYNISS 131
+P SL+ LSLA N G IP+ L G L L GN G +P + S
Sbjct: 262 PIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 132 IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS-NLQVLDFAENG 190
+ +++ N G+LP D L + LK+ + N F+G +P SL+N S +L LD + N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 191 LTGTIPGNFG--SLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248
+G I N L L N + +I L+NC+ L L L+ N G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGF-TGKIPP-----TLSNCSELVSLHLSFNYLSGT 433
Query: 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKL 308
+P S+ +LS LR L + N++ G IP + + L L L+ N+L+G +P + L
Sbjct: 434 IPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 309 EGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
+ L+ N+ +G IP +G L L L + N G+IP LG+C+ L+ L+L++N NG
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 369 TIPKE 373
TIP
Sbjct: 553 TIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 297 bits (764), Expect = 2e-90
Identities = 103/370 (27%), Positives = 168/370 (45%), Gaps = 21/370 (5%)
Query: 13 QDLNLTYNYLSGKIPTNL---SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN 69
+ L+L+ N +SG C EL+ S N G + +S LE + + +N
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211
Query: 70 LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
+ +P ++G+ S+L+ L ++ N L G + + L + N G IP +
Sbjct: 212 FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PL 268
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
S+ Y S+ +N+ G++P + L + N+F G++P + S L+ L + N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 190 GLTGTIPGN-FGSLKDLVRLNFDQNEL-GS--REIGDLNFLKFLANCTSLEVLGLARNSF 245
+G +P + ++ L L+ NE G + +L SL L L+ N+F
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL--------SASLLTLDLSSNNF 380
Query: 246 GGEMPISIANLS-THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR 304
G + ++ L+ L + N G IP + N L L L N LSG++P +G
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364
L+KL L L +N G IP L + L L ++ N L G IP L NC L ++LS+N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 365 DLNGTIPKEV 374
L G IPK +
Sbjct: 501 RLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-84
Identities = 110/363 (30%), Positives = 170/363 (46%), Gaps = 16/363 (4%)
Query: 13 QDLNLTYNYLSGKIPTNLSHC--TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNL 70
L+L+ N SG I NL L+ N F G+IP LS+ ++L + L + L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 71 TGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNIS 130
+G +P+ +G+ S L+ L L N L G IP EL + L L N ++G IPS + N +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 131 SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG 190
++ + S++ N+L G++P +G L NL I + N F+G+IP L + +L LD N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 191 LTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN--SFGGE 248
GTIP + NF ++ N + A N F G
Sbjct: 550 FNGTIPAAMFKQSGKIAANFIAG----------KRYVYIKNDGMKKECHGAGNLLEFQGI 599
Query: 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKL 308
+ LST + + G+ N ++ L + N LSG +P+ IG + L
Sbjct: 600 RSEQLNRLST-RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 309 EGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
L L N SG IP +G+L L L + N+L+G IP ++ L ++LS+N+L+G
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 369 TIP 371
IP
Sbjct: 719 PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 4e-77
Identities = 102/372 (27%), Positives = 161/372 (43%), Gaps = 26/372 (6%)
Query: 15 LNLTYNYLS---GKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
++L+ L+ + ++L T L S S + G + L + L ++L+
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 72 GNVPA--WIGNFSSLKALSLAWNNLRGSIPNELG-QLSGLGFFTLYGNFISGIIPSSIY- 127
G V +G+ S LK L+++ N L G +L+ L L N ISG
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 128 --NISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLD 185
+ + +++ N++ G + V NL+ + N F+ IP L + S LQ LD
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSR-CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLD 229
Query: 186 FAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSF 245
+ N L+G + +L LN N+ G + SL+ L LA N F
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFV----GPIP----PLPLKSLQYLSLAENKF 281
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP-EVIGR 304
GE+P ++ L L + N +G +P G+ L L L NN SG +P + + +
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTI-LTRLWMEENRLEGSIPPSLGNCQK--LLVLNL 361
+ L+ L L+ N+FSG +P SL NL+ L L + N G I P+L K L L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 362 SSNDLNGTIPKE 373
+N G IP
Sbjct: 402 QNNGFTGKIPPT 413
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-70
Identities = 103/360 (28%), Positives = 162/360 (45%), Gaps = 21/360 (5%)
Query: 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
T + +N + + L SLT LE + L S++ G+V +SL +L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 89 LAWNNLRGSIP--NELGQLSGLGFFTLYGNFISGIIP-SSIYNISSIYYFSVTQNQLHGQ 145
L+ N+L G + LG SGL F + N + S ++S+ ++ N + G
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 146 LPTDVGLT--LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLK 203
L+ LK A + N +G + +S NL+ LD + N + IP G
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 204 DLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRL 263
L L+ N+L +F + ++ CT L++L ++ N F G +P L+ L
Sbjct: 224 ALQHLDISGNKLSG------DFSRAISTCTELKLLNISSNQFVGPIPPLP---LKSLQYL 274
Query: 264 TMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI 322
++ EN G IP + G L L L GN+ G+VP G + LE L L+ N FSG +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 323 P-SSLGNLTILTRLWMEENRLEGSIPPSLGNC-QKLLVLNLSSNDLNGTIPKEVRQSGMS 380
P +L + L L + N G +P SL N LL L+LSSN+ +G I + Q+ +
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 2e-60
Identities = 87/315 (27%), Positives = 142/315 (45%), Gaps = 14/315 (4%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L+L++NYLSG IP++L ++LR + +N G+IP +L + LE + L ++LTG
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+P+ + N ++L +SL+ N L G IP +G+L L L N SG IP+ + + S+
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG-- 190
+ + N +G +P + + N+ G V + N + A N
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGKIA-----ANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 191 LTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250
G L N N S+ L ++ N G +P
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVY-GGHT-----SPTFDNNGSMMFLDMSYNMLSGYIP 649
Query: 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEG 310
I ++ +L L +G N + G+IP +G+L LN+L L N L G +P+ + L L
Sbjct: 650 KEIGSMP-YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708
Query: 311 LGLNVNKFSGLIPSS 325
+ L+ N SG IP
Sbjct: 709 IDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-25
Identities = 30/139 (21%), Positives = 56/139 (40%)
Query: 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN 69
G L+ + + + G + + + + +
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM 643
Query: 70 LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
L+G +P IG+ L L+L N++ GSIP+E+G L GL L N + G IP ++ +
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 130 SSIYYFSVTQNQLHGQLPT 148
+ + ++ N L G +P
Sbjct: 704 TMLTEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-18
Identities = 34/125 (27%), Positives = 55/125 (44%), Gaps = 4/125 (3%)
Query: 5 MIPEHLMT----QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
+ E L N+T G + + + S N G IP ++ S+ L
Sbjct: 599 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG 120
I+ LG ++++G++P +G+ L L L+ N L G IP + L+ L L N +SG
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 121 IIPSS 125
IP
Sbjct: 719 PIPEM 723
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 8e-83
Identities = 104/330 (31%), Positives = 163/330 (49%), Gaps = 49/330 (14%)
Query: 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ-QQGALKSFIDECNA 438
S ++ ++DNFS +N++G G FG VYKG L DGT+VA+K LK + QG F E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
+ HRN+LR+ C + + LV+ +M+NG++ L P L +
Sbjct: 81 ISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLRERPESQ---PPLDWPK 132
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
R IA+ A L YLH HCD I H D+K +N+LLD++ A VGDFGLAK +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------DY 186
Query: 559 KNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
K+ V+ ++G+IG+I PE+ G+ S D++ YG++LLE+ TG+R +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 618 MFVSMALP----DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC 673
M + + ++D L +E++E++I+
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVD--LQGNYKDEEVEQLIQ--------------------- 283
Query: 674 FVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703
+ L+C+ +SP ER M+ VV L+
Sbjct: 284 ------VALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 93/329 (28%), Positives = 152/329 (46%), Gaps = 52/329 (15%)
Query: 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ-QQGALKSFIDECNA 438
D+ ++T+NF + LIG G FG VYKG L DG VA+K + QG ++ F E
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG-IEEFETEIET 88
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
L RH +++ +I C E N+ L++++M NGNL + L+ S +S Q
Sbjct: 89 LSFCRHPHLVSLIGFCD----ERNE-MILIYKYMENGNLKRHLYGSDL---PTMSMSWEQ 140
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
RL I I A L YLH I H D+K N+LLD++ + DFG++K
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK------KGTE 191
Query: 559 KNQT-VSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
+QT +S +KG++GYI PE + G+++ D+YS+G++L E+ +
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA----------- 240
Query: 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHID--LEVNTKNKLEECF 674
+ +LP ++++ + ++ EQI +D L + E
Sbjct: 241 ---IVQSLPREMVNLAEWAVESHNNGQLEQI------------VDPNLADKIR---PESL 282
Query: 675 VSVLRIGLMCSTTSPRERIAMNVVVNNLK 703
+ C S +R +M V+ L+
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-65
Identities = 80/343 (23%), Positives = 143/343 (41%), Gaps = 71/343 (20%)
Query: 380 SYSDISKSTDNFSKE------NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ-----QQGA 428
S+ ++ T+NF + N +G G FG VYKG + + T VA+K L ++
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL- 73
Query: 429 LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH 488
+ F E + +H N++ ++ +G+D LV+ +M NG+L L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFS----SDGDD-LCLVYVYMPNGSLLDRLSCLDGT- 127
Query: 489 YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
LS R IA A+ +++LH + H D+K +N+LLD+ TA + DFGLA+
Sbjct: 128 ---PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 549 FLFEISDNPSKNQT-VSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTG 607
+ QT ++ + G+ Y+ PE + G+++ DIYS+G++LLE+ TG
Sbjct: 182 ------ASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV- 234
Query: 608 DMFKDDFSIHMFVSMALP-----DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDL 662
D ++ + + + + D +D M + D +E +
Sbjct: 235 DEHREP---QLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYS---------- 278
Query: 663 EVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
+ C +R + V L+ +
Sbjct: 279 -----------------VASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-62
Identities = 77/341 (22%), Positives = 116/341 (34%), Gaps = 67/341 (19%)
Query: 36 LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLR 95
L + + + P LSS G + + L L+ NL
Sbjct: 11 LLQIKKDLGN-----PTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 96 GS--IPNELGQLSGLGFFTLYG-NFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGL 152
IP+ L L L F + G N + G IP +I
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK------------------------ 99
Query: 153 TLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQ 212
L L +G+IP LS L LDF+ N L+GT+P +
Sbjct: 100 -LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS------------ 146
Query: 213 NELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG 272
+ +L + N G +P S + S +T+ N + G
Sbjct: 147 ------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 273 NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTIL 332
IP NL NL + L N L G + G + + L N + + +G L
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNL 246
Query: 333 TRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKE 373
L + NR+ G++P L + L LN+S N+L G IP+
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 14/290 (4%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQ--IPNQLSSLTKLEIIGLGGSN 69
+ G + + + + + S + IP+ L++L L + +GG N
Sbjct: 28 LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN 87
Query: 70 -LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYN 128
L G +P I + L L + N+ G+IP+ L Q+ L N +SG +P SI +
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE 188
+ ++ + N++ G +P G + N TG IP + +N NL +D +
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 189 NGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248
N L G FGS K+ +++ +N L + ++G + K +L L L N G
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSL-AFDLGKVGLSK------NLNGLDLRNNRIYGT 259
Query: 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN-LSGS 297
+P + L L L + N + G IP G GNL ++ N L GS
Sbjct: 260 LPQGLTQL-KFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 229 LANCTSLEVLGLARNSFGGEMPI--SIANLSTHLRRLTM-GENLMHGNIPVGIGNLVNLN 285
+ L L+ + PI S+ANL +L L + G N + G IP I L L+
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 286 LLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGS 345
L + N+SG++P+ + ++ L L + N SG +P S+ +L L + + NR+ G+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 346 IPPSLGNCQKLL-VLNLSSNDLNGTIPKEVRQSGMSYSDIS 385
IP S G+ KL + +S N L G IP +++ D+S
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 8/159 (5%)
Query: 223 LNFLKFLANCTSL----EVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG--NIPV 276
L K L N T+L ++ G + + + + L + + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 277 GIGNLVNLNLLGLEG-NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRL 335
+ NL LN L + G NNL G +P I +L +L L + SG IP L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 336 WMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
N L G++PPS+ + L+ + N ++G IP
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 33/140 (23%), Positives = 56/140 (40%), Gaps = 8/140 (5%)
Query: 6 IPEHL-----MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
IP+ + + ++ N L+GKIP ++ L + S N G S
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG 120
+ I L ++L ++ +G +L L L N + G++P L QL L + N + G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 121 IIPSSIYNISSIYYFSVTQN 140
IP N+ + N
Sbjct: 283 EIPQGG-NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 6 IPEHL----MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLE 61
TQ ++L N L+ + + L + N G +P L+ L L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 62 IIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIP 99
+ + +NL G +P GN + A N P
Sbjct: 272 SLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 70/342 (20%), Positives = 123/342 (35%), Gaps = 50/342 (14%)
Query: 377 SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDEC 436
+ ++ + + G FG V+K L VA+K+ +Q + + + E
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEV 69
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+L +H NIL+ I A D L+ F G+L +L + +S
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV--------VSW 120
Query: 497 IQRLNIAIDVASALDYLHHHCDT-------PIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ +IA +A L YLH I+H D+K NVLL ++TA + DFGLA
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEMFTGK 603
K+ + G G+ Y+ PE + G ++ D+Y+ G++L E+ +
Sbjct: 181 F-----EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663
+ LP PS+ E+ E V+ +K
Sbjct: 236 TAADGPVDEY---------MLPFEEEIGQHPSL-------EDMQEVVVHKK-----KRPV 274
Query: 664 VNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
+ + + C R++ V + +
Sbjct: 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-58
Identities = 52/374 (13%), Positives = 119/374 (31%), Gaps = 26/374 (6%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQ----IPNQLSSLTKLEIIGLGGSNL 70
L+L SG++P + TEL + P +S+ E +
Sbjct: 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145
Query: 71 TGNVPAWIG--NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYN 128
+ +FS L + + + SI N I+ + ++
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR 204
Query: 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE 188
++ + F + + + N + + N +L ++
Sbjct: 205 LTKLRQFYMGNSPFVAENIC-EAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 189 NGLTGTIPGNFGSLKDLVRLNFDQNEL--GSREIGDLNFLKFLANCTSLEVLGLARNSF- 245
+P +L ++ +N N G + D L ++++ + N+
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL 305
+ S+ + L L N + G +P G+ + L L L N ++ G
Sbjct: 319 TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 306 NKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEG-------SIPPSLGNCQKLL 357
++E L NK + ++++++ + N + + P+ +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 358 VLNLSSNDLNGTIP 371
+NLS+N ++
Sbjct: 437 SINLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-53
Identities = 59/388 (15%), Positives = 121/388 (31%), Gaps = 37/388 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ + + + + +L L + +
Sbjct: 209 RQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 73 NVPAWIGNFSSLKALSLAWNNLR--------GSIPNELGQLSGLGFFTLYGN-FISGIIP 123
+P ++ ++ +++A N + + + N + +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 124 SSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQV 183
+S+ + + NQL G G + L A N T ++
Sbjct: 324 TSLQKMKKLGMLECLYNQLEG-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVEN 381
Query: 184 LDFAENGLTGTIPGNF--GSLKDLVRLNFDQNELGSREIGDLNFL-KFLANCTSLEVLGL 240
L FA N L IP F S+ + ++F NE+GS + + + L ++ + L
Sbjct: 382 LSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHG-------NIPVGIGNLVNLNLLGLEGNN 293
+ N + + L + + N++ + N L + L N
Sbjct: 441 SNNQISKFPKELFSTG-SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 294 LSGSVPEV-IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE------NRLEGSI 346
L+ + L L G+ L+ N FS P+ N + L + NR
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
Query: 347 PPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
P + C L L + SND+ + +++
Sbjct: 559 PEGITLCPSLTQLQIGSNDIR-KVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-52
Identities = 62/377 (16%), Positives = 114/377 (30%), Gaps = 32/377 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFV--------GQIPNQLSSLTKLEIIG 64
D+ + K+PT L E++ + N + Q K++II
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 65 LGGSNL-TGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIP 123
+G +NL T V + L L +N L G +P G L L N I+ I
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA 370
Query: 124 SSIYNISSIYYFSVTQNQLHGQLPTDVGL-TLPNLKI-------FAGAVNYFTGSIPVSL 175
+ + S N+L +P ++ + + +
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 176 SNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL-KFLANCTS 234
N+ ++ + N ++ F + L +N N L L + N
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 235 LEVLGLARNSFGGEMPISIANLS-THLRRLTMGENLMHGNIPVGIGNLVNL------NLL 287
L + L N + + +L + + N P N L N
Sbjct: 490 LTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 288 GLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347
+GN PE I L L + N + N+++ L +++N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIKDNPNISIDL 604
Query: 348 PSLGNCQKLLVLNLSSN 364
+ + + L +
Sbjct: 605 SYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-52
Identities = 54/394 (13%), Positives = 108/394 (27%), Gaps = 45/394 (11%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ N ++ + + T+LR F + FV + + E +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYK 239
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI--------IPS 124
N L + + +P L L + + N +
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 125 SIYNISSIYYFSVTQNQL-HGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQV 183
I + N L + T + + L + N G +P + + L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357
Query: 184 LDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN 243
L+ A N +T G + + L+F N+L + + + + + + + N
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-----IPNIFDAKSVSVMSAIDFSYN 412
Query: 244 SFGG-------EMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
G + + ++ + + N + L+ + L GN L+
Sbjct: 413 EIGSVDGKNFDPLDPTPFKG-INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 297 -------SVPEVIGRLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEGSIPP 348
E L + L NK + L L L + + N P
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 349 SLGNCQKLLVL------NLSSNDLNGTIPKEVRQ 376
N L + N P+ +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-47
Identities = 48/350 (13%), Positives = 110/350 (31%), Gaps = 31/350 (8%)
Query: 38 SFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRG- 96
+F ++ + Q L+S ++ + L G +G VP IG + L+ L+L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 97 ---SIPNELGQLSGLGFFTLYGNFISGIIPSSI--YNISSIYYFSVTQNQLHGQLPTDVG 151
P + + S + + + +
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD 211
+TL + +I N T + ++ + L+ + ++
Sbjct: 181 ITLKDTQIG-QLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ-- 236
Query: 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
Q + + N L + + ++P + L ++ + + N
Sbjct: 237 QYKTEDLKWD---------NLKDLTDVEVYNCPNLTKLPTFLKAL-PEMQLINVACNRGI 286
Query: 272 --------GNIPVGIGNLVNLNLLGLEGNNL-SGSVPEVIGRLNKLEGLGLNVNKFSGLI 322
+ ++ + NNL + V + ++ KL L N+ G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 323 PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372
P + G+ L L + N++ G +++ L+ + N L IP
Sbjct: 347 P-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPN 394
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 34/311 (10%), Positives = 66/311 (21%), Gaps = 75/311 (24%)
Query: 77 WIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG----IIPSSIYNISSI 132
+ + + LSL G +P+ +GQL+ L L + P I S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 133 YYFSVTQNQLHGQLPTDVG-LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191
+ +L + SI S + N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 192 TGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251
T + T L + + F E
Sbjct: 196 TF-VSKAVM------------------------------RLTKLRQFYMGNSPFVAENIC 224
Query: 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGL 311
E + L L +
Sbjct: 225 EA------------------------------WENENSEYAQQYKTEDLKWDNLKDLTDV 254
Query: 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRL--------EGSIPPSLGNCQKLLVLNLSS 363
+ +P+ L L + + + NR + +K+ ++ +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 364 NDL-NGTIPKE 373
N+L +
Sbjct: 315 NNLKTFPVETS 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-19
Identities = 38/236 (16%), Positives = 73/236 (30%), Gaps = 30/236 (12%)
Query: 13 QDLNLTYNYLSG-------KIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGL 65
++ +YN + + + S S N S+ + L I L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 66 GGSNLTG-------NVPAWIGNFSSLKALSLAWNNLRGSIPNEL--GQLSGLGFFTLYGN 116
G+ LT + N L ++ L +N L + ++ L L L N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYN 523
Query: 117 FISGIIPSSIYNISSIYYFSVTQ------NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
S P+ N S++ F + N+ + P + P+L N
Sbjct: 524 SFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT-LCPSLTQLQIGSNDIR-K 580
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL 226
+ ++ N+ VLD +N + ++ ++I + L
Sbjct: 581 VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT--QDIRGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 25/115 (21%), Positives = 42/115 (36%), Gaps = 7/115 (6%)
Query: 270 MHGNIP-VGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG----LIPS 324
M G P V + + + L LEG SG VP+ IG+L +LE L L + P
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 325 SLGNLTILTRLWMEENRLEGSIPPSLGNCQ--KLLVLNLSSNDLNGTIPKEVRQS 377
+ + + + L+ ++S+ +I K R +
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-54
Identities = 66/219 (30%), Positives = 117/219 (53%), Gaps = 21/219 (9%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVI 451
+ IG GSFG+V++ G+ VA+K+L Q + F+ E +K RH NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
A + + ++V E++S G+L + LH + ++L +RL++A DVA ++
Sbjct: 101 GAV----TQPPNL-SIVTEYLSRGSLYRLLH----KSGAREQLDERRRLSMAYDVAKGMN 151
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
YLH+ + PI H +LK N+L+DK T V DFGL++ + S G+
Sbjct: 152 YLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-------ASTFLSSKSAAGTP 203
Query: 572 GYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609
++ PE + + + D+YS+G++L E+ T ++P G++
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 83/346 (23%), Positives = 126/346 (36%), Gaps = 51/346 (14%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECN- 437
+ S+ S DN LIG G +G+VYKG+L D VA+KV + ++FI+E N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 438 -ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+ H NI R I V +G LV E+ NG+L ++L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--------HTSDW 110
Query: 497 IQRLNIAIDVASALDYLH------HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
+ +A V L YLH H I+H DL NVL+ D T + DFGL+ L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 551 FEISDNPSKNQ-TVSIGLKGSIGYIPPEHMNGQVSILG--------DIYSYGILLLEMFT 601
+ +I G+I Y+ PE + G V++ D+Y+ G++ E+F
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 602 GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHID 661
D F + P+ E+ V EK
Sbjct: 231 RC-------TDLFPGESVPEYQMAFQTEVGNHPTF-------EDMQVLVSREK-----QR 271
Query: 662 LEVNTKNKLEECFVSVLRIGLM--CSTTSPRERIAMNVVVNNLKTI 705
+ K V L+ + C R+ + +
Sbjct: 272 PKFPEAWKENSLAVRSLK-ETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
E ++G G+FG V K VAIK ++ + + K+FI E L H NI+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ AC N LV E+ G+L LH + ++ + +
Sbjct: 65 KLYGACL------NPV-CLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQ 113
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMT-AHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ YLH + H DLKP N+LL T + DFG A + QT
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNN 163
Query: 568 KGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
KGS ++ PE G S D++S+GI+L E+ T ++P ++ F I V
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-52
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 35/241 (14%)
Query: 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA--LKSF 432
+ SG+ + ++ + G ++KG G + +KVLK++ + F
Sbjct: 3 KHSGIDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDF 54
Query: 433 IDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK 492
+EC L+ H N+L V+ AC S L+ +M G+L LH
Sbjct: 55 NEECPRLRIFSHPNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTN-----F 106
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
+ Q + A+D+A + +LH + I L +V++D+DMTA + +
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF---- 161
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG----DIYSYGILLLEMFTGKRPTGD 608
S G + ++ PE + + D++S+ +LL E+ T + P D
Sbjct: 162 -----SFQSP---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 609 M 609
+
Sbjct: 214 L 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ----GALKSFIDECNALKSTRHRNILR 449
E +IG G FG VY+ G VA+K + +++ E +H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ C L+ + LV EF G L++ L K++ +N A+ +A
Sbjct: 71 LRGVC----LKEPNL-CLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARG 117
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH--------VGDFGLAKFLFEISDNPSKNQ 561
++YLH PI H DLK SN+L+ + + + DFGLA+ ++
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---------WHR 168
Query: 562 TVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609
T + G+ ++ PE + S D++SYG+LL E+ TG+ P +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-49
Identities = 67/370 (18%), Positives = 123/370 (33%), Gaps = 36/370 (9%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
LNLT+N L N + ++L S + N P L L+++ L + L+
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
++L L L N+++ N + L L N +S + + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 132 IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191
+ ++ N++ + + + S+L+ L+ + N +
Sbjct: 147 LQELLLSNNKIQALKSEE-----------------------LDIFANSSLKKLELSSNQI 183
Query: 192 TGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251
PG F ++ L L + +LG L TS+ L L+ +
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPS---LTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 252 SIANLS-THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEG 310
+ L T+L L + N ++ L L LE NN+ + L +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 311 LGLN---------VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNL 361
L L + + S L L L ME+N + G L L+L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 362 SSNDLNGTIP 371
S++ +
Sbjct: 361 SNSFTSLRTL 370
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-48
Identities = 75/384 (19%), Positives = 131/384 (34%), Gaps = 32/384 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHC--TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNL 70
++L+L+ + LS T T L + S N+ + + L +LE L +N+
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 71 TGNVPAWIGNFSSLKALSLA---------WNNLRGSIPNELGQLSGLGFFTLYGNFISGI 121
+ +++ L+L +L L L + N I GI
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 122 IPSSIYNISSIYYFSVTQNQLHGQLPTD---VGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178
+ + ++ Y S++ + + T+ V L L I N + + S
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404
Query: 179 SNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEV 237
+L+VLD N + + G + L+++ + N+ A SL+
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF------ALVPSLQR 458
Query: 238 LGLARNSFGG--EMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS 295
L L R + P L +L L + N + + L L +L L+ NNL+
Sbjct: 459 LMLRRVALKNVDSSPSPFQPL-RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 296 --------GSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347
G + L+ L L L N F + +L L + + N L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 348 PSLGNCQKLLVLNLSSNDLNGTIP 371
N L LNL N +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-48
Identities = 70/382 (18%), Positives = 128/382 (33%), Gaps = 28/382 (7%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L++ +N +S P L+ N+ + T L + L +++
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI--S 130
+L L L+ N L + QL L L N I + + S
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 131 SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLS---NASNLQVLDFA 187
S+ ++ NQ+ P + L S+ L ++++ L +
Sbjct: 172 SLKKLELSSNQIKEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 188 ENGLTGTIPGNFGSLKD--LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSF 245
+ L+ T F LK L L+ N L +G+ A LE L N+
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNL--NVVGN----DSFAWLPQLEYFFLEYNNI 284
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNI---------PVGIGNLVNLNLLGLEGNNLSG 296
S+ L ++R L + + +I L L L +E N++ G
Sbjct: 285 QHLFSHSLHGL-FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 297 SVPEVIGRLNKLEGLGLNVNKFS--GLIPSSLGNLTI--LTRLWMEENRLEGSIPPSLGN 352
+ L L+ L L+ + S L + +L L L + +N++ +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 353 CQKLLVLNLSSNDLNGTIPKEV 374
L VL+L N++ + +
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQE 425
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 46/206 (22%), Positives = 74/206 (35%), Gaps = 11/206 (5%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
+P L +N+ VL+ N L NF L L+ N + E
Sbjct: 18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE------LC 69
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
L+VL L N + A T+L L + N + NL L L
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFC-TNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLG--NLTILTRLWMEENRLEGSIP 347
N LS + +L L+ L L+ NK L L + L +L + N+++ P
Sbjct: 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188
Query: 348 PSLGNCQKLLVLNLSSNDLNGTIPKE 373
+L L L++ L ++ ++
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 58/300 (19%), Positives = 89/300 (29%), Gaps = 31/300 (10%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQ-LSSLTKLEIIGLGGSNLT 71
LNLT N +S S L + +N+ ++ Q L + I L +
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
SL+ L L L+ S P+ L L L N I+ I + +
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+ + N L L + G L S+L +L+ N
Sbjct: 504 EKLEILDLQHNNLA---------RLWK--------HANPGGPIYFLKGLSHLHILNLESN 546
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249
G F L +L ++ N L + N SL+ L L +N
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNL-NTLPAS-----VFNNQVSLKSLNLQKNLITSVE 600
Query: 250 PISIANLSTHLRRLTMGENLMHGNIP-----VGIGNLVNLNLLGLEGNNLSGSVPEVIGR 304
+L L M N V N + N+ L + L + P G
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF 660
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-24
Identities = 42/194 (21%), Positives = 67/194 (34%), Gaps = 12/194 (6%)
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
+ +V D + LT +P + ++ LN N+L R + NF + L L
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQL--RRLPAANF----TRYSQLTSLD 55
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299
+ N+ P L L+ L + N + NL L L N++
Sbjct: 56 VGFNTISKLEPELCQKL-PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 300 EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQ--KLL 357
+ L L L+ N S + L L L + N+++ L L
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 358 VLNLSSNDLNGTIP 371
L LSSN + P
Sbjct: 175 KLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 32/148 (21%), Positives = 51/148 (34%), Gaps = 1/148 (0%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGN 292
T++ VL L N + + L L +G N + P L L +L L+ N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRY-SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 293 NLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGN 352
LS + L L L N + + L L + N L + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 353 CQKLLVLNLSSNDLNGTIPKEVRQSGMS 380
+ L L LS+N + +E+ S
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-18
Identities = 35/141 (24%), Positives = 57/141 (40%), Gaps = 5/141 (3%)
Query: 232 CT-SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290
CT S EV + ++P +L T++ L + N + L L +
Sbjct: 2 CTVSHEVADCSHLKLT-QVP---DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSL 350
N +S PE+ +L L+ L L N+ S L + T LT L + N ++
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 351 GNCQKLLVLNLSSNDLNGTIP 371
+ L+ L+LS N L+ T
Sbjct: 118 VKQKNLITLDLSHNGLSSTKL 138
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 30/220 (13%)
Query: 397 IGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITA 453
IG+GSFG+VYKG GD VA+K+L + L++F +E L+ TRH NIL +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
++ L A+V ++ +L LH K + + ++IA A +DYL
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLH------ASETKFEMKKLIDIARQTARGMDYL 136
Query: 514 HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGY 573
H I H DLK +N+ L +D T +GDFGLA S + L GSI +
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE-----QLSGSILW 188
Query: 574 IPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDM 609
+ PE + Q S D+Y++GI+L E+ TG+ P ++
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-49
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 30/230 (13%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECN--ALKSTRHRNILRVI 451
+G G +G V++G+ G VA+K+ + KS+ E RH NIL I
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
+ + L+ + G+L +L L + L I + +AS L
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLA 119
Query: 512 YLH-----HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+LH IAH DLK N+L+ K+ + D GLA S + ++ +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH---SQSTNQLDVGNNP 176
Query: 567 LKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRPTGDM 609
G+ Y+ PE ++ + + DI+++G++L E+ G +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 394 ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ-------QGALKSFIDECNALKSTRHR 445
E IG G FG V+KG + D ++VAIK L L + F E + + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+++ + +V EF+ G+L L + +L + +D
Sbjct: 84 NIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLD 130
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDK-----DMTAHVGDFGLAKFLFEISDNPSKN 560
+A ++Y+ + + PI H DL+ N+ L + A V DFGL++
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---------SV 180
Query: 561 QTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDM 609
+VS GL G+ ++ PE + + + D YS+ ++L + TG+ P +
Sbjct: 181 HSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 69/291 (23%), Positives = 107/291 (36%), Gaps = 46/291 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECN--ALKSTRHRN 446
IG G +G V+ G G VA+KV + S+ E RH N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
IL I A L+ ++ NG+L +L L L +A
Sbjct: 93 ILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSS 143
Query: 507 ASALDYLH-----HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
S L +LH IAH DLK N+L+ K+ T + D GLA + ++
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF---ISDTNEVD 200
Query: 562 TVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRPTG------- 607
G+ Y+PPE ++ ++ D+YS+G++L E+ G
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 608 ---DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDE--EQIEEVIEE 653
D+ D S + + L PS P +DE Q+ +++ E
Sbjct: 261 PYHDLVPSDPSYEDMREIV----CIKKLRPSFPNRWSSDECLRQMGKLMTE 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 394 ENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVIT 452
++G G FG K T G ++ +K L + ++F+ E ++ H N+L+ I
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
+ + E++ G L + + QR++ A D+AS + Y
Sbjct: 75 VLYK---DKRLN--FITEYIKGGTLRGIIKS------MDSQYPWSQRVSFAKDIASGMAY 123
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK---- 568
LH I H DL N L+ ++ V DFGLA+ + + P +++ +
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 569 ---GSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDM 609
G+ ++ PE +NG+ D++S+GI+L E+ D
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 55/254 (21%), Positives = 96/254 (37%), Gaps = 33/254 (12%)
Query: 369 TIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-- 425
+ P++ Q+ + + + LIG G FG VY G G+ VAI+++ +++
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN 69
Query: 426 QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP 485
+ LK+F E A + TRH N++ + AC S A++ L +
Sbjct: 70 EDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVR--- 121
Query: 486 AEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545
L V + IA ++ + YLH I H DLK NV D + + DFG
Sbjct: 122 ---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG----------DIYSYGIL 595
L + + G + ++ PE + D+++ G +
Sbjct: 175 LFSI--SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 596 LLEMFTGKRPTGDM 609
E+ + P
Sbjct: 233 WYELHAREWPFKTQ 246
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-46
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 38/282 (13%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECN--ALKSTRHRNILRVI 451
+ IG G FG V++G G VA+K+ ++ +S+ E RH NIL I
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
A + + LV ++ +G+L +L+ ++V + +A+ AS L
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLA 153
Query: 512 YLH-----HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+LH IAH DLK N+L+ K+ T + D GLA
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNH 210
Query: 567 LKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRPTGDM------FKDD 613
G+ Y+ PE ++ +++ DIY+ G++ E+ G + D
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDE--EQIEEVIEE 653
V L P++P ++ E + +++ E
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-43
Identities = 56/397 (14%), Positives = 126/397 (31%), Gaps = 48/397 (12%)
Query: 2 ELIMIPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLE 61
+ +D N Y + S+ +L E + Q+P+ L L +L+
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 62 IIGLGGSNLTG---------NVPAWIGNFSSLKALSLAWNNLRG-SIPNELGQLSGLGFF 111
+ + + + ++ + +NNL L ++ LG
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578
Query: 112 TLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171
N + + + + + NQ+ ++P D ++ + N I
Sbjct: 579 DCVHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634
Query: 172 P--VSLSNASNLQVLDFAENGLTGTIPGNFGSLKD-----LVRLNFDQNELGSREIGDLN 224
P + + + +DF+ N + S+ D + NE+ + +L
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI-QKFPTEL- 692
Query: 225 FLKFLANCTSLEVLGLARNSFG-------GEMPISIANLSTHLRRLTMGENLMHGNIPVG 277
A + + + L+ N + N L + + N + +
Sbjct: 693 ----FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT-YLLTTIDLRFNKLTS-LSDD 746
Query: 278 I--GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL------NVNKFSGLIPSSLGNL 329
L L+ + + N S S P ++L+ G+ N+ P+ +
Sbjct: 747 FRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805
Query: 330 TILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
L +L + N + + L +L +L+++ N
Sbjct: 806 PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-43
Identities = 51/396 (12%), Positives = 100/396 (25%), Gaps = 43/396 (10%)
Query: 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS 68
L + N ++ I + T+L+ + + F + +
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YA 477
Query: 69 NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI------- 121
N N L + L +P+ L L L + N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 122 --IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLT-LPNLKIFAGAVNYFTGSIPVSLSNA 178
+ I F + N L P L + L + N + +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTN 594
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
L L N + + L F N+L + + + + +
Sbjct: 595 VKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-----IPNIFNAKSVYVMGSV 649
Query: 239 GLARNSFGGEMPISIANLS----THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294
+ N G E ++ + +T+ N + ++ + L N +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
Query: 295 S-------GSVPEVIGRLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEGSI 346
+ L + L NK + L L L+ + + N S
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SF 768
Query: 347 PPSLGNCQKLLVLNL------SSNDLNGTIPKEVRQ 376
P N +L + N + P +
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-40
Identities = 57/379 (15%), Positives = 104/379 (27%), Gaps = 32/379 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVG---------QIPNQLSSLTKLEII 63
D+ L ++P L EL+S + N + ++ + + K++I
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 64 GLGGSNLTG-NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII 122
+G +NL A + L L N + G L L N I I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIP 611
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVGLT-LPNLKIFAGAVNYFTG-----SIPVSLS 176
+ + N+L +P + + + N S +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
Query: 177 NASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL-KFLANCTSL 235
N + + N + F + + + N + S L N L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 236 EVLGLARNSFGGEMPISIANLS-THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE---- 290
+ L N + + +L + + N P N L G+
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 291 --GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP 348
GN + P I L L + N + L I L + +N
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYI---LDIADNPNISIDVT 845
Query: 349 SLGNCQKLLVLNLSSNDLN 367
S+ + + L +
Sbjct: 846 SVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-40
Identities = 49/374 (13%), Positives = 112/374 (29%), Gaps = 28/374 (7%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNV 74
L+L G++P + TEL+ + ++ + +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 75 -PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI------IPSSIY 127
++ L L + + + E+ + +L I + I +I
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ 445
Query: 128 NISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFA 187
++ + + V N + +S SN +L ++
Sbjct: 446 RLTKLQIIYFANSPFTY-DNIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELY 499
Query: 188 ENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKF---LANCTSLEVLGLARNS 244
+P L +L LN N S ++ + +++ + N+
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 245 FGGEMP-ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIG 303
S+ + L L N + ++ G V L L L+ N + +
Sbjct: 560 LEEFPASASLQKM-VKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCA 616
Query: 304 RLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEG-----SIPPSLGNCQKLL 357
+++EGLG + NK + + ++ ++ + N++ S
Sbjct: 617 FTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676
Query: 358 VLNLSSNDLNGTIP 371
+ LS N++
Sbjct: 677 TVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-39
Identities = 63/360 (17%), Positives = 118/360 (32%), Gaps = 35/360 (9%)
Query: 38 SFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGS 97
+F ++ + Q L + ++ + L G G VP IG + LK LS ++ S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 98 IPNELGQLSGLGFFTLYGNFISGIIPS------SIYNISSIYYFSVTQNQLHGQLPTDVG 151
+ + I N+S + ++ +N + D
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD 211
++L + +I G + I ++ + LQ++ FA + T +
Sbjct: 423 ISLKDTQI--GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
Query: 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN--- 268
+NE S +N L + L ++P + +L L+ L + N
Sbjct: 481 ENEELS-----------WSNLKDLTDVELYNCPNMTQLPDFLYDL-PELQSLNIACNRGI 528
Query: 269 ------LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV-IGRLNKLEGLGLNVNKFSGL 321
+ + + + NNL + ++ KL L NK L
Sbjct: 529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
Query: 322 IPSSLGNLTILTRLWMEENRLEGSIPPSLG-NCQKLLVLNLSSNDLNGTIPKEVRQSGMS 380
+ G LT L ++ N++E IP ++ L S N L IP +
Sbjct: 589 --EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 21/115 (18%), Positives = 46/115 (40%), Gaps = 10/115 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSF------EASVNDFVGQIPNQLSSLTKLEIIGLG 66
+++++YN S PT + ++L++F +A N + Q P +++ L + +G
Sbjct: 756 SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI 121
+++ V + L L +A N + G + L + I
Sbjct: 815 SNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 16/108 (14%), Positives = 32/108 (29%), Gaps = 1/108 (0%)
Query: 293 NLSGSVPEV-IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG 351
++ G P V + ++ GL L G +P ++G LT L L + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 352 NCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGT 399
+ + + K + D ++ +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-42
Identities = 66/380 (17%), Positives = 119/380 (31%), Gaps = 29/380 (7%)
Query: 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIP----NQLSSLTKLEIIG 64
L+ L+L+ N ++ P L N + L+ L ++
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLR------GSIPNELGQLSGLGFFTLYGNFI 118
N L L++ L I + L+ + F+L I
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 119 SGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178
+ S + + + GQ PT +L L G S +
Sbjct: 295 ERVKDFS--YNFGWQHLELVNCKF-GQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDL 346
Query: 179 SNLQVLDFAENGLT--GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLE 236
+L+ LD + NGL+ G + L L+ N + + LE
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-------FLGLEQLE 399
Query: 237 VLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
L ++ S+ +L L + L +L +L + GN+
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 297 SV-PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQK 355
+ P++ L L L L+ + L P++ +L+ L L M N
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 356 LLVLNLSSNDLNGTIPKEVR 375
L VL+ S N + + +E++
Sbjct: 520 LQVLDYSLNHIMTSKKQELQ 539
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-41
Identities = 63/379 (16%), Positives = 118/379 (31%), Gaps = 23/379 (6%)
Query: 6 IPEHLM--TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEII 63
IP++L T++L+L++N L + EL+ + S + SL+ L +
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-I 122
L G+ + SSL+ L NL +G L L + N I +
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG----AVNYFTGSIPVSLSNA 178
P N++++ + ++ N++ TD+ L + + ++N P +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKE- 199
Query: 179 SNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEV 237
L L N + + L L E + + L +L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 238 LGLARNS---FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294
+ ++ L T++ ++ + L L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 295 SGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRL--EGSIPPSLGN 352
+ L + L G S +L L L + N L +G S
Sbjct: 317 GQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 353 CQKLLVLNLSSNDLNGTIP 371
L L+LS N +
Sbjct: 372 TTSLKYLDLSFNGVITMSS 390
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 71/373 (19%), Positives = 118/373 (31%), Gaps = 29/373 (7%)
Query: 13 QDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQ------IPNQLSSLTKLEIIGL 65
L L N+ S + + L + +F + + L L L I
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 66 GGSNL---TGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII 122
+ L ++ +++ + SL + G L
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFP 320
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKI--FAGAVNYFTGSIPVSLSNASN 180
+ ++ + + S ++ LP+L+ + F G S ++
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVD------LPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 181 LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240
L+ LD + NG+ T+ NF L+ L L+F + L ++ + +L L +
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-----MSEFSVFLSLRNLIYLDI 428
Query: 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVP 299
+ LS L L M N N I L NL L L L P
Sbjct: 429 SHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 300 EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLL-V 358
L+ L+ L ++ N F L L L L N + S L + L
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 359 LNLSSNDLNGTIP 371
LNL+ ND T
Sbjct: 548 LNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-33
Identities = 68/362 (18%), Positives = 114/362 (31%), Gaps = 25/362 (6%)
Query: 9 HLMTQDLNLTYNYLS-GKIPTNLSHCTELRSFEASVNDFVGQIPNQ-LSSLTKLEIIGLG 66
+L ++ L Y I + T + SF LE++
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFIS--GIIPS 124
SLK L+ + +G L L F L N +S G
Sbjct: 316 FGQFPTL------KLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 125 SIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVS-LSNASNLQV 183
S + +S+ Y ++ N + +GL L+ + S + NL
Sbjct: 368 SDFGTTSLKYLDLSFNGVITMSSNFLGL--EQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 184 LDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN 243
LD + G F L L L N + D +L L L++
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-----IFTELRNLTFLDLSQC 480
Query: 244 SFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIG 303
P + +L + L+ L M N L +L +L N++ S + +
Sbjct: 481 QLEQLSPTAFNSL-SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 304 RL-NKLEGLGLNVNKFSGLIPSS--LGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLN 360
+ L L L N F+ L + +L +E R+E + P +L LN
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MPVLSLN 598
Query: 361 LS 362
++
Sbjct: 599 IT 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-39
Identities = 68/397 (17%), Positives = 121/397 (30%), Gaps = 31/397 (7%)
Query: 6 IPEHLM--TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEII 63
IP L T+ L ++N L T S L + + + S +L+ +
Sbjct: 27 IPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTL 86
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIP 123
L + L + +LK L + L L L N IS I
Sbjct: 87 VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146
Query: 124 SSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNY-FTGSIPVSLSNASNLQ 182
+ + N +H D+ +L + +N I +++ Q
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMS-SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205
Query: 183 VLDFAENGLTGTIPGN--FGSLKDLVRLNFDQNELGSREIGDLNFLKFL----------- 229
L+F I +++ L F+ + L +
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 230 ---------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGN 280
+ L+ L L E+P + LS L++L + N + N
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQISASN 323
Query: 281 LVNLNLLGLEGNNLSGSV-PEVIGRLNKLEGLGLNVNK--FSGLIPSSLGNLTILTRLWM 337
+L L ++GN + + L L L L+ + S L NL+ L L +
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 338 EENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
N + C +L +L+L+ L +
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-39
Identities = 76/366 (20%), Positives = 119/366 (32%), Gaps = 17/366 (4%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCT--ELRSFEASVNDFVGQIPNQLSSLTK--LEIIGLGGS 68
Q LN I L + T L D P L + +E I L
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 69 NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYN 128
FS L+ L L +L +P+ L LS L L N + S N
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVN--YFTGSIPVSLSNASNLQVLDF 186
S+ + S+ N +L T L NL+ + + + + L N S+LQ L+
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 187 AENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246
+ N F L L+ L + N L+VL L+ +
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKV-----KDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 247 GEMPISIANLSTHLRRLTMGENLMHGNIPVGIG---NLVNLNLLGLEGNNLSGSVPEVIG 303
L L+ L + N L L +L L +LS
Sbjct: 439 ISSEQLFDGLP-ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
Query: 304 RLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSS 363
L + + L+ N+ + +L +L + L + N + +P L + +NL
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQ 556
Query: 364 NDLNGT 369
N L+ T
Sbjct: 557 NPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 61/371 (16%), Positives = 114/371 (30%), Gaps = 19/371 (5%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLG-GSNLT 71
+ L L N++S +L+ + N +SSL + + L N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELG--QLSGLGFFTLYGNFISGIIPSSIYNI 129
+ + + ++L+ I L + L T I P+ +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 130 S--SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFA 187
S+ ++ ++ + ++ L+ + + +P L S L+ L +
Sbjct: 252 CEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 188 ENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN--SF 245
N + + L L+ N L N +L L L+ +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLEL-----GTGCLENLENLRELDLSHDDIET 364
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGR 304
+ + NL +HL+ L + N L LL L L +
Sbjct: 365 SDCCNLQLRNL-SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSI---PPSLGNCQKLLVLNL 361
L+ L+ L L+ + L L L ++ N SL +L +L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 362 SSNDLNGTIPK 372
S DL+
Sbjct: 484 SFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 41/213 (19%), Positives = 74/213 (34%), Gaps = 12/213 (5%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
IP +L ++ + L+F+ N L F L +L L+ + ++ I + F
Sbjct: 26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI--YWIHEDTF---- 77
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
+ L+ L L N +++ L+ L + + + + N L L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGP-KALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTR--LWMEENRLEGSIP 347
N++S KL+ L N L + +L T L + N + I
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIE 195
Query: 348 PSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMS 380
P + LN I K ++ S +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 55/345 (15%), Positives = 108/345 (31%), Gaps = 54/345 (15%)
Query: 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
T LR + + LS + + N ++ + +
Sbjct: 18 YFQGSTALRPY-----------HDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 89 LAWNNLRGSIPNELGQLS--GLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQL 146
L+ + + L + G L + P + +S + + ++ L
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM--- 117
Query: 147 PTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLV 206
+P ++ + L+ L A N L +P + SL L
Sbjct: 118 -----------------------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 207 RLNF-DQNELGS--REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRL 263
L+ EL + + +L+ L L +P SIANL +L+ L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL-QNLKSL 211
Query: 264 TMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL-NVNKFSGLI 322
+ + + + I +L L L L G + P + G L+ L L + + L
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL- 269
Query: 323 PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
P + LT L +L + +P + ++ + +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 56/311 (18%), Positives = 95/311 (30%), Gaps = 31/311 (9%)
Query: 78 IGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137
+ S + L + + L Q N ++ +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETR 63
Query: 138 TQNQLHGQLPTDVG-LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP 196
T L + T P P S+LQ + GL +P
Sbjct: 64 TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 197 GNFGSLKDLVRLNFDQNELGS--REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA 254
L L +N L + I + L L + E+P +A
Sbjct: 121 DTMQQFAGLETLTLARNPLRALPASIA---------SLNRLRELSIRACPELTELPEPLA 171
Query: 255 NLS--------THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLN 306
+ +L+ L + + ++P I NL NL L + + LS ++ I L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE-NRLEGSIPPSLGNCQKLLVLNLSSND 365
KLE L L P G L RL +++ + L ++P + +L L+L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 366 LNGTIPKEVRQ 376
+P + Q
Sbjct: 289 NLSRLPSLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/355 (15%), Positives = 113/355 (31%), Gaps = 60/355 (16%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
++L + LS + + + + N +I G L
Sbjct: 15 ENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK- 69
Query: 73 NVPAWIGNFSS--LKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNIS 130
+ + + AL L L P++ +LS L T+ + +P ++ +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 131 SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG 190
+ ++ +N L ++P S+++ + L+ L
Sbjct: 128 GLETLTLARNPLR--------------------------ALPASIASLNRLRELSIRACP 161
Query: 191 LTGTIPGNFGS---------LKDLVRLNFDQNELGS--REIGDLNFLKFLANCTSLEVLG 239
+P S L +L L + + S I +L +L+ L
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANL---------QNLKSLK 212
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299
+ + + +I +L L L + N P G L L L+ + ++P
Sbjct: 213 IRNSPLS-ALGPAIHHL-PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 300 EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN---RLEGSIPPSLG 351
I RL +LE L L +PS + L + + + +L+ P +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 39/231 (16%), Positives = 74/231 (32%), Gaps = 32/231 (13%)
Query: 169 GSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKF 228
GS ++S + L F + + + ++ + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQI 60
Query: 229 L----------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG 272
A L L + P L +HL+ +T+ +
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRL-SHLQHMTIDAAGLM- 117
Query: 273 NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI- 331
+P + L L L N L ++P I LN+L L + +P L +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 332 --------LTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
L L +E + S+P S+ N Q L L + ++ L+ + +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 73/354 (20%), Positives = 134/354 (37%), Gaps = 33/354 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L ++ + + + V I + LT LE + L G+ +T
Sbjct: 25 IRAVLQKASVTDVVT--QEELESITKLVVAGEK-VASIQG-IEYLTNLEYLNLNGNQITD 80
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
P + N L L + N + + + L L+ L L + IS I P + N++ +
Sbjct: 81 ISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKM 134
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
Y ++ N + + + L + P ++N ++L L N +
Sbjct: 135 YSLNLGANHNLS-DLSPLS-NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
P SL L N++ + +AN T L L + N
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITD--------ITPVANMTRLNSLKIGNNKI--TDLSP 238
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
+ANL + L L +G N + +I + +L L +L + N +S V+ L++L L
Sbjct: 239 LANL-SQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
LN N+ +G LT LT L++ +N + P L + K+ + ++ +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-32
Identities = 67/323 (20%), Positives = 129/323 (39%), Gaps = 31/323 (9%)
Query: 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113
+ L + L +++T V S+ L +A + SI + L+ L + L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173
GN I+ I P + N+ + + N++ + + L NL+ + + P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQ-NLTNLRELYLNEDNISDISP- 127
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
L+N + + L+ N + ++ L L ++++ + +AN T
Sbjct: 128 -LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--------VTPIANLT 177
Query: 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293
L L L N E +A+L T L T N + P + N+ LN L + N
Sbjct: 178 DLYSLSLNYNQI--EDISPLASL-TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232
Query: 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353
++ P + L++L L + N+ S + +++ +LT L L + N++ L N
Sbjct: 233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNL 286
Query: 354 QKLLVLNLSSNDLNGTIPKEVRQ 376
+L L L++N L + +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGG 309
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-36
Identities = 60/401 (14%), Positives = 119/401 (29%), Gaps = 54/401 (13%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+L LT N + P + S T L + A + L L+ + + + +
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 73 -NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY----GNFISGIIPSSIY 127
+PA+ N ++L + L++N ++ N+L L L N I I +
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 128 NISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQ----- 182
I ++ ++ N + L L + + F + + S ++
Sbjct: 203 GIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 183 ---VLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
F L ++ ++ + +L+ + + L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLS 313
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG--- 296
+ R +L L+ LT+ N G+I L +L+ L L N LS
Sbjct: 314 IIRCQLKQ---FPTLDLP-FLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 297 ----------------------SVPEVIGRLNKLEGLGLNVNKFSGLIP-SSLGNLTILT 333
+ L +L+ L + + S+ +L L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 334 RLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
L + + L L ++ N V
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 67/375 (17%), Positives = 119/375 (31%), Gaps = 30/375 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVN---DFVGQIPNQLSSLTKLEIIGLGGSN 69
++L+YNY+ +L E S++ + + I +Q KL + L G+
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF 215
Query: 70 LTGNVPAW-IGNFSSLKALSLAWNNLRG---------SIPNELGQLSGLGFFTLYGNFIS 119
+ N+ + N + L L + SI L ++ F L
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTYTNDF 274
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
+ ++++ S+ + L + + + L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF--KWQSLSIIRCQLKQFPTLDLPF-- 329
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
L+ L N + I +L L L+ +N L + L SL L
Sbjct: 330 -LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL----GTNSLRHLD 382
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVG-IGNLVNLNLLGLEGNNLSGSV 298
L+ N M + L L+ L + + +L L L + N
Sbjct: 383 LSFNGAI-IMSANFMGL-EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 299 PEVIGRLNKLEGLGLNVNKFSGLIPSS-LGNLTILTRLWMEENRLEGSIPPSLGNCQKLL 357
+ L L L + N F S+ N T LT L + + +LE +L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 358 VLNLSSNDLNGTIPK 372
+LN+S N+L
Sbjct: 501 LLNMSHNNLLFLDSS 515
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 72/376 (19%), Positives = 129/376 (34%), Gaps = 44/376 (11%)
Query: 6 IPEHLM--TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEII 63
+P+ + T++++L++N L + S+ +EL+ + S + L L +
Sbjct: 26 VPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNL 85
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-I 122
L G+ + P +SL+ L L +GQL L + NFI +
Sbjct: 86 ILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKL 145
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQ 182
P+ N++++ + ++ N + + + L
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENP--------------------QVNL 184
Query: 183 VLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242
LD + N + F +K L L N S + L N L V L
Sbjct: 185 SLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKT-----CLQNLAGLHVHRLIL 238
Query: 243 NSFGGEMPISIANLST--HLRRLTMGE-NLMHGNI----PVGIGNLVNLNLLGLEGNNLS 295
F E + I S L +T+ E L + N V L N++ + L G ++
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 296 GSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQK 355
+ + K + L + + L L LT + N+ SI
Sbjct: 299 YLED--VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT---LTMNKG--SISFKKVALPS 351
Query: 356 LLVLNLSSNDLNGTIP 371
L L+LS N L+ +
Sbjct: 352 LSYLDLSRNALSFSGC 367
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 66/361 (18%), Positives = 105/361 (29%), Gaps = 64/361 (17%)
Query: 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS 68
+ + LTY + + + + + K + + +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRC 317
Query: 69 NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYN 128
L + LK+L+L N SI + L L + L N +S S +
Sbjct: 318 QLKQFPTL---DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372
Query: 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE 188
L +L+ + N + + LQ LDF
Sbjct: 373 -----------------------LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 189 NGLTGTIP-GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG 247
+ L F SL+ L+ L+ G TSL L +A NSF
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG------IFLGLTSLNTLKMAGNSF-- 460
Query: 248 EMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLN 306
N + N NL L L L V L+
Sbjct: 461 -----------------------KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
+L+ L ++ N L S L L+ L NR+E S + L NL++N +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 367 N 367
Sbjct: 558 A 558
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 62/230 (26%), Positives = 91/230 (39%), Gaps = 28/230 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
+ +G GSFG V +G G VA+K LK L Q A+ FI E NA+ S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
HRN++R+ + + +V E G+L L +
Sbjct: 78 LDHRNLIRLYGVVLTPPM------KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSR 125
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
A+ VA + YL H DL N+LL +GDFGL + L + D +
Sbjct: 126 YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HY 178
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ K + PE + S D + +G+ L EMFT G+ P +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 33/239 (13%)
Query: 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNA 438
+++ + +F + LIG+G FG V+K DG IK +K + A + E A
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKA 57
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKA-----------LVFEFMSNGNLDQWLHPSPAE 487
L H NI+ D + + EF G L+QW+ E
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----E 112
Query: 488 HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
+ +KL + L + + +DY+H + + DLKPSN+ L +GDFGL
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
L N K KG++ Y+ PE ++ Q D+Y+ G++L E+
Sbjct: 170 TSL----KNDGKRTRS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRNILRVIT 452
IG GSF +VYKG VA L+ ++ + F +E LK +H NI+R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
+ S LV E M++G L +L +FK + + + + L +
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLK-------RFKVMKIKVLRSWCRQILKGLQF 144
Query: 513 LHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSI 571
LH PI H DLK N+ + + +GD GLA S + V G+
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAV----IGTP 194
Query: 572 GYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
++ PE + D+Y++G+ +LEM T + P
Sbjct: 195 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 16/224 (7%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
++ +G G F V L DG A+K + +Q + E + + H NIL
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 449 RVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
R++ + G +A L+ F G L + + L+ Q L + + +
Sbjct: 90 RLVA--YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG---NFLTEDQILWLLLGIC 144
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS--I 565
L+ +H AH DLKP+N+LL + + D G + + T+
Sbjct: 145 RGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 566 GLKGSIGYIPPEHMNGQVSILG----DIYSYGILLLEMFTGKRP 605
+ +I Y PE + Q + D++S G +L M G+ P
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 28/245 (11%)
Query: 366 LNGTIPKEVRQSGMSYSD-ISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL 423
G + ++ G S S +F + + +G GS+G V+K DG + A+K
Sbjct: 33 FRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92
Query: 424 QQQGA--LKSFIDECNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQW 480
+G + E + + +H +R+ A E L E +L Q
Sbjct: 93 PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTEL-CGPSLQQH 146
Query: 481 LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540
L Q D AL +LH + H D+KP+N+ L
Sbjct: 147 CEAWG------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMF 600
+GDFGL L + +G Y+ PE + G D++S G+ +LE+
Sbjct: 198 LGDFGLLVEL----GTAGAGEVQ----EGDPRYMAPELLQGSYGTAADVFSLGLTILEVA 249
Query: 601 TGKRP 605
Sbjct: 250 CNMEL 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
++ E +G G FG V+ T T VA+K +K ++++F+ E N +K+ +H ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ + + ++ EFM+ G+L +L KL ++ + +A
Sbjct: 247 KLHAVVT------KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAE 295
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ ++ H DL+ +N+L+ + + DFGLA+ + + T G K
Sbjct: 296 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY------TAREGAK 346
Query: 569 GSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
I + PE +N G +I D++S+GILL+E+ T G+ P M
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 30/230 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTI-VAIKVLKL-QQQGALKSFIDECNALKST 442
F K ++G+G+FG+VYKG I VAIK L+ A K +DE + S
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
+ ++ R++ C + + L+ + M G L ++ + LN
Sbjct: 75 DNPHVCRLLGICLTSTV------QLITQLMPFGCLLDYVREHK------DNIGSQYLLNW 122
Query: 503 AIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ +A ++YL H DL NVL+ + DFGLAK L +
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----E 173
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ G K I ++ E + + D++SYG+ + E+ T G +P +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 349 SLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKG 408
+ G C +L + +S + K+ + I + ++ E +G G FG V+ G
Sbjct: 153 ADGLCHRLTTVCPTSKPQTQGLAKDAWE-------IPR--ESLRLEVKLGQGCFGEVWMG 203
Query: 409 TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468
T T VAIK LK + ++F+ E +K RH ++++ S + +V
Sbjct: 204 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIV 256
Query: 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528
E+MS G+L +L K L + Q +++A +AS + Y+ H DL+
Sbjct: 257 TEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 308
Query: 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILG 587
+N+L+ +++ V DFGLA+ + + T G K I + PE G+ +I
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 588 DIYSYGILLLEMFT-GKRPTGDM 609
D++S+GILL E+ T G+ P M
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM 385
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 1e-33
Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 32/263 (12%)
Query: 349 SLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKG 408
+ G C +L + +S + K+ + I + ++ E +G G FG V+ G
Sbjct: 236 ADGLCHRLTTVCPTSKPQTQGLAKDAWE-------IPR--ESLRLEVKLGQGCFGEVWMG 286
Query: 409 TLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468
T T VAIK LK + ++F+ E +K RH ++++ S + +V
Sbjct: 287 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIV 339
Query: 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528
E+MS G+L +L K L + Q +++A +AS + Y+ H DL+
Sbjct: 340 TEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 391
Query: 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILG 587
+N+L+ +++ V DFGLA+ + + + K I + PE G+ +I
Sbjct: 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGA------KFPIKWTAPEAALYGRFTIKS 445
Query: 588 DIYSYGILLLEMFT-GKRPTGDM 609
D++S+GILL E+ T G+ P M
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGM 468
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 393 KENLIGTGSFGSVYKGTL---GDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNI 447
++ +G+G+FG+V KG VA+K+LK + E N ++ + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+R+I C + LV E G L+++L + + + + + V+
Sbjct: 81 VRMIGICEAESW------MLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVS 127
Query: 508 SALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+ YL + H DL NVLL A + DFGL+K L +
Sbjct: 128 MGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN----YYKAQTH 179
Query: 567 LKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
K + + PE +N + S D++S+G+L+ E F+ G++P M
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/254 (22%), Positives = 100/254 (39%), Gaps = 27/254 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR 443
+ + +G G+FGSV G +VA+K L+ + F E LK+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
I++ G LV E++ +G L +L A +L + L +
Sbjct: 83 SDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRA------RLDASRLLLYS 133
Query: 504 IDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ ++YL C H DL N+L++ + + DFGLAK L D
Sbjct: 134 SQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----YYV 185
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP-TGDMFKDDFSIHMF 619
V + I + PE ++ S D++S+G++L E+FT + +
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 620 VSMALPDHVMDILD 633
AL ++++L+
Sbjct: 246 DVPALSR-LLELLE 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
+ + ++ +G G +G VY+G VA+K LK + ++ F+ E +K +H N+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
++++ C+ F ++ EFM+ GNL +L +++S + L +A ++
Sbjct: 279 VQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQIS 328
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
SA++YL H +L N L+ ++ V DFGL++ ++ + T G
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL---MTGD---TYTAHAGA 379
Query: 568 KGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
K I + PE + + SI D++++G+LL E+ T G P +
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRN 446
+ IG+G FG V+ G + VAIK ++ +GA+ + FI+E + H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
++++ C LV EFM +G L +L + L + +DV
Sbjct: 65 LVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDV 113
Query: 507 ASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ YL H DL N L+ ++ V DFG+ +F + D+ T S
Sbjct: 114 CEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF---VLDD---QYTSST 163
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K + + PE + + S D++S+G+L+ E+F+ GK P +
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 394 ENLIGTGSFGSVYKGTL--GDGTI-VAIKVLKL-QQQGALKSFIDECNALKSTRHRNILR 449
+ +G G+FGSV +G I VAIKVLK ++ + + E + + I+R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+I C + L LV E G L ++L +++ V + V+
Sbjct: 75 LIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMG 122
Query: 510 LDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ YL + H DL NVLL A + DFGL+K L T K
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS----YYTARSAGK 174
Query: 569 GSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ + PE +N + S D++SYG+ + E + G++P M
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-33
Identities = 45/217 (20%), Positives = 81/217 (37%), Gaps = 28/217 (12%)
Query: 396 LIGTGSFGSVYKG--TLGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVIT 452
I G G +Y +G V +K L A + E L H +I+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDY 512
D G+ +V E++ +L + +KL V + + +++ AL Y
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSY 197
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIG 572
LH + + DLKP N++L ++ + D G + N + G+ G
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI---------NSFGYLY--GTPG 242
Query: 573 YIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP-TGD 608
+ PE + ++ DIY+ G L + G
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 23/240 (9%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQG-- 427
P+ Q + + NF E IG G F VY+ L DG VA+K +++
Sbjct: 14 PQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73
Query: 428 -ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA 486
A I E + LK H N+++ + +E N+ +V E G+L + +
Sbjct: 74 KARADCIKEIDLLKQLNHPNVIKYYASF----IEDNELN-IVLELADAGDLSRMIKHFKK 128
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
+ + +V + + SAL+++H + H D+KP+NV + +GD GL
Sbjct: 129 QKRLIPERTV---WKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+F S + ++ G+ Y+ PE ++ + DI+S G LL EM + P
Sbjct: 183 GRFF---SSKTTAAHSL----VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 25/228 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKL-QQQGALKSFIDECNALKSTR 443
E +IG+G G V G L VAIK LK + + F+ E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H NI+R+ + G +V E+M NG+LD +L + +++Q + +
Sbjct: 109 HPNIIRLEGVVT----RGRLA-MIVTEYMENGSLDTFLRTHD------GQFTIMQLVGML 157
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
V + + YL H DL NVL+D ++ V DFGL++ L + D
Sbjct: 158 RGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-- 212
Query: 564 SIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K I + PE + S D++S+G+++ E+ G+RP +M
Sbjct: 213 --GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 19/223 (8%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHR 445
+++ IGTGS+G K DG I+ K L + + E N L+ +H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+R + N +V E+ G+L + E + V L +
Sbjct: 66 NIVRYY---DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV---LRVMTQ 119
Query: 506 VASALDYLH--HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ AL H + H DLKP+NV LD +GDFGLA+ L + + S +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTF 176
Query: 564 SIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE MN + DI+S G LL E+ P
Sbjct: 177 ----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 36/247 (14%)
Query: 380 SYSDISKSTDNFSKE---------NLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQ-Q 425
++ D +++ F+KE ++G G FG V G L VAIK LK+
Sbjct: 27 TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 426 QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP 485
+ + F+ E + + H NI+R+ + + +V E+M NG+LD +L
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHD 141
Query: 486 AEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544
+ +VIQ + + +AS + YL H DL N+L++ ++ V DF
Sbjct: 142 ------AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDF 191
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-G 602
GL + L + + + G K I + PE + + + D++SYGI+L E+ + G
Sbjct: 192 GLGRVLEDDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 603 KRPTGDM 609
+RP +M
Sbjct: 248 ERPYWEM 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRN 446
+ + +GTG FG V G VAIK++K +G++ FI+E + + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
++++ C+ ++ E+M+NG L +L + Q L + DV
Sbjct: 81 LVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDV 129
Query: 507 ASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
A++YL H DL N L++ V DFGL+++ + D+ T S+
Sbjct: 130 CEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDD---EYTSSV 179
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K + + PPE + + S DI+++G+L+ E+++ GK P
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRN 446
+ +G G FG V+ G T VA+K LK QG++ +F+ E N +K +H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQR 69
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
++R+ + + ++ E+M NG+L +L KL++ + L++A +
Sbjct: 70 LVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQI 118
Query: 507 ASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
A + ++ + H DL+ +N+L+ ++ + DFGLA+ + + T
Sbjct: 119 AEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIED------NEYTARE 168
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K I + PE +N G +I D++S+GILL E+ T G+ P M
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR 443
+ +G G+FGSV G +VA+K L+ + L+ F E LKS +
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H NI++ C S L+ E++ G+L +L +++ I+ L
Sbjct: 70 HDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 504 IDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ ++YL H DL N+L++ + +GDFGL K L + +
Sbjct: 121 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----FFK 172
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT 601
V + I + PE + + S+ D++S+G++L E+FT
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 29/224 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA-LKSFIDECNALKSTRHRNI 447
IG G FG V G G VA+K +K A ++F+ E + + RH N+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNL 248
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
++++ E +V E+M+ G+L +L L L ++DV
Sbjct: 249 VQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVC 299
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
A++YL + H DL NVL+ +D A V DFGL K D
Sbjct: 300 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----------TG 346
Query: 568 KGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
K + + PE + + S D++S+GILL E+++ G+ P +
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHRN 446
+ + +G+G FG V G VA+K++K +G++ F E + H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
+++ CS +V E++SNG L +L K L Q L + DV
Sbjct: 65 LVKFYGVCSK-----EYPIYIVTEYISNGCLLNYLRSHG------KGLEPSQLLEMCYDV 113
Query: 507 ASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ +L H H DL N L+D+D+ V DFG+ ++ + D+ S+
Sbjct: 114 CEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDD---QYVSSV 163
Query: 566 GLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G K + + PE + + S D++++GIL+ E+F+ GK P
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 52/242 (21%), Positives = 94/242 (38%), Gaps = 27/242 (11%)
Query: 371 PKEVRQSGMSYSDISKST---DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ 426
SG+ + + + + IG GSFG DG IK + + +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62
Query: 427 GA--LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS 484
+ + E L + +H NI++ + E +V ++ G+L + +
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESF----EENGSLY-IVMDYCEGGDLFKRI--- 114
Query: 485 PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544
+ Q L+ + + AL ++H I H D+K N+ L KD T +GDF
Sbjct: 115 --NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGK 603
G+A+ L + + G+ Y+ PE + + DI++ G +L E+ T K
Sbjct: 170 GIARVL---NSTVELARAC----IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
Query: 604 RP 605
Sbjct: 223 HA 224
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 76/356 (21%), Positives = 141/356 (39%), Gaps = 37/356 (10%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L ++ + + ++ + +A + + + L L I + LT
Sbjct: 27 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTD 82
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
P + N + L + + N + P L L+ L TL+ N I+ I P + N++++
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNL 136
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
++ N + + + L +L+ + N T P L+N + L+ LD + N ++
Sbjct: 137 NRLELSSNTISD--ISALS-GLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
L +L L N++ + L T+L+ L L N + +
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISD--------ITPLGILTNLDELSLNGNQL--KDIGT 238
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
+A+L T+L L + N + P + L L L L N +S P + L L L
Sbjct: 239 LASL-TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
LN N+ + P + NL LT L + N + P + + KL L +N ++
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-31
Identities = 79/331 (23%), Positives = 128/331 (38%), Gaps = 37/331 (11%)
Query: 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113
++L + LG +N+T V + + L + + + L+ L
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173
N ++ I P + N++ + + NQ+ P L NL N T P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDIDP- 129
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL---- 229
L N +NL L+ + N ++ L L +L+F + + +L L+ L
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 186
Query: 230 ---------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGN 280
A T+LE L N + L T+L L++ N + + +
Sbjct: 187 NKVSDISVLAKLTNLESLIATNNQI--SDITPLGIL-TNLDELSLNGNQLKD--IGTLAS 241
Query: 281 LVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
L NL L L N +S P + L KL L L N+ S + P L LT LT L + EN
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 297
Query: 341 RLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371
+LE P + N + L L L N+++ P
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-30
Identities = 90/380 (23%), Positives = 153/380 (40%), Gaps = 37/380 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L L N ++ L + T L E S N + I LS LT L+ + G + +T
Sbjct: 115 TGLTLFNNQITD--IDPLKNLTNLNRLELSSNT-ISDISA-LSGLTSLQQLSFG-NQVTD 169
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
P + N ++L+ L ++ N + S + L +L+ L N IS I P + ++++
Sbjct: 170 LKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
S+ NQL + T LT NL A N + P LS + L L N ++
Sbjct: 224 DELSLNGNQLKD-IGTLASLT--NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
P L L L ++N+L + ++N +L L L N+
Sbjct: 279 NISP--LAGLTALTNLELNENQLED--------ISPISNLKNLTYLTLYFNNI--SDISP 326
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
+++L T L+RL N + + + NL N+N L N +S P + L ++ LG
Sbjct: 327 VSSL-TKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372
LN ++ + N++I + L P ++ + +++ N +
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLP--SYTN 437
Query: 373 EVRQSGMSYSDISKSTDNFS 392
EV + I K T FS
Sbjct: 438 EVSYTFSQPVTIGKGTTTFS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 29/314 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ L+++ N +S + L+ T L S A+ N P L LT L+ + L G+ L
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+ + ++L L LA N + P L L+ L L N IS I P + ++++
Sbjct: 236 IGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 289
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+ +NQL P L NL N + P +S+ + LQ L F N ++
Sbjct: 290 TNLELNENQLEDISPIS---NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
+ +L ++ L+ N++ L LAN T + LGL ++ P++
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISD--------LTPLANLTRITQLGLNDQAWTNA-PVN 393
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
+ + + P I + + + N S EV ++ +G
Sbjct: 394 YKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIG 450
Query: 313 LNVNKFSGLIPSSL 326
FSG + L
Sbjct: 451 KGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 58/303 (19%)
Query: 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQL 142
L + ++ + I L+ L ++ + + ++ + + +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 143 HGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSL 202
+ +NL ++F+ N LT P +L
Sbjct: 59 ---------------------------KSIDGVEYLNNLTQINFSNNQLTDITP--LKNL 89
Query: 203 KDLVRLNFDQNEL-GSREIGDLNFLKFL-------------ANCTSLEVLGLARNSFGGE 248
LV + + N++ + +L L L N T+L L L+ N+
Sbjct: 90 TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD- 148
Query: 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKL 308
+++ L T L++L+ G + + NL L L + N +S V+ +L L
Sbjct: 149 -ISALSGL-TSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNL 201
Query: 309 EGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
E L N+ S + P LG LT L L + N+L+ +L + L L+L++N ++
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 369 TIP 371
P
Sbjct: 258 LAP 260
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 29/257 (11%)
Query: 363 SNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL----GDGTIVAI 418
+ +G +P+ + D+ + ++G G FGSV +G L G VA+
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 419 KVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGN 476
K +KL Q ++ F+ E +K H N++R++ C + +G ++ FM G+
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 477 LDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDK 535
L +L S E K + + L +D+A ++YL + + H DL N +L
Sbjct: 128 LHTYLLYSRLETGP-KHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARNCMLRD 182
Query: 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMN-GQVSILGDI 589
DMT V DFGL+K ++ +G I +P E + + D+
Sbjct: 183 DMTVCVADFGLSKKIYSG----------DYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 232
Query: 590 YSYGILLLEMFT-GKRP 605
+++G+ + E+ T G P
Sbjct: 233 WAFGVTMWEIATRGMTP 249
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR 443
+ +G G+FGSV G +VA+K L+ + L+ F E LKS +
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H NI++ C S L+ E++ G+L +L +++ I+ L
Sbjct: 101 HDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 151
Query: 504 IDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ ++YL H DL N+L++ + +GDFGL K L + +
Sbjct: 152 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----YYK 203
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT 601
V + I + PE + + S+ D++S+G++L E+FT
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 28/229 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQ-QQGALKSFIDECNALKST 442
K ++G+G FG+V+KG V IKV++ + + + ++ D A+ S
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H +I+R++ C L LV +++ G+L + L LN
Sbjct: 73 DHAHIVRLLGLCPGSSL------QLVTQYLPLGSLLDHVRQHR------GALGPQLLLNW 120
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ +A + YL H + H +L NVLL V DFG+A L Q
Sbjct: 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QL 172
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ K I ++ E ++ G+ + D++SYG+ + E+ T G P +
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 35/288 (12%), Positives = 77/288 (26%), Gaps = 42/288 (14%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECN 437
S +S+ + G V+ + A+KV + L+ +
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 438 ALKSTRHRNI------LRVITACSSVDLEG-----------NDFKA----LVFEFMSNGN 476
A + R++ +V ++ +D+ L+ S +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VD 173
Query: 477 LDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536
L+ + ++ + + L + H P N+ + D
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPD 230
Query: 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYG 593
+GD K T + Y P E +N + + + G
Sbjct: 231 GRLMLGDVSALW----------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 594 ILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEE 641
+ + ++ P G + S+ +P PL +
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 30/232 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQG-ALKSFIDECNALKSTRHRN 446
+F +G G FG V++ D AIK ++L + A + + E AL H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 447 ILRVITACSSVDLEGNDFKA-------LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
I+R A + + + + NL W++ ++
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN----GRCTIEERERSVC 120
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD--NP 557
L+I + +A A+++LH + H DLKPSN+ D VGDFGL + + +
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 558 SKNQTVSIGLKGSIG---YIPPEHMNGQ-----VSILGDIYSYGILLLEMFT 601
G +G Y+ PE ++G V DI+S G++L E+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV----DIFSLGLILFELLY 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 33/230 (14%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRN 446
++ IG G+FG V+ G L D T+VA+K + F+ E LK H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+R+I C+ +V E + G+ +L +L V L + D
Sbjct: 174 IVRLIGVCT-----QKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDA 222
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
A+ ++YL H DL N L+ + + DFG+++ + +
Sbjct: 223 AAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-------GVYAA-- 270
Query: 567 LKGSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
G + +P PE +N G+ S D++S+GILL E F+ G P ++
Sbjct: 271 -SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKL-QQQGALKSFIDECNALKST 442
+ +G G FG V G VA+K LK + E L++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H NI++ C+ +G + L+ EF+ +G+L ++L + K+++ Q+L
Sbjct: 81 YHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNK------NKINLKQQLKY 131
Query: 503 AIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
A+ + +DYL H DL NVL++ + +GDFGL K + +
Sbjct: 132 AVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE----YY 183
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
TV + + PE + + I D++S+G+ L E+ T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 30/237 (12%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR 443
+ +F + ++G G+FG V K D AIK ++ ++ L + + E L S
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLN 60
Query: 444 HRNILRVITACSSVDLEGNDFKA--------LVFEFMSNGNLDQWLHPSPAEHYQFKKLS 495
H+ ++R A A + E+ NG L +H
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQ 114
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+ + + AL Y+H I H DLKP N+ +D+ +GDFGLAK + D
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 556 NPSKNQTVSIG----LKGSIG---YIPPEHMNGQVSILG---DIYSYGILLLEMFTG 602
+ G L +IG Y+ E ++G D+YS GI+ EM
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYP 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 34/233 (14%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTI-----VAIKVLKLQQQGA----LKSFIDECNAL 439
+++ +IG G FG VYKG L + VAIK LK G F+ E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
H NI+R+ S ++ E+M NG LD++L + SV+Q
Sbjct: 101 GQFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKD------GEFSVLQL 149
Query: 500 LNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
+ + +A+ + YL + + H DL N+L++ ++ V DFGL++ L + +
Sbjct: 150 VGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--- 202
Query: 559 KNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ G K I + PE ++ + + D++S+GI++ E+ T G+RP ++
Sbjct: 203 -ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 47/229 (20%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKL-QQQGALKSFIDECNALKSTR 443
+ IG G FG V++G VAIK K + F+ E ++
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H +I+++I + + ++ E + G L +L L + + A
Sbjct: 75 HPHIVKLIGVITENPV------WIIMELCTLGELRSFLQVRK------YSLDLASLILYA 122
Query: 504 IDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+++AL YL H D+ NVL+ + +GDFGL++++ +
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYY 172
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ K I ++ PE +N + + D++ +G+ + E+ G +P +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDG-----TIVAIKVLKL-QQQGALKSFIDECNALKST 442
F K ++G+G+FG+VYKG VAIK L+ A K +DE + S
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
+ ++ R++ C + + L+ + M G L ++ + LN
Sbjct: 75 DNPHVCRLLGICLTSTV------QLITQLMPFGCLLDYVREHK------DNIGSQYLLNW 122
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ +A ++YL + H DL NVL+ + DFGLAK L +
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ G K I ++ E + + D++SYG+ + E+ T G +P +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 396 LIGTGSFGSVYKGTLGD---GTIVAIKVLKLQQQG---ALKSFIDECNALKSTRHRNILR 449
+G G +VY D VAIK + + + LK F E + H+NI+
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 450 VITACSSVDL-EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+I D+ E +D LV E++ L +++ LSV +N +
Sbjct: 76 MI------DVDEEDDCYYLVMEYIEGPTLSEYIE-------SHGPLSVDTAINFTNQILD 122
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ + H I H D+KP N+L+D + T + DFG+AK L S QT +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHV--L 173
Query: 569 GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGD 608
G++ Y PE G+ DIYS GI+L EM G+ P G+
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 46/229 (20%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKL-QQQGALKSFIDECNALKSTR 443
++ ++G G FG VY+G G+ VA+K K + F+ E +K+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H +I+++I ++ E G L +L + L V+ + +
Sbjct: 72 HPHIVKLIGIIEEEPT------WIIMELYPYGELGHYLERNK------NSLKVLTLVLYS 119
Query: 504 IDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ + A+ YL +C H D+ N+L+ +GDFGL++++ + ++
Sbjct: 120 LQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED------EDYY 169
Query: 563 VSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ + I ++ PE +N + + D++ + + + E+ + GK+P +
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDG----TIVAIKVLK-LQQQGALKSFIDECNA 438
I + +IG G FG VY G D AIK L + + +++F+ E
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
++ H N+L +I EG ++ +M +G+L Q++ + +V
Sbjct: 76 MRGLNHPNVLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQ------RNPTVKD 125
Query: 499 RLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
++ + VA ++YL H DL N +LD+ T V DFGLA+ + +
Sbjct: 126 LISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181
Query: 558 SKNQTVSIGLKGSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
+ + +P E + + + D++S+G+LL E+ T G P
Sbjct: 182 VQ--------QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 394 ENLIGTGSFGSVYKGTL----GDGTIVAIKVLK-LQQQGALKSFIDECNALKSTRHRNIL 448
+IG G FG VY GTL G A+K L + G + F+ E +K H N+L
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ C EG+ +V +M +G+L ++ +V + + VA
Sbjct: 154 SLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAK 203
Query: 509 ALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ +L H DL N +LD+ T V DFGLA+ +++ +
Sbjct: 204 GMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-------- 251
Query: 568 KGSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
+ +P E + + + D++S+G+LL E+ T G P
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 394 ENLIGTGSFGSVYKGTL--GDGTI-VAIKVLKL-QQQGALKSFIDECNALKSTRHRNILR 449
+ +G G+FGSV +G I VAIKVLK ++ + + E + + I+R
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+I C + L LV E G L ++L +++ V + V+
Sbjct: 401 LIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMG 448
Query: 510 LDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ YL + H +L NVLL A + DFGL+K L T K
Sbjct: 449 MKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS----YYTARSAGK 500
Query: 569 GSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
+ + PE +N + S D++SYG+ + E + G++P M
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA-LKSFIDECNALKSTRHRNI 447
IG G FG V G G VA+K +K A ++F+ E + + RH N+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNL 76
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
++++ E +V E+M+ G+L +L L L ++DV
Sbjct: 77 VQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVC 127
Query: 508 SALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
A++YL ++ H DL NVL+ +D A V DFGL K D
Sbjct: 128 EAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----------T 173
Query: 567 LKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
K + + PE + + S D++S+GILL E+++ G+ P
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 394 ENLIGTGSFGSVYKGTL----GDGTIVAIKVLK-LQQQGALKSFIDECNALKSTRHRNIL 448
+IG G FG VY GTL G A+K L + G + F+ E +K H N+L
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ C EG+ +V +M +G+L ++ +V + + VA
Sbjct: 90 SLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAK 139
Query: 509 ALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ YL H DL N +LD+ T V DFGLA+ +++ +
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHNKTGA- 192
Query: 568 KGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
K + ++ E + + + D++S+G+LL E+ T G P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 30/224 (13%)
Query: 397 IGTGSFGSVYKGTL----GDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHRNILRV 450
+G G FGSV + L G VA+K+LK + ++ F+ E +K H ++ ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 451 ITACSSVDLEGNDFKAL-VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
+ +G + + FM +G+L +L S L + + +D+A
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-FNLPLQTLVRFMVDIACG 149
Query: 510 LDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
++YL + H DL N +L +DMT V DFGL++ ++ +
Sbjct: 150 MEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----------DYYRQ 195
Query: 569 GSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
G +P E + ++ D++++G+ + E+ T G+ P
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGAL--KSFIDECNALKSTRHR 445
+ + ++ +G G +G VY+G VA+K LK + + + F+ E +K +H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
N+++++ C+ ++ EFM+ GNL +L + +S + L +A
Sbjct: 70 NLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQE-----VSAVVLLYMATQ 119
Query: 506 VASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
++SA++YL + H DL N L+ ++ V DFGL++ ++ + T
Sbjct: 120 ISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRL---MTGD---TYTAH 169
Query: 565 IGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
G K I + PE + + SI D++++G+LL E+ T G P
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 58/232 (25%), Positives = 88/232 (37%), Gaps = 28/232 (12%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQ-QQGALKSFIDECNALKST 442
K +G G FG V G G +VA+K LK + E + L++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H +I++ C LV E++ G+L +L + + Q L
Sbjct: 91 YHEHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYL--------PRHSIGLAQLLLF 139
Query: 503 AIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
A + + YLH H H DL NVLLD D +GDFGLAK + E +
Sbjct: 140 AQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----YY 191
Query: 562 TVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFK 611
V + + PE + + D++S+G+ L E+ T K
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
D ++G G++G VY G L + +AIK + + + +E K +H+N
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL-SVIQRLNIAID 505
I++ + E K + E + G+L L ++ K I
Sbjct: 81 IVQYL----GSFSENGFIK-IFMEQVPGGSLSALLR---SKWGPLKDNEQTIG--FYTKQ 130
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L YLH + I H D+K NVL++ + DFG +K ++ +T
Sbjct: 131 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETF- 183
Query: 565 IGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRP 605
G++ Y+ PE ++ G DI+S G ++EM TGK P
Sbjct: 184 ---TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 56/276 (20%), Positives = 109/276 (39%), Gaps = 35/276 (12%)
Query: 347 PPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENL-----IGTGS 401
P L N +K V + + + E+ +Y+ S +E + IG G
Sbjct: 343 IPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQ 402
Query: 402 FGSVYKGTL----GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSS 456
FG V++G VAIK K + F+ E ++ H +I+++I +
Sbjct: 403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462
Query: 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH-H 515
+ ++ E + G L +L L + + A +++AL YL
Sbjct: 463 NPV------WIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK 510
Query: 516 HCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP 575
H D+ NVL+ + +GDFGL++++ + + K I ++
Sbjct: 511 RF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMA 560
Query: 576 PEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDM 609
PE +N + + D++ +G+ + E+ G +P +
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/258 (22%), Positives = 106/258 (41%), Gaps = 38/258 (14%)
Query: 364 NDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKL 423
+ + + ++ + + +S +S IG+G V++ I AIK + L
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 424 QQ--QGALKSFIDECNALKSTRHRN--ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQ 479
++ L S+ +E L + + I+R+ + + +V E N +L+
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMEC-GNIDLNS 116
Query: 480 WLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539
WL + K + +R + ++ A+ +H H I H DLKP+N L+ M
Sbjct: 117 WLK-------KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-L 165
Query: 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------------ 587
+ DFG+A + + + K+ V G++ Y+PPE + S
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQV-----GTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 588 DIYSYGILLLEMFTGKRP 605
D++S G +L M GK P
Sbjct: 221 DVWSLGCILYYMTYGKTP 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 396 LIGTGSFGSVYKGTLGD---GTIVAIKVLKLQQQG---ALKSFIDECNALKSTRHRNILR 449
++G G V+ D VA+KVL+ F E + H I+
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
V + +V E++ L +H ++ + + + D A
Sbjct: 77 VYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVH-------TEGPMTPKRAIEVIADACQA 128
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
L++ H + I H D+KP+N+++ V DFG+A+ + + + T + + G
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI----ADSGNSVTQTAAVIG 181
Query: 570 SIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGD 608
+ Y+ PE G V D+YS G +L E+ TG+ P TGD
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 37/235 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLK-LQQQGALKSFIDECNALKS 441
N + +G G+FG VY+G + VA+K L + + F+ E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
H+NI+R I + + ++ E M+ G+L +L + Q L+++ L+
Sbjct: 90 FNHQNIVRCIGVSLQ-----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 502 IAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDK---DMTAHVGDFGLAKFLFEISDNP 557
+A D+A YL +H H D+ N LL A +GDFG+A+ ++
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---- 196
Query: 558 SKNQTVSIGLKGSIGYIP-----PE-HMNGQVSILGDIYSYGILLLEMFT-GKRP 605
S KG +P PE M G + D +S+G+LL E+F+ G P
Sbjct: 197 ------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 46/241 (19%), Positives = 98/241 (40%), Gaps = 46/241 (19%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL--------GDGTIVAIKVLKLQQQGALKSFIDECNALK 440
++ +G G+F ++KG T V +KVL + +SF + + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
H++++ C D LV EF+ G+LD +L + ++++ +L
Sbjct: 68 KLSHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNK------NCINILWKL 116
Query: 501 NIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAH--------VGDFGLAKFLF 551
+A +A+A+ +L + H ++ N+LL ++ + D G++ +
Sbjct: 117 EVAKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFT-GKRPTGD 608
L+ I ++PPE +++ D +S+G L E+ + G +P
Sbjct: 173 P-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 609 M 609
+
Sbjct: 222 L 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 63/277 (22%), Positives = 100/277 (36%), Gaps = 37/277 (13%)
Query: 344 GSIPPSLGNCQKLLVLNLSSNDLNGTI----PKEVRQSGMSYSDISKSTD--------NF 391
GS S G L L + + + + P+ G+ ++ K D
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 392 SKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRV 450
+ + +G GSFG V++ G A+K ++L+ +E A I+ +
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPL 115
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
EG + E + G+L Q + Q L + L L
Sbjct: 116 Y----GAVREGPWVN-IFMELLEGGSLGQLIK-------QMGCLPEDRALYYLGQALEGL 163
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
+YLH I H D+K NVLL D A + DFG A L S + G
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPG 218
Query: 570 SIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ ++ PE + G+ DI+S ++L M G P
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 38/251 (15%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGA 428
+ + S + IS +S IG+G V++ I AIK + L++
Sbjct: 38 DDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 97
Query: 429 LKSFIDECNALKSTRH--RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA 486
L S+ +E L + I+R+ + + +V E N +L+ WL
Sbjct: 98 LDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMEC-GNIDLNSWLK---- 147
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
+ K + +R + ++ A+ +H H I H DLKP+N L+ M + DFG+
Sbjct: 148 ---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGI 200
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------------DIYSYGI 594
A + + + K+ G++ Y+PPE + S D++S G
Sbjct: 201 ANQMQPDTTSVVKDS-----QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 595 LLLEMFTGKRP 605
+L M GK P
Sbjct: 256 ILYYMTYGKTP 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRH--R 445
+S IG+G V++ I AIK + L++ L S+ +E L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I+R+ + + +V E N +L+ WL + K + +R + +
Sbjct: 70 KIIRLYDY-----EITDQYIYMVMEC-GNIDLNSWLK-------KKKSIDPWERKSYWKN 116
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ A+ +H H I H DLKP+N L+ M + DFG+A + + + K+ V
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-- 170
Query: 566 GLKGSIGYIPPEHMNGQVSILG------------DIYSYGILLLEMFTGKRP 605
G++ Y+PPE + S D++S G +L M GK P
Sbjct: 171 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 18/229 (7%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKS-TRHRNI 447
++ G F VY+ +G G A+K L ++ ++ I E +K + H NI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 448 LRVITACSSV--DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
++ +A S + + + L+ + G L ++L + LS L I
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK----KMESRGPLSCDTVLKIFYQ 144
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS- 564
A+ ++H PI H DLK N+LL T + DFG A + D Q +
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 565 ----IGLKGSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFTGKRP 605
I + Y PE + N + DI++ G +L + + P
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 51/267 (19%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA--LKSFIDECNALKS 441
S+ T F + IG+G FGSV+K DG I AIK K G+ ++ + E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
+H +++R +A E + + E+ + G+L + + +
Sbjct: 67 LGQHSHVVRYFSA----WAEDDHM-LIQNEYCNGGSLADAIS---ENYRIMSYFKEAELK 118
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-------------------MTAHV 541
++ + V L Y+H + H D+KPSN+ + + + +
Sbjct: 119 DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--DIYSYGILLLEM 599
GD G + S Q +G ++ E + + L DI++ + ++
Sbjct: 176 GDLGHVTRI-------SSPQVE----EGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224
Query: 600 FTGKRPTGDMFKDDFSIHMFVSMALPD 626
+ ++ H LP
Sbjct: 225 AGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 397 IGTGSFGSVYKGTL------GDGTIVAIKVLK-LQQQGALKSFIDECNALKSTRHRNILR 449
+G GSFG VY+G T VAIK + F++E + +K +++R
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---PSPAEHYQFKKLSVIQRLNIAIDV 506
++ S ++ E M+ G+L +L P+ A + S+ + + +A ++
Sbjct: 93 LLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 507 ASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
A + YL+ + H DL N ++ +D T +GDFG+ + ++E
Sbjct: 148 ADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----------DY 193
Query: 566 GLKGSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
KG G +P PE + G + D++S+G++L E+ T ++P
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 50/275 (18%)
Query: 362 SSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKE---------NLIGTGSFGSVYKGTL-- 410
S + L+ T K G + +D +G G+FG V+
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 411 ----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466
D +VA+K LK + A + F E L +H++I+R C+
Sbjct: 65 LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----GRPLL 119
Query: 467 LVFEFMSNGNLDQWL--------HPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHC 517
+VFE+M +G+L+++L + E L + Q L +A VA+ + YL H
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179
Query: 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-- 575
H DL N L+ + + +GDFG+++ ++ +D G +P
Sbjct: 180 ----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TD---------YYRVGGRTMLPIR 225
Query: 576 ---PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
PE + + + D++S+G++L E+FT GK+P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 56/273 (20%), Positives = 97/273 (35%), Gaps = 57/273 (20%)
Query: 394 ENLIGTGSFGSVYKGTLGD---GTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNI 447
L+G G G VY+ D IVA+K++ E + ++
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 448 LRVITACSSVDL-EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
+ + D E + + ++ +L L + L+ + + I +
Sbjct: 97 VPIH------DFGEIDGQLYVDMRLINGVDLAAMLR-------RQGPLAPPRAVAIVRQI 143
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
SALD H H D+KP N+L+ D A++ DFG+A + Q +
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT----TDEKLTQLGNT- 195
Query: 567 LKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSMAL 624
G++ Y+ PE + + DIY+ +L E TG P GD +S+
Sbjct: 196 -VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----------LSVMG 244
Query: 625 PDHVMD------ILDPSMPLDEENDEEQIEEVI 651
H+ + P +P + VI
Sbjct: 245 -AHINQAIPRPSTVRPGIP-------VAFDAVI 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 37/235 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLK-LQQQGALKSFIDECNALKS 441
N + +G G+FG VY+G + VA+K L + + F+ E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
H+NI+R I + + ++ E M+ G+L +L + Q L+++ L+
Sbjct: 131 FNHQNIVRCIGVSLQ-----SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 502 IAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDK---DMTAHVGDFGLAKFLFEISDNP 557
+A D+A YL +H H D+ N LL A +GDFG+A+ ++
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---- 237
Query: 558 SKNQTVSIGLKGSIGYIP-----PE-HMNGQVSILGDIYSYGILLLEMFT-GKRP 605
KG +P PE M G + D +S+G+LL E+F+ G P
Sbjct: 238 ------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 54/258 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRH 444
++F +G G FG+VY I+A+KVL +L++ G E RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN--- 501
NILR+ L+ E+ G + +++L + + +
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTV-------------YRELQKLSKFDEQR 110
Query: 502 ---IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
++A+AL Y H + H D+KP N+LL + DFG + S
Sbjct: 111 TATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-----PSS 162
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQV---SILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615
+ L G++ Y+PPE + G++ + D++S G+L E GK P F+ +
Sbjct: 163 RRTD----LCGTLDYLPPEMIEGRMHDEKV--DLWSLGVLCYEFLVGKPP----FEANTY 212
Query: 616 IHMF-----VSMALPDHV 628
+ V PD V
Sbjct: 213 QETYKRISRVEFTFPDFV 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 47/292 (16%), Positives = 87/292 (29%), Gaps = 58/292 (19%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECN 437
S++ + + ++G + + T G + V + A+K +E
Sbjct: 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125
Query: 438 ALKSTRH-------RNILRVITACSSVDLEG-----------------NDFKALVFEFMS 473
L+ R + LR I V + F +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533
+ L + H K L RL + + V L LHH+ + H L+P +++L
Sbjct: 186 LQTFGEVLLSHSSTH---KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 239
Query: 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------ 587
D+ + F S S G+ PPE + +I
Sbjct: 240 DQRGGVFLTGFEHLVR-------DGARVVSS----VSRGFEPPELEARRATISYHRDRRT 288
Query: 588 ------DIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSMALPDHVMDIL 632
D ++ G+++ ++ P T D +P V +L
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALL 340
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 39/251 (15%)
Query: 378 GMSYSDISK---STDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA 428
G +S I + + +G G+FG V+ D +VA+K LK A
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA 60
Query: 429 LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL------- 481
K F E L + +H +I++ C +G+ +VFE+M +G+L+++L
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDA 115
Query: 482 --HPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMT 538
+L + Q L+IA +AS + YL H H DL N L+ ++
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLL 171
Query: 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGS--IGYIPPEHMN-GQVSILGDIYSYGIL 595
+GDFG+++ ++ +G I ++PPE + + + D++S+G++
Sbjct: 172 VKIGDFGMSRDVYS-------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 596 LLEMFT-GKRP 605
L E+FT GK+P
Sbjct: 225 LWEIFTYGKQP 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 40/286 (13%), Positives = 82/286 (28%), Gaps = 47/286 (16%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ---GALKSFIDECN 437
S++ + + ++G + + T G + V ++ A+K +E
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 438 ALKSTRH-------RNILRVITACSSVDLEG-----------------NDFKALVFEFMS 473
L+ R + LR I V + F +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533
+ L + H K L RL + + V L LHH+ + H L+P +++L
Sbjct: 191 LQTFGEVLLSHSSTH---KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 244
Query: 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ------VSILG 587
D+ + F + + + ++
Sbjct: 245 DQRGGVFLTGFEHLVRD------GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 588 DIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSMALPDHVMDIL 632
D ++ G+ + ++ P T D +P V +L
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALL 344
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 33/236 (13%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-KLQQQGALKSFIDECNALKST 442
S S + +++G G+ +V++G G + AIKV + + + E LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H+NI+++ + + K L+ EF G+L L E L + L +
Sbjct: 65 NHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIV 117
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTAHVGDFGLAKFLFEISDNPS 558
DV +++L + I H ++KP N++ D + DFG A+ L ++
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDE 170
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQVSILG---------DIYSYGILLLEMFTGKRP 605
+ + L G+ Y+ P+ V D++S G+ TG P
Sbjct: 171 QFVS----LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 60/391 (15%), Positives = 119/391 (30%), Gaps = 33/391 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT- 71
L LT N + S + L+ A + + L L+ + + + +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFT----LYGNFISGIIPSSIY 127
+P + N ++L+ L L+ N ++ +L L + L N ++ I P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 128 NISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVS------LSNASNL 181
I ++ ++ N + L L++ + F + L NL
Sbjct: 199 EIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 182 QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLA 241
+ +F L + L ++ L S I + + LE++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVS--SFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 242 RNSFGGEMPISIANLS---------------THLRRLTMGENLMH--GNIPVGIGNLVNL 284
F S+ L+ L L + N + G +L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 285 NLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS-LGNLTILTRLWMEENRLE 343
L L N + ++ L +LE L + + S +L L L +
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 344 GSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
+ L VL ++ N ++
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 67/392 (17%), Positives = 130/392 (33%), Gaps = 41/392 (10%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVN---DFVGQIPNQLSSLTKLEIIGLGGSN 69
+ L+L+ N + T+L ++ S++ + + I +L + L +
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211
Query: 70 LTGNVPA-WIGNFSSLKALSLAWNNLRG---------SIPNELGQLSGLGFFTLYGNFIS 119
+ NV I + L+ L R S L L+ F Y ++
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSL---- 175
I ++++ FS+ + +L++ F SL
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 176 ------------SNASNLQVLDFAENGLT--GTIPGNFGSLKDLVRLNFDQNELGSREIG 221
+ +L+ LD + NGL+ G + L L+ N + +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN 391
Query: 222 DLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNL 281
LE L ++ S+ +L L + L
Sbjct: 392 -------FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 282 VNLNLLGLEGNNLSGSV-PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
+L +L + GN+ + P++ L L L L+ + L P++ +L+ L L M N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 341 RLEGSIPPS-LGNCQKLLVLNLSSNDLNGTIP 371
+L+ S+P L + L +N + + P
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 66/402 (16%), Positives = 129/402 (32%), Gaps = 34/402 (8%)
Query: 3 LIMIPEHLM--TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
IP++L T++L+L++N L + EL+ + S + SL+ L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG 120
+ L G+ + SSL+ L NL +G L L + N I
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 121 I-IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT---GSIPVSLS 176
+P N++++ + ++ N++ + L + + +++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 177 NASNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSL 235
L L N + + L L E + + L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 236 EVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIP-----VGIGNLVNLNLLGLE 290
+ R ++ I +L L ++ +L+ I +L L+ +
Sbjct: 258 TIEEF-RLAYLDYYLDDIIDLFNCLTNVSS-FSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 291 GNNLSGSVPEVIGRLN----------------KLEGLGLNVNK--FSGLIPSSLGNLTIL 332
+ + RL LE L L+ N F G S T L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 333 TRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
L + N + ++ + ++L L+ ++L V
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL---GDGTIVAIKVLKLQQQGA----LKSFIDECNALKS 441
++ +++IG G+FG V K + G AIK +K + A + F E L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---------HPSPAEHYQF 491
H NI+ ++ AC G + L E+ +GNL +L +
Sbjct: 82 LGHHPNIINLLGACE---HRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 492 KKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
LS Q L+ A DVA +DYL H DL N+L+ ++ A + DFGL++
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-- 190
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEMFT-GK 603
+ +K ++G +P E +N V + D++SYG+LL E+ + G
Sbjct: 191 -----------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 604 RP 605
P
Sbjct: 240 TP 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 49/239 (20%)
Query: 394 ENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDECNALKSTR 443
+G FG VYKG L VAIK LK A + F E +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQ 70
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---------HPSPAEHYQFKKL 494
H N++ ++ + + +++F + S+G+L ++L + + L
Sbjct: 71 HPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 495 SVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
+++ +A+ ++YL HH H DL NVL+ + + D GL + ++
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 554 SDNPSKNQTVSIGLKGSIGYIP-----PEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605
+P PE + G+ SI DI+SYG++L E+F+ G +P
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 49/245 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDECNA 438
D +G G+FG V + VA+K+LK +GA ++ + E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 439 LKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---------HPSPAEH 488
L H N++ ++ AC+ ++ EF GNL +L + E
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 489 YQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
L++ + + VA +++L C I H DL N+LL + + DFGLA
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---I-HRDLAARNILLSEKNVVKICDFGLA 195
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEMFT 601
+ +++ D ++ +P PE + +V +I D++S+G+LL E+F+
Sbjct: 196 RDIYKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 602 -GKRP 605
G P
Sbjct: 246 LGASP 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 59/343 (17%), Positives = 115/343 (33%), Gaps = 58/343 (16%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-KLQQQGALKSFIDECNALKST 442
S S + +++G G+ +V++G G + AIKV + + + E LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H+NI+++ + + K L+ EF G+L L E L + L +
Sbjct: 65 NHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIV 117
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTAHVGDFGLAKFLFEISDNPS 558
DV +++L + I H ++KP N++ D + DFG A+ L ++
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDE 170
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQVSILG---------DIYSYGILLLEMFTGKRPTGDM 609
+ + L G+ Y+ P+ V D++S G+ TG P
Sbjct: 171 QFVS----LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---- 222
Query: 610 FKDDFSIHMFVSMALPDHVMDILD-----PSMPLDEENDEEQIEEVIEEKEMMIHIDLEV 664
F P +++ + + + +M + L
Sbjct: 223 ---------FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 665 NTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707
+ L ++L + + I +
Sbjct: 274 GLQVLLTPVLANILEA-------DQEKCWGFDQFFAETSDILH 309
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 62/255 (24%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDE 435
F ++NL +G G FG V K T T VA+K+LK + A L+ + E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSE 76
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-------------- 481
N LK H +++++ ACS +G L+ E+ G+L +L
Sbjct: 77 FNVLKQVNHPHVIKLYGACS---QDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 482 ---HPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDM 537
+ S +H + L++ ++ A ++ + YL + H DL N+L+ +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---V-HRDLAARNILVAEGR 187
Query: 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYS 591
+ DFGL++ ++E +K S G IP E + + + D++S
Sbjct: 188 KMKISDFGLSRDVYEEDSY----------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237
Query: 592 YGILLLEMFT-GKRP 605
+G+LL E+ T G P
Sbjct: 238 FGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 57/250 (22%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDE 435
F + L +G G+FG V + T VA+K+LK A ++ + E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSE 76
Query: 436 CNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-----------HP 483
L H NI+ ++ AC+ + G ++ E+ G+L +L
Sbjct: 77 LKVLSYLGNHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 484 SPAEHYQFKKLSVIQRLNIAIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAHVG 542
L + L+ + VA + +L +C I H DL N+LL +
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---I-HRDLAARNILLTHGRITKIC 187
Query: 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILL 596
DFGLA+ + S + +P PE + V + D++SYGI L
Sbjct: 188 DFGLARDIKND----------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 597 LEMFT-GKRP 605
E+F+ G P
Sbjct: 238 WELFSLGSSP 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 60/234 (25%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-ECNALKST 442
+++ + + +GTG FG V + G VAIK + + + E +K
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 443 RHRNILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
H N++ V L ND L E+ G+L ++L+ + L
Sbjct: 70 NHPNVVSAREVPD--GLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPI 123
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTAHVGDFGLAKFLFEISDN 556
+ D++SAL YLH + I H DLKP N++L + + + D G AK L D
Sbjct: 124 RTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQ 176
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
G++ Y+ PE + + V D +S+G L E TG RP
Sbjct: 177 GELCTE----FVGTLQYLAPELLEQKKYTVTV----DYWSFGTLAFECITGFRP 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/244 (23%), Positives = 107/244 (43%), Gaps = 46/244 (18%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL--------GDGTIVAIKVLK-LQQQGALKSFIDECNAL 439
D + +G G+FG V + VA+K+LK + L + E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 440 KS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---------HPSPAEHY 489
K +H+NI+ ++ AC+ +G + ++ E+ S GNL ++L +
Sbjct: 95 KMIGKHKNIINLLGACT---QDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 490 QFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
++++ ++ +A ++YL C I H DL NVL+ ++ + DFGLA+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKC---I-HRDLAARNVLVTENNVMKIADFGLAR 205
Query: 549 FLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEMFT- 601
+ I K + G +P PE + +V + D++S+G+L+ E+FT
Sbjct: 206 DINNI----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 602 GKRP 605
G P
Sbjct: 256 GGSP 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 53/246 (21%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDE 435
F + NL +G G+FG V + T VA+K+LK A ++ + E
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSE 99
Query: 436 CNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-------HPSPAE 487
+ +H NI+ ++ AC+ G ++ E+ G+L +L PA
Sbjct: 100 LKIMSHLGQHENIVNLLGACT---HGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 488 HYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
S L+ + VA + +L +C I H D+ NVLL A +GDFGL
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNC---I-HRDVAARNVLLTNGHVAKIGDFGL 210
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEMF 600
A+ + S+ + +P PE + V ++ D++SYGILL E+F
Sbjct: 211 ARDIMNDSNY----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 601 T-GKRP 605
+ G P
Sbjct: 261 SLGLNP 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 35/257 (13%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECN 437
+ I + ++F NL+G GSF VY+ + G VAIK++ + + G ++ +E
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+H +IL + E +++ LV E NG ++++L + K S
Sbjct: 64 IHCQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKN------RVKPFSEN 112
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+ + + + + YLH H I H DL SN+LL ++M + DFGLA L
Sbjct: 113 EARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--- 166
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
K+ T+ G+ YI PE + D++S G + + G+ P F D
Sbjct: 167 EKHYTLC----GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDTVK 218
Query: 617 HMF-----VSMALPDHV 628
+ +P +
Sbjct: 219 NTLNKVVLADYEMPSFL 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 42/262 (16%)
Query: 382 SDISKSTDNFSK----ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECN 437
++I + E ++G GS G+V G VA+K + + + E
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIK 60
Query: 438 AL-KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
L +S H N++R + + F + E N NL + K
Sbjct: 61 LLTESDDHPNVIRYYCSE-----TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE 114
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-------------KDMTAHVGD 543
+++ +AS + +LH I H DLKP N+L+ +++ + D
Sbjct: 115 YNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--------DIYSYGIL 595
FGL K L S +T G+ G+ PE + ++ DI+S G +
Sbjct: 172 FGLCKKL---DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 596 LLEMFT-GKRPTGDMFKDDFSI 616
+ + GK P GD + + +I
Sbjct: 229 FYYILSKGKHPFGDKYSRESNI 250
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 75/376 (19%), Positives = 134/376 (35%), Gaps = 33/376 (8%)
Query: 6 IPEHL-MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQI-PNQLSSLTKLEII 63
+P+ L T+ L L++NY+ ++ +L+ E I +L L I+
Sbjct: 19 VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRIL 78
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSI--PNELGQLSGLGFFTLYGNFISGI 121
LG S + P L L L + L ++ L L L N I +
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138
Query: 122 -IPSSIYNISSIYYFSVTQNQLHGQLPTD-VGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
+ S ++S+ + NQ+ + L L F+ A N + V
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 180 N------LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
N L++LD + NG T I GNF N + + L
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFSLILAH------ 240
Query: 234 SLEVLGLARNSFGGEMPISIANL-STHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
+ G ++ + A L + +R L + + ++ + L +L +L L
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAY 299
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG 351
N ++ E L+ L+ L L+ N L S+ L + + +++N + +
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 352 NCQKLLVLNLSSNDLN 367
+KL L+L N L
Sbjct: 360 FLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 59/337 (17%), Positives = 109/337 (32%), Gaps = 21/337 (6%)
Query: 49 QIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNE-LGQLSG 107
Q+P L++ +L L + + + L+ L L +I E L
Sbjct: 18 QVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 108 LGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQL-HGQLPTDVGLTLPNLKIFAGAVNY 166
L L + I + P + + ++ + L L L L + N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 167 FTG-SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSL--KDLVRLNFDQNELGSREIGDL 223
+ S ++L+ +DF+ N + L K L + N L SR D
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 224 NFLKFLANCTSLEVLGLARNSFGGEMPISIAN-----------LSTHLRRLTMGENLMHG 272
LE+L ++ N + ++ + +N L+ H+ G + +
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 273 NIPVGIGNLVNLNL--LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330
L ++ L L + V L L+ L L NK + + + L
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314
Query: 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
L L + N L + K+ ++L N +
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-22
Identities = 76/417 (18%), Positives = 142/417 (34%), Gaps = 50/417 (11%)
Query: 13 QDLNLTYNYLSG-KIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLT--KLEIIGLGGSN 69
L+L+ N + + + L+S + S N ++L L L L ++
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 70 LTGNVP-AWIGNFSSLKALSL-----------------AWNNLRGSIPNELGQLSGLGFF 111
L V W + + + L N + S L +
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 112 TLYGNFISGIIPSSIYNI--SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169
+ I ++ + SS+ + ++ + L + V TL +LK+ A N
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINK 304
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
+ NLQVL+ + N L NF L + ++ +N + + FL+ L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 230 -------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN-LMHGNIP 275
S+ + L+ N +++ ++ + + EN L + +I
Sbjct: 365 QTLDLRDNALTTIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRLENLDIL 419
Query: 276 VGIGNLVNLNLLGLEGNNLSGSVPEVI-GRLNKLEGLGLNVNKF-----SGLIPSSLGNL 329
+ + +L +L L N S + LE L L N + L L
Sbjct: 420 YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 330 TILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISK 386
+ L L++ N L P + L L+L+SN L + + + DIS+
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISR 535
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 54/256 (21%), Positives = 87/256 (33%), Gaps = 23/256 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q LNL+YN L +N ++ + N L KL+ + L + LT
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-IPSSIYNISS 131
I S+ + L+ N L ++P + + L N + + I + +
Sbjct: 377 -----IHFIPSIPDIFLSGNKLV-TLPKINLTANLI---HLSENRLENLDILYFLLRVPH 427
Query: 132 IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSL-----SNASNLQVLDF 186
+ + QN+ P+L+ N + L S+LQVL
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 187 AENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246
N L PG F L L L+ + N L L +LE+L ++RN
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSN--------RLTVLSHNDLPANLEILDISRNQLL 539
Query: 247 GEMPISIANLSTHLRR 262
P +LS
Sbjct: 540 APNPDVFVSLSVLDIT 555
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 40/203 (19%), Positives = 71/203 (34%), Gaps = 17/203 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
Q L+L N L T + + S N V +P + + + NL
Sbjct: 365 QTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL-- 416
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSI----- 126
++ ++ L+ L L N ++ + L L N + + +
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 127 YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDF 186
+S + + N L+ LP V L L+ + N T + + +NL++LD
Sbjct: 477 EGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHN-DLPANLEILDI 533
Query: 187 AENGLTGTIPGNFGSLKDLVRLN 209
+ N L P F SL L +
Sbjct: 534 SRNQLLAPNPDVFVSLSVLDITH 556
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 52/247 (21%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL--------GDGTIVAIKVLKLQQQGA----LKSFIDEC 436
D + +G G FG V + VA+K+LK A L + E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 437 NALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL---------HPSPA 486
+K +H+NI+ ++ AC+ +G + ++ E+ S GNL ++L +
Sbjct: 138 EMMKMIGKHKNIINLLGACT---QDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545
++++ ++ +A ++YL C I H DL NVL+ ++ + DFG
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---I-HRDLAARNVLVTENNVMKIADFG 248
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEM 599
LA+ + I K + G +P PE + +V + D++S+G+L+ E+
Sbjct: 249 LARDINNI----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 600 FT-GKRP 605
FT G P
Sbjct: 299 FTLGGSP 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 54/256 (21%), Positives = 99/256 (38%), Gaps = 33/256 (12%)
Query: 372 KEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKS 431
E S + +F ++++G G+ G++ + D VA+K + +
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR 66
Query: 432 FIDECNALK-STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
E L+ S H N++R + F+ + E + L +++ H
Sbjct: 67 ---EVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIELCA-ATLQEYVEQKDFAHLG 117
Query: 491 FKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-----DKDMTAHVGDFG 545
+ ++++Q S L +LH I H DLKP N+L+ + A + DFG
Sbjct: 118 LEPITLLQ------QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFT 601
L K L + + G+ G+ G+I PE + DI+S G + + +
Sbjct: 169 LCKKL----AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 602 -GKRPTGDMFKDDFSI 616
G P G + +I
Sbjct: 225 EGSHPFGKSLQRQANI 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 58/260 (22%)
Query: 389 DNFSKENLIGTGSFGSVYKG-TLGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRH 444
D+F +G G FG+VY + I+A+KVL +L+++G E RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN--- 501
NILR+ + L+ EF G L +K+L R +
Sbjct: 74 PNILRMYNYFHD---RKRIY--LMLEFAPRGEL-------------YKELQKHGRFDEQR 115
Query: 502 ---IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
++A AL Y H + H D+KP N+L+ + DFG + + +
Sbjct: 116 SATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPS-L 167
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
+ +T + G++ Y+PPE + G+ V D++ G+L E G P F
Sbjct: 168 RRRT----MCGTLDYLPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP----FDSP 215
Query: 614 FSIHMF-----VSMALPDHV 628
V + P +
Sbjct: 216 SHTETHRRIVNVDLKFPPFL 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 49/260 (18%), Positives = 99/260 (38%), Gaps = 48/260 (18%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALK 440
+S + + +G G F ++ + + A K++ L + + E + +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
S H++++ E NDF +V E +L + + L
Sbjct: 71 SLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSL-------------LELHKRRKAL 112
Query: 501 N------IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
+ YLH + + H DLK N+ L++D+ +GDFGLA ++
Sbjct: 113 TEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVE 166
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
+ + + + G+ YI PE ++ + S D++S G ++ + GK P F+
Sbjct: 167 YDGERKKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETS 218
Query: 614 FSIHMF-----VSMALPDHV 628
+ ++P H+
Sbjct: 219 CLKETYLRIKKNEYSIPKHI 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 49/260 (18%), Positives = 98/260 (37%), Gaps = 48/260 (18%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALK 440
+S + + +G G F ++ + + A K++ L + + E + +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
S H++++ E NDF +V E +L + + L
Sbjct: 97 SLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSL-------------LELHKRRKAL 138
Query: 501 N------IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
+ YLH + + H DLK N+ L++D+ +GDFGLA +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
+ + + + G+ YI PE ++ + S D++S G ++ + GK P F+
Sbjct: 196 E---RKKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETS 244
Query: 614 FSIHMF-----VSMALPDHV 628
+ ++P H+
Sbjct: 245 CLKETYLRIKKNEYSIPKHI 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 58/281 (20%), Positives = 94/281 (33%), Gaps = 67/281 (23%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL-QQQGALKSFIDECNALKST 442
S+ +F +G G FG V++ D AIK ++L ++ A + + E AL
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFM------------------------------ 472
H I+R A E +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 473 ----------------------SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
NL W++ + L+I I +A A+
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN----RRCSLEDREHGVCLHIFIQIAEAV 177
Query: 511 DYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK-- 568
++LH + H DLKPSN+ D VGDFGL + + + + +
Sbjct: 178 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 569 GSIG---YIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP 605
G +G Y+ PE ++G S DI+S G++L E+
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 49/252 (19%), Positives = 98/252 (38%), Gaps = 42/252 (16%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVL-----------------KLQQQGA 428
K +++ + G F + D A+K K+ +
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 429 LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL-HPSPAE 487
F +E + ++ L + D +++E+M N ++ ++ + +
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 488 HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
+ + I V ++ Y+H+ + I H D+KPSN+L+DK+ + DFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKR 604
+++ + K + +G+ ++PPE + + S G DI+S GI L MF
Sbjct: 200 EYMVD-----KKIKG----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 605 PTGDMFKDDFSI 616
P F S+
Sbjct: 251 P----FSLKISL 258
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 68/321 (21%), Positives = 116/321 (36%), Gaps = 51/321 (15%)
Query: 57 LTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN 116
++ +G S LT +P + + L + NNL S+P +L L + GN
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 117 FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLS 176
++ +P + + FS L L + ++ S+PV
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQL---------TSLPVLPP 141
Query: 177 NASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS--REIGDL-------NFLK 227
LQ L ++N L ++P L +L N+L S L N L
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELC---KLWAYNNQLTSLPMLPSGLQELSVSDNQLA 194
Query: 228 FL-ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNL 286
L + L L N S+ L + L+ L + N + ++PV L L +
Sbjct: 195 SLPTLPSELYKLWAYNNRL-----TSLPALPSGLKELIVSGNRL-TSLPVLPSELKELMV 248
Query: 287 LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSI 346
GN L+ S+P + L L + N+ + L P SL +L+ T + +E N L
Sbjct: 249 ---SGNRLT-SLPMLPSGLLSLS---VYRNQLTRL-PESLIHLSSETTVNLEGNPLS-ER 299
Query: 347 PPSLGNCQKLLVLNLSSNDLN 367
+++ S +
Sbjct: 300 TLQ--ALREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 81/377 (21%), Positives = 130/377 (34%), Gaps = 77/377 (20%)
Query: 1 MELIMIPEHLMT-QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTK 59
L +P + L ++ N L+ +P EL F + +P S L K
Sbjct: 71 NNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCK 125
Query: 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFIS 119
L + G+ LT ++P L+ LS++ N L S+P +L L Y N ++
Sbjct: 126 LW---IFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT 174
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
+ P + + V+ NQL LPT L L + N T S+P S
Sbjct: 175 SL-PMLPSGLQELS---VSDNQLA-SLPTLPS-ELYKLWAYN---NRLT-SLPALPSG-- 222
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
L+ L + N LT ++P LK L N L TSL
Sbjct: 223 -LKELIVSGNRLT-SLPVLPSELK---ELMVSGNRL-----------------TSL---- 256
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299
P+ + L L++ N + +P + +L + + LEGN LS
Sbjct: 257 ----------PMLPSGL----LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301
Query: 300 EVIGRLNKLEGLGLNVNKFSGLI---PSSLGNLTILTRLWMEENRLEGSIPP----SLGN 352
+ + + G + +F P L + W+ R P G
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361
Query: 353 CQKLLVLNLSSNDLNGT 369
+L + L+ T
Sbjct: 362 EDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 44/207 (21%), Positives = 70/207 (33%), Gaps = 37/207 (17%)
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS--REIGDL-------NFLKFL 229
+ VL+ E+GLT T+P + L N L S +L N L L
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSL 96
Query: 230 ----ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLN 285
L + + L + L +L + N + ++PV L L+
Sbjct: 97 PVLPPGLLELSIFSNPLTH--------LPALPSGLCKLWIFGNQLT-SLPVLPPGLQELS 147
Query: 286 LLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGS 345
+ +N S+P + L KL N+ + L P L L+ + +N+L S
Sbjct: 148 V----SDNQLASLPALPSELCKLW---AYNNQLTSL-PMLPSGLQELS---VSDNQLA-S 195
Query: 346 IPPSLGNCQKLLVLNLSSNDLNGTIPK 372
+P KL N L
Sbjct: 196 LPTLPSELYKLWAYNNRLTSLPALPSG 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 57/250 (22%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL--------GDGTIVAIKVLKLQQQGA----LKSFI 433
++ L +G G+FG V T VA+K+LK A L I
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLI 122
Query: 434 DECNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQ 490
E +K +H+NI+ ++ AC+ +G + ++ E+ S GNL ++L P Y
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACT---QDGPLY--VIVEYASKGNLREYLQARRPPGLEYS 177
Query: 491 F-------KKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542
+ ++LS ++ A VA ++YL C H DL NVL+ +D +
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIA 233
Query: 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILL 596
DFGLA+ + I K + G +P PE + ++ + D++S+G+LL
Sbjct: 234 DFGLARDIHHI----------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
Query: 597 LEMFT-GKRP 605
E+FT G P
Sbjct: 284 WEIFTLGGSP 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 16/312 (5%)
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPS 124
VP I + + L L N ++ +E L L N +S + P
Sbjct: 18 CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG 74
Query: 125 SIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL 184
+ N+ ++ + N+L +P V L NL + N + + NL+ L
Sbjct: 75 AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 185 DFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244
+ +N L F L L +L ++ L I ++ L VL L +
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNL--TSIPTEAL----SHLHGLIVLRLRHLN 187
Query: 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIG 303
S L L+ L + + +NL L + NL+ +VP +
Sbjct: 188 INAIRDYSFKRL-YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
Query: 304 RLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-SLGNCQKLLVLNLS 362
L L L L+ N S + S L L L + + +L + P + L VLN+S
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVS 304
Query: 363 SNDLNGTIPKEV 374
N L T+ + V
Sbjct: 305 GNQLT-TLEESV 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 66/334 (19%), Positives = 118/334 (35%), Gaps = 17/334 (5%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
+ + +P + TE R + N ++ +S LE + L + ++
Sbjct: 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNE-LGQLSGLGFFTLYGNFISGIIPSSIYNIS 130
P N +L+ L L N L+ IP LS L + N I ++ ++
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 131 SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SLSNASNLQVLDFAEN 189
++ V N L + L +L+ T SIP +LS+ L VL
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL 186
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249
+ +F L L L + +L L + +
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC------LYGLNLTSLSITHCNLTAVP 240
Query: 250 PISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKL 308
+++ +L +LR L + N + I + L+ L + L G L+ P LN L
Sbjct: 241 YLAVRHL-VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298
Query: 309 EGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRL 342
L ++ N+ + L S ++ L L ++ N L
Sbjct: 299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 58/322 (18%), Positives = 112/322 (34%), Gaps = 16/322 (4%)
Query: 3 LIMIPEHLM--TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
+ +PE + T+ L+L N + + L E + N P ++L L
Sbjct: 23 FVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 61 EIIGLGGSNLTGNVPAWI-GNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFI 118
+GL + L +P + S+L L ++ N + + + + L L + N +
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 119 SGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178
I + ++S+ ++ + L +PT+ L L + S
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
L+VL+ + T+ N +L L+ L + L + L L
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL--TAVPYLAV----RHLVYLRFL 253
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGS 297
L+ N + L L+ + + + + L L +L + GN L+
Sbjct: 254 NLSYNPISTIEGSMLHEL-LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTL 311
Query: 298 VPEVIGRLNKLEGLGLNVNKFS 319
V + LE L L+ N +
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 41/246 (16%), Positives = 78/246 (31%), Gaps = 41/246 (16%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGD------GTIVAIKVLKLQQQGALKSFIDE 435
++ + +L+G G+F VY+ T GD +KV K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLS 495
LK + ++ +A + LV E S G L ++ ++ K +
Sbjct: 118 MERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAIN--LYKNTPEKVMP 170
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG-----------DF 544
++ A+ + ++ +H D I H D+KP N +L D
Sbjct: 171 QGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----QVSILGDIYSYGILLLEM 599
G + + T+ + G+ E ++ Q+ D + + M
Sbjct: 228 GQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNKPWNYQI----DYFGVAATVYCM 278
Query: 600 FTGKRP 605
G
Sbjct: 279 LFGTYM 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 66/255 (25%), Positives = 105/255 (41%), Gaps = 62/255 (24%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLKLQQQGA----LKSFIDE 435
F +ENL +G+G+FG V T G VA+K+LK + A ++ + E
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSE 98
Query: 436 CNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL------------- 481
+ H NI+ ++ AC+ L G + L+FE+ G+L +L
Sbjct: 99 LKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 482 ---HPSPAEHYQFKKLSVIQRLNIAIDVASALDYL-HHHCDTPIAHCDLKPSNVLLDKDM 537
E L+ L A VA +++L C + H DL NVL+
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---V-HRDLAARNVLVTHGK 209
Query: 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMNGQV-SILGDIYS 591
+ DFGLA+ + S+ + +P PE + + +I D++S
Sbjct: 210 VVKICDFGLARDIMSDSNY----------VVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259
Query: 592 YGILLLEMFT-GKRP 605
YGILL E+F+ G P
Sbjct: 260 YGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 56/252 (22%)
Query: 391 FSKENL-----IGTGSFGSVYKGTL------GDGTIVAIKVLK-LQQQGALKSFIDECNA 438
+ + N+ IG G+FG V++ T+VA+K+LK F E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL----------------- 481
+ + NI++++ C+ L+FE+M+ G+L+++L
Sbjct: 104 MAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 482 HPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDMTAH 540
+ LS ++L IA VA+ + YL H DL N L+ ++M
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVK 214
Query: 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP-----PEHMN-GQVSILGDIYSYGI 594
+ DFGL++ ++ +D IP PE + + + D+++YG+
Sbjct: 215 IADFGLSRNIYS-AD---------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 595 LLLEMFT-GKRP 605
+L E+F+ G +P
Sbjct: 265 VLWEIFSYGLQP 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 51/316 (16%), Positives = 105/316 (33%), Gaps = 46/316 (14%)
Query: 50 IPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109
I + + +I + S+L + + + ++K L L+ N L +L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 110 FFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169
L N + + ++S++ + N + +L P+++ A N +
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR 113
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
VS S + + A N +T + G + L+ NE+ + +NF +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----VNFAELA 165
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
A+ +LE L L N + ++ + L L L
Sbjct: 166 ASSDTLEHLNLQYN------------------FIY--------DVKGQV-VFAKLKTLDL 198
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE-GSIPP 348
N L+ + + + L NK I +L L + N G++
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 349 SLGNCQKLLVLNLSSN 364
Q++ + +
Sbjct: 257 FFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 43/293 (14%), Positives = 92/293 (31%), Gaps = 23/293 (7%)
Query: 97 SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPN 156
+I + + + + + S + ++ ++ N L Q+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK 59
Query: 157 LKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELG 216
L++ + N L + S L+ LD N + + L+ N +
Sbjct: 60 LELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 217 SREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN-LMHGNIP 275
+ + LA N + + ++ L + N + N
Sbjct: 113 RVSCSRG---------QGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFA 162
Query: 276 VGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRL 335
+ L L L+ N + V + KL+ L L+ NK + + + +T +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219
Query: 336 WMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKST 388
+ N+L I +L Q L +L N + ++ ++K T
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/382 (15%), Positives = 127/382 (33%), Gaps = 21/382 (5%)
Query: 6 IPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEII 63
IP L + L+L++N ++ +L C L+ + + SL LE +
Sbjct: 20 IPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL 79
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRG-SIPNELGQLSGLGFFTLYG-NFISGI 121
L ++L+ +W G SSLK L+L N + + + L+ L + S I
Sbjct: 80 DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 122 IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNL 181
++S+ + L + ++ ++ ++ + + S++
Sbjct: 140 RRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 182 QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL----KFLANCTSLEV 237
+ L+ + L + + N L +++ + +E
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 238 LGLARNSFGGEMPISIANLS-------THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290
N G P +S +RRL + + + ++ L + + +E
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318
Query: 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI---PSSLGNLTILTRLWMEENRLE--GS 345
+ + L LE L L+ N + G L L + +N L
Sbjct: 319 NSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK 378
Query: 346 IPPSLGNCQKLLVLNLSSNDLN 367
L + L L++S N +
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 57/382 (14%), Positives = 115/382 (30%), Gaps = 35/382 (9%)
Query: 13 QDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
Q L + +I + T L E L S+ + + L S
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
+ + SS++ L L NL + L S + S +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 132 IYYFSVTQNQLH-----------------GQLPTDVGLTLPNLKIFAGAVNYFTGSIPVS 174
+ + + +++ + + ++ Y +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234
S ++ + + + LK L L+ +N + + + S
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA---CKGAWPS 362
Query: 235 LEVLGLARNSFG--GEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGN 292
L+ L L++N + + L +L L + N H +P + L L
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTL-KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 293 NLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGN 352
+ V LE L ++ N L L L++ N+L+ ++P +
Sbjct: 421 GIR-VVKT--CIPQTLEVLDVSNNNLDS-FSLFLPR---LQELYISRNKLK-TLPDA-SL 471
Query: 353 CQKLLVLNLSSNDLNGTIPKEV 374
LLV+ +S N L ++P +
Sbjct: 472 FPVLLVMKISRNQLK-SVPDGI 492
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 56/331 (16%), Positives = 113/331 (34%), Gaps = 16/331 (4%)
Query: 49 QIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGL 108
IP+ L+ ++ + L + +T + ++L+ L L + + + L L
Sbjct: 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 109 GFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFA-GAVNYF 167
L N +S + S +SS+ Y ++ N T + L NL+ G V F
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 168 TGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLK 227
+ + + ++L L+ L + S++D+ L +E + L
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 228 FLANCTSLEVLGLARNSFG----GEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVN 283
+ L LAR F E+ + L+ LT + I L
Sbjct: 197 SV-RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 284 LNLLGLEGNNLSGSVPEVIGRLNK--------LEGLGLNVNKFSGLIPSSLGNLTILTRL 335
+ N L P +++ + L + + + L + R+
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 336 WMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
+E +++ + + L L+LS N +
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 57/368 (15%), Positives = 112/368 (30%), Gaps = 47/368 (12%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+L + L +L ++ +++ + L+ + + L +NL
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 73 NVPAWIGNFSSLKALSLAWNNLRG----------SIPNELGQLSGLGFFTLYGNFISGII 122
+ + + + + +LS + F N +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 123 PSSIYNIS--------SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVS 174
PS +S +I + Q L + V L +K +
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 175 LSNASNLQVLDFAENGLTGTIPGN---FGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
+ +L+ LD +EN + N G+ L L QN L S +
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL----LT 385
Query: 232 CTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN-----------------LMHGNI 274
+L L ++RN+F MP S +R L + + + N+
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWP-EKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443
Query: 275 PVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTR 334
L L L + N L ++P+ L + ++ N+ + LT L +
Sbjct: 444 DSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 335 LWMEENRL 342
+W+ N
Sbjct: 502 IWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 37/201 (18%), Positives = 65/201 (32%), Gaps = 11/201 (5%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
SIP L+ + ++ LD + N +T G+ + +L L + + + E L
Sbjct: 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL--- 73
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN-LMHGNIPVGIGNLVNLNLLG 288
SLE L L+ N L + L+ L + N + NL NL L
Sbjct: 74 ---GSLEHLDLSDNHLSSLSSSWFGPL-SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 289 LEGNNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347
+ + L L L + SL ++ + L + + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 348 PSLGNCQKLLVLNLSSNDLNG 368
+ L L +L
Sbjct: 190 IFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 43/286 (15%), Positives = 90/286 (31%), Gaps = 33/286 (11%)
Query: 82 SSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQ 141
+ + SIP+ L + + L N I+ I + +++ + ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 142 LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGS 201
++ + D + +L+ LD ++N L+ FG
Sbjct: 62 IN-TIEGDA------------------------FYSLGSLEHLDLSDNHLSSLSSSWFGP 96
Query: 202 LKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLR 261
L L LN N + L N T+L+ L + E+ T L
Sbjct: 97 LSSLKYLNLMGNPYQT-----LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN 151
Query: 262 RLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321
L + + + ++ +++ L L + + + L+ + L L +
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 322 IPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
S L + + + R S KLL L +++
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-24
Identities = 50/319 (15%), Positives = 110/319 (34%), Gaps = 24/319 (7%)
Query: 50 IPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109
I + + +I + S+L + + + ++K L L+ N L +L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 110 FFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169
L N + + ++S++ + N + +L P+++ A N +
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR 113
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
VS S + + A N +T + G + L+ NE+ + +NF +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----VNFAELA 165
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
A+ +LE L L N + + L+ L + N + + + + + L
Sbjct: 166 ASSDTLEHLNLQYNFIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFS-GLIPSSLGNLTILTRLWMEENRLEGSIPP 348
N L + + + LE L N F G + + + + ++
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQ 278
Query: 349 SLGNCQKLLVLNLSSNDLN 367
+ C + + +
Sbjct: 279 NEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 57/368 (15%), Positives = 108/368 (29%), Gaps = 50/368 (13%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
+ +T + L + + ++ + S N L+ TKLE++ L + L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
+ + S+L+ L L N + EL + N IS + S +
Sbjct: 72 -ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKKN 124
Query: 132 IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191
IY + N++ T + S +Q LD N +
Sbjct: 125 IY---LANNKI-------------------------TMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 192 TG-TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250
S L LN N + +K L+ L L+ N M
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTLDLSSNKL-AFMG 207
Query: 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS-GSVPEVIGRLNKLE 309
+ + +++ N + I + NL L GN G++ + + +++
Sbjct: 208 PEFQSA-AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369
+ L + T+ T E P L + G+
Sbjct: 266 TVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 370 IPKEVRQS 377
+ +
Sbjct: 324 ETERLECE 331
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 44/304 (14%), Positives = 99/304 (32%), Gaps = 47/304 (15%)
Query: 97 SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPN 156
+I + + + + + S + ++ ++ N L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-------------- 46
Query: 157 LKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELG 216
+ L+ + L++L+ + N L T+ SL L L+ + N +
Sbjct: 47 -----------SQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV- 92
Query: 217 SREIGDLNFLKFL------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLT 264
+E+ ++ L + + + LA N + + ++ L
Sbjct: 93 -QELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLD 150
Query: 265 MGEN-LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP 323
+ N + N + L L L+ N + V + KL+ L L+ NK + +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MG 207
Query: 324 SSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSD 383
+ +T + + N+L I +L Q L +L N + ++
Sbjct: 208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
Query: 384 ISKS 387
++K
Sbjct: 267 VAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-18
Identities = 46/377 (12%), Positives = 105/377 (27%), Gaps = 38/377 (10%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIP--------------NQLSSL- 57
++L+L+ N LS +L+ T+L S N + N + L
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELL 96
Query: 58 --TKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYG 115
+E + +N++ V K + LA N + + G S + + L
Sbjct: 97 VGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 116 NFISGI-IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVS 174
N I + + ++ + ++ N ++ + + LK + N +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ--VVFAKLKTLDLSSNKLA-FMGPE 209
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234
+A+ + + N L I ++L + N F +
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-----GTLRDFFSKNQR 263
Query: 235 LEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294
++ + ++ T G L+ L +
Sbjct: 264 VQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 295 SGSVPEVIGR----LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSL 350
GS E + + + ++ +I L ++ L+ +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 351 GNCQKLLVLNLSSNDLN 367
+L +
Sbjct: 381 RAHAELDGTLQQAVGQI 397
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHR 445
+ K IG G++G+V+K IVA+K ++L G S + E LK +H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 446 NILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRL 500
NI+R V+ + + LVFEF +L ++ + K + Q L
Sbjct: 62 NIVRLHDVLHSDKKL--------TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF-LFQLL 111
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
L + H + H DLKP N+L++++ + +FGLA+ F I
Sbjct: 112 -------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSA 160
Query: 561 QTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRP 605
+ V ++ Y PP+ + G SI D++S G + E+ RP
Sbjct: 161 EVV------TLWYRPPDVLFGAKLYSTSI--DMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRN 446
+ + K +G G++G VYK G IVA+K ++L + G + I E + LK H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIAI 504
I+ +I S E LVFEFM +L + L + + + Q K + Q L
Sbjct: 81 IVSLIDVIHS---ERCLT--LVFEFMEK-DLKKVLDENKTGLQDSQIKIY-LYQLL---- 129
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ + H H I H DLKP N+L++ D + DFGLA+ F I ++ V
Sbjct: 130 ---RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA-FGIPVRSYTHEVV- 181
Query: 565 IGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
++ Y P+ + G S+ DI+S G + EM TGK
Sbjct: 182 -----TLWYRAPDVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/386 (16%), Positives = 124/386 (32%), Gaps = 40/386 (10%)
Query: 6 IPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQL-SSLTKLEIIG 64
+P H ++L+ N ++ T+ S +L+ + I N L+ L I+
Sbjct: 28 LPAH--VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 65 LGGSNLTGNVPAWI-GNFSSLKALSLAWNNLRGSI--PNELGQLSGLGFFTLYGNFISGI 121
L + + ++L+ L+L NL G++ N L+ L L N I I
Sbjct: 86 LDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144
Query: 122 IPSSI-YNISSIYYFSVTQNQLHGQLPTDV----------GLTLPNLKIFAGAVNYFTGS 170
P+S N+ + +T N++ + + L L ++ + +
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
+ +++ LD + NG ++ F ++ F
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263
Query: 231 NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGL 289
+F G + ++ + + + +L L L
Sbjct: 264 ---------PDNFTFKGLEASGVKTCDLSKSKIF--------ALLKSVFSHFTDLEQLTL 306
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP- 348
N ++ L L L L+ N + NL L L + N + ++
Sbjct: 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
Query: 349 SLGNCQKLLVLNLSSNDLNGTIPKEV 374
S L L L +N L ++P +
Sbjct: 366 SFLGLPNLKELALDTNQLK-SVPDGI 390
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 3/118 (2%)
Query: 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGRLNKLEG 310
+ L H+ + + N + L +L L +E + L+ L
Sbjct: 24 QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 311 LGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP--SLGNCQKLLVLNLSSNDL 366
L L+ N+F L + L L L + + L+G++ L +L L N++
Sbjct: 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 62/377 (16%), Positives = 127/377 (33%), Gaps = 19/377 (5%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
T LN++ NY+S +++ ++LR S N + +LE + L + L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIP--NELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
+ +LK L L++N ++P E G +S L F L + I ++
Sbjct: 83 -KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 130 SSIYYFSVTQNQL--HGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFA 187
+ V +L I F + VS+ +NL++ +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 188 ENGLTGTIPGNFGSLKDLVRLNFDQN-ELGSREIGDLNFLKFLA--NCTSLEVLGLARNS 244
L L N L + E +F++ L T++ ++
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 245 FGGEMPISIANLSTH----LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE 300
G++ + S L + ++ N+N+ +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318
Query: 301 VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG---NCQKLL 357
+++ L + N + + + G+LT L L ++ N+L+ + + L
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ 377
Query: 358 VLNLSSNDLNGTIPKEV 374
L++S N ++ K
Sbjct: 378 QLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 68/374 (18%), Positives = 128/374 (34%), Gaps = 35/374 (9%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ L L+ +L ++H + + L L T
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTN 175
Query: 73 NVPAWIGNFSSLKALSLAWNNLRG-----------SIPNELGQLSGLGFFTLYGNFISGI 121
+I + S +L +N++ SI +L L TL +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 122 IPSSIYNI---SSIYYFSVTQNQLHGQLPTD----VGLTLPNLKIFAGAVNYFTGSIPVS 174
I + ++++YFS++ +L GQL G +L L I + F
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234
SN+ + +F +G + + L+F N L + L T
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL------TE 349
Query: 235 LEVLGLARNSFG--GEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
LE L L N ++ + L++L + +N + + G +L L +
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQM-KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-SL 350
N L+ ++ + +++ L L+ NK + P + L L L + N+L+ S+P
Sbjct: 409 NILTDTIFRCL--PPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLK-SVPDGIF 464
Query: 351 GNCQKLLVLNLSSN 364
L + L +N
Sbjct: 465 DRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 60/380 (15%), Positives = 128/380 (33%), Gaps = 29/380 (7%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDF-VGQIPNQLSSLTKLEIIGLGGSNLT 71
+ L+L++N L + L S N F I + ++++L+ +GL ++L
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKHLD---LSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
+ I + + K L + + L +L+ F + I ++S
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 132 IYYFSVTQNQLHGQLPTDV----------GLTLPNLKIFAGAVNYFTGSIPVSLSN---A 178
++ + + L + T P L T + + +
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
+ + + L G + +++ S G + +++ +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE-IFSNMNIK 305
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298
+ + + + + L NL+ + G+L L L L+ N L +
Sbjct: 306 NFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 299 PEVIG---RLNKLEGLGLNVNKFSGLIPSSL-GNLTILTRLWMEENRLEGSIPPSLGNCQ 354
++ ++ L+ L ++ N S L L M N L +I L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421
Query: 355 KLLVLNLSSNDLNGTIPKEV 374
++ VL+L SN + +IPK+V
Sbjct: 422 RIKVLDLHSNKIK-SIPKQV 440
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 57/231 (24%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
+++ IG G+ G+VY + G VAI+ + LQQQ + I+E ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+ + + L G++ +V E+++ G+L + + + Q ++ + R +
Sbjct: 79 IVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCR-----EC 125
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
AL++LH + + H D+K N+LL D + + DFG +I+ SK T+
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTM--- 176
Query: 567 LKGSIG---YIPPE-----HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+G ++ PE +V DI+S GI+ +EM G+ P +
Sbjct: 177 ----VGTPYWMAPEVVTRKAYGPKV----DIWSLGIMAIEMIEGEPPYLNE 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 51/268 (19%)
Query: 362 SSNDLNGTIPKEVRQSGMSYSDISKS----------TDNFSKENLIGTGSFGSVYKGT-L 410
SS GT + +++ + IG GS G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 411 GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470
G VA+K++ L++Q + +E ++ +H N++ + + L G + ++ E
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY----LVGEEL-WVLME 122
Query: 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530
F+ G L + Q ++ + V AL YLH + H D+K +
Sbjct: 123 FLQGGALTDIVSQVRLNEEQ---IATVCE-----AVLQALAYLHAQ---GVIHRDIKSDS 171
Query: 531 VLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG---------LKGSIGYIPPEHMNG 581
+LL D + DFG +IS + K +++ +G + S Y
Sbjct: 172 ILLTLDGRVKLSDFGFCA---QISKDVPKRKSL-VGTPYWMAPEVISRS-LY------AT 220
Query: 582 QVSILGDIYSYGILLLEMFTGKRPTGDM 609
+V DI+S GI+++EM G+ P
Sbjct: 221 EV----DIWSLGIMVIEMVDGEPPYFSD 244
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 74/375 (19%), Positives = 125/375 (33%), Gaps = 66/375 (17%)
Query: 27 PTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGN------ 80
P N+S+ S N + ++P + ++ S N P G
Sbjct: 5 PRNVSNTFLQEPLRHSSN--LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 81 -------FSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133
L L L S+P L L N ++ +P ++ S+
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLL 117
Query: 134 YFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG 193
+ L P L + N ++ +P L N+S L+++D N L
Sbjct: 118 VDNNNLKALSDLPPLLEYLGVSNNQL---------EKLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 194 TIPGNFGSLKDLVRLNFDQNELGS-REIGDLNFLKFL-----------ANCTSLEVLGLA 241
+P SL+ + N+L E+ +L FL + SLE +
Sbjct: 167 KLPDLPPSLE---FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAG 223
Query: 242 RNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV 301
N E + NL L + NL+ +P +L LN+ +N +PE+
Sbjct: 224 NNIL--EELPELQNL-PFLTTIYADNNLLK-TLPDLPPSLEALNVR----DNYLTDLPEL 275
Query: 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNL 361
L L+ + S L P+ L L N + S+ + L LN+
Sbjct: 276 PQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPS---LEELNV 324
Query: 362 SSNDLNGTIPKEVRQ 376
S+N L +P +
Sbjct: 325 SNNKLI-ELPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 77/383 (20%), Positives = 128/383 (33%), Gaps = 71/383 (18%)
Query: 2 ELIMIPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLE 61
L +P L + L ++ N L K+P L + + L+ + N ++P+ SL +
Sbjct: 125 ALSDLPPLL--EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA 179
Query: 62 IIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI 121
G + L +P + N L A+ N+L+ +P+ L + N +
Sbjct: 180 ---AGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE-- 228
Query: 122 IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNL 181
+ N+ + N L LP P+L+ NY T +P + L
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPD----LPPSLEALNVRDNYLT-DLPELPQS---L 279
Query: 182 QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLA 241
LD +EN + + +L LN NE+ S SLE L ++
Sbjct: 280 TFLDVSENIFS-GLSELPPNLY---YLNASSNEIRS----------LCDLPPSLEELNVS 325
Query: 242 RNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV 301
N I + L L RL N + +P NL L++ E N L P++
Sbjct: 326 NNKL-----IELPALPPRLERLIASFNHLA-EVPELPQNLKQLHV---EYNPLR-EFPDI 375
Query: 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNLTIL-----------------TRLWMEENRLEG 344
+ L +N +P NL L L M R+
Sbjct: 376 PESVEDL-----RMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVD 430
Query: 345 SIPPSLGNCQKLLVLNLSSNDLN 367
+ KL + +
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHH 453
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 50/251 (19%), Positives = 90/251 (35%), Gaps = 34/251 (13%)
Query: 375 RQSGMSYSDISKSTDN---FSKENLIGTG--SFGSVYKGT-LGDGTIVAIKVLKLQQQG- 427
+ + +S + +IG G +V G V ++ + L+
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 428 -ALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA 486
+ E + K H NI+ + N+ +V FM+ G+ +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATF----IADNEL-WVVTSFMAYGSAKDLICTHFM 122
Query: 487 EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546
+ ++ I + V ALDY+HH H +K S++L+ D ++
Sbjct: 123 DGMNELAIAYILQ-----GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIP---PEHMNGQVSILG-----DIYSYGILLLE 598
+ + + + V K S+ +P PE + Q ++ G DIYS GI E
Sbjct: 175 N---LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL--QQNLQGYDAKSDIYSVGITACE 229
Query: 599 MFTGKRPTGDM 609
+ G P DM
Sbjct: 230 LANGHVPFKDM 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL-QQQGALKSFI 433
S + +S + D++ + +IG+G+ V VAIK + L + Q ++ +
Sbjct: 5 SSALPWSI---NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL 61
Query: 434 DECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFK 492
E A+ H NI+ S V D LV + +S G++ D H ++
Sbjct: 62 KEIQAMSQCHHPNIVSYY--TSFVV---KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 493 KLSVIQRLNIAI---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
L IA +V L+YLH + H D+K N+LL +D + + DFG++ F
Sbjct: 117 VLDEST---IATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170
Query: 550 LFEISDNP--SKNQTVSIGLKGSIG---YIPPEHMNGQVSILG---DIYSYGILLLEMFT 601
L D +T +G ++ PE M QV DI+S+GI +E+ T
Sbjct: 171 LATGGDITRNKVRKTF-------VGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELAT 222
Query: 602 GKRPTGDM 609
G P
Sbjct: 223 GAAPYHKY 230
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRN 446
+ + K + +G G++ +VYKG +VA+K ++L+ + GA + I E + LK +H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 447 ILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLN 501
I+ +I S+ LVFE++ +L Q+L + + K + Q L
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHNVKLF-LFQLL- 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
L Y H + H DLKP N+L+++ + DFGLA+ I N+
Sbjct: 111 ------RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNE 160
Query: 562 TVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
V ++ Y PP+ + G I D++ G + EM TG+
Sbjct: 161 VV------TLWYRPPDILLGSTDYSTQI--DMWGVGCIFYEMATGR 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 60/360 (16%), Positives = 124/360 (34%), Gaps = 39/360 (10%)
Query: 13 QDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
+ + + + K+P L ++ + + ++ + +G + +
Sbjct: 48 KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 72 GNVPAWI-GNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIYNI 129
+P + N L L L N+L S+P + L ++ N + I +
Sbjct: 107 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+S+ ++ N+L + +P+L + N + +L+ ++ LD + N
Sbjct: 165 TSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 215
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249
+ + G +L L N L +L N L + L+ N M
Sbjct: 216 SIN-VVRGPV--NVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIM 264
Query: 250 PISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE 309
+ L RL + N + + + + L +L L N+L V + ++LE
Sbjct: 265 YHPFVKM-QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 321
Query: 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369
L L+ N L L L L + N + N + L N++ ++
Sbjct: 322 NLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 55/288 (19%), Positives = 91/288 (31%), Gaps = 47/288 (16%)
Query: 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139
++ K ++ + +R L + L I I + +I +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNF 199
N + LP V N L VL N L+ G F
Sbjct: 103 NAIR-YLPPHV------------------------FQNVPLLTVLVLERNDLSSLPRGIF 137
Query: 200 GSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTH 259
+ L L+ N L I D F TSL+ L L+ N + ++ +
Sbjct: 138 HNTPKLTTLSMSNNNL--ERIEDDTF----QATTSLQNLQLSSNRLTH---VDLSLI-PS 187
Query: 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS 319
L + NL+ + + + L N+++ V +L L L N +
Sbjct: 188 LFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT 239
Query: 320 GLIPSSLGNLTILTRLWMEENRLEGSIPP-SLGNCQKLLVLNLSSNDL 366
+ L N L + + N LE I Q+L L +S+N L
Sbjct: 240 DT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 42/224 (18%), Positives = 83/224 (37%), Gaps = 21/224 (9%)
Query: 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD 211
++ I + + G ++L+N +++ F + + S + + LN +
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77
Query: 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
++ EI F A +++ L + N+ P N+ L L + N +
Sbjct: 78 DLQI--EEIDTYAF----AYAHTIQKLYMGFNAIRYLPPHVFQNV-PLLTVLVLERNDLS 130
Query: 272 GNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330
++P GI N L L + NNL + L+ L L+ N+ + + L +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 186
Query: 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
L + N L +L + L+ S N +N + V
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV 224
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 29/164 (17%), Positives = 49/164 (29%), Gaps = 6/164 (3%)
Query: 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLT 264
F + + + + + +++ ++ + + + L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSF-RQVELLN 75
Query: 265 MGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP 323
+ + + I + L + N + P V + L L L N S L
Sbjct: 76 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 324 SSLGNLTILTRLWMEENRLEGSIPPS-LGNCQKLLVLNLSSNDL 366
N LT L M N LE I L L LSSN L
Sbjct: 135 GIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL 177
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 40/226 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHRN 446
+ + IG G++G VYK G A+K ++L+++ G + I E + LK +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 447 ILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLN 501
I++ VI + LVFE + +L + L E K ++Q L
Sbjct: 62 IVKLYDVIHTKKRL--------VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL- 110
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
+ + Y H + H DLKP N+L++++ + DFGLA+ F I ++
Sbjct: 111 ------NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHE 160
Query: 562 TVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
V ++ Y P+ + G +I DI+S G + EM G
Sbjct: 161 IV------TLWYRAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNGT 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 41/238 (17%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFID-ECNALKSTRHRNILR- 449
L+G GS+G V + A+K+L KL++ ++ + E L+ RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 450 --VITACSSVDLEGNDFKALVFEFMSNGN---LDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
V+ + +V E+ G LD K+ V Q
Sbjct: 72 VDVLYNEEKQKM------YMVMEYCVCGMQEMLDSVPE---------KRFPVCQAHGYFC 116
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L+YLH I H D+KP N+LL T + G+A+ L + + +T
Sbjct: 117 QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQ 172
Query: 565 IGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619
GS + PPE NG + G DI+S G+ L + TG P F+ D +F
Sbjct: 173 ----GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLF 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 50/261 (19%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL-QQQGALKSFIDECNALKSTRHR 445
+ F+K IG GSFG V+KG +VAIK++ L + + ++ E L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
+ + + L+ ++ E++ G+ L P P + Q ++ I R +
Sbjct: 81 YVTKYYGSY----LKDTKL-WIIMEYLGGGSALDLLEPGPLDETQ---IATILR-----E 127
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ LDYLH H D+K +NVLL + + DFG+A +++D K T
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTF-- 179
Query: 566 GLKGSIG---YIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDM------------ 609
+G ++ PE + DI+S GI +E+ G+ P ++
Sbjct: 180 -----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234
Query: 610 ----FKDDFS--IHMFVSMAL 624
+ ++S + FV L
Sbjct: 235 NPPTLEGNYSKPLKEFVEACL 255
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 42/260 (16%)
Query: 369 TIPKEVRQSGMSYSDISKSTD---NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ 424
++ + + D+S D F L+G G++G VYKG + G + AIKV+ +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 425 QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWLH 482
+ E N LK HRNI A + G D + LV EF G++ +
Sbjct: 61 GD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 483 PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542
+ + + ++ I R ++ L +LH H + H D+K NVLL ++ +
Sbjct: 120 NTKGNTLKEEWIAYICR-----EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171
Query: 543 DFGLAKFLFEISDNPSKNQTVSIG-------------LKGSIGYIPPEHMNGQVSILGDI 589
DFG++ ++ + T IG Y + + D+
Sbjct: 172 DFGVSA---QLDRTVGRRNTF-IGTPYWMAPEVIACDENPDATY------DFKS----DL 217
Query: 590 YSYGILLLEMFTGKRPTGDM 609
+S GI +EM G P DM
Sbjct: 218 WSLGITAIEMAEGAPPLCDM 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKS 441
+ S D + + +G G++G VYK VAIK ++L+ + G + I E + LK
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 442 TRHRNILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
+HRNI+ VI + L+FE+ N +L +++ +P + K + Q
Sbjct: 90 LQHRNIIELKSVIHHNHRL--------HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG-----DFGLAKFLFEI 553
+ + +++ H H DLKP N+LL + DFGLA+ F I
Sbjct: 141 LI-------NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-FGI 189
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
++ + ++ Y PPE + G S+ DI+S + EM
Sbjct: 190 PIRQFTHEII------TLWYRPPEILLGSRHYSTSV--DIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 386 KSTDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKS 441
K ++F ++G GSF +V T AIK+L+ K I + N +
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILE-------KRHIIKENKVPY 76
Query: 442 TRH-RNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
R+++ + V L ++ + NG L K +
Sbjct: 77 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-------------LKYIRK 123
Query: 497 IQRLNI------AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
I + ++ SAL+YLH I H DLKP N+LL++DM + DFG AK
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-- 178
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
+S + + S G+ Y+ PE + + D+++ G ++ ++ G P
Sbjct: 179 -VLSPESKQARANS--FVGTAQYVSPELLTEKSACKSS----DLWALGCIIYQLVAGLPP 231
Query: 606 TGDMFKDDFSIHMF 619
F+ +F
Sbjct: 232 ----FRAGNEYLIF 241
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRH 444
S+ F + +G G++ +VYKG G VA+K +KL + G + I E + +K +H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI+R+ + E LVFEFM N +L +++ S + L +
Sbjct: 63 ENIVRLYDVIHT---ENKLT--LVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQW 115
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L + H + I H DLKP N+L++K +GDFGLA+ F I N ++ V
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFSSEVV- 170
Query: 565 IGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
++ Y P+ + G SI DI+S G +L EM TGK
Sbjct: 171 -----TLWYRAPDVLMGSRTYSTSI--DIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 383 DISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALK-----SFIDEC 436
D+ + K + +G G F +VYK IVAIK +KL + K + + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFK-ALVFEFMSNGNLDQWL--HPSPAEHYQFKK 493
L+ H NI+ ++ D G+ +LVF+FM +L+ + + K
Sbjct: 64 KLLQELSHPNIIGLL------DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
++ L L+YLH H I H DLKP+N+LLD++ + DFGLAK F
Sbjct: 117 Y-MLMTL-------QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS-FGS 164
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
+ +Q V + Y PE + G V + D+++ G +L E+
Sbjct: 165 PNRAYTHQVV------TRWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRV 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 45/243 (18%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKG--TLGDGTIVAIKVLKLQQQ--GALKSFID 434
M + ++ + IG G++G V+K G VA+K +++Q G S I
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 435 ECNALK---STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHY 489
E L+ + H N++R+ C+ + LVFE + +L +L P P
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ K + Q L LD+LH H + H DLKP N+L+ + DFGLA+
Sbjct: 120 ETIKDMMFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 550 LFEISDNPSK--NQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMF 600
+ + V ++ Y PE +L D++S G + EMF
Sbjct: 170 -YSF---QMALTSVVV------TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMF 213
Query: 601 TGK 603
K
Sbjct: 214 RRK 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 54/248 (21%), Positives = 95/248 (38%), Gaps = 49/248 (19%)
Query: 381 YSDISKSTD---NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDEC 436
Y + + D + +G G+FG VYK G + A KV++ + + L+ +I E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
L + H I++++ A ++ EF G +D + + L+
Sbjct: 68 EILATCDHPYIVKLLGAY----YHDGKL-WIMIEFCPGGAVDAIMLELD------RGLTE 116
Query: 497 IQRLNIAI---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
Q I + + AL++LH I H DLK NVL+ + + DFG++ +
Sbjct: 117 PQ---IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KN 167
Query: 554 SDNPSKNQT------------VSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFT 601
K + V Y + + DI+S GI L+EM
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY------DYKA----DIWSLGITLIEMAQ 217
Query: 602 GKRPTGDM 609
+ P ++
Sbjct: 218 IEPPHHEL 225
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 371 PKEVRQSGMSYSD--ISKSTDNFSK----ENLIGTGSFGSVYKGT-LGDGTIVAIKVL-- 421
P + + + ST FS + ++G GSFG V G A+KV+
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 422 -KLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQW 480
+++Q+ +S + E LK H NI+++ E + LV E + G L
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDE 116
Query: 481 LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTA 539
+ + + + I R V S + Y+H + I H DLKP N+LL K A
Sbjct: 117 IISR--KRFSEVDAARIIR-----QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDA 166
Query: 540 HV--GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLL 597
++ DFGL+ + + G+ YI PE ++G D++S G++L
Sbjct: 167 NIRIIDFGLSTH---FEASKKMKDKI-----GTAYYIAPEVLHGTYDEKCDVWSTGVILY 218
Query: 598 EMFTGKRP 605
+ +G P
Sbjct: 219 ILLSGCPP 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTR 443
+ K IG G+FG V+K G VA+K + ++ + G + + E L+ +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 444 HRNILRVITACSSVDLEGNDFKA---LVFEFMSN---GNLDQWLHPSPAEHYQFKKLSVI 497
H N++ +I C + N K LVF+F + G L + K++ +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRV-MQ 131
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
L + L Y+H + I H D+K +NVL+ +D + DFGLA+ ++
Sbjct: 132 MLL-------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 558 SKNQT---VSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
T V ++ Y PPE + G+ I D++ G ++ EM+T
Sbjct: 182 PNRYTNRVV------TLWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL-QQQGALKSF----IDECNA 438
S +T + IG G++G+VYK G VA+K +++ G + E
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 439 LK---STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKK 493
L+ + H N++R++ C++ + LVFE + +L +L P P + K
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
+ Q L LD+LH +C I H DLKP N+L+ T + DFGLA+ +
Sbjct: 124 DLMRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI-YSY 172
Query: 554 SDNPSK--NQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGK 603
V ++ Y PE + + D++S G + EMF K
Sbjct: 173 ---QMALTPVVV------TLWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRK 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 34/281 (12%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFID-ECNALKSTRH 444
D+F K + +G G+ G V+K + G ++A K++ L+ + A+++ I E L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 445 RNILRVITACSSVDLEGNDFKA----LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
I V G + + E M G+LDQ L + ++
Sbjct: 91 PYI---------VGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILG 134
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
++I V L YL I H D+KPSN+L++ + DFG++ L + S
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMA 187
Query: 561 QTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619
+ G+ Y+ PE + G S+ DI+S G+ L+EM G+ P + +
Sbjct: 188 NSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243
Query: 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHI 660
+ + + E++ +I
Sbjct: 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 33/232 (14%)
Query: 384 ISKSTDNFSK----ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ--QGALKSFIDEC 436
I+ + S+ +G+G++G V AIK+++ + ++E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
LK H NI+++ E LV E G L + + +V
Sbjct: 88 AVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAV 140
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHV--GDFGLAKFLFEI 553
I + V S + YLH H I H DLKP N+LL K+ A + DFGL+
Sbjct: 141 IIK-----QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---F 189
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ + + G+ YI PE + + D++S G++L + G P
Sbjct: 190 ENQKKMKERL-----GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-21
Identities = 60/360 (16%), Positives = 124/360 (34%), Gaps = 39/360 (10%)
Query: 13 QDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
+ + + + K+P L ++ + + ++ + +G + +
Sbjct: 54 KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 72 GNVPAWI-GNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIYNI 129
+P + N L L L N+L S+P + L ++ N + I +
Sbjct: 113 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+S+ ++ N+L + +P+L + N + +L+ ++ LD + N
Sbjct: 171 TSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249
+ + G +L L N L +L N L + L+ N M
Sbjct: 222 SIN-VVRG--PVNVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIM 270
Query: 250 PISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE 309
+ L RL + N + + + + L +L L N+L V + ++LE
Sbjct: 271 YHPFVKM-QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 327
Query: 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369
L L+ N L L L L + N + N + L N++ ++
Sbjct: 328 NLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 2e-17
Identities = 56/289 (19%), Positives = 93/289 (32%), Gaps = 49/289 (16%)
Query: 80 NFSSLKALSLAWNNLRGSIPNE-LGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138
++ K ++ + +R +P L + L I I + +I +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGN 198
N + LP V N L VL N L+ G
Sbjct: 108 FNAIR-YLPPHV------------------------FQNVPLLTVLVLERNDLSSLPRGI 142
Query: 199 FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLST 258
F + L L+ N L I D F TSL+ L L+ N + ++ +
Sbjct: 143 FHNTPKLTTLSMSNNNL--ERIEDDTF----QATTSLQNLQLSSNRLTH---VDLSLI-P 192
Query: 259 HLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKF 318
L + NL+ + + + L N+++ V +L L L N
Sbjct: 193 SLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 244
Query: 319 SGLIPSSLGNLTILTRLWMEENRLEGSIPP-SLGNCQKLLVLNLSSNDL 366
+ + L N L + + N LE I Q+L L +S+N L
Sbjct: 245 TDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 42/224 (18%), Positives = 83/224 (37%), Gaps = 21/224 (9%)
Query: 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD 211
++ I + + G ++L+N +++ F + + S + + LN +
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83
Query: 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
++ EI F A +++ L + N+ P N+ L L + N +
Sbjct: 84 DLQI--EEIDTYAF----AYAHTIQKLYMGFNAIRYLPPHVFQNV-PLLTVLVLERNDLS 136
Query: 272 GNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330
++P GI N L L + NNL + L+ L L+ N+ + + L +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 192
Query: 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
L + N L +L + L+ S N +N + V
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 40/246 (16%)
Query: 375 RQSGMSYSDISKSTD---NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALK 430
R+ + S + F +G GS+GSVYK G IVAIK + ++ L+
Sbjct: 12 RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQ 69
Query: 431 SFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
I E + ++ ++++ + + D +V E+ G++ +
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSY----FKNTDL-WIVMEYCGAGSVSDIIRLRN----- 119
Query: 491 FKKLSVIQRLNIAI---DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
K L+ + IA L+YLH H D+K N+LL+ + A + DFG+A
Sbjct: 120 -KTLTEDE---IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIG---YIPPE-HMNGQVSILGDIYSYGILLLEMFTGK 603
+++D +K TV IG ++ PE + + DI+S GI +EM GK
Sbjct: 173 G---QLTDTMAKRNTV-------IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 604 RPTGDM 609
P D+
Sbjct: 223 PPYADI 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
D+F IG GSFG V T + A+K + K +C R+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMN-------K---QKCVERNEVRN 61
Query: 445 ----RNILRVITACSSVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
I++ + V+L E + F +V + + G+L L Q
Sbjct: 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMF--MVVDLLLGGDLRYHL-------QQNVHF 112
Query: 495 SVIQ-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
+L I ++ ALDYL + I H D+KP N+LLD+ H+ DF +A +
Sbjct: 113 KEETVKLFIC-ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA---ML 165
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-----DIYSYGILLLEMFTGKRP 605
++ T++ G+ Y+ PE + + G D +S G+ E+ G+RP
Sbjct: 166 PRE-TQITTMA----GTKPYMAPEMFSSRKGA-GYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 58/297 (19%), Positives = 99/297 (33%), Gaps = 62/297 (20%)
Query: 367 NGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKV----- 420
+ + + + G S ++ + + IG GS+G V I AIK+
Sbjct: 7 HSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 421 LKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL--- 477
++ ++ E +K H NI R+ E + LV E G+L
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDK 118
Query: 478 ------------------------DQWLHPSPAEHYQFKKLSVIQRLN------IAIDVA 507
+ + + S+ I +
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSI 565
SAL YLH+ I H D+KP N L + + + DFGL+K +++++ T
Sbjct: 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 566 GLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619
G+ ++ PE +N G D +S G+LL + G P F
Sbjct: 236 ---GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPGVNDADTI 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 63/265 (23%), Positives = 102/265 (38%), Gaps = 47/265 (17%)
Query: 362 SSNDLNGTIPKEVRQSGMSYSDISKSTDNFSK----ENLIGTGSFGSVYKGT-LGDGTIV 416
SS N GM + K + +G+G++G V +
Sbjct: 8 SSGRENLYFQGIAINPGMY---VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 417 AIKVLKLQQ-------------QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463
AIKV+K Q + + +E + LKS H NI+++ E
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKK 119
Query: 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523
+ LV EF G L + + K NI + S + YLH H I H
Sbjct: 120 YFYLVTEFYEGGELFEQI-------INRHKFDECDAANIMKQILSGICYLHKHN---IVH 169
Query: 524 CDLKPSNVLL-DKDMTAH--VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN 580
D+KP N+LL +K+ + + DFGL+ F S + + G+ YI PE +
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRL-----GTAYYIAPEVLK 221
Query: 581 GQVSILGDIYSYGILLLEMFTGKRP 605
+ + D++S G+++ + G P
Sbjct: 222 KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 60/271 (22%), Positives = 99/271 (36%), Gaps = 54/271 (19%)
Query: 360 NLSSNDLNGTIPKEVRQSGMSYSDISKS------TDNFSKENLIGTGSFGSVYKGT-LGD 412
NL +P R + D+++ FS IG GSFG+VY + +
Sbjct: 19 NLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRN 78
Query: 413 GTIVAIKVLKLQQQGA---LKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469
+VAIK + + + + I E L+ RH N ++ L + LV
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY----LREHTA-WLVM 133
Query: 470 EFMSNGNLD-QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528
E+ D +H P + + ++ + L YLH H + H D+K
Sbjct: 134 EYCLGSASDLLEVHKKPLQEVE---IAAVTH-----GALQGLAYLHSH---NMIHRDVKA 182
Query: 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS----------IGLKGSIGYIPPEH 578
N+LL + +GDFG A + + + I Y
Sbjct: 183 GNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMAPEVILAMDEGQY----- 230
Query: 579 MNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+G+V D++S GI +E+ K P +M
Sbjct: 231 -DGKV----DVWSLGITCIELAERKPPLFNM 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-20
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 31/237 (13%)
Query: 382 SDISKSTDNFSKENL-IGTGSFGSVYKG---TLGDGTIVAIKVLKLQQQGALKSFIDECN 437
S+ + D F E +G G++G VYK D A+K +++ G S E
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIA 70
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKA-LVFEFMSNGNLDQWL--HPSPAEHYQFKKL 494
L+ +H N++ + V L D K L+F++ + +L + H + + + +L
Sbjct: 71 LLRELKHPNVISLQ----KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH----VGDFGLAKFL 550
++ + + YLH + + H DLKP+N+L+ + + D G A+ L
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-L 181
Query: 551 FEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
F P K + + Y PE + G +I DI++ G + E+ T +
Sbjct: 182 FNS---PLKPLADLDPVVVTFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTSE 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 39/230 (16%)
Query: 385 SKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKS 441
+S + + L+G GS+G V K G IVAIK K + E LK
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQR 499
RH N++ ++ C + + LVFEF+ + + L P+ ++ +K + Q
Sbjct: 81 LRHENLVNLLEVCKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKY-LFQI 133
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
+N + + H H I H D+KP N+L+ + + DFG A+
Sbjct: 134 IN-------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYD 182
Query: 560 NQTVSI------GLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGK 603
++ + L G + Y V D+++ G L+ EMF G+
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKA------V----DVWAIGCLVTEMFMGE 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 41/230 (17%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRH 444
+ ++ ++G GSFG V K A+KV+ + + E LK H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN--- 501
NI+++ E + +V E + G L F ++ +R +
Sbjct: 81 PNIMKLFEIL-----EDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHD 122
Query: 502 ---IAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH--VGDFGLAKFLFEISD 555
I V S + Y+H H I H DLKP N+LL K+ + DFGL+
Sbjct: 123 AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQ 176
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
N + G+ YI PE + G D++S G++L + +G P
Sbjct: 177 NTKMKDRI-----GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 60/318 (18%), Positives = 100/318 (31%), Gaps = 50/318 (15%)
Query: 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFIS 119
L ++ L VP + L L N + + L L L N IS
Sbjct: 33 LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
I P + + + +++NQL +P +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK--------------------------ELPEKM--PK 121
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
LQ L EN +T F L ++ + N L S I + F L +
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIR 177
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSV 298
+A + +P L L L + N + + L NL LGL N++S
Sbjct: 178 IADTNI-TTIP---QGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVD 232
Query: 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS-------LG 351
+ L L LN NK +P L + + +++ N + +I +
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT 290
Query: 352 NCQKLLVLNLSSNDLNGT 369
++L SN +
Sbjct: 291 KKASYSGVSLFSNPVQYW 308
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 43/266 (16%), Positives = 87/266 (32%), Gaps = 49/266 (18%)
Query: 13 QDLNLTYNYLSGKIPTNL-SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
+ L L+ N L ++P + ELR N+ + + L ++ ++ LG + L
Sbjct: 103 ERLYLSKNQLK-ELPEKMPKTLQELR---VHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 72 GNV--PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
+ L + +A N+ +IP L L L GN I+ + +S+ +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 215
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+++ ++ N + + SL+N +L+ L N
Sbjct: 216 NNLAKLGLSFNSIS---------AVD----------------NGSLANTPHLRELHLNNN 250
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249
L +PG K + + N + + D + S + L N
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN------ 303
Query: 250 PISIANLS-------THLRRLTMGEN 268
P+ + + +G
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 6/101 (5%)
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333
+P + + LL L+ N ++ L L L L NK S + P + L L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 334 RLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
RL++ +N+L+ +P + + L L + N++ + K V
Sbjct: 104 RLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSV 140
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 45/235 (19%)
Query: 387 STDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
D F ++G G FG V+ K T G + A K L K + + +
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLN-------KKRLKKRKGYQGA 232
Query: 443 RH-RNILRVITACSSVDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ IL + + V L E LV M+ G++ ++ ++ F++
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA- 291
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISD 555
A + S L++LH I + DLKP NVLLD D +V D GLA +
Sbjct: 292 -IFYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAV------E 338
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
+ G G+ G++ PE + G+ V D ++ G+ L EM + P
Sbjct: 339 LKAGQTKTK-GYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 63/249 (25%), Positives = 95/249 (38%), Gaps = 46/249 (18%)
Query: 377 SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSF 432
S S +D N+ IG G+F V + G VAIK++ +L K F
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 433 IDECNALKSTRHRNILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY 489
E +K H NI++ VI E L+ E+ S G + +L H
Sbjct: 63 -REVRIMKILNHPNIVKLFEVI--------ETEKTLYLIMEYASGGEVFDYL----VAH- 108
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
++ + + + SA+ Y H I H DLK N+LLD DM + DFG
Sbjct: 109 --GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF--- 160
Query: 550 LFEISDNPSKNQTVSIGLK---GSIGYIPPEHMNGQVSI--LGDIYSYGILLLEMFTGKR 604
S+ + L G+ Y PE G+ D++S G++L + +G
Sbjct: 161 ----SNEFTVGGK----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 605 PTGDMFKDD 613
P F
Sbjct: 213 P----FDGQ 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 22/164 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQ--GALKSFIDECNALKSTRHR 445
+ + K IG GS+G V+K G IVAIK + K + E LK +H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL--HPSPAEHYQFKKLSVIQRLNIA 503
N++ ++ + LVFE+ + + L + + K + Q L
Sbjct: 63 NLVNLLEVFRR---KRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVKSI-TWQTLQ-- 113
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
A+++ H H H D+KP N+L+ K + DFG A
Sbjct: 114 -----AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 17/209 (8%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
++PV + + Q + N ++ +F + ++L L N L + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL--- 79
Query: 230 ANCTSLEVLGLARNSFGGEMPISI-ANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLL 287
LE L L+ N+ + + L L L + + + G+ L L L
Sbjct: 80 ---ALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 288 GLEGNNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSI 346
L+ N L ++P+ L L L L+ N+ S + + L L RL + +NR+ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HV 192
Query: 347 PP-SLGNCQKLLVLNLSSNDLNGTIPKEV 374
P + + +L+ L L +N+L+ +P E
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 47/276 (17%), Positives = 80/276 (28%), Gaps = 62/276 (22%)
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSI 126
L VP I ++ + + L N + L L+ N ++ I ++
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 127 YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDF 186
++ + ++ N + L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPAT------------------------FHGLGRLHTLHL 112
Query: 187 AENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSF 245
GL + F L L L N L + + D F + +L L L N
Sbjct: 113 DRCGLQ-ELGPGLFRGLAALQYLYLQDNAL--QALPDDTF----RDLGNLTHLFLHGN-- 163
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGR 304
R++ ++P L +L+ L L N ++ P
Sbjct: 164 ----------------RIS--------SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
L +L L L N S L +L L L L + +N
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 393 KENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKS-TRHRNILRV 450
+E+++G G+ V L A+K+++ Q E L HRN+L +
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509
I E D LVFE M G++ H H+ + SV+ + DVASA
Sbjct: 77 IEFF-----EEEDRFYLVFEKMRGGSILS---HIHKRRHFNELEASVVVQ-----DVASA 123
Query: 510 LDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
LD+LH+ IAH DLKP N+L ++ + DF L + D + +
Sbjct: 124 LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 567 LKGSIGYIPPEHMNGQVSILG------DIYSYGILL 596
GS Y+ PE + D++S G++L
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 31/218 (14%), Positives = 55/218 (25%), Gaps = 62/218 (28%)
Query: 396 LIGTGSFGSVYKGTLGD---GTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILR 449
G ++ D VA+ + Q L+ + L + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLH--PSPAEHYQFKKLSVIQRLNIAIDVA 507
V+ + +V E++ G+L + PSP + +A
Sbjct: 96 VLDV-----VHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----------AIRAMQSLA 139
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+A D H +A PS V + D +
Sbjct: 140 AAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------- 174
Query: 568 KGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
+P + DI G L + + P
Sbjct: 175 -----TMPD------ANPQDDIRGIGASLYALLVNRWP 201
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 47/208 (22%), Positives = 79/208 (37%), Gaps = 13/208 (6%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
S+P + S+ L+ N L G F L L +L+ N L + +
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF--- 75
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLG 288
TSL+ L L+ N M + L L L + + + +L NL L
Sbjct: 76 -GTTSLKYLDLSFNGV-ITMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132
Query: 289 LEGNNLSGSVPEVIGRLNKLEGLGLNVNKF-SGLIPSSLGNLTILTRLWMEENRLEGSIP 347
+ + + + L+ LE L + N F +P L LT L + + +LE +
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 191
Query: 348 P-SLGNCQKLLVLNLSSNDLNGTIPKEV 374
P + + L VLN+S N+ ++
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFF-SLDTFP 218
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 56/282 (19%), Positives = 93/282 (32%), Gaps = 39/282 (13%)
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPS 124
LT +VP I SS L L N L+ +L+ L +L N +S
Sbjct: 14 CNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK--- 67
Query: 125 SIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL 184
+ +LK + N ++ + L+ L
Sbjct: 68 --------------------GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106
Query: 185 DFAENGLTGTIP--GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242
DF + L + F SL++L+ L+ G +SLEVL +A
Sbjct: 107 DFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG------IFNGLSSLEVLKMAG 159
Query: 243 NSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEV 301
NSF I +L L + + + + +L +L +L + NN
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218
Query: 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNL-TILTRLWMEENRL 342
LN L+ L ++N L + + L L + +N
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 50/268 (18%), Positives = 89/268 (33%), Gaps = 40/268 (14%)
Query: 6 IPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGL 65
IP L L N L +P LT+L + L
Sbjct: 26 IPSS--ATRLELESNKLQ-SLP-----------------------HGVFDKLTQLTKLSL 59
Query: 66 GGSNLTGNVPAWIGNF---SSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII 122
+ L+ + +SLK L L++N + ++ + L L + + +
Sbjct: 60 SSNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 117
Query: 123 PSSI-YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI-PVSLSNASN 180
S+ ++ ++ Y ++ + L +L++ A N F + P + N
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 181 LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240
L LD ++ L P F SL L LN N S + SL+VL
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF------PYKCLNSLQVLDY 230
Query: 241 ARNSFGGEMPISIANLSTHLRRLTMGEN 268
+ N + + + L L + +N
Sbjct: 231 SLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/237 (20%), Positives = 85/237 (35%), Gaps = 35/237 (14%)
Query: 13 QDLNLTYNYLSGK--IPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNL 70
L+L+ N LS K + T L+ + S N V + + L +LE + SNL
Sbjct: 55 TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNL 113
Query: 71 TGNVPA-WIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN-FISGIIPSSIYN 128
+ +L L ++ + R + LS L + GN F +P
Sbjct: 114 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE 188
+ ++ + ++Q QL L P + ++ S+LQVL+ +
Sbjct: 174 LRNLTFLDLSQCQLE---------QLS----------------PTAFNSLSSLQVLNMSH 208
Query: 189 NGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSF 245
N + L L L++ N + + + +SL L L +N F
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMT-----SKKQELQHFPSSLAFLNLTQNDF 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 71/321 (22%), Positives = 113/321 (35%), Gaps = 70/321 (21%)
Query: 330 TILTRLWMEENRLEGSIPPSLGNCQKLL-VLNLSSNDLNGTIP---KEVRQSGMSYSDIS 385
+ TR +N L P S N LL L+ DL+ K + Y D
Sbjct: 1 SFETRFEKMDNLLRD--PKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTI 58
Query: 386 KST-------DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKS 431
+++ +IG G+FG V K T + A+K+L + ++
Sbjct: 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF 115
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWL--HPSP 485
F +E + + + V L + + +V E+M G+L + + P
Sbjct: 116 FWEERDIMAFANSPWV---------VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 166
Query: 486 AEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GD 543
+ +F +V ALD +H H D+KP N+LLDK H+ D
Sbjct: 167 EKWARF----------YTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLAD 211
Query: 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-----DIYSYGILLLE 598
FG + + G+ YI PE + Q D +S G+ L E
Sbjct: 212 FGTCMKMNKEGMVRCDT------AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 599 MFTGKRPTGDMFKDDFSIHMF 619
M G P F D + +
Sbjct: 266 MLVGDTP----FYADSLVGTY 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 51/227 (22%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA-LKSFIDECN-ALKSTR 443
+ ++ IG G++GSV K G I+A+K ++ K + + + ++S+
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
I++ A D + E M + + D++ + ++ + I
Sbjct: 80 CPYIVQFYGAL----FREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--IT 131
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ AL++L + I H D+KPSN+LLD+ + DFG++ ++ D+ +K +
Sbjct: 132 LATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDA 186
Query: 564 SIGLKGSIGYIPPEHMNGQV-----SILGDIYSYGILLLEMFTGKRP 605
G Y+ PE ++ + D++S GI L E+ TG+ P
Sbjct: 187 -----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
F ++G+G+F V+ G + A+K +K S +E LK +H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I+ + E LV + +S G L D+ L Y K S++ +
Sbjct: 68 IVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILE---RGVYTEKDASLVIQ-----Q 114
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
V SA+ YLH + I H DLKP N+L +++ + DFGL+K + T
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM-----EQNGIMST 166
Query: 563 VSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYG----ILL 596
G+ GY+ PE + + V D +S G ILL
Sbjct: 167 AC----GTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 28/225 (12%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-KLQQQGALKSFIDECNALKSTRHR 445
D F + +G+G+FG V+ G IK + K + Q ++ E LKS H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLH-PSPAEHYQFKKLSVIQRLNIA 503
NI+++ E +V E G L ++ + + + ++ + +
Sbjct: 81 NIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK---- 131
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ +AL Y H + H DLKP N+L + DFGLA+ +
Sbjct: 132 -QMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHST 184
Query: 561 QTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE V+ DI+S G+++ + TG P
Sbjct: 185 NAA-----GTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 70/244 (28%), Positives = 102/244 (41%), Gaps = 61/244 (25%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILR-- 449
+G G+FG V G G VA+K+L K++ + E LK RH +I++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 450 -VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA- 507
VI+ + D +V E++S G L F + R+ A
Sbjct: 78 QVIS--TPTDF------FMVMEYVSGGEL-------------FDYICKHGRVEE--MEAR 114
Query: 508 -------SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
SA+DY H H + H DLKP NVLLD M A + DFGL S+ S
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDG 164
Query: 561 QTVSIGLK---GSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615
+ L+ GS Y PE ++G+ DI+S G++L + G P F D+
Sbjct: 165 EF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP----FDDEHV 216
Query: 616 IHMF 619
+F
Sbjct: 217 PTLF 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 72/263 (27%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFID----------------- 434
IG GS+G V D T A+KVL KL +Q
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 435 ------ECNALKSTRHRNILR---VITACSSVDLEGNDFKALVFEFMSNGNL-----DQW 480
E LK H N+++ V+ + L +VFE ++ G + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL------YMVFELVNQGPVMEVPTLKP 133
Query: 481 LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540
L A Y F+ D+ ++YLH+ I H D+KPSN+L+ +D
Sbjct: 134 LSEDQARFY-FQ------------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIK 177
Query: 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSI----LGDIYSYGILL 596
+ DFG++ F+ SD N G+ ++ PE ++ I D+++ G+ L
Sbjct: 178 IADFGVSN-EFKGSDALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 597 LEMFTGKRPTGDMFKDDFSIHMF 619
G+ P F D+ + +
Sbjct: 231 YCFVFGQCP----FMDERIMCLH 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 72/349 (20%), Positives = 130/349 (37%), Gaps = 70/349 (20%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQ 426
PK V G++ + + + +S + +G+G+FG V+ V +K + K+ +
Sbjct: 7 PKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65
Query: 427 GALKSFID-----ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGN-LDQW 480
++ E L H NI++V+ E F LV E +G L
Sbjct: 66 CWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDL--- 117
Query: 481 LHPSPAEHYQFKKLSVIQRLN------IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534
F + RL+ I + SA+ YL I H D+K N+++
Sbjct: 118 ----------FAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIA 164
Query: 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYS 591
+D T + DFG A + + G+I Y PE + G G +++S
Sbjct: 165 EDFTIKLIDFGSAAY---LERGKLFYTFC-----GTIEYCAPEVLMGN-PYRGPELEMWS 215
Query: 592 YGILLLEMFTGKRPTGDMFK---DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQ-- 646
G+ L + + P ++ + VS L V +L P E+
Sbjct: 216 LGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQP--------VPERRT 267
Query: 647 -IEEVIEEKEMMIHIDL------EVNTKNKLEECFVSVLRIGLMCSTTS 688
+E+++ + + ++L EV NK E +S + + + S
Sbjct: 268 TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLS 316
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 33/229 (14%)
Query: 386 KSTDNFSK----ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALK 440
+ + ++ EN IG GS+G V G A K + + F E +K
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQR 499
S H NI+R+ E N LV E + G L ++ +H ++ + I +
Sbjct: 62 SLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMK 113
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDN 556
DV SA+ Y H +AH DLKP N L D + DFGLA
Sbjct: 114 -----DVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPG 162
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
V G+ Y+ P+ + G D +S G+++ + G P
Sbjct: 163 KMMRTKV-----GTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 46/225 (20%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-ECNALKSTRHRNILR---V 450
+G G++G V VA+K++ +++ I E K H N+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA--- 507
L E+ S G L F ++ + A
Sbjct: 74 RR--EGNIQ------YLFLEYCSGGEL-------------FDRIEPDIGMPE--PDAQRF 110
Query: 508 -----SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ + YLH I H D+KP N+LLD+ + DFGLA +F ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNK 166
Query: 563 VSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRP 605
+ G++ Y+ PE + + + D++S GI+L M G+ P
Sbjct: 167 MC----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 47/235 (20%)
Query: 387 STDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
+ ++FS +IG G FG VY T G + A+K L K I
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD-------KKRIKMKQGETLA 236
Query: 443 RH-RNILRVITACSS---VDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
+ R +L +++ V + D + + + M+ G+L L +H F +
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEA 292
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFE 552
+ R A ++ L+++H+ + + DLKP+N+LLD+ HV D GLA +
Sbjct: 293 DM--RFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLAC---D 341
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV--SILGDIYSYGILLLEMFTGKRP 605
S G+ GY+ PE + V D +S G +L ++ G P
Sbjct: 342 FSKKKPH------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 48/235 (20%)
Query: 387 STDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
+ + F + ++G G FG V + T G + A K L+ K I +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLE-------KKRIKKRKGEAMA 231
Query: 443 RH-RNILRVITACSSVDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ + IL + + V L E D LV M+ G+L H F +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARA- 288
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISD 555
A ++ L+ LH I + DLKP N+LLD H+ D GLA + +
Sbjct: 289 -VFYAA-EICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAV---HVPE 338
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
+ V G++GY+ PE + + D ++ G LL EM G+ P
Sbjct: 339 GQTIKGRV-----GTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 72/424 (16%), Positives = 130/424 (30%), Gaps = 64/424 (15%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPN-QLSSLTKLEIIGLGGSNLT 71
L T N ++ +LS T L N ++ N ++ LTKL + + LT
Sbjct: 67 TKLICTSNNITT---LDLSQNTNLTYLACDSN----KLTNLDVTPLTKLTYLNCDTNKLT 119
Query: 72 GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISS 131
+ + L L+ A N L I + + L + N + + +
Sbjct: 120 -KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQ 171
Query: 132 IYYFSVTQNQLHGQLPTDVGLT-LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG 190
+ + N++ T++ ++ L N T + L+ L LD + N
Sbjct: 172 LTTLDCSFNKI-----TELDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNK 223
Query: 191 LTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL------------ANCTSLEVL 238
LT I L L + N L ++ L+ L L + T L
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298
+ + + T L L + + + L L L L+ +
Sbjct: 281 QAEGCRK--IKELDVTHN-TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333
Query: 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLV 358
+ KL+ L SS+G + L + E + +L N +
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 359 LNLSSNDLNGTIPKEVRQSGMSY-------------SDISKSTDNFSKENLIGTGSFGSV 405
++ D G G Y +D T F+ EN G+ +
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTP 449
Query: 406 YKGT 409
++
Sbjct: 450 FEAP 453
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 53/355 (14%), Positives = 109/355 (30%), Gaps = 47/355 (13%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L+ + ++ T + T L + N+ + LS T L + + LT
Sbjct: 45 TSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT- 98
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
N+ + + L L+ N L + + Q L + N ++ I + + + +
Sbjct: 99 NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQL 150
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
N+ +L L + N T + +S L L+ N +T
Sbjct: 151 TELDCHLNKKITKLDVT---PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT 204
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS 252
+ L L+ N+L ++ T L + N +
Sbjct: 205 -KLD--LNQNIQLTFLDCSSNKLTEIDVT---------PLTQLTYFDCSVNPLT---ELD 249
Query: 253 IANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
++ L + L L + + I + N L+ + + +L L
Sbjct: 250 VSTL-SKLTTLHCIQTDLL-EIDLTH----NTQLIYFQAEGCRKIKELDVTHNTQLYLLD 303
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
+ L L L L++ L + + + KL L+ + +
Sbjct: 304 CQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 56/344 (16%), Positives = 111/344 (32%), Gaps = 46/344 (13%)
Query: 36 LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLR 95
S A+ + L L + S++T ++ I + L L NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 96 GSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLT-L 154
++ L Q + L + N ++ + + ++ + Y + N+L T + ++
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL-----TKLDVSQN 126
Query: 155 PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNE 214
P L A N T + +S+ + L LD N + L L+ N+
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 215 LGSREIGDLNFLKFL------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRR 262
+ ++ L L L L + N I + L T L
Sbjct: 182 ITELDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE---IDVTPL-TQLTY 237
Query: 263 LTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI 322
N + + + L L L +L + + +L + +
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK--IK 289
Query: 323 PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
+ + T L L + + + L KL+ L L++ +L
Sbjct: 290 ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 40/225 (17%), Positives = 71/225 (31%), Gaps = 29/225 (12%)
Query: 155 PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNE 214
N A + +S + L LD + +T + G L L +L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 215 LGSREIGDLNFLKFL------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRR 262
+ + ++ L +L T L L N + ++ L
Sbjct: 76 ITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQN-PLLTY 131
Query: 263 LTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI 322
L N + + + + L L N + + +L L + NK + L
Sbjct: 132 LNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL- 185
Query: 323 PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
+ +L RL + N + + L +L L+ SSN L
Sbjct: 186 --DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 37/242 (15%)
Query: 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKV-----LKLQQQGALKS 431
M+ D+ D + +IG G F V + G A+K+ + +
Sbjct: 14 DMADDDVL-FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 432 FIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWL-HPSPAEHY 489
E + +H +I+ ++ + +VFEFM +L + + Y
Sbjct: 73 LKREASICHMLKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 127
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGL 546
S R + AL Y H + I H D+KP VLL + +G FG+
Sbjct: 128 SEAVASHYMR-----QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLLEMFTGK 603
A L E + V+ G G+ ++ PE + + G D++ G++L + +G
Sbjct: 180 AIQLGE-------SGLVAGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGC 230
Query: 604 RP 605
P
Sbjct: 231 LP 232
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 53/235 (22%), Positives = 88/235 (37%), Gaps = 47/235 (20%)
Query: 385 SKSTDNFSKE----NLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKS-------- 431
S ST F + ++G G V + A+K++ + G+ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 432 -FIDECNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEH 488
+ E + L+ + H NI+++ E N F LVF+ M G L D
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTE---KVT 120
Query: 489 YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548
K+ I R + + LH I H DLKP N+LLD DM + DFG +
Sbjct: 121 LSEKETRKIMR-----ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILL 596
L + G+ Y+ PE + ++ D++S G+++
Sbjct: 173 QL--------DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 68/253 (26%), Positives = 103/253 (40%), Gaps = 68/253 (26%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F +GTGSFG V+ + G A+KVLK K + ++ T
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLK-------KEIVVRLKQVEHTND 55
Query: 445 -RNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
R +L ++T + + G ++ +++ G L F L QR
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-------------FSLLRKSQR 102
Query: 500 LNI------AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLF 551
A +V AL+YLH I + DLKP N+LLDK+ H+ DFG AK
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK--- 154
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRPT 606
P T L G+ YI PE ++ + + D +S+GIL+ EM G P
Sbjct: 155 ---YVPDVTYT----LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP- 202
Query: 607 GDMFKDDFSIHMF 619
F D ++ +
Sbjct: 203 ---FYDSNTMKTY 212
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/258 (22%), Positives = 94/258 (36%), Gaps = 62/258 (24%)
Query: 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKS 431
+ + + K D F E + G G+FG+V G G VAIK K+ Q
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQD---PR 61
Query: 432 F----IDECNALKSTRHRNILRVITACSSVDLEGND--FKALVFEFM---------SNGN 476
F + L H NI+++ + ++ + +V E++ +
Sbjct: 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYR 121
Query: 477 LDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK- 535
P K+ + Q + ++ LH + H D+KP NVL+++
Sbjct: 122 RQVAP---PPILI---KVFLFQLI-------RSIGCLHLPS-VNVCHRDIKPHNVLVNEA 167
Query: 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI------PPEHMNGQ----VSI 585
D T + DFG AK L N + YI PE + G ++
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPN--------------VAYICSRYYRAPELIFGNQHYTTAV 213
Query: 586 LGDIYSYGILLLEMFTGK 603
DI+S G + EM G+
Sbjct: 214 --DIWSVGCIFAEMMLGE 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 51/250 (20%), Positives = 98/250 (39%), Gaps = 34/250 (13%)
Query: 368 GTIPKEVRQSGMSYSDISK---STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL 423
G+ +Q+G + ++ +G+G+ G V+K G ++A+K ++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 424 QQQGA-LKSFIDECNAL-KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWL 481
K + + + + KS I++ + D + E M
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF----ITNTDVF-IAMELMGTCAEKLKK 115
Query: 482 HPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541
+ + + + AL YL + H D+KPSN+LLD+ +
Sbjct: 116 R-------MQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKL 166
Query: 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV------SILGDIYSYGIL 595
DFG++ L D+ +K+++ G Y+ PE ++ I D++S GI
Sbjct: 167 CDFGISGRL---VDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 596 LLEMFTGKRP 605
L+E+ TG+ P
Sbjct: 219 LVELATGQFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 50/227 (22%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA-LKSFIDECN-ALKSTR 443
D+ +G G++G V K + G I+A+K ++ K + + + ++++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
+ A D + E M + +LD++ + + ++ + IA
Sbjct: 65 CPFTVTFYGAL----FREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPE-DILGK--IA 115
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ + AL++LH + H D+KPSNVL++ + DFG++ +L D+ +K+
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDA 170
Query: 564 SIGLKGSIGYIPPEHMNGQV-----SILGDIYSYGILLLEMFTGKRP 605
G Y+ PE +N ++ S+ DI+S GI ++E+ + P
Sbjct: 171 -----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 28/223 (12%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
D++ +GTG+FG V++ T G A K + + ++ E + RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAID 505
++ + A E ++ +++EFMS G L ++ + R
Sbjct: 216 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMR-----Q 263
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTV 563
V L ++H + H DLKP N++ + + DFGL L +P ++ V
Sbjct: 264 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DPKQSVKV 315
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ G+ + PE G+ V D++S G+L + +G P
Sbjct: 316 TT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 46/225 (20%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-ECNALKSTRHRNILR---V 450
+G G++G V VA+K++ +++ I E K H N+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA--- 507
L E+ S G L F ++ + A
Sbjct: 74 RR--EGNIQ------YLFLEYCSGGEL-------------FDRIEPDIGMPE--PDAQRF 110
Query: 508 -----SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
+ + YLH I H D+KP N+LLD+ + DFGLA +F ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNK 166
Query: 563 VSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRP 605
+ G++ Y+ PE + + + D++S GI+L M G+ P
Sbjct: 167 MC----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 33/226 (14%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTR 443
+ ++ ++G GSFG V K A+KV+ + + + + E LK
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNI 502
H NI+++ E + +V E + G L D+ + + + + I +
Sbjct: 80 HPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIK--- 128
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSK 559
V S + Y+H H I H DLKP N+LL +KD + DFGL+ N
Sbjct: 129 --QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKM 180
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605
+ G+ YI PE + G D++S G++L + +G P
Sbjct: 181 KDRI-----GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
D + +G+G+FG V++ G + K + + +E + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAID 505
++ + A E L+ EF+S G L D+ AE Y+ + VI N
Sbjct: 110 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVI---NYMRQ 157
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTV 563
L ++H H I H D+KP N++ + + V DFGLA L NP + V
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-----NPDEIVKV 209
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILL 596
+ + + PE ++ + V D+++ G+L
Sbjct: 210 TT---ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 51/260 (19%), Positives = 95/260 (36%), Gaps = 72/260 (27%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
++F +IG G+FG V K + A+K+L + ++ F +E + L +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 442 TRHRNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ I L ++ LV ++ G+L L+++
Sbjct: 131 GDSKWI---------TTLHYAFQDDNNLYLVMDYYVGGDL----------------LTLL 165
Query: 498 QRLNIAID----------VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFG 545
+ + + A+D +H H D+KP N+L+D + H+ DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFG 220
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEM 599
L + D ++ G+ YI PE + G D +S G+ + EM
Sbjct: 221 SCLKL--MEDGTVQSSV----AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274
Query: 600 FTGKRPTGDMFKDDFSIHMF 619
G+ P F + + +
Sbjct: 275 LYGETP----FYAESLVETY 290
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 68/263 (25%), Positives = 107/263 (40%), Gaps = 59/263 (22%)
Query: 363 SNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVL 421
S D +G+ V + D +++ +IG GSFG VY+ L D G +VAIK +
Sbjct: 29 SRDKDGSKVTTVVATPGQGPD-RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV 87
Query: 422 KLQQQGALKSFIDECNALKSTRHRNILRVITA-CSSVDLEGNDFKALVFEFM-------- 472
++ + E ++ H NI+R+ SS + + + LV +++
Sbjct: 88 LQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 143
Query: 473 -SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531
Q L P + KL + Q +L Y+H I H D+KP N+
Sbjct: 144 RHYSRAKQTL---PVIYV---KLYMYQLF-------RSLAYIHSFG---ICHRDIKPQNL 187
Query: 532 LLDKDMTA-HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI------PPEHMNGQ-- 582
LLD D + DFG AK L + P ++ YI PE + G
Sbjct: 188 LLDPDTAVLKLCDFGSAKQL--VRGEP------------NVSYICSRYYRAPELIFGATD 233
Query: 583 --VSILGDIYSYGILLLEMFTGK 603
SI D++S G +L E+ G+
Sbjct: 234 YTSSI--DVWSAGCVLAELLLGQ 254
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 54/368 (14%), Positives = 120/368 (32%), Gaps = 18/368 (4%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQL-SSLTKLEIIGLGGSNL 70
T+ L+L+ N +S ++S +ELR S N + + LE + + + L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 71 TGNVPAWIGNFSSLKALSLAWNNLRGSIP--NELGQLSGLGFFTLYGNFISGIIPSSIYN 128
N+ +SL+ L L++N+ +P E G L+ L F L + + +
Sbjct: 113 Q-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 129 ISSIYYFSVTQNQLHGQLPTDV--GLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQV--L 184
+ + T+ L + + F+ + +S++ +LQ+ +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 185 DFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244
+ + + LN + + + +F +E L + +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLT 287
Query: 245 FGGEMPISIANLSTHLRRLTMGENLMHGNI---PVGIGN-LVNLNLLGLEGNNLSGSVPE 300
+ S + M E++ + + + +N+ L ++
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 301 VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLN 360
+ L N F+ + L L L ++ N L+ + + + L
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLE 406
Query: 361 LSSNDLNG 368
LN
Sbjct: 407 TLDVSLNS 414
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 60/345 (17%), Positives = 126/345 (36%), Gaps = 20/345 (5%)
Query: 9 HLMTQDLNLTYNYLSGKIPTNLS--HCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLG 66
HL L+L ++ G +L + T L + F Q+ +++L L++ +
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 67 GSNLTG----NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQL---SGLGFFTLYGNFIS 119
++ + + +L ++L +L Q + + +Y I+
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQ----LPTDVGLTLPNLKIFAGAVNYFTGSIPVSL 175
I + S S+ + Q + + I +++ V
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 176 SNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSL 235
+ S+ L+F +N T ++ +LK L L +N L + L N +SL
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL----MTKNMSSL 405
Query: 236 EVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS 295
E L ++ NS + + L + N++ G++ + + +L L N +
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463
Query: 296 GSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
S+P+ + L L+ L + N+ + LT L +W+ +N
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333
+P + L L N++S I L++L L L+ N+ L L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103
Query: 334 RLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
L + NRL+ +I L L+LS ND
Sbjct: 104 YLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 58/268 (21%), Positives = 98/268 (36%), Gaps = 47/268 (17%)
Query: 361 LSSND---LNGTIPKEVRQSGMSYSDISKSTDNFSKE----NLIGTGSFGSVYKGT-LGD 412
L++N L+ + K ++ D S E +G+G+ G V
Sbjct: 100 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT 159
Query: 413 GTIVAIKVLK--------LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464
VAI+++ ++ + E LK H I+++ + D
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY----- 214
Query: 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524
+V E M G L + + K+L + A+ YLH + I H
Sbjct: 215 -YIVLELMEGGELFDKV----VGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHR 263
Query: 525 DLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG 581
DLKP NVLL ++D + DFG +K L ++ L G+ Y+ PE +
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKIL--------GETSLMRTLCGTPTYLAPEVLVS 315
Query: 582 QV----SILGDIYSYGILLLEMFTGKRP 605
+ D +S G++L +G P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 15/213 (7%)
Query: 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLN 224
N + + +L+VL N + G F L L L N L I
Sbjct: 85 NNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL--TVIPSGA 142
Query: 225 FLKFLANCTSLEVLGLARNSFGGEMPISI-ANLSTHLRRLTMGENLMHGNIPVGI-GNLV 282
F + L L L N +P + L RL +GE I G L
Sbjct: 143 F----EYLSKLRELWLRNNPIE-SIPSYAFNRV-PSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 283 NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRL 342
NL L L N+ +P + L LE L ++ N F + P S L+ L +LW+ +++
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254
Query: 343 EGSIPP-SLGNCQKLLVLNLSSNDLNGTIPKEV 374
I + L+ LNL+ N+L+ ++P ++
Sbjct: 255 S-LIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 62/301 (20%)
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPS 124
L+ VP I S+ + L+L NN++ + L L L N I I
Sbjct: 61 CTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117
Query: 125 SIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL 184
+ ++S+ + N L +P+ S L+ L
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGA------------------------FEYLSKLREL 152
Query: 185 DFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244
N + F + L+RL ++G+L L++++ +
Sbjct: 153 WLRNNPIESIPSYAFNRVPSLMRL----------DLGELKKLEYIS-----------EGA 191
Query: 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR 304
F L +L+ L +G + ++P + LV L L + GN+ P
Sbjct: 192 F--------EGL-FNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHG 240
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS-LGNCQKLLVLNLSS 363
L+ L+ L + ++ S + ++ L L L + N L S+P + L+ L+L
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
Query: 364 N 364
N
Sbjct: 300 N 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 46/293 (15%), Positives = 83/293 (28%), Gaps = 61/293 (20%)
Query: 49 QIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGL 108
++P + + + L +N+ + L+ L L N++R L+ L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 109 GFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT 168
L+ N+++ I + +S + + N + ++P
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE---------SIP------------- 163
Query: 169 GSIPVSLSNASNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLK 227
+ + +L LD E I F L +L LN + +
Sbjct: 164 ---SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--------MP 212
Query: 228 FLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLL 287
L LE L ++ N + L +L L
Sbjct: 213 NLTPLVGLEELEMSGN--------HFPEIRPGS-----------------FHGLSSLKKL 247
Query: 288 GLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
+ + +S L L L L N S L L L L + N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 69/244 (28%), Positives = 99/244 (40%), Gaps = 61/244 (25%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILR-- 449
+G G+FG V G G VA+K+L K++ + E LK RH +I++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 450 -VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA- 507
VI +V E++S G L F + RL+ +
Sbjct: 83 QVI--------STPSDIFMVMEYVSGGEL-------------FDYICKNGRLDE--KESR 119
Query: 508 -------SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
S +DY H H + H DLKP NVLLD M A + DFGL S+ S
Sbjct: 120 RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDG 169
Query: 561 QTVSIGLK---GSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615
+ L+ GS Y PE ++G+ DI+S G++L + G P F DD
Sbjct: 170 EF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP----FDDDHV 221
Query: 616 IHMF 619
+F
Sbjct: 222 PTLF 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 47/241 (19%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECN 437
M S + D K+ +G GSF K A+K++ + + + E
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57
Query: 438 ALKS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLS 495
ALK H NI+++ LV E ++ G L ++ +H+ + S
Sbjct: 58 ALKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKK---KKHFSETEAS 109
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFE 552
I R + SA+ ++H + H DLKP N+L + ++ + DFG A+
Sbjct: 110 YIMR-----KLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--------DIYSYGILLLEMFTGKR 604
DN ++ Y PE +L D++S G++L M +G+
Sbjct: 162 --DNQPLKTPC-----FTLHYAAPE-------LLNQNGYDESCDLWSLGVILYTMLSGQV 207
Query: 605 P 605
P
Sbjct: 208 P 208
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HR 445
D++ +G G + V++ + + V +K+LK ++ K E L++ R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 446 NILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
NI+ ++ S ALVFE ++N + Q +F + + L
Sbjct: 92 NIITLADIVKDPVSRTP------ALVFEHVNNTDFKQLYQTLTDYDIRF---YMYEILK- 141
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQ 561
ALDY H I H D+KP NV++D + + D+GLA+F +P +
Sbjct: 142 ------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-----HPGQEY 187
Query: 562 TVSIGLKGSIGYIPPEHM-NGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
V + S + PE + + Q S+ D++S G +L M K P F +
Sbjct: 188 NVRV---ASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHGHDNYD 239
Query: 618 MFVSMA 623
V +A
Sbjct: 240 QLVRIA 245
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/315 (19%), Positives = 105/315 (33%), Gaps = 66/315 (20%)
Query: 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFIS 119
L ++ L VP I L L N++ ++ L L L N IS
Sbjct: 35 LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
I + + + +++N L IP +L S
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV--------------------------EIPPNLP--S 123
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
+L L +N + G F L+++ + N L + F + L L
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF-----DGLKLNYLR 178
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299
++ +LT IP + LN L L+ N +
Sbjct: 179 ISEA------------------KLTG--------IPKDL--PETLNELHLDHNKIQAIEL 210
Query: 300 EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVL 359
E + R +KL LGL N+ + SL L L L ++ N+L +P L + + L V+
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 360 NLSSNDLNGTIPKEV 374
L +N++ +
Sbjct: 270 YLHTNNIT-KVGVND 283
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 51/300 (17%), Positives = 96/300 (32%), Gaps = 48/300 (16%)
Query: 51 PNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110
+ L L + L + ++ L+ L ++ N+L IP L S L
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVE 127
Query: 111 FTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
++ N I + + ++ + N L
Sbjct: 128 LRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE------------------------NSG 163
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
+ L L +E LTG +L L+ D N++ + I +
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLTGIPKDLPETLN---ELHLDHNKI--QAIELEDL----L 214
Query: 231 NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290
+ L LGL N S++ L LR L + N + +P G+ +L L ++ L
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFL-PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 291 GNNLSGSVPE-------VIGRLNKLEGLGLNVN--KFSGLIPSSLGNLTILTRLWMEENR 341
NN++ V + G+ L N + + P++ +T + +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 53/294 (18%), Positives = 94/294 (31%), Gaps = 46/294 (15%)
Query: 6 IPEHLMTQDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIG 64
I T L+L N +S ++ + L + N S L KL+ +
Sbjct: 52 ISPD--TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNE-LGQLSGLGFFTLYGNFI-SGII 122
+ ++L +P SSL L + N +R +P L + + GN + +
Sbjct: 109 ISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDV-----GLTLPNLKIFAGAVNYFTG-------- 169
++ + Y +++ +L +P D+ L L + KI A +
Sbjct: 165 EPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 170 -------SIPV-SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIG 221
I SLS L+ L N L+ +P LK L + N + +
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282
Query: 222 DLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS-------THLRRLTMGEN 268
D + F + L N P+ + T + G
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNN------PVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
S + +L++L + N + G F L +L L N L + G +L
Sbjct: 81 VNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYL----- 135
Query: 232 CTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLE 290
+ L+ L L N +P N LRRL +GE I G L NL L L
Sbjct: 136 -SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-S 349
NL +P + L KL+ L L+ N S + P S L L +LWM +++++ I +
Sbjct: 194 MCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNA 250
Query: 350 LGNCQKLLVLNLSSNDLNGTIPKEV 374
N Q L+ +NL+ N+L +P ++
Sbjct: 251 FDNLQSLVEINLAHNNLT-LLPHDL 274
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 57/301 (18%), Positives = 101/301 (33%), Gaps = 62/301 (20%)
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPS 124
NL VP I ++ + L+L N ++ N L L L N I I
Sbjct: 50 CVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 125 SIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL 184
+ ++++ + N+L +P S L+ L
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGA------------------------FVYLSKLKEL 141
Query: 185 DFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244
N + F + L RL ++G+L L +++ +
Sbjct: 142 WLRNNPIESIPSYAFNRIPSLRRL----------DLGELKRLSYISE-----------GA 180
Query: 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR 304
F L ++LR L + + IP + L+ L+ L L GN+LS P
Sbjct: 181 F--------EGL-SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS-LGNCQKLLVLNLSS 363
L L+ L + ++ + ++ NL L + + N L +P L ++L
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 364 N 364
N
Sbjct: 289 N 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 48/249 (19%), Positives = 96/249 (38%), Gaps = 17/249 (6%)
Query: 49 QIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGL 108
++P+ +S+ T+ ++ L + + + L+ L L+ N++R L+ L
Sbjct: 57 EVPDGISTNTR--LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 109 GFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKI-FAGAVNYF 167
L+ N ++ I + +S + + N + +P+ +P+L+ G +
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173
Query: 168 TGSIPV-SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFL 226
+ I + SNL+ L+ A L IP N L L L+ N L I +F
Sbjct: 174 S-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHL--SAIRPGSF- 227
Query: 227 KFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLN 285
L+ L + ++ + NL L + + N + +P + L +L
Sbjct: 228 ---QGLMHLQKLWMIQSQIQVIERNAFDNL-QSLVEINLAHNNLT-LLPHDLFTPLHHLE 282
Query: 286 LLGLEGNNL 294
+ L N
Sbjct: 283 RIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 5/79 (6%)
Query: 289 LEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP 348
NL VP+ I L L+ N+ + +S +L L L + N + +I
Sbjct: 50 CVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEI 105
Query: 349 -SLGNCQKLLVLNLSSNDL 366
+ L L L N L
Sbjct: 106 GAFNGLANLNTLELFDNRL 124
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 62/251 (24%), Positives = 99/251 (39%), Gaps = 64/251 (25%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
D F + +GTGSFG V K + G A+K+L K + + ++ T +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILD-------KQKVVKLKQIEHTLN 90
Query: 445 -RNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
+ IL+ + V LE N +V E+++ G + F L I R
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-------------FSHLRRIGR 137
Query: 500 LN------IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
+ A + +YLH + + DLKP N+L+D+ V DFG AK
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRPTGD 608
+ T L G+ + PE + + V D ++ G+L+ EM G P
Sbjct: 190 -RVKGRTWT----LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP--- 237
Query: 609 MFKDDFSIHMF 619
F D I ++
Sbjct: 238 -FFADQPIQIY 247
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 59/238 (24%)
Query: 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
++ +IG GSFG V++ L + VAIK + ++ + E ++ +H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 448 LRVITACSSVDLEGNDFKA--LVFEFM---------SNGNLDQWLHPSPAEHYQFKKLSV 496
+ + A + + D LV E++ L Q + P KL +
Sbjct: 95 VD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM---PMLLI---KLYM 147
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA-HVGDFGLAKFLFEISD 555
Q L +L Y+H I H D+KP N+LLD + DFG AK L
Sbjct: 148 YQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 556 NPSKNQTVSIGLKGSIGYI------PPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
N + YI PE + G +I DI+S G ++ E+ G+
Sbjct: 198 N--------------VSYICSRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQGQ 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 33/235 (14%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGAL 429
P + R ++ SK ++G G FG V+K G +A K++K +
Sbjct: 72 PFDHRIVTAKQGAVNSFYT-VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130
Query: 430 KSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEH 488
+ +E + + H N++++ A E + LV E++ G L D+ + E
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFDRII----DES 181
Query: 489 YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGL 546
Y +L I + + ++H I H DLKP N+L + DFGL
Sbjct: 182 YNLTELDTI---LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYG----ILL 596
A+ P + V+ G+ ++ PE +N VS D++S G +LL
Sbjct: 236 ARRY-----KPREKLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 62/262 (23%), Positives = 98/262 (37%), Gaps = 57/262 (21%)
Query: 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFI 433
+G I +D + IG+G+FG +VA+K ++ + +
Sbjct: 6 VTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENV 63
Query: 434 D-ECNALKSTRHRNILR---VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY 489
E +S RH NI+R VI + L A++ E+ S G L
Sbjct: 64 QREIINHRSLRHPNIVRFKEVIL--TPTHL------AIIMEYASGGEL------------ 103
Query: 490 QFKKLSVIQRLNIAIDVA--------SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH- 540
++++ R + D A S + Y H I H DLK N LLD
Sbjct: 104 -YERICNAGRFSE--DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRL 157
Query: 541 -VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLL 597
+ DFG +K S S+ ++ G+ YI PE + Q + D++S G+ L
Sbjct: 158 KICDFGYSK----SSVLHSQPKSTV----GTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209
Query: 598 EMFTGKRPTGDMFKDDFSIHMF 619
M G P F+D +
Sbjct: 210 VMLVGAYP----FEDPEEPRDY 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 57/307 (18%), Positives = 105/307 (34%), Gaps = 45/307 (14%)
Query: 78 IGNFSSLKALSLAWNNLRGSIPNEL----GQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133
I N SL S N + + N ++ + I+
Sbjct: 7 INNNFSLSQNSF--YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 134 YFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG 193
+ + L LP ++ P + + N S+P ++ L+ LD +N L+
Sbjct: 63 ELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS- 113
Query: 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253
T+P SLK L+ D N+L + +L LE + N +
Sbjct: 114 TLPELPASLK---HLDVDNNQL--TMLPEL--------PALLEYINADNNQLT-----ML 155
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE---- 309
L T L L++ N + +P +L L++ N L S+P V R + E
Sbjct: 156 PELPTSLEVLSVRNNQLTF-LPELPESLEALDV---STNLLE-SLPAVPVRNHHSEETEI 210
Query: 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369
N+ + + P ++ +L + +E+N L I SL + + +
Sbjct: 211 FFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269
Query: 370 IPKEVRQ 376
++
Sbjct: 270 DGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 61/359 (16%), Positives = 105/359 (29%), Gaps = 68/359 (18%)
Query: 15 LNLTYNYLSGKIPTNLSHC----TELRSFEASVNDFVGQIPN-QLSSLTKLEIIGLGGSN 69
N YN +S + + + N+ V + ++ ++L+ L N
Sbjct: 15 QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ---LNRLN 70
Query: 70 LTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNI 129
L+ ++P + + L + N L S+P L L N +S +P ++
Sbjct: 71 LS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPASL 122
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+ V NQL LP L+ N T +P ++ L+VL N
Sbjct: 123 KHLD---VDNNQLT-MLPELPA----LLEYINADNNQLT-MLPELPTS---LEVLSVRNN 170
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQNELGS--REIGDLNFLKFLANCTSLEVLGLARNSFGG 247
LT +P SL+ L+ N L S + + + N
Sbjct: 171 QLT-FLPELPESLE---ALDVSTNLLESLPAVPVRNHHSE-----ETEIFFRCREN---- 217
Query: 248 EMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNK 307
R+T +IP I +L + LE N LS + E + +
Sbjct: 218 --------------RIT--------HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 308 LEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
FS N + + +N
Sbjct: 256 QPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF 312
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTR 443
+DN+ + +G G+F V + G A K++ KL + + E + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNI 502
H NI+R+ + + F LVF+ ++ G L + + E Y S +
Sbjct: 64 HPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQ--- 112
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHV--GDFGLAKFLFEISDNPSK 559
+ ++ Y H + I H +LKP N+LL K A V DFGLA ++D+ +
Sbjct: 113 --QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAW 164
Query: 560 NQTVSIGLKGSIGYIPPE 577
+ G+ GY+ PE
Sbjct: 165 HGFA-----GTPGYLSPE 177
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 74/262 (28%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
D+F +IG G+F V K T G + A+K++ + ++G + F +E + L +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 442 TRHRNILRVITACSSVDL----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
R I L + ++ LV E+ G+L L+++
Sbjct: 118 GDRRWI---------TQLHFAFQDENYLYLVMEYYVGGDL----------------LTLL 152
Query: 498 QRLNIAID----------VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFG 545
+ I + A+D +H H D+KP N+LLD+ H+ DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFG 207
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--------DIYSYGILLL 597
L +D ++ G+ Y+ PE + G D ++ G+
Sbjct: 208 SCLKL--RADGTVRSLVAV----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 598 EMFTGKRPTGDMFKDDFSIHMF 619
EMF G+ P F D + +
Sbjct: 262 EMFYGQTP----FYADSTAETY 279
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 52/257 (20%), Positives = 94/257 (36%), Gaps = 49/257 (19%)
Query: 362 SSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKV 420
+ P++ + + + +++IG G V + G A+K+
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEF---YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 421 L--------KLQQQGALKSFIDECNALKS-TRHRNILRVITACSSVDLEGNDFKALVFEF 471
+ Q + ++ E + L+ H +I+ +I + E + F LVF+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDL 181
Query: 472 MSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530
M G L D K+ I R + A+ +LH + I H DLKP N
Sbjct: 182 MRKGELFDYLTE---KVALSEKETRSIMR-----SLLEAVSFLHANN---IVHRDLKPEN 230
Query: 531 VLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--- 587
+LLD +M + DFG + + + G+ GY+ PE + +
Sbjct: 231 ILLDDNMQIRLSDFGFSCH---LEPGEKLRELC-----GTPGYLAPEILKCSMDETHPGY 282
Query: 588 ----DIYSYG----ILL 596
D+++ G LL
Sbjct: 283 GKEVDLWACGVILFTLL 299
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 57/275 (20%), Positives = 87/275 (31%), Gaps = 73/275 (26%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQ 426
+ + L+G+G FGSVY G + D VAIK + ++
Sbjct: 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84
Query: 427 GALKSFID---ECNALKSTRHR--NILR---VITACSSVDLEGNDFKALVFEFMSN-GNL 477
G L + E LK ++R E D L+ E +L
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--------ERPDSFVLILERPEPVQDL 136
Query: 478 DQWLHPSPAEHYQFKKLSVIQRLN------IAIDVASALDYLHHHCDTPIAHCDLKPSNV 531
F ++ L V A+ + H+ + H D+K N+
Sbjct: 137 -------------FDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENI 180
Query: 532 LLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK---GSIGYIPPEHMNGQ----- 582
L+D + + DFG L D G+ Y PPE +
Sbjct: 181 LIDLNRGELKLIDFGSGALL---KDTV---------YTDFDGTRVYSPPEWIRYHRYHGR 228
Query: 583 -VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
++S GILL +M G P F+ D I
Sbjct: 229 SA----AVWSLGILLYDMVCGDIP----FEHDEEI 255
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 36/207 (17%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK--------LQQQGALKSFIDECNA 438
D + +G+G+ G V VAIK++ ++ + E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ 498
LK H I+++ + D +V E M G L + + + +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 120
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISD 555
+ A+ YLH + I H DLKP NVLL ++D + DFG +K L
Sbjct: 121 Y-----QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ 582
S +T+ G+ Y+ PE +
Sbjct: 169 ETSLMRTLC----GTPTYLAPEVLVSV 191
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 44/243 (18%)
Query: 390 NFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNAL-KSTRHRNI 447
SK+ L G G G V + G A+K+L E + +++ +I
Sbjct: 31 QLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHI 84
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ ++ ++ ++ E M G L + + + ++ + I R D+
Sbjct: 85 VCILDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-----DIG 138
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHV--GDFGLAKFLFEISDNPSKNQTVS 564
+A+ +LH H IAH D+KP N+L K+ A + DFG AK +
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPC- 190
Query: 565 IGLKGSIGYIPPEHMNGQVSILG--------DIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
+ Y+ PE +LG D++S G+++ + G P S
Sbjct: 191 ----YTPYYVAPE-------VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 617 HMF 619
M
Sbjct: 240 GMK 242
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 35/218 (16%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKE----NLIGTGSFGSVYKGT-LGDGTIVAIKVL---K 422
+Q G + ++ FS +G G+F V + G A K++ K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 423 LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH 482
L + + E + +H NI+R+ + + F LVF+ ++ G L + +
Sbjct: 67 LSAR-DFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDI- 119
Query: 483 PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTA 539
E Y S + + ++ Y H + I H +LKP N+LL K
Sbjct: 120 -VAREFYSEADASHCIQ-----QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170
Query: 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPE 577
+ DFGLA + + G G+ GY+ PE
Sbjct: 171 KLADFGLAIEV--------NDSEAWHGFAGTPGYLSPE 200
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 61/362 (16%), Positives = 120/362 (33%), Gaps = 80/362 (22%)
Query: 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113
+L I G SN+T V + + LS + +I + L+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173
N I+ + + + N++ I ++ N L
Sbjct: 71 KDNQITDL--APLKNLTKITELELSGNPL---------------------------KNVS 101
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
+++ +++ LD +T P L +L L D N++ + + LA T
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN--------ISPLAGLT 151
Query: 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293
+L+ L + +++L+ + NL L L + N
Sbjct: 152 NLQYLSIGNA--------QVSDLT-------------------PLANLSKLTTLKADDNK 184
Query: 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353
+S P + L L + L N+ S + S L N + L + + + + P N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNN- 238
Query: 354 QKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDG 413
L+V N+ I +Y+ + + ++ + I S+ T +
Sbjct: 239 -NLVVPNVVKGPSGAPIAPATISDNGTYASPNLT---WNLTSFINNVSYTFNQSVTFKNT 294
Query: 414 TI 415
T+
Sbjct: 295 TV 296
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 59/271 (21%), Positives = 87/271 (32%), Gaps = 69/271 (25%)
Query: 371 PKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQ 426
P D + L+G G FG+V+ G L D VAIKV+ ++
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 427 GALKSFID---ECNALK----STRHRNILR---VITACSSVDLEGNDFKALVFEFMSNGN 476
L + E L H ++R E + LV E
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--------ETQEGFMLVLERPLPAQ 124
Query: 477 -LDQWLHPSPAEHYQFKKLSVIQRL------NIAIDVASALDYLHHHCDTPIAHCDLKPS 529
L F ++ L V +A+ + H + H D+K
Sbjct: 125 DL-------------FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168
Query: 530 NVLLDKDM-TAHVGDFGLAKFLFEISDNPSKNQTVSIGLK---GSIGYIPPEHMNGQVSI 585
N+L+D A + DFG L D P G+ Y PPE ++
Sbjct: 169 NILIDLRRGCAKLIDFGSGALL---HDEP---------YTDFDGTRVYSPPEWISRH-QY 215
Query: 586 LG---DIYSYGILLLEMFTGKRPTGDMFKDD 613
++S GILL +M G P F+ D
Sbjct: 216 HALPATVWSLGILLYDMVCGDIP----FERD 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 43/234 (18%)
Query: 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL--KLQQQGALKSFIDE 435
M+ ++ T+ + +G G+F V + + G A ++ K + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKL 494
+ +H NI+R+ + L+F+ ++ G L + + E+Y
Sbjct: 61 ARICRLLKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVA---REYYSEADA 112
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLF 551
S + + A+ + H + H +LKP N+LL K + DFGLA +
Sbjct: 113 SHCIQ-----QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV- 163
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYG----ILL 596
Q G G+ GY+ PE + V D+++ G ILL
Sbjct: 164 ------EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV----DLWACGVILYILL 207
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/284 (17%), Positives = 107/284 (37%), Gaps = 22/284 (7%)
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSI 126
+L ++P+ G ++K+L L+ N + ++L + L L N I+ I S
Sbjct: 40 SGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96
Query: 127 YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSL-SNASNLQVLD 185
++ S+ + ++ N L L + L +L N + SL S+ + LQ+L
Sbjct: 97 SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 186 FAENGLTGTIP-GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244
I +F L L L D ++L S E L + ++ L L
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL------KSIQNVSHLILHMKQ 209
Query: 245 FGGEMPISIANLSTHLRRLTMGENLMHGN----IPVGI----GNLVNLNLLGLEGNNLSG 296
+ ++++ + L + + + + G + + +L
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267
Query: 297 SVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
V +++ +++ L L + N+ + LT L ++W+ N
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 39/224 (17%), Positives = 77/224 (34%), Gaps = 29/224 (12%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIG---DLNFL 226
SIP L+ ++ LD + N +T + +L L N + + E L L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 227 KFL---------------ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
+ L +SL L L N + S+ + T L+ L +G
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 272 GNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330
I L L L ++ ++L P+ + + + L L++ + L+ + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 331 ILTRLWMEENRLEG----SIPP----SLGNCQKLLVLNLSSNDL 366
+ L + + L+ + SL + ++ L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 46/271 (16%), Positives = 99/271 (36%), Gaps = 19/271 (7%)
Query: 58 TKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGN 116
++ + L + +T + + +L+AL L N + +I + L L L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 117 FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SL 175
++S + S +SS+ + ++ N T + L L+I I
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 176 SNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSL 235
+ + L+ L+ + L P + S++++ L + + ++ +S+
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL--LLEIFV----DVTSSV 224
Query: 236 EVLGLARNSFGGEMPISIANLST-------HLRRLTMGENLMHGNIPVGIGNLVNLNLLG 288
E L L ++ T R + + + + + + + L L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 289 LEGNNLSGSVPE-VIGRLNKLEGLGLNVNKF 318
N L SVP+ + RL L+ + L+ N +
Sbjct: 284 FSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 38/204 (18%), Positives = 67/204 (32%), Gaps = 22/204 (10%)
Query: 13 QDLNLTYNYLSGKIPTNL-SHCTELRSFEASVNDFVGQIPNQ-LSSLTKLEIIGLGGSNL 70
LNL N T+L SH T+L+ D +I + + LT LE + + S+L
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 71 TGNVPAWIGNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIYNI 129
P + + ++ L L + S + L + S +
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189
+ + T + + + +F + L+ S L L+F+ N
Sbjct: 246 ET---------NSLIKKFTFRNVKITDESLF---------QVMKLLNQISGLLELEFSRN 287
Query: 190 GLTGTIPGNFGSLKDLVRLNFDQN 213
L G F L L ++ N
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 387 STDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
+ + F L+G G+FG V K T G A+K+LK K I + + T
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILK-------KEVIVAKDEVAHT 195
Query: 443 RH-RNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+L+ L+ +D V E+ + G L L + + S
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-------RERVFSED 248
Query: 498 Q-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
+ R A ++ SALDYLH + + + DLK N++LDKD + DFGL K E +
Sbjct: 249 RARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKD 302
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
+ +T G+ Y+ PE + V D + G+++ EM G+ P
Sbjct: 303 GATMKTFC----GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 61/270 (22%)
Query: 362 SSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVY----KGTLGDGTIVA 417
+ T+ E+R + ++ +NF ++GTG++G V+ G + A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 418 IKVLKLQQQGALKSFIDECNALKSTRH----RNILRVITACS-SVDL------EGNDFKA 466
+KVLK K+ I K+T H R +L I V L E
Sbjct: 87 MKVLK-------KATI--VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH-- 135
Query: 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI------AIDVASALDYLHHHCDTP 520
L+ ++++ G L F LS +R ++ AL++LH
Sbjct: 136 LILDYINGGEL-------------FTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---G 179
Query: 521 IAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH 578
I + D+K N+LLD + HV DFGL+K ++D + G+I Y+ P+
Sbjct: 180 IIYRDIKLENILLDSN--GHVVLTDFGLSK--EFVADETERAYD----FCGTIEYMAPDI 231
Query: 579 MNGQVSILG---DIYSYGILLLEMFTGKRP 605
+ G S D +S G+L+ E+ TG P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 54/288 (18%), Positives = 94/288 (32%), Gaps = 85/288 (29%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKS 441
D +G G+FG V + VA+K+LK ++ + E L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
H N++ ++ AC+ ++ EF GNL +L E +K R
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 501 ------NIAIDVASALDYL--------------------------HHHCDTPIAHCDL-- 526
I +D+ LD + + L
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 527 ----------------------KPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
N+LL + + DFGLA+ +++ D
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-------- 249
Query: 565 IGLKGSIGYIP-----PEHMNGQV-SILGDIYSYGILLLEMFT-GKRP 605
++ +P PE + +V +I D++S+G+LL E+F+ G P
Sbjct: 250 --VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
+ + +G G FG V++ K +K++ E + L RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRN 62
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAID 505
IL + + E + ++FEF+S ++ ++ ++ + ++ +
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERIN----TSAFELNEREIV---SYVHQ 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTV 563
V AL +LH H I H D++P N++ ++ + +FG A+ L P N +
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRL 162
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ Y PE VS D++S G L+ + +G P
Sbjct: 163 LF---TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 37/222 (16%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
D + +G+G F V K G A K +K +Q A + + E + L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQR 499
H N++ + E L+ E +S G L D E ++ + +
Sbjct: 71 QVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIK 122
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH---VGDFGLAKFLFEISD 555
+ ++YLH IAH DLKP N++L DK++ + DFGLA +
Sbjct: 123 -----QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----- 169
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILL 596
G+ ++ PE +N + + + D++S G++
Sbjct: 170 EDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 49/265 (18%), Positives = 98/265 (36%), Gaps = 57/265 (21%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALK--------STRHRN 446
+G G F +V+ + + T VA+K+++ + ++ DE L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 447 ILRVITACSSVDLEGNDFK--ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
++ + +G + +VFE + NL + Y+ + + +I I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIK-----KYEHRGIPLIYVKQISK 138
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH------VGDFGLAKFLFEISDNPS 558
+ LDY+H C I H D+KP NVL++ + + D G A +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--------- 187
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKR--PTGDM 609
++ + ++ + Y PE +LG DI+S L+ E+ TG +
Sbjct: 188 YDEHYTNSIQ-TREYRSPE------VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 610 FKDDFSIHMFVSMALPDHVMDILDP 634
+ +++L
Sbjct: 241 HSYTKDDDHIAQI------IELLGE 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 7e-16
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 56/237 (23%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F+ ++G GSFG V KGT + A+K+LK K + + + ++ T
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMV 390
Query: 445 -RNILRVITACSS-VDLEG----NDFKALVFEFMSNGNLDQWLHPS---PAEHYQFKKLS 495
+ +L + L D V E+++ G+L + H F
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF---- 446
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEI 553
A ++A L +L I + DLK NV+LD + H+ DFG+ K E
Sbjct: 447 ------YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK---EN 492
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
+ +T G+ YI PE + Q V D +++G+LL EM G+ P
Sbjct: 493 IWDGVTTKTFC----GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 35/231 (15%)
Query: 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID-- 434
GM K D + +G+G F V K G A K +K +Q A + +
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 435 ----ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ 490
E + L+ H NI+ + E L+ E +S G L +L E
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQK--ESLS 113
Query: 491 FKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH---VGDFGL 546
++ + + + ++YLH IAH DLKP N++L DK++ + DFGL
Sbjct: 114 EEEATSFIK-----QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILL 596
A + G+ ++ PE +N + + + D++S G++
Sbjct: 166 AHEI-----EDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 66/244 (27%), Positives = 97/244 (39%), Gaps = 62/244 (25%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVL---KLQQQGALKSFIDECNALKSTRHRNILR-- 449
+G GSFG V T VA+K + L++ E + LK RH +I++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 450 -VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA- 507
VI +V E+ + G L F + +R+ D
Sbjct: 76 DVI--------TTPTDIVMVIEY-AGGEL-------------FDYIVEKKRMTE--DEGR 111
Query: 508 -------SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
A++Y H H I H DLKP N+LLD ++ + DFGL+
Sbjct: 112 RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI----------- 157
Query: 561 QTVSIGLK---GSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615
T LK GS Y PE +NG+ D++S GI+L M G+ P F D+F
Sbjct: 158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP----FDDEFI 213
Query: 616 IHMF 619
++F
Sbjct: 214 PNLF 217
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 62/251 (24%), Positives = 96/251 (38%), Gaps = 48/251 (19%)
Query: 371 PKEVRQSGMSYSDISKST----DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ 425
+ R + +I ST + IG+G+ G V VAIK KL +
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSR 60
Query: 426 QGALKSFID------ECNALKSTRHRNILR---VITACSSVDLEGNDFKA--LVFEFMSN 474
++ E +K H+NI+ V T S++ +F+ +V E M
Sbjct: 61 --PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELMDA 114
Query: 475 GNLDQWLH-PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533
NL Q + E + + Q L + +LH I H DLKPSN+++
Sbjct: 115 -NLCQVIQMELDHERMSY---LLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVV 160
Query: 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSY 592
D T + DFGLA+ + S T + + Y PE + DI+S
Sbjct: 161 KSDCTLKILDFGLAR-----TAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSV 212
Query: 593 GILLLEMFTGK 603
G ++ EM G
Sbjct: 213 GCIMGEMIKGG 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 37/222 (16%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
D + +G+G F V K G A K +K ++ + + + E + LK
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQR 499
+H N++ + E L+ E ++ G L D E ++ + +
Sbjct: 70 EIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLK 121
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH---VGDFGLAKFLFEISD 555
+ + + YLH IAH DLKP N++L D+++ + DFGLA +
Sbjct: 122 -----QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----- 168
Query: 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILL 596
+ G+ ++ PE +N + + + D++S G++
Sbjct: 169 DFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-KLQQQGALKSFIDE 435
G + + +D F E+ +G G+ VY+ G A+KVL K + ++ E
Sbjct: 45 GSNRDAL---SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TE 98
Query: 436 CNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLS 495
L H NI+++ E +LV E ++ G L + +Y + +
Sbjct: 99 IGVLLRLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRI--VEKGYYSERDAA 151
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFE 552
+ + A+ YLH + I H DLKP N+L D + DFGL+K +
Sbjct: 152 DAVK-----QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-- 201
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYG----ILL 596
++Q + + G+ GY PE + G V D++S G ILL
Sbjct: 202 ------EHQVLMKTVCGTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 47/235 (20%), Positives = 89/235 (37%), Gaps = 34/235 (14%)
Query: 384 ISKSTDNFSK-----ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA--LKSFIDE 435
+S +NF+ +G G F V + G A K LK +++G + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 436 CNALKSTRHR-NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
L+ + ++ + E L+ E+ + G + P AE +
Sbjct: 79 IAVLELAKSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHV--GDFGLAKFLF 551
+ + + + YLH + I H DLKP N+LL + DFG+++ +
Sbjct: 134 IRLIK-----QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI- 184
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ + G+ Y+ PE +N ++ D+++ GI+ + T P
Sbjct: 185 ----GHACELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 382 SDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ 434
S + D++ +G+G F V K G G A K +K ++ + + +
Sbjct: 1 SMV---EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKK 493
E N L+ RH NI+ + E L+ E +S G L D E +
Sbjct: 58 EVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAE---KESLTEDE 109
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH---VGDFGLAKF 549
+ + + + YLH IAH DLKP N++L DK++ + DFG+A
Sbjct: 110 ATQFLK-----QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYG----ILL 596
+ G+ ++ PE +N + + + D++S G ILL
Sbjct: 162 I-----EAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 56/248 (22%)
Query: 387 STDNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST 442
F ++G GSFG V+ + A+KVLK K+ + + +++
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTK 74
Query: 443 RHRNILRVITACSSVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
R+IL + V L EG + L+ +F+ G+L L + +
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRL-------SKEVMFTE 125
Query: 497 IQ-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEI 553
+ +A ++A ALD+LH I + DLKP N+LLD++ H+ DFGL+K E
Sbjct: 126 EDVKFYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK---ES 176
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP--- 605
D+ K + G++ Y+ PE +N + D +S+G+L+ EM TG P
Sbjct: 177 IDHEKKAYSFC----GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLPFQG 228
Query: 606 --TGDMFK 611
+
Sbjct: 229 KDRKETMT 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 51/275 (18%), Positives = 94/275 (34%), Gaps = 42/275 (15%)
Query: 344 GSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFG 403
+ PP P+ +SG+ + D ++G G G
Sbjct: 17 PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGING 76
Query: 404 SVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKS-TRHRNILRVITACSSVDLEG 461
V + A+K+L+ E ++ +I+R++ + G
Sbjct: 77 KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAG 130
Query: 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521
+V E + G L + + + ++ S I + + A+ YLH I
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIGEAIQYLHSIN---I 182
Query: 522 AHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH 578
AH D+KP N+L + + DFG AK + + S + Y+ PE
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPC-----YTPYYVAPE- 233
Query: 579 MNGQVSILG--------DIYSYGILLLEMFTGKRP 605
+LG D++S G+++ + G P
Sbjct: 234 ------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 57/246 (23%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
++F ++G GSFG V +K T AIK LK K + + ++ T
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALK-------KDVVLMDDDVECTMV 66
Query: 445 -RNILRVITAC-------SSVDLEGNDFKALVFEFMSNGNLDQWLHPS---PAEHYQFKK 493
+ +L + + + N F V E+++ G+L + F
Sbjct: 67 EKRVLSLAWEHPFLTHMFCTFQTKENLF--FVMEYLNGGDLMYHIQSCHKFDLSRATF-- 122
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLF 551
A ++ L +LH I + DLK N+LLDKD H+ DFG+ K
Sbjct: 123 --------YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK--- 166
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRP----- 605
E +K T G+ YI PE + GQ + D +S+G+LL EM G+ P
Sbjct: 167 ENMLGDAKTNT----FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 606 TGDMFK 611
++F
Sbjct: 223 EEELFH 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 75/271 (27%), Positives = 105/271 (38%), Gaps = 68/271 (25%)
Query: 371 PKEVRQSGMSYSDISKST---DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKL 423
PKE + G S + DNF ++G GSFG V K T G + A+KVLK
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLK- 57
Query: 424 QQQGALKSFIDECNALKSTRH-RNILRVITACS-SVDL------EGNDFKALVFEFMSNG 475
K I + + ++ T + IL + L F V EF++ G
Sbjct: 58 ------KDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF--FVMEFVNGG 109
Query: 476 NLDQWLHPS---PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532
+L + S +F A ++ SAL +LH I + DLK NVL
Sbjct: 110 DLMFHIQKSRRFDEARARF----------YAAEIISALMFLHDK---GIIYRDLKLDNVL 156
Query: 533 LDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSI 585
LD + H DFG+ K E N T G+ YI PE + V
Sbjct: 157 LDHE--GHCKLADFGMCK---EGICNGVTTATFC----GTPDYIAPEILQEMLYGPAV-- 205
Query: 586 LGDIYSYGILLLEMFTGKRP-----TGDMFK 611
D ++ G+LL EM G P D+F+
Sbjct: 206 --DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 60/239 (25%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F+ ++G GSFG V KGT + A+K+LK K + + + ++ T
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMV 69
Query: 445 -RNILRVITACS-SVDL------EGNDFKALVFEFMSNGNLDQWLHPS---PAEHYQFKK 493
+ +L + L + V E+++ G+L + H F
Sbjct: 70 EKRVLALPGKPPFLTQLHSCFQTMDRLY--FVMEYVNGGDLMYHIQQVGRFKEPHAVF-- 125
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLF 551
A ++A L +L I + DLK NV+LD + H+ DFG+ K
Sbjct: 126 --------YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--- 169
Query: 552 EISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
E + +T G+ YI PE + Q V D +++G+LL EM G+ P
Sbjct: 170 ENIWDGVTTKT----FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 74/298 (24%), Positives = 112/298 (37%), Gaps = 83/298 (27%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F +IG GSFG V K A+KVL+ K I + K
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQ-------KKAILKKKEEKHIMS 87
Query: 445 -RNILRVITACSS---VDL------EGNDFKALVFEFMSNGNLDQWLHPS---PAEHYQF 491
RN+L + V L + V ++++ G L L +F
Sbjct: 88 ERNVL--LKNVKHPFLVGLHFSFQTADKLY--FVLDYINGGELFYHLQRERCFLEPRARF 143
Query: 492 KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKF 549
A ++ASAL YLH I + DLKP N+LLD H+ DFGL K
Sbjct: 144 ----------YAAEIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK- 187
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKR 604
E ++ S T G+ Y+ PE ++ Q V D + G +L EM G
Sbjct: 188 --ENIEHNSTTSTFC----GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLP 237
Query: 605 P-----TGDMFKDDFSIHMFVSMALPDHV----MDIL------DPSMPLDEENDEEQI 647
P T +M+ +I + + L ++ +L D + L ++D +I
Sbjct: 238 PFYSRNTAEMYD---NI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 51/244 (20%), Positives = 88/244 (36%), Gaps = 56/244 (22%)
Query: 370 IPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGA 428
+ V+Q + TD + + IG GS+ + A+K++
Sbjct: 6 VHSIVQQLHRNSIQF---TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------ 56
Query: 429 LKSFID---ECNAL-KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPS 484
KS D E L + +H NI+ + + + +V E M G L +
Sbjct: 57 -KSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQ 110
Query: 485 PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL-DKDMTAH--- 540
+ + ++ S + + ++YLH + H DLKPSN+L D+
Sbjct: 111 --KFFSEREASAVLF-----TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR 160
Query: 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG--------DIYSY 592
+ DFG AK + T + ++ PE +L DI+S
Sbjct: 161 ICDFGFAKQ---LRAENGLLMTPC----YTANFVAPE-------VLERQGYDAACDIWSL 206
Query: 593 GILL 596
G+LL
Sbjct: 207 GVLL 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
+ +F ++L+G G++G V T G IVAIK K++ + E LK
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIE---PFDKPLFALRTLREIKILK 64
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP--AEHYQFKKLSVIQ 498
+H NI+ + E + ++ E M +L + + +H Q+ + Q
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY---FIYQ 120
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
L A+ LH + + H DLKPSN+L++ + V DFGLA+ + E + + S
Sbjct: 121 TLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 559 KNQTVSIGLKGSIG---YIPPEHMNGQ----VSILGDIYSYGILLLEMFTGK 603
+ G+ + Y PE M ++ D++S G +L E+F +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM--DVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 58/260 (22%), Positives = 92/260 (35%), Gaps = 61/260 (23%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
DN+ ++LIG GS+G VY VAIK K+ + + ID E L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNR--MFEDLIDCKRILREITILN 80
Query: 441 STRHRNILRVITACSSVDLEGNDFKA--LVFEFM---------SNGNLDQWLHPSPAEHY 489
+ I+R+ DL F +V E + L + EH
Sbjct: 81 RLKSDYIIRLYDLIIPDDLL--KFDELYIVLEIADSDLKKLFKTPIFLTE-------EHI 131
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
+ + L +++H ++ I H DLKP+N LL++D + V DFGLA+
Sbjct: 132 KT---ILYNLLL-------GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVS---------ILG--------DIYSY 592
+ D N G + + V IL DI+S
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238
Query: 593 GILLLEMFTGKRPTGDMFKD 612
G + E+ + + +
Sbjct: 239 GCIFAELLNMLQSHINDPTN 258
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 25/196 (12%), Positives = 68/196 (34%), Gaps = 14/196 (7%)
Query: 147 PTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLV 206
+V + K + + + + ++ + ++L + A +T + G ++
Sbjct: 12 QDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIK 69
Query: 207 RLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG 266
L + + ++ ++LE L + + +++ L T L L +
Sbjct: 70 DLTINNIHATN--------YNPISGLSNLERLRIMGKDVTSDKIPNLSGL-TSLTLLDIS 120
Query: 267 ENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSL 326
+ +I I L +N + L N + + L +L+ L + + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGI 177
Query: 327 GNLTILTRLWMEENRL 342
+ L +L+ +
Sbjct: 178 EDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 18/188 (9%)
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
S + G + T + L + + L + +++ L
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--------LTGIEYAHNIKDL 71
Query: 239 GLARNSFGGEMPISIANLS--THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
+ + +S ++L RL + + + + L +L LL + +
Sbjct: 72 TINNIHAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 297 SVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKL 356
S+ I L K+ + L+ N I L L L L ++ + + + + KL
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKL 183
Query: 357 LVLNLSSN 364
L S
Sbjct: 184 NQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 5/121 (4%)
Query: 250 PISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE 309
I+ A + L +T+ + ++ GI N+ L + + + P I L+ LE
Sbjct: 37 NITEAQM-NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLE 91
Query: 310 GLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGT 369
L + + +L LT LT L + + + SI + K+ ++LS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 370 I 370
I
Sbjct: 152 I 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 31/198 (15%), Positives = 67/198 (33%), Gaps = 41/198 (20%)
Query: 51 PNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110
Q++SLT + + + ++LTG I ++K L++ + P + LS L
Sbjct: 40 EAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 111 FTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
+ G ++ ++ L +L + + + S
Sbjct: 93 LRIMGKDVTSDKIPNLSG-------------------------LTSLTLLDISHSAHDDS 127
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
I ++ + +D + NG I +L +L LN + + + +
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--------YRGIE 178
Query: 231 NCTSLEVLGLARNSFGGE 248
+ L L + GG+
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 19/130 (14%), Positives = 41/130 (31%), Gaps = 5/130 (3%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+DL + + + +S + L D LS LT L ++ + S
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
++ I + ++ L++N I L L L + + + I + +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIEDFPKL 183
Query: 133 YYFSVTQNQL 142
+
Sbjct: 184 NQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 22/122 (18%), Positives = 42/122 (34%), Gaps = 10/122 (8%)
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234
+S SNL+ L +T N L L L+ + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL------TKINTLPK 137
Query: 235 LEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294
+ + L+ N ++ + L L+ L + + +H + GI + LN L +
Sbjct: 138 VNSIDLSYNGAITDIM-PLKTL-PELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAFSQTI 193
Query: 295 SG 296
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 17/114 (14%), Positives = 42/114 (36%), Gaps = 4/114 (3%)
Query: 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS 319
+ G + + +L + L N++ I + ++ L +N +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHAT 79
Query: 320 GLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKE 373
+ + L+ L RL + + P+L L +L++S + + +I +
Sbjct: 80 NY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 56/237 (23%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F +IG GS+ V K T I A+KV+K K +++ + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVK-------KELVNDDEDIDWVQT 58
Query: 445 -RNILRVITACS-SVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+++ + V L E F V E+++ G+L + + +KL
Sbjct: 59 EKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQ-------RQRKLPE 109
Query: 497 IQ-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEI 553
R A +++ AL+YLH I + DLK NVLLD + H+ D+G+ K E
Sbjct: 110 EHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EG 160
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
T G+ YI PE + G+ V D ++ G+L+ EM G+ P
Sbjct: 161 LRPGDTTSTFC----GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 56/237 (23%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
+F +IG GS+ V K T I A++V+K K +++ + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVVK-------KELVNDDEDIDWVQT 101
Query: 445 -RNILRVITACS-SVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+++ + V L E F V E+++ G+L + + +KL
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQ-------RQRKLPE 152
Query: 497 IQ-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEI 553
R A +++ AL+YLH I + DLK NVLLD + H+ D+G+ K E
Sbjct: 153 EHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EG 203
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP 605
T G+ YI PE + G+ V D ++ G+L+ EM G+ P
Sbjct: 204 LRPGDTTSTFC----GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 50/228 (21%), Positives = 79/228 (34%), Gaps = 16/228 (7%)
Query: 151 GLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSL--KDLVRL 208
L+L L + A + + + S LQ L +TGT P DL L
Sbjct: 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 209 NFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN 268
N +R+ ++L L+VL +A+ + L L + +N
Sbjct: 127 NLRNVSWATRDAWLAELQQWLK--PGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDN 183
Query: 269 -------LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321
L+ P+ L L L SG + +L+GL L+ N
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 322 IPSSL-GNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
+ + L L + L+ +P L KL VL+LS N L+
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 49/296 (16%), Positives = 86/296 (29%), Gaps = 31/296 (10%)
Query: 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
S L+ + + + SL +L + + + S L+ L+
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT 148
L + G+ P L + +G L ++ N+S L
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNIL-----------NLRNVSW--------ATRDAWLAE 142
Query: 149 DVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP----GNFGSLKD 204
P LK+ + A + + L LD ++N G
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLT 264
L L + + A L+ L L+ NS + + L L
Sbjct: 203 LQVLALRNAGMET---PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 265 MGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320
+ + +P G+ L++L L N L P L ++ L L N F
Sbjct: 260 LSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 35/216 (16%), Positives = 63/216 (29%), Gaps = 18/216 (8%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCT--ELRSFEASVNDFVGQIPN----QLSSLTKLEIIGLG 66
Q+L L ++G P L T +L + + Q L+++ +
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNE----LGQLSGLGFFTLYGNF---IS 119
++ + F +L L L+ N G + L L S
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
G+ + + ++ N L L + +P L +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--A 274
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNEL 215
L VLD + N L P + L + L+ N
Sbjct: 275 KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 58/236 (24%), Positives = 89/236 (37%), Gaps = 56/236 (23%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
+ IG+G+ G V VAIK KL + ++ E +K
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSR--PFQNQTHAKRAYRELVLMK 116
Query: 441 STRHRNILR---VITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLH-PSPAEHYQFKKL 494
H+NI+ V T +++ +F+ LV E M + NL Q + E +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-DANLCQVIQMELDHERMSY--- 168
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
+ Q L + +LH I H DLKPSN+++ D T + DFGLA+ +
Sbjct: 169 LLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----T 213
Query: 555 DNPSKNQTVSIGLKGSIGYI------PPEHM-NGQVSILGDIYSYGILLLEMFTGK 603
S T Y+ PE + DI+S G ++ EM K
Sbjct: 214 AGTSFMMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 18/211 (8%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
IP +L + + LD + N L +F S +L L+ + E+ + E G L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL--- 75
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLG 288
+ L L L N + + + + L++L E + ++ G+L L L
Sbjct: 76 ---SHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130
Query: 289 LEGNNL-SGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT----RLWMEENRLE 343
+ N + S +PE L LE L L+ NK + + L L + L + N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 344 GSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374
I P +L L L +N L ++P +
Sbjct: 191 -FIQPGAFKEIRLKELALDTNQLK-SVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 45/208 (21%), Positives = 78/208 (37%), Gaps = 12/208 (5%)
Query: 113 LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172
L N + + S ++ + +++ ++ + +L +L N S+
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLA 92
Query: 173 VSL-SNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
+ S S+LQ L E L G LK L LN N + S ++ + +N
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY-----FSN 147
Query: 232 CTSLEVLGLARN---SFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLG 288
T+LE L L+ N S + + L + N M+ I G + L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 289 LEGNNLSGSVPEVIGRLNKLEGLGLNVN 316
L+ N L + RL L+ + L+ N
Sbjct: 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 46/241 (19%), Positives = 84/241 (34%), Gaps = 45/241 (18%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
T++L+L++N L + S +L+++ L +
Sbjct: 30 TKNLDLSFNPLR-HLG-----------------------SYSFFSFPELQVLDLSRCEIQ 65
Query: 72 GNVPAWIGNFS---SLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIY 127
+ G + L L L N ++ S+ LS L ++ + I
Sbjct: 66 -TIED--GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 128 NISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SLSNASNLQV--- 183
++ ++ +V N + + L NL+ + N SI L + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 184 -LDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242
LD + N + PG F ++ L L D N+L S G + L TSL+ + L
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRL------TSLQKIWLHT 233
Query: 243 N 243
N
Sbjct: 234 N 234
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 55/259 (21%), Positives = 92/259 (35%), Gaps = 54/259 (20%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL----QQQGALKSFIDECNALKST 442
D + +LIGTGS+G V + + +VAIK K+ + K + E L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRL 109
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH-------PSPAEHYQFKKLS 495
H ++++V+ D+E D +V E D H +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKT---L 161
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555
+ L + Y+H I H DLKP+N L+++D + V DFGLA+ + +
Sbjct: 162 LYNLLV-------GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 556 NPSKNQTVSIGLKGSIGYIPPE-----HMNGQVS---------ILG--------DIYSYG 593
S+ ++ P + G V IL D++S G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 594 ILLLEMFTGKRPTGDMFKD 612
+ E+ + D
Sbjct: 272 CIFAELLNMIKENVAYHAD 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 389 DNFSKENLIGTGSFGSV----YKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
++F L+G G+FG V K T G A+K+L+ K I + + T
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILR-------KEVIIAKDEVAHTVT 54
Query: 445 -RNILRVITACSSVDLEG----NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQ- 498
+L+ L+ +D V E+ + G L L + + + +
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERA 107
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDN 556
R A ++ SAL+YLH + + D+K N++LDKD H+ DFGL K ISD
Sbjct: 108 RFYGA-EIVSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDG 159
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP-----T 606
+ G+ Y+ PE + V D + G+++ EM G+ P
Sbjct: 160 ---ATMKTFC--GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 607 GDMFK 611
+F+
Sbjct: 211 ERLFE 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 65/248 (26%), Positives = 95/248 (38%), Gaps = 58/248 (23%)
Query: 389 DNFSKENLIGTGSFGSVY----KGTLGDGTIVAIKVLKLQQQGALKSFI-DECNALKSTR 443
+ F ++G G +G V+ G I A+KVLK K+ I T+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTK 69
Query: 444 H-RNILRVITACSSVDL------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
RNIL + VDL G + L+ E++S G L L +
Sbjct: 70 AERNILEEVKHPFIVDLIYAFQTGGKLY--LILEYLSGGELFMQLE-------REGIFME 120
Query: 497 IQ-RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEI 553
+A +++ AL +LH I + DLKP N++L+ HV DFGL K I
Sbjct: 121 DTACFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK--ESI 172
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRP--- 605
D T + G+I Y+ PE + V D +S G L+ +M TG P
Sbjct: 173 HDG---TVTHTFC--GTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPPFTG 223
Query: 606 --TGDMFK 611
Sbjct: 224 ENRKKTID 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 55/233 (23%), Positives = 87/233 (37%), Gaps = 39/233 (16%)
Query: 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIK--VLKLQQQGALKSFIDECNA------- 438
++ + I +GS+G+V G +G VAIK + + D
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 439 --LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPA----EHYQFK 492
L H NIL + + LV E M +L Q +H +H Q+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
+ L L LH + + H DL P N+LL + + DF LA+ E
Sbjct: 139 --FMYHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---E 183
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGK 603
+ + +K V+ Y PE + + L D++S G ++ EMF K
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
+IP ++ ++ + LD N L+ F L L L + N+L + G L
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL--- 84
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLG 288
+LE L + N +PI + + +L L + N + ++P + +L L L
Sbjct: 85 ---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 289 LEGNNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347
L N L S+P+ V +L L+ L L N+ + + LT L L ++ N+L+ +P
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP 197
Query: 348 P-SLGNCQKLLVLNLSSN 364
+ + +KL +L L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 14/148 (9%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
+ L L N + L T LR L + +N + +P GI L NL L +
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRL-TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 292 NNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-- 348
N L ++P V +L L L L+ N+ L P +LT LT L + N L+ S+P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 349 --SLGNCQKLLVLNLSSNDLNGTIPKEV 374
L + L L L +N L +P+
Sbjct: 153 FDKLTS---LKELRLYNNQLK-RVPEGA 176
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 31/205 (15%)
Query: 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT 71
T+ L+L N LS +P LTKL ++ L + L
Sbjct: 39 TKKLDLQSNKLS-SLP-----------------------SKAFHRLTKLRLLYLNDNKLQ 74
Query: 72 GNVPAWI-GNFSSLKALSLAWNNLRGSIPNEL-GQLSGLGFFTLYGNFISGIIPSSIYNI 129
+PA I +L+ L + N L+ ++P + QL L L N + + P ++
Sbjct: 75 -TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSL-SNASNLQVLDFAE 188
+ + Y S+ N+L LP V L +LK N +P + L+ L
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDN 190
Query: 189 NGLTGTIPGNFGSLKDLVRLNFDQN 213
N L G F SL+ L L +N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 62/237 (26%), Positives = 95/237 (40%), Gaps = 73/237 (30%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLK----LQQQGALKSFIDECNALKSTRHR----- 445
+IG GSFG V K VA+K+++ +Q +E L+ R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRILEHLRKQDKDNT 158
Query: 446 -NILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
N++ + LE F+ + FE +S NL + + + +F+ S+
Sbjct: 159 MNVIHM--------LENFTFRNHICMTFELLSM-NLYELI-----KKNKFQGFSLPLVRK 204
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH--VGDFGLAKFLFEISDNPSK 559
A + LD LH + I HCDLKP N+LL + + V DFG + +
Sbjct: 205 FAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--------- 252
Query: 560 NQTVSIGLKGSIGYI------PPEHMNGQVSILG-------DIYSYGILLLEMFTGK 603
+Q V YI PE V ILG D++S G +L E+ TG
Sbjct: 253 HQRVYT-------YIQSRFYRAPE-----V-ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 48/205 (23%), Positives = 74/205 (36%), Gaps = 41/205 (20%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
++P L + +L +EN L L +LN D+ EL ++
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG------- 74
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
L L L+ N +L ++P+ L L +L +
Sbjct: 75 -TLPVLGTLDLSHN------------------QLQ--------SLPLLGQTLPALTVLDV 107
Query: 290 EGNNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP 348
N L+ S+P + L +L+ L L N+ L P L L +L + N L +P
Sbjct: 108 SFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPA 165
Query: 349 SL-GNCQKLLVLNLSSNDLNGTIPK 372
L + L L L N L TIPK
Sbjct: 166 GLLNGLENLDTLLLQENSLY-TIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 57/314 (18%), Positives = 85/314 (27%), Gaps = 116/314 (36%)
Query: 52 NQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFF 111
++++S ++ NLT +P + L L+ N L L + L
Sbjct: 7 SKVASHLEVN---CDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 112 TLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171
L ++ +L D L
Sbjct: 61 NLDRAELT-------------------------KLQVDGTLP------------------ 77
Query: 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
L LD + N L ++P +L L L+ N L
Sbjct: 78 --------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL---------------- 112
Query: 232 CTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEG 291
TSL + G L L L L+G
Sbjct: 113 -TSLP-----LGALRG---------------------------------LGELQELYLKG 133
Query: 292 NNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSL 350
N L ++P ++ KLE L L N + L L L L L ++EN L +IP
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 351 GNCQKLLVLNLSSN 364
L L N
Sbjct: 192 FGSHLLPFAFLHGN 205
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 47/272 (17%), Positives = 73/272 (26%), Gaps = 63/272 (23%)
Query: 372 KEVRQSG-MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKL------- 423
E Q G + +S T+ + IG G FG V++ D T VAIK++ +
Sbjct: 3 GECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVN 60
Query: 424 -QQQGALKSFIDECNALK---------STRHRNILRVITAC------------------- 454
Q + + E K R + + +
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 455 ------SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
D +D +V EF G E + K S+ +I + +
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGG--------IDLEQMRTKLSSLATAKSILHQLTA 172
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK--------FLFEISDNPSKN 560
+L H DL NVLL K + K I D
Sbjct: 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSR 230
Query: 561 QTVSIGLKGSIGYIPPEHMNGQVSILGDIYSY 592
+ + + G DIY
Sbjct: 231 LERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 47/231 (20%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
+ +G+G++GSV G VAIK KL + +S I E LK
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSR--PFQSEIFAKRAYRELLLLK 78
Query: 441 STRHRNILR---VITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLH-PSPAEHYQFKKL 494
+H N++ V T SS+ +F LV FM +L + + E Q+
Sbjct: 79 HMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQY--- 130
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
V Q L L Y+H + H DLKP N+ +++D + DFGLA+
Sbjct: 131 LVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----H 175
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGK 603
+ V + Y PE + + DI+S G ++ EM TGK
Sbjct: 176 ADAEMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 7e-14
Identities = 61/347 (17%), Positives = 108/347 (31%), Gaps = 58/347 (16%)
Query: 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139
F+ +L ++ ++ +L+ + + I ++ I Y
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQY----- 63
Query: 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNF 199
LPN+ N T I L+N NL L EN + + +
Sbjct: 64 --------------LPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLS-SL 105
Query: 200 GSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS-IANLS- 257
LK L L+ + N + + L + LE L L N I+ I LS
Sbjct: 106 KDLKKLKSLSLEHNGISD--------INGLVHLPQLESLYLGNNK------ITDITVLSR 151
Query: 258 -THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVN 316
T L L++ +N + +I + L L L L N++S + + L L+ L L
Sbjct: 152 LTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQ 207
Query: 317 KFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQ 376
+ + NL + + + L P + + N+ + EV
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH--LPEFTNEVSF 263
Query: 377 SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKL 423
I K+ F +V G ++
Sbjct: 264 IFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTR 310
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 35/205 (17%), Positives = 73/205 (35%), Gaps = 37/205 (18%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
L L N L+ I L++ L N + + + L L KL+ + L + ++
Sbjct: 68 TKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENK-IKDLSS-LKDLKKLKSLSLEHNGIS- 122
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
++ + + L++L L N + I L +L+ L +L N IS I + ++ +
Sbjct: 123 DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKL 177
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+++N + +D+ +L+ NL VL+
Sbjct: 178 QNLYLSKNHI-----SDLR----------------------ALAGLKNLDVLELFSQECL 210
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGS 217
+ +L + L +
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSLVT 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 52/225 (23%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALKSTRHRNILR 449
+G+G++G+V G VAIK KL + +S + E LK RH N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK--KLYR--PFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 450 ---VITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSP--AEHYQFKKLSVIQRLNI 502
V T ++D DF LV FM +L + + + QF V Q L
Sbjct: 89 LLDVFTPDETLD----DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF---LVYQMLK- 139
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
L Y+H I H DLKP N+ +++D + DFGLA+ +
Sbjct: 140 ------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGY 185
Query: 563 VSIGLKGSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFTGK 603
V + Y PE M ++ DI+S G ++ EM TGK
Sbjct: 186 VV-----TRWYRAPEVILNWMRYTQTV--DIWSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/259 (22%), Positives = 91/259 (35%), Gaps = 64/259 (24%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRH 444
S+ +S +GTGSFG V + + G A+K + + + E + +K H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDH 59
Query: 445 RNILRVI----TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR- 499
NI++++ T N ++ Q K L+VI
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 500 ----LNIAIDVAS--------------------ALDYLHHHCDTPIAHCDLKPSNVLLD- 534
L+ + A+ ++H I H D+KP N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYI------PPEHMNGQ----VS 584
KD T + DFG AK L + + YI PE M G S
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS--------------VAYICSRFYRAPELMLGATEYTPS 222
Query: 585 ILGDIYSYGILLLEMFTGK 603
I D++S G + E+ GK
Sbjct: 223 I--DLWSIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 55/235 (23%), Positives = 89/235 (37%), Gaps = 50/235 (21%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
++ + IG G++G V + VAIK K+ + E L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KIS---PFEHQTYCQRTLREIKILL 80
Query: 441 STRHRNILRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSP--AEHYQFKKLSV 496
RH NI+ + + +E K +V + M +L + L +H + +
Sbjct: 81 RFRHENIIGINDIIRAPTIE--QMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY---FL 134
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
Q L L Y+H + H DLKPSN+LL+ + DFGLA+ D+
Sbjct: 135 YQILR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 557 PSKNQTVSIGLKGSIGYI------PPEHM--NGQVSILGDIYSYGILLLEMFTGK 603
+ T Y+ PE M + + DI+S G +L EM + +
Sbjct: 185 -TGFLT---------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 19/178 (10%)
Query: 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID 434
+SG+ + D ++G G G V + A+K+L+
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARR 59
Query: 435 ECNAL-KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKK 493
E ++++ +I+R++ + G +V E + G L + + + ++
Sbjct: 60 EVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAK 548
S I + + A+ YLH IAH D+KP N+L + + DFG AK
Sbjct: 119 ASEIMK-----SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 48/232 (20%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID------ECNALK 440
+ + + +G+G++GSV G VA+K + +S I E LK
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLK 83
Query: 441 STRHRNILR---VITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSP--AEHYQFKK 493
+H N++ V T S++ +F LV M +L+ + +H QF
Sbjct: 84 HMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF-- 136
Query: 494 LSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEI 553
+ Q L L Y+H I H DLKPSN+ +++D + DFGLA+
Sbjct: 137 -LIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----- 180
Query: 554 SDNPSKNQTVSIGLKGSIGYIPPEHM--NGQVSILGDIYSYGILLLEMFTGK 603
V+ + Y PE M + DI+S G ++ E+ TG+
Sbjct: 181 HTADEMTGYVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 62/232 (26%), Positives = 91/232 (39%), Gaps = 59/232 (25%)
Query: 395 NLIGTGSFGSVYKGT-LGDGTIVAIKVLK----LQQQGALKSFIDECNALKSTRHR---- 445
+LIG GSFG V K + VAIK++K Q E L+
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEM 114
Query: 446 --NILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
I+ + F+ LVFE +S NL L + F+ +S+
Sbjct: 115 KYYIVHL--------KRHFMFRNHLCLVFEMLSY-NLYDLL-----RNTNFRGVSLNLTR 160
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL--DKDMTAHVGDFGLAKFLFEISDNPS 558
A + +AL +L + I HCDLKP N+LL K + DFG +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--------- 210
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGK 603
Q + ++ S Y PE +LG D++S G +L+EM TG+
Sbjct: 211 LGQRIYQYIQ-SRFYRSPE------VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 50/243 (20%), Positives = 90/243 (37%), Gaps = 57/243 (23%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN 446
+ +G G G V+ VAIK + L ++K + E ++ H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 447 ILRVI-------TACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSP--AEHYQFKKLS 495
I++V + + + + +V E+M +L L P EH +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL---F 125
Query: 496 VIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLFEIS 554
+ Q L L Y+H + H DLKP+N+ ++ +D+ +GDFGLA+ +
Sbjct: 126 MYQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 555 DNPSKNQTVSIGLKGSIGYI------PPEHMNGQVSILG--------DIYSYGILLLEMF 600
+ + + + P + L D+++ G + EM
Sbjct: 176 SH-KGHLS---------EGLVTKWYRSPRLL------LSPNNYTKAIDMWAAGCIFAEML 219
Query: 601 TGK 603
TGK
Sbjct: 220 TGK 222
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 33/171 (19%), Positives = 58/171 (33%), Gaps = 31/171 (18%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQG--------------ALKSFIDECNALK 440
IG+G FG +Y A V+K++ Q A K I + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF-KKLSVIQR 499
+ I + +G ++ +V E L +
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVMER---------LGIDLQKISGQNGTFKKSTV 153
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM--TAHVGDFGLAK 548
L + I + L+Y+H + H D+K +N+LL ++ D+GL+
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 53/248 (21%), Positives = 97/248 (39%), Gaps = 59/248 (23%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR--- 443
+ +G G++G V+K G +VA+K K+ +F + +A ++ R
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIF-----DAFQNSTDAQRTFREIM 60
Query: 444 -------HRNILRVITACSSVDLEGNDFKA--LVFEFMSNGNLDQWLHPSP--AEHYQFK 492
H NI+ ++ + ++ + LVF++M +L + + H Q+
Sbjct: 61 ILTELSGHENIVNLLNVLRA-----DNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY- 113
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
V Q + + YLH + H D+KPSN+LL+ + V DFGL++
Sbjct: 114 --VVYQLIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVS---------ILG--------DIYSYGIL 595
I + + P + V+ +LG D++S G +
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQP-ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 596 LLEMFTGK 603
L E+ GK
Sbjct: 221 LGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 33/174 (18%), Positives = 62/174 (35%), Gaps = 34/174 (19%)
Query: 396 LIGTGSFGSVYKGTLGDGTIVAIKV-----------------LKLQQQGALKSFIDECNA 438
IG G FG +Y + V LK Q+ A I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 439 LKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSV 496
+ ++ + + D G ++ ++ + + Y+ K+ S
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDR---------FGSDLQKIYEANAKRFSR 151
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD--KDMTAHVGDFGLAK 548
L +++ + L+Y+H H H D+K SN+LL+ ++ D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 182 QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLA 241
+ LD GL F L L LN D N+L + G + L T L LGLA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL------TELGTLGLA 91
Query: 242 RNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPE 300
N +P+ + + T L +L +G N + +P G+ L L L L N L S+P
Sbjct: 92 NNQL-ASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 301 -VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
+L L+ L L+ N+ + + L L + + N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 42/140 (30%), Positives = 58/140 (41%), Gaps = 13/140 (9%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
E L L + L T L L + N + + G+ +L L LGL
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGL-TKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLAN 92
Query: 292 NNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-- 348
N L+ S+P V L +L+ L L N+ L LT L L + N+L+ SIP
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 349 --SLGNCQKLLVLNLSSNDL 366
L N L L+LS+N L
Sbjct: 151 FDKLTN---LQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGRLNKLEGLG 312
+ + +L + + L L L L+ N L ++ V L +L LG
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP----SLGNCQKLLVLNLSSNDL 366
L N+ + L +LT L +L++ N+L+ S+P L ++ L L++N L
Sbjct: 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE---LRLNTNQL 143
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 8e-12
Identities = 58/496 (11%), Positives = 143/496 (28%), Gaps = 131/496 (26%)
Query: 233 TSLEVLGLARNSFGGEMP-----ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLL 287
T + + +M +++ N ++ L M + L++ P N
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP-------NWTSR 216
Query: 288 GLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347
+N+ + + L +L L + + L L +L + + +
Sbjct: 217 SDHSSNIKLRIHSIQAELRRL----LKSKPY----ENCL--L-VLLNVQNAK-----AWN 260
Query: 348 PSLGNCQKLLVL--NLS-SNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGS 404
+C K+L+ ++ L+ + + + + + +
Sbjct: 261 AFNLSC-KILLTTRFKQVTDFLSAATTTHIS--------LDHHSMTLTPDEVKSL--LLK 309
Query: 405 VYKGTLGDGTIVAIKV--LKLQQQGALKSFIDECNALKSTRHRNILRVITAC-SSVD-LE 460
D + +L D + +H N ++ T SS++ LE
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIR--DGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 461 GNDFKALVFE----FMSNGNLDQ------WLHPSPAEH----YQFKKLSVIQRLNIAIDV 506
+++ + F+ F + ++ W ++ + K S++++
Sbjct: 368 PAEYRKM-FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK-----QP 421
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL--FEISDNPSKNQTVS 564
+ + + +LK L+ + H + + I + +
Sbjct: 422 KESTISIPSI------YLELKVK---LENEYALH------RSIVDHYNIPKTFDSDDLIP 466
Query: 565 IGLKG----SIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKD---DFS-- 615
L IG+ H+ I E +F+ DF
Sbjct: 467 PYLDQYFYSHIGH----HL------------KNIEHPERM-------TLFRMVFLDFRFL 503
Query: 616 ----IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
H + +++ L + + I + + E +++ + E
Sbjct: 504 EQKIRHDSTAWNASGSILNTL-----QQLKFYKPYICDNDPKYERLVN-AILDFLPKIEE 557
Query: 672 EC----FVSVLRIGLM 683
+ +LRI LM
Sbjct: 558 NLICSKYTDLLRIALM 573
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 39/215 (18%), Positives = 76/215 (35%), Gaps = 17/215 (7%)
Query: 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD------QNELGSR 218
+ L + + T + S K+L L + L R
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 219 EIGDLNF----LKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNI 274
+ L + L++ + +++ + A + ++ +L H ++
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 275 --PVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTIL 332
+ L+ + L L N L ++P + L LE L + N + + NL L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRL 510
Query: 333 TRLWMEENRLEG-SIPPSLGNCQKLLVLNLSSNDL 366
L + NRL+ + L +C +L++LNL N L
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 7e-08
Identities = 41/326 (12%), Positives = 88/326 (26%), Gaps = 11/326 (3%)
Query: 19 YNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWI 78
+ Y + H + + ++ ++ L + W
Sbjct: 229 WFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWR 288
Query: 79 GNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138
+ + +L + N+ + + +
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATD 348
Query: 139 QNQLHGQLPTDVGLTLPN-LKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG 197
+ +L + L + L+ + L+ ++ LD
Sbjct: 349 EQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL--Q 406
Query: 198 NFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257
F +LK + + + R L + VL LA + + L
Sbjct: 407 YFSTLKAVDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQL- 462
Query: 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNK 317
+ L + N + +P + L L +L N L +V + L +L+ L L N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519
Query: 318 FSGL-IPSSLGNLTILTRLWMEENRL 342
L + L L ++ N L
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 38/245 (15%), Positives = 72/245 (29%), Gaps = 30/245 (12%)
Query: 6 IPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVN--DFVGQIPNQLSSLTKLEII 63
++ L + + + +L E SV + L +LE
Sbjct: 322 WTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEKSTVLQSELESCKELQELEPE 380
Query: 64 GLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIP 123
+ + K ++ L+ P L L L N +
Sbjct: 381 NKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL---- 436
Query: 124 SSIYNISSIYYFSVTQNQLH-----GQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178
+ + + L QL L L + ++ ++P +L+
Sbjct: 437 --KMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR---------ALPPALAAL 485
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
L+VL ++N L + G +L L L N + ++ L +C L +L
Sbjct: 486 RCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN-----RLQQSAAIQPLVSCPRLVLL 538
Query: 239 GLARN 243
L N
Sbjct: 539 NLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 27/181 (14%), Positives = 51/181 (28%), Gaps = 18/181 (9%)
Query: 188 ENGLTGTIPGNFGSLKDLVRLNFDQNEL--GSREIGDLNFLKFLANCTSLEVLGLARNSF 245
+ + + L R + E+ L+ L +L +
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 246 GGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL 305
+ + + L + + L + +
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPM-------------RAAYLDDLRSKFLLENSVLKMEY 440
Query: 306 NKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND 365
+ L L + L L L ++T L + NRL ++PP+L + L VL S N
Sbjct: 441 ADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497
Query: 366 L 366
L
Sbjct: 498 L 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 3e-06
Identities = 39/234 (16%), Positives = 74/234 (31%), Gaps = 23/234 (9%)
Query: 78 IGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137
L L+ + +EL L + I + + + Y
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY--- 400
Query: 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG 197
+ + T + + F V ++++VL A LT +
Sbjct: 401 -EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC- 457
Query: 198 NFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257
+ L + L+ N L + LA LEVL + N+ ++ ++
Sbjct: 458 HLEQLLLVTHLDLSHNRLRALPPA-------LAALRCLEVLQASDNAL-----ENVDGVA 505
Query: 258 --THLRRLTMGEN-LMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKL 308
L+ L + N L + + L LL L+GN+L + RL ++
Sbjct: 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 46/284 (16%), Positives = 89/284 (31%), Gaps = 39/284 (13%)
Query: 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQL 142
S + + + IP++L + I + + ++QN +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 143 HGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSL 202
+ DV LP L + + A+NL ++ P F +L
Sbjct: 67 LEVIEADVFSNLPKLHE-------------IRIEKANNLLYIN----------PEAFQNL 103
Query: 203 KDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI-SIANLSTHLR 261
+L L + + + D++ + + +L + N + S LS
Sbjct: 104 PNLQYLLISNTGI--KHLPDVHKI----HSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157
Query: 262 RLTMGENLMHGNIPVGIGNLVNL-NLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320
L + +N + I N L L + NNL +V + L ++ +
Sbjct: 158 ILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216
Query: 321 LIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364
L L NL L + +P L L+ +L+
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 36/216 (16%), Positives = 75/216 (34%), Gaps = 28/216 (12%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
IP L N L F L G F DL ++ QN++ I F
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV-IEADVF---- 75
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLS-------THLRRLTMGENLMHGNIPVGI-GNL 281
+N L + + + + ++ ++ +L+ L + + ++P +
Sbjct: 76 SNLPKLHEIRIEKAN-------NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 282 VNLNLLGLEGNNLSGSVPEVI--GRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE 339
+ LL ++ N ++ G + L LN N + S+ + +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187
Query: 340 NRLEGSIPP-SLGNCQKLLVLNLSSNDLNGTIPKEV 374
N LE +P ++L++S ++ ++P
Sbjct: 188 NNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 30/134 (22%), Positives = 60/134 (44%), Gaps = 5/134 (3%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
++ + L +N+ P + + LRR+ + N + + L +LN L L G
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPY-KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-SL 350
N ++ + L L+ L LN NK + L + +L L L + +N+L+ +I +
Sbjct: 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 351 GNCQKLLVLNLSSN 364
+ + ++L+ N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 33/173 (19%), Positives = 57/173 (32%), Gaps = 37/173 (21%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
IP +L + + +N + PG F K L R++ N++ L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL--- 79
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLG 288
SL L L N ++T +P + L +L LL
Sbjct: 80 ---RSLNSLVLYGN------------------KIT--------ELPKSLFEGLFSLQLLL 110
Query: 289 LEGNNLSGSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
L N ++ + L+ L L L NK + + L + + + +N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 9/134 (6%)
Query: 113 LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172
L N I I P + + ++ NQ+ +L D L +L N T +P
Sbjct: 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELP 96
Query: 173 VSL-SNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
SL +LQ+L N + F L +L L+ N+L + G + L
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL----- 151
Query: 232 CTSLEVLGLARNSF 245
+++ + LA+N F
Sbjct: 152 -RAIQTMHLAQNPF 164
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 28/161 (17%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILRVITAC 454
IG G+FG + G L VAIK+ ++ + E K I +V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSVIQRLNIAIDVASALDY 512
+ A+V E L PS + + + S+ L IAI + S ++Y
Sbjct: 75 PC-----GKYNAMVLEL---------LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTA-----HVGDFGLAK 548
+H + + D+KP N L+ + H+ DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 4/134 (2%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
L L N F I LR++ N + +I G +N + L
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-SL 350
N L ++ L L+ L L N+ + + S L+ + L + +N++ ++ P +
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 351 GNCQKLLVLNLSSN 364
L LNL +N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 32/206 (15%), Positives = 64/206 (31%), Gaps = 42/206 (20%)
Query: 367 NGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT---------LGDGTIVA 417
+ T E +G +D S + ++ + G +Y+ +
Sbjct: 22 SMTTSLEALPTGTVLTDKSGR--QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFS 79
Query: 418 IKV----------LKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467
+K+ Q+ A +++ L ST I + + ++ L
Sbjct: 80 LKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFL 135
Query: 468 VFEFMSNGNLDQWLHPSPAEHYQF---KKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524
V L S LS L +A + AL++LH + H
Sbjct: 136 VLPS---------LGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHG 183
Query: 525 DLKPSNVLLDKDMTAHV--GDFGLAK 548
++ N+ +D + + V +G A
Sbjct: 184 NVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 45/241 (18%), Positives = 85/241 (35%), Gaps = 59/241 (24%)
Query: 396 LIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID----ECNALKSTRHR----- 445
+G G+FG V + + A+KV++ +K + E + LK ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 446 NILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
NI++ + L+FE + +L + + + +
Sbjct: 97 NIVKY--------HGKFMYYDHMCLIFEPLGP-SLYEII-----TRNNYNGFHIEDIKLY 142
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
I++ AL+YL + H DLKP N+LLD + T
Sbjct: 143 CIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 563 VSIGLK----GSIGYIPPEHMNGQVS---------ILG-------DIYSYGILLLEMFTG 602
G+K G + ++ ++ IL D++S+G +L E++TG
Sbjct: 200 ---GIKLIDFGCATFK-SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 603 K 603
Sbjct: 256 S 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 42/246 (17%), Positives = 87/246 (35%), Gaps = 73/246 (29%)
Query: 396 LIGTGSFGSVYKG--TLGDGTIVAIKVLKLQQQGALKSFID----ECNALKSTRHR---- 445
+G G+FG V + + VA+K+++ + + + E N LK + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKEN 80
Query: 446 --NILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
+ + + +F + FE + N ++L + F+ +
Sbjct: 81 KFLCVLM--------SDWFNFHGHMCIAFELLGK-NTFEFL-----KENNFQPYPLPHVR 126
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK- 559
++A + AL +LH + + H DLKP N+L + + + + + +
Sbjct: 127 HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 560 ---------NQTVSIGLKGSIGYI------PPEHMNGQVSILG-------DIYSYGILLL 597
++ + + PPE V IL D++S G +L
Sbjct: 184 ADFGSATFDHEHHT-------TIVATRHYRPPE-----V-ILELGWAQPCDVWSIGCILF 230
Query: 598 EMFTGK 603
E + G
Sbjct: 231 EYYRGF 236
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 33/147 (22%), Positives = 59/147 (40%), Gaps = 8/147 (5%)
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEG 291
+ +L L+ N+ T+L L + N ++ I + NL L L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP--- 348
N+L + L LE L L N + ++ ++ L +L++ +N++ P
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 349 -SLGNCQKLLVLNLSSNDLNGTIPKEV 374
KL++L+LSSN L +P
Sbjct: 157 KDGNKLPKLMLLDLSSNKLK-KLPLTD 182
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 37/202 (18%), Positives = 60/202 (29%), Gaps = 41/202 (20%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKF 228
++P SL S +LD + N L+ L +L L N L
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE------A 83
Query: 229 LANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLL 287
+L L L+ N L + + +L L +L
Sbjct: 84 FVPVPNLRYLDLSSN------------------HLH--------TLDEFLFSDLQALEVL 117
Query: 288 GLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP---SSLGNLTILTRLWMEENRLEG 344
L N++ + +L+ L L+ N+ S L L L + N+L+
Sbjct: 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 345 SIPPSLGNCQKL--LVLNLSSN 364
L L L +N
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 41/219 (18%), Positives = 77/219 (35%), Gaps = 57/219 (26%)
Query: 3 LIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
L +P+ L T L+L++N L + LR+ + LT L
Sbjct: 30 LPNVPQSLPSYTALLDLSHNNL-----------SRLRAEWT------------PTRLTNL 66
Query: 61 EIIGLGGSNLTGNVPAWIGNFS---SLKALSLAWNNLRGSIPNE-LGQLSGLGFFTLYGN 116
+ L ++L + + F +L+ L L+ N+L ++ L L LY N
Sbjct: 67 HSLLLSHNHLN-FISS--EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122
Query: 117 FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLS 176
I + ++ +++ + ++QNQ+ + P ++ L
Sbjct: 123 HIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL------------------- 162
Query: 177 NASNLQVLDFAENGLTGTIPGNFGSLKDLVR--LNFDQN 213
L +LD + N L + L V+ L N
Sbjct: 163 --PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 34/163 (20%)
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
+N Q+L +N +T PG F SL +L L N+LG+ +G + L T L VL
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL------TQLTVL 93
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGS 297
L N +LT +P + LV+L L + N L+
Sbjct: 94 DLGTN------------------QLT--------VLPSAVFDRLVHLKELFMCCNKLT-E 126
Query: 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
+P I RL L L L+ N+ + + L+ LT ++ N
Sbjct: 127 LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGRLNKLEGLG 312
A + T+ + L + +N + P +L+NL L L N L ++P V L +L L
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366
L N+ + L + L L L+M N+L +P + L L L N L
Sbjct: 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 38/153 (24%), Positives = 51/153 (33%), Gaps = 34/153 (22%)
Query: 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLN 224
N T P + NL+ L N L G F SL L L+ N+L +
Sbjct: 50 NQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFD 109
Query: 225 FLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNL 284
L L+ L + N +LT +P GI L +L
Sbjct: 110 RL------VHLKELFMCCN------------------KLT--------ELPRGIERLTHL 137
Query: 285 NLLGLEGNNLSGSVPE-VIGRLNKLEGLGLNVN 316
L L+ N L S+P RL+ L L N
Sbjct: 138 THLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 26/159 (16%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILRVITAC 454
IG+GSFG +Y GT + G VAIK+ ++ + E K + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSVIQRLNIAIDVASALDY 512
+ D+ +V E L PS + + F +K S+ L +A + S ++Y
Sbjct: 75 AE-----GDYNVMVMEL---------LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAH---VGDFGLAK 548
+H H D+KP N L+ + + DFGLAK
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 35/196 (17%), Positives = 68/196 (34%), Gaps = 17/196 (8%)
Query: 179 SNLQVLDFAENGLTGTIPGN-FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEV 237
+ Q L E L TIP + F +L ++ R+ + + L F N + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID----VTLQQLESHSF-YNLSKVTH 84
Query: 238 LGLARNSFGGEMPISI-ANLSTHLRRLTMGENLMHGNIP--VGIGNLVNLNLLGLEGNNL 294
+ + + L L+ L + + P + + +L + N
Sbjct: 85 IEIRNTRNLTYIDPDALKEL-PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY 142
Query: 295 SGSVPE--VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSL-- 350
S+P G N+ L L N F+ + N T L +++ +N+ I
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
Query: 351 GNCQKLLVLNLSSNDL 366
G +L++S +
Sbjct: 202 GVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 33/208 (15%), Positives = 73/208 (35%), Gaps = 15/208 (7%)
Query: 12 TQDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVGQIPNQL-SSLTKLEIIGLGGSN 69
TQ L L +L IP++ S+ + S++ + Q+ + +L+K+ I + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 70 LTGNVPA-WIGNFSSLKALSLAWNNLRGSIPNE--LGQLSGLGFFTLYGN-FISGIIPSS 125
+ + LK L + L+ P+ + + N +++ I ++
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 126 IYNISS-IYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SLSNA-SNLQ 182
+ + + N + L N + I + S
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 183 VLDFAENGLTGTIPGN-FGSLKDLVRLN 209
+LD ++ +T +P LK+L+ N
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 41/246 (16%), Positives = 85/246 (34%), Gaps = 73/246 (29%)
Query: 396 LIGTGSFGSVYKG--TLGDGTIVAIKVLKLQQQGALKSFID----ECNALKSTRHR---- 445
+G G+FG V + G VA+K++K + + + E L+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 446 --NILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
+++ LE + +VFE + + ++ + F +
Sbjct: 76 TFRCVQM--------LEWFEHHGHICIVFELLGL-STYDFI-----KENGFLPFRLDHIR 121
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK- 559
+A + ++++LH + + H DLKP N+L + + + + + + K
Sbjct: 122 KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 560 ---------NQTVSIGLKGSIGYI------PPEHMNGQVSILG-------DIYSYGILLL 597
++ S + PE V IL D++S G +L+
Sbjct: 179 VDFGSATYDDEHHS-------TLVSTRHYRAPE-----V-ILALGWSQPCDVWSIGCILI 225
Query: 598 EMFTGK 603
E + G
Sbjct: 226 EYYLGF 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 28/161 (17%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILRVITAC 454
IG GSFG +++GT L + VAIK + DE K I V
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSVIQRLNIAIDVASALDY 512
LV + L PS + +K SV A + + +
Sbjct: 76 QE-----GLHNVLVIDL---------LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTA-----HVGDFGLAK 548
+H + + D+KP N L+ + + +V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 62/307 (20%), Positives = 104/307 (33%), Gaps = 44/307 (14%)
Query: 97 SIPNELGQLSGLGFFT------LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDV 150
++P + Q+ F L ++ + ++SI + + V
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSV 61
Query: 151 -GL-TLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRL 208
G+ LPN+ N T I L+N NL L EN + + LK L L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSL 117
Query: 209 NFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS-IANLS--THLRRLTM 265
+ + N + + L + LE L L N I+ I LS T L L++
Sbjct: 118 SLEHNGISD--------INGLVHLPQLESLYLGNNK------ITDITVLSRLTKLDTLSL 163
Query: 266 GENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS 325
+N + +I + L L L L N++S + L L+ L L + +
Sbjct: 164 EDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINH 219
Query: 326 LGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDIS 385
NL + + + L P + + N+ + T EV I
Sbjct: 220 QSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFT--NEVSFIFYQPVTIG 275
Query: 386 KSTDNFS 392
K+ F
Sbjct: 276 KAKARFH 282
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 36/217 (16%), Positives = 75/217 (34%), Gaps = 39/217 (17%)
Query: 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG 72
+ + + + + + + + N + I L++L L + L + +
Sbjct: 49 DQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK-LTDIKP-LANLKNLGWLFLDENKVKD 104
Query: 73 NVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
+ + LK+LSL N + I L L L L N I+ I + + ++ +
Sbjct: 105 LSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKL 158
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
S+ NQ+ +D+ L+ + LQ L ++N ++
Sbjct: 159 DTLSLEDNQI-----SDIV----------------------PLAGLTKLQNLYLSKNHIS 191
Query: 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
+ LK+L L E ++ I + L
Sbjct: 192 -DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 41/230 (17%), Positives = 72/230 (31%), Gaps = 37/230 (16%)
Query: 174 SLSNASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSRE----IGDLNF 225
L +++ + + N + + N S KDL F G +
Sbjct: 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86
Query: 226 LKFLANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGEN-------------L 269
L+ L C L + L+ N+FG + + T L L + N L
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 270 MHGNIPVGIGNLVNLNLLGLEGNNL-SGSVP---EVIGRLNKLEGLGLNVNKF-----SG 320
+ N L + N L +GS+ + L + + N
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 321 LIPSSLGNLTILTRLWMEENRL--EG--SIPPSLGNCQKLLVLNLSSNDL 366
L+ L L L +++N G ++ +L + L L L+ L
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 27/198 (13%), Positives = 58/198 (29%), Gaps = 36/198 (18%)
Query: 203 KDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANL---STH 259
+ + + + + + + L S++ + L+ N+ G E ++
Sbjct: 4 FSIEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 260 LRRLTMGEN---LMHGNIPVGIGNLV-------NLNLLGLEGNNLSGSVPEVIGRL---- 305
L + + IP + L+ L+ + L N + E +
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 306 NKLEGLGLNVNKFS-------------GLIPSSLGNLTILTRLWMEENRLEG----SIPP 348
LE L L+ N + N L + NRLE
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 349 SLGNCQKLLVLNLSSNDL 366
+ + + L + + N +
Sbjct: 182 TFQSHRLLHTVKMVQNGI 199
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 40/164 (24%), Positives = 61/164 (37%), Gaps = 19/164 (11%)
Query: 174 SLSNASNLQVLDFAENGLTG----TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
NA L+ + N L F S + L + QN + I L L+ L
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL-LLEGL 212
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGN----IPVGIGNLV 282
A C L+VL L N+F ++A +LR L + + L+ + L
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 283 NLNL--LGLEGNNLSGSVPEVIGR-----LNKLEGLGLNVNKFS 319
N+ L L L+ N + + + L L LN N+FS
Sbjct: 273 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 45/230 (19%), Positives = 71/230 (30%), Gaps = 40/230 (17%)
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSL----KDLVRLNFDQNELG-------SREIGD 222
+L L + ++N T L L N LG +R + +
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 223 LNFLKFLANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGNIPVGIG 279
L K N L + RN A L + M +N + P GI
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR---PEGIE 205
Query: 280 NLV--------NLNLLGLEGNNLSG----SVPEVIGRLNKLEGLGLNVNKFSG----LIP 323
+L+ L +L L+ N + ++ + L LGLN S +
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 324 SSLGNL--TILTRLWMEENRLEGSIPPSLG-----NCQKLLVLNLSSNDL 366
+ L L L ++ N +E +L LL L L+ N
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 26/159 (16%)
Query: 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITAC 454
IG+GSFG +Y GT + VAIK+ ++ + + E + + I V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQF--KKLSVIQRLNIAIDVASALDY 512
D+ LV + L PS + + F +KLS+ L +A + + +++
Sbjct: 73 VE-----GDYNVLVMDL---------LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAH---VGDFGLAK 548
+H H D+KP N L+ A+ + DFGLAK
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 49/257 (19%), Positives = 86/257 (33%), Gaps = 57/257 (22%)
Query: 397 IGTGSFGSVYKG-TLGDGTIVAIKVLKLQQQGALKSFIDECNALK-----STRHRNILRV 450
+G G F +V+ + VA+KV+K + ++ +DE LK N V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 451 ITACSSVDLEGNDFK--ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+ + G + +VFE + + +L +W+ ++ L + I V
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWI-----IKSNYQGLPLPCVKKIIQQVLQ 157
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVGDFGLAKFLFE--ISDNPSKNQTV 563
LDYLH C I H D+KP N+LL ++ + + + S +
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 564 SIGLKGSIGYIPPEHMNGQVS----------------------------ILG-------D 588
+ G P +V ++G D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 589 IYSYGILLLEMFTGKRP 605
I+S + E+ TG
Sbjct: 276 IWSTACMAFELATGDYL 292
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 35/196 (17%)
Query: 182 QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLA 241
+ + +T + N L + ++ + +++ S + ++ L L
Sbjct: 22 IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--------YLPNVRYLALG 71
Query: 242 RNSFGGEMPISIANLS-----THLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLS 295
N + ++S T+L L + N ++P G+ L NL L L N L
Sbjct: 72 GNK--------LHDISALKELTNLTYLILTGN-QLQSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 296 GSVPE-VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP----SL 350
S+P+ V +L L L L N+ L LT LT L + N+L+ S+P L
Sbjct: 123 -SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 351 GNCQKLLVLNLSSNDL 366
+ L L N L
Sbjct: 181 TQLKD---LRLYQNQL 193
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 46/224 (20%), Positives = 72/224 (32%), Gaps = 42/224 (18%)
Query: 176 SNASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
+ + +Q L LTG + +L L L+ N LG + L L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLL-CEGLLDP 140
Query: 232 CTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGNIPVGIG--------- 279
LE L L S +A++ + LT+ N I
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN--------DINEAGVRVLCQ 192
Query: 280 ----NLVNLNLLGLEGNNLS----GSVPEVIGRLNKLEGLGLNVNKFSG-----LIPSSL 326
+ L L LE ++ + ++ L L L NK L P L
Sbjct: 193 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252
Query: 327 GNLTILTRLWMEENRLE----GSIPPSLGNCQKLLVLNLSSNDL 366
+ L LW+ E + G + L + L L+L+ N+L
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 41/221 (18%), Positives = 67/221 (30%), Gaps = 34/221 (15%)
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSL----KDLVRLNFDQNELGSREIGDLNFLKFLA 230
L L+ L L+ S+ D L N++ G + L
Sbjct: 138 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA--GVRVLCQGLK 195
Query: 231 NCT-SLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGNIPVGIGNLV---- 282
+ LE L L + + + LR L +G N + G+ L
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV---GMAELCPGLL 252
Query: 283 ----NLNLLGLEGNNLS----GSVPEVIGRLNKLEGLGLNVNKFS-----GLIPSSLGNL 329
L L + ++ G + V+ L+ L L N+ L + L
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 330 TILTRLWMEENRL--EG--SIPPSLGNCQKLLVLNLSSNDL 366
L LW++ L + LL L +S+N L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 37/216 (17%), Positives = 75/216 (34%), Gaps = 26/216 (12%)
Query: 176 SNASNLQVLDFAENGLT----GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231
+ L+ L G+T + G S L L N+LG + +L L
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL-CPGLLHP 254
Query: 232 CTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGNIPVGIGNLV-----N 283
+ L L + + + + L+ L++ N + + +
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 284 LNLLGLEGNNLSG----SVPEVIGRLNKLEGLGLNVNKF--SGLIPSSLG---NLTILTR 334
L L ++ + + V+ + L L ++ N+ +G+ G ++L
Sbjct: 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374
Query: 335 LWMEENRL--EG--SIPPSLGNCQKLLVLNLSSNDL 366
LW+ + + S+ +L L L+LS+N L
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 36/203 (17%), Positives = 60/203 (29%), Gaps = 36/203 (17%)
Query: 179 SNLQVLDFAENGLTGT-IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEV 237
++Q LD L+ L+ + D L D++ L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60
Query: 238 LGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS-- 295
L L N G + + L + + L L+ L+
Sbjct: 61 LNLRSNELGDVGVHCVL------------QGLQTPS--------CKIQKLSLQNCCLTGA 100
Query: 296 --GSVPEVIGRLNKLEGLGLNVNKFSG-----LIPSSLGNLTILTRLWMEENRL--EG-- 344
G + + L L+ L L+ N L L L +L +E L
Sbjct: 101 GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160
Query: 345 SIPPSLGNCQKLLVLNLSSNDLN 367
+ L L +S+ND+N
Sbjct: 161 PLASVLRAKPDFKELTVSNNDIN 183
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333
+P GI ++ L L+GN + VP+ + L + L+ N+ S L S N+T L
Sbjct: 25 LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 334 RLWMEENRLEGSIPP----SLGNCQKLLVLNLSSNDLNGTIPK 372
L + NRL IPP L + L +L+L ND++ +P+
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKS---LRLLSLHGNDIS-VVPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 2/92 (2%)
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333
+P + N +L L+ L N +S + + +L L L+ N+ + P + L L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR 105
Query: 334 RLWMEENRLEGSIPP-SLGNCQKLLVLNLSSN 364
L + N + +P + + L L + +N
Sbjct: 106 LLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 32/118 (27%), Positives = 44/118 (37%), Gaps = 10/118 (8%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE-VIGRLNKLEGLG 312
+ L + N + L +L L L GN L S+P V +L L L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP----SLGNCQKLLVLNLSSNDL 366
L+ N+ L LT L L + N+L+ S+P L L L L N L
Sbjct: 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQL 136
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 48/272 (17%), Positives = 89/272 (32%), Gaps = 36/272 (13%)
Query: 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113
L LG ++T V S ++ + +N++ S+ + + L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDV-GLTLPNLKIFAGAVNYFTGSIP 172
N IS + S + +++ + SV +N+L ++ G+ L N
Sbjct: 71 SHNQISDL--SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR-DTD 122
Query: 173 VSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANC 232
SL + NL++L N L +I G L L L+ NE+ + L
Sbjct: 123 -SLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--------TGGLTRL 171
Query: 233 TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENL--MHGNI--PVGIGNLVNLNLLG 288
+ + L + + L + + G P I N +
Sbjct: 172 KKVNWIDLTGQ------KCVNEPV-KYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
Query: 289 LEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320
+ L EV + ++ +G F G
Sbjct: 225 VL-WELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 29/146 (19%), Positives = 60/146 (41%), Gaps = 16/146 (10%)
Query: 223 LNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS--THLRRLTMGENLMHGNIPVGIGN 280
+N + + L + S + + + ++ + + ++ G+
Sbjct: 9 INQVFPDPGLANAVKQNLGKQSVT-----DLVSQKELSGVQNFNGDNSNIQ-SLA-GMQF 61
Query: 281 LVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
NL L L N +S + L KLE L +N N+ L + + + L+RL+++ N
Sbjct: 62 FTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNRLKNL--NGIPSAC-LSRLFLDNN 116
Query: 341 RLEGSIPPSLGNCQKLLVLNLSSNDL 366
L SL + + L +L++ +N L
Sbjct: 117 EL--RDTDSLIHLKNLEILSIRNNKL 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 49/315 (15%), Positives = 97/315 (30%), Gaps = 75/315 (23%)
Query: 78 IGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137
++ +L ++ + + +LSG+ F + I + + + +++ +
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG 197
+ NQ+ +D+ L + + L+ L N L + G
Sbjct: 71 SHNQI-----SDLS----------------------PLKDLTKLEELSVNRNRLK-NLNG 102
Query: 198 NFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257
L RL D NEL L + +LE+L + N + ++
Sbjct: 103 --IPSACLSRLFLDNNELRD--------TDSLIHLKNLEILSIRNN--------KLKSIV 144
Query: 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNK 317
+G L L +L L GN + + + RL K+ + L K
Sbjct: 145 -------------------MLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQK 183
Query: 318 FSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQS 377
L I + + R P + N + + T EV
Sbjct: 184 CVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVYT--DEVSYK 239
Query: 378 GMSYSDISKSTDNFS 392
Y ++ ++ F
Sbjct: 240 FSEYINVGETEAIFD 254
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 29/113 (25%), Positives = 49/113 (43%), Gaps = 3/113 (2%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
++ H L + +N + G+ G L +L L L+ N L+G P + ++ L
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP-SLGNCQKLLVLNLSSN 364
L NK + L L L + +N++ + P S + L LNL+SN
Sbjct: 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 4/85 (4%)
Query: 292 NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEGSIPP-S 349
+ + + L L + + + L L L L + ++ L + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 350 LGNCQKLLVLNLSSNDLNGTIPKEV 374
+L LNLS N L ++ +
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKT 99
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 19/117 (16%), Positives = 38/117 (32%), Gaps = 8/117 (6%)
Query: 230 ANCT---SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVG-IGNLVNLN 285
C S + + + + +L L + ++ + + L L
Sbjct: 3 DACCPHGSSGLRCTRDGAL--DSLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELR 59
Query: 286 LLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRL 342
L + + L P+ +L L L+ N L ++ L+ L L + N L
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 49/282 (17%), Positives = 94/282 (33%), Gaps = 26/282 (9%)
Query: 105 LSGLGFFTLYGNFISGIIPSSIYNISSI--YYFSVTQNQLHGQLPTDVGLTL-----PNL 157
L G F + G I ++ Y + + +L + TD L L N
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 158 KI--FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSL----KDLVRLNFD 211
K+ + + T + + NL+ LD E+ + LV LN
Sbjct: 133 KVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS 192
Query: 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG----- 266
+ E+ + + C +L+ L L R ++ ++ + L L G
Sbjct: 193 C---LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKL-ATLLQRAPQLEELGTGGYTAE 248
Query: 267 -ENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS--GLIP 323
++ + V + L L + + +P V ++L L L+ L+
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV- 307
Query: 324 SSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND 365
L L RLW+ + + + C+ L L + ++
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSE 349
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 39/234 (16%), Positives = 65/234 (27%), Gaps = 25/234 (10%)
Query: 148 TDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFG-SLKDLV 206
D L Y I S+ + L+ + +T S K+
Sbjct: 80 ADFNLVPDGWG------GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133
Query: 207 RLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG 266
L A C +L+ L L + +++ L
Sbjct: 134 VLVLS----SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV-S 188
Query: 267 ENLMHGNIPVGIGNLVNL--NLLGLEGNNLSGSVP-----EVIGRLNKLEGLGLNV---- 315
N+ V L L L+ L+ +VP ++ R +LE LG
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 316 --NKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
+ +L L L + + +P C +L LNLS +
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 23/125 (18%), Positives = 42/125 (33%), Gaps = 13/125 (10%)
Query: 242 RNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV 301
+ + L ++ + ENL L + + N + +
Sbjct: 10 EQAAQYTNAVRDRELDLRGYKIPVIENLGA--------TLDQFDAIDFSDNEIR--KLDG 59
Query: 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE--GSIPPSLGNCQKLLVL 359
L +L+ L +N N+ + L LT L + N L G + P L + + L L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYL 118
Query: 360 NLSSN 364
+ N
Sbjct: 119 CILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 3/91 (3%)
Query: 277 GIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLW 336
N V L L G + + + L++ + + + N+ L L L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70
Query: 337 MEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
+ NR+ L L L++N L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 30/121 (24%), Positives = 52/121 (42%), Gaps = 13/121 (10%)
Query: 248 EMPISIANLSTHLRRLTMGENLMHGNIPV--GIGNLVNLNLLGLEGNNLSGSVPEVIGRL 305
+M +++ L + L + N NI + + NL +L L N + + +
Sbjct: 39 KMDATLSTL-KACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 306 NKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE--GSIPPSLGNCQKLLVLNLSS 363
+ LE L ++ N+ + L S + L L L+M N++ G I L KL L L+
Sbjct: 93 DTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAG 149
Query: 364 N 364
N
Sbjct: 150 N 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 11/124 (8%)
Query: 229 LANCTSLEVLGLARNSFGGEMPISIANLS--THLRRLTMGENLMHGNIPVGIGNLVNLNL 286
L+ + + L L+ N+ I++LS +LR L++G NL+ I L
Sbjct: 44 LSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97
Query: 287 LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP-SSLGNLTILTRLWMEENRLEGS 345
L + N ++ I +L L L ++ NK + L L L L + N L
Sbjct: 98 LWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155
Query: 346 IPPS 349
+
Sbjct: 156 YKEN 159
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 10/97 (10%)
Query: 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILT 333
+P GI + L LE N L V +L +L L L+ N+ L LT LT
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 334 RLWMEENRLEGSIPP----SLGNCQKLLVLNLSSNDL 366
L++ EN+L+ S+P L L L L +N L
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQ---LKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 36/140 (25%), Positives = 54/140 (38%), Gaps = 35/140 (25%)
Query: 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
S+ L+ N L G F L L +L+ QN++ S G + L T L +L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKL------TKLTIL 81
Query: 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGS 297
L N +L ++P G+ L L L L+ N L S
Sbjct: 82 YLHEN------------------KLQ--------SLPNGVFDKLTQLKELALDTNQLK-S 114
Query: 298 VPE-VIGRLNKLEGLGLNVN 316
VP+ + RL L+ + L+ N
Sbjct: 115 VPDGIFDRLTSLQKIWLHTN 134
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 32/191 (16%), Positives = 64/191 (33%), Gaps = 24/191 (12%)
Query: 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLT 264
++F++ E+ E DL+ L L L + + +L+ L
Sbjct: 146 WGDIDFEEQEISWIEQVDLS--PVLDAMPLLNNLKIKGTNNLSIGKKP----RPNLKSLE 199
Query: 265 MGENLMHGNIPVGIG-----NLVNLNLLGLEGNNLSGSVPEVI------GRLNKLEGLGL 313
+ + ++ I NL L L + V R L+ LG+
Sbjct: 200 IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259
Query: 314 NVNKFSGLIPSSLGN---LTILTRLWMEENRL--EG--SIPPSLGNCQKLLVLNLSSNDL 366
+ ++ L L + + L EG + + + L +N+ N L
Sbjct: 260 VDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
Query: 367 NGTIPKEVRQS 377
+ + KE+++S
Sbjct: 320 SDEMKKELQKS 330
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 33/203 (16%), Positives = 62/203 (30%), Gaps = 18/203 (8%)
Query: 176 SNASNLQVLDFAENGLT--GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
+N L+ + F ++ DL L D L + +C
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDGLLSIVTHCR 164
Query: 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIG----------NLVN 283
++ L + +SF + + L+ H L + M + +LV+
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224
Query: 284 LNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343
+ + E L G + L + G LN + +L L RL +
Sbjct: 225 VKVGDFEILELVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283
Query: 344 GSIPPSLGNCQKLLVLNLSSNDL 366
+P ++ L+L L
Sbjct: 284 E-MPILFPFAAQIRKLDLLYALL 305
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 16/69 (23%), Positives = 31/69 (44%), Gaps = 5/69 (7%)
Query: 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234
L + L+ L+ ++N ++G + +L LN L +I DL+ ++ L +
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN-----LSGNKIKDLSTIEPLKKLEN 114
Query: 235 LEVLGLARN 243
L+ L L
Sbjct: 115 LKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/111 (22%), Positives = 38/111 (34%), Gaps = 4/111 (3%)
Query: 257 STHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVN 316
S+ + M + + L L + G + + LE L L
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNC--KSNDGKIEGLTAEFVNLEFLSLINV 59
Query: 317 KFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLN 367
+ S+L L L +L + ENR+ G + L LNLS N L
Sbjct: 60 GLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 37/224 (16%), Positives = 70/224 (31%), Gaps = 37/224 (16%)
Query: 176 SNASNLQVLDFAENGLTGTIPGNFGSL-----KDLVRLNFDQNELGSREIGDL-NFLKFL 229
+ +++ L+ + N L + ++ LN N L + +L L
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLA-- 105
Query: 230 ANCTSLEVLGLARNSFGGEMPISIA----NLSTHLRRLTMGENLMHGNIPVGIGNL---- 281
A ++ VL L N F + NL + L + N + L
Sbjct: 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQIL 162
Query: 282 --VNLNL--LGLEGNNLSGSVPEVIGRL-----NKLEGLGLNVNKF-----SGLIPSSLG 327
+ N+ L L GNNL+ + + + L L+ N + L
Sbjct: 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222
Query: 328 NLTILTRLWMEENRLEGS----IPPSLGNCQKLLVLNLSSNDLN 367
+ L + N L G + + + L + L + +
Sbjct: 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.93 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.64 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.47 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.51 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.85 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.71 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.68 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.4 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.04 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.08 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.18 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.26 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=415.97 Aligned_cols=270 Identities=29% Similarity=0.471 Sum_probs=210.2
Q ss_pred ccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
.+|....+++++.++||+|+||.||+|+++. .||||+++.. .....+.|.+|++++++++||||+++++++..
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--- 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--- 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---
Confidence 3455667889999999999999999999753 4899988643 24456789999999999999999999998632
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+. +||||||||+|||++.++.+
T Consensus 104 ---~~~~iVmEy~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~ 171 (307)
T 3omv_A 104 ---DNLAIVTQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTV 171 (307)
T ss_dssp ---SSCEEEEECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEE
T ss_pred ---CeEEEEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcE
Confidence 35799999999999999997543 5699999999999999999999997 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
||+|||+|+...... .........||+.|||||++. +.++.++|||||||++|||+||+.||.+......
T Consensus 172 Ki~DFGla~~~~~~~-----~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~- 245 (307)
T 3omv_A 172 KIGDFGLATVKSRWS-----GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ- 245 (307)
T ss_dssp EECCCSSCBC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-
T ss_pred EEeeccCceecccCC-----cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-
Confidence 999999998652211 112234467999999999974 3489999999999999999999999976433211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
....+... ...+.... .+.+|+..+.+++.+||+.+|++||||
T Consensus 246 ~~~~~~~~-------~~~p~~~~------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~ 288 (307)
T 3omv_A 246 IIFMVGRG-------YASPDLSK------------------------------LYKNCPKAMKRLVADCVKKVKEERPLF 288 (307)
T ss_dssp HHHHHHTT-------CCCCCSTT------------------------------SCTTSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred HHHHHhcC-------CCCCCccc------------------------------ccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 11111111 11111110 123456778999999999999999999
Q ss_pred HHHHHHHHHHHHHHHh
Q 005045 696 NVVVNNLKTIRNCFLE 711 (717)
Q Consensus 696 ~eil~~l~~i~~~~~~ 711 (717)
+||++.|+.++..+++
T Consensus 289 ~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 289 PQILSSIELLQHSLPK 304 (307)
T ss_dssp HHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhccCCC
Confidence 9999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=417.61 Aligned_cols=266 Identities=25% Similarity=0.431 Sum_probs=206.1
Q ss_pred cccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...+|.+.++||+|+||.||+|+++ +++.||||+++.......+.|.+|++++++++||||++++++|.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 113 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT----- 113 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 3467889999999999999999853 57889999998766667788999999999999999999999964
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCc--------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEH--------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
+.+..++||||+++|+|.++++...... .....+++.++..++.||+.||+|||+. +|+||||||+|||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NIL 190 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCL 190 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEE
Confidence 4458999999999999999997643211 1225689999999999999999999997 9999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMF 610 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~ 610 (717)
++.++.+||+|||+|+..... ..........||+.|+|||++.+ .++.++|||||||++|||+| |+.||....
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~-----~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYST-----DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EETTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred ECCCCcEEEcccccceeccCC-----CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999865221 11222234568999999999665 58999999999999999999 999997642
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
..+ ....+... . .. +.+..|+..+.+++.+||+.||+
T Consensus 266 ~~~--~~~~i~~g--------~--~~-------------------------------~~p~~~~~~~~~li~~cl~~dP~ 302 (329)
T 4aoj_A 266 NTE--AIDCITQG--------R--EL-------------------------------ERPRACPPEVYAIMRGCWQREPQ 302 (329)
T ss_dssp HHH--HHHHHHHT--------C--CC-------------------------------CCCTTCCHHHHHHHHHHCCSSTT
T ss_pred HHH--HHHHHHcC--------C--CC-------------------------------CCcccccHHHHHHHHHHcCcChh
Confidence 211 11111100 0 00 11233467789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~ 708 (717)
+||||+||++.|+.+.+.
T Consensus 303 ~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 303 QRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TSCCHHHHHHHHHHHHHS
T ss_pred HCcCHHHHHHHHHHHhhC
Confidence 999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=414.49 Aligned_cols=267 Identities=25% Similarity=0.440 Sum_probs=210.6
Q ss_pred cccccccccccCcccccceEEEEeC------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|.+.++||+|+||.||+|++. +++.||||+++.......+.|.+|++++++++||||++++++|.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----
Confidence 3468999999999999999999853 47789999998666666788999999999999999999999964
Q ss_pred CCceEEEEEecCCCCChhhhccCCCC------CcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPA------EHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
+++..++||||+++|+|.++++.... .......+++..+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 162 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEEC
Confidence 44589999999999999999975321 001225699999999999999999999997 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.++.+||+|||+|+...... .........||+.|+|||++. +.++.++|||||||++|||+| |+.||.+....
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~-----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGG-----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CCCcEEECCcccceecCCCC-----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999998762221 111223356899999999965 569999999999999999999 99999764321
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
+ ....+.. .... +.+..|+.++.+++.+||+.+|++|
T Consensus 238 ~--~~~~i~~-----------~~~~------------------------------~~p~~~~~~~~~li~~cl~~dP~~R 274 (299)
T 4asz_A 238 E--VIECITQ-----------GRVL------------------------------QRPRTCPQEVYELMLGCWQREPHMR 274 (299)
T ss_dssp H--HHHHHHH-----------TCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred H--HHHHHHc-----------CCCC------------------------------CCCccchHHHHHHHHHHcCCChhHC
Confidence 1 1111110 0000 0123346778999999999999999
Q ss_pred CCHHHHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 693 ps~~eil~~l~~i~~~~ 709 (717)
|||+||++.|+.+.+.-
T Consensus 275 Ps~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 275 KNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CCHHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHhcC
Confidence 99999999999887653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=405.57 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=199.7
Q ss_pred ccc-ccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNF-SKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y-~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++| ++.++||+|+||.||+|.++ +++.||+|.+... .....+++.+|++++++++||||+++++++... ......
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcE
Confidence 344 67788999999999999965 7899999998643 234467899999999999999999999987543 123457
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeC-CCCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNVLLD-KDMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl 541 (717)
.|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++ + |+||||||+|||++ .+|.+||
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred EEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEE
Confidence 89999999999999999754 5789999999999999999999997 6 99999999999998 4799999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
+|||+|+.. .........||+.|+|||++.++++.++|||||||++|||+||+.||.+...... +...+.
T Consensus 174 ~DFGla~~~---------~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~ 243 (290)
T 3fpq_A 174 GDLGLATLK---------RASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVT 243 (290)
T ss_dssp CCTTGGGGC---------CTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHT
T ss_pred EeCcCCEeC---------CCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHH
Confidence 999999753 1122345679999999999999999999999999999999999999975422211 111111
Q ss_pred hcC-ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MAL-PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... |.. .+..++.++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~-----------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGVKPAS-----------------------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGG-----------------------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCC-----------------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100 000 01112445788999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=417.93 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=197.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
-++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 368999999999999999999965 7999999998644 234567899999999999999999999995 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECST
T ss_pred EEEEEeCCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccc
Confidence 9999999999999999964421 4579999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+.... .........||+.|+|||++.++ |+.++|||||||++|||++|+.||......+ .+..
T Consensus 170 Gla~~~~~-------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~----- 236 (350)
T 4b9d_A 170 GIARVLNS-------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLK----- 236 (350)
T ss_dssp TEESCCCH-------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-----
T ss_pred ccceeecC-------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-----
Confidence 99986521 11123446799999999998765 8999999999999999999999997542211 1111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+.....+.. +..++..+.+|+.+||+.||++|||++|+++
T Consensus 237 -------i~~~~~~~~------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 237 -------IISGSFPPV------------------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------HHHTCCCCC------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHcCCCCCC------------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111100 1112556789999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=412.05 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=204.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
....|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~ 146 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL 146 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 3467999999999999999999975 89999999997665555677889999999999999999999954 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 147 ~ivmEy~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EEEECCCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence 999999999999999864 4589999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+|+.+.. .........||+.|+|||++.+ .|+.++|||||||++|||++|..||.+... ......+...
T Consensus 216 la~~~~~-------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~- 285 (346)
T 4fih_A 216 FCAQVSK-------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDN- 285 (346)
T ss_dssp TCEECCS-------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHS-
T ss_pred CceecCC-------CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcC-
Confidence 9987521 1222345679999999999765 489999999999999999999999965321 1111111111
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+... ....++..+.+|+.+||+.||++|||++|+++
T Consensus 286 -------~~~~~~-------------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 -------LPPRLK-------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -------SCCCCS-------------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCCCCC-------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11223556789999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=410.01 Aligned_cols=270 Identities=23% Similarity=0.369 Sum_probs=209.0
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEE
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
...+.++. ..++++.++||+|+||.||+|.+. +++.||||.++... ....+.|.+|+.++++++||||+++
T Consensus 17 ~~~~~ei~--~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 17 QAKLKEIS--LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp --CCCBCC--GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCcccCC--HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 34455544 456778899999999999999852 56789999986442 3345789999999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 521 (717)
+++|. +++..++||||+++|+|.+++....... .....+++..+..++.|||.||+|||+. +|
T Consensus 95 ~g~~~-----~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~i 166 (308)
T 4gt4_A 95 LGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HV 166 (308)
T ss_dssp EEEEC-----SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ceEEE-----ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CC
Confidence 99964 3457899999999999999996542110 1125689999999999999999999998 99
Q ss_pred eecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHH
Q 005045 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMF 600 (717)
Q Consensus 522 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ell 600 (717)
|||||||+|||++.++.+||+|||+|+....... ........||+.|+|||++ .+.++.++|||||||++|||+
T Consensus 167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCccccceEECCCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 9999999999999999999999999987633221 1122345689999999995 456999999999999999999
Q ss_pred h-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 601 T-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 601 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
| |..||.+.... .....+. +.... +.+++|+..+.+
T Consensus 242 t~g~~Pf~~~~~~--~~~~~i~-----------~~~~~------------------------------~~p~~~~~~~~~ 278 (308)
T 4gt4_A 242 SYGLQPYCGYSNQ--DVVEMIR-----------NRQVL------------------------------PCPDDCPAWVYA 278 (308)
T ss_dssp TTTCCTTTTCCHH--HHHHHHH-----------TTCCC------------------------------CCCTTCCHHHHH
T ss_pred hCCCCCCCCCCHH--HHHHHHH-----------cCCCC------------------------------CCcccchHHHHH
Confidence 9 89999765321 1111111 11000 122345777899
Q ss_pred HhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 680 IGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 680 li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
++.+||+.+|++||||+||++.|+.+
T Consensus 279 li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 279 LMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=408.44 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=205.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..+.|++.++||+|+||.||+|+++ +|+.||||+++.... ..+|++++++++||||+++++++. +++..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 4567899999999999999999965 799999999875422 246999999999999999999954 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEeee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGDF 544 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Df 544 (717)
|+||||++||+|.++++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.+| .+||+||
T Consensus 126 ~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCC
T ss_pred EEEEeccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeC
Confidence 9999999999999999754 5799999999999999999999998 999999999999999988 6999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+....... ...........||+.|||||++.++ ++.++|||||||++|||++|..||.+........ ......
T Consensus 196 Gla~~~~~~~~--~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i~~~~ 272 (336)
T 4g3f_A 196 GHALCLQPDGL--GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEP 272 (336)
T ss_dssp TTCEEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HHHHSC
T ss_pred CCCeEccCCCc--ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HHHcCC
Confidence 99987522111 0111122335799999999997765 8999999999999999999999997654332211 111100
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
.+ . .+.+++++..+.+++.+||+.||++|||++|+++.+.
T Consensus 273 ~~--~--------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 273 PP--I--------------------------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp CG--G--------------------------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC--c--------------------------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 00 0 0012233667889999999999999999999999998
Q ss_pred HHHHHH
Q 005045 704 TIRNCF 709 (717)
Q Consensus 704 ~i~~~~ 709 (717)
...++.
T Consensus 313 ~~l~~~ 318 (336)
T 4g3f_A 313 KALQEV 318 (336)
T ss_dssp HHHHHT
T ss_pred HHHhhh
Confidence 887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=403.95 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=202.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|++++++++||||+++++++ ++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 467999999999999999999965 8999999998643 234467899999999999999999999994 5566
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||++||+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEE
Confidence 999999999999999999754 5799999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||+|+.+... ..........||+.|+|||++.++ ++.++||||+||++|+|++|..||...... .....
T Consensus 176 FGla~~~~~~-----~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~--- 245 (311)
T 4aw0_A 176 FGTAKVLSPE-----SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAK--- 245 (311)
T ss_dssp CTTCEECCTT-----TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH---
T ss_pred cCCceecCCC-----CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---
Confidence 9999876211 112233456799999999997664 899999999999999999999999653211 11111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+....... +...+.++.+|+.+||+.||++|||++|++.
T Consensus 246 --------i~~~~~~~-------------------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 246 --------IIKLEYDF-------------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --------HHHTCCCC-------------------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --------HHcCCCCC-------------------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11101100 0111445788999999999999999998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=449.17 Aligned_cols=356 Identities=31% Similarity=0.495 Sum_probs=258.8
Q ss_pred eecEEEcCCCcCcCCCCcCCcCC-CCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcc-ccCCCCCCEEe
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHC-TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAW-IGNFSSLKALS 88 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~ 88 (717)
.+++|+|++|++++.+|..++.+ ++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|.. +..+++|++|+
T Consensus 270 ~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~ 349 (768)
T 3rgz_A 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349 (768)
T ss_dssp TCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEE
T ss_pred CCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEe
Confidence 45555555555555555555443 55555555555555555555555555555555555555444433 55555555555
Q ss_pred ccCCcCcccCChhhhc---------------------------cCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCc
Q 005045 89 LAWNNLRGSIPNELGQ---------------------------LSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 89 L~~n~l~~~~~~~~~~---------------------------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 141 (717)
|++|++++.+|..+.. +++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 350 Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 429 (768)
T 3rgz_A 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429 (768)
T ss_dssp CCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSE
T ss_pred CcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCc
Confidence 5555555444444444 4456666666666666677777777778888888887
Q ss_pred ccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccC
Q 005045 142 LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIG 221 (717)
Q Consensus 142 l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 221 (717)
+++.+|..+. .+++|+.|++++|.+.+.+|..+..+++|++|++++|++++.+|..|..+++|+.|++++|+++...
T Consensus 430 l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-- 506 (768)
T 3rgz_A 430 LSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI-- 506 (768)
T ss_dssp EESCCCGGGG-GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC--
T ss_pred ccCcccHHHh-cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC--
Confidence 7766665543 6778888888888887777777888888888888888888777777888888888888888887654
Q ss_pred chhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCcc------------------------
Q 005045 222 DLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVG------------------------ 277 (717)
Q Consensus 222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~------------------------ 277 (717)
|.++..+++|++|+|++|.+++.+|..+..+ ++|+.|++++|.+.+.+|..
T Consensus 507 ----p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (768)
T 3rgz_A 507 ----PKWIGRLENLAILKLSNNSFSGNIPAELGDC-RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581 (768)
T ss_dssp ----CGGGGGCTTCCEEECCSSCCEEECCGGGGGC-TTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECC
T ss_pred ----ChHHhcCCCCCEEECCCCcccCcCCHHHcCC-CCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccc
Confidence 6677788888888888888888888888777 47888888888877665543
Q ss_pred ----------------------------------------------ccCCCCCCEEEccCCcCccccchhhhcCCCCCeE
Q 005045 278 ----------------------------------------------IGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGL 311 (717)
Q Consensus 278 ----------------------------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 311 (717)
+..+++|+.|||++|++++.+|..++.++.|+.|
T Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 661 (768)
T 3rgz_A 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661 (768)
T ss_dssp SCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEE
T ss_pred cccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEE
Confidence 3345678888888888888888888888889999
Q ss_pred EcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCccc
Q 005045 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 312 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
+|++|++++.+|..|+++++|+.|||++|+++|.+|..+..+++|+.||+++|+++|.+|+.-
T Consensus 662 ~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~ 724 (768)
T 3rgz_A 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724 (768)
T ss_dssp ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSS
T ss_pred eCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCch
Confidence 999999988888888888899999999999988888888888889999999999988888764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=392.91 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=186.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++... ......++.+|++++++++||||+++++++ .+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 368999999999999999999965 8999999998643 233457789999999999999999999994 4556
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||+ +|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~D 155 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIAD 155 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECC
T ss_pred EEEEEEeCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEee
Confidence 899999999 67999998754 5799999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||+|+.... ........||+.|+|||++.++ + +.++||||+||++|+|++|+.||.+... ........
T Consensus 156 FGla~~~~~--------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~ 225 (275)
T 3hyh_A 156 FGLSNIMTD--------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNIS 225 (275)
T ss_dssp SSCC-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred cCCCeecCC--------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence 999986521 1122346799999999998775 3 6899999999999999999999965321 11111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...... +...+..+.+++.+||+.||++|||++|+++.
T Consensus 226 -----------~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 226 -----------NGVYTL-------------------------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -----------HTCCCC-------------------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -----------cCCCCC-------------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000 01124557889999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=413.65 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=205.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|++++++++||||+++++++. +.+.
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~ 222 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDE 222 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCE
Confidence 34568999999999999999999965 79999999997665555677899999999999999999999954 4568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 223 ~~iVmEy~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEEEEeCCCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence 9999999999999999863 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+.+.. .........||+.|||||++.+ .|+.++|||||||++|||++|..||.+... ......+...
T Consensus 292 Gla~~~~~-------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~ 362 (423)
T 4fie_A 292 GFCAQVSK-------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDN 362 (423)
T ss_dssp TTCEECCS-------SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHS
T ss_pred ccceECCC-------CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcC
Confidence 99987521 1223345679999999999766 489999999999999999999999965321 1111111111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.+.. ...++..+.+|+.+||+.||++|||++|+++
T Consensus 363 --------~~~~~~~-------------------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 363 --------LPPRLKN-------------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --------CCCCCSC-------------------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CCCCCcc-------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 1112456789999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=400.69 Aligned_cols=283 Identities=22% Similarity=0.270 Sum_probs=205.6
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
.++|.+.++||+|+||.||+|++ +|+.||||++...... ...++.|+..+.+++||||+++++++.... ......|+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 45789999999999999999998 5899999998754322 233445677777899999999999986532 12236899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCEEeCCCCceEEe
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC-----DTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
||||+++|+|.++++. ..+++..+.+++.|++.||+|||+++ .++|+||||||+|||++.++.+||+
T Consensus 79 V~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 9999999999999964 35899999999999999999999752 3489999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-------CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-------VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
|||+|+........ .........||+.|+|||++.+. ++.++|||||||++|||+||..||.........
T Consensus 151 DFGla~~~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 151 DLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp CCTTCEEEETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred eCCCCccccCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999865322111 11122345799999999997653 567899999999999999999887544322111
Q ss_pred hhHHHHhcC-Chhhh-hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 616 IHMFVSMAL-PDHVM-DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 616 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
+........ ...+. .+.+..+ ++.........+++..+.+++.+||+.||++||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~------------------------rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP 283 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKL------------------------RPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC------------------------CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC
T ss_pred chhcccccchHHHHHHHHhcccC------------------------CCCCCccccchHHHHHHHHHHHHHcccCHhHCc
Confidence 110000000 00011 1111111 111112223445678899999999999999999
Q ss_pred CHHHHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTIRNC 708 (717)
Q Consensus 694 s~~eil~~l~~i~~~ 708 (717)
||+||++.|+++.++
T Consensus 284 t~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 284 TALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=401.81 Aligned_cols=279 Identities=21% Similarity=0.336 Sum_probs=216.8
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCC-Cce
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRH-RNI 447 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~ni 447 (717)
...+..+.+....++|++.++||+|+||.||+|.+. .++.||||.+.... ....+.+.+|+++++++.| |||
T Consensus 51 ~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 51 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 334555567777899999999999999999999853 24578999886543 3345779999999999965 899
Q ss_pred eEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
++++++|. ..++..++|||||++|+|.++++..... ......+++..+..++.|||.||+|||++
T Consensus 131 V~l~g~~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-- 204 (353)
T 4ase_A 131 VNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-- 204 (353)
T ss_dssp CCEEEEEC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred EEEEEEEE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--
Confidence 99999973 3345789999999999999999753211 01124589999999999999999999998
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHH
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLL 597 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ 597 (717)
+||||||||+|||++.++.+||+|||+|+.... ...........||+.|||||++. +.++.++|||||||++|
T Consensus 205 -~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~-----~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 205 -KCIHRDLAARNILLSEKNVVKICDFGLARDIYK-----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 278 (353)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTT-----CTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred -CeecCccCccceeeCCCCCEEECcchhhhhccc-----CCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHH
Confidence 999999999999999999999999999986521 12223344567899999999965 56899999999999999
Q ss_pred HHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 598 EMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 598 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
||+| |..||.+...... +...+... ..+. .++.++.+
T Consensus 279 El~t~G~~Pf~~~~~~~~-~~~~i~~g--------~~~~---------------------------------~p~~~~~~ 316 (353)
T 4ase_A 279 EIFSLGASPYPGVKIDEE-FCRRLKEG--------TRMR---------------------------------APDYTTPE 316 (353)
T ss_dssp HHTTTSCCSSTTCCCSHH-HHHHHHHT--------CCCC---------------------------------CCTTCCHH
T ss_pred HHHhCCCCCCCCCCHHHH-HHHHHHcC--------CCCC---------------------------------CCccCCHH
Confidence 9998 9999976533221 11111110 0001 11233667
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 317 ~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 317 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999998764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=437.99 Aligned_cols=364 Identities=33% Similarity=0.506 Sum_probs=249.0
Q ss_pred cceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCC-CCCCEEEccCccccccCCccccCCCCCCEE
Q 005045 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSL-TKLEIIGLGGSNLTGNVPAWIGNFSSLKAL 87 (717)
Q Consensus 9 ~~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 87 (717)
..++++|+|++|++++.+|.. .+++|++|+|++|.+++.+|..+..+ ++|++|+|++|.+++.+|..|+.+++|++|
T Consensus 246 l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 323 (768)
T 3rgz_A 246 CTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323 (768)
T ss_dssp CSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEE
Confidence 348899999999999888875 89999999999999999999998876 999999999999999999999999999999
Q ss_pred eccCCcCcccCChh-hhccCCCCeEeccCCCCCCCCCccccCCC-CccEEEcccCcccccCCccccc-CCCCcceeeccc
Q 005045 88 SLAWNNLRGSIPNE-LGQLSGLGFFTLYGNFISGIIPSSIYNIS-SIYYFSVTQNQLHGQLPTDVGL-TLPNLKIFAGAV 164 (717)
Q Consensus 88 ~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~l~~~~~~-~l~~L~~L~l~~ 164 (717)
+|++|++++.+|.. |..+++|++|+|++|.+++..|..+.+++ +|++|+|++|.+++.+|..+.. .+++|+.|++++
T Consensus 324 ~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~ 403 (768)
T 3rgz_A 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403 (768)
T ss_dssp ECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCS
T ss_pred ECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCC
Confidence 99999999788865 99999999999999999988898888876 7778888777777655554432 145555555555
Q ss_pred ccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCch------------------hhh
Q 005045 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDL------------------NFL 226 (717)
Q Consensus 165 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------------------~~~ 226 (717)
|.+.+.+|..+.++++|++|++++|.+++..|..|..+++|+.|++++|.+.......+ ..+
T Consensus 404 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 483 (768)
T 3rgz_A 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483 (768)
T ss_dssp SEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred CccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCC
Confidence 55555555555555555555555555555555555555555555555555543320000 003
Q ss_pred hhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhh---
Q 005045 227 KFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIG--- 303 (717)
Q Consensus 227 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--- 303 (717)
..+.++++|++|+|++|++++.+|..+..+ ++|++|++++|++.+.+|..+.++++|+.|+|++|++++.+|..+.
T Consensus 484 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~ 562 (768)
T 3rgz_A 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRL-ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGC-TTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTT
T ss_pred HHHhcCCCCCEEEccCCccCCcCChHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhccc
Confidence 445555555555555555555555555554 3555555555555555555555555555555555555544443322
Q ss_pred -------------------------------------------------------------------cCCCCCeEEcccC
Q 005045 304 -------------------------------------------------------------------RLNKLEGLGLNVN 316 (717)
Q Consensus 304 -------------------------------------------------------------------~l~~L~~L~Ls~N 316 (717)
.+++|+.|+|++|
T Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N 642 (768)
T 3rgz_A 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642 (768)
T ss_dssp TCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSS
T ss_pred chhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCC
Confidence 1344556666666
Q ss_pred cCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCcccc
Q 005045 317 KFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVR 375 (717)
Q Consensus 317 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 375 (717)
++++.+|..|++++.|+.|+|++|+++|.+|..++.+++|+.|||++|.++|.+|..+.
T Consensus 643 ~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~ 701 (768)
T 3rgz_A 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701 (768)
T ss_dssp CCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGG
T ss_pred cccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHh
Confidence 66666666666666666666666666666666666666666666666666666665543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=395.01 Aligned_cols=199 Identities=28% Similarity=0.384 Sum_probs=165.5
Q ss_pred cccccccccCcccccceEEEEeC----CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .....++.+|++++++++||||+++++++ .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 58999999999999999999852 57789999986432 22345688899999999999999999995 445
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~ 168 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLT 168 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEec
Confidence 6899999999999999999754 5799999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||+|+..... ........||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.
T Consensus 169 DFGla~~~~~~-------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 169 DFGLSKESIDH-------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp SSEEEEC------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccceeccCC-------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 99999864211 122334679999999999765 4899999999999999999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=386.06 Aligned_cols=261 Identities=24% Similarity=0.393 Sum_probs=187.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC------
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDL------ 459 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------ 459 (717)
.++|++++.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999965 89999999986543 3445788999999999999999999998754331
Q ss_pred -CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 460 -EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 460 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
......|+|||||++|+|.+++.... .....++..++.++.||+.||+|||++ +|+||||||+|||++.+|.
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC----SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC----CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCc
Confidence 12335799999999999999997653 123456778899999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCC-----CCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 005045 539 AHVGDFGLAKFLFEISDNPS-----KNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKD 612 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~ 612 (717)
+||+|||+|+.......... ..........||+.|||||++.++ ++.++|||||||++|||++ ||....+
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~- 232 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME- 232 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-
Confidence 99999999987633221110 111223346799999999997764 8999999999999999996 7643100
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
.. .. +..+.....+ +...+......+++.+||+.||++|
T Consensus 233 --~~-~~--------~~~~~~~~~p------------------------------~~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 233 --RV-RT--------LTDVRNLKFP------------------------------PLFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp --HH-HH--------HHHHHTTCCC------------------------------HHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred --HH-HH--------HHHHhcCCCC------------------------------CCCcccCHHHHHHHHHHcCCChhHC
Confidence 00 00 0011110000 0112223445789999999999999
Q ss_pred CCHHHHHH
Q 005045 693 IAMNVVVN 700 (717)
Q Consensus 693 ps~~eil~ 700 (717)
||+.|+++
T Consensus 272 ps~~eil~ 279 (299)
T 4g31_A 272 PEAINIIE 279 (299)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=395.27 Aligned_cols=369 Identities=20% Similarity=0.227 Sum_probs=313.7
Q ss_pred cceeeCCcc-eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccC-CcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL-MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQI-PNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~-~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
+++.+|... .+++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++..|..|.
T Consensus 21 ~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 100 (455)
T 3v47_A 21 GLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN 100 (455)
T ss_dssp CCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTT
T ss_pred CcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhcc
Confidence 356677733 7899999999999888999999999999999999987444 66799999999999999999988899999
Q ss_pred CCCCCCEEeccCCcCcccCChh--hhccCCCCeEeccCCCCCCCCCcc-ccCCCCccEEEcccCcccccCCcccccCC--
Q 005045 80 NFSSLKALSLAWNNLRGSIPNE--LGQLSGLGFFTLYGNFISGIIPSS-IYNISSIYYFSVTQNQLHGQLPTDVGLTL-- 154 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~l~~~~~~~l-- 154 (717)
++++|++|+|++|++++..+.. |..+++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+..+. .+
T Consensus 101 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~ 179 (455)
T 3v47_A 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL-NFQG 179 (455)
T ss_dssp TCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSG-GGTT
T ss_pred CcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhh-cccc
Confidence 9999999999999998755544 899999999999999999887776 88999999999999999854454433 33
Q ss_pred CCcceeecccccccccCCccC--------CCCCCCCEEeccCccccccCCCCccCC---CCCCeeeccccccCCcccCch
Q 005045 155 PNLKIFAGAVNYFTGSIPVSL--------SNASNLQVLDFAENGLTGTIPGNFGSL---KDLVRLNFDQNELGSREIGDL 223 (717)
Q Consensus 155 ~~L~~L~l~~n~l~~~~~~~~--------~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~ 223 (717)
.+|+.|++++|.+....+..+ ..+++|++|++++|++++..|..+... ++|+.|++++|.+.....+..
T Consensus 180 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~ 259 (455)
T 3v47_A 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259 (455)
T ss_dssp CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCC
T ss_pred ccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchh
Confidence 789999999999987665443 367899999999999988777766544 889999999886654332111
Q ss_pred hh----hhhhc--cCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccc
Q 005045 224 NF----LKFLA--NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS 297 (717)
Q Consensus 224 ~~----~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 297 (717)
.+ ...+. ..++|+.|++++|.+++..|..+..+ ++|++|++++|.+.+..+..|.++++|++|+|++|++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 338 (455)
T 3v47_A 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF-TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI 338 (455)
T ss_dssp SSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred hhccCcccccccccccCceEEEecCccccccchhhcccC-CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc
Confidence 00 11122 23689999999999998888888887 5999999999999988899999999999999999999988
Q ss_pred cchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCc
Q 005045 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 298 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
.|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|.
T Consensus 339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 899999999999999999999999999999999999999999999976667789999999999999999999983
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=393.23 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=174.8
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~ 463 (717)
.++|++++.||+|+||.||+|+++ +|+.||||++.... ....+++.+|++++++++||||+++++++.... +.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999965 89999999986442 334577889999999999999999999865432 34567
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||++ |+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~D 201 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGD 201 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEee
Confidence 8999999995 6899999765 6799999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
||+|+.+.... ...........||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.
T Consensus 202 FGla~~~~~~~---~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 202 FGMARGLCTSP---AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp CTTCBCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cceeeecccCc---cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99998652211 111222345689999999999665 3689999999999999999999999764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=403.93 Aligned_cols=364 Identities=21% Similarity=0.188 Sum_probs=278.0
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
+++.+|..+ .+++|+|++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+
T Consensus 23 ~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 102 (606)
T 3t6q_A 23 GLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS 102 (606)
T ss_dssp CCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTS
T ss_pred CcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhc
Confidence 467788766 889999999999988899999999999999999999988899999999999999999999988899999
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcc-
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLK- 158 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~- 158 (717)
++++|++|+|++|++++..+..|.++++|++|+|++|.++++....+.++++|++|++++|.++ .++...+..+++|+
T Consensus 103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~ 181 (606)
T 3t6q_A 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATN 181 (606)
T ss_dssp SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCS
T ss_pred ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc-ccChhhhhhhcccce
Confidence 9999999999999999777888999999999999999999876667777999999999999998 66666666888888
Q ss_pred -eeecccccccccCCccCCCC---------------------------------------------------CCCCEEec
Q 005045 159 -IFAGAVNYFTGSIPVSLSNA---------------------------------------------------SNLQVLDF 186 (717)
Q Consensus 159 -~L~l~~n~l~~~~~~~~~~l---------------------------------------------------~~L~~L~l 186 (717)
.|++++|.+.+..|..+... .+|+.|++
T Consensus 182 l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l 261 (606)
T 3t6q_A 182 LSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261 (606)
T ss_dssp EEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEEC
T ss_pred eEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEe
Confidence 78888888887666554321 05666667
Q ss_pred cCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecC
Q 005045 187 AENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG 266 (717)
Q Consensus 187 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~ 266 (717)
++|.+++..+..|..+++|+.|++++|.++.++ ..+.++++|++|++++|.+++..|..+..+ ++|++|+++
T Consensus 262 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp-------~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~ 333 (606)
T 3t6q_A 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSELP-------SGLVGLSTLKKLVLSANKFENLCQISASNF-PSLTHLSIK 333 (606)
T ss_dssp TTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC-------SSCCSCTTCCEEECTTCCCSBGGGGCGGGC-TTCSEEECC
T ss_pred ecCccCccCHHHhccccCCCEEeccCCccCCCC-------hhhcccccCCEEECccCCcCcCchhhhhcc-CcCCEEECC
Confidence 777777666666777777777777777776553 346666777777777777775555566555 467777777
Q ss_pred CCccCCCCCc-cccCCCCCCEEEccCCcCcccc--chhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 267 ENLMHGNIPV-GIGNLVNLNLLGLEGNNLSGSV--PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 267 ~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
+|.+.+.++. .+.++++|++|++++|++++.. +..+..+++|++|++++|++++..|..|..+++|+.|+|++|+++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 7766644433 3666777777777777776544 556666777777777777776666666777777777777777776
Q ss_pred ccCCcC-ccCcCCCceEEeecccCCCCCCccc
Q 005045 344 GSIPPS-LGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 344 ~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
+..|.. +..+++|+.|++++|.+++..|..+
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 445 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence 554433 6667777777777777765555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=405.95 Aligned_cols=363 Identities=18% Similarity=0.162 Sum_probs=257.2
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|..+ .+++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+
T Consensus 22 ~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 101 (606)
T 3vq2_A 22 KLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFS 101 (606)
T ss_dssp CCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSST
T ss_pred CcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcC
Confidence 467778766 789999999999988888899999999999999999988888899999999999999999977788999
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCC-CCCccccCCCCccEEEcccCcccccCCccc--------
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG-IIPSSIYNISSIYYFSVTQNQLHGQLPTDV-------- 150 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~-------- 150 (717)
++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|..|.++++|++|+|++|++++..+..+
T Consensus 102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 181 (606)
T 3vq2_A 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181 (606)
T ss_dssp TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTT
T ss_pred CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcccc
Confidence 99999999999999987777889999999999999999886 458889999999999999888873322211
Q ss_pred -------------------c------------------------------------------------------------
Q 005045 151 -------------------G------------------------------------------------------------ 151 (717)
Q Consensus 151 -------------------~------------------------------------------------------------ 151 (717)
+
T Consensus 182 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l 261 (606)
T 3vq2_A 182 VNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261 (606)
T ss_dssp CCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS
T ss_pred ccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc
Confidence 0
Q ss_pred ------------------------------------------cCCCCcceeecccccccccCC-----------------
Q 005045 152 ------------------------------------------LTLPNLKIFAGAVNYFTGSIP----------------- 172 (717)
Q Consensus 152 ------------------------------------------~~l~~L~~L~l~~n~l~~~~~----------------- 172 (717)
..+++|+.|++++|.+. .+|
T Consensus 262 ~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~ 340 (606)
T 3vq2_A 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKG 340 (606)
T ss_dssp EEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSS
T ss_pred cHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCCCccceeeccCCcC
Confidence 01112222333333221 111
Q ss_pred ---ccCCCCCCCCEEeccCccccccC--CCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC
Q 005045 173 ---VSLSNASNLQVLDFAENGLTGTI--PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG 247 (717)
Q Consensus 173 ---~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 247 (717)
..+..+++|++|++++|.+++.. +..+..+++|+.|++++|.++.++ ..+..+++|+.|++++|.+.+
T Consensus 341 ~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-------~~~~~l~~L~~L~l~~n~l~~ 413 (606)
T 3vq2_A 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-------ANFMGLEELQHLDFQHSTLKR 413 (606)
T ss_dssp CEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEEC-------CCCTTCTTCCEEECTTSEEES
T ss_pred ccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccch-------hhccCCCCCCeeECCCCccCC
Confidence 12345667777777777777542 566677777777777777766643 345666667777777777665
Q ss_pred cCc-hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcc-ccchhhhcCCCCCeEEcccCcCCCCCCcc
Q 005045 248 EMP-ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG-SVPEVIGRLNKLEGLGLNVNKFSGLIPSS 325 (717)
Q Consensus 248 ~~p-~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 325 (717)
..| ..+..+ ++|++|++++|.+.+..|..|.++++|++|++++|++++ ..|..+..+++|++|+|++|++++..|..
T Consensus 414 ~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 492 (606)
T 3vq2_A 414 VTEFSAFLSL-EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492 (606)
T ss_dssp TTTTTTTTTC-TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccChhhhhcc-ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhh
Confidence 555 344444 466777777776666666666666667777776666665 35666666666666677666666666666
Q ss_pred cccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCccc
Q 005045 326 LGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
|.++++|+.|+|++|++++..|..+..+++|+.|++++|+++ .+|..+
T Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~ 540 (606)
T 3vq2_A 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGIL 540 (606)
T ss_dssp TTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCG
T ss_pred hcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhH
Confidence 666666666666666666666666666666666666666666 455543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=406.57 Aligned_cols=340 Identities=17% Similarity=0.272 Sum_probs=203.9
Q ss_pred eecEEEcCCCcCcCC-----------------CCcCCc--CCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcc-c
Q 005045 11 MTQDLNLTYNYLSGK-----------------IPTNLS--HCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN-L 70 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l 70 (717)
++++|+|++|.+++. +|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +
T Consensus 207 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l 286 (636)
T 4eco_A 207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286 (636)
T ss_dssp TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTS
T ss_pred CCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCC
Confidence 556666666666653 566666 66666666666666666666666666666666666665 5
Q ss_pred cc-cCCccccCC------CCCCEEeccCCcCcccCCh--hhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCc
Q 005045 71 TG-NVPAWIGNF------SSLKALSLAWNNLRGSIPN--ELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 71 ~~-~~p~~~~~l------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 141 (717)
++ .+|..++.+ ++|++|+|++|+++ .+|. .|.++++|++|+|++|.+++.+| .|..+++|++|+|++|+
T Consensus 287 ~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ 364 (636)
T ss_dssp CHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSE
T ss_pred ccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCc
Confidence 55 555555554 56666666666666 5555 56666666666666666665555 56666666666666666
Q ss_pred ccccCCcccccCCCC-cceeecccccccccCCccCCCCC--CCCEEeccCccccccCCCCcc-------CCCCCCeeecc
Q 005045 142 LHGQLPTDVGLTLPN-LKIFAGAVNYFTGSIPVSLSNAS--NLQVLDFAENGLTGTIPGNFG-------SLKDLVRLNFD 211 (717)
Q Consensus 142 l~~~l~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~l~ 211 (717)
++ .+|..+. .+++ |+.|++++|.++ .+|..+..++ +|++|++++|.+++..|..|. .+++|+.|+++
T Consensus 365 l~-~lp~~l~-~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls 441 (636)
T 4eco_A 365 IT-EIPANFC-GFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441 (636)
T ss_dssp EE-ECCTTSE-EECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECC
T ss_pred cc-cccHhhh-hhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECc
Confidence 65 5555533 4555 666666666666 4555555433 566666666666655565555 55566666666
Q ss_pred ccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccc-------cccEEecCCCccCCCCCcccc--CCC
Q 005045 212 QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLST-------HLRRLTMGENLMHGNIPVGIG--NLV 282 (717)
Q Consensus 212 ~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-------~L~~L~l~~N~l~~~~~~~~~--~l~ 282 (717)
+|.++.++ ...+..+++|++|+|++|.++ .+|..++.... +|++|++++|.++ .+|..+. .++
T Consensus 442 ~N~l~~lp------~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~ 513 (636)
T 4eco_A 442 NNQISKFP------KELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP 513 (636)
T ss_dssp SSCCCSCC------THHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCT
T ss_pred CCccCcCC------HHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCC
Confidence 66666554 344455666666666666666 55554443322 5666666666666 4555554 666
Q ss_pred CCCEEEccCCcCccccchhhhcCCCCCeEEc------ccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCC
Q 005045 283 NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL------NVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKL 356 (717)
Q Consensus 283 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 356 (717)
+|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|+|++|+++ .+|..+. ++|
T Consensus 514 ~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L 589 (636)
T 4eco_A 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNI 589 (636)
T ss_dssp TCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTC
T ss_pred CcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcC
Confidence 66666666666664 5555666666666666 345555566666666666666666666663 5555544 566
Q ss_pred ceEEeecccCC
Q 005045 357 LVLNLSSNDLN 367 (717)
Q Consensus 357 ~~L~l~~N~l~ 367 (717)
+.|++++|++.
T Consensus 590 ~~L~Ls~N~l~ 600 (636)
T 4eco_A 590 SVLDIKDNPNI 600 (636)
T ss_dssp CEEECCSCTTC
T ss_pred CEEECcCCCCc
Confidence 66666666554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=405.67 Aligned_cols=339 Identities=21% Similarity=0.321 Sum_probs=305.8
Q ss_pred cCcCCCCcCCcCCCCCCEEECCCCccccc-----------------CCcCCC--CCCCCCEEEccCccccccCCccccCC
Q 005045 21 YLSGKIPTNLSHCTELRSFEASVNDFVGQ-----------------IPNQLS--SLTKLEIIGLGGSNLTGNVPAWIGNF 81 (717)
Q Consensus 21 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l 81 (717)
++++ +|..|+++++|++|+|++|.+++. +|..++ ++++|++|+|++|.+.+.+|..|+++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4555 888999999999999999999985 999999 99999999999999999999999999
Q ss_pred CCCCEEeccCCc-Ccc-cCChhhhcc------CCCCeEeccCCCCCCCCCc--cccCCCCccEEEcccCcccccCCcccc
Q 005045 82 SSLKALSLAWNN-LRG-SIPNELGQL------SGLGFFTLYGNFISGIIPS--SIYNISSIYYFSVTQNQLHGQLPTDVG 151 (717)
Q Consensus 82 ~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~l~~~~~ 151 (717)
++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .|.++++|++|+|++|.++|.+| .+
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip--~~ 349 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP--AF 349 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC--CC
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh--hh
Confidence 999999999999 998 799999887 99999999999999 7887 99999999999999999998999 55
Q ss_pred cCCCCcceeecccccccccCCccCCCCCC-CCEEeccCccccccCCCCccCCC--CCCeeeccccccCCcccCchhhhhh
Q 005045 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASN-LQVLDFAENGLTGTIPGNFGSLK--DLVRLNFDQNELGSREIGDLNFLKF 228 (717)
Q Consensus 152 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~~~~ 228 (717)
..+++|+.|++++|.++ .+|..+..+++ |++|++++|.++ .+|..+..++ +|+.|++++|.++... |..
T Consensus 350 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~------p~~ 421 (636)
T 4eco_A 350 GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD------GKN 421 (636)
T ss_dssp EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT------TCS
T ss_pred CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc------hhh
Confidence 68999999999999999 78888999999 999999999999 7888887755 9999999999998866 455
Q ss_pred hc-------cCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCC-------CCCEEEccCCcC
Q 005045 229 LA-------NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV-------NLNLLGLEGNNL 294 (717)
Q Consensus 229 ~~-------~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l 294 (717)
+. .+++|+.|+|++|.++ .+|..++...++|++|++++|.++...+..+.... +|+.|+|++|++
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred hcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC
Confidence 66 7789999999999999 78877766446999999999999944444454443 999999999999
Q ss_pred ccccchhhh--cCCCCCeEEcccCcCCCCCCcccccccccceeec------ccccccccCCcCccCcCCCceEEeecccC
Q 005045 295 SGSVPEVIG--RLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWM------EENRLEGSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 295 ~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|+|++|.+
T Consensus 501 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 501 T-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp C-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred C-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 9 7888887 99999999999999998 7889999999999999 56888889999999999999999999999
Q ss_pred CCCCCcccc
Q 005045 367 NGTIPKEVR 375 (717)
Q Consensus 367 ~~~~p~~~~ 375 (717)
+.+|..+.
T Consensus 579 -~~ip~~~~ 586 (636)
T 4eco_A 579 -RKVNEKIT 586 (636)
T ss_dssp -CBCCSCCC
T ss_pred -CccCHhHh
Confidence 68888754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=397.73 Aligned_cols=361 Identities=19% Similarity=0.237 Sum_probs=242.3
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|..+ .+++|+|++|++++..+.+|..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.
T Consensus 18 ~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (570)
T 2z63_A 18 NFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97 (570)
T ss_dssp CCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred CccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhc
Confidence 567788755 789999999999988888999999999999999999988888899999999999999999977778899
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCC-CCccccCCCCccEEEcccCcccccCCcccccC-----
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLT----- 153 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~----- 153 (717)
++++|++|+|++|++++..+..|+++++|++|+|++|.++++ .|..|.++++|++|++++|.++ .++...+..
T Consensus 98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~ 176 (570)
T 2z63_A 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMP 176 (570)
T ss_dssp TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC-EECGGGGHHHHTCT
T ss_pred CccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc-eecHHHccchhccc
Confidence 999999999999999966666799999999999999999864 5889999999999999999887 333222222
Q ss_pred --------------------------------------------------------------------------------
Q 005045 154 -------------------------------------------------------------------------------- 153 (717)
Q Consensus 154 -------------------------------------------------------------------------------- 153 (717)
T Consensus 177 ~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~ 256 (570)
T 2z63_A 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256 (570)
T ss_dssp TCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGG
T ss_pred hhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccc
Confidence
Q ss_pred ------------------------CCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCC-Cc---------
Q 005045 154 ------------------------LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG-NF--------- 199 (717)
Q Consensus 154 ------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~--------- 199 (717)
+++|+.|++++|.+. .+|..+..+ +|++|++++|.++ .+|. .+
T Consensus 257 l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~ 333 (570)
T 2z63_A 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFT 333 (570)
T ss_dssp SEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEE
T ss_pred cchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCc
Confidence 234444444444444 233333333 3333333333333 1111 00
Q ss_pred ----------cCCCCCCeeeccccccCCcccCchhhhhh-----------------------hccCCCCCEEEeecCccc
Q 005045 200 ----------GSLKDLVRLNFDQNELGSREIGDLNFLKF-----------------------LANCTSLEVLGLARNSFG 246 (717)
Q Consensus 200 ----------~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-----------------------~~~l~~L~~L~L~~N~l~ 246 (717)
..+++|+.|++++|.++..... +.. +..+++|+.|++++|.++
T Consensus 334 ~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~ 409 (570)
T 2z63_A 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC----SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 409 (570)
T ss_dssp SCBSCCBCCCCBCTTCCEEECCSSCCBEEEEE----EHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEE
T ss_pred CCccccccccccCCCCCEEeCcCCccCccccc----cccccccCccCEEECCCCccccccccccccCCCCEEEccCCccc
Confidence 3455666666666666543210 123 444555555555555555
Q ss_pred CcCch-hhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCc-cccchhhhcCCCCCeEEcccCcCCCCCCc
Q 005045 247 GEMPI-SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS-GSVPEVIGRLNKLEGLGLNVNKFSGLIPS 324 (717)
Q Consensus 247 ~~~p~-~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 324 (717)
+..|. .+..+ ++|++|++++|.+.+..+..|.++++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++..|.
T Consensus 410 ~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 488 (570)
T 2z63_A 410 QMSEFSVFLSL-RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488 (570)
T ss_dssp SCTTSCTTTTC-TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccchhhhhcC-CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChh
Confidence 33332 23333 45666666666665555566666666666666666665 34556666666666666666666666666
Q ss_pred ccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 325 SLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
.|..+++|++|+|++|++++..|..|..+++|+.|++++|++++.+|
T Consensus 489 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 66666666666666666665555556666666666666666666655
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=381.64 Aligned_cols=209 Identities=23% Similarity=0.342 Sum_probs=169.3
Q ss_pred cccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
.+....++|++.++||+|+||.||+|+++ +++.||+|.+.... ...++.+|+++++.+ +||||+++++++
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~--- 89 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF--- 89 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE---
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE---
Confidence 44556789999999999999999999853 57889999876443 235678899999998 799999999984
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD- 536 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~- 536 (717)
.+.++.|+||||++|++|.+++. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 90 --~~~~~~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 90 --RKNDHVVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp --EETTEEEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred --EECCEEEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCC
Confidence 44569999999999999999983 478999999999999999999998 99999999999999876
Q ss_pred CceEEeeeccchhcccccCCC---------------------CCCcceeecccccccccCCCccCC--CCCcccchhhHH
Q 005045 537 MTAHVGDFGLAKFLFEISDNP---------------------SKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYG 593 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG 593 (717)
+.+||+|||+|+......... ...........||+.|+|||++.+ .++.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 799999999997542211000 000112234579999999999765 378999999999
Q ss_pred HHHHHHHhCCCCCCCCCC
Q 005045 594 ILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 594 ~vl~elltg~~p~~~~~~ 611 (717)
|++|||++|+.||.....
T Consensus 235 ~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 235 VIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp HHHHHHHHTCSSSSCCSS
T ss_pred HHHHHHHHCCCCCCCCCC
Confidence 999999999999976543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=390.42 Aligned_cols=350 Identities=19% Similarity=0.158 Sum_probs=304.8
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
.++++|+|++|++++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 38999999999999989999999999999999999999888999999999999999999999776888999999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCcc--EEEcccCcccccCCcccccC--------------
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY--YFSVTQNQLHGQLPTDVGLT-------------- 153 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~--~L~L~~N~l~~~l~~~~~~~-------------- 153 (717)
++|++++.....+..+++|++|+|++|.+++..+..|..+++|+ .|++++|.+++ ++...+..
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~-~~~~~~~~~~L~~L~l~~~~~~ 215 (606)
T 3t6q_A 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNL 215 (606)
T ss_dssp CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE-ECTTTTTTCEEEEEECTTCSCH
T ss_pred CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc-cChhHhhhccccccccCCchhH
Confidence 99999975555666699999999999999988899999999999 89999999984 44333321
Q ss_pred -----------------------------------C--CCcceeecccccccccCCccCCCCCCCCEEeccCccccccCC
Q 005045 154 -----------------------------------L--PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP 196 (717)
Q Consensus 154 -----------------------------------l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 196 (717)
+ .+|+.|++++|.+.+..+..|..+++|++|++++|.++ .+|
T Consensus 216 ~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp 294 (606)
T 3t6q_A 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294 (606)
T ss_dssp HHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCC
T ss_pred HHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCC
Confidence 1 16788889999999888888999999999999999999 788
Q ss_pred CCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchh-hhhccccccEEecCCCccCCCC-
Q 005045 197 GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPIS-IANLSTHLRRLTMGENLMHGNI- 274 (717)
Q Consensus 197 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~L~~L~l~~N~l~~~~- 274 (717)
..+..+++|++|++++|.++.+. +..+.++++|+.|++++|.+.+.+|.. +..+ ++|++|++++|.+.+..
T Consensus 295 ~~l~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~ 367 (606)
T 3t6q_A 295 SGLVGLSTLKKLVLSANKFENLC------QISASNFPSLTHLSIKGNTKRLELGTGCLENL-ENLRELDLSHDDIETSDC 367 (606)
T ss_dssp SSCCSCTTCCEEECTTCCCSBGG------GGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC-TTCCEEECCSSCCCEEEE
T ss_pred hhhcccccCCEEECccCCcCcCc------hhhhhccCcCCEEECCCCCcccccchhhhhcc-CcCCEEECCCCccccccC
Confidence 88999999999999999998876 667888899999999999988777665 4555 68999999999988665
Q ss_pred -CccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCc-ccccccccceeecccccccccCCcCccC
Q 005045 275 -PVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLEGSIPPSLGN 352 (717)
Q Consensus 275 -~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 352 (717)
+..+.++++|+.|++++|++.+..|..|..+++|++|++++|++++..+. .|..+++|+.|+|++|.+++..|..+..
T Consensus 368 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 447 (606)
T 3t6q_A 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447 (606)
T ss_dssp STTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTT
T ss_pred cchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhC
Confidence 67788899999999999999888888888899999999999998877654 4888899999999999998888888888
Q ss_pred cCCCceEEeecccCCC
Q 005045 353 CQKLLVLNLSSNDLNG 368 (717)
Q Consensus 353 l~~L~~L~l~~N~l~~ 368 (717)
+++|++|++++|++++
T Consensus 448 l~~L~~L~L~~n~l~~ 463 (606)
T 3t6q_A 448 LPALQHLNLQGNHFPK 463 (606)
T ss_dssp CTTCCEEECTTCBCGG
T ss_pred CCCCCEEECCCCCCCc
Confidence 9999999999998876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=399.08 Aligned_cols=340 Identities=20% Similarity=0.303 Sum_probs=185.8
Q ss_pred CcCcCCCCcCCcCCCCCCEEECCCCcccc-----------------cCCcCCC--CCCCCCEEEccCccccccCCccccC
Q 005045 20 NYLSGKIPTNLSHCTELRSFEASVNDFVG-----------------QIPNQLS--SLTKLEIIGLGGSNLTGNVPAWIGN 80 (717)
Q Consensus 20 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~ 80 (717)
|++++ +|..|+++++|++|+|++|.+++ .+|..++ ++++|++|+|++|.+.+.+|..|++
T Consensus 435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~ 513 (876)
T 4ecn_A 435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513 (876)
T ss_dssp CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence 55554 55556666666666666666654 2555555 5666666666666655555655666
Q ss_pred CCCCCEEeccCCc-Ccc-cCChhhhccC-------CCCeEeccCCCCCCCCCc--cccCCCCccEEEcccCcccccCCcc
Q 005045 81 FSSLKALSLAWNN-LRG-SIPNELGQLS-------GLGFFTLYGNFISGIIPS--SIYNISSIYYFSVTQNQLHGQLPTD 149 (717)
Q Consensus 81 l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~l~~~ 149 (717)
+++|++|+|++|+ +++ .+|..|..++ +|++|+|++|.++ .+|. .|.++++|+.|+|++|+++ .+|
T Consensus 514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-- 589 (876)
T 4ecn_A 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-- 589 (876)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC--
T ss_pred CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch--
Confidence 6666666666665 554 4555555444 5666666666665 4454 5666666666666666665 555
Q ss_pred cccCCCCcceeecccccccccCCccCCCCCC-CCEEeccCccccccCCCCccCCCC--CCeeeccccccCCcccCchhhh
Q 005045 150 VGLTLPNLKIFAGAVNYFTGSIPVSLSNASN-LQVLDFAENGLTGTIPGNFGSLKD--LVRLNFDQNELGSREIGDLNFL 226 (717)
Q Consensus 150 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~~~~~~~~ 226 (717)
.+..+++|+.|++++|.+. .+|..+..+++ |++|+|++|.++ .+|..+..++. |+.|++++|++...... + +
T Consensus 590 ~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~-l--~ 664 (876)
T 4ecn_A 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN-I--S 664 (876)
T ss_dssp CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS-C--S
T ss_pred hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc-c--h
Confidence 3345556666666666655 45555555555 666666666665 45555544433 56666666655442200 0 0
Q ss_pred hhhc--cCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCcc-ccC-------CCCCCEEEccCCcCcc
Q 005045 227 KFLA--NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVG-IGN-------LVNLNLLGLEGNNLSG 296 (717)
Q Consensus 227 ~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~-------l~~L~~L~L~~N~l~~ 296 (717)
..+. .+++|+.|+|++|.++ .+|..++...++|+.|+|++|.+. .+|.. +.. +++|+.|+|++|+|+
T Consensus 665 ~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~- 741 (876)
T 4ecn_A 665 CSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT- 741 (876)
T ss_dssp SCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-
T ss_pred hhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-
Confidence 0111 2235556666666665 555554432245666666666555 23322 221 125666666666665
Q ss_pred ccchhhh--cCCCCCeEEcccCcCCCCCCcccccccccceeeccc------ccccccCCcCccCcCCCceEEeecccCCC
Q 005045 297 SVPEVIG--RLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE------NRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368 (717)
Q Consensus 297 ~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 368 (717)
.+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +
T Consensus 742 ~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~ 819 (876)
T 4ecn_A 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-R 819 (876)
T ss_dssp CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-C
T ss_pred cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-C
Confidence 4555554 55566666666666654 355555556666665544 555555555565566666666666666 4
Q ss_pred CCCccc
Q 005045 369 TIPKEV 374 (717)
Q Consensus 369 ~~p~~~ 374 (717)
.+|..+
T Consensus 820 ~Ip~~l 825 (876)
T 4ecn_A 820 KVDEKL 825 (876)
T ss_dssp BCCSCC
T ss_pred ccCHhh
Confidence 555543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=397.87 Aligned_cols=311 Identities=19% Similarity=0.224 Sum_probs=200.1
Q ss_pred CCcCCCCCCCCCEEEccCccccc-----------------cCCcccc--CCCCCCEEeccCCcCcccCChhhhccCCCCe
Q 005045 50 IPNQLSSLTKLEIIGLGGSNLTG-----------------NVPAWIG--NFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110 (717)
Q Consensus 50 ~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 110 (717)
+|..|+++++|++|+|++|.+++ .+|..++ ++++|++|+|++|++.+.+|..|.++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 56666777777777777777775 2666655 7777777777777766677777777777777
Q ss_pred EeccCCC-CCC-CCCccccCCC-------CccEEEcccCcccccCCc-ccccCCCCcceeecccccccccCCccCCCCCC
Q 005045 111 FTLYGNF-ISG-IIPSSIYNIS-------SIYYFSVTQNQLHGQLPT-DVGLTLPNLKIFAGAVNYFTGSIPVSLSNASN 180 (717)
Q Consensus 111 L~L~~N~-i~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~l~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 180 (717)
|+|++|+ +++ .+|..++.++ +|++|+|++|.++ .+|. ..+..+++|+.|++++|.+. .+| .|..+++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 7777776 665 5565554443 7777777777776 6665 23346777777777777776 555 6777777
Q ss_pred CCEEeccCccccccCCCCccCCCC-CCeeeccccccCCcccCchhhhhhhccCC--CCCEEEeecCcccCcCchhh---h
Q 005045 181 LQVLDFAENGLTGTIPGNFGSLKD-LVRLNFDQNELGSREIGDLNFLKFLANCT--SLEVLGLARNSFGGEMPISI---A 254 (717)
Q Consensus 181 L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~---~ 254 (717)
|+.|+|++|+++ .+|..+..+++ |+.|++++|.++.++ ..+..++ +|+.|+|++|.+.+.+|... .
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp-------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~ 668 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP-------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC-------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTT
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc-------hhhhccccCCCCEEECcCCcCCCccccchhhhc
Confidence 777777777777 66666777776 777777777776443 3344443 37777777777765544221 1
Q ss_pred --hccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcC--------CCCCeEEcccCcCCCCCCc
Q 005045 255 --NLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRL--------NKLEGLGLNVNKFSGLIPS 324 (717)
Q Consensus 255 --~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--------~~L~~L~Ls~N~l~~~~~~ 324 (717)
.. ++|+.|++++|.+....+..+..+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|+++ .+|.
T Consensus 669 ~~~~-~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~ 745 (876)
T 4ecn_A 669 DYKG-INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745 (876)
T ss_dssp TCCC-CCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCG
T ss_pred cccC-CCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchH
Confidence 11 25777777777776333333446677777777777776 444433322 26777777777777 4455
Q ss_pred ccc--cccccceeecccccccccCCcCccCcCCCceEEeec------ccCCCCCCcccc
Q 005045 325 SLG--NLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSS------NDLNGTIPKEVR 375 (717)
Q Consensus 325 ~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~------N~l~~~~p~~~~ 375 (717)
.+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |.+.+.+|..+.
T Consensus 746 ~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~ 803 (876)
T 4ecn_A 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803 (876)
T ss_dssp GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGG
T ss_pred HhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHh
Confidence 555 67777777777777774 666677777777777755 556666665553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=390.25 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=196.7
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhH---HHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGA---LKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
...-++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ... ......++.+++.++||||++++++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~---- 260 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA---- 260 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE----
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE----
Confidence 345678999999999999999999965 89999999986432 111 2233345677788899999999999
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
+.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++ |||||||||+|||++.+|
T Consensus 261 -f~~~~~lylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 261 -FHTPDKLSFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp -EECSSEEEEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred -EEECCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 45566999999999999999999754 6799999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-C-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-G-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||+|+.... .......||+.|+|||++. + .|+.++|||||||++|||++|..||.+....+..
T Consensus 330 ~vKL~DFGlA~~~~~---------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~ 400 (689)
T 3v5w_A 330 HVRISDLGLACDFSK---------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400 (689)
T ss_dssp CEEECCCTTCEECSS---------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred CEEecccceeeecCC---------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999986521 1223467999999999975 4 4899999999999999999999999754332211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA- 694 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps- 694 (717)
. .. ..+....... +...+..+.+|+.+||+.||++|++
T Consensus 401 ~--i~--------~~i~~~~~~~-------------------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 401 E--ID--------RMTLTMAVEL-------------------------------PDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp H--HH--------HHHHHCCCCC-------------------------------CTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred H--HH--------HhhcCCCCCC-------------------------------CccCCHHHHHHHHHHccCCHhHCCCC
Confidence 0 00 0001111100 0112456788999999999999998
Q ss_pred ----HHHHHH
Q 005045 695 ----MNVVVN 700 (717)
Q Consensus 695 ----~~eil~ 700 (717)
++||.+
T Consensus 440 ~~~ga~ei~~ 449 (689)
T 3v5w_A 440 LGRGAQEVKE 449 (689)
T ss_dssp SSSTHHHHTT
T ss_pred CCCCHHHHhc
Confidence 677764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=384.11 Aligned_cols=361 Identities=19% Similarity=0.229 Sum_probs=255.5
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|... .+++|+|++|++++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+
T Consensus 16 ~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 95 (549)
T 2z81_A 16 SFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95 (549)
T ss_dssp CCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHT
T ss_pred ccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhc
Confidence 467788766 899999999999988899999999999999999999988889999999999999999999977777799
Q ss_pred CCCCCCEEeccCCcCccc-CChhhhccCCCCeEeccCCC-CCCCCCccccCCCCccEEEcccCcccccCCcccc------
Q 005045 80 NFSSLKALSLAWNNLRGS-IPNELGQLSGLGFFTLYGNF-ISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVG------ 151 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~------ 151 (717)
++++|++|+|++|++++. .|..|.++++|++|+|++|. +..+.+..|.++++|++|++++|.+++.+|..+.
T Consensus 96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 175 (549)
T 2z81_A 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175 (549)
T ss_dssp TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEE
T ss_pred cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCc
Confidence 999999999999999863 56789999999999999998 5555557899999999999999998865554432
Q ss_pred -----------------cCCCCcceeecccccccccC--Ccc-CCC----------------------------------
Q 005045 152 -----------------LTLPNLKIFAGAVNYFTGSI--PVS-LSN---------------------------------- 177 (717)
Q Consensus 152 -----------------~~l~~L~~L~l~~n~l~~~~--~~~-~~~---------------------------------- 177 (717)
..+++|+.|++++|.+.+.. +.. ...
T Consensus 176 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~ 255 (549)
T 2z81_A 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255 (549)
T ss_dssp EEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCE
T ss_pred eEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccc
Confidence 24677778888887776531 000 000
Q ss_pred -----------------------------------------------------CCCCCEEeccCccccccCCCCc-cCCC
Q 005045 178 -----------------------------------------------------ASNLQVLDFAENGLTGTIPGNF-GSLK 203 (717)
Q Consensus 178 -----------------------------------------------------l~~L~~L~l~~N~l~~~~~~~~-~~l~ 203 (717)
..+|++|++++|.++ .+|..+ ..++
T Consensus 256 l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~ 334 (549)
T 2z81_A 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLK 334 (549)
T ss_dssp EEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCT
T ss_pred cccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCc
Confidence 112333333333333 233222 3456
Q ss_pred CCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc--hhhhhccccccEEecCCCccCCCCCccccCC
Q 005045 204 DLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP--ISIANLSTHLRRLTMGENLMHGNIPVGIGNL 281 (717)
Q Consensus 204 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l 281 (717)
+|+.|++++|+++..... .+..+..+++|++|+|++|.+++..+ ..+..+ ++|++|++++|+++ .+|..+..+
T Consensus 335 ~L~~L~Ls~N~l~~~~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l-~~L~~L~Ls~N~l~-~lp~~~~~~ 409 (549)
T 2z81_A 335 SLEFLDLSENLMVEEYLK---NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL-KNLTSLDISRNTFH-PMPDSCQWP 409 (549)
T ss_dssp TCCEEECCSSCCCHHHHH---HHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC-TTCCEEECTTCCCC-CCCSCCCCC
T ss_pred cccEEEccCCcccccccc---chhhhhccccCcEEEccCCcccccccchhhhhcC-CCCCEEECCCCCCc-cCChhhccc
Confidence 666666666666542200 01124455666666666666652211 223333 35666666666665 345555555
Q ss_pred CCCCEEEccCCcCccccchh------------------hhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 282 VNLNLLGLEGNNLSGSVPEV------------------IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 282 ~~L~~L~L~~N~l~~~~~~~------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
++|++|++++|+++ .+|.. +..+++|++|+|++|+++.+ |. ...+++|+.|+|++|+++
T Consensus 410 ~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~i-p~-~~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 410 EKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTL-PD-ASLFPVLLVMKISRNQLK 486 (549)
T ss_dssp TTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSC-CC-GGGCTTCCEEECCSSCCC
T ss_pred ccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcC-CC-cccCccCCEEecCCCccC
Confidence 55555555555554 22221 13678888888888888844 44 467888999999999998
Q ss_pred ccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 344 GSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 344 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
+..|..+..+++|+.|++++|++++.+|
T Consensus 487 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 487 SVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 7777788889999999999999988887
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=390.55 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=203.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++........+.+.+|+++|+.++||||+++++++ .+.+..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999965 8999999998765555567889999999999999999999994 4566999
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--CceEEeee
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD--MTAHVGDF 544 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Df 544 (717)
+|||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 231 iv~E~~~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEeecCCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeec
Confidence 9999999999999986542 5689999999999999999999998 99999999999999854 89999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+.+. .........||+.|+|||++.++ ++.++||||+||++|+|++|..||.+....+ ....
T Consensus 302 G~a~~~~--------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~---- 367 (573)
T 3uto_A 302 GLTAHLD--------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRN---- 367 (573)
T ss_dssp SSCEECC--------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH----
T ss_pred cceeEcc--------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH----
Confidence 9998762 12233456799999999997765 8999999999999999999999997542211 1111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+......... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 368 -------i~~~~~~~~~---------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 368 -------VKSCDWNMDD---------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -------HHTTCCCCCS---------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------HHhCCCCCCc---------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111100000 001112455788999999999999999999986
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=399.88 Aligned_cols=363 Identities=23% Similarity=0.246 Sum_probs=292.9
Q ss_pred cceeeCCcc-eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccC-CcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL-MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQI-PNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~-~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.||... .+++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|..|.
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 577888832 8999999999999888999999999999999999655455 78899999999999999999988899999
Q ss_pred CCCCCCEEeccCCcCcccCChh--hhccCCCCeEeccCCCCCCCCC-ccccCCCCccEEEcccCcccccCCcccccCC--
Q 005045 80 NFSSLKALSLAWNNLRGSIPNE--LGQLSGLGFFTLYGNFISGIIP-SSIYNISSIYYFSVTQNQLHGQLPTDVGLTL-- 154 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l-- 154 (717)
++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..+..+. .+
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~-~l~~ 173 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE-PLQG 173 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH-HHHH
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc-cccC
Confidence 9999999999999999766655 9999999999999999987765 5799999999999999999754444332 22
Q ss_pred CC------------------------------cceeecccccccccCCccCC----------------------------
Q 005045 155 PN------------------------------LKIFAGAVNYFTGSIPVSLS---------------------------- 176 (717)
Q Consensus 155 ~~------------------------------L~~L~l~~n~l~~~~~~~~~---------------------------- 176 (717)
++ |+.|++++|.+.+..+..+.
T Consensus 174 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~ 253 (844)
T 3j0a_A 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253 (844)
T ss_dssp CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSST
T ss_pred CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccC
Confidence 33 56666666655443332221
Q ss_pred --------C--CCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc
Q 005045 177 --------N--ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246 (717)
Q Consensus 177 --------~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 246 (717)
+ .++|+.|++++|.+++..+..|..+++|+.|++++|.++.+. +..|.++++|++|+|++|.++
T Consensus 254 ~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~------~~~~~~l~~L~~L~Ls~N~l~ 327 (844)
T 3j0a_A 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA------DEAFYGLDNLQVLNLSYNLLG 327 (844)
T ss_dssp TGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC------TTTTTTCSSCCEEEEESCCCS
T ss_pred CCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC------hHHhcCCCCCCEEECCCCCCC
Confidence 1 257888888888888777888889999999999999998876 667888999999999999998
Q ss_pred CcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc----------------------------
Q 005045 247 GEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV---------------------------- 298 (717)
Q Consensus 247 ~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------------- 298 (717)
+..|..+..+ ++|+.|++++|.+.+..+..|.++++|+.|+|++|.+++..
T Consensus 328 ~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L 406 (844)
T 3j0a_A 328 ELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI 406 (844)
T ss_dssp CCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEE
T ss_pred ccCHHHhcCC-CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCccccccccccccee
Confidence 7778788777 58999999999998888888999999999999998876421
Q ss_pred ------------chhhhcCCCCCeEEcccCcCCCC------------------------------CCcccccccccceee
Q 005045 299 ------------PEVIGRLNKLEGLGLNVNKFSGL------------------------------IPSSLGNLTILTRLW 336 (717)
Q Consensus 299 ------------~~~~~~l~~L~~L~Ls~N~l~~~------------------------------~~~~~~~l~~L~~L~ 336 (717)
+..+.++++|+.|+|++|++++. .+..|.++++|+.|+
T Consensus 407 ~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~ 486 (844)
T 3j0a_A 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486 (844)
T ss_dssp ECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCC
T ss_pred ecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEE
Confidence 11233566777777777776633 224467788899999
Q ss_pred cccccccccCCcCccCcCCCceEEeecccCCCCCCc
Q 005045 337 MEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 337 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
|++|++++..|..|..+++|+.|+|++|.|++..|.
T Consensus 487 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 522 (844)
T 3j0a_A 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522 (844)
T ss_dssp CCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred CCCCcccccChhHccchhhhheeECCCCCCCccChh
Confidence 999999988888889999999999999999854443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=357.54 Aligned_cols=285 Identities=29% Similarity=0.503 Sum_probs=225.8
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
.+++.++....++|++.+.||+|+||.||+|++++++.||+|.+........+.+.+|+++++.++||||+++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 104 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--- 104 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 56778888999999999999999999999999888999999988766556678899999999999999999999994
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
...+..++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 105 --~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 105 --DERNEMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENF 176 (321)
T ss_dssp --CCTTCCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTC
T ss_pred --cCCCeEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCC
Confidence 445688999999999999999975431 124589999999999999999999997 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-h
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF-S 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~ 615 (717)
.+||+|||.+....... .........|++.|+|||++ .+.++.++|||||||++|+|++|..||....+... .
T Consensus 177 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 177 VPKITDFGISKKGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp CEEECCCTTCEECSSSS-----CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred CEEEeeccccccccccc-----ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 99999999987642111 11122334589999999996 45689999999999999999999999976543322 1
Q ss_pred hhHHHHh-cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 616 IHMFVSM-ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 616 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
...+... .....+...+++..... ...+++..+.+++.+||+.+|++|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps 302 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLADK-----------------------------IRPESLRKFGDTAVKCLALSSEDRPS 302 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTTC-----------------------------SCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHhhhccccccHHHhcChhhccc-----------------------------cCHHHHHHHHHHHHHHcCCCcccCcC
Confidence 2111111 11111222333322211 23456788999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 005045 695 MNVVVNNLKTIRN 707 (717)
Q Consensus 695 ~~eil~~l~~i~~ 707 (717)
++|+++.|+.+.+
T Consensus 303 ~~ell~~L~~~l~ 315 (321)
T 2qkw_B 303 MGDVLWKLEYALR 315 (321)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=383.57 Aligned_cols=353 Identities=19% Similarity=0.174 Sum_probs=303.1
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
..+++.++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 367999999999 6777665 8999999999999988888999999999999999999988899999999999999999
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccc-cCCcccccCCCCcceeeccccccccc
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHG-QLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
|++++..|.+|.++++|++|+|++|.+++..+..|+++++|++|+|++|.+++ .+|..+ ..+++|+.|++++|.+++.
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-~~l~~L~~L~Ls~n~l~~~ 168 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF-SNLTNLVHVDLSYNYIQTI 168 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGG-GTCTTCCEEECCSSCCCEE
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhH-hhcCCCCEEEccCCcceec
Confidence 99998889999999999999999999998888999999999999999999984 456554 4899999999999998876
Q ss_pred CCccCCCC------------------------------------------------------------------------
Q 005045 171 IPVSLSNA------------------------------------------------------------------------ 178 (717)
Q Consensus 171 ~~~~~~~l------------------------------------------------------------------------ 178 (717)
.+..+..+
T Consensus 169 ~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~ 248 (606)
T 3vq2_A 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248 (606)
T ss_dssp CTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred ChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence 55433222
Q ss_pred ----------------------------------------------------------CCCCEEeccCccccccCCC---
Q 005045 179 ----------------------------------------------------------SNLQVLDFAENGLTGTIPG--- 197 (717)
Q Consensus 179 ----------------------------------------------------------~~L~~L~l~~N~l~~~~~~--- 197 (717)
++|++|++++|.++ .+|.
T Consensus 249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l 327 (606)
T 3vq2_A 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDL 327 (606)
T ss_dssp CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCC
T ss_pred ccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCC
Confidence 23444444444432 2221
Q ss_pred -----------------CccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccc
Q 005045 198 -----------------NFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHL 260 (717)
Q Consensus 198 -----------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L 260 (717)
.+..+++|+.|++++|.++..... +..+..+++|++|++++|.++ .+|..+..+ ++|
T Consensus 328 ~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~----~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l-~~L 401 (606)
T 3vq2_A 328 PFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCC----SYSDLGTNSLRHLDLSFNGAI-IMSANFMGL-EEL 401 (606)
T ss_dssp SSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEEC----CHHHHCCSCCCEEECCSCSEE-EECCCCTTC-TTC
T ss_pred CccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcch----hhhhccCCcccEeECCCCccc-cchhhccCC-CCC
Confidence 234567788888888888765311 456889999999999999999 677777777 599
Q ss_pred cEEecCCCccCCCCC-ccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC-CCCcccccccccceeecc
Q 005045 261 RRLTMGENLMHGNIP-VGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG-LIPSSLGNLTILTRLWME 338 (717)
Q Consensus 261 ~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~ 338 (717)
+.|++++|.+.+..+ ..|.++++|+.|++++|++++..|..+.++++|++|++++|++++ ..|..|..+++|+.|+|+
T Consensus 402 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls 481 (606)
T 3vq2_A 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481 (606)
T ss_dssp CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECC
Confidence 999999999998877 689999999999999999998899999999999999999999997 478899999999999999
Q ss_pred cccccccCCcCccCcCCCceEEeecccCCCCCCcccc
Q 005045 339 ENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVR 375 (717)
Q Consensus 339 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 375 (717)
+|++++..|..|..+++|+.|++++|++++.+|..+.
T Consensus 482 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred CCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 9999988999999999999999999999987777654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=375.61 Aligned_cols=351 Identities=21% Similarity=0.267 Sum_probs=278.6
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|... .+++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|..
T Consensus 11 ~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-- 87 (520)
T 2z7x_B 11 GLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH-- 87 (520)
T ss_dssp CCSSCCCSCCTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--
T ss_pred CcccccccccccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--
Confidence 356677655 7899999999999877788999999999999999999888888999999999999999999 56665
Q ss_pred CCCCCCEEeccCCcCcc-cCChhhhccCCCCeEeccCCCCCCCCCccccCCCCc--cEEEcccCcc--cccCCccccc--
Q 005045 80 NFSSLKALSLAWNNLRG-SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI--YYFSVTQNQL--HGQLPTDVGL-- 152 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~L~~N~l--~~~l~~~~~~-- 152 (717)
.+++|++|+|++|++++ ..|..|+++++|++|+|++|.+++ ..|..+++| +.|++++|.+ .+..|..+..
T Consensus 88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccc
Confidence 78999999999999986 367899999999999999999985 567777777 9999999988 4444433321
Q ss_pred -----------------------C--------------------------------------------------------
Q 005045 153 -----------------------T-------------------------------------------------------- 153 (717)
Q Consensus 153 -----------------------~-------------------------------------------------------- 153 (717)
.
T Consensus 165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~ 244 (520)
T 2z7x_B 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244 (520)
T ss_dssp EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHH
T ss_pred cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHh
Confidence 1
Q ss_pred -CCCcceeecccccccccCCccC-----CCCCCCCEEeccCccccccCC-------------------------CC-ccC
Q 005045 154 -LPNLKIFAGAVNYFTGSIPVSL-----SNASNLQVLDFAENGLTGTIP-------------------------GN-FGS 201 (717)
Q Consensus 154 -l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~-------------------------~~-~~~ 201 (717)
.++|+.|++++|.+.+.+|..+ ..+++|+.+++++|.+. +| .. +..
T Consensus 245 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~--~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 322 (520)
T 2z7x_B 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG--FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322 (520)
T ss_dssp HTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCC--SCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSS
T ss_pred hhCcccEEEeecccccCccccchhhcccccCceeEecccccccee--cchhhhhcccccCceeEEEcCCCccccccchhh
Confidence 1256667777777776677766 56655555555555541 12 01 257
Q ss_pred CCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC--cCchhhhhccccccEEecCCCccCCCCCc-cc
Q 005045 202 LKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG--EMPISIANLSTHLRRLTMGENLMHGNIPV-GI 278 (717)
Q Consensus 202 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~~L~~L~l~~N~l~~~~~~-~~ 278 (717)
+++|++|++++|+++... +..+..+++|++|++++|.+++ .+|..+..+ ++|++|++++|.+.+.+|. .+
T Consensus 323 l~~L~~L~Ls~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l-~~L~~L~Ls~N~l~~~l~~~~~ 395 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTV------FENCGHLTELETLILQMNQLKELSKIAEMTTQM-KSLQQLDISQNSVSYDEKKGDC 395 (520)
T ss_dssp CCCCCEEECCSSCCCTTT------TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTC-TTCCEEECCSSCCBCCGGGCSC
T ss_pred CCcccEEEeECCccChhh------hhhhccCCCCCEEEccCCccCccccchHHHhhC-CCCCEEECCCCcCCcccccchh
Confidence 788999999999888755 5678889999999999999985 455667777 5899999999999874554 48
Q ss_pred cCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcC-ccCcCCCc
Q 005045 279 GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS-LGNCQKLL 357 (717)
Q Consensus 279 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~ 357 (717)
..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+
T Consensus 396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471 (520)
T ss_dssp CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCccc
Confidence 8889999999999999877776554 68999999999998 55776779999999999999998 56655 88899999
Q ss_pred eEEeecccCCCCCC
Q 005045 358 VLNLSSNDLNGTIP 371 (717)
Q Consensus 358 ~L~l~~N~l~~~~p 371 (717)
.|++++|++++.++
T Consensus 472 ~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 472 KIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCBCCCHH
T ss_pred EEECcCCCCcccCC
Confidence 99999999998776
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=387.20 Aligned_cols=363 Identities=20% Similarity=0.224 Sum_probs=303.0
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|..+ .+++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.
T Consensus 15 ~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~ 94 (680)
T 1ziw_A 15 KLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA 94 (680)
T ss_dssp CCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhc
Confidence 567788766 899999999999988888899999999999999999988899999999999999999999965556799
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccc--cCCCCc
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVG--LTLPNL 157 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~--~~l~~L 157 (717)
++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|++|++++|.++ .++...+ ..+++|
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L 173 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ-ALKSEELDIFANSSL 173 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC-CBCHHHHGGGTTCEE
T ss_pred cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc-ccCHHHhhccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999998 5554433 256899
Q ss_pred ceeecccccccccCCccCCCC---------------------------CCCCEEeccCccccccCCCCccCCCC--CCee
Q 005045 158 KIFAGAVNYFTGSIPVSLSNA---------------------------SNLQVLDFAENGLTGTIPGNFGSLKD--LVRL 208 (717)
Q Consensus 158 ~~L~l~~n~l~~~~~~~~~~l---------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L 208 (717)
+.|++++|.+.+..|..+..+ ++|+.|++++|.+++..|..|..++. |+.|
T Consensus 174 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L 253 (680)
T 1ziw_A 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253 (680)
T ss_dssp SEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEE
T ss_pred cEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEE
Confidence 999999999998888766544 56788888888888888888888755 9999
Q ss_pred eccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCC-----CCC----cccc
Q 005045 209 NFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG-----NIP----VGIG 279 (717)
Q Consensus 209 ~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~-----~~~----~~~~ 279 (717)
++++|.++.+. +..|..+++|++|++++|.+++..|..+..+ ++|+.|++++|...+ .+| ..|.
T Consensus 254 ~Ls~n~l~~~~------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~ 326 (680)
T 1ziw_A 254 DLSYNNLNVVG------NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL-FNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326 (680)
T ss_dssp ECTTSCCCEEC------TTTTTTCTTCCEEECCSCCBSEECTTTTTTC-TTCCEEECTTCBCCC------CCEECTTTTT
T ss_pred ECCCCCcCccC------cccccCcccccEeeCCCCccCccChhhhcCC-CCccEEeccchhhhcccccccccccChhhcc
Confidence 99999998876 6678889999999999999997777777777 588888888875542 122 2677
Q ss_pred CCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCC--CCCCcccccc--cccceeecccccccccCCcCccCcCC
Q 005045 280 NLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS--GLIPSSLGNL--TILTRLWMEENRLEGSIPPSLGNCQK 355 (717)
Q Consensus 280 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~ 355 (717)
.+++|++|++++|++++..+..|.++++|++|++++|.++ .+....|..+ ++|+.|+|++|++++..|..|..+++
T Consensus 327 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 406 (680)
T 1ziw_A 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406 (680)
T ss_dssp TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence 8888888888888888877778888888888888888743 2233344433 47888888888888777778888888
Q ss_pred CceEEeecccCCCCCCc
Q 005045 356 LLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 356 L~~L~l~~N~l~~~~p~ 372 (717)
|+.|++++|.+++.+|.
T Consensus 407 L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 407 LEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCEEECCSSCCEEECCS
T ss_pred CCEEeCCCCcCccccCc
Confidence 88888888888766664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=382.95 Aligned_cols=364 Identities=22% Similarity=0.249 Sum_probs=297.4
Q ss_pred CcceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccc
Q 005045 1 MELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWI 78 (717)
Q Consensus 1 ~~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 78 (717)
+.|+.||..+ .+++|+|++|+|+++.|.+|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+.+|
T Consensus 41 ~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f 120 (635)
T 4g8a_A 41 LNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 120 (635)
T ss_dssp SCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGG
T ss_pred CCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHh
Confidence 3678899877 89999999999998888899999999999999999998888899999999999999999997777889
Q ss_pred cCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCC-CCccccCCCCccEEEcccCcccccCCcccccC----
Q 005045 79 GNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLT---- 153 (717)
Q Consensus 79 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~---- 153 (717)
.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++. .|..+..+++|++|+|++|++++..+.. +..
T Consensus 121 ~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-l~~L~~l 199 (635)
T 4g8a_A 121 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD-LRVLHQM 199 (635)
T ss_dssp TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG-GHHHHTC
T ss_pred cCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc-ccchhhh
Confidence 9999999999999999977778899999999999999999864 5788999999999999999987322211 100
Q ss_pred --------------------------------------------------------------------------------
Q 005045 154 -------------------------------------------------------------------------------- 153 (717)
Q Consensus 154 -------------------------------------------------------------------------------- 153 (717)
T Consensus 200 ~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~ 279 (635)
T 4g8a_A 200 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 279 (635)
T ss_dssp TTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGG
T ss_pred hhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccccc
Confidence
Q ss_pred -----------------------------------------------CCCcceeecccccccccCCc-------------
Q 005045 154 -----------------------------------------------LPNLKIFAGAVNYFTGSIPV------------- 173 (717)
Q Consensus 154 -----------------------------------------------l~~L~~L~l~~n~l~~~~~~------------- 173 (717)
..+|+.|++.+|.+....+.
T Consensus 280 ~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n 359 (635)
T 4g8a_A 280 NLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 359 (635)
T ss_dssp GSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESC
T ss_pred chhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccc
Confidence 11233333444433322111
Q ss_pred ------cCCCCCCCCEEeccCcccccc-------------------------CCCCccCCCCCCeeeccccccCCcccCc
Q 005045 174 ------SLSNASNLQVLDFAENGLTGT-------------------------IPGNFGSLKDLVRLNFDQNELGSREIGD 222 (717)
Q Consensus 174 ------~~~~l~~L~~L~l~~N~l~~~-------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 222 (717)
....+++|+.|++++|.+... .+..+..+++|+.++++.|+......
T Consensus 360 ~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~-- 437 (635)
T 4g8a_A 360 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE-- 437 (635)
T ss_dssp CSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTS--
T ss_pred cCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccc--
Confidence 123467788888888877532 22345556666777776665554331
Q ss_pred hhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCcc-CCCCCccccCCCCCCEEEccCCcCccccchh
Q 005045 223 LNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLM-HGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV 301 (717)
Q Consensus 223 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 301 (717)
...+.++++++.++++.|.+.+..+..+... +.|+.|++++|.+ .+..|..|..+++|++|+|++|+|++..|..
T Consensus 438 ---~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~-~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 438 ---FSVFLSLRNLIYLDISHTHTRVAFNGIFNGL-SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp ---SCTTTTCTTCCEEECTTSCCEECCTTTTTTC-TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ---ccccccccccccccccccccccccccccccc-hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 3457788999999999999996666666666 6999999999974 4457888999999999999999999888999
Q ss_pred hhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCc-CCCceEEeecccCCCCCC
Q 005045 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC-QKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p 371 (717)
|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|+|++..|..+..+ ++|+.|+|++|||++.+.
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999999999999999999999998889999988 689999999999998765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=393.43 Aligned_cols=354 Identities=23% Similarity=0.221 Sum_probs=203.7
Q ss_pred eecEEEcCCCcCcCCC-CcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcc--ccCCCCCCEE
Q 005045 11 MTQDLNLTYNYLSGKI-PTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAW--IGNFSSLKAL 87 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L 87 (717)
+|++|+|++|...+.+ |.+|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.+|.. |.++++|++|
T Consensus 49 ~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L 128 (844)
T 3j0a_A 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128 (844)
T ss_dssp SCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEE
T ss_pred cCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEE
Confidence 5666666666443333 556666666666666666666555666666666666666666666544433 5666666666
Q ss_pred eccCCcCcccCC-hhhhccCCCCeEeccCCCCCCCCCccccCC--------------------------CC------ccE
Q 005045 88 SLAWNNLRGSIP-NELGQLSGLGFFTLYGNFISGIIPSSIYNI--------------------------SS------IYY 134 (717)
Q Consensus 88 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l--------------------------~~------L~~ 134 (717)
+|++|.+++..+ ..|.++++|++|+|++|.+++..+..|..+ ++ |+.
T Consensus 129 ~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~ 208 (844)
T 3j0a_A 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208 (844)
T ss_dssp EEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSE
T ss_pred ECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeE
Confidence 666666654433 356666666666666666654444433222 11 444
Q ss_pred EEcccCcccc-------------------------------------------------------------cCCcccccC
Q 005045 135 FSVTQNQLHG-------------------------------------------------------------QLPTDVGLT 153 (717)
Q Consensus 135 L~L~~N~l~~-------------------------------------------------------------~l~~~~~~~ 153 (717)
|+|++|.+++ .++...+..
T Consensus 209 L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~ 288 (844)
T 3j0a_A 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288 (844)
T ss_dssp EBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS
T ss_pred EecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc
Confidence 4444443322 222233344
Q ss_pred CCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCC
Q 005045 154 LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233 (717)
Q Consensus 154 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~ 233 (717)
+++|+.|++++|.+.+..+..|.++++|++|+|++|.+++..|..|..+++|+.|++++|.+..++ +..|.+++
T Consensus 289 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~------~~~~~~l~ 362 (844)
T 3j0a_A 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ------DQTFKFLE 362 (844)
T ss_dssp CCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCC------SSCSCSCC
T ss_pred CCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccC------hhhhcCCC
Confidence 555555555555555555555555555555555555555555555555555555555555555544 33455555
Q ss_pred CCCEEEeecCcccCcCch-----------------------------------------hhhhccccccEEecCCCccCC
Q 005045 234 SLEVLGLARNSFGGEMPI-----------------------------------------SIANLSTHLRRLTMGENLMHG 272 (717)
Q Consensus 234 ~L~~L~L~~N~l~~~~p~-----------------------------------------~~~~~~~~L~~L~l~~N~l~~ 272 (717)
+|+.|+|++|.+++ ++. .+..+ ++|+.|++++|.+++
T Consensus 363 ~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l-~~L~~L~Ls~N~l~~ 440 (844)
T 3j0a_A 363 KLQTLDLRDNALTT-IHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV-PHLQILILNQNRFSS 440 (844)
T ss_dssp CCCEEEEETCCSCC-CSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTC-TTCCEEEEESCCCCC
T ss_pred CCCEEECCCCCCCc-ccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcC-CccceeeCCCCcccc
Confidence 66666665555542 110 01122 345555555555543
Q ss_pred CCCc-cccCCCCCCEEEccCCcCc-----cccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccC
Q 005045 273 NIPV-GIGNLVNLNLLGLEGNNLS-----GSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSI 346 (717)
Q Consensus 273 ~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 346 (717)
..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++.+|..|.++++|+.|+|++|++++..
T Consensus 441 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~ 520 (844)
T 3j0a_A 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS 520 (844)
T ss_dssp CCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCC
T ss_pred cccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccC
Confidence 2221 2334455555555555554 223345677788888888888888888888888888888888888888655
Q ss_pred CcCccCcCCCceEEeecccCCCCCCccc
Q 005045 347 PPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 347 p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
|..+. ++|+.|++++|.|++..|...
T Consensus 521 ~~~~~--~~L~~L~Ls~N~l~~~~~~~~ 546 (844)
T 3j0a_A 521 HNDLP--ANLEILDISRNQLLAPNPDVF 546 (844)
T ss_dssp CCCCC--SCCCEEEEEEECCCCCCSCCC
T ss_pred hhhhh--ccccEEECCCCcCCCCChhHh
Confidence 55555 678888888888877666543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.54 Aligned_cols=351 Identities=17% Similarity=0.167 Sum_probs=306.5
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcccccc-CCccccCCCCCCEEec
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN-VPAWIGNFSSLKALSL 89 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L 89 (717)
.-+.++.++++++ .+|. +. ++|++|+|++|.+++..|..|.++++|++|+|++|.+.+. .+..|.++++|++|+|
T Consensus 11 ~~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 11 IGYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp ETTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred EccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 3457899999998 6776 33 7899999999999988899999999999999999999744 4678999999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCcc--ccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccc
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSS--IYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYF 167 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l 167 (717)
++|++++..|..|.++++|++|+|++|.+++..+.. |.++++|++|+|++|.+++..|...+..+++|++|++++|.+
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 999999888999999999999999999999755544 999999999999999999666777788999999999999999
Q ss_pred cccCCccCCCC--CCCCEEeccCccccccCCCC--------ccCCCCCCeeeccccccCCcccCchhhhhhhcc---CCC
Q 005045 168 TGSIPVSLSNA--SNLQVLDFAENGLTGTIPGN--------FGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN---CTS 234 (717)
Q Consensus 168 ~~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~--------~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~---l~~ 234 (717)
.+..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+.|++++|.++... +..+.. .++
T Consensus 167 ~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~------~~~~~~~~~~~~ 240 (455)
T 3v47_A 167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM------AKRFFDAIAGTK 240 (455)
T ss_dssp SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHH------HHHHHHHTTTCC
T ss_pred cccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccc------hhhhhccccccc
Confidence 99999888876 79999999999999655544 336789999999999998755 444443 389
Q ss_pred CCEEEeecCcccCc----------Cchhhhhc-cccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhh
Q 005045 235 LEVLGLARNSFGGE----------MPISIANL-STHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIG 303 (717)
Q Consensus 235 L~~L~L~~N~l~~~----------~p~~~~~~-~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 303 (717)
|+.|++++|.+.+. .+..+... .++|+.|++++|.+.+..+..|.++++|++|+|++|++++..|..|.
T Consensus 241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 320 (455)
T 3v47_A 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320 (455)
T ss_dssp EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred eeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhc
Confidence 99999999865532 11222221 14899999999999999999999999999999999999988899999
Q ss_pred cCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCc
Q 005045 304 RLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|++++|.+++ +|.
T Consensus 321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~ 388 (455)
T 3v47_A 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPD 388 (455)
T ss_dssp TCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC-CCT
T ss_pred CcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc-CCH
Confidence 99999999999999999989999999999999999999998889999999999999999999985 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=373.89 Aligned_cols=354 Identities=21% Similarity=0.261 Sum_probs=275.1
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|... .+++|+|++|++++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|.|+ .+|..
T Consensus 42 ~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-- 118 (562)
T 3a79_B 42 NLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC-- 118 (562)
T ss_dssp CCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--
T ss_pred CCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--
Confidence 356677654 7889999999998777788999999999999999998888888999999999999999988 56665
Q ss_pred CCCCCCEEeccCCcCccc-CChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcc--cccCCccccc----
Q 005045 80 NFSSLKALSLAWNNLRGS-IPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQL--HGQLPTDVGL---- 152 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l--~~~l~~~~~~---- 152 (717)
.+++|++|+|++|++++. .|..|.++++|++|+|++|.++......+.++ +|++|++++|.+ ++..|..+..
T Consensus 119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l~~~~~~~~~l~~l~~~ 197 (562)
T 3a79_B 119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESLQIPNTT 197 (562)
T ss_dssp CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSCCCCSSSCCEEEECCEE
T ss_pred ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccccccccCcccccccCcc
Confidence 788999999999998863 35788999999999999999886433333333 449999999888 5444433221
Q ss_pred ---------------------CC-------------------------------------------------------CC
Q 005045 153 ---------------------TL-------------------------------------------------------PN 156 (717)
Q Consensus 153 ---------------------~l-------------------------------------------------------~~ 156 (717)
.+ ++
T Consensus 198 ~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~ 277 (562)
T 3a79_B 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277 (562)
T ss_dssp EEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSS
T ss_pred eEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhccc
Confidence 11 25
Q ss_pred cceeecccccccccCCccC-----CCC--------------------------CCCCEEeccCccccccCCCCccCCCCC
Q 005045 157 LKIFAGAVNYFTGSIPVSL-----SNA--------------------------SNLQVLDFAENGLTGTIPGNFGSLKDL 205 (717)
Q Consensus 157 L~~L~l~~n~l~~~~~~~~-----~~l--------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L 205 (717)
|++|++++|.+.+.+|..+ ..+ .+|++|++++|.+.... .+..+++|
T Consensus 278 L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L 355 (562)
T 3a79_B 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSF 355 (562)
T ss_dssp EEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCC
T ss_pred ccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCc
Confidence 6666666777766666555 222 23555666666554211 12678899
Q ss_pred CeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC--cCchhhhhccccccEEecCCCccCCCCC-ccccCCC
Q 005045 206 VRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG--EMPISIANLSTHLRRLTMGENLMHGNIP-VGIGNLV 282 (717)
Q Consensus 206 ~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~ 282 (717)
+.|++++|+++... +..+.++++|++|+|++|++++ .+|..+..+ ++|++|++++|.+++.+| ..+..++
T Consensus 356 ~~L~l~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~l~ 428 (562)
T 3a79_B 356 TFLNFTQNVFTDSV------FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM-SSLETLDVSLNSLNSHAYDRTCAWAE 428 (562)
T ss_dssp CEEECCSSCCCTTT------TTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTC-TTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred eEEECCCCccccch------hhhhcccCCCCEEECCCCCcCCcccchhhhcCC-CCCCEEECCCCcCCCccChhhhcCcc
Confidence 99999999999865 6778999999999999999995 234556666 599999999999997444 4588999
Q ss_pred CCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcC-ccCcCCCceEEe
Q 005045 283 NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS-LGNCQKLLVLNL 361 (717)
Q Consensus 283 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l 361 (717)
+|+.|+|++|++++..|..+. ++|++|+|++|+++.+ |..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l 504 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL 504 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCC-CTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEEC
T ss_pred cCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCccc-ChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEe
Confidence 999999999999876666543 6999999999999954 555669999999999999999 56665 999999999999
Q ss_pred ecccCCCCCCc
Q 005045 362 SSNDLNGTIPK 372 (717)
Q Consensus 362 ~~N~l~~~~p~ 372 (717)
++|++++.+|-
T Consensus 505 ~~N~~~c~c~~ 515 (562)
T 3a79_B 505 HDNPWDCTCPG 515 (562)
T ss_dssp CSCCBCCCHHH
T ss_pred cCCCcCCCcch
Confidence 99999988773
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=379.73 Aligned_cols=356 Identities=21% Similarity=0.196 Sum_probs=280.5
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCC--CCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEE
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTE--LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKAL 87 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 87 (717)
..+++|+|++|++++..|..|..++. |+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|..+++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 36788999999999888888888865 9999999999998888889999999999999999998888889999999999
Q ss_pred eccCCcCcc-----cCC----hhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccc-cCCcccccCC--C
Q 005045 88 SLAWNNLRG-----SIP----NELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHG-QLPTDVGLTL--P 155 (717)
Q Consensus 88 ~L~~n~l~~-----~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~l~~~~~~~l--~ 155 (717)
+|++|...+ .+| ..|..+++|++|+|++|.++++.+..|.++++|++|++++|.++. .++...|..+ +
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 998875542 222 368888999999999999998888889999999999999887532 4444444333 5
Q ss_pred CcceeecccccccccCCccCCCCCCCCEEeccCccccccCC-CCccCCCCCCeeeccccccCCcccCchhhhhhhccCCC
Q 005045 156 NLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIP-GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234 (717)
Q Consensus 156 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~ 234 (717)
+|+.|++++|.+.+..|..|..+++|++|++++|.+++.+| ..|..+++|+.|++++|++..+. +..|..+++
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~------~~~~~~~~~ 455 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT------RNSFALVPS 455 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC------TTTTTTCTT
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC------hhhhhcCcc
Confidence 78888888888888888888888888888888888876555 57888888888888888887766 556777788
Q ss_pred CCEEEeecCccc--CcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccc--------hhhhc
Q 005045 235 LEVLGLARNSFG--GEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP--------EVIGR 304 (717)
Q Consensus 235 L~~L~L~~N~l~--~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~ 304 (717)
|+.|++++|.++ +.+|..+..+ ++|+.|++++|.+++..+..|.++++|++|+|++|++++..+ ..|.+
T Consensus 456 L~~L~l~~n~l~~~~~~p~~~~~l-~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~ 534 (680)
T 1ziw_A 456 LQRLMLRRVALKNVDSSPSPFQPL-RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534 (680)
T ss_dssp CCEEECTTSCCBCTTCSSCTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred cccchhccccccccccCCcccccC-CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence 888888888775 4566667666 478888888888877777778888888888888888775422 23677
Q ss_pred CCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCc
Q 005045 305 LNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 305 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
+++|+.|+|++|+++.+.+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+++..|.
T Consensus 535 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~ 602 (680)
T 1ziw_A 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHH
T ss_pred CCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChh
Confidence 78888888888888866666778888888888888888755556677788888888888888754443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.91 Aligned_cols=270 Identities=24% Similarity=0.409 Sum_probs=213.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++. +++.
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 81 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKR 81 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCe
Confidence 45679999999999999999999965 78999999886666666788999999999999999999999964 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCC
T ss_pred eEEEEEecCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeec
Confidence 999999999999999997532 5689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCC-------CcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 545 GLAKFLFEISDNPSK-------NQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 545 g~~~~~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
|.+............ .........||+.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 999875322211100 0011124569999999999765 47999999999999999999999987643322111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
... .....+.. .+..++..+.+++.+||+.+|++|||++
T Consensus 233 ~~~--------~~~~~~~~---------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ 271 (310)
T 3s95_A 233 GLN--------VRGFLDRY---------------------------------CPPNCPPSFFPITVRCCDLDPEKRPSFV 271 (310)
T ss_dssp SBC--------HHHHHHHT---------------------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHH
T ss_pred hhh--------hhcccccc---------------------------------CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 000 00000000 1122355678899999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 005045 697 VVVNNLKTIRNCFL 710 (717)
Q Consensus 697 eil~~l~~i~~~~~ 710 (717)
|+++.|++++....
T Consensus 272 ~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 272 KLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcc
Confidence 99999999997764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.50 Aligned_cols=286 Identities=36% Similarity=0.612 Sum_probs=224.4
Q ss_pred CCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 377 SGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 377 ~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
..+++.++....++|++.+.||+|+||.||+|..++++.||+|++..... .....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 35888999999999999999999999999999988899999999875432 22346889999999999999999999954
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
..+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+||+++.
T Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 98 -----TPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp -----CSSCCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred -----cCCceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 44578999999999999999976532 1245899999999999999999999965558999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCC---CC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDM---FK 611 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~---~~ 611 (717)
++.+||+|||.+..... ..........||+.|+|||++. +.++.++|||||||++|+|++|..||... ..
T Consensus 170 ~~~~kl~Dfg~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDY------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp TCCEEECCCSSCEECCS------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred CCCEEeccCccccccCc------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 99999999999986521 1122233455899999999964 45899999999999999999999999632 12
Q ss_pred CchhhhHHHHhcCChh-hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 612 DDFSIHMFVSMALPDH-VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.......+........ +....+...... ...+++..+.+++.+||+.+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~ 294 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGN-----------------------------YKDEEVEQLIQVALLCTQSSPM 294 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTS-----------------------------CCHHHHHHHHHHHHHHTCSCGG
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhccc-----------------------------cCHHHHHHHHHHHHHHhCcCCc
Confidence 2223333333322222 333333333221 2344577899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTI 705 (717)
Q Consensus 691 ~Rps~~eil~~l~~i 705 (717)
+|||++||++.|+..
T Consensus 295 ~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 295 ERPKMSEVVRMLEGD 309 (326)
T ss_dssp GSCCHHHHHHHHHTS
T ss_pred cCCCHHHHHHHhcCc
Confidence 999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.54 Aligned_cols=272 Identities=28% Similarity=0.426 Sum_probs=203.1
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEe
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITA 453 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 453 (717)
+......++....++|++.+.||+|+||.||+|++ .|+.||+|++.... ....+.+.+|++++++++||||++++++
T Consensus 24 ~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 24 QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp --------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 44677778888899999999999999999999987 58889999986442 3445778899999999999999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCE
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNV 531 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NI 531 (717)
+ ......++||||+++++|.+++.... ....+++..+..++.||+.||+|||+. + |+||||||+||
T Consensus 103 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NI 170 (309)
T 3p86_A 103 V-----TQPPNLSIVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNL 170 (309)
T ss_dssp E-----CSTTCCEEEEECCTTCBHHHHHHSTT----HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGE
T ss_pred E-----EECCceEEEEecCCCCcHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhE
Confidence 5 34557899999999999999997642 113489999999999999999999997 8 99999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+++.++.+||+|||.+..... .........||+.|+|||++.+. ++.++|||||||++|+|++|..||....
T Consensus 171 ll~~~~~~kL~Dfg~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 171 LVDKKYTVKVCDFGLSRLKAS-------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp EECTTCCEEECCCC------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred EEeCCCcEEECCCCCCccccc-------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999975411 11222345689999999997654 8999999999999999999999997542
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
... ........ ..... .+..++..+.+++.+||+.+|+
T Consensus 244 ~~~--~~~~~~~~---------~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dP~ 281 (309)
T 3p86_A 244 PAQ--VVAAVGFK---------CKRLE-------------------------------IPRNLNPQVAAIIEGCWTNEPW 281 (309)
T ss_dssp HHH--HHHHHHHS---------CCCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHH--HHHHHHhc---------CCCCC-------------------------------CCccCCHHHHHHHHHHccCChh
Confidence 211 11111000 00000 1122355688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~~ 709 (717)
+|||++|+++.|+.+.+..
T Consensus 282 ~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 282 KRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp GSCCHHHHHHHHHHHHC--
T ss_pred hCcCHHHHHHHHHHHHHhC
Confidence 9999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.39 Aligned_cols=287 Identities=21% Similarity=0.274 Sum_probs=214.7
Q ss_pred ccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.++....++|++.++||+|+||.||+|++. ++.||+|++...... ......|+.++++++||||+++++++.... ..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred cccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 445566789999999999999999999975 789999998755332 345567999999999999999999976532 22
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhc-------CCCCeeecCCCCCCEEeC
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH-------CDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~dlkp~NIll~ 534 (717)
....++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +.++|+||||||+||+++
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred CceEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 3458999999999999999964 3489999999999999999999984 123899999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.++.+||+|||.++...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||..
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGK-----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp TTCCEEECCCTTCEEECTTS-----CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred CCCeEEEccCCccccccccc-----CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999997653221 1112233568999999999765 356788999999999999999999976
Q ss_pred CCCCchhhhHHHHhcCC--hhhhhh-cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccC
Q 005045 609 MFKDDFSIHMFVSMALP--DHVMDI-LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCS 685 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 685 (717)
................+ ..+... ....... ..........++..+.+++.+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP------------------------VLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCC------------------------CCCGGGGSSHHHHHHHHHHHHHT
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCC------------------------CccccccccchHHHHHHHHHHHc
Confidence 54432211111111111 011111 1111111 11111223345777999999999
Q ss_pred CCCcCCCCCHHHHHHHHHHHHHH
Q 005045 686 TTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 686 ~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+.||++||||+||++.|+++++.
T Consensus 297 ~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 297 DHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.98 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=203.3
Q ss_pred cccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
....++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++. ..+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 90 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGD 90 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECC
Confidence 34667999999999999999999995 489999999987665555678899999999999999999999854 345
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEEEECCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 89999999999999999864 3488999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+..... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... .....
T Consensus 160 fg~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~ 231 (297)
T 3fxz_A 160 FGFCAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231 (297)
T ss_dssp CTTCEECCS-------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHH
T ss_pred CCCceecCC-------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhC
Confidence 999876521 1112334569999999999655 58999999999999999999999996542211100 00000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.. ..++.++..+.+++.+||+.||++|||++|+++
T Consensus 232 ---------~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 232 ---------GTPEL-------------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ---------CSCCC-------------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CCCCC-------------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00000 012233566889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=361.59 Aligned_cols=319 Identities=19% Similarity=0.182 Sum_probs=195.9
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
+.++.++++++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46777777777 5665553 56777777777777666777777777777777777777666777777777777777777
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 172 (717)
+++...+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.++ .++...+..+++|+.|++++|.++...+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC-EECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc-eeChhhccCCCCCCEEECCCCcCcccCh
Confidence 777555566777777777777777777777777777777777777777776 4444444456666666666666665544
Q ss_pred ccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc-h
Q 005045 173 VSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP-I 251 (717)
Q Consensus 173 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~ 251 (717)
..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+.... +.......+|+.|+|++|.++ .+| .
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~------~~~~~~~~~L~~L~l~~n~l~-~~~~~ 242 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM------TPNCLYGLNLTSLSITHCNLT-AVPYL 242 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEE------CTTTTTTCCCSEEEEESSCCC-SCCHH
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccccc------CcccccCccccEEECcCCccc-ccCHH
Confidence 55666666666666666666555555555666666666555433221 122222335555555555555 333 2
Q ss_pred hhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccc
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI 331 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 331 (717)
.+..+ ++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+++++.+..|..+++
T Consensus 243 ~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 321 (477)
T 2id5_A 243 AVRHL-VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321 (477)
T ss_dssp HHTTC-TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGG
T ss_pred HhcCc-cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcc
Confidence 33333 35555555555555444555555555555555555555555555555555555555555555555455555555
Q ss_pred cceeeccccccc
Q 005045 332 LTRLWMEENRLE 343 (717)
Q Consensus 332 L~~L~L~~N~l~ 343 (717)
|+.|+|++|++.
T Consensus 322 L~~L~l~~N~l~ 333 (477)
T 2id5_A 322 LETLILDSNPLA 333 (477)
T ss_dssp CCEEECCSSCEE
T ss_pred cCEEEccCCCcc
Confidence 555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=361.02 Aligned_cols=341 Identities=18% Similarity=0.159 Sum_probs=301.7
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCcccc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIG 79 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 79 (717)
.++.+|..+ .+++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+..|.
T Consensus 22 ~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 101 (477)
T 2id5_A 22 RFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101 (477)
T ss_dssp CCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSST
T ss_pred CcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCccccc
Confidence 466788766 899999999999988899999999999999999999988899999999999999999999966667789
Q ss_pred CCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcce
Q 005045 80 NFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKI 159 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~ 159 (717)
++++|++|+|++|++++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|+++ .++...+..+++|+.
T Consensus 102 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~ 180 (477)
T 2id5_A 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIV 180 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS-SCCHHHHTTCTTCCE
T ss_pred CCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc-ccChhHhcccCCCcE
Confidence 9999999999999999888999999999999999999999999999999999999999999998 888888889999999
Q ss_pred eecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEE
Q 005045 160 FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239 (717)
Q Consensus 160 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~ 239 (717)
|++++|.+.+..+..|..+++|++|++++|...+.+|.......+|+.|++++|.++.++ ...+..+++|+.|+
T Consensus 181 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~ 254 (477)
T 2id5_A 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP------YLAVRHLVYLRFLN 254 (477)
T ss_dssp EEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCC------HHHHTTCTTCCEEE
T ss_pred EeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccC------HHHhcCccccCeeE
Confidence 999999999998899999999999999999888788877777789999999999999887 67889999999999
Q ss_pred eecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCC
Q 005045 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS 319 (717)
Q Consensus 240 L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 319 (717)
|++|.+++..+..+..+ ++|+.|+|++|.+.+..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++.
T Consensus 255 Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 255 LSYNPISTIEGSMLHEL-LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CCSSCCCEECTTSCTTC-TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CCCCcCCccChhhcccc-ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 99999996666667766 59999999999999999999999999999999999999877788899999999999999998
Q ss_pred CCCCcccccccccceeecccccccccCCcCcc
Q 005045 320 GLIPSSLGNLTILTRLWMEENRLEGSIPPSLG 351 (717)
Q Consensus 320 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 351 (717)
..-+ ...-...+..+.+.++...+..|..+.
T Consensus 334 c~c~-~~~~~~~~~~~~~~~~~~~C~~p~~~~ 364 (477)
T 2id5_A 334 CDCR-LLWVFRRRWRLNFNRQQPTCATPEFVQ 364 (477)
T ss_dssp CSGG-GHHHHTTTTSSCCTTCCCBEEESGGGT
T ss_pred Cccc-hHhHHhhhhccccCccCceeCCchHHc
Confidence 5421 111122333455555555554554443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.05 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=202.1
Q ss_pred cccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
.++.....++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+++.+|+++++.++||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--- 83 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI--- 83 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 345556678999999999999999999996 48999999998654 334567788999999999999999999995
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
...+..++||||+++++|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 84 --~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~ 151 (328)
T 3fe3_A 84 --ETEKTLYLIMEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADM 151 (328)
T ss_dssp --ECSSEEEEEECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred --EECCEEEEEEECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCC
Confidence 4456899999999999999998644 5689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||++..... ........||+.|+|||++.+. + +.++||||+||++|+|++|..||.......
T Consensus 152 ~~kl~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 221 (328)
T 3fe3_A 152 NIKIADFGFSNEFTV--------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-- 221 (328)
T ss_dssp CEEECSTTCCGGGSS--------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CEEEeeccCceecCC--------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999976521 1122345699999999997654 3 589999999999999999999997542111
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
..... ....... +..++..+.+++.+||+.||++|||+
T Consensus 222 ~~~~i-----------~~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dP~~R~t~ 259 (328)
T 3fe3_A 222 LRERV-----------LRGKYRI-------------------------------PFYMSTDCENLLKRFLVLNPIKRGTL 259 (328)
T ss_dssp HHHHH-----------HHCCCCC-------------------------------CTTSCHHHHHHHHHHCCSSTTTSCCH
T ss_pred HHHHH-----------HhCCCCC-------------------------------CCCCCHHHHHHHHHHCCCChhHCcCH
Confidence 11110 0000000 01114457789999999999999999
Q ss_pred HHHHHH
Q 005045 696 NVVVNN 701 (717)
Q Consensus 696 ~eil~~ 701 (717)
+|+++.
T Consensus 260 ~eil~h 265 (328)
T 3fe3_A 260 EQIMKD 265 (328)
T ss_dssp HHHTTC
T ss_pred HHHhcC
Confidence 999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.83 Aligned_cols=283 Identities=26% Similarity=0.435 Sum_probs=220.5
Q ss_pred CCCCcccccccccccccc------cccCcccccceEEEEeCCCchhhhHHhHhh----hhhHHHHHHHHHHHHhcCCCCc
Q 005045 377 SGMSYSDISKSTDNFSKE------NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ----QQGALKSFIDECNALKSTRHRN 446 (717)
Q Consensus 377 ~~~s~~~~~~~~~~y~~~------~~ig~g~~g~v~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~n 446 (717)
..|++.++...+++|... ++||+|+||.||+|.. +++.||+|++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 346666667776666655 8999999999999997 5788999987642 2344678899999999999999
Q ss_pred eeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 005045 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDL 526 (717)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 526 (717)
|+++++++ ...+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+. +++||||
T Consensus 92 i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl 159 (307)
T 2nru_A 92 LVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDI 159 (307)
T ss_dssp BCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred eEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCC
Confidence 99999995 34457899999999999999987432 114689999999999999999999998 9999999
Q ss_pred CCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCC
Q 005045 527 KPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 527 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
||+||+++.++.+||+|||.+...... ..........|++.|+|||++.+.++.++|||||||++|+|++|..||
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKF-----AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSC-----SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred CHHHEEEcCCCcEEEeecccccccccc-----cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999998765211 111222345689999999999888999999999999999999999999
Q ss_pred CCCCCCchhhhHH-HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccC
Q 005045 607 GDMFKDDFSIHMF-VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCS 685 (717)
Q Consensus 607 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 685 (717)
............. ........+.+.+++.+.. ....++..+.+++.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl 284 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND------------------------------ADSTSVEAMYSVASQCL 284 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC------------------------------CCHHHHHHHHHHHHHHT
T ss_pred ccCcchHHHHHHHHHhhhhhhhhhhhccccccc------------------------------cchHHHHHHHHHHHHHc
Confidence 8754332211111 0111122234444444322 22445778899999999
Q ss_pred CCCcCCCCCHHHHHHHHHHHHH
Q 005045 686 TTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 686 ~~~p~~Rps~~eil~~l~~i~~ 707 (717)
+.+|++|||++||++.|+++.+
T Consensus 285 ~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 285 HEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CSSTTTSCCHHHHHHHHHHHC-
T ss_pred CCCcccCcCHHHHHHHHHHHhc
Confidence 9999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=349.85 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=207.2
Q ss_pred ccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...++|++.+.||+|+||.||.|.+. .+..||+|++... .....+.+.+|++++++++||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 34679999999999999999999964 3445999998754 334567889999999999999999999995 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEE
Confidence 4558899999999999999996543 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.+...... ...........+|+.|+|||++.+ .++.++|||||||++|+|++ |..||....... ...
T Consensus 192 l~Dfg~a~~~~~~----~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~ 265 (325)
T 3kul_A 192 VSDFGLSRVLEDD----PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VIS 265 (325)
T ss_dssp ECCCSSCEECC--------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHH
T ss_pred ECCCCcccccccC----ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHH
Confidence 9999999865221 111222233446778999999754 58999999999999999999 999996542221 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... ..... .+..++..+.+++.+||+.+|++|||++||
T Consensus 266 ~~~~--------~~~~~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 266 SVEE--------GYRLP---------------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp HHHT--------TCCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHc--------CCCCC---------------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1100 00000 112235678899999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 005045 699 VNNLKTIRNCFLE 711 (717)
Q Consensus 699 l~~l~~i~~~~~~ 711 (717)
++.|+.+.+....
T Consensus 305 l~~L~~l~~~~~~ 317 (325)
T 3kul_A 305 VSVLDALIRSPES 317 (325)
T ss_dssp HHHHHHHHHSCC-
T ss_pred HHHHHHHHhCccc
Confidence 9999999865443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=360.68 Aligned_cols=323 Identities=19% Similarity=0.236 Sum_probs=274.6
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcccccc-CCccccCCCCCCEEe
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN-VPAWIGNFSSLKALS 88 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~ 88 (717)
.++++|+|++|++++..|++|..+++|++|+|++|.++ .+|.. .+++|++|+|++|.+++. .|..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 38999999999999988999999999999999999999 67765 899999999999999963 468999999999999
Q ss_pred ccCCcCcccCChhhhccCCC--CeEeccCCCC--CCCCCccccCCC----------------------------------
Q 005045 89 LAWNNLRGSIPNELGQLSGL--GFFTLYGNFI--SGIIPSSIYNIS---------------------------------- 130 (717)
Q Consensus 89 L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~---------------------------------- 130 (717)
|++|++++ ..|..+++| ++|+|++|.+ ++..|..|..+.
T Consensus 153 L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 153 LSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp EECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred cCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 99999985 346666666 9999999999 777787777654
Q ss_pred -----------------------------------------------CccEEEcccCcccccCCccccc----CC-----
Q 005045 131 -----------------------------------------------SIYYFSVTQNQLHGQLPTDVGL----TL----- 154 (717)
Q Consensus 131 -----------------------------------------------~L~~L~L~~N~l~~~l~~~~~~----~l----- 154 (717)
+|++|++++|.++|.+|..+|. .+
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 7888888889988888877641 22
Q ss_pred ---------------------CCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeecccc
Q 005045 155 ---------------------PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQN 213 (717)
Q Consensus 155 ---------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 213 (717)
.+|+.|++++|.+.... ....+++|++|++++|.+++..|..|..+++|+.|++++|
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 387 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSS
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCC
Confidence 34677777777765322 1278899999999999999889999999999999999999
Q ss_pred ccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCc
Q 005045 214 ELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293 (717)
Q Consensus 214 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 293 (717)
+++.++. .+..+.++++|+.|++++|.+++.+|...+...++|++|++++|.+++..|..+. ++|+.|+|++|+
T Consensus 388 ~l~~~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~ 461 (562)
T 3a79_B 388 GLKNFFK----VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNR 461 (562)
T ss_dssp CCCBTTH----HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSC
T ss_pred CcCCccc----chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCc
Confidence 9998651 2467899999999999999999757776554447999999999999877666654 799999999999
Q ss_pred CccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCC
Q 005045 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347 (717)
Q Consensus 294 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 347 (717)
|+ .+|..+..+++|++|+|++|+++++++..|..+++|+.|+|++|++.+..+
T Consensus 462 l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 462 IM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred Cc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 99 677777799999999999999997665569999999999999999986544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=360.18 Aligned_cols=324 Identities=23% Similarity=0.305 Sum_probs=276.8
Q ss_pred cceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccc-cCCccccCCCCCCEE
Q 005045 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTG-NVPAWIGNFSSLKAL 87 (717)
Q Consensus 9 ~~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L 87 (717)
..++++|+|++|++++..|..|+.+++|++|+|++|.++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 348999999999999888999999999999999999999 57765 89999999999999996 468899999999999
Q ss_pred eccCCcCcccCChhhhccCCC--CeEeccCCCC--CCCCCccccCCC---------------------------------
Q 005045 88 SLAWNNLRGSIPNELGQLSGL--GFFTLYGNFI--SGIIPSSIYNIS--------------------------------- 130 (717)
Q Consensus 88 ~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~--------------------------------- 130 (717)
+|++|+|++ ..|..+++| +.|+|++|.+ .+..|..|..+.
T Consensus 121 ~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 197 (520)
T 2z7x_B 121 GLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197 (520)
T ss_dssp EEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCE
T ss_pred EecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccc
Confidence 999999985 568888888 9999999999 667777776643
Q ss_pred --------------------------------------------------CccEEEcccCcccccCCcccc----cCCCC
Q 005045 131 --------------------------------------------------SIYYFSVTQNQLHGQLPTDVG----LTLPN 156 (717)
Q Consensus 131 --------------------------------------------------~L~~L~L~~N~l~~~l~~~~~----~~l~~ 156 (717)
+|++|++++|+++|.+|..++ ..+++
T Consensus 198 ~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~ 277 (520)
T 2z7x_B 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277 (520)
T ss_dssp EECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCE
T ss_pred cccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCce
Confidence 788888888888888888774 45666
Q ss_pred cceeecccccccccCC-------------------------cc-CCCCCCCCEEeccCccccccCCCCccCCCCCCeeec
Q 005045 157 LKIFAGAVNYFTGSIP-------------------------VS-LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNF 210 (717)
Q Consensus 157 L~~L~l~~n~l~~~~~-------------------------~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 210 (717)
|+.+++++|.+ .+| .. +..+++|++|++++|++++..|..+..+++|+.|++
T Consensus 278 L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 355 (520)
T 2z7x_B 278 LSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355 (520)
T ss_dssp EEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEEC
T ss_pred eEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEc
Confidence 66666666655 122 11 268899999999999999889999999999999999
Q ss_pred cccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEcc
Q 005045 211 DQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290 (717)
Q Consensus 211 ~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 290 (717)
++|+++.++ ..+..+..+++|++|++++|.+++.+|...+...++|++|++++|.+++..|..+. ++|+.|+|+
T Consensus 356 ~~N~l~~l~----~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls 429 (520)
T 2z7x_B 356 QMNQLKELS----KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLH 429 (520)
T ss_dssp CSSCCCBHH----HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECC
T ss_pred cCCccCccc----cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECC
Confidence 999998753 12567899999999999999999768876444446999999999999877777665 799999999
Q ss_pred CCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCC
Q 005045 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIP 347 (717)
Q Consensus 291 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 347 (717)
+|+++ .+|..+..+++|++|+|++|+++++.+..|..+++|++|+|++|++++..+
T Consensus 430 ~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp SSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 99999 788888899999999999999997655569999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.93 Aligned_cols=270 Identities=22% Similarity=0.393 Sum_probs=209.6
Q ss_pred cccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEee
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITAC 454 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~ 454 (717)
....++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345689999999999999999999852 45569999987542 34467889999999999 899999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
. ..+..|+||||+++++|.+++...... ......+++..+..++.||+.||+|||+. +|+|||
T Consensus 157 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 228 (370)
T 2psq_A 157 T-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 228 (370)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred c-----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 3 455789999999999999998754311 01124589999999999999999999998 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CC
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GK 603 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~ 603 (717)
|||+||+++.++.+||+|||++........ ........+++.|+|||++.+ .++.++|||||||++|||++ |.
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 303 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999986522111 111223446788999999654 58999999999999999999 99
Q ss_pred CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhc
Q 005045 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683 (717)
Q Consensus 604 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.||........ ....... .... .+..++..+.+++.+
T Consensus 304 ~p~~~~~~~~~--~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~ 340 (370)
T 2psq_A 304 SPYPGIPVEEL--FKLLKEG--------HRMD---------------------------------KPANCTNELYMMMRD 340 (370)
T ss_dssp CSSTTCCGGGH--HHHHHTT--------CCCC---------------------------------CCTTSCHHHHHHHHH
T ss_pred CCCCCCCHHHH--HHHHhcC--------CCCC---------------------------------CCCCCCHHHHHHHHH
Confidence 99976432211 1111000 0000 112235678899999
Q ss_pred cCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 684 CSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 684 cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
||+.+|++|||+.|+++.|+.+.....
T Consensus 341 ~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 341 CWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 999999999999999999999986543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=365.37 Aligned_cols=353 Identities=18% Similarity=0.187 Sum_probs=271.3
Q ss_pred EEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCc
Q 005045 14 DLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN 93 (717)
Q Consensus 14 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 93 (717)
+.++++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 9 ~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred eEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence 4688999999 6777665 799999999999998889999999999999999999998888999999999999999999
Q ss_pred CcccCChhhhccCCCCeEeccCCCCCCC-CCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC
Q 005045 94 LRGSIPNELGQLSGLGFFTLYGNFISGI-IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172 (717)
Q Consensus 94 l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 172 (717)
+++..|..|.++++|++|+|++|.+++. .|..|.++++|++|++++|.+.+.+|...+..+++|+.|++++|.+++..|
T Consensus 86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 9988788899999999999999999964 567899999999999999995558887778899999999999999999999
Q ss_pred ccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchh-------------------------h--
Q 005045 173 VSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLN-------------------------F-- 225 (717)
Q Consensus 173 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-------------------------~-- 225 (717)
..+..+++|++|++++|.+....+..+..+++|+.|++++|+++..+..... +
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 9998877777777777766532222233466666666666666553210000 0
Q ss_pred ---------------------------------------------------------hhhhccCCCCCEEEeecCcccCc
Q 005045 226 ---------------------------------------------------------LKFLANCTSLEVLGLARNSFGGE 248 (717)
Q Consensus 226 ---------------------------------------------------------~~~~~~l~~L~~L~L~~N~l~~~ 248 (717)
...+...++|+.|++++|.++ .
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ 324 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-C
T ss_pred HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-c
Confidence 000122346777777777776 6
Q ss_pred CchhhhhccccccEEecCCCccCCCCC---ccccCCCCCCEEEccCCcCccccc--hhhhcCCCCCeEEcccCcCCCCCC
Q 005045 249 MPISIANLSTHLRRLTMGENLMHGNIP---VGIGNLVNLNLLGLEGNNLSGSVP--EVIGRLNKLEGLGLNVNKFSGLIP 323 (717)
Q Consensus 249 ~p~~~~~~~~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~ 323 (717)
+|..++...++|++|++++|.+.+..| ..+..+++|+.|+|++|++++..+ ..+..+++|++|+|++|+++ .+|
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 777765433588888888888876543 346777888888888888875432 45777888888888888887 446
Q ss_pred cccccccccceeecccccccccCCcCc------------------cCcCCCceEEeecccCCCCCCcc
Q 005045 324 SSLGNLTILTRLWMEENRLEGSIPPSL------------------GNCQKLLVLNLSSNDLNGTIPKE 373 (717)
Q Consensus 324 ~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------~~l~~L~~L~l~~N~l~~~~p~~ 373 (717)
..+..+++|++|+|++|+++ .+|..+ ..+++|++|++++|.|+ .+|..
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 469 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA 469 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCG
T ss_pred hhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCc
Confidence 66777777777777777776 333322 36788999999999998 77764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=340.79 Aligned_cols=279 Identities=25% Similarity=0.326 Sum_probs=205.0
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
+.+....+...++|++.++||+|+||.||+|++++|+.||+|++.... ......+.+|++++++++||||+++++++
T Consensus 10 ~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 88 (311)
T 3niz_A 10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI- 88 (311)
T ss_dssp -----CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccceeecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-
Confidence 344455667789999999999999999999998889999999986442 33457788999999999999999999995
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
...+..++||||++ +++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 89 ----~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~ 154 (311)
T 3niz_A 89 ----HSERCLTLVFEFME-KDLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINS 154 (311)
T ss_dssp ----CCSSCEEEEEECCS-EEHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred ----ccCCEEEEEEcCCC-CCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECC
Confidence 44568999999997 58888876543 4589999999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
++.+||+|||.+...... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+
T Consensus 155 ~~~~kl~Dfg~a~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 155 DGALKLADFGLARAFGIP-------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp TCCEEECCCTTCEETTSC-------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred CCCEEEccCcCceecCCC-------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999865211 112233468999999999654 47999999999999999999999998765443
Q ss_pred hhhhHHHHh--cCChhhhh------hcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccC
Q 005045 614 FSIHMFVSM--ALPDHVMD------ILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCS 685 (717)
Q Consensus 614 ~~~~~~~~~--~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 685 (717)
......... ..+..+.. ..+........... ....+.++.++.+++.+||
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~li~~~L 285 (311)
T 3niz_A 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW----------------------SSIIPGFCQEGIDLLSNML 285 (311)
T ss_dssp HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH----------------------HHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcH----------------------HHhCcccCHHHHHHHHHHc
Confidence 322111111 11111111 00111110000000 0011223556789999999
Q ss_pred CCCcCCCCCHHHHHH
Q 005045 686 TTSPRERIAMNVVVN 700 (717)
Q Consensus 686 ~~~p~~Rps~~eil~ 700 (717)
++||++|||++|+++
T Consensus 286 ~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 286 CFDPNKRISARDAMN 300 (311)
T ss_dssp CSCTTTSCCHHHHHT
T ss_pred CCChhHCCCHHHHhc
Confidence 999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=344.19 Aligned_cols=280 Identities=23% Similarity=0.377 Sum_probs=208.4
Q ss_pred cccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++... +
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---H
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 467999999999999999999983 37889999998866666678899999999999999999999986432 2
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEE
Confidence 345899999999999999997542 4589999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+....... ..........++..|+|||++. +.++.++|||||||++|+|++|..||.....+ .....
T Consensus 156 ~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~ 228 (295)
T 3ugc_A 156 GDFGLTKVLPQDK----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMI 228 (295)
T ss_dssp CCCCSCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHH
T ss_pred ccCcccccccCCc----ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhh
Confidence 9999998752211 1112223345777899999965 45899999999999999999999998543110 00000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.... ............... ....+.+..++..+.+++.+||+.+|++|||++|+++
T Consensus 229 ~~~~-----------------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 229 GNDK-----------------QGQMIVFHLIELLKN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CTTC-----------------CTHHHHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCcc-----------------ccchhHHHHHHHHhc-------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 000000000000000 0011123345778899999999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 701 NLKTIRNCF 709 (717)
Q Consensus 701 ~l~~i~~~~ 709 (717)
.|+.++++.
T Consensus 285 ~L~~l~~~l 293 (295)
T 3ugc_A 285 RVDQIRDNM 293 (295)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHhc
Confidence 999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.90 Aligned_cols=269 Identities=24% Similarity=0.376 Sum_probs=202.1
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhc--CCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKS--TRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|.+++.. ++||||+++++++... .....
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS-RHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCc
Confidence 3467999999999999999999998 68899999986543 2444556666655 7999999999986543 23445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEeCC
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH--------HHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~NIll~~ 535 (717)
..++||||+++++|.++++. ..+++..+..++.||+.||+||| +. +|+||||||+||+++.
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~ 148 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKK 148 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECT
T ss_pred eeEEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcC
Confidence 78999999999999999964 35899999999999999999999 75 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-------CCcccchhhHHHHHHHHHhC------
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-------VSILGDIYSYGILLLEMFTG------ 602 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~sDvwslG~vl~elltg------ 602 (717)
++.+||+|||.+......... .........||+.|+|||++.+. ++.++|||||||++|||++|
T Consensus 149 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 149 NGQCCIADLGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp TSCEEECCCTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCEEEeeCCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 999999999999765221111 00111234689999999997654 34789999999999999999
Q ss_pred ----CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHH
Q 005045 603 ----KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVL 678 (717)
Q Consensus 603 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (717)
..||................... ....+.. ........++..+.
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~----------------------------~~~~~~~~~~~~l~ 273 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCV----DQQRPNI----------------------------PNRWFSDPTLTSLA 273 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCC----------------------------CGGGGGSHHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhc----cCCCCCC----------------------------ChhhccCccHHHHH
Confidence 77776544332222111111000 0000000 01112344578899
Q ss_pred HHhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 679 RIGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 679 ~li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
+++.+||+.+|++||||+||++.|++|
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=339.97 Aligned_cols=262 Identities=23% Similarity=0.404 Sum_probs=208.1
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
+....++|++.+.||+|+||.||+|.+++++.||+|++...... .+.+.+|++++++++||||+++++++ .+..
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 76 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY 76 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 44567899999999999999999999888888999998754332 36688999999999999999999995 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEcc
Confidence 8999999999999999987532 4589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||.+..... ..........++..|+|||++.+ .++.++|||||||++|+|++ |..||......... ...
T Consensus 148 fg~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~- 218 (268)
T 3sxs_A 148 FGMTRYVLD------DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--LKV- 218 (268)
T ss_dssp TTCEEECCT------TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHH-
T ss_pred Cccceecch------hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--HHH-
Confidence 999976521 11222233456778999999765 58999999999999999999 99999654222110 000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....... .+..++..+.+++.+||+.+|++|||++|+++.
T Consensus 219 ----------~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 219 ----------SQGHRLY------------------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------HTTCCCC------------------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------HcCCCCC------------------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000000 001114567889999999999999999999999
Q ss_pred HHHHHHHH
Q 005045 702 LKTIRNCF 709 (717)
Q Consensus 702 l~~i~~~~ 709 (717)
|+.++++.
T Consensus 259 L~~l~~~~ 266 (268)
T 3sxs_A 259 IEPLREKD 266 (268)
T ss_dssp HGGGCC--
T ss_pred HHHhhhcc
Confidence 99987553
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.86 Aligned_cols=281 Identities=21% Similarity=0.326 Sum_probs=217.3
Q ss_pred ccCCCCcccccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCc
Q 005045 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRN 446 (717)
Q Consensus 375 ~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~n 446 (717)
....+....+....++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+++++++ +|||
T Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 344566777788899999999999999999999973 256889999987542 33457789999999999 8999
Q ss_pred eeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcc-------------------------------------
Q 005045 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY------------------------------------- 489 (717)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------------------------------------- 489 (717)
|+++++++.. .+...++||||+++++|.+++........
T Consensus 88 iv~~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 88 VVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp BCCEEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred eeeeeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 9999999743 34568999999999999999976532100
Q ss_pred ----------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccc
Q 005045 490 ----------------------QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547 (717)
Q Consensus 490 ----------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 547 (717)
....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 240 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 240 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccce
Confidence 012289999999999999999999998 9999999999999999999999999999
Q ss_pred hhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCC
Q 005045 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALP 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 625 (717)
...... ..........+|+.|+|||++. +.++.++|||||||++|+|++ |..||.......... ......
T Consensus 241 ~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~-- 312 (359)
T 3vhe_A 241 RDIYKD-----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RRLKEG-- 312 (359)
T ss_dssp SCTTSC-----TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HHHHHT--
T ss_pred eeeccc-----ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-HHHHcC--
Confidence 865211 1122334456888999999964 458999999999999999998 999997654332111 111110
Q ss_pred hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHH
Q 005045 626 DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i 705 (717)
..... +..++..+.+++.+||+.+|++||||+||++.|+.+
T Consensus 313 ------~~~~~---------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 ------TRMRA---------------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ------CCCCC---------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCC---------------------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00001 111245678999999999999999999999999999
Q ss_pred HHHH
Q 005045 706 RNCF 709 (717)
Q Consensus 706 ~~~~ 709 (717)
.+..
T Consensus 354 ~~~~ 357 (359)
T 3vhe_A 354 LQAN 357 (359)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.93 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=208.0
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
....++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++ .+.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAP 79 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSS
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCc
Confidence 3456789999999999999999999888889999998754322 36788999999999999999999995 34557
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCT
T ss_pred eEEEEEeCCCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccc
Confidence 999999999999999997543 5689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... ........++..|+|||++. +.++.++||||+||++|+|++ |..||....... .......
T Consensus 151 g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~ 222 (269)
T 4hcu_A 151 GMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST 222 (269)
T ss_dssp TGGGGBCCHH------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT
T ss_pred cccccccccc------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhc
Confidence 9998652211 11122344677899999965 568999999999999999999 999997542211 1111110
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
. ..... +..++..+.+++.+||+.+|++|||++|+++.|
T Consensus 223 ~--------~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 223 G--------FRLYK---------------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp T--------CCCCC---------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--------ccCCC---------------------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 0 00000 011245678999999999999999999999999
Q ss_pred HHHHHH
Q 005045 703 KTIRNC 708 (717)
Q Consensus 703 ~~i~~~ 708 (717)
+++.++
T Consensus 262 ~~l~~~ 267 (269)
T 4hcu_A 262 AEIAES 267 (269)
T ss_dssp HHHHHC
T ss_pred HHHHHc
Confidence 999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.77 Aligned_cols=279 Identities=17% Similarity=0.242 Sum_probs=208.9
Q ss_pred cccccccccccCcccccceEEEEeCC------CchhhhHHhHhhhhh-----------HHHHHHHHHHHHhcCCCCceeE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGD------GTIVAIKVLKLQQQG-----------ALKSFIDECNALKSTRHRNILR 449 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~ 449 (717)
..++|++.+.||+|+||.||+|.++. ++.||+|++...... ....+..|+..++.+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 46699999999999999999999753 478999987543211 1123445677788889999999
Q ss_pred EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005045 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPS 529 (717)
Q Consensus 450 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 529 (717)
+++++.... ......++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~ 181 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKAS 181 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHH
Confidence 999975532 2235689999999 999999987542 5689999999999999999999998 9999999999
Q ss_pred CEEeC--CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCC
Q 005045 530 NVLLD--KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 530 NIll~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~ 606 (717)
||+++ .++.+||+|||+++.+..................||+.|+|||++.+. ++.++|||||||++|||++|..||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999 889999999999987644332222222223445699999999997664 899999999999999999999999
Q ss_pred CCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCC
Q 005045 607 GDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 686 (717)
........ .........+..+..++++.+. ...++..+.+++.+||+
T Consensus 262 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~cl~ 308 (364)
T 3op5_A 262 EDNLKDPK-YVRDSKIRYRENIASLMDKCFP--------------------------------AANAPGEIAKYMETVKL 308 (364)
T ss_dssp GGGTTCHH-HHHHHHHHHHHCHHHHHHHHSC--------------------------------TTCCCHHHHHHHHHHHT
T ss_pred cccccCHH-HHHHHHHHhhhhHHHHHHHhcc--------------------------------cccCHHHHHHHHHHHhc
Confidence 75332211 1111111111111111111110 01236678999999999
Q ss_pred CCcCCCCCHHHHHHHHHHHHHHH
Q 005045 687 TSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 687 ~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
.+|++||++++|++.|+.+.++.
T Consensus 309 ~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 309 LDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHHHHHc
Confidence 99999999999999999998764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=361.97 Aligned_cols=356 Identities=19% Similarity=0.171 Sum_probs=278.4
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
.+++.++.+++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 56888999998 6787664 68999999999999888889999999999999999999888889999999999999999
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccc-cCCcccccCCCCcceeecccccccccC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHG-QLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
++++..|.+|.++++|++|+|++|.++++.+..|+++++|++|+|++|.+++ .+|..+ ..+++|+.|++++|.+++..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECTTSCCCEEC
T ss_pred cCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhh-cccCCCCEEeCcCCccceec
Confidence 9998888999999999999999999998777789999999999999999984 356554 48999999999999988765
Q ss_pred CccCCCCCCC----CEEeccCcccccc-----------------------------------------------------
Q 005045 172 PVSLSNASNL----QVLDFAENGLTGT----------------------------------------------------- 194 (717)
Q Consensus 172 ~~~~~~l~~L----~~L~l~~N~l~~~----------------------------------------------------- 194 (717)
+..++.+++| ..|++++|.+++.
T Consensus 166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~ 245 (570)
T 2z63_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245 (570)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEE
T ss_pred HHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhh
Confidence 5555544444 4555555544332
Q ss_pred ---------------------------------------------------CCCCccCCCCCCeeeccccccCCcccCch
Q 005045 195 ---------------------------------------------------IPGNFGSLKDLVRLNFDQNELGSREIGDL 223 (717)
Q Consensus 195 ---------------------------------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 223 (717)
+|..+..+ +|+.|++++|.+..++...+
T Consensus 246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l 324 (570)
T 2z63_A 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLELVNCKFGQFPTLKL 324 (570)
T ss_dssp CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCC-CCSEEEEESCBCSSCCBCBC
T ss_pred cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccC-CccEEeeccCcccccCcccc
Confidence 33333333 44444444444443332111
Q ss_pred hhhh-------------hhccCCCCCEEEeecCcccCcC--chhhhhccccccEEecCCCccCCCCCccccCCCCCCEEE
Q 005045 224 NFLK-------------FLANCTSLEVLGLARNSFGGEM--PISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLG 288 (717)
Q Consensus 224 ~~~~-------------~~~~l~~L~~L~L~~N~l~~~~--p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 288 (717)
.... ....+++|++|++++|.+++.. |..+..+ ++|++|++++|.+.+..+ .+.++++|+.|+
T Consensus 325 ~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~ 402 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVITMSS-NFLGLEQLEHLD 402 (570)
T ss_dssp SSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTC-SCCCEEECCSCSEEEEEE-EEETCTTCCEEE
T ss_pred cccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccccc-CccCEEECCCCccccccc-cccccCCCCEEE
Confidence 0000 0146789999999999998543 6777777 589999999998885444 488888888888
Q ss_pred ccCCcCccccc-hhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc-ccCCcCccCcCCCceEEeecccC
Q 005045 289 LEGNNLSGSVP-EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE-GSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 289 L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
+++|++.+..+ ..+..+++|++|++++|.+++..|..|.++++|+.|+|++|+++ +.+|..+..+++|+.|++++|.+
T Consensus 403 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l 482 (570)
T 2z63_A 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482 (570)
T ss_dssp CTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred ccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence 88888886555 46788888888888888888888888888888888888888887 56888888888888888888888
Q ss_pred CCCCCcccc
Q 005045 367 NGTIPKEVR 375 (717)
Q Consensus 367 ~~~~p~~~~ 375 (717)
++..|..+.
T Consensus 483 ~~~~~~~~~ 491 (570)
T 2z63_A 483 EQLSPTAFN 491 (570)
T ss_dssp CEECTTTTT
T ss_pred ccCChhhhh
Confidence 866665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=356.19 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=208.9
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
..+....++|++.+.||+|+||.||+|.++ +++.||+|.+.... ......+.+|++++++++||||+++++++.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 182 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT---- 182 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe----
Confidence 345566789999999999999999999976 78999999987442 334567889999999999999999999963
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
..+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 183 -~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~ 252 (377)
T 3cbl_A 183 -QKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVL 252 (377)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred -cCCCcEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcE
Confidence 4457899999999999999987432 4689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 617 (717)
||+|||+++...... .........++..|+|||++. +.++.++|||||||++|||++ |..||....... ..
T Consensus 253 kl~DfG~s~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~ 325 (377)
T 3cbl_A 253 KISDFGMSREEADGV-----YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TR 325 (377)
T ss_dssp EECCGGGCEECTTSE-----EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HH
T ss_pred EECcCCCceecCCCc-----eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 999999987541110 000111123567899999965 458999999999999999998 999997642211 11
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
....... .. +.+..++..+.+++.+||+.+|++|||++|
T Consensus 326 ~~~~~~~----------~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 326 EFVEKGG----------RL-------------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp HHHHTTC----------CC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHcCC----------CC-------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 1111000 00 011223667889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 698 VVNNLKTIRNC 708 (717)
Q Consensus 698 il~~l~~i~~~ 708 (717)
|++.|+.++++
T Consensus 365 i~~~L~~i~~~ 375 (377)
T 3cbl_A 365 IYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=341.70 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=200.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++... .......+.+|+++++.++||||+++++++ ...
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeC
Confidence 3578999999999999999999965 7999999998654 233456788999999999999999999985 445
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..|+||||++|++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||+
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~ 147 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEe
Confidence 6899999999999999998743 5689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||++..... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...... ......
T Consensus 148 DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i- 217 (337)
T 1o6l_A 148 DFGLCKEGIS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELI- 217 (337)
T ss_dssp CCTTCBCSCC-------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-
T ss_pred eccchhhccc-------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHH-
Confidence 9999875311 1112334679999999999765 4899999999999999999999999653211 111100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMN 696 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ 696 (717)
....... +..++..+.+++.+||+.+|++|| +++
T Consensus 218 ----------~~~~~~~-------------------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ 256 (337)
T 1o6l_A 218 ----------LMEEIRF-------------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256 (337)
T ss_dssp ----------HHCCCCC-------------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred ----------HcCCCCC-------------------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHH
Confidence 0001100 011245678899999999999999 899
Q ss_pred HHHHH
Q 005045 697 VVVNN 701 (717)
Q Consensus 697 eil~~ 701 (717)
||++.
T Consensus 257 ei~~h 261 (337)
T 1o6l_A 257 EVMEH 261 (337)
T ss_dssp HHHTS
T ss_pred HHHcC
Confidence 98753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=342.78 Aligned_cols=269 Identities=19% Similarity=0.238 Sum_probs=208.4
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+|+++++++ +||||+++++++. ..+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCc
Confidence 457899999999999999999996 4899999998864432 34678899999999 9999999999854 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc-----e
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT-----A 539 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~ 539 (717)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~ 149 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVI 149 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSE
T ss_pred cEEEEEeC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceE
Confidence 99999999 899999987532 5689999999999999999999998 9999999999999998887 9
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
||+|||.+.....................||+.|+|||++.+ .++.++|||||||++|||++|..||...........
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~- 228 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER- 228 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH-
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH-
Confidence 999999998763332222222222345679999999999765 489999999999999999999999976533221100
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
...+.. ....... ......++ .+.+++.+||+.+|.+||++.+|
T Consensus 229 ----------------------------~~~i~~-~~~~~~~------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 229 ----------------------------YQKIGD-TKRATPI------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp ----------------------------HHHHHH-HHHHSCH------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred ----------------------------HHHHHh-hhccCCH------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 000000 0000000 00111234 78999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 699 VNNLKTIRNCF 709 (717)
Q Consensus 699 l~~l~~i~~~~ 709 (717)
.+.|+.+.+..
T Consensus 273 ~~~l~~~~~~~ 283 (330)
T 2izr_A 273 RKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHc
Confidence 99999887654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=336.73 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=203.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 3678999999999999999999965 7899999987532 234567889999999999999999999995 445
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~ 153 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIF 153 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred CeEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEE
Confidence 6899999999999999999744 5689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... ....
T Consensus 154 Dfg~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~ 226 (294)
T 4eqm_A 154 DFGIAKALSET------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-KHIQ 226 (294)
T ss_dssp CCSSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-HHHS
T ss_pred eCCCccccccc------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhh
Confidence 99999865211 1112234568999999999655 47899999999999999999999997542211100 0000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-CHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-AMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~eil~ 700 (717)
...+.. .. +...+++..+.+++.+|++.+|++|| +++++.+
T Consensus 227 ~~~~~~-~~-------------------------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 227 DSVPNV-TT-------------------------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp SCCCCH-HH-------------------------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred ccCCCc-ch-------------------------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHH
Confidence 000000 00 01122356788999999999999998 9999999
Q ss_pred HHHHHHHH
Q 005045 701 NLKTIRNC 708 (717)
Q Consensus 701 ~l~~i~~~ 708 (717)
.|+.+..+
T Consensus 269 ~l~~~~~~ 276 (294)
T 4eqm_A 269 DLSSVLHE 276 (294)
T ss_dssp HHHTSSSS
T ss_pred HHHHHHhh
Confidence 99877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=343.12 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=199.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +.+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCe
Confidence 3578999999999999999999966 89999999986432 223466889999999999999999999954 4568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Df 149 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF 149 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEe
Confidence 99999999999999999755 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... .........||+.|+|||++.+. .+.++|||||||++|+|++|..||............+...
T Consensus 150 g~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 224 (323)
T 3tki_A 150 GLATVFRYNN-----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224 (323)
T ss_dssp TTCEECEETT-----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred eccceeccCC-----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence 9997652111 11112345689999999997553 3788999999999999999999997654433322222111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. .... ....++..+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~------------~~~~-----------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 K------------TYLN-----------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp C------------TTST-----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c------------ccCC-----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000 011224567889999999999999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=349.72 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=196.7
Q ss_pred cccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|+++ +++.||+|.+... .....+.+.+|++++++++||||+++++++. .
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----K 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----e
Confidence 4568999999999999999999864 5778999998754 3345678999999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl 188 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKV 188 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEE
Confidence 458899999999999999997543 4689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+........ .........++..|+|||++. +.++.++|||||||++|||++ |..||....... ....
T Consensus 189 ~Dfg~a~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~ 262 (373)
T 2qol_A 189 SDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKA 262 (373)
T ss_dssp CCC--------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHH
T ss_pred CcCccccccccCCc----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence 99999987522111 111112233577899999965 468999999999999999998 999996542211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.. .... .+.+.+++..+.+++.+||+.+|++|||+.||+
T Consensus 263 i~------------~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~ 301 (373)
T 2qol_A 263 VD------------EGYR-----------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301 (373)
T ss_dssp HH------------TTEE-----------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH------------cCCC-----------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHH
Confidence 10 0000 001122356788999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 700 NNLKTIRNCF 709 (717)
Q Consensus 700 ~~l~~i~~~~ 709 (717)
+.|+++...-
T Consensus 302 ~~L~~~~~~~ 311 (373)
T 2qol_A 302 SILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHCG
T ss_pred HHHHHHHhCc
Confidence 9999997643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=335.67 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=208.9
Q ss_pred cccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...+....++|++.+.||+|+||.||.|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++ .
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~ 89 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC-----T 89 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEE-----e
Confidence 34556678899999999999999999999888889999998755332 36788999999999999999999995 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEE
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEE
Confidence 4568999999999999999997532 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.+....... ........+++.|+|||++. +.++.++|||||||++|+|++ |..||....... ...
T Consensus 161 l~Dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~ 232 (283)
T 3gen_A 161 VSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAE 232 (283)
T ss_dssp ECSTTGGGGBCCHH------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH
T ss_pred Eccccccccccccc------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHH
Confidence 99999998652211 11112334677899999965 568999999999999999998 999997643221 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.. ........+ ..++..+.+++.+||+.+|++|||++|+
T Consensus 233 ~~--------~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l 271 (283)
T 3gen_A 233 HI--------AQGLRLYRP---------------------------------HLASEKVYTIMYSCWHEKADERPTFKIL 271 (283)
T ss_dssp HH--------HTTCCCCCC---------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HH--------hcccCCCCC---------------------------------CcCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 11 111111110 1114567889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 699 VNNLKTIRNCF 709 (717)
Q Consensus 699 l~~l~~i~~~~ 709 (717)
++.|+.+..+.
T Consensus 272 l~~L~~~~~~e 282 (283)
T 3gen_A 272 LSNILDVMDEE 282 (283)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHhhcc
Confidence 99999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=351.35 Aligned_cols=307 Identities=16% Similarity=0.194 Sum_probs=208.9
Q ss_pred CcccccccccccccccccCcc--cccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEee
Q 005045 380 SYSDISKSTDNFSKENLIGTG--SFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITAC 454 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 454 (717)
+.+.+....++|++.++||+| +||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 345566778899999999999 99999999976 79999999987543 34567888999999999999999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
. ..+..++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++
T Consensus 96 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~ 162 (389)
T 3gni_B 96 I-----ADNELWVVTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS 162 (389)
T ss_dssp E-----ETTEEEEEEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred E-----ECCEEEEEEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 4 44589999999999999999875421 5689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
.++.+||+|||.+.....................||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999886543222111111222233468999999999765 489999999999999999999999977544
Q ss_pred CchhhhHHHHhcCChhhhhhcCCC--CCCCC--CCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPS--MPLDE--ENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
..... .......+........+. ..... ........+..... .................++..+.+|+.+||++
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 243 TQMLL-EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS-TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp TTHHH-HC---------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred HHHHH-HHhcCCCCccccccccccccccccccccccccccccccccC-ccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 33221 111111111100000000 00000 00000000000000 00000011111123344567789999999999
Q ss_pred CcCCCCCHHHHHHH
Q 005045 688 SPRERIAMNVVVNN 701 (717)
Q Consensus 688 ~p~~Rps~~eil~~ 701 (717)
||++|||++|+++.
T Consensus 321 dP~~Rpta~ell~h 334 (389)
T 3gni_B 321 NPDARPSASTLLNH 334 (389)
T ss_dssp CTTTSCCHHHHTTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.02 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=201.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|+||.||+|.++ +++.||+|.+.... .....+.+|+++++.++||||+++++++. +.+..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEE
Confidence 4579999999999999999999965 78899999886443 23466889999999999999999999954 44589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--CCceEEee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK--DMTAHVGD 543 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~D 543 (717)
++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEE
Confidence 99999999999999997542 4689999999999999999999998 9999999999999987 78999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+.... .........|++.|+|||++.+. ++.++|||||||++|+|++|..||...... .....
T Consensus 148 fg~a~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~--- 214 (321)
T 1tki_A 148 FGQARQLK--------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN--- 214 (321)
T ss_dssp CTTCEECC--------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH---
T ss_pred CCCCeECC--------CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH---
Confidence 99998651 11223446689999999997665 799999999999999999999999653221 11111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+......... ....+++..+.+++.+||+.+|++|||+.|+++.
T Consensus 215 --------i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 215 --------IMNAEYTFDE---------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------HHHTCCCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------HHcCCCCCCh---------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111110000 0111235668899999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.42 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=200.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhh------HHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG------ALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---- 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---- 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence 34678999999999999999999965 7999999998754321 246788999999999999999999995
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM- 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~- 537 (717)
.+....++||||++|++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 85 -ENRTDVVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred -EeCCEEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCC
Confidence 4456899999999999999999754 5689999999999999999999998 999999999999998776
Q ss_pred ---ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 538 ---TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 538 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
.+||+|||++..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 154 ~~~~vkl~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~- 224 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIED--------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 224 (361)
T ss_dssp SSCCEEECCCSSCEECCT--------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-
T ss_pred CccCEEEEecCCceEcCC--------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 799999999986521 111234569999999999765 5899999999999999999999999654211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
... ..+......... +.....+..+.+++.+||+.||++||
T Consensus 225 -~~~-----------~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~ 265 (361)
T 2yab_A 225 -ETL-----------ANITAVSYDFDE---------------------------EFFSQTSELAKDFIRKLLVKETRKRL 265 (361)
T ss_dssp -HHH-----------HHHHTTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred -HHH-----------HHHHhcCCCCCc---------------------------hhccCCCHHHHHHHHHHCCCChhHCc
Confidence 111 111111111000 00112245678999999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
|+.|+++
T Consensus 266 t~~e~l~ 272 (361)
T 2yab_A 266 TIQEALR 272 (361)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.72 Aligned_cols=295 Identities=24% Similarity=0.413 Sum_probs=206.4
Q ss_pred ccCCCCCCcccccCCCCcccccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh--hhhHHHHHHHHHH
Q 005045 364 NDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ--QQGALKSFIDECN 437 (717)
Q Consensus 364 N~l~~~~p~~~~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~ 437 (717)
++.++............+.++....++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++
T Consensus 9 ~~~~~~~~~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~ 88 (313)
T 3brb_A 9 HHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88 (313)
T ss_dssp ---------------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHH
T ss_pred cccCCCCcCchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHH
Confidence 444555555666667778888889999999999999999999999843 4557999998754 2344577899999
Q ss_pred HHhcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 005045 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC 517 (717)
Q Consensus 438 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 517 (717)
++++++||||+++++++...........++||||+++++|.+++...... .....+++..++.++.||+.||.|||+.
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~- 166 (313)
T 3brb_A 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR- 166 (313)
T ss_dssp HHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 99999999999999997654322233569999999999999998422110 0125689999999999999999999998
Q ss_pred CCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHH
Q 005045 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILL 596 (717)
Q Consensus 518 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl 596 (717)
+|+||||||+||+++.++.+||+|||.+....... .........+++.|+|||.+.+ .++.++|||||||++
T Consensus 167 --~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 239 (313)
T 3brb_A 167 --NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239 (313)
T ss_dssp --TCCCCCCSGGGEEECTTSCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHH
T ss_pred --CcccCCCCcceEEEcCCCcEEEeecCcceeccccc-----ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHH
Confidence 99999999999999999999999999998652211 1112233457788999999654 589999999999999
Q ss_pred HHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHH
Q 005045 597 LEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFV 675 (717)
Q Consensus 597 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (717)
|+|++ |..||........ ..... ...... .+..++.
T Consensus 240 ~el~~~g~~p~~~~~~~~~--~~~~~-----------~~~~~~------------------------------~~~~~~~ 276 (313)
T 3brb_A 240 WEIATRGMTPYPGVQNHEM--YDYLL-----------HGHRLK------------------------------QPEDCLD 276 (313)
T ss_dssp HHHHTTSCCSSTTCCGGGH--HHHHH-----------TTCCCC------------------------------CBTTCCH
T ss_pred HHHHhcCCCCCccCCHHHH--HHHHH-----------cCCCCC------------------------------CCccccH
Confidence 99999 8899876432211 11110 000000 1112356
Q ss_pred HHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 676 SVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 676 ~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
.+.+++.+||+.+|++|||+.|+++.|+++.+..+
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 68899999999999999999999999999987754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.43 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=200.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||.|.++ +++.||+|++.... ......+.+|+++++.++||||+++++++ .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34679999999999999999999965 78899999886432 33457788999999999999999999995 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||++|++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.+|.+||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEE
Confidence 55899999999999999999865 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh-
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI- 616 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~- 616 (717)
+|||++..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 157 ~DFG~a~~~~~--------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 228 (384)
T 4fr4_A 157 TDFNIAAMLPR--------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228 (384)
T ss_dssp CCCTTCEECCT--------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred eccceeeeccC--------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 99999986521 122334679999999999753 37899999999999999999999997543322111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-H
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-M 695 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~ 695 (717)
...... .... .+..++..+.+++.+||+.+|++||+ +
T Consensus 229 ~~~~~~-----------~~~~-------------------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~ 266 (384)
T 4fr4_A 229 VHTFET-----------TVVT-------------------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQL 266 (384)
T ss_dssp HHHHHH-----------CCCC-------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSH
T ss_pred HHHHhh-----------cccC-------------------------------CCCcCCHHHHHHHHHHhcCCHhHhcccH
Confidence 000000 0000 01112556789999999999999998 6
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
++|.+
T Consensus 267 ~~l~~ 271 (384)
T 4fr4_A 267 SDVQN 271 (384)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 66653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=344.06 Aligned_cols=321 Identities=28% Similarity=0.392 Sum_probs=221.8
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
++++|+|++|.+++..| |..+++|++|++++|.+++..+ +.++++|++|+|++|.+++ ++. +..+++|++|+|+
T Consensus 69 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 69 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDP-LKNLTNLNRLELS 142 (466)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCSEEEEE
T ss_pred CCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCC-ChH-HcCCCCCCEEECC
Confidence 44445555555443222 4444555555555554442222 4445555555555555442 222 4444555555555
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.+++ ++ .+..+++|+.|+++ |.+.+. ..+.++++|++|++++|.++ .++. +..+++|+.|++++|.+.+.
T Consensus 143 ~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~ 214 (466)
T 1o6v_A 143 SNTISD-IS-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVS-DISV--LAKLTNLESLIATNNQISDI 214 (466)
T ss_dssp EEEECC-CG-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEECCSSCCCCC
T ss_pred CCccCC-Ch-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcCC-CChh--hccCCCCCEEEecCCccccc
Confidence 555442 22 24445555555553 233322 23777788888888888887 4443 45788888888888888865
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
.+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.++... + +..+++|+.|++++|.+++ ++
T Consensus 215 ~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~------~--~~~l~~L~~L~l~~n~l~~-~~ 281 (466)
T 1o6v_A 215 TP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA------P--LSGLTKLTELKLGANQISN-IS 281 (466)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG------G--GTTCTTCSEEECCSSCCCC-CG
T ss_pred cc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccch------h--hhcCCCCCEEECCCCccCc-cc
Confidence 55 67788888888888888843 35778888888888888888764 2 7788899999999999884 44
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
. +..+ ++|+.|++++|.+.+..+ +..+++|+.|+|++|++++..| +..+++|++|++++|++++. ..+..++
T Consensus 282 ~-~~~l-~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~ 353 (466)
T 1o6v_A 282 P-LAGL-TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLT 353 (466)
T ss_dssp G-GTTC-TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred c-ccCC-CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCC
Confidence 3 5555 589999999999886443 7888999999999999986655 78889999999999999876 4688899
Q ss_pred ccceeecccccccccCCcCccCcCCCceEEeecccCCC
Q 005045 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368 (717)
Q Consensus 331 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 368 (717)
+|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 354 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 99999999999987666 8889999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=340.75 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=198.4
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+++++.++||||+++++++. .
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence 3467999999999999999999996 489999999886432 233467889999999999999999999954 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+ +|++.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl 149 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKI 149 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEE
T ss_pred CCEEEEEEECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEE
Confidence 55899999999 68999888643 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|||++...... .......||+.|+|||++.+. + +.++|||||||++|+|++|..||........
T Consensus 150 ~DFG~s~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----- 216 (336)
T 3h4j_B 150 ADFGLSNIMTDG--------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----- 216 (336)
T ss_dssp CCSSCTBTTTTS--------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----
T ss_pred EEeccceeccCC--------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----
Confidence 999999865211 112335689999999998775 3 7899999999999999999999975422210
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...+..... . .+...+..+.+++.+||+.||.+|||++|++
T Consensus 217 --------~~~i~~~~~-~------------------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 217 --------FKKVNSCVY-V------------------------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp --------BCCCCSSCC-C------------------------------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred --------HHHHHcCCC-C------------------------------CcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 000000000 0 0011245678899999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 258 ~h 259 (336)
T 3h4j_B 258 RD 259 (336)
T ss_dssp TC
T ss_pred hC
Confidence 63
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=348.15 Aligned_cols=268 Identities=24% Similarity=0.390 Sum_probs=208.0
Q ss_pred ccccccccccccCcccccceEEEEeC------CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--- 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--- 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe---
Confidence 34678999999999999999999842 5678999998643 2334567889999999999999999999953
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM- 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~- 537 (717)
.....++||||+++++|.+++............+++..++.++.||+.||+|||+. +|+||||||+||+++.+|
T Consensus 145 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 145 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred --cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCC
Confidence 44578999999999999999875432222335689999999999999999999998 999999999999999555
Q ss_pred --ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 005045 538 --TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613 (717)
Q Consensus 538 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 613 (717)
.+||+|||.++........ .......+|+.|+|||++ .+.++.++|||||||++|||++ |..||......
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~- 293 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ- 293 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred CceEEECCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 5999999999865332211 112234578899999996 4568999999999999999998 99999754221
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
.......... ... .+..++..+.+++.+||+.+|++||
T Consensus 294 -~~~~~i~~~~--------~~~---------------------------------~~~~~~~~l~~li~~~l~~dP~~Rp 331 (367)
T 3l9p_A 294 -EVLEFVTSGG--------RMD---------------------------------PPKNCPGPVYRIMTQCWQHQPEDRP 331 (367)
T ss_dssp -HHHHHHHTTC--------CCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -HHHHHHHcCC--------CCC---------------------------------CCccCCHHHHHHHHHHcCCCHhHCc
Confidence 1111111000 000 1122355688999999999999999
Q ss_pred CHHHHHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTIRNCF 709 (717)
Q Consensus 694 s~~eil~~l~~i~~~~ 709 (717)
|+.||++.|+.+.+..
T Consensus 332 s~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 332 NFAIILERIEYCTQDP 347 (367)
T ss_dssp CHHHHHHHHHHHHHCH
T ss_pred CHHHHHHHHHHHhhCh
Confidence 9999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.12 Aligned_cols=273 Identities=18% Similarity=0.201 Sum_probs=211.4
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.+.||+|++|.||+|.+ .+++.||+|++.... ....+.+|+++++.+ +|++++++++++. ...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 79 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 79 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCc
Confidence 3467899999999999999999995 489999999875432 235677899999999 8999999998853 455
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc-----
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT----- 538 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~----- 538 (717)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCe
Confidence 899999999 999999997542 4589999999999999999999997 9999999999999987775
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
+||+|||.+.....................||+.|+|||++.+ .++.++|||||||++|+|++|..||...........
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 9999999998764332222222223345679999999999765 489999999999999999999999976533221100
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
...+...... . ........++..+.+++.+||+.+|++|||+++
T Consensus 230 -----------------------------~~~~~~~~~~-~------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~ 273 (298)
T 1csn_A 230 -----------------------------YERIGEKKQS-T------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 273 (298)
T ss_dssp -----------------------------HHHHHHHHHH-S------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred -----------------------------HHHHHhhccC-c------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHH
Confidence 0000000000 0 000011234667899999999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 005045 698 VVNNLKTIRNCFLE 711 (717)
Q Consensus 698 il~~l~~i~~~~~~ 711 (717)
|++.|+++.++...
T Consensus 274 l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 274 LQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhcCC
Confidence 99999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.47 Aligned_cols=253 Identities=26% Similarity=0.463 Sum_probs=201.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-------hHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-------GALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 94 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN-- 94 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--
Confidence 4578999999999999999999964 889999999854321 112678899999999999999999998633
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeCCC
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNVLLDKD 536 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~ 536 (717)
. .++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. + |+||||||+||+++.+
T Consensus 95 ---~--~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 95 ---P--PRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp ---T--TEEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCC
T ss_pred ---C--CeEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEecc
Confidence 2 279999999999998886543 5689999999999999999999997 8 9999999999999887
Q ss_pred Cc-----eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 537 MT-----AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 537 ~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
+. +||+|||.+.... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSV----------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCS----------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCceeEEeCCCCcccccc----------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 76 9999999987431 12334668999999999733 368999999999999999999999976
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
............... ...+.. +..++..+.+++.+||+.+
T Consensus 231 ~~~~~~~~~~~~~~~-------~~~~~~---------------------------------~~~~~~~l~~li~~~l~~d 270 (287)
T 4f0f_A 231 YSYGKIKFINMIREE-------GLRPTI---------------------------------PEDCPPRLRNVIELCWSGD 270 (287)
T ss_dssp CCCCHHHHHHHHHHS-------CCCCCC---------------------------------CTTSCHHHHHHHHHHTCSS
T ss_pred ccccHHHHHHHHhcc-------CCCCCC---------------------------------CcccCHHHHHHHHHHhcCC
Confidence 544332222111110 001111 1123567889999999999
Q ss_pred cCCCCCHHHHHHHHHHH
Q 005045 689 PRERIAMNVVVNNLKTI 705 (717)
Q Consensus 689 p~~Rps~~eil~~l~~i 705 (717)
|++|||++|+++.|+++
T Consensus 271 p~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 271 PKKRPHFSYIVKELSEL 287 (287)
T ss_dssp GGGSCCHHHHHHHHHTC
T ss_pred hhhCcCHHHHHHHHHhC
Confidence 99999999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.80 Aligned_cols=268 Identities=30% Similarity=0.474 Sum_probs=198.5
Q ss_pred CcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
..+......++|++.++||+|+||.||+|++.. .||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 90 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-- 90 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--
Confidence 344556668899999999999999999998643 4899988644 2344678899999999999999999998642
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 91 ----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~ 157 (289)
T 3og7_A 91 ----APQLAIVTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDN 157 (289)
T ss_dssp ----SSSCEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred ----CCccEEEEEecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 235799999999999999996543 5689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
.+||+|||.+....... .........|++.|+|||++. +.++.++|||||||++|+|++|..||.......
T Consensus 158 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 158 TVKIGDFGLATEKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp EEEECCCC-----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred CEEEccceecccccccc-----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 99999999997652211 111223356899999999964 347889999999999999999999997653322
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
...........+ +.... ....++..+.+++.+||+.+|++||
T Consensus 233 ~~~~~~~~~~~~--------~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 233 QIIEMVGRGSLS--------PDLSK------------------------------VRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp HHHHHHHHTSCC--------CCTTS------------------------------SCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHhcccccC--------cchhh------------------------------ccccCCHHHHHHHHHHccCChhhCC
Confidence 111111111111 00000 1122356789999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTIRN 707 (717)
Q Consensus 694 s~~eil~~l~~i~~ 707 (717)
|++|+++.|+++.+
T Consensus 275 s~~ell~~L~~l~~ 288 (289)
T 3og7_A 275 SFPRILAEIEELAR 288 (289)
T ss_dssp CHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.35 Aligned_cols=272 Identities=22% Similarity=0.375 Sum_probs=210.8
Q ss_pred cccccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEe
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITA 453 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 453 (717)
-..+....++|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|++++++++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 344556688999999999999999999985 24578999998754 23456788999999999999999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------------ccccccCHHHHHHHHHHHHHHHHHHHhc
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH-----------------YQFKKLSVIQRLNIAIDVASALDYLHHH 516 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 516 (717)
+ ...+..++||||+++++|.+++....... .....+++..+..++.||+.||+|||+.
T Consensus 95 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 95 C-----SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp E-----CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred E-----ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 5 34557899999999999999987542100 0113589999999999999999999998
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHH
Q 005045 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGIL 595 (717)
Q Consensus 517 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~v 595 (717)
+|+||||||+||+++.++.+||+|||.+...... ..........+++.|+|||++.+ .++.++|||||||+
T Consensus 170 ---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 170 ---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241 (314)
T ss_dssp ---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTT-----SCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHH
T ss_pred ---CCcccccchheEEEcCCCCEEEcccccccccccc-----ccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHH
Confidence 9999999999999999999999999999765221 11112223446788999999654 48999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHH
Q 005045 596 LLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECF 674 (717)
Q Consensus 596 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (717)
+|+|++ |..||........ ....... .... .+..++
T Consensus 242 l~el~t~g~~p~~~~~~~~~--~~~~~~~--------~~~~---------------------------------~~~~~~ 278 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPERL--FNLLKTG--------HRME---------------------------------RPDNCS 278 (314)
T ss_dssp HHHHHTTSCCSSTTCCGGGH--HHHHHTT--------CCCC---------------------------------CCTTCC
T ss_pred HHHHHhCCCCCCCCCCHHHH--HHHhhcC--------CcCC---------------------------------CCccCC
Confidence 999999 9999976533211 1111100 0000 011225
Q ss_pred HHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 675 VSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 675 ~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
..+.+++.+||+.+|++|||+.|+++.|+++..+
T Consensus 279 ~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 279 EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 6688999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.29 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=209.5
Q ss_pred cccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++....++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE---- 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----
Confidence 3455667889999999999999999999985 7899999987543 45778999999999999999999998633
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.....++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEE
Confidence 33478999999999999999975421 3478999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+++.... ......++..|+|||++. +.++.++|||||||++|||++ |..||......+.. .
T Consensus 330 l~DfG~a~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~--~ 397 (450)
T 1k9a_A 330 VSDFGLTKEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--P 397 (450)
T ss_dssp ECCCTTCEECC----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH--H
T ss_pred EeeCCCcccccc----------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H
Confidence 999999875411 111234678899999964 458999999999999999998 99999765333211 1
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+... .. . +.+..|+..+.+++.+||+.+|++|||+.||
T Consensus 398 ~i~~~--------~~--~-------------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 398 RVEKG--------YK--M-------------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp HHHTT--------CC--C-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHcC--------CC--C-------------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11100 00 0 0122346778999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 699 VNNLKTIRNCF 709 (717)
Q Consensus 699 l~~l~~i~~~~ 709 (717)
++.|+.++...
T Consensus 437 ~~~L~~i~~~~ 447 (450)
T 1k9a_A 437 REQLEHIRTHE 447 (450)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHhh
Confidence 99999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.90 Aligned_cols=269 Identities=24% Similarity=0.423 Sum_probs=215.6
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
.+.++....++|++.+.||+|++|.||.|.++ +++.||+|.+.... ...+.+.+|++++++++||||+++++++
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 78 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC---- 78 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 34566677899999999999999999999966 68899999987543 3457788999999999999999999995
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
.+.+..++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 79 -~~~~~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 79 -TREPPFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHL 149 (288)
T ss_dssp -CSSSSEEEEEECCTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGC
T ss_pred -ccCCCEEEEEEcCCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCC
Confidence 445579999999999999999975422 5689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||.+..... ..........+++.|+|||++. +.++.++|||||||++|+|++ |..||........
T Consensus 150 ~~l~Dfg~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-- 221 (288)
T 3kfa_A 150 VKVADFGLSRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-- 221 (288)
T ss_dssp EEECCCCGGGTSCS------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred EEEccCccceeccC------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999986521 1222333455778899999965 468999999999999999999 9999976432211
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
..... ...... .+..++..+.+++.+|++.+|++|||++
T Consensus 222 ~~~~~--------~~~~~~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 260 (288)
T 3kfa_A 222 YELLE--------KDYRME---------------------------------RPEGCPEKVYELMRACWQWNPSDRPSFA 260 (288)
T ss_dssp HHHHH--------TTCCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHh--------ccCCCC---------------------------------CCCCCCHHHHHHHHHHhCCChhhCcCHH
Confidence 11111 000000 1112256788999999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 005045 697 VVVNNLKTIRNCFLE 711 (717)
Q Consensus 697 eil~~l~~i~~~~~~ 711 (717)
|+++.|+.+.++...
T Consensus 261 ~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 261 EIHQAFETMFQESSI 275 (288)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccc
Confidence 999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=344.72 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=194.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|+++ +++.||+|++... .......+..|.++++.+ .||||+++++++ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 4578999999999999999999965 7899999998654 233456788999999988 799999999995 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||++|++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEE
Confidence 56899999999999999998754 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||++.... ..........||+.|+|||++.+. ++.++|||||||++|||++|..||......+ ...
T Consensus 166 ~DFG~a~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~-- 234 (353)
T 3txo_A 166 ADFGMCKEGI-------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFE-- 234 (353)
T ss_dssp CCCTTCBCSC-------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH--
T ss_pred ccccceeecc-------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHH--
Confidence 9999987531 111223346799999999997654 8999999999999999999999997542211 111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH-----
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM----- 695 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----- 695 (717)
.+........ ...+..+.+++.+||+.+|++||++
T Consensus 235 ---------~i~~~~~~~p-------------------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~ 274 (353)
T 3txo_A 235 ---------AILNDEVVYP-------------------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGG 274 (353)
T ss_dssp ---------HHHHCCCCCC-------------------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTC
T ss_pred ---------HHHcCCCCCC-------------------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCC
Confidence 1111111100 1114457889999999999999998
Q ss_pred -HHHHH
Q 005045 696 -NVVVN 700 (717)
Q Consensus 696 -~eil~ 700 (717)
+||++
T Consensus 275 ~~~il~ 280 (353)
T 3txo_A 275 EHAILR 280 (353)
T ss_dssp THHHHT
T ss_pred HHHHhh
Confidence 67764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.97 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=193.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--------------------------hhHHHHHHHHHHHH
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--------------------------QGALKSFIDECNAL 439 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l 439 (717)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999965 78999999985332 11235688999999
Q ss_pred hcCCCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005045 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDT 519 (717)
Q Consensus 440 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 519 (717)
++++||||+++++++.. ...+..++||||+++++|.++... ..+++..+..++.||+.||+|||+.
T Consensus 91 ~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~--- 156 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLHYQ--- 156 (298)
T ss_dssp HTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 99999999999999653 225689999999999999887542 4689999999999999999999998
Q ss_pred CeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC----CCcccchhhHHHH
Q 005045 520 PIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGIL 595 (717)
Q Consensus 520 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~v 595 (717)
+|+||||||+||+++.++.+||+|||.+..... .........||+.|+|||++.+. ++.++|||||||+
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~ 229 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-------SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSS-------SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCcccccc-------ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence 999999999999999999999999999986521 11223345689999999997654 3788999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHH
Q 005045 596 LLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFV 675 (717)
Q Consensus 596 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (717)
+|+|++|..||...... ........ ...... ....++.
T Consensus 230 l~~l~~g~~pf~~~~~~--~~~~~~~~-----------~~~~~~-----------------------------~~~~~~~ 267 (298)
T 2zv2_A 230 LYCFVFGQCPFMDERIM--CLHSKIKS-----------QALEFP-----------------------------DQPDIAE 267 (298)
T ss_dssp HHHHHHSSCSSCCSSHH--HHHHHHHH-----------CCCCCC-----------------------------SSSCCCH
T ss_pred HHHHHHCCCCCCCccHH--HHHHHHhc-----------ccCCCC-----------------------------CccccCH
Confidence 99999999999653211 11110000 000000 0011245
Q ss_pred HHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 676 SVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 676 ~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+.+++.+||+.+|++|||+.|+++
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6789999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.08 Aligned_cols=266 Identities=21% Similarity=0.343 Sum_probs=199.6
Q ss_pred CcccccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEee
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITAC 454 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 454 (717)
+..+.....++|++.+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 34556677889999999999999999999964 2456999988653 334567889999999999999999999985
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
. .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++
T Consensus 86 ~------~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 150 (281)
T 1mp8_A 86 T------ENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 150 (281)
T ss_dssp C------SSSCEEEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred c------cCccEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEEC
Confidence 2 246799999999999999997542 4689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKD 612 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 612 (717)
.++.+||+|||.+....... ........+++.|+|||++. +.++.++|||||||++|+|++ |..||......
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 151 SNDCVKLGDFGLSRYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCCEEECccccccccCccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 99999999999998652211 11122334677899999965 458999999999999999997 99999765332
Q ss_pred chhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 613 DFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
+. ..... ...... .+..++..+.+++.+||+.+|++|
T Consensus 225 ~~--~~~i~-----------~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~R 261 (281)
T 1mp8_A 225 DV--IGRIE-----------NGERLP------------------------------MPPNCPPTLYSLMTKCWAYDPSRR 261 (281)
T ss_dssp GH--HHHHH-----------TTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HH--HHHHH-----------cCCCCC------------------------------CCCCCCHHHHHHHHHHccCChhhC
Confidence 21 11110 000000 111235668899999999999999
Q ss_pred CCHHHHHHHHHHHHHHH
Q 005045 693 IAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 693 ps~~eil~~l~~i~~~~ 709 (717)
||+.|+++.|+++.++.
T Consensus 262 ps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 262 PRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHh
Confidence 99999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.84 Aligned_cols=284 Identities=18% Similarity=0.234 Sum_probs=210.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCc
Confidence 44678999999999999999999966 69999999987543 3345777899999999999999999998643 2344
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----CCCCce
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTA 539 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~ 539 (717)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEE
T ss_pred eEEEEEeCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceE
Confidence 78999999999999999976421 13389999999999999999999998 99999999999999 778899
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC---------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN---------GQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
||+|||.+...... .......||+.|+|||++. +.++.++|||||||++|||++|..||....
T Consensus 156 kL~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 156 KLTDFGAARELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCCTTCEECCTT--------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred EEccCCCceecCCC--------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999865211 1122356899999999863 468999999999999999999999997543
Q ss_pred CCch--hhhHHHHhcCChh-hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 611 KDDF--SIHMFVSMALPDH-VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 611 ~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
.... ..........|.. +..+.... .....+.. ............+..+.+++.+||++
T Consensus 228 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 228 GPRRNKEVMYKIITGKPSGAISGVQKAE-NGPIDWSG-----------------DMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp CGGGCHHHHHHHHHHCCTTCCEEEECST-TCCEEEES-----------------SCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred ccchhHHHHHHHhcCCCcccchhhhccc-CCccccCc-----------------cCCcccccchhHHHHhHHHHHHhccC
Confidence 3221 1111111112211 11111000 00000000 00000112345577889999999999
Q ss_pred CcCCCCCHHHHHHHHHHH
Q 005045 688 SPRERIAMNVVVNNLKTI 705 (717)
Q Consensus 688 ~p~~Rps~~eil~~l~~i 705 (717)
||++|||++|+++.....
T Consensus 290 dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 290 DQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTTSCCHHHHHHHHHHH
T ss_pred ChhhhccHHHhhhccHHH
Confidence 999999999999887643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.29 Aligned_cols=279 Identities=24% Similarity=0.359 Sum_probs=207.8
Q ss_pred cccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEee
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITAC 454 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~ 454 (717)
++....++|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+++++++ .||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3556678999999999999999999995 24667999998743 233457889999999999 999999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH----------------YQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
. ..+..++||||+++++|.+++....... .....+++..+..++.||+.||+|||+.
T Consensus 119 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 191 (344)
T 1rjb_A 119 T-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 191 (344)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred e-----eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4 4457899999999999999997653210 0113479999999999999999999998
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHH
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLL 597 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ 597 (717)
||+||||||+||+++.++.+||+|||.+...... ..........+++.|+|||++ .+.++.++|||||||++|
T Consensus 192 -~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 192 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265 (344)
T ss_dssp -TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC-----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred -CcccCCCChhhEEEcCCCcEEeCCCccCcccccC-----ccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHH
Confidence 9999999999999999999999999999865321 112233345578899999996 456899999999999999
Q ss_pred HHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 598 EMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 598 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
+|++ |..||........ ........ ..... +..++..
T Consensus 266 el~t~g~~p~~~~~~~~~-~~~~~~~~--------~~~~~---------------------------------~~~~~~~ 303 (344)
T 1rjb_A 266 EIFSLGVNPYPGIPVDAN-FYKLIQNG--------FKMDQ---------------------------------PFYATEE 303 (344)
T ss_dssp HHTTTSCCSSTTCCCSHH-HHHHHHTT--------CCCCC---------------------------------CTTCCHH
T ss_pred HHHcCCCCCcccCCcHHH-HHHHHhcC--------CCCCC---------------------------------CCCCCHH
Confidence 9998 9999976533221 11111110 00000 1112556
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFLEFKKRN 716 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~~~~~~~~~ 716 (717)
+.+++.+||+.+|++|||+.|+++.|+.+.....+...+|
T Consensus 304 l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~ 343 (344)
T 1rjb_A 304 IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQN 343 (344)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----------
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHHhcc
Confidence 8899999999999999999999999999988776655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=358.30 Aligned_cols=265 Identities=24% Similarity=0.451 Sum_probs=212.1
Q ss_pred CCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+...++....++|++.+.||+|+||.||+|.+++++.||||.+.... ...+.+.+|++++++++||||+++++++.
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--- 253 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--- 253 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---
Confidence 44566777889999999999999999999998888899999987543 23578999999999999999999999863
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 254 ---~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 254 ---KEPIYIITEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLV 322 (454)
T ss_dssp ---SSSCEEEECCCTTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCC
T ss_pred ---CCccEEEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCc
Confidence 346899999999999999997541 13688999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||+++...... ........++..|+|||++. +.++.++|||||||++|||++ |..||......+ .
T Consensus 323 ~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~ 394 (454)
T 1qcf_A 323 CKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--V 394 (454)
T ss_dssp EEECSTTGGGGBCCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred EEEeeCCCceEcCCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999998652111 11112234677899999965 568999999999999999999 999997542211 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
...+... . .. +.+..++..+.+++.+||+.+|++|||++
T Consensus 395 ~~~i~~~--------~--~~-------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 395 IRALERG--------Y--RM-------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp HHHHHHT--------C--CC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHcC--------C--CC-------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 1111100 0 00 01223466789999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 697 VVVNNLKTIRN 707 (717)
Q Consensus 697 eil~~l~~i~~ 707 (717)
+|++.|+.+..
T Consensus 434 ~i~~~L~~~~~ 444 (454)
T 1qcf_A 434 YIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHTSSS
T ss_pred HHHHHHHHHHh
Confidence 99999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.17 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=202.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...+.|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++... ....
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCC
Confidence 34556899999999999999999965 7888999988644 234567889999999999999999999986543 2345
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeC-CCCce
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNVLLD-KDMTA 539 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~ 539 (717)
...++||||+++++|.+++... ..+++..+..++.||+.||+|||+. + |+||||||+||+++ .++.+
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred ceEEEEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence 6789999999999999999743 5689999999999999999999997 7 99999999999998 78999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
||+|||.+.... ........|++.|+|||++.+.++.++|||||||++|+|++|..||.............
T Consensus 172 kl~Dfg~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 242 (290)
T 1t4h_A 172 KIGDLGLATLKR---------ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242 (290)
T ss_dssp EECCTTGGGGCC---------TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred EEeeCCCccccc---------ccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH
Confidence 999999997541 11223456899999999998889999999999999999999999997643222111111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.....+.. .+..++..+.+++.+||+.+|++|||++|++
T Consensus 243 ~~~~~~~~-----------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 243 TSGVKPAS-----------------------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TTTCCCGG-----------------------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hccCCccc-----------------------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 10000000 0111134678999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 282 ~ 282 (290)
T 1t4h_A 282 N 282 (290)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.34 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=201.0
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
..++|++.+.||+|+||.||+|++. ++.||+|.+... ...+.+.+|++++++++||||+++++++. +..+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 4578999999999999999999975 788999998643 34577899999999999999999999853 2468
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc-eEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT-AHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg 545 (717)
+||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||
T Consensus 76 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp EEEECCTTCBHHHHHHCSS----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred EEEEcCCCCCHHHHHhccC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 9999999999999997653 1245789999999999999999999943338999999999999998886 7999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
.+..... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||..................
T Consensus 152 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 152 TACDIQT----------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp C----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred ccccccc----------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 9875421 1123458999999999765 5899999999999999999999999765433222211111100
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
.+. ....++..+.+++.+||+.+|++|||++|+++.|+.
T Consensus 222 --------~~~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 222 --------RPP---------------------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp --------CCC---------------------------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCC---------------------------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 000 011225567899999999999999999999999999
Q ss_pred HHHHHHh
Q 005045 705 IRNCFLE 711 (717)
Q Consensus 705 i~~~~~~ 711 (717)
+.+.+..
T Consensus 261 ~~~~~~~ 267 (307)
T 2eva_A 261 LMRYFPG 267 (307)
T ss_dssp HGGGCCC
T ss_pred HHHhccC
Confidence 9866543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=335.32 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=200.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh------hHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ------GALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 84 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--- 84 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence 34578999999999999999999965 789999999864421 13577889999999999999999999953
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM- 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~- 537 (717)
.....++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 85 --~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 85 --NKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSS
T ss_pred --eCCEEEEEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCC
Confidence 455899999999999999999754 5689999999999999999999998 999999999999999877
Q ss_pred ---ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 538 ---TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 538 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
.+||+|||.+...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp SSCCEEECCCTTCEECCTT--------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CCCCEEEEECCCCeECCCC--------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 8999999999865211 11223568999999999765 58999999999999999999999996532111
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
...... ....... ......++..+.+++.+||+.+|++||
T Consensus 225 --~~~~~~-----------~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rp 264 (326)
T 2y0a_A 225 --TLANVS-----------AVNYEFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRM 264 (326)
T ss_dssp --HHHHHH-----------HTCCCCC---------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred --HHHHHH-----------hcCCCcC---------------------------ccccccCCHHHHHHHHHHccCChhhCC
Confidence 100000 0000000 001112255678999999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
|+.|+++
T Consensus 265 t~~e~l~ 271 (326)
T 2y0a_A 265 TIQDSLQ 271 (326)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.39 Aligned_cols=245 Identities=29% Similarity=0.362 Sum_probs=198.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++ .+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence 3578999999999999999999965 79999999986542 23456788999999999999999999995 445
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+|.+||+
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~ 148 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT 148 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEe
Confidence 6899999999999999999754 5689999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||...... ...
T Consensus 149 Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~---- 212 (318)
T 1fot_A 149 DFGFAKYVPD----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTY---- 212 (318)
T ss_dssp CCSSCEECSS----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----
T ss_pred ecCcceecCC----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----
Confidence 9999986411 1223568999999999765 4899999999999999999999999653211 110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMN 696 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ 696 (717)
..+........ ...+..+.+++.+|++.+|++|| +++
T Consensus 213 -------~~i~~~~~~~p-------------------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 254 (318)
T 1fot_A 213 -------EKILNAELRFP-------------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTE 254 (318)
T ss_dssp -------HHHHHCCCCCC-------------------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTH
T ss_pred -------HHHHhCCCCCC-------------------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHH
Confidence 11111111100 11145678899999999999999 888
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
||++
T Consensus 255 ~i~~ 258 (318)
T 1fot_A 255 DVKN 258 (318)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.09 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=199.2
Q ss_pred ccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
.|...++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEE
Confidence 4778889999999999999976 799999999876655556788899999999999999999999643 4589999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 121 ~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp ECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 999999999999864 3589999999999999999999997 99999999999999999999999999987
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ......
T Consensus 190 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~------- 253 (321)
T 2c30_A 190 QISKD-------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL------- 253 (321)
T ss_dssp ECCSS-------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH-------
T ss_pred ecccC-------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-------
Confidence 65211 112234568999999999655 5899999999999999999999999653211 111111
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.....+... ....++..+.+++.+||+.+|++|||++|+++.
T Consensus 254 -~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 -RDSPPPKLK-------------------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHSSCCCCT-------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hcCCCCCcC-------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111110 111224567899999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=341.31 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=200.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..........+.+|++++++++||||+++++++ .+....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 568999999999999999999965 7899999998765444556788999999999999999999995 3456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--CCceEEeee
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK--DMTAHVGDF 544 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Df 544 (717)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. .+.+||+||
T Consensus 125 lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEcCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEec
Confidence 9999999999999987542 4689999999999999999999998 9999999999999974 578999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ........
T Consensus 196 G~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~- 264 (387)
T 1kob_A 196 GLATKLNP--------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKR- 264 (387)
T ss_dssp TTCEECCT--------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH-
T ss_pred ccceecCC--------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHh-
Confidence 99986511 112234568999999999765 4899999999999999999999999754211 11111100
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....... .....++..+.+++.+||+.+|++|||+.|+++.
T Consensus 265 ----------~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 ----------CDWEFDE---------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----------CCCCCCS---------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----------CCCCCCc---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000 0011225567899999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.49 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=198.6
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++ .+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 34678999999999999999999965 89999999886432 33456788999999999999999999995 455
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---CCCce
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTA 539 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~ 539 (717)
+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCE
T ss_pred CEEEEEEEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcE
Confidence 6899999999999999988754 5689999999999999999999998 999999999999998 46789
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
||+|||.+..... .........||+.|+|||++.+ .++.++||||+||++|+|++|..||...... ....
T Consensus 153 kL~DFG~a~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~ 223 (444)
T 3soa_A 153 KLADFGLAIEVEG-------EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQ 223 (444)
T ss_dssp EECCCSSCBCCCT-------TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred EEccCceeEEecC-------CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHH
Confidence 9999999976521 1122234679999999999766 5899999999999999999999999653211 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
...... .+...+ ....++..+.+++.+||+.||++|||+.|+
T Consensus 224 ~i~~~~-------~~~~~~-------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~ 265 (444)
T 3soa_A 224 QIKAGA-------YDFPSP-------------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEA 265 (444)
T ss_dssp HHHHTC-------CCCCTT-------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHhCC-------CCCCcc-------------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 111000 000000 001124567899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 266 L~ 267 (444)
T 3soa_A 266 LK 267 (444)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.88 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=201.3
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
........++|++.+.||+|+||.||+|.++ +|+.||+|++.... ....+.+.+|++++++++||||+++++++
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--- 97 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--- 97 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 3334445678999999999999999999965 78999999986442 33457788999999999999999999995
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD- 536 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~- 536 (717)
.+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 98 --~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 165 (362)
T 2bdw_A 98 --QEESFHYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKA 165 (362)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSS
T ss_pred --EeCCEEEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCC
Confidence 4456899999999999999998754 5689999999999999999999998 99999999999999865
Q ss_pred --CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 537 --MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 537 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
+.+||+|||.+..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 166 ~~~~~kl~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~- 236 (362)
T 2bdw_A 166 KGAAVKLADFGLAIEVND--------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH- 236 (362)
T ss_dssp TTCCEEECCCTTCBCCTT--------CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCCCEEEeecCcceEecC--------CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-
Confidence 4699999999976521 111234569999999999766 5899999999999999999999999653211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
........ ....... .....++..+.+++.+||+.+|++||
T Consensus 237 -~~~~~i~~-----------~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~R~ 277 (362)
T 2bdw_A 237 -RLYAQIKA-----------GAYDYPS---------------------------PEWDTVTPEAKSLIDSMLTVNPKKRI 277 (362)
T ss_dssp -HHHHHHHH-----------TCCCCCT---------------------------TGGGGSCHHHHHHHHHHSCSSGGGSC
T ss_pred -HHHHHHHh-----------CCCCCCc---------------------------ccccCCCHHHHHHHHHHcCCChhhCc
Confidence 11111100 0000000 00112255678999999999999999
Q ss_pred CHHHHHHH
Q 005045 694 AMNVVVNN 701 (717)
Q Consensus 694 s~~eil~~ 701 (717)
|+.|+++.
T Consensus 278 t~~e~l~h 285 (362)
T 2bdw_A 278 TADQALKV 285 (362)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.65 Aligned_cols=278 Identities=21% Similarity=0.414 Sum_probs=196.7
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCc---hhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEe
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGT---IVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITA 453 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 453 (717)
.+.++....++|++.+.||+|+||.||+|.+. +++ .||+|++... .....+.+.+|++++++++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 45566778889999999999999999999965 332 7999998754 33456789999999999999999999998
Q ss_pred eccccCC-CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 454 CSSVDLE-GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 454 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
+...... .....++||||+++++|.+++....... ....+++..+..++.||+.||+|||+. +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIl 169 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE-NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCM 169 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccc-cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEE
Confidence 6543211 1112489999999999999986331100 113589999999999999999999998 9999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMF 610 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~ 610 (717)
++.++.+||+|||.+....... .........+++.|+|||.+.+ .++.++|||||||++|+|++ |..||....
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECTTSCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcCCCCEEEeeccccccccccc-----cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999999999998652211 1112223446788999999654 58999999999999999999 999997653
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.... ... +....... .+.+++..+.+++.+||+.+|+
T Consensus 245 ~~~~--~~~-----------~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~ 281 (323)
T 3qup_A 245 NAEI--YNY-----------LIGGNRLK------------------------------QPPECMEEVYDLMYQCWSADPK 281 (323)
T ss_dssp GGGH--HHH-----------HHTTCCCC------------------------------CCTTCCHHHHHHHHHTTCSSGG
T ss_pred hHHH--HHH-----------HhcCCCCC------------------------------CCCccCHHHHHHHHHHccCChh
Confidence 3221 111 11100000 1112255688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~~ 709 (717)
+|||+.|+++.|+++.+..
T Consensus 282 ~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 282 QRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GSCCHHHHHHHHHHHHHC-
T ss_pred hCcCHHHHHHHHHHHHHHh
Confidence 9999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.18 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=197.1
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.+.||+|+||.||+|++.+|+.||+|++.... ......+.+|++++++++||||+++++++. ..+..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeEE
Confidence 5899999999999999999998889999999986432 223467889999999999999999999954 445899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 77 lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEECCSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEecCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 99999974 9998887543 5689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh-c
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM-A 623 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~ 623 (717)
+...... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+. ....... .
T Consensus 147 ~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 218 (288)
T 1ob3_A 147 ARAFGIP-------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILG 218 (288)
T ss_dssp HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred ccccCcc-------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHC
Confidence 9875211 112233468999999999754 479999999999999999999999976532221 1111110 0
Q ss_pred C--Chhhhh-----hcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 624 L--PDHVMD-----ILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 624 ~--~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
. ...+.. ..++......... -.......+..+.+++.+||+.||++|||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 276 (288)
T 1ob3_A 219 TPNSKNWPNVTELPKYDPNFTVYEPLP----------------------WESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (288)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCC----------------------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCChhhchhhhcccccccccccccCcc----------------------HHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 0 000000 0111111000000 0001112355678999999999999999999
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
|+++
T Consensus 277 e~l~ 280 (288)
T 1ob3_A 277 QALE 280 (288)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.40 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=197.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-----hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-----GALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 568999999999999999999965 799999998864321 13577899999999999999999999954 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc---
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT--- 538 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--- 538 (717)
.+..|+||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCc
Confidence 4589999999999999887753210 113589999999999999999999998 9999999999999986654
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
+||+|||.+...... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....
T Consensus 172 vkl~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~ 241 (351)
T 3c0i_A 172 VKLGGFGVAIQLGES-------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLF 241 (351)
T ss_dssp EEECCCTTCEECCTT-------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHH
T ss_pred EEEecCcceeEecCC-------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHH
Confidence 999999999865221 112234569999999999765 48999999999999999999999996531 1110
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
. .+........+ .....++..+.+++.+||+.||++|||+.|
T Consensus 242 ~-----------~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 242 E-----------GIIKGKYKMNP---------------------------RQWSHISESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp H-----------HHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred H-----------HHHcCCCCCCc---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 01111110000 001122556789999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 284 ~l~ 286 (351)
T 3c0i_A 284 ALN 286 (351)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.55 Aligned_cols=202 Identities=24% Similarity=0.388 Sum_probs=172.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
...++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+..|..+++++ +||||+++++++ .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 34678999999999999999999965 78899999987542 33346678899999887 899999999985 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+|
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEE
Confidence 456899999999999999998754 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|+|||+++.... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 194 L~DFGla~~~~~-------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 194 LTDYGMCKEGLR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp ECCCTTCBCCCC-------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred Eeecceeeeccc-------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999975311 1122344679999999999765 4899999999999999999999999654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=332.55 Aligned_cols=274 Identities=21% Similarity=0.265 Sum_probs=205.2
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...++|++.+.||+|+||.||+|.+ .+++.||+|+..... ....+.+|+++++.+.|++++..+..+. ...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCc
Confidence 3467999999999999999999996 489999999865432 2245778999999999888777777653 34568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl 541 (717)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEE
T ss_pred eEEEEEcc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEE
Confidence 89999999 899999987432 4689999999999999999999998 99999999999999 78899999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+.....................|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--- 226 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--- 226 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH---
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh---
Confidence 9999998764332222112223345679999999999665 589999999999999999999999976533211000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...+.... .... .......++..+.+++.+||+.+|++|||++||++
T Consensus 227 --------------------------~~~~~~~~-~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 227 --------------------------YERISEKK-MSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------------HHHHHHHH-HHSC------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------------hhhhhccc-ccch------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00000000 0000 00011223567899999999999999999999999
Q ss_pred HHHHHHHHHHh
Q 005045 701 NLKTIRNCFLE 711 (717)
Q Consensus 701 ~l~~i~~~~~~ 711 (717)
.|+++.++...
T Consensus 274 ~l~~~~~~~~~ 284 (296)
T 4hgt_A 274 LFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhCC
Confidence 99999877643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.15 Aligned_cols=279 Identities=24% Similarity=0.368 Sum_probs=186.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|.++ +|+.||+|++.... ......+.+|++++++++||||+++++++ ...+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 77 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence 4568999999999999999999965 78999999986543 22346788999999999999999999995 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++ ++|.+++....... ....+++..+..++.||+.||+|||+. ||+||||||+||+++.+|.+||+||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGN-TPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSS-CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecC-CCHHHHHHhccccc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcC
Confidence 999999997 69998876421100 114589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+...... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+. .......
T Consensus 153 g~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~ 224 (317)
T 2pmi_A 153 GLARAFGIP-------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDI 224 (317)
T ss_dssp SSCEETTSC-------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred ccceecCCC-------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 999865211 111223468999999999755 479999999999999999999999976533221 1111110
Q ss_pred -c-CChh-hhhh-----cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 623 -A-LPDH-VMDI-----LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 623 -~-~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
. .+.. +... ..+........ ...+.+ .. ......+..+.+++.+||+.||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------~~-----~~~~~~~~~l~~li~~~L~~dP~~Rpt 287 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPR---DLRQVL---------QP-----HTKEPLDGNLMDFLHGLLQLNPDMRLS 287 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCC---CSHHHH---------GG-----GCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred hCCCChhHhhhhhhhhhcccccccccch---hHHHhh---------cc-----cccccCCHHHHHHHHHHCCCCcccCCC
Confidence 0 0110 0000 00111100000 000000 00 001122556889999999999999999
Q ss_pred HHHHHH
Q 005045 695 MNVVVN 700 (717)
Q Consensus 695 ~~eil~ 700 (717)
++|+++
T Consensus 288 ~~e~l~ 293 (317)
T 2pmi_A 288 AKQALH 293 (317)
T ss_dssp HHHHTT
T ss_pred HHHHhC
Confidence 999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.09 Aligned_cols=271 Identities=18% Similarity=0.249 Sum_probs=201.3
Q ss_pred ccccccccccCcccccceEEEEeC----CCchhhhHHhHhhhhh-----------HHHHHHHHHHHHhcCCCCceeEEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQQQG-----------ALKSFIDECNALKSTRHRNILRVIT 452 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~ 452 (717)
.++|++.+.||+|+||.||+|.+. ++..+|+|+....... ....+.+|+..++.+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 578999999999999999999965 5778899987543211 1234678889999999999999999
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
++... ..+....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 183 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL 183 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence 87553 23466899999999 99999999754 4789999999999999999999998 9999999999999
Q ss_pred eCCCC--ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 533 LDKDM--TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 533 l~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
++.++ .+||+|||.++.+..................|+..|+|||++.+. ++.++|||||||++|||++|..||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99877 999999999987643332222222223456799999999997654 899999999999999999999999643
Q ss_pred CCCchhhhHH---HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCC
Q 005045 610 FKDDFSIHMF---VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686 (717)
Q Consensus 610 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 686 (717)
.......... ....++..+.... ....++..+.+++.+||+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~ 307 (345)
T 2v62_A 264 LKDPVAVQTAKTNLLDELPQSVLKWA------------------------------------PSGSSCCEIAQFLVCAHS 307 (345)
T ss_dssp TTCHHHHHHHHHHHHHTTTHHHHHHS------------------------------------CTTSCCHHHHHHHHHHHT
T ss_pred ccccHHHHHHHHhhcccccHHHHhhc------------------------------------cccccHHHHHHHHHHHhh
Confidence 2222111111 1111111111111 011336678999999999
Q ss_pred CCcCCCCCHHHHHHHHHHHH
Q 005045 687 TSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 687 ~~p~~Rps~~eil~~l~~i~ 706 (717)
.+|++|||++||++.|+.+.
T Consensus 308 ~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 308 LAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CCTTCCCCHHHHHHHHCTTC
T ss_pred cCcccCCCHHHHHHHHhccC
Confidence 99999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.70 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=197.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchh----hhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIV----AIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|++.++||+|+||.||+|++. +++.+ |+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES----
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----
Confidence 3568999999999999999999954 55554 77776533 23445788999999999999999999999743
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
...++|+|++++++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 89 --STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp --SSEEEEEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred --CCeEEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEE
Confidence 24789999999999999987543 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.++...... .........+|..|+|||++. +.++.++|||||||++|||++ |..||........ ..
T Consensus 158 l~Dfg~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~ 230 (327)
T 3poz_A 158 ITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS 230 (327)
T ss_dssp ECCTTHHHHHTTTC-----C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH
T ss_pred EccCcceeEccCCc-----ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HH
Confidence 99999998762211 112223345688999999964 458999999999999999999 9999976533221 11
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
... ...... .+..++..+.+++.+||+.+|++|||++|+
T Consensus 231 ~~~------------~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 231 ILE------------KGERLP-----------------------------QPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHH------------TTCCCC-----------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred HHH------------cCCCCC-----------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 111 100000 111225567899999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
++.|+.+...
T Consensus 270 l~~l~~~~~~ 279 (327)
T 3poz_A 270 IIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHhh
Confidence 9999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.51 Aligned_cols=273 Identities=21% Similarity=0.266 Sum_probs=208.5
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|++|.||+|++ .+++.||+|++..... ...+.+|+++++.+.|++++..+..+. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCce
Confidence 467999999999999999999996 4899999998764432 356889999999999888776666652 345688
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---CCCceEEe
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTAHVG 542 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~ 542 (717)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEEec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 9999999 899999987432 4689999999999999999999998 999999999999994 78899999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+.....................|++.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----- 225 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----- 225 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-----
Confidence 999998764332222111222345679999999999765 58999999999999999999999997643221100
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
....+.... .... .......++..+.+++.+||+.+|++|||+.||++.
T Consensus 226 ------------------------~~~~~~~~~-~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 226 ------------------------KYERISEKK-MSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ------------------------HHHHHHHHH-HHSC------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ------------------------hhhhhcccc-cCCc------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 000000000 0000 000112235678999999999999999999999999
Q ss_pred HHHHHHHHHh
Q 005045 702 LKTIRNCFLE 711 (717)
Q Consensus 702 l~~i~~~~~~ 711 (717)
|+++..+...
T Consensus 275 l~~~~~~~~~ 284 (296)
T 3uzp_A 275 FRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHhcCC
Confidence 9999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=326.80 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=203.6
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...++|++.+.||+|+||.||+|.++ +++.+|+|.+........+.+.+|++++++++||||+++++++. +.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCe
Confidence 34678999999999999999999965 67789999987665555678999999999999999999999953 4568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl 541 (717)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++ +.++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEeccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999988644 5689999999999999999999998 99999999999999 78889999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
+|||.+..... ........|++.|+|||++.+.++.++|||||||++|+|++|..||....... ......
T Consensus 151 ~Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~ 220 (277)
T 3f3z_A 151 IDFGLAARFKP--------GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKIR 220 (277)
T ss_dssp CCCTTCEECCT--------TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EecccceeccC--------ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 99999976521 11223356899999999998889999999999999999999999997542211 111110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
........ .....++..+.+++.+||+.+|++|||+.|+++.
T Consensus 221 -----------~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 221 -----------EGTFTFPE---------------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -----------HCCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----------hCCCCCCc---------------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0001235678899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.92 Aligned_cols=300 Identities=23% Similarity=0.306 Sum_probs=206.8
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.....++|++.+.||+|+||.||+|+. +++.||+|++....... .....|+..+..++||||+++++.+.........
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 344578999999999999999999987 68999999986543221 1222344445568999999999876554455666
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCEEeCCCC
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC------DTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlkp~NIll~~~~ 537 (717)
..++||||+++++|.+++... ..++..+..++.||+.||+|||+.+ .++|+||||||+||+++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 789999999999999999643 3588899999999999999999852 12899999999999999999
Q ss_pred ceEEeeeccchhcccccCCC-CCCcceeecccccccccCCCccCC--------CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNP-SKNQTVSIGLKGSIGYIPPEHMNG--------QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.+||+|||.+.......... ...........||+.|+|||++.+ .++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998653221110 011122234569999999999765 256789999999999999999777644
Q ss_pred CCCC-chhhhHHH-HhcCC--hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhcc
Q 005045 609 MFKD-DFSIHMFV-SMALP--DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMC 684 (717)
Q Consensus 609 ~~~~-~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 684 (717)
.... ........ ....+ ..+............ + .........++..+.+++.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~---~~~~~~~~~~~~~l~~li~~c 295 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK-------------------F---PEAWKENSLAVRSLKETIEDC 295 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC-------------------C---CTTCCCCSHHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCC-------------------C---CcccccccchHHHHHHHHHHH
Confidence 3221 11110000 00000 001111110000000 0 000011233567899999999
Q ss_pred CCCCcCCCCCHHHHHHHHHHHHHHHHhhhhc
Q 005045 685 STTSPRERIAMNVVVNNLKTIRNCFLEFKKR 715 (717)
Q Consensus 685 l~~~p~~Rps~~eil~~l~~i~~~~~~~~~~ 715 (717)
|+.+|++|||++|+++.|+++...+.+++++
T Consensus 296 l~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 296 WDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp SCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred hcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 9999999999999999999999888777654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=337.08 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=188.3
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.......++|++.+.||+|+||.||+|+++ +++.||+|++.... ..+.+.+|++++++++||||+++++++.
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----- 118 (349)
T 2w4o_A 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE----- 118 (349)
T ss_dssp SBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----
T ss_pred cccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----
Confidence 334556788999999999999999999976 68889999987543 3366788999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CC
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DM 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~ 537 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTC
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCC
Confidence 455899999999999999999755 5689999999999999999999998 9999999999999975 88
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
.+||+|||.+..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 189 ~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 260 (349)
T 2w4o_A 189 PLKIADFGLSKIVEH--------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260 (349)
T ss_dssp CEEECCCC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred CEEEccCccccccCc--------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence 999999999986521 111234568999999999765 58999999999999999999999997543322111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.... ........ ....+++..+.+++.+||+.||++|||+.
T Consensus 261 ~~i~------------~~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (349)
T 2w4o_A 261 RRIL------------NCEYYFIS---------------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTF 301 (349)
T ss_dssp HHHH------------TTCCCCCT---------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HHHH------------hCCCccCC---------------------------chhhhCCHHHHHHHHHHccCChhhCcCHH
Confidence 1111 11100000 00012255678999999999999999999
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
|+++
T Consensus 302 e~l~ 305 (349)
T 2w4o_A 302 QALQ 305 (349)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.66 Aligned_cols=280 Identities=22% Similarity=0.315 Sum_probs=209.1
Q ss_pred cccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++.. ++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence 356999999999999999999983 3788999999987666667889999999999999999999998642 34
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred CceEEEEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEE
Confidence 567899999999999999997432 4689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... ...........++..|+|||++.+ .++.++|||||||++|+|++|..||.....+. .
T Consensus 169 ~Dfg~~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~------~ 238 (327)
T 3lxl_A 169 ADFGLAKLLPLD----KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF------L 238 (327)
T ss_dssp CCGGGCEECCTT----CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH------H
T ss_pred cccccceecccC----CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh------h
Confidence 999999865211 111112233457888999999655 47999999999999999999999986431110 0
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.... .. . ......++...... ......+..++..+.+++.+||+.+|++|||++|+++
T Consensus 239 ~~~~---------~~--~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 239 RMMG---------CE--R----DVPALSRLLELLEE-------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHCC-------------------CCHHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcc---------cc--c----ccccHHHHHHHhhc-------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 00 0 00000000000000 0001122344677899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 701 NLKTIRNCFL 710 (717)
Q Consensus 701 ~l~~i~~~~~ 710 (717)
.|+.+.....
T Consensus 297 ~L~~~~~~~~ 306 (327)
T 3lxl_A 297 QLDMLWSGSR 306 (327)
T ss_dssp HHHHC-----
T ss_pred HHHHHHhhhc
Confidence 9999876544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=329.71 Aligned_cols=272 Identities=21% Similarity=0.304 Sum_probs=197.3
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++.++||+|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++. +++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 58999999999999999999965 78999999986442 334577889999999999999999999954 45589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++ ++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999975 6655554322 5689999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+..... .........+|+.|+|||++.+ . ++.++|||||||++|+|++|..||.................
T Consensus 147 ~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 147 LARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp TCEECCS-------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred cceecCC-------ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9986521 1122234568999999999654 3 79999999999999999999888654333222222211110
Q ss_pred -CC--hhhhhhcCC-CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 624 -LP--DHVMDILDP-SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 624 -~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.+ ..+...... .....+.. ..........+..+..+.+++.+||+.||++|||++|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMY------------------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCC------------------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCChhhhhhhcccccccccccc------------------cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 00 001100000 00000000 000000011122356678999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 282 ~ 282 (292)
T 3o0g_A 282 Q 282 (292)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.63 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=201.2
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+++++.++||||+++++++. .
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence 45678999999999999999999976 89999999986442 234567899999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEE
Confidence 45899999999999999999754 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|||++..... ........||+.|+|||++.+. .+.++|||||||++|+|++|..||...... ...
T Consensus 158 ~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~-- 225 (476)
T 2y94_A 158 ADFGLSNMMSD--------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLF-- 225 (476)
T ss_dssp CCCSSCEECCT--------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHH--
T ss_pred Eeccchhhccc--------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHH--
Confidence 99999986521 1122345689999999997765 378999999999999999999999754221 111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
..+.+..... +..++..+.+++.+||+.||++|||++||+
T Consensus 226 ---------~~i~~~~~~~-------------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil 265 (476)
T 2y94_A 226 ---------KKICDGIFYT-------------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIR 265 (476)
T ss_dssp ---------HHHHTTCCCC-------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ---------HHHhcCCcCC-------------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 1111111110 011144578899999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 266 ~ 266 (476)
T 2y94_A 266 E 266 (476)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=342.20 Aligned_cols=270 Identities=25% Similarity=0.390 Sum_probs=209.7
Q ss_pred ccccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+....++|++.++||+|+||.||+|.+. .++.||+|++.... ......+.+|+++++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3456789999999999999999999842 33569999987542 34457889999999999 99999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+. ..+..++||||+++++|.+++....... .....+++..++.++.||+.||+|||+. +|+||
T Consensus 144 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 215 (382)
T 3tt0_A 144 CT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 215 (382)
T ss_dssp EC-----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred ec-----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence 53 4557899999999999999987543110 1124689999999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.+....... .........+++.|+|||++.+ .++.++|||||||++|+|++ |
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g 290 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCC-----TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCcceEEEcCCCcEEEcccCccccccccc-----ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999998652211 1112233457889999999654 58999999999999999999 9
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||....... ....... ..... .+..++..+.+++.
T Consensus 291 ~~p~~~~~~~~--~~~~~~~--------~~~~~---------------------------------~~~~~~~~l~~li~ 327 (382)
T 3tt0_A 291 GSPYPGVPVEE--LFKLLKE--------GHRMD---------------------------------KPSNCTNELYMMMR 327 (382)
T ss_dssp CCSSTTCCHHH--HHHHHHT--------TCCCC---------------------------------CCSSCCHHHHHHHH
T ss_pred CCCCCCCCHHH--HHHHHHc--------CCCCC---------------------------------CCccCCHHHHHHHH
Confidence 99997542211 1111110 00000 11123566889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+||+.+|++|||++||++.|+++....
T Consensus 328 ~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 328 DCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=337.76 Aligned_cols=273 Identities=22% Similarity=0.388 Sum_probs=208.2
Q ss_pred cccccccccccccCcccccceEEEEeC--------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEee
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITAC 454 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~ 454 (717)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445789999999999999999999853 46779999987542 34467789999999999 999999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCD 525 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 525 (717)
. ..+..++||||+++++|.+++....... .....+++..++.++.||+.||+|||+. +|+|||
T Consensus 111 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 182 (334)
T 2pvf_A 111 T-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182 (334)
T ss_dssp C-----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred c-----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 3 4458899999999999999997653210 0113589999999999999999999998 999999
Q ss_pred CCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CC
Q 005045 526 LKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GK 603 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~ 603 (717)
|||+||+++.++.+||+|||.+....... .........+++.|+|||++.+ .++.++|||||||++|+|++ |.
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTS-----SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEEcCCCCEEEccccccccccccc-----cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999998652211 1112223446788999999644 58999999999999999999 99
Q ss_pred CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhc
Q 005045 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683 (717)
Q Consensus 604 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 683 (717)
.||....... ........ .... .+..++..+.+++.+
T Consensus 258 ~p~~~~~~~~--~~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~ 294 (334)
T 2pvf_A 258 SPYPGIPVEE--LFKLLKEG--------HRMD---------------------------------KPANCTNELYMMMRD 294 (334)
T ss_dssp CSSTTCCHHH--HHHHHHHT--------CCCC---------------------------------CCTTCCHHHHHHHHH
T ss_pred CCcCcCCHHH--HHHHHhcC--------CCCC---------------------------------CCccCCHHHHHHHHH
Confidence 9997542211 11111000 0000 111235668899999
Q ss_pred cCCCCcCCCCCHHHHHHHHHHHHHHHHhhh
Q 005045 684 CSTTSPRERIAMNVVVNNLKTIRNCFLEFK 713 (717)
Q Consensus 684 cl~~~p~~Rps~~eil~~l~~i~~~~~~~~ 713 (717)
||+.+|++|||++|+++.|+++.......+
T Consensus 295 ~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 295 CWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 999999999999999999999987665443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=332.32 Aligned_cols=271 Identities=23% Similarity=0.332 Sum_probs=210.8
Q ss_pred ccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
+....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 455678999999999999999999984 257789999987543 23457889999999999 9999999999953
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH-----------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
..+..++||||+++++|.+++....... .....+++..+..++.||+.||+|||+. +++||
T Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~ 169 (313)
T 1t46_A 98 -----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHR 169 (313)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred -----cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence 4457899999999999999987543110 0113589999999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.+...... ..........+++.|+|||++ .+.++.++|||||||++|+|++ |
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSC-----TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCccceEEEcCCCCEEEcccccccccccc-----ccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999865221 112223345577889999995 4468999999999999999999 9
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||........ ........ ..... +..++..+.+++.
T Consensus 245 ~~p~~~~~~~~~-~~~~~~~~--------~~~~~---------------------------------~~~~~~~l~~li~ 282 (313)
T 1t46_A 245 SSPYPGMPVDSK-FYKMIKEG--------FRMLS---------------------------------PEHAPAEMYDIMK 282 (313)
T ss_dssp CCSSTTCCSSHH-HHHHHHHT--------CCCCC---------------------------------CTTSCHHHHHHHH
T ss_pred CCCCCcccchhH-HHHHhccC--------CCCCC---------------------------------cccCCHHHHHHHH
Confidence 999976533221 11111110 00000 1122556889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+||+.+|++|||+.|+++.|+++..+.
T Consensus 283 ~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 283 TCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999988653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=336.47 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=173.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|+++ +++.||+|++... .....+.+.+|+.+++++ +||||+++++++ ..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----Ee
Confidence 3578999999999999999999965 7899999998754 234456788999999988 899999999995 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL 151 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL 151 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence 56899999999999999998743 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|||+++.... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 152 ~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 152 TDYGMCKEGLR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp CCGGGCBCSCC-------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred EeccccccccC-------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 99999975311 1112334679999999999765 5899999999999999999999999653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.05 Aligned_cols=277 Identities=24% Similarity=0.363 Sum_probs=209.7
Q ss_pred ccccccc-ccccccCcccccceEEEEeC-----CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 385 SKSTDNF-SKENLIGTGSFGSVYKGTLG-----DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y-~~~~~ig~g~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
....++| ++.++||+|+||.||++++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3345566 99999999999999988642 68889999987543 34467789999999999999999999997542
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
.....++||||+++++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 106 ---~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~ 171 (318)
T 3lxp_A 106 ---GAASLQLVMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR 171 (318)
T ss_dssp ---TTTEEEEEECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred ---CCceEEEEEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCC
Confidence 245789999999999999999643 489999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
.+||+|||.+...... ...........++..|+|||++.+ .++.++|||||||++|+|++|..||.......
T Consensus 172 ~~kl~Dfg~a~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--- 244 (318)
T 3lxp_A 172 LVKIGDFGLAKAVPEG----HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--- 244 (318)
T ss_dssp CEEECCGGGCEECCTT----CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---
T ss_pred CEEECCcccccccccc----ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---
Confidence 9999999999865211 111122234457888999999655 57899999999999999999999986421110
Q ss_pred hHHHHhcCC----hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 617 HMFVSMALP----DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 617 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
......... ..+.+.+.... ....+..++..+.+++.+||+.+|++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R 295 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGE-----------------------------RLPRPDKCPAEVYHLMKNCWETEASFR 295 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhcccccchhHHHHHHHHhccc-----------------------------CCCCCccccHHHHHHHHHHcCCCcccC
Confidence 000000000 00111111110 011223346778999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHHh
Q 005045 693 IAMNVVVNNLKTIRNCFLE 711 (717)
Q Consensus 693 ps~~eil~~l~~i~~~~~~ 711 (717)
||++|+++.|+.+.++...
T Consensus 296 ps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 296 PTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHHhhcc
Confidence 9999999999999987754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.17 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=209.5
Q ss_pred cccccccccccc-ccCcccccceEEEEeC---CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKEN-LIGTGSFGSVYKGTLG---DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~-~ig~g~~g~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+....++|.+.+ .||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--- 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---
Confidence 345567888887 9999999999999853 6788999998754 2345678899999999999999999999862
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.
T Consensus 81 ---~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~ 148 (287)
T 1u59_A 81 ---AEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 148 (287)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred ---CCCcEEEEEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCC
Confidence 235899999999999999987542 5689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||.+....... ..........+++.|+|||++. +.++.++|||||||++|+|++ |..||....... .
T Consensus 149 ~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 222 (287)
T 1u59_A 149 AKISDFGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--V 222 (287)
T ss_dssp EEECCCTTCEECTTCS----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--H
T ss_pred EEECcccceeeeccCc----ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--H
Confidence 9999999998652211 1111122334678899999975 458999999999999999998 999997643221 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
....... .... .+..++..+.+++.+||+.+|++|||+.
T Consensus 223 ~~~i~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 261 (287)
T 1u59_A 223 MAFIEQG--------KRME---------------------------------CPPECPPELYALMSDCWIYKWEDRPDFL 261 (287)
T ss_dssp HHHHHTT--------CCCC---------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred HHHHhcC--------CcCC---------------------------------CCCCcCHHHHHHHHHHcCCChhhCcCHH
Confidence 1111110 0000 1112356788999999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 005045 697 VVVNNLKTIRNCFLE 711 (717)
Q Consensus 697 eil~~l~~i~~~~~~ 711 (717)
|+++.|+++..+...
T Consensus 262 ~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 262 TVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999999877654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=325.81 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=191.5
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhh----hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ----GALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|+++++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 77 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----K 77 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----c
Confidence 34678999999999999999999985 88899999875422 23577889999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC---eeecCCCCCCEEeCC---
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP---IAHCDLKPSNVLLDK--- 535 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlkp~NIll~~--- 535 (717)
.+..++||||+++++|.+++.. ..+++..+..++.|++.|++|||+. + |+||||||+||+++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCS
T ss_pred CCceEEEEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccc
Confidence 4578999999999999999853 4589999999999999999999998 7 999999999999986
Q ss_pred -----CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 536 -----DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 536 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
++.+||+|||.+...... ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp SSCCSSCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccCcceEEccCCcccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999865211 1123468999999999654 5899999999999999999999999764
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
....... . ......... .+..++..+.+++.+||+.+|
T Consensus 218 ~~~~~~~--~-----------~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p 255 (271)
T 3dtc_A 218 DGLAVAY--G-----------VAMNKLALP-----------------------------IPSTCPEPFAKLMEDCWNPDP 255 (271)
T ss_dssp CHHHHHH--H-----------HHTSCCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CHHHHHH--h-----------hhcCCCCCC-----------------------------CCcccCHHHHHHHHHHhcCCc
Confidence 2211110 0 000000000 111225668899999999999
Q ss_pred CCCCCHHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKTI 705 (717)
Q Consensus 690 ~~Rps~~eil~~l~~i 705 (717)
++|||++|+++.|+++
T Consensus 256 ~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 256 HSRPSFTNILDQLTTI 271 (271)
T ss_dssp GGSCCHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHhcC
Confidence 9999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=336.33 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=199.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|+++ +|+.||+|++.... ......+.+|+++++.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 45679999999999999999999965 79999999986442 23457788999999999999999999985 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEE
Confidence 56899999999999999999754 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .....
T Consensus 183 ~DFg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~- 249 (350)
T 1rdq_E 183 TDFGFAKRVKG----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEK- 249 (350)
T ss_dssp CCCTTCEECSS----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-
T ss_pred cccccceeccC----------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHHH-
Confidence 99999986521 1223568999999999655 5899999999999999999999999753211 11111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----H
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----M 695 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~ 695 (717)
+....... +..++..+.+++.+||+.+|++||+ +
T Consensus 250 ----------i~~~~~~~-------------------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 288 (350)
T 1rdq_E 250 ----------IVSGKVRF-------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV 288 (350)
T ss_dssp ----------HHHCCCCC-------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred ----------HHcCCCCC-------------------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCH
Confidence 11111100 0112456789999999999999998 8
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
+||++
T Consensus 289 ~ei~~ 293 (350)
T 1rdq_E 289 NDIKN 293 (350)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 88865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.06 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=207.2
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
....++|++.+.||+|++|.||.|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++. ..+.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAP 77 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSS
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence 3456799999999999999999999888889999998755432 367889999999999999999999953 4457
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCT
T ss_pred eEEEEeCCCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccc
Confidence 899999999999999997542 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHh
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 622 (717)
|.+....... ........++..|+|||++. +.++.++||||||+++|+|++ |..||....... .......
T Consensus 149 g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~ 220 (267)
T 3t9t_A 149 GMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST 220 (267)
T ss_dssp TGGGGBCCHH------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT
T ss_pred cccccccccc------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhc
Confidence 9998652111 11112344677899999965 458999999999999999999 899997542211 1111110
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
. ..... +..++..+.+++.+||+.+|++|||++|+++.|
T Consensus 221 ~--------~~~~~---------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 221 G--------FRLYK---------------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp T--------CCCCC---------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--------CcCCC---------------------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0 00000 011245678999999999999999999999999
Q ss_pred HHHHHH
Q 005045 703 KTIRNC 708 (717)
Q Consensus 703 ~~i~~~ 708 (717)
+++.++
T Consensus 260 ~~l~~~ 265 (267)
T 3t9t_A 260 AEIAES 265 (267)
T ss_dssp HHHHHC
T ss_pred HHHHhc
Confidence 999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.07 Aligned_cols=266 Identities=21% Similarity=0.350 Sum_probs=196.7
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|++ .+++.||+|++... .......+.+|++++++++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 4467999999999999999999996 48999999998654 2344577899999999999999999999865432 22
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEE
T ss_pred CcccEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEE
Confidence 23569999999999999999743 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+........ .........|++.|+|||++.+ .++.++|||||||++|+|++|..||..............
T Consensus 158 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 233 (311)
T 3ork_A 158 MDFGIARAIADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233 (311)
T ss_dssp CCCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeccCccccccccc----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence 99999986532211 1122234568999999999655 589999999999999999999999975432211110000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH-H
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV-V 699 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei-l 699 (717)
....+. ......++..+.+++.+||+.+|++||++.++ .
T Consensus 234 ~~~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 234 EDPIPP----------------------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCCCH----------------------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCc----------------------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 000000 00111235678899999999999999965554 4
Q ss_pred HHHHHHH
Q 005045 700 NNLKTIR 706 (717)
Q Consensus 700 ~~l~~i~ 706 (717)
+.+.++.
T Consensus 274 ~~l~~~~ 280 (311)
T 3ork_A 274 ADLVRVH 280 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 5555543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.03 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=197.0
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDL 459 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 459 (717)
....++|++.+.||+|+||.||+|+++ +|+.||+|++.... ......+..|.++++.+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~----- 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF----- 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----
Confidence 345679999999999999999999975 78999999987542 23456678899999876 999999999995
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+|.+
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCE
Confidence 4456899999999999999998743 5689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
||+|||++..... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...... ....
T Consensus 158 kL~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~ 228 (345)
T 1xjd_A 158 KIADFGMCKENML-------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH 228 (345)
T ss_dssp EECCCTTCBCCCC-------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH
T ss_pred EEeEChhhhhccc-------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHH
Confidence 9999999875311 1112344679999999999765 4899999999999999999999999754221 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH-H
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN-V 697 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-e 697 (717)
..... .+..+ ...+..+.+++.+||+.+|++||++. |
T Consensus 229 ~i~~~---------~~~~p---------------------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~ 266 (345)
T 1xjd_A 229 SIRMD---------NPFYP---------------------------------RWLEKEAKDLLVKLFVREPEKRLGVRGD 266 (345)
T ss_dssp HHHHC---------CCCCC---------------------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred HHHhC---------CCCCC---------------------------------cccCHHHHHHHHHHhcCCHhHcCCChHH
Confidence 11000 00111 01145678899999999999999997 6
Q ss_pred HH
Q 005045 698 VV 699 (717)
Q Consensus 698 il 699 (717)
|+
T Consensus 267 i~ 268 (345)
T 1xjd_A 267 IR 268 (345)
T ss_dssp GG
T ss_pred HH
Confidence 64
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=331.69 Aligned_cols=245 Identities=21% Similarity=0.270 Sum_probs=189.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++.++||+|+||.||+|++. +++.||||++.... .........|+..+.++ .||||+++++++. +.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence 478999999999999999999976 89999999875431 22334444555555554 9999999999964 456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECC
T ss_pred EEEEEEecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcc
Confidence 899999999 679998886432 4689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
||.+..... ........||+.|+|||++.+.++.++|||||||++|||++|..|+... ....
T Consensus 201 FG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~------ 262 (311)
T 3p1a_A 201 FGLLVELGT--------AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG----EGWQ------ 262 (311)
T ss_dssp CTTCEECC--------------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHH------
T ss_pred ceeeeeccc--------CCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHH------
Confidence 999876521 1122334589999999999889999999999999999999997776431 0000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+.....+ ......++..+.+++.+||+++|++|||++|+++
T Consensus 263 ------~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 ------QLRQGYLP-----------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHTTTCCC-----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------HHhccCCC-----------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01000000 0011223567889999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.73 Aligned_cols=269 Identities=25% Similarity=0.447 Sum_probs=200.0
Q ss_pred ccccccccccccCcccccceEEEEeC--CC--chhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG--DG--TIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.....|++.+.||+|+||.||+|.+. ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++. .
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~ 161 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----R 161 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----C
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----c
Confidence 34457889999999999999999853 22 35889987643 3345678999999999999999999999863 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k 232 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVK 232 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEE
Confidence 4457899999999999999997543 4578999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+++....... ..........+++.|+|||++. +.++.++|||||||++|||++ |..||......+...
T Consensus 233 L~DFG~a~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-- 307 (373)
T 3c1x_A 233 VADFGLARDMYDKEF---DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-- 307 (373)
T ss_dssp ECCC------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--
T ss_pred Eeecccccccccccc---ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--
Confidence 999999986522111 1111223345778899999964 458999999999999999999 777876553332211
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
..... .... .+..++..+.+++.+||+.+|++|||++|+
T Consensus 308 ~~~~~-----------~~~~------------------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 308 YLLQG-----------RRLL------------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp HHHTT-----------CCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHcC-----------CCCC------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11100 0000 111235668899999999999999999999
Q ss_pred HHHHHHHHHHHHhhh
Q 005045 699 VNNLKTIRNCFLEFK 713 (717)
Q Consensus 699 l~~l~~i~~~~~~~~ 713 (717)
++.|+++...+....
T Consensus 347 l~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 347 VSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHHHHHTCCSCC
T ss_pred HHHHHHHHHhccccc
Confidence 999999998766544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=328.81 Aligned_cols=265 Identities=24% Similarity=0.448 Sum_probs=210.1
Q ss_pred ccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
+++....++|++.+.||+|++|.||.|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------ 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------
Confidence 456677889999999999999999999988888899999875432 3467889999999999999999999853
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred CCCcEEEEecCCCCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEE
Confidence 235799999999999999997531 13689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+...... .........++..|+|||++. +.++.++|||||||++|+|++ |..||....... ....
T Consensus 151 ~Dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~ 222 (279)
T 1qpc_A 151 ADFGLARLIEDN------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN 222 (279)
T ss_dssp CCCTTCEECSSS------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH
T ss_pred CCCcccccccCc------ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHH
Confidence 999999865211 111122344677899999965 458999999999999999999 999997542211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... .... .+..++..+.+++.+|++.+|++|||+.+++
T Consensus 223 ~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 261 (279)
T 1qpc_A 223 LERG--------YRMV---------------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261 (279)
T ss_dssp HHTT--------CCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Hhcc--------cCCC---------------------------------CcccccHHHHHHHHHHhccChhhCCCHHHHH
Confidence 1100 0000 0112256788999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 700 NNLKTIRNCFL 710 (717)
Q Consensus 700 ~~l~~i~~~~~ 710 (717)
+.|+.+.....
T Consensus 262 ~~l~~~~~~~~ 272 (279)
T 1qpc_A 262 SVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHhcc
Confidence 99999886543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=352.63 Aligned_cols=377 Identities=19% Similarity=0.177 Sum_probs=276.8
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
.+.+-++-+++ .+|..+- +++++|+|++|.|+++.|.+|.++++|++|+|++|+|++..|.+|.++++|++|+|++|
T Consensus 34 ~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N 110 (635)
T 4g8a_A 34 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 110 (635)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence 46778888898 6887664 48999999999999877889999999999999999999878889999999999999999
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 172 (717)
+|++..+.+|.++++|++|+|++|+++++.+..|+++++|++|+|++|.+++.-....+..+++|+.|++++|.+++..+
T Consensus 111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 99987888999999999999999999988888999999999999999999843234455689999999999999987666
Q ss_pred ccCCCCCCC----CEEeccCccccccCCCC--------------------------------------------------
Q 005045 173 VSLSNASNL----QVLDFAENGLTGTIPGN-------------------------------------------------- 198 (717)
Q Consensus 173 ~~~~~l~~L----~~L~l~~N~l~~~~~~~-------------------------------------------------- 198 (717)
..|..+.++ ..++++.|.++...+..
T Consensus 191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~ 270 (635)
T 4g8a_A 191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 270 (635)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred ccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence 555433222 13333333332111100
Q ss_pred -----------------------------------------------------ccCCCCCCeeeccccccCCcccCchhh
Q 005045 199 -----------------------------------------------------FGSLKDLVRLNFDQNELGSREIGDLNF 225 (717)
Q Consensus 199 -----------------------------------------------------~~~l~~L~~L~l~~N~l~~~~~~~~~~ 225 (717)
+.....|+.|++.+|.+..+....+..
T Consensus 271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~ 350 (635)
T 4g8a_A 271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 350 (635)
T ss_dssp CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTT
T ss_pred cccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchh
Confidence 111122333333333332221110000
Q ss_pred -------------hhhhccCCCCCEEEeecCc------------------------------------------------
Q 005045 226 -------------LKFLANCTSLEVLGLARNS------------------------------------------------ 244 (717)
Q Consensus 226 -------------~~~~~~l~~L~~L~L~~N~------------------------------------------------ 244 (717)
+.....+++|+.|++++|.
T Consensus 351 L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~ 430 (635)
T 4g8a_A 351 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 430 (635)
T ss_dssp CCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTS
T ss_pred hhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhc
Confidence 0001123344444444443
Q ss_pred -ccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcC-ccccchhhhcCCCCCeEEcccCcCCCCC
Q 005045 245 -FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL-SGSVPEVIGRLNKLEGLGLNVNKFSGLI 322 (717)
Q Consensus 245 -l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 322 (717)
.....+...+...++++.+++++|.+.+..+..+..++.|+.|+|++|++ ....|..|..+++|++|+|++|+++++.
T Consensus 431 ~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~ 510 (635)
T 4g8a_A 431 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 510 (635)
T ss_dssp EEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcC
Confidence 33233322222235788888889988888888899999999999999975 4457788999999999999999999999
Q ss_pred CcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCcccccCCCCcccccccccccc
Q 005045 323 PSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFS 392 (717)
Q Consensus 323 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~s~~~~~~~~~~y~ 392 (717)
|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.|++..|..+....-++..+.-..+.|.
T Consensus 511 ~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 511 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp TTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred hHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999998888889999999999999999998777766443333444444444443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.63 Aligned_cols=279 Identities=21% Similarity=0.332 Sum_probs=215.5
Q ss_pred CCCcccccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeE
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILR 449 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~ 449 (717)
.+....+....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 455556667789999999999999999999983 256889999987543 33456788999999999 7999999
Q ss_pred EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcc---------cccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005045 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHY---------QFKKLSVIQRLNIAIDVASALDYLHHHCDTP 520 (717)
Q Consensus 450 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 520 (717)
+++++.. .+...++||||+++++|.+++........ ....+++..+..++.||+.||+|||+. +
T Consensus 96 ~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ 168 (316)
T 2xir_A 96 LLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---K 168 (316)
T ss_dssp EEEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 9999632 34568999999999999999976532110 012388999999999999999999998 9
Q ss_pred eeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHH
Q 005045 521 IAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEM 599 (717)
Q Consensus 521 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~el 599 (717)
|+||||||+||+++.++.+||+|||.+..... ...........+++.|+|||++. +.++.++|||||||++|+|
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYK-----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTT-----CTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cccccCccceEEECCCCCEEECCCcccccccc-----CccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHH
Confidence 99999999999999999999999999986521 11222333456788999999964 4589999999999999999
Q ss_pred Hh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHH
Q 005045 600 FT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVL 678 (717)
Q Consensus 600 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (717)
++ |..||.......... ....... .... +..++..+.
T Consensus 244 ~t~g~~p~~~~~~~~~~~-~~~~~~~--------~~~~---------------------------------~~~~~~~l~ 281 (316)
T 2xir_A 244 FSLGASPYPGVKIDEEFC-RRLKEGT--------RMRA---------------------------------PDYTTPEMY 281 (316)
T ss_dssp HTTSCCSSTTCCCSHHHH-HHHHHTC--------CCCC---------------------------------CTTCCHHHH
T ss_pred HhCCCCCCcccchhHHHH-HHhccCc--------cCCC---------------------------------CCCCCHHHH
Confidence 98 999997653322111 1111100 0000 011245678
Q ss_pred HHhhccCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 679 RIGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 679 ~li~~cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
+++.+||+.+|++|||+.||++.|+.+.++..
T Consensus 282 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 282 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 99999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.11 Aligned_cols=272 Identities=24% Similarity=0.424 Sum_probs=209.3
Q ss_pred cccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
.+....++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34566789999999999999999999964 34789999987543 344678899999999999999999999953
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH-----------------YQFKKLSVIQRLNIAIDVASALDYLHHHCD 518 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 518 (717)
..+..++||||+++++|.+++....... .....+++..++.++.||+.||+|||+.
T Consensus 121 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-- 193 (343)
T 1luf_A 121 -----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 193 (343)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred -----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4558899999999999999987532110 0115689999999999999999999998
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHH
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLL 597 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ 597 (717)
+|+||||||+||+++.++.+||+|||.+........ ........+++.|+|||++. +.++.++|||||||++|
T Consensus 194 -~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 194 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267 (343)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred -CeecCCCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHH
Confidence 999999999999999999999999999987632211 11223345788999999964 46899999999999999
Q ss_pred HHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 598 EMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 598 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
+|++ |..||....... ..... .+..... .+..++..
T Consensus 268 el~t~g~~p~~~~~~~~--~~~~~-----------~~~~~~~------------------------------~~~~~~~~ 304 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEE--VIYYV-----------RDGNILA------------------------------CPENCPLE 304 (343)
T ss_dssp HHHTTTCCTTTTSCHHH--HHHHH-----------HTTCCCC------------------------------CCTTCCHH
T ss_pred HHHhcCCCcCCCCChHH--HHHHH-----------hCCCcCC------------------------------CCCCCCHH
Confidence 9999 999997542211 11111 1111100 11123566
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
+.+++.+||+.+|++|||+.||++.|+++.++..
T Consensus 305 l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 305 LYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 8899999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=344.70 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=203.8
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
.+.++....++|++.++||+|+||.||+|+++ +++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 143 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF- 143 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 35566677899999999999999999999976 68899999986532 22334588999999999999999999995
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.+.+..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 144 ----~~~~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~ 210 (437)
T 4aw2_A 144 ----QDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDM 210 (437)
T ss_dssp ----ECSSEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred ----eeCCEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcC
Confidence 44568999999999999999997632 5689999999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|.+||+|||+++.... ..........||+.|+|||++. +.++.++|||||||++|||++|..||...
T Consensus 211 ~g~vkL~DFGla~~~~~------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 211 NGHIRLADFGSCLKLME------DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp TSCEEECCCTTCEECCT------TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCEEEcchhhhhhccc------CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999976521 1112223457999999999964 35899999999999999999999999754
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
...+. ....... ... ...+.. ....+..+.+++.+|+..+|
T Consensus 285 ~~~~~-~~~i~~~-----~~~---~~~p~~------------------------------~~~~s~~~~dLi~~lL~~~~ 325 (437)
T 4aw2_A 285 SLVET-YGKIMNH-----KER---FQFPTQ------------------------------VTDVSENAKDLIRRLICSRE 325 (437)
T ss_dssp SHHHH-HHHHHTH-----HHH---CCCCSS------------------------------CCCSCHHHHHHHHTTSSCGG
T ss_pred ChhHH-HHhhhhc-----ccc---ccCCcc------------------------------cccCCHHHHHHHHHHhcccc
Confidence 22111 0000000 000 000000 01124567889999999988
Q ss_pred CC--CCCHHHHHH
Q 005045 690 RE--RIAMNVVVN 700 (717)
Q Consensus 690 ~~--Rps~~eil~ 700 (717)
++ ||+++|+++
T Consensus 326 ~r~~r~~~~eil~ 338 (437)
T 4aw2_A 326 HRLGQNGIEDFKK 338 (437)
T ss_dssp GCTTTTTTHHHHT
T ss_pred cccCCCCHHHHhC
Confidence 88 999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.95 Aligned_cols=263 Identities=24% Similarity=0.460 Sum_probs=210.6
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
+..+.....+|++.++||+|+||.||+|.++ +++.||+|.+..... ..+.+.+|++++++++||||+++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~---- 286 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT---- 286 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe----
Confidence 4556667889999999999999999999976 588999999875432 3577899999999999999999999964
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
.....++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 287 -~~~~~~lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~ 357 (495)
T 1opk_A 287 -REPPFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLV 357 (495)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred -cCCcEEEEEEccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcE
Confidence 34578999999999999999975421 4689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 617 (717)
||+|||+++.... ..........++..|+|||++. +.++.++|||||||++|||++ |..||....... ..
T Consensus 358 kl~DFG~a~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~ 429 (495)
T 1opk_A 358 KVADFGLSRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY 429 (495)
T ss_dssp EECCTTCEECCTT------CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH
T ss_pred EEeecccceeccC------CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 9999999986521 1111222344677899999965 458999999999999999999 999997653221 11
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+. ..... ..+..++..+.+++.+||+.+|++|||++|
T Consensus 430 ~~~~------------~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 430 ELLE------------KDYRM-----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp HHHH------------TTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHH------------cCCCC-----------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 1111 11000 012234667889999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 698 VVNNLKTIR 706 (717)
Q Consensus 698 il~~l~~i~ 706 (717)
|++.|+.+.
T Consensus 469 l~~~L~~~~ 477 (495)
T 1opk_A 469 IHQAFETMF 477 (495)
T ss_dssp HHHHHHTSC
T ss_pred HHHHHHHHH
Confidence 999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.04 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=196.3
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCC--CceeEEEEeeccccC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRH--RNILRVITACSSVDL 459 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~ 459 (717)
+....++|++.+.||+|+||.||+|.+.+++.||+|++... .....+.+.+|+++++++.| +||+++++++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~---- 79 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI---- 79 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE----
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe----
Confidence 34567889999999999999999999888999999998644 33445788999999999976 99999999954
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
.....++|||+ .+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+
T Consensus 80 -~~~~~~lv~e~-~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 80 -TDQYIYMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp -CSSEEEEEECC-CSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred -eCCEEEEEEeC-CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 45589999995 578999999754 5689999999999999999999998 999999999999997 6889
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------------GQVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
||+|||.+...... ..........||+.|+|||++. +.++.++|||||||++|+|++|..||.
T Consensus 147 kl~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 147 KLIDFGIANQMQPD-----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp EECCCSSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEeecccccccCcc-----cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 99999999865211 1111223456999999999963 457899999999999999999999997
Q ss_pred CCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 608 DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
........ +...+++...... +..++..+.+++.+||+.
T Consensus 222 ~~~~~~~~------------~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~L~~ 260 (343)
T 3dbq_A 222 QIINQISK------------LHAIIDPNHEIEF-----------------------------PDIPEKDLQDVLKCCLKR 260 (343)
T ss_dssp TCCSHHHH------------HHHHHCTTSCCCC-----------------------------CCCSCHHHHHHHHHHTCS
T ss_pred hhhhHHHH------------HHHHhcCCcccCC-----------------------------cccCCHHHHHHHHHHcCC
Confidence 54322111 1112222111110 011134578899999999
Q ss_pred CcCCCCCHHHHHHH
Q 005045 688 SPRERIAMNVVVNN 701 (717)
Q Consensus 688 ~p~~Rps~~eil~~ 701 (717)
+|++|||+.|+++.
T Consensus 261 dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 261 DPKQRISIPELLAH 274 (343)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhHCCCHHHHHhC
Confidence 99999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=325.82 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=204.0
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
....++|++.+.||+|+||.||+|++. ++.||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PA 81 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CC
Confidence 345679999999999999999999985 8889999987542 34457799999999999999999999996432 23
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeCCCCceE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~k 540 (717)
...++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. + ++||||||+||+++.++.++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEE
T ss_pred CCeEeeecccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCccee
Confidence 578999999999999999986531 3589999999999999999999997 7 99999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C---CcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V---SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~---~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
|+|||.+... ......+|+.|+|||++.+. + +.++|||||||++|+|++|..||..........
T Consensus 154 l~~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 221 (271)
T 3kmu_A 154 ISMADVKFSF------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM 221 (271)
T ss_dssp EEGGGSCCTT------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH
T ss_pred EEeccceeee------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH
Confidence 9998876542 11224578999999997654 3 347999999999999999999997543221100
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.... ....+.. +..++..+.+++.+||+.+|++|||++
T Consensus 222 -~~~~--------~~~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ 259 (271)
T 3kmu_A 222 -KVAL--------EGLRPTI---------------------------------PPGISPHVSKLMKICMNEDPAKRPKFD 259 (271)
T ss_dssp -HHHH--------SCCCCCC---------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -HHHh--------cCCCCCC---------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 0000 0011111 112255688999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 697 VVVNNLKTIRN 707 (717)
Q Consensus 697 eil~~l~~i~~ 707 (717)
|+++.|+++++
T Consensus 260 ~il~~L~~l~~ 270 (271)
T 3kmu_A 260 MIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHCC
T ss_pred HHHHHHHHhhc
Confidence 99999998864
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=336.82 Aligned_cols=324 Identities=28% Similarity=0.365 Sum_probs=283.6
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.++.|++++|.++. +|. +..+++|++|+|++|.+++.. . +.++++|++|++++|.+++..+ +.++++|++|+|+
T Consensus 47 ~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp TCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred cccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 78999999999984 564 899999999999999999554 4 9999999999999999995444 9999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.+++..+ +..+++|++|+|++|.+++. ..+.++++|++|+++ |.+. .++. +..+++|+.|++++|.+...
T Consensus 121 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~-~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 121 NNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVT-DLKP--LANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCC-CCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-Cccc-Cchh--hccCCCCCEEECcCCcCCCC
Confidence 999995543 99999999999999999953 359999999999997 5665 3433 56899999999999999854
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
..+..+++|++|++++|.+++..| +..+++|+.|++++|.++.++ .+..+++|+.|++++|.+++..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~n~l~~~~~ 260 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG--------TLASLTNLTDLDLANNQISNLAP 260 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECCSSCCCCCGG
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch--------hhhcCCCCCEEECCCCccccchh
Confidence 458899999999999999996655 788999999999999998853 47889999999999999995544
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
+..+ ++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..++
T Consensus 261 --~~~l-~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 331 (466)
T 1o6v_A 261 --LSGL-TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331 (466)
T ss_dssp --GTTC-TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred --hhcC-CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCc
Confidence 5566 599999999999986544 8899999999999999996544 8899999999999999998865 78999
Q ss_pred ccceeecccccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 331 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
+|+.|++++|++++. ..+..+++|+.|++++|++++..|
T Consensus 332 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 332 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 999999999999954 578999999999999999997766
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=332.72 Aligned_cols=280 Identities=25% Similarity=0.350 Sum_probs=198.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-----hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-----QGALKSFIDECNALKST---RHRNILRVITACSSV 457 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~ 457 (717)
..++|++.++||+|+||.||+|++. +++.||+|++.... ......+.+|+++++++ .||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999964 78999999986432 11124556677776666 599999999997654
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
........++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 4333446899999996 699999876532 4489999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
.+||+|||.+.... .........||+.|+|||++ .+.++.++|||||||++|+|++|..||......+...
T Consensus 158 ~~kl~Dfg~a~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 158 TVKLADFGLARIYS--------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp CEEECSCSCTTTST--------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred CEEEeeCccccccC--------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999998651 11222346789999999996 4568999999999999999999999997653322111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
........+.. ..+........ . ..............++++..+.+++.+||++||++|||+.
T Consensus 230 ~i~~~~~~~~~--~~~~~~~~~~~-~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 230 KIFDLIGLPPE--DDWPRDVSLPR-G--------------AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp HHHHHHCCCCT--TTSCSSCSSCG-G--------------GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCh--hhccchhhccc-c--------------ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 11111111100 00000000000 0 0000000000011123356788999999999999999999
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
|+++
T Consensus 293 e~l~ 296 (308)
T 3g33_A 293 RALQ 296 (308)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=332.94 Aligned_cols=274 Identities=22% Similarity=0.275 Sum_probs=196.5
Q ss_pred cccccccc-cccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKE-NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~-~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++. +.||+|+||.||+|.+. +++.||+|++..........+.+|++++.++ +||||+++++++. +.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence 45688885 78999999999999954 7999999998765545567888999999985 7999999999954 445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc---eE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT---AH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~k 540 (717)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~k 154 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVK 154 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEE
T ss_pred EEEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceE
Confidence 899999999999999999754 5689999999999999999999998 9999999999999998775 99
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
|+|||.+.....................||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234 (316)
T ss_dssp ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence 99999987653221111111112223458999999999653 478999999999999999999999977543321
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
..... . ........+....... .... .......++..+.+++.+||+.||++|||
T Consensus 235 ~~~~~---~------------------~~~~~~~~~~~~i~~~-~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (316)
T 2ac3_A 235 GWDRG---E------------------ACPACQNMLFESIQEG-KYEF---PDKDWAHISCAAKDLISKLLVRDAKQRLS 289 (316)
T ss_dssp CC-------------------------CCHHHHHHHHHHHHHC-CCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ccccc---c------------------cchhHHHHHHHHHhcc-Cccc---CchhcccCCHHHHHHHHHHhhCChhhCCC
Confidence 11000 0 0000000000000000 0000 00011223567889999999999999999
Q ss_pred HHHHHH
Q 005045 695 MNVVVN 700 (717)
Q Consensus 695 ~~eil~ 700 (717)
++|+++
T Consensus 290 ~~e~l~ 295 (316)
T 2ac3_A 290 AAQVLQ 295 (316)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.83 Aligned_cols=269 Identities=25% Similarity=0.384 Sum_probs=198.9
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
....++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 103 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE---- 103 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence 345678999999999999999999964 8999999988642 34456788999999999999999999999643
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.+..++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.+|
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 104 -DNELNIVLELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp -TTEEEEEEECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred -CCcEEEEEecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence 4589999999999999999863210 115689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||.............
T Consensus 177 l~Dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 177 LGDLGLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp ECCC-------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred EEeccceeeecCC-------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 9999998765211 111223468999999999654 58999999999999999999999996543221111111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
... .-.+... ...++..+.+++.+||+.+|++|||++||+
T Consensus 250 ~~~--------~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il 289 (310)
T 2wqm_A 250 IEQ--------CDYPPLP--------------------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVY 289 (310)
T ss_dssp HHT--------TCSCCCC--------------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhc--------ccCCCCc--------------------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 110 0000000 011255688999999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 005045 700 NNLKTIRNCFLE 711 (717)
Q Consensus 700 ~~l~~i~~~~~~ 711 (717)
+.|++++....+
T Consensus 290 ~~l~~l~~~~~~ 301 (310)
T 2wqm_A 290 DVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHhhhh
Confidence 999999977654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=329.37 Aligned_cols=268 Identities=26% Similarity=0.458 Sum_probs=205.5
Q ss_pred ccccccccccccccCcccccceEEEEeCC----CchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGD----GTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+.....+|++.+.||+|+||.||+|.+.. ...||+|.+... .....+.+.+|++++++++||||+++++++
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 95 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC---- 95 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE----
Confidence 34556789999999999999999998542 235788887643 334567889999999999999999999986
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
....+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCC
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCC
Confidence 334567899999999999999997543 5679999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||.+......... .........+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||......+...
T Consensus 167 ~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~ 243 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243 (298)
T ss_dssp EEECSCGGGCCCSCGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH
T ss_pred EEECcccccccccccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 999999999865322111 1122234557889999999654 58999999999999999999 555665443322111
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.... ..... .+..++..+.+++.+||+.+|++|||++
T Consensus 244 --~~~~-----------~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 280 (298)
T 3f66_A 244 --YLLQ-----------GRRLL------------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFS 280 (298)
T ss_dssp --HHHT-----------TCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred --HHhc-----------CCCCC------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 1100 00000 0111245688999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 005045 697 VVVNNLKTIRNCFL 710 (717)
Q Consensus 697 eil~~l~~i~~~~~ 710 (717)
|+++.|+++..++.
T Consensus 281 ell~~L~~~~~~~~ 294 (298)
T 3f66_A 281 ELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHHHHHHTSC
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.59 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=190.6
Q ss_pred ccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEEe
Q 005045 392 SKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++. ..+..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEe
Confidence 33678999999999999964 79999999987665555678899999999999999999999954 4458999999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe--CCCCceEEeeeccch
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL--DKDMTAHVGDFGLAK 548 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~~ 548 (717)
|+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 167 ~~~~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 167 YVDGGELFDRIIDES------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp CCTTCEEHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred CCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 999999999886432 4689999999999999999999998 99999999999999 567899999999998
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .....
T Consensus 238 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i-------- 300 (373)
T 2x4f_A 238 RYKPR--------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNI-------- 300 (373)
T ss_dssp ECCTT--------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH--------
T ss_pred ecCCc--------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH--------
Confidence 65211 11223458999999999765 47999999999999999999999997542211 11111
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
......... .....++..+.+++.+||+.+|++|||+.|+++
T Consensus 301 ----~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 301 ----LACRWDLED---------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----HHTCCCSCS---------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HhccCCCCh---------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110000000 011122556789999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=336.70 Aligned_cols=201 Identities=23% Similarity=0.344 Sum_probs=172.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+..|.++++.+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 4578999999999999999999976 68899999987542 23456788999999988 899999999984 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.+|.+||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEE
Confidence 56899999999999999998743 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|||++..... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 163 ~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 163 ADFGMCKENIW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCTTCBCCCC-------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeCCccccccc-------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 99999875311 1112334679999999999765 5899999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.69 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=206.6
Q ss_pred CCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
++...+....++|++.++||+|+||.||+|.++.+..||+|++..... ..+.+.+|++++++++||||+++++++..
T Consensus 174 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 250 (452)
T 1fmk_A 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 250 (452)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 345566777889999999999999999999988778899999875432 24678999999999999999999998632
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 251 ----~~~~iv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~ 318 (452)
T 1fmk_A 251 ----EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV 318 (452)
T ss_dssp ----SSCEEEECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred ----CceEEEehhhcCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCC
Confidence 46799999999999999997431 14589999999999999999999997 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||+++..... .........++..|+|||++. +.++.++|||||||++|||++ |..||......+ .
T Consensus 319 ~kl~DfG~a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~ 390 (452)
T 1fmk_A 319 CKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V 390 (452)
T ss_dssp EEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H
T ss_pred EEECCCccceecCCC------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 999999999865211 111122344678899999954 568999999999999999999 999997542211 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
...+... . .. +.+..++..+.+++.+||+.+|++|||++
T Consensus 391 ~~~i~~~--------~--~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 391 LDQVERG--------Y--RM-------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp HHHHHTT--------C--CC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHcC--------C--CC-------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 1111000 0 00 01123466788999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 697 VVVNNLKTIRN 707 (717)
Q Consensus 697 eil~~l~~i~~ 707 (717)
+|++.|+.+..
T Consensus 430 ~l~~~L~~~~~ 440 (452)
T 1fmk_A 430 YLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHTTTS
T ss_pred HHHHHHHHHhc
Confidence 99999988754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=351.12 Aligned_cols=205 Identities=24% Similarity=0.349 Sum_probs=158.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++.+.||+|+||.||+|+++ +++.||+|++... .....+++.+|++++++++||||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999965 7899999988543 334457889999999999999999999997655445567
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecc
Confidence 899999998 57999998754 5689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCC--------------------CcceeecccccccccCCCcc-C-CCCCcccchhhHHHHHHHHHh
Q 005045 544 FGLAKFLFEISDNPSK--------------------NQTVSIGLKGSIGYIPPEHM-N-GQVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~y~aPE~~-~-~~~~~~sDvwslG~vl~ellt 601 (717)
||+++........... .........||+.|+|||++ . +.++.++|||||||++|||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999876322111000 00123456789999999984 3 358999999999999999999
Q ss_pred C
Q 005045 602 G 602 (717)
Q Consensus 602 g 602 (717)
|
T Consensus 280 g 280 (458)
T 3rp9_A 280 M 280 (458)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.40 Aligned_cols=314 Identities=17% Similarity=0.151 Sum_probs=237.0
Q ss_pred CCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeE
Q 005045 32 HCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFF 111 (717)
Q Consensus 32 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 111 (717)
.+++++.|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 35677777777777774444446677777777777777776666677777777777777777776666777777777777
Q ss_pred eccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccc
Q 005045 112 TLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191 (717)
Q Consensus 112 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 191 (717)
+|++|.++.+.+..|.++++|++|+|++|.++ .++...+..+++|+.|++++|.++.. .+..+++|+.|++++|.+
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccC-ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 77777777655556677777777777777776 55555556777777777777777754 255567888888888877
Q ss_pred cccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccC
Q 005045 192 TGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 192 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~ 271 (717)
++. ...++|+.|++++|.+..++. ...++|+.|++++|.+++ . ..+..+ ++|++|++++|.+.
T Consensus 199 ~~~-----~~~~~L~~L~l~~n~l~~~~~---------~~~~~L~~L~l~~n~l~~-~-~~l~~l-~~L~~L~Ls~n~l~ 261 (390)
T 3o6n_A 199 STL-----AIPIAVEELDASHNSINVVRG---------PVNVELTILKLQHNNLTD-T-AWLLNY-PGLVEVDLSYNELE 261 (390)
T ss_dssp SEE-----ECCSSCSEEECCSSCCCEEEC---------CCCSSCCEEECCSSCCCC-C-GGGGGC-TTCSEEECCSSCCC
T ss_pred ccc-----CCCCcceEEECCCCeeeeccc---------cccccccEEECCCCCCcc-c-HHHcCC-CCccEEECCCCcCC
Confidence 732 334578888888888877642 224678888888888884 3 355555 58899999999888
Q ss_pred CCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCcc
Q 005045 272 GNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG 351 (717)
Q Consensus 272 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 351 (717)
+..|..|.++++|+.|+|++|+++ .+|..+..+++|++|+|++|+++++ |..+..+++|+.|+|++|+++. ++ +.
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~N~i~~-~~--~~ 336 (390)
T 3o6n_A 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENLYLDHNSIVT-LK--LS 336 (390)
T ss_dssp EEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCCCC-GGGHHHHTTCSEEECCSSCCCC-CC--CC
T ss_pred CcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcceec-CccccccCcCCEEECCCCccce-eC--ch
Confidence 878888999999999999999998 4666777889999999999999854 6668889999999999999984 43 77
Q ss_pred CcCCCceEEeecccCCCCCC
Q 005045 352 NCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 352 ~l~~L~~L~l~~N~l~~~~p 371 (717)
.+++|+.|++++|++++...
T Consensus 337 ~~~~L~~L~l~~N~~~~~~~ 356 (390)
T 3o6n_A 337 THHTLKNLTLSHNDWDCNSL 356 (390)
T ss_dssp TTCCCSEEECCSSCEEHHHH
T ss_pred hhccCCEEEcCCCCccchhH
Confidence 88899999999999986543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.48 Aligned_cols=278 Identities=24% Similarity=0.368 Sum_probs=201.5
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC--CCCceeEEEEeeccccCCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST--RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~~~~~ 461 (717)
.....++|++.+.||+|+||.||+|++. ++.||+|++..... ..+..|.+++... +||||+++++++.... ..
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 3445689999999999999999999985 89999999864432 3344455555554 9999999999875431 22
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCEEeCCC
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC-----DTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~NIll~~~ 536 (717)
....++||||+++++|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCceEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 2578999999999999999964 35899999999999999999999841 2389999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCc------ccchhhHHHHHHHHHhC-------
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSI------LGDIYSYGILLLEMFTG------- 602 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~------~sDvwslG~vl~elltg------- 602 (717)
+.+||+|||.+......... .........||+.|+|||++.+. .+. ++|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp SCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCEEEEeCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999765221111 11112245689999999997654 333 38999999999999999
Q ss_pred ---CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 603 ---KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 603 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
..||................ ....... ..........+++..+.+
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~------------------------~~~~~~~~~~~~~~~l~~ 303 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREI--------VCIKKLR------------------------PSFPNRWSSDECLRQMGK 303 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHH--------HTTSCCC------------------------CCCCGGGGGSHHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHH--------HhhhccC------------------------ccccccchhhHHHHHHHH
Confidence 45554432222111111000 0000000 111111233467888999
Q ss_pred HhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 680 IGLMCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 680 li~~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
++.+||+.+|++|||+.||++.|+++.++.
T Consensus 304 li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 304 LMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 999999999999999999999999988653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.20 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=201.4
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.+.||+|++|.||.|.++ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 468999999999999999999965 78999999986443 334578889999999999999999999854 34588
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 9999999999999999754 5689999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+........ ........|++.|+|||++.+. .+.++|||||||++|+|++|..||............+....
T Consensus 151 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (276)
T 2yex_A 151 LATVFRYNNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (276)
T ss_dssp TCEECEETTE-----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred CccccCCCcc-----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence 9876522110 1112335689999999997654 37789999999999999999999976544332222211110
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.... .....+..+.+++.+||+.+|++|||++|+++
T Consensus 226 ------------~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 ------------TYLN-----------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------------TTST-----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------------cccC-----------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0000 01122456788999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=328.79 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=196.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.++||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence 3578999999999999999999965 78899999987553 234578899999999999999999999953 4558
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl 541 (717)
.++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEeCCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999998853210 115689999999999999999999998 99999999999999 45678999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
+|||.+..... ........|++.|+|||++.+.++.++|||||||++|+|++|..||........ .....
T Consensus 169 ~Dfg~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~ 238 (285)
T 3is5_A 169 IDFGLAELFKS--------DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKAT 238 (285)
T ss_dssp CCCCCCCC------------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EeeecceecCC--------cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhhc
Confidence 99999976521 112234568999999999988899999999999999999999999976432111 11000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..+...... ...+..+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~---------~~~~~~~~~------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 Y---------KEPNYAVEC------------------------------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp H---------CCCCCCC--------------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---------CCccccccc------------------------------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000100000 001445778999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.05 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=189.7
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...++|++.+.||+|+||.||+|+++ +++.||+|++..... ..+.+.+|+.++++++||||+++++++. ..+.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 90 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTH 90 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCE
Confidence 45679999999999999999999976 899999999864332 2366789999999999999999999954 4558
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc--eEEe
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT--AHVG 542 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~ 542 (717)
.++||||+++++|.+++... +.+++..+..++.||+.||+|||+. ||+||||||+||+++.++. +||+
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEe
Confidence 99999999999999998643 5689999999999999999999998 9999999999999987765 9999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCC-cccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVS-ILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.++... .........||+.|+|||++.+ .++ .++|||||||++|+|++|..||.......... ..
T Consensus 161 Dfg~a~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~~- 230 (361)
T 3uc3_A 161 DFGYSKSSV--------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-KT- 230 (361)
T ss_dssp CCCCC-----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-HH-
T ss_pred ecCcccccc--------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-HH-
Confidence 999987431 1112234569999999999654 454 44899999999999999999997653322111 11
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+..+........ ....++..+.+++.+||+.+|++|||+.|+++
T Consensus 231 -------~~~~~~~~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 231 -------IQRILSVKYSIP-----------------------------DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -------HHHHHTTCCCCC-----------------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -------HHHHhcCCCCCC-----------------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 111111111100 00112456788999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 275 h 275 (361)
T 3uc3_A 275 H 275 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.67 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=182.6
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ....+.+.+|++++++++||||+++++++. +
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 82 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----D 82 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----C
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----c
Confidence 3457899999999999999999996 489999999986442 233577899999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEE
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 568999999999999999987543 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||........
T Consensus 154 ~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------ 220 (278)
T 3cok_A 154 ADFGLATQLKMP-------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------ 220 (278)
T ss_dssp CCCTTCEECC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------
T ss_pred EeecceeeccCC-------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------
Confidence 999998765211 111223568999999999765 478999999999999999999999975432211
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
........... +..++..+.+++.+||+.+|++|||++|+++
T Consensus 221 -------~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 -------LNKVVLADYEM-------------------------------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----------CCSSCCCC-------------------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------HHHHhhcccCC-------------------------------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00111111000 0112456788999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.51 Aligned_cols=281 Identities=23% Similarity=0.371 Sum_probs=209.5
Q ss_pred cccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|++|.||.|++ .+++.||+|++........+.+.+|++++++++||||+++++++... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence 467899999999999999999983 37889999998876666678899999999999999999999986432 2
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred CCceEEEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEE
Confidence 346899999999999999997542 4589999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+....... ..........++..|+|||++.+ .++.++|||||||++|+|++|..||..... ......
T Consensus 187 ~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~ 259 (326)
T 2w1i_A 187 GDFGLTKVLPQDK----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMI 259 (326)
T ss_dssp CCCTTCEECCSSC----SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHH
T ss_pred ecCcchhhccccc----cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhh
Confidence 9999998652111 10111223446778999999654 478999999999999999999999753210 000000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..... ......++....... ...+.+..++..+.+++.+||+.+|++|||+.||++
T Consensus 260 ~~~~~-----------------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 260 GNDKQ-----------------GQMIVFHLIELLKNN-------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTTCC-----------------THHHHHHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccc-----------------hhhhHHHHHHHhhcC-------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 000000000000000 000112334677899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 701 NLKTIRNCFL 710 (717)
Q Consensus 701 ~l~~i~~~~~ 710 (717)
.|+++++++.
T Consensus 316 ~L~~l~~~l~ 325 (326)
T 2w1i_A 316 RVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 9999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.55 Aligned_cols=264 Identities=20% Similarity=0.353 Sum_probs=205.3
Q ss_pred cccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
.+....++|++.+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 44567789999999999999999999853 2345999998754 23456788999999999999999999998532
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++
T Consensus 85 -----~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 150 (281)
T 3cc6_A 85 -----EPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPE 150 (281)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETT
T ss_pred -----CCCEEEEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCC
Confidence 24689999999999999996432 4589999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 615 (717)
.+||+|||.+....... ........+++.|+|||++. +.++.++|||||||++|+|++ |..||......+.
T Consensus 151 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~- 223 (281)
T 3cc6_A 151 CVKLGDFGLSRYIEDED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV- 223 (281)
T ss_dssp EEEECCCCGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-
T ss_pred cEEeCccCCCccccccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-
Confidence 99999999998652211 11122345678899999965 458999999999999999998 9999975433221
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
....... .... .+..++..+.+++.+||+.+|++|||+
T Consensus 224 -~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~ 261 (281)
T 3cc6_A 224 -IGVLEKG--------DRLP---------------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRF 261 (281)
T ss_dssp -HHHHHHT--------CCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -HHHHhcC--------CCCC---------------------------------CCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 1111100 0000 011125568899999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 005045 696 NVVVNNLKTIRNCFL 710 (717)
Q Consensus 696 ~eil~~l~~i~~~~~ 710 (717)
.|+++.|+.+.+...
T Consensus 262 ~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 262 TELVCSLSDVYQMEK 276 (281)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999999986543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.65 Aligned_cols=253 Identities=21% Similarity=0.392 Sum_probs=199.6
Q ss_pred cccccccccccCcccccceEEEEeC-CC-------chhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DG-------TIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
..++|++.+.||+|+||.||+|.+. ++ +.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence 4678999999999999999999855 34 469999987666666788999999999999999999999954
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
.++..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREED 151 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCB
T ss_pred --eCCCCEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCc
Confidence 4457899999999999999997542 4489999999999999999999998 9999999999999998886
Q ss_pred --------eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 539 --------AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 539 --------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
+||+|||.+.... ......++..|+|||++.+ .++.++|||||||++|+|++|..|+..
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVL-----------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTS-----------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccceeeeccCccccccc-----------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9999999987541 1123457889999999764 489999999999999999996555433
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
........ ..... ....+. .++..+.+++.+||+.+
T Consensus 221 ~~~~~~~~-~~~~~----------~~~~~~---------------------------------~~~~~l~~li~~~l~~d 256 (289)
T 4fvq_A 221 ALDSQRKL-QFYED----------RHQLPA---------------------------------PKAAELANLINNCMDYE 256 (289)
T ss_dssp TSCHHHHH-HHHHT----------TCCCCC---------------------------------CSSCTTHHHHHHHSCSS
T ss_pred ccchHHHH-HHhhc----------cCCCCC---------------------------------CCCHHHHHHHHHHcCCC
Confidence 22111111 00000 000000 01334678999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHH
Q 005045 689 PRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 689 p~~Rps~~eil~~l~~i~~~ 708 (717)
|++|||++|+++.|+++...
T Consensus 257 p~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 257 PDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp GGGSCCHHHHHHHHHTCC--
T ss_pred hhHCcCHHHHHHHHHHhcCC
Confidence 99999999999999988643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=330.39 Aligned_cols=276 Identities=22% Similarity=0.396 Sum_probs=203.6
Q ss_pred cccccccccccCcccccceEEEEe-----CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-----GDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|++.+.||+|+||.||.|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED--- 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---
Confidence 356799999999999999999983 378899999987543 33457789999999999999999999986532
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence 2356899999999999999985432 4689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+...... ...........+|..|+|||++.+ .++.++|||||||++|+|++|..|+.... ...
T Consensus 167 l~Dfg~~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~ 236 (302)
T 4e5w_A 167 IGDFGLTKAIETD----KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALF 236 (302)
T ss_dssp ECCCTTCEECCTT----CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHH
T ss_pred ECcccccccccCC----CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHH
Confidence 9999999865211 111122334567888999999654 57899999999999999999999864321 000
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.. ...+.. . ......+...... ......+..++..+.+++.+||+.+|++|||++|++
T Consensus 237 ~~---------~~~~~~---~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 294 (302)
T 4e5w_A 237 LK---------MIGPTH---G---QMTVTRLVNTLKE-------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294 (302)
T ss_dssp HH---------HHCSCC---G---GGHHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred hh---------ccCCcc---c---ccCHHHHHHHHhc-------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 00 000000 0 0000000000000 000111233466789999999999999999999999
Q ss_pred HHHHHHH
Q 005045 700 NNLKTIR 706 (717)
Q Consensus 700 ~~l~~i~ 706 (717)
+.|+++.
T Consensus 295 ~~L~~ll 301 (302)
T 4e5w_A 295 EGFEALL 301 (302)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.20 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=196.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-----
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDL----- 459 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----- 459 (717)
..++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3568999999999999999999976 89999999987433 3356788999999999999999999998754321
Q ss_pred -----------------------------------------------CCCceEEEEEecCCCCChhhhccCCCCCccccc
Q 005045 460 -----------------------------------------------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK 492 (717)
Q Consensus 460 -----------------------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 492 (717)
......++||||+++++|.+++..... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~ 159 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LE 159 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GG
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----cc
Confidence 122348999999999999999986542 24
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCC-----Ccceeecc
Q 005045 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK-----NQTVSIGL 567 (717)
Q Consensus 493 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~-----~~~~~~~~ 567 (717)
..++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+............ ........
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 567778999999999999999998 9999999999999999999999999999876322111000 01122345
Q ss_pred cccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHH
Q 005045 568 KGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQ 646 (717)
Q Consensus 568 ~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (717)
.||+.|+|||++.+ .++.++|||||||++|+|++|..|+... .. ..........+
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~-----------~~~~~~~~~~~--------- 292 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VR-----------IITDVRNLKFP--------- 292 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HH-----------HHHHHHTTCCC---------
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HH-----------HHHHhhccCCC---------
Confidence 69999999999655 5899999999999999999987664210 00 00000000000
Q ss_pred HHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 647 IEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.....++..+.+++.+||+.+|++|||++|+++
T Consensus 293 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 ---------------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ---------------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ---------------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 012233556788999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=342.98 Aligned_cols=211 Identities=24% Similarity=0.380 Sum_probs=178.8
Q ss_pred CCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEee
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITAC 454 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 454 (717)
+.+.++....++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|++++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566777899999999999999999999975 79999999986432 23345688999999999999999999985
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.+.+..|+||||++||+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 131 -----~~~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld 196 (412)
T 2vd5_A 131 -----QDENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLD 196 (412)
T ss_dssp -----ECSSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred -----eeCCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeec
Confidence 44568999999999999999997432 4689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC--------CCCCcccchhhHHHHHHHHHhCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--------GQVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
.+|.+||+|||++...... .........||+.|+|||++. +.++.++|||||||++|||++|..||
T Consensus 197 ~~g~vkL~DFGla~~~~~~------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRAD------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp TTSCEEECCCTTCEECCTT------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCEEEeechhheeccCC------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 9999999999999765211 111223457999999999964 35899999999999999999999999
Q ss_pred CCC
Q 005045 607 GDM 609 (717)
Q Consensus 607 ~~~ 609 (717)
...
T Consensus 271 ~~~ 273 (412)
T 2vd5_A 271 YAD 273 (412)
T ss_dssp CCS
T ss_pred CCC
Confidence 754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.23 Aligned_cols=288 Identities=18% Similarity=0.228 Sum_probs=212.9
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.++||+|+||.||+|++. +|+.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 82 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCC
Confidence 44679999999999999999999976 69999999987543 23456778999999999999999999986432 244
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----CCCCce
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKDMTA 539 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~ 539 (717)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEE
T ss_pred eeEEEEecCCCCCHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeE
Confidence 78999999999999999976421 13389999999999999999999998 99999999999999 777889
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC---------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN---------GQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
||+|||.+..... ........||..|+|||++. +.++.++|||||||++|||++|..||....
T Consensus 156 kL~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 156 KLTDFGAARELED--------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCGGGCEECCC--------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred EEecCCCceEccC--------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999986521 11223356899999999964 346889999999999999999999997643
Q ss_pred CCc--hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 611 KDD--FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 611 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
... ...........|......+.........+.. ............+..+.+++.+||++|
T Consensus 228 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG-----------------DMPVSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp CTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEES-----------------SCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred cccchHHHHHHHhcCCCcccchhheeccCCCcccCc-----------------cCCcccccchHHHhhchHHHHHhhccC
Confidence 322 1222222222221111111100000000000 000001123455778899999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHH
Q 005045 689 PRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 689 p~~Rps~~eil~~l~~i~~~ 708 (717)
|++|||++|+++.++.+...
T Consensus 291 P~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTTSCCHHHHHHHHHHHHTC
T ss_pred hhhhccHHHHHHHHHHHhhc
Confidence 99999999999999888753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.69 Aligned_cols=273 Identities=15% Similarity=0.181 Sum_probs=207.0
Q ss_pred ccccccccccCcccccceEEEEeCC---------CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeE---------
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGD---------GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR--------- 449 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~--------- 449 (717)
.++|++.+.||+|+||.||+|++.. ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5799999999999999999999653 789999998643 46778999999999999987
Q ss_pred ------EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005045 450 ------VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523 (717)
Q Consensus 450 ------~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 523 (717)
+++++. ......++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +|+|
T Consensus 116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH 182 (352)
T 2jii_A 116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP-----KHVLSERSVLQVACRLLDALEFLHEN---EYVH 182 (352)
T ss_dssp TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBC
T ss_pred ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence 344432 2356889999999 999999997541 15689999999999999999999998 9999
Q ss_pred cCCCCCCEEeCCCC--ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHH
Q 005045 524 CDLKPSNVLLDKDM--TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMF 600 (717)
Q Consensus 524 ~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ell 600 (717)
|||||+||+++.++ .+||+|||.+.....................||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999998 99999999998764433322222223344579999999999766 5899999999999999999
Q ss_pred hCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHH
Q 005045 601 TGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680 (717)
Q Consensus 601 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 680 (717)
+|..||............... .+......+.+.... ...++..+.++
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--------------------------------~~~~~~~l~~l 309 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQ-KFVDKPGPFVGPCGH--------------------------------WIRPSETLQKY 309 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHH-HHHHSCCCEECTTSC--------------------------------EECCCHHHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHH-hccCChhhhhhhccc--------------------------------cCCCcHHHHHH
Confidence 999999765322221111111 000000111111000 01125668899
Q ss_pred hhccCCCCcCCCCCHHHHHHHHHHHHHHHHh
Q 005045 681 GLMCSTTSPRERIAMNVVVNNLKTIRNCFLE 711 (717)
Q Consensus 681 i~~cl~~~p~~Rps~~eil~~l~~i~~~~~~ 711 (717)
+.+||+.+|++|||++||++.|+++.++...
T Consensus 310 i~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 310 LKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999877653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=326.64 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=200.3
Q ss_pred cccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
-.++....++|++.+.||+|++|.||.|.++ |+.||+|++.... ..+.+.+|++++++++||||+++++++. .
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~ 85 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----E 85 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----C
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----c
Confidence 3344556789999999999999999999874 8899999987443 4577889999999999999999999863 3
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 157 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred CCCceEEEEecCCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEE
Confidence 3457899999999999999987431 13478999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.+...... .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+. ..
T Consensus 158 l~Dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~ 225 (278)
T 1byg_A 158 VSDFGLTKEASST----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP 225 (278)
T ss_dssp ECCCCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HH
T ss_pred Eeecccccccccc----------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 9999998754211 11234678899999964 458999999999999999998 9999976432211 11
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
... ...... .+..++..+.+++.+||+.+|++|||+.|+
T Consensus 226 ~~~--------~~~~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 226 RVE--------KGYKMD---------------------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp HHT--------TTCCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHh--------cCCCCC---------------------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 110 000001 111235678899999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
++.|+.++..
T Consensus 265 ~~~L~~i~~~ 274 (278)
T 1byg_A 265 REQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=330.91 Aligned_cols=263 Identities=19% Similarity=0.230 Sum_probs=197.6
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~----- 104 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE----- 104 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----
Confidence 344679999999999999999999965 78999999987542 334578899999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~k 174 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAY 174 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred eCCeEEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEE
Confidence 345899999999999999999743 4689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+...... .........+++.|+|||++.+ .++.++|||||||++|+|++|..||...... .....
T Consensus 175 l~Dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~ 246 (309)
T 2h34_A 175 LVDFGIASATTDE------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAH 246 (309)
T ss_dssp ECSCCC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHH
T ss_pred EecCccCcccccc------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHH
Confidence 9999998765211 1112234568999999999755 4799999999999999999999999753211 11111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-CHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-AMNVV 698 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~ei 698 (717)
.....+.. . .....++..+.+++.+||+.+|++|| |++|+
T Consensus 247 ~~~~~~~~--~-------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l 287 (309)
T 2h34_A 247 INQAIPRP--S-------------------------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL 287 (309)
T ss_dssp HHSCCCCG--G-------------------------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred hccCCCCc--c-------------------------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH
Confidence 11110000 0 01122255678999999999999999 99999
Q ss_pred HHHHHHHHHHH
Q 005045 699 VNNLKTIRNCF 709 (717)
Q Consensus 699 l~~l~~i~~~~ 709 (717)
++.|+++....
T Consensus 288 ~~~l~~~l~~~ 298 (309)
T 2h34_A 288 SAAAHAALATA 298 (309)
T ss_dssp HHHHHHTCC--
T ss_pred HHHHHHHHHhh
Confidence 99999876544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.96 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=198.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCch----hhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTI----VAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 3568999999999999999999964 5665 5556553222 223456778999999999999999999863
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEE
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEE
Confidence 246899999999999999987542 5688999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.++...... .........++..|+|||++. +.++.++|||||||++|+|++ |..||........ ..
T Consensus 156 l~Dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~ 228 (325)
T 3kex_A 156 VADFGVADLLPPDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PD 228 (325)
T ss_dssp ECSCSGGGGSCCCT-----TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HH
T ss_pred ECCCCcccccCccc-----ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HH
Confidence 99999998762211 112223456788999999965 568999999999999999999 9999976533221 11
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
...... .... +..++..+.+++.+||+.+|++|||++|+
T Consensus 229 ~~~~~~--------~~~~---------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 229 LLEKGE--------RLAQ---------------------------------PQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp HHHTTC--------BCCC---------------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHcCC--------CCCC---------------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111100 0000 01123346789999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
++.|+.+...
T Consensus 268 ~~~l~~~~~~ 277 (325)
T 3kex_A 268 ANEFTRMARD 277 (325)
T ss_dssp HHHHHHHTTS
T ss_pred HHHHHHHHhc
Confidence 9999988643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=329.08 Aligned_cols=270 Identities=23% Similarity=0.354 Sum_probs=208.1
Q ss_pred cccccccccccccc-ccCcccccceEEEEe---CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeec
Q 005045 382 SDISKSTDNFSKEN-LIGTGSFGSVYKGTL---GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACS 455 (717)
Q Consensus 382 ~~~~~~~~~y~~~~-~ig~g~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 455 (717)
.++....++|++.+ .||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 88 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 88 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence 34455677899998 999999999999963 357889999987542 334678999999999999999999999862
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.
T Consensus 89 ------~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~ 152 (291)
T 1xbb_A 89 ------AESWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT 152 (291)
T ss_dssp ------SSSEEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ------CCCcEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeC
Confidence 34689999999999999999754 4689999999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 613 (717)
++.+||+|||.+...... ...........+++.|+|||++.+ .++.++|||||||++|+|++ |..||.......
T Consensus 153 ~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 153 QHYAKISDFGLSKALRAD----ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp TTEEEECCCTTCEECCTT----CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred CCcEEEccCCcceeeccC----CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999765211 111111222346788999999654 47899999999999999999 999997643211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
........ .... .+..++..+.+++.+||+.+|++||
T Consensus 229 --~~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rp 265 (291)
T 1xbb_A 229 --VTAMLEKG--------ERMG---------------------------------CPAGCPREMYDLMNLCWTYDVENRP 265 (291)
T ss_dssp --HHHHHHTT--------CCCC---------------------------------CCTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred --HHHHHHcC--------CCCC---------------------------------CCCCCCHHHHHHHHHHcCCChhhCc
Confidence 11111100 0000 0112356788999999999999999
Q ss_pred CHHHHHHHHHHHHHHHHhhhh
Q 005045 694 AMNVVVNNLKTIRNCFLEFKK 714 (717)
Q Consensus 694 s~~eil~~l~~i~~~~~~~~~ 714 (717)
|+.|+++.|+.+.........
T Consensus 266 s~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 266 GFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhhccc
Confidence 999999999999877765543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.00 Aligned_cols=267 Identities=25% Similarity=0.444 Sum_probs=201.8
Q ss_pred ccccccccccccCcccccceEEEEeC-C----CchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-D----GTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
....+|++.+.||+|+||.||+|.+. + +..||+|.+... .......+.+|++++++++||||+++++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 115 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI----- 115 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 34678999999999999999999854 2 235999998754 233456788999999999999999999995
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
...+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcE
Confidence 44568999999999999999987532 5689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 617 (717)
||+|||.+........ .........++..|+|||++. +.++.++|||||||++|+|++ |..||....... ..
T Consensus 187 kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~ 260 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM 260 (333)
T ss_dssp EECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH
T ss_pred EECCCCcchhhccccc----cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HH
Confidence 9999999987532111 111112234677899999965 458999999999999999999 999996542211 11
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+.. .. ..+ .+..++..+.+++.+||+.+|++|||+.|
T Consensus 261 ~~~~~--------~~--~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 299 (333)
T 1mqb_A 261 KAIND--------GF--RLP-------------------------------TPMDCPSAIYQLMMQCWQQERARRPKFAD 299 (333)
T ss_dssp HHHHT--------TC--CCC-------------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHC--------CC--cCC-------------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11100 00 000 01123566889999999999999999999
Q ss_pred HHHHHHHHHHHHHhhh
Q 005045 698 VVNNLKTIRNCFLEFK 713 (717)
Q Consensus 698 il~~l~~i~~~~~~~~ 713 (717)
+++.|+++.......+
T Consensus 300 l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 300 IVSILDKLIRAPDSLK 315 (333)
T ss_dssp HHHHHHHHHHSGGGGG
T ss_pred HHHHHHHHHhcchhhh
Confidence 9999999987655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=342.29 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=202.5
Q ss_pred cccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
+.++....++|++.++||+|+||.||+|+++ +++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-- 138 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 138 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 4566778899999999999999999999976 78899999986432 22345678999999999999999999995
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.+.+..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 139 ---~~~~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 139 ---QDDRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp ---ECSSEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred ---EECCEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCC
Confidence 445689999999999999999863 3589999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-----CCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-----VSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
|.+||+|||++..... ..........||+.|+|||++.+. ++.++|||||||++|||++|..||.....
T Consensus 205 g~ikL~DFG~a~~~~~------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 205 GHLKLADFGTCMKMNK------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp SCEEECCCTTCEECCT------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCEEEeccceeEeecc------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 9999999999976521 111223356799999999996442 67899999999999999999999975321
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
... ....... ......+ .....+..+.+++.+||+.+|.+
T Consensus 279 ~~~-~~~i~~~--------~~~~~~p-------------------------------~~~~~s~~~~~li~~lL~~~~~r 318 (410)
T 3v8s_A 279 VGT-YSKIMNH--------KNSLTFP-------------------------------DDNDISKEAKNLICAFLTDREVR 318 (410)
T ss_dssp HHH-HHHHHTH--------HHHCCCC-------------------------------TTCCCCHHHHHHHHHHSSCGGGC
T ss_pred hhH-HHHHHhc--------cccccCC-------------------------------CcccccHHHHHHHHHHccChhhh
Confidence 110 0000000 0000000 00112456789999999999988
Q ss_pred --CCCHHHHHHH
Q 005045 692 --RIAMNVVVNN 701 (717)
Q Consensus 692 --Rps~~eil~~ 701 (717)
||+++||++.
T Consensus 319 lgR~~~~ei~~H 330 (410)
T 3v8s_A 319 LGRNGVEEIKRH 330 (410)
T ss_dssp TTSSCHHHHHTS
T ss_pred CCCCCHHHHhcC
Confidence 9999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=329.87 Aligned_cols=309 Identities=17% Similarity=0.169 Sum_probs=275.6
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+++.|++++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 78999999999996656668999999999999999998888899999999999999999998888889999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|+++...+..|.++++|++|+|++|.++++.+..|.++++|++|++++|+++ .++ ...+++|+.|++++|.+.+.
T Consensus 126 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~---~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD---LSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS-BCC---GGGCTTCSEEECCSSCCSEE
T ss_pred CCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC-ccc---cccccccceeeccccccccc
Confidence 99999666666899999999999999999888999999999999999999998 554 33679999999999998853
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
...++|++|++++|.++.. |.. ..++|+.|++++|.++.. ..+..+++|++|++++|.+++..|
T Consensus 202 -----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~Ls~n~l~~~~~ 265 (390)
T 3o6n_A 202 -----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEKIMY 265 (390)
T ss_dssp -----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCEEES
T ss_pred -----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--------HHHcCCCCccEEECCCCcCCCcCh
Confidence 3456899999999999954 443 357999999999999875 368899999999999999997778
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
..+..+ ++|++|++++|.+++ ++..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++... +..++
T Consensus 266 ~~~~~l-~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~ 339 (390)
T 3o6n_A 266 HPFVKM-QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHH 339 (390)
T ss_dssp GGGTTC-SSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTC
T ss_pred hHcccc-ccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhc
Confidence 888888 599999999999985 5677788999999999999999 67778999999999999999999763 67889
Q ss_pred ccceeeccccccccc
Q 005045 331 ILTRLWMEENRLEGS 345 (717)
Q Consensus 331 ~L~~L~L~~N~l~~~ 345 (717)
+|+.|+|++|++.+.
T Consensus 340 ~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 340 TLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCSEEECCSSCEEHH
T ss_pred cCCEEEcCCCCccch
Confidence 999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=323.56 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=196.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|++|.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++. +
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence 35679999999999999999999965 67889999885432 233567889999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 150 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 150 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEE
Confidence 55899999999999999998744 5689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+.... ........|++.|+|||.+.+. ++.++|||||||++|+|++|..||....... .....
T Consensus 151 ~Dfg~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~ 219 (279)
T 3fdn_A 151 ADFGWSVHAP---------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRI 219 (279)
T ss_dssp CSCCEESCC-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH
T ss_pred EeccccccCC---------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHH
Confidence 9999886531 1122345689999999997654 7899999999999999999999996532111 00000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ..... +..++..+.+++.+||+.+|++|||++|+++
T Consensus 220 ~~---------~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 220 SR---------VEFTF---------------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HH---------TCCCC---------------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred Hh---------CCCCC---------------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000 1112456788999999999999999999997
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 258 h 258 (279)
T 3fdn_A 258 H 258 (279)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.72 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=189.2
Q ss_pred ccccccccccccCcccccceEEEEe----CCCchhhhHHhHhhh----hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ----QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--- 90 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF--- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE---
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE---
Confidence 3467899999999999999999996 478899999986432 23346678899999999999999999995
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
...+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+|
T Consensus 91 --~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 91 --QTGGKLYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp --ECSSCEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTS
T ss_pred --EcCCEEEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCC
Confidence 3456899999999999999998743 5689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
.+||+|||.+...... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~ 229 (327)
T 3a62_A 159 HVKLTDFGLCKESIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--T 229 (327)
T ss_dssp CEEECCCSCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred cEEEEeCCcccccccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--H
Confidence 9999999998754211 112234568999999999655 58999999999999999999999997542211 0
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC---
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI--- 693 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp--- 693 (717)
. ..+....... +...+..+.+++.+||+.+|++||
T Consensus 230 ~-----------~~i~~~~~~~-------------------------------p~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 230 I-----------DKILKCKLNL-------------------------------PPYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp H-----------HHHHHTCCCC-------------------------------CTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred H-----------HHHHhCCCCC-------------------------------CCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 0 0011111100 011245678899999999999999
Q ss_pred --CHHHHHH
Q 005045 694 --AMNVVVN 700 (717)
Q Consensus 694 --s~~eil~ 700 (717)
++.|+++
T Consensus 268 ~~~~~e~l~ 276 (327)
T 3a62_A 268 PGDAGEVQA 276 (327)
T ss_dssp TTTHHHHHH
T ss_pred CCCHHHHHc
Confidence 7778775
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.96 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=200.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhh------HHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG------ALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ..+.+.+|+++++++.||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 85 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--- 85 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe---
Confidence 45678999999999999999999965 7899999998754221 3567899999999999999999999953
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM- 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~- 537 (717)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 86 --~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 86 --NRTDVVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred --cCCEEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCC
Confidence 456899999999999999999754 5689999999999999999999998 999999999999999887
Q ss_pred ---ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 538 ---TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 538 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
.+||+|||.+...... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||......+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 225 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDG--------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (321)
T ss_dssp SSCCEEECCCTTCEECCTT--------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CcCCEEEccCccceecCcc--------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 7999999999765211 11233568999999999765 58999999999999999999999996542211
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
... .+......... .....++..+.+++.+||+.+|++||
T Consensus 226 --~~~-----------~i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp 265 (321)
T 2a2a_A 226 --TLA-----------NITSVSYDFDE---------------------------EFFSHTSELAKDFIRKLLVKETRKRL 265 (321)
T ss_dssp --HHH-----------HHHTTCCCCCH---------------------------HHHTTCCHHHHHHHHTTSCSSTTTSC
T ss_pred --HHH-----------HHHhcccccCh---------------------------hhhcccCHHHHHHHHHHcCCChhhCc
Confidence 100 11111100000 00112255678999999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
|+.|+++
T Consensus 266 s~~e~l~ 272 (321)
T 2a2a_A 266 TIQEALR 272 (321)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.94 Aligned_cols=242 Identities=22% Similarity=0.343 Sum_probs=196.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
..++|++.+.||+|+||.||+|+++ +++.||+|++.... ......+.+|++++++++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--- 98 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--- 98 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 4579999999999999999999964 78999999987542 11334667899999999999999999995
Q ss_pred cCCCCceEEEEEecCCCC-ChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 458 DLEGNDFKALVFEFMSNG-NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.+.+..++||||+.++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 99 --~~~~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 99 --ENQGFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED 166 (335)
T ss_dssp --ECSSEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred --eeCCEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence 4456899999998666 999999765 5689999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
+.+||+|||.+..... ........||+.|+|||++.+. + +.++|||||||++|+|++|..||.....
T Consensus 167 ~~~kL~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--- 235 (335)
T 3dls_A 167 FTIKLIDFGSAAYLER--------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--- 235 (335)
T ss_dssp SCEEECCCTTCEECCT--------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---
T ss_pred CcEEEeecccceECCC--------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---
Confidence 9999999999986521 1122335689999999997654 4 7899999999999999999999964211
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
......... ..++..+.+++.+||+.+|++|||
T Consensus 236 ----------------~~~~~~~~~-------------------------------~~~~~~l~~li~~~L~~dP~~Rps 268 (335)
T 3dls_A 236 ----------------TVEAAIHPP-------------------------------YLVSKELMSLVSGLLQPVPERRTT 268 (335)
T ss_dssp ----------------GTTTCCCCS-------------------------------SCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----------------HHhhccCCC-------------------------------cccCHHHHHHHHHHccCChhhCcC
Confidence 011111100 001456789999999999999999
Q ss_pred HHHHHHH
Q 005045 695 MNVVVNN 701 (717)
Q Consensus 695 ~~eil~~ 701 (717)
+.|+++.
T Consensus 269 ~~ell~h 275 (335)
T 3dls_A 269 LEKLVTD 275 (335)
T ss_dssp HHHHHHC
T ss_pred HHHHhcC
Confidence 9999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=341.17 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=195.8
Q ss_pred cccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCC--CCceeEEEEeeccccCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTR--HRNILRVITACSSVDLE 460 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~ 460 (717)
....++|++.+.||+|+||.||+|.+.+++.||+|++... .......+.+|+++++++. ||||+++++++.
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~----- 126 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI----- 126 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----
Confidence 3445679999999999999999999888999999998643 3345678899999999996 599999999854
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||| +.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+|
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 3457999999 5588999999754 4688999999999999999999998 999999999999995 68999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------------CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------------QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
|+|||++....... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 195 l~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 195 LIDFGIANQMQPDT-----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ECCCSSSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEecCccccccCCC-----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 99999998652211 1112234569999999999653 588999999999999999999999965
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
....... +..++++...... +..++..+.+++.+||+.+
T Consensus 270 ~~~~~~~------------~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~L~~d 308 (390)
T 2zmd_A 270 IINQISK------------LHAIIDPNHEIEF-----------------------------PDIPEKDLQDVLKCCLKRD 308 (390)
T ss_dssp CCCHHHH------------HHHHHCTTSCCCC-----------------------------CCCSCHHHHHHHHHHTCSS
T ss_pred hhHHHHH------------HHHHhCccccCCC-----------------------------CccchHHHHHHHHHHcccC
Confidence 4221111 1122222211110 0001345788999999999
Q ss_pred cCCCCCHHHHHHH
Q 005045 689 PRERIAMNVVVNN 701 (717)
Q Consensus 689 p~~Rps~~eil~~ 701 (717)
|++|||+.|+++.
T Consensus 309 P~~Rps~~ell~h 321 (390)
T 2zmd_A 309 PKQRISIPELLAH 321 (390)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhhC
Confidence 9999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=344.36 Aligned_cols=203 Identities=27% Similarity=0.266 Sum_probs=166.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.++||+|+||.||+|.+. +++.||+|++... .....+++.+|+++++.++||||+++++++.... .++.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4678999999999999999999965 7999999998643 3345678889999999999999999999875432 2344
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||+++ ++.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~ 206 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 206 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred CeEEEEEeCCCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEE
Confidence 578999999965 5766664 3488999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|||+++.... ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..
T Consensus 207 DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 207 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CCCCC-------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeeecCC--------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986521 112234678999999999655 58999999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.08 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=196.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|++.++||+|++|.||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++. ..+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 368999999999999999999975 68999999875432 334577889999999999999999999954 4458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||++++++.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeC
Confidence 99999999999999888654 5689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH-HHH
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM-FVS 621 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~~ 621 (717)
|.+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||......+..... ...
T Consensus 147 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (311)
T 4agu_A 147 GFARLLTGP-------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219 (311)
T ss_dssp TTCEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCchhccCc-------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999865211 112233568999999999654 4799999999999999999999999765332211110 000
Q ss_pred hcCChhhhhh------cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 622 MALPDHVMDI------LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 622 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
.......... ........+.... ......++++..+.+++.+||+.+|++|||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 279 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDME--------------------PLELKFPNISYPALGLLKGCLHMDPTERLTC 279 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCC--------------------CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred cccccccccccccccccccCcCCCccccc--------------------hhhhhcccccHHHHHHHHHHccCChhhcCCH
Confidence 1111110000 0000000000000 0000112235668899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
+|+++
T Consensus 280 ~ell~ 284 (311)
T 4agu_A 280 EQLLH 284 (311)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.17 Aligned_cols=275 Identities=23% Similarity=0.329 Sum_probs=211.2
Q ss_pred cccccccccccccccCcccccceEEEEeC-CC-----chhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEee
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DG-----TIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITAC 454 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~ 454 (717)
.+....++|++.+.||+|+||.||.|.+. ++ +.||+|.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45566789999999999999999999964 33 368999886542 34457789999999999 899999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCC-------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE-------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLK 527 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 527 (717)
. ..+..++||||+++++|.+++...... ......+++..+..++.||+.||+|||+. +|+|||||
T Consensus 120 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 191 (333)
T 2i1m_A 120 T-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191 (333)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred e-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence 3 445789999999999999998642100 00014579999999999999999999998 99999999
Q ss_pred CCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCC
Q 005045 528 PSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p 605 (717)
|+||+++.++.+||+|||.+....... .........+++.|+|||++. +.++.++|||||||++|+|++ |..|
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCT-----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cceEEECCCCeEEECcccccccccccc-----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999998653221 112223345788999999954 468999999999999999999 9999
Q ss_pred CCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccC
Q 005045 606 TGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCS 685 (717)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 685 (717)
|........ ........ ..... +..++..+.+++.+||
T Consensus 267 ~~~~~~~~~-~~~~~~~~--------~~~~~---------------------------------~~~~~~~l~~li~~~l 304 (333)
T 2i1m_A 267 YPGILVNSK-FYKLVKDG--------YQMAQ---------------------------------PAFAPKNIYSIMQACW 304 (333)
T ss_dssp STTCCSSHH-HHHHHHHT--------CCCCC---------------------------------CTTCCHHHHHHHHHHT
T ss_pred CcccchhHH-HHHHHhcC--------CCCCC---------------------------------CCCCCHHHHHHHHHHh
Confidence 976533221 11111110 00000 1112456789999999
Q ss_pred CCCcCCCCCHHHHHHHHHHHHHHHHhh
Q 005045 686 TTSPRERIAMNVVVNNLKTIRNCFLEF 712 (717)
Q Consensus 686 ~~~p~~Rps~~eil~~l~~i~~~~~~~ 712 (717)
+.+|++|||+.||++.|+++.++....
T Consensus 305 ~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 305 ALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred ccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 999999999999999999998876554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.16 Aligned_cols=283 Identities=20% Similarity=0.253 Sum_probs=211.0
Q ss_pred CCCcccccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
+.+...+....++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++..
T Consensus 18 ~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp SEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred eecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 444555566778999999999999999999996 4899999998876555567788999999999999999999998753
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
. .......++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 98 ~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~ 170 (317)
T 2buj_A 98 E-RGAKHEAWLLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDE 170 (317)
T ss_dssp E-ETTEEEEEEEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred c-cCCCceeEEEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCC
Confidence 2 1234578999999999999998864211 115689999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCC--CcceeecccccccccCCCccCCC----CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSK--NQTVSIGLKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+.+||+|||.+............ .........|++.|+|||++.+. ++.++|||||||++|+|++|..||....
T Consensus 171 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 99999999988754111000000 00001123468999999997653 5899999999999999999999985421
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
............. . ..+ ....++..+.+++.+||+.+|+
T Consensus 251 ~~~~~~~~~~~~~--------~--~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~ 289 (317)
T 2buj_A 251 QKGDSVALAVQNQ--------L--SIP-------------------------------QSPRHSSALWQLLNSMMTVDPH 289 (317)
T ss_dssp HTTSCHHHHHHCC------------CC-------------------------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccchhhHHhhcc--------C--CCC-------------------------------ccccCCHHHHHHHHHHhhcChh
Confidence 1111111111000 0 000 0112255688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~ 708 (717)
+|||+.|+++.|+.++..
T Consensus 290 ~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 290 QRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp GSCCHHHHHHHHHHTCCC
T ss_pred hCCCHHHHHHHhhhcCCC
Confidence 999999999999988643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=337.79 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=188.5
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHH-HhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNA-LKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+..|..+ ++.++||||+++++++ .
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence 45678999999999999999999966 78889999987543 2234556667776 5678999999999985 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..|+||||++|++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+|
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEE
Confidence 456899999999999999998743 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+++..... ........||+.|+|||++.+ .++.++|||||||++|||++|..||....... .
T Consensus 180 L~DFG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~--- 247 (373)
T 2r5t_A 180 LTDFGLCKENIEH-------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--M--- 247 (373)
T ss_dssp ECCCCBCGGGBCC-------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--H---
T ss_pred EeeCccccccccC-------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--H---
Confidence 9999999864211 112334679999999999765 48999999999999999999999996532111 1
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...++....... ...+..+.+++.+||+.+|++||++.+.+
T Consensus 248 --------~~~i~~~~~~~~-------------------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 248 --------YDNILNKPLQLK-------------------------------PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --------HHHHHHSCCCCC-------------------------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --------HHHHHhcccCCC-------------------------------CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 011111111111 11245678899999999999999986433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=335.89 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=194.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+|++++.++ .||||+++++++ .+.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 4678999999999999999999965 789999999865432 234688888887 799999999995 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC----CceE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD----MTAH 540 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~k 540 (717)
.|+||||++|++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||++..+ +.+|
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEE
T ss_pred EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEE
Confidence 99999999999999998755 5689999999999999999999998 99999999999998533 3599
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCch-hhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDF-SIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~~~ 618 (717)
|+|||.+...... ........||+.|+|||++.+. ++.++|||||||++|+|++|..||........ ....
T Consensus 161 l~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 233 (342)
T 2qr7_A 161 ICDFGFAKQLRAE-------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233 (342)
T ss_dssp ECCCTTCEECBCT-------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH
T ss_pred EEECCCcccCcCC-------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH
Confidence 9999999865221 1122345689999999997664 88999999999999999999999975432211 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... ....... .....++..+.+++.+||+.||++|||+.|+
T Consensus 234 ~i~~-----------~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 234 RIGS-----------GKFSLSG---------------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp HHHH-----------CCCCCCS---------------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHcc-----------CCcccCc---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1110 0000000 0001125567899999999999999999999
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 276 l~h 278 (342)
T 2qr7_A 276 LRH 278 (342)
T ss_dssp TTS
T ss_pred hcC
Confidence 864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.38 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=201.6
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-----hhhHHHHHHHHHHHHhcCCCCceeEEEEe
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNILRVITA 453 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 453 (717)
-..++....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||++++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 34455667889999999999999999999965 7888999988643 23456788999999999999999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCC---------------------------------cccccccCHHHHH
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---------------------------------HYQFKKLSVIQRL 500 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------~~~~~~~~~~~~~ 500 (717)
+. +.+..++||||+++++|.+++...... ......+++..+.
T Consensus 97 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 97 YE-----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp EE-----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred hc-----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 53 456899999999999999998521000 0001234678889
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCc
Q 005045 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM--TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH 578 (717)
Q Consensus 501 ~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 578 (717)
.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||.+......... .........||+.|+|||+
T Consensus 172 ~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~ 245 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEV 245 (345)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchh
Confidence 9999999999999998 999999999999998776 8999999999865332211 1112234568999999999
Q ss_pred cC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHH
Q 005045 579 MN---GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKE 655 (717)
Q Consensus 579 ~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (717)
+. +.++.++|||||||++|+|++|..||......+. . ..+.........
T Consensus 246 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~------------~~~~~~~~~~~~--------------- 297 (345)
T 3hko_A 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-I------------SQVLNKKLCFEN--------------- 297 (345)
T ss_dssp HTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHCCCCTTS---------------
T ss_pred hccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-H------------HHHHhcccccCC---------------
Confidence 75 3578999999999999999999999976432211 1 111111111100
Q ss_pred HHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 656 MMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+....++..+.+++.+||+.+|++|||+.|+++
T Consensus 298 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 298 ------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp ------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011122556889999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.98 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=177.3
Q ss_pred cccccc---cccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCc
Q 005045 389 DNFSKE---NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGND 463 (717)
Q Consensus 389 ~~y~~~---~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 463 (717)
++|++. +.||+|+||.||+|.++ +++.||+|++... ....+.+|+.+++.+. ||||+++++++ .+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCC
Confidence 456654 78999999999999965 7899999998643 3456778999999996 99999999995 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---ceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM---TAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k 540 (717)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~k 149 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIK 149 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEE
T ss_pred EEEEEEEccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEE
Confidence 899999999999999999754 5689999999999999999999998 999999999999998765 899
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch--hhh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF--SIH 617 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~--~~~ 617 (717)
|+|||.+..... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...
T Consensus 150 l~Dfg~a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 150 IIDFGFARLKPP-------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp ECCCTTCEECCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred EeccccceecCC-------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 999999975421 1122234567999999999765 489999999999999999999999976432110 000
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
. .+..+......... +....++..+.+++.+||+.+|++|||++|
T Consensus 223 ~--------~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 267 (325)
T 3kn6_A 223 E--------IMKKIKKGDFSFEG---------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267 (325)
T ss_dssp H--------HHHHHTTTCCCCCS---------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred H--------HHHHHHcCCCCCCc---------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence 0 01111111111110 011223567889999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 268 ll~ 270 (325)
T 3kn6_A 268 LRY 270 (325)
T ss_dssp STT
T ss_pred Hhc
Confidence 873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.78 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=198.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++.+.||+|++|.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 4679999999999999999999965 78999999986543 33457788999999999999999999995 3455
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc---eE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT---AH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~k 540 (717)
..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++. +|
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEE
Confidence 889999999999999888644 5689999999999999999999998 9999999999999986654 99
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+..... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... ....
T Consensus 149 l~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~ 218 (284)
T 3kk8_A 149 LADFGLAIEVND--------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQ 218 (284)
T ss_dssp ECCCTTCEECCS--------SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred EeeceeeEEccc--------CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHH
Confidence 999999976521 111233568999999999665 48999999999999999999999996542211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
..... .....+ ....++..+.+++.+||+.+|++|||+.|++
T Consensus 219 ~~~~~-------~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (284)
T 3kk8_A 219 IKAGA-------YDYPSP-------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260 (284)
T ss_dssp HHHTC-------CCCCTT-------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHhcc-------ccCCch-------------------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 10000 000000 0012245678999999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 261 ~h 262 (284)
T 3kk8_A 261 KV 262 (284)
T ss_dssp TS
T ss_pred cC
Confidence 73
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.62 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=196.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchh----hhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIV----AIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
..++|++.+.||+|+||.||+|.+. +++.+ |+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 88 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 88 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES----
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec----
Confidence 3578999999999999999999954 66666 44544322 23346788999999999999999999998643
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
...++|++++++++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 --~~~~~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k 157 (327)
T 3lzb_A 89 --STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp --SSEEEEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred --CCceEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEE
Confidence 24789999999999999987543 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||.+....... .........++..|+|||++.+ .++.++|||||||++|+|++ |..||........ ..
T Consensus 158 L~DfG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~ 230 (327)
T 3lzb_A 158 ITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS 230 (327)
T ss_dssp ECCTTC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH
T ss_pred EccCcceeEccCcc-----ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HH
Confidence 99999998752211 1112223446788999999654 58999999999999999999 9999976533221 11
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... ..... .+..++..+.+++.+||+.+|++|||++|+
T Consensus 231 ~~~~------------~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 231 ILEK------------GERLP-----------------------------QPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHHT------------TCCCC-----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHc------------CCCCC-----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1110 00000 011125568899999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 699 VNNLKTIRNC 708 (717)
Q Consensus 699 l~~l~~i~~~ 708 (717)
++.|+++...
T Consensus 270 l~~L~~~~~~ 279 (327)
T 3lzb_A 270 IIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHhC
Confidence 9999998743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.72 Aligned_cols=209 Identities=24% Similarity=0.323 Sum_probs=177.5
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-----CCceeE
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-----HRNILR 449 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~ 449 (717)
...+++.+.....++|++.++||+|+||.||+|++. +++.||+|++.... .....+..|+++++.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 345777888888999999999999999999999964 78999999986432 23456778999999986 999999
Q ss_pred EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005045 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPS 529 (717)
Q Consensus 450 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 529 (717)
+++++.. .+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+
T Consensus 101 ~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 166 (360)
T 3llt_A 101 YHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPE 166 (360)
T ss_dssp EEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcc
Confidence 9998543 45899999999 8999999975421 4589999999999999999999998 9999999999
Q ss_pred CEEeCC-------------------------CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CC
Q 005045 530 NVLLDK-------------------------DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QV 583 (717)
Q Consensus 530 NIll~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 583 (717)
||+++. ++.+||+|||.+..... ......||+.|+|||++.+ .+
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----------YHGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----------CCCSCCSCGGGCCHHHHTTCCC
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC----------CCcCccCcccccCcHHHcCCCC
Confidence 999975 78999999999976411 1123568999999999655 58
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 584 SILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 584 ~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+.++|||||||++|+|++|+.||...
T Consensus 237 ~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 237 DVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.89 Aligned_cols=273 Identities=24% Similarity=0.327 Sum_probs=193.1
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.....++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH----- 103 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----
Confidence 3456779999999999999999999955 89999999986442 233466789999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-----C
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-----K 535 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-----~ 535 (717)
..+..++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 172 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE 172 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCc
Confidence 4558999999997 5999998755 4689999999999999999999998 999999999999994 5
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
++.+||+|||.+...... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 245 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIP-------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245 (329)
T ss_dssp CCEEEECCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cceEEECcCCCccccCCc-------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 556999999999876211 112233567999999999755 37999999999999999999999997653322
Q ss_pred hhhhHHHHhcCChh--hhhh-----cCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCC
Q 005045 614 FSIHMFVSMALPDH--VMDI-----LDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686 (717)
Q Consensus 614 ~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 686 (717)
...........+.. +... +....+.. ........ ....++..+.+++.+||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------------------~~~~~~~~~~~li~~~L~ 304 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF---RGKTLKRV------------------LGALLDDEGLDLLTAMLE 304 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC---CCCCHHHH------------------HGGGSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhh---ccccHhhh------------------cccccCHHHHHHHHHHcc
Confidence 21111111111111 0000 00011100 00000100 111124567899999999
Q ss_pred CCcCCCCCHHHHHH
Q 005045 687 TSPRERIAMNVVVN 700 (717)
Q Consensus 687 ~~p~~Rps~~eil~ 700 (717)
.||++|||++|+++
T Consensus 305 ~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 305 MDPVKRISAKNALE 318 (329)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.78 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=200.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++.++||+|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 4578999999999999999999965 89999999986432 23457788999999999999999999995 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---CCCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~k 540 (717)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 899999999999999988644 5689999999999999999999998 999999999999995 456899
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|+|||++..... ........||+.|+|||++.+.++.++||||+||++|+|++|..||......+ ....+
T Consensus 165 l~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i 234 (486)
T 3mwu_A 165 IIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRV 234 (486)
T ss_dssp ECSCSCTTTBCC--------C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH
T ss_pred EEECCcCeECCC--------CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 999999986521 11223456999999999999999999999999999999999999996542211 11111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ........ +....++..+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~-----------~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 235 E-----------TGKYAFDL---------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp H-----------HTCCCSCS---------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-----------hCCCCCCC---------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00000000 011122556789999999999999999999987
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 277 h 277 (486)
T 3mwu_A 277 H 277 (486)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.85 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=189.6
Q ss_pred cccccccc-cccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHh-cCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKE-NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALK-STRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~-~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|.+. +.||+|+||.||+|.++ +++.||+|++... ..+.+|++++. ..+||||+++++++... ..+..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~ 132 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRK 132 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCc
Confidence 34577776 78999999999999965 7899999998532 34567888874 45899999999986432 23356
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 540 (717)
..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEE
Confidence 78999999999999999976521 4689999999999999999999997 9999999999999997 78999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh--hh
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS--IH 617 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~ 617 (717)
|+|||+++.... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||......... ..
T Consensus 205 l~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 205 LTDFGFAKETTS--------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp ECCCTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred EEecccccccCC--------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 999999986421 112234568999999999755 5899999999999999999999999765332210 10
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
...... ....+.. ....++..+.+++.+||+.+|++|||+.|
T Consensus 277 ~~i~~~---------~~~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 318 (400)
T 1nxk_A 277 TRIRMG---------QYEFPNP-----------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITE 318 (400)
T ss_dssp HHHHHT---------CCCCCTT-----------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHcC---------cccCCCc-----------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 0000000 00122556789999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
+++.
T Consensus 319 il~h 322 (400)
T 1nxk_A 319 FMNH 322 (400)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=321.56 Aligned_cols=268 Identities=22% Similarity=0.381 Sum_probs=204.8
Q ss_pred ccccccccccCcccccceEEEEeC-C---CchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-D---GTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...|.+.++||+|+||.||+|.+. + +..||+|.+.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PE 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CC
Confidence 346777899999999999999843 2 3369999887533 3456788999999999999999999999632 33
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~ 166 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVA 166 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred CCcEEEEecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeC
Confidence 45589999999999999997643 5688999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+......... .........+++.|+|||.+.+ .++.++|||||||++|+|++|..|+....... .......
T Consensus 167 Dfg~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~ 242 (298)
T 3pls_A 167 DFGLARDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLA 242 (298)
T ss_dssp CTTSSCTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHH
T ss_pred cCCCcccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhh
Confidence 99999765222111 1112233567889999999765 58999999999999999999666543322211 1111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
... ... .+..++..+.+++.+||+.+|++|||++|+++.
T Consensus 243 ~~~--------~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 243 QGR--------RLP---------------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TTC--------CCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC--------CCC---------------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 000 011124568899999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 005045 702 LKTIRNCFLEFK 713 (717)
Q Consensus 702 l~~i~~~~~~~~ 713 (717)
|+++.+++....
T Consensus 282 l~~~~~~l~~~~ 293 (298)
T 3pls_A 282 VEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHCCSCC
T ss_pred HHHHHHHHhccc
Confidence 999998876544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.80 Aligned_cols=209 Identities=23% Similarity=0.385 Sum_probs=162.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... ......++.+|+.+++++. ||||+++++++.. ++.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 3578999999999999999999965 8999999987532 3344577889999999997 9999999999643 234
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CEEEEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 57899999996 689888863 3588999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCC--------------CCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCC
Q 005045 543 DFGLAKFLFEISDNP--------------SKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
|||+++......... ...........||+.|+|||++.+ .++.++||||+||++|||++|..||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999998653211100 011122344679999999999754 5899999999999999999999999
Q ss_pred CCCC
Q 005045 607 GDMF 610 (717)
Q Consensus 607 ~~~~ 610 (717)
.+..
T Consensus 232 ~~~~ 235 (388)
T 3oz6_A 232 PGSS 235 (388)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 7653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=345.81 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=201.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|++++++++||||+++++++ .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 45678999999999999999999965 89999999986442 23356788999999999999999999985 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||++||+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL 327 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRI 327 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEE
Confidence 5689999999999999999875421 4589999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch--hhhH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF--SIHM 618 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~--~~~~ 618 (717)
+|||++..... ........||+.|+|||++.+ .++.++|||||||++|||++|..||........ ....
T Consensus 328 ~DFGla~~~~~--------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~ 399 (576)
T 2acx_A 328 SDLGLAVHVPE--------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399 (576)
T ss_dssp CCCTTCEECCT--------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH
T ss_pred Eecccceeccc--------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH
Confidence 99999986521 112234579999999999766 489999999999999999999999976432211 0110
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI----- 693 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----- 693 (717)
... .. ....+ ...+..+.+++.+||+.+|++||
T Consensus 400 ~i~-~~--------~~~~p---------------------------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~ 437 (576)
T 2acx_A 400 LVK-EV--------PEEYS---------------------------------ERFSPQARSLCSQLLCKDPAERLGCRGG 437 (576)
T ss_dssp HHH-HC--------CCCCC---------------------------------TTSCHHHHHHHHHHTCSSGGGSTTCSSS
T ss_pred Hhh-cc--------cccCC---------------------------------ccCCHHHHHHHHHhccCCHHHcCCCCCC
Confidence 000 00 00000 11245678999999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
+++||++
T Consensus 438 sa~eil~ 444 (576)
T 2acx_A 438 SAREVKE 444 (576)
T ss_dssp HHHHHHT
T ss_pred CHHHHHh
Confidence 7888875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.97 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=190.5
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
..++|.+.+.||+|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3578999999999999999999965 78999999986432 122345789999999999999999999852
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 211 ----~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 211 ----AEDYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp ----SSEEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred ----cCceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 23579999999999999998755 5689999999999999999999998 999999999999997544
Q ss_pred ---ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC----CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 538 ---TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN----GQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 538 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+||+|||.+..... ........||+.|+|||++. +.++.++|||||||++|+|++|..||....
T Consensus 277 ~~~~~kl~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CcceEEEeecccceecCC--------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 599999999986521 11223456899999999974 347889999999999999999999997643
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
....... ..... .....+ ....+++..+.+++.+||+.+|+
T Consensus 349 ~~~~~~~-~i~~~-----------~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~ 389 (419)
T 3i6u_A 349 TQVSLKD-QITSG-----------KYNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPK 389 (419)
T ss_dssp SSCCHHH-HHHTT-----------CCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTT
T ss_pred chHHHHH-HHhcC-----------CCCCCc---------------------------hhhcccCHHHHHHHHHHccCChh
Confidence 3221111 11110 000000 01112356688999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||++|+++
T Consensus 390 ~Rps~~e~l~ 399 (419)
T 3i6u_A 390 ARFTTEEALR 399 (419)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHhC
Confidence 9999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=340.12 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=172.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++. ..+.
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCE
Confidence 4678999999999999999999965 7899999998754 3344678899999999999999999999854 3458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+||
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEECCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEEC
Confidence 99999999999999999744 56899999999999999999999831 8999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|.+...... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 177 g~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 177 GVSGQLIDS---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp CCCHHHHHH---------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCcccccc---------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999765221 1223468999999999765 58999999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.34 Aligned_cols=273 Identities=25% Similarity=0.395 Sum_probs=205.6
Q ss_pred ccccc-ccccccccccccCcccccceEEEEe------CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEE
Q 005045 381 YSDIS-KSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVIT 452 (717)
Q Consensus 381 ~~~~~-~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 452 (717)
++++. ...++|++.+.||+|+||.||+|++ .+++.||+|.+... .......+.+|+.++++++||||+++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 34443 3568999999999999999999983 25778999998643 2344567889999999999999999999
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
++. ..+..++||||+++++|.+++............+++..++.++.||+.||.|||+. +|+||||||+||+
T Consensus 101 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIl 172 (327)
T 2yfx_A 101 VSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 172 (327)
T ss_dssp EEC-----SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred EEc-----CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEE
Confidence 953 44578999999999999999976533222335689999999999999999999998 9999999999999
Q ss_pred eCCC---CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 005045 533 LDKD---MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTG 607 (717)
Q Consensus 533 l~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~ 607 (717)
++.+ +.+||+|||.+........ ........+++.|+|||++ .+.++.++|||||||++|+|++ |..||.
T Consensus 173 i~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 173 LTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EecCCCcceEEECccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9844 4699999999986532211 1122334578899999996 4568999999999999999998 999996
Q ss_pred CCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 608 DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
..... ......... .... .+..++..+.+++.+||+.
T Consensus 248 ~~~~~--~~~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~ 284 (327)
T 2yfx_A 248 SKSNQ--EVLEFVTSG--------GRMD---------------------------------PPKNCPGPVYRIMTQCWQH 284 (327)
T ss_dssp TCCHH--HHHHHHHTT--------CCCC---------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred CcCHH--HHHHHHhcC--------CCCC---------------------------------CCCCCCHHHHHHHHHHhcC
Confidence 54221 111111100 0000 0112255688999999999
Q ss_pred CcCCCCCHHHHHHHHHHHHHHH
Q 005045 688 SPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 688 ~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+|++|||+.||++.++.+....
T Consensus 285 dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 285 QPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp SGGGSCCHHHHHHHHHHHHHCH
T ss_pred ChhhCcCHHHHHHHHHHHhcCH
Confidence 9999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=333.35 Aligned_cols=274 Identities=20% Similarity=0.399 Sum_probs=211.7
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEE
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
.+..+++....++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3566778888999999999999999999999853 47789999987442 3345678899999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCC---cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLK 527 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 527 (717)
++++ .+.+..++||||+++++|.+++...... ......+++..+..++.||+.||+|||+. +|+|||||
T Consensus 94 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dik 165 (322)
T 1p4o_A 94 LGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA 165 (322)
T ss_dssp EEEE-----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCS
T ss_pred EEEE-----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCc
Confidence 9995 3455789999999999999998642100 00113568999999999999999999998 99999999
Q ss_pred CCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCC
Q 005045 528 PSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRP 605 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p 605 (717)
|+||+++.++.+||+|||.+....... .........+++.|+|||++. +.++.++|||||||++|+|++ |..|
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cceEEEcCCCeEEECcCcccccccccc-----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999998653221 111122345678899999965 458999999999999999999 8999
Q ss_pred CCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccC
Q 005045 606 TGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCS 685 (717)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 685 (717)
|....... .... +....... .+..++..+.+++.+||
T Consensus 241 ~~~~~~~~--~~~~-----------~~~~~~~~------------------------------~~~~~~~~l~~li~~~l 277 (322)
T 1p4o_A 241 YQGLSNEQ--VLRF-----------VMEGGLLD------------------------------KPDNCPDMLFELMRMCW 277 (322)
T ss_dssp TTTSCHHH--HHHH-----------HHTTCCCC------------------------------CCTTCCHHHHHHHHHHT
T ss_pred cccCCHHH--HHHH-----------HHcCCcCC------------------------------CCCCCCHHHHHHHHHHc
Confidence 86542211 1111 01111100 11123566889999999
Q ss_pred CCCcCCCCCHHHHHHHHHHHHH
Q 005045 686 TTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 686 ~~~p~~Rps~~eil~~l~~i~~ 707 (717)
+.+|++|||+.|+++.|+++..
T Consensus 278 ~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 278 QYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCcccCcCHHHHHHHHHHhhc
Confidence 9999999999999999988754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.87 Aligned_cols=278 Identities=23% Similarity=0.301 Sum_probs=194.6
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-----hHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-----GALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
+....++|++.+.||+|+||.||.|.+. +|+.||+|++..... .....+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 81 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--- 81 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE---
Confidence 4455789999999999999999999965 789999999875321 1235678999999999999999999995
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
...+..++||||+++ ++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 82 --~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 149 (346)
T 1ua2_A 82 --GHKSNISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENG 149 (346)
T ss_dssp --CCTTCCEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred --eeCCceEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCC
Confidence 345588999999975 8988887543 4688889999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||.+...... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+..
T Consensus 150 ~~kl~Dfg~a~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 150 VLKLADFGLAKSFGSP-------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp CEEECCCGGGSTTTSC-------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEEecccceeccCC-------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999865211 112234568999999999754 3789999999999999999999998765322211
Q ss_pred hhHHHHhcCC--hhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 616 IHMFVSMALP--DHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 616 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
.........+ ..+.+............. ...........++..+.+++.+||+.+|++||
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSF------------------PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCC------------------CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHHHcCCCChhhhhhhccCccccccccc------------------CCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 1111111111 111111100000000000 00000001122356789999999999999999
Q ss_pred CHHHHHHH
Q 005045 694 AMNVVVNN 701 (717)
Q Consensus 694 s~~eil~~ 701 (717)
|++|+++.
T Consensus 285 t~~ell~h 292 (346)
T 1ua2_A 285 TATQALKM 292 (346)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.07 Aligned_cols=272 Identities=24% Similarity=0.341 Sum_probs=206.1
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhc--CCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKS--TRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.+.||+|+||.||+|++ +++.||+|++.... ...+.+|+++++. ++||||+++++++.... .....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccce
Confidence 457999999999999999999998 48999999986432 3566778888887 79999999999965432 11237
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCEEeCCC
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH--------HHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.++||||+++++|.+++.. ..+++..+..++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred eEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 8999999999999999964 35899999999999999999999 65 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-------CCcccchhhHHHHHHHHHhC-------
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-------VSILGDIYSYGILLLEMFTG------- 602 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~sDvwslG~vl~elltg------- 602 (717)
+.+||+|||.+......... .........|++.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp SCEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999765221110 00112345689999999997664 23689999999999999999
Q ss_pred ---CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 603 ---KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 603 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
..||................ +......... .......+++..+.+
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~------------------------~~~~~~~~~~~~l~~ 308 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKV--------VCEQKLRPNI------------------------PNRWQSCEALRVMAK 308 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHH--------HTTSCCCCCC------------------------CGGGGTSHHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHH--------HHHHHhCCCC------------------------cccccchhHHHHHHH
Confidence 67776543332222111111 1111111110 011123456778999
Q ss_pred HhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 680 IGLMCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 680 li~~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
++.+||+.+|++|||++||++.|+.+.++.
T Consensus 309 li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 309 IMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.54 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=201.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC------
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL------ 459 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------ 459 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3578999999999999999999976 89999999987543 346689999999999999999998643211
Q ss_pred -----CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 460 -----EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 460 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
......++||||+++++|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+||+++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 22456899999999999999996432 15689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
.++.+||+|||.+...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..|+...
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 224 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKND--------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---- 224 (284)
T ss_dssp ETTEEEECCCTTCEESSCC--------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----
T ss_pred CCCCEEECcchhheecccc--------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----
Confidence 9999999999998765221 11223458999999999655 4899999999999999999999886321
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
... .......... ..++..+.+++.+||+.+|++||
T Consensus 225 ~~~-----------~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 225 SKF-----------FTDLRDGIIS---------------------------------DIFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp HHH-----------HHHHHTTCCC---------------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHH-----------HHHhhccccc---------------------------------ccCCHHHHHHHHHHccCChhhCc
Confidence 000 0001111111 11144578899999999999999
Q ss_pred CHHHHHHHHHHHHHHHHhhhh
Q 005045 694 AMNVVVNNLKTIRNCFLEFKK 714 (717)
Q Consensus 694 s~~eil~~l~~i~~~~~~~~~ 714 (717)
|+.|+++.++.++....+.++
T Consensus 261 s~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 261 NTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp CHHHHHHHHHHHTC-------
T ss_pred CHHHHHHHHHHHhhCCCcccc
Confidence 999999999998866555443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.73 Aligned_cols=328 Identities=16% Similarity=0.163 Sum_probs=267.5
Q ss_pred cceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEe
Q 005045 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88 (717)
Q Consensus 9 ~~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 88 (717)
...+++|+|++|.+++. | .|+.+++|++|+|++|.+++ +| ++.+++|++|+|++|.+++ ++ ++.+++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEE
Confidence 34789999999999964 5 69999999999999999996 45 8999999999999999995 44 88999999999
Q ss_pred ccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccc
Q 005045 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT 168 (717)
Q Consensus 89 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~ 168 (717)
|++|++++ ++ +..+++|++|+|++|+++++ .++++++|++|++++|...+.++ +..+++|+.|++++|.++
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccc
Confidence 99999995 44 89999999999999999975 38899999999999996554663 457899999999999999
Q ss_pred ccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCc
Q 005045 169 GSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248 (717)
Q Consensus 169 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 248 (717)
+. | +..+++|+.|++++|++++. .+..+++|+.|++++|+++.++ +..+++|+.|++++|.+++.
T Consensus 184 ~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip---------~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 184 EL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID---------VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC---------CTTCTTCSEEECCSSCCSCC
T ss_pred ee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC---------ccccCCCCEEEeeCCcCCCc
Confidence 74 4 88999999999999999964 3889999999999999999864 67789999999999999965
Q ss_pred Cchhhhhcc------ccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccch--------hhhcCCCCCeEEcc
Q 005045 249 MPISIANLS------THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE--------VIGRLNKLEGLGLN 314 (717)
Q Consensus 249 ~p~~~~~~~------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~Ls 314 (717)
.+..+..+. .+|+.|++++|.+.+.+| +..+++|+.|+|++|+..+.+|. .++++++|++|+|+
T Consensus 249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~ 326 (457)
T 3bz5_A 249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLN 326 (457)
T ss_dssp CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECC
Confidence 443333221 134455555555444443 56789999999999987666654 25667899999999
Q ss_pred cCcCCCCCCcccccccccceeecccccccccCCcCcc-------------CcCCCceEEeecccCCCCCCcccc
Q 005045 315 VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG-------------NCQKLLVLNLSSNDLNGTIPKEVR 375 (717)
Q Consensus 315 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-------------~l~~L~~L~l~~N~l~~~~p~~~~ 375 (717)
+|+++++ + ++.+++|+.|++++|++++ ++. +. .+..|..+++++|.++|.+|+.+.
T Consensus 327 ~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l~~-L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 327 NTELTEL-D--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp TCCCSCC-C--CTTCTTCSEEECCSSCCCB-CTT-GGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CCccccc-c--cccCCcCcEEECCCCCCCC-ccc-cccccccCCcEEecceeeecCccccccCcEEEEcChhHh
Confidence 9999985 2 8899999999999999985 221 11 235578889999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.44 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=190.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.++||+|+||.||+|++. +|+.||+|++... .......+.+|+++++.++||||+++++++. .
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----T 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----E
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----e
Confidence 34678999999999999999999965 7999999998754 2334566788999999999999999999954 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEeCCCCceE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ . ||+||||||+||+++.++.+|
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~k 289 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIK 289 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEE
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEE
Confidence 45899999999999999998744 568999999999999999999998 6 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||++..... .........||+.|+|||++.+ .++.++|||||||++|||++|..||....... ....
T Consensus 290 l~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~ 360 (446)
T 4ejn_A 290 ITDFGLCKEGIK-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL 360 (446)
T ss_dssp ECCCCCCCTTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred EccCCCceeccC-------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHH
Confidence 999999875311 1122334679999999999654 58999999999999999999999996542211 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----C
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----A 694 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s 694 (717)
. ....... +...+..+.+++.+||+.||++|| |
T Consensus 361 i-----------~~~~~~~-------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t 398 (446)
T 4ejn_A 361 I-----------LMEEIRF-------------------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSED 398 (446)
T ss_dssp H-----------HHCCCCC-------------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred H-----------HhCCCCC-------------------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCC
Confidence 0 0001100 011245678999999999999999 9
Q ss_pred HHHHHH
Q 005045 695 MNVVVN 700 (717)
Q Consensus 695 ~~eil~ 700 (717)
++|+++
T Consensus 399 ~~ell~ 404 (446)
T 4ejn_A 399 AKEIMQ 404 (446)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999985
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=344.54 Aligned_cols=315 Identities=17% Similarity=0.151 Sum_probs=239.2
Q ss_pred CCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeE
Q 005045 32 HCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFF 111 (717)
Q Consensus 32 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 111 (717)
.+++++.|++++|.++...+..|.++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 34667777777777775555556677777777777777776666677777777777777777776666677777777777
Q ss_pred eccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccc
Q 005045 112 TLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGL 191 (717)
Q Consensus 112 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 191 (717)
+|++|.|+++.+..|.++++|++|+|++|.++ .++...+..+++|+.|++++|.+++.. +..+++|+.|++++|.+
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 204 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC-CCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcc
Confidence 77777777666666677777777777777776 455555557777777777777777542 45567788888888877
Q ss_pred cccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccC
Q 005045 192 TGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 192 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~ 271 (717)
++ +...++|+.|++++|.+..++.. ..++|+.|+|++|.+++ +..+..+ ++|+.|+|++|.+.
T Consensus 205 ~~-----l~~~~~L~~L~ls~n~l~~~~~~---------~~~~L~~L~L~~n~l~~--~~~l~~l-~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 205 ST-----LAIPIAVEELDASHNSINVVRGP---------VNVELTILKLQHNNLTD--TAWLLNY-PGLVEVDLSYNELE 267 (597)
T ss_dssp SE-----EECCTTCSEEECCSSCCCEEECS---------CCSCCCEEECCSSCCCC--CGGGGGC-TTCSEEECCSSCCC
T ss_pred cc-----ccCCchhheeeccCCcccccccc---------cCCCCCEEECCCCCCCC--ChhhccC-CCCCEEECCCCccC
Confidence 73 23445788888888888766521 13578888888888884 3456666 58999999999998
Q ss_pred CCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCcc
Q 005045 272 GNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLG 351 (717)
Q Consensus 272 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 351 (717)
+..|..|.++++|+.|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++ +| +.
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~-~~--~~ 342 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT-LK--LS 342 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCC-CC--CC
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCC-cC--hh
Confidence 8888899999999999999999994 67777889999999999999994 57778899999999999999984 33 77
Q ss_pred CcCCCceEEeecccCCCCCCc
Q 005045 352 NCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 352 ~l~~L~~L~l~~N~l~~~~p~ 372 (717)
.+++|+.|++++|+|++.++.
T Consensus 343 ~~~~L~~L~l~~N~~~~~~~~ 363 (597)
T 3oja_B 343 THHTLKNLTLSHNDWDCNSLR 363 (597)
T ss_dssp TTCCCSEEECCSSCEEHHHHH
T ss_pred hcCCCCEEEeeCCCCCChhHH
Confidence 788999999999999876543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.11 Aligned_cols=307 Identities=23% Similarity=0.354 Sum_probs=236.3
Q ss_pred CcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCC
Q 005045 30 LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109 (717)
Q Consensus 30 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 109 (717)
+..+++|++|++++|.+. .+|. +..+++|++|++++|.+++ ++. +..+++|++|+|++|.++. ++ .|..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 567778888888888877 4553 7778888888888888874 444 7788888888888888874 33 578888888
Q ss_pred eEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCc
Q 005045 110 FFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189 (717)
Q Consensus 110 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 189 (717)
+|+|++|.+++..+ +..+++|++|++++|.....++. +..+++|+.|++++|.+....+ +..+++|++|++++|
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~--~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccccc--hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 88888888875433 77888888888888865434443 4577888888888888775443 778888888888888
Q ss_pred cccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCc
Q 005045 190 GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENL 269 (717)
Q Consensus 190 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~ 269 (717)
.+++..+ +..+++|+.|++++|.+.... + +..+++|++|++++|.++ .++. +..+ ++|++|++++|.
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~------~--~~~~~~L~~L~l~~n~l~-~~~~-~~~l-~~L~~L~l~~n~ 254 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDIT------P--VANMTRLNSLKIGNNKIT-DLSP-LANL-SQLTWLEIGTNQ 254 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCG------G--GGGCTTCCEEECCSSCCC-CCGG-GTTC-TTCCEEECCSSC
T ss_pred ccccccc--ccCCCccceeecccCCCCCCc------h--hhcCCcCCEEEccCCccC-CCcc-hhcC-CCCCEEECCCCc
Confidence 8884433 778888888888888888764 2 778888888888888888 4444 5555 588888888888
Q ss_pred cCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcC
Q 005045 270 MHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS 349 (717)
Q Consensus 270 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 349 (717)
+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 255 l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-- 328 (347)
T 4fmz_A 255 ISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328 (347)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--
T ss_pred cCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--
Confidence 8753 5688888999999999988853 458888899999999999888888888888999999999999885545
Q ss_pred ccCcCCCceEEeecccCC
Q 005045 350 LGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 350 ~~~l~~L~~L~l~~N~l~ 367 (717)
+..+++|+.|++++|+|+
T Consensus 329 ~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 329 LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGCTTCSEESSSCC---
T ss_pred hhhhhccceeehhhhccc
Confidence 888889999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.94 Aligned_cols=270 Identities=20% Similarity=0.268 Sum_probs=204.6
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.++||+|+||.||+|++ .+++.||||++..... ...+..|+++++.+.|++.+..+..+ ....+..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEE
Confidence 467999999999999999999996 4799999998764432 24577899999999775444333333 2345688
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCceEEe
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVG 542 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~ 542 (717)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 79 ~lvme~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEECC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEE
Confidence 9999999 899999997432 5689999999999999999999998 99999999999999 588899999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||++..+..................||..|+|||++.+ .++.++|||||||++|||++|..||...........
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---- 224 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---- 224 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH----
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH----
Confidence 999998764332222222223345679999999999665 589999999999999999999999977543221110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+..+.... .... .......++.++.+++.+||+.+|++||++.+|++.
T Consensus 225 -------------------------~~~i~~~~-~~~~------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 225 -------------------------YEKISEKK-VATS------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp -------------------------HHHHHHHH-HHSC------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred -------------------------HHHHhhcc-cccc------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00000000 0000 001112346778999999999999999999999999
Q ss_pred HHHHHHH
Q 005045 702 LKTIRNC 708 (717)
Q Consensus 702 l~~i~~~ 708 (717)
|+.+...
T Consensus 273 L~~l~~~ 279 (483)
T 3sv0_A 273 FRDLFIR 279 (483)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.28 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=203.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|+++ +++.||+|++.... ......+.+|++++++++||||+++++++ ..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 44678999999999999999999976 89999999986432 33467889999999999999999999995 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCc
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMT 538 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~ 538 (717)
.+..++||||+.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCc
Confidence 56899999999999999998755 5689999999999999999999998 99999999999999 56789
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
+||+|||.+..... ........||+.|+|||++.+.++.++||||+||++|+|++|..||...... ....
T Consensus 168 ~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~ 237 (484)
T 3nyv_A 168 IRIIDFGLSTHFEA--------SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILK 237 (484)
T ss_dssp EEECCTTHHHHBCC--------CCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH
T ss_pred EEEEeeeeeEEccc--------ccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHH
Confidence 99999999987521 1122345699999999999889999999999999999999999999764221 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+. ........ +....++..+.+++.+||+.+|++|||+.|+
T Consensus 238 ~i~-----------~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 279 (484)
T 3nyv_A 238 KVE-----------KGKYTFEL---------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDA 279 (484)
T ss_dssp HHH-----------HCCCCCCS---------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHH-----------cCCCCCCC---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111 00000000 0111235567899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 280 l~ 281 (484)
T 3nyv_A 280 LD 281 (484)
T ss_dssp HT
T ss_pred hh
Confidence 85
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.84 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=197.9
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.....++|++.++||+|+||.||+|+++ +++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----- 106 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE----- 106 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----
Confidence 3345668999999999999999999975 78899999986442 233567889999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---C
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD---M 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~ 537 (717)
+....|+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.. +
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCC
Confidence 456899999999999999988644 5689999999999999999999998 99999999999999764 4
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
.+||+|||++...... .......||+.|+|||++.+.++.++||||+||++|+|++|..||....... ..
T Consensus 177 ~~kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~ 246 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQ--------KKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--IL 246 (494)
T ss_dssp CEEECCCTTCEECBTT--------BCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred cEEEEECCCCeECCCC--------ccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence 6999999999765211 1223456999999999998889999999999999999999999997642211 11
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..... ....... +....++..+.+++.+||+.+|++|||+.|
T Consensus 247 ~~i~~-----------~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 247 RKVEK-----------GKYTFDS---------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HHHHH-----------TCCCCCS---------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHh-----------CCCCCCc---------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence 11110 0000000 000122456789999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
+++.
T Consensus 289 ~l~h 292 (494)
T 3lij_A 289 ALEH 292 (494)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.84 Aligned_cols=281 Identities=22% Similarity=0.251 Sum_probs=197.8
Q ss_pred cCCCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEe
Q 005045 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITA 453 (717)
Q Consensus 376 ~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~ 453 (717)
...+....+.....+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||++++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 15 QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CCSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred HHHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 344556667777889999999999999999999965 78999999986655556678899999999995 9999999998
Q ss_pred ecccc---CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCC
Q 005045 454 CSSVD---LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKP 528 (717)
Q Consensus 454 ~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp 528 (717)
+.... .......++||||+. |+|.+++.... ....+++..+..++.||+.||+|||+. + |+||||||
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp 166 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKV 166 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCG
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCc
Confidence 74321 144556899999995 79988876421 114689999999999999999999997 8 99999999
Q ss_pred CCEEeCCCCceEEeeeccchhcccccCCCCC-----CcceeecccccccccCCCccC---C-CCCcccchhhHHHHHHHH
Q 005045 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSK-----NQTVSIGLKGSIGYIPPEHMN---G-QVSILGDIYSYGILLLEM 599 (717)
Q Consensus 529 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~---~-~~~~~sDvwslG~vl~el 599 (717)
+||+++.++.+||+|||.+............ .........+++.|+|||++. + .++.++|||||||++|+|
T Consensus 167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 9999999999999999999875322111000 001112345899999999972 3 478999999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 600 FTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 600 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
++|..||........ ......... ...++..+.+
T Consensus 247 ~~g~~p~~~~~~~~~-----------------~~~~~~~~~-----------------------------~~~~~~~~~~ 280 (337)
T 3ll6_A 247 CFRQHPFEDGAKLRI-----------------VNGKYSIPP-----------------------------HDTQYTVFHS 280 (337)
T ss_dssp HHSSCCC-----------------------------CCCCT-----------------------------TCCSSGGGHH
T ss_pred HhCCCCCcchhHHHh-----------------hcCcccCCc-----------------------------ccccchHHHH
Confidence 999999965322110 000000000 0011234678
Q ss_pred HhhccCCCCcCCCCCHHHHHHHHHHHHHHHH
Q 005045 680 IGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 680 li~~cl~~~p~~Rps~~eil~~l~~i~~~~~ 710 (717)
++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 281 li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 281 LIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 9999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=322.04 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=200.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||.|.++ +++.||+|++... .....+.+.+|+.+++++.||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----c
Confidence 35679999999999999999999976 6888999988644 2345677889999999999999999999953 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 156 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI 156 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEE
Confidence 55899999999999999988643 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... ........|++.|+|||++.+. ++.++|||||||++|+|++|..||......+. .
T Consensus 157 ~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~---- 224 (294)
T 2rku_A 157 GDFGLATKVEYD-------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-Y---- 224 (294)
T ss_dssp CCCTTCEECCST-------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H----
T ss_pred EeccCceecccC-------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----
Confidence 999999765211 1112335689999999997654 78999999999999999999999965422110 0
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+....... +..++..+.+++.+||+.+|++|||++|+++
T Consensus 225 --------~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 225 --------LRIKKNEYSI-------------------------------PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --------HHHHTTCCCC-------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --------HHHhhccCCC-------------------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000101000 0112456788999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 266 ~ 266 (294)
T 2rku_A 266 D 266 (294)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=345.00 Aligned_cols=309 Identities=17% Similarity=0.170 Sum_probs=264.3
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.++.|++++|.+....+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 67889999999987666678889999999999999998888889999999999999999998888888999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.|++..+..|.++++|++|+|++|.++++.|..|.++++|++|+|++|.++ .++. ..+++|+.|++++|.+.+
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~---~~l~~L~~L~l~~n~l~~- 206 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANVSYNLLST- 206 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS-BCCG---GGCTTCSEEECCSSCCSE-
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC-CcCh---hhhhhhhhhhcccCcccc-
Confidence 99999666667899999999999999999888889999999999999999998 4542 357899999999998874
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+...++|+.|++++|.++...+ .+ .++|+.|++++|.++.. ..+..+++|+.|+|++|.+++..|
T Consensus 207 ----l~~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~~--------~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 207 ----LAIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp ----EECCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCEEES
T ss_pred ----ccCCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCCC--------hhhccCCCCCEEECCCCccCCCCH
Confidence 3445689999999999984433 33 36899999999998873 467889999999999999998888
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
..+..+ ++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++.. +..++
T Consensus 272 ~~~~~l-~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~ 345 (597)
T 3oja_B 272 HPFVKM-QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHH 345 (597)
T ss_dssp GGGTTC-SSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTC
T ss_pred HHhcCc-cCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcC
Confidence 888887 589999999999985 5777788999999999999998 67778889999999999999998663 66778
Q ss_pred ccceeeccccccccc
Q 005045 331 ILTRLWMEENRLEGS 345 (717)
Q Consensus 331 ~L~~L~L~~N~l~~~ 345 (717)
+|+.|+|++|++.+.
T Consensus 346 ~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 346 TLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCSEEECCSSCEEHH
T ss_pred CCCEEEeeCCCCCCh
Confidence 999999999998864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=319.72 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=198.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|++|.||.|.+. +++.||+|++.... ......+.+|++++++++||||+++++++. +.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence 4578999999999999999999965 78889999886432 233567889999999999999999999953 45
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++++|.+++... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEe
Confidence 6899999999999999998744 4689999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+..... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||....... ..
T Consensus 157 Dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---- 221 (284)
T 2vgo_A 157 DFGWSVHAPS---------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--TH---- 221 (284)
T ss_dssp CCTTCEECSS---------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----
T ss_pred cccccccCcc---------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HH----
Confidence 9999865411 11233568999999999765 48999999999999999999999996542111 00
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
..+........ ...+..+.+++.+||+.+|++|||++|+++.
T Consensus 222 -------~~~~~~~~~~~-------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 222 -------RRIVNVDLKFP-------------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -------HHHHTTCCCCC-------------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -------HHHhccccCCC-------------------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01111111100 1124567889999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.94 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=199.7
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-------------hHHHHHHHHHHHHhcCCCCceeEE
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-------------GALKSFIDECNALKSTRHRNILRV 450 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~ 450 (717)
....++|++.++||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345789999999999999999999965 788999999864321 235678899999999999999999
Q ss_pred EEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 530 (717)
++++ .+....++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|
T Consensus 112 ~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~N 176 (504)
T 3q5i_A 112 FDVF-----EDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPEN 176 (504)
T ss_dssp EEEE-----ECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred EEEE-----EcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHH
Confidence 9995 4456899999999999999988643 5689999999999999999999998 99999999999
Q ss_pred EEeCCCC---ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 531 VLLDKDM---TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 531 Ill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
|+++.++ .+||+|||++..... ........||+.|+|||++.+.++.++||||+||++|+|++|..||.
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSK--------DYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCT--------TSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEecCCCCccEEEEECCCCEEcCC--------CCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9998776 699999999986521 11223456899999999998889999999999999999999999997
Q ss_pred CCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 608 DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
...... ....+. ....... .+....++..+.+++.+||+.
T Consensus 249 ~~~~~~--~~~~i~-----------~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~ 288 (504)
T 3q5i_A 249 GQNDQD--IIKKVE-----------KGKYYFD---------------------------FNDWKNISDEAKELIKLMLTY 288 (504)
T ss_dssp CSSHHH--HHHHHH-----------HCCCCCC---------------------------HHHHTTSCHHHHHHHHHHTCS
T ss_pred CCCHHH--HHHHHH-----------cCCCCCC---------------------------ccccCCCCHHHHHHHHHHcCC
Confidence 642211 111110 0000000 001112255688999999999
Q ss_pred CcCCCCCHHHHHHH
Q 005045 688 SPRERIAMNVVVNN 701 (717)
Q Consensus 688 ~p~~Rps~~eil~~ 701 (717)
+|.+|||++|+++.
T Consensus 289 dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 289 DYNKRCTAEEALNS 302 (504)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhHCCCHHHHhcC
Confidence 99999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.75 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=201.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchh--hhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIV--AIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|++. +++.+ |+|.+... .....+.+.+|+++++++ +||||+++++++. +.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eC
Confidence 578999999999999999999965 56654 88887643 233456788999999999 9999999999954 44
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 533 (717)
+..++||||+++++|.+++....... .....+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence 58999999999999999997642000 0114689999999999999999999998 99999999999999
Q ss_pred CCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 005045 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFK 611 (717)
Q Consensus 534 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 611 (717)
+.++.+||+|||.+...... .......+++.|+|||++.+ .++.++|||||||++|+|++ |..||.....
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp CGGGCEEECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCCCeEEEcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999999998743111 11122346788999999755 47999999999999999998 9999965422
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
.. .... +........ +..++..+.+++.+||+.+|++
T Consensus 248 ~~--~~~~--------~~~~~~~~~---------------------------------~~~~~~~l~~li~~~l~~dp~~ 284 (327)
T 1fvr_A 248 AE--LYEK--------LPQGYRLEK---------------------------------PLNCDDEVYDLMRQCWREKPYE 284 (327)
T ss_dssp HH--HHHH--------GGGTCCCCC---------------------------------CTTBCHHHHHHHHHHTCSSGGG
T ss_pred HH--HHHH--------hhcCCCCCC---------------------------------CCCCCHHHHHHHHHHccCChhh
Confidence 11 1110 000000010 1122556889999999999999
Q ss_pred CCCHHHHHHHHHHHHHHHH
Q 005045 692 RIAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 692 Rps~~eil~~l~~i~~~~~ 710 (717)
|||+.|+++.|+++.++..
T Consensus 285 Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 285 RPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp SCCHHHHHHHHHHHHHSSS
T ss_pred CcCHHHHHHHHHHHHHhhc
Confidence 9999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.92 Aligned_cols=274 Identities=22% Similarity=0.293 Sum_probs=192.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh-hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|++.++||+|+||.||+|++. +++.||+|++..... .....+.+|++++++++||||+++++++. ..+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 58999999999999999999975 789999998864432 22234557999999999999999999953 455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.
T Consensus 77 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp EEEECCS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred EEecccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcc
Confidence 9999996 58988887542 4689999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH--Hh
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV--SM 622 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--~~ 622 (717)
+..... .........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+....... ..
T Consensus 147 a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T 3mtl_A 147 ARAKSI-------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219 (324)
T ss_dssp EECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccC-------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 875421 1112233467999999999654 479999999999999999999999976533221111000 00
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+..+...... .++... ..............+.++..+.+++.+||++||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~-------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 220 PTEETWPGILSN-------------EEFKTY---NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCTTTSTTGGGC-------------HHHHHT---CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChHhchhhhcc-------------hhhccc---ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 001111111100 000000 00000000000111233556789999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=333.46 Aligned_cols=264 Identities=14% Similarity=0.119 Sum_probs=204.4
Q ss_pred cccccccccccccccccCcccccceEEEE------eCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC---CCceeEEE
Q 005045 381 YSDISKSTDNFSKENLIGTGSFGSVYKGT------LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR---HRNILRVI 451 (717)
Q Consensus 381 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~ 451 (717)
..++....++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+..|+++++.+. |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34555667899999999999999999994 3478899999987543 345667777777776 99999999
Q ss_pred EeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
+++. ..+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 134 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NI 203 (365)
T 3e7e_A 134 SAHL-----FQNGSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNF 203 (365)
T ss_dssp EEEE-----CSSCEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGE
T ss_pred eeee-----cCCCcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHE
Confidence 9954 345889999999999999998632100 115699999999999999999999997 999999999999
Q ss_pred EeCC-----------CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHH
Q 005045 532 LLDK-----------DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEM 599 (717)
Q Consensus 532 ll~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~el 599 (717)
+++. ++.+||+|||+++.+... ..........||+.|+|||++.+. ++.++|||||||++|||
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF-----PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGS-----CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhcc-----CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHH
Confidence 9998 899999999999754211 122233456799999999997664 89999999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 600 FTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 600 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
++|+.||......... +.......+ ....+.+
T Consensus 279 ltg~~pf~~~~~~~~~----------------~~~~~~~~~--------------------------------~~~~~~~ 310 (365)
T 3e7e_A 279 LFGTYMKVKNEGGECK----------------PEGLFRRLP--------------------------------HLDMWNE 310 (365)
T ss_dssp HHSSCCCEEEETTEEE----------------ECSCCTTCS--------------------------------SHHHHHH
T ss_pred HhCCCccccCCCCcee----------------echhccccC--------------------------------cHHHHHH
Confidence 9999998543221110 111111110 0445678
Q ss_pred HhhccCCCCcCCC-CCHHHHHHHHHHHHHHHH
Q 005045 680 IGLMCSTTSPRER-IAMNVVVNNLKTIRNCFL 710 (717)
Q Consensus 680 li~~cl~~~p~~R-ps~~eil~~l~~i~~~~~ 710 (717)
++.+|++.+|.+| |+++++.+.++.+..+..
T Consensus 311 ~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 311 FFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp HHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 9999999999999 689999999988876643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.81 Aligned_cols=273 Identities=24% Similarity=0.333 Sum_probs=199.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|++++++++||||+++++++. ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence 45679999999999999999999965 68999999875432 334566889999999999999999999954 44
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||++++++.++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 166 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLC 166 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEecCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEE
Confidence 5899999999999898886644 5689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+...... ........++..|+|||++.+ .++.++|||||||++|+|++|..||......+.......
T Consensus 167 Dfg~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 167 DFGFARTLAAP-------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp CCTTC-------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eCCCceeecCC-------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 99999765221 112233568999999999765 478999999999999999999999976533221111110
Q ss_pred H-hcCChhhhhhc-------CCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 621 S-MALPDHVMDIL-------DPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 621 ~-~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
. ..........+ ....+..... .......+.++..+.+++.+||+.+|++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~R 298 (331)
T 4aaa_A 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKER---------------------EPLERRYPKLSEVVIDLAKKCLHIDPDKR 298 (331)
T ss_dssp HHCSCCHHHHHHHHHCGGGTTCCCCCCSSC---------------------CCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HhCCCChhhhhHhhhccccccccCcccccc---------------------chhhhcccchhHHHHHHHHHHhccCcccC
Confidence 0 01111100000 0000000000 00001112346678999999999999999
Q ss_pred CCHHHHHHH
Q 005045 693 IAMNVVVNN 701 (717)
Q Consensus 693 ps~~eil~~ 701 (717)
||++|+++.
T Consensus 299 pt~~ell~h 307 (331)
T 4aaa_A 299 PFCAELLHH 307 (331)
T ss_dssp CCGGGGGGS
T ss_pred CCHHHHhcC
Confidence 999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.93 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=197.1
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
....++|++.+.||+|+||.||.|.++ +++.||+|++..........+.+|+++++.++||||+++++++. ..+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 89 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDG 89 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCC
Confidence 356789999999999999999999976 68999999987665556688899999999999999999999964 345
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999886432 4689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCcc------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM------NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
||.+....... .......|++.|+|||++ .+.++.++|||||||++|+|++|..||........ ..
T Consensus 161 fg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~ 232 (302)
T 2j7t_A 161 FGVSAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL 232 (302)
T ss_dssp CHHHHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH
T ss_pred CCCCccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HH
Confidence 99876432111 111234589999999996 34578999999999999999999999975432111 00
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
...... .+.. ..+..++..+.+++.+||+.+|++|||+.|
T Consensus 233 ~~~~~~---------~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 272 (302)
T 2j7t_A 233 KIAKSD---------PPTL-------------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272 (302)
T ss_dssp HHHHSC---------CCCC-------------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHhccC---------Cccc-------------------------------CCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence 000000 0000 011223556889999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 273 ll~ 275 (302)
T 2j7t_A 273 LLE 275 (302)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.80 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=195.7
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence 456799999999999999999996 48999999998643 23345678899999999999999999999643 4
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||++ |++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 196 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 196 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred CeEEEEEecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEe
Confidence 58999999996 68888775322 5689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCcc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|||.+..... .....||+.|+|||++ .+.++.++|||||||++|||++|..||........ ...
T Consensus 197 DfG~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~ 264 (348)
T 1u5q_A 197 DFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYH 264 (348)
T ss_dssp CCTTCBSSSS-----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH
T ss_pred eccCceecCC-----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH
Confidence 9999976511 1234689999999996 34589999999999999999999999965422111 000
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... ..+... ...++..+.+++.+||+.+|++|||++|+
T Consensus 265 ~~~~---------~~~~~~--------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l 303 (348)
T 1u5q_A 265 IAQN---------ESPALQ--------------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303 (348)
T ss_dssp HHHS---------CCCCCC--------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhc---------CCCCCC--------------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 0000 001100 01124567889999999999999999999
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 304 l~h 306 (348)
T 1u5q_A 304 LKH 306 (348)
T ss_dssp TTC
T ss_pred hhC
Confidence 853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.92 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=193.3
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
.....++|++.+.||+|++|.||.|.++ +|+.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 81 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS---- 81 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe----
Confidence 3445679999999999999999999976 79999999986442 234567889999999999999999999953
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+
T Consensus 82 -~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 82 -TPTDFFMVMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCE
T ss_pred -cCCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCE
Confidence 455899999999999999998744 4689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
||+|||.+..... ........+++.|+|||++.+. + +.++||||||+++|+|++|..||...... ...
T Consensus 151 ~l~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~ 220 (276)
T 2h6d_A 151 KIADFGLSNMMSD--------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLF 220 (276)
T ss_dssp EECCCCGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred EEeecccccccCC--------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHH
Confidence 9999999876521 1112234588999999998765 3 68999999999999999999999653211 111
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
...... ... .+..++..+.+++.+||+.+|++|||+.|
T Consensus 221 ~~~~~~-----------~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 221 KKIRGG-----------VFY-------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp HHHHHC-----------CCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhhcC-----------ccc-------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 111000 000 00112456788999999999999999999
Q ss_pred HHHH
Q 005045 698 VVNN 701 (717)
Q Consensus 698 il~~ 701 (717)
+++.
T Consensus 259 ~l~h 262 (276)
T 2h6d_A 259 IREH 262 (276)
T ss_dssp HHHS
T ss_pred HHhC
Confidence 9874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.15 Aligned_cols=280 Identities=21% Similarity=0.219 Sum_probs=203.3
Q ss_pred CcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh-----------hhhHHHHHHHHHHHHhcCCCCcee
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ-----------QQGALKSFIDECNALKSTRHRNIL 448 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni~ 448 (717)
.+.++....++|++.+.||+|+||.||.|.+.+|+.||+|++... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 345667778999999999999999999999888999999988532 122347889999999999999999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 528 (717)
++++++...........++||||++ +++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 9999876544345567899999996 68888876542 4689999999999999999999998 999999999
Q ss_pred CCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCC
Q 005045 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 529 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
+||+++.++.+||+|||.+..... ........+++.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTA--------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp GGEEECTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHEEEcCCCCEEEEecCccccccc--------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 999999999999999999975411 112234568899999999654 5899999999999999999999999
Q ss_pred CCCCCCchhhhHHHHh-cC----------ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHH
Q 005045 607 GDMFKDDFSIHMFVSM-AL----------PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFV 675 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (717)
........ ....... .. .....+.+.......+.... ......++.
T Consensus 235 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~ 291 (362)
T 3pg1_A 235 RGSTFYNQ-LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW----------------------TAVVPTADP 291 (362)
T ss_dssp CCSSHHHH-HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH----------------------HHHSTTSCH
T ss_pred CCCCHHHH-HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH----------------------HhhCCCCCH
Confidence 76432211 1111100 00 01111222222211111110 011122355
Q ss_pred HHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 676 SVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 676 ~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+.+++.+||+.+|++|||+.|+++
T Consensus 292 ~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 292 VALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHc
Confidence 6889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=341.33 Aligned_cols=211 Identities=25% Similarity=0.295 Sum_probs=170.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++.+.||+|+||.||+|.++ +++.||+|++... .....+++.+|++++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3579999999999999999999965 7899999998643 334467889999999999999999999997654444446
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||++ ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEcc
Confidence 7999999985 6999999754 5689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCC---------------CCcceeecccccccccCCCcc-CC-CCCcccchhhHHHHHHHHHhCCCCC
Q 005045 544 FGLAKFLFEISDNPS---------------KNQTVSIGLKGSIGYIPPEHM-NG-QVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 544 fg~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~y~aPE~~-~~-~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
||+++.......... ..........||+.|+|||++ .+ .++.++||||+||++|||++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999987632211100 000123456789999999984 33 4899999999999999999976666
Q ss_pred CC
Q 005045 607 GD 608 (717)
Q Consensus 607 ~~ 608 (717)
..
T Consensus 253 ~~ 254 (432)
T 3n9x_A 253 IN 254 (432)
T ss_dssp CS
T ss_pred cc
Confidence 43
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.77 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=200.9
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
...++|++.+.||+|++|.||+|.++ +++.||+|.+... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 79 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTN 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGG
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCC
Confidence 34679999999999999999999965 7899999998643 23456788999999999999999999997642 234
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCEEeCCCC
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP-----IAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~NIll~~~~ 537 (717)
...++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSS
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCC
Confidence 578999999999999999864311 113489999999999999999999998 7 99999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
.+||+|||.+..... .........|+..|+|||++.+ .++.++|||||||++|+|++|..||...... ..
T Consensus 154 ~~kl~dfg~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~ 224 (279)
T 2w5a_A 154 NVKLGDFGLARILNH-------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--EL 224 (279)
T ss_dssp CEEECCCCHHHHC----------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH
T ss_pred CEEEecCchheeecc-------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HH
Confidence 999999999986521 1112233568999999999655 5899999999999999999999999764221 11
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
....... ..+.+ +..++..+.+++.+||+.+|++|||+.
T Consensus 225 ~~~i~~~--------~~~~~---------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ 263 (279)
T 2w5a_A 225 AGKIREG--------KFRRI---------------------------------PYRYSDELNEIITRMLNLKDYHRPSVE 263 (279)
T ss_dssp HHHHHHT--------CCCCC---------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHhhc--------ccccC---------------------------------CcccCHHHHHHHHHHcCCCcccCCCHH
Confidence 1111000 00011 112255688999999999999999999
Q ss_pred HHHHHH
Q 005045 697 VVVNNL 702 (717)
Q Consensus 697 eil~~l 702 (717)
||++..
T Consensus 264 ~ll~~~ 269 (279)
T 2w5a_A 264 EILENP 269 (279)
T ss_dssp HHHTST
T ss_pred HHHhCh
Confidence 999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.26 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=196.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|.+.+.||+|+||.||.|++. +|+.||+|++..........+.+|++++++++||||+++++++. +.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEE
Confidence 3568999999999999999999965 79999999987554444567889999999999999999999853 45589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCCCceEEe
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL---DKDMTAHVG 542 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~ 542 (717)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||++ +.++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred EEEEEcCCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEc
Confidence 9999999999999988643 5689999999999999999999998 99999999999999 778899999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+.... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||...... .......
T Consensus 152 Dfg~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~ 220 (304)
T 2jam_A 152 DFGLSKMEQ---------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIK 220 (304)
T ss_dssp SCSTTCCCC---------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred cCCcceecC---------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 999987531 111233568999999999765 4899999999999999999999999654221 1111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ..... .....++..+.+++.+||+.+|++|||+.|+++
T Consensus 221 ~~~-----------~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 221 EGY-----------YEFES---------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HCC-----------CCCCT---------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCC-----------CCCCc---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 00000 001122556789999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=340.64 Aligned_cols=265 Identities=14% Similarity=0.164 Sum_probs=194.5
Q ss_pred cccccccccccccccCcccccceEEEEe-CCCchhhhHHhHh---hhhhHHHHHHHHH---HHHhcCCCCceeEEE----
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKL---QQQGALKSFIDEC---NALKSTRHRNILRVI---- 451 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~ni~~~~---- 451 (717)
++....++|++.+.||+|+||.||+|++ .+|+.||+|++.. ......+.+.+|+ +++++++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3445678999999999999999999996 4799999999873 2344567888999 555666899999887
Q ss_pred ---Eeecccc-------CCCCc-----eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhc
Q 005045 452 ---TACSSVD-------LEGND-----FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516 (717)
Q Consensus 452 ---~~~~~~~-------~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 516 (717)
+++.... +.+.+ ..++||||+ +|+|.+++.....-......+++..+..++.||+.||+|||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 3322211 00111 378999999 6899999874311000113345688889999999999999998
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------------CCC
Q 005045 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------------QVS 584 (717)
Q Consensus 517 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~ 584 (717)
+|+||||||+||+++.++.+||+|||+++... .......| +.|+|||++.+ .++
T Consensus 226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 291 (377)
T 3byv_A 226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT 291 (377)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCC
Confidence 99999999999999999999999999998531 12234557 89999999654 489
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhh
Q 005045 585 ILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEV 664 (717)
Q Consensus 585 ~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (717)
.++|||||||++|||++|..||........ ...+... .
T Consensus 292 ~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~-~---------------------------- 329 (377)
T 3byv_A 292 FSFDAWALGLVIYWIWCADLPITKDAALGG-------------SEWIFRS-C---------------------------- 329 (377)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC------CC-------------SGGGGSS-C----------------------------
T ss_pred hhhhHHHHHHHHHHHHHCCCCCcccccccc-------------hhhhhhh-c----------------------------
Confidence 999999999999999999999965432211 0000000 0
Q ss_pred cchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH--HHHHHHHHHH
Q 005045 665 NTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN--NLKTIRNCFL 710 (717)
Q Consensus 665 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~--~l~~i~~~~~ 710 (717)
..++..+.+++.+||+.+|++|||+.|+++ .+..+++...
T Consensus 330 ------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 330 ------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371 (377)
T ss_dssp ------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred ------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence 011456788999999999999999999996 5666665543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.64 Aligned_cols=288 Identities=22% Similarity=0.249 Sum_probs=206.5
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
.++....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 344456679999999999999999999965 78899999986432 3345778899999999999999999999766544
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
......++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 167 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDL 167 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred cccceEEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCE
Confidence 55567999999996 599998863 3589999999999999999999998 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
||+|||.+.......... .......||+.|+|||++ .+ .++.++|||||||++|+|++|..||......+....
T Consensus 168 kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 243 (364)
T 3qyz_A 168 KICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243 (364)
T ss_dssp EECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred EEEeCcceEecCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 999999998653221111 112335689999999985 33 379999999999999999999999976543322111
Q ss_pred HHHHhc-CChh-hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 618 MFVSMA-LPDH-VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 618 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
...... .+.. +....+. ...... .................++..+.+++.+||++||++|||+
T Consensus 244 i~~~~~~~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 308 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINL-----------KARNYL----LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCH-----------HHHHHH----HTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHhCCCCHHHHHHhhhh-----------hHHHHH----HhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 100000 0000 1100000 000000 0000000000001112235668899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
.|+++
T Consensus 309 ~e~l~ 313 (364)
T 3qyz_A 309 EQALA 313 (364)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.48 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=175.3
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|+||.||+|+++ +|+.||+|++.... ......+..|++++++++||||+++++++ ..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 34678999999999999999999975 79999999986542 23356788999999999999999999984 44
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||++|++|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEE
Confidence 5689999999999999999875421 124689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+|||++...... ........||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 331 ~DFGla~~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 331 SDLGLAVELKAG-------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CCCTTCEECCTT-------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred eecceeeeccCC-------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 999999865211 112233579999999999766 4899999999999999999999999764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.15 Aligned_cols=302 Identities=24% Similarity=0.319 Sum_probs=264.9
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+++|++++|.+.. +|. +..+++|++|++++|.+++ ++. |.++++|++|++++|.++ .+| .+..+++|++|+|+
T Consensus 45 ~L~~L~l~~~~i~~-~~~-~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 45 SITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLN 118 (347)
T ss_dssp TCSEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECT
T ss_pred cccEEEEeCCcccc-chh-hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECc
Confidence 78999999999984 554 9999999999999999994 454 999999999999999999 455 59999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.+++. +. +..+++|++|++++|..... +..+..+++|++|++++|.+. .++. +..+++|+.|++++|.+...
T Consensus 119 ~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (347)
T 4fmz_A 119 EDNISDI-SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVK-DVTP--IANLTDLYSLSLNYNQIEDI 192 (347)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEECTTSCCCCC
T ss_pred CCcccCc-hh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcC-Cchh--hccCCCCCEEEccCCccccc
Confidence 9999944 43 99999999999999976643 455999999999999999998 5554 56899999999999999865
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
.+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.++..+ + +..+++|++|++++|.+++ ++
T Consensus 193 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~------~--~~~l~~L~~L~l~~n~l~~-~~ 259 (347)
T 4fmz_A 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS------P--LANLSQLTWLEIGTNQISD-IN 259 (347)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG------G--GTTCTTCCEEECCSSCCCC-CG
T ss_pred cc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc------c--hhcCCCCCEEECCCCccCC-Ch
Confidence 44 8899999999999999995544 889999999999999999875 2 8899999999999999994 43
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
.+..+ ++|++|++++|.+++. ..+..+++|+.|++++|++++..+..+..+++|++|++++|++++..| +..++
T Consensus 260 -~~~~l-~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~ 333 (347)
T 4fmz_A 260 -AVKDL-TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333 (347)
T ss_dssp -GGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCT
T ss_pred -hHhcC-CCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhh
Confidence 46666 5999999999999864 568999999999999999998899999999999999999999998766 88999
Q ss_pred ccceeeccccccc
Q 005045 331 ILTRLWMEENRLE 343 (717)
Q Consensus 331 ~L~~L~L~~N~l~ 343 (717)
+|+.|++++|.|+
T Consensus 334 ~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 334 KMDSADFANQVIK 346 (347)
T ss_dssp TCSEESSSCC---
T ss_pred ccceeehhhhccc
Confidence 9999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.52 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=209.7
Q ss_pred CCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+....+....++|++.++||+|+||.||+|.+..++.||||++..... ..+.+.+|++++++++||||+++++++..
T Consensus 257 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 333 (535)
T 2h8h_A 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 333 (535)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 445667778899999999999999999999988778899999875432 24678999999999999999999998632
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 334 ----~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 401 (535)
T 2h8h_A 334 ----EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV 401 (535)
T ss_dssp ----SSCEEEECCCTTEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred ----ccceEeeehhcCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCc
Confidence 46899999999999999997431 14589999999999999999999997 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||+++...... ........++..|+|||++ .+.++.++|||||||++|||++ |..||......+ .
T Consensus 402 ~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~ 473 (535)
T 2h8h_A 402 CKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V 473 (535)
T ss_dssp EEECCTTSTTTCCCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--H
T ss_pred EEEcccccceecCCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999998652110 1111233467789999995 4568999999999999999999 999997642211 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
...+... . .+ ..+..++..+.+++.+||+.+|++|||++
T Consensus 474 ~~~i~~~--------~--~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 474 LDQVERG--------Y--RM-------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp HHHHHTT--------C--CC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHcC--------C--CC-------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 1111000 0 00 01123466788999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 697 VVVNNLKTIR 706 (717)
Q Consensus 697 eil~~l~~i~ 706 (717)
+|++.|+.+.
T Consensus 513 ~l~~~L~~~~ 522 (535)
T 2h8h_A 513 YLQAFLEDYF 522 (535)
T ss_dssp HHHHHHHTSS
T ss_pred HHHHHHHHHh
Confidence 9999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=327.78 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=200.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence 34679999999999999999999965 6888999988644 2345677889999999999999999999954 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl 182 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI 182 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred CCeEEEEEecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEE
Confidence 55899999999999999988643 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||.+...... ........|+..|+|||++.+ .++.++|||||||++|+|++|..||......+. . ...
T Consensus 183 ~Dfg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-~~~ 253 (335)
T 2owb_A 183 GDFGLATKVEYD-------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-Y-LRI 253 (335)
T ss_dssp CCCTTCEECCST-------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H-HHH
T ss_pred eeccCceecccC-------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-H-HHH
Confidence 999999865211 111233568999999999655 478999999999999999999999965421110 0 000
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..... .+..++..+.+++.+||+.+|++|||++|+++
T Consensus 254 ~-----------~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 254 K-----------KNEYS-------------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp H-----------HTCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred h-----------cCCCC-------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 00112445788999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 292 ~ 292 (335)
T 2owb_A 292 D 292 (335)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.67 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=194.1
Q ss_pred ccccccccccccCcccccceEEEEeC--CCc--hhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG--DGT--IVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
...++|++.+.||+|++|.||+|.+. +++ .||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 92 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-- 92 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--
Confidence 34678999999999999999999843 333 5899998754 23456788999999999999999999998642
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
. ..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.
T Consensus 93 ---~-~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~ 159 (291)
T 1u46_A 93 ---P-PMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 159 (291)
T ss_dssp ---S-SCEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred ---C-CceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCC
Confidence 2 3789999999999999987432 4689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||.+....... ..........++..|+|||++.+ .++.++|||||||++|+|++ |..||....... .
T Consensus 160 ~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~ 233 (291)
T 1u46_A 160 VKIGDFGLMRALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I 233 (291)
T ss_dssp EEECCCTTCEECCC-C----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H
T ss_pred EEEccccccccccccc----cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--H
Confidence 9999999988652111 11112233457778999999654 47899999999999999999 999997542211 1
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
.... ....... ..+..++..+.+++.+||+.+|++|||+.
T Consensus 234 ~~~~-----------~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 273 (291)
T 1u46_A 234 LHKI-----------DKEGERL-----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273 (291)
T ss_dssp HHHH-----------HTSCCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHH-----------HccCCCC-----------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHH
Confidence 1110 0000000 01112356788999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 005045 697 VVVNNLKTIRNCF 709 (717)
Q Consensus 697 eil~~l~~i~~~~ 709 (717)
|+++.|++++...
T Consensus 274 ~l~~~l~~~~~~~ 286 (291)
T 1u46_A 274 ALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHHHHHHC---
T ss_pred HHHHHHHHhCccc
Confidence 9999999887544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.84 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=197.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--------QGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
.++|++.+.||+|++|.||+|.++ +|+.||||++.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 170 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-- 170 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe--
Confidence 468999999999999999999975 79999999875432 23356788999999999 8999999999854
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+||+++.+|
T Consensus 171 ---~~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 171 ---SSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM 237 (365)
T ss_dssp ---BSSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred ---eCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 455899999999999999998743 5689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-------CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-------QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 238 ~ikl~DfG~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPG--------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CEEECCCTTCEECCTT--------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CEEEEecCcccccCCC--------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999998765211 11234568999999999642 47899999999999999999999996532
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.. ....... ....... .+....++..+.+++.+||+.+|+
T Consensus 310 ~~--~~~~~i~-----------~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~ 349 (365)
T 2y7j_A 310 QI--LMLRMIM-----------EGQYQFS---------------------------SPEWDDRSSTVKDLISRLLQVDPE 349 (365)
T ss_dssp HH--HHHHHHH-----------HTCCCCC---------------------------HHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred HH--HHHHHHH-----------hCCCCCC---------------------------CcccccCCHHHHHHHHHHcCCChh
Confidence 11 1111000 0000000 000112255688999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||+.|+++
T Consensus 350 ~Rps~~ell~ 359 (365)
T 2y7j_A 350 ARLTAEQALQ 359 (365)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHhc
Confidence 9999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=351.73 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=202.3
Q ss_pred cccccccccc-ccCcccccceEEEEeC---CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKEN-LIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~-~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...+++.+.. .||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 3445555555 7999999999999853 56679999987542 3346789999999999999999999999642
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred --CCeEEEEEeCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEE
Confidence 35899999999999999997542 5689999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+++...... ..........++..|+|||++. +.++.++|||||||++|||++ |..||......+ ...
T Consensus 477 L~DFGla~~~~~~~----~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~ 550 (613)
T 2ozo_A 477 ISDFGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA 550 (613)
T ss_dssp ECCCSTTTTCC------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHH
T ss_pred EeeccCcccccCCC----ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH
Confidence 99999998652211 1111112234568899999965 568999999999999999998 999997653321 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+.... .+ ..+..++..+.+++.+||+.+|++|||+.+|
T Consensus 551 ~i~~~~----------~~-------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 551 FIEQGK----------RM-------------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp HHHTTC----------CC-------------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred HHHcCC----------CC-------------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 111100 00 0112346778999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 005045 699 VNNLKTIRNCF 709 (717)
Q Consensus 699 l~~l~~i~~~~ 709 (717)
++.|+.+....
T Consensus 590 ~~~L~~~~~~~ 600 (613)
T 2ozo_A 590 EQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999987655
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.58 Aligned_cols=272 Identities=24% Similarity=0.353 Sum_probs=183.5
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
....++|++.+.||+|++|.||.|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++. ..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 85 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VK 85 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SS
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ec
Confidence 345679999999999999999999964 78999999986543 334567889999999999999999999854 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCC-cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAE-HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
+..++||||+++++|.+++...... ......+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 5789999999999999998631000 00125689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|||.+......... ..........|++.|+|||++.+ .++.++|||||||++|+|++|..||.......... ..
T Consensus 163 ~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~ 239 (303)
T 2vwi_A 163 ADFGVSAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LT 239 (303)
T ss_dssp CCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HH
T ss_pred EeccchheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HH
Confidence 999999765221110 11112234568999999999754 58999999999999999999999997653322111 11
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.....+.......++.. ...++..+.+++.+||+.+|++|||+.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEM---------------------------------LKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp HTSSCCCTTC-----CC---------------------------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred hccCCCccccccccchh---------------------------------hhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11110000000000010 111245678999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 287 ~ 287 (303)
T 2vwi_A 287 R 287 (303)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.54 Aligned_cols=281 Identities=19% Similarity=0.215 Sum_probs=200.3
Q ss_pred cccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..++|++.++||+|+||.||+|++ .+++.||+|++... ..+.+.+|+++++++. ||||+++++++... ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCc
Confidence 357899999999999999999996 48899999998643 2467889999999996 99999999986532 2557
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~D 543 (717)
.++||||+++++|.+++. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 108 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~D 174 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLID 174 (330)
T ss_dssp EEEEEECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEeccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEe
Confidence 899999999999999874 478899999999999999999998 999999999999999777 899999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||.+...... .......++..|+|||++.+ .++.++|||||||++|+|++|..||...............
T Consensus 175 fg~a~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 175 WGLAEFYHPG--------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp CTTCEECCTT--------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CCCceEcCCC--------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 9999765211 11223468889999999654 4899999999999999999999999654433222222221
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..-.....+.++....... . ...++..... ...............++..+.+++.+||++||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELD-P---RFNDILGRHS--RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCC-T---HHHHHHCCCC--CCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCchhhhHHHHhccccc-c---chhhhhhhcc--ccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111111111100000 0 0000000000 0000000000111223667899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.57 Aligned_cols=211 Identities=25% Similarity=0.384 Sum_probs=171.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC---C
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDL---E 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~ 460 (717)
..++|++.++||+|+||.||+|++. +|+.||+|++.... ......+.+|++++++++||||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4579999999999999999999964 89999999886442 2234567899999999999999999998755321 1
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
..+..++||||+++ ++.+.+.... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+|
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~k 164 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK 164 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEE
Confidence 14578999999964 7777766442 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
|+|||.+......... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 165 l~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 165 LADFGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp ECCCTTCEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Eccchhcccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999865322111 1122234568999999999754 37999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.38 Aligned_cols=277 Identities=22% Similarity=0.265 Sum_probs=195.5
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|+||.||.|.+. +|+.||+|++... .....+++.+|++++++++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999964 7999999988532 3344677889999999999999999999875432 1223
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEE
Confidence 4579999999 7899999864 3588999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.++.... ......+|..|+|||++.+ .++.++||||+||++|+|++|+.||.+....+. +....
T Consensus 171 Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~ 239 (367)
T 1cm8_A 171 DFGLARQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIM 239 (367)
T ss_dssp CCTTCEECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH
T ss_pred eeeccccccc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 9999986411 1233568999999999654 589999999999999999999999976432211 11111
Q ss_pred H--hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 621 S--MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 621 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
. ...+......+.. .....+...... .....-.......+..+.+++.+||+.||++|||++|+
T Consensus 240 ~~~g~~~~~~~~~~~~----------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~ 305 (367)
T 1cm8_A 240 KVTGTPPAEFVQRLQS----------DEAKNYMKGLPE----LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305 (367)
T ss_dssp HHHCCCCHHHHHTCSC----------HHHHHHHHHSCC----CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HhcCCCCHHHHHHhhh----------HHHHHHHHhCCC----CCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence 0 1111111110000 000001000000 00000000112235668899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 306 l~ 307 (367)
T 1cm8_A 306 LA 307 (367)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.30 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=199.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh------hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ------GALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++|++.+.||+|+||.||.|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE----- 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence 468999999999999999999976 799999998864321 13577899999999999999999999954
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM--- 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--- 537 (717)
.....++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSS
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCC
Confidence 445899999999999999998643 5689999999999999999999998 999999999999998877
Q ss_pred -ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 -TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||.+...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 149 ~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-- 218 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-- 218 (283)
T ss_dssp CCEEECCCTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--
T ss_pred CceEEEecccceeccCC--------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--
Confidence 8999999999765211 11233458999999999764 58999999999999999999999997542211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
.... +........ ......++..+.+++.+||+.+|++|||+
T Consensus 219 ~~~~-----------~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 260 (283)
T 3bhy_A 219 TLTN-----------ISAVNYDFD---------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTI 260 (283)
T ss_dssp HHHH-----------HHTTCCCCC---------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHHH-----------hHhcccCCc---------------------------chhcccCCHHHHHHHHHHccCCHhHCcCH
Confidence 1000 000000000 00111225567899999999999999999
Q ss_pred HHHHH--HHHHHHH
Q 005045 696 NVVVN--NLKTIRN 707 (717)
Q Consensus 696 ~eil~--~l~~i~~ 707 (717)
.|+++ .++.++.
T Consensus 261 ~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 261 AQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHCHHHHHHHH
T ss_pred HHHHhCHHHHHHHH
Confidence 99997 4555554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=325.82 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=199.9
Q ss_pred ccccCCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCC--CCcee
Q 005045 373 EVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTR--HRNIL 448 (717)
Q Consensus 373 ~~~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~ni~ 448 (717)
......+.+..+....++|++.+.||+|+||.||+|.+++++.||+|++... .......+.+|+++++++. |+||+
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp --------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred cCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 3345567788888899999999999999999999999888999999998643 2345678899999999996 59999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKP 528 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 528 (717)
++++++. .....++||| +.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||
T Consensus 92 ~~~~~~~-----~~~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp 155 (313)
T 3cek_A 92 RLYDYEI-----TDQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKP 155 (313)
T ss_dssp CEEEEEE-----CSSEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred EEEEEee-----cCCEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCc
Confidence 9999854 3458999999 4588999999754 5689999999999999999999998 999999999
Q ss_pred CCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC------------CCCcccchhhHHHHH
Q 005045 529 SNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG------------QVSILGDIYSYGILL 596 (717)
Q Consensus 529 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~sDvwslG~vl 596 (717)
+||+++ ++.+||+|||.+....... .........|++.|+|||++.+ .++.++|||||||++
T Consensus 156 ~NIl~~-~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il 229 (313)
T 3cek_A 156 ANFLIV-DGMLKLIDFGIANQMQPDT-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229 (313)
T ss_dssp GGEEEE-TTEEEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred ccEEEE-CCeEEEeeccccccccCcc-----ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence 999996 4899999999998652211 1112233568999999999754 578899999999999
Q ss_pred HHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 597 LEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 597 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
|+|++|..||......... +....++...... +..++..
T Consensus 230 ~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~~~~-----------------------------~~~~~~~ 268 (313)
T 3cek_A 230 YYMTYGKTPFQQIINQISK------------LHAIIDPNHEIEF-----------------------------PDIPEKD 268 (313)
T ss_dssp HHHHHSSCTTTTCCSHHHH------------HHHHHCTTSCCCC-----------------------------CCCSCHH
T ss_pred HHHHhCCCchhhHHHHHHH------------HHHHHhcccccCC-----------------------------cccchHH
Confidence 9999999999754322111 1111121111110 0111446
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
+.+++.+||+.+|++|||++|+++.
T Consensus 269 l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 269 LQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCCcccCcCHHHHhcC
Confidence 7889999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=321.92 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=194.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|.....||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++. ..+..+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 95 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIK 95 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEE
Confidence 445566669999999999999964 78899999987665556678999999999999999999999954 345899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCceEEeeec
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFG 545 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 545 (717)
+||||+++++|.+++..... ...+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred EEEEeCCCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence 99999999999999875421 13567889999999999999999998 9999999999999987 8999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
.+...... ........|++.|+|||++.+. ++.++|||||||++|+|++|..||................
T Consensus 169 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 241 (295)
T 2clq_A 169 TSKRLAGI-------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241 (295)
T ss_dssp TCEESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH
T ss_pred cccccCCC-------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc
Confidence 99765211 1112345689999999996542 7899999999999999999999996432221111100000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...+.+ +..++..+.+++.+||+.+|++|||+.|+++
T Consensus 242 --------~~~~~~---------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 --------KVHPEI---------------------------------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --------CCCCCC---------------------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --------cccccc---------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001111 1122556789999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=325.95 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=200.9
Q ss_pred CCCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 378 GMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
.+.+.++....++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4677788889999999999999999999999964 789999999864432 346788999999998 8999999999975
Q ss_pred cccC-CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 456 SVDL-EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 456 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.... ...+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+. +++||||||+||+++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT 163 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence 4321 11457899999999999999987542 15689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.++.+||+|||.+...... ........|++.|+|||++. +.++.++|||||||++|+|++|..||..
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp TTCCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCEEEeeCcCceecCcC-------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999998765211 11223356899999999964 3478999999999999999999999965
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
...... . .... ....+... ...++..+.+++.+||+.+
T Consensus 237 ~~~~~~-~-~~~~--------~~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~d 274 (326)
T 2x7f_A 237 MHPMRA-L-FLIP--------RNPAPRLK--------------------------------SKKWSKKFQSFIESCLVKN 274 (326)
T ss_dssp SCHHHH-H-HHHH--------HSCCCCCS--------------------------------CSCSCHHHHHHHHHHCCSS
T ss_pred CcHHHH-H-HHhh--------cCccccCC--------------------------------ccccCHHHHHHHHHHhccC
Confidence 422111 0 0000 00000000 0112456789999999999
Q ss_pred cCCCCCHHHHHH
Q 005045 689 PRERIAMNVVVN 700 (717)
Q Consensus 689 p~~Rps~~eil~ 700 (717)
|++|||+.|+++
T Consensus 275 p~~Rps~~~ll~ 286 (326)
T 2x7f_A 275 HSQRPATEQLMK 286 (326)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhh
Confidence 999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.01 Aligned_cols=283 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred ccccccccccccccCcccccceEEEEe-CCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC---
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL--- 459 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--- 459 (717)
+....++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ....+|+++++.++||||+++++++.....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999996 489999999886432 223469999999999999999998754321
Q ss_pred ------------------------------CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHH
Q 005045 460 ------------------------------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASA 509 (717)
Q Consensus 460 ------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~ 509 (717)
.+....++||||++ ++|.+.+..... ....+++..+..++.||+.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---SGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 33456899999997 577766642100 11568999999999999999
Q ss_pred HHHHHhcCCCCeeecCCCCCCEEeC-CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcc
Q 005045 510 LDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSIL 586 (717)
Q Consensus 510 l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~ 586 (717)
|+|||+. ||+||||||+||+++ .++.+||+|||.+...... .......++..|+|||++.+ .++.+
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--------EPSVAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--------SCCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--------CCCcCcccCCCccCHHHhcCCCCCCcc
Confidence 9999997 999999999999997 6889999999999865211 12233567999999999655 38999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh-cCC--hhhhhhc----CCCCCCCCCCcHHHHHHHHHHHHHHhh
Q 005045 587 GDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM-ALP--DHVMDIL----DPSMPLDEENDEEQIEEVIEEKEMMIH 659 (717)
Q Consensus 587 sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (717)
+||||+||++|+|++|+.||......+. ....... ..+ +.+..+- +...+....... .
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~---~----------- 287 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW---R----------- 287 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH---H-----------
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH---H-----------
Confidence 9999999999999999999976433221 1111111 111 1111110 000000000000 0
Q ss_pred hhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH--HHHHHHH
Q 005045 660 IDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN--NLKTIRN 707 (717)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~--~l~~i~~ 707 (717)
...+..++..+.+++.+||+++|++|||+.|+++ .+..++.
T Consensus 288 -------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 288 -------KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp -------HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred -------hhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 0011223566889999999999999999999984 3444443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.62 Aligned_cols=279 Identities=22% Similarity=0.291 Sum_probs=185.2
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~ 461 (717)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .....+++.+|+++++.++||||+++++++.... ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 34579999999999999999999954 7999999998643 2344577889999999999999999999875431 223
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++|||++ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCCCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCeEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEE
Confidence 35689999999 7899988864 3589999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|||.++.... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+. +...
T Consensus 174 ~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i 242 (367)
T 2fst_X 174 LDFGLARHTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 242 (367)
T ss_dssp CC-------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred eeccccccccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999986421 1234568999999999654 589999999999999999999999976432211 1111
Q ss_pred HHh-cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 620 VSM-ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 620 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
... ..+. .+.+... .......+...... .....-......++..+.+|+.+||+.||++|||+.|+
T Consensus 243 ~~~~g~p~--~~~~~~~-------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~ 309 (367)
T 2fst_X 243 LRLVGTPG--AELLKKI-------SSESARNYIQSLTQ----MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309 (367)
T ss_dssp HHHHCSCC--HHHHTTC-------CCHHHHHHHHTSCC----CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhCCCC--HHHHHHh-------hhHHHHHHHhccCC----CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence 110 0010 0000000 00000111100000 00000000111224567899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 310 L~ 311 (367)
T 2fst_X 310 LA 311 (367)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.61 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=193.4
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
...++|++.+.||+|+||.||.|.+. +|+.||+|.+.... ....+.+|++++++++||||+++++++.. .+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 45678999999999999999999965 68999999987543 34678899999999999999999999643 458
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeec
Confidence 899999999999999986321 5689999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+...... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||........ .......
T Consensus 170 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~ 240 (314)
T 3com_A 170 GVAGQLTDT-------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTN 240 (314)
T ss_dssp TTCEECBTT-------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS
T ss_pred ccchhhhhh-------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcC
Confidence 999765221 112233568999999999655 589999999999999999999999975422110 0000000
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.. ..+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 241 --------~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 241 --------PPPTF-------------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --------CCCCC-------------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------CCccc-------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 011223556889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.91 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=193.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTRHRNILRVITACSSV 457 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 457 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3568999999999999999999965 78999999885432 1223457899999999999999999998532
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
. ..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 87 ----~-~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 87 ----E-DYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp ----S-SEEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred ----C-ceEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence 2 379999999999999998754 5689999999999999999999998 999999999999998766
Q ss_pred c---eEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 538 T---AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----NGQVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 538 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
. +||+|||.+.... .........|++.|+|||++ .+.++.++|||||||++|+|++|..||....
T Consensus 152 ~~~~~kl~Dfg~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILG--------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SSCCEEECCCTTCEECC--------CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCCeEEEccCccceecc--------cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 4 9999999997651 11122345689999999995 3457899999999999999999999997643
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
............. ....+ ....+++..+.+++.+||+.+|+
T Consensus 224 ~~~~~~~~~~~~~------------~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~ 264 (322)
T 2ycf_A 224 TQVSLKDQITSGK------------YNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPK 264 (322)
T ss_dssp CSSCHHHHHHHTC------------CCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTT
T ss_pred hHHHHHHHHHhCc------------cccCc---------------------------hhhhhcCHHHHHHHHHHcccCHh
Confidence 3221111111000 00000 01112356788999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||+.|+++
T Consensus 265 ~Rps~~~~l~ 274 (322)
T 2ycf_A 265 ARFTTEEALR 274 (322)
T ss_dssp TSCCHHHHHT
T ss_pred hCCCHHHHhh
Confidence 9999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.91 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=186.1
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.++...++.+.||||+++++++. .
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~ 77 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----R 77 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----c
Confidence 456789999999999999999999964 89999999986542 223344555666688889999999999964 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||++ +++.+++..... ....+++..+..++.||+.|++|||+.+ +++||||||+||+++.++.+||
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVID---KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEB
T ss_pred cCCEEEEEehhc-cchHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEE
Confidence 458999999996 588777653100 1156899999999999999999999852 8999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhh
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 616 (717)
+|||.+...... .......|++.|+|||++. +.++.++|||||||++|+|++|..||..........
T Consensus 152 ~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (290)
T 3fme_A 152 CDFGISGYLVDD--------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223 (290)
T ss_dssp CCC-----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred eecCCccccccc--------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence 999999765211 1122345899999999952 247899999999999999999999997543322222
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
........ ... ....++..+.+++.+||+.+|++|||+.
T Consensus 224 ~~~~~~~~------------~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 262 (290)
T 3fme_A 224 KQVVEEPS------------PQL-----------------------------PADKFSAEFVDFTSQCLKKNSKERPTYP 262 (290)
T ss_dssp HHHHHSCC------------CCC-----------------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHhccCC------------CCc-----------------------------ccccCCHHHHHHHHHHhhcChhhCcCHH
Confidence 11111110 000 0011255678999999999999999999
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
|+++
T Consensus 263 e~l~ 266 (290)
T 3fme_A 263 ELMQ 266 (290)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.66 Aligned_cols=202 Identities=27% Similarity=0.282 Sum_probs=162.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3579999999999999999999965 7899999998643 2344577889999999999999999999875432 2334
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||++ +++.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 169 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 169 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cceEEEEEcCC-CCHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEE
Confidence 47899999996 57888875 3478999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|||.+..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 170 Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 170 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp CCCC------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Eeeccccccc--------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999986521 112234568999999999655 5899999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.33 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=201.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...+.|++.+.||+|++|.||.|.+. +++.||+|++.... ....+.+.+|+.+++++.||||+++++++.. ..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 93 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DT 93 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CC
Confidence 34567999999999999999999964 78999999986543 3346788999999999999999999998643 45
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~D 162 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLAD 162 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eEEEEEEeCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEee
Confidence 89999999999999999864 3589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+...... ........|++.|+|||++.+ .++.++|||||||++|+|++|..||....... ......
T Consensus 163 fg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~- 232 (303)
T 3a7i_A 163 FGVAGQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIP- 232 (303)
T ss_dssp CTTCEECBTT-------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH-
T ss_pred cccceecCcc-------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhh-
Confidence 9999765221 112234568999999999655 57999999999999999999999996542211 111110
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
....+... ..++..+.+++.+||+.+|++|||+.|+++..
T Consensus 233 -------~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 233 -------KNNPPTLE---------------------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -------HSCCCCCC---------------------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -------cCCCCCCc---------------------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00001111 11245678999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=349.30 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=199.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKST-RHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 460 (717)
...++|++.+.||+|+||.||+|+++ +++.||+|++... .......+..|..++..+ +||+|+.++++ +.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EE
Confidence 34678999999999999999999965 7888999998743 233456788899999988 79999999998 55
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.+|.+|
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEE
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEE
Confidence 667899999999999999999754 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+++.... .........||+.|+|||++.+ .++.++|||||||++|||++|..||...... ..
T Consensus 483 L~DFGla~~~~~-------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~--- 550 (674)
T 3pfq_A 483 IADFGMCKENIW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL--- 550 (674)
T ss_dssp ECCCTTCEECCC-------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---
T ss_pred Eeecceeecccc-------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HH---
Confidence 999999975311 1122345679999999999765 5899999999999999999999999764221 11
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH----
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM---- 695 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~---- 695 (717)
...+........ ...+..+.+++.+||+.+|++||++
T Consensus 551 --------~~~i~~~~~~~p-------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~ 591 (674)
T 3pfq_A 551 --------FQSIMEHNVAYP-------------------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEG 591 (674)
T ss_dssp --------HHHHHSSCCCCC-------------------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTH
T ss_pred --------HHHHHhCCCCCC-------------------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCc
Confidence 111111111111 1124567889999999999999997
Q ss_pred -HHHHH
Q 005045 696 -NVVVN 700 (717)
Q Consensus 696 -~eil~ 700 (717)
+||++
T Consensus 592 ~~ei~~ 597 (674)
T 3pfq_A 592 ERDIKE 597 (674)
T ss_dssp HHHHHS
T ss_pred HHHHhc
Confidence 66653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.14 Aligned_cols=263 Identities=18% Similarity=0.273 Sum_probs=202.0
Q ss_pred CCCcccccccccccccc-cccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC-CCCceeEEEE
Q 005045 378 GMSYSDISKSTDNFSKE-NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKST-RHRNILRVIT 452 (717)
Q Consensus 378 ~~s~~~~~~~~~~y~~~-~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~ 452 (717)
...+.......++|.+. +.||+|+||.||+|.++ +++.||+|++.... ......+.+|+.+++.+ .||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455556667888888 89999999999999965 79999999987542 23357788999999999 5699999999
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
++ ...+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. ||+||||||+||+
T Consensus 97 ~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl 163 (327)
T 3lm5_A 97 VY-----ENTSEIILILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNIL 163 (327)
T ss_dssp EE-----ECSSEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred EE-----EeCCeEEEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEE
Confidence 95 445689999999999999999865421 5689999999999999999999998 9999999999999
Q ss_pred eCC---CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 533 LDK---DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 533 l~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
++. ++.+||+|||.+...... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHA--------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCCCCCcEEEeeCccccccCCc--------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 987 789999999999865211 11233568999999999765 589999999999999999999999965
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
...... ....... ...... +....++..+.+++.+||+.+
T Consensus 236 ~~~~~~--~~~i~~~---------~~~~~~-----------------------------~~~~~~~~~~~~li~~~L~~d 275 (327)
T 3lm5_A 236 EDNQET--YLNISQV---------NVDYSE-----------------------------ETFSSVSQLATDFIQSLLVKN 275 (327)
T ss_dssp SSHHHH--HHHHHHT---------CCCCCT-----------------------------TTTTTSCHHHHHHHHHHSCSS
T ss_pred CCchHH--HHHHHhc---------ccccCc-----------------------------hhhcccCHHHHHHHHHHcCCC
Confidence 422111 0000000 000000 011123556789999999999
Q ss_pred cCCCCCHHHHHHH
Q 005045 689 PRERIAMNVVVNN 701 (717)
Q Consensus 689 p~~Rps~~eil~~ 701 (717)
|++|||++|+++.
T Consensus 276 P~~Rpt~~~ll~h 288 (327)
T 3lm5_A 276 PEKRPTAEICLSH 288 (327)
T ss_dssp GGGSCCHHHHTTC
T ss_pred hhhCcCHHHHhCC
Confidence 9999999999853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.62 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=201.9
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhH-----------------HHHHHHHHHHHhcCCCCcee
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA-----------------LKSFIDECNALKSTRHRNIL 448 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~ni~ 448 (717)
...++|++.+.||+|+||.||+|.+ +++.||+|++....... ...+.+|++++++++||||+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 4467999999999999999999999 89999999987553221 17889999999999999999
Q ss_pred EEEEeeccccCCCCceEEEEEecCCCCChhhh------ccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCe
Q 005045 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQW------LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPI 521 (717)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i 521 (717)
++++++. +.+..++||||+++++|.++ +.... ...+++..+..++.||+.||+|||+ . |+
T Consensus 107 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i 173 (348)
T 2pml_X 107 TCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NI 173 (348)
T ss_dssp CCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CE
T ss_pred eEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccC---CE
Confidence 9999954 34589999999999999999 54321 2678999999999999999999999 7 99
Q ss_pred eecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCc-ccchhhHHHHHHH
Q 005045 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSI-LGDIYSYGILLLE 598 (717)
Q Consensus 522 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~-~sDvwslG~vl~e 598 (717)
+||||+|+||+++.++.+||+|||.+..... .......|+..|+|||++.+. ++. ++|||||||++|+
T Consensus 174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVD---------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECBT---------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred eecCCChHhEEEcCCCcEEEecccccccccc---------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999999999986521 133445689999999997664 444 9999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHhcC--ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 599 MFTGKRPTGDMFKDDFSIHMFVSMAL--PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 599 lltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
|++|..||.................. +........+..... .......++..
T Consensus 245 l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~ 298 (348)
T 2pml_X 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK--------------------------STCSNNFLSNE 298 (348)
T ss_dssp HHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC----------------------------------CCCHH
T ss_pred HHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccc--------------------------cccchhhcCHH
Confidence 99999999765432221111111110 100000000000000 00011223567
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+.+++.+||+.+|++|||+.|+++
T Consensus 299 l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 299 DIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.26 Aligned_cols=280 Identities=20% Similarity=0.259 Sum_probs=197.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-------
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD------- 458 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------- 458 (717)
..++|++.+.||+|++|.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4579999999999999999999976 69999999987666666788899999999999999999998864321
Q ss_pred --CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-C
Q 005045 459 --LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-K 535 (717)
Q Consensus 459 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~ 535 (717)
.......++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+||+++ .
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE 156 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC
Confidence 234568899999997 699999864 3588999999999999999999998 999999999999997 5
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
++.+||+|||.+........ .........++..|+|||++. +.++.++|||||||++|+|++|..||.......
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp TTEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCeEEEccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 67999999999986522111 111223345788999999853 458999999999999999999999997653211
Q ss_pred hhhhHHHHhcCChh----hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 614 FSIHMFVSMALPDH----VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 614 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
.........+.. ..++... .+ ..... . ..............++..+.+++.+||+.+|
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~-~~-----------~~~~~---~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (320)
T 2i6l_A 233 --QMQLILESIPVVHEEDRQELLSV-IP-----------VYIRN---D-MTEPHKPLTQLLPGISREAVDFLEQILTFSP 294 (320)
T ss_dssp --HHHHHHHHSCCCCHHHHHHHHTT-SC-----------HHHHH---H-TTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred --HHHHHHHhcCCCchhhhhhhhhc-Cc-----------ccccc---c-ccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence 111111111100 0000000 00 00000 0 0000000001112346778999999999999
Q ss_pred CCCCCHHHHHH
Q 005045 690 RERIAMNVVVN 700 (717)
Q Consensus 690 ~~Rps~~eil~ 700 (717)
++|||++|+++
T Consensus 295 ~~Rpt~~ell~ 305 (320)
T 2i6l_A 295 MDRLTAEEALS 305 (320)
T ss_dssp GGSCCHHHHHT
T ss_pred cccCCHHHHhC
Confidence 99999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.97 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=195.9
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh----hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ----QGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||.|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.. .+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence 3578999999999999999999965 78899999986542 2345788999999999999999999998632 34
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
....++||||++++ +.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTT-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcc-----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEe
Confidence 55789999999765 7776654321 5689999999999999999999998 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ---VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
+|||.+...... ..........|++.|+|||++.+. ++.++|||||||++|+|++|..||...... ....
T Consensus 151 ~dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~ 223 (305)
T 2wtk_C 151 SALGVAEALHPF-----AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFE 223 (305)
T ss_dssp CCCTTCEECCTT-----CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred eccccccccCcc-----ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHH
Confidence 999999765211 112223345689999999997653 478999999999999999999999753211 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.... .... .+.+++..+.+++.+||+.+|++|||++|+
T Consensus 224 ~i~~-----------~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 224 NIGK-----------GSYA-------------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp HHHH-----------CCCC-------------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHhc-----------CCCC-------------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1000 0000 111225567899999999999999999999
Q ss_pred HHH
Q 005045 699 VNN 701 (717)
Q Consensus 699 l~~ 701 (717)
++.
T Consensus 262 l~~ 264 (305)
T 2wtk_C 262 RQH 264 (305)
T ss_dssp HHS
T ss_pred hcC
Confidence 874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=349.64 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=196.4
Q ss_pred cccCcccccceEEEEe---CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTL---GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
++||+|+||.||+|.+ +.++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999964 257889999987543 3346789999999999999999999998632 3578999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 449 E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 449 EMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp ECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred EccCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 999999999999754 5689999999999999999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
..... ..........++..|+|||++.+ .++.++|||||||++|||++ |..||......+ ....+...
T Consensus 519 ~~~~~----~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~---- 588 (635)
T 4fl3_A 519 LRADE----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKG---- 588 (635)
T ss_dssp TTC-----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT----
T ss_pred cccCc----cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----
Confidence 62211 11122233446788999999654 68999999999999999998 999997643221 11111100
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.... .+..++..+.+++.+||+.+|++|||+++|++.|+.+..
T Consensus 589 ----~~~~---------------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 589 ----ERMG---------------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ----CCCC---------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCC---------------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0000 112346678999999999999999999999999999876
Q ss_pred HH
Q 005045 708 CF 709 (717)
Q Consensus 708 ~~ 709 (717)
+.
T Consensus 632 ~l 633 (635)
T 4fl3_A 632 DV 633 (635)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.21 Aligned_cols=280 Identities=22% Similarity=0.351 Sum_probs=203.5
Q ss_pred CCCcccccCCCCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCc
Q 005045 369 TIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRN 446 (717)
Q Consensus 369 ~~p~~~~~~~~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~n 446 (717)
++|...........++....++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 90 (319)
T 2y4i_B 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90 (319)
T ss_dssp ---------CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTT
T ss_pred ccCccccccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCC
Confidence 34444445556677888889999999999999999999999753 48899886432 223456778999999999999
Q ss_pred eeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 005045 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDL 526 (717)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 526 (717)
|+++++++. ..+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||
T Consensus 91 iv~~~~~~~-----~~~~~~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl 156 (319)
T 2y4i_B 91 VVLFMGACM-----SPPHLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDL 156 (319)
T ss_dssp BCCCCEEEE-----CSSCEEEECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred EeEEEEEEe-----cCCceEEEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCC
Confidence 999999964 3457999999999999999997643 4689999999999999999999998 9999999
Q ss_pred CCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC----------CCCcccchhhHHHHH
Q 005045 527 KPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----------QVSILGDIYSYGILL 596 (717)
Q Consensus 527 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~sDvwslG~vl 596 (717)
||+||+++ ++.+||+|||.+......... ..........|++.|+|||++.+ .++.++|||||||++
T Consensus 157 kp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CSTTEEEC---CCEECCCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred ChhhEEEe-CCCEEEeecCCcccccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 99999998 789999999998754221111 11112233458999999999653 368899999999999
Q ss_pred HHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 597 LEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 597 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
|+|++|..||.....+. ........ ..+.... ..++..
T Consensus 234 ~el~~g~~p~~~~~~~~--~~~~~~~~--------~~~~~~~--------------------------------~~~~~~ 271 (319)
T 2y4i_B 234 YELHAREWPFKTQPAEA--IIWQMGTG--------MKPNLSQ--------------------------------IGMGKE 271 (319)
T ss_dssp HHHHHSSCSSSSCCHHH--HHHHHHTT--------CCCCCCC--------------------------------SSCCTT
T ss_pred HHHHhCCCCCCCCCHHH--HHHHhccC--------CCCCCCc--------------------------------CCCCHH
Confidence 99999999997543221 11111110 1111100 011345
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~~l~~i~~~~ 709 (717)
+.+++.+||+.+|++|||++|+++.|+.+.++.
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 788999999999999999999999999988654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.26 Aligned_cols=200 Identities=26% Similarity=0.343 Sum_probs=167.0
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcC------CCCceeEEEEeecccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKST------RHRNILRVITACSSVD 458 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~ 458 (717)
....+|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+++++.+ .|+||+++++.+..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 34668999999999999999999965 78999999987543 2345667788877776 67799999999543
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
....++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 171 ---~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 171 ---RNHICMTFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp ---TTEEEEEECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTS
T ss_pred ---CCeEEEEEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCC
Confidence 458999999995 699998875421 4589999999999999999999998 9999999999999999887
Q ss_pred --eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 539 --AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 539 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+||+|||.++... .......||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 239 ~~vkL~DFG~a~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEH----------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCEEECCCTTCEETT----------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceEEeecccceecC----------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999997541 11223568999999999655 58999999999999999999999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.62 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=198.6
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---------hhHHHHHHHHHHHHhcCC-CCceeEEEEee
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---------QGALKSFIDECNALKSTR-HRNILRVITAC 454 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~ 454 (717)
...++|++.+.||+|++|.||+|.++ +++.||+|++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34679999999999999999999975 78999999986432 233567889999999995 99999999995
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
......++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||+|+||+++
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD 158 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEc
Confidence 3456899999999999999999743 5689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 535 KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-------GQVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 535 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
.++.+||+|||.+..... ........+++.|+|||++. +.++.++|||||||++|+|++|..||.
T Consensus 159 ~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDP--------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp TTCCEEECCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcEEEecccchhhcCC--------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 999999999999876521 11123356899999999863 347899999999999999999999996
Q ss_pred CCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 608 DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
..... ........ ....... +....++..+.+++.+||+.
T Consensus 231 ~~~~~--~~~~~~~~-----------~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~ 270 (298)
T 1phk_A 231 HRKQM--LMLRMIMS-----------GNYQFGS---------------------------PEWDDYSDTVKDLVSRFLVV 270 (298)
T ss_dssp CSSHH--HHHHHHHH-----------TCCCCCT---------------------------TTGGGSCHHHHHHHHHHCCS
T ss_pred CccHH--HHHHHHhc-----------CCcccCc---------------------------ccccccCHHHHHHHHHHccC
Confidence 53211 11111000 0000000 01122356788999999999
Q ss_pred CcCCCCCHHHHHH
Q 005045 688 SPRERIAMNVVVN 700 (717)
Q Consensus 688 ~p~~Rps~~eil~ 700 (717)
+|++|||+.|+++
T Consensus 271 dp~~Rps~~~ll~ 283 (298)
T 1phk_A 271 QPQKRYTAEEALA 283 (298)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHHh
Confidence 9999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.10 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=198.4
Q ss_pred ccccccccccccCcccccceEEEEe----CCCchhhhHHhHhhh----hhHHHHHHHHHHHHhcC-CCCceeEEEEeecc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ----QGALKSFIDECNALKST-RHRNILRVITACSS 456 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 456 (717)
...++|++.++||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++++ .||||+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ- 129 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-
Confidence 3457999999999999999999996 378899999986432 22345677899999999 7999999999853
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 130 ----~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 130 ----TETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 195 (355)
T ss_dssp ----ETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred ----eCceEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 345899999999999999998743 5689999999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 613 (717)
+.+||+|||+++..... .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.......
T Consensus 196 ~~~kl~DfG~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp SCEEESCSSEEEECCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred CcEEEeeCCCCeecccC------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 99999999999764211 1112234568999999999764 36899999999999999999999997543221
Q ss_pred hhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
... .... .+...... .+.+++..+.+++.+||+.+|++||
T Consensus 270 ~~~-~~~~--------~~~~~~~~-------------------------------~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 270 SQA-EISR--------RILKSEPP-------------------------------YPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp CHH-HHHH--------HHHHCCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred hHH-HHHH--------HHhccCCC-------------------------------CCcccCHHHHHHHHHHhhhCHHHhc
Confidence 110 0000 00000000 0112245678899999999999999
Q ss_pred -----CHHHHHHHH
Q 005045 694 -----AMNVVVNNL 702 (717)
Q Consensus 694 -----s~~eil~~l 702 (717)
|++|+++..
T Consensus 310 ~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 310 GCGPRDADEIKEHL 323 (355)
T ss_dssp TSSTTTHHHHHTSG
T ss_pred CCCCCCHHHHHcCc
Confidence 999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.92 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=199.3
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|++.+.||+|++|.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++. ..+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 568999999999999999999975 78999999986543 234577889999999999999999999953 4558
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---CceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD---MTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl 541 (717)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.+ +.+||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEE
Confidence 99999999999999988643 5689999999999999999999998 99999999999999754 47999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
+|||.+...... .......+++.|+|||++.+.++.++|||||||++|+|++|..||....... ......
T Consensus 166 ~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~ 235 (287)
T 2wei_A 166 IDFGLSTCFQQN--------TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVE 235 (287)
T ss_dssp CSTTGGGTBCCC--------SSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred eccCcceeecCC--------CccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 999998865211 1112345889999999998889999999999999999999999997642211 111110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. ....... +....++..+.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~-----------~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 236 T-----------GKYAFDL---------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp H-----------CCCCCCS---------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-----------CCCCCCc---------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0000000 0111225568899999999999999999999973
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=316.06 Aligned_cols=311 Identities=25% Similarity=0.342 Sum_probs=178.8
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+++|+|++|++++ +|.. +++|++|++++|.+++ +|.. .++|++|++++|.+++ +| .|+++++|++|+++
T Consensus 92 ~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 92 HLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp TCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 45566666666654 4432 2556666666666552 3221 1466666666666663 55 36666666666666
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|++++ +|..+ .+|++|+|++|++++ +| .|.++++|++|++++|.++ .+|.. .++|+.|++++|.+. .
T Consensus 162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~-~l~~~----~~~L~~L~l~~n~l~-~ 229 (454)
T 1jl5_A 162 NNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-E 229 (454)
T ss_dssp SSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-S
T ss_pred CCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC-cCCCC----cCcccEEECcCCcCC-c
Confidence 666663 44332 366666666666664 33 4666667777777777666 34432 246667777777666 3
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+| .+..+++|++|++++|++++ +|.. +++|+.|++++|+++.++. .+++|+.|++++|.+++ +|
T Consensus 230 lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~----------~~~~L~~L~ls~N~l~~-l~ 293 (454)
T 1jl5_A 230 LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPE----------LPQSLTFLDVSENIFSG-LS 293 (454)
T ss_dssp CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSE-ES
T ss_pred cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCc----------ccCcCCEEECcCCccCc-cc
Confidence 44 36666777777777777663 3432 3566777777776666431 13567777777777763 22
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCC-CCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNL-VNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNL 329 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 329 (717)
. .+++|+.|++++|.+++ +..+ ++|+.|++++|++++ +|.. +++|++|++++|+++++ |. .+
T Consensus 294 ~----~~~~L~~L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~l-p~---~l 356 (454)
T 1jl5_A 294 E----LPPNLYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEV-PE---LP 356 (454)
T ss_dssp C----CCTTCCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CC
T ss_pred C----cCCcCCEEECcCCcCCc-----ccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccc-cc---hh
Confidence 1 12467777777777764 1223 478888888888874 5543 57788888888888754 43 36
Q ss_pred cccceeecccccccc--cCCcCccCc-------------CCCceEEeecccCCC--CCCccccc
Q 005045 330 TILTRLWMEENRLEG--SIPPSLGNC-------------QKLLVLNLSSNDLNG--TIPKEVRQ 376 (717)
Q Consensus 330 ~~L~~L~L~~N~l~~--~~p~~~~~l-------------~~L~~L~l~~N~l~~--~~p~~~~~ 376 (717)
++|++|+|++|++++ .+|..+..+ ++|+.|++++|++++ .+|+++..
T Consensus 357 ~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~ 420 (454)
T 1jl5_A 357 QNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVED 420 (454)
T ss_dssp TTCCEEECCSSCCSSCCCCCTTCCEEECCC----------------------------------
T ss_pred hhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHhh
Confidence 778888888888887 677777777 778888888888876 67766543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.93 Aligned_cols=288 Identities=20% Similarity=0.231 Sum_probs=197.9
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+++.++++++.++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|.++++.|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666666 4554443 456666666666665555566666666666666666665556666666666666666
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccc--cCCCCccCCCCCCeeeccccccC
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG--TIPGNFGSLKDLVRLNFDQNELG 216 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~ 216 (717)
+|.++ .+|..++ ++|++|++++|.+....+..|.++++|++|++++|.++. ..+..|..+ +|+.|++++|.++
T Consensus 111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 66665 5555544 566666666666665555556677777777777777642 555666666 7777777777776
Q ss_pred CcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcc
Q 005045 217 SREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296 (717)
Q Consensus 217 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 296 (717)
.++.. + .++|++|++++|.+++..+..+..+ ++|++|++++|.+++..+..|..+++|+.|+|++|+++
T Consensus 186 ~l~~~-------~--~~~L~~L~l~~n~i~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 186 GIPKD-------L--PETLNELHLDHNKIQAIELEDLLRY-SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254 (332)
T ss_dssp SCCSS-------S--CSSCSCCBCCSSCCCCCCTTSSTTC-TTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred ccCcc-------c--cCCCCEEECCCCcCCccCHHHhcCC-CCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence 65421 1 1567777777777775555666666 47888888888887777777888888888888888888
Q ss_pred ccchhhhcCCCCCeEEcccCcCCCCCCcccccc------cccceeeccccccc--ccCCcCccCcCCCceEEeeccc
Q 005045 297 SVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNL------TILTRLWMEENRLE--GSIPPSLGNCQKLLVLNLSSND 365 (717)
Q Consensus 297 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~ 365 (717)
.+|..+..+++|+.|++++|+++++.+..|..+ +.|+.|++++|++. +..|..|..+++|+.+++++|.
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 677778888888888888888888777777653 56888899998886 5677788888899999888874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.78 Aligned_cols=268 Identities=12% Similarity=0.031 Sum_probs=183.2
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHH---HHHhcCCCCceeEEEEee---
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDEC---NALKSTRHRNILRVITAC--- 454 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~ni~~~~~~~--- 454 (717)
.....+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+ ++++. +||||++++..+
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLP 136 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEee
Confidence 334567999999999999999999965 89999999987642 23456677784 45555 799988865332
Q ss_pred ----ccccC------------CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHH------HHHHHHHHHHHHH
Q 005045 455 ----SSVDL------------EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR------LNIAIDVASALDY 512 (717)
Q Consensus 455 ----~~~~~------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~ 512 (717)
..... ......|+||||++ ++|.+++.... ..+++..+ ..++.||+.||+|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 11100 00145899999997 89999997531 22344444 6778999999999
Q ss_pred HHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccch
Q 005045 513 LHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDI 589 (717)
Q Consensus 513 LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDv 589 (717)
||+. +|+||||||+||+++.+|.+||+|||++.... .......+++.|+|||++.+ .++.++||
T Consensus 210 LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 210 LQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----------TRGPASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETT----------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecC----------CCccCccCCcCCcChhhccCCCCCcCccccH
Confidence 9998 99999999999999999999999999998651 11113456799999999765 48999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhh
Q 005045 590 YSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNK 669 (717)
Q Consensus 590 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
|||||++|+|++|..||............. .............. .
T Consensus 277 wSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~-----------------------------~ 321 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKR------PSLRVPGTDSLAFG-----------------------------S 321 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTBCCTTCTTCCCB------CCTTSCCCCSCCCT-----------------------------T
T ss_pred HHHHHHHHHHHhCCCCCCCcCcccccchhh------hhhhhccccccchh-----------------------------h
Confidence 999999999999999997654331110000 00000000000000 0
Q ss_pred hHHHHHHHHHHhhccCCCCcCCCCCHHHHHH--HHHHHHHH
Q 005045 670 LEECFVSVLRIGLMCSTTSPRERIAMNVVVN--NLKTIRNC 708 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~p~~Rps~~eil~--~l~~i~~~ 708 (717)
...++..+.+++.+||+.+|++|||+.|+++ .+..+..+
T Consensus 322 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 1122566889999999999999999999985 44444443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=326.00 Aligned_cols=278 Identities=20% Similarity=0.229 Sum_probs=197.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~ 462 (717)
..++|++.+.||+|+||.||+|.++ +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..... ...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4579999999999999999999965 7999999998643 23346788899999999999999999999654321 111
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred eeEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEE
Confidence 23499999996 68888874 4489999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+..... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+.......
T Consensus 187 Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 187 DFGLARHADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp STTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ecCccccccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999986421 1233568999999999655 589999999999999999999999976432211111100
Q ss_pred HhcC-ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 621 SMAL-PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 621 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.... +......+.. .......... .-.....-....+.++..+.+++.+||+.+|++|||++|++
T Consensus 257 ~~~~~~~~~~~~~~~----------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 257 VTGVPGTEFVQKLND----------KAAKSYIQSL----PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp HHCCCCHHHHTTCSC----------HHHHHHHHHS----CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HhCCCcHHHHHHhhh----------hhhhhhhhcc----CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 0111 1111111100 0000000000 00000000011123466789999999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 323 ~h 324 (371)
T 4exu_A 323 TH 324 (371)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.46 Aligned_cols=291 Identities=19% Similarity=0.216 Sum_probs=217.9
Q ss_pred CCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEE
Q 005045 57 LTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136 (717)
Q Consensus 57 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 136 (717)
..+++.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.++++.|..|.++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 346777777777777 5565554 5677777777777766666777777777777777777777777777777777777
Q ss_pred cccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccc--cCCCCccCCCCCCeeeccccc
Q 005045 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG--TIPGNFGSLKDLVRLNFDQNE 214 (717)
Q Consensus 137 L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~ 214 (717)
|++|.++ .+|..++ ++|+.|++++|.+.+..+..|.++++|++|++++|.++. ..+..|..+++|+.|++++|.
T Consensus 107 Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp CCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence 7777776 6666554 677777777777776666667777888888888887753 556677778888888888888
Q ss_pred cCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcC
Q 005045 215 LGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294 (717)
Q Consensus 215 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 294 (717)
++.++.. + .++|++|++++|.+++..|..+..+ ++|++|++++|.+++..+..|..+++|+.|+|++|++
T Consensus 183 l~~l~~~-------~--~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 252 (330)
T 1xku_A 183 ITTIPQG-------L--PPSLTELHLDGNKITKVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252 (330)
T ss_dssp CCSCCSS-------C--CTTCSEEECTTSCCCEECTGGGTTC-TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred cccCCcc-------c--cccCCEEECCCCcCCccCHHHhcCC-CCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence 7776521 1 2678888888888886666777766 4888888888888877777888888888888888888
Q ss_pred ccccchhhhcCCCCCeEEcccCcCCCCCCcccccc------cccceeecccccccc--cCCcCccCcCCCceEEeeccc
Q 005045 295 SGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNL------TILTRLWMEENRLEG--SIPPSLGNCQKLLVLNLSSND 365 (717)
Q Consensus 295 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~ 365 (717)
+ .+|..+..+++|++|+|++|+++++.+..|... +.|+.|++++|++.. ..|..|..+++++.++|++|.
T Consensus 253 ~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred c-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 8 677788888888888888888888877777543 678889999998863 566788888899999998884
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.57 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=193.1
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
...++|++.+.||+|++|.||+|.+. +++.||+|++... .......+.+|+..+..+ +||||+++++++. +
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~ 82 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----E 82 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----E
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----c
Confidence 34678999999999999999999976 8999999998743 233456788899999999 9999999999954 3
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-----
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD----- 536 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----- 536 (717)
.+..++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcc
Confidence 4589999999999999999874310 114589999999999999999999998 99999999999999844
Q ss_pred --------------CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHH
Q 005045 537 --------------MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMF 600 (717)
Q Consensus 537 --------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~ell 600 (717)
+.+||+|||.+..... .....|++.|+|||++.+. ++.++|||||||++|+|+
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISS-----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp -------------CCCEEECCCTTCEETTC-----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccCCceEEEEcccccccccCC-----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence 4799999999886521 1123489999999997664 457999999999999999
Q ss_pred hCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHH
Q 005045 601 TGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680 (717)
Q Consensus 601 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 680 (717)
+|..|+... ..... +.....+.. +..++..+.++
T Consensus 226 ~~~~~~~~~----~~~~~------------~~~~~~~~~------------------------------~~~~~~~~~~l 259 (289)
T 1x8b_A 226 GAEPLPRNG----DQWHE------------IRQGRLPRI------------------------------PQVLSQEFTEL 259 (289)
T ss_dssp TCCCCCSSS----HHHHH------------HHTTCCCCC------------------------------SSCCCHHHHHH
T ss_pred cCCCCCcch----hHHHH------------HHcCCCCCC------------------------------CcccCHHHHHH
Confidence 998876432 11111 111111100 01125567899
Q ss_pred hhccCCCCcCCCCCHHHHHH
Q 005045 681 GLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 681 i~~cl~~~p~~Rps~~eil~ 700 (717)
+.+||+.+|++|||+.|+++
T Consensus 260 i~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 260 LKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCcccCCCHHHHhh
Confidence 99999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.57 Aligned_cols=291 Identities=22% Similarity=0.278 Sum_probs=203.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|++++++++||||+++++++....+....
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45689999999999999999999965 7999999998643 233456788999999999999999999987655455567
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEe
Confidence 8999999996 689988863 3589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCC---CcceeecccccccccCCCccC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 544 FGLAKFLFEISDNPSK---NQTVSIGLKGSIGYIPPEHMN--GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
||.+............ .........||+.|+|||++. +.++.++|||||||++|+|++|..||............
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9999876322111110 011122356899999999853 45899999999999999999999999765322111100
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
......+.. +..... .......+...... ...........+.++..+.+++.+||+.||++|||++|+
T Consensus 236 ~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (353)
T 2b9h_A 236 FGIIGTPHS-----DNDLRC---IESPRAREYIKSLP----MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303 (353)
T ss_dssp HHHHCCCCS-----TTTTTT---CCCHHHHHHHHTSC----CCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhCCCch-----hccccc---cccchhhHHhhccc----CCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 000000000 000000 00000111110000 000000001112346678899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 304 l~ 305 (353)
T 2b9h_A 304 LE 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=346.32 Aligned_cols=264 Identities=21% Similarity=0.346 Sum_probs=205.0
Q ss_pred ccccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
.+.....++|++.+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345556789999999999999999999864 2456899987643 3344578899999999999999999999852
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 462 -----~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~ 527 (656)
T 2j0j_A 462 -----ENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN 527 (656)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred -----cCceEEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCC
Confidence 235799999999999999997442 4589999999999999999999998 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCch
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDF 614 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 614 (717)
+.+||+|||++...... .........+++.|+|||++. +.++.++|||||||++|||++ |..||......+
T Consensus 528 ~~vkL~DFG~a~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 600 (656)
T 2j0j_A 528 DCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 600 (656)
T ss_dssp TEEEECCCCCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred CCEEEEecCCCeecCCC------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 99999999999865211 111122344678899999965 458999999999999999997 999997642221
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
........ .... .+..++..+.+++.+||+.+|++|||
T Consensus 601 -~~~~i~~~--------~~~~---------------------------------~~~~~~~~l~~li~~~l~~dP~~RPs 638 (656)
T 2j0j_A 601 -VIGRIENG--------ERLP---------------------------------MPPNCPPTLYSLMTKCWAYDPSRRPR 638 (656)
T ss_dssp -HHHHHHHT--------CCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -HHHHHHcC--------CCCC---------------------------------CCccccHHHHHHHHHHcCCChhHCcC
Confidence 11111000 0000 11223567889999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 005045 695 MNVVVNNLKTIRNCF 709 (717)
Q Consensus 695 ~~eil~~l~~i~~~~ 709 (717)
+.||++.|+++.++.
T Consensus 639 ~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 639 FTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=326.87 Aligned_cols=275 Identities=20% Similarity=0.246 Sum_probs=194.0
Q ss_pred ccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCCce
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGNDF 464 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~~~ 464 (717)
....+|++.+.||+|+||.||+|++..+..+|+|.+.... ....+|+++++.++||||+++++++..... .+...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 3466899999999999999999998766668888775432 122369999999999999999998755432 33445
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDMTAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~D 543 (717)
.++||||++++ +.+.+..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.+||+|
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEeeccCcc-HHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEee
Confidence 88999999764 4333321000 115689999999999999999999998 999999999999999 799999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||.++..... .......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+. +.....
T Consensus 186 FG~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~ 256 (394)
T 4e7w_A 186 FGSAKILIAG--------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIK 256 (394)
T ss_dssp CTTCEECCTT--------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH
T ss_pred CCCcccccCC--------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 9999865211 11223568999999999754 489999999999999999999999976532221 111111
Q ss_pred h-cCCh--hhh----hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 622 M-ALPD--HVM----DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 622 ~-~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
. ..+. .+. .+.....+......... .....++..+.+++.+||+.+|++|||
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK---------------------VFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH---------------------HSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHH---------------------hccccCCHHHHHHHHHHhCCChhhCCC
Confidence 1 1110 011 11111111100000000 001123557889999999999999999
Q ss_pred HHHHHHH
Q 005045 695 MNVVVNN 701 (717)
Q Consensus 695 ~~eil~~ 701 (717)
+.|+++.
T Consensus 316 ~~e~l~h 322 (394)
T 4e7w_A 316 AIEALCH 322 (394)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.10 Aligned_cols=283 Identities=20% Similarity=0.261 Sum_probs=201.7
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC--------CCceeEEEEeecc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR--------HRNILRVITACSS 456 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~~~~~ 456 (717)
...++|++.++||+|+||.||+|++. +++.||+|++.... ...+.+.+|+++++++. |+||+++++.+..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34689999999999999999999964 78999999987442 34567889999999885 7889999998653
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.. ......++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+.+ ||+||||||+||+++.+
T Consensus 113 ~~-~~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~ 183 (397)
T 1wak_A 113 SG-VNGTHICMVFEVL-GHHLLKWIIKSN-----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVN 183 (397)
T ss_dssp EE-TTEEEEEEEECCC-CCBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCC
T ss_pred cC-CCCceEEEEEecc-CccHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEecc
Confidence 21 2455899999999 567766665332 146899999999999999999999942 89999999999999977
Q ss_pred C-------------------------------------------------ceEEeeeccchhcccccCCCCCCcceeecc
Q 005045 537 M-------------------------------------------------TAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567 (717)
Q Consensus 537 ~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 567 (717)
+ .+||+|||.+..... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----------~~~~~ 253 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----------HFTED 253 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----------CSCSC
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----------cCccC
Confidence 5 799999999986521 12234
Q ss_pred cccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH-----H--HHhcCChhhh-------hhc
Q 005045 568 KGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM-----F--VSMALPDHVM-------DIL 632 (717)
Q Consensus 568 ~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~-----~--~~~~~~~~~~-------~~~ 632 (717)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||............ . .....+..+. .++
T Consensus 254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 68999999999655 4899999999999999999999999875543321110 0 0111111110 011
Q ss_pred CCCCC--CCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 633 DPSMP--LDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 633 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...-. ...........+.+.+ ....+.+++..+.+|+.+||+.+|++|||++|+++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVE------------KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHH------------TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCccccccccccCCcchhHhhhh------------hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 10000 0000000000111100 11233556788999999999999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.77 Aligned_cols=312 Identities=17% Similarity=0.192 Sum_probs=266.6
Q ss_pred CCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccC
Q 005045 19 YNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSI 98 (717)
Q Consensus 19 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 98 (717)
.+...+..+..++.+++|++|++++|.+++ +| .|..+++|++|+|++|.+++ +| ++.+++|++|+|++|++++.
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-
Confidence 344555666788999999999999999995 46 69999999999999999995 45 89999999999999999964
Q ss_pred ChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCC
Q 005045 99 PNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178 (717)
Q Consensus 99 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 178 (717)
+ |.++++|++|+|++|+++++ + +..+++|++|++++|+++ .++ +..+++|+.|++++|...+.+ .+..+
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~-~l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLT-EID---VSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCS-CCC---CTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccc-eec---cccCCcCCEEECCCCCccccc--ccccC
Confidence 4 89999999999999999974 3 899999999999999998 454 458999999999999655444 58899
Q ss_pred CCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccc
Q 005045 179 SNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLST 258 (717)
Q Consensus 179 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~ 258 (717)
++|++|++++|++++ +| +..+++|+.|++++|.++.++ +..+++|+.|++++|++++ +| +..+ +
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~---------l~~l~~L~~L~Ls~N~l~~-ip--~~~l-~ 233 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLD---------LNQNIQLTFLDCSSNKLTE-ID--VTPL-T 233 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCC---------CTTCTTCSEEECCSSCCSC-CC--CTTC-T
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeec---------cccCCCCCEEECcCCcccc-cC--cccc-C
Confidence 999999999999995 45 889999999999999999864 6788999999999999995 67 5566 5
Q ss_pred cccEEecCCCccCCCCCccccCCC-------CCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCc-------
Q 005045 259 HLRRLTMGENLMHGNIPVGIGNLV-------NLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPS------- 324 (717)
Q Consensus 259 ~L~~L~l~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------- 324 (717)
+|+.|++++|.+++..+..+.++. +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|.
T Consensus 234 ~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~ 311 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITE 311 (457)
T ss_dssp TCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSC
T ss_pred CCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceE
Confidence 999999999999987666666655 56777777777766666 56789999999999986554442
Q ss_pred -ccccccccceeecccccccccCCcCccCcCCCceEEeecccCCC
Q 005045 325 -SLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368 (717)
Q Consensus 325 -~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 368 (717)
.+.++++|+.|+|++|++++ ++ +..+++|+.|++++|.|++
T Consensus 312 L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 312 LDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB
T ss_pred echhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC
Confidence 35677899999999999996 43 8999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.30 Aligned_cols=280 Identities=23% Similarity=0.369 Sum_probs=200.6
Q ss_pred cccccccccccccccCcccccceEEEEe--CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcC---CCCceeEEEEeec
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTL--GDGTIVAIKVLKLQQ--QGALKSFIDECNALKST---RHRNILRVITACS 455 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~ 455 (717)
.+....++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+.+++.+ .||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 3456678999999999999999999997 368899999986432 11223455677766655 8999999999875
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
..........++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+. |++||||||+||+++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 155 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcC
Confidence 433345568999999997 699999875421 4589999999999999999999998 9999999999999999
Q ss_pred CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 536 DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 536 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
++.+||+|||.+..... ........++..|+|||++.+ .++.++|||||||++|+|++|..||........
T Consensus 156 ~~~~kl~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 156 SGQIKLADFGLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp TCCEEECSCCSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred CCCEEEecCcccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999999876421 112234568999999999654 589999999999999999999999976532211
Q ss_pred hhhHHHH-hcCCh--hhhhhcC-CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 615 SIHMFVS-MALPD--HVMDILD-PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 615 ~~~~~~~-~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
...... ...+. .+..... +...... ...........+++..+.+++.+||+.+|+
T Consensus 228 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 228 -LGKILDVIGLPGEEDWPRDVALPRQAFHS--------------------KSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp -HHHHHHHHCCCCGGGSCTTCSSCGGGSCC--------------------CCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred -HHHHHHHcCCCCcccCccccccchhhhcc--------------------cCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 111111 01110 0000000 0000000 000000001122356678999999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||+.|+++
T Consensus 287 ~Rpt~~e~l~ 296 (326)
T 1blx_A 287 KRISAYSALS 296 (326)
T ss_dssp TSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 9999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.62 Aligned_cols=320 Identities=23% Similarity=0.300 Sum_probs=174.7
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCC-------------CEEEccCccccccCCcc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL-------------EIIGLGGSNLTGNVPAW 77 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~p~~ 77 (717)
.+++|++++|++ +.+|.+|+++++|++|++++|.+++.+|..++++++| ++|++++|.++ .+|..
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~ 89 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL 89 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC
Confidence 678888888888 5788888888888888888888888888888777654 66666666666 33432
Q ss_pred ccCCCCCCEEeccCCcCcccCChhhh----------------cc-CCCCeEeccCCCCCCCCCccccCCCCccEEEcccC
Q 005045 78 IGNFSSLKALSLAWNNLRGSIPNELG----------------QL-SGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQN 140 (717)
Q Consensus 78 ~~~l~~L~~L~L~~n~l~~~~~~~~~----------------~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 140 (717)
.++|++|++++|++++ +|..+. .+ ++|++|+|++|++++ +| .|.++++|++|++++|
T Consensus 90 ---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N 163 (454)
T 1jl5_A 90 ---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN 163 (454)
T ss_dssp ---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred ---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence 1455555555555553 332210 11 466666666666664 44 4666777777777777
Q ss_pred cccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCccc
Q 005045 141 QLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREI 220 (717)
Q Consensus 141 ~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 220 (717)
+++ .+|.. .++|++|++++|.+++ +| .+.++++|++|++++|.+++ +|... ++|+.|++++|.++.++
T Consensus 164 ~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~lp- 231 (454)
T 1jl5_A 164 SLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEELP- 231 (454)
T ss_dssp CCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSSCC-
T ss_pred cCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCCccc-
Confidence 766 45532 3466777777776665 34 46667777777777776663 33322 46666666666666442
Q ss_pred CchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccc--c
Q 005045 221 GDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS--V 298 (717)
Q Consensus 221 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~ 298 (717)
.+..+++|++|++++|+++ .+|.. +++|+.|++++|.+++ +|.. +++|+.|++++|++++. .
T Consensus 232 -------~~~~l~~L~~L~l~~N~l~-~l~~~----~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~ 295 (454)
T 1jl5_A 232 -------ELQNLPFLTTIYADNNLLK-TLPDL----PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSEL 295 (454)
T ss_dssp -------CCTTCTTCCEEECCSSCCS-SCCSC----CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCC
T ss_pred -------ccCCCCCCCEEECCCCcCC-ccccc----ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCc
Confidence 2566777777777777777 34432 2467777777777664 3332 25666666666666641 1
Q ss_pred chhh-------------hcC-CCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecc
Q 005045 299 PEVI-------------GRL-NKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364 (717)
Q Consensus 299 ~~~~-------------~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 364 (717)
|..+ ..+ ++|++|++++|+++++ |.. +++|+.|++++|+++ .+|. .+++|+.|++++|
T Consensus 296 ~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N 367 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYN 367 (454)
T ss_dssp CTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSS
T ss_pred CCcCCEEECcCCcCCcccCCcCcCCEEECCCCccccc-ccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCC
Confidence 1111 111 3555566666655542 222 355666666666665 3444 3456666666666
Q ss_pred cCCC--CCCccc
Q 005045 365 DLNG--TIPKEV 374 (717)
Q Consensus 365 ~l~~--~~p~~~ 374 (717)
++++ .+|.++
T Consensus 368 ~l~~l~~ip~~l 379 (454)
T 1jl5_A 368 PLREFPDIPESV 379 (454)
T ss_dssp CCSSCCCCCTTC
T ss_pred CCCcCCCChHHH
Confidence 6665 444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.55 Aligned_cols=288 Identities=22% Similarity=0.290 Sum_probs=180.9
Q ss_pred CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEecc
Q 005045 35 ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 114 (717)
+++.+++++|.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666655 4554442 456666666666665555556666666666666666665555566666666666666
Q ss_pred CCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccc--ccCCccCCCCCCCCEEeccCcccc
Q 005045 115 GNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT--GSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 115 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
+|.++. +|..+. ++|++|++++|.++ .++...+..+++|+.|++++|.++ +..+..+..+ +|++|++++|+++
T Consensus 111 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 111 KNHLVE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp SSCCCS-CCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCcCCc-cCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 666653 333332 55666666666665 555555556666666666666664 2455566666 6777777777776
Q ss_pred ccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCC
Q 005045 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG 272 (717)
Q Consensus 193 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~ 272 (717)
+ +|..+. ++|+.|++++|.++.+. +..+.++++|+.|+|++|.+++..+..+..+ ++|++|++++|.++
T Consensus 186 ~-l~~~~~--~~L~~L~l~~n~i~~~~------~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 186 G-IPKDLP--ETLNELHLDHNKIQAIE------LEDLLRYSKLYRLGLGHNQIRMIENGSLSFL-PTLRELHLDNNKLS- 254 (332)
T ss_dssp S-CCSSSC--SSCSCCBCCSSCCCCCC------TTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC-TTCCEEECCSSCCC-
T ss_pred c-cCcccc--CCCCEEECCCCcCCccC------HHHhcCCCCCCEEECCCCcCCcCChhHhhCC-CCCCEEECCCCcCe-
Confidence 3 444333 56777777777776665 4556667777777777777775555555555 47777777777776
Q ss_pred CCCccccCCCCCCEEEccCCcCccccchhhhc------CCCCCeEEcccCcCC--CCCCcccccccccceeeccccc
Q 005045 273 NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR------LNKLEGLGLNVNKFS--GLIPSSLGNLTILTRLWMEENR 341 (717)
Q Consensus 273 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 341 (717)
.+|..+..+++|+.|++++|++++..+..|.. ...|+.|++++|++. ++.|..|..+++|+.|+|++|+
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 56666777777777777777777655555554 356778888888877 6677778888888888888775
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.22 Aligned_cols=285 Identities=22% Similarity=0.231 Sum_probs=188.2
Q ss_pred ccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC--C
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL--E 460 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~ 460 (717)
.....++|++.+.||+|+||.||+|++. +|+.||+|++.... .......++++.++.++||||+++++++..... .
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4456789999999999999999999975 78999999875432 233566778888899999999999998755332 2
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCEEeCC-CC
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH--HHCDTPIAHCDLKPSNVLLDK-DM 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlkp~NIll~~-~~ 537 (717)
.....++||||+++ ++.+.+..... ....+++..+..++.|++.|+.||| +. +|+||||||+||+++. ++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYR---RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 23347899999975 55444321000 1156889999999999999999999 76 9999999999999996 89
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+||+|||.+...... .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||........
T Consensus 170 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~- 240 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPS--------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ- 240 (360)
T ss_dssp EEEECCCTTCBCCCTT--------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred cEEEeeCCCceecCCC--------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-
Confidence 9999999999865211 11233568999999999644 3 79999999999999999999999976432211
Q ss_pred hhHHHHh--cCChhhhhhcCCCCCCCCCC--cHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 616 IHMFVSM--ALPDHVMDILDPSMPLDEEN--DEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 616 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
....... ..+......+++........ ....... . -.....+++..+.+++.+||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~--~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN-------------V--FSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHH-------------H--TTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCccc-------------c--cchhhccccHHHHHHHHHHhccCccc
Confidence 1111111 11111212222111100000 0000000 0 00011123667899999999999999
Q ss_pred CCCHHHHHH
Q 005045 692 RIAMNVVVN 700 (717)
Q Consensus 692 Rps~~eil~ 700 (717)
|||+.|+++
T Consensus 306 Rpt~~e~l~ 314 (360)
T 3e3p_A 306 RMKPYEALC 314 (360)
T ss_dssp SCCHHHHTT
T ss_pred cCCHHHHhc
Confidence 999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=328.67 Aligned_cols=211 Identities=21% Similarity=0.268 Sum_probs=155.3
Q ss_pred ccccccc-ccccCcccccceEEEEeC---CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSK-ENLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~-~~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..+.|++ .++||+|+||.||+|+++ +++.||+|++.... ....+.+|++++++++||||+++++++.. ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCC
Confidence 3456776 458999999999999954 68899999986443 23567889999999999999999998642 345
Q ss_pred ceEEEEEecCCCCChhhhccCCCCC--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----CCC
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAE--HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL----DKD 536 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~ 536 (717)
...++||||+. ++|.+++...... ......+++..++.++.||+.||+|||+. +|+||||||+||++ +.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 68999999996 5888777522100 00113589999999999999999999998 99999999999999 677
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
+.+||+|||.++...... ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TCEEECCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CcEEEEECCCceecCCCC----cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 899999999998752211 11122334678999999999755 38999999999999999999999997653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=329.05 Aligned_cols=272 Identities=22% Similarity=0.291 Sum_probs=193.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~~~ 464 (717)
...+|++.+.||+|+||.||+|++. +|+.||||++.... ....+|++++++++||||+++++++..... .+...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3457999999999999999999975 79999999886432 223469999999999999999988754321 22335
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-CceEEee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGD 543 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D 543 (717)
.++||||+++ ++.+.+..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeehhcccc-cHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence 7799999975 66665542100 115689999999999999999999997 99999999999999965 5789999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
||+++..... .......+|+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+ .+.....
T Consensus 201 FG~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~ 271 (420)
T 1j1b_A 201 FGSAKQLVRG--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIK 271 (420)
T ss_dssp CTTCEECCTT--------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred chhhhhcccC--------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999865211 11223568999999999754 48999999999999999999999997643221 1111111
Q ss_pred h-cCC--hhhhhhcCCCCC-----CCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 622 M-ALP--DHVMDILDPSMP-----LDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 622 ~-~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
. ..+ +.+..+ ++... ......... ......+..+.+|+.+||+.||++||
T Consensus 272 ~lg~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~---------------------~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 272 VLGTPTREQIREM-NPNYTEFKFPQIKAHPWTK---------------------VFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp HHCSCCHHHHHHH-CSCCCCCCCCCCCCCCHHH---------------------HSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCHHHHHhh-ChhhhhhccCccCCCCHHH---------------------hcCCCCCHHHHHHHHHhccCChhHCC
Confidence 1 111 112111 11110 000000000 00112245678999999999999999
Q ss_pred CHHHHHH
Q 005045 694 AMNVVVN 700 (717)
Q Consensus 694 s~~eil~ 700 (717)
|+.|+++
T Consensus 330 t~~e~l~ 336 (420)
T 1j1b_A 330 TPLEACA 336 (420)
T ss_dssp CHHHHHT
T ss_pred CHHHHhC
Confidence 9999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=320.75 Aligned_cols=283 Identities=18% Similarity=0.244 Sum_probs=202.6
Q ss_pred ccccccccccccCcccccceEEEEe-C-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCC------ceeEEEEeeccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-G-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHR------NILRVITACSSV 457 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~ 457 (717)
...++|++.+.||+|+||.||+|.+ + +++.||+|++.... .....+.+|+++++.+.|+ +++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-- 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-- 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE--
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc--
Confidence 4467999999999999999999986 3 78899999986432 3356778899999888655 4899999853
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-- 535 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-- 535 (717)
..+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 88 ---~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 88 ---HHGHICIVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSD 155 (339)
T ss_dssp ---ETTEEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCC
T ss_pred ---cCCcEEEEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccc
Confidence 445899999999 8899999875421 4688999999999999999999998 9999999999999987
Q ss_pred -----------------CCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHH
Q 005045 536 -----------------DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLL 597 (717)
Q Consensus 536 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ 597 (717)
++.+||+|||.+..... ......||+.|+|||++.+ .++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE----------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTS----------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcc----------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 66899999999875411 1123568999999999765 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCch-hhhHHHHhcCChhhhhhcCC-------CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhh
Q 005045 598 EMFTGKRPTGDMFKDDF-SIHMFVSMALPDHVMDILDP-------SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNK 669 (717)
Q Consensus 598 elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
||++|..||......+. .........++..+...... ...+.. ... ........ ..........
T Consensus 226 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~-----~~~~~~~~~~ 297 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE--HSS-AGRYVSRA-----CKPLKEFMLS 297 (339)
T ss_dssp HHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCT--TSH-HHHHHHHH-----CCCGGGGCSC
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccc--ccc-ccchhhhc-----Ccchhhhccc
Confidence 99999999976533221 11111122233222111110 000000 000 01000000 0000011112
Q ss_pred hHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 670 LEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
...++..+.+++.+||+.||++|||++|+++.
T Consensus 298 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred chhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 34557789999999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.54 Aligned_cols=209 Identities=30% Similarity=0.354 Sum_probs=169.6
Q ss_pred CCcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CC-----ceeEEE
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HR-----NILRVI 451 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni~~~~ 451 (717)
+.+.......++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+..|+++++.+. |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344555666889999999999999999999965 78899999987432 23466777888888774 44 499998
Q ss_pred EeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
+.+. ..+..++||||++ ++|.+++..... ..+++..+..++.||+.||.|||++ ..+|+||||||+||
T Consensus 123 ~~~~-----~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NI 190 (382)
T 2vx3_A 123 RHFM-----FRNHLCLVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI 190 (382)
T ss_dssp EEEE-----ETTEEEEEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGE
T ss_pred eeec-----cCCceEEEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccE
Confidence 8854 3458999999995 599999875421 4589999999999999999999952 23899999999999
Q ss_pred EeC--CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 532 LLD--KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 532 ll~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
+++ .++.+||+|||.++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 191 ll~~~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 191 LLCNPKRSAIKIVDFGSSCQLGQ----------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EESSTTSCCEEECCCTTCEETTC----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEecCCCCcEEEEeccCceeccc----------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 995 477899999999986521 1223568999999999665 589999999999999999999999986
Q ss_pred CC
Q 005045 609 MF 610 (717)
Q Consensus 609 ~~ 610 (717)
..
T Consensus 261 ~~ 262 (382)
T 2vx3_A 261 AN 262 (382)
T ss_dssp SS
T ss_pred CC
Confidence 53
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.62 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=190.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-------
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD------- 458 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------- 458 (717)
..++|++.+.||+|+||.||.|++. +++.||+|.+... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999965 8999999998643 234577889999999999999999999865421
Q ss_pred -CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 459 -LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 459 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
.......++||||+++++|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 123567899999999999999997432 4678899999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCC-------CCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNP-------SKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
.+||+|||.+.......... ...........|++.|+|||++.+ .++.++|||||||++|+|++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999997653211000 001122234568999999999754 48999999999999999998 5532
Q ss_pred CCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCC
Q 005045 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTS 688 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 688 (717)
.... ....... .. .....+.. ...+++..+.+++.+||+.|
T Consensus 231 ~~~~-~~~~~~~--------~~-~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~d 271 (303)
T 1zy4_A 231 GMER-VNILKKL--------RS-VSIEFPPD-----------------------------FDDNKMKVEKKIIRLLIDHD 271 (303)
T ss_dssp HHHH-HHHHHHH--------HS-TTCCCCTT-----------------------------CCTTTSHHHHHHHHHHTCSS
T ss_pred chhH-HHHHHhc--------cc-cccccCcc-----------------------------ccccchHHHHHHHHHHHhcC
Confidence 1100 0000000 00 00000000 01122456788999999999
Q ss_pred cCCCCCHHHHHH
Q 005045 689 PRERIAMNVVVN 700 (717)
Q Consensus 689 p~~Rps~~eil~ 700 (717)
|++|||+.|+++
T Consensus 272 p~~Rps~~~ll~ 283 (303)
T 1zy4_A 272 PNKRPGARTLLN 283 (303)
T ss_dssp GGGSCCHHHHHH
T ss_pred cccCcCHHHHhC
Confidence 999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.34 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=173.1
Q ss_pred cccccccccc-ccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKEN-LIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~-~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
...++|++.+ .||+|+||.||+|.++ +++.||+|++.... ....+....++.+.||||+++++++.... ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence 4567899965 6999999999999976 79999999986432 11122333456679999999999875432 2345
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 540 (717)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEE
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEE
Confidence 68999999999999999986532 4689999999999999999999998 9999999999999986 45699
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||.+..... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||...........
T Consensus 172 l~Dfg~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-- 240 (336)
T 3fhr_A 172 LTDFGFAKETTQ---------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-- 240 (336)
T ss_dssp ECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred Eeccccceeccc---------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--
Confidence 999999975421 11223557999999999755 478999999999999999999999965433211000
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
....+ ........ ......++..+.+++.+||+.+|++|||++|++
T Consensus 241 ~~~~~-------~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 241 MKRRI-------RLGQYGFP---------------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp -----------------CCC---------------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhh-------hccccccC---------------------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 00000000 000112355678999999999999999999999
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 287 ~h 288 (336)
T 3fhr_A 287 NH 288 (336)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.72 Aligned_cols=276 Identities=20% Similarity=0.233 Sum_probs=196.3
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC-CCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL-EGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~~ 462 (717)
..++|.+.+.||+|+||.||.|.++ +|+.||+|++... .....+.+.+|+.++++++||||+++++++..... ...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3578999999999999999999965 7999999998643 23345778899999999999999999998654321 111
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...++||||++ ++|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEEC
T ss_pred eeEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEe
Confidence 24599999996 68888774 3489999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|||.+..... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||......+. .....
T Consensus 169 Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~ 237 (353)
T 3coi_A 169 DFGLARHADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL 237 (353)
T ss_dssp STTCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHH
T ss_pred ecccccCCCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 9999876411 1223568999999999655 579999999999999999999999976432211 11111
Q ss_pred H--hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 621 S--MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 621 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
. ...+..+...+.. ......... ........-......++..+.+++.+||+.||++|||++|+
T Consensus 238 ~~~~~~~~~~~~~~~~----------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 238 KVTGVPGTEFVQKLND----------KAAKSYIQS----LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp HHHCBCCHHHHTTCSC----------HHHHHHHHT----SCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHhCCCCHHHHHHHhh----------HHHHHHHHh----CcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 1 0111111111000 000000000 00000000001112346678999999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 304 l~ 305 (353)
T 3coi_A 304 LT 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 85
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.71 Aligned_cols=289 Identities=20% Similarity=0.276 Sum_probs=177.8
Q ss_pred CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEecc
Q 005045 35 ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 114 (717)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555555 3444332 345555555555554444445555555555555555554445555555555555555
Q ss_pred CCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc--cCCccCCCCCCCCEEeccCcccc
Q 005045 115 GNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG--SIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 115 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
+|.++. +|..+. ++|++|++++|.++ .++...+..+++|+.|++++|.+.. ..+..+.++++|++|++++|.++
T Consensus 109 ~n~l~~-l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 109 KNQLKE-LPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SSCCSB-CCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCcCCc-cChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 555552 232222 45555555555555 4444444455555555555555542 45556667777777777777777
Q ss_pred ccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCC
Q 005045 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG 272 (717)
Q Consensus 193 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~ 272 (717)
.+|..+. ++|++|++++|.++.+. +..+.++++|+.|+|++|.+++..+..+..+ ++|++|++++|.++
T Consensus 185 -~l~~~~~--~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~- 253 (330)
T 1xku_A 185 -TIPQGLP--PSLTELHLDGNKITKVD------AASLKGLNNLAKLGLSFNSISAVDNGSLANT-PHLRELHLNNNKLV- 253 (330)
T ss_dssp -SCCSSCC--TTCSEEECTTSCCCEEC------TGGGTTCTTCCEEECCSSCCCEECTTTGGGS-TTCCEEECCSSCCS-
T ss_pred -cCCcccc--ccCCEEECCCCcCCccC------HHHhcCCCCCCEEECCCCcCceeChhhccCC-CCCCEEECCCCcCc-
Confidence 3444333 67777777777777665 4566777777777777777775555556655 47777777777777
Q ss_pred CCCccccCCCCCCEEEccCCcCccccchhhhc------CCCCCeEEcccCcCCC--CCCcccccccccceeeccccc
Q 005045 273 NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGR------LNKLEGLGLNVNKFSG--LIPSSLGNLTILTRLWMEENR 341 (717)
Q Consensus 273 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 341 (717)
.+|..+..+++|++|+|++|+|++..+..|.. .+.|+.|++++|++.. +.|..|..+..|+.++|++|+
T Consensus 254 ~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 56777777888888888888888666665643 3677888888888763 567788888888888888885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=317.16 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=193.3
Q ss_pred CcccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhh------HHHHHHHHHHHHhcCC--CCceeEE
Q 005045 380 SYSDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQG------ALKSFIDECNALKSTR--HRNILRV 450 (717)
Q Consensus 380 s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~ni~~~ 450 (717)
+..+.....++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++++. |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 34445566889999999999999999999954 7899999998754321 2245667999999995 5999999
Q ss_pred EEeeccccCCCCceEEEEEecCCC-CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005045 451 ITACSSVDLEGNDFKALVFEFMSN-GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPS 529 (717)
Q Consensus 451 ~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 529 (717)
++++. ..+..++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+
T Consensus 114 ~~~~~-----~~~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~ 178 (320)
T 3a99_A 114 LDWFE-----RPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDE 178 (320)
T ss_dssp EEEEE-----CSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred EEEEe-----cCCcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHH
Confidence 99954 45589999999975 8999998743 5689999999999999999999997 9999999999
Q ss_pred CEEeC-CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCC
Q 005045 530 NVLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 530 NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~ 606 (717)
||+++ .++.+||+|||.+..... .......|++.|+|||++.+ . .+.++|||||||++|+|++|..||
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKD---------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCS---------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred HEEEeCCCCCEEEeeCcccccccc---------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 99999 789999999999886521 11223568999999999654 3 368899999999999999999999
Q ss_pred CCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCC
Q 005045 607 GDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 686 (717)
.... ..... ..... ..++..+.+++.+||+
T Consensus 250 ~~~~-------~~~~~------------~~~~~-------------------------------~~~~~~~~~li~~~l~ 279 (320)
T 3a99_A 250 EHDE-------EIIRG------------QVFFR-------------------------------QRVSSECQHLIRWCLA 279 (320)
T ss_dssp CSHH-------HHHHC------------CCCCS-------------------------------SCCCHHHHHHHHHHTC
T ss_pred CChh-------hhhcc------------ccccc-------------------------------ccCCHHHHHHHHHHcc
Confidence 5421 00000 00000 0114567889999999
Q ss_pred CCcCCCCCHHHHHH
Q 005045 687 TSPRERIAMNVVVN 700 (717)
Q Consensus 687 ~~p~~Rps~~eil~ 700 (717)
.+|++|||++||++
T Consensus 280 ~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 280 LRPSDRPTFEEIQN 293 (320)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.66 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=183.9
Q ss_pred ccccccccc-ccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeecccc
Q 005045 381 YSDISKSTD-NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVD 458 (717)
Q Consensus 381 ~~~~~~~~~-~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 458 (717)
+.++....+ .|.+.+.||+|+||.||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++.+
T Consensus 6 ~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~---- 78 (434)
T 2rio_A 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE---- 78 (434)
T ss_dssp --CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEE----
T ss_pred ccchhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE----
Confidence 334444444 455568899999999987766689999999886432 34567899999876 899999999884
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-- 536 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-- 536 (717)
.+.+..++||||+. ++|.+++.............++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 79 -~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ 153 (434)
T 2rio_A 79 -TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSR 153 (434)
T ss_dssp -ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHH
T ss_pred -ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcc
Confidence 44568999999995 699999976532111111123445678999999999999998 99999999999999754
Q ss_pred -----------CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--------CCCcccchhhHHHHHH
Q 005045 537 -----------MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--------QVSILGDIYSYGILLL 597 (717)
Q Consensus 537 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~sDvwslG~vl~ 597 (717)
+.+||+|||.+........ ..........||+.|+|||++.+ .++.++|||||||++|
T Consensus 154 ~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ 230 (434)
T 2rio_A 154 FTADQQTGAENLRILISDFGLCKKLDSGQS---SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230 (434)
T ss_dssp HHSCCTTCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred cccccccCCCceEEEEcccccceecCCCCc---cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence 4899999999987522111 00111234569999999999643 4789999999999999
Q ss_pred HHHh-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHH
Q 005045 598 EMFT-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676 (717)
Q Consensus 598 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (717)
||++ |..||........ .... .......... .....++..
T Consensus 231 ellt~g~~Pf~~~~~~~~---~i~~--------~~~~~~~~~~----------------------------~~~~~~~~~ 271 (434)
T 2rio_A 231 YILSKGKHPFGDKYSRES---NIIR--------GIFSLDEMKC----------------------------LHDRSLIAE 271 (434)
T ss_dssp HHHTTSCCTTCSTTTHHH---HHHH--------TCCCCCCCTT----------------------------CCCHHHHHH
T ss_pred HHHhCCCCCCCCchhhHH---HHhc--------CCCCcccccc----------------------------cccccchHH
Confidence 9999 9999965422211 0110 0000000000 011234667
Q ss_pred HHHHhhccCCCCcCCCCCHHHHHH
Q 005045 677 VLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 677 l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+.+++.+||+.+|++|||+.||++
T Consensus 272 ~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 272 ATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhhCChhhCCCHHHHHh
Confidence 889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.84 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=177.8
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHH-HHhcCCCCceeEEEEeeccccC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECN-ALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
.+....++|++.+.||+|+||.||+|.++ +|+.||+|++.... ......+..|+. +++.++||||+++++++.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~---- 91 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF---- 91 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE----
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE----
Confidence 34455789999999999999999999975 79999999986542 223344555555 777789999999999964
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
..+..++||||+++ +|.+++...... ....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+
T Consensus 92 -~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 92 -REGDCWICMELMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp -CSSEEEEEECCCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEE
T ss_pred -eCCceEEEEeecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCE
Confidence 34589999999974 887776521000 015689999999999999999999995 289999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-----GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
||+|||.+...... .......|++.|+|||++. +.++.++|||||||++|+|++|..||........
T Consensus 166 kl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (327)
T 3aln_A 166 KLCDFGISGQLVDS--------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237 (327)
T ss_dssp EECCCSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred EEccCCCceecccc--------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH
Confidence 99999999765211 1122335899999999973 2478999999999999999999999976422111
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
. +..+.......... .....++..+.+++.+||+.+|++|||
T Consensus 238 ~------------~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps 279 (327)
T 3aln_A 238 Q------------LTQVVKGDPPQLSN--------------------------SEEREFSPSFINFVNLCLTKDESKRPK 279 (327)
T ss_dssp --------------CCCCCSCCCCCCC--------------------------CSSCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred H------------HHHHhcCCCCCCCC--------------------------cccccCCHHHHHHHHHHhhCChhhCcC
Confidence 0 00111100000000 000112556889999999999999999
Q ss_pred HHHHHHH
Q 005045 695 MNVVVNN 701 (717)
Q Consensus 695 ~~eil~~ 701 (717)
+.|+++.
T Consensus 280 ~~ell~h 286 (327)
T 3aln_A 280 YKELLKH 286 (327)
T ss_dssp HHHHTTS
T ss_pred HHHHHhC
Confidence 9999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=310.78 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=181.8
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
.......++|++.+.||+|+||.||+|.++ +|+.||+|++.... ....+.+.++..+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--- 94 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--- 94 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe---
Confidence 344566789999999999999999999975 79999999986542 223344555666788889999999999954
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEeCCCC
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~ 537 (717)
..+..++||||+ ++.+..+..... ..+++..+..++.||+.||+|||+ . +++||||||+||+++.++
T Consensus 95 --~~~~~~lv~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~ 162 (318)
T 2dyl_A 95 --TNTDVFIAMELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERG 162 (318)
T ss_dssp --CSSEEEEEECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTS
T ss_pred --cCCcEEEEEecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCC
Confidence 345899999999 555655544211 568999999999999999999998 4 899999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
.+||+|||.+...... .......+++.|+|||++. +.++.++|||||||++|+|++|..||.....
T Consensus 163 ~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 163 QIKLCDFGISGRLVDD--------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp CEEECCCTTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CEEEEECCCchhccCC--------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 9999999998765211 1122346899999999973 2478999999999999999999999975422
Q ss_pred CchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRE 691 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 691 (717)
........... . .+..+. ...++..+.+++.+||+.+|++
T Consensus 235 ~~~~~~~~~~~-~--------~~~~~~-------------------------------~~~~~~~l~~li~~~l~~dp~~ 274 (318)
T 2dyl_A 235 DFEVLTKVLQE-E--------PPLLPG-------------------------------HMGFSGDFQSFVKDCLTKDHRK 274 (318)
T ss_dssp HHHHHHHHHHS-C--------CCCCCS-------------------------------SSCCCHHHHHHHHHHTCSCTTT
T ss_pred cHHHHHHHhcc-C--------CCCCCc-------------------------------cCCCCHHHHHHHHHHccCChhH
Confidence 21111111110 0 000100 0112456789999999999999
Q ss_pred CCCHHHHHHH
Q 005045 692 RIAMNVVVNN 701 (717)
Q Consensus 692 Rps~~eil~~ 701 (717)
|||++|+++.
T Consensus 275 Rps~~~ll~h 284 (318)
T 2dyl_A 275 RPKYNKLLEH 284 (318)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhhC
Confidence 9999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.19 Aligned_cols=281 Identities=23% Similarity=0.291 Sum_probs=199.2
Q ss_pred ccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 44579999999999999999999964 7999999998653 3445677899999999999999999999865422 2336
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc---e
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT---A 539 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~ 539 (717)
+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++. +
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEE
T ss_pred CeEEEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeE
Confidence 678999999999999999976431 13588889999999999999999998 9999999999999997764 9
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
||+|||.+...... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||...... ..
T Consensus 164 KL~DFG~a~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~ 231 (676)
T 3qa8_A 164 KIIDLGYAKELDQG--------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQ 231 (676)
T ss_dssp EECSCCCCCBTTSC--------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HH
T ss_pred EEcccccccccccc--------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hh
Confidence 99999999865211 11233568999999999765 5899999999999999999999999653111 11
Q ss_pred HHHhcCChh-----hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 619 FVSMALPDH-----VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 619 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
+........ ..+............ ..........+..+.+++.+||++||++||
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~l---------------------p~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVL---------------------PTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSS---------------------CCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred hhhhhhcccchhhhhhhhhcccccccccc---------------------CCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 100000000 000000000000000 000011223467789999999999999999
Q ss_pred CHHH-----HHHHHHHHH
Q 005045 694 AMNV-----VVNNLKTIR 706 (717)
Q Consensus 694 s~~e-----il~~l~~i~ 706 (717)
|++| +.+.++.+.
T Consensus 291 Ta~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 291 TDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCTTCCCCTTHHHHHHHH
T ss_pred CHHHHhcCHHHHHHHHHH
Confidence 9988 455555554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=314.14 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=186.0
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh------hHHHHHHHHHHHHhcC----CCCceeEEE
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ------GALKSFIDECNALKST----RHRNILRVI 451 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~ni~~~~ 451 (717)
+.....++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556789999999999999999999964 788999999864421 1234456788988888 899999999
Q ss_pred EeeccccCCCCceEEEEEec-CCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 005045 452 TACSSVDLEGNDFKALVFEF-MSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSN 530 (717)
Q Consensus 452 ~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 530 (717)
+++ ...+..++|||+ +.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|
T Consensus 105 ~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 169 (312)
T 2iwi_A 105 DWF-----ETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDEN 169 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGG
T ss_pred EEE-----ecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhh
Confidence 984 445578999999 7899999999753 4689999999999999999999998 99999999999
Q ss_pred EEeC-CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CC-CcccchhhHHHHHHHHHhCCCCCC
Q 005045 531 VLLD-KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QV-SILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 531 Ill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~-~~~sDvwslG~vl~elltg~~p~~ 607 (717)
|+++ .++.+||+|||.+..... .......|+..|+|||++.+ .+ +.++|||||||++|+|++|..||.
T Consensus 170 il~~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 170 ILIDLRRGCAKLIDFGSGALLHD---------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EEEETTTTEEEECCCSSCEECCS---------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEeCCCCeEEEEEcchhhhccc---------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 9999 889999999999886521 11233558999999999644 33 568999999999999999999995
Q ss_pred CCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCC
Q 005045 608 DMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 687 (717)
... ... ...... +..++..+.+++.+||+.
T Consensus 241 ~~~-------~~~------------~~~~~~-------------------------------~~~~~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 241 RDQ-------EIL------------EAELHF-------------------------------PAHVSPDCCALIRRCLAP 270 (312)
T ss_dssp SHH-------HHH------------HTCCCC-------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred ChH-------HHh------------hhccCC-------------------------------cccCCHHHHHHHHHHccC
Confidence 420 000 000000 011245678899999999
Q ss_pred CcCCCCCHHHHHH
Q 005045 688 SPRERIAMNVVVN 700 (717)
Q Consensus 688 ~p~~Rps~~eil~ 700 (717)
+|++|||++|+++
T Consensus 271 ~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 271 KPSSRPSLEEILL 283 (312)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.13 Aligned_cols=235 Identities=13% Similarity=0.081 Sum_probs=183.9
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----EC
Confidence 4578999999999999999999975 69999999997542 344578899999999999999999999954 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..|+||||++|++|.++++.. ....++..++.||+.||+|||+. ||+||||||+||+++.+|.+||+
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS---------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred CcEEEEEEecCCCCHHHHHhcC---------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence 5899999999999999999632 35557889999999999999998 99999999999999999999998
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
+++ |++ .++.++|||||||++|+|++|+.||...........
T Consensus 172 ~~~---------------------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----- 213 (286)
T 3uqc_A 172 YPA---------------------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----- 213 (286)
T ss_dssp SCC---------------------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----
T ss_pred ecc---------------------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----
Confidence 543 222 257899999999999999999999986543221000
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNL 702 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l 702 (717)
....+..... . . .....+++..+.+++.+||+.||++| |+.|+++.|
T Consensus 214 -----~~~~~~~~~~-~----~----------------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 214 -----AERDTAGQPI-E----P----------------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp -----CCBCTTSCBC-C----H----------------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred -----HHHHhccCCC-C----h----------------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 0000000000 0 0 00112235678899999999999999 999999999
Q ss_pred HHHHHHH
Q 005045 703 KTIRNCF 709 (717)
Q Consensus 703 ~~i~~~~ 709 (717)
+++....
T Consensus 261 ~~~~~~~ 267 (286)
T 3uqc_A 261 QQATAVA 267 (286)
T ss_dssp HHHHC--
T ss_pred HHHhccC
Confidence 9987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.49 Aligned_cols=283 Identities=20% Similarity=0.263 Sum_probs=198.7
Q ss_pred cccccccccccccCcccccceEEEEeC-CC-chhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCc------eeEEEEeecc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DG-TIVAIKVLKLQQQGALKSFIDECNALKSTRHRN------ILRVITACSS 456 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~~ 456 (717)
....++|++.+.||+|+||.||+|.+. ++ +.||+|++.... .....+.+|+++++++.|++ ++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-- 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-- 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE--
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee--
Confidence 344689999999999999999999964 44 689999986432 33467788999999887665 88888874
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL--- 533 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll--- 533 (717)
...+..++||||+ ++++.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++
T Consensus 92 ---~~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 92 ---NFHGHMCIAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp ---EETTEEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred ---eeCCeEEEEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 3445899999999 6677777654321 4689999999999999999999997 99999999999999
Q ss_pred ----------------CCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHH
Q 005045 534 ----------------DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILL 596 (717)
Q Consensus 534 ----------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl 596 (717)
+.++.+||+|||.+..... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE----------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCccccccc----------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 5678999999999975411 1123568999999999654 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCch-hhhHHHHhcCChhhhhhcC-------CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchh
Q 005045 597 LEMFTGKRPTGDMFKDDF-SIHMFVSMALPDHVMDILD-------PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKN 668 (717)
Q Consensus 597 ~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
|+|++|..||........ .........+|..+..... ......... .......+.. ........
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~ 301 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS---SDGRYVKENC-----KPLKSYML 301 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTS---HHHHHHHHHC-----CCGGGGCS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccccccc---chhccccccC-----Cccccccc
Confidence 999999999976533221 1111112223322211110 001111000 0000110000 00000111
Q ss_pred hhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 669 KLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....++..+.+++.+||+.||++|||++|+++
T Consensus 302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 22344668899999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.89 Aligned_cols=279 Identities=21% Similarity=0.286 Sum_probs=197.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-----------CCceeEEEEee
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-----------HRNILRVITAC 454 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~ 454 (717)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+++++++. |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3568999999999999999999964 89999999986432 23466788999988875 89999999986
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD 534 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 534 (717)
.... ......++|||++ +++|.+++..... ..+++..+..++.||+.||+|||+.+ +|+||||||+||+++
T Consensus 96 ~~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 96 NHKG-PNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLME 166 (373)
T ss_dssp EEEE-TTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEE
T ss_pred hccC-CCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEe
Confidence 5432 2334789999999 8999999875421 45899999999999999999999942 899999999999994
Q ss_pred ------CCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 535 ------KDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 535 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
..+.+||+|||.+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCCCcCcceEEEcccccccccCC----------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 445899999999976521 1123468999999999655 48999999999999999999999997
Q ss_pred CCCCCchh-----hhHHH--HhcCChhhh-------hhcCCC-----CCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchh
Q 005045 608 DMFKDDFS-----IHMFV--SMALPDHVM-------DILDPS-----MPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKN 668 (717)
Q Consensus 608 ~~~~~~~~-----~~~~~--~~~~~~~~~-------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (717)
........ ..... ...+|..+. .++... ........ ..++... ...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------------~~~ 301 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP---LEDVLTE------------KYK 301 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC---HHHHHHH------------TTC
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc---hhhhhhh------------ccc
Confidence 65432111 11100 111121110 000000 00000000 0001000 111
Q ss_pred hhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 669 KLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 669 ~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+..++..+.+++.+||+.||++|||++|+++
T Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 23556788999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.27 Aligned_cols=254 Identities=21% Similarity=0.309 Sum_probs=184.9
Q ss_pred cccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
.+.....+|.+.+.||+|+||.||.....+++.||||++..... ..+.+|+++++++ +||||+++++++. +
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~ 89 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----D 89 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----E
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----c
Confidence 34455668999999999999997765556899999998864322 3356799999999 8999999999853 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---C--
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---D-- 536 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~-- 536 (717)
....|+||||++ ++|.+++.... ...+...+..++.||+.||+|||+. +|+||||||+||+++. +
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~ 159 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGK 159 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTB
T ss_pred CCEEEEEEECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCc
Confidence 558999999995 69999987553 2334445678999999999999998 9999999999999953 2
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFT-GKRPTGDMFK 611 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 611 (717)
..+||+|||++....... ..........||+.|+|||++.+ .++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~kL~DFG~a~~~~~~~----~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 160 IKAMISDFGLCKKLAVGR----HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp CCEEECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred eeEEEecccceeeccCCC----cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 368899999998652211 11122334669999999999753 46789999999999999999 9999854322
Q ss_pred CchhhhHHHHhcCChhhhhhcCC-CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 612 DDFSIHMFVSMALPDHVMDILDP-SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
... .. .... ...... ........+.+++.+||+.+|+
T Consensus 236 ~~~---~~-----------~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~L~~dP~ 273 (432)
T 3p23_A 236 RQA---NI-----------LLGACSLDCLH----------------------------PEKHEDVIARELIEKMIAMDPQ 273 (432)
T ss_dssp HHH---HH-----------HTTCCCCTTSC----------------------------TTCHHHHHHHHHHHHHSCSSGG
T ss_pred HHH---HH-----------HhccCCccccC----------------------------ccccccHHHHHHHHHHHhCCHh
Confidence 110 00 0000 000000 0111244567899999999999
Q ss_pred CCCCHHHHHH
Q 005045 691 ERIAMNVVVN 700 (717)
Q Consensus 691 ~Rps~~eil~ 700 (717)
+|||+.||++
T Consensus 274 ~Rps~~evl~ 283 (432)
T 3p23_A 274 KRPSAKHVLK 283 (432)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHHh
Confidence 9999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=334.16 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=198.5
Q ss_pred cccccccccccCcccccceEEEEeC--CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG--DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|++.++||+|+||.||+|.+. +++.||+|++... .......+.+|++++++++||||+++++++.........
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4589999999999999999999965 6899999988643 334567788999999999999999999997654422222
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||++|++|.+++. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.+ .+||+|
T Consensus 158 ~~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp EEEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECC
T ss_pred eeEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEe
Confidence 3799999999999988775 3589999999999999999999998 99999999999999875 999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
||.+...... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.......
T Consensus 225 FG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------- 283 (681)
T 2pzi_A 225 LGAVSRINSF-----------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------- 283 (681)
T ss_dssp CTTCEETTCC-----------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------
T ss_pred cccchhcccC-----------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc----------
Confidence 9999865211 3356899999999987777999999999999999999998876421110
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-CHHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-AMNVVVNNL 702 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~eil~~l 702 (717)
+.... .....+..+.+++.+||+.+|++|| +++++.+.+
T Consensus 284 ------------~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 284 ------------LPEDD----------------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp ------------CCTTC----------------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred ------------ccccc----------------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 00000 0111245678999999999999999 677788888
Q ss_pred HHHHHHHH
Q 005045 703 KTIRNCFL 710 (717)
Q Consensus 703 ~~i~~~~~ 710 (717)
..+..+..
T Consensus 324 ~~~~~~~~ 331 (681)
T 2pzi_A 324 TGVLREVV 331 (681)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 87765543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.05 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=188.7
Q ss_pred CCCCEEeccCCcCcc--cCChhhhccCCCCeEeccC-CCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcc
Q 005045 82 SSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYG-NFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLK 158 (717)
Q Consensus 82 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~ 158 (717)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+..|..|.++++|++|+|++|.+++.+|..+. .+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-QIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG-GCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHh-CCCCCC
Confidence 468888888888887 7788888888888888884 888777888888888888888888887755444332 444555
Q ss_pred eeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCC-CCCE
Q 005045 159 IFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT-SLEV 237 (717)
Q Consensus 159 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~-~L~~ 237 (717)
+|++++|.+.+.+|..+..+++|++|++++|++++.+| ..+..++ .|++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------------------~~l~~l~~~L~~ 178 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP------------------------------DSYGSFSKLFTS 178 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC------------------------------GGGGCCCTTCCE
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCC------------------------------HHHhhhhhcCcE
Confidence 55555555444444444444444444444444443333 3455555 6777
Q ss_pred EEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCc
Q 005045 238 LGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNK 317 (717)
Q Consensus 238 L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 317 (717)
|++++|.+++.+|..+..+ .|+.|++++|.+++..|..|..+++|+.|+|++|++++..|. +..+++|++|+|++|+
T Consensus 179 L~L~~N~l~~~~~~~~~~l--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 255 (313)
T 1ogq_A 179 MTISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNR 255 (313)
T ss_dssp EECCSSEEEEECCGGGGGC--CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSC
T ss_pred EECcCCeeeccCChHHhCC--cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCc
Confidence 7777777777777777776 388888888888878888888899999999999999865555 7888999999999999
Q ss_pred CCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeeccc-CCCC
Q 005045 318 FSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND-LNGT 369 (717)
Q Consensus 318 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~ 369 (717)
+++..|..|..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+ ++|.
T Consensus 256 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred ccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 98888999999999999999999999888886 888999999999998 6653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=308.84 Aligned_cols=263 Identities=16% Similarity=0.175 Sum_probs=185.8
Q ss_pred cccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCCC-Cce----------
Q 005045 383 DISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTRH-RNI---------- 447 (717)
Q Consensus 383 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni---------- 447 (717)
++......|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.+.| ++.
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 45556677999999999999999999954 89999999887332 2235778999999999977 211
Q ss_pred -----eE------EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhc
Q 005045 448 -----LR------VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH 516 (717)
Q Consensus 448 -----~~------~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 516 (717)
+. ++..............+++|+++ +++|.+++............+++..+..++.||+.||+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 11110000000122467888876 6899988841100000115688889999999999999999998
Q ss_pred CCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc----------CCC-CCc
Q 005045 517 CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM----------NGQ-VSI 585 (717)
Q Consensus 517 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~-~~~ 585 (717)
+|+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++ .+. ++.
T Consensus 231 ---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 296 (413)
T 3dzo_A 231 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF 296 (413)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred ---CcccCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCc
Confidence 999999999999999999999999999876421 1233456 899999997 332 788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhc
Q 005045 586 LGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVN 665 (717)
Q Consensus 586 ~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (717)
++|||||||++|||++|+.||........ ...++....
T Consensus 297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~~~~----------------------------- 334 (413)
T 3dzo_A 297 AFDTWTLGLAIYWIWCADLPNTDDAALGG-------------SEWIFRSCK----------------------------- 334 (413)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGSSCC-----------------------------
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHhhcc-----------------------------
Confidence 99999999999999999999975432110 001111000
Q ss_pred chhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH--HHHHHHH
Q 005045 666 TKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN--LKTIRNC 708 (717)
Q Consensus 666 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~--l~~i~~~ 708 (717)
.++..+.+++.+||+.+|++|||+.|+++. ++.+++.
T Consensus 335 ------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 335 ------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp ------CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred ------cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 114567899999999999999999988754 4444433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.26 Aligned_cols=357 Identities=17% Similarity=0.177 Sum_probs=282.3
Q ss_pred eecEEEcCCCcCcCCCCcC-CcCCCCCCEEECCCCcccc----cCCcCCCCCCCCCEEEccCccccccCCccc-cCCC--
Q 005045 11 MTQDLNLTYNYLSGKIPTN-LSHCTELRSFEASVNDFVG----QIPNQLSSLTKLEIIGLGGSNLTGNVPAWI-GNFS-- 82 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~-- 82 (717)
.+++|+|++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+ ..+.
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 6789999999998554433 8889999999999999884 356678888999999999999986544443 3455
Q ss_pred --CCCEEeccCCcCcc----cCChhhhccCCCCeEeccCCCCCCCCCcccc-----CCCCccEEEcccCcccccCC---c
Q 005045 83 --SLKALSLAWNNLRG----SIPNELGQLSGLGFFTLYGNFISGIIPSSIY-----NISSIYYFSVTQNQLHGQLP---T 148 (717)
Q Consensus 83 --~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~l~---~ 148 (717)
+|++|+|++|+|+. .++..|..+++|++|+|++|.++...+..+. .+++|++|+|++|.+++... .
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 69999999999984 4588899999999999999999754444333 36689999999999984322 2
Q ss_pred ccccCCCCcceeecccccccccCCccCC-----CCCCCCEEeccCcccccc----CCCCccCCCCCCeeeccccccCCcc
Q 005045 149 DVGLTLPNLKIFAGAVNYFTGSIPVSLS-----NASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSRE 219 (717)
Q Consensus 149 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~ 219 (717)
..+..+++|+.|++++|.+....+..+. ..++|++|++++|.++.. ++..+..+++|++|++++|.++..+
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 2234679999999999998865554443 367999999999999863 4667778999999999999988754
Q ss_pred cCchhhhhhhccCCCCCEEEeecCcccCc----CchhhhhccccccEEecCCCccCCCCCccccC-----CCCCCEEEcc
Q 005045 220 IGDLNFLKFLANCTSLEVLGLARNSFGGE----MPISIANLSTHLRRLTMGENLMHGNIPVGIGN-----LVNLNLLGLE 290 (717)
Q Consensus 220 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~ 290 (717)
...+. +..+..+++|++|++++|.+++. ++..+... ++|++|++++|.+.+..+..+.. .++|+.|+|+
T Consensus 244 ~~~l~-~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 244 MAELC-PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK-ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHH-HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC-TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHH-HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC-CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 32221 22334689999999999999954 56666666 58999999999987554444433 3799999999
Q ss_pred CCcCccc----cchhhhcCCCCCeEEcccCcCCCCCCccccc-----ccccceeecccccccc----cCCcCccCcCCCc
Q 005045 291 GNNLSGS----VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGN-----LTILTRLWMEENRLEG----SIPPSLGNCQKLL 357 (717)
Q Consensus 291 ~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~ 357 (717)
+|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 9999865 4667778899999999999998765555553 5799999999999986 6888888999999
Q ss_pred eEEeecccCCCC
Q 005045 358 VLNLSSNDLNGT 369 (717)
Q Consensus 358 ~L~l~~N~l~~~ 369 (717)
+|++++|++++.
T Consensus 402 ~L~l~~N~i~~~ 413 (461)
T 1z7x_W 402 ELDLSNNCLGDA 413 (461)
T ss_dssp EEECCSSSCCHH
T ss_pred EEECCCCCCCHH
Confidence 999999999843
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.91 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=206.1
Q ss_pred CCCCEEEccCccccc--cCCccccCCCCCCEEeccC-CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccE
Q 005045 58 TKLEIIGLGGSNLTG--NVPAWIGNFSSLKALSLAW-NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 58 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 134 (717)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++..|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999998 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCC-CCCEEeccCccccccCCCCccCCCCCCeeecccc
Q 005045 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS-NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQN 213 (717)
Q Consensus 135 L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 213 (717)
|+|++|.+++.+|..+. .+++|++|++++|.+++.+|..+..++ +|++|++++|++++..|..|..++ |+.|++++|
T Consensus 130 L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHh-cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 99999999977776654 899999999999999999999999998 999999999999988888777776 777777777
Q ss_pred ccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCc
Q 005045 214 ELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293 (717)
Q Consensus 214 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 293 (717)
.++... +..+..+++|+.|+|++|.+++.+| . +..+++|++|+|++|+
T Consensus 208 ~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~-------------------------~-~~~l~~L~~L~Ls~N~ 255 (313)
T 1ogq_A 208 MLEGDA------SVLFGSDKNTQKIHLAKNSLAFDLG-------------------------K-VGLSKNLNGLDLRNNR 255 (313)
T ss_dssp EEEECC------GGGCCTTSCCSEEECCSSEECCBGG-------------------------G-CCCCTTCCEEECCSSC
T ss_pred cccCcC------CHHHhcCCCCCEEECCCCceeeecC-------------------------c-ccccCCCCEEECcCCc
Confidence 776554 4556666666666666666653322 2 4456677777777777
Q ss_pred CccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccc
Q 005045 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENR 341 (717)
Q Consensus 294 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 341 (717)
+++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 256 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 77677777777777777777777777666665 677777777777777
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=294.45 Aligned_cols=237 Identities=20% Similarity=0.275 Sum_probs=179.0
Q ss_pred cccccccc-cccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHH-hcCCCCceeEEEEeeccccCCCCc
Q 005045 387 STDNFSKE-NLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNAL-KSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 387 ~~~~y~~~-~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..++|.+. +.||+|+||.||.|.+. +++.||+|++... ..+.+|+.++ +...||||+++++++... .....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCc
Confidence 44677777 78999999999999964 7899999998532 4566788887 556999999999986542 23356
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceE
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAH 540 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 540 (717)
..++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred eEEEEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEE
Confidence 78999999999999999975421 4689999999999999999999998 9999999999999997 78999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
|+|||.+.... ...++.++|||||||++|+|++|..||..........
T Consensus 161 l~Dfg~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---- 208 (299)
T 3m2w_A 161 LTDFGFAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---- 208 (299)
T ss_dssp ECCCTTCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----
T ss_pred Eeccccccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----
Confidence 99999886430 1346789999999999999999999996543221100
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ...+........ ......++..+.+++.+||+.+|++|||+.|+++
T Consensus 209 --~~---~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 --GM---KTRIRMGQYEFP---------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --CS---CCSSCTTCCSSC---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HH---HHHHhhccccCC---------------------------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 000000000000 0011223567889999999999999999999986
Q ss_pred H
Q 005045 701 N 701 (717)
Q Consensus 701 ~ 701 (717)
.
T Consensus 257 h 257 (299)
T 3m2w_A 257 H 257 (299)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.02 Aligned_cols=197 Identities=20% Similarity=0.203 Sum_probs=161.6
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhh--------hhHHHHHHHHHHHHhcCC---------CCceeE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--------QGALKSFIDECNALKSTR---------HRNILR 449 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~ni~~ 449 (717)
..++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+.+.+|++++++++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999998 68999999997542 223467888999988885 777777
Q ss_pred EEEeecccc-------------------------CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHH
Q 005045 450 VITACSSVD-------------------------LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504 (717)
Q Consensus 450 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 504 (717)
+.+.+.... +.+.+..|+||||+++|++.+.+.+ ..+++..++.++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILH 168 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHH
Confidence 776532110 1125689999999999977666643 3579999999999
Q ss_pred HHHHHHHHHH-hcCCCCeeecCCCCCCEEeCCCC--------------------ceEEeeeccchhcccccCCCCCCcce
Q 005045 505 DVASALDYLH-HHCDTPIAHCDLKPSNVLLDKDM--------------------TAHVGDFGLAKFLFEISDNPSKNQTV 563 (717)
Q Consensus 505 ~i~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~ 563 (717)
||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------- 234 (336)
T 2vuw_A 169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------- 234 (336)
T ss_dssp HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------
T ss_pred HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------
Confidence 9999999999 87 999999999999999887 999999999986521
Q ss_pred eecccccccccCCCccCCCCCcccchhhHHHH-HHHHHhCCCCCC
Q 005045 564 SIGLKGSIGYIPPEHMNGQVSILGDIYSYGIL-LLEMFTGKRPTG 607 (717)
Q Consensus 564 ~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~v-l~elltg~~p~~ 607 (717)
....||+.|+|||++.|..+.++||||+|++ .+++++|..||.
T Consensus 235 -~~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred -CcEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCc
Confidence 1246899999999998888999999998877 777888999873
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-32 Score=285.65 Aligned_cols=279 Identities=17% Similarity=0.221 Sum_probs=169.1
Q ss_pred CcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCC
Q 005045 30 LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109 (717)
Q Consensus 30 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 109 (717)
-..|+.....++++|.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|+
T Consensus 27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103 (353)
T ss_dssp CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence 445566667788888877 6666554 3788888888888765555777788888888888888776677777788888
Q ss_pred eEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCc-ccccCCCCcceeecccc-cccccCCccCCCCCCCCEEecc
Q 005045 110 FFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT-DVGLTLPNLKIFAGAVN-YFTGSIPVSLSNASNLQVLDFA 187 (717)
Q Consensus 110 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~-~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~ 187 (717)
+|+|++|+++++.+..|.++++|++|+|++|+++ .+|. ..+..+++|+.|++++| .+....+..|.++++|++|+++
T Consensus 104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 8888888887655556777778888888888776 5555 45556666666666666 3554455556666666666666
Q ss_pred CccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCC
Q 005045 188 ENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGE 267 (717)
Q Consensus 188 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~ 267 (717)
+|.+++..|..|..+++|++|++++|.++.++ ...+..+++|+.|++++|.++
T Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~------~~~~~~~~~L~~L~L~~n~l~--------------------- 235 (353)
T 2z80_A 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLL------EIFVDVTSSVECLELRDTDLD--------------------- 235 (353)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSCSTTHH------HHHHHHTTTEEEEEEESCBCT---------------------
T ss_pred CCCcCccCHHHHhccccCCeecCCCCccccch------hhhhhhcccccEEECCCCccc---------------------
Confidence 66666555555555555555555555554433 223334455555555555544
Q ss_pred CccCCCCCccc---cCCCCCCEEEccCCcCcc----ccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccc
Q 005045 268 NLMHGNIPVGI---GNLVNLNLLGLEGNNLSG----SVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340 (717)
Q Consensus 268 N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 340 (717)
+..+..+ .....++.++|++|.+++ .+|..+..+++|++|+|++|+++.+.+..|..+++|++|+|++|
T Consensus 236 ----~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 311 (353)
T 2z80_A 236 ----TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311 (353)
T ss_dssp ----TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ----cccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCC
Confidence 3222221 123456666666666553 24445555555555555555555333333344444444444444
Q ss_pred ccc
Q 005045 341 RLE 343 (717)
Q Consensus 341 ~l~ 343 (717)
++.
T Consensus 312 ~~~ 314 (353)
T 2z80_A 312 PWD 314 (353)
T ss_dssp CBC
T ss_pred Ccc
Confidence 444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-35 Score=324.85 Aligned_cols=360 Identities=18% Similarity=0.096 Sum_probs=285.2
Q ss_pred ceecEEEcCCCcCcC----CCCcCCcCCCCCCEEECCCCcccccCCcCC-CCCC----CCCEEEccCccccc----cCCc
Q 005045 10 LMTQDLNLTYNYLSG----KIPTNLSHCTELRSFEASVNDFVGQIPNQL-SSLT----KLEIIGLGGSNLTG----NVPA 76 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~----~L~~L~L~~n~l~~----~~p~ 76 (717)
.++++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+ ..++ +|++|+|++|.+++ .++.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 378999999999984 357788899999999999999986444333 3344 79999999999984 5588
Q ss_pred cccCCCCCCEEeccCCcCcccCChhhhc-----cCCCCeEeccCCCCCCCC----CccccCCCCccEEEcccCcccccCC
Q 005045 77 WIGNFSSLKALSLAWNNLRGSIPNELGQ-----LSGLGFFTLYGNFISGII----PSSIYNISSIYYFSVTQNQLHGQLP 147 (717)
Q Consensus 77 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~l~ 147 (717)
.+..+++|++|+|++|.++...+..+.. .++|++|+|++|.+++.. +..+..+++|++|+|++|.+++..+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 8999999999999999998655555443 568999999999998643 5667788999999999999974333
Q ss_pred cccc----cCCCCcceeeccccccccc----CCccCCCCCCCCEEeccCccccccC-----CCCccCCCCCCeeeccccc
Q 005045 148 TDVG----LTLPNLKIFAGAVNYFTGS----IPVSLSNASNLQVLDFAENGLTGTI-----PGNFGSLKDLVRLNFDQNE 214 (717)
Q Consensus 148 ~~~~----~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~l~~L~~L~l~~N~ 214 (717)
..+. ...++|+.|++++|.++.. ++..+..+++|++|++++|.+++.. +..+..+++|++|++++|.
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 3332 2467999999999999864 4667788999999999999998543 3334468999999999999
Q ss_pred cCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhc----cccccEEecCCCccCCC----CCccccCCCCCCE
Q 005045 215 LGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANL----STHLRRLTMGENLMHGN----IPVGIGNLVNLNL 286 (717)
Q Consensus 215 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~----~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~ 286 (717)
++..+... ++..+..+++|++|++++|.+++..+..+... .++|++|++++|.+++. ++..+..+++|++
T Consensus 268 l~~~~~~~--l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 345 (461)
T 1z7x_W 268 ITAKGCGD--LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345 (461)
T ss_dssp CCHHHHHH--HHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCE
T ss_pred CCHHHHHH--HHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccE
Confidence 98754222 25667889999999999999986656555543 24899999999999865 4566778899999
Q ss_pred EEccCCcCccccchhhhc-----CCCCCeEEcccCcCCC----CCCcccccccccceeecccccccccCCcCcc-----C
Q 005045 287 LGLEGNNLSGSVPEVIGR-----LNKLEGLGLNVNKFSG----LIPSSLGNLTILTRLWMEENRLEGSIPPSLG-----N 352 (717)
Q Consensus 287 L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~ 352 (717)
|+|++|++++..+..+.. .++|++|+|++|++++ .+|..+..+++|++|+|++|++++.....+. .
T Consensus 346 L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~ 425 (461)
T 1z7x_W 346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 425 (461)
T ss_dssp EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTST
T ss_pred EEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccC
Confidence 999999999766666654 6799999999999986 6678888899999999999999854222221 2
Q ss_pred cCCCceEEeecccCCCCCC
Q 005045 353 CQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 353 l~~L~~L~l~~N~l~~~~p 371 (717)
..+|+.|++.++.+....+
T Consensus 426 ~~~L~~L~~~~~~~~~~~~ 444 (461)
T 1z7x_W 426 GCLLEQLVLYDIYWSEEME 444 (461)
T ss_dssp TCCCCEEECTTCCCCHHHH
T ss_pred CcchhheeecccccCHHHH
Confidence 3468888888888764433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=285.46 Aligned_cols=280 Identities=16% Similarity=0.161 Sum_probs=221.7
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
...++++++++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 45899999999 6777665 59999999999999777778999999999999999999888889999999999999999
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCC-ccccCCCCccEEEcccCc-ccccCCcccccCCCCcceeeccccccccc
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIP-SSIYNISSIYYFSVTQNQ-LHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~-l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
++++..+..|.++++|++|+|++|+++.+.+ ..|.++++|++|++++|. ++ .++...+..+++|+.|++++|.+.+.
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcCcc
Confidence 9996666669999999999999999996655 589999999999999995 65 77777777999999999999999999
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
.|..+..+++|++|++++|.++...+..+..+++|+.|++++|.++..+...+. .......++.++|+++.+.+.
T Consensus 190 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~---~~~~~~~l~~l~L~~~~l~~~-- 264 (353)
T 2z80_A 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS---TGETNSLIKKFTFRNVKITDE-- 264 (353)
T ss_dssp CTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------CCCCCCEEEEESCBCCHH--
T ss_pred CHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc---cccccchhhccccccccccCc--
Confidence 999999999999999999999854444455689999999999999987644322 233456677777777776631
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 320 (717)
.+. .+|..+.++++|+.|+|++|+++...+..|..+++|++|+|++|++++
T Consensus 265 ------------------~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 265 ------------------SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp ------------------HHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ------------------chh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 111 133445556666666666666663222234666666666666666653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=265.62 Aligned_cols=254 Identities=19% Similarity=0.170 Sum_probs=215.3
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
++++.++++++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67999999998 567655 479999999999999877788999999999999999999887899999999999999999
Q ss_pred c-CcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 93 N-LRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 93 ~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
. ++...|..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.++ .++...+..+++|+.|++++|.++...
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccC
Confidence 7 88777889999999999999999999888999999999999999999998 778777778999999999999999877
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCch
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 251 (717)
+..|..+++|++|++++|.+++..|..|..+++|+.|++++|.++.++ +..+..+++|+.|++++|.+....+.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP------TEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC------HHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCC------HHHcccCcccCEEeccCCCccCCCCc
Confidence 778999999999999999999888889999999999999999998876 67788899999999999998854433
Q ss_pred hhhhccccccEEecCCCccCCCCCccc
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIPVGI 278 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~~~~ 278 (717)
... ...++.+..+.+.+....|..+
T Consensus 244 ~~~--~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 244 RPL--WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHH--HHHHHHCCSEECCCBEEESGGG
T ss_pred HHH--HHHHHhcccccCccccCCchHh
Confidence 211 1234444455555554444444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=271.39 Aligned_cols=280 Identities=20% Similarity=0.256 Sum_probs=123.4
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcccccc--CCccccCCCCCCEEecc
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN--VPAWIGNFSSLKALSLA 90 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~ 90 (717)
+.+++++++++ .+|..+. ++|++|+|++|.++...+..|.++++|++|+|++|.++.. .|..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 34555555554 3443332 3455555555555422222344455555555555544411 13333444444444444
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCC-ccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIP-SSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
+|.++ .+|..|..+++|++|+|++|.+++..+ ..|..+++|++|++++|.+ .+
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l-------------------------~~ 140 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-------------------------RV 140 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCC-------------------------EE
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcC-------------------------Cc
Confidence 44444 233334444444444444444443322 2334444444444444443 33
Q ss_pred cCCccCCCCCCCCEEeccCccccc-cCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCc
Q 005045 170 SIPVSLSNASNLQVLDFAENGLTG-TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 248 (717)
..+..+..+++|++|++++|.+++ ..|..|..+++|+.|++++|.++.+. +..+..+++|++|+|++|.++
T Consensus 141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~-- 212 (306)
T 2z66_A 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS------PTAFNSLSSLQVLNMSHNNFF-- 212 (306)
T ss_dssp CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC------TTTTTTCTTCCEEECTTSCCS--
T ss_pred cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcC------HHHhcCCCCCCEEECCCCccC--
Confidence 344444555555555555555543 34444444444555554444444433 233444444444444444444
Q ss_pred CchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCC-CCCeEEcccCcCCCCCC--cc
Q 005045 249 MPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLN-KLEGLGLNVNKFSGLIP--SS 325 (717)
Q Consensus 249 ~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--~~ 325 (717)
+..+..|..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++.-. ..
T Consensus 213 -----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~ 269 (306)
T 2z66_A 213 -----------------------SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 269 (306)
T ss_dssp -----------------------BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHH
T ss_pred -----------------------ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHH
Confidence 33333344444444444444444444444444442 44444444444443211 11
Q ss_pred cccccccceeecccccccccCCcCccC
Q 005045 326 LGNLTILTRLWMEENRLEGSIPPSLGN 352 (717)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~~~~p~~~~~ 352 (717)
...+..++.+....+.+.+..|..+.+
T Consensus 270 ~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 270 LQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp HHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred HHHHHhhhhhhccccccccCCchhhCC
Confidence 122333444445555555555555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=273.81 Aligned_cols=214 Identities=20% Similarity=0.214 Sum_probs=161.4
Q ss_pred cceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCccccc--CCcCCCCCCCCCEEEccCccccccCCcc
Q 005045 2 ELIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQ--IPNQLSSLTKLEIIGLGGSNLTGNVPAW 77 (717)
Q Consensus 2 ~l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 77 (717)
.++.+|... .+++|+|++|+++...+..|..+++|++|+|++|.++.. .|..+..+++|++|+|++|.++ .+|..
T Consensus 18 ~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~ 96 (306)
T 2z66_A 18 GLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 96 (306)
T ss_dssp CCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEE
T ss_pred CcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhh
Confidence 366777765 899999999999966666789999999999999999833 3666778999999999999999 67888
Q ss_pred ccCCCCCCEEeccCCcCcccCC-hhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCC
Q 005045 78 IGNFSSLKALSLAWNNLRGSIP-NELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPN 156 (717)
Q Consensus 78 ~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~ 156 (717)
+..+++|++|+|++|++++..+ ..|..+++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..
T Consensus 97 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------- 166 (306)
T 2z66_A 97 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF---------- 166 (306)
T ss_dssp EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE----------
T ss_pred cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc----------
Confidence 9999999999999999996655 68999999999999999999888999999999999999999987322
Q ss_pred cceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCC
Q 005045 157 LKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLE 236 (717)
Q Consensus 157 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~ 236 (717)
.|..+..+++|++|++++|.+++..|..|..+++|+.|++++|.++.++ +..+..+++|+
T Consensus 167 --------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~ 226 (306)
T 2z66_A 167 --------------LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD------TFPYKCLNSLQ 226 (306)
T ss_dssp --------------ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC------SGGGTTCTTCC
T ss_pred --------------chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC------hhhccCcccCC
Confidence 2334445555555555555555444555555555555555555555544 22334444444
Q ss_pred EEEeecCccc
Q 005045 237 VLGLARNSFG 246 (717)
Q Consensus 237 ~L~L~~N~l~ 246 (717)
.|+|++|.++
T Consensus 227 ~L~L~~N~l~ 236 (306)
T 2z66_A 227 VLDYSLNHIM 236 (306)
T ss_dssp EEECTTSCCC
T ss_pred EeECCCCCCc
Confidence 4444444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=299.11 Aligned_cols=306 Identities=16% Similarity=0.165 Sum_probs=174.1
Q ss_pred CCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeec
Q 005045 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG 162 (717)
Q Consensus 83 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l 162 (717)
+|++|+|++|.|++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.++ .+|. .
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~-----~-------- 98 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----G-------- 98 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEE-----C--------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCC-----C--------
Confidence 56666666666665555566666666666666666654333 555666666666666555 2221 1
Q ss_pred ccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeec
Q 005045 163 AVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242 (717)
Q Consensus 163 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 242 (717)
++|++|++++|.+++..+. .+++|+.|++++|.++... +..+.++++|+.|+|++
T Consensus 99 ----------------~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~Ls~ 153 (487)
T 3oja_A 99 ----------------PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLR------DLDEGCRSRVQYLDLKL 153 (487)
T ss_dssp ----------------TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGG------GBCGGGGSSEEEEECTT
T ss_pred ----------------CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCC------chhhcCCCCCCEEECCC
Confidence 4555555555555543332 2345555555555555543 33445555666666666
Q ss_pred CcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCC
Q 005045 243 NSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI 322 (717)
Q Consensus 243 N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 322 (717)
|.+++..|..+....++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.+++ +
T Consensus 154 N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-l 229 (487)
T 3oja_A 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-I 229 (487)
T ss_dssp SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCCCcChHHHhhhCCcccEEecCCCccccc--cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-c
Confidence 6666555555542224666666666666543 223347777788888887775 34447777778888888888775 4
Q ss_pred Ccccccccccceeeccccccc-ccCCcCccCcCCCceEEee-------cccCCCCCCcccccCCCCcccccccccccccc
Q 005045 323 PSSLGNLTILTRLWMEENRLE-GSIPPSLGNCQKLLVLNLS-------SNDLNGTIPKEVRQSGMSYSDISKSTDNFSKE 394 (717)
Q Consensus 323 ~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~-------~N~l~~~~p~~~~~~~~s~~~~~~~~~~y~~~ 394 (717)
|..+..+++|+.|+|++|.+. +.+|..+..++.|+.++++ .|+..+.+|.......
T Consensus 230 p~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~~~~~~~---------------- 293 (487)
T 3oja_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA---------------- 293 (487)
T ss_dssp CTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSSTTCEEETT----------------
T ss_pred chhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCCccccccc----------------
Confidence 556777777888888888776 4566667777777777775 4444333322211100
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecc
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSS 456 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 456 (717)
++.+..+.+|. ++.+++|..... .....+.|..|++.+.+++|+|+++++++|..
T Consensus 294 --~~~~~~~~~~~-----~~l~~~~~~~~~~~~~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s 350 (487)
T 3oja_A 294 --YCCEDLPAPFA-----DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350 (487)
T ss_dssp --EEECCCSCHHH-----HHHHHHHHHHHCSCC-----CHHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred --cccccccchhh-----hHHHHHHHHhhhhcccccHHHHHHHHHHHhcccccchhhHHHHhcC
Confidence 11111111111 112233322211 12235679999999999999999999998743
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=280.89 Aligned_cols=253 Identities=21% Similarity=0.206 Sum_probs=163.1
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
....++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567888888887 6666554 578888888888887777888888888888888888887777888888888888888
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|+++ .+|...+..+++|+.|+|++|.+....+..|.++++|++|++++| |.+..+
T Consensus 132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~i 187 (452)
T 3zyi_A 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL-----------------------KKLEYI 187 (452)
T ss_dssp SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCEE
T ss_pred CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC-----------------------CCcccc
Confidence 88887 555544444444444444444444433444444444444444442 233333
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 298 (717)
+ ...|.++++|+.|+|++|.++ .+| .+..+++|+.|+|++|++++..
T Consensus 188 ~------~~~~~~l~~L~~L~L~~n~l~-~~~--------------------------~~~~l~~L~~L~Ls~N~l~~~~ 234 (452)
T 3zyi_A 188 S------EGAFEGLFNLKYLNLGMCNIK-DMP--------------------------NLTPLVGLEELEMSGNHFPEIR 234 (452)
T ss_dssp C------TTTTTTCTTCCEEECTTSCCS-SCC--------------------------CCTTCTTCCEEECTTSCCSEEC
T ss_pred C------hhhccCCCCCCEEECCCCccc-ccc--------------------------cccccccccEEECcCCcCcccC
Confidence 2 233445555555555555555 222 1344556666666666666666
Q ss_pred chhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 299 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
|..|.++++|+.|+|++|+++++.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++.+.+.
T Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 6666666677777777777766666666777777777777777765555666677777777777777765543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=284.36 Aligned_cols=175 Identities=27% Similarity=0.355 Sum_probs=94.6
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
+++|++++|+++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 566666666666 5555554 56666666666666 4444 3556666666666666 4444 456666666666
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|+|++ +|. .+++|++|+|++|+|+. +|.. +++|++|+|++|+++ .+|. .+++|+.|++++|.++. +
T Consensus 111 N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~l~~----~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 111 NPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPA----LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp CCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-C
T ss_pred CcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC-CcCC----ccCCCCEEECCCCCCCC-C
Confidence 66663 333 44566666666666664 2322 355666666666665 3432 23455555555555553 2
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
| ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++.+
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l 216 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL 216 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc
Confidence 2 233455555555555552 2221 24444455555544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=263.86 Aligned_cols=256 Identities=20% Similarity=0.165 Sum_probs=121.5
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccC
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQN 140 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 140 (717)
++++++++.++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCCC--CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34444444444 3333221 34455555555554444444444555555555555554444444555555555555555
Q ss_pred c-ccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcc
Q 005045 141 Q-LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSRE 219 (717)
Q Consensus 141 ~-l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 219 (717)
. ++ .++...+..+++|++|++++|.+.+..+..+.++++|++|++++|++++..+..|..+++|+.|++++|+++.++
T Consensus 91 ~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 4 33 332222223333333333333333334444555555555555555555444444555555555555555544433
Q ss_pred cCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccc
Q 005045 220 IGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299 (717)
Q Consensus 220 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 299 (717)
+..+.++++|+.|++++|.++ +..|..|.++++|+.|+|++|++++..+
T Consensus 170 ------~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 170 ------ERAFRGLHSLDRLLLHQNRVA-------------------------HVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp ------TTTTTTCTTCCEEECCSSCCC-------------------------EECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred ------HHHhcCccccCEEECCCCccc-------------------------ccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 223344444444444444444 3444455555555556666665554444
Q ss_pred hhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccC
Q 005045 300 EVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGN 352 (717)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 352 (717)
..+..+++|+.|+|++|++....+. ..-+..++.+..+.+.+.+..|..+.+
T Consensus 219 ~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 219 EALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred HHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCC
Confidence 4555566666666666655533211 111233444555566666566655543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-30 Score=276.63 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=147.3
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
..+.++.+++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456667776666 5565554 566777777777776666667777777777777777776666667777777777777
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccC-ccccccCCCCccCCCCCCeeeccccccCC
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE-NGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
+|+++ .++...+..+++|+.|++++|.+....+..|..+++|++|++++ |.++...+..|..+++|+.|++++|.++.
T Consensus 121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 77776 55555555566666666666666655555666666666666666 34443334455566666666666665554
Q ss_pred cccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccc
Q 005045 218 REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS 297 (717)
Q Consensus 218 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 297 (717)
++ .+..+++|++|+|++|.+ ++..+..|.++++|+.|+|++|++++.
T Consensus 200 ~~--------~~~~l~~L~~L~Ls~N~l-------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~ 246 (440)
T 3zyj_A 200 IP--------NLTPLIKLDELDLSGNHL-------------------------SAIRPGSFQGLMHLQKLWMIQSQIQVI 246 (440)
T ss_dssp CC--------CCTTCSSCCEEECTTSCC-------------------------CEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred cc--------ccCCCcccCEEECCCCcc-------------------------CccChhhhccCccCCEEECCCCceeEE
Confidence 42 133444444444444444 444444555555555555555555555
Q ss_pred cchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 298 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
.+..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|++.
T Consensus 247 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 5555555555555555555555555555555555555555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-30 Score=276.81 Aligned_cols=248 Identities=23% Similarity=0.221 Sum_probs=220.7
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
...++.++++++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 468899999998 6787665 7899999999999988888999999999999999999987788999999999999999
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|+|+...+..|..+++|++|+|++|.|+.+.+..|.++++|++|+|++|+..+.++...+..+++|+.|++++|.++. +
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-I 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-C
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-c
Confidence 999977777899999999999999999988888999999999999999654458888888899999999999999984 3
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCch
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 251 (717)
| .+..+++|++|+|++|++++..|..|..+++|+.|++++|+|+.+. +..|.++++|+.|+|++|++++..+.
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE------RNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC------TTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC------hhhhcCCCCCCEEECCCCCCCccChh
Confidence 4 5889999999999999999888999999999999999999999887 67788999999999999999954455
Q ss_pred hhhhccccccEEecCCCccC
Q 005045 252 SIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~ 271 (717)
.+..+ ++|+.|+|++|.+.
T Consensus 274 ~~~~l-~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 274 LFTPL-HHLERIHLHHNPWN 292 (440)
T ss_dssp TTSSC-TTCCEEECCSSCEE
T ss_pred Hhccc-cCCCEEEcCCCCcc
Confidence 55555 69999999999986
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-30 Score=277.96 Aligned_cols=248 Identities=21% Similarity=0.191 Sum_probs=219.6
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
...++.++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 467899999998 6777665 6899999999999988889999999999999999999988888999999999999999
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|+|+...+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|++|+..+.++...+..+++|+.|++++|.+++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 9999777788999999999999999999888889999999999999995544488888888999999999999999854
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCch
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 251 (717)
| .+..+++|++|+|++|.+++..|..|..+++|+.|++++|+++.+. +..|.++++|+.|+|++|++++..+.
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~ 284 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE------RNAFDGLASLVELNLAHNNLSSLPHD 284 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC------TTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC------HHHhcCCCCCCEEECCCCcCCccChH
Confidence 3 5889999999999999999888999999999999999999999887 67788999999999999999944444
Q ss_pred hhhhccccccEEecCCCccC
Q 005045 252 SIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~ 271 (717)
.+..+ ++|+.|+|++|.+.
T Consensus 285 ~~~~l-~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 285 LFTPL-RYLVELHLHHNPWN 303 (452)
T ss_dssp SSTTC-TTCCEEECCSSCEE
T ss_pred Hhccc-cCCCEEEccCCCcC
Confidence 45555 69999999999886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-29 Score=280.80 Aligned_cols=269 Identities=24% Similarity=0.281 Sum_probs=230.9
Q ss_pred CCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEec
Q 005045 34 TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113 (717)
Q Consensus 34 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 113 (717)
.+++.|++++|.++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35899999999999 7887776 79999999999999 6666 5789999999999999 5665 7899999999
Q ss_pred cCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccc
Q 005045 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 114 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 193 (717)
++|+|+++.. .+++|+.|++++|+++ .+|. .+++|++|++++|.+++. |. .+++|+.|++++|.+++
T Consensus 109 s~N~l~~l~~----~l~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~ 175 (622)
T 3g06_A 109 FSNPLTHLPA----LPSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS 175 (622)
T ss_dssp CSCCCCCCCC----CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC
T ss_pred cCCcCCCCCC----CCCCcCEEECCCCCCC-cCCC----CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC
Confidence 9999996543 6789999999999998 6776 358999999999999963 43 35789999999999994
Q ss_pred cCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCC
Q 005045 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGN 273 (717)
Q Consensus 194 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~ 273 (717)
+| ..+++|+.|++++|.|+.++. .+++|+.|++++|.++ .+|.. .++|+.|++++|.+++
T Consensus 176 -l~---~~~~~L~~L~Ls~N~l~~l~~----------~~~~L~~L~L~~N~l~-~l~~~----~~~L~~L~Ls~N~L~~- 235 (622)
T 3g06_A 176 -LP---MLPSGLQELSVSDNQLASLPT----------LPSELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS- 235 (622)
T ss_dssp -CC---CCCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-
T ss_pred -Cc---ccCCCCcEEECCCCCCCCCCC----------ccchhhEEECcCCccc-ccCCC----CCCCCEEEccCCccCc-
Confidence 55 457899999999999998751 3479999999999999 66643 2589999999999995
Q ss_pred CCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCc
Q 005045 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353 (717)
Q Consensus 274 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 353 (717)
+| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++..|..+..+
T Consensus 236 lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 236 LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 55 55689999999999999 5665 6789999999999999 558889999999999999999998888877665
Q ss_pred C
Q 005045 354 Q 354 (717)
Q Consensus 354 ~ 354 (717)
+
T Consensus 308 ~ 308 (622)
T 3g06_A 308 T 308 (622)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=259.27 Aligned_cols=234 Identities=21% Similarity=0.249 Sum_probs=117.5
Q ss_pred CCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEc
Q 005045 58 TKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137 (717)
Q Consensus 58 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 137 (717)
.+++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..|..+++|++|+|++|.++ .+|..|.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45556666666665 45555555566666666666665 55555555666666666666555 44555555555555555
Q ss_pred ccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC
Q 005045 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 138 ~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
++|++.+.+|..+.. . ..+..|.++++|++|++++|+++ .+|.
T Consensus 158 ~~n~~~~~~p~~~~~-------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~-------------------- 200 (328)
T 4fcg_A 158 RACPELTELPEPLAS-------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPA-------------------- 200 (328)
T ss_dssp EEETTCCCCCSCSEE-------E---------C-CCCEEESTTCCEEEEEEECCC-CCCG--------------------
T ss_pred CCCCCccccChhHhh-------c---------cchhhhccCCCCCEEECcCCCcC-cchH--------------------
Confidence 555544444433220 0 01112223333333333333333 2222
Q ss_pred cccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccc
Q 005045 218 REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS 297 (717)
Q Consensus 218 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 297 (717)
.+.++++|++|+|++|.++ .+|..+..+ ++|++|++++|.+.+.+|..|.++++|+.|+|++|++.+.
T Consensus 201 ----------~l~~l~~L~~L~L~~N~l~-~l~~~l~~l-~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 268 (328)
T 4fcg_A 201 ----------SIANLQNLKSLKIRNSPLS-ALGPAIHHL-PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268 (328)
T ss_dssp ----------GGGGCTTCCEEEEESSCCC-CCCGGGGGC-TTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCB
T ss_pred ----------hhcCCCCCCEEEccCCCCC-cCchhhccC-CCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhh
Confidence 2444444555555555554 333334333 2455555555444444555555555555555555555555
Q ss_pred cchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 298 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
+|..+..+++|++|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus 269 ~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 5555555555555555555555555555555555555555544443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=260.95 Aligned_cols=236 Identities=20% Similarity=0.248 Sum_probs=175.3
Q ss_pred CCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEe
Q 005045 33 CTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFT 112 (717)
Q Consensus 33 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 112 (717)
.++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..|..+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478999999999999 88988999999999999999999 89999999999999999999999 8899999999999999
Q ss_pred ccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccc
Q 005045 113 LYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 113 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
|++|++.+..|..+... .+. ..+..+++|+.|++++|.++ .+|..+..+++|++|++++|.++
T Consensus 157 L~~n~~~~~~p~~~~~~-----------~~~-----~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 157 IRACPELTELPEPLAST-----------DAS-----GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEETTCCCCCSCSEEE-----------C-C-----CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred CCCCCCccccChhHhhc-----------cch-----hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 99999888888876541 010 11224555555555555555 56677888999999999999999
Q ss_pred ccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCC
Q 005045 193 GTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHG 272 (717)
Q Consensus 193 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~ 272 (717)
+ +|..+..+++|+.|++++|.+.. .+|..+..+ ++|++|++++|.+.+
T Consensus 220 ~-l~~~l~~l~~L~~L~Ls~n~~~~------------------------------~~p~~~~~l-~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 220 A-LGPAIHHLPKLEELDLRGCTALR------------------------------NYPPIFGGR-APLKRLILKDCSNLL 267 (328)
T ss_dssp C-CCGGGGGCTTCCEEECTTCTTCC------------------------------BCCCCTTCC-CCCCEEECTTCTTCC
T ss_pred c-CchhhccCCCCCEEECcCCcchh------------------------------hhHHHhcCC-CCCCEEECCCCCchh
Confidence 4 55556666666666666555544 444444444 255555555555555
Q ss_pred CCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC
Q 005045 273 NIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 273 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 320 (717)
.+|..+.++++|+.|+|++|++.+.+|..++.+++|+.+++..|.+..
T Consensus 268 ~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp BCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred hcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 566666666677777777776666777777777777777776665543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-31 Score=275.32 Aligned_cols=257 Identities=17% Similarity=0.207 Sum_probs=134.3
Q ss_pred CCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 60 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
++.++++++.+...+...+..+++|++|+|++|+|++..|..|.++++|++|+|++|.+++..+ |..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3344555555554444444445556666666666665555556666666666666666654332 56666666666666
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcc
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSRE 219 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 219 (717)
|.++ .++ ..++|+.|++++|.+++..+.. +++|++|++++|++++..+..|..+++|+.|++++|.++.+.
T Consensus 90 n~l~-~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 90 NYVQ-ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SEEE-EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred Cccc-ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 6665 332 1245555555555555443332 355666666666666555555666666666666666665544
Q ss_pred cCchhhhhhh-ccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc
Q 005045 220 IGDLNFLKFL-ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298 (717)
Q Consensus 220 ~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 298 (717)
+..+ ..+++|++|+|++|.++ .++.... + ++|++|++++|.+++ ++..+..+++|+.|+|++|+++ .+
T Consensus 161 ------~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~-l-~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l 229 (317)
T 3o53_A 161 ------FAELAASSDTLEHLNLQYNFIY-DVKGQVV-F-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LI 229 (317)
T ss_dssp ------GGGGGGGTTTCCEEECTTSCCC-EEECCCC-C-TTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EE
T ss_pred ------HHHHhhccCcCCEEECCCCcCc-ccccccc-c-ccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-ch
Confidence 2222 34556666666666655 2222211 2 345555555555543 2223444555555555555555 34
Q ss_pred chhhhcCCCCCeEEcccCcCC-CCCCcccccccccceeecc
Q 005045 299 PEVIGRLNKLEGLGLNVNKFS-GLIPSSLGNLTILTRLWME 338 (717)
Q Consensus 299 ~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~ 338 (717)
|..+..+++|+.|+|++|+++ +..+..+..+++|+.|+++
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 444445555555555555554 3344444455555555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=270.09 Aligned_cols=269 Identities=16% Similarity=0.133 Sum_probs=222.8
Q ss_pred CCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeec
Q 005045 83 SLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAG 162 (717)
Q Consensus 83 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l 162 (717)
+++.++++.+.+...+...+..+++|++|+|++|.++++.|..|.++++|++|+|++|.+++. +. +..+++|++|++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-LD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEE-EE--ETTCTTCCEEEC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcc-hh--hhhcCCCCEEEC
Confidence 456678889988866667778888999999999999988889999999999999999999844 33 668999999999
Q ss_pred ccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeec
Q 005045 163 AVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242 (717)
Q Consensus 163 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 242 (717)
++|.+++.. ..++|++|++++|.+++..+.. +++|+.|++++|+++.+. +..+..+++|++|+|++
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~------~~~~~~l~~L~~L~Ls~ 153 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLR------DLDEGCRSRVQYLDLKL 153 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGG------GBCTGGGSSEEEEECTT
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCcc------chhhhccCCCCEEECCC
Confidence 999998543 3489999999999999666543 578999999999999876 56778899999999999
Q ss_pred CcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCC
Q 005045 243 NSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLI 322 (717)
Q Consensus 243 N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 322 (717)
|.+++..+..+....++|++|++++|.+++. + ....+++|++|+|++|++++ +|..+..+++|+.|+|++|++++ +
T Consensus 154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l 229 (317)
T 3o53_A 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-I 229 (317)
T ss_dssp SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-h
Confidence 9999766777754336899999999999854 2 33458899999999999995 55558899999999999999985 4
Q ss_pred Ccccccccccceeeccccccc-ccCCcCccCcCCCceEEeecc-cCCCCCCc
Q 005045 323 PSSLGNLTILTRLWMEENRLE-GSIPPSLGNCQKLLVLNLSSN-DLNGTIPK 372 (717)
Q Consensus 323 ~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~ 372 (717)
|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++| .++|..|.
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 677888999999999999998 677788888999999998844 45554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=266.53 Aligned_cols=256 Identities=20% Similarity=0.188 Sum_probs=128.9
Q ss_pred CCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCc-ccCChhhh-------ccCCCCeEeccCCCCCCCCCcc
Q 005045 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLR-GSIPNELG-------QLSGLGFFTLYGNFISGIIPSS 125 (717)
Q Consensus 54 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~i~~~~~~~ 125 (717)
++..++|+.|++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. ++++|++|+|++|.+++..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34455666666666666 455544433 666666666663 23444443 5666666666666666556655
Q ss_pred c--cCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCC
Q 005045 126 I--YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLK 203 (717)
Q Consensus 126 ~--~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 203 (717)
+ ..+++|++|+|++|++++ +|..+. .+ + ...+++|++|++++|++++..+..|..++
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~-~~~~~~-~l-----------------~--~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWAT-RDAWLA-EL-----------------Q--QWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSS-SSSHHH-HH-----------------H--TTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred HHHhcCCCccEEEccCCCCcc-hhHHHH-HH-----------------H--HhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 4 566666666666666652 232221 11 0 00115556666666666555555555566
Q ss_pred CCCeeeccccccCCcccCchhhhhhh--ccCCCCCEEEeecCcccC--cCchhhhhccccccEEecCCCccCCCCC-ccc
Q 005045 204 DLVRLNFDQNELGSREIGDLNFLKFL--ANCTSLEVLGLARNSFGG--EMPISIANLSTHLRRLTMGENLMHGNIP-VGI 278 (717)
Q Consensus 204 ~L~~L~l~~N~l~~~~~~~~~~~~~~--~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~~L~~L~l~~N~l~~~~~-~~~ 278 (717)
+|++|++++|++.... ..+..+ ..+++|++|+|++|.+++ .++..++...++|++|++++|.+++..| ..+
T Consensus 174 ~L~~L~Ls~N~l~~~~----~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 249 (312)
T 1wwl_A 174 ALSTLDLSDNPELGER----GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249 (312)
T ss_dssp SCCEEECCSCTTCHHH----HHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCC
T ss_pred CCCEEECCCCCcCcch----HHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhh
Confidence 6666666665543210 012222 556666666666666662 1122222111355555555555554332 233
Q ss_pred cCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 279 GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 279 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
..+++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++|++|+|++|+++
T Consensus 250 ~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred hhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 44455555555555555 3443333 4444444444444433 22 444444444444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=265.65 Aligned_cols=255 Identities=18% Similarity=0.214 Sum_probs=185.6
Q ss_pred CCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcccc-ccCCcccc-------CCCCCCEEeccCCcCcccCCh
Q 005045 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLT-GNVPAWIG-------NFSSLKALSLAWNNLRGSIPN 100 (717)
Q Consensus 29 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~L~~n~l~~~~~~ 100 (717)
.++..++|++|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|+|++|++++..|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 356677899999999999 677766554 999999999994 45666665 799999999999999988888
Q ss_pred hh--hccCCCCeEeccCCCCCCCCCccccCC-----CCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCc
Q 005045 101 EL--GQLSGLGFFTLYGNFISGIIPSSIYNI-----SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173 (717)
Q Consensus 101 ~~--~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~ 173 (717)
.+ ..+++|++|+|++|++++. |..|..+ ++|++|+|++|+++ .++ +.
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~-~~~------------------------~~ 167 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSL-NFS------------------------CE 167 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCC-CCC------------------------TT
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCc-cch------------------------HH
Confidence 76 8999999999999999977 8888877 78888888888886 333 34
Q ss_pred cCCCCCCCCEEeccCcccccc--CCCC--ccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcC
Q 005045 174 SLSNASNLQVLDFAENGLTGT--IPGN--FGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249 (717)
Q Consensus 174 ~~~~l~~L~~L~l~~N~l~~~--~~~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 249 (717)
.|+.+++|++|++++|++.+. .+.. +..+++|++|++++|+++.++. + ....+.++++|++|+|++|.+++..
T Consensus 168 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~-~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG--V-CSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp TCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHH--H-HHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred HhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHH--H-HHHHHhcCCCCCEEECCCCcCCccc
Confidence 455555666666666655432 1112 2556666666666666663320 0 0234456777888888888877655
Q ss_pred chhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCC
Q 005045 250 PISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGL 321 (717)
Q Consensus 250 p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 321 (717)
|.......++|++|++++|.++ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|+|++|++++.
T Consensus 245 ~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred chhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 4333332357888888888887 5666655 7888888888888854 55 78888888888888888753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=269.48 Aligned_cols=236 Identities=20% Similarity=0.204 Sum_probs=130.3
Q ss_pred CCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEE
Q 005045 56 SLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYF 135 (717)
Q Consensus 56 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 135 (717)
.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|+++. ..++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 33456666666666665555566666666666666666664443 666666666666666665322 22566777
Q ss_pred EcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCcc-CCCCCCeeeccccc
Q 005045 136 SVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFG-SLKDLVRLNFDQNE 214 (717)
Q Consensus 136 ~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~ 214 (717)
+|++|.++ .++.. .+++|+.|++++|.+++..|..+..+++|++|+|++|.+++..|..+. .+++|+.|+|++|.
T Consensus 105 ~L~~N~l~-~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNIS-RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp ECCSSCCC-CEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred ECcCCcCC-CCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 77777666 33322 235555555555555555555666666666666666666655555554 45666666666666
Q ss_pred cCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcC
Q 005045 215 LGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294 (717)
Q Consensus 215 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 294 (717)
|+.++ .+..+++|+.|+|++|.++ .+|..+..+ ++|+.|++++|.+++ +|..+..+++|+.|++++|.+
T Consensus 181 l~~~~--------~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l-~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 181 IYDVK--------GQVVFAKLKTLDLSSNKLA-FMGPEFQSA-AGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp CCEEE--------CCCCCTTCCEEECCSSCCC-EECGGGGGG-TTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ccccc--------ccccCCCCCEEECCCCCCC-CCCHhHcCC-CCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 65542 1223555666666666655 233334433 345555555555542 344445555555555555555
Q ss_pred c-cccchhhhcCCCCCeEEc
Q 005045 295 S-GSVPEVIGRLNKLEGLGL 313 (717)
Q Consensus 295 ~-~~~~~~~~~l~~L~~L~L 313 (717)
. +.+|..+..++.|+.|++
T Consensus 250 ~c~~~~~~~~~l~~L~~l~~ 269 (487)
T 3oja_A 250 HCGTLRDFFSKNQRVQTVAK 269 (487)
T ss_dssp CHHHHHHHHTTCHHHHHHHH
T ss_pred cCcchHHHHHhCCCCcEEec
Confidence 4 334444444444444444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.05 Aligned_cols=227 Identities=20% Similarity=0.202 Sum_probs=184.0
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
.+++.++.+++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 35677777777 5776554 57888999999888777778888888999999999888777778888888999999999
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccccc-CCcccccCCCCcceeecccccccccC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQ-LPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
++++..+..|.++++|++|++++|.+++..+..|.++++|++|+|++|.+++. +|. .+..+++|+.|++++|.+++..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~-~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG-GGGGCTTCCEEECCSSCCCEEC
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCch-hhccCCCCCEEECCCCCCCcCC
Confidence 88877778888888999999999988877777888888999999999988731 344 4457888999999999888877
Q ss_pred CccCCCCCCCC----EEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccC
Q 005045 172 PVSLSNASNLQ----VLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG 247 (717)
Q Consensus 172 ~~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 247 (717)
+..+..+++|+ +|++++|.+++..+..+. ..+|+.|++++|+++.++ +..|..+++|+.|+|++|.+++
T Consensus 166 ~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVP------DGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCC------TTTTTTCCSCCEEECCSSCBCC
T ss_pred HHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecC------HhHhcccccccEEEccCCcccc
Confidence 77777777776 899999999965555444 458999999999999877 5667889999999999999986
Q ss_pred cCc
Q 005045 248 EMP 250 (717)
Q Consensus 248 ~~p 250 (717)
..|
T Consensus 239 ~c~ 241 (276)
T 2z62_A 239 SCP 241 (276)
T ss_dssp CTT
T ss_pred cCC
Confidence 554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=233.71 Aligned_cols=221 Identities=20% Similarity=0.204 Sum_probs=102.6
Q ss_pred EECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCC
Q 005045 39 FEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFI 118 (717)
Q Consensus 39 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 118 (717)
.+.++..++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 334444444 3443332 2455555555555544444455555555555555555544444455555555555555555
Q ss_pred CCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc-CCccCCCCCCCCEEeccCccccccCCC
Q 005045 119 SGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS-IPVSLSNASNLQVLDFAENGLTGTIPG 197 (717)
Q Consensus 119 ~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~ 197 (717)
++..+..|.++++|++|++++|.++ .++...+..+++|+.|++++|.+... +|..+..+++|++|++++|++++..+.
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 5444445555555555555555554 33333334455555555555555432 244455555555555555555544444
Q ss_pred CccCCCCCC----eeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccC
Q 005045 198 NFGSLKDLV----RLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271 (717)
Q Consensus 198 ~~~~l~~L~----~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~ 271 (717)
.|..+++|+ .|++++|.++.++ +..+. ..+|+.|+|++|.+++..+..+..+ ++|+.|++++|++.
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~------~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQ------PGAFK-EIRLKELALDTNQLKSVPDGIFDRL-TSLQKIWLHTNPWD 237 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEEC------TTSSC-SCCEEEEECCSSCCSCCCTTTTTTC-CSCCEEECCSSCBC
T ss_pred HhhhhhhccccceeeecCCCcccccC------ccccC-CCcccEEECCCCceeecCHhHhccc-ccccEEEccCCccc
Confidence 444444444 4455555554443 11111 2245555555555552222222223 34555555555544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-29 Score=281.98 Aligned_cols=350 Identities=13% Similarity=0.082 Sum_probs=213.1
Q ss_pred eecEEEcCCCcCcCCCCcCCcC-CC-CCCEEECCCCc-ccc-cCCcCCCCCCCCCEEEccCcccccc----CCccccCCC
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSH-CT-ELRSFEASVND-FVG-QIPNQLSSLTKLEIIGLGGSNLTGN----VPAWIGNFS 82 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~-l~-~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~ 82 (717)
.+++|+|++|.+++..+..+.. ++ +|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..++
T Consensus 113 ~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~ 192 (592)
T 3ogk_B 113 QLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNT 192 (592)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCC
T ss_pred CCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCC
Confidence 5677777777666554444444 22 36666666665 111 1122223556666666666666543 222334556
Q ss_pred CCCEEeccCCcCcc----cCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEc---------------------
Q 005045 83 SLKALSLAWNNLRG----SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV--------------------- 137 (717)
Q Consensus 83 ~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L--------------------- 137 (717)
+|++|+|++|.+++ .++..+..+++|++|+|++|.+.+ .+..+.++++|++|++
T Consensus 193 ~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~ 271 (592)
T 3ogk_B 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271 (592)
T ss_dssp CCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTT
T ss_pred CccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccc
Confidence 66666666666652 233334456666666666666553 3344455555555555
Q ss_pred ------ccCcccccCCcccccCCCCcceeecccccccccCC-ccCCCCCCCCEEeccCccccc-cCCCCccCCCCCCeee
Q 005045 138 ------TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP-VSLSNASNLQVLDFAENGLTG-TIPGNFGSLKDLVRLN 209 (717)
Q Consensus 138 ------~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~ 209 (717)
+++... .+|. .+..+++|+.|++++|.++.... ..+..+++|++|+++ +.+.. .++..+..+++|++|+
T Consensus 272 L~~L~l~~~~~~-~l~~-~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 272 LCRLGLSYMGPN-EMPI-LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp CCEEEETTCCTT-TGGG-GGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEE
T ss_pred ccccCccccchh-HHHH-HHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEE
Confidence 443222 3333 23356777777777777654333 235667777777777 33332 2333335567788888
Q ss_pred cc-----------ccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecC----CCccCCC-
Q 005045 210 FD-----------QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG----ENLMHGN- 273 (717)
Q Consensus 210 l~-----------~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~----~N~l~~~- 273 (717)
++ .|.++... +......+++|++|+++.|.+++..+..+....++|+.|+++ .|.+++.
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~-----~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p 423 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRG-----LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP 423 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHH-----HHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCC
T ss_pred eecCccccccccccCccCHHH-----HHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCch
Confidence 87 35555432 123345678888888888888877777776634588888885 6677643
Q ss_pred ----CCccccCCCCCCEEEccCCc--Cccccchhhhc-CCCCCeEEcccCcCCCC-CCcccccccccceeeccccccccc
Q 005045 274 ----IPVGIGNLVNLNLLGLEGNN--LSGSVPEVIGR-LNKLEGLGLNVNKFSGL-IPSSLGNLTILTRLWMEENRLEGS 345 (717)
Q Consensus 274 ----~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 345 (717)
++..+.++++|+.|+|++|. +++..+..+.. +++|++|+|++|++++. .+..+.++++|+.|+|++|.+++.
T Consensus 424 ~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 424 LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp CHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 22336668888888887543 66555555544 78888888888888753 234456778888899988887644
Q ss_pred -CCcCccCcCCCceEEeecccCCCC
Q 005045 346 -IPPSLGNCQKLLVLNLSSNDLNGT 369 (717)
Q Consensus 346 -~p~~~~~l~~L~~L~l~~N~l~~~ 369 (717)
++..+..+++|+.|++++|++++.
T Consensus 504 ~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 504 AIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHHhcCccCeeECcCCcCCHH
Confidence 334446788888899998888754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-26 Score=228.70 Aligned_cols=200 Identities=22% Similarity=0.292 Sum_probs=121.6
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
.+++++++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.++...+..|..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 456777777776 4555443 4677777777777655555667777777777777777644444556667777777777
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|++++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|.++ .+|...+..+++|+.|++++|.++...
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcCcEeC
Confidence 7776555556666777777777777776666666666667777777776666 555554445555555555555555444
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeecccccc
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNEL 215 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 215 (717)
+..|..+++|++|++++|++++..+..|..+++|+.|++++|.+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 44455555555555555555543333444444444444444444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-29 Score=275.55 Aligned_cols=184 Identities=17% Similarity=0.059 Sum_probs=126.6
Q ss_pred cCcccccceEEEE-eCCCchhhhHHhHhh----------hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCCCce
Q 005045 397 IGTGSFGSVYKGT-LGDGTIVAIKVLKLQ----------QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 397 ig~g~~g~v~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+.|+.|.+..++ .-.|+.+++|++... .....+.+.+|+++|+++ .|+||++++++ ++++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence 4455555555444 225788888887532 123356799999999999 79999999999 556679
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.||||||++|++|.+++... +.++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 99999999999999999865 345543 5899999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP 605 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p 605 (717)
|+|+.... .........||+.|+|||++.|++..++|+||+|+++|++.++..|
T Consensus 384 GlAr~~~~-------~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 384 GSIVTTPQ-------DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTEESCC----------CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred ccCeeCCC-------CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 99986521 1223345679999999999999999999999999998877665444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-25 Score=225.69 Aligned_cols=202 Identities=19% Similarity=0.241 Sum_probs=143.4
Q ss_pred CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEecc
Q 005045 35 ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 114 (717)
+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4677888888877 5665554 567788888888776555677777888888888888775555666777788888888
Q ss_pred CCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccccc
Q 005045 115 GNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194 (717)
Q Consensus 115 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 194 (717)
+|.++.+.+..|.++++|++|+|++|.++ .++...+..+++|+.|++++|.++...+..|..+++|++|++++|.+++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 88877776677777777888888877776 56666666677777777777777766555667777777777777777755
Q ss_pred CCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc
Q 005045 195 IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246 (717)
Q Consensus 195 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 246 (717)
.+..|..+++|+.|++++|.++.++ +..|..+++|+.|+|++|.+.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVP------EGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCC------TTTTTTCTTCCEEECCSSCBC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCC------HHHhccccCCCEEEecCCCee
Confidence 5556666777777777777766655 344566666666666666665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=228.49 Aligned_cols=206 Identities=23% Similarity=0.244 Sum_probs=149.9
Q ss_pred ccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCC
Q 005045 126 IYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDL 205 (717)
Q Consensus 126 ~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 205 (717)
+.++++|+.+++++|.++ .+|..++ ++++.|++++|.+++..+..|.++++|++|++++|.|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~------------- 68 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT------------- 68 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-------------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-------------
Confidence 556667777777777776 5555443 34445555555554444455555555555555555555
Q ss_pred CeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCC
Q 005045 206 VRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLN 285 (717)
Q Consensus 206 ~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 285 (717)
.++ . ...+++|++|+|++|.++ .+|..+..+ ++|++|++++|++++..+..|.++++|+
T Consensus 69 -----------~~~------~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l-~~L~~L~l~~N~l~~l~~~~~~~l~~L~ 127 (290)
T 1p9a_G 69 -----------KLQ------V--DGTLPVLGTLDLSHNQLQ-SLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQ 127 (290)
T ss_dssp -----------EEE------C--CSCCTTCCEEECCSSCCS-SCCCCTTTC-TTCCEEECCSSCCCCCCSSTTTTCTTCC
T ss_pred -----------ccc------C--CCCCCcCCEEECCCCcCC-cCchhhccC-CCCCEEECCCCcCcccCHHHHcCCCCCC
Confidence 332 0 134455666666666665 555555555 4777777777777766677888999999
Q ss_pred EEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeeccc
Q 005045 286 LLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND 365 (717)
Q Consensus 286 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 365 (717)
.|+|++|+|++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+
T Consensus 128 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred EEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCC
Confidence 9999999999777777889999999999999999888888889999999999999998 788888888999999999999
Q ss_pred CCCCC
Q 005045 366 LNGTI 370 (717)
Q Consensus 366 l~~~~ 370 (717)
+.+.+
T Consensus 207 ~~C~c 211 (290)
T 1p9a_G 207 WLCNC 211 (290)
T ss_dssp BCCSG
T ss_pred ccCcC
Confidence 98665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=225.86 Aligned_cols=197 Identities=23% Similarity=0.232 Sum_probs=112.9
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+++++++++|+++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.|++. +. ...+++|++|+|+
T Consensus 11 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls 85 (290)
T 1p9a_G 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLS 85 (290)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECC
T ss_pred CccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECC
Confidence 4566666666666 4444443 4666666666666655556666666666666666666632 22 2556666666666
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|+|+ .+|..+..+++|++|+|++|+|+++.+..|.++++|++|+|++|+++ .+|...|..+++|+.|++++|.++..
T Consensus 86 ~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~l 163 (290)
T 1p9a_G 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL 163 (290)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC-ccChhhcccccCCCEEECCCCcCCcc
Confidence 66666 55555666666666666666666555566666666666666666665 55555554555555555555555544
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeecccccc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNEL 215 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 215 (717)
.+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|.+
T Consensus 164 ~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 4444455555555555555555 3444444444444444444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=231.31 Aligned_cols=226 Identities=19% Similarity=0.268 Sum_probs=163.7
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+..+++.++.+.... .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ ++ .+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-IS-ALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-ch-hhcCCCCCCEEECC
Confidence 4455667777776443 3567788888888888877 344 37778888888888888874 33 57788888888888
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.+++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|++|+++ .++...+..+++|+.|++++|.+++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCcc
Confidence 88888777777788888888888888888777777888888888888888887 66666666777777777777777766
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
.+..+..+++|++|++++|++++..+..|..+++|+.|++++|.+.. .+++|+.|+++.|.++|.+|
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------------~~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------------TCPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------------CTTTTHHHHHHHHHTGGGBB
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------------cCcHHHHHHHHHHhCCCccc
Confidence 66667777777777777777776666666777777777777776542 23456666666677666666
Q ss_pred hhhhhc
Q 005045 251 ISIANL 256 (717)
Q Consensus 251 ~~~~~~ 256 (717)
..+..+
T Consensus 240 ~~~~~~ 245 (272)
T 3rfs_A 240 NSAGSV 245 (272)
T ss_dssp CTTSCB
T ss_pred Cccccc
Confidence 665544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-27 Score=250.15 Aligned_cols=266 Identities=19% Similarity=0.216 Sum_probs=160.2
Q ss_pred EEECCCCcccccCCcCCCCCCCCCEEEccCccccccCC----ccccCCC-CCCEEeccCCcCcccCChhhhcc-----CC
Q 005045 38 SFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVP----AWIGNFS-SLKALSLAWNNLRGSIPNELGQL-----SG 107 (717)
Q Consensus 38 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~ 107 (717)
.+++++|.+++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777777666666667777777777775555 5666777 77777777777776666666665 77
Q ss_pred CCeEeccCCCCCCCCCcccc----CC-CCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCC-CCCC
Q 005045 108 LGFFTLYGNFISGIIPSSIY----NI-SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSN-ASNL 181 (717)
Q Consensus 108 L~~L~L~~N~i~~~~~~~~~----~l-~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L 181 (717)
|++|+|++|.+++..+..+. .+ ++|++|+|++|.++ ..+...+ ...+.. .++|
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l--------------------~~~l~~~~~~L 140 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-SKSSSEF--------------------KQAFSNLPASI 140 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-GSCHHHH--------------------HHHHTTSCTTC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC-cHHHHHH--------------------HHHHHhCCCce
Confidence 77777777777755555333 33 67777777777776 3322211 011222 2456
Q ss_pred CEEeccCccccccCC----CCccCCC-CCCeeeccccccCCcccCchhhhhhhccC-CCCCEEEeecCcccCc----Cch
Q 005045 182 QVLDFAENGLTGTIP----GNFGSLK-DLVRLNFDQNELGSREIGDLNFLKFLANC-TSLEVLGLARNSFGGE----MPI 251 (717)
Q Consensus 182 ~~L~l~~N~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~ 251 (717)
++|+|++|.+++... ..+..++ +|++|+|++|.++...... +...+..+ ++|++|+|++|.|++. ++.
T Consensus 141 ~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~--l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAE--LAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH--HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHH--HHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 666666666653222 2223333 6666666666665544211 12334444 4777777777777642 444
Q ss_pred hhhhccccccEEecCCCccCCCCC----ccccCCCCCCEEEccCCcCccccc-------hhhhcCCCCCeEEcccCcCCC
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIP----VGIGNLVNLNLLGLEGNNLSGSVP-------EVIGRLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~Ls~N~l~~ 320 (717)
.+....++|++|++++|.+++..+ ..+..+++|+.|+|++|.+....+ ..+..+++|+.||+++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 444443467777777777765443 234566778888888887443322 345566777777777777765
Q ss_pred CCCccc
Q 005045 321 LIPSSL 326 (717)
Q Consensus 321 ~~~~~~ 326 (717)
..+..+
T Consensus 299 ~~~~~~ 304 (362)
T 3goz_A 299 SHSIPI 304 (362)
T ss_dssp GGCHHH
T ss_pred cchHHH
Confidence 544433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=227.72 Aligned_cols=227 Identities=22% Similarity=0.287 Sum_probs=123.6
Q ss_pred CCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccC
Q 005045 36 LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYG 115 (717)
Q Consensus 36 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 115 (717)
+..+++.++.+..... +..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|++
T Consensus 21 l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccccc--cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCC
Confidence 4444555555443322 445566666666666665 333 25566666666666666653 2 2556666666666666
Q ss_pred CCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccC
Q 005045 116 NFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTI 195 (717)
Q Consensus 116 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 195 (717)
|.++++.+..|.++++|++|+|++|+++ .++... |..+++|++|++++|.+++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~------------------------~~~l~~L~~L~L~~n~l~~~~ 149 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGV------------------------FDKLTNLTYLNLAHNQLQSLP 149 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTT------------------------TTTCTTCCEEECCSSCCCCCC
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCC-ccCHHH------------------------hccCCCCCEEECCCCccCccC
Confidence 6666555555666666666666666665 444444 444444555555555544444
Q ss_pred CCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCC
Q 005045 196 PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIP 275 (717)
Q Consensus 196 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~ 275 (717)
+..|..+++|+.|++++|+++.++ +..+..+++|+.|++++|.+++..|..+..+ ++|+.|++++|.+.+
T Consensus 150 ~~~~~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~~~~--- 219 (272)
T 3rfs_A 150 KGVFDKLTNLTELDLSYNQLQSLP------EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL-TSLQYIWLHDNPWDC--- 219 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCC------TTTTTTCTTCCEEECCSSCCSCCCTTTTTTC-TTCCEEECCSSCBCC---
T ss_pred HHHhccCccCCEEECCCCCcCccC------HHHhcCCccCCEEECCCCcCCccCHHHHhCC-cCCCEEEccCCCccc---
Confidence 444444555555555555544443 3334455555555555555554333334444 356666666665542
Q ss_pred ccccCCCCCCEEEccCCcCccccchhhhcCCC
Q 005045 276 VGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNK 307 (717)
Q Consensus 276 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 307 (717)
.+++|++|+++.|++++.+|.+++.+..
T Consensus 220 ----~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 220 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp ----CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred ----cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 2445677777777777777776665543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-27 Score=271.13 Aligned_cols=344 Identities=13% Similarity=0.078 Sum_probs=233.3
Q ss_pred ecEEEcCCCc-CcC-CCCcCCcCCCCCCEEECCCCccccc----CCcCCCCCCCCCEEEccCcccc----ccCCccccCC
Q 005045 12 TQDLNLTYNY-LSG-KIPTNLSHCTELRSFEASVNDFVGQ----IPNQLSSLTKLEIIGLGGSNLT----GNVPAWIGNF 81 (717)
Q Consensus 12 ~~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~----~~~p~~~~~l 81 (717)
+++|+|++|. +.. .++..+..+++|++|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 6777777765 110 1122233567777777777766543 2223345666777777777765 2333344566
Q ss_pred CCCCEEeccCCcCcccCChhhhccCCCCeEecc---------------------------CCCCCCCCCccccCCCCccE
Q 005045 82 SSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY---------------------------GNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 82 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~---------------------------~N~i~~~~~~~~~~l~~L~~ 134 (717)
++|++|+|++|.+. .++..+..+++|+.|+++ ++.. ...|..+..+++|++
T Consensus 220 ~~L~~L~L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 220 RSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRK 297 (592)
T ss_dssp TTCCEEECSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCE
T ss_pred CCCcEEeccCccHH-HHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcE
Confidence 67777777777666 345556666666666665 3322 245667778899999
Q ss_pred EEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEecc-----------CccccccCC-CCccCC
Q 005045 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFA-----------ENGLTGTIP-GNFGSL 202 (717)
Q Consensus 135 L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-----------~N~l~~~~~-~~~~~l 202 (717)
|+|++|.+++.....+...+++|+.|+++++-....++..+..+++|++|+++ .|.++.... ..+..+
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC
Confidence 99999998754444555689999999999443333333444678999999999 366664322 224568
Q ss_pred CCCCeeeccccccCCcccCchhhhhhhcc-CCCCCEEEee----cCcccCc-----CchhhhhccccccEEecCCCc--c
Q 005045 203 KDLVRLNFDQNELGSREIGDLNFLKFLAN-CTSLEVLGLA----RNSFGGE-----MPISIANLSTHLRRLTMGENL--M 270 (717)
Q Consensus 203 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~~~~~L~~L~l~~N~--l 270 (717)
++|+.|+++.|.++... +..+.. +++|+.|+++ .|.+++. ++..+... ++|++|++++|. +
T Consensus 378 ~~L~~L~l~~~~l~~~~------~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~-~~L~~L~L~~~~~~l 450 (592)
T 3ogk_B 378 QELEYMAVYVSDITNES------LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC-KKLRRFAFYLRQGGL 450 (592)
T ss_dssp TTCSEEEEEESCCCHHH------HHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHC-TTCCEEEEECCGGGC
T ss_pred ccCeEEEeecCCccHHH------HHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhC-CCCCEEEEecCCCCc
Confidence 99999999999988754 445554 8999999997 7788853 33345555 699999997543 5
Q ss_pred CCCCCcccc-CCCCCCEEEccCCcCcc-ccchhhhcCCCCCeEEcccCcCCCCC-CcccccccccceeecccccccccCC
Q 005045 271 HGNIPVGIG-NLVNLNLLGLEGNNLSG-SVPEVIGRLNKLEGLGLNVNKFSGLI-PSSLGNLTILTRLWMEENRLEGSIP 347 (717)
Q Consensus 271 ~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p 347 (717)
++..+..+. .+++|++|+|++|++++ .++..+.++++|++|+|++|.+++.. +..+..+++|++|+|++|++++.-.
T Consensus 451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~ 530 (592)
T 3ogk_B 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQ 530 (592)
T ss_dssp CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCT
T ss_pred cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHH
Confidence 544444443 48899999999999986 34556688999999999999987543 3344678999999999999986543
Q ss_pred cCc-cCcCCCceEEeecc
Q 005045 348 PSL-GNCQKLLVLNLSSN 364 (717)
Q Consensus 348 ~~~-~~l~~L~~L~l~~N 364 (717)
..+ ..++.+....+..+
T Consensus 531 ~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 531 DLMQMARPYWNIELIPSR 548 (592)
T ss_dssp TGGGGCCTTEEEEEECCC
T ss_pred HHHHHhCCCcEEEEecCc
Confidence 433 35677766666554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=221.07 Aligned_cols=206 Identities=18% Similarity=0.188 Sum_probs=164.9
Q ss_pred cCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcc-ccccCCccccCCCCCCEEeccC-CcCcccC
Q 005045 21 YLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN-LTGNVPAWIGNFSSLKALSLAW-NNLRGSI 98 (717)
Q Consensus 21 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~ 98 (717)
+++ .+|. +. ++|++|++++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|+|++ |++++..
T Consensus 22 ~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 22 DIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp SCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred Ccc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 365 5666 44 378888888888887767678888888999998886 8866666788888899999988 8888777
Q ss_pred ChhhhccCCCCeEeccCCCCCCCCCccccCCCCcc---EEEcccC-cccccCCcccccCCCCcc-eeecccccccccCCc
Q 005045 99 PNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY---YFSVTQN-QLHGQLPTDVGLTLPNLK-IFAGAVNYFTGSIPV 173 (717)
Q Consensus 99 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~~l~~~~~~~l~~L~-~L~l~~n~l~~~~~~ 173 (717)
+..|.++++|++|+|++|.+++ +|. |..+++|+ +|++++| .++ .+|...|..+++|+ .|++++|.++.+.+.
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~ 174 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFTSVQGY 174 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCCEECTT
T ss_pred HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCcccCHh
Confidence 7788888889999998888885 454 88888887 8899988 887 77777777888888 889988888855555
Q ss_pred cCCCCCCCCEEeccCcc-ccccCCCCccCC-CCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecC
Q 005045 174 SLSNASNLQVLDFAENG-LTGTIPGNFGSL-KDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARN 243 (717)
Q Consensus 174 ~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N 243 (717)
.|.. ++|++|++++|+ ++...+..|..+ ++|+.|++++|+++.++ .. .+++|+.|+++++
T Consensus 175 ~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~------~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 175 AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP------SK---GLEHLKELIARNT 236 (239)
T ss_dssp TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC------CT---TCTTCSEEECTTC
T ss_pred hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC------hh---HhccCceeeccCc
Confidence 5555 789999999995 886777788888 88999999999888776 22 5678888888775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-26 Score=244.00 Aligned_cols=264 Identities=15% Similarity=0.225 Sum_probs=159.9
Q ss_pred EEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCC----ccccCCC-CccEEEcccCcccccCCcccccCCCCccee
Q 005045 86 ALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIP----SSIYNIS-SIYYFSVTQNQLHGQLPTDVGLTLPNLKIF 160 (717)
Q Consensus 86 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L 160 (717)
.++|++|.+++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+. .+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~-~~------ 74 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV-QI------ 74 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHH-HH------
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHH-HH------
Confidence 45778888887777666666668888888888876666 6677777 788888888887633232222 21
Q ss_pred ecccccccccCCccCCC-CCCCCEEeccCccccccCCCC----ccCC-CCCCeeeccccccCCcccCchhhhhhhccC-C
Q 005045 161 AGAVNYFTGSIPVSLSN-ASNLQVLDFAENGLTGTIPGN----FGSL-KDLVRLNFDQNELGSREIGDLNFLKFLANC-T 233 (717)
Q Consensus 161 ~l~~n~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~----~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l-~ 233 (717)
+.. .++|++|+|++|.+++..+.. +..+ ++|++|++++|.++..+...+ ...+..+ +
T Consensus 75 --------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--~~~l~~~~~ 138 (362)
T 3goz_A 75 --------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF--KQAFSNLPA 138 (362)
T ss_dssp --------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH--HHHHTTSCT
T ss_pred --------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH--HHHHHhCCC
Confidence 111 144555555555554333332 2222 455555555555554431111 1223332 4
Q ss_pred CCCEEEeecCcccCcCchhh----hhccccccEEecCCCccCCCCCccc----cCC-CCCCEEEccCCcCccc----cch
Q 005045 234 SLEVLGLARNSFGGEMPISI----ANLSTHLRRLTMGENLMHGNIPVGI----GNL-VNLNLLGLEGNNLSGS----VPE 300 (717)
Q Consensus 234 ~L~~L~L~~N~l~~~~p~~~----~~~~~~L~~L~l~~N~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~----~~~ 300 (717)
+|++|+|++|.+++..+..+ ...+++|++|++++|.+++..+..+ ..+ ++|++|+|++|+|+.. ++.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 66666666666664333332 2232366666666666665554433 334 4788888888888752 445
Q ss_pred hhhcC-CCCCeEEcccCcCCCCCCc----ccccccccceeeccccccccc-------CCcCccCcCCCceEEeecccCCC
Q 005045 301 VIGRL-NKLEGLGLNVNKFSGLIPS----SLGNLTILTRLWMEENRLEGS-------IPPSLGNCQKLLVLNLSSNDLNG 368 (717)
Q Consensus 301 ~~~~l-~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l~~ 368 (717)
.+..+ ++|++|+|++|++++..+. .+..+++|+.|+|++|.+.+. ++..+..+++|+.||+++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 55553 4888888888888876552 345668888888888885432 34467788889999999999876
Q ss_pred CCCc
Q 005045 369 TIPK 372 (717)
Q Consensus 369 ~~p~ 372 (717)
..|.
T Consensus 299 ~~~~ 302 (362)
T 3goz_A 299 SHSI 302 (362)
T ss_dssp GGCH
T ss_pred cchH
Confidence 5443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-27 Score=267.29 Aligned_cols=348 Identities=15% Similarity=0.156 Sum_probs=186.2
Q ss_pred eecEEEcCCCcCcCCCCcCCc-CCCCCCEEECCCC-ccccc-CCcCCCCCCCCCEEEccCccccccCCcccc----CCCC
Q 005045 11 MTQDLNLTYNYLSGKIPTNLS-HCTELRSFEASVN-DFVGQ-IPNQLSSLTKLEIIGLGGSNLTGNVPAWIG----NFSS 83 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~ 83 (717)
.+++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 455555555555544444443 4555555555555 33321 222233455566666665555543333332 3445
Q ss_pred CCEEeccCCc--Ccc-cCChhhhccCCCCeEeccCC-CCCCCCCccccCCCCccEEEcccCc------------------
Q 005045 84 LKALSLAWNN--LRG-SIPNELGQLSGLGFFTLYGN-FISGIIPSSIYNISSIYYFSVTQNQ------------------ 141 (717)
Q Consensus 84 L~~L~L~~n~--l~~-~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~------------------ 141 (717)
|++|+|++|. ++. .++..+..+++|++|+|++| .+.+ .+..+..+++|+.|+++++.
T Consensus 186 L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~ 264 (594)
T 2p1m_B 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264 (594)
T ss_dssp CCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTC
T ss_pred CcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcC
Confidence 6666665554 110 01111233455666666555 2222 34444455555555533331
Q ss_pred --------ccc----cCCcccccCCCCcceeecccccccccCCc-cCCCCCCCCEEeccCcccccc-CCCCccCCCCCCe
Q 005045 142 --------LHG----QLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SLSNASNLQVLDFAENGLTGT-IPGNFGSLKDLVR 207 (717)
Q Consensus 142 --------l~~----~l~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~ 207 (717)
+.+ .++. +...+++|+.|++++|.++..... .+..+++|++|++++| ++.. .+.....+++|++
T Consensus 265 ~~L~~Ls~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 265 KELRCLSGFWDAVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp TTCCEEECCBTCCGGGGGG-GHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCcccccCCcccchhhHHH-HHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 100 0111 111356666777766665533222 2445666777777666 3321 1112224666777
Q ss_pred eecc---------ccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecC--C----CccCC
Q 005045 208 LNFD---------QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMG--E----NLMHG 272 (717)
Q Consensus 208 L~l~---------~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~--~----N~l~~ 272 (717)
|+++ .+.++... ......++++|+.|.++.|.+++..+..+....++|+.|+++ + |.++.
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~-----l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQG-----LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHH-----HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred EEEecCcccccccCCCCCHHH-----HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 7663 23443322 112223467778887777777765555555433578888887 3 44542
Q ss_pred CC-----CccccCCCCCCEEEccCCcCccccchhhhc-CCCCCeEEcccCcCCCCCCccc-ccccccceeeccccccccc
Q 005045 273 NI-----PVGIGNLVNLNLLGLEGNNLSGSVPEVIGR-LNKLEGLGLNVNKFSGLIPSSL-GNLTILTRLWMEENRLEGS 345 (717)
Q Consensus 273 ~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~ 345 (717)
.. +..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 11 11255677888888876 666555555555 7788888888888765544444 5578888888888887544
Q ss_pred CCc-CccCcCCCceEEeecccCC
Q 005045 346 IPP-SLGNCQKLLVLNLSSNDLN 367 (717)
Q Consensus 346 ~p~-~~~~l~~L~~L~l~~N~l~ 367 (717)
.+. .+..+++|+.|++++|+++
T Consensus 497 ~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 497 ALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHHHHhCCCCCEEeeeCCCCC
Confidence 333 3455788888888888774
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=215.84 Aligned_cols=206 Identities=16% Similarity=0.239 Sum_probs=156.6
Q ss_pred ccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCc-CcccCChhhhccCCCCeEeccC-CCCCCCCC
Q 005045 46 FVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN-LRGSIPNELGQLSGLGFFTLYG-NFISGIIP 123 (717)
Q Consensus 46 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~ 123 (717)
++ .+|. +.. +|++|+|++|++++..+..|.++++|++|+|++|+ ++.+.+.+|.++++|++|+|++ |+++.+.+
T Consensus 23 l~-~ip~-~~~--~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LPP--STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CCT--TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CCC--cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 55 5665 433 78888888888886666678888888888888886 8766667788888888888887 88887777
Q ss_pred ccccCCCCccEEEcccCcccccCCcccccCCCCcc---eeecccc-cccccCCccCCCCCCCC-EEeccCccccccCCCC
Q 005045 124 SSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLK---IFAGAVN-YFTGSIPVSLSNASNLQ-VLDFAENGLTGTIPGN 198 (717)
Q Consensus 124 ~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~ 198 (717)
..|.++++|++|++++|+++ .+|. +..+++|+ .|++++| .++...+..|.++++|+ +|++++|+++...+..
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~ 175 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYA 175 (239)
T ss_dssp TSEECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTT
T ss_pred HHhCCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhh
Confidence 78888888888888888887 5775 55777777 8888888 88877777788888888 8888888888444444
Q ss_pred ccCCCCCCeeeccccc-cCCcccCchhhhhhhccC-CCCCEEEeecCcccCcCchhhhhccccccEEecCCCc
Q 005045 199 FGSLKDLVRLNFDQNE-LGSREIGDLNFLKFLANC-TSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENL 269 (717)
Q Consensus 199 ~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~ 269 (717)
|.. ++|+.|++++|+ ++.++ +..|.++ ++|+.|++++|.++ .+|.. .+ ++|+.|+++++.
T Consensus 176 ~~~-~~L~~L~L~~n~~l~~i~------~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~-~~L~~L~l~~~~ 237 (239)
T 2xwt_C 176 FNG-TKLDAVYLNKNKYLTVID------KDAFGGVYSGPSLLDVSQTSVT-ALPSK--GL-EHLKELIARNTW 237 (239)
T ss_dssp TTT-CEEEEEECTTCTTCCEEC------TTTTTTCSBCCSEEECTTCCCC-CCCCT--TC-TTCSEEECTTC-
T ss_pred cCC-CCCCEEEcCCCCCcccCC------HHHhhccccCCcEEECCCCccc-cCChh--Hh-ccCceeeccCcc
Confidence 444 788888888884 87776 5567777 88888888888888 55544 22 478888887763
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.8e-27 Score=248.93 Aligned_cols=193 Identities=19% Similarity=0.250 Sum_probs=122.4
Q ss_pred CCCCCCCEEeccCccccc----cCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccC---------CCCCEEEeec
Q 005045 176 SNASNLQVLDFAENGLTG----TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANC---------TSLEVLGLAR 242 (717)
Q Consensus 176 ~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l---------~~L~~L~L~~ 242 (717)
..+++|++|+|++|.++. .++..+..+++|++|+|++|.++..... .++..+..+ ++|++|+|++
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~l~~~~~~~~~~~L~~L~L~~ 168 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA--KIARALQELAVNKKAKNAPPLRSIICGR 168 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH--HHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH--HHHHHHHHHhhhhhcccCCCCcEEECCC
Confidence 444555555555555543 2334444555555555555555432211 112223333 6666666666
Q ss_pred Cccc-CcCc---hhhhhccccccEEecCCCccCC-----CCCccccCCCCCCEEEccCCcCc----cccchhhhcCCCCC
Q 005045 243 NSFG-GEMP---ISIANLSTHLRRLTMGENLMHG-----NIPVGIGNLVNLNLLGLEGNNLS----GSVPEVIGRLNKLE 309 (717)
Q Consensus 243 N~l~-~~~p---~~~~~~~~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~ 309 (717)
|.++ ..+| ..+... ++|++|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+
T Consensus 169 n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 169 NRLENGSMKEWAKTFQSH-RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp SCCTGGGHHHHHHHHHHC-TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred CCCCcHHHHHHHHHHHhC-CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 6665 2233 233344 367777777776652 23336777888888888888885 46777888888888
Q ss_pred eEEcccCcCCCC----CCccc--ccccccceeecccccccc----cCCcCc-cCcCCCceEEeecccCCCCCC
Q 005045 310 GLGLNVNKFSGL----IPSSL--GNLTILTRLWMEENRLEG----SIPPSL-GNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 310 ~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~p 371 (717)
+|+|++|++++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..|
T Consensus 248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 888888888765 34455 337888999999998886 377776 568899999999999987664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-23 Score=208.97 Aligned_cols=179 Identities=19% Similarity=0.289 Sum_probs=108.2
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
.+++++++++++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 456666666666 4555444 4666666666666655555666666666666666666655555566666666666666
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|++++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+++ .++
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~------------------------ 147 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIP------------------------ 147 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCC------------------------
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC-ccC------------------------
Confidence 6666555555666666666666666666555555566666666666666665 333
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+...
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 33455555566666666666555555555566666666666655543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-26 Score=245.76 Aligned_cols=272 Identities=23% Similarity=0.250 Sum_probs=143.1
Q ss_pred CCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCC----ccccCCCCCCEEeccCCc---CcccCChhh------
Q 005045 36 LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVP----AWIGNFSSLKALSLAWNN---LRGSIPNEL------ 102 (717)
Q Consensus 36 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~L~~n~---l~~~~~~~~------ 102 (717)
|+...++...+. .++..+..+++|++|+|++|.|++..+ ..+..+++|++|+|++|. +++.+|..+
T Consensus 11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~ 89 (386)
T 2ca6_A 11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89 (386)
T ss_dssp CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence 333344444444 555666777778888888887775433 335677788888887754 333445444
Q ss_pred -hccCCCCeEeccCCCCCC----CCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCC
Q 005045 103 -GQLSGLGFFTLYGNFISG----IIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSN 177 (717)
Q Consensus 103 -~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 177 (717)
..+++|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+...+..+ ..|.+.+ .
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l-----~~~~~~~-------~ 157 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL-----AVNKKAK-------N 157 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH-----HHHHHHH-------T
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH-----hhhhhcc-------c
Confidence 566777777777777775 3555667777777777777777522222221111000 0011110 0
Q ss_pred CCCCCEEeccCcccc-ccCC---CCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc----CcC
Q 005045 178 ASNLQVLDFAENGLT-GTIP---GNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG----GEM 249 (717)
Q Consensus 178 l~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~----~~~ 249 (717)
.++|++|++++|+++ ...+ ..+..+++|++|++++|.++..++..+. +..+..+++|+.|+|++|.++ ..+
T Consensus 158 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~-~~~l~~~~~L~~L~Ls~n~l~~~g~~~l 236 (386)
T 2ca6_A 158 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL-LEGLAYCQELKVLDLQDNTFTHLGSSAL 236 (386)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHH-HTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred CCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHH-HHHhhcCCCccEEECcCCCCCcHHHHHH
Confidence 056666666666665 2222 2344555666666666655532111110 124555666666666666663 234
Q ss_pred chhhhhccccccEEecCCCccCCC----CCccc--cCCCCCCEEEccCCcCcc----ccchhh-hcCCCCCeEEcccCcC
Q 005045 250 PISIANLSTHLRRLTMGENLMHGN----IPVGI--GNLVNLNLLGLEGNNLSG----SVPEVI-GRLNKLEGLGLNVNKF 318 (717)
Q Consensus 250 p~~~~~~~~~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l 318 (717)
|..+..+ ++|++|+|++|.+++. ++..+ +.+++|+.|+|++|.++. .+|..+ .++++|++|+|++|++
T Consensus 237 ~~~l~~~-~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 237 AIALKSW-PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp HHHGGGC-TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HHHHccC-CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 4444444 2455555555554432 23333 225556666666666654 244444 3455666666666665
Q ss_pred CCCC
Q 005045 319 SGLI 322 (717)
Q Consensus 319 ~~~~ 322 (717)
++..
T Consensus 316 ~~~~ 319 (386)
T 2ca6_A 316 SEED 319 (386)
T ss_dssp CTTS
T ss_pred Ccch
Confidence 5443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-23 Score=207.75 Aligned_cols=180 Identities=21% Similarity=0.227 Sum_probs=138.3
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+.++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666666666 5555444 466677777777766666666667777777777777766666666777777777777
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|+++ .++...+..+++|++|++++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++.+
T Consensus 92 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 92 NNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 77776 66666666677777777777777766667788999999999999999977777899999999999999999988
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGE 248 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 248 (717)
+ +..|..+++|+.|+|++|.+.+.
T Consensus 171 ~------~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 171 P------HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp C------TTTTTTCTTCCEEECCSCCBCTT
T ss_pred C------HHHHhCCCCCCEEEeeCCceeCC
Confidence 7 56788999999999999999865
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=219.91 Aligned_cols=229 Identities=16% Similarity=0.120 Sum_probs=136.0
Q ss_pred CCCCEEeccCCcCcccCCh---hhhccCCCCeEeccCCCCCCCCCccc--cCCCCccEEEcccCcccccCCc---ccccC
Q 005045 82 SSLKALSLAWNNLRGSIPN---ELGQLSGLGFFTLYGNFISGIIPSSI--YNISSIYYFSVTQNQLHGQLPT---DVGLT 153 (717)
Q Consensus 82 ~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~l~~---~~~~~ 153 (717)
..++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+. ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3467777777776522111 13345678888888888887888777 7888888888888888743331 11224
Q ss_pred CCCcceeecccccccccCCccCCCCCCCCEEeccCcccccc--C--CCCccCCCCCCeeeccccccCCcccCchhhhhhh
Q 005045 154 LPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT--I--PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229 (717)
Q Consensus 154 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~ 229 (717)
+++|++|++++|.+.+..+..|..+++|++|+|++|++.+. . +..+..+++|++|++++|+++.++.. ....+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~---~~~l~ 220 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGV---CAALA 220 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHH---HHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHH---HHHHH
Confidence 55666666666666655556666666666666666665431 1 12234555555555555555433200 00012
Q ss_pred ccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCC---CCCCEEEccCCcCccccchhhhcCC
Q 005045 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNL---VNLNLLGLEGNNLSGSVPEVIGRLN 306 (717)
Q Consensus 230 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~ 306 (717)
.+++ +|++|+|++|.+++..|..+..+ ++|++|+|++|+|+ .+|..+. +
T Consensus 221 ~~l~-------------------------~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~ 272 (310)
T 4glp_A 221 AAGV-------------------------QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A 272 (310)
T ss_dssp HHTC-------------------------CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred hcCC-------------------------CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence 3444 45555555555554444444444 57777777777777 4555443 6
Q ss_pred CCCeEEcccCcCCCCCCcccccccccceeeccccccc
Q 005045 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 307 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 343 (717)
+|++|+|++|+++++ |. +..+++|+.|+|++|+++
T Consensus 273 ~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 273 KLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 777777777777755 22 566677777777777775
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=220.60 Aligned_cols=241 Identities=19% Similarity=0.150 Sum_probs=118.8
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCC-CCccccCCCCccE-EEcc
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGI-IPSSIYNISSIYY-FSVT 138 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~-L~L~ 138 (717)
++++.++++++ .+|..+. +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+.+|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45566666666 4554442 4556666666666544444555555555555555555332 2234455544433 3333
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccc-cccCC
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQ-NELGS 217 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~ 217 (717)
+|++ ..+.|..|..+++|++|++++|+++...+..+....++..|++.+ |++..
T Consensus 89 ~N~l-------------------------~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 89 ANNL-------------------------LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp ETTC-------------------------CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCE
T ss_pred CCcc-------------------------cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccc
Confidence 4444 444455566666666666666666654444455555555555533 34444
Q ss_pred cccCchhhhhhhccCC-CCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccC-CcCc
Q 005045 218 REIGDLNFLKFLANCT-SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEG-NNLS 295 (717)
Q Consensus 218 ~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~ 295 (717)
++ ...|..+. .++.|+|++|+|+ .+|...+.. .+|+.|++++ |.++
T Consensus 144 l~------~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~-------------------------~~L~~l~l~~~n~l~ 191 (350)
T 4ay9_X 144 IE------RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG-------------------------TQLDELNLSDNNNLE 191 (350)
T ss_dssp EC------TTSSTTSBSSCEEEECCSSCCC-EECTTSSTT-------------------------EEEEEEECTTCTTCC
T ss_pred cc------ccchhhcchhhhhhcccccccc-CCChhhccc-------------------------cchhHHhhccCCccc
Confidence 43 22233322 3444555555555 333333332 3444444442 3444
Q ss_pred cccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeeccc
Q 005045 296 GSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND 365 (717)
Q Consensus 296 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 365 (717)
.+.++.|.++++|++|+|++|+|+.+++..|.++++|+.+++ +.++ .+| .+..+++|+.++++++.
T Consensus 192 ~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 333334555555555555555555544444444444443333 2232 444 35566666666665443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=222.63 Aligned_cols=227 Identities=17% Similarity=0.167 Sum_probs=178.8
Q ss_pred CCCCEEECCCCcccccC-Cc--CCCCCCCCCEEEccCccccccCCccc--cCCCCCCEEeccCCcCcccCC----hhhhc
Q 005045 34 TELRSFEASVNDFVGQI-PN--QLSSLTKLEIIGLGGSNLTGNVPAWI--GNFSSLKALSLAWNNLRGSIP----NELGQ 104 (717)
Q Consensus 34 ~~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~ 104 (717)
..++.|.+.++.++... .. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 35788888888775211 00 12335679999999999998888887 889999999999999997555 34567
Q ss_pred cCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccccc--CC-cccccCCCCcceeecccccccccCC--c-cCCCC
Q 005045 105 LSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQ--LP-TDVGLTLPNLKIFAGAVNYFTGSIP--V-SLSNA 178 (717)
Q Consensus 105 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--l~-~~~~~~l~~L~~L~l~~n~l~~~~~--~-~~~~l 178 (717)
+++|++|+|++|.+.+..+..|.++++|++|+|++|++.+. ++ ...+..+++|++|++++|.++...+ . .+..+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 89999999999999988889999999999999999998642 22 2334578999999999999973221 1 25678
Q ss_pred CCCCEEeccCccccccCCCCccCC---CCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhh
Q 005045 179 SNLQVLDFAENGLTGTIPGNFGSL---KDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIAN 255 (717)
Q Consensus 179 ~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 255 (717)
++|++|+|++|++++..|..+..+ ++|++|++++|+|+.++ ..+ .++|++|+|++|++++ +|. +..
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp-------~~~--~~~L~~L~Ls~N~l~~-~~~-~~~ 292 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVP-------KGL--PAKLRVLDLSSNRLNR-APQ-PDE 292 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCC-------SCC--CSCCSCEECCSCCCCS-CCC-TTS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchh-------hhh--cCCCCEEECCCCcCCC-Cch-hhh
Confidence 999999999999997778777766 69999999999999775 223 2799999999999994 444 444
Q ss_pred ccccccEEecCCCccCC
Q 005045 256 LSTHLRRLTMGENLMHG 272 (717)
Q Consensus 256 ~~~~L~~L~l~~N~l~~ 272 (717)
+ ++|+.|++++|+++.
T Consensus 293 l-~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 293 L-PEVDNLTLDGNPFLV 308 (310)
T ss_dssp C-CCCSCEECSSTTTSC
T ss_pred C-CCccEEECcCCCCCC
Confidence 4 589999999999873
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-25 Score=233.26 Aligned_cols=254 Identities=17% Similarity=0.136 Sum_probs=158.2
Q ss_pred ecEEEcCCCcCcCCCCcCCcCC--CCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcccccc-CCccccCCCCCCEEe
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHC--TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGN-VPAWIGNFSSLKALS 88 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~ 88 (717)
.+.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 567778777765 4555666 7788888888887755554 55677888888888877754 666777777888888
Q ss_pred ccCCcCcccCChhhhccCCCCeEeccCC-CCCCC-CCccccCCCCccEEEcccC-cccccCCcccccCCC-Ccceeeccc
Q 005045 89 LAWNNLRGSIPNELGQLSGLGFFTLYGN-FISGI-IPSSIYNISSIYYFSVTQN-QLHGQLPTDVGLTLP-NLKIFAGAV 164 (717)
Q Consensus 89 L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~l~~~~~~~l~-~L~~L~l~~ 164 (717)
|++|.+++..+..|..+++|++|+|++| .+++. .+..+.++++|++|+|++| .+++......+..++ +|+.|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888777667777777788888888887 56642 4555777777888888877 776321122233566 777777777
Q ss_pred cc--cc-ccCCccCCCCCCCCEEeccCcc-ccccCCCCccCCCCCCeeeccccc-cCCcccCchhhhhhhccCCCCCEEE
Q 005045 165 NY--FT-GSIPVSLSNASNLQVLDFAENG-LTGTIPGNFGSLKDLVRLNFDQNE-LGSREIGDLNFLKFLANCTSLEVLG 239 (717)
Q Consensus 165 n~--l~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~ 239 (717)
|. ++ ..++..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.... ...+.++++|+.|+
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~------~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET------LLELGEIPTLKTLQ 278 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG------GGGGGGCTTCCEEE
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHH------HHHHhcCCCCCEEe
Confidence 73 33 2344455566677777777776 555555566666666666666663 22211 22455566666666
Q ss_pred eecCcccCcCchhhhhccccccEEecCCCccCCCCCcccc
Q 005045 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIG 279 (717)
Q Consensus 240 L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~ 279 (717)
+++| ++.. .+..+...+..|++++|.+++..|..+.
T Consensus 279 l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 279 VFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred ccCc-cCHH---HHHHHHhhCcceEEecccCccccCCccc
Confidence 6666 3321 1222212344444555555544444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=227.45 Aligned_cols=253 Identities=18% Similarity=0.237 Sum_probs=135.0
Q ss_pred CCEEeccCCcCcccCChhhhcc--CCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccccc-CCcccccCCCCccee
Q 005045 84 LKALSLAWNNLRGSIPNELGQL--SGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQ-LPTDVGLTLPNLKIF 160 (717)
Q Consensus 84 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-l~~~~~~~l~~L~~L 160 (717)
++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++. .+..+++|++|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L 123 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNL 123 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHH-HHTTBCCCSEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHH-HHhhCCCCCEE
Confidence 667777777665 4556666 6777777777777755444 44567777777777766532 222 22244444444
Q ss_pred ecccccccccCCccCCCCCCCCEEeccCc-ccccc-CCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEE
Q 005045 161 AGAVNYFTGSIPVSLSNASNLQVLDFAEN-GLTGT-IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238 (717)
Q Consensus 161 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L 238 (717)
++++|.++...+..++.+++|++|++++| .+++. ++ ..+.++++|++|
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~------------------------------~~~~~~~~L~~L 173 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ------------------------------TLLSSCSRLDEL 173 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH------------------------------HHHHHCTTCCEE
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHH------------------------------HHHhcCCCCCEE
Confidence 44444444444444444555555555555 34321 22 334445555555
Q ss_pred EeecC-cccCc-CchhhhhccccccEEecCCCc--cC-CCCCccccCCCCCCEEEccCCc-CccccchhhhcCCCCCeEE
Q 005045 239 GLARN-SFGGE-MPISIANLSTHLRRLTMGENL--MH-GNIPVGIGNLVNLNLLGLEGNN-LSGSVPEVIGRLNKLEGLG 312 (717)
Q Consensus 239 ~L~~N-~l~~~-~p~~~~~~~~~L~~L~l~~N~--l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ 312 (717)
++++| .+++. ++..+..++.+|++|++++|. ++ +.++..+.++++|+.|+|++|. +++..+..+..+++|++|+
T Consensus 174 ~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~ 253 (336)
T 2ast_B 174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 253 (336)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred cCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEee
Confidence 55555 44432 233333331155555555552 22 2234445556666666666666 5545555666666666666
Q ss_pred cccCc-CCCCCCcccccccccceeecccccccccCCcCccCcC-CCceEEeecccCCCCCCcccc
Q 005045 313 LNVNK-FSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQ-KLLVLNLSSNDLNGTIPKEVR 375 (717)
Q Consensus 313 Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~ 375 (717)
+++|. ++......+..+++|+.|+|++| ++ ...+..+. .+..|++++|.+++..|+...
T Consensus 254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 254 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 66664 22111124556666777777666 22 22333332 355666777777766666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=216.36 Aligned_cols=208 Identities=18% Similarity=0.296 Sum_probs=124.4
Q ss_pred EEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCc
Q 005045 14 DLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN 93 (717)
Q Consensus 14 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 93 (717)
.+.+..+.+...++ +..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCc
Confidence 33455555553332 456677777777777776 344 46777777777777777773 333 7777777777777777
Q ss_pred CcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCc
Q 005045 94 LRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173 (717)
Q Consensus 94 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~ 173 (717)
+++ ++ .+..+++|++|+|++|.++++ + .+..+++|++|+|++|.++ .++. +..+++|+.|++++|.++...+
T Consensus 97 l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~- 168 (308)
T 1h6u_A 97 LKN-VS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSDLTP- 168 (308)
T ss_dssp CSC-CG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred CCC-ch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccC-cCcc--ccCCCCccEEEccCCcCCCChh-
Confidence 773 33 577777777777777777753 2 3777777777777777776 3333 3355555555555555554322
Q ss_pred cCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc
Q 005045 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246 (717)
Q Consensus 174 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 246 (717)
+..+++|+.|++++|.+++..+ +..+++|+.|++++|+++.+. .+..+++|+.|++++|.++
T Consensus 169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--------~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--------PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--------GGTTCTTCCEEEEEEEEEE
T ss_pred -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--------cccCCCCCCEEEccCCeee
Confidence 5555555555555555553222 455555555555555555432 1444555555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=219.04 Aligned_cols=241 Identities=16% Similarity=0.170 Sum_probs=125.3
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCC-ccccCCCCCCE-Eecc
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVP-AWIGNFSSLKA-LSLA 90 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~-L~L~ 90 (717)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45555666665 455444 2456666666666654333455666666666666665543333 34555555443 4444
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc-CcccccCCcccccCCCCcceeecccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ-NQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
.|+|+.+.|++|.++++|++|++++|+|+...+..+....++..|++.+ |++. .++.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~--------------------- 146 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIER--------------------- 146 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECT---------------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccc---------------------
Confidence 5555555555555555555555555555554444555555555555543 3343 3333
Q ss_pred cCCccCCCCC-CCCEEeccCccccccCCCCccCCCCCCeeecc-ccccCCcccCchhhhhhhccCCCCCEEEeecCcccC
Q 005045 170 SIPVSLSNAS-NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFD-QNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGG 247 (717)
Q Consensus 170 ~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 247 (717)
..|..+. .++.|+|++|+|+. ++......++|++|+++ +|.++.++ ...|.++++|++|+|++|+|+
T Consensus 147 ---~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~------~~~f~~l~~L~~LdLs~N~l~- 215 (350)
T 4ay9_X 147 ---NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELP------NDVFHGASGPVILDISRTRIH- 215 (350)
T ss_dssp ---TSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCC------TTTTTTEECCSEEECTTSCCC-
T ss_pred ---cchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCC------HHHhccCcccchhhcCCCCcC-
Confidence 3344432 45556666666663 33333334456666654 35555554 344556666666666666666
Q ss_pred cCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCc
Q 005045 248 EMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293 (717)
Q Consensus 248 ~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 293 (717)
.+|...+ .+|+.|.+.++.--..+| .+.++++|+.++++++.
T Consensus 216 ~lp~~~~---~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 216 SLPSYGL---ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCCSSSC---TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred ccChhhh---ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 4443221 245555544433222344 36667777777776543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.33 Aligned_cols=193 Identities=21% Similarity=0.304 Sum_probs=171.2
Q ss_pred ceecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 10 LMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
.++++|++++|+++. +| .+..+++|++|+|++|.+++ ++. +.++++|++|+|++|.+++ ++ .+..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 378999999999984 55 69999999999999999995 444 9999999999999999994 54 6999999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
++|++++ ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|.++ .++. +..+++|+.|++++|.+++
T Consensus 115 ~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 115 TSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp TTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC-CChh--hcCCCCCCEEECCCCccCc
Confidence 9999995 44 39999999999999999996544 999999999999999998 5665 6689999999999999996
Q ss_pred cCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcc
Q 005045 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSRE 219 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 219 (717)
..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.++..+
T Consensus 188 ~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred Chh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 554 8899999999999999996553 899999999999999998765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-25 Score=254.45 Aligned_cols=347 Identities=14% Similarity=0.106 Sum_probs=244.8
Q ss_pred ceecEEEcCCC-cCcCC-CCcCCcCCCCCCEEECCCCcccccCCcC----CCCCCCCCEEEccCcc--ccc-cCCccccC
Q 005045 10 LMTQDLNLTYN-YLSGK-IPTNLSHCTELRSFEASVNDFVGQIPNQ----LSSLTKLEIIGLGGSN--LTG-NVPAWIGN 80 (717)
Q Consensus 10 ~~~~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~L~~n~--l~~-~~p~~~~~ 80 (717)
.++++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.. ...+++|++|++++|. ++. .++..+..
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~ 209 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence 37899999999 55532 4454558899999999999987544333 3467799999999987 321 12222345
Q ss_pred CCCCCEEeccCC-cCcccCChhhhccCCCCeEeccCCC--------------------------CCCC----CCccccCC
Q 005045 81 FSSLKALSLAWN-NLRGSIPNELGQLSGLGFFTLYGNF--------------------------ISGI----IPSSIYNI 129 (717)
Q Consensus 81 l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~--------------------------i~~~----~~~~~~~l 129 (717)
+++|++|+|++| .++ .++..+..+++|+.|+++.+. +... ++..+..+
T Consensus 210 ~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~ 288 (594)
T 2p1m_B 210 CPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288 (594)
T ss_dssp CTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred CCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence 789999999998 455 477778888888888866552 2111 23333467
Q ss_pred CCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCc-cCCCCCCCCEEecc---------CccccccCCCCc
Q 005045 130 SSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-SLSNASNLQVLDFA---------ENGLTGTIPGNF 199 (717)
Q Consensus 130 ~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~---------~N~l~~~~~~~~ 199 (717)
++|++|+|++|.+++.....+...+++|+.|++++| +...... ....+++|++|+++ .+.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 899999999999875444445568899999999998 4422222 23358999999994 355654333333
Q ss_pred c-CCCCCCeeeccccccCCcccCchhhhhhh-ccCCCCCEEEee--c----CcccCc-----CchhhhhccccccEEecC
Q 005045 200 G-SLKDLVRLNFDQNELGSREIGDLNFLKFL-ANCTSLEVLGLA--R----NSFGGE-----MPISIANLSTHLRRLTMG 266 (717)
Q Consensus 200 ~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~l~~L~~L~L~--~----N~l~~~-----~p~~~~~~~~~L~~L~l~ 266 (717)
. .+++|+.|.++.|.++... ...+ ..+++|+.|+++ + |.+++. ++..+... ++|+.|+++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~------~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~-~~L~~L~L~ 440 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAA------LITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC-KDLRRLSLS 440 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHH------HHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHC-TTCCEEECC
T ss_pred HHhchhHHHHHHhcCCcCHHH------HHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhC-CCccEEeec
Confidence 3 4899999999999988654 3344 368999999999 4 566621 11123344 589999998
Q ss_pred CCccCCCCCccccC-CCCCCEEEccCCcCccccchhh-hcCCCCCeEEcccCcCCCCCCc-ccccccccceeeccccccc
Q 005045 267 ENLMHGNIPVGIGN-LVNLNLLGLEGNNLSGSVPEVI-GRLNKLEGLGLNVNKFSGLIPS-SLGNLTILTRLWMEENRLE 343 (717)
Q Consensus 267 ~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~ 343 (717)
+ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++|+|++|++++.... ....+++|+.|+|++|+++
T Consensus 441 ~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 441 G-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp S-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred C-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 8 666555555554 8999999999999986666555 6799999999999999654443 3456899999999999996
Q ss_pred ccCCcCc-cCcCCCceEEeecccC
Q 005045 344 GSIPPSL-GNCQKLLVLNLSSNDL 366 (717)
Q Consensus 344 ~~~p~~~-~~l~~L~~L~l~~N~l 366 (717)
......+ ..+++|+...+..+.-
T Consensus 520 ~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 520 FGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp HHHHHHHHHHCTTEEEEEECSSSC
T ss_pred HHHHHHHHHhCCCCEEEEecCCCc
Confidence 4433334 4567777766666544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.6e-22 Score=191.10 Aligned_cols=183 Identities=19% Similarity=0.200 Sum_probs=153.7
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.-+.+++++++++ .+|..+ .++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 8 ~~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 8 SGTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 3467889999998 566554 4689999999999997667778899999999999999996666678889999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|++++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|.++ .++...+..+++|+.|++++|.+.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~-- 161 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWD-- 161 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBC--
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccCCCccEEEecCCCee--
Confidence 99999777777899999999999999999888888899999999999999998 777777778889999999988765
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCC
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKD 204 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 204 (717)
+.+++|++|+++.|.+++.+|..++.++.
T Consensus 162 -----~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 162 -----CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -----CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -----cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 34567888888888888888887776654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-22 Score=191.08 Aligned_cols=170 Identities=19% Similarity=0.234 Sum_probs=153.7
Q ss_pred ceeeCCcc--eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccC
Q 005045 3 LIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGN 80 (717)
Q Consensus 3 l~~~p~~~--~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 80 (717)
++.+|... ++++|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|.+++..+..|..
T Consensus 19 l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 98 (208)
T 2o6s_A 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK 98 (208)
T ss_dssp CSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcC
Confidence 45566655 7899999999999877888999999999999999999776777899999999999999999777777899
Q ss_pred CCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCccee
Q 005045 81 FSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIF 160 (717)
Q Consensus 81 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L 160 (717)
+++|++|+|++|+|++..+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|.+.+ .+++|+.|
T Consensus 99 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L 170 (208)
T 2o6s_A 99 LTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYL 170 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--------CTTTTHHH
T ss_pred ccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--------CCCCHHHH
Confidence 9999999999999997777789999999999999999998888889999999999999999873 56789999
Q ss_pred ecccccccccCCccCCCCCC
Q 005045 161 AGAVNYFTGSIPVSLSNASN 180 (717)
Q Consensus 161 ~l~~n~l~~~~~~~~~~l~~ 180 (717)
+++.|.+++.+|..++.++.
T Consensus 171 ~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 171 SEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp HHHHHHCTTTBBCTTSSBCT
T ss_pred HHHHHhCCceeeccCccccC
Confidence 99999999999999987765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-24 Score=234.42 Aligned_cols=188 Identities=18% Similarity=0.152 Sum_probs=137.5
Q ss_pred ccccccCcccccceEEEEeCCCchhhhHHhHhh--------hhhHHHHHHHHHHHHhcCCCCcee--EEEEeeccccCCC
Q 005045 392 SKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--------QQGALKSFIDECNALKSTRHRNIL--RVITACSSVDLEG 461 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~--~~~~~~~~~~~~~ 461 (717)
...+.||+|+||.||+|.. .++.+++|..... .....+++.+|++++++++||||+ ..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------- 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD------- 410 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-------
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-------
Confidence 4467899999999999964 4666777764321 122356789999999999999999 555441
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..|+||||+++++|.+++.. +..++.|++.||+|||++ +|+||||||+||+++. .+||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred CCccEEEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence 2355999999999999999863 457999999999999998 9999999999999998 9999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTG 607 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~ 607 (717)
+|||+++....................||+.|+|||++.+ .|+..+|+||..+-..+-+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999998752110000000001235679999999999765 36788899999988888888877764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-21 Score=212.08 Aligned_cols=195 Identities=22% Similarity=0.288 Sum_probs=92.4
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+|+.|+|++|.|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 44444444444442 333221 34444444444444 333 223444444444444443 222 333 44445555
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|+|+ .+|. .+++|+.|++++|.|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+.+
T Consensus 129 ~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~l 195 (571)
T 3cvr_A 129 NNQLT-MLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESL 195 (571)
T ss_dssp SSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSC
T ss_pred CCcCC-CCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCch
Confidence 55444 2443 24445555555555443 222 34455555555555553 333 33 5555555555555544
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCC
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV 282 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~ 282 (717)
+. +. ...+...+.|+.|+|++|.|+ .+|..++.+ ++|+.|+|++|.+++..|..+..+.
T Consensus 196 p~--~~-~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l-~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA--VP-VRNHHSEETEIFFRCRENRIT-HIPENILSL-DPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC--CC---------CCEEEECCSSCCC-CCCGGGGGS-CTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh--HH-HhhhcccccceEEecCCCcce-ecCHHHhcC-CCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 31 00 000011122366667777666 566666664 4677777777776666666655543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=182.91 Aligned_cols=153 Identities=20% Similarity=0.260 Sum_probs=105.3
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
-+.+++++++++ .+|..+. ++|+.|+|++|.|+++.+..|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 356777777777 5565554 5677777777777766666677777777777777777766677777777777777777
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|+|+...+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++ .++.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~----------------------- 145 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK----------------------- 145 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCT-----------------------
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-EECH-----------------------
Confidence 7777555556677777777777777777766777777777777777777776 4443
Q ss_pred CccCCCCCCCCEEeccCcccc
Q 005045 172 PVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~ 192 (717)
..|..+++|++|+|++|.+.
T Consensus 146 -~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 146 -GTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp -TTTTTCTTCCEEECCSSCEE
T ss_pred -HHHhCCCCCCEEEeCCCCcC
Confidence 34555556666666666655
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=208.03 Aligned_cols=188 Identities=19% Similarity=0.297 Sum_probs=148.6
Q ss_pred CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEecc
Q 005045 35 ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114 (717)
Q Consensus 35 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 114 (717)
+|+.|+|++|.+++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888885 666553 67888888888888 666 346788888888888885 665 555 88888888
Q ss_pred CCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccccc
Q 005045 115 GNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT 194 (717)
Q Consensus 115 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 194 (717)
+|+|++ +|. .+++|+.|+|++|.|+ .+|. .+++|+.|++++|.+++ +|. |. ++|+.|+|++|+|+ .
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~ 194 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLT-MLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S 194 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccC-cCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence 888886 444 5788888888888887 5766 46788888888888886 555 65 89999999999999 6
Q ss_pred CCCCccCCCCC-------CeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhcc
Q 005045 195 IPGNFGSLKDL-------VRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257 (717)
Q Consensus 195 ~~~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 257 (717)
+|. |.. +| +.|+|++|+|+.++ ..+..+++|+.|+|++|.+++.+|..+..+.
T Consensus 195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp-------~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 195 LPA-VPV--RNHHSEETEIFFRCRENRITHIP-------ENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CCC-CC----------CCEEEECCSSCCCCCC-------GGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hhh-HHH--hhhcccccceEEecCCCcceecC-------HHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 666 554 77 99999999999875 4566699999999999999999999888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-21 Score=203.03 Aligned_cols=182 Identities=19% Similarity=0.205 Sum_probs=132.5
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCC-CCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLS-SLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
..+++++++++++ .+|..+. +.++.|+|++|.|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 19 ~~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 19 ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp ETTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 3467888888887 5666554 4578888888888876666676 7888888888888888666677888888888888
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
++|+|+...+..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|+|+ .+|...+..
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~---------------- 158 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD---------------- 158 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC-----------------
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcC----------------
Confidence 888888777777888888888888888888777788888888888888888887 566555411
Q ss_pred cCCccCCCCCCCCEEeccCccccccCCCCccCCCC--CCeeeccccccCC
Q 005045 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKD--LVRLNFDQNELGS 217 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~ 217 (717)
+..+++|+.|+|++|+|+...+..|..++. ++.|+|++|.+..
T Consensus 159 -----~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 159 -----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp --------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred -----cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 144566777777777776544455666665 3677777777653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=196.00 Aligned_cols=186 Identities=21% Similarity=0.301 Sum_probs=107.1
Q ss_pred EEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCc
Q 005045 14 DLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN 93 (717)
Q Consensus 14 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 93 (717)
.+.+..+.+.+..+ +..+++|++|++++|.++ .++. +..+++|++|+|++|++++. +. +..+++|++|+|++|+
T Consensus 28 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCc
Confidence 34455555543322 345566666666666665 2332 55666666666666666633 22 5666666666666666
Q ss_pred CcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCc
Q 005045 94 LRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV 173 (717)
Q Consensus 94 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~ 173 (717)
+++ ++ .+..+++|++|+|++|+++++ ..+..+++|+.|++++|+++ +. .
T Consensus 102 l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~-------------------------~~--~ 150 (291)
T 1h6t_A 102 VKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-------------------------DI--T 150 (291)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC-------------------------CC--G
T ss_pred CCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC-------------------------cc--h
Confidence 653 22 256666666666666666542 34555566666666666555 22 3
Q ss_pred cCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc
Q 005045 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246 (717)
Q Consensus 174 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 246 (717)
.+..+++|++|++++|++++..+ +..+++|+.|++++|.++.++ .+..+++|+.|++++|.++
T Consensus 151 ~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~--------~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR--------ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG--------GGTTCTTCSEEEEEEEEEE
T ss_pred hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCCh--------hhccCCCCCEEECcCCccc
Confidence 45555666666666666664333 666666666666666666542 2566677777777777766
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.1e-21 Score=215.59 Aligned_cols=191 Identities=21% Similarity=0.266 Sum_probs=115.3
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+..+.|+.+.+....+ +..+++|+.|++++|.+. .+| .|..+++|+.|+|++|.|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34455666666664433 466677777777777776 344 36777777777777777774333 6677777777777
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.|++ ++ .|..+++|+.|+|++|.|+++ ..+..+++|+.|+|++|.++ .+ ..+..+++|+.|+|++|.+.+.
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~-~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-DI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCC-CC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccC-Cc--hhhcccCCCCEEECcCCcCCCc
Confidence 777763 33 566777777777777777642 45667777777777777776 33 2233555555555555555544
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
.| +..+++|+.|+|++|.|++. + .+..+++|+.|+|++|.+...
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred hh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 33 55555555555555555532 2 345555555555555555443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-21 Score=198.94 Aligned_cols=157 Identities=18% Similarity=0.128 Sum_probs=122.6
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhh------------------hHHHHHHHHHHHHhcCCCCceeE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQ------------------GALKSFIDECNALKSTRHRNILR 449 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ni~~ 449 (717)
...|.+.+.||+|++|.||+|.+.+|+.||+|++..... .....+.+|++++++++|+++..
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~ 168 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 168 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe
Confidence 445566699999999999999997899999999863321 23567889999999998555555
Q ss_pred EEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005045 450 VITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPS 529 (717)
Q Consensus 450 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 529 (717)
+++. +..++||||++|++|.+ +... ....++.||+.|++|||+. ||+||||||+
T Consensus 169 ~~~~---------~~~~lvmE~~~g~~L~~-l~~~-------------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~ 222 (282)
T 1zar_A 169 VYAW---------EGNAVLMELIDAKELYR-VRVE-------------NPDEVLDMILEEVAKFYHR---GIVHGDLSQY 222 (282)
T ss_dssp EEEE---------ETTEEEEECCCCEEGGG-CCCS-------------CHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred EEec---------cceEEEEEecCCCcHHH-cchh-------------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence 4322 35699999999999998 4321 2346999999999999998 9999999999
Q ss_pred CEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-----------CCCcccchhh
Q 005045 530 NVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-----------QVSILGDIYS 591 (717)
Q Consensus 530 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~sDvws 591 (717)
||+++ +|.+||+|||.|+. +..|.|||.+.+ +++..+|+|.
T Consensus 223 NILl~-~~~vkl~DFG~a~~--------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE--------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE--------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HEEEE-CCcEEEEECCCCeE--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999 99999999999873 334688888643 3456666665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=182.67 Aligned_cols=153 Identities=20% Similarity=0.312 Sum_probs=115.1
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccC
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQN 140 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 140 (717)
+.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 56777777777 5665554 56777888888777666667777778888888888887777777888888888888888
Q ss_pred cccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC
Q 005045 141 QLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 141 ~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
+|+ .+|...|..+++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|.+..
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 887 6777666667777777777777776777778888888888888888886666667777777777777777653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=199.55 Aligned_cols=176 Identities=22% Similarity=0.211 Sum_probs=115.7
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhh-ccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELG-QLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
+.++++++.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56777777777 5665554 3467777777777766666666 777777777777777766667777777777777777
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCc---cCCCCCCeeeccccccC
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNF---GSLKDLVRLNFDQNELG 216 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~ 216 (717)
|+|+ .++...|..+++|+.|+|++|.|....+..|.++++|+.|+|++|+|+...+..| ..+++|+.|+|++|+|+
T Consensus 98 N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 7776 5555555566666666666666666666677777777777777777774444444 45666666666666666
Q ss_pred CcccCchhhhhhhccCCC--CCEEEeecCccc
Q 005045 217 SREIGDLNFLKFLANCTS--LEVLGLARNSFG 246 (717)
Q Consensus 217 ~~~~~~~~~~~~~~~l~~--L~~L~L~~N~l~ 246 (717)
.++ +..+..++. |+.|+|++|.+.
T Consensus 177 ~l~------~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 177 KLP------LTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCC------HHHHHHSCHHHHTTEECCSSCEE
T ss_pred ccC------HHHhhhccHhhcceEEecCCCcc
Confidence 655 444555554 255666666655
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=8e-21 Score=212.26 Aligned_cols=205 Identities=20% Similarity=0.254 Sum_probs=120.5
Q ss_pred CCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCccee
Q 005045 81 FSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIF 160 (717)
Q Consensus 81 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L 160 (717)
+..+..+.++.+.+....+ +..+++|+.|+|++|.|..+ + .|..+++|+.|+|++|.++ .++. +..+++|+.|
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~-~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-DIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCC-CCGG--GGGCTTCCEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCC-CChh--hccCCCCCEE
Confidence 3446667777777774443 57788888888888888843 3 5788888888888888887 3333 3345555555
Q ss_pred ecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEe
Q 005045 161 AGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240 (717)
Q Consensus 161 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L 240 (717)
+|++|.+... ..+. .+++|+.|+|++|.|..++ .+..+++|+.|+|
T Consensus 93 ~Ls~N~l~~l--~~l~------------------------~l~~L~~L~Ls~N~l~~l~--------~l~~l~~L~~L~L 138 (605)
T 1m9s_A 93 FLDENKIKDL--SSLK------------------------DLKKLKSLSLEHNGISDIN--------GLVHLPQLESLYL 138 (605)
T ss_dssp ECCSSCCCCC--TTST------------------------TCTTCCEEECTTSCCCCCG--------GGGGCTTCSEEEC
T ss_pred ECcCCCCCCC--hhhc------------------------cCCCCCEEEecCCCCCCCc--------cccCCCccCEEEC
Confidence 5555554421 1344 4444444444444444321 2444555555555
Q ss_pred ecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC
Q 005045 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 241 ~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 320 (717)
++|.+++ + ..+..+ ++|+.|+|++|.+.+..| +..+++|+.|+|++|+|++ ++ .+..+++|+.|+|++|++++
T Consensus 139 s~N~l~~-l-~~l~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 139 GNNKITD-I-TVLSRL-TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCC-C-GGGGSC-TTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEEC
T ss_pred CCCccCC-c-hhhccc-CCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcC
Confidence 5555552 2 233333 355555555555554333 6666677777777777764 33 46667777777777777765
Q ss_pred CCCcccccccccc
Q 005045 321 LIPSSLGNLTILT 333 (717)
Q Consensus 321 ~~~~~~~~l~~L~ 333 (717)
.....+..+..+.
T Consensus 212 ~p~~~~~~l~~~~ 224 (605)
T 1m9s_A 212 KPINHQSNLVVPN 224 (605)
T ss_dssp CCCCCCSSCEEEC
T ss_pred CcccccccEEecc
Confidence 5444444443333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=189.62 Aligned_cols=168 Identities=18% Similarity=0.226 Sum_probs=140.6
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+++|++++|.++.. + .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.+++ +|. +..+++|++|+|+
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECC
Confidence 789999999999854 4 48999999999999999996544 9999999999999999994 554 9999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|++++. ..+..+++|+.|+|++|+++++ ..+..+++|++|+|++|.++ .++. +..+++|+.|++++|.++..
T Consensus 121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~-~~~~--l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 121 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc-cchh--hcCCCccCEEECCCCcCCCC
Confidence 9999953 5799999999999999999965 78999999999999999998 4444 45677777777777777743
Q ss_pred CCccCCCCCCCCEEeccCccccc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~ 193 (717)
+ .+..+++|+.|++++|+++.
T Consensus 194 -~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 -R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -G-GGTTCTTCSEEEEEEEEEEC
T ss_pred -h-hhccCCCCCEEECcCCcccC
Confidence 2 36677777777777777763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.3e-20 Score=178.91 Aligned_cols=152 Identities=22% Similarity=0.236 Sum_probs=85.6
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCC-hhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIP-NELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35555555555 3444332 234555555555554433 3355555555555555555555555555555666666666
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccC
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELG 216 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 216 (717)
|+++ .++...+..+++|++|+|++|.+++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|.+.
T Consensus 91 N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 6555 444444445555555555555555555566666666666666666666555666666666666666666554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.2e-20 Score=178.94 Aligned_cols=153 Identities=19% Similarity=0.234 Sum_probs=91.8
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCC-cCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIP-NQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
+++++++|+++ .+|..+. +.+++|+|++|.+++..| ..|.++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46666666666 3554443 345666666666664433 3355666666666666666655555566666666666666
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|+|++..+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+++ +..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~ 145 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-------------------------TVA 145 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC-------------------------CBC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC-------------------------EEC
Confidence 6666555555666666666666666666555555555555555555555555 445
Q ss_pred CccCCCCCCCCEEeccCccccc
Q 005045 172 PVSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~ 193 (717)
|..|..+++|++|+|++|.+.+
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEEC
T ss_pred HHHhcCCCCCCEEEecCcCCcC
Confidence 5666677777777777777764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-19 Score=177.15 Aligned_cols=152 Identities=16% Similarity=0.159 Sum_probs=79.7
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
+.++.++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44555555555 3443332 45555555555555444555555555555555555555333344455555555555555
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 172 (717)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|+ +|.++...+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~-------------------------~N~l~~~~~ 152 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD-------------------------QNQLKSIPH 152 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECC-------------------------SSCCCCCCT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECC-------------------------CCcCCccCH
Confidence 555444444455555555555555554 334444444444444444 444444444
Q ss_pred ccCCCCCCCCEEeccCccccc
Q 005045 173 VSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 173 ~~~~~l~~L~~L~l~~N~l~~ 193 (717)
..|..+++|+.|++++|.+.+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCT
T ss_pred HHHhCCCCCCEEEeeCCCccC
Confidence 556667777777777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=196.31 Aligned_cols=223 Identities=11% Similarity=0.008 Sum_probs=144.0
Q ss_pred cCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEE
Q 005045 105 LSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVL 184 (717)
Q Consensus 105 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 184 (717)
+++|+.|+|.+ .++.+...+|.++++|+.|++++|.+. .++. .+|.++.++..+
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~------------------------~aF~~~~~l~~l 153 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLP------------------------EALADSVTAIFI 153 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECT------------------------TSSCTTTCEEEE
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccch------------------------hhhcCCCceEEe
Confidence 55555555555 455444555555555555555555554 4444 444444444444
Q ss_pred eccCc----cccccCCCCccCCCCCC-eeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhcccc
Q 005045 185 DFAEN----GLTGTIPGNFGSLKDLV-RLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTH 259 (717)
Q Consensus 185 ~l~~N----~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~ 259 (717)
.+..+ .........|.++..|+ .+.+.... .++. .....-....++..+.+.++-.. .....+....++
T Consensus 154 ~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~--~l~~---~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~ 227 (329)
T 3sb4_A 154 PLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG--KLED---EIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPN 227 (329)
T ss_dssp CTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC--CHHH---HHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTT
T ss_pred cCcchhhhhccccccccccccccccceeEEecCCC--cHHH---HHhhcccCccccceEEEeeeecH-HHHHHHHHhcCC
Confidence 44432 12223344455555555 33333211 1110 00111123456777777766433 223333333368
Q ss_pred ccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCC-eEEcccCcCCCCCCcccccccccceeecc
Q 005045 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLE-GLGLNVNKFSGLIPSSLGNLTILTRLWME 338 (717)
Q Consensus 260 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 338 (717)
|+.|++++|.++.+...+|.++.+|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|+++
T Consensus 228 L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~ 305 (329)
T 3sb4_A 228 LVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLAT 305 (329)
T ss_dssp CCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEEC
T ss_pred CeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeC
Confidence 999999999998778888999999999999998 8777788899999999 999988 7888888999999999999999
Q ss_pred cccccccCCcCccCcCCCceEEe
Q 005045 339 ENRLEGSIPPSLGNCQKLLVLNL 361 (717)
Q Consensus 339 ~N~l~~~~p~~~~~l~~L~~L~l 361 (717)
+|.++...+.+|.++++|+.++.
T Consensus 306 ~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 306 GDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp SSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCccCccchhhhcCCcchhhhcc
Confidence 99999777789999999998874
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-19 Score=176.56 Aligned_cols=154 Identities=21% Similarity=0.224 Sum_probs=110.7
Q ss_pred CCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 60 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
-+.++++++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 455666666666 4554443 5666666666666655566666666666666666666655555666666666666666
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
|+|+ .++...|..+++|+.|++++|.++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|.+...
T Consensus 98 N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 6666 566665556666666666666666 5677788999999999999999977778899999999999999998753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=6e-20 Score=184.27 Aligned_cols=170 Identities=24% Similarity=0.346 Sum_probs=81.8
Q ss_pred CCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCccee
Q 005045 81 FSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIF 160 (717)
Q Consensus 81 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L 160 (717)
+.++..+++++|.+++. + .+..+++|++|++++|.|+.+ + .+..+++|++|+|++|+++ .++
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~-~~~------------- 79 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQIS-DLS------------- 79 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCG-------------
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccC-CCh-------------
Confidence 34455555555555522 2 355555555555555555532 2 4555555555555555554 222
Q ss_pred ecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEe
Q 005045 161 AGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240 (717)
Q Consensus 161 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L 240 (717)
+ +..+++|++|++++|++++ +|.. .. ++|+.|++++|+++.++ .+..+++|+.|+|
T Consensus 80 -----------~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~~--------~l~~l~~L~~L~L 135 (263)
T 1xeu_A 80 -----------P--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDTD--------SLIHLKNLEILSI 135 (263)
T ss_dssp -----------G--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBSG--------GGTTCTTCCEEEC
T ss_pred -----------h--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCCCh--------hhcCcccccEEEC
Confidence 1 4455555555555555553 2221 11 44455555544444421 2344444444444
Q ss_pred ecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCC
Q 005045 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 241 ~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 320 (717)
++|+++ .++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++
T Consensus 136 s~N~i~-~~~--------------------------~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 136 RNNKLK-SIV--------------------------MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp TTSCCC-BCG--------------------------GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCCcCC-CCh--------------------------HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 444444 111 344445555555555555533 345555555555555555554
Q ss_pred C
Q 005045 321 L 321 (717)
Q Consensus 321 ~ 321 (717)
.
T Consensus 187 ~ 187 (263)
T 1xeu_A 187 E 187 (263)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-20 Score=194.12 Aligned_cols=286 Identities=11% Similarity=0.069 Sum_probs=191.2
Q ss_pred eecEEEcCCCcCcCCCCcCCcC-CCCCCEEECCCCccc--ccCCcCCCCCCCCCEEEccCccccccCCccccC-------
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSH-CTELRSFEASVNDFV--GQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGN------- 80 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~------- 80 (717)
+++.|.++++--. ..-..+.. +++|+.|||++|++. ...+..+ +.++.+.+..|.| .+..|.+
T Consensus 26 ~l~~L~l~g~i~~-~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 26 SITHLTLTGKLNA-EDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTK 98 (329)
T ss_dssp HCSEEEEEEEECH-HHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEE
T ss_pred ceeEEEEeccccH-HHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccccc
Confidence 5677777764211 11122233 777888888888877 3333222 3355666666643 3567778
Q ss_pred -CCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccc---ccCCcccccCCCC
Q 005045 81 -FSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLH---GQLPTDVGLTLPN 156 (717)
Q Consensus 81 -l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~---~~l~~~~~~~l~~ 156 (717)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+|++|.+..+.+.+|.++.++..+.+..+... ..+....|..
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~--- 174 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE--- 174 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE---
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc---
Confidence 99999999999 899788889999999999999999999899999999888888877664321 1223333333
Q ss_pred cceeecccccccccCCccCCCCCCCC-EEeccCcc-ccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCC
Q 005045 157 LKIFAGAVNYFTGSIPVSLSNASNLQ-VLDFAENG-LTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTS 234 (717)
Q Consensus 157 L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~ 234 (717)
+..|+ .+.+.... +.......-....++..+.+.++- .... +......+++
T Consensus 175 ---------------------~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l-~~~~-----~~~l~~~~~~ 227 (329)
T 3sb4_A 175 ---------------------GEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKL-DNAD-----FKLIRDYMPN 227 (329)
T ss_dssp ---------------------SCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECC-CHHH-----HHHHHHHCTT
T ss_pred ---------------------ccccceeEEecCCCcHHHHHhhcccCccccceEEEeeee-cHHH-----HHHHHHhcCC
Confidence 33333 22222211 110000111123455555555442 1111 1122234778
Q ss_pred CCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCC-EEEccCCcCccccchhhhcCCCCCeEEc
Q 005045 235 LEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLN-LLGLEGNNLSGSVPEVIGRLNKLEGLGL 313 (717)
Q Consensus 235 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L 313 (717)
|+.|+|++|+++ .+|...+...++|+.|++++| ++.+...+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|++
T Consensus 228 L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 228 LVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp CCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 888888888888 555443333358888888887 7667788899999999 999988 777677889999999999999
Q ss_pred ccCcCCCCCCcccccccccceeec
Q 005045 314 NVNKFSGLIPSSLGNLTILTRLWM 337 (717)
Q Consensus 314 s~N~l~~~~~~~~~~l~~L~~L~L 337 (717)
++|.++.+.+.+|.++++|+.|+.
T Consensus 305 ~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 305 TGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCCccCccchhhhcCCcchhhhcc
Confidence 999999888889999999998874
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=174.18 Aligned_cols=153 Identities=13% Similarity=0.197 Sum_probs=85.3
Q ss_pred cCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCe
Q 005045 31 SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110 (717)
Q Consensus 31 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 110 (717)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45556666666666665 444 3556666666666666554 222 4555666666666666666555555666666666
Q ss_pred EeccCCCCCCCCCccccCCCCccEEEcccCc-ccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCc
Q 005045 111 FTLYGNFISGIIPSSIYNISSIYYFSVTQNQ-LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAEN 189 (717)
Q Consensus 111 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 189 (717)
|+|++|.+++..+..|..+++|++|+|++|. ++ .+| .+..+++|++|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~--------------------------~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM--------------------------PLKTLPELKSLNIQFD 169 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG--------------------------GGGGCSSCCEEECTTB
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH--------------------------hhcCCCCCCEEECCCC
Confidence 6666666665555556666666666666665 43 333 3444555555555555
Q ss_pred cccccCCCCccCCCCCCeeeccccccC
Q 005045 190 GLTGTIPGNFGSLKDLVRLNFDQNELG 216 (717)
Q Consensus 190 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 216 (717)
.+++ ++ .+..+++|+.|++++|+|.
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 5552 22 4555555555555555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-21 Score=217.87 Aligned_cols=203 Identities=19% Similarity=0.151 Sum_probs=117.4
Q ss_pred cCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCC-------------CCCCCCccccCCCCccEEE-cccCcccc
Q 005045 79 GNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNF-------------ISGIIPSSIYNISSIYYFS-VTQNQLHG 144 (717)
Q Consensus 79 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------i~~~~~~~~~~l~~L~~L~-L~~N~l~~ 144 (717)
..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56778888888888887 778888888888888887664 4445566666666666666 5555443
Q ss_pred cCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchh
Q 005045 145 QLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLN 224 (717)
Q Consensus 145 ~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 224 (717)
+|..+.+++|.+....+ ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|.|+
T Consensus 424 -----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-------- 476 (567)
T 1dce_A 424 -----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-------- 476 (567)
T ss_dssp -----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC--------
T ss_pred -----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc--------
Confidence 23444555555553322 135666666666663 343 555555555555555554
Q ss_pred hhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc-chhhh
Q 005045 225 FLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV-PEVIG 303 (717)
Q Consensus 225 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~ 303 (717)
.+|..+..+ ++|+.|+|++|.|++ +| .|.++++|+.|+|++|+|++.. |..++
T Consensus 477 -----------------------~lp~~~~~l-~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~ 530 (567)
T 1dce_A 477 -----------------------ALPPALAAL-RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530 (567)
T ss_dssp -----------------------CCCGGGGGC-TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGG
T ss_pred -----------------------ccchhhhcC-CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHh
Confidence 444444444 245555555555543 33 4555566666666666666444 55666
Q ss_pred cCCCCCeEEcccCcCCCCCCcc---cccccccceee
Q 005045 304 RLNKLEGLGLNVNKFSGLIPSS---LGNLTILTRLW 336 (717)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~ 336 (717)
.+++|+.|+|++|++++.+|.. +..+++|+.|+
T Consensus 531 ~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 531 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp GCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred cCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 6666666666666666543321 22355666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-20 Score=182.70 Aligned_cols=167 Identities=14% Similarity=0.229 Sum_probs=117.3
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+..+++++|.+++. + .+..+++|++|++++|.++ .+| .+..+++|++|+|++|+|++ ++. +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECC
Confidence 556677888888743 3 5777888888888888887 455 57778888888888888884 333 7788888888888
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|++++ +|. +.. ++|++|+|++|++++. +.+..+++|+.|+|++|+++ .++ .+..+++|+.|++++|.+++.
T Consensus 94 ~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~-~~~--~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 94 RNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIV--MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp SSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCC-BCG--GGGGCTTCCEEECTTSCCCBC
T ss_pred CCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCC-CCh--HHccCCCCCEEECCCCcCcch
Confidence 888874 333 222 7788888888888753 35777888888888888877 444 234566666777776666654
Q ss_pred CCccCCCCCCCCEEeccCccccc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~ 193 (717)
..+..+++|+.|++++|.++.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEEC
T ss_pred --HHhccCCCCCEEeCCCCcccC
Confidence 456666666666666666663
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-20 Score=209.70 Aligned_cols=224 Identities=19% Similarity=0.168 Sum_probs=112.9
Q ss_pred CCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEc
Q 005045 58 TKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137 (717)
Q Consensus 58 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 137 (717)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.|. .++++.|.+. ..++.|..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEEC
Confidence 345566666666652 222 22444555555444 2244455555 56777778888888888
Q ss_pred ccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC
Q 005045 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 138 ~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
++|.+. .+|..++ .+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+.
T Consensus 232 s~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp TTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence 888887 7777777 7788888888888887 67778888888899999998888 678888888889999999888886
Q ss_pred cccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCC-----
Q 005045 218 REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGN----- 292 (717)
Q Consensus 218 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N----- 292 (717)
++ ..|.++++|+.|+|++|.|++.+|..+......+..|+|++|.+++.+|. .|+.|++++|
T Consensus 308 lp-------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~ 374 (727)
T 4b8c_D 308 LP-------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQR 374 (727)
T ss_dssp CC-------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C--------------
T ss_pred cC-------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeeccccccc
Confidence 64 45888889999999999999888887766533445578888888876665 4556667766
Q ss_pred ---cCccccchhhhcCCCCCeEEcccCcCC
Q 005045 293 ---NLSGSVPEVIGRLNKLEGLGLNVNKFS 319 (717)
Q Consensus 293 ---~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 319 (717)
.+.+..+..+..+.++....++.|.+.
T Consensus 375 ~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 375 EYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ---------------------------CCC
T ss_pred ccCCccccccchhhcccccceeeeeccccc
Confidence 222223333344444444555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-21 Score=216.58 Aligned_cols=122 Identities=20% Similarity=0.193 Sum_probs=82.3
Q ss_pred CCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEc
Q 005045 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL 313 (717)
Q Consensus 234 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 313 (717)
.|+.|+|++|.|+ .+|. +..+ ++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~-~lp~-~~~l-~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLT-VLCH-LEQL-LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCS-SCCC-GGGG-TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCC-CCcC-cccc-ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 4677777777777 4564 5555 47777777777777 566677777777777777777774 55 6777777777777
Q ss_pred ccCcCCCCC-CcccccccccceeecccccccccCCcC---ccCcCCCceEEe
Q 005045 314 NVNKFSGLI-PSSLGNLTILTRLWMEENRLEGSIPPS---LGNCQKLLVLNL 361 (717)
Q Consensus 314 s~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~l 361 (717)
++|++++.. |..|+.+++|+.|+|++|++++..|.. +..+++|+.|++
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 777777665 677777777777777777777443321 233667776653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-19 Score=168.42 Aligned_cols=149 Identities=14% Similarity=0.194 Sum_probs=125.5
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+++|++++|+++ .+| .+..+++|++|++++|.++ .+ ..+..+++|++|++++|.+++..|..++.+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 7899999999999 566 6999999999999999776 33 469999999999999999998788999999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCC-CCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNF-ISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT 168 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~ 168 (717)
+|++++..+..|..+++|++|+|++|. ++. .+ .+..+++|++|++++|.++ .++ .+..+++|+.|++++|++.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~-~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVH-DYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCC-CCT--TGGGCSSCCEEEECBC---
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCc-ChH--HhccCCCCCEEEeeCcccC
Confidence 999998888999999999999999998 774 44 7999999999999999998 444 2334555555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-17 Score=176.04 Aligned_cols=270 Identities=11% Similarity=0.108 Sum_probs=149.4
Q ss_pred CCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEc
Q 005045 58 TKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137 (717)
Q Consensus 58 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 137 (717)
..++.+.+.+ .++.+...+|.+. +|+.++|..| ++.+...+|.+ .+|+.+.|.. .++.+...+|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 3444444433 2332333444442 4555555443 44344444444 2455555543 344444445555555555555
Q ss_pred ccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC
Q 005045 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 138 ~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
++|+++ .++...|. ..+|+.+.+..+ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.
T Consensus 188 ~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 188 SKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp TTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred CCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 555554 44444443 344444444422 33344444444444555444443 33233344444 44444444 233333
Q ss_pred cccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccc
Q 005045 218 REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGS 297 (717)
Q Consensus 218 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 297 (717)
++ ...|.++++|+.+++.+|.+. .+.+..+...+|.++++|+.++|. +.++.+
T Consensus 262 I~------~~aF~~c~~L~~l~l~~~~~~--------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I 314 (401)
T 4fdw_A 262 IA------SRAFYYCPELAEVTTYGSTFN--------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRIL 314 (401)
T ss_dssp EC------TTTTTTCTTCCEEEEESSCCC--------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEE
T ss_pred EC------hhHhhCCCCCCEEEeCCcccc--------------------CCcccEECHHHhhCCccCCeEEeC-CceEEE
Confidence 33 333444444444444444332 011113566778888899999988 457767
Q ss_pred cchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcC-CCceEEeecccCC
Q 005045 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQ-KLLVLNLSSNDLN 367 (717)
Q Consensus 298 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~ 367 (717)
...+|.++.+|+.+.|..| ++.+...+|.++ +|+.|++++|.+....+..|..++ +++.|++..|.+.
T Consensus 315 ~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 315 GQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 7778888899999999655 777778888888 899999999988866667787775 6788888776653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=165.40 Aligned_cols=134 Identities=20% Similarity=0.242 Sum_probs=119.1
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCc-CCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPN-QLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
.-+++++++|+++ .+|..+.. +|++|+|++|.+++..+. .|..+++|++|+|++|.|++..|..|..+++|++|+|
T Consensus 9 ~~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 85 (192)
T 1w8a_A 9 EGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEEC
Confidence 4478999999997 67776654 899999999999966654 4899999999999999999888999999999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCC
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLP 147 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~ 147 (717)
++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus 86 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999998888889999999999999999999999999999999999999999985544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-19 Score=204.79 Aligned_cols=219 Identities=20% Similarity=0.143 Sum_probs=84.6
Q ss_pred CCCCEEECCCCcccccCCcCCCCCCCCC-----EEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCC
Q 005045 34 TELRSFEASVNDFVGQIPNQLSSLTKLE-----IIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGL 108 (717)
Q Consensus 34 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~-----~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 108 (717)
+.++.|+|++|.+.. ++..+....+|. .++++.|.+. ..|+.|..+.+|+.|+|++|.|. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 446666777676663 333332222222 2334445555 56777777788888888888877 666666677888
Q ss_pred CeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccC
Q 005045 109 GFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAE 188 (717)
Q Consensus 109 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 188 (717)
++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..+. .+++|+.|+|++|.|+ .+|..|..+++|++|+|++
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~ 325 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG-SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEG 325 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG-GGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTT
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhc-CCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCC
Confidence 88888888887 66777777788888888888776 5554432 3444444444444443 3344444445555555555
Q ss_pred ccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCC
Q 005045 189 NGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGEN 268 (717)
Q Consensus 189 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N 268 (717)
|.|++.+|..+..+. ..+..|+|++|.+++.+|. .|..|++++|
T Consensus 326 N~l~~~~p~~~~~~~-----------------------------~~~~~l~l~~N~l~~~~p~-------~l~~l~l~~n 369 (727)
T 4b8c_D 326 NPLEKQFLKILTEKS-----------------------------VTGLIFYLRDNRPEIPLPH-------ERRFIEINTD 369 (727)
T ss_dssp SCCCSHHHHHHHHHH-----------------------------HHHHHHHHHHCCCCCCCCC-------C---------
T ss_pred CccCCCChHHHhhcc-----------------------------hhhhHHhhccCcccCcCcc-------ccceeEeecc
Confidence 554444443332211 0112355666666655553 4445555555
Q ss_pred --------ccCCCCCccccCCCCCCEEEccCCcCc
Q 005045 269 --------LMHGNIPVGIGNLVNLNLLGLEGNNLS 295 (717)
Q Consensus 269 --------~l~~~~~~~~~~l~~L~~L~L~~N~l~ 295 (717)
.+.+..+..+.++..+....+++|-+.
T Consensus 370 ~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 370 GEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp --------------------------------CCC
T ss_pred cccccccCCccccccchhhcccccceeeeeccccc
Confidence 333344445566667777777888765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-17 Score=173.30 Aligned_cols=268 Identities=12% Similarity=0.064 Sum_probs=192.6
Q ss_pred cCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCe
Q 005045 31 SHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGF 110 (717)
Q Consensus 31 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 110 (717)
..+..++.+.+-++ ++.+-..+|.+. +|+.+.|..+ ++.+...+|.+ .+|+.++|.. .++.+.+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence 34466777777643 554556667764 6888887666 66555666766 3688888875 666566777888888888
Q ss_pred EeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcc
Q 005045 111 FTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG 190 (717)
Q Consensus 111 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 190 (717)
++|++|+++.+...+|. .++|+.+.|..+ ++ .++...|.++++|+.+.+..| ++.+...+|.+ .+|+.+.+ .+.
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~ 258 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG 258 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence 88888888766666666 477888888744 65 777778878888888888764 55566677777 77888888 455
Q ss_pred ccccCCCCccCCCCCCeeeccccccC-----CcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEec
Q 005045 191 LTGTIPGNFGSLKDLVRLNFDQNELG-----SREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTM 265 (717)
Q Consensus 191 l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l 265 (717)
++.+...+|.++++|+.+.+.+|.+. .++ ...|.++++|+.++|. +.++.....+|... ++|+.+.+
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~------~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c-~~L~~l~l 330 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIH------PYCLEGCPKLARFEIP-ESIRILGQGLLGGN-RKVTQLTI 330 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEEC------TTTTTTCTTCCEECCC-TTCCEECTTTTTTC-CSCCEEEE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEEC------HHHhhCCccCCeEEeC-CceEEEhhhhhcCC-CCccEEEE
Confidence 66566778888888888888877665 344 5667888888888888 44663344445444 58888888
Q ss_pred CCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCC-CCCeEEcccCcCC
Q 005045 266 GENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLN-KLEGLGLNVNKFS 319 (717)
Q Consensus 266 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 319 (717)
..| ++.+...+|.++ +|+.+++++|.+....+..|.+++ ++..|++..+.+.
T Consensus 331 p~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 331 PAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred Ccc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 665 665777888888 999999999988877777788874 6888888777643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=162.46 Aligned_cols=132 Identities=24% Similarity=0.307 Sum_probs=110.2
Q ss_pred CEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCc-cccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcc
Q 005045 236 EVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPV-GIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLN 314 (717)
Q Consensus 236 ~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 314 (717)
+.+++++|.++ .+|..+. .+|++|++++|.+++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 56777777776 6676543 3788888888888866654 48888899999999999988778888889999999999
Q ss_pred cCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 315 VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 315 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
+|+++++.+..|.++++|++|+|++|++++..|..|..+++|+.|++++|+|++.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999988888888888999999999999988888888889999999999999988766
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-17 Score=156.54 Aligned_cols=127 Identities=22% Similarity=0.351 Sum_probs=89.8
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
+++++++|+++ .+|..+. ++|++|+|++|.++ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 56777777777 5565443 46777777777776 56666777777777777777777666666777777777777777
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccc
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
+|++..+..|.++++|++|+|++|.|+.+.+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666667777777777777777777666666777777777777777765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=153.31 Aligned_cols=133 Identities=19% Similarity=0.217 Sum_probs=92.2
Q ss_pred CCCCCEEECCCCccc-ccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeE
Q 005045 33 CTELRSFEASVNDFV-GQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFF 111 (717)
Q Consensus 33 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 111 (717)
.++|++|++++|.++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367778888888776 56777777777888888888877743 567777778888888888876677777777788888
Q ss_pred eccCCCCCCCCC-ccccCCCCccEEEcccCcccccCCc---ccccCCCCcceeeccccccc
Q 005045 112 TLYGNFISGIIP-SSIYNISSIYYFSVTQNQLHGQLPT---DVGLTLPNLKIFAGAVNYFT 168 (717)
Q Consensus 112 ~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~l~~---~~~~~l~~L~~L~l~~n~l~ 168 (717)
+|++|.|+++.. ..+..+++|++|++++|.++ .+|. ..+..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh
Confidence 888887775432 66777777777777777776 4443 33344555555555555444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.3e-18 Score=156.54 Aligned_cols=136 Identities=18% Similarity=0.236 Sum_probs=123.1
Q ss_pred eecEEEcCCCcCc-CCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 11 MTQDLNLTYNYLS-GKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 11 ~~~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
.+++|+|++|+++ +.+|..|..+++|++|++++|.+++. ..|..+++|++|+|++|.+++.+|..+..+++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 6899999999998 77898899999999999999999965 77999999999999999999778888888999999999
Q ss_pred cCCcCcccCC-hhhhccCCCCeEeccCCCCCCCCC---ccccCCCCccEEEcccCcccccCCcc
Q 005045 90 AWNNLRGSIP-NELGQLSGLGFFTLYGNFISGIIP---SSIYNISSIYYFSVTQNQLHGQLPTD 149 (717)
Q Consensus 90 ~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~l~~~ 149 (717)
++|+|++... ..|..+++|++|+|++|.+++..+ ..|..+++|++|++++|.+. .+|..
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999995432 789999999999999999997666 58999999999999999997 66653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.9e-17 Score=154.67 Aligned_cols=127 Identities=19% Similarity=0.243 Sum_probs=69.3
Q ss_pred CEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCC
Q 005045 37 RSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN 116 (717)
Q Consensus 37 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 116 (717)
+.+++++|.++ .+|..+. ++|++|+|++|.|+ .+|..|.++++|++|+|++|+|++..+.+|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555555 4444332 34555555555555 44455555555555555555555444455555555555555555
Q ss_pred CCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccc
Q 005045 117 FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 117 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
+|+++.+..|.++++|++|+|++|.|+ ...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-------------------------VVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCC-------------------------eeChhhhhcCccccEEEeCCCCee
Confidence 555555555555555555555555554 344444556666666666666665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-16 Score=149.48 Aligned_cols=132 Identities=15% Similarity=0.176 Sum_probs=107.9
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
..+.+++++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 8 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 4578889999988 5665443 688999999998886666677888899999999999886666677888889999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQ 145 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 145 (717)
+|+|++..+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|.+.+.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 9998877777788888899999999988877777778888888888888888743
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.8e-17 Score=148.73 Aligned_cols=127 Identities=18% Similarity=0.255 Sum_probs=84.8
Q ss_pred CCCCEEECCCCccc-ccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEe
Q 005045 34 TELRSFEASVNDFV-GQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFT 112 (717)
Q Consensus 34 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 112 (717)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56777777777776 56666667777777777777777743 5567777777777777777755666666677777777
Q ss_pred ccCCCCCCC-CCccccCCCCccEEEcccCcccccCCc---ccccCCCCcceeecc
Q 005045 113 LYGNFISGI-IPSSIYNISSIYYFSVTQNQLHGQLPT---DVGLTLPNLKIFAGA 163 (717)
Q Consensus 113 L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~l~~---~~~~~l~~L~~L~l~ 163 (717)
|++|.+++. .+..+..+++|++|++++|.++ .++. ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG-GSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc-chHHHHHHHHHHCCCcccccCC
Confidence 777777753 2366777777777777777776 4443 344455555555544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-18 Score=169.48 Aligned_cols=138 Identities=20% Similarity=0.213 Sum_probs=105.8
Q ss_pred cccccccccCcccccceEEEEe-CCCch--hhhHHhHhhhh------------------------hHHHHHHHHHHHHhc
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTI--VAIKVLKLQQQ------------------------GALKSFIDECNALKS 441 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~ 441 (717)
.-|.+.+.||+|++|.||+|.+ .+|+. ||||++..... .....+.+|++++++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999997 68999 99998643210 112468899999999
Q ss_pred CCCCce--eEEEEeeccccCCCCceEEEEEecCCC-C----ChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHH
Q 005045 442 TRHRNI--LRVITACSSVDLEGNDFKALVFEFMSN-G----NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLH 514 (717)
Q Consensus 442 l~h~ni--~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH 514 (717)
+.|+++ +..+.. +..++||||+.+ | +|.++... .++..+..++.|++.|+.|||
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHH
Confidence 977753 333332 245899999942 3 66665431 223457789999999999999
Q ss_pred -hcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhc
Q 005045 515 -HHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550 (717)
Q Consensus 515 -~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 550 (717)
+. ||+||||||+|||++. .++|+|||.|...
T Consensus 188 ~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 76 9999999999999988 9999999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.5e-16 Score=163.92 Aligned_cols=319 Identities=13% Similarity=0.067 Sum_probs=245.7
Q ss_pred cCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCCh
Q 005045 21 YLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPN 100 (717)
Q Consensus 21 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 100 (717)
.++.+-..+|.++.+|+.+.|..+ ++.+-..+|.++++|+.++|.++ ++.....+|.++.+|+.+.+..+ ++.....
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 456567789999999999999754 77666778999999999999765 66566778999999999888755 5547777
Q ss_pred hhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCC
Q 005045 101 ELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASN 180 (717)
Q Consensus 101 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 180 (717)
+|.+...+...... .+..+...+|.++++|+.+.+.++ +. .++...|.++.+|+.+.+..| +..+...+|.++..
T Consensus 135 aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~-~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~ 209 (394)
T 4fs7_A 135 AFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDS-ME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL 209 (394)
T ss_dssp TTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred eeecccccccccCc--cccccchhhhcccCCCcEEecCCc-cc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence 88887654433332 333356778999999999999765 44 788899989999999999877 56577788999999
Q ss_pred CCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccc
Q 005045 181 LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHL 260 (717)
Q Consensus 181 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L 260 (717)
|+.+.+..+... +...+....+|+.+.+..+ ++.++ ...|.++..|+.+.+..+... .....+... ..+
T Consensus 210 L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~------~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~-~~l 278 (394)
T 4fs7_A 210 LENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELG------KSVFYGCTDLESISIQNNKLR-IGGSLFYNC-SGL 278 (394)
T ss_dssp CCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEEC------SSTTTTCSSCCEEEECCTTCE-ECSCTTTTC-TTC
T ss_pred cceeecCCCceE--eehhhcccCCCceEEECCC-ceecc------cccccccccceeEEcCCCcce-eeccccccc-ccc
Confidence 999988877654 3344555678888888643 34444 356788899999999887655 555555555 578
Q ss_pred cEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccc
Q 005045 261 RRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340 (717)
Q Consensus 261 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 340 (717)
+.+....+.+ ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.++|..|
T Consensus 279 ~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 279 KKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 8888877654 3456888899999999765 66567778999999999999754 77787889999999999999877
Q ss_pred cccccCCcCccCcCCCceEEeecc
Q 005045 341 RLEGSIPPSLGNCQKLLVLNLSSN 364 (717)
Q Consensus 341 ~l~~~~p~~~~~l~~L~~L~l~~N 364 (717)
++..-..+|.++.+|+.+++..+
T Consensus 354 -l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 354 -LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp -CCEECTTTBTTCTTCCEEEEEGG
T ss_pred -ccEehHHHhhCCCCCCEEEECCC
Confidence 76566788999999999998654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.9e-17 Score=150.62 Aligned_cols=133 Identities=22% Similarity=0.244 Sum_probs=116.0
Q ss_pred CCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcc
Q 005045 235 LEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLN 314 (717)
Q Consensus 235 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 314 (717)
.+.+++++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 467788888887 6665443 589999999999987777788999999999999999997777778999999999999
Q ss_pred cCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 315 VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 315 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
+|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999998888889999999999999999996666667899999999999999998876
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=149.34 Aligned_cols=128 Identities=16% Similarity=0.222 Sum_probs=116.5
Q ss_pred ceecEEEcCCCcCc-CCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEe
Q 005045 10 LMTQDLNLTYNYLS-GKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88 (717)
Q Consensus 10 ~~~~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 88 (717)
.++++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+.++++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47899999999998 78899999999999999999999965 6799999999999999999977888888899999999
Q ss_pred ccCCcCccc-CChhhhccCCCCeEeccCCCCCCCCC---ccccCCCCccEEEccc
Q 005045 89 LAWNNLRGS-IPNELGQLSGLGFFTLYGNFISGIIP---SSIYNISSIYYFSVTQ 139 (717)
Q Consensus 89 L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~ 139 (717)
|++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999954 34789999999999999999997766 6899999999999874
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-15 Score=163.11 Aligned_cols=321 Identities=9% Similarity=0.015 Sum_probs=180.9
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+|+++.|.. .++.+...+|.+|++|+.++|.++ ++.+-..+|.++.+|+.+.+..+ +......+|.+...+.....
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~- 147 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP- 147 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC-
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC-
Confidence 566666653 355455566667777777776544 44344555666666666666544 33344455555543333222
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+.+..+...+|.++++|+.+.+.++.. .+...+|.++++|+.+++..| ++ .++...|.....|+.+.+..+...
T Consensus 148 -~~~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~~~~-- 221 (394)
T 4fs7_A 148 -EGVTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFPNSLYY-- 221 (394)
T ss_dssp -TTCCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTTCCE--
T ss_pred -ccccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecCCCceE--
Confidence 222224455666666777777665433 355666666667776666655 44 566666666666666666655433
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+...+....+|+.+.+..+. +......|..+..|+.+.+..+.. .+. ...|.++..++.+....+.+. .
T Consensus 222 i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~-~i~------~~~F~~~~~l~~~~~~~~~i~---~ 290 (394)
T 4fs7_A 222 LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKL-RIG------GSLFYNCSGLKKVIYGSVIVP---E 290 (394)
T ss_dssp ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTC-EEC------SCTTTTCTTCCEEEECSSEEC---T
T ss_pred eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcc-eee------ccccccccccceeccCceeec---c
Confidence 22333344566666665433 324555666666666666665532 222 234566666666666554332 1
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCccccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 330 (717)
..+... .+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.+...+|.+++
T Consensus 291 ~~F~~~-~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 291 KTFYGC-SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTC-TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccc-ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 223333 46666666554 44455566666667777766533 55455566666677777766655 5556666666666
Q ss_pred ccceeecccccccccCCcCccCcCCCce
Q 005045 331 ILTRLWMEENRLEGSIPPSLGNCQKLLV 358 (717)
Q Consensus 331 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 358 (717)
+|+.+++..+ ++ .+..+|.++++|+.
T Consensus 367 ~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 367 NLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 7777766544 22 23445666666654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=146.82 Aligned_cols=133 Identities=14% Similarity=0.143 Sum_probs=85.5
Q ss_pred CCcCCCCCCEEECCCCcccccCCcCCCCCC-CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCC
Q 005045 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLT-KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSG 107 (717)
Q Consensus 29 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 107 (717)
.+..+++|+.|++++|.++ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3566677777777777777 4444 44443 777777777777743 45777777777777777777555555677777
Q ss_pred CCeEeccCCCCCCCCCc--cccCCCCccEEEcccCcccccCCcc---cccCCCCcceeecccccc
Q 005045 108 LGFFTLYGNFISGIIPS--SIYNISSIYYFSVTQNQLHGQLPTD---VGLTLPNLKIFAGAVNYF 167 (717)
Q Consensus 108 L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~l~~~---~~~~l~~L~~L~l~~n~l 167 (717)
|++|+|++|.|+. .|. .+..+++|+.|++++|.++ .+|.. ++..+++|+.|++++|.+
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 7777777777763 343 6677777777777777776 45543 233444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=143.29 Aligned_cols=129 Identities=16% Similarity=0.234 Sum_probs=112.3
Q ss_pred cceecEEEcCCCcCcCCCCcCCcCCC-CCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEE
Q 005045 9 HLMTQDLNLTYNYLSGKIPTNLSHCT-ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKAL 87 (717)
Q Consensus 9 ~~~~~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 87 (717)
...+++|+|++|+++. +|. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|.|++..+..|..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3478999999999994 565 55554 999999999999965 579999999999999999996655666999999999
Q ss_pred eccCCcCcccCCh--hhhccCCCCeEeccCCCCCCCCCc----cccCCCCccEEEcccCccc
Q 005045 88 SLAWNNLRGSIPN--ELGQLSGLGFFTLYGNFISGIIPS----SIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 88 ~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~ 143 (717)
+|++|+|+ .+|. .+..+++|+.|+|++|.+.. .|. .+..+++|+.||+++|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999998 5665 89999999999999999984 455 4999999999999999986
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.5e-18 Score=161.83 Aligned_cols=106 Identities=21% Similarity=0.275 Sum_probs=52.1
Q ss_pred CCCCCEEECCCCcccccCCc------CCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccC
Q 005045 33 CTELRSFEASVNDFVGQIPN------QLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLS 106 (717)
Q Consensus 33 l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 106 (717)
...++.++++.+.+.+.+|. .|..+++|++|+|++|.+++ +| .+..+++|++|+|++|+|+ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34445555555555544443 44455555555555555552 34 4455555555555555555 3444444445
Q ss_pred CCCeEeccCCCCCCCCCccccCCCCccEEEcccCccc
Q 005045 107 GLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 107 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
+|++|+|++|+++++ | .+..+++|++|+|++|+++
T Consensus 94 ~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 94 TLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECC
T ss_pred cCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCC
Confidence 555555555555432 2 3444445555555555444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=158.28 Aligned_cols=137 Identities=17% Similarity=0.176 Sum_probs=101.9
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhh----------------------hhHHHHHHHHHHHHhcCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ----------------------QGALKSFIDECNALKSTRHR 445 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~ 445 (717)
..=|++...||+|++|.||.|..++|+.||||+++... .........|...+.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 33499999999999999999999899999999864321 00112234577777777444
Q ss_pred ce--eEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005045 446 NI--LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAH 523 (717)
Q Consensus 446 ni--~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 523 (717)
.+ ...++. ...++||||++|+++.++.... ....++.||+.+|.+||++ |+||
T Consensus 174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~~-------------~~~~l~~qll~~l~~lH~~---gIVH 228 (397)
T 4gyi_A 174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSVP-------------DPASLYADLIALILRLAKH---GLIH 228 (397)
T ss_dssp TCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCCS-------------CHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred CCCCCeeeec---------cCceEEEEecCCccHhhhcccH-------------HHHHHHHHHHHHHHHHHHC---CCcC
Confidence 33 222222 1237999999998887654321 2356889999999999998 9999
Q ss_pred cCCCCCCEEeCCCC----------ceEEeeeccchh
Q 005045 524 CDLKPSNVLLDKDM----------TAHVGDFGLAKF 549 (717)
Q Consensus 524 ~dlkp~NIll~~~~----------~~kl~Dfg~~~~ 549 (717)
|||||.|||++++| .+.|+||+-+..
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999998776 389999997764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=134.96 Aligned_cols=109 Identities=24% Similarity=0.313 Sum_probs=82.7
Q ss_pred ccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeeccc
Q 005045 260 LRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEE 339 (717)
Q Consensus 260 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 339 (717)
.+.+++++|.++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566666666663 444442 6778888888888877777788888888888888888877777778888888888888
Q ss_pred ccccccCCcCccCcCCCceEEeecccCCCCCC
Q 005045 340 NRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371 (717)
Q Consensus 340 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 371 (717)
|+|++..+..|..+++|+.|+|++|+|++.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88886555668888888888888888887665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-13 Score=146.67 Aligned_cols=321 Identities=10% Similarity=0.066 Sum_probs=209.0
Q ss_pred cCCCCcCCcCCC-CCCEEECCCCcccccCCcCCCCCCCCCEEEccCcc---ccccCCccccCCCCCCEEeccCCcCcccC
Q 005045 23 SGKIPTNLSHCT-ELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN---LTGNVPAWIGNFSSLKALSLAWNNLRGSI 98 (717)
Q Consensus 23 ~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 98 (717)
+.+-..+|.++. .|+.+.+-.+ ++.+-..+|.++++|+.+.+..|. ++.....+|..+.+|+.+.+..+ ++.+.
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh
Confidence 434456777774 5888888754 665667778888888888887764 66455667888888888777655 55466
Q ss_pred ChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCC
Q 005045 99 PNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNA 178 (717)
Q Consensus 99 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 178 (717)
..+|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++ .++...|. ..+|+.+.+..+-.. ....+|.++
T Consensus 130 ~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c 204 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFT-GTALTQIHIPAKVTR-IGTNAFSEC 204 (394)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTC
T ss_pred hhhhhhhcccccccccce-eeeecccceecccccccccccce-ee-Eecccccc-ccceeEEEECCcccc-cccchhhhc
Confidence 677888888888888654 34467778888888888888755 44 67777774 456787777665433 566677777
Q ss_pred CCCCEEeccCccccccCCCCcc--------------CCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCc
Q 005045 179 SNLQVLDFAENGLTGTIPGNFG--------------SLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244 (717)
Q Consensus 179 ~~L~~L~l~~N~l~~~~~~~~~--------------~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 244 (717)
.++.......+... .....+. ....+..+.+. +.++.++ ...|.++..|+.+.+..+.
T Consensus 205 ~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~------~~aF~~c~~L~~i~lp~~~ 276 (394)
T 4gt6_A 205 FALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIE------THAFDSCAYLASVKMPDSV 276 (394)
T ss_dssp TTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEEC------TTTTTTCSSCCEEECCTTC
T ss_pred cccceecccccccc-cccceeecccccccccccccccccccceEEcC-CcceEcc------cceeeecccccEEeccccc
Confidence 88887776665544 2222111 11223333332 2233333 3467788888888887665
Q ss_pred ccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCc
Q 005045 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPS 324 (717)
Q Consensus 245 l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 324 (717)
.. .....|... +.|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...
T Consensus 277 ~~-I~~~aF~~c-~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~ 351 (394)
T 4gt6_A 277 VS-IGTGAFMNC-PALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES 351 (394)
T ss_dssp CE-ECTTTTTTC-TTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred ce-ecCcccccc-cccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence 54 445555555 4788888863 455466677888888888888754 66566677888888888888654 6667777
Q ss_pred ccccccccceeecccccccccCCcCccCcCCCceEEeecccC
Q 005045 325 SLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
+|.++++|+.+++.+|.... ..+..+.+|+.+.+..|.+
T Consensus 352 aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 352 AFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred HhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 88888888888888876542 4566777788777776654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.8e-17 Score=155.78 Aligned_cols=136 Identities=21% Similarity=0.187 Sum_probs=92.4
Q ss_pred CCCCCCCEEEccCccccccCCc------cccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccC
Q 005045 55 SSLTKLEIIGLGGSNLTGNVPA------WIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYN 128 (717)
Q Consensus 55 ~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 128 (717)
.....++.++++.+.+++..|. .+..+++|++|+|++|++++ +| .|.++++|++|+|++|.++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445666666777666666555 77778888888888888874 55 7788888888888888887 45666777
Q ss_pred CCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC-ccCCCCCCCCEEeccCccccccCC
Q 005045 129 ISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP-VSLSNASNLQVLDFAENGLTGTIP 196 (717)
Q Consensus 129 l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~ 196 (717)
+++|++|+|++|+++ .+| .+..+++|+.|++++|.++...+ ..+..+++|++|++++|.+++..|
T Consensus 92 ~~~L~~L~L~~N~l~-~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 92 ADTLEELWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHCSEEEEEEEECC-CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CCcCCEEECcCCcCC-cCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 778888888888887 444 23356666666666666664322 345666666666666666654444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=133.80 Aligned_cols=105 Identities=18% Similarity=0.221 Sum_probs=60.8
Q ss_pred CCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccC
Q 005045 36 LRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYG 115 (717)
Q Consensus 36 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 115 (717)
.+.+++++|.++ .+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345555555555 3444332 4555566666666555555555666666666666666655555556666666666666
Q ss_pred CCCCCCCCccccCCCCccEEEcccCccc
Q 005045 116 NFISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 116 N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
|+|+++.+..|.++++|++|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 6666555555666666666666666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.1e-14 Score=132.74 Aligned_cols=104 Identities=16% Similarity=0.204 Sum_probs=62.6
Q ss_pred CEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCC
Q 005045 37 RSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN 116 (717)
Q Consensus 37 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 116 (717)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666555 4554443 55666666666666555555666666666666666666544445566666666666666
Q ss_pred CCCCCCCccccCCCCccEEEcccCccc
Q 005045 117 FISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 117 ~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
+|+++.+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666555555666666666666666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.5e-14 Score=131.60 Aligned_cols=107 Identities=19% Similarity=0.220 Sum_probs=97.1
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.-+.+++++|+++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 13 ~~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 13 DQTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp CSSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence 3478999999998 6787665 899999999999998889999999999999999999997666678999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCC
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISG 120 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 120 (717)
+|+|++..+..|..+++|++|+|++|.+..
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 999997777779999999999999999983
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.5e-12 Score=135.86 Aligned_cols=308 Identities=9% Similarity=0.053 Sum_probs=232.2
Q ss_pred ccccCCcCCCCCC-CCCEEEccCccccccCCccccCCCCCCEEeccCCc---CcccCChhhhccCCCCeEeccCCCCCCC
Q 005045 46 FVGQIPNQLSSLT-KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN---LRGSIPNELGQLSGLGFFTLYGNFISGI 121 (717)
Q Consensus 46 l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 121 (717)
++.+-..+|.+.. .|+.+.+..+ ++.+-..+|.++.+|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 4545566788874 6999999765 776778899999999999998874 77677789999999999998766 5557
Q ss_pred CCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccC
Q 005045 122 IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGS 201 (717)
Q Consensus 122 ~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 201 (717)
...+|.++.+|+.+.+..+ +. .++...|....+|+.+.+.++ +..+...+|.+ .+|+.+.+..+-.. .....|..
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~ 203 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE 203 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred hhhhhhhhcccccccccce-ee-eecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence 8889999999999999754 44 788889989999999999876 55466666764 67999999876555 77788999
Q ss_pred CCCCCeeeccccccCCcccCchhh-------hhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCC
Q 005045 202 LKDLVRLNFDQNELGSREIGDLNF-------LKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNI 274 (717)
Q Consensus 202 l~~L~~L~l~~N~l~~~~~~~~~~-------~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~ 274 (717)
+..+.......+.....+-..... ...+.....+..+.+.. .++.....+|... ..|+.+.+.++... +.
T Consensus 204 c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c-~~L~~i~lp~~~~~-I~ 280 (394)
T 4gt6_A 204 CFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSC-AYLASVKMPDSVVS-IG 280 (394)
T ss_dssp CTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTC-SSCCEEECCTTCCE-EC
T ss_pred ccccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeec-ccccEEecccccce-ec
Confidence 999998887766554433110000 00111223445555433 3332334455555 58999999877654 67
Q ss_pred CccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcC
Q 005045 275 PVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQ 354 (717)
Q Consensus 275 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 354 (717)
..+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++..-..+|.+++
T Consensus 281 ~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 281 TGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred CcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence 7889999999999996 5566577788999999999999865 77778889999999999999755 6645567899999
Q ss_pred CCceEEeecccC
Q 005045 355 KLLVLNLSSNDL 366 (717)
Q Consensus 355 ~L~~L~l~~N~l 366 (717)
+|+.+++.+|..
T Consensus 358 ~L~~i~~~~~~~ 369 (394)
T 4gt6_A 358 ALNNIEYSGSRS 369 (394)
T ss_dssp TCCEEEESSCHH
T ss_pred CCCEEEECCcee
Confidence 999999998754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-14 Score=152.99 Aligned_cols=136 Identities=20% Similarity=0.240 Sum_probs=62.0
Q ss_pred CCCCEEeccCccccccCCCCccC-----CCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhh
Q 005045 179 SNLQVLDFAENGLTGTIPGNFGS-----LKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 179 ~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
++|+.|+|++|.++......+.. .++|+.|+|++|.|+.... ......+++|+.|+|++|.+++.....+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~-----~~l~~~L~~L~~L~Ls~n~l~~~~~~~L 146 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGL-----RTLLPVFLRARKLGLQLNSLGPEACKDL 146 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHH-----HHTHHHHHTEEEEECCSSCCCHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHH-----HHHHHHHHhccHhhcCCCCCCHHHHHHH
Confidence 45677777777766433222221 2456666666666544321 1112233455566666665553333333
Q ss_pred hhc----cccccEEecCCCccCCC----CCccccCCCCCCEEEccCCcCcccc----chhhhcCCCCCeEEcccCcCC
Q 005045 254 ANL----STHLRRLTMGENLMHGN----IPVGIGNLVNLNLLGLEGNNLSGSV----PEVIGRLNKLEGLGLNVNKFS 319 (717)
Q Consensus 254 ~~~----~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~ 319 (717)
... .++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+... +..+...++|++|+|++|.++
T Consensus 147 ~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 147 RDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred HHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 221 12455555555554321 1222234444555555555544221 223334444555555555444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.1e-15 Score=157.26 Aligned_cols=119 Identities=19% Similarity=0.214 Sum_probs=56.6
Q ss_pred CCCCCEEeccCcccccc----CCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhh
Q 005045 178 ASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 253 (717)
.++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+..+.. .+...+...++|++|+|++|.|++.....+
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--HHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--HHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 45566666666666531 222234445555555555555443211 112334444455555555555542222121
Q ss_pred hhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCC-----CCeEE--cccCcCC
Q 005045 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNK-----LEGLG--LNVNKFS 319 (717)
Q Consensus 254 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----L~~L~--Ls~N~l~ 319 (717)
...+...++|++|+|++|.|+......+..+.. |+.+. +..|.+.
T Consensus 232 ---------------------~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ---------------------ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp ---------------------HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred ---------------------HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 223344567888888888877655555555432 44444 4444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=5.8e-13 Score=139.44 Aligned_cols=103 Identities=15% Similarity=0.179 Sum_probs=71.7
Q ss_pred EEECCCC-cccccCCcCCCCCCCCCEEEccC-ccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccC
Q 005045 38 SFEASVN-DFVGQIPNQLSSLTKLEIIGLGG-SNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYG 115 (717)
Q Consensus 38 ~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 115 (717)
.++++++ +++ .+|. |..+++|++|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 4666 77777777777775 777755556677777777777777777766667777777777777777
Q ss_pred CCCCCCCCccccCCCCccEEEcccCccc
Q 005045 116 NFISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 116 N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
|+|+++.+..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777766666666555 777777777775
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.33 E-value=9.9e-11 Score=123.97 Aligned_cols=288 Identities=13% Similarity=0.094 Sum_probs=131.8
Q ss_pred CcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCC
Q 005045 30 LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109 (717)
Q Consensus 30 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 109 (717)
+....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|... +|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence 44555666666653 355455556677777777777543 554445556554 5666665433 443444455443 566
Q ss_pred eEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc------------cCCccCCC
Q 005045 110 FFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG------------SIPVSLSN 177 (717)
Q Consensus 110 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~------------~~~~~~~~ 177 (717)
.+.+..+- ..+...+|.+. +|+.+.+..+ ++ .+....|....+++.+.+..+.... .....+..
T Consensus 117 ~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~-~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 117 DFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VT-TIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp EEECCTTC-CEECTTTTTTC-CCCEEEECTT-CC-EECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred cccCCCcc-ccccccccccc-eeeeeeccce-ee-ccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 66665543 22444444443 4444444332 33 4444555555555555444332211 11122333
Q ss_pred CCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhcc
Q 005045 178 ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 257 (717)
...+..+.+..+.-. .....+....+|+.+.+..+ +..++ ...|.++..|+.+.+..+ ++......+...
T Consensus 193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~------~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~- 262 (379)
T 4h09_A 193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLG------DGAFYGMKALDEIAIPKN-VTSIGSFLLQNC- 262 (379)
T ss_dssp TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEEC------TTTTTTCSSCCEEEECTT-CCEECTTTTTTC-
T ss_pred cccccccccccceeE-Eeecccccccccceeeeccc-eeEEc------cccccCCccceEEEcCCC-ccEeCcccccee-
Confidence 334444443333222 33444445555555555433 22222 233445555555555443 331222222222
Q ss_pred ccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeec
Q 005045 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWM 337 (717)
Q Consensus 258 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 337 (717)
.+|+.+.+..+ +..+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 24444444332 22233334444445555555444444333444444444544444332 33344444444444444444
Q ss_pred c
Q 005045 338 E 338 (717)
Q Consensus 338 ~ 338 (717)
.
T Consensus 341 p 341 (379)
T 4h09_A 341 P 341 (379)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.3e-12 Score=133.68 Aligned_cols=105 Identities=21% Similarity=0.162 Sum_probs=95.8
Q ss_pred cEEEcCCC-cCcCCCCcCCcCCCCCCEEECCC-CcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 13 QDLNLTYN-YLSGKIPTNLSHCTELRSFEASV-NDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 13 ~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
..++++++ +|+ .+|. |..+++|++|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 46799998 998 5788 99999999999996 99998888899999999999999999999889999999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCC
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISG 120 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 120 (717)
+|+|++..+..|..++ |+.|+|++|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999977777777776 9999999999983
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-10 Score=120.50 Aligned_cols=301 Identities=12% Similarity=0.068 Sum_probs=220.2
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
+++.+.+. ..++.+-..+|.+|.+|+.+.|..+ ++.+-..+|.+. +|+.+.+..+ ++.....+|.. .+|+.+++.
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFP 121 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECC
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCC
Confidence 56677775 3566677889999999999999765 675667778886 7888888654 66355556655 489999998
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccC-----------CcccccCCCCcce
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQL-----------PTDVGLTLPNLKI 159 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l-----------~~~~~~~l~~L~~ 159 (717)
.+ ++.+...+|.+. +|+.+.+..+ ++.+....|.++.+++.+.+..+...... ....+.....+..
T Consensus 122 ~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 122 GA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp TT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred Cc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 76 443556666654 6887777654 55577888999999999988766543110 1112223444555
Q ss_pred eecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEE
Q 005045 160 FAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239 (717)
Q Consensus 160 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~ 239 (717)
+.+..+.. ......+....+|+.+.+..+ ++......|.++..|+.+.+..+ ++.++ ...|.++..|+.+.
T Consensus 199 ~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~------~~aF~~~~~l~~i~ 269 (379)
T 4h09_A 199 FTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIG------SFLLQNCTALKTLN 269 (379)
T ss_dssp EECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEEC------TTTTTTCTTCCEEE
T ss_pred ccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeC------ccccceeehhcccc
Confidence 55444332 245667888899999998766 44477788999999999999876 66666 56788999999999
Q ss_pred eecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCC
Q 005045 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFS 319 (717)
Q Consensus 240 L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 319 (717)
+..+ ++......|... ++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++
T Consensus 270 l~~~-i~~i~~~aF~~c-~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 270 FYAK-VKTVPYLLCSGC-SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp ECCC-CSEECTTTTTTC-TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred cccc-ceeccccccccc-cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 9765 552334444454 69999999999998788889999999999999755 77677789999999999999765 67
Q ss_pred CCCCccccccccc
Q 005045 320 GLIPSSLGNLTIL 332 (717)
Q Consensus 320 ~~~~~~~~~l~~L 332 (717)
.+...+|.+...+
T Consensus 346 ~I~~~aF~~c~~~ 358 (379)
T 4h09_A 346 LIESGAFEGSSIT 358 (379)
T ss_dssp EECTTTTTTSSCC
T ss_pred EEchhHhhCCCCC
Confidence 6777788776433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=4.8e-11 Score=119.41 Aligned_cols=144 Identities=13% Similarity=0.067 Sum_probs=108.5
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
...|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++. ..+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceE
Confidence 456888888888888999999864 6789999886532222346788999998884 667778887753 345789
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC----------------------------- 517 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 517 (717)
+||||++|.++.+..... .....++.+++++++.||+..
T Consensus 87 lv~e~i~G~~l~~~~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEECCSSEEHHHHCCTT------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred EEEEecCCeehhhccCCc------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 999999999998764211 123467889999999999810
Q ss_pred ---------------------------CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 ---------------------------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 ---------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
...++|||++|.||+++.++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13599999999999998765667999987653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=120.48 Aligned_cols=65 Identities=12% Similarity=0.195 Sum_probs=31.6
Q ss_pred cCCCCCEEEeecCcccCcCchhhhh--ccccccEEecCCCccCCCC----CccccCCCCCCEEEccCCcCc
Q 005045 231 NCTSLEVLGLARNSFGGEMPISIAN--LSTHLRRLTMGENLMHGNI----PVGIGNLVNLNLLGLEGNNLS 295 (717)
Q Consensus 231 ~l~~L~~L~L~~N~l~~~~p~~~~~--~~~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 295 (717)
.+++|+.|+|++|.+.+..+..+.. ..++|++|+|+.|.+.+.. +..+.++++|+.|+|++|.|+
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 3567777777777776444444432 1134445555444444321 112233445555555555444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.7e-10 Score=120.00 Aligned_cols=162 Identities=15% Similarity=0.176 Sum_probs=75.1
Q ss_pred hhhhccCCCCeEeccCCC-CCCCCCccccCCCCccEEEcccCcccccCCcccc-cCCCCcceeeccc--cccccc-----
Q 005045 100 NELGQLSGLGFFTLYGNF-ISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVG-LTLPNLKIFAGAV--NYFTGS----- 170 (717)
Q Consensus 100 ~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~-~~l~~L~~L~l~~--n~l~~~----- 170 (717)
..+..+++|+.|+|++|. +. .+. +. +++|++|+|..|.++......+. ..+|+|+.|+|+. |...+-
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 344555666666666652 21 122 22 56666666666655422111111 1455666665532 111100
Q ss_pred CCccC--CCCCCCCEEeccCccccccCCCCc---cCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcc
Q 005045 171 IPVSL--SNASNLQVLDFAENGLTGTIPGNF---GSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSF 245 (717)
Q Consensus 171 ~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 245 (717)
+...+ ..+++|++|+|++|.++...+..+ ..+++|++|+|+.|.|+..+...+ +..+.++++|+.|+|++|.|
T Consensus 242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L--~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL--LDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHH--HTTHHHHTTCSEEECCSBBC
T ss_pred HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHH--HhhcccCCcceEEECCCCcC
Confidence 00111 235667777776666653222211 135666666666666655432111 22234456666666666666
Q ss_pred cCcCchhhhhccccccEEecCCCc
Q 005045 246 GGEMPISIANLSTHLRRLTMGENL 269 (717)
Q Consensus 246 ~~~~p~~~~~~~~~L~~L~l~~N~ 269 (717)
++..-..+... -...++++++.
T Consensus 320 ~d~~~~~l~~a--lg~~~~~~~~~ 341 (362)
T 2ra8_A 320 SDEMKKELQKS--LPMKIDVSDSQ 341 (362)
T ss_dssp CHHHHHHHHHH--CCSEEECCSBC
T ss_pred CHHHHHHHHHH--cCCEEEecCCc
Confidence 53333333321 12345555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=4.7e-10 Score=112.02 Aligned_cols=140 Identities=16% Similarity=0.088 Sum_probs=97.0
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCc--eeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN--ILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~~~~ 464 (717)
...+|.+....+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ ++++++... .++.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~ 89 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGR 89 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSC
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCC
Confidence 34455554444455568999998777888999986543 2245678888888884433 455676642 3346
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC--------------------------- 517 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------- 517 (717)
.++||||++|.++. ... .. ...++.+++..++.+|+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 154 (264)
T ss_dssp EEEEEECCSSEETT--TSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred CEEEEEecCCcccC--cCc----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence 89999999998884 211 11 1256777888888888741
Q ss_pred ----------------------------CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 ----------------------------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 ----------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..+++|||++|.||+++.++.+.|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.2e-09 Score=108.66 Aligned_cols=146 Identities=14% Similarity=0.133 Sum_probs=104.7
Q ss_pred ccccccCcccccceEEEEeCCCchhhhHHhH--hhh-hhHHHHHHHHHHHHhcCC--CCceeEEEEeeccccCCCCceEE
Q 005045 392 SKENLIGTGSFGSVYKGTLGDGTIVAIKVLK--LQQ-QGALKSFIDECNALKSTR--HRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 392 ~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
...+.++.|.++.||.+...+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++..+.... ..+..+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 346778999999999998754 567778765 322 112346778999998886 455778887764421 124578
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC----------------------------- 517 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 517 (717)
+||||++|.++.+... ..++......++.+++++|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp EEEECCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 9999999877754221 34678888899999999999999731
Q ss_pred --------------------------CCCeeecCCCCCCEEeCCCCc--eEEeeeccchh
Q 005045 518 --------------------------DTPIAHCDLKPSNVLLDKDMT--AHVGDFGLAKF 549 (717)
Q Consensus 518 --------------------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~ 549 (717)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 147999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=1.1e-09 Score=111.87 Aligned_cols=195 Identities=17% Similarity=0.136 Sum_probs=118.9
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcC-CCCc--eeEEEEeeccccCCCCceEEEEEe
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKST-RHRN--ILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--i~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
.+.++.|.+..||.+. +.+++|+.... .....+.+|+++++.+ .+.. +++++..+... ..-...|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEc
Confidence 3457888888888753 45778875432 3346788899998877 3322 44444443211 11123589999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC--------------------------------- 517 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 517 (717)
+++|.++.+... ..++..++..++.+++..++.||+..
T Consensus 97 ~i~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 97 KIKGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CCCCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred ccCCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 999988865322 34677778888899999998888610
Q ss_pred ----------------------CCCeeecCCCCCCEEeCC--CCceEEeeeccchhcccccCC---CCC----Ccceeec
Q 005045 518 ----------------------DTPIAHCDLKPSNVLLDK--DMTAHVGDFGLAKFLFEISDN---PSK----NQTVSIG 566 (717)
Q Consensus 518 ----------------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~---~~~----~~~~~~~ 566 (717)
...++|+|++|.||+++. .+.+.|+||+.+.......+- ... .......
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 135899999999999997 456889999987653110000 000 0000000
Q ss_pred ccccccccC-CCccCCCCCcccchhhHHHHHHHHHhCCCCC
Q 005045 567 LKGSIGYIP-PEHMNGQVSILGDIYSYGILLLEMFTGKRPT 606 (717)
Q Consensus 567 ~~~~~~y~a-PE~~~~~~~~~sDvwslG~vl~elltg~~p~ 606 (717)
.....++.. |+... +.....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~-r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLE-KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHH-HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHH-HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111111 11110 0122358999999999999998876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.62 E-value=3.9e-09 Score=99.02 Aligned_cols=113 Identities=13% Similarity=0.132 Sum_probs=49.1
Q ss_pred CcCCCCCCEEECCCC-cccc----cCCcCCCCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCCcCccc---
Q 005045 30 LSHCTELRSFEASVN-DFVG----QIPNQLSSLTKLEIIGLGGSNLTGN----VPAWIGNFSSLKALSLAWNNLRGS--- 97 (717)
Q Consensus 30 ~~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~--- 97 (717)
+...++|++|+|++| .+.. .+...+...++|++|+|++|.|.+. +...+...++|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344455555555555 4432 1222234444555555555555421 122233334455555555555422
Q ss_pred -CChhhhccCCCCeEec--cCCCCCCC----CCccccCCCCccEEEcccCcc
Q 005045 98 -IPNELGQLSGLGFFTL--YGNFISGI----IPSSIYNISSIYYFSVTQNQL 142 (717)
Q Consensus 98 -~~~~~~~l~~L~~L~L--~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l 142 (717)
+..++...++|++|+| ++|.|+.. +...+...++|++|+|++|.+
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 2233344444555555 44554421 112233334444555544444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.8e-08 Score=94.38 Aligned_cols=42 Identities=14% Similarity=0.245 Sum_probs=20.3
Q ss_pred ccCCCCCCEEEc--cCCcCcccc----chhhhcCCCCCeEEcccCcCC
Q 005045 278 IGNLVNLNLLGL--EGNNLSGSV----PEVIGRLNKLEGLGLNVNKFS 319 (717)
Q Consensus 278 ~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~ 319 (717)
+...++|++|+| ++|.|.... ...+...+.|++|+|++|.+.
T Consensus 117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 344445556666 555555322 223333455555555555543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=8.1e-09 Score=101.66 Aligned_cols=67 Identities=19% Similarity=0.241 Sum_probs=40.8
Q ss_pred cCCCCCCEEeccCCcCcc--cCChhhhccCCCCeEeccCCCCCCCCCccccCCC--CccEEEcccCcccccCC
Q 005045 79 GNFSSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNIS--SIYYFSVTQNQLHGQLP 147 (717)
Q Consensus 79 ~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~l~ 147 (717)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 346667777777777765 3345566677777777777777644 2233333 66677777776665444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.51 E-value=7.5e-09 Score=101.92 Aligned_cols=105 Identities=17% Similarity=0.223 Sum_probs=70.4
Q ss_pred CcCCCCCCE--EECCCCccc---ccCCcCCCCCCCCCEEEccCccccc--cCCccccCCCCCCEEeccCCcCcccCChhh
Q 005045 30 LSHCTELRS--FEASVNDFV---GQIPNQLSSLTKLEIIGLGGSNLTG--NVPAWIGNFSSLKALSLAWNNLRGSIPNEL 102 (717)
Q Consensus 30 ~~~l~~L~~--L~L~~n~l~---~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~ 102 (717)
|...+.|.. ++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455655 667777433 2222222557788888888888885 3446667888888888888888854 334
Q ss_pred hccC--CCCeEeccCCCCCCCCC-------ccccCCCCccEEE
Q 005045 103 GQLS--GLGFFTLYGNFISGIIP-------SSIYNISSIYYFS 136 (717)
Q Consensus 103 ~~l~--~L~~L~L~~N~i~~~~~-------~~~~~l~~L~~L~ 136 (717)
..+. +|++|+|++|.+.+..| ..+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4454 88888888888875544 2366778888765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.6e-06 Score=86.70 Aligned_cols=137 Identities=16% Similarity=0.099 Sum_probs=91.8
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCC---ceeEEEEeeccccCCCCceEEEEEe
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHR---NILRVITACSSVDLEGNDFKALVFE 470 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~~~~~~~~~~~~lv~e 470 (717)
.+.++.|....||.. |+.+++|+.. .......+..|+++++.+.+. .+.+++.++. ...+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEe
Confidence 345677777888887 5678888742 223456788999999998542 3556565543 12346789999
Q ss_pred cCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 005045 471 FMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC--------------------------------- 517 (717)
Q Consensus 471 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 517 (717)
+++|.++.+..- ..++......++.++++.++.||+..
T Consensus 94 ~i~G~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 94 KVQGQILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp CCCSEECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred ccCCeECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 999988866321 22344455555566666665555421
Q ss_pred ------------------------CCCeeecCCCCCCEEeCC---CCc-eEEeeeccchh
Q 005045 518 ------------------------DTPIAHCDLKPSNVLLDK---DMT-AHVGDFGLAKF 549 (717)
Q Consensus 518 ------------------------~~~ivH~dlkp~NIll~~---~~~-~kl~Dfg~~~~ 549 (717)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999987 455 58999997653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.16 E-value=5.3e-07 Score=82.10 Aligned_cols=92 Identities=10% Similarity=0.084 Sum_probs=61.4
Q ss_pred CCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCc-CcccCChhhhcc----CCCCeEeccCCC-CCCCCC
Q 005045 50 IPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNN-LRGSIPNELGQL----SGLGFFTLYGNF-ISGIIP 123 (717)
Q Consensus 50 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~ 123 (717)
+|.....-.+|+.|||++|.|++.--..+..+++|++|+|++|. |+..--..+..+ ++|++|+|++|. |+...-
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34433333467888888888776655667778888888888874 664433445543 358888888874 775445
Q ss_pred ccccCCCCccEEEcccCc
Q 005045 124 SSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 124 ~~~~~l~~L~~L~L~~N~ 141 (717)
..+..+++|++|+|+++.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 566777888888888775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.11 E-value=7e-07 Score=81.32 Aligned_cols=94 Identities=12% Similarity=0.131 Sum_probs=71.4
Q ss_pred CCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCcc-ccccCCccccCC----CCCCEEeccCCc-CcccCC
Q 005045 26 IPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSN-LTGNVPAWIGNF----SSLKALSLAWNN-LRGSIP 99 (717)
Q Consensus 26 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~~ 99 (717)
+|.....--.|+.|||++|.++..--..+.++++|+.|+|++|. |++.--..++.+ ++|++|+|++|. |+..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 45443334579999999999886555567889999999999985 776555556654 379999999985 876555
Q ss_pred hhhhccCCCCeEeccCCC-CC
Q 005045 100 NELGQLSGLGFFTLYGNF-IS 119 (717)
Q Consensus 100 ~~~~~l~~L~~L~L~~N~-i~ 119 (717)
..+..+++|++|+|+++. ++
T Consensus 133 ~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHGGGCTTCCEEEEESCTTCC
T ss_pred HHHhcCCCCCEEECCCCCCCC
Confidence 667889999999999986 44
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=5e-06 Score=83.04 Aligned_cols=134 Identities=19% Similarity=0.095 Sum_probs=90.9
Q ss_pred cCccccc-ceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceEEEEEecCC
Q 005045 397 IGTGSFG-SVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKALVFEFMS 473 (717)
Q Consensus 397 ig~g~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 473 (717)
+..|.++ .||+...+ .++.+++|+-... ....+.+|...++.+. +--+.+++.++. +.+..++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeC
Confidence 3445554 58888755 5667888875533 3355677888888773 333666677643 3357899999999
Q ss_pred CCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005045 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC------------------------------------ 517 (717)
Q Consensus 474 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 517 (717)
|.++.+..... ......++.+++..++.||...
T Consensus 104 G~~~~~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 104 GKTAFQVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp SEEHHHHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CccccccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 98887654321 1123456667777777777531
Q ss_pred -------------------CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 -------------------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 -------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
...++|||+++.||+++.++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01289999999999999877777999987753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=1.9e-05 Score=82.35 Aligned_cols=85 Identities=9% Similarity=-0.037 Sum_probs=53.5
Q ss_pred ccccc-CcccccceEEEEeC-------CCchhhhHHhHhhh---hhHHHHHHHHHHHHhcCC---CCceeEEEEeecccc
Q 005045 393 KENLI-GTGSFGSVYKGTLG-------DGTIVAIKVLKLQQ---QGALKSFIDECNALKSTR---HRNILRVITACSSVD 458 (717)
Q Consensus 393 ~~~~i-g~g~~g~v~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~ 458 (717)
..+.+ +.|....+|..... +++.+++|...... ......+..|+.+++.+. ...+.+++..+....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 78888899988753 26678888765332 001245667888877773 234666776643321
Q ss_pred CCCCceEEEEEecCCCCChhh
Q 005045 459 LEGNDFKALVFEFMSNGNLDQ 479 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~ 479 (717)
..+..++||||++|.++.+
T Consensus 104 --~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 --VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp --TTSSCEEEEECCCCBCCCB
T ss_pred --ccCCceEEEEecCCCChhh
Confidence 1135689999999877654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.68 E-value=2.2e-05 Score=72.82 Aligned_cols=69 Identities=13% Similarity=0.278 Sum_probs=29.9
Q ss_pred CCCCCCCEEeccCc-ccccc----CCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCccc
Q 005045 176 SNASNLQVLDFAEN-GLTGT----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246 (717)
Q Consensus 176 ~~l~~L~~L~l~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 246 (717)
.+-+.|++|+|++| .|... +...+...+.|+.|+|++|.|.+.+...+ ...+..-+.|+.|+|+.|.|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~al--A~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL--IELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTH--HHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHH--HHHHhcCCccCeEecCCCcCC
Confidence 33445555555553 44321 12233334445555555555544332222 233334444444444444444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.52 E-value=2.2e-05 Score=72.81 Aligned_cols=118 Identities=15% Similarity=0.208 Sum_probs=70.5
Q ss_pred ccCCCCCCeeecccc-ccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhc---cccccEEecCCCccCCC-
Q 005045 199 FGSLKDLVRLNFDQN-ELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGN- 273 (717)
Q Consensus 199 ~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~---~~~L~~L~l~~N~l~~~- 273 (717)
+..-+.|++|+|++| .|...++. .+...+..-+.|+.|+|++|.|.+.....+... .+.|++|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~--~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIR--SLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHH--HHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHH--HHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 345567777777774 66654322 234556666777777777777775443333322 14677777777777643
Q ss_pred ---CCccccCCCCCCEEEccCCc---Cccc----cchhhhcCCCCCeEEcccCcC
Q 005045 274 ---IPVGIGNLVNLNLLGLEGNN---LSGS----VPEVIGRLNKLEGLGLNVNKF 318 (717)
Q Consensus 274 ---~~~~~~~l~~L~~L~L~~N~---l~~~----~~~~~~~l~~L~~L~Ls~N~l 318 (717)
+..++..-+.|++|+|++|. +... +...+..-+.|+.|+++.|.+
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 22345556667777777553 3321 233455567777777776653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00011 Score=77.70 Aligned_cols=76 Identities=18% Similarity=0.098 Sum_probs=47.4
Q ss_pred cccccCcccccceEEEEeC-CCchhhhHHhHhhhh-------hHHHHHHHHHHHHhcCC---CCceeEEEEeeccccCCC
Q 005045 393 KENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-------GALKSFIDECNALKSTR---HRNILRVITACSSVDLEG 461 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~ 461 (717)
..+.+|.|..+.||++... +++.+++|....... ....++..|.++++.+. ...+++++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------
Confidence 3567899999999999754 567889986532111 12345677888887763 23344555442
Q ss_pred CceEEEEEecCCCC
Q 005045 462 NDFKALVFEFMSNG 475 (717)
Q Consensus 462 ~~~~~lv~e~~~~~ 475 (717)
.+..++|||++++.
T Consensus 107 ~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEMAVTVMEDLSHL 120 (397)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCccEEEEEeCCCc
Confidence 12357999999764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00043 Score=59.94 Aligned_cols=55 Identities=27% Similarity=0.268 Sum_probs=25.7
Q ss_pred EEEccCcccc-ccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCC
Q 005045 62 IIGLGGSNLT-GNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFI 118 (717)
Q Consensus 62 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 118 (717)
.++.+++.++ ..+|..+. .+|+.|+|++|+|+.+.++.|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 23333232 2355555555555544444444455555544444444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00064 Score=70.07 Aligned_cols=30 Identities=23% Similarity=0.296 Sum_probs=27.2
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
..++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 589999999999999888899999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00025 Score=71.20 Aligned_cols=79 Identities=18% Similarity=0.119 Sum_probs=56.2
Q ss_pred ccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC---CceeEEEEeeccccCCCCceEE
Q 005045 390 NFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH---RNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 390 ~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
+..-++.+|.|..+.||+....+|+.|++|+...........+..|++.|+.+.- --++++++.. ..+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 3445677899999999999988999999998664443334567889988887732 2345555542 237
Q ss_pred EEEecCCCCCh
Q 005045 467 LVFEFMSNGNL 477 (717)
Q Consensus 467 lv~e~~~~~~L 477 (717)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999876643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00075 Score=58.42 Aligned_cols=58 Identities=19% Similarity=0.172 Sum_probs=41.0
Q ss_pred eEEcccCcCC--CCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCC
Q 005045 310 GLGLNVNKFS--GLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTI 370 (717)
Q Consensus 310 ~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 370 (717)
.++.+++.++ .+ |..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|+|...+
T Consensus 12 ~v~Cs~~~L~~~~v-P~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 12 LVDCGRRGLTWASL-PTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp EEECCSSCCCTTTS-CSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred EEEeCCCCCccccC-CCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 6777777776 33 43322 35788888888888555566788888888888888887544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0029 Score=63.81 Aligned_cols=76 Identities=14% Similarity=0.128 Sum_probs=55.4
Q ss_pred cccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC---CCceeEEEEeeccccCCCCceEEEEE
Q 005045 393 KENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR---HRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
..+.++.|....+|.... +++.+++|+.... ....+..|++.++.+. ...+++++..+.. .+..++||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence 346688899999999886 3567788876533 2456778888887772 3567777777532 35789999
Q ss_pred ecCCCCCh
Q 005045 470 EFMSNGNL 477 (717)
Q Consensus 470 e~~~~~~L 477 (717)
||++|.++
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0017 Score=69.03 Aligned_cols=30 Identities=23% Similarity=0.396 Sum_probs=26.7
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..++|||++|.|||++.++ ++++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4899999999999998776 99999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0014 Score=66.05 Aligned_cols=30 Identities=23% Similarity=0.353 Sum_probs=25.2
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..++|+|+.+.||+ ..++.+.++||+.+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5667889999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0065 Score=56.53 Aligned_cols=98 Identities=12% Similarity=0.092 Sum_probs=66.1
Q ss_pred ChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccC
Q 005045 476 NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISD 555 (717)
Q Consensus 476 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 555 (717)
+|.++++... ..+++.+++.++.|.+.+|.-.-.. +.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 34 SLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred cHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 6888887544 6899999999999999998776211 0112334567999999999988764 1110
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHh
Q 005045 556 NPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFT 601 (717)
Q Consensus 556 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~ellt 601 (717)
.....+.|||......+.+.=|||||+++|.-+-
T Consensus 98 ------------~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ------------AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------------CCSSSSSCHHHHHHHHHHHHHHHHT
T ss_pred ------------ccccCCCChhhccccchHHHHHHHHHHHHHHHhh
Confidence 1223467888875566788899999999999885
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.003 Score=64.77 Aligned_cols=31 Identities=29% Similarity=0.306 Sum_probs=27.0
Q ss_pred CCeeecCCCCCCEEeCCC----CceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKD----MTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~----~~~kl~Dfg~~~~ 549 (717)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6899999987764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0026 Score=64.83 Aligned_cols=152 Identities=14% Similarity=0.054 Sum_probs=76.8
Q ss_pred ccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCc--eeEEEEeecccc-CCCCceEEEEEe
Q 005045 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN--ILRVITACSSVD-LEGNDFKALVFE 470 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~-~~~~~~~~lv~e 470 (717)
.+.++.|....+|.....+| .+++|+..... ....+..|..+++.+.... +++++....... ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45567788889999887555 57788776421 1234455677666652212 233332210000 011245789999
Q ss_pred cCCCCChhhh--------------cc----CCCCCc-ccccccCHHHHH------------HHHHHHHHHHHHHHhc---
Q 005045 471 FMSNGNLDQW--------------LH----PSPAEH-YQFKKLSVIQRL------------NIAIDVASALDYLHHH--- 516 (717)
Q Consensus 471 ~~~~~~L~~~--------------l~----~~~~~~-~~~~~~~~~~~~------------~i~~~i~~~l~~LH~~--- 516 (717)
|++|..+... ++ .-.... .......|.... .+...+...++.++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9988654210 11 000000 000000111100 0011234455555532
Q ss_pred -CCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 517 -CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 517 -~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
...+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13479999999999999877666899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0025 Score=65.12 Aligned_cols=80 Identities=11% Similarity=0.103 Sum_probs=46.6
Q ss_pred cccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC--CceeEEEEeecccc-CCCCceEEEEEec
Q 005045 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRH--RNILRVITACSSVD-LEGNDFKALVFEF 471 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~-~~~~~~~~lv~e~ 471 (717)
..++ |....||.+...+|+.+++|....... ....+..|..+++.+.. -.+++++.. .... ....+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 3455 777889988776777889998763211 12445567777766632 123333332 1000 1123467899999
Q ss_pred CCCCCh
Q 005045 472 MSNGNL 477 (717)
Q Consensus 472 ~~~~~L 477 (717)
++|.++
T Consensus 109 i~G~~~ 114 (328)
T 1zyl_A 109 VGGRQF 114 (328)
T ss_dssp CCCEEC
T ss_pred cCCCCC
Confidence 987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0065 Score=64.85 Aligned_cols=74 Identities=16% Similarity=0.075 Sum_probs=44.3
Q ss_pred ccccCcccccceEEEEeCC-CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCce-eEEEEeeccccCCCCceEEEEEec
Q 005045 394 ENLIGTGSFGSVYKGTLGD-GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI-LRVITACSSVDLEGNDFKALVFEF 471 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~~~~~~lv~e~ 471 (717)
.+.|+.|-...+|++...+ ++.+++|+......... ....|..+++.+...++ +++++.+ . + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 4567777788999988654 47788887643221111 12478888888754444 4555553 1 1 359999
Q ss_pred CCCCCh
Q 005045 472 MSNGNL 477 (717)
Q Consensus 472 ~~~~~L 477 (717)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987655
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0047 Score=64.13 Aligned_cols=146 Identities=10% Similarity=0.096 Sum_probs=78.1
Q ss_pred ccccCcccccceEEEEeC--------CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 394 ENLIGTGSFGSVYKGTLG--------DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.+.+.-|-...+|++... +++.+++|+.-... .......+|.++++.+. +.-.+++++.+ ++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC---
Confidence 345666778889998864 24678888863321 12344557888887763 21124555553 22
Q ss_pred EEEEEecCCCCChhhh-----------------ccCCCCCcccccccCHHHHHHHHHHHHH-------------------
Q 005045 465 KALVFEFMSNGNLDQW-----------------LHPSPAEHYQFKKLSVIQRLNIAIDVAS------------------- 508 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~-----------------l~~~~~~~~~~~~~~~~~~~~i~~~i~~------------------- 508 (717)
.+||||++|.++..- ++............-+..+.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 299999998665421 1111000000001113344444443321
Q ss_pred HHHHHHhc-----CCCCeeecCCCCCCEEeCCC----CceEEeeeccchh
Q 005045 509 ALDYLHHH-----CDTPIAHCDLKPSNVLLDKD----MTAHVGDFGLAKF 549 (717)
Q Consensus 509 ~l~~LH~~-----~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~~~~ 549 (717)
.++.|.+. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22333211 12369999999999999876 7899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0053 Score=65.17 Aligned_cols=73 Identities=14% Similarity=0.181 Sum_probs=45.5
Q ss_pred ccccCcccccceEEEEeCC--------CchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCce-eEEEEeeccccCCCCce
Q 005045 394 ENLIGTGSFGSVYKGTLGD--------GTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI-LRVITACSSVDLEGNDF 464 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~~~~ 464 (717)
.+.++.|....+|.+...+ ++.+++|+..... ....+..|..+++.+...++ +++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIF-----SG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence 4567778888999988642 4678888874211 11344568888877732222 4555542 11
Q ss_pred EEEEEecCCCCCh
Q 005045 465 KALVFEFMSNGNL 477 (717)
Q Consensus 465 ~~lv~e~~~~~~L 477 (717)
.+|+||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.40 E-value=0.012 Score=61.20 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=24.7
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..++|+|+++.||+++.++ +.++||+.+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3699999999999997654 89999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.08 E-value=0.023 Score=58.20 Aligned_cols=31 Identities=19% Similarity=0.353 Sum_probs=27.4
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.18 E-value=0.048 Score=57.36 Aligned_cols=30 Identities=23% Similarity=0.362 Sum_probs=26.3
Q ss_pred CCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 519 TPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 519 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 36999999999999 7788999999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.43 E-value=1.6 Score=40.47 Aligned_cols=117 Identities=15% Similarity=0.183 Sum_probs=76.0
Q ss_pred CCCceeEEEEeeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005045 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIA 522 (717)
Q Consensus 443 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 522 (717)
.||+++.. .. .+..+.+.+.++.-+ ....+-. .+..+...+++++.+|+....+++.. +
T Consensus 43 ~~~~Fl~~-~I-----~e~eD~v~~~y~~~~--~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~ 101 (215)
T 4ann_A 43 HSPYFIDA-EL-----TELRDSFQIHYDIND--NHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVNRTR-----Y 101 (215)
T ss_dssp CCTTBCCE-EE-----EECSSEEEEEECCCT--TSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGGGSS-----E
T ss_pred cCCcccce-EE-----EEcccEEEEEEEcCc--ccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHhcCc-----e
Confidence 67777643 22 122345556666533 2222221 15678899999999999988666553 7
Q ss_pred ecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhC
Q 005045 523 HCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTG 602 (717)
Q Consensus 523 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg 602 (717)
|--++|+||+++.++.+++.-.|+...+ +|.. .+...=+-.+=|++..++++
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l------------------------~P~~----~~ee~fL~qyKAliiall~~ 153 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVV------------------------DPLP----VSEAEFLTRYKALVICAFNE 153 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTB------------------------SCCC----CCHHHHHHHHHHHHHHHHCT
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCC------------------------CCCC----CCHHHHHHHHHHHHHHHHcC
Confidence 8899999999999999999887764332 2221 11122233566788889999
Q ss_pred CCCCCC
Q 005045 603 KRPTGD 608 (717)
Q Consensus 603 ~~p~~~ 608 (717)
+..|..
T Consensus 154 K~~Fe~ 159 (215)
T 4ann_A 154 KQSFDA 159 (215)
T ss_dssp TCCHHH
T ss_pred CCCHHH
Confidence 888754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.26 E-value=3.1 Score=38.72 Aligned_cols=83 Identities=17% Similarity=0.218 Sum_probs=58.2
Q ss_pred CCCceeEEEEeeccccCCCCceEEEEEecCCCC-ChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHH-HHHhcCCCC
Q 005045 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNG-NLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD-YLHHHCDTP 520 (717)
Q Consensus 443 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~ 520 (717)
.||.+..-+.. +.+.+.+.++.-+++ ++. .+ ...+..++++++.+|+.... +++.
T Consensus 48 ~~~~f~~~I~~-------~eD~~~i~y~~~~~~~~f~-~i----------~~~~~~eKlrll~nl~~L~~~~~~~----- 104 (219)
T 4ano_A 48 VDPCIVRDIDV-------SEDEVKVVIKPPSSFLTFA-AI----------RKTTLLSRIRAAIHLVSKVKHHSAR----- 104 (219)
T ss_dssp SCSSSEEEEEE-------CSSEEEEEEECCTTCEEHH-HH----------HTSCHHHHHHHHHHHHHHHSSCCSS-----
T ss_pred cCCCCCeEEEE-------eCCEEEEEEEcCcccCcHH-HH----------HhcCHHHHHHHHHHHHHHHHHhhhC-----
Confidence 57777433332 345666666654332 333 23 45788899999999988777 5555
Q ss_pred eeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 521 IAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 521 ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
-+|--++|+||+++.++.+++.-.|+-.
T Consensus 105 r~tf~l~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 105 RLIFIVCPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp SEECCCCGGGEEECTTCCEEESCCEETT
T ss_pred ceeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence 4888999999999999999998877643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 717 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-59
Identities = 80/324 (24%), Positives = 134/324 (41%), Gaps = 66/324 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGA--LKSFIDECNALKSTRHRN 446
+ IG+GSFG+VYKG VA+K+L + L++F +E L+ TRH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
IL + ++ L A+V ++ +L LH K +I+ ++IA
Sbjct: 66 ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQT 113
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
A +DYLH I H DLK +N+ L +D+T +GDFGLA S + Q
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--- 167
Query: 567 LKGSIGYIPPEHMNGQ----VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622
GSI ++ PE + Q S D+Y++GI+L E+ TG+ P ++
Sbjct: 168 --GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI------------- 212
Query: 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682
N+ +QI ++ + + C ++ R+
Sbjct: 213 -------------------NNRDQIIFMVGRGYLSPDLS------KVRSNCPKAMKRLMA 247
Query: 683 MCSTTSPRERIAMNVVVNNLKTIR 706
C ER ++ +++ +
Sbjct: 248 ECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 3e-53
Identities = 69/341 (20%), Positives = 130/341 (38%), Gaps = 73/341 (21%)
Query: 380 SYSDISKSTDNFSKE---------NLIGTGSFGSVYKGTL----GDGTIVAIKVLKLQQ- 425
++ D +++ F+KE +IG G FG V G L VAIK LK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 426 QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSP 485
+ + F+ E + + H N++ + + + ++ EFM NG+LD +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSF----- 117
Query: 486 AEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545
+ +VIQ + + +A+ + YL H DL N+L++ ++ V DFG
Sbjct: 118 -LRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173
Query: 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKR 604
L++FL D T ++G K I + PE + + D++SYGI++ E+ +
Sbjct: 174 LSRFLE--DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 605 PTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEV 664
P + +++ I + ++ +
Sbjct: 232 R-------------------------------PYWDMTNQDVINAIEQDYRLPPP----- 255
Query: 665 NTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
+C ++ ++ L C R +VN L +
Sbjct: 256 ------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 68/315 (21%), Positives = 120/315 (38%), Gaps = 32/315 (10%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHR 445
D+F K + +G G+ G V+K + G ++A K++ L+ + I E L
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
I+ A + ++ E M G+LDQ L + ++ ++I
Sbjct: 65 YIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILGKVSIA 112
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
V L YL I H D+KPSN+L++ + DFG++ L + +++
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMAN 161
Query: 566 GLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP--TGDMFKDDFSIHMFVSM 622
G+ Y+ PE + G S+ DI+S G+ L+EM G+ P D + + V
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221
Query: 623 ALPDHVMDILDPSMPLDEEN-DEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681
+ P PL D + E + +++ F +
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-- 279
Query: 682 LMCSTTSPRERIAMN 696
C +P ER +
Sbjct: 280 -KCLIKNPAERADLK 293
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-51
Identities = 64/318 (20%), Positives = 121/318 (38%), Gaps = 64/318 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
+ +G G FG V+ G T VA+K LK +F+ E N +K +H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
R+ + + ++ E+M NG+L +L KL++ + L++A +A
Sbjct: 72 RLYAVVT------QEPIYIITEYMENGSLVDFLK-----TPSGIKLTINKLLDMAAQIAE 120
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ ++ H DL+ +N+L+ ++ + DFGLA+ + T G K
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI------EDNEYTAREGAK 171
Query: 569 GSIGYIPP-EHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
I + P G +I D++S+GILL E+ T R
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---------------------- 209
Query: 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687
P + E I+ + M+ + C + ++ +C
Sbjct: 210 ---------PYPGMTNPEVIQNLERGYRMVRP-----------DNCPEELYQLMRLCWKE 249
Query: 688 SPRERIAMNVVVNNLKTI 705
P +R + + + L+
Sbjct: 250 RPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 74/330 (22%), Positives = 128/330 (38%), Gaps = 64/330 (19%)
Query: 375 RQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFID 434
+ G++ ++ E +G G FG V+ GT T VAIK LK ++F+
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 61
Query: 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
E +K RH ++++ S + +V E+MS G+L +L ++ +
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP-- 113
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
Q +++A +AS + Y+ H DL+ +N+L+ +++ V DFGLA+ +
Sbjct: 114 ---QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI---- 163
Query: 555 DNPSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
T G K I + PE + G+ +I D++S+GILL E+ T R
Sbjct: 164 --EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------- 213
Query: 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC 673
P + E +++V M EC
Sbjct: 214 -----------------------PYPGMVNREVLDQVERGYRMPCP-----------PEC 239
Query: 674 FVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703
S+ + C P ER + L+
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-50
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 22/247 (8%)
Query: 394 ENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRV 450
+ IG GSF +VYKG VA L+ ++ + + F +E LK +H NI+R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 451 ITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASAL 510
+ S +G LV E M++G L +L +FK + + + + L
Sbjct: 74 YDSWESTV-KGKKCIVLVTELMTSGTLKTYLK-------RFKVMKIKVLRSWCRQILKGL 125
Query: 511 DYLHHHCDTPIAHCDLKPSNVLL-DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKG 569
+LH PI H DLK N+ + + +GD GLA K + + + G
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIG 175
Query: 570 SIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVM 629
+ ++ PE + D+Y++G+ +LEM T + P + S P
Sbjct: 176 TPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
Query: 630 DILDPSM 636
+ P +
Sbjct: 236 KVAIPEV 242
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-50
Identities = 64/326 (19%), Positives = 118/326 (36%), Gaps = 48/326 (14%)
Query: 394 ENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITA 453
+ IG G FG V++G G VA+K+ +++ + E RH NIL I A
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYL 513
+ + LV ++ +G+L +L+ ++V + +A+ AS L +L
Sbjct: 66 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHL 116
Query: 514 HHHC-----DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
H IAH DLK N+L+ K+ T + D GLA +D
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN---HRV 173
Query: 569 GSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621
G+ Y+ PE ++ +++ DIY+ G++ E+ G
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE----------- 222
Query: 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681
D +P + + E + + + + + + E + +I
Sbjct: 223 -----------DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 271
Query: 682 LMCSTTSPRERIAMNVVVNNLKTIRN 707
C + R+ + L +
Sbjct: 272 RECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-50
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 19/223 (8%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHR 445
+++ IGTGS+G K DG I+ K L + + + E N L+ +H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+R N +V E+ G+L + E + L L +
Sbjct: 64 NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKER---QYLDEEFVLRVMTQ 117
Query: 506 VASALDYLHHH--CDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ AL H + H DLKP+NV LD +GDFGLA+ L + + +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSF 170
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ G+ Y+ PE MN + DI+S G LL E+ P
Sbjct: 171 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 70/358 (19%), Positives = 132/358 (36%), Gaps = 69/358 (19%)
Query: 359 LNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL----GDGT 414
+++ + LN + + V+ + S + +F +IG G FG VY GTL G
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSL---IVHF--NEVIGRGHFGCVYHGTLLDNDGKKI 56
Query: 415 IVAIKVL-KLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMS 473
A+K L ++ G + F+ E +K H N+L ++ C L +V +M
Sbjct: 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLPYMK 112
Query: 474 NGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLL 533
+G+L + + +V + + VA + H DL N +L
Sbjct: 113 HGDLRNF------IRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCML 163
Query: 534 DKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSY 592
D+ T V DFGLA+ + D + G K + ++ E + + D++S+
Sbjct: 164 DEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220
Query: 593 GILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIE 652
G+LL E+ T P P + N + +++
Sbjct: 221 GVLLWELMTRGAP-------------------------------PYPDVNTFDITVYLLQ 249
Query: 653 EKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRNCFL 710
+ ++ E C + + L C R + + +V+ + I + F+
Sbjct: 250 GRRLLQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-49
Identities = 67/320 (20%), Positives = 113/320 (35%), Gaps = 68/320 (21%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
IG G FG V G G VA+K +K ++F+ E + + RH N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 63
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
+++ +E +V E+M+ G+L +L L L ++DV
Sbjct: 64 QLLGVI----VEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCE 114
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
A++YL + H DL NVL+ +D A V DFGL K D K
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----------GK 161
Query: 569 GSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
+ + PE + S D++S+GILL E+++ R
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------------- 199
Query: 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687
P ++ + V + +M + C +V + C
Sbjct: 200 ---------PYPRIPLKDVVPRVEKGYKMDA-----------PDGCPPAVYEVMKNCWHL 239
Query: 688 SPRERIAMNVVVNNLKTIRN 707
R + + L+ I+
Sbjct: 240 DAAMRPSFLQLREQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 64/324 (19%), Positives = 108/324 (33%), Gaps = 67/324 (20%)
Query: 388 TDNFSKENL-IGTGSFGSVYKGTL---GDGTIVAIKVLKLQ-QQGALKSFIDECNALKST 442
DN ++ +G G+FGSV +G VAIKVLK ++ + + E +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
+ I+R+I C + L LV E G L ++L + +++ V +
Sbjct: 67 DNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV------GKREEIPVSNVAEL 114
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
V+ + YL H DL NVLL A + DFGL+K L +
Sbjct: 115 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 563 VSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621
K + + PE + S D++SYG+ + E + +
Sbjct: 172 G----KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------- 211
Query: 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIG 681
P + E + + + K M EC + +
Sbjct: 212 ---------------PYKKMKGPEVMAFIEQGKRMECP-----------PECPPELYALM 245
Query: 682 LMCSTTSPRERIAMNVVVNNLKTI 705
C +R V ++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 63/318 (19%), Positives = 115/318 (36%), Gaps = 64/318 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
+ + +GTG FG V G VAIK++K FI+E + + H ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ C+ ++ E+M+NG L +L + Q L + DV
Sbjct: 63 QLYGVCTK-----QRPIFIITEYMANGCLLNYL------REMRHRFQTQQLLEMCKDVCE 111
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
A++YL H DL N L++ V DFGL++++ T S+G K
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV------LDDEYTSSVGSK 162
Query: 569 GSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
+ + PPE M + S DI+++G+L+ E+++ +
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM---------------------- 200
Query: 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687
P + + E E + + + V I C
Sbjct: 201 ---------PYERFTNSETAEHIAQGLRLYRP-----------HLASEKVYTIMYSCWHE 240
Query: 688 SPRERIAMNVVVNNLKTI 705
ER ++++N+ +
Sbjct: 241 KADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-48
Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 64/319 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNIL 448
+ IG+G FG V+ G + VAIK ++ + FI+E + H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ C LVFEFM +G L + Q + L + +DV
Sbjct: 64 QLYGVC-----LEQAPICLVFEFMEHGCLSDY------LRTQRGLFAAETLLGMCLDVCE 112
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
+ YL C + H DL N L+ ++ V DFG+ +F+ T S G K
Sbjct: 113 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV------LDDQYTSSTGTK 163
Query: 569 GSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
+ + PE + S D++S+G+L+ E+F+ +
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---------------------- 201
Query: 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTT 687
P + ++ E +E++ + V +I C
Sbjct: 202 ---------PYENRSNSEVVEDISTGFRLYKP-----------RLASTHVYQIMNHCWKE 241
Query: 688 SPRERIAMNVVVNNLKTIR 706
P +R A + ++ L I
Sbjct: 242 RPEDRPAFSRLLRQLAEIA 260
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 60/248 (24%), Positives = 98/248 (39%), Gaps = 30/248 (12%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
+ ++F +G G FG+VY I+A+KVL L++ G E
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
RH NILR+ L+ E+ G + + L + K +
Sbjct: 64 RHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQ-------KLSKFDEQRTATY 111
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
++A+AL Y H + H D+KP N+LL + DFG + +
Sbjct: 112 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSS 159
Query: 563 VSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFV 620
L G++ Y+PPE + G+ D++S G+L E GK P + +++ + V
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 621 SMALPDHV 628
PD V
Sbjct: 220 EFTFPDFV 227
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 31/235 (13%)
Query: 381 YSDISKS---TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDEC 436
Y +++ D + +G G+FG VYK + A KV+ + + L+ ++ E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 437 NALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+ L S H NI++++ A + ++ EF + G +D + + L+
Sbjct: 61 DILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML------ELERPLTE 109
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
Q + AL+YLH + I H DLK N+L D + DFG++
Sbjct: 110 SQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN------ 160
Query: 557 PSKNQTVSIGLKGSIGYIPPEHMNGQVSILG------DIYSYGILLLEMFTGKRP 605
++ G+ ++ PE + + S D++S GI L+EM + P
Sbjct: 161 -TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 61/319 (19%), Positives = 107/319 (33%), Gaps = 68/319 (21%)
Query: 393 KENLIGTGSFGSVYKGTL---GDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNI 447
++ +G+G+FG+V KG VA+K+LK + + E N ++ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+R+I C + LV E G L+++L Q + + + + V+
Sbjct: 71 VRMIGICE------AESWMLVMEMAELGPLNKYLQ-------QNRHVKDKNIIELVHQVS 117
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
+ YL H DL NVLL A + DFGL+K L +
Sbjct: 118 MGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG---- 170
Query: 568 KGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626
K + + PE + + S D++S+G+L+ E F+ +
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--------------------- 209
Query: 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686
P E + + + M C + + +C T
Sbjct: 210 ----------PYRGMKGSEVTAMLEKGERMGCP-----------AGCPREMYDLMNLCWT 248
Query: 687 TSPRERIAMNVVVNNLKTI 705
R V L+
Sbjct: 249 YDVENRPGFAAVELRLRNY 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 2e-45
Identities = 65/342 (19%), Positives = 123/342 (35%), Gaps = 80/342 (23%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKS 441
+N IG G+FG V++ T+VA+K+LK + F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH-----------------PS 484
+ NI++++ C L+FE+M+ G+L+++L +
Sbjct: 73 FDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 485 PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544
LS ++L IA VA+ + YL H DL N L+ ++M + DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 184
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGK 603
GL++ + + I ++PPE + + + D+++YG++L E+F+
Sbjct: 185 GLSRNI-----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663
P EE I V + +
Sbjct: 240 LQ-------------------------------PYYGMAHEEVIYYVRDGNILACP---- 264
Query: 664 VNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
E C + + + +C + P +R + + L+ +
Sbjct: 265 -------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 2e-45
Identities = 56/230 (24%), Positives = 84/230 (36%), Gaps = 34/230 (14%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL---QQQGALKSFIDECNALKSTR 443
FS IG GSFG+VY + + +VAIK + Q + I E L+ R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H N ++ LV E+ D K L ++ +
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV-------HKKPLQEVEIAAVT 121
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
L YLH H + H D+K N+LL + +GDFG A +
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----------AP 167
Query: 564 SIGLKGSIGYIPPE----HMNGQVSILGDIYSYGILLLEMFTGKRPTGDM 609
+ G+ ++ PE GQ D++S GI +E+ K P +M
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 2e-45
Identities = 67/321 (20%), Positives = 125/321 (38%), Gaps = 64/321 (19%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
+ + ++ +G G +G VY+G VA+K LK ++ F+ E +K +H N+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 75
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
++++ C ++ EFM+ GNL +L +++S + L +A ++
Sbjct: 76 VQLLGVC-----TREPPFYIITEFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQIS 125
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGL 567
SA++YL H DL N L+ ++ V DFGL++ + T G
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGA 176
Query: 568 KGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPD 626
K I + PE + + SI D++++G+LL E+ T
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM---------------------- 214
Query: 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCST 686
D Q+ E++E+ M + E C V + C
Sbjct: 215 ----------SPYPGIDLSQVYELLEKDYRM----------ERPEGCPEKVYELMRACWQ 254
Query: 687 TSPRERIAMNVVVNNLKTIRN 707
+P +R + + +T+
Sbjct: 255 WNPSDRPSFAEIHQAFETMFQ 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 376 QSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFID 434
+S +S D +++ IG G+ G+VY + G VAI+ + LQQQ + I+
Sbjct: 10 RSIVSVGDP---KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 435 ECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKL 494
E ++ ++ NI+ + + D +V E+++ G+L + +
Sbjct: 67 EILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTE--------TCM 113
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
Q + + AL++LH + + H D+K N+LL D + + DFG +
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---- 166
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
+ Q+ + G+ ++ PE + + DI+S GI+ +EM G+ P
Sbjct: 167 ---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 66/340 (19%), Positives = 114/340 (33%), Gaps = 79/340 (23%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQ-QQGALKSFIDECNALKS 441
+N ++G+G+FG V T G VA+K+LK + ++ + E +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH----------------PS 484
H NI+ ++ AC + L+FE+ G+L +L
Sbjct: 97 LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 485 PAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544
E L+ L A VA +++L H DL NVL+ + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208
Query: 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGK 603
GLA+ + N V + + ++ PE G +I D++SYGILL E+F+
Sbjct: 209 GLARDI-----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 604 RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663
P + ++I+ M
Sbjct: 264 VN-------------------------------PYPGIPVDANFYKLIQNGFKM------ 286
Query: 664 VNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLK 703
++ + I C R+R + + + L
Sbjct: 287 ----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 48/252 (19%), Positives = 93/252 (36%), Gaps = 24/252 (9%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRN 446
+++ +G G++G V VA+K++ +++ ++ E K H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
+++ + + L E+ S G L + P + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQL 112
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+ + YLH I H D+KP N+LLD+ + DFGLA + N+
Sbjct: 113 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--- 166
Query: 567 LKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624
G++ Y+ PE + + + D++S GI+L M G+ P +
Sbjct: 167 --GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 625 PDHVMDILDPSM 636
+ +D +
Sbjct: 225 YLNPWKKIDSAP 236
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-45
Identities = 51/249 (20%), Positives = 98/249 (39%), Gaps = 26/249 (10%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
K ++F ++G GSF +V L AIK+L+ + ++ + E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
H +++ + ++ + NG L +++ +
Sbjct: 65 LDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIR-------KIGSFDETCTRF 112
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
++ SAL+YLH I H DLKP N+LL++DM + DFG AK +P Q
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-----LSPESKQ 164
Query: 562 TVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMF 619
+ G+ Y+ PE + + D+++ G ++ ++ G P F +
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
Query: 620 VSMALPDHV 628
+ P+
Sbjct: 225 LEYDFPEKF 233
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-44
Identities = 69/326 (21%), Positives = 112/326 (34%), Gaps = 68/326 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLK---LQQQGALKSFIDECNALKS 441
+ +G GSFG V +G G VA+K LK L Q A+ FI E NA+ S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
HRN++R+ + ++ +V E G+L +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDR------LRKHQGHFLLGTLSR 115
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQ 561
A+ VA + YL H DL N+LL +GDFGL + L + D+ +
Sbjct: 116 YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 562 TVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620
K + PE S D + +G+ L EMFT +
Sbjct: 173 HR----KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------- 213
Query: 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRI 680
P N + + ++ +E E + + E+C + +
Sbjct: 214 ----------------PWIGLNGSQILHKIDKEGERL----------PRPEDCPQDIYNV 247
Query: 681 GLMCSTTSPRERIAMNVVVNNLKTIR 706
+ C P +R + + L +
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 65/326 (19%), Positives = 125/326 (38%), Gaps = 67/326 (20%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTLGDGT-----IVAIKVLKLQQ-QGALKSFIDECNALK 440
+++ +IG G FG VYKG L + VAIK LK + F+ E +
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 441 STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRL 500
H NI+R+ S ++ E+M NG LD++ + + SV+Q +
Sbjct: 65 QFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKF------LREKDGEFSVLQLV 113
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKN 560
+ +A+ + YL + H DL N+L++ ++ V DFGL++ L ++ +
Sbjct: 114 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL----EDDPEA 166
Query: 561 QTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619
+ G K I + PE + + D++S+GI++ E+ T
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------- 212
Query: 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679
P E ++ E ++ + + + +C ++ +
Sbjct: 213 -----------------PYWELSNHEVMKAINDGFRLPTP-----------MDCPSAIYQ 244
Query: 680 IGLMCSTTSPRERIAMNVVVNNLKTI 705
+ + C R +V+ L +
Sbjct: 245 LMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (401), Expect = 1e-43
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
D++ +GTG+FG V++ T G A K + + ++ E + RH +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ + A E ++ +++EFMS G L + + + K+S + + V
Sbjct: 86 VNLHDAF-----EDDNEMVMIYEFMSGGELFEKVAD------EHNKMSEDEAVEYMRQVC 134
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSI 565
L ++H + H DLKP N++ + + DFGL L
Sbjct: 135 KGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT------ 185
Query: 566 GLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ + PE G+ V D++S G+L + +G P
Sbjct: 186 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 5e-42
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 20/223 (8%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKSTR 443
+D + ++G G V+ L VA+KVL+ + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H I+ V + G +V E++ L +H ++ + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVH-------TEGPMTPKRAIEVI 117
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
D AL++ H + I H D+KP+N+++ V DFG+A+ + + ++ ++ V
Sbjct: 118 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP 605
G+ Y+ PE G V D+YS G +L E+ TG+ P
Sbjct: 175 ----IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 60/326 (18%), Positives = 129/326 (39%), Gaps = 66/326 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKS 441
+ + +G GSFG VY+G T VAIK + F++E + +K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---PSPAEHYQFKKLSVIQ 498
+++R++ ++ E M+ G+L +L P+ A + S+ +
Sbjct: 80 FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 499 RLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPS 558
+ +A ++A + YL+ + H DL N ++ +D T +GDFG+ + ++E
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 559 KNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
+ + + ++ PE +G + D++S+G++L E+ T
Sbjct: 192 GGKGL-----LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------------ 234
Query: 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSV 677
P ++E+ + V+E + +K + C +
Sbjct: 235 -------------------PYQGLSNEQVLRFVMEGGLL-----------DKPDNCPDML 264
Query: 678 LRIGLMCSTTSPRERIAMNVVVNNLK 703
+ MC +P+ R + +++++K
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 69/333 (20%), Positives = 119/333 (35%), Gaps = 73/333 (21%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL---GDGTIVAIKVLK-LQQQGALKSFIDECNALKS-TR 443
++ +++IG G+FG V K + G AIK +K + + F E L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQ---------FKKL 494
H NI+ ++ AC E + L E+ +GNL +L S L
Sbjct: 70 HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 495 SVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEIS 554
S Q L+ A DVA +DYL H DL N+L+ ++ A + DFGL++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG----- 176
Query: 555 DNPSKNQTVSIGLKGSIGYIPPEHMNGQV-SILGDIYSYGILLLEMFTGKRPTGDMFKDD 613
+ + + ++ E +N V + D++SYG+LL E+ +
Sbjct: 177 ---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------- 225
Query: 614 FSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEEC 673
P E E++ + + ++ C
Sbjct: 226 -----------------------PYCGMTCAELYEKLPQGYRLEKPLN-----------C 251
Query: 674 FVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706
V + C P ER + ++ +L +
Sbjct: 252 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 60/339 (17%), Positives = 107/339 (31%), Gaps = 74/339 (21%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKS 441
+ S +G G+FG V + T VA+K+LK ++ + E L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 442 -TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFK-------- 492
H NI+ ++ AC+ ++ E+ G+L +L K
Sbjct: 83 LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 493 ---KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
L + L+ + VA + +L H DL N+LL + DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGD 608
+ N V + + ++ PE N + D++SYGI L E+F+
Sbjct: 195 I-----KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--- 246
Query: 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKN 668
+ M + ++ +
Sbjct: 247 ---------PYPGMPVDSKFYKMIKEGFRMLSP--------------------------- 270
Query: 669 KLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707
E + I C P +R +V ++ +
Sbjct: 271 --EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 64/331 (19%), Positives = 116/331 (35%), Gaps = 70/331 (21%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-----KLQQQGALKSFIDECN 437
I K T+ F K ++G+G+FG+VYKG + +G V I V + A K +DE
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 438 ALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
+ S + ++ R++ C + ++ L+ + M G L + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDY------VREHKDNIGSQ 111
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
LN + +A ++YL + H DL NVL+ + DFGLAK L
Sbjct: 112 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GA 163
Query: 558 SKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSI 616
+ + + G K I ++ E ++ + D++SYG+ + E+ T
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----------- 212
Query: 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVS 676
P D E + + + + C +
Sbjct: 213 --------------------PYDGIPASEISSILEKGERLPQP-----------PICTID 241
Query: 677 VLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707
V I + C R ++ +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (379), Expect = 1e-40
Identities = 47/253 (18%), Positives = 92/253 (36%), Gaps = 27/253 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
D + +G+G+FG V++ G + K + + +E + + H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ + A E L+ EF+S G L + + K+S + +N
Sbjct: 89 INLHDAF-----EDKYEMVLILEFLSGGELFDRIAA------EDYKMSEAEVINYMRQAC 137
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSI 565
L ++H H I H D+KP N++ + + V DFGLA L +
Sbjct: 138 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--------NPDEIVK 186
Query: 566 GLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSMA 623
+ + PE ++ + V D+++ G+L + +G P G+ +
Sbjct: 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246
Query: 624 LPDHVMDILDPSM 636
+ + P
Sbjct: 247 FDEDAFSSVSPEA 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 53/323 (16%), Positives = 106/323 (32%), Gaps = 69/323 (21%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLK-LQQQGALKSFIDECNALKSTR 443
+ IG G FG V++G VAIK K + F+ E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H +I+++I + + ++ E + G L + + L + + A
Sbjct: 67 HPHIVKLIGVIT------ENPVWIIMELCTLGELRSF------LQVRKYSLDLASLILYA 114
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
+++AL YL H D+ NVL+ + +GDFGL++++
Sbjct: 115 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYK 165
Query: 564 SIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622
+ K I ++ PE +N + + D++ +G+ + E+
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----------------- 208
Query: 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682
P + + I + + + + C ++ +
Sbjct: 209 --------------PFQGVKNNDVIGRIENGERLPMP-----------PNCPPTLYSLMT 243
Query: 683 MCSTTSPRERIAMNVVVNNLKTI 705
C P R + L TI
Sbjct: 244 KCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 59/334 (17%), Positives = 110/334 (32%), Gaps = 69/334 (20%)
Query: 389 DNFSKENLIGTGSFGSVYKGT------LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKS 441
D +G G+FG V + VA+K+LK ++ + E L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---------PSPAEHYQFK 492
H + + + + ++ EF GNL +L E
Sbjct: 73 IGHHLNVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 493 KLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFE 552
L++ + + VA +++L H DL N+LL + + DFGLA+ +++
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 553 ISDNPSKNQTVSIGLKGSIGYIPPEH-MNGQVSILGDIYSYGILLLEMFTGKRPTGDMFK 611
D K + ++ PE + +I D++S+G+LL E+F+
Sbjct: 187 DPDYVRKGDAR-----LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------ 235
Query: 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
P +E+ ++E M D
Sbjct: 236 -------------------------PYPGVKIDEEFCRRLKEGTRMRAPD---------- 260
Query: 672 ECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
+ + L C P +R + +V +L +
Sbjct: 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 70/337 (20%), Positives = 121/337 (35%), Gaps = 75/337 (22%)
Query: 389 DNFSKENLIGTGSFGSVYKGTL--------GDGTIVAIKVLKLQQ-QGALKSFIDECNAL 439
D +G G+FG V T VA+K+LK + L I E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 440 KS-TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH---------PSPAEHY 489
K +H+NI+ ++ AC+ + ++ E+ S GNL ++L H
Sbjct: 73 KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 490 QFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549
++LS ++ A VA ++YL H DL NVL+ +D + DFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGD 608
+ + + + + ++ PE + + + D++S+G+LL E+FT
Sbjct: 185 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--- 236
Query: 609 MFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKN 668
P EE + + E M +
Sbjct: 237 ----------------------------PYPGVPVEELFKLLKEGHRM-----------D 257
Query: 669 KLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTI 705
K C + + C P +R +V +L I
Sbjct: 258 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 3e-38
Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 41/235 (17%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL---------QQQGALKSFIDECNA 438
+N+ + ++G G V + A+K++ + + Q ++ + E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 439 LKSTR-HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVI 497
L+ H NI+++ E N F LVF+ M G L +L + LS
Sbjct: 63 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLT-------EKVTLSEK 110
Query: 498 QRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNP 557
+ I + + LH I H DLKP N+LLD DM + DFG + L +P
Sbjct: 111 ETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DP 162
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQVSILG-------DIYSYGILLLEMFTGKRP 605
+ G+ Y+ PE + ++ D++S G+++ + G P
Sbjct: 163 GEKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 65/335 (19%), Positives = 121/335 (36%), Gaps = 44/335 (13%)
Query: 384 ISKSTDNFSKENLIGTGSFGSVYKGT--LGDGTIVAIKVLKLQ--QQGALKSFIDECNAL 439
+ ++ + IG G++G V+K G VA+K +++Q ++G S I E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 440 K---STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSV 496
+ + H N++R+ C+ + LVFE + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK------VPEPGVPT 115
Query: 497 IQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDN 556
++ + LD+LH H + H DLKP N+L+ + DFGLA+
Sbjct: 116 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 172
Query: 557 PSKNQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615
S + ++ Y PE + + D++S G + EMF K F+
Sbjct: 173 TS--------VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRG--- 217
Query: 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFV 675
+D L + + EE + H + + +
Sbjct: 218 ----------SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 676 SVLRIGLMCSTTSPRERIAMNVVVNN--LKTIRNC 708
+ L C T +P +RI+ +++ + + C
Sbjct: 268 LGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 55/280 (19%), Positives = 93/280 (33%), Gaps = 20/280 (7%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL-KLQQQGALKSFIDECNALKSTRHR 445
++ + IG G++G V + VAIK + + Q + + E L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+ + + +E LV M + + LS
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK---------LLKTQHLSNDHICYFLYQ 117
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L Y+H + H DLKPSN+LL+ + DFGLA+ D+
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-- 172
Query: 566 GLKGSIGYIPPEHMNGQVSIL--GDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
+ Y PE M DI+S G +L EM + + D H+ +
Sbjct: 173 --VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663
P ++ + + + + D +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 6e-38
Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 23/225 (10%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHR 445
D + +++GTG+F V +VAIK + + +G S +E L +H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+ + E L+ + +S G L + + + +
Sbjct: 68 NIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERDASRLIFQ 115
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
V A+ YLH LD+D + DFGL+K +V
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--------DPGSVLS 167
Query: 566 GLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM 609
G+ GY+ PE + + S D +S G++ + G P D
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 49/251 (19%), Positives = 95/251 (37%), Gaps = 26/251 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
+ + +G G FG V++ K +K++ E + L RHRNI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
L + + E + ++FEF+S ++ + ++ S +L+ + ++ V
Sbjct: 64 LHLHESF-----ESMEELVMIFEFISGLDIFERINTSA------FELNEREIVSYVHQVC 112
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV--GDFGLAKFLFEISDNPSKNQTVSI 565
AL +LH H I H D++P N++ ++ + +FG A+ L +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 566 GLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSMAL 624
Y P H + VS D++S G L+ + +G P + + M
Sbjct: 170 -------YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222
Query: 625 PDHVMDILDPS 635
+ +
Sbjct: 223 DEEAFKEISIE 233
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 29/247 (11%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKST-R 443
++F ++G GSFG V+ AIK LK + ++ + E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 444 HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIA 503
H + + + + V E+++ G+L + K + + A
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ-------SCHKFDLSRATFYA 109
Query: 504 IDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTV 563
++ L +LH I + DLK N+LLDKD + DFG+ K
Sbjct: 110 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN-------MLGDAK 159
Query: 564 SIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVS 621
+ G+ YI PE + GQ + D +S+G+LL EM G+ P G ++ F +
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219
Query: 622 MALPDHV 628
P +
Sbjct: 220 PFYPRWL 226
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (352), Expect = 3e-37
Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 41/265 (15%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
S +F +GTGSFG V+ +G A+KVLK + + ++ DE L
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
H I+R+ + ++ +++ G L + ++
Sbjct: 62 THPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSL-------LRKSQRFPNPVAKFY 109
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
A +V AL+YLH I + DLKP N+LLDK+ + DFG AK++ P T
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYT 160
Query: 563 VSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDM---------FKD 612
+ G+ YI PE ++ + + D +S+GIL+ EM G P D
Sbjct: 161 L----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216
Query: 613 DFSIHMFVSMALPDHVMDIL--DPS 635
+ F + + D + ++ D S
Sbjct: 217 ELRFPPFFNEDVKDLLSRLITRDLS 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 56/287 (19%), Positives = 118/287 (41%), Gaps = 22/287 (7%)
Query: 386 KSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ--QQGALKSFIDECNALKST 442
+ K IG G+FG V+K G VA+K + ++ ++G + + E L+
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 443 RHRNILRVITACSSVDLEGNDFKA---LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
+H N++ +I C + N K LVF+F + + K ++ +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEI 119
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
+ + L+ L++ I H D+K +NVL+ +D + DFGLA+ ++
Sbjct: 120 KRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSI 616
T + ++ Y PPE + G+ D++ G ++ EM+T G+ + ++
Sbjct: 177 RYTNRV---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233
Query: 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLE 663
+ ++ V +D ++ + + ++++ D
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-37
Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 28/241 (11%)
Query: 387 STDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHR 445
+++ +IG GSFG VY+ L G +VAIK + + + E ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHC 73
Query: 446 NILRVITACSSVDLEGND-FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI+R+ S + ++ + LV +++ H S A+ + L VI
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMY 129
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPSKNQTV 563
+ +L Y+H I H D+KP N+LLD D + DFG AK L N S +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS- 185
Query: 564 SIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621
Y PE + G + D++S G +L E+ G+ F D + V
Sbjct: 186 -------RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVE 234
Query: 622 M 622
+
Sbjct: 235 I 235
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (349), Expect = 2e-36
Identities = 50/259 (19%), Positives = 95/259 (36%), Gaps = 33/259 (12%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL------QQQGALKSFIDECNAL 439
+ ++FS +IG G FG VY G + A+K L Q + + + +
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 440 KSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
+ I+ + A D + + + M+ G+L L
Sbjct: 62 STGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DM 109
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSK 559
A ++ L+++H+ + + DLKP+N+LLD+ + D GLA
Sbjct: 110 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------- 157
Query: 560 NQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617
++ G+ GY+ PE + D +S G +L ++ G P D
Sbjct: 158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 618 MFVSMALPDHVMDILDPSM 636
+++ + + D P +
Sbjct: 218 DRMTLTMAVELPDSFSPEL 236
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 7e-36
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 22/255 (8%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
+ + IG+GSFG +Y GT + G VAIK+ ++ + E K +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ I C D+ +V E + D + S +K S+ L +A +
Sbjct: 65 IPTIRWCG----AEGDYNVMVMELLGPSLEDLFNFCS-------RKFSLKTVLLLADQMI 113
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVL---LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
S ++Y+H H D+KP N L K ++ DFGLAK + + +
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 565 IGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKR-PTGDMFKDDFSIHMFVSM 622
L G+ Y H+ + S D+ S G +L+ G G + +S
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 623 ALPDHVMDILDPSMP 637
+++L P
Sbjct: 231 KKMSTPIEVLCKGYP 245
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL--QQQGALKSFIDECNALKSTRHR 445
+NF K IG G++G VYK G +VA+K ++L + +G + I E + LK H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI++++ + LVFEF+ + + + +
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFM------DASALTGIPLPLIKSYLFQ 110
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L + H H + H DLKP N+L++ + + DFGLA+ P + T +
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEV 163
Query: 566 GLKGSIGYIPPE--HMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
++ Y PE S DI+S G + EM T + + D +F ++
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 624 LPDHVMDILDPSMP 637
PD V+ SMP
Sbjct: 221 TPDEVVWPGVTSMP 234
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 5e-35
Identities = 45/257 (17%), Positives = 83/257 (32%), Gaps = 24/257 (9%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNI 447
++ IG GSFG +++GT L + VAIK + DE K
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 448 LRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVA 507
+ + + LV + + D +K SV A +
Sbjct: 63 IPNVYYFG----QEGLHNVLVIDLLGPSLEDLL-------DLCGRKFSVKTVAMAAKQML 111
Query: 508 SALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG-----DFGLAKFLFEISDNPSKNQT 562
+ + +H + + D+KP N L+ + + + DFG+ KF +
Sbjct: 112 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 563 VSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGK-RPTGDMFKDDFSIHMFV 620
L G+ Y+ H+ + S D+ + G + + G G + + +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 621 SMALPDHVMDILDPSMP 637
+ L P
Sbjct: 229 GEKKQSTPLRELCAGFP 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 44/248 (17%), Positives = 88/248 (35%), Gaps = 28/248 (11%)
Query: 394 ENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNAL-KSTRHRNILRVI 451
++G G G V + A+K+L+ + E ++++ +I+R++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 452 TACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALD 511
++ +V E + G L + + + + I + A+
Sbjct: 72 DVYENLYAGRKCL-LIVMECLDGGELFSRIQ-----DRGDQAFTEREASEIMKSIGEAIQ 125
Query: 512 YLHHHCDTPIAHCDLKPSNVLLDK---DMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
YLH IAH D+KP N+L + + DFG AK + + T
Sbjct: 126 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT------ 176
Query: 569 GSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627
Y+ PE + + D++S G+++ + G P S M + + +
Sbjct: 177 --PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 628 VMDILDPS 635
+ S
Sbjct: 235 EFPNPEWS 242
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 395 NLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ-----QQGALKSFIDECNALKSTRHRNIL 448
+ +G G F +VYK IVAIK +KL + G ++ + E L+ H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 449 RVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVAS 508
++ A +LVF+FM S L+ +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQ 111
Query: 509 ALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLK 568
L+YLH H I H DLKP+N+LLD++ + DFGLAK +P++ T +
Sbjct: 112 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF----GSPNRAYTHQV--- 161
Query: 569 GSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRP 605
+ Y PE + G + D+++ G +L E+
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (325), Expect = 4e-34
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 43/312 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRN 446
+ + IG G++G VYK G A+K ++L++ +G + I E + LK +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 447 ILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDV 506
I+++ + LVFE + L + + + +
Sbjct: 62 IVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQL 109
Query: 507 ASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIG 566
+ + Y H + H DLKP N+L++++ + DFGLA+
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF-------GIPVRKYTH 159
Query: 567 LKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624
++ Y P+ + G + S DI+S G + EM G F ++
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL-------------FPGVSE 206
Query: 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNK-LEECFVSVLRIGLM 683
D +M I + +N E + ++ L + K L+E + +L
Sbjct: 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---K 263
Query: 684 CSTTSPRERIAM 695
P +RI
Sbjct: 264 MLKLDPNQRITA 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-34
Identities = 50/248 (20%), Positives = 97/248 (39%), Gaps = 28/248 (11%)
Query: 387 STDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK---LQQQGALKSFIDECNALKST 442
+ ++F L+G G+FG V G A+K+L+ + + + + E L++T
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 443 RHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNI 502
RH + + A + +D V E+ + G L L + + + +
Sbjct: 63 RHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFY 110
Query: 503 AIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQT 562
++ SAL + + + D+K N++LDKD + DFGL K +
Sbjct: 111 GAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-------DGA 160
Query: 563 VSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFV 620
G+ Y+ PE + D + G+++ EM G+ P + F + +
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 621 SMALPDHV 628
+ P +
Sbjct: 221 EIRFPRTL 228
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-34
Identities = 51/261 (19%), Positives = 97/261 (37%), Gaps = 36/261 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKL------QQQGALKSFIDECNALKS 441
D + +G+G F V K G A K +K ++ + + E + LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 442 TRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLN 501
+H N++ + E L+ E ++ G L + + + L+ +
Sbjct: 70 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDF-------LAEKESLTEEEATE 117
Query: 502 IAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA----HVGDFGLAKFLFEISDNP 557
+ + + YLH IAH DLKP N++L + DFGLA +
Sbjct: 118 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI------- 167
Query: 558 SKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFS 615
+ G+ ++ PE +N + + + D++S G++ + +G P GD ++ +
Sbjct: 168 -DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 616 IHMFVSMALPDHVMDILDPSM 636
V+ D
Sbjct: 227 NVSAVNYEFEDEYFSNTSALA 247
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 65/313 (20%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHR 445
+ K IG G++G+V+K IVA+K ++L +G S + E LK +H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 446 NILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAID 505
NI+R+ + LVFEF + + + +
Sbjct: 62 NIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-------IVKSFLFQ 109
Query: 506 VASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSI 565
+ L + H + H DLKP N+L++++ + +FGLA+ P + + +
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVRCYSAEV 162
Query: 566 GLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
++ Y PP+ + G S D++S G + E+ RP +F
Sbjct: 163 ---VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP------------LFPGND 207
Query: 624 LPDHVMDILD-PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682
+ D + I P +E+ + M VN KL +L+
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ--- 264
Query: 683 MCSTTSPRERIAM 695
+P +RI+
Sbjct: 265 NLLKCNPVQRISA 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-32
Identities = 56/264 (21%), Positives = 89/264 (33%), Gaps = 40/264 (15%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQ------QQGALKSFIDECNALK- 440
+ L+G+G FGSVY G + D VAIK ++ + E LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 441 -STRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQR 499
S+ ++R++ D L+ E + L
Sbjct: 64 VSSGFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFI------TERGALQEELA 112
Query: 500 LNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD-MTAHVGDFGLAKFLFEISDNPS 558
+ V A+ + H+ + H D+K N+L+D + + DFG L
Sbjct: 113 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL-------- 161
Query: 559 KNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRP---TGDMFKDD 613
TV G+ Y PPE + ++S GILL +M G P ++ +
Sbjct: 162 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220
Query: 614 FSIHMFVSMALPDHVMDIL--DPS 635
VS + L PS
Sbjct: 221 VFFRQRVSSECQHLIRWCLALRPS 244
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 3e-32
Identities = 56/268 (20%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 370 IPKEVRQSGMSYSDISKST---DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVL---K 422
+ K + S++T D F + +GTGSFG V G A+K+L K
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 423 LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLH 482
+ + ++ ++E L++ ++++ + N +V E+++ G + L
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLR 133
Query: 483 PSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542
+ + S A + +YLH + + DLKP N+L+D+ V
Sbjct: 134 -------RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVT 183
Query: 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFT 601
DFG AK + + L G+ + PE + + + D ++ G+L+ EM
Sbjct: 184 DFGFAKRVKGRTWT----------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 602 GKRP-TGDMFKDDFSIHMFVSMALPDHV 628
G P D + + + P H
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 31/284 (10%)
Query: 376 QSGMSYSDISKST----DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGA 428
+SG +++K+ + +G+G++G+V G VAIK L Q +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 429 LKSFIDECNALKSTRHRNILRVITACSSVD-LEGNDFKALVFEFMSNGNLDQWLHPSPAE 487
K E LK RH N++ ++ + + L+ LV FM H
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----- 115
Query: 488 HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLA 547
+KL + + + L Y+H I H DLKP N+ +++D + DFGLA
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 548 KFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRP- 605
+ + ++ + P +N + DI+S G ++ EM TGK
Sbjct: 169 RQA---------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
Query: 606 TGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEE 649
G D M V+ P + L + ++E+
Sbjct: 220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 2e-31
Identities = 65/339 (19%), Positives = 122/339 (35%), Gaps = 47/339 (13%)
Query: 364 NDLNGTIPKE---VRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIK 419
D+N P+E + + + D++ +G G + V++ + + V +K
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66
Query: 420 VLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFKALVFEFMSNGNLD 478
+LK ++ K E L++ R NI+ + + ALVFE ++N +
Sbjct: 67 ILKPVKK---KKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVFEHVNNTDFK 120
Query: 479 QWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD-KDM 537
Q + L+ ++ ALDY H I H D+KP NV++D +
Sbjct: 121 QLY----------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 167
Query: 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGIL 595
+ D+GLA+F N V S + PE + D++S G +
Sbjct: 168 KLRLIDWGLAEF---YHPGQEYNVRV-----ASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 596 LLEMFTGKRP-TGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEK 654
L M K P D + + + D I ++ LD ++ +
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 655 EMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693
E +H + + + + + L + R+
Sbjct: 280 ERFVHSENQ----HLVSPEALDFLD---KLLRYDHQSRL 311
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 31/248 (12%)
Query: 369 TIPKEVRQSGMSYSDISKSTDNFSKENLIGTGSFGSVYKGTL----GDGTIVAIKVLK-- 422
T+ E+R + ++ +NF ++GTG++G V+ G + A+KVLK
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63
Query: 423 --LQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQW 480
+Q+ + E L+ R L + + L+ ++++ G L
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTH 119
Query: 481 LHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540
L + I V + L H I + D+K N+LLD +
Sbjct: 120 LSQRER----------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILG---DIYSYGILLL 597
+ DFGL+K + + G+I Y+ P+ + G S D +S G+L+
Sbjct: 170 LTDFGLSKEF------VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223
Query: 598 EMFTGKRP 605
E+ TG P
Sbjct: 224 ELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 66/311 (21%), Positives = 102/311 (32%), Gaps = 30/311 (9%)
Query: 389 DNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRHR 445
+ IG+G+ G V VAIK L Q Q K E +K H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 446 NILRVITACSSVD-LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
NI+ ++ + LE LV E M E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----------RMSYLLY 126
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ + +LH I H DLKPSN+++ D T + DFGLA+ S T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPY 178
Query: 565 IGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRP-TGDMFKDDFSIHMFVSM 622
+ + Y PE + G DI+S G ++ EM K G + D ++ +
Sbjct: 179 V---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682
M L P++ EN + + + +L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS--- 292
Query: 683 MCSTTSPRERI 693
P +RI
Sbjct: 293 KMLVIDPAKRI 303
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-29
Identities = 58/310 (18%), Positives = 109/310 (35%), Gaps = 37/310 (11%)
Query: 388 TDNFSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLK--LQQQGALKSFIDECNALKSTRH 444
+ + + +G+G++GSV G VA+K L Q K E LK +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
N++ ++ + + + +L+ + +KL+ +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--------VKCQKLTDDHVQFLIY 128
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVS 564
+ L Y+H I H DLKPSN+ +++D + DFGLA+ + ++
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT---------DDEMT 176
Query: 565 IGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623
+ P +N + DI+S G ++ E+ TG+ F I +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLI- 231
Query: 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLM 683
+ + P L ++ E I+ M ++ N V +L
Sbjct: 232 ----LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLE---K 283
Query: 684 CSTTSPRERI 693
+RI
Sbjct: 284 MLVLDSDKRI 293
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-26
Identities = 49/322 (15%), Positives = 107/322 (33%), Gaps = 35/322 (10%)
Query: 391 FSKENLIGTGSFGSVYKGT-LGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILR 449
+ +G G F +V+ + + T VA+K+++ + ++ DE L+ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTK 73
Query: 450 VITACSSVDLEGNDFKAL-VFEFMSNGNLDQWLHPSPAEH--------YQFKKLSVIQRL 500
+ ++ + K L F + + Y+ + + +I
Sbjct: 74 EDSMGAN-----HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 501 NIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-DMTAHVGDFGLAKFLFEISDNPSK 559
I+ + LDY+H C I H D+KP NVL++ D ++ +A +
Sbjct: 129 QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 560 NQTVSIGLKGSIGYIPPE-HMNGQVSILGDIYSYGILLLEMFTGKRP-------TGDMFK 611
+ + Y PE + DI+S L+ E+ TG +
Sbjct: 187 TNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 612 DDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLE 671
D + + + LP +++ + + ++ + + +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 672 ECFVSVLRIGLMCSTTSPRERI 693
+ L PR+R
Sbjct: 302 KEISDFLS---PMLQLDPRKRA 320
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 23/166 (13%), Positives = 47/166 (28%), Gaps = 29/166 (17%)
Query: 395 NLIGTGSFGSVYKGTLGDGTIVAIKVLKL----------QQQGALKSFIDECNALKSTRH 444
L+G G +V+ +K K+ ++ F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 445 RNILRVITACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAI 504
R + ++ A++ E + L + +P E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE--------------VLD 110
Query: 505 DVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFL 550
+ + +H I H DL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 4e-18
Identities = 80/362 (22%), Positives = 119/362 (32%), Gaps = 39/362 (10%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS------ 68
L + + + L S N P L +LTKL I + +
Sbjct: 49 LQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 104
Query: 69 ------NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII 122
NLTG +L N N + +S L T G
Sbjct: 105 PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ 164
Query: 123 PSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQ 182
+ + ++++ + V L NL+ N + P+ +NL
Sbjct: 165 VTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLD 222
Query: 183 VLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242
L N L G SL +L L+ N++ + L L+ T L L L
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--------LAPLSGLTKLTELKLGA 272
Query: 243 NSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVI 302
N P++ T+ + N I NL NL L L NN+S P +
Sbjct: 273 NQISNISPLAGLTALTN-----LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 325
Query: 303 GRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLS 362
L KL+ L NK S SSL NLT + L N++ P L N ++ L L+
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 363 SN 364
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 4e-10
Identities = 43/203 (21%), Positives = 70/203 (34%), Gaps = 17/203 (8%)
Query: 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNL 70
+ L T N +S P T L + N L+SLT L + L + +
Sbjct: 198 NLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 71 TGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNIS 130
+ P + + L L L N + P L L+ L L N + I P S
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 131 SIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENG 190
+ N + P +L L+ A N + SL+N +N+ L N
Sbjct: 310 TYLTLY--FNNISDISPVS---SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 191 LTGTIPGNFGSLKDLVRLNFDQN 213
++ P +L + +L +
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 63/338 (18%), Positives = 110/338 (32%), Gaps = 37/338 (10%)
Query: 55 SSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114
++L + LG +N+T V + + L ++ SI + L+ L
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 74
Query: 115 GNFISGIIP----SSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170
N ++ I P + + +I L N + T
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
+ LS+ + + + + N E ++ + LA
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 231 NCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE 290
T+LE L N P+ I T+L L++ N + + +L NL L L
Sbjct: 195 KLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 291 GNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP--------------------SSLGNLT 330
N +S P + L KL L L N+ S + P S + NL
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
LT L + N + P + + KL L ++N ++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 48/231 (20%), Positives = 78/231 (33%), Gaps = 44/231 (19%)
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS---------------- 217
+ +NL ++F+ N LT P +L LV + + N++
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 218 -----------------REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHL 260
R N + ++ + L L +ANL+T
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 261 RRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSG 320
R + ++ L NL L N +S P I L+ L LN N+
Sbjct: 179 RLDISSNKVSDISVL---AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD 233
Query: 321 LIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371
+L +LT LT L + N++ P L KL L L +N ++ P
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.0 bits (175), Expect = 2e-14
Identities = 48/273 (17%), Positives = 90/273 (32%), Gaps = 14/273 (5%)
Query: 3 LIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
L +P+ L T L+L N ++ + + L + N P + L KL
Sbjct: 22 LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG 120
E + L + L L+ +R S+ N L Q+ + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 121 IIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASN 180
I + + + Y + + +P P+L N T SL +N
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQG---LPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 181 LQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240
L L + N ++ G+ + L L+ + N+L G A+ ++V+ L
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL-------ADHKYIQVVYL 249
Query: 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHGN 273
N+ + ++ + + N
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.0 bits (149), Expect = 6e-11
Identities = 43/217 (19%), Positives = 80/217 (36%), Gaps = 14/217 (6%)
Query: 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS------- 217
N T N NL L N ++ PG F L L RL +N+L
Sbjct: 41 NKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPK 100
Query: 218 ------REIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMH 271
++ ++ +++ + + + +++L+
Sbjct: 101 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
Query: 272 GNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTI 331
+ G +L L L+GN ++ + LN L LGL+ N S + SL N
Sbjct: 161 NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 332 LTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368
L L + N+L +P L + + + V+ L +N+++
Sbjct: 221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 39/202 (19%), Positives = 68/202 (33%), Gaps = 37/202 (18%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
+P L + +LD N +T G+F +LK+L L N++ G
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG------AF 75
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
A LE L L++N + L+ L + EN + L + ++ L
Sbjct: 76 APLVKLERLYLSKNQLKELPE----KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS 349
N L K SG+ + + L+ + + + + +IP
Sbjct: 132 GTNPL----------------------KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168
Query: 350 LGNCQKLLVLNLSSNDLNGTIP 371
L L L+L N +
Sbjct: 169 L--PPSLTELHLDGNKITKVDA 188
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 28/132 (21%), Positives = 42/132 (31%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGL 313
+L L + N + NL NL+ L L N +S P L KLE L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 314 NVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKE 373
+ N+ L L L E ++ S+ L + +
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 374 VRQSGMSYSDIS 385
+SY I+
Sbjct: 147 QGMKKLSYIRIA 158
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 7e-14
Identities = 46/278 (16%), Positives = 81/278 (29%), Gaps = 14/278 (5%)
Query: 67 GSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSI 126
L VP I ++ + + L N + L L+ N ++ I ++
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 127 YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDF 186
++ + ++ N + L L P + LQ L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 187 AENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFG 246
+N L F L +L L N + S SL+ L L +N
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR------GLHSLDRLLLHQNRVA 190
Query: 247 GEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLN 306
P + +L L L + N + + L L L L N
Sbjct: 191 HVHPHAFRDL-GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWA 248
Query: 307 KLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEG 344
L+ + ++ +P L + + N L+G
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (164), Expect = 5e-13
Identities = 49/297 (16%), Positives = 88/297 (29%), Gaps = 39/297 (13%)
Query: 3 LIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
L +P + +Q + L N +S + C L N + L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 61 EIIGLGGSNLTGNV-PAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFIS 119
E + L + +V PA L L L L+ P L+ L + L N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 120 GIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNAS 179
+ + ++ ++ + + N++ +P L +L N P + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 180 NLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLG 239
L L N L+ L+ L L + N C
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW---------------VCD------ 240
Query: 240 LARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
L L++ + + ++P L +L L N+L G
Sbjct: 241 -----------CRARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (146), Expect = 9e-11
Identities = 41/221 (18%), Positives = 74/221 (33%), Gaps = 22/221 (9%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLK-- 227
++PV + + Q + N ++ +F + ++L L N L + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 228 -----------------FLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLM 270
L L L E+ + L+ L + +N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 271 HGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLT 330
+L NL L L GN +S L+ L+ L L+ N+ + + P + +L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 331 ILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP 371
L L++ N L +L + L L L+ N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 1e-10
Identities = 50/267 (18%), Positives = 94/267 (35%), Gaps = 14/267 (5%)
Query: 122 IPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNL 181
+P I ++ + N++ +P NL I N + + + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 182 QVLDFAENGLTGTI-PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240
+ LD ++N ++ P F L L L+ D+ L G +L+ L L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG------LAALQYLYL 136
Query: 241 ARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPE 300
N+ + + +L L + N + L +L+ L L N ++ P
Sbjct: 137 QDNALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 301 VIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLN 360
L +L L L N S L +L L L L + +N + L
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFR 254
Query: 361 LSSNDLNGTIPKEVRQSGMSYSDISKS 387
SS+++ ++P+ + G ++ +
Sbjct: 255 GSSSEVPCSLPQRLA--GRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (118), Expect = 3e-07
Identities = 35/191 (18%), Positives = 57/191 (29%), Gaps = 9/191 (4%)
Query: 183 VLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242
+ GL +P + R+ N + C +L +L L
Sbjct: 15 TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASF------RACRNLTILWLHS 65
Query: 243 NSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVI 302
N + L+ + + P L L+ L L+ L P +
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 303 GRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLS 362
L L+ L L N L + +L LT L++ NR+ + L L L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 363 SNDLNGTIPKE 373
N + P
Sbjct: 186 QNRVAHVHPHA 196
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.6 bits (171), Expect = 9e-14
Identities = 64/279 (22%), Positives = 102/279 (36%), Gaps = 17/279 (6%)
Query: 79 GNFSSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYGN-FISGIIPSSIYNISSIYYF 135
+ L L+ NL IP+ L L L F + G + G IP +I ++ ++Y
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 136 SVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTI 195
+T D + L + N +G++P S+S+ NL + F N ++G I
Sbjct: 107 YITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 196 PGNFGSLKDLVR-LNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA 254
P ++GS L + +N L + L S E S+
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS---------RNMLEGDASVL 216
Query: 255 NLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLN 314
S + +G NLN L L N + G++P+ + +L L L ++
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 315 VNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353
N G IP GNL N+ P L C
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 62/286 (21%), Positives = 103/286 (36%), Gaps = 33/286 (11%)
Query: 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS-NLTGN 73
L+L+ L P IP+ L++L L + +GG NL G
Sbjct: 55 LDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYIGGINNLVGP 92
Query: 74 VPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133
+P I + L L + N+ G+IP+ L Q+ L N +SG +P SI ++ ++
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 134 YFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG 193
+ N++ G +P G + N TG IP + +N + V
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212
Query: 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISI 253
+ + ++ + L + +L L L N G +P +
Sbjct: 213 ASVLFGS--------DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVP 299
L L L + N + G IP G GNL ++ N P
Sbjct: 265 TQL-KFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.4 bits (116), Expect = 7e-07
Identities = 15/50 (30%), Positives = 24/50 (48%)
Query: 336 WMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQSGMSYSDIS 385
+ NR+ G++P L + L LN+S N+L G IP+ S +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 1/71 (1%)
Query: 5 MIPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIG 64
+ L+L N + G +P L+ L S S N+ G+IP Q +L + ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297
Query: 65 LGGSNLTGNVP 75
+ P
Sbjct: 298 YANNKCLCGSP 308
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 44/198 (22%), Positives = 66/198 (33%), Gaps = 13/198 (6%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFL 229
++P L + +L +EN L L +LN L E+ L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN-----LDRAELTKLQVDGTL 76
Query: 230 ANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGL 289
+L+ + + + L L + N + + L L L L
Sbjct: 77 PVLGTLD-----LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 290 EGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPS 349
+GN L P ++ KLE L L N + L L L L L ++EN L +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 350 LGNCQKLLVLNLSSNDLN 367
L L N
Sbjct: 191 FFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 42/204 (20%), Positives = 64/204 (31%), Gaps = 14/204 (6%)
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
+S ++ ++ + LT +P + KD L+ +N L + + L T
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATL------MPYT 55
Query: 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293
L L L R + L + V N
Sbjct: 56 RLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV----SFNR 111
Query: 294 LSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353
L+ + L +L+ L L N+ L P L L +L + N L L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 354 QKLLVLNLSSNDLNGTIPKEVRQS 377
+ L L L N L TIPK S
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGS 194
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 33/197 (16%), Positives = 49/197 (24%), Gaps = 25/197 (12%)
Query: 55 SSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLY 114
S + + NLT +P + L L+ N L L + L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 115 GN--------------------FISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTL 154
+ LP L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 155 PNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNE 214
L+ N P L+ L+ L A N LT G L++L L +N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 215 LGS--REIGDLNFLKFL 229
L + + + L F
Sbjct: 184 LYTIPKGFFGSHLLPFA 200
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 38/189 (20%), Positives = 59/189 (31%), Gaps = 7/189 (3%)
Query: 3 LIMIPEHL--MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKL 60
L +P L T L+L+ N L L T L +++ +L L
Sbjct: 22 LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL--NLDRAELTKLQVDGTLPVL 79
Query: 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG 120
+ L + L + L +++N L L L L L GN +
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 121 IIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASN 180
+ P + + S+ N L LP + L NL N +IP +
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 181 LQVLDFAEN 189
L N
Sbjct: 197 LPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 44/217 (20%), Positives = 75/217 (34%), Gaps = 15/217 (6%)
Query: 78 IGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSV 137
+ +S ++ NL ++P +L L N + +++ + + ++
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 138 TQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG 197
+ +L TLP L + N + + + + D + N LT G
Sbjct: 63 DRAELTKLQVDG---TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 198 NFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257
L +L L NEL + G L LE L LA N+ + L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPG------LLTPTPKLEKLSLANNNLTELPAGLLNGL- 171
Query: 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNL 294
+L L + EN ++ IP G L L GN
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 4e-08
Identities = 36/278 (12%), Positives = 83/278 (29%), Gaps = 8/278 (2%)
Query: 87 LSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQL 146
L L NL + L G+ F +F+ + + + + ++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 147 PTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFA--ENGLTGTIPGNFGSLKD 204
+ L+ + + I +L+ SNL L+ + + S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 205 LVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLT 264
L LN + + + T L + G +N ++ + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 265 MGENLMHGNIPVGIGNLVNLNLLGLEG-NNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIP 323
++ + L L L L ++ +G + L+ L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 324 SSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNL 361
L L + + P++GN + + +
Sbjct: 243 LLKEA---LPHLQINCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.003
Identities = 33/260 (12%), Positives = 73/260 (28%), Gaps = 47/260 (18%)
Query: 178 ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEV 237
+ + + + + +F + + ++ + I L+ C+ L+
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSV-----IEVSTLHGILSQCSKLQN 75
Query: 238 LGLARNSFGGEMPISIANLSTHLRRLTMGE--NLMHGNIPVGIGNLVNLN---------- 285
L L + ++A S +L RL + + + + L+
Sbjct: 76 LSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 134
Query: 286 --------------------LLGLEGNNLSGSVPEVIGRLNKLEGLGLNVN-KFSGLIPS 324
L G N + ++ R L L L+ +
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 325 SLGNLTILTRLWMEE-NRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIP------KEVRQS 377
L L L + + LG L L + +GT+ ++ +
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQIN 254
Query: 378 GMSYSDISKSTDNFSKENLI 397
++ I++ T K I
Sbjct: 255 CSHFTTIARPTIGNKKNQEI 274
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 40/234 (17%), Positives = 79/234 (33%), Gaps = 17/234 (7%)
Query: 136 SVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTI 195
S+TQ + D L N A + T V+ ++ + L G+T TI
Sbjct: 2 SITQPTAINVIFPDPALA--NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI 56
Query: 196 PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIAN 255
G L +L+ L N++ + + ++ + +
Sbjct: 57 EG-VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115
Query: 256 LSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLE-------GNNLSGSVPEVIGRLNKL 308
+ + + + + + N++ L N S + L+KL
Sbjct: 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175
Query: 309 EGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLS 362
L + NK S + P L +L L + ++ N++ P L N L ++ L+
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 35/225 (15%), Positives = 76/225 (33%), Gaps = 30/225 (13%)
Query: 29 NLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALS 88
L++ ++ + +++V D V Q L +T L G G + + G + ++L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLE 69
Query: 89 LAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPT 148
L N + P + + I + + + +
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 149 DVGLTLPNLKIFAGA-------------VNYFTGSIPVSLSNASNLQVLDFAENGLTGTI 195
++ + +L + S L+N S L L +N ++
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 196 PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240
P SL +L+ ++ N++ + LAN ++L ++ L
Sbjct: 190 P--LASLPNLIEVHLKNNQISD--------VSPLANTSNLFIVTL 224
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 7/97 (7%)
Query: 180 NLQVLDFAENGLTGT-IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238
++Q LD L+ L+ + D L D+ L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 239 GLARNSFGGEMPISIANL----STHLRRLTMGENLMH 271
L N G + S +++L++ +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 9e-05
Identities = 21/98 (21%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 175 LSNASNLQVLDFAENGLTGT----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLA 230
S L+VL A+ ++ + + + L L+ N LG + G L ++ +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG--DAGILQLVESVR 422
Query: 231 -NCTSLEVLGLARNSFGGEMPISIANLST---HLRRLT 264
LE L L + EM + L LR ++
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 15/101 (14%), Positives = 26/101 (25%), Gaps = 6/101 (5%)
Query: 189 NGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGE 248
G+ G L L ++ L L SL L L+ N G
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDA 412
Query: 249 MPISIA----NLSTHLRRLTMGENLMHGNIPVGIGNLVNLN 285
+ + L +L + + + + L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 11/92 (11%), Positives = 29/92 (31%), Gaps = 3/92 (3%)
Query: 208 LNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLT 264
L+ ++ E+ D + + L +V+ L I++ + L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 265 MGENLMHGNIPVGIGNLVNLNLLGLEGNNLSG 296
+ N + + + ++ +L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 8e-04
Identities = 13/80 (16%), Positives = 23/80 (28%), Gaps = 9/80 (11%)
Query: 306 NKLEGLGLNVNKFSGL----IPSSLGNLTILTRLWMEENRLEGSIPPSLG-----NCQKL 356
+ L L L S + ++L L L + N L + L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 357 LVLNLSSNDLNGTIPKEVRQ 376
L L + + ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 16/97 (16%), Positives = 33/97 (34%), Gaps = 21/97 (21%)
Query: 282 VNLNLLGLEGNNLSGS-VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEEN 340
+++ L ++ LS + E++ L + + + L+ + + +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS------------ 49
Query: 341 RLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPKEVRQS 377
+L L LNL SN+L V Q
Sbjct: 50 --------ALRVNPALAELNLRSNELGDVGVHCVLQG 78
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 7e-05
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 268 NLMHGNI--PVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSS 325
+L H ++ + L+ + L L N L P + L LE L + +
Sbjct: 4 HLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALENVDG 60
Query: 326 LGNLTILTRLWMEENRLEG-SIPPSLGNCQKLLVLNLSSNDLNG 368
+ NL L L + NRL+ + L +C +L++LNL N L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 268 NLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLG 327
N I +L L + N L +P + RL +L + N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPELPQ 324
Query: 328 NLTILTRLWMEENRLEGSIPPSLGNCQKL 356
N L +L +E N L P + + L
Sbjct: 325 N---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 9e-04
Identities = 21/100 (21%), Positives = 33/100 (33%), Gaps = 9/100 (9%)
Query: 9 HLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS 68
N S +I + L S N + ++P L +L +
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFN 314
Query: 69 NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGL 108
+L VP N LK L + +N LR P+ + L
Sbjct: 315 HLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 10/76 (13%)
Query: 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNK 317
L L + N + +P L L N+L+ VPE+ L +L + N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQLH---VEYNP 335
Query: 318 FSGL--IPSSLGNLTI 331
IP S+ +L +
Sbjct: 336 LREFPDIPESVEDLRM 351
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 24/145 (16%), Positives = 44/145 (30%), Gaps = 7/145 (4%)
Query: 45 DFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQ 104
+ + Q Q ++ + + L G + + A+ + N +R
Sbjct: 6 ELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--L 61
Query: 105 LSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNL---KIFA 161
L L + N I I + + +T N L D +L +L I
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121
Query: 162 GAVNYFTGSIPVSLSNASNLQVLDF 186
V + ++VLDF
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVLDF 146
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 21/141 (14%), Positives = 42/141 (29%), Gaps = 12/141 (8%)
Query: 174 SLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCT 233
+NA + LD + I +L ++F N ++ L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN--------EIRKLDGFPLLR 63
Query: 234 SLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNN 293
L+ L + N L + +L+ + +L +L L + N
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 294 ---LSGSVPEVIGRLNKLEGL 311
VI ++ ++ L
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVL 144
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.5 bits (85), Expect = 0.002
Identities = 34/169 (20%), Positives = 58/169 (34%), Gaps = 26/169 (15%)
Query: 254 ANLSTHLRRLTMGENLMHGNIPVGI-GNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLG 312
++ H L + +N + G+ G L +L L L+ N L+G P + ++ L
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 313 LNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLV-------------- 358
L NK + L L L + +N++ +P S + L
Sbjct: 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144
Query: 359 ---------LNLSSNDLNGTIPKEVRQSGMSYSDISKSTDNFSKENLIG 398
+L+ P +VR + D+ S S EN G
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPSKVR--DVQIKDLPHSEFKCSSENSEG 191
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 29/216 (13%), Positives = 49/216 (22%), Gaps = 23/216 (10%)
Query: 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR---------EI 220
IP L N L F L G F DL ++ QN++
Sbjct: 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 221 GDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGN 280
++ N + + IS + + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 281 LVNLNL------------LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGN 328
+ + L L N + E + N L
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 329 LTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364
+ L + R+ L N +KL + +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 12/96 (12%), Positives = 28/96 (29%), Gaps = 3/96 (3%)
Query: 5 MIPEHLMTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIG 64
+ + L L N + + + N+ + + I+
Sbjct: 148 FVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 207
Query: 65 LGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPN 100
+ + + + N L+A S NL+ +P
Sbjct: 208 ISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 32/197 (16%), Positives = 59/197 (29%), Gaps = 26/197 (13%)
Query: 28 TNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKAL 87
+ + + SV D V Q N+L+S+ ++ ++ G I ++ L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG-----IQYLPNVTKL 73
Query: 88 SLAWNNLRG---------------SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSI 132
L N L S L + S I + +
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192
+ V L L + N + +P L+ + LQ L ++N ++
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191
Query: 193 GTIPGNFGSLKDLVRLN 209
+ LK+L L
Sbjct: 192 -DLRA-LAGLKNLDVLE 206
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.64 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.48 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.74 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.72 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.45 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.77 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=401.92 Aligned_cols=269 Identities=30% Similarity=0.489 Sum_probs=209.8
Q ss_pred ccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDL 459 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 459 (717)
+|+....++|++.+.||+|+||.||+|+++ ..||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--- 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--- 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---
Confidence 356677889999999999999999999864 34999998643 34456889999999999999999999998532
Q ss_pred CCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCce
Q 005045 460 EGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTA 539 (717)
Q Consensus 460 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 539 (717)
+..++||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +||||||||+||+++.++.+
T Consensus 76 ---~~~~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 76 ---PQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp ---SSCEEEEECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSE
T ss_pred ---cEEEEEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCE
Confidence 35799999999999999997543 4689999999999999999999997 99999999999999999999
Q ss_pred EEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 540 HVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 540 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
||+|||+|+...... .........||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.......
T Consensus 144 Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 144 KIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp EECCCCCSCC-----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred EEccccceeeccccC-----CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence 999999997652211 1122334678999999999743 3789999999999999999999999765332211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
. ....... ..+.. .....+++..+.+++.+||+.+|++||||
T Consensus 219 ~-~~~~~~~-------~~p~~------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 219 I-FMVGRGY-------LSPDL------------------------------SKVRSNCPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp H-HHHHHTS-------CCCCG------------------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred H-HHHhcCC-------CCCcc------------------------------hhccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 1 1111110 00000 01123346778999999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 005045 696 NVVVNNLKTIRNCFL 710 (717)
Q Consensus 696 ~eil~~l~~i~~~~~ 710 (717)
+||++.|+.+++..+
T Consensus 261 ~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 261 PQILASIELLARSLP 275 (276)
T ss_dssp HHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHcCC
Confidence 999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=395.06 Aligned_cols=252 Identities=20% Similarity=0.313 Sum_probs=199.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++||||+++++++. +++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 468999999999999999999975 79999999986543 234467889999999999999999999954 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 79 ~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEeccCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence 9999999999999999755 5799999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-V-SILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
+|+...... .........||+.|+|||++.+. + +.++||||+||++|||++|+.||................
T Consensus 149 ~a~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~- 222 (271)
T d1nvra_ 149 LATVFRYNN-----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK- 222 (271)
T ss_dssp TCEECEETT-----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-
T ss_pred hheeeccCC-----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-
Confidence 998752211 11123346799999999997654 4 678999999999999999999997654333222111110
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..... .....+..+.+++.+||+.+|++|||++|+++
T Consensus 223 -----------~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 -----------KTYLN-----------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----------CTTST-----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------CCCCC-----------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 01122455678999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=394.98 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=203.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.++||+|+||.||+|+++ +|+.||+|++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 92 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL 92 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEE
Confidence 3468999999999999999999964 79999999987665555678999999999999999999999954 45589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~ivmEy~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccch
Confidence 999999999999998753 3589999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+|+.... .........||+.|+|||++.++ ++.++||||+||++|+|++|..||.+...... ........
T Consensus 162 ~a~~~~~-------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~- 232 (293)
T d1yhwa1 162 FCAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNG- 232 (293)
T ss_dssp TCEECCS-------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHC-
T ss_pred hheeecc-------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCC-
Confidence 9986521 12223446799999999997664 89999999999999999999999965422111 11110000
Q ss_pred ChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 625 PDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.+.. ..+..++..+.+++.+||+.||++|||++|+++
T Consensus 233 --------~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 233 --------TPEL-------------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --------SCCC-------------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------CCCC-------------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 011223566789999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=387.64 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=199.4
Q ss_pred cc-ccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 390 NF-SKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 390 ~y-~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+| +..++||+|+||.||+|.++ +++.||+|.+... .....+.+.+|++++++++||||+++++++... .......
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEE
Confidence 44 67778999999999999965 7889999988654 234467889999999999999999999987543 2345678
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeC-CCCceEEe
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTP--IAHCDLKPSNVLLD-KDMTAHVG 542 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~ 542 (717)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ + |+||||||+||+++ .++.+||+
T Consensus 88 ~ivmE~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEeCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEe
Confidence 9999999999999999754 5689999999999999999999997 6 99999999999997 57899999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
|||+|+... ........||+.|+|||++.++++.++|||||||++|||++|+.||.+...... ....+..
T Consensus 158 DFGla~~~~---------~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~ 227 (270)
T d1t4ha_ 158 DLGLATLKR---------ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTS 227 (270)
T ss_dssp CTTGGGGCC---------TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTT
T ss_pred ecCcceecc---------CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHc
Confidence 999997541 112335679999999999999999999999999999999999999975432211 1111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+.. ..+..++.++.+++.+||+.+|++||||+|+++
T Consensus 228 ~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA----------------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG----------------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc----------------------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00000 001112445789999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=388.21 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=200.5
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|+++ +++.||+|++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 57999999999999999999975 7899999988643 234467789999999999999999999995 44568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccc
Confidence 99999999999999999754 5689999999999999999999997 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|.... ........||+.|+|||++.++ ++.++|||||||++|+|++|+.||....... ....
T Consensus 151 G~a~~~~---------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~---- 215 (263)
T d2j4za1 151 GWSVHAP---------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKR---- 215 (263)
T ss_dssp CSCSCCC---------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----
T ss_pred ceeeecC---------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHHH----
Confidence 9997641 1123346799999999998775 7999999999999999999999996532111 1111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+....... +..++..+.+++.+||+.||++|||++|+++
T Consensus 216 -------i~~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 -------ISRVEFTF-------------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------HHTTCCCC-------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHcCCCCC-------------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111100 0112556788999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=387.10 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=196.8
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|++++++++||||+++++++.. ++..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEE
Confidence 5799999999999999999999888899999987543 234678999999999999999999999643 4578999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~E~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EECCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEecCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 99999999999987543 5689999999999999999999998 99999999999999999999999999998
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
...... ........||..|+|||++.+ .++.++|||||||++|||+|+..|+...... ......+...
T Consensus 150 ~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~---- 218 (263)
T d1sm2a_ 150 FVLDDQ------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG---- 218 (263)
T ss_dssp ---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHT----
T ss_pred eccCCC------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhc----
Confidence 652211 112233568999999999765 5899999999999999999954444322111 1111111111
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.... .+..++.++.+++.+||+.+|++||||+||++.|++|++
T Consensus 219 ----~~~~---------------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 219 ----FRLY---------------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----CCCC---------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCC---------------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0000 112235678899999999999999999999999999976
Q ss_pred H
Q 005045 708 C 708 (717)
Q Consensus 708 ~ 708 (717)
.
T Consensus 262 s 262 (263)
T d1sm2a_ 262 S 262 (263)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-48 Score=389.39 Aligned_cols=265 Identities=23% Similarity=0.416 Sum_probs=210.8
Q ss_pred ccccccccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
+++....++|++.+.||+|+||.||+|.++ +++.||||+++.... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT----- 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEe-----
Confidence 445566789999999999999999999975 789999999875433 3567899999999999999999999953
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+++..++||||+++|++.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred eCCeeEEEeecccCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEE
Confidence 45588999999999999999864421 5789999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+|+.... ..........|++.|+|||++ .+.++.++|||||||++|||++|..||....... .....
T Consensus 156 l~DFG~a~~~~~------~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~ 228 (287)
T d1opja_ 156 VADFGLSRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYEL 228 (287)
T ss_dssp ECCCCCTTTCCS------SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHH
T ss_pred EccccceeecCC------CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHH
Confidence 999999986521 122233445688999999995 4568999999999999999999777764332211 11111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
+.. .... +.+..++..+.+++.+||+.+|++||||+||+
T Consensus 229 i~~------------~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 229 LEK------------DYRM-----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp HHT------------TCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Hhc------------CCCC-----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 111 1100 01122366788999999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 700 NNLKTIRNC 708 (717)
Q Consensus 700 ~~l~~i~~~ 708 (717)
+.|+.+.++
T Consensus 268 ~~L~~~~~~ 276 (287)
T d1opja_ 268 QAFETMFQE 276 (287)
T ss_dssp HHHHHTTSS
T ss_pred HHHHHHHHh
Confidence 999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=394.40 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=202.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
+.+.|++++.||+|+||.||+|+++ +++.||+|++........+.+.+|++++++++||||+++++++. +++..
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~ 84 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNL 84 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeE
Confidence 3457999999999999999999965 79999999987665566678899999999999999999999954 45589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG 155 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG 155 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence 99999999999999876432 4689999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN------GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
+|...... ........||+.|+|||++. +.++.++|||||||++|+|++|..||.+....+. +...
T Consensus 156 ~a~~~~~~-------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i 227 (288)
T d2jfla1 156 VSAKNTRT-------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKI 227 (288)
T ss_dssp TCEECHHH-------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHH
T ss_pred hhhccCCC-------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHH
Confidence 98754211 11223456999999999963 2378999999999999999999999976533221 1111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
..... +.. ..+..++..+.+|+.+||+.||++|||++|++
T Consensus 228 ~~~~~---------~~~-------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 228 AKSEP---------PTL-------------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp HHSCC---------CCC-------------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HcCCC---------CCC-------------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 10000 000 01223356788999999999999999999998
Q ss_pred H
Q 005045 700 N 700 (717)
Q Consensus 700 ~ 700 (717)
+
T Consensus 268 ~ 268 (288)
T d2jfla1 268 Q 268 (288)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=402.64 Aligned_cols=203 Identities=28% Similarity=0.451 Sum_probs=175.6
Q ss_pred cccccccccccccCcccccceEEEEeC-CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+...++|+++++||+|+||.||+|++. +|+.||+|+++.. .......+.+|++++++++||||+++++++. +.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~ 76 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SD 76 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CS
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 345789999999999999999999965 8999999998654 3344578899999999999999999999954 45
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHH-HCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
+..|+||||++||+|.+++.+. +.+++..++.++.||+.||+|||+ + +|+||||||+||+++.+|.+||
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred CEEEEEEEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEE
Confidence 5899999999999999999754 568999999999999999999996 5 8999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
+|||+|+..... ......||+.|+|||++.+ +++.++||||+||++|||++|+.||.....
T Consensus 147 ~DFGla~~~~~~---------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 147 CDFGVSGQLIDS---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CCCCCCHHHHHH---------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred eeCCCccccCCC---------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999876322 1234579999999999765 589999999999999999999999976543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=388.36 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=191.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|.+... .....+.+.+|++++++++||||+++++++.+ ...+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 468999999999999999999965 7999999998644 23446778999999999999999999998643 22456
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEeCCCCceEEe
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC--DTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
.|+||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.+|.+||+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 8999999999999999864211 1156899999999999999999999861 0139999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||+|+.... .........||+.|+|||++.+ .++.++|||||||++|||++|+.||......+ ......
T Consensus 157 DFG~a~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i~ 227 (269)
T d2java1 157 DFGLARILNH-------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIR 227 (269)
T ss_dssp CHHHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH
T ss_pred eccceeeccc-------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHHH
Confidence 9999987622 1122334678999999999765 58999999999999999999999997542211 111110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
...... .+..++.++.+++.+||+.||++|||++|+++
T Consensus 228 -----------~~~~~~------------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 -----------EGKFRR------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----------HTCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------cCCCCC------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000000 01122556889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-47 Score=389.73 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=195.9
Q ss_pred ccccccccccCcccccceEEEEeC-CCc---hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGT---IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.++|++.+.||+|+||.||+|.++ +++ .||||.+... .....+.+.+|++++++++||||+++++++. .+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 467899999999999999999965 333 4788887543 3445678999999999999999999999963 44
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++||||+++|+|.+++.... +.+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVS 170 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred CEEEEEEEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEEC
Confidence 58899999999999999887543 5689999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||+++........ ..........||+.|+|||++. +.++.++|||||||++|||+| |..||.+.... .....+
T Consensus 171 DFGla~~~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i 246 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSD--PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAI 246 (299)
T ss_dssp CC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH
T ss_pred CcccceEccCCCCc--ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence 99999876322111 1111223345789999999964 568999999999999999998 89999764321 111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ...+ .+.+++..+.+++.+||+.+|++||||+||++
T Consensus 247 ~~~----------~~~~-------------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 247 EQD----------YRLP-------------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp HTT----------CCCC-------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcC----------CCCC-------------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 110 0000 12234667889999999999999999999999
Q ss_pred HHHHHHHH
Q 005045 701 NLKTIRNC 708 (717)
Q Consensus 701 ~l~~i~~~ 708 (717)
.|+++.+.
T Consensus 286 ~L~~~l~~ 293 (299)
T d1jpaa_ 286 TLDKMIRN 293 (299)
T ss_dssp HHHHHHHS
T ss_pred HHHHHhcC
Confidence 99998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=383.42 Aligned_cols=263 Identities=24% Similarity=0.430 Sum_probs=207.6
Q ss_pred ccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
+++....++|++.+.||+|+||.||+|.+++++.||||++..... ..+.+.+|++++++++||||+++++++..
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ----- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-----
Confidence 345566789999999999999999999998888999999875432 34679999999999999999999998632
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
+..++||||+++|+|.+++.... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceee
Confidence 35689999999999999876542 14689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||+|+.... ..........||+.|+|||++. +.++.++|||||||++|||+||..|+....... .....+
T Consensus 151 ~DFGla~~~~~------~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i 223 (272)
T d1qpca_ 151 ADFGLARLIED------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL 223 (272)
T ss_dssp CCCTTCEECSS------SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH
T ss_pred ccccceEEccC------CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHH
Confidence 99999987521 1112223456889999999965 568999999999999999999666654322211 111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ....+. .+..++..+.+++.+||+.+|++||||+||++
T Consensus 224 ~--------~~~~~~---------------------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 224 E--------RGYRMV---------------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp H--------TTCCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--------hcCCCC---------------------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1 100111 11223567889999999999999999999999
Q ss_pred HHHHHHH
Q 005045 701 NLKTIRN 707 (717)
Q Consensus 701 ~l~~i~~ 707 (717)
.|+.+-.
T Consensus 263 ~L~~~ft 269 (272)
T d1qpca_ 263 VLEDFFT 269 (272)
T ss_dssp HHHHHHH
T ss_pred Hhhhhhh
Confidence 9987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=383.78 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=207.4
Q ss_pred cccccccccc-ccCcccccceEEEEeC---CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 386 KSTDNFSKEN-LIGTGSFGSVYKGTLG---DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 386 ~~~~~y~~~~-~ig~g~~g~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
...++|.+.+ +||+|+||.||+|.++ ++..||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 3446777777 4999999999999854 4557999998644 33456789999999999999999999998632
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 35799999999999999976543 5689999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+++...... ..........||+.|+|||++. +.++.++|||||||++|||+| |..||.+....+ ...
T Consensus 150 l~DFGla~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~ 223 (285)
T d1u59a_ 150 ISDFGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA 223 (285)
T ss_dssp ECCCTTCEECTTCS----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHH
T ss_pred eccchhhhcccccc----cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 99999998762211 1112223345889999999965 568999999999999999998 999997653221 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+.... .+. .++.++..+.+++.+||+.+|++||||.+|
T Consensus 224 ~i~~~~--------~~~---------------------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 224 FIEQGK--------RME---------------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp HHHTTC--------CCC---------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHHcCC--------CCC---------------------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 111100 000 122346678899999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 005045 699 VNNLKTIRNCFLE 711 (717)
Q Consensus 699 l~~l~~i~~~~~~ 711 (717)
++.|+.+..+...
T Consensus 263 ~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 263 EQRMRACYYSLAS 275 (285)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhh
Confidence 9999887765443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=386.14 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=198.5
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++|++.+.||+|+||.||+|+++ +|+.||||++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 57999999999999999999975 7999999998643 234457889999999999999999999994 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||++||+|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+||+++.+|.+||+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccc
Confidence 99999999999999998744 5799999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+.+... ..........||+.|+|||++.+ .++.++||||+||++|||++|..||...... ....
T Consensus 153 G~a~~~~~~-----~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~----- 220 (288)
T d1uu3a_ 153 GTAKVLSPE-----SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQ----- 220 (288)
T ss_dssp TTCEECC---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----
T ss_pred ccceecccC-----CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHHH-----
Confidence 999865211 11222334579999999999765 5899999999999999999999999753211 1111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
.+....... +..++..+.+|+.+||+.||++|||++|+++.
T Consensus 221 ------~i~~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 221 ------KIIKLEYDF-------------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ------HHHTTCCCC-------------------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ------HHHcCCCCC-------------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111111100 01124567889999999999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=382.75 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=186.6
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
..+.|++.+.||+|+||.||+|+++ +|+.||+|++.... ......+.+|++++++++||||+++++++ .+++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 4567999999999999999999965 78999999986443 23346688999999999999999999994 45568
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---CCCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD---KDMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl 541 (717)
.|+||||++||+|.+++... +.+++..+..++.||+.||+|||+. +|+||||||+||++. .++.+||
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEeccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence 99999999999999999755 5799999999999999999999998 999999999999995 5789999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||+|+.... ........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ......
T Consensus 152 ~DFG~a~~~~~--------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i 221 (307)
T d1a06a_ 152 SDFGLSKMEDP--------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQI 221 (307)
T ss_dssp CCC--------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred eccceeEEccC--------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999986521 1122345699999999997664 899999999999999999999999753221 111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
......... +...+++..+.+++.+||+.||++|||++|+++
T Consensus 222 -----------~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 222 -----------LKAEYEFDS---------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----------HTTCCCCCT---------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------hccCCCCCC---------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111110000 011122556789999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=376.17 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=204.4
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
++|++.++||+|+||.||+|++++++.||||+++.... ..+.+.+|++++++++||||+++++++. +++..++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence 68999999999999999999998888999999875433 3467899999999999999999999964 44589999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||+++|++.+++.... ..+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 78 ~Ey~~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EECCTTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEccCCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 99999999999876543 5689999999999999999999997 99999999999999999999999999998
Q ss_pred hcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCCh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPD 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...... ........+|+.|+|||++. +.++.++|||||||++|||+| |+.||......+ ....+...
T Consensus 149 ~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~--- 217 (258)
T d1k2pa_ 149 YVLDDE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG--- 217 (258)
T ss_dssp BCSSSS------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT---
T ss_pred eccCCC------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC---
Confidence 653221 11223456899999999965 568999999999999999998 899997653221 11111110
Q ss_pred hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHH
Q 005045 627 HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKT 704 (717)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~ 704 (717)
.. .. .+..++.++.+++.+||+.+|++||||+||++.|..
T Consensus 218 -----~~---~~------------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 -----LR---LY------------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----CC---CC------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CC---CC------------------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 00 00 111235678899999999999999999999998854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-46 Score=389.79 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=202.4
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++........+.+.+|++++++++||||+++++++. +.+..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 468999999999999999999965 89999999987665556678899999999999999999999954 456899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCCceEEeee
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD--KDMTAHVGDF 544 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Df 544 (717)
+||||++||+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+||
T Consensus 100 ivmE~~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEEcCCCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence 9999999999999986442 5699999999999999999999998 999999999999996 4679999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|+... .........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ......
T Consensus 171 G~a~~~~--------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i--- 237 (350)
T d1koaa2 171 GLTAHLD--------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV--- 237 (350)
T ss_dssp TTCEECC--------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---
T ss_pred chheecc--------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH---
Confidence 9998651 12233456799999999997664 899999999999999999999999654221 111111
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
......... .....++..+.+|+.+||+.||++|||++|+++
T Consensus 238 --------~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 238 --------KSCDWNMDD---------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --------HHTCCCSCC---------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------HhCCCCCCc---------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 011122556789999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-47 Score=385.06 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=197.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
+...|+.+++||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++. ++
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~ 87 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----RE 87 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ET
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----EC
Confidence 3457999999999999999999965 7999999998643 2344577899999999999999999999954 34
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..|+||||+++|++..+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred CEEEEEEEecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence 5899999999999987766543 5689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG----QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|||+|..... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... ....
T Consensus 158 DFG~a~~~~~-----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~ 225 (309)
T d1u5ra_ 158 DFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH 225 (309)
T ss_dssp CCTTCBSSSS-----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH
T ss_pred ecccccccCC-----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence 9999986411 123569999999999643 47899999999999999999999996542211 1111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
..... .+.. ....++..+.+|+.+||+.||++||||+|+
T Consensus 226 i~~~~---------~~~~--------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 264 (309)
T d1u5ra_ 226 IAQNE---------SPAL--------------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (309)
T ss_dssp HHHSC---------CCCC--------------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhCC---------CCCC--------------------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 11100 0000 011125567899999999999999999999
Q ss_pred HH
Q 005045 699 VN 700 (717)
Q Consensus 699 l~ 700 (717)
++
T Consensus 265 l~ 266 (309)
T d1u5ra_ 265 LK 266 (309)
T ss_dssp TT
T ss_pred Hh
Confidence 75
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-46 Score=385.53 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=202.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.++|++++.||+|+||.||+|++. +|+.||+|++..........+.+|++++++++||||+++++++ .+++..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 467999999999999999999964 8999999998765555567888999999999999999999994 4556899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCCceEEeee
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLD--KDMTAHVGDF 544 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Df 544 (717)
+||||++||+|.+++.... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+||
T Consensus 103 ivmE~~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEcCCCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence 9999999999998876542 4699999999999999999999997 999999999999998 6789999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|+|.... .........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..... ....+...
T Consensus 174 Gla~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~~ 243 (352)
T d1koba_ 174 GLATKLN--------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRC 243 (352)
T ss_dssp TTCEECC--------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHC
T ss_pred ccceecC--------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhC
Confidence 9998752 12233456789999999997664 8999999999999999999999997542211 11111100
Q ss_pred CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
+...+.. .....+..+.+|+.+||+.||++|||++|+++
T Consensus 244 ---------~~~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 ---------DWEFDED-----------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---------CCCCCSS-----------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---------CCCCCcc-----------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 01122556789999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=373.26 Aligned_cols=261 Identities=24% Similarity=0.404 Sum_probs=197.1
Q ss_pred ccccccccccCcccccceEEEEeCC-C----chhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGD-G----TIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEG 461 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 461 (717)
.+.|+..+.||+|+||.||+|.++. + ..||||.+... .......+.+|++++++++||||+++++++. +
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----c
Confidence 4578999999999999999998652 2 36999988643 2334567899999999999999999999964 4
Q ss_pred CceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHV 541 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 541 (717)
.+..++||||+.++++.+++.... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl 151 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV 151 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred CCceEEEEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEE
Confidence 457899999999999998876442 5689999999999999999999997 9999999999999999999999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||+++...... ..........||+.|+|||++. +.++.++|||||||++|||++|..|+...... ......+
T Consensus 152 ~DFGla~~~~~~~----~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i 226 (283)
T d1mqba_ 152 SDFGLSRVLEDDP----EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAI 226 (283)
T ss_dssp CCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHH
T ss_pred cccchhhcccCCC----ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHH
Confidence 9999998763211 1112223456899999999964 46899999999999999999976665432211 1111111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.. ...+. .+.+++..+.+++.+||+.+|++||||+||++
T Consensus 227 ~~--------~~~~~---------------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 227 ND--------GFRLP---------------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HT--------TCCCC---------------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hc--------cCCCC---------------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11 00000 11234667889999999999999999999999
Q ss_pred HHHHHHHH
Q 005045 701 NLKTIRNC 708 (717)
Q Consensus 701 ~l~~i~~~ 708 (717)
.|+++.+.
T Consensus 266 ~L~~l~~~ 273 (283)
T d1mqba_ 266 ILDKLIRA 273 (283)
T ss_dssp HHHHHHHS
T ss_pred HHHHHhhC
Confidence 99998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=376.39 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=195.3
Q ss_pred cccCcccccceEEEEeC---CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEEE
Q 005045 395 NLIGTGSFGSVYKGTLG---DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALVF 469 (717)
Q Consensus 395 ~~ig~g~~g~v~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 469 (717)
++||+|+||.||+|.++ .++.||||+++.. +....+.+.+|++++++++||||+++++++.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999853 4578999998643 33456789999999999999999999998632 2578999
Q ss_pred ecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 470 EFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 470 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp ECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EcCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhh
Confidence 999999999998754 5689999999999999999999997 999999999999999999999999999986
Q ss_pred cccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 550 LFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.... ...........||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.... .....+....
T Consensus 157 ~~~~----~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~--- 227 (277)
T d1xbba_ 157 LRAD----ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE--- 227 (277)
T ss_dssp CCTT----CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC---
T ss_pred cccc----ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence 5211 11112223456899999999964 458999999999999999998 89999764321 1111111100
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
... .+..++.++.+++.+||+.+|++||||+||++.|+..-.
T Consensus 228 -------~~~-------------------------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 -------RMG-------------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -------CCC-------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCC-------------------------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 000 112346678899999999999999999999998887653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=383.88 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=201.8
Q ss_pred ccccccccccccCcccccceEEEEeC-CC-----chhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTLG-DG-----TIVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSV 457 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 457 (717)
...++|++.+.||+|+||.||+|++. .+ ..||+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-- 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--
Confidence 45678999999999999999999854 22 25888887543 334456788999999998 8999999999954
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCc----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEH----------------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPI 521 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 521 (717)
+.+..++||||+++|+|.++++...... .....+++..++.++.||+.||+|||++ +|
T Consensus 112 ---~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~I 185 (325)
T d1rjba_ 112 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 185 (325)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ---eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4558999999999999999997543110 0124589999999999999999999997 99
Q ss_pred eecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHH
Q 005045 522 AHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMF 600 (717)
Q Consensus 522 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ell 600 (717)
+||||||+||+++.++.+||+|||+|+..... ..........||+.|+|||++ .+.++.++|||||||++|||+
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~-----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSD-----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGC-----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eeccCchhccccccCCeEEEeeccccccccCC-----CceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 99999999999999999999999999865321 122233456689999999996 456899999999999999999
Q ss_pred h-CCCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHH
Q 005045 601 T-GKRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLR 679 (717)
Q Consensus 601 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 679 (717)
| |..||.+..... .+...+.... ... .+..++..+.+
T Consensus 261 t~g~~Pf~~~~~~~-~~~~~~~~~~--------~~~---------------------------------~p~~~~~~l~~ 298 (325)
T d1rjba_ 261 SLGVNPYPGIPVDA-NFYKLIQNGF--------KMD---------------------------------QPFYATEEIYI 298 (325)
T ss_dssp TTSCCSSTTCCCSH-HHHHHHHTTC--------CCC---------------------------------CCTTCCHHHHH
T ss_pred hCCCCCCCCCCHHH-HHHHHHhcCC--------CCC---------------------------------CCCcCCHHHHH
Confidence 8 899997653332 1111111110 000 11223567889
Q ss_pred HhhccCCCCcCCCCCHHHHHHHHH
Q 005045 680 IGLMCSTTSPRERIAMNVVVNNLK 703 (717)
Q Consensus 680 li~~cl~~~p~~Rps~~eil~~l~ 703 (717)
|+.+||+.+|++||||+||++.|.
T Consensus 299 li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 299 IMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHh
Confidence 999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=369.13 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred ccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
|...-++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||+++++++ .++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~----~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEE----CCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEE----EecCC
Confidence 3455678999999999999999999984 788999998643 3447789999999999999999999987 33445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+++|+|.+++.... ...+++..+++++.||+.||.|||+. +++||||||+||+++.+|.+|++|
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred cEEEEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecc
Confidence 6899999999999999986431 14589999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 621 (717)
||.++.... ......++..|+|||++ .+.++.++|||||||++|||+| |..||......+ ....+.
T Consensus 147 fg~s~~~~~----------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~ 214 (262)
T d1byga_ 147 FGLTKEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE 214 (262)
T ss_dssp CCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT
T ss_pred cccceecCC----------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
Confidence 999986521 12234578899999995 5678999999999999999998 788876543221 111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. -..+. .++.++.++.+++.+||+.||++||||+||+++
T Consensus 215 ~--------~~~~~---------------------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 215 K--------GYKMD---------------------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp T--------TCCCC---------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c--------CCCCC---------------------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 01111 112235678899999999999999999999999
Q ss_pred HHHHHHH
Q 005045 702 LKTIRNC 708 (717)
Q Consensus 702 l~~i~~~ 708 (717)
|++++..
T Consensus 254 L~~i~~~ 260 (262)
T d1byga_ 254 LEHIKTH 260 (262)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.1e-46 Score=375.00 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=202.1
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++.+.||+|+||.||+|++. +|+.||+|+++.. +.....++.+|++++++++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 3578999999999999999999964 8999999998643 3445678999999999999999999999875432 233
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||++|++|.+++... +.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++++
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred ceEEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceee
Confidence 4689999999999999988744 5789999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.+...... ...........||+.|+|||++.+. +++++|||||||++|+|+||+.||......+. ......
T Consensus 154 d~~~~~~~~~~----~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~ 228 (277)
T d1o6ya_ 154 DFGIARAIADS----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVR 228 (277)
T ss_dssp CCTTCEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred hhhhhhhhccc----cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHh
Confidence 99988754211 1122233456799999999997664 89999999999999999999999975422111 111111
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-CHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-AMNVVVN 700 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~eil~ 700 (717)
.... .. .....+++..+.+++.+||+.||++|| ||+|+++
T Consensus 229 ~~~~--~~-------------------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 229 EDPI--PP-------------------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp CCCC--CG-------------------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cCCC--CC-------------------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 0000 00 001112356788999999999999999 8999999
Q ss_pred HHHHHH
Q 005045 701 NLKTIR 706 (717)
Q Consensus 701 ~l~~i~ 706 (717)
.|.+++
T Consensus 270 ~l~r~~ 275 (277)
T d1o6ya_ 270 DLVRVH 275 (277)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=372.22 Aligned_cols=262 Identities=21% Similarity=0.340 Sum_probs=198.9
Q ss_pred ccccccccccccccCcccccceEEEEeC----CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
+....++|++.+.||+|+||.||+|++. .+..||+|.+... .....+.+.+|++++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 4556789999999999999999999864 2346888887643 3445678999999999999999999999863
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
.+..++||||+++|++.+++.... ..+++..++.++.||++||.|||+. +++||||||+||+++.++.
T Consensus 79 ---~~~~~iv~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 79 ---ENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred ---cCeEEEEEEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCc
Confidence 246899999999999999876432 5689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSI 616 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 616 (717)
+||+|||+|+..... .........||+.|+|||++. +.++.++|||||||++|||++ |..||......+.
T Consensus 147 ~Kl~DfG~a~~~~~~------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-- 218 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-- 218 (273)
T ss_dssp EEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred EEEccchhheeccCC------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--
Confidence 999999999865221 112223456889999999965 568999999999999999998 8999876533221
Q ss_pred hHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH
Q 005045 617 HMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN 696 (717)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 696 (717)
...+... ... +.+..++..+.+++.+||+.+|++||||+
T Consensus 219 ~~~i~~~-----------~~~------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 257 (273)
T d1mp8a_ 219 IGRIENG-----------ERL------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257 (273)
T ss_dssp HHHHHTT-----------CCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHcC-----------CCC------------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 1111110 000 01123366789999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 005045 697 VVVNNLKTIRNCF 709 (717)
Q Consensus 697 eil~~l~~i~~~~ 709 (717)
||++.|+++.++.
T Consensus 258 ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 258 ELKAQLSTILEEE 270 (273)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=377.28 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=201.2
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
..++|++++.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|+.++++++||||+++++++ .+.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 77 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccc
Confidence 3568999999999999999999965 8999999998643 233467788999999999999999999994 456
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~ 147 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred cccccceeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEe
Confidence 6999999999999999998754 5789999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.|+.... .........||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .....
T Consensus 148 DFG~a~~~~~-------~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i- 217 (337)
T d1o6la_ 148 DFGLCKEGIS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI- 217 (337)
T ss_dssp CCTTCBCSCC-------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-
T ss_pred eccccccccc-------CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHH-
Confidence 9999986521 1122334679999999999766 48999999999999999999999997643211 11110
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC-----HH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA-----MN 696 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~ 696 (717)
....... +..++.++.+|+.+||+.||++||+ ++
T Consensus 218 ----------~~~~~~~-------------------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ 256 (337)
T d1o6la_ 218 ----------LMEEIRF-------------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256 (337)
T ss_dssp ----------HHCCCCC-------------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred ----------hcCCCCC-------------------------------CccCCHHHHHHHHhhccCCchhhcccccccHH
Confidence 0000000 0112455788999999999999995 78
Q ss_pred HHHH
Q 005045 697 VVVN 700 (717)
Q Consensus 697 eil~ 700 (717)
|+++
T Consensus 257 eil~ 260 (337)
T d1o6la_ 257 EVME 260 (337)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 8875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=373.58 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=200.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh------hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ------QGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++||||+++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 468999999999999999999965 89999999986432 12357889999999999999999999995 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM--- 537 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--- 537 (717)
+.+..|+||||+++|+|.+++... +.+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSS
T ss_pred ECCEEEEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcc
Confidence 556899999999999999999754 5699999999999999999999998 999999999999998776
Q ss_pred -ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 538 -TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 538 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
.+|++|||.|..... ........||+.|+|||++.+. ++.++||||+||++|||++|..||.+....+
T Consensus 154 ~~vkl~DfG~a~~~~~--------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-- 223 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDF--------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-- 223 (293)
T ss_dssp CCEEECCCTTCEECTT--------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cceEecchhhhhhcCC--------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--
Confidence 599999999986521 1122345689999999997664 8999999999999999999999997542211
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
..... ........ ......++..+.+|+.+||+.||++|||+
T Consensus 224 ~~~~i-----------~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 265 (293)
T d1jksa_ 224 TLANV-----------SAVNYEFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTI 265 (293)
T ss_dssp HHHHH-----------HTTCCCCC---------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHHHH-----------HhcCCCCC---------------------------chhcCCCCHHHHHHHHHHccCChhHCcCH
Confidence 11111 11000000 00112235667899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
+|+++
T Consensus 266 ~eil~ 270 (293)
T d1jksa_ 266 QDSLQ 270 (293)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=372.03 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=204.1
Q ss_pred CCcccccccccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc
Q 005045 379 MSYSDISKSTDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD 458 (717)
Q Consensus 379 ~s~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 458 (717)
.+-.++....++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-- 83 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 83 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec--
Confidence 344555667789999999999999999999988888899999875433 34679999999999999999999998632
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
+..++||||+++|++.+++.... .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.+++
T Consensus 84 ----~~~~lv~Ey~~~g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~ 151 (285)
T d1fmka3 84 ----EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV 151 (285)
T ss_dssp ----SSCEEEECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred ----CCeEEEEEecCCCchhhhhhhcc-----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCc
Confidence 35789999999999998886431 14689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIH 617 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 617 (717)
+||+|||+++..... .........||+.|+|||++ .+.++.++|||||||++|||++|..|+....... ...
T Consensus 152 ~kl~DfGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~ 224 (285)
T d1fmka3 152 CKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVL 224 (285)
T ss_dssp EEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH
T ss_pred EEEcccchhhhccCC------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 999999999765211 11122335689999999995 5568999999999999999999766654432211 111
Q ss_pred HHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 618 MFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
..+.... ... .+.+++.++.+++.+||+.+|++||||++
T Consensus 225 ~~i~~~~--------~~~---------------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 263 (285)
T d1fmka3 225 DQVERGY--------RMP---------------------------------CPPECPESLHDLMCQCWRKEPEERPTFEY 263 (285)
T ss_dssp HHHHTTC--------CCC---------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhcC--------CCC---------------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHH
Confidence 1111110 000 11234667889999999999999999999
Q ss_pred HHHHHHHHH
Q 005045 698 VVNNLKTIR 706 (717)
Q Consensus 698 il~~l~~i~ 706 (717)
|+++|+...
T Consensus 264 i~~~L~~~~ 272 (285)
T d1fmka3 264 LQAFLEDYF 272 (285)
T ss_dssp HHHHHHTTT
T ss_pred HHHHHhhhh
Confidence 999887654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=372.83 Aligned_cols=284 Identities=22% Similarity=0.266 Sum_probs=207.1
Q ss_pred ccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKAL 467 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 467 (717)
+++|.+.+.||+|+||.||+|++ +|+.||||++...... ....+.|+..+.+++||||+++++++.... ......|+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 46889999999999999999997 5889999998654322 222344555667789999999999986543 23346899
Q ss_pred EEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 468 VFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHH-----CDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 468 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
||||+++|+|.+++++ ..+++..+.+++.|++.||+|+|+. +.++|+||||||+||+|+.+|.+||+
T Consensus 79 v~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999999974 3589999999999999999999973 12599999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-------CCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-------VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
|||++......... .........||+.|+|||++.+. ++.++|||||||++|||+||..||.........
T Consensus 151 DFGl~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 151 DLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp CCTTCEEEETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred ecCccccccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 99999876322111 11123346799999999997653 467899999999999999999887554322211
Q ss_pred hhHHHHhcCC-hhhh-hhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC
Q 005045 616 IHMFVSMALP-DHVM-DILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI 693 (717)
Q Consensus 616 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 693 (717)
.......... ..+. ...+..+ ++.........+++..+.+++.+||+.+|++||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~------------------------~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 283 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKL------------------------RPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC------------------------CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred hhhcccccchHHHHHHHHhcccc------------------------CCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence 1110000000 0011 1111111 111122233455677899999999999999999
Q ss_pred CHHHHHHHHHHHHHHH
Q 005045 694 AMNVVVNNLKTIRNCF 709 (717)
Q Consensus 694 s~~eil~~l~~i~~~~ 709 (717)
||.||++.|+++.++.
T Consensus 284 s~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 284 TALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhc
Confidence 9999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=373.65 Aligned_cols=273 Identities=21% Similarity=0.333 Sum_probs=199.2
Q ss_pred ccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+.+....++|++.++||+|+||.||+|.+. +++.||+|+++... ....+.+..|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444555689999999999999999999843 35679999987542 33456677888888776 78999999988
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+ ...+...++||||+++|+|.+++....... .....+++..+..++.||+.||+|||++ +|+||
T Consensus 86 ~----~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 86 C----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp E----CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred e----ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 6 344567899999999999999986432100 0124589999999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCC
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGK 603 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~ 603 (717)
||||+||+++.++.+||+|||+|+...... .........||+.|+|||++. +.++.++|||||||++|||++|.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCT-----TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCCccceeECCCCcEEEccCcchhhccccc-----cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 999999999999999999999998652221 122223456999999999964 45899999999999999999965
Q ss_pred -CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 604 -RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 604 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
.||....... .+....... ..+. .+..++..+.+++.
T Consensus 234 ~~p~~~~~~~~-~~~~~~~~~--------~~~~---------------------------------~~~~~~~~l~~li~ 271 (299)
T d1ywna1 234 ASPYPGVKIDE-EFCRRLKEG--------TRMR---------------------------------APDYTTPEMYQTML 271 (299)
T ss_dssp CCSSTTCCCSH-HHHHHHHHT--------CCCC---------------------------------CCTTCCHHHHHHHH
T ss_pred CCCCCCCCHHH-HHHHHHhcC--------CCCC---------------------------------CCccCCHHHHHHHH
Confidence 5776543221 111111111 0111 11123556889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+||+.+|++||||+||++.|+.+.+.
T Consensus 272 ~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 272 DCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-45 Score=373.57 Aligned_cols=244 Identities=29% Similarity=0.366 Sum_probs=199.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
-++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|+.++++++||||+++++++ .+++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCC
Confidence 367999999999999999999975 7999999998643 234467889999999999999999999995 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||++||++..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~D 147 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD 147 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred eeeeEeeecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEec
Confidence 999999999999999998755 5688999999999999999999997 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.|+.... ......||+.|+|||++.++ ++.++||||+||++|+|++|+.||....... ..
T Consensus 148 FG~a~~~~~----------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~----- 210 (316)
T d1fota_ 148 FGFAKYVPD----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY----- 210 (316)
T ss_dssp CSSCEECSS----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH-----
T ss_pred CccceEecc----------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HH-----
Confidence 999987521 12346799999999998765 8999999999999999999999997532211 10
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNV 697 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e 697 (717)
..+....... ++..+..+.+++.+||+.+|++|| |++|
T Consensus 211 ------~~i~~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~ 253 (316)
T d1fota_ 211 ------EKILNAELRF-------------------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 253 (316)
T ss_dssp ------HHHHHCCCCC-------------------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH
T ss_pred ------HHHHcCCCCC-------------------------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHH
Confidence 0111111100 011245578899999999999996 8999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 254 il~ 256 (316)
T d1fota_ 254 VKN 256 (316)
T ss_dssp HHT
T ss_pred HHc
Confidence 986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=374.87 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=197.8
Q ss_pred cccccccccCcccccceEEEEeC-CCc----hhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCC
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGT----IVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGN 462 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 462 (717)
.+|+++++||+|+||.||+|.+. +|+ +||+|.+... .....+.+.+|++++++++||||+++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 47999999999999999999964 555 4777776532 33456789999999999999999999999743
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
+..++++|++.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~ 153 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 153 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred CCeeEEEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEee
Confidence 24678899999999998876543 5789999999999999999999997 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 620 (717)
|||+|+...... .........||+.|+|||++ .+.++.++|||||||++|||+| |..||....... +...+
T Consensus 154 DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i 226 (317)
T d1xkka_ 154 DFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL 226 (317)
T ss_dssp CCSHHHHTTTTC-----C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH
T ss_pred ccccceeccccc-----ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH
Confidence 999998763211 12222334689999999995 4568999999999999999999 888887643222 11111
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
.... ..+ .++.++..+.+++.+||+.+|++||||+||++
T Consensus 227 ~~~~----------~~~-------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 227 EKGE----------RLP-------------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp HHTC----------CCC-------------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCC----------CCC-------------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 1100 000 11233667889999999999999999999999
Q ss_pred HHHHHHHH
Q 005045 701 NLKTIRNC 708 (717)
Q Consensus 701 ~l~~i~~~ 708 (717)
.++.+...
T Consensus 266 ~l~~~~~~ 273 (317)
T d1xkka_ 266 EFSKMARD 273 (317)
T ss_dssp HHHHHHHS
T ss_pred HHHHHHhC
Confidence 99988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=375.49 Aligned_cols=269 Identities=24% Similarity=0.421 Sum_probs=207.4
Q ss_pred ccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhhh-hhHHHHHHHHHHHHhcCCCCceeEEEEee
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQQ-QGALKSFIDECNALKSTRHRNILRVITAC 454 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 454 (717)
.+++.+.++|++.+.||+|+||.||+|+++ +++.||||++.... ....+++.+|++++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345667889999999999999999999853 45789999987543 33467899999999999999999999996
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------------ccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH-----------------YQFKKLSVIQRLNIAIDVASALDYLHHHC 517 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 517 (717)
. .....++||||+++|+|.+++....... .....+++..+..++.||+.||+|||+.
T Consensus 86 ~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-
Confidence 4 3458899999999999999986432110 0123589999999999999999999997
Q ss_pred CCCeeecCCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHH
Q 005045 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILL 596 (717)
Q Consensus 518 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl 596 (717)
++|||||||+||+++.++.+||+|||+|+...... .........+++.|+|||.+.+ .++.++|||||||++
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred --CeEeeEEcccceEECCCCcEEEccchhheeccCCc-----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 99999999999999999999999999998663221 1122234568899999999654 689999999999999
Q ss_pred HHHHhCC-CCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHH
Q 005045 597 LEMFTGK-RPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFV 675 (717)
Q Consensus 597 ~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (717)
|||++|. .||......+ ....+. +..... .++.++.
T Consensus 233 ~ell~~~~~p~~~~~~~e--~~~~v~-----------~~~~~~------------------------------~p~~~~~ 269 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEE--VIYYVR-----------DGNILA------------------------------CPENCPL 269 (301)
T ss_dssp HHHHTTTCCTTTTSCHHH--HHHHHH-----------TTCCCC------------------------------CCTTCCH
T ss_pred HHHHccCCCCCCCCCHHH--HHHHHH-----------cCCCCC------------------------------CCccchH
Confidence 9999986 5665432221 111111 111110 1123356
Q ss_pred HHHHHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 005045 676 SVLRIGLMCSTTSPRERIAMNVVVNNLKTIR 706 (717)
Q Consensus 676 ~l~~li~~cl~~~p~~Rps~~eil~~l~~i~ 706 (717)
.+.+++.+||+.+|++||||.||+++|++|.
T Consensus 270 ~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 270 ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7889999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-45 Score=378.71 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=195.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---hhH---HHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---QGA---LKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
-++|++.+.||+|+||.||+|+++ +|+.||+|++.... ... ......++++++.++||||+++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 468999999999999999999965 79999999875332 111 22334457788888999999999995 4
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
+.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.+|.+|
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEE
T ss_pred ECCEEEEEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEE
Confidence 456899999999999999999754 5689999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 618 (717)
|+|||+|+.... .......||+.|+|||++. +. ++.++|||||||++|||+||+.||..........
T Consensus 148 l~DFGla~~~~~---------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-- 216 (364)
T d1omwa3 148 ISDLGLACDFSK---------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-- 216 (364)
T ss_dssp ECCCTTCEECSS---------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--
T ss_pred EeeeceeeecCC---------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 999999986521 1223456999999999964 43 7999999999999999999999997654332211
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC----
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA---- 694 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---- 694 (717)
... ......... +..++..+.+++.+||+.||++|||
T Consensus 217 ~~~--------~~~~~~~~~-------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 257 (364)
T d1omwa3 217 IDR--------MTLTMAVEL-------------------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGR 257 (364)
T ss_dssp HHH--------HSSSCCCCC-------------------------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSS
T ss_pred HHH--------hcccCCCCC-------------------------------CCCCCHHHHHHHHHHcccCHHHhCCCccc
Confidence 110 011111100 0112456789999999999999999
Q ss_pred -HHHHHH
Q 005045 695 -MNVVVN 700 (717)
Q Consensus 695 -~~eil~ 700 (717)
|+|+++
T Consensus 258 ~a~eil~ 264 (364)
T d1omwa3 258 GAQEVKE 264 (364)
T ss_dssp THHHHHT
T ss_pred CHHHHHc
Confidence 688875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=366.83 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=192.5
Q ss_pred ccccccccccCcccccceEEEEeC--CC--chhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCC
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG--DG--TIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLE 460 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 460 (717)
.++|++.+.||+|+||.||+|++. ++ ..||||++... .....+.+.+|++++++++||||+++++++..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----
Confidence 467999999999999999999843 22 36899998754 33456789999999999999999999999632
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
...++||||++++++.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+|
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vk 151 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK 151 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred --cchheeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccccee
Confidence 25689999999999998876432 5699999999999999999999997 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFT-GKRPTGDMFKDDFSIHM 618 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 618 (717)
|+|||+++...... ..........++..|+|||++.+ .++.++|||||||++|||+| |..||.+....+ ...
T Consensus 152 l~DfGl~~~~~~~~----~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~ 225 (273)
T d1u46a_ 152 IGDFGLMRALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILH 225 (273)
T ss_dssp ECCCTTCEECCC-C----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH
T ss_pred eccchhhhhcccCC----CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHH
Confidence 99999998752211 11222234557889999999655 48999999999999999998 899997542221 111
Q ss_pred HHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHH
Q 005045 619 FVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVV 698 (717)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ei 698 (717)
.+ ....... +.++.++..+.+++.+||+.+|++||||.||
T Consensus 226 ~i-----------~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 226 KI-----------DKEGERL-----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp HH-----------HTSCCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HH-----------HhCCCCC-----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11 1111100 0112235678899999999999999999999
Q ss_pred HHHHHHH
Q 005045 699 VNNLKTI 705 (717)
Q Consensus 699 l~~l~~i 705 (717)
++.|++.
T Consensus 266 ~~~L~~~ 272 (273)
T d1u46a_ 266 RDFLLEA 272 (273)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 9988875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-45 Score=364.68 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=200.0
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhh---------hhHHHHHHHHHHHHhcCC-CCceeEEEEeecc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQ---------QGALKSFIDECNALKSTR-HRNILRVITACSS 456 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~ 456 (717)
.++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+++.+|+.+++++. ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 368999999999999999999964 89999999986431 223467889999999996 99999999994
Q ss_pred ccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD 536 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 536 (717)
.+++..|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~ 146 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 146 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCC
Confidence 4567999999999999999999744 5799999999999999999999997 99999999999999999
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-------CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-------QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
+.+||+|||.++.... ........||+.|+|||.+.+ .++.++||||+||++|+|++|+.||...
T Consensus 147 ~~~kl~DFG~a~~~~~--------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDP--------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CCEEECCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCeEEccchheeEccC--------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 9999999999987521 112234669999999998642 3688999999999999999999999754
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
.... .......... ..+. +....++.++.+++.+||+.+|
T Consensus 219 ~~~~-~~~~i~~~~~----------~~~~-----------------------------~~~~~~s~~~~~li~~~L~~~p 258 (277)
T d1phka_ 219 KQML-MLRMIMSGNY----------QFGS-----------------------------PEWDDYSDTVKDLVSRFLVVQP 258 (277)
T ss_dssp SHHH-HHHHHHHTCC----------CCCT-----------------------------TTGGGSCHHHHHHHHHHCCSSG
T ss_pred CHHH-HHHHHHhCCC----------CCCC-----------------------------cccccCCHHHHHHHHHHccCCh
Confidence 2211 1111111000 0000 0112335678899999999999
Q ss_pred CCCCCHHHHHH
Q 005045 690 RERIAMNVVVN 700 (717)
Q Consensus 690 ~~Rps~~eil~ 700 (717)
++|||++||++
T Consensus 259 ~~R~s~~eil~ 269 (277)
T d1phka_ 259 QKRYTAEEALA 269 (277)
T ss_dssp GGSCCHHHHTT
T ss_pred hHCcCHHHHHc
Confidence 99999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-44 Score=375.06 Aligned_cols=244 Identities=22% Similarity=0.287 Sum_probs=199.2
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
.++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|++++++++||||+++++++ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 468999999999999999999975 8999999988643 234457789999999999999999999995 4456
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..++||||+.+|++.+++... +.+++..++.++.||+.||.|||++ +||||||||+|||++.+|.+||+|
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeee
Confidence 899999999999999998754 5689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||+|+.... ......||+.|+|||++.++ ++.++|||||||++|+|+||..||.+... .......
T Consensus 185 FG~a~~~~~----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i-- 250 (350)
T d1rdqe_ 185 FGFAKRVKG----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKI-- 250 (350)
T ss_dssp CTTCEECSS----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH--
T ss_pred ceeeeeccc----------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHH--
Confidence 999987521 12345699999999997665 89999999999999999999999965321 1111111
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC-----CHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-----AMNV 697 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~e 697 (717)
....... +..++..+.+++.+||+.||.+|+ |++|
T Consensus 251 ---------~~~~~~~-------------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e 290 (350)
T d1rdqe_ 251 ---------VSGKVRF-------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290 (350)
T ss_dssp ---------HHCCCCC-------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred ---------hcCCCCC-------------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHH
Confidence 0000000 011245678999999999999994 8999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 291 ll~ 293 (350)
T d1rdqe_ 291 IKN 293 (350)
T ss_dssp HHT
T ss_pred HHc
Confidence 885
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=368.48 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=200.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|+||.||+|.++ +++.||+|+++..... ...+.+|++++++++||||+++++++ .+.+..
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF-----ESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence 4678999999999999999999975 7899999998755332 35678999999999999999999995 445689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--CceEEee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKD--MTAHVGD 543 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~D 543 (717)
|+||||++|++|.+++.... ..+++.+++.++.||+.||+|||+. ||+||||||+||+++.+ +.+||+|
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcc
Confidence 99999999999999997542 4689999999999999999999997 99999999999999854 4899999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.+.... .........+++.|+|||...+ .++.++||||+||++|+|++|..||......+ ..
T Consensus 148 FG~~~~~~--------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~----- 212 (321)
T d1tkia_ 148 FGQARQLK--------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--II----- 212 (321)
T ss_dssp CTTCEECC--------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH-----
T ss_pred cchhhccc--------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--HH-----
Confidence 99998651 1223344668999999999665 48999999999999999999999997542211 11
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
..+........ ......++..+.+|+.+||+.||++|||++|+++
T Consensus 213 ------~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 213 ------ENIMNAEYTFD---------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------HHHHHTCCCCC---------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHHhCCCCCC---------------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111000 0011123556789999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=370.26 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=195.6
Q ss_pred cccccccc-ccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhc-CCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKEN-LIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKS-TRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~-~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|.+.. .||+|+||.||+|++. +++.||||++.. ...+.+|++++.+ .+||||+++++++... ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 56899875 5999999999999964 899999999853 2456689988665 4899999999986542 233467
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceEE
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAHV 541 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl 541 (717)
.|+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. .+.+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEECCCCCcHHHHHHhcCC-----CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccc
Confidence 8999999999999999975421 5699999999999999999999998 9999999999999985 567999
Q ss_pred eeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 005045 542 GDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFV 620 (717)
Q Consensus 542 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 620 (717)
+|||+|+..... .......||+.|+|||++.+. ++.++|||||||++|+|+||+.||.+........ ..
T Consensus 156 ~DFG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~~ 225 (335)
T d2ozaa1 156 TDFGFAKETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GM 225 (335)
T ss_dssp CCCTTCEECCCC--------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred cccceeeeccCC--------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--HH
Confidence 999999865211 122345699999999998774 8999999999999999999999996543221100 00
Q ss_pred HhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 621 SMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
. ..+........ ......++.++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~-------~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 K-------TRIRMGQYEFP---------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---------CCCSCSSSCC---------------------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-------HHHhcCCCCCC---------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00000000000 0011234667889999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=365.38 Aligned_cols=270 Identities=22% Similarity=0.312 Sum_probs=208.9
Q ss_pred ccccccccccccccCcccccceEEEEe------CCCchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEeec
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTL------GDGTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITACS 455 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 455 (717)
+....++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 445568999999999999999999984 256789999987543 34456789999999999 6999999999964
Q ss_pred cccCCCCceEEEEEecCCCCChhhhccCCCCCc-----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 456 SVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH-----------YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 456 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+....++||||+++|+|.+++....... .....+++..+..++.||+.|++|||++ ++|||
T Consensus 98 -----~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHr 169 (311)
T d1t46a_ 98 -----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHR 169 (311)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred -----eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 4457899999999999999986542110 1124689999999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhC-
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTG- 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg- 602 (717)
||||+||+++.++.+|++|||.++..... ..........||+.|+|||++. +.++.++|||||||++|||+|+
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSC-----TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccCcccccccchheeccCC-----CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 99999999999999999999999875221 1223344567899999999964 5689999999999999999995
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
.+||.... ....+...+....+ +.. +..++..+.+|+.
T Consensus 245 ~p~~~~~~-~~~~~~~~i~~~~~--------~~~---------------------------------~~~~~~~l~~Li~ 282 (311)
T d1t46a_ 245 SSPYPGMP-VDSKFYKMIKEGFR--------MLS---------------------------------PEHAPAEMYDIMK 282 (311)
T ss_dssp CCSSTTCC-SSHHHHHHHHHTCC--------CCC---------------------------------CTTSCHHHHHHHH
T ss_pred CCCCCCCC-HHHHHHHHHhcCCC--------CCC---------------------------------cccccHHHHHHHH
Confidence 55554432 22222222221111 110 1122566889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+||+.+|++||||+||+++|+++..+
T Consensus 283 ~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 283 TCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=366.72 Aligned_cols=263 Identities=24% Similarity=0.254 Sum_probs=191.3
Q ss_pred cccccCcccccceEEEEeC-CCchhhhHHhHhhhh-----hHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 393 KENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ-----GALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 393 ~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
.+++||+|+||.||+|+++ +|+.||||++..... ...+.+.+|++++++++||||+++++++ ..++..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 4678999999999999965 799999999864422 2245788999999999999999999995 4556899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
+||||+.++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ivmE~~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ehhhhhcchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcc
Confidence 999999888777666543 5688899999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccC-C-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh-c
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-G-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM-A 623 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~ 623 (717)
|..... .........||+.|+|||++. + .++.++||||+||++|||++|..||....+.+. +...... .
T Consensus 147 a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~ 218 (299)
T d1ua2a_ 147 AKSFGS-------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLG 218 (299)
T ss_dssp GSTTTS-------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred ccccCC-------CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcC
Confidence 976521 112223456899999999964 3 379999999999999999999999976432221 1111110 0
Q ss_pred C--ChhhhhhcCC----CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 624 L--PDHVMDILDP----SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 624 ~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
. ...+.+.... .....+.... . ......+..+.+|+.+||++||++||||+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------------------~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPL---H-------------------HIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCH---H-------------------HHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCChhhccchhccchhhhhccCCCCCh---H-------------------HhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0 0001111000 0000000000 0 011122456789999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 277 ~L~ 279 (299)
T d1ua2a_ 277 ALK 279 (299)
T ss_dssp HHT
T ss_pred HhC
Confidence 986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=368.70 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=196.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh---hhhHHHHHHHHHHHHh-cCCCCceeEEEEeeccccCCCCc
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ---QQGALKSFIDECNALK-STRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
++|++.+.||+|+||.||+|+++ +|+.||||++... .....+.+..|..++. .++||||+++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999965 8999999998643 2333456667777665 68999999999994 4556
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +++||||||+|||++.+|.+||+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred ceeEEEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccc
Confidence 899999999999999999754 5689999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHh
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSM 622 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 622 (717)
||.++... ..........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.... ........
T Consensus 147 FG~a~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~ 217 (320)
T d1xjda_ 147 FGMCKENM-------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRM 217 (320)
T ss_dssp CTTCBCCC-------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred cchhhhcc-------cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHc
Confidence 99998642 11222334579999999999665 5899999999999999999999999754221 11111110
Q ss_pred cCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHH-HHHH
Q 005045 623 ALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMN-VVVN 700 (717)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-eil~ 700 (717)
. .+..+ ..++..+.+++.+||+.+|++|||+. |+++
T Consensus 218 ~---------~~~~p---------------------------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 D---------NPFYP---------------------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C---------CCCCC---------------------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C---------CCCCC---------------------------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 11111 11245678999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=364.14 Aligned_cols=273 Identities=24% Similarity=0.344 Sum_probs=195.8
Q ss_pred cccccccccCcccccceEEEEe-CCCchhhhHHhHhhh--hhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQQ--QGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|++++.||+|+||.||+|++ .+|+.||+|+++... ......+.+|++++++++||||+++++++. +++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5899999999999999999996 489999999986543 223578889999999999999999999954 45689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
|+||||+.+ ++.+++.... ...+++..++.++.||+.||+|||+. +||||||||+||+++.++.+||+|||
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred eEEEeecCC-chhhhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCC
Confidence 999999965 4444443221 15699999999999999999999997 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.|+.... .........||+.|+|||++.. .++.++||||+||++|+|++|+.||......+..........
T Consensus 148 ~a~~~~~-------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~ 220 (298)
T d1gz8a_ 148 LARAFGV-------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220 (298)
T ss_dssp HHHHHCC-------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cceeccC-------CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9987622 1222234569999999998543 358999999999999999999999976432221111111111
Q ss_pred CChh--hhhhc--CCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 624 LPDH--VMDIL--DPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 624 ~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.+.. ..... .......+........ ......+..+.+|+.+||+.||++|||++|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFS-------------------KVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCCCCCCCHH-------------------HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCchhhccccccccccccccccccccchh-------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1110 00000 0000000000000000 01112245678999999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 282 ~H 283 (298)
T d1gz8a_ 282 AH 283 (298)
T ss_dssp TS
T ss_pred CC
Confidence 63
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=361.80 Aligned_cols=269 Identities=25% Similarity=0.399 Sum_probs=203.9
Q ss_pred ccccccccccccccCcccccceEEEEeC-C-------CchhhhHHhHhhh-hhHHHHHHHHHHHHhcC-CCCceeEEEEe
Q 005045 384 ISKSTDNFSKENLIGTGSFGSVYKGTLG-D-------GTIVAIKVLKLQQ-QGALKSFIDECNALKST-RHRNILRVITA 453 (717)
Q Consensus 384 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~ 453 (717)
+....++|++.+.||+|+||.||+|+.. . +..||||+++... ......+.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4456789999999999999999999843 2 2469999987553 34457788899988888 89999999999
Q ss_pred eccccCCCCceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005045 454 CSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHC 524 (717)
Q Consensus 454 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 524 (717)
+. +++..++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+. +||||
T Consensus 88 ~~-----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHr 159 (299)
T d1fgka_ 88 CT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 159 (299)
T ss_dssp EC-----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred cc-----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEee
Confidence 64 455899999999999999999754311 11225689999999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHh-C
Q 005045 525 DLKPSNVLLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFT-G 602 (717)
Q Consensus 525 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~ellt-g 602 (717)
||||+||+++.++.+||+|||.++....... ........+++.|+|||.+ .+.++.++|||||||++|||++ |
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eecccceeecCCCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 9999999999999999999999987643221 1222345688999999995 4569999999999999999998 7
Q ss_pred CCCCCCCCCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhh
Q 005045 603 KRPTGDMFKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGL 682 (717)
Q Consensus 603 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 682 (717)
..||.+.... .....+... ..+.. +..++..+.+++.
T Consensus 235 ~~p~~~~~~~--~~~~~i~~~--------~~~~~---------------------------------p~~~~~~l~~li~ 271 (299)
T d1fgka_ 235 GSPYPGVPVE--ELFKLLKEG--------HRMDK---------------------------------PSNCTNELYMMMR 271 (299)
T ss_dssp CCSSTTCCHH--HHHHHHHTT--------CCCCC---------------------------------CSSCCHHHHHHHH
T ss_pred CCCCCCCCHH--HHHHHHHcC--------CCCCC---------------------------------CccchHHHHHHHH
Confidence 8888654221 111111110 01111 1122566889999
Q ss_pred ccCCCCcCCCCCHHHHHHHHHHHHHH
Q 005045 683 MCSTTSPRERIAMNVVVNNLKTIRNC 708 (717)
Q Consensus 683 ~cl~~~p~~Rps~~eil~~l~~i~~~ 708 (717)
+||+.+|++||||+||++.|++|.+.
T Consensus 272 ~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 272 DCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=361.27 Aligned_cols=260 Identities=25% Similarity=0.455 Sum_probs=201.1
Q ss_pred ccccCcccccceEEEEeCC--C--chhhhHHhHh-hhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEEEE
Q 005045 394 ENLIGTGSFGSVYKGTLGD--G--TIVAIKVLKL-QQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKALV 468 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~--~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 468 (717)
.++||+|+||+||+|.+.. + ..||||.++. ......+++.+|++++++++||||+++++++.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 4779999999999999642 2 2589998864 344556889999999999999999999998743 34578999
Q ss_pred EecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeeccch
Q 005045 469 FEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGLAK 548 (717)
Q Consensus 469 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 548 (717)
|||++++++.+++.... ...++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~E~~~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred EEEeecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchh
Confidence 99999999999987653 5678889999999999999999997 99999999999999999999999999998
Q ss_pred hcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcCChh
Q 005045 549 FLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMALPDH 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
........ .........||+.|+|||.+ .+.++.++|||||||++|||++|..||....... .....+...
T Consensus 179 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g---- 250 (311)
T d1r0pa_ 179 DMYDKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQG---- 250 (311)
T ss_dssp CTTTTTCC---CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTT----
T ss_pred hccccccc---cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcC----
Confidence 76322211 11222345689999999995 5678999999999999999999888875432211 111111100
Q ss_pred hhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 005045 628 VMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNNLKTIRN 707 (717)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~l~~i~~ 707 (717)
.... .+..++..+.+++.+||+.||++||||+||++.|+.+++
T Consensus 251 -------~~~~------------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 -------RRLL------------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------CCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCC------------------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0000 112235668899999999999999999999999999987
Q ss_pred HHHh
Q 005045 708 CFLE 711 (717)
Q Consensus 708 ~~~~ 711 (717)
.+..
T Consensus 294 ~~~~ 297 (311)
T d1r0pa_ 294 TFIG 297 (311)
T ss_dssp TCCS
T ss_pred hhhh
Confidence 6443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-43 Score=359.76 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=197.7
Q ss_pred cccccccccCcccccceEEEEeCCCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceEE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFKA 466 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 466 (717)
++|+++++||+|+||+||+|++++|+.||||++... .....+++.+|+.++++++||||+++++.+. ..+..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCcee
Confidence 589999999999999999999999999999998654 2333578999999999999999999999954 455899
Q ss_pred EEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeecc
Q 005045 467 LVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFGL 546 (717)
Q Consensus 467 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 546 (717)
++||++.++.+..+.... +.+++..+..++.||+.||+|||+. +||||||||+||+++.++.+|++|||.
T Consensus 77 i~~e~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEECCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEeehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 999999776666665544 6799999999999999999999998 999999999999999999999999999
Q ss_pred chhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhcC
Q 005045 547 AKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMAL 624 (717)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 624 (717)
+...... ........+++.|+|||.+.+ .++.++||||+||++|||++|+.||.+....+...........
T Consensus 147 a~~~~~~-------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~ 219 (286)
T d1ob3a_ 147 ARAFGIP-------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219 (286)
T ss_dssp HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ceecccC-------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9876221 122234468899999999654 3689999999999999999999999765332211111110000
Q ss_pred C--hhhhhhcC-----CCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHH
Q 005045 625 P--DHVMDILD-----PSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNV 697 (717)
Q Consensus 625 ~--~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 697 (717)
+ ..+..... ....... ........+..+..+.+|+.+||++||++||||+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e 277 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPNFTVYE----------------------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (286)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCC----------------------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CChhhccchhhhhhccccccccc----------------------CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 00111000 0000000 00000011222456789999999999999999999
Q ss_pred HHH
Q 005045 698 VVN 700 (717)
Q Consensus 698 il~ 700 (717)
+++
T Consensus 278 ll~ 280 (286)
T d1ob3a_ 278 ALE 280 (286)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=364.71 Aligned_cols=208 Identities=25% Similarity=0.392 Sum_probs=169.3
Q ss_pred cccccccccccccCcccccceEEEEeC-C-CchhhhHHhHhhh--hhHHHHHHHHHHHHhcC---CCCceeEEEEeeccc
Q 005045 385 SKSTDNFSKENLIGTGSFGSVYKGTLG-D-GTIVAIKVLKLQQ--QGALKSFIDECNALKST---RHRNILRVITACSSV 457 (717)
Q Consensus 385 ~~~~~~y~~~~~ig~g~~g~v~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~ 457 (717)
..+.++|+++++||+|+||.||+|++. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 456789999999999999999999964 4 6779999986432 22234455677766655 899999999987655
Q ss_pred cCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 005045 458 DLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM 537 (717)
Q Consensus 458 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 537 (717)
..+.....+++||+++++.+........ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred ccccCceEEEEEEeccCCchhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 4556678999999998776654443322 5689999999999999999999998 999999999999999999
Q ss_pred ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 538 TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 538 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
.+||+|||.+.... .........||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 154 ~~kl~dfg~~~~~~--------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 154 QIKLADFGLARIYS--------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CEEECSCCSCCCCC--------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ceeecchhhhhhhc--------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99999999987542 1223345679999999999654 5899999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=359.03 Aligned_cols=264 Identities=26% Similarity=0.366 Sum_probs=200.4
Q ss_pred cccccccccccCcccccceEEEEeC-CCc--hhhhHHhHhh-hhhHHHHHHHHHHHHhcC-CCCceeEEEEeeccccCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGT--IVAIKVLKLQ-QQGALKSFIDECNALKST-RHRNILRVITACSSVDLEG 461 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 461 (717)
..++|++.+.||+|+||.||+|.++ +|. .||||.+... .....+.+.+|+++++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----- 82 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 82 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----
Confidence 3578999999999999999999965 454 4677776432 333457799999999998 79999999999643
Q ss_pred CceEEEEEecCCCCChhhhccCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 462 NDFKALVFEFMSNGNLDQWLHPSPAE---------HYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 462 ~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
.+..++||||+++|+|.++++..... ......+++..+..++.||+.|+.|+|+. +++||||||+||+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence 45899999999999999999754210 01225789999999999999999999998 9999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCCC-CCCCCC
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGKR-PTGDMF 610 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~~-p~~~~~ 610 (717)
++.++.+||+|||+++...... ......||..|+|||.+. +.++.++|||||||++|||++|.. ||....
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcCCCceEEccccccccccccc--------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999997652211 112345899999999964 558999999999999999999765 565432
Q ss_pred CCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcC
Q 005045 611 KDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPR 690 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 690 (717)
.. .+...+. +...+. .+..++.++.+++.+||+.+|+
T Consensus 232 ~~--~~~~~i~--------~~~~~~---------------------------------~~~~~~~~~~~li~~cl~~dP~ 268 (309)
T d1fvra_ 232 CA--ELYEKLP--------QGYRLE---------------------------------KPLNCDDEVYDLMRQCWREKPY 268 (309)
T ss_dssp HH--HHHHHGG--------GTCCCC---------------------------------CCTTBCHHHHHHHHHHTCSSGG
T ss_pred HH--HHHHHHH--------hcCCCC---------------------------------CCccCCHHHHHHHHHHcCCChh
Confidence 11 1111110 000111 1122356788999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHH
Q 005045 691 ERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 691 ~Rps~~eil~~l~~i~~~~ 709 (717)
+||||+||++.|+++.++.
T Consensus 269 ~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 269 ERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GSCCHHHHHHHHHHHHHSS
T ss_pred HCcCHHHHHHHHHHHHhcC
Confidence 9999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=357.22 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=190.4
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhh------hHHHHHHHHHHHHhcCC--CCceeEEEEeecccc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQ------GALKSFIDECNALKSTR--HRNILRVITACSSVD 458 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~ 458 (717)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ....++.+|+.++++++ ||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 568999999999999999999965 799999999864321 12244668999999986 89999999995
Q ss_pred CCCCceEEEEEecCCC-CChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-C
Q 005045 459 LEGNDFKALVFEFMSN-GNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-D 536 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~ 536 (717)
.+++..++|||++.+ +++.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++. +
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 147 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCC
Confidence 455689999999975 5777777643 5689999999999999999999998 9999999999999985 4
Q ss_pred CceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCch
Q 005045 537 MTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDF 614 (717)
Q Consensus 537 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 614 (717)
+.+||+|||.|.... ........||+.|+|||++.+. ++.++||||+||++|+|++|+.||....
T Consensus 148 ~~vkl~DFG~a~~~~---------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 148 GELKLIDFGSGALLK---------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp TEEEECCCTTCEECC---------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred CeEEECccccceecc---------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----
Confidence 799999999997641 1122346799999999997543 4678999999999999999999996420
Q ss_pred hhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCC
Q 005045 615 SIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIA 694 (717)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 694 (717)
..... ..... ..++.++.+++.+||+.||++|||
T Consensus 215 ---~i~~~------------~~~~~-------------------------------~~~s~~~~~li~~~L~~dp~~R~s 248 (273)
T d1xwsa_ 215 ---EIIRG------------QVFFR-------------------------------QRVSSECQHLIRWCLALRPSDRPT 248 (273)
T ss_dssp ---HHHHC------------CCCCS-------------------------------SCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---HHhhc------------ccCCC-------------------------------CCCCHHHHHHHHHHccCCHhHCcC
Confidence 00000 00000 011455788999999999999999
Q ss_pred HHHHHH
Q 005045 695 MNVVVN 700 (717)
Q Consensus 695 ~~eil~ 700 (717)
++|+++
T Consensus 249 ~~eil~ 254 (273)
T d1xwsa_ 249 FEEIQN 254 (273)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=361.50 Aligned_cols=272 Identities=21% Similarity=0.383 Sum_probs=209.2
Q ss_pred ccccccccccccccccCcccccceEEEEeC------CCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEee
Q 005045 382 SDISKSTDNFSKENLIGTGSFGSVYKGTLG------DGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITAC 454 (717)
Q Consensus 382 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 454 (717)
+++....++|++.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|++++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 456667789999999999999999999853 3578999998643 334456789999999999999999999996
Q ss_pred ccccCCCCceEEEEEecCCCCChhhhccCCCCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 005045 455 SSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEH---YQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNV 531 (717)
Q Consensus 455 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 531 (717)
. ..+..++||||+++|+|.+++....... .....+++..+.+++.|+++||.|||+. +|+||||||+||
T Consensus 93 ~-----~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 93 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 164 (308)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred e-----cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCce
Confidence 3 4457899999999999999876321100 0113468999999999999999999997 999999999999
Q ss_pred EeCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccCCCccC-CCCCcccchhhHHHHHHHHHhCC-CCCCCC
Q 005045 532 LLDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMN-GQVSILGDIYSYGILLLEMFTGK-RPTGDM 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~sDvwslG~vl~elltg~-~p~~~~ 609 (717)
+++.++.+||+|||+|+...... .........+|+.|+|||.+. +.++.++|||||||++|||+||. .||...
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred eecCCceEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998763322 112223345899999999965 45899999999999999999985 666543
Q ss_pred CCCchhhhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCc
Q 005045 610 FKDDFSIHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSP 689 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 689 (717)
.... . +..+.+..... .+..++..+.+++.+||+.+|
T Consensus 240 ~~~~--~-----------~~~i~~~~~~~------------------------------~p~~~~~~l~~li~~cl~~~P 276 (308)
T d1p4oa_ 240 SNEQ--V-----------LRFVMEGGLLD------------------------------KPDNCPDMLFELMRMCWQYNP 276 (308)
T ss_dssp CHHH--H-----------HHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CHHH--H-----------HHHHHhCCCCC------------------------------CcccchHHHHHHHHHHcCCCh
Confidence 1111 1 11111111111 112335678999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHH
Q 005045 690 RERIAMNVVVNNLKTIRNCF 709 (717)
Q Consensus 690 ~~Rps~~eil~~l~~i~~~~ 709 (717)
++||||+||+++|++..+..
T Consensus 277 ~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 277 KMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp GGSCCHHHHHHHHGGGSCTT
T ss_pred hHCcCHHHHHHHHHHhcCCC
Confidence 99999999999998775433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-42 Score=352.89 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=201.9
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
..++|++.+.||+|+||.||+|++. +|+.||||++..... ...+..|+++++.+.|++++..+..+ ..+.+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~ 78 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYN 78 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEE----EecCCEE
Confidence 3468999999999999999999964 799999998765432 24577899999999887766655554 3345688
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---CCceEEe
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK---DMTAHVG 542 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~ 542 (717)
++||||+ ++++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+||+
T Consensus 79 ~ivme~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEEEc-CCchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeee
Confidence 9999999 567766654332 5689999999999999999999998 9999999999999864 4579999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS 621 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 621 (717)
|||.|+....................||+.|+|||++.+. ++.++|||||||++|||++|+.||..............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~- 227 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER- 227 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH-
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH-
Confidence 9999998754433333333444567799999999997765 89999999999999999999999976533221110000
Q ss_pred hcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHHH
Q 005045 622 MALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVNN 701 (717)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~~ 701 (717)
. ...... .........++.++.+++.+||+.+|++||+++++.+.
T Consensus 228 ----------------------------~-~~~~~~------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~ 272 (299)
T d1ckia_ 228 ----------------------------I-SEKKMS------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272 (299)
T ss_dssp ----------------------------H-HHHHHH------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred ----------------------------h-hcccCC------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 000000 00001122346778999999999999999999999998
Q ss_pred HHHHHH
Q 005045 702 LKTIRN 707 (717)
Q Consensus 702 l~~i~~ 707 (717)
|+.+..
T Consensus 273 l~~~~~ 278 (299)
T d1ckia_ 273 FRNLFH 278 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=357.06 Aligned_cols=209 Identities=25% Similarity=0.289 Sum_probs=170.2
Q ss_pred ccccccccccccCcccccceEEEEe-CCCchhhhHHhHhh-hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCc
Q 005045 386 KSTDNFSKENLIGTGSFGSVYKGTL-GDGTIVAIKVLKLQ-QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGND 463 (717)
Q Consensus 386 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 463 (717)
..+.+|+++++||+|+||.||+|.+ .+|+.||||++... .....+++.+|++++++++||||+++++++.........
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4456899999999999999999996 48999999998644 234567889999999999999999999998665544445
Q ss_pred eEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEee
Q 005045 464 FKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGD 543 (717)
Q Consensus 464 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 543 (717)
..+++++ +.+++|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|
T Consensus 85 ~~~l~~~-~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 85 DVYLVTH-LMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp CEEEEEE-CCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEe-ecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcc
Confidence 5666665 558999999863 3589999999999999999999998 999999999999999999999999
Q ss_pred eccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 005045 544 FGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMF 610 (717)
Q Consensus 544 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~ 610 (717)
||++......... ........||+.|+|||++.. .++.++||||+||++|+|++|..||....
T Consensus 153 fG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 153 FGLARVADPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CTTCEECCGGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCceeeccCCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 9999865332211 112234668999999999643 36889999999999999999999997643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=352.66 Aligned_cols=210 Identities=24% Similarity=0.364 Sum_probs=167.7
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc---CC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD---LE 460 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~ 460 (717)
..++|+++++||+|+||+||+|++. +|+.||||++... ......++.+|++++++++||||+++++.+.... ..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3589999999999999999999964 8999999998644 2334577889999999999999999999875432 12
Q ss_pred CCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceE
Q 005045 461 GNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAH 540 (717)
Q Consensus 461 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 540 (717)
.....|+||||+.++.+..+.... ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+|
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~k 157 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK 157 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred cCceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEE
Confidence 245689999999876666554433 5789999999999999999999998 999999999999999999999
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|+|||++........ ..........||+.|+|||++.+ .+++++||||+||++|||++|+.||.+.
T Consensus 158 l~dfg~~~~~~~~~~---~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 158 LADFGLARAFSLAKN---SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp ECCCTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeecceeeecccccc---cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 999999976532211 11122234569999999999654 4789999999999999999999999754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-41 Score=343.38 Aligned_cols=269 Identities=18% Similarity=0.210 Sum_probs=206.5
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCC-CceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRH-RNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|++.++||+|+||.||+|++. +|+.||+|++.... ....+.+|++.++.+.| +|++.+++++ ..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence 578999999999999999999965 79999999875432 22456788999999965 8999998885 345689
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-----CCceE
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK-----DMTAH 540 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~k 540 (717)
++||||+ +++|.+++.... ..++...+..++.|++.||+|||+. ||+||||||+||+++. ++.+|
T Consensus 77 ~~vme~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceE
Confidence 9999999 789999886543 4689999999999999999999998 9999999999999974 57899
Q ss_pred EeeeccchhcccccCCCCCCcceeecccccccccCCCccCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH
Q 005045 541 VGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ-VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF 619 (717)
Q Consensus 541 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 619 (717)
|+|||+|+....................||+.|+|||++.++ ++.++|||||||++|||++|..||...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-- 224 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-- 224 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--
Confidence 999999987644332222223334456799999999997665 89999999999999999999999976533322110
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
...+... ....+. .+....++.++.+++..|++.+|++||+++.+.
T Consensus 225 ---------------------------~~~i~~~-~~~~~~------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 225 ---------------------------YERIGEK-KQSTPL------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ---------------------------HHHHHHH-HHHSCH------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ---------------------------HHHHHhc-cCCCCh------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 0000000 000000 011123466789999999999999999999999
Q ss_pred HHHHHHHHHH
Q 005045 700 NNLKTIRNCF 709 (717)
Q Consensus 700 ~~l~~i~~~~ 709 (717)
+.++.+.++.
T Consensus 271 ~~l~~~~~~~ 280 (293)
T d1csna_ 271 GLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHc
Confidence 9988876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=351.80 Aligned_cols=279 Identities=22% Similarity=0.284 Sum_probs=195.8
Q ss_pred cccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCC
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGN 462 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 462 (717)
..++|+++++||+|+||.||+|.++ +|+.||||++... .....+.+.+|++++++++||||+++++++...+ ....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3579999999999999999999965 7999999998743 3344678899999999999999999999975543 2234
Q ss_pred ceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEe
Q 005045 463 DFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVG 542 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 542 (717)
...|+||||+ +.++..+++. ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+|++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred ceEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccc
Confidence 4679999999 6678777653 4689999999999999999999998 99999999999999999999999
Q ss_pred eeccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHH-
Q 005045 543 DFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMF- 619 (717)
Q Consensus 543 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~- 619 (717)
|||.|+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.............
T Consensus 164 Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 164 DFGLARQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CCTTCEECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccceeccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 9999986521 1234568999999999644 36899999999999999999999997653222111111
Q ss_pred HHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHH
Q 005045 620 VSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVV 699 (717)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil 699 (717)
.....+.......... ........ ..... ...-.......+..+.+|+.+||++||++||||+|++
T Consensus 234 ~~~~~~~~~~~~~~~~----------~~~~~~~~---~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSD----------EAKNYMKG---LPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp HHCCCCHHHHHTCSCH----------HHHHHHHH---SCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccCCCcHHHHhhhcch----------hhhhhhcc---CCccc-ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 1111111111111000 00000000 00000 0000001122245678999999999999999999998
Q ss_pred HH
Q 005045 700 NN 701 (717)
Q Consensus 700 ~~ 701 (717)
+.
T Consensus 300 ~H 301 (346)
T d1cm8a_ 300 AH 301 (346)
T ss_dssp HS
T ss_pred cC
Confidence 74
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=346.76 Aligned_cols=273 Identities=21% Similarity=0.254 Sum_probs=200.6
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCceE
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
++|+++++||+|+||+||+|++. +++.||||+++.. ......++.+|+.++++++||||+++++++ .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 58999999999999999999965 8899999998644 234568889999999999999999999995 445589
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeeec
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDFG 545 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 545 (717)
++|++++.++++..++... +.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 77 ~iv~~~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred eEEeeeccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecc
Confidence 9999999998888887655 5789999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccccCCCCCCcceeecccccccccCCCccCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 546 LAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNGQ--VSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
.+...... ........++..|+|||++.+. ++.++||||+||++|||++|..||.................
T Consensus 147 ~a~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 147 LARAFGIP-------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp TCEECCSC-------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred hhhcccCC-------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 99875221 1122234577889999996543 68999999999999999999999755433222222111111
Q ss_pred --CCh-hhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 624 --LPD-HVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 624 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
... ................ ..............+..+.+|+.+||++||.+||||+|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPM-----------------YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCC-----------------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhhhhhhhhccccccccc-----------------ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000000000 00000011112223456788999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-41 Score=346.11 Aligned_cols=197 Identities=25% Similarity=0.324 Sum_probs=166.6
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
.++|+++++||+|+||.||+|+++ +|+.||+|+++.. ..+++.+|+++++++. ||||+++++++.. ......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCce
Confidence 468999999999999999999964 8999999998643 2467889999999995 9999999998643 234578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEeee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGDF 544 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Df 544 (717)
++||||+++++|..+. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus 108 ~~v~e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp EEEEECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCG
T ss_pred eEEEeecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccc
Confidence 9999999999997764 4589999999999999999999998 999999999999998655 6999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFK 611 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~ 611 (717)
|.|...... .......+|+.|+|||.+.+ .++.++||||+||++|+|++|..||.....
T Consensus 175 G~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 175 GLAEFYHPG--------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp GGCEECCTT--------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccceeccCC--------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 999865211 12234568999999999654 379999999999999999999999976543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=352.18 Aligned_cols=272 Identities=23% Similarity=0.273 Sum_probs=192.7
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCceE
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGNDFK 465 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~~~ 465 (717)
.-+|+..++||+|+||+||+|+++ +|+.||||++.... ....+|++++++++||||+++++++.... ..+..+.
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 337999999999999999999975 79999999986443 22346999999999999999999875432 2344568
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-ceEEeee
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDM-TAHVGDF 544 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Df 544 (717)
++||||++++.+..+..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEEEeccCCccHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecc
Confidence 99999997654333322110 115689999999999999999999997 999999999999999775 8999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHH-
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG--QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVS- 621 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~- 621 (717)
|++...... .......|+..|+|||.+.+ .++.++||||+||++|||++|..||......+. +.....
T Consensus 168 G~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~ 238 (350)
T d1q5ka_ 168 GSAKQLVRG--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKV 238 (350)
T ss_dssp TTCEECCTT--------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHH
T ss_pred cchhhccCC--------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHH
Confidence 999865211 12233568999999998543 489999999999999999999999976432211 111110
Q ss_pred --hcCChhhhhhc----CCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCCCH
Q 005045 622 --MALPDHVMDIL----DPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERIAM 695 (717)
Q Consensus 622 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 695 (717)
....+.+.... +...+....... ........+..+.+|+.+||++||++||||
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 297 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPW---------------------TKVFRPRTPPEAIALCSRLLEYTPTARLTP 297 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCG---------------------GGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hCCChHHhhhhhccchhhccccccccCch---------------------hhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence 00111111111 111110000000 000011224567899999999999999999
Q ss_pred HHHHH
Q 005045 696 NVVVN 700 (717)
Q Consensus 696 ~eil~ 700 (717)
+|+++
T Consensus 298 ~e~L~ 302 (350)
T d1q5ka_ 298 LEACA 302 (350)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=345.46 Aligned_cols=279 Identities=21% Similarity=0.173 Sum_probs=193.2
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeecccc-CCCCce
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVD-LEGNDF 464 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~~ 464 (717)
++|+++++||+|+||+||+|+++ +|+.||||++... ......++.+|+.++++++||||+++++++.... .+...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 7999999998643 2345577899999999999999999999875433 235678
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.|+||||+.++.+. .+. ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+|++||
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEeccchHHHH-hhh---------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 99999999765444 443 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchhhhHHHHhc
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFSIHMFVSMA 623 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 623 (717)
|.+..... ........+|+.|+|||++.+ .+++++||||+||++|+|++|+.||.+.... .....+...
T Consensus 164 ~~~~~~~~--------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~~~ 233 (355)
T d2b1pa1 164 GLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQ 233 (355)
T ss_dssp CC-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred hhhhcccc--------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--HHHHHHHHh
Confidence 99876521 223344568999999999765 4899999999999999999999999754221 111111100
Q ss_pred -----------CChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCC
Q 005045 624 -----------LPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRER 692 (717)
Q Consensus 624 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 692 (717)
................... ..... .-.............+..+.+|+.+||++||++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-------~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLT----FPKLF-------PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCC----HHHHS-------CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred ccCCCHHHHHHhhhhHHHHhhcCccccccc----ccccc-------ccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence 0111111111111100000 00000 0000001112233456778999999999999999
Q ss_pred CCHHHHHHH
Q 005045 693 IAMNVVVNN 701 (717)
Q Consensus 693 ps~~eil~~ 701 (717)
|||+|+++.
T Consensus 303 ~ta~elL~H 311 (355)
T d2b1pa1 303 ISVDDALQH 311 (355)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=347.36 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=165.1
Q ss_pred ccccccccccCcccccceEEEEeC-CCchhhhHHhHhh--hhhHHHHHHHHHHHHhcCCCCceeEEEEeeccccCCCCce
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ--QQGALKSFIDECNALKSTRHRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 464 (717)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|++++++++||||+++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999964 8999999998644 2334567889999999999999999999875443223334
Q ss_pred EEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCceEEeee
Q 005045 465 KALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMTAHVGDF 544 (717)
Q Consensus 465 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 544 (717)
.+++|+++.+++|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 4555666779999999864 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccchhcccccCCCCCCcceeecccccccccCCCccCC-C-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 005045 545 GLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG-Q-VSILGDIYSYGILLLEMFTGKRPTGDM 609 (717)
Q Consensus 545 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~sDvwslG~vl~elltg~~p~~~~ 609 (717)
|.+.... .......|+..|+|||+..+ . ++.++||||+||++|+|++|..||.+.
T Consensus 166 g~a~~~~----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 166 GLARHTD----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ----CCT----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chhcccC----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9987542 22234568999999998544 3 689999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=343.75 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=197.1
Q ss_pred ccccccccccCcccccceEEEEeC----CCchhhhHHhHhh----hhhHHHHHHHHHHHHhcCCC-CceeEEEEeecccc
Q 005045 388 TDNFSKENLIGTGSFGSVYKGTLG----DGTIVAIKVLKLQ----QQGALKSFIDECNALKSTRH-RNILRVITACSSVD 458 (717)
Q Consensus 388 ~~~y~~~~~ig~g~~g~v~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~ 458 (717)
-++|++.++||+|+||+||+|+.. +|+.||+|+++.. +....+.+.+|++++++++| |||+++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 367999999999999999999842 5788999998643 22335678899999999966 8999999984
Q ss_pred CCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCc
Q 005045 459 LEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDKDMT 538 (717)
Q Consensus 459 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 538 (717)
++....+++|||+.+++|.+++... ..+++..+..++.||+.|++|+|+. +|+||||||+||+++.+|.
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~ 167 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH 167 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred -ccCCceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCC
Confidence 4456899999999999999998755 5678899999999999999999998 9999999999999999999
Q ss_pred eEEeeeccchhcccccCCCCCCcceeecccccccccCCCccCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchh
Q 005045 539 AHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHMNG---QVSILGDIYSYGILLLEMFTGKRPTGDMFKDDFS 615 (717)
Q Consensus 539 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 615 (717)
+||+|||.+..+... .........|++.|+|||.+.+ .++.++|||||||++|+|++|..||......+..
T Consensus 168 vkL~DFG~a~~~~~~------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 168 VVLTDFGLSKEFVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp EEESCSSEEEECCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred EEEeeccchhhhccc------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999765221 1222334678999999999754 3688999999999999999999999765433221
Q ss_pred hhHHHHhcCChhhhhhcCCCCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhhhHHHHHHHHHHhhccCCCCcCCCC--
Q 005045 616 IHMFVSMALPDHVMDILDPSMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNKLEECFVSVLRIGLMCSTTSPRERI-- 693 (717)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-- 693 (717)
.. .... ....... .+.+++.++.+++.+||+++|++||
T Consensus 242 ~~-i~~~--------~~~~~~~-------------------------------~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 242 AE-ISRR--------ILKSEPP-------------------------------YPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HH-HHHH--------HHHCCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HH-HHHh--------cccCCCC-------------------------------CcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 11 0000 0000000 1112366788999999999999999
Q ss_pred ---CHHHHHH
Q 005045 694 ---AMNVVVN 700 (717)
Q Consensus 694 ---s~~eil~ 700 (717)
||+|+++
T Consensus 282 ~~~t~~eil~ 291 (322)
T d1vzoa_ 282 GPRDADEIKE 291 (322)
T ss_dssp STTTHHHHHT
T ss_pred CcccHHHHHc
Confidence 4888876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-35 Score=310.23 Aligned_cols=276 Identities=20% Similarity=0.246 Sum_probs=185.1
Q ss_pred cccccccccCcccccceEEEEeC-CCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-----------CCceeEEEEeecc
Q 005045 389 DNFSKENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQQQGALKSFIDECNALKSTR-----------HRNILRVITACSS 456 (717)
Q Consensus 389 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~~ 456 (717)
++|+++++||+|+||.||+|+++ +|+.||||+++.... ..+.+.+|+++++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999965 899999999875432 3466778898888775 5789988887643
Q ss_pred ccCCCCceEEEEEecCCCCCh-hhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 005045 457 VDLEGNDFKALVFEFMSNGNL-DQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVLLDK 535 (717)
Q Consensus 457 ~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 535 (717)
. .....+++|+++..+.. ....... ....+++..+..++.||+.|++|||+. .||+||||||+|||++.
T Consensus 92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 92 K---GPNGVHVVMVFEVLGENLLALIKKY-----EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEI 161 (362)
T ss_dssp E---ETTEEEEEEEECCCCEEHHHHHHHT-----TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEE
T ss_pred c---cccceeeeeeecccccccccccccc-----cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeec
Confidence 2 23355566666544432 2222211 126789999999999999999999983 29999999999999986
Q ss_pred CC------ceEEeeeccchhcccccCCCCCCcceeecccccccccCCCcc-CCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 005045 536 DM------TAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIPPEHM-NGQVSILGDIYSYGILLLEMFTGKRPTGD 608 (717)
Q Consensus 536 ~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~sDvwslG~vl~elltg~~p~~~ 608 (717)
++ .++++|||.+..... ......||+.|+|||++ .+.++.++||||+||++++|++|+.||..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cCcccccceeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 55 499999999875411 12335689999999995 45689999999999999999999999975
Q ss_pred CCCCch-----hhhHH--HHhcCChhh-------hhhcCC-----CCCCCCCCcHHHHHHHHHHHHHHhhhhhhhcchhh
Q 005045 609 MFKDDF-----SIHMF--VSMALPDHV-------MDILDP-----SMPLDEENDEEQIEEVIEEKEMMIHIDLEVNTKNK 669 (717)
Q Consensus 609 ~~~~~~-----~~~~~--~~~~~~~~~-------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (717)
...... ..... .....+..+ ....+. ........ ........ ....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------------~~~~ 296 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW---PLEDVLTE------------KYKF 296 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC---CHHHHHHH------------TTCC
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC---chhhhccc------------cccc
Confidence 432111 00000 111111111 111110 00000000 01111100 0112
Q ss_pred hHHHHHHHHHHhhccCCCCcCCCCCHHHHHH
Q 005045 670 LEECFVSVLRIGLMCSTTSPRERIAMNVVVN 700 (717)
Q Consensus 670 ~~~~~~~l~~li~~cl~~~p~~Rps~~eil~ 700 (717)
....+..+.+|+.+||++||.+||||+|+++
T Consensus 297 ~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3455778899999999999999999999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=4.2e-29 Score=264.39 Aligned_cols=320 Identities=28% Similarity=0.350 Sum_probs=196.0
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
++++|++++|+|+. + +.+..+++|++|+|++|+|++ +|. |+++++|++|++++|.+++ ++. ++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~-i~~-l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccccccccc-ccc-ccccccccccccc
Confidence 34555555555542 2 234455555555555555552 221 5555555555555555542 221 4455555555555
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCc-------------------cccCCCCccEEEcccCcccccCCcccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPS-------------------SIYNISSIYYFSVTQNQLHGQLPTDVG 151 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-------------------~~~~l~~L~~L~L~~N~l~~~l~~~~~ 151 (717)
+|.+++..+ ......+..+....|.+....+. .+...+.........|... ....+
T Consensus 119 ~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 193 (384)
T d2omza2 119 NNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS---DISVL 193 (384)
T ss_dssp SSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC---CCGGG
T ss_pred ccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc---ccccc
Confidence 555542221 22233344444444433321111 1122222222222223221 11233
Q ss_pred cCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhcc
Q 005045 152 LTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLAN 231 (717)
Q Consensus 152 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 231 (717)
..+++++.+++++|.+++..| +...++|++|++++|.++. ++ .+..+++|+.|++++|.++.++ .+..
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--------~~~~ 261 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--------PLSG 261 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--------GGTT
T ss_pred ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--------cccc
Confidence 467788888888888876544 4556788888888888873 33 5777888888888888887753 3677
Q ss_pred CCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeE
Q 005045 232 CTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGL 311 (717)
Q Consensus 232 l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 311 (717)
+++|++|++++|.++ .++. +... +.++.+++++|.+.+ ...+..+++++.|++++|++++.. .+..+++|++|
T Consensus 262 ~~~L~~L~l~~~~l~-~~~~-~~~~-~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L 334 (384)
T d2omza2 262 LTKLTELKLGANQIS-NISP-LAGL-TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL 334 (384)
T ss_dssp CTTCSEEECCSSCCC-CCGG-GTTC-TTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred cccCCEeeccCcccC-CCCc-cccc-ccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEE
Confidence 888888888888887 3332 4444 478888888888874 345777888888888888888543 37788888888
Q ss_pred EcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecc
Q 005045 312 GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSN 364 (717)
Q Consensus 312 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 364 (717)
++++|+++++ ..+.++++|++|+|++|++++..| +.++++|+.|+|++|
T Consensus 335 ~L~~n~l~~l--~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 335 FFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCCC--GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCC--hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8888888854 257888888888888888885443 788888888888887
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1e-30 Score=268.62 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=195.3
Q ss_pred CCCCEEeccCCcCcc--cCChhhhccCCCCeEeccC-CCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcc
Q 005045 82 SSLKALSLAWNNLRG--SIPNELGQLSGLGFFTLYG-NFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLK 158 (717)
Q Consensus 82 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~ 158 (717)
.+++.|+|++|.+++ .+|..++++++|++|+|++ |++++.+|..|++|++|++|+|++|++. .++...+..+..|+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-GAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE-EECCGGGGGCTTCC
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccc-ccccccccchhhhc
Confidence 468899999998886 4788899999999999986 7888888888999999999999999888 44444445667777
Q ss_pred eeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEE
Q 005045 159 IFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVL 238 (717)
Q Consensus 159 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L 238 (717)
.++++.|.+.+.+|..+.++++|+.+++++|.+++.+|..+..+..+ ++.+
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------------~~~l 179 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------------FTSM 179 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------------CCEE
T ss_pred ccccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------------cccc
Confidence 77777777776667777777777777777777766666555444332 2556
Q ss_pred EeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcC
Q 005045 239 GLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKF 318 (717)
Q Consensus 239 ~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 318 (717)
++++|++++..|..+..+ .+..+++++|...+..|..+..+++|+.|++++|.+.+.+ ..+..+++|+.|+|++|++
T Consensus 180 ~~~~n~l~~~~~~~~~~l--~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l 256 (313)
T d1ogqa_ 180 TISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRI 256 (313)
T ss_dssp ECCSSEEEEECCGGGGGC--CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCC
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCee
Confidence 666666666666666554 4557888888877778888888888888888888888544 4577888888888888888
Q ss_pred CCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeeccc-CCCC-CCc
Q 005045 319 SGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSND-LNGT-IPK 372 (717)
Q Consensus 319 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~-~p~ 372 (717)
++.+|..|+++++|++|+|++|+|+|.+|. +.++++|+.+++++|+ ++|. +|+
T Consensus 257 ~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp EECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSSC
T ss_pred cccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCCC
Confidence 888888888888888888888888888874 5778888888888887 5653 443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.5e-30 Score=267.21 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=128.6
Q ss_pred CCEEEccCccccc--cCCccccCCCCCCEEeccC-CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEE
Q 005045 60 LEIIGLGGSNLTG--NVPAWIGNFSSLKALSLAW-NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136 (717)
Q Consensus 60 L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 136 (717)
++.|+|++|.+++ .+|..+++|++|++|+|++ |++++.+|..|.++++|++|+|++|++.+..+..+..+.+|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4444444444433 2334444444444444443 344444444444444444444444444444444444444444444
Q ss_pred cccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCC-CEEeccCccccccCCCCccCCCCCCeeecccccc
Q 005045 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNL-QVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNEL 215 (717)
Q Consensus 137 L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 215 (717)
+++|.+.+.+|..+. .++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++++.+
T Consensus 132 l~~N~~~~~~p~~l~-~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 132 FSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp CCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred cccccccccCchhhc-cCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 444444433333322 44444444444444444444444444443 455555555555445444444322 455555544
Q ss_pred CCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCc
Q 005045 216 GSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLS 295 (717)
Q Consensus 216 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 295 (717)
.... +..+..+++|+.|++++|.+.+.+| .+... ++|+.|+|++|++++.+|..|.++++|++|+|++|+|+
T Consensus 210 ~~~~------~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~-~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 210 EGDA------SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLS-KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp EECC------GGGCCTTSCCSEEECCSSEECCBGG-GCCCC-TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred cccc------ccccccccccccccccccccccccc-ccccc-cccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 4433 3445555566666666666654333 33333 46667777777776667777777777777777777777
Q ss_pred cccchhhhcCCCCCeEEcccCc-CCC
Q 005045 296 GSVPEVIGRLNKLEGLGLNVNK-FSG 320 (717)
Q Consensus 296 ~~~~~~~~~l~~L~~L~Ls~N~-l~~ 320 (717)
|.+|. ++.+++|+.+++++|+ +.+
T Consensus 282 g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 282 GEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp EECCC-STTGGGSCGGGTCSSSEEES
T ss_pred ccCCC-cccCCCCCHHHhCCCccccC
Confidence 66664 5667777777777776 444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.1e-28 Score=252.40 Aligned_cols=276 Identities=20% Similarity=0.238 Sum_probs=174.6
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
.++.++.+++.++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5666777777777 5666554 567778888887775555577777788888888888777777777778888888888
Q ss_pred cCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCc
Q 005045 139 QNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 139 ~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 218 (717)
+|+++ .+|...+ +.+..|++.+|.+....+..+.....+..++...|... ..
T Consensus 88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~------------------------~~ 139 (305)
T d1xkua_ 88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK------------------------SS 139 (305)
T ss_dssp SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC------------------------GG
T ss_pred CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhcccccccccccccccc------------------------cc
Confidence 88776 5554332 34444444444444433333444444445554444332 21
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCcccc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSV 298 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 298 (717)
... ...+..+++|+.+++++|.++ .+|..+ .++|+.|++++|.+....+..|.+++.++.|++++|.+.+..
T Consensus 140 ~~~----~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 140 GIE----NGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp GBC----TTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred CCC----ccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 110 223445555566666666555 444332 246667777777666666667777777777777777777666
Q ss_pred chhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCc------CccCcCCCceEEeecccCC-CCCC
Q 005045 299 PEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPP------SLGNCQKLLVLNLSSNDLN-GTIP 371 (717)
Q Consensus 299 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~l~~N~l~-~~~p 371 (717)
+..+.++++|++|+|++|+|+.+ |.+|..+++|+.|+|++|+|+..... .+..+.+|+.|+|++|+++ .+++
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred cccccccccceeeeccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 66777777777777777777744 55677777777777777777633222 2345677888888888885 3444
Q ss_pred ccc
Q 005045 372 KEV 374 (717)
Q Consensus 372 ~~~ 374 (717)
+..
T Consensus 291 ~~~ 293 (305)
T d1xkua_ 291 PST 293 (305)
T ss_dssp GGG
T ss_pred HhH
Confidence 443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.6e-27 Score=252.07 Aligned_cols=322 Identities=24% Similarity=0.344 Sum_probs=255.7
Q ss_pred EEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcC
Q 005045 15 LNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNL 94 (717)
Q Consensus 15 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 94 (717)
..++.+.+++.+.. ..+.+|++|++++|+|+. +. .+..+++|++|+|++|+|++ +|. ++++++|++|++++|+|
T Consensus 27 ~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~-l~-gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEECH--HHHTTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccCH--HHhCCCCEEECCCCCCCC-cc-ccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccccccc
Confidence 35777777765553 677899999999999984 43 48899999999999999994 543 99999999999999999
Q ss_pred cccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccc-------------------cCCC
Q 005045 95 RGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVG-------------------LTLP 155 (717)
Q Consensus 95 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~-------------------~~l~ 155 (717)
++.. .+..+++|+.|++++|.+++.. .......+..+....|.+. .+..... ....
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQVTDLKPLANLT 175 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEEC-CCGGGTTCTTCSEEEEEESCCCCGGGTTCT
T ss_pred cccc--cccccccccccccccccccccc--ccccccccccccccccccc-ccccccccccccccccccccchhhhhcccc
Confidence 9543 3899999999999999998543 3456667788888877765 2222111 1222
Q ss_pred CcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCC
Q 005045 156 NLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSL 235 (717)
Q Consensus 156 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L 235 (717)
.........|... ....+..+++++.+++++|.+++..| +..+++|++|++++|.++.++ .+..+++|
T Consensus 176 ~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~~--------~l~~l~~L 243 (384)
T d2omza2 176 TLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG--------TLASLTNL 243 (384)
T ss_dssp TCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--------GGGGCTTC
T ss_pred ccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCcc--------hhhccccc
Confidence 2233333334333 44567788999999999999996554 567789999999999998853 57889999
Q ss_pred CEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEccc
Q 005045 236 EVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNV 315 (717)
Q Consensus 236 ~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 315 (717)
+.|++++|.+++..+ +... ++|+.|++++|.+.+.. .+..++.++.+++++|.+++ + ..+..+++++.|++++
T Consensus 244 ~~L~l~~n~l~~~~~--~~~~-~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 244 TDLDLANNQISNLAP--LSGL-TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYF 316 (384)
T ss_dssp SEEECCSSCCCCCGG--GTTC-TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCS
T ss_pred chhccccCccCCCCc--cccc-ccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCC
Confidence 999999999995433 5555 59999999999998543 48889999999999999984 3 3588999999999999
Q ss_pred CcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCCCC
Q 005045 316 NKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTI 370 (717)
Q Consensus 316 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 370 (717)
|+++++. .+..+++|+.|+|++|+|+ .++ .+..+++|++|++++|++++-.
T Consensus 317 n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 317 NNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred CCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCCh
Confidence 9999874 4889999999999999998 444 6999999999999999999543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.7e-27 Score=243.33 Aligned_cols=279 Identities=17% Similarity=0.200 Sum_probs=221.8
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
..++++-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5678899999998 6777774 689999999999995555679999999999999999997778889999999999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccc-cCCcccccCCCCcceeecccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHG-QLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
+|+|+ .+|..+ ...|+.|++++|.+..+.+..+.....+..++...|.... ......+..+++|+.+++++|.+..
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 99999 455433 3578999999999998888888888899999999887542 2334556788999999999999884
Q ss_pred cCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcC
Q 005045 170 SIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEM 249 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 249 (717)
+|..+ +++|++|++++|.++...+..|..++.++.|++++|.+..++ +..+.++++|++|+|++|+|+ .+
T Consensus 165 -l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~------~~~~~~l~~L~~L~L~~N~L~-~l 234 (305)
T d1xkua_ 165 -IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD------NGSLANTPHLRELHLNNNKLV-KV 234 (305)
T ss_dssp -CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC------TTTGGGSTTCCEEECCSSCCS-SC
T ss_pred -cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc------cccccccccceeeeccccccc-cc
Confidence 44443 589999999999999888889999999999999999999987 677889999999999999998 67
Q ss_pred chhhhhccccccEEecCCCccCCCCCccc------cCCCCCCEEEccCCcCc--cccchhhhcCC
Q 005045 250 PISIANLSTHLRRLTMGENLMHGNIPVGI------GNLVNLNLLGLEGNNLS--GSVPEVIGRLN 306 (717)
Q Consensus 250 p~~~~~~~~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~--~~~~~~~~~l~ 306 (717)
|.++..+ ++|++|++++|+|+.+....| ..+.+|+.|+|++|+++ ...|.+|..+.
T Consensus 235 p~~l~~l-~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 235 PGGLADH-KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp CTTTTTC-SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred ccccccc-cCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence 7777776 478888888887775433333 34455666666666554 23344444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.5e-27 Score=237.39 Aligned_cols=253 Identities=18% Similarity=0.170 Sum_probs=204.2
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc-C
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA-W 91 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~-~ 91 (717)
.+++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|++....+..+..+..++.++.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 35678888888 6777664 578999999999986666789999999999999999998888888888889888764 6
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|.++...+..|.++++|++|+|++|.+..+.+..+..+++|+.+++++|+++ .+|...|..+++|+.|++++|.+....
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccc
Confidence 6787777888999999999999999998888888888999999999999998 788888888888999999999998888
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCch
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPI 251 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 251 (717)
+..|.++++|+.+++++|++++..|..|..+++|+.|++++|++..++ +..|.++++|+.|+|++|.+...-+.
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~------~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP------TEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC------HHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccc------ccccccccccCEEEecCCCCCCCccc
Confidence 888889999999999999998888888888899999999999988877 77788888888888888888754332
Q ss_pred hhhhccccccEEecCCCccCCCCCcc
Q 005045 252 SIANLSTHLRRLTMGENLMHGNIPVG 277 (717)
Q Consensus 252 ~~~~~~~~L~~L~l~~N~l~~~~~~~ 277 (717)
... ...++.+....+.+....|..
T Consensus 244 ~~l--~~~l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 244 RPL--WAWLQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp HHH--HHHHHHCCSEECCCBEEESGG
T ss_pred hHH--HHHHHhCcCCCCceEeCCchH
Confidence 211 123444444444444333333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.4e-27 Score=236.24 Aligned_cols=267 Identities=20% Similarity=0.168 Sum_probs=138.5
Q ss_pred EEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc-cCc
Q 005045 63 IGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT-QNQ 141 (717)
Q Consensus 63 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~N~ 141 (717)
++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+.+++.++.++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 455555555 4454443 345666666666654444556666666666666666655555555555555555443 233
Q ss_pred ccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccC
Q 005045 142 LHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIG 221 (717)
Q Consensus 142 l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 221 (717)
++ .++...+..+++|++|++++|.+....+..+....+|+.+++++|.|+++.+..
T Consensus 93 ~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~----------------------- 148 (284)
T d1ozna_ 93 LR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT----------------------- 148 (284)
T ss_dssp CC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-----------------------
T ss_pred cc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH-----------------------
Confidence 33 333333333333333333333333333333444444444444444444333333
Q ss_pred chhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchh
Q 005045 222 DLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEV 301 (717)
Q Consensus 222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 301 (717)
|..+++|+.|++++|+++...+..+..+ ++|+++++++|.+++..|..|.++++|++|++++|++.+..+..
T Consensus 149 -------f~~~~~L~~L~l~~N~l~~l~~~~f~~l-~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~ 220 (284)
T d1ozna_ 149 -------FRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220 (284)
T ss_dssp -------TTTCTTCCEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred -------hccccchhhcccccCcccccchhhhccc-cccchhhhhhccccccChhHhhhhhhcccccccccccccccccc
Confidence 3444444444444444443333333333 35555555555555555666666677777777777777666666
Q ss_pred hhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccCCC
Q 005045 302 IGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNG 368 (717)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 368 (717)
|..+++|++|+|++|++...-+ .-.-...++.+....+++.+..|..+.+ ....+++.+.|+|
T Consensus 221 ~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 221 LAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 7777777777777777664311 1111224556666667777666665543 3344456666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.7e-25 Score=219.85 Aligned_cols=205 Identities=23% Similarity=0.237 Sum_probs=145.4
Q ss_pred cCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCC
Q 005045 127 YNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLV 206 (717)
Q Consensus 127 ~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 206 (717)
.+.+.+.+++.++++++ .+|.+++ ++|+.|+|++|.|+++.+..|.++++|++|+|++|+|+
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-------------- 68 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-------------- 68 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC--------------
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc--------------
Confidence 34455666677777776 5665432 23444444444444444444555555555555555554
Q ss_pred eeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCE
Q 005045 207 RLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNL 286 (717)
Q Consensus 207 ~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 286 (717)
.++ .++.+++|++|+|++|+++ ..+..+..+ ++|+.|++++|.+.+..+..+..+.+++.
T Consensus 69 ----------~l~--------~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l-~~L~~L~l~~~~~~~~~~~~~~~l~~l~~ 128 (266)
T d1p9ag_ 69 ----------KLQ--------VDGTLPVLGTLDLSHNQLQ-SLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQE 128 (266)
T ss_dssp ----------EEE--------CCSCCTTCCEEECCSSCCS-SCCCCTTTC-TTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred ----------ccc--------ccccccccccccccccccc-ccccccccc-cccccccccccccceeecccccccccccc
Confidence 332 1234555556666666655 344445555 36777777777777667777888889999
Q ss_pred EEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeecccC
Q 005045 287 LGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDL 366 (717)
Q Consensus 287 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 366 (717)
|++++|.++...+..+..+++|+.|++++|+++++.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|||
T Consensus 129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 999999998777778888999999999999999888888999999999999999998 8888888999999999999999
Q ss_pred CCCC
Q 005045 367 NGTI 370 (717)
Q Consensus 367 ~~~~ 370 (717)
.+.+
T Consensus 208 ~CdC 211 (266)
T d1p9ag_ 208 LCNC 211 (266)
T ss_dssp CCSG
T ss_pred CCCc
Confidence 8654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-24 Score=216.45 Aligned_cols=198 Identities=23% Similarity=0.234 Sum_probs=140.6
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
.+.+++.++++|+ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccc
Confidence 3455677778887 4666554 46778888888877655566777888888888888777 4443 5667778888888
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|+++ ..+..+.++++|+.|++++|.+..+.+..+..+.++++|++++|.++ .+|...+..+++|+.|++++|++++.
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhccccccccccc
Confidence 88777 55667777777777777777777777777777777777777777776 66666666677777777777777766
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccC
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELG 216 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 216 (717)
.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 6666677777777777777776 55655666666666666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.89 E-value=1.5e-21 Score=202.95 Aligned_cols=302 Identities=26% Similarity=0.308 Sum_probs=218.0
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEecc
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLA 90 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 90 (717)
++++|+|++|+++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|.++ .+++.. +.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence 5789999999998 67864 578999999999999 778654 57999999999998 555422 469999999
Q ss_pred CCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccccccccc
Q 005045 91 WNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGS 170 (717)
Q Consensus 91 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~ 170 (717)
+|.++ .+|. +..+++|+.|++++|.+... +. ....+..+.+..+... .. ..+..++.++.+.+++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~-~~--~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE-EL--PELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-SC--CCCTTCTTCCEEECCSSCCSSC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc-cc--ccccccccceeccccccccccc
Confidence 99999 5564 68899999999999999843 33 2456777788777664 21 2233678899999999987743
Q ss_pred CCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCc
Q 005045 171 IPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMP 250 (717)
Q Consensus 171 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 250 (717)
+. .....+.+..+++.+. ..+. +..++.|+.+++++|...... ....++..+.+.+|.+. ..+
T Consensus 178 -~~---~~~~~~~l~~~~~~~~-~~~~-~~~l~~L~~l~l~~n~~~~~~----------~~~~~l~~~~~~~~~~~-~~~ 240 (353)
T d1jl5a_ 178 -PD---LPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLP----------DLPPSLEALNVRDNYLT-DLP 240 (353)
T ss_dssp -CC---CCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCC----------SCCTTCCEEECCSSCCS-CCC
T ss_pred -cc---cccccccccccccccc-cccc-ccccccccccccccccccccc----------ccccccccccccccccc-ccc
Confidence 22 2244567777777776 4443 677889999999998877653 23467888888888887 333
Q ss_pred hhhhhccccccEEecCCCccCCCCCccccCC-CCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccc
Q 005045 251 ISIANLSTHLRRLTMGENLMHGNIPVGIGNL-VNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNL 329 (717)
Q Consensus 251 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 329 (717)
.. ...+...++..+.+.+ +..+ ......++..|.+.+ ++ ..+++|++|+|++|+++.+ |. .+
T Consensus 241 ~~----~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~~l-p~---~~ 303 (353)
T d1jl5a_ 241 EL----PQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLIEL-PA---LP 303 (353)
T ss_dssp CC----CTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCSCC-CC---CC
T ss_pred cc----cccccccccccccccc-----cccccchhcccccccCcccc-cc---ccCCCCCEEECCCCccCcc-cc---cc
Confidence 22 2466777777766542 1222 345667777777763 22 2357888888888888854 43 35
Q ss_pred cccceeecccccccccCCcCccCcCCCceEEeecccCCCCCCc
Q 005045 330 TILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSSNDLNGTIPK 372 (717)
Q Consensus 330 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 372 (717)
++|+.|+|++|+|+ .+|.. +++|++|++++|+|+ .+|.
T Consensus 304 ~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 304 PRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 67888888888887 66653 457888888888887 5553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=5.2e-21 Score=198.86 Aligned_cols=285 Identities=24% Similarity=0.271 Sum_probs=215.8
Q ss_pred CCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEec
Q 005045 34 TELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTL 113 (717)
Q Consensus 34 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 113 (717)
.+|++|+|++|+++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .+++. .+.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 46999999999998 68864 568999999999999 778754 57999999999998 44432 146999999
Q ss_pred cCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccc
Q 005045 114 YGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 114 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 193 (717)
++|.+.. +|. +..+++|+.|++++|.+. ..+. ....+..+.+..+... ....+..++.++.|++++|.+.
T Consensus 106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~-~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~- 175 (353)
T d1jl5a_ 106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK- 175 (353)
T ss_dssp CSSCCSS-CCC-CTTCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-
T ss_pred ccccccc-ccc-hhhhccceeecccccccc-cccc----ccccccchhhcccccc--ccccccccccceeccccccccc-
Confidence 9999995 453 688999999999999997 4443 3567778887777665 4566888999999999999988
Q ss_pred cCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCC
Q 005045 194 TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGN 273 (717)
Q Consensus 194 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~ 273 (717)
..+.. ....+.+...++.+...+ .+..++.|+.+++++|... .++.. ..++..+.+.+|.+..
T Consensus 176 ~~~~~---~~~~~~l~~~~~~~~~~~--------~~~~l~~L~~l~l~~n~~~-~~~~~----~~~l~~~~~~~~~~~~- 238 (353)
T d1jl5a_ 176 KLPDL---PLSLESIVAGNNILEELP--------ELQNLPFLTTIYADNNLLK-TLPDL----PPSLEALNVRDNYLTD- 238 (353)
T ss_dssp SCCCC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCS-SCCSC----CTTCCEEECCSSCCSC-
T ss_pred ccccc---cccccccccccccccccc--------ccccccccccccccccccc-ccccc----cccccccccccccccc-
Confidence 33332 234567777777776643 3567899999999999987 45533 2478899999998873
Q ss_pred CCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecccccccccCCcCccCc
Q 005045 274 IPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNC 353 (717)
Q Consensus 274 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 353 (717)
.+. ....+...++..|.+.+. +.. .......++..|.+.+. ...+++|++|+|++|+|+ .+|.. +
T Consensus 239 ~~~---~~~~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~ 303 (353)
T d1jl5a_ 239 LPE---LPQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---P 303 (353)
T ss_dssp CCC---CCTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---C
T ss_pred ccc---cccccccccccccccccc-ccc---cchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---c
Confidence 222 245678888888777632 211 13456678888877744 234689999999999999 67754 5
Q ss_pred CCCceEEeecccCCCCCCcc
Q 005045 354 QKLLVLNLSSNDLNGTIPKE 373 (717)
Q Consensus 354 ~~L~~L~l~~N~l~~~~p~~ 373 (717)
++|+.|+|++|.|+ .+|+.
T Consensus 304 ~~L~~L~L~~N~L~-~l~~~ 322 (353)
T d1jl5a_ 304 PRLERLIASFNHLA-EVPEL 322 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC
T ss_pred CCCCEEECCCCcCC-ccccc
Confidence 78999999999998 67653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.2e-23 Score=193.20 Aligned_cols=164 Identities=18% Similarity=0.111 Sum_probs=120.2
Q ss_pred cccccccCcccccceEEEEeCCCchhhhHHhHhhh------------------hhHHHHHHHHHHHHhcCCCCceeEEEE
Q 005045 391 FSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQ------------------QGALKSFIDECNALKSTRHRNILRVIT 452 (717)
Q Consensus 391 y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~ni~~~~~ 452 (717)
|.+.++||+|+||.||+|.+.+|+.||||++.... .........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45678999999999999998889999999754210 112344567899999999999998876
Q ss_pred eeccccCCCCceEEEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 005045 453 ACSSVDLEGNDFKALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHCDTPIAHCDLKPSNVL 532 (717)
Q Consensus 453 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 532 (717)
.. ..+++|||+++..+.+ ++...+..++.|++.+++|||+. ||+||||||+|||
T Consensus 82 ~~---------~~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 82 WE---------GNAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp EE---------TTEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred ec---------CCEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 62 2379999998765533 23334567999999999999998 9999999999999
Q ss_pred eCCCCceEEeeeccchhcccccCCCCCCcceeecccccccccC------CCccCCCCCcccchhhHHHHH
Q 005045 533 LDKDMTAHVGDFGLAKFLFEISDNPSKNQTVSIGLKGSIGYIP------PEHMNGQVSILGDIYSYGILL 596 (717)
Q Consensus 533 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~sDvwslG~vl 596 (717)
++++ .++|+|||.|.....+ . ...|.. .+.+.++++.++|+||..--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~-------~--------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEE-------G--------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTST-------T--------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCC-------C--------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9865 5899999998754110 0 001111 122345678999999975433
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-20 Score=185.56 Aligned_cols=220 Identities=17% Similarity=0.107 Sum_probs=102.4
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCC-CCCccccCCCCccEEEccc
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISG-IIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~ 139 (717)
+.++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45556665565 4444332 345566666666554444455555555555555555543 2233455555555554432
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCC-CccCCCCCCeeeccccccCCc
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPG-NFGSLKDLVRLNFDQNELGSR 218 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~ 218 (717)
.|.+....+..|.++++|++|++++|+++...+. .+..+..+..+..+++.+..+
T Consensus 88 ------------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 88 ------------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp ------------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred ------------------------cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 1233334444556666666666666666532221 122233333333444444443
Q ss_pred ccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCC-EEEccCCcCccc
Q 005045 219 EIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLN-LLGLEGNNLSGS 297 (717)
Q Consensus 219 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~ 297 (717)
+ ...|.++ ...+..|++++|+++...+..|. ..++. .+++++|+++..
T Consensus 144 ~------~~~~~~~------------------------~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l 192 (242)
T d1xwdc1 144 E------RNSFVGL------------------------SFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEEL 192 (242)
T ss_dssp C------TTSSTTS------------------------BSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCC
T ss_pred c------ccccccc------------------------cccceeeeccccccccccccccc-chhhhccccccccccccc
Confidence 3 1222222 12344444444444432222222 22222 223444555533
Q ss_pred cchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeecc
Q 005045 298 VPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWME 338 (717)
Q Consensus 298 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 338 (717)
.+..|.++++|++|+|++|+++.+.+..|.++++|+.|++.
T Consensus 193 ~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 33345555555555555555555555555555555555543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3e-20 Score=182.08 Aligned_cols=220 Identities=14% Similarity=0.087 Sum_probs=153.8
Q ss_pred cEEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccccc-CCCCccCCCCCCeeecc
Q 005045 133 YYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGT-IPGNFGSLKDLVRLNFD 211 (717)
Q Consensus 133 ~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~ 211 (717)
+.++.+++.++ .+|..++ +++++|++++|.|+.+.+..|.++++|++|++++|.+... .+..|..+++++++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 45555555555 5555443 3556666666666655555667777777777777776543 34456677777777664
Q ss_pred c-cccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhccccccEEecCCCccCCCCCccccCCC-CCCEEEc
Q 005045 212 Q-NELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLV-NLNLLGL 289 (717)
Q Consensus 212 ~-N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L 289 (717)
. |.+.... +..|.++++|+.|++++|.++...+.......+.+..+..+++.+....+..|.+++ .++.|++
T Consensus 87 ~~n~l~~~~------~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l 160 (242)
T d1xwdc1 87 KANNLLYIN------PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 160 (242)
T ss_dssp CCTTCCEEC------TTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred ccccccccc------cccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeec
Confidence 3 5666555 456777777888888887776333333333335677777788888777777787765 8999999
Q ss_pred cCCcCccccchhhhcCCCCCeE-EcccCcCCCCCCcccccccccceeecccccccccCCcCccCcCCCceEEeec
Q 005045 290 EGNNLSGSVPEVIGRLNKLEGL-GLNVNKFSGLIPSSLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLSS 363 (717)
Q Consensus 290 ~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 363 (717)
++|+++...+..| ...++..+ ++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 161 ~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 161 NKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 9999995555444 45555555 6788999988788899999999999999999955556789999998888754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3.4e-23 Score=223.74 Aligned_cols=358 Identities=18% Similarity=0.118 Sum_probs=213.7
Q ss_pred ceecEEEcCCCcCcCCC-CcCCcCCCCCCEEECCCCcccc----cCCcCCCCCCCCCEEEccCcccccc----CCcccc-
Q 005045 10 LMTQDLNLTYNYLSGKI-PTNLSHCTELRSFEASVNDFVG----QIPNQLSSLTKLEIIGLGGSNLTGN----VPAWIG- 79 (717)
Q Consensus 10 ~~~~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~- 79 (717)
.++++||+++|+++... ...+..++++++|+|++|+++. .+...+..+++|++|||++|.|++. +.+.+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 47899999999997532 3446778899999999998873 3345567889999999999998632 223332
Q ss_pred CCCCCCEEeccCCcCccc----CChhhhccCCCCeEeccCCCCCCCCCccc-----------------------------
Q 005045 80 NFSSLKALSLAWNNLRGS----IPNELGQLSGLGFFTLYGNFISGIIPSSI----------------------------- 126 (717)
Q Consensus 80 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~----------------------------- 126 (717)
...+|++|+|++|+|+.. ++..+..+++|++|+|++|.|+......+
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 234799999999999743 34567778999999999998763211111
Q ss_pred ----cCCCCccEEEcccCccccc----CCcccccCCCCcceeeccccccccc----CCccCCCCCCCCEEeccCccccc-
Q 005045 127 ----YNISSIYYFSVTQNQLHGQ----LPTDVGLTLPNLKIFAGAVNYFTGS----IPVSLSNASNLQVLDFAENGLTG- 193 (717)
Q Consensus 127 ----~~l~~L~~L~L~~N~l~~~----l~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~- 193 (717)
.....++.++++++.+... +...+.........+++..+.+... ....+...+.++.+++++|.+..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 1223455555555544310 0011111223344555555544321 11223345677777777776542
Q ss_pred ----cCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhh----hccccccEEec
Q 005045 194 ----TIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIA----NLSTHLRRLTM 265 (717)
Q Consensus 194 ----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~~~~~L~~L~l 265 (717)
.....+.....++.+++++|.+....... ....+...+.++.+++++|.+++.....+. .....|+.+++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~--~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l 319 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGD--LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 319 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH--HHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred ccchhhccccccccccccccccccccccccccc--ccccccccccccccccccccccccccchhhccccccccccccccc
Confidence 12223344567777777777776543221 134455677777777777777643333322 12236777777
Q ss_pred CCCccCCCCCcc----ccCCCCCCEEEccCCcCccc----cchhhh-cCCCCCeEEcccCcCCCC----CCccccccccc
Q 005045 266 GENLMHGNIPVG----IGNLVNLNLLGLEGNNLSGS----VPEVIG-RLNKLEGLGLNVNKFSGL----IPSSLGNLTIL 332 (717)
Q Consensus 266 ~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L 332 (717)
++|.+....... +...++|++|+|++|+|++. ++..+. ..+.|++|+|++|.+++. ++..+..+++|
T Consensus 320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L 399 (460)
T d1z7xw1 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399 (460)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence 777776443222 33455777788877777643 222232 345677778877777642 22334455777
Q ss_pred ceeecccccccccCCcC----cc-CcCCCceEEeecccCCCC
Q 005045 333 TRLWMEENRLEGSIPPS----LG-NCQKLLVLNLSSNDLNGT 369 (717)
Q Consensus 333 ~~L~L~~N~l~~~~p~~----~~-~l~~L~~L~l~~N~l~~~ 369 (717)
++|+|++|+|+...... +. ....|+.|++++|.+.+.
T Consensus 400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 77787777776432222 22 223577777777777643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=2.5e-20 Score=180.65 Aligned_cols=204 Identities=20% Similarity=0.357 Sum_probs=106.0
Q ss_pred CEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeeccc
Q 005045 85 KALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAV 164 (717)
Q Consensus 85 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~ 164 (717)
..++++.+++++.. .+..+.+|+.|++++|.|+.+ ..+..+++|++|++++|.++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~--------------------- 76 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT--------------------- 76 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC---------------------
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceee---------------------
Confidence 33444445554322 234455555555555555532 23445555555555555443
Q ss_pred ccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCc
Q 005045 165 NYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNS 244 (717)
Q Consensus 165 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 244 (717)
... .+..+++|+++++++|.++ .++ .+..+++|+.+.++++...... .+...+.+..+.++.+.
T Consensus 77 ----~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--------~~~~~~~~~~l~~~~~~ 140 (227)
T d1h6ua2 77 ----DLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--------PLAGLSNLQVLYLDLNQ 140 (227)
T ss_dssp ----CCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--------GGTTCTTCCEEECCSSC
T ss_pred ----ccc--ccccccccccccccccccc-ccc-cccccccccccccccccccccc--------hhccccchhhhhchhhh
Confidence 111 2556677777777777766 232 3556666666666666554432 23444455555555554
Q ss_pred ccCcCchhhhhccccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCc
Q 005045 245 FGGEMPISIANLSTHLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPS 324 (717)
Q Consensus 245 l~~~~p~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 324 (717)
+.. ...+.++++|+.|++++|.+... + .+.++++|++|+|++|+++++.
T Consensus 141 ~~~---------------------------~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~-- 189 (227)
T d1h6ua2 141 ITN---------------------------ISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDIS-- 189 (227)
T ss_dssp CCC---------------------------CGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--
T ss_pred hch---------------------------hhhhccccccccccccccccccc-h-hhcccccceecccCCCccCCCh--
Confidence 442 12244455555555555555522 1 2555666666666666665432
Q ss_pred ccccccccceeecccccccccCCcCccCcCCCceEEee
Q 005045 325 SLGNLTILTRLWMEENRLEGSIPPSLGNCQKLLVLNLS 362 (717)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 362 (717)
.++++++|++|+|++|++++ ++ .++++++|+.|+++
T Consensus 190 ~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 190 PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 25556666666666666653 32 25566666666665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=5.1e-20 Score=173.13 Aligned_cols=174 Identities=18% Similarity=0.180 Sum_probs=129.7
Q ss_pred eecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccC-CcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEec
Q 005045 11 MTQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQI-PNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSL 89 (717)
Q Consensus 11 ~~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 89 (717)
..++++.++++++ .+|..+. +++++|+|++|.|+..+ +..|.++++|+.|+|++|.+....+..|..+++|++|+|
T Consensus 9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 3467889999998 6776664 68999999999997544 556788999999999999998888888888999999999
Q ss_pred cCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 90 AWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 90 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
++|+|+.+.+++|.++++|++|+|++|+|+++.+++|.++++|++|+|++|.+....+...+ ...++.+.+..|.+..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARC 163 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBB
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEe
Confidence 99999988888899999999999999999988888899999999999999988633222222 1234445555555554
Q ss_pred cCCccCCCCCCCCEEeccCcccc
Q 005045 170 SIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 170 ~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
..|..+ ..++.++|+.|.++
T Consensus 164 ~~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 164 GAPSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp CSSTTT---TTSBGGGSCTTTCC
T ss_pred CCChhh---cCCEeeecCHhhCc
Confidence 444333 33444455555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=3.3e-19 Score=172.60 Aligned_cols=204 Identities=18% Similarity=0.280 Sum_probs=121.5
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
..++++.+++++.. .+..+.+|+.|++++|+|+ .++ .+.++++|++|++++|.+++..| +..+++|++|++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33556666666433 3456667777777777776 343 36777777777777777764322 667777777777777
Q ss_pred cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccCC
Q 005045 93 NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP 172 (717)
Q Consensus 93 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 172 (717)
.++ .++ .|.++++|+.+++++|.+.+ ...+...+.++.+.++++.+. .... +..+++|+.|++++|.+...
T Consensus 96 ~~~-~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~-~~~~--~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 96 PLK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCS-CCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECCSSCCCCC--
T ss_pred ccc-ccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhc-hhhh--hccccccccccccccccccc--
Confidence 776 332 46667777777777776653 234556666777777766665 2211 23455666666666665532
Q ss_pred ccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEee
Q 005045 173 VSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLA 241 (717)
Q Consensus 173 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~ 241 (717)
..+.++++|++|+|++|++++ ++ .|..+++|++|++++|+|++++ .+.++++|+.|+++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--------~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--------PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--------GGTTCTTCCEEEEE
T ss_pred hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--------ccccCCCCCEEEee
Confidence 235566666666666666653 22 2555666666666666665543 24555666666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=9.6e-20 Score=171.22 Aligned_cols=128 Identities=24% Similarity=0.287 Sum_probs=73.6
Q ss_pred CEEEccCccccccCCccccCCCCCCEEeccCCcCcc-cCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEccc
Q 005045 61 EIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRG-SIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQ 139 (717)
Q Consensus 61 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 139 (717)
+++++++++++ .+|..+. +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+..+.+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45566666666 4554443 456666666666653 2344556666666666666666666666666666666666666
Q ss_pred CcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccc
Q 005045 140 NQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 140 N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
|+|+ .+|...|.++++|+.|+|++|.|+++.+++|..+++|++|+|++|.+.
T Consensus 88 N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 6665 555555545555555555555555455555555555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.5e-19 Score=167.93 Aligned_cols=165 Identities=23% Similarity=0.315 Sum_probs=79.5
Q ss_pred CCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEE
Q 005045 57 LTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136 (717)
Q Consensus 57 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 136 (717)
+.+|+.|++++|.++ .++ .+..+++|++|+|++|+|++. + .+..+++|++|++++|+|+++ + .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccccc-c-cccccccccccc
Confidence 334444444444444 222 144444444444444444422 1 234444445555544444421 1 344444555555
Q ss_pred cccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccC
Q 005045 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELG 216 (717)
Q Consensus 137 L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 216 (717)
+++|.+. .++. +..+++++.+++++|.++. +..+..+++|+++++++|++++. + .+.++++|++|++++|+|+
T Consensus 119 l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 119 LEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccc-cccc--ccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence 5554443 2221 2234444444444444432 22344556666666666666632 2 2556666666666666665
Q ss_pred CcccCchhhhhhhccCCCCCEEEeec
Q 005045 217 SREIGDLNFLKFLANCTSLEVLGLAR 242 (717)
Q Consensus 217 ~~~~~~~~~~~~~~~l~~L~~L~L~~ 242 (717)
+++ .+.++++|++|+|++
T Consensus 192 ~l~--------~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 DLR--------ALAGLKNLDVLELFS 209 (210)
T ss_dssp BCG--------GGTTCTTCSEEEEEE
T ss_pred CCh--------hhcCCCCCCEEEccC
Confidence 532 356666666666653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.2e-18 Score=162.79 Aligned_cols=41 Identities=32% Similarity=0.503 Sum_probs=18.9
Q ss_pred CCCCCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCC
Q 005045 175 LSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGS 217 (717)
Q Consensus 175 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 217 (717)
+..+++|++|++++|++++. + .+.++++|+.|++++|++++
T Consensus 146 l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 44444555555555554422 1 14444445555555544444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2e-18 Score=163.13 Aligned_cols=180 Identities=19% Similarity=0.294 Sum_probs=148.6
Q ss_pred ecEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccC
Q 005045 12 TQDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAW 91 (717)
Q Consensus 12 ~~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 91 (717)
...+.++.+.+++.++ ...+++|++|++++|.++ .++ .+..+++|++|+|++|++++ ++. ++++++|++|++++
T Consensus 20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~ 93 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNN 93 (199)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccc
Confidence 3455678888876554 356789999999999998 454 48889999999999999995 443 89999999999999
Q ss_pred CcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccccC
Q 005045 92 NNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSI 171 (717)
Q Consensus 92 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~ 171 (717)
|.+. .++ .+.++++|+.|++++|.+.. ...+..+++|+.|++++|++. .++. +..+++|+.|++++|.++...
T Consensus 94 n~~~-~~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~-~~~~--l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 94 NQIA-DIT-PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp SCCC-CCG-GGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCCG
T ss_pred cccc-ccc-cccccccccccccccccccc--ccccchhhhhHHhhhhhhhhc-cccc--ccccccccccccccccccCCc
Confidence 9998 444 48899999999999999984 346889999999999999997 5553 458999999999999998643
Q ss_pred CccCCCCCCCCEEeccCccccccCCCCccCCCCCCee
Q 005045 172 PVSLSNASNLQVLDFAENGLTGTIPGNFGSLKDLVRL 208 (717)
Q Consensus 172 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 208 (717)
.+.++++|++|++++|++++ ++ .++.+++|++|
T Consensus 167 --~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 167 --PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred --cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 48999999999999999994 44 47888888775
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.8e-18 Score=164.85 Aligned_cols=165 Identities=26% Similarity=0.388 Sum_probs=114.9
Q ss_pred CCCCCEEeccCccccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeecCcccCcCchhhhhcc
Q 005045 178 ASNLQVLDFAENGLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLARNSFGGEMPISIANLS 257 (717)
Q Consensus 178 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 257 (717)
+.+|++|++++|.++. ++ .+..+++|++|++++|+|+.++ .+..+++|+.|++++|+++ .+| .+..+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--------~~~~l~~L~~L~l~~n~i~-~l~-~l~~l- 111 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--------PLANLKNLGWLFLDENKVK-DLS-SLKDL- 111 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCC-CGG-GGTTC-
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--------ccccCcccccccccccccc-ccc-ccccc-
Confidence 4566666666666663 22 2556667777777777666543 2456677777777777776 444 34554
Q ss_pred ccccEEecCCCccCCCCCccccCCCCCCEEEccCCcCccccchhhhcCCCCCeEEcccCcCCCCCCcccccccccceeec
Q 005045 258 THLRRLTMGENLMHGNIPVGIGNLVNLNLLGLEGNNLSGSVPEVIGRLNKLEGLGLNVNKFSGLIPSSLGNLTILTRLWM 337 (717)
Q Consensus 258 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 337 (717)
++|+.|++++|.+.. ...+.++++|+.+++++|.+++ +..+..+++|+.+++++|+++++. .+.++++|+.|+|
T Consensus 112 ~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~L 185 (210)
T d1h6ta2 112 KKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYL 185 (210)
T ss_dssp TTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred ccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEEC
Confidence 477777777777652 3457778888888888888873 335677888888888888888653 3778888888888
Q ss_pred ccccccccCCcCccCcCCCceEEeec
Q 005045 338 EENRLEGSIPPSLGNCQKLLVLNLSS 363 (717)
Q Consensus 338 ~~N~l~~~~p~~~~~l~~L~~L~l~~ 363 (717)
++|+++ .+| .+..+++|++|+|++
T Consensus 186 s~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 186 SKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 888887 454 588888888888874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=9.6e-21 Score=204.23 Aligned_cols=350 Identities=19% Similarity=0.134 Sum_probs=241.2
Q ss_pred CCcceecEEEcCCCcCcC----CCCcCCcCCCCCCEEECCCCcccc----cCCcCCC-CCCCCCEEEccCcccccc----
Q 005045 7 PEHLMTQDLNLTYNYLSG----KIPTNLSHCTELRSFEASVNDFVG----QIPNQLS-SLTKLEIIGLGGSNLTGN---- 73 (717)
Q Consensus 7 p~~~~~~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~-~l~~L~~L~L~~n~l~~~---- 73 (717)
|...++++|+|++|+++. .+..++..+++|++|+|++|.|+. .+...+. ...+|++|+|++|+|++.
T Consensus 24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~ 103 (460)
T d1z7xw1 24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103 (460)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccc
Confidence 444578999999999873 345667899999999999999863 2233333 345899999999999853
Q ss_pred CCccccCCCCCCEEeccCCcCcccCCh---------------------------------hhhccCCCCeEeccCCCCCC
Q 005045 74 VPAWIGNFSSLKALSLAWNNLRGSIPN---------------------------------ELGQLSGLGFFTLYGNFISG 120 (717)
Q Consensus 74 ~p~~~~~l~~L~~L~L~~n~l~~~~~~---------------------------------~~~~l~~L~~L~L~~N~i~~ 120 (717)
++..+..+++|++|+|++|.|+..... .+.....++.++++++.+..
T Consensus 104 l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~ 183 (460)
T d1z7xw1 104 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 183 (460)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred ccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccc
Confidence 456678899999999999987631111 12234677888888777652
Q ss_pred CCC----ccc-cCCCCccEEEcccCcccccCC----cccccCCCCcceeecccccccc-----cCCccCCCCCCCCEEec
Q 005045 121 IIP----SSI-YNISSIYYFSVTQNQLHGQLP----TDVGLTLPNLKIFAGAVNYFTG-----SIPVSLSNASNLQVLDF 186 (717)
Q Consensus 121 ~~~----~~~-~~l~~L~~L~L~~N~l~~~l~----~~~~~~l~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l 186 (717)
... ..+ ........+++..+.+. ... .......+.++.+++++|.+.. ...........++.|++
T Consensus 184 ~~~~~~~~~l~~~~~~~~~l~~~~~~~~-~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l 262 (460)
T d1z7xw1 184 AGVRVLCQGLKDSPCQLEALKLESCGVT-SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 262 (460)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCB-TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred cccccccccccccccccccccccccccc-chhhhcccccccccccccccchhhccccccccchhhccccccccccccccc
Confidence 111 111 22345678888888775 221 1122357889999999998652 23344566789999999
Q ss_pred cCccccccC----CCCccCCCCCCeeeccccccCCcccCchhhhhh-hccCCCCCEEEeecCcccCcCchhhhhc---cc
Q 005045 187 AENGLTGTI----PGNFGSLKDLVRLNFDQNELGSREIGDLNFLKF-LANCTSLEVLGLARNSFGGEMPISIANL---ST 258 (717)
Q Consensus 187 ~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~---~~ 258 (717)
++|.+.... ...+...+.++.+++++|.++..+...+ ... ......|+.+++++|.++......+... .+
T Consensus 263 ~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l--~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~ 340 (460)
T d1z7xw1 263 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL--CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 340 (460)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH--HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCS
T ss_pred ccccccccccccccccccccccccccccccccccccccchh--hccccccccccccccccccchhhhhhhhccccccccc
Confidence 999987432 2234567899999999999876442222 122 2345689999999999986554444432 24
Q ss_pred cccEEecCCCccCCCC----Cccc-cCCCCCCEEEccCCcCccc----cchhhhcCCCCCeEEcccCcCCCCCCcccc--
Q 005045 259 HLRRLTMGENLMHGNI----PVGI-GNLVNLNLLGLEGNNLSGS----VPEVIGRLNKLEGLGLNVNKFSGLIPSSLG-- 327 (717)
Q Consensus 259 ~L~~L~l~~N~l~~~~----~~~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-- 327 (717)
+|++|+|++|.++... +..+ ...+.|++|+|++|+|+.. ++..+..+++|++|+|++|++++.....+.
T Consensus 341 ~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 420 (460)
T d1z7xw1 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420 (460)
T ss_dssp SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHH
T ss_pred chhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHH
Confidence 7999999999986432 2333 2467899999999999853 445577789999999999999854333332
Q ss_pred ---cccccceeecccccccccCCcCc----cCcCCCceE
Q 005045 328 ---NLTILTRLWMEENRLEGSIPPSL----GNCQKLLVL 359 (717)
Q Consensus 328 ---~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L 359 (717)
+..+|+.|++.+|.+.......+ ...++|+.|
T Consensus 421 l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp HTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred HHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 23479999999999975444433 345566554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4.5e-17 Score=162.71 Aligned_cols=252 Identities=17% Similarity=0.216 Sum_probs=118.7
Q ss_pred EEeccCCcCcccCChhhhcc--CCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecc
Q 005045 86 ALSLAWNNLRGSIPNELGQL--SGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGA 163 (717)
Q Consensus 86 ~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~ 163 (717)
+|||+++.+. |+.+..+ ..+..+.++...+... ........+|++|||++|.+++.....++..+++|++|+++
T Consensus 4 ~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCC---chHHHHHHhccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 5666666554 2222221 1244555555444422 22233445677777777766533223334444455555555
Q ss_pred cccccccCCccCCCCCCCCEEeccCc-cccccCCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEeec
Q 005045 164 VNYFTGSIPVSLSNASNLQVLDFAEN-GLTGTIPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGLAR 242 (717)
Q Consensus 164 ~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 242 (717)
++.+....+..++.+++|++|+++++ .++ +.. +...+.++++|++|++++
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it------------------------d~~-----l~~l~~~~~~L~~L~ls~ 130 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFS------------------------EFA-----LQTLLSSCSRLDELNLSW 130 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCC------------------------HHH-----HHHHHHHCTTCCEEECCC
T ss_pred ccCCCcHHHHHHhcCCCCcCcccccccccc------------------------ccc-----cchhhHHHHhcccccccc
Confidence 54444444444445555555555553 333 211 011223445555555554
Q ss_pred C-cccCc-CchhhhhccccccEEecCCCc--cCCC-CCccccCCCCCCEEEccCC-cCccccchhhhcCCCCCeEEcccC
Q 005045 243 N-SFGGE-MPISIANLSTHLRRLTMGENL--MHGN-IPVGIGNLVNLNLLGLEGN-NLSGSVPEVIGRLNKLEGLGLNVN 316 (717)
Q Consensus 243 N-~l~~~-~p~~~~~~~~~L~~L~l~~N~--l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N 316 (717)
+ .+++. +...+....+.|+.|+++++. ++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++|
T Consensus 131 c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 131 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp CTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred ccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 3 23211 112222222345555555431 2211 1112334566666777664 355555556666677777777764
Q ss_pred -cCCCCCCcccccccccceeeccccccccc-CCcCccCcCCCceEEeecccCCCCCCccc
Q 005045 317 -KFSGLIPSSLGNLTILTRLWMEENRLEGS-IPPSLGNCQKLLVLNLSSNDLNGTIPKEV 374 (717)
Q Consensus 317 -~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 374 (717)
.+++.....++++++|+.|+++++ ++.. ++.....+++| .+..+++++..++.+
T Consensus 211 ~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 211 YDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIARPTI 266 (284)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCSSC
T ss_pred CCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCCCCcc
Confidence 455554555666677777777666 3211 11111234443 456666665444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.2e-16 Score=144.53 Aligned_cols=128 Identities=14% Similarity=0.172 Sum_probs=87.5
Q ss_pred CcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCC
Q 005045 30 LSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLG 109 (717)
Q Consensus 30 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 109 (717)
|.++..|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 566677778888888877 45655667777888888888877 443 377777888888888888755555667777888
Q ss_pred eEeccCCCCCCCCC-ccccCCCCccEEEcccCcccccCCc---ccccCCCCcceee
Q 005045 110 FFTLYGNFISGIIP-SSIYNISSIYYFSVTQNQLHGQLPT---DVGLTLPNLKIFA 161 (717)
Q Consensus 110 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~l~~---~~~~~l~~L~~L~ 161 (717)
+|+|++|+|+.... ..+..+++|++|++++|.++ ..|. .++..+|+|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 88888888774322 45677777777888777776 4442 2233445555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=5e-16 Score=133.40 Aligned_cols=102 Identities=17% Similarity=0.242 Sum_probs=60.5
Q ss_pred CEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCC
Q 005045 37 RSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGN 116 (717)
Q Consensus 37 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 116 (717)
|.|+|++|+++ .++. +.++++|++|++++|+|+ .+|..|+.+++|++|++++|+|+ .+| .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 35566666665 3332 566666666666666666 45555666666666666666666 233 3566666666666666
Q ss_pred CCCCCC-CccccCCCCccEEEcccCccc
Q 005045 117 FISGII-PSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 117 ~i~~~~-~~~~~~l~~L~~L~L~~N~l~ 143 (717)
+|+... ...+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 666433 245666666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=1.3e-16 Score=144.34 Aligned_cols=112 Identities=17% Similarity=0.170 Sum_probs=52.8
Q ss_pred CCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCcc
Q 005045 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133 (717)
Q Consensus 54 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 133 (717)
|.+..+|++|+|++|+|+ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+++.+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 334444555555555554 334434444455555555555542 21 244444444444444444433333344444444
Q ss_pred EEEcccCcccccCCcccccCCCCcceeecccccccccCCccCCCCCCCCEEeccCcccc
Q 005045 134 YFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPVSLSNASNLQVLDFAENGLT 192 (717)
Q Consensus 134 ~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 192 (717)
+|++++|+++ .++. ...+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~-~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGG
T ss_pred cceecccccc-cccc-----------------------ccccccccccchhhcCCCccc
Confidence 4444444443 2211 123555666666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1.7e-16 Score=158.48 Aligned_cols=80 Identities=16% Similarity=0.036 Sum_probs=42.2
Q ss_pred CCEEEccCccccccCCccccCCCCCCEEeccCCcCccc-CChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcc
Q 005045 60 LEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGS-IPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVT 138 (717)
Q Consensus 60 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 138 (717)
+..+.++...+... ........+|++|||++|.++.. +...+..+++|++|+|++|.++...+..+..+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 33445554444422 12223344566666666655432 23345556666666666666655555556666666666666
Q ss_pred cC
Q 005045 139 QN 140 (717)
Q Consensus 139 ~N 140 (717)
++
T Consensus 104 ~c 105 (284)
T d2astb2 104 GC 105 (284)
T ss_dssp TC
T ss_pred cc
Confidence 63
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=9.1e-16 Score=131.72 Aligned_cols=118 Identities=23% Similarity=0.266 Sum_probs=99.2
Q ss_pred cEEEcCCCcCcCCCCcCCcCCCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCC
Q 005045 13 QDLNLTYNYLSGKIPTNLSHCTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN 92 (717)
Q Consensus 13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 92 (717)
++|+|++|+++ .++ .++.+++|++|++++|.|+ .+|..|+.+++|++|++++|.|+ .+|. +..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCC
Confidence 57999999999 555 4999999999999999999 67888999999999999999999 5554 899999999999999
Q ss_pred cCcccCC-hhhhccCCCCeEeccCCCCCCC---CCccccCCCCccEE
Q 005045 93 NLRGSIP-NELGQLSGLGFFTLYGNFISGI---IPSSIYNISSIYYF 135 (717)
Q Consensus 93 ~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~---~~~~~~~l~~L~~L 135 (717)
+|++... ..+..+++|++|++++|.++.. ....+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 9995443 5789999999999999999733 23334456666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.60 E-value=6.3e-17 Score=166.98 Aligned_cols=39 Identities=33% Similarity=0.394 Sum_probs=23.9
Q ss_pred CCCCEEEccCCcCcccc----chhhh-cCCCCCeEEcccCcCCC
Q 005045 282 VNLNLLGLEGNNLSGSV----PEVIG-RLNKLEGLGLNVNKFSG 320 (717)
Q Consensus 282 ~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~ 320 (717)
+.|+.|++++|+|+... ...+. ++++|++|+|++|++..
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 45777777777776322 22232 45677777777777763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=4e-16 Score=160.84 Aligned_cols=255 Identities=15% Similarity=0.155 Sum_probs=135.9
Q ss_pred cCCcCCCCCCEEECCCCcccc----cCCcCCCCCCCCCEEEccCcccccc----------CCccccCCCCCCEEeccCCc
Q 005045 28 TNLSHCTELRSFEASVNDFVG----QIPNQLSSLTKLEIIGLGGSNLTGN----------VPAWIGNFSSLKALSLAWNN 93 (717)
Q Consensus 28 ~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----------~p~~~~~l~~L~~L~L~~n~ 93 (717)
.++.....|++|+|++|.+.. .+...+...++|+.|+++++..... +...+...++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 345556666666666666542 2233455566666666665543311 11223344556666666665
Q ss_pred Cccc----CChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEEcccCcccccCCcccccCCCCcceeecccccccc
Q 005045 94 LRGS----IPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTG 169 (717)
Q Consensus 94 l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~ 169 (717)
++.. +...+...++|+.|++++|.+.......+.. .|..+ .........+.|+.+.+++|.+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~----------~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQEL----------AVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHH----------HHHHHHHTCCCCCEEECCSSCCTG
T ss_pred cccccccchhhhhcccccchheecccccccccccccccc--ccccc----------ccccccccCcccceeecccccccc
Confidence 5532 1222334455555555555543110000000 00000 000001133445555555555442
Q ss_pred c----CCccCCCCCCCCEEeccCcccccc-----CCCCccCCCCCCeeeccccccCCcccCchhhhhhhccCCCCCEEEe
Q 005045 170 S----IPVSLSNASNLQVLDFAENGLTGT-----IPGNFGSLKDLVRLNFDQNELGSREIGDLNFLKFLANCTSLEVLGL 240 (717)
Q Consensus 170 ~----~~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L 240 (717)
. +...+...++|++|+|++|.|+.. +...+..+++|+.|++++|.++..+... +...+..+++|++|+|
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~--L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA--LAIALKSWPNLRELGL 250 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH--HHHHGGGCTTCCEEEC
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc--ccccccccccchhhhh
Confidence 1 222344556777788877777532 3345666777888888888776543222 2355677788888888
Q ss_pred ecCcccCcCchhhhhc-----cccccEEecCCCccCCCC----Cccc-cCCCCCCEEEccCCcCcc
Q 005045 241 ARNSFGGEMPISIANL-----STHLRRLTMGENLMHGNI----PVGI-GNLVNLNLLGLEGNNLSG 296 (717)
Q Consensus 241 ~~N~l~~~~p~~~~~~-----~~~L~~L~l~~N~l~~~~----~~~~-~~l~~L~~L~L~~N~l~~ 296 (717)
++|.|++.....+... .+.|++|++++|.|+... ...+ .+.++|+.|+|++|++..
T Consensus 251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 8888875544444321 136888888888876422 2223 256789999999999873
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=9.5e-14 Score=124.24 Aligned_cols=109 Identities=14% Similarity=0.140 Sum_probs=70.6
Q ss_pred CCCCCEEECCCCcccccCCcCCCCCCCCCEEEccCc-cccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeE
Q 005045 33 CTELRSFEASVNDFVGQIPNQLSSLTKLEIIGLGGS-NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFF 111 (717)
Q Consensus 33 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 111 (717)
+.....++++++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 334455666666666 45666666677777777654 3665555566777777777777777776666667777777777
Q ss_pred eccCCCCCCCCCccccCCCCccEEEcccCccc
Q 005045 112 TLYGNFISGIIPSSIYNISSIYYFSVTQNQLH 143 (717)
Q Consensus 112 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 143 (717)
+|++|+|+.+.++.|..+ +|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCccc
Confidence 777777775555555444 5777777777664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.47 E-value=4.5e-16 Score=145.85 Aligned_cols=84 Identities=21% Similarity=0.290 Sum_probs=32.7
Q ss_pred CCCCCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCcc
Q 005045 54 LSSLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIY 133 (717)
Q Consensus 54 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 133 (717)
+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|..+..+++|++|++++|+|+.+ +.+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 333444444444444444 222 2334444444444444443 2233333333344444444444321 2233334444
Q ss_pred EEEcccCcc
Q 005045 134 YFSVTQNQL 142 (717)
Q Consensus 134 ~L~L~~N~l 142 (717)
.|+|++|+|
T Consensus 119 ~L~L~~N~i 127 (198)
T d1m9la_ 119 VLYMSNNKI 127 (198)
T ss_dssp EEEESEEEC
T ss_pred ccccccchh
Confidence 444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.9e-14 Score=125.64 Aligned_cols=110 Identities=13% Similarity=0.045 Sum_probs=93.4
Q ss_pred CCCCCCEEEccCccccccCCccccCCCCCCEEeccCC-cCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccE
Q 005045 56 SLTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWN-NLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 56 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 134 (717)
.....+.++++++++. ..|..+..+++|++|+|++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|.++++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3445677999999998 67888999999999999766 588777788999999999999999999888999999999999
Q ss_pred EEcccCcccccCCcccccCCCCcceeeccccccc
Q 005045 135 FSVTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFT 168 (717)
Q Consensus 135 L~L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~ 168 (717)
|+|++|+|+ .+|..++..+ +|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence 999999998 8888887444 5777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=1.1e-15 Score=143.25 Aligned_cols=128 Identities=23% Similarity=0.228 Sum_probs=83.6
Q ss_pred CCCEEEccCc--cccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCCCccccCCCCccEEE
Q 005045 59 KLEIIGLGGS--NLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYYFS 136 (717)
Q Consensus 59 ~L~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 136 (717)
.++.++++++ .+. .+|..+..+++|++|+|++|+|+ .++ .|.++++|++|+|++|.|+. ++..+..+++|++|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-ccccccccccccccc
Confidence 4555666554 344 55667788888888888888887 343 47888888888888888873 455555566788888
Q ss_pred cccCcccccCCcccccCCCCcceeecccccccccCC-ccCCCCCCCCEEeccCccccc
Q 005045 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIP-VSLSNASNLQVLDFAENGLTG 193 (717)
Q Consensus 137 L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~ 193 (717)
+++|+++ .++. +..+++|+.|++++|.|+.... ..+..+++|++|++++|++..
T Consensus 100 l~~N~i~-~l~~--~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 100 ISYNQIA-SLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEECC-CHHH--HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccc-cccc--ccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 8888876 4432 2355666666666666654321 345666666666666666653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=4.3e-10 Score=100.78 Aligned_cols=86 Identities=15% Similarity=0.045 Sum_probs=40.5
Q ss_pred CCCCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccC--ChhhhccCCCCeEeccCCCCCCCCCccccCCCCccE
Q 005045 57 LTKLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSI--PNELGQLSGLGFFTLYGNFISGIIPSSIYNISSIYY 134 (717)
Q Consensus 57 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 134 (717)
+..+..|+..++.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+.+.+-.+....+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333333444333333 33333444555555666666555322 233455555555555555555433323333334555
Q ss_pred EEcccCccc
Q 005045 135 FSVTQNQLH 143 (717)
Q Consensus 135 L~L~~N~l~ 143 (717)
|++++|.+.
T Consensus 120 L~L~~Npl~ 128 (162)
T d1koha1 120 LWLDGNSLS 128 (162)
T ss_dssp CCCTTSTTS
T ss_pred eecCCCCcC
Confidence 555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=4.8e-10 Score=100.42 Aligned_cols=121 Identities=12% Similarity=0.004 Sum_probs=74.6
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEeccCCcCcccCChhhhccCCCCeEeccCCCCCCCC--CccccCCCCccEEE
Q 005045 59 KLEIIGLGGSNLTGNVPAWIGNFSSLKALSLAWNNLRGSIPNELGQLSGLGFFTLYGNFISGII--PSSIYNISSIYYFS 136 (717)
Q Consensus 59 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~ 136 (717)
+.+.|+++++... + .+..+..+..+++..+.+. .++..+..+++|++|+|++|+|+.+. +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455566554432 1 2344444555555555444 45555667777888888888777543 34466777777788
Q ss_pred cccCcccccCCcccccCCCCcceeecccccccccCCc-------cCCCCCCCCEEe
Q 005045 137 VTQNQLHGQLPTDVGLTLPNLKIFAGAVNYFTGSIPV-------SLSNASNLQVLD 185 (717)
Q Consensus 137 L~~N~l~~~l~~~~~~~l~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~ 185 (717)
|++|.|+ .++...+.....|+.|++++|.+...... .+..+|+|+.||
T Consensus 98 Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 8888776 66654444556777777887777654332 245677777775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=8.3e-07 Score=85.89 Aligned_cols=145 Identities=13% Similarity=0.067 Sum_probs=92.3
Q ss_pred cccccccccccCcccccceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCceE
Q 005045 387 STDNFSKENLIGTGSFGSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDFK 465 (717)
Q Consensus 387 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~ 465 (717)
....|++.+..+-++.+.||+.... ++.+++|............+.+|...+..+. +--+.++++.+ +.++..
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~ 85 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWS 85 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCce
Confidence 3456666665433334689988754 5556778776554433445667888776652 33345555553 234578
Q ss_pred EEEEecCCCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 005045 466 ALVFEFMSNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC---------------------------- 517 (717)
Q Consensus 466 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 517 (717)
++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEEEecccccccccccccc------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 99999999988865443211 12334556666666666431
Q ss_pred ----------------------------CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 ----------------------------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 ----------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999998776677999987653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.98 E-value=3e-06 Score=75.43 Aligned_cols=39 Identities=10% Similarity=-0.009 Sum_probs=21.1
Q ss_pred ccCCCCCCEEEccCCcCccc-------cchhhhcCCCCCeEEcccC
Q 005045 278 IGNLVNLNLLGLEGNNLSGS-------VPEVIGRLNKLEGLGLNVN 316 (717)
Q Consensus 278 ~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~Ls~N 316 (717)
+...+.|++|+|++|++... +...+...+.|+.|+++.+
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 34445666666666654422 2333444566666666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.92 E-value=1.4e-06 Score=77.56 Aligned_cols=110 Identities=13% Similarity=0.077 Sum_probs=55.5
Q ss_pred CCCCCCEEECCCC-ccccc----CCcCCCCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCCcCcccC----
Q 005045 32 HCTELRSFEASVN-DFVGQ----IPNQLSSLTKLEIIGLGGSNLTGN----VPAWIGNFSSLKALSLAWNNLRGSI---- 98 (717)
Q Consensus 32 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~---- 98 (717)
+.++|++|+|+++ .++.. +-..+...++|++|+|++|.+.+. +.+.+...+.|++|+|++|.|+...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456666666653 34321 122345556666666666666532 2223344556666666666665321
Q ss_pred ChhhhccCCCCeEeccCCCCCCCC-------CccccCCCCccEEEcccCc
Q 005045 99 PNELGQLSGLGFFTLYGNFISGII-------PSSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 99 ~~~~~~l~~L~~L~L~~N~i~~~~-------~~~~~~l~~L~~L~L~~N~ 141 (717)
-.++...++|++|+|++|.+..+. ...+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 123344455666666666554221 2223344555556555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=1.8e-05 Score=75.66 Aligned_cols=131 Identities=15% Similarity=0.090 Sum_probs=81.3
Q ss_pred ccCcccc-cceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCC--CCceeEEEEeeccccCCCCceEEEEEecC
Q 005045 396 LIGTGSF-GSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTR--HRNILRVITACSSVDLEGNDFKALVFEFM 472 (717)
Q Consensus 396 ~ig~g~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 472 (717)
.+..|.. +.||+.....+..+++|...... ...+..|+..++.+. +-.+.+++..+. +++..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEee
Confidence 3445554 57899988778888888755332 234566777776652 233555666532 345789999999
Q ss_pred CCCChhhhccCCCCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005045 473 SNGNLDQWLHPSPAEHYQFKKLSVIQRLNIAIDVASALDYLHHHC----------------------------------- 517 (717)
Q Consensus 473 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 517 (717)
+|.++.+... .. ...+.+++..++-||+..
T Consensus 89 ~G~~~~~~~~------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 89 PGQDLLSSHL------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp SSEETTTSCC------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eccccccccc------------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 9876643211 10 112233334444444211
Q ss_pred --------------------CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 --------------------DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 --------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12389999999999999876778999987653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.45 E-value=3.2e-05 Score=68.48 Aligned_cols=90 Identities=13% Similarity=0.286 Sum_probs=40.2
Q ss_pred hhccCCCCCEEEeecCcccCcCchhhhhc---cccccEEecCCCccCCC----CCccccCCCCCCEEEc--cCCcCcc--
Q 005045 228 FLANCTSLEVLGLARNSFGGEMPISIANL---STHLRRLTMGENLMHGN----IPVGIGNLVNLNLLGL--EGNNLSG-- 296 (717)
Q Consensus 228 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~---~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~-- 296 (717)
.+...+.|++|+|++|.++...-..+... .+.++.+++++|.+... +...+...++|+.++| ++|.+..
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~ 120 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 120 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHH
Confidence 33444555555555555443222222111 12344444444443321 1223445566665444 3455543
Q ss_pred --ccchhhhcCCCCCeEEcccCc
Q 005045 297 --SVPEVIGRLNKLEGLGLNVNK 317 (717)
Q Consensus 297 --~~~~~~~~l~~L~~L~Ls~N~ 317 (717)
.+...+...++|+.|+++.+.
T Consensus 121 ~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 121 EMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHHHhCCCcCEEeCcCCC
Confidence 233344456666776665553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.30 E-value=1.7e-05 Score=70.22 Aligned_cols=111 Identities=14% Similarity=0.146 Sum_probs=54.6
Q ss_pred cCCCCCCEEECCC-Ccccc----cCCcCCCCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCCcCccc----
Q 005045 31 SHCTELRSFEASV-NDFVG----QIPNQLSSLTKLEIIGLGGSNLTGN----VPAWIGNFSSLKALSLAWNNLRGS---- 97 (717)
Q Consensus 31 ~~l~~L~~L~L~~-n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~---- 97 (717)
.+.++|++|+|++ +.++. .+-..+...++|++|+|++|.++.. +-..+...++++.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3445666666665 33431 1122244556666666666666532 122334455666666666665422
Q ss_pred CChhhhccCCCCeEec--cCCCCCC----CCCccccCCCCccEEEcccCc
Q 005045 98 IPNELGQLSGLGFFTL--YGNFISG----IIPSSIYNISSIYYFSVTQNQ 141 (717)
Q Consensus 98 ~~~~~~~l~~L~~L~L--~~N~i~~----~~~~~~~~l~~L~~L~L~~N~ 141 (717)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2233445555654333 3445542 122334455556666655544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.95 E-value=0.00033 Score=71.08 Aligned_cols=77 Identities=18% Similarity=0.112 Sum_probs=46.4
Q ss_pred ccccCcccccceEEEEeC-CCchhhhHHhHhh----h---hhHHHHHHHHHHHHhcC-C--CCceeEEEEeeccccCCCC
Q 005045 394 ENLIGTGSFGSVYKGTLG-DGTIVAIKVLKLQ----Q---QGALKSFIDECNALKST-R--HRNILRVITACSSVDLEGN 462 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~-~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l-~--h~ni~~~~~~~~~~~~~~~ 462 (717)
.+.||.|....||++... +++.+++|.-... . +....+...|.+.++.+ . ...+++++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 446888999999999865 4667887753211 1 11234555677777665 2 244666665532
Q ss_pred ceEEEEEecCCCCCh
Q 005045 463 DFKALVFEFMSNGNL 477 (717)
Q Consensus 463 ~~~~lv~e~~~~~~L 477 (717)
+..++|||++++..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEeccCCccc
Confidence 244799999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.00055 Score=67.50 Aligned_cols=73 Identities=12% Similarity=0.115 Sum_probs=45.1
Q ss_pred cceEEEEeCCCchhhhHHhHhhhhhHHHHHHHHHHHHhcCCCCc--eeEEEEeeccccCCCCceEEEEEecCCCCC
Q 005045 403 GSVYKGTLGDGTIVAIKVLKLQQQGALKSFIDECNALKSTRHRN--ILRVITACSSVDLEGNDFKALVFEFMSNGN 476 (717)
Q Consensus 403 g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 476 (717)
-.||++...+|+.|++|+...... ..+.+..|...+..+.... ++..+...........+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 579999988999999999865432 2355667888777763222 222222211111234556889999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.04 E-value=0.0071 Score=61.02 Aligned_cols=74 Identities=12% Similarity=0.083 Sum_probs=43.8
Q ss_pred ccccCcccccceEEEEeCCC--------chhhhHHhHhhhhhHHHHHHHHHHHHhcCC-CCceeEEEEeeccccCCCCce
Q 005045 394 ENLIGTGSFGSVYKGTLGDG--------TIVAIKVLKLQQQGALKSFIDECNALKSTR-HRNILRVITACSSVDLEGNDF 464 (717)
Q Consensus 394 ~~~ig~g~~g~v~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 464 (717)
++.++-|-.-.+|.+..+++ +.|++++.-. .... ....+|..+++.+. +.-.+++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-SHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-hHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 45677777788999885432 3455555432 1122 23456888877763 322345666631
Q ss_pred EEEEEecCCCCChh
Q 005045 465 KALVFEFMSNGNLD 478 (717)
Q Consensus 465 ~~lv~e~~~~~~L~ 478 (717)
-+.|+||++|.++.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 16899999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.77 E-value=0.015 Score=56.54 Aligned_cols=32 Identities=28% Similarity=0.246 Sum_probs=28.1
Q ss_pred CCCeeecCCCCCCEEeCCCCceEEeeeccchh
Q 005045 518 DTPIAHCDLKPSNVLLDKDMTAHVGDFGLAKF 549 (717)
Q Consensus 518 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 549 (717)
++|+||+|+.++||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 45899999999999999887778999998764
|